Citrus Sinensis ID: 047629
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 615 | 2.2.26 [Sep-21-2011] | |||||||
| A8R7E6 | 617 | Chitin elicitor receptor | yes | no | 0.764 | 0.761 | 0.307 | 2e-57 | |
| O64825 | 612 | LysM domain receptor-like | no | no | 0.876 | 0.880 | 0.284 | 4e-54 | |
| Q9SGI7 | 654 | Protein LYK2 OS=Arabidops | no | no | 0.852 | 0.801 | 0.292 | 1e-53 | |
| O22808 | 664 | Protein LYK5 OS=Arabidops | no | no | 0.429 | 0.397 | 0.380 | 1e-46 | |
| D7UPN3 | 605 | Chitin elicitor receptor | no | no | 0.834 | 0.847 | 0.288 | 1e-42 | |
| F4IB81 | 651 | LysM domain receptor-like | no | no | 0.430 | 0.407 | 0.349 | 5e-38 | |
| Q7X8C5 | 748 | Wall-associated receptor | no | no | 0.489 | 0.402 | 0.290 | 9e-34 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.391 | 0.192 | 0.342 | 1e-33 | |
| Q9FIJ6 | 751 | Serine/threonine-protein | no | no | 0.666 | 0.545 | 0.282 | 2e-33 | |
| Q9SGY7 | 718 | Putative proline-rich rec | no | no | 0.572 | 0.490 | 0.280 | 4e-33 |
| >sp|A8R7E6|CERK1_ARATH Chitin elicitor receptor kinase 1 OS=Arabidopsis thaliana GN=CERK1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 224 bits (570), Expect = 2e-57, Method: Compositional matrix adjust.
Identities = 167/543 (30%), Positives = 272/543 (50%), Gaps = 73/543 (13%)
Query: 90 LLVPIICGCTGNQYFA-NITYQIKKGDSYYLVSITSFENLTNWHAVLEMNPGINPNLLQI 148
+LVP C C + N +Y +++ D+Y V+I+++ NLT ++ NP N+ +
Sbjct: 85 VLVPFPCECQPGDFLGHNFSYSVRQEDTYERVAISNYANLTTMESLQARNPFPATNI-PL 143
Query: 149 GVKVTFPLFCKCPSKTNMEDGIENLITYVWQPGDDVSQVGAKLNASSAAIETENEYRNFS 208
+ + C C ++ +D +TY +P D +S + S+ ++ N NF+
Sbjct: 144 SATLNVLVNCSCGDESVSKD-FGLFVTYPLRPEDSLSSIARSSGVSADILQRYNPGVNFN 202
Query: 209 EA---VSLPVLIPVSQLPSLSQSYPSTKRNGSKHHLTLIIPISAGGALLILLVAALVIYN 265
V +P P P + S+K++G + I I G ++ LL+ ++Y
Sbjct: 203 SGNGIVYVPGRDPNGAFPP----FKSSKQDGVGAGVIAGIVI---GVIVALLLILFIVYY 255
Query: 266 HHLQRKRVRILNRNGSSLESADLIPMKENSKSDRFEPKLAQNKLL------PGVSGY-LG 318
+ + K G S S+ IP+ ++K+D Q+ L PG++ +
Sbjct: 256 AYRKNKS------KGDSFSSS--IPL--STKADHASSTSLQSGGLGGAGVSPGIAAISVD 305
Query: 319 KPIVYEIEVIMESTMNLSEHYSIGK----SVYRATIDGKVLAVKKIKEDVTE----ELRI 370
K + + +E + ++T N + + IG+ +VY A + G+ A+KK+ + ++ EL++
Sbjct: 306 KSVEFSLEELAKATDNFNLSFKIGQGGFGAVYYAELRGEKAAIKKMDMEASKQFLAELKV 365
Query: 371 LQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQR 430
L R++H NLV+L+G +G+ FLVYEY ENG+L + LH + L W++R
Sbjct: 366 LTRVHHVNLVRLIGYCV--EGSLFLVYEYVENGNLGQHLHGSGREP--------LPWTKR 415
Query: 431 LRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA------------ 478
+++ALD A GL+Y+HEH P VHRDI++ NI +D +F+AK+A+F L
Sbjct: 416 VQIALDSARGLEYIHEHTVPVYVHRDIKSANILIDQKFRAKVADFGLTKLTEVGGSATRG 475
Query: 479 --------APAT--NDVMPKFDVFAFGVVLLELLSGKKA-TRTTEN-GKTAVLWKEIREV 526
AP T +V K DV+AFGVVL EL+S K A + TE G+ L E
Sbjct: 476 AMGTFGYMAPETVYGEVSAKVDVYAFGVVLYELISAKGAVVKMTEAVGEFRGLVGVFEES 535
Query: 527 LKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLT 586
K E +EE LR +DP L YP D +A L +ACT + + RP+M +V LS L
Sbjct: 536 FK-ETDKEEALRKIIDPRLGDSYPFDSVYKMAELGKACTQENAQLRPSMRYIVVALSTLF 594
Query: 587 QST 589
ST
Sbjct: 595 SST 597
|
Lysin motif (LysM) receptor kinase that functions as a cell surface receptor in chitin elicitor (chitooligosaccharides) signaling leading to innate immunity toward both biotic and abiotic stresses (e.g. tolerance to salinity, heavy-metal stresses, and Botrytis cinerea infection). Recognizes microbe-derived N-acetylglucosamine (NAG)-containing ligands. Involved in the resistance to pathogenic fungi Alternaria brassicicola and Erysiphe cichoracearum, probably by sensing microbe-associated molecular patterns (MAMP) and pathogen-associated molecular patterns (PAMP). Plays an essential role in detecting peptidoglycans (e.g. PGNs) and restricting bacterial growth. Target of the bacterial type III effector E3-ligase protein hopAB2/avrPtoB of Pseudomonas syringae pv. tomato DC3000 that mediates ubiquitination and subsequent proteolysis, thus blocking all defense responses by suppressing PAMP-triggered immunity (PTI). Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O64825|LYK4_ARATH LysM domain receptor-like kinase 4 OS=Arabidopsis thaliana GN=LYK4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 213 bits (542), Expect = 4e-54, Method: Compositional matrix adjust.
Identities = 184/647 (28%), Positives = 309/647 (47%), Gaps = 108/647 (16%)
Query: 11 LFLLMTI--HITAQSPAANGTDFSCS-ADSLPS------------CKTYVAYFAQSPEFL 55
+F+L+++ TAQ P + CS +D+ S C+ YV F +P F
Sbjct: 10 VFILLSLSSFATAQQPYVGISTTDCSVSDNTTSVFGYSCNGLNKTCQAYVI-FRSTPSFS 68
Query: 56 DLSNISDLFGVSRLSIARASNLVSEDTPLVPKQLLLVPIICGCTGNQYFANITYQIKKGD 115
+++IS LF V S+ + N S T Q +++P+ C CTG+ +NITY I+ D
Sbjct: 69 TVTSISSLFSVDP-SLVSSLNDASPSTSFPSGQQVIIPLTCSCTGDDSQSNITYTIQPND 127
Query: 116 SYYLVSITSFENLTNWHAVLEMNPGINPNLLQIGVKVTFPLFCKCPSKTNM-EDGIENLI 174
SY+ ++ + + L+ A+ + N ++ L G+++ P+ C CP+ + EDG++ L+
Sbjct: 128 SYFAIANDTLQGLSTCQALAKQN-NVSSQSLFPGMRIVVPIRCACPTAKQINEDGVKYLM 186
Query: 175 TYVWQPGDDVSQVGAKLNASSAAIETENEYRNFSEAVSLP---VLIPVSQLPSLSQSY-- 229
+Y D ++ + + ++ NE +F + P +LIP+ P+ + S
Sbjct: 187 SYTVVFEDTIAIISDRFGVETSKTLKANE-MSFENSEVFPFTTILIPLVNPPANTNSLIP 245
Query: 230 ---------------PSTKRNGSKHHLTLIIPISAGGALLILLVAALVIYNHHLQRKRVR 274
R K + GGAL++ ++ A + L +K+ +
Sbjct: 246 PPPPPPPQSVSPPPLSPDGRKSKKKTWVYALAGVLGGALVLSVIGAAIFC---LSKKKTK 302
Query: 275 ILNRNGSSLESADLIPMKENSKSDR-FEPKLAQNKLLPGVSGYLGKPI-VYEIEVIMEST 332
+ + + D K+ SD+ F+P L G+SG + + + VY+ + +T
Sbjct: 303 TQTQEETG--NLDSFMGKKPPMSDQEFDP-------LDGLSGMVVESLKVYKFHELQSAT 353
Query: 333 MNLSEHYSIGKSVYRATIDGKVLAVKKIKEDVTEELRILQRINHANLVKLMGVSSDSQGN 392
+ + SIG S Y I+G +KKI+ + +EE+ +L ++NH N+++L G +G+
Sbjct: 354 SDFTSSSSIGGSGYIGKINGDGAMIKKIEGNASEEVNLLSKLNHLNIIRLSGFCFH-EGD 412
Query: 393 RFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSI 452
+LVYE+A NGSL +W+H +KS L+ +Q+L++ALD+A GL Y+H A P
Sbjct: 413 WYLVYEHASNGSLSEWIH-TTKS--------LLSLTQKLQIALDIATGLNYLHNFADPPY 463
Query: 453 VHRDIRTNNIQLDSRFKAKIANFSLAAPATND-----------------------VMPKF 489
VHRD+ +NN+ LD F+AKI + A T D V K
Sbjct: 464 VHRDLNSNNVFLDLEFRAKIGSLGSARSTTEDFVLTKHVEGTRGYLAPEYLEHGLVSTKL 523
Query: 490 DVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKR-EERLRNWMDPNLESF 548
DV+AFGVVLLE+++GK+A+ L KEI E ++E RL + L SF
Sbjct: 524 DVYAFGVVLLEIVTGKEASE---------LKKEIDEGKAIDEILIHGRL---LPEGLTSF 571
Query: 549 YPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQSTETLERS 595
+ L C L+RP+M E V +LS + +T+ E S
Sbjct: 572 --------VERLVVDCLKKDHLNRPSMDENVMSLSKILAATQNWEES 610
|
Lysin motif (LysM) receptor kinase that functions as a cell surface receptor in chitin elicitor (chitooligosaccharides) signaling leading to innate immunity. Recognizes microbe-derived N-acetylglucosamine (NAG)-containing ligands. Involved in the resistance to the pathogenic fungus Alternaria brassicicola and to the bacterial pathogen the bacterial pathogen Pseudomonas syringae pv tomato DC3000, probably by sensing microbe-associated molecular pattern (MAMP) and pathogen-associated molecular patterns (PAMP). May play a role in detecting peptidoglycans (e.g. PGNs) during bacterial growth. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGI7|LYK2_ARATH Protein LYK2 OS=Arabidopsis thaliana GN=LYK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 211 bits (538), Expect = 1e-53, Method: Compositional matrix adjust.
Identities = 179/612 (29%), Positives = 297/612 (48%), Gaps = 88/612 (14%)
Query: 26 ANGTDFSCSADSLPSCKTYVAYFAQSPEFLDLSNISDLFGVSRLSIARASNLVSEDTPLV 85
A+ + C ++ L C T+ A+ P F LS++S G+ D V
Sbjct: 43 ASSFGYVCHSN-LQKCHTFAILRAKPP-FYSLSDLSRHLGLD------------ADDEYV 88
Query: 86 PK-QLLLVPIICGCTGNQYFANITYQIKKGDSYYLVSITSFENLTNWHAVLEMNPGINPN 144
PK QLLL+PI C C G+ Y A++ KGD++ VS S + LT ++ E NP I+ +
Sbjct: 89 PKGQLLLIPIECRCNGSIYEASLIKNCVKGDTFRSVS-QSLQGLTTCLSIREKNPHISED 147
Query: 145 LLQIGVKVTFPLFCKCPSKTNMEDGIEN---LITYVWQPGDDVSQVGAKLNASSAAIETE 201
L +K+ + C CP ++G+ N L+TY D VS + + N + AI +
Sbjct: 148 KLGDNIKLRLAIRCSCP-----QEGVSNASFLVTYPVGVRDSVSSLAVRFNTTEDAIVSA 202
Query: 202 NEYRNFSEAVSL-PVLIPVSQLPSLSQSYPSTKRNGSKHH---LTLIIPISAGGALLILL 257
N N S V L P LIP+ P + S KRN SK + L+I +S+ A + L
Sbjct: 203 N---NKSGVVPLKPALIPLDHKP---EKQGSRKRNPSKKKRSKMKLMIAVSSAIAGVCGL 256
Query: 258 VAALVIYNHHLQRKRVRILNRNGSSLESAD----LIPMKENSKSDR---FEPKLAQNKLL 310
V L+++ + +K +I + + + D + + + SD+ FE +Q+ +
Sbjct: 257 VT-LMVFGYLHWKKETQIQTQTQKWISNKDPETRQLSLSIRTTSDKKISFEG--SQDGSI 313
Query: 311 PGVSGYLG-----KPI--VYEIEVIMESTMNLSEHYSIGKSVYRATIDGKVLAVKKIKED 363
+G KP+ +Y E + ++T N S I SVY ++ GK LA+K++ D
Sbjct: 314 LDSHNTVGTTTPRKPVLEIYAFEELEKATENFSSSNHIKGSVYFGSLKGKDLAIKQVNAD 373
Query: 364 VTE--ELRILQRINH---ANLVKLMGVS-SDSQGNRFLVYEYAENGSLDKWLHPK--SKS 415
+ + +L +H N+++++G + + +LV+EYA NGSL W+ K K+
Sbjct: 374 EMKRFDFGLLNDQSHYYNHNVIRVLGTCFREIDQDSYLVFEYARNGSLWDWIQNKLAIKN 433
Query: 416 SSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANF 475
FL W QR+++ DVA L+YMH + + VH +I++ NI L+ + K+ NF
Sbjct: 434 QFIESCYCFLAWKQRIKICHDVAIALKYMH---RINYVHGNIKSRNIFLNEDLRGKVGNF 490
Query: 476 SLAAPATNDVM-----------PKFDVFAFGVVLLELLSGK--------KATRTTENGKT 516
++ TN++ P D+FA+G++++E+LSG+ + TT G
Sbjct: 491 GMSKCVTNELATEENLIESSLSPASDIFAYGIIVMEVLSGQTPDMLLGLQEVETTSLGTQ 550
Query: 517 AVL---WKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRP 573
W +R +L +EK LR MD L Y +D A +A++AR CT +++ SRP
Sbjct: 551 ETFVSEWSRLRRLLGDKEK----LREVMDSTLGESYSVDSAFEIASIARDCTAEEAESRP 606
Query: 574 NMAEVVFNLSVL 585
+ E+ +S L
Sbjct: 607 SAVEIAERVSRL 618
|
May recognize microbe-derived N-acetylglucosamine (NAG)-containing ligands. Arabidopsis thaliana (taxid: 3702) |
| >sp|O22808|LYK5_ARATH Protein LYK5 OS=Arabidopsis thaliana GN=LYK5 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 188 bits (477), Expect = 1e-46, Method: Compositional matrix adjust.
Identities = 116/305 (38%), Positives = 172/305 (56%), Gaps = 41/305 (13%)
Query: 322 VYEIEVIMESTMNLSEHYSIGKSVYRATIDGKVLAVKKIKEDVTE-ELRILQRINHANLV 380
+Y + +T N S+ I SVYRATI+G AVK IK DV+ E+ +L+++NH+N++
Sbjct: 359 LYRFNDLQSATSNFSDENRIKGSVYRATINGDDAAVKVIKGDVSSSEINLLKKLNHSNII 418
Query: 381 KLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANG 440
+L G +G +LV+EY+ENGS+ WLH K S LTW QR+ +A DVA
Sbjct: 419 RLSGFCI-REGTSYLVFEYSENGSISDWLHSSGKKS--------LTWKQRVEIARDVAEA 469
Query: 441 LQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA---------------------- 478
L Y+H + P +H+++ + NI LDS F+AKIANF +A
Sbjct: 470 LDYLHNYITPPHIHKNLESTNILLDSNFRAKIANFGVARILDEGDLDLQLTRHVEGTQGY 529
Query: 479 -AP--ATNDVM-PKFDVFAFGVVLLELLSGKKAT----RTTENGKTAVLWKEIREVLKVE 530
AP N V+ K DVFAFGV +LELLSG++A + + +L K I VL E
Sbjct: 530 LAPEYVENGVITSKLDVFAFGVAVLELLSGREAVTIHKKKEGEEEVEMLCKVINSVLGGE 589
Query: 531 EKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQSTE 590
R E+L+ +MDP+L + YP++ A ++A LA++C SRP++ +V+ LS++ S+
Sbjct: 590 NVR-EKLKEFMDPSLGNEYPLELAYTMAQLAKSCVATDLNSRPSVTQVLTTLSMIVSSSI 648
Query: 591 TLERS 595
E S
Sbjct: 649 DWEPS 653
|
May recognize microbe-derived N-acetylglucosamine (NAG)-containing ligands. Arabidopsis thaliana (taxid: 3702) |
| >sp|D7UPN3|CERK1_ORYSJ Chitin elicitor receptor kinase 1 OS=Oryza sativa subsp. japonica GN=CERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 174 bits (442), Expect = 1e-42, Method: Compositional matrix adjust.
Identities = 175/606 (28%), Positives = 273/606 (45%), Gaps = 93/606 (15%)
Query: 40 SCKTYVA--YFAQSPEFLDLSNISDLFGVSRLSIARASNLVSEDTPLVPKQLLLVPIICG 97
C +A YF++ ++ I + G ++ + ++ +V +LVP C
Sbjct: 29 GCSLAIAAYYFSEGSNLTFIATIFAIGGGGYQALLPYNPAITNPDYVVTGDRVLVPFPCS 88
Query: 98 CTG------NQYFAN-ITYQI----KKGDSYYLVSITSFENLTNWHAVLEMNPGINPNLL 146
C G + + A I Y + GD+Y V+ ++ +LT A LE P +
Sbjct: 89 CLGLPAAPASTFLAGAIPYPLPLPRGGGDTYDAVA-ANYADLTT-AAWLEATNAYPPGRI 146
Query: 147 QIG-VKVTFPLFCKCPS-KTNMEDGIENLITYVWQPGDDVSQVGAKLNASSAA-IETENE 203
G +V + C C + + G+ +TY G+ + V A+ SS A +E
Sbjct: 147 PGGDGRVNVTINCSCGDERVSPRYGL--FLTYPLWDGETLESVAAQYGFSSPAEMELIRR 204
Query: 204 YRNFSEAVSLP--VLIPVSQLPSLSQSYPSTKRNGSKHHLTLIIPISAGGALLILLVAAL 261
Y VS V IPV + SY K G + L+ GGA+ +++A +
Sbjct: 205 YNPGMGGVSGKGIVFIPVKDP---NGSYHPLKSGGMGNSLS-------GGAIAGIVIACI 254
Query: 262 VIYNHHLQRKRVRILNRNGSSLESADLIPMKENSKSDRFEPKLAQNKLLPGVSGYLGKPI 321
I+ + + I+ A P E + L G+ + + I
Sbjct: 255 AIF---IVAIWLIIMFYRWQKFRKATSRPSPEETS------HLDDASQAEGIK--VERSI 303
Query: 322 VYEIEVIMESTMNLSEHYSIGK----SVYRATIDGKVLAVKKIKEDVTEE----LRILQR 373
+ E I +T S + IG+ SVY A + G+ A+KK+ T+E L++L
Sbjct: 304 EFSYEEIFNATQGFSMEHKIGQGGFGSVYYAELRGEKTAIKKMGMQATQEFLAELKVLTH 363
Query: 374 INHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRV 433
++H NLV+L+G ++ FLVYE+ +NG+L + L + L+W+ R+++
Sbjct: 364 VHHLNLVRLIGYCVEN--CLFLVYEFIDNGNLSQHLQRTGYAP--------LSWATRVQI 413
Query: 434 ALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA--------------- 478
ALD A GL+Y+HEH P VHRDI++ NI LD F+AKIA+F LA
Sbjct: 414 ALDSARGLEYLHEHVVPVYVHRDIKSANILLDKDFRAKIADFGLAKLTEVGSMSQSLSTR 473
Query: 479 --------APAT--NDVMPKFDVFAFGVVLLELLSGKKA----TRTTENGKTAVLWKEIR 524
P +V PK DV+AFGVVL ELLS K+A + + K V E
Sbjct: 474 VAGTFGYMPPEARYGEVSPKVDVYAFGVVLYELLSAKQAIVRSSESVSESKGLVFLFE-- 531
Query: 525 EVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSV 584
E L E L +DP+L+ YP+D AL +A+LA++CT ++ RP M VV L
Sbjct: 532 EALSAPNPTEA-LDELIDPSLQGDYPVDSALKIASLAKSCTHEEPGMRPTMRSVVVALMA 590
Query: 585 LTQSTE 590
LT +T+
Sbjct: 591 LTANTD 596
|
Plays an essential role in detecting peptidoglycans (e.g. PGNs) and restricting bacterial growth. Recognizes microbe-derived N-acetylglucosamine (NAG)-containing ligands (By similarity). Lysin motif (LysM) receptor kinase required as a cell surface receptor for chitin elicitor (chitooligosaccharides) signaling leading to innate immunity in response to both biotic and abiotic stresses. Involved in the resistance to pathogenic fungi, probably by sensing microbe-associated molecular patterns (MAMP) and pathogen-associated molecular patterns (PAMP). Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|F4IB81|LYK3_ARATH LysM domain receptor-like kinase 3 OS=Arabidopsis thaliana GN=LYK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 159 bits (403), Expect = 5e-38, Method: Compositional matrix adjust.
Identities = 110/315 (34%), Positives = 168/315 (53%), Gaps = 50/315 (15%)
Query: 319 KPIVYEIEVIMESTMNLSEHYSIGK----SVYRATIDGKVLAVKKIKEDVTEE----LRI 370
KP+V+ E I +T S+ +G SVY + + +AVK++ T+E +++
Sbjct: 325 KPMVFTYEEIRAATDEFSDSNLLGHGNYGSVYFGLLREQEVAVKRMTATKTKEFAAEMKV 384
Query: 371 LQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH-PKSKSSSSSGSVIFLTWSQ 429
L +++H+NLV+L+G ++ + F+VYEY G L LH P+SK ++ L+W
Sbjct: 385 LCKVHHSNLVELIGYAA-TVDELFVVYEYVRKGMLKSHLHDPQSKGNTP------LSWIM 437
Query: 430 RLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA----------- 478
R ++ALD A GL+Y+HEH + VHRDI+T+NI LD F+AKI++F LA
Sbjct: 438 RNQIALDAARGLEYIHEHTKTHYVHRDIKTSNILLDEAFRAKISDFGLAKLVEKTGEGEI 497
Query: 479 ------------AP---ATNDVMPKFDVFAFGVVLLELLSGKKATRTTE-----NGKTAV 518
AP + K D++AFGVVL E++SG++A TE N +
Sbjct: 498 SVTKVVGTYGYLAPEYLSDGLATSKSDIYAFGVVLFEIISGREAVIRTEAIGTKNPERRP 557
Query: 519 LWKEIREVLK--VEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMA 576
L + VLK + L+ ++DPN+ YP D +ATLA+ C D + RPNM
Sbjct: 558 LASIMLAVLKNSPDSMNMSSLKEFVDPNMMDLYPHDCLFKIATLAKQCVDDDPILRPNMK 617
Query: 577 EVVFNLS-VLTQSTE 590
+VV +LS +L S E
Sbjct: 618 QVVISLSQILLSSIE 632
|
Putative Lysin motif (LysM) receptor kinase that may recognize microbe-derived N-acetylglucosamine (NAG)-containing ligands. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q7X8C5|WAKLB_ARATH Wall-associated receptor kinase-like 2 OS=Arabidopsis thaliana GN=WAKL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 145 bits (366), Expect = 9e-34, Method: Compositional matrix adjust.
Identities = 111/382 (29%), Positives = 182/382 (47%), Gaps = 81/382 (21%)
Query: 250 GGALLILLVAALVIYNHHLQRKRV----RILNRNGSSLESADLIPMKENSKSDRFEPKLA 305
G ALL+ +Y +R+++ + RNG L L + N + R
Sbjct: 349 GSALLLFAFGIFGLYKFVQKRRKLIRMRKFFRRNGGMLLKQQLARKEGNVEMSR------ 402
Query: 306 QNKLLPGVSGYLGKPIVYEIEVIMESTMNLSEHYSIGK----SVYRAT-IDGKVLAVKKI 360
++ + ++T N +++ +G+ +VY+ +DG+++AVK+
Sbjct: 403 ----------------IFSSHELEKATDNFNKNRVLGQGGQGTVYKGMLVDGRIVAVKRS 446
Query: 361 K-------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKS 413
K E+ E+ +L +INH N+VKL+G +++ LVYE+ NG L K LH +S
Sbjct: 447 KAVDEDRVEEFINEVVVLAQINHRNIVKLLGCCLETE-VPVLVYEFVPNGDLCKRLHDES 505
Query: 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIA 473
+ +TW RL +A+++A L Y+H A I HRDI+T NI LD R +AK++
Sbjct: 506 DDYT-------MTWEVRLHIAIEIAGALSYLHSAASFPIYHRDIKTTNILLDERNRAKVS 558
Query: 474 NFSLAAPATND--------------VMPKF----------DVFAFGVVLLELLSGKKAT- 508
+F + T D V P++ DV++FGVVL+ELL+G+K +
Sbjct: 559 DFGTSRSVTIDQTHLTTQVAGTFGYVDPEYFQSSKFTEKSDVYSFGVVLVELLTGEKPSS 618
Query: 509 --RTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTM 566
R+ EN A + VE +E R+ + +D ++ +D +S+A LAR C
Sbjct: 619 RVRSEENRGLAAHF--------VEAVKENRVLDIVDDRIKDECNMDQVMSVANLARRCLN 670
Query: 567 DKSLSRPNMAEVVFNLSVLTQS 588
K RPNM EV L ++ S
Sbjct: 671 RKGKKRPNMREVSIELEMIRSS 692
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 144 bits (364), Expect = 1e-33, Method: Compositional matrix adjust.
Identities = 100/292 (34%), Positives = 151/292 (51%), Gaps = 51/292 (17%)
Query: 326 EVIMESTMNLSEHYSIGKS----VYRATID-GKVLAVKKI--KEDV------TEELRILQ 372
E IME+T NLSE + IG VY+A ++ G+ +AVKKI K+D+ + E++ L
Sbjct: 942 EDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSREVKTLG 1001
Query: 373 RINHANLVKLMG-VSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRL 431
RI H +LVKLMG SS S+G L+YEY +NGS+ WLH + L W RL
Sbjct: 1002 RIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKL--LDWEARL 1059
Query: 432 RVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATND------- 484
R+A+ +A G++Y+H P IVHRDI+++N+ LDS +A + +F LA T +
Sbjct: 1060 RIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDS 1119
Query: 485 ----------VMPKF----------DVFAFGVVLLELLSGKKATRTTENGKT-AVLWKEI 523
+ P++ DV++ G+VL+E+++GK T + + V W E
Sbjct: 1120 NTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWVET 1179
Query: 524 REVLKVEEKREERLRNWMDPNLESFYPI--DGALSLATLARACTMDKSLSRP 573
L+V ++L +DP L+ P D A + +A CT RP
Sbjct: 1180 H--LEVAGSARDKL---IDPKLKPLLPFEEDAACQVLEIALQCTKTSPQERP 1226
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIJ6|ACCR4_ARATH Serine/threonine-protein kinase-like protein CCR4 OS=Arabidopsis thaliana GN=CCR4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 144 bits (363), Expect = 2e-33, Method: Compositional matrix adjust.
Identities = 144/510 (28%), Positives = 225/510 (44%), Gaps = 100/510 (19%)
Query: 155 PLFCKCPSK--TNMEDGIENLITYVWQPGDD-VSQVGAKLNASSAAIETENEYRNFSEAV 211
P+FC ++ T + G EN + V+ P +SQV E YR S +
Sbjct: 274 PMFCGVATRNYTLICWGNENFKSGVFTPFQGLISQV-----VMPGPCRRECPYRPLSGSQ 328
Query: 212 SLPV-LIPVSQLPSLSQSYPSTKRNGSKHHL-----TLIIPISAGGALLILLVAALVIYN 265
SL + + L +P T+ SK+ + + G +LLV + +I+
Sbjct: 329 SLCGNELMICDLKRNDGEFPDTRAQNSKNKTWSRRNIAFLVVGCVGTFSLLLVISFLIFK 388
Query: 266 HHLQRKRVRILNRNGSSLESADLIPMKENSKSDRFEPKLAQNKLLPGVSGYLGKPIVYEI 325
H R R+ + L+ I + PKL + G G+ + + I
Sbjct: 389 SHC---RCRV--HDSGRLDDTRTIDI----------PKLEKRLCTLASLGNPGQLMEFSI 433
Query: 326 EVIMESTMNLSEHYSIG----KSVYRATI-DGKVLAVKKIK------------------- 361
+ + +T S + +G SVY+ + DG+ +A+K+ +
Sbjct: 434 DELALATDGFSVRFHLGIGSFGSVYQGVLSDGRHVAIKRAELTNPTLSGTTMRHRRADKD 493
Query: 362 EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH-PKSKSSSSSG 420
EL + R+NH NLV+L+G D++ R LVYEY +NGSL LH P+
Sbjct: 494 SAFVNELESMSRLNHKNLVRLLGFYEDTE-ERILVYEYMKNGSLADHLHNPQFDP----- 547
Query: 421 SVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA-- 478
L+W RL +ALD A G+QY+HE P ++HRDI+++NI LD+ + AK+++F L+
Sbjct: 548 ----LSWQTRLMIALDAARGIQYLHEFIVPPVIHRDIKSSNILLDATWTAKVSDFGLSQM 603
Query: 479 APATND---------------VMPKF----------DVFAFGVVLLELLSGKKATRTTEN 513
P D + P++ DV++FGVVLLELLSG KA E+
Sbjct: 604 GPTEEDDVSHLSLHAAGTLGYIDPEYYKFQQLTTKSDVYSFGVVLLELLSGHKAIHNNED 663
Query: 514 GKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRP 573
L + + + ++E R+ + P + Y I+ + LA C M S RP
Sbjct: 664 ENPRNLVEYVVPYILLDEA--HRILDQRIPP-PTPYEIEAVAHVGYLAAECLMPCSRKRP 720
Query: 574 NMAEVVFNL-----SVLTQ-STETLERSWT 597
+M EVV L + LT TET+ RS T
Sbjct: 721 SMVEVVSKLESALAACLTAPKTETVSRSNT 750
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGY7|PEK11_ARATH Putative proline-rich receptor-like protein kinase PERK11 OS=Arabidopsis thaliana GN=PERK11 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 143 bits (361), Expect = 4e-33, Method: Compositional matrix adjust.
Identities = 125/445 (28%), Positives = 203/445 (45%), Gaps = 93/445 (20%)
Query: 231 STKRNGSKHHLTLIIPISAGGALLILLVAALVIYNHHLQRK------------------- 271
S + N S + +I I G L+IL +A V + Q+K
Sbjct: 250 SQQSNESNYTEKTVIGIGIAGVLVILFIAG-VFFVRRKQKKGSSSPRSNQYLPPANVSVN 308
Query: 272 -------RVRILNRNGSSLESADLIPMKENSKSDRFEPKLAQNKLLPGVSGYLGKPIVYE 324
R + N N S+ S+ N K R P A + G S I +
Sbjct: 309 TEGFIHYRQKPGNGNSSAQNSSPDTNSLGNPKHGRGTPDSA----VIGTS-----KIHFT 359
Query: 325 IEVIMESTMNLSEHYSIGKS----VYRATI-DGKVLAVKKIK-------EDVTEELRILQ 372
E + + T + + +G+ VY+ + +GK +A+K++K + E+ I+
Sbjct: 360 YEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSVSAEGYREFKAEVEIIS 419
Query: 373 RINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLR 432
R++H +LV L+G Q +RFL+YE+ N +LD LH K+ + L WS+R+R
Sbjct: 420 RVHHRHLVSLVGYCISEQ-HRFLIYEFVPNNTLDYHLHGKN--------LPVLEWSRRVR 470
Query: 433 VALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA-------------- 478
+A+ A GL Y+HE P I+HRDI+++NI LD F+A++A+F LA
Sbjct: 471 IAIGAAKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLARLNDTAQSHISTRV 530
Query: 479 -------AP---ATNDVMPKFDVFAFGVVLLELLSGKKATRTTE--NGKTAVLWKEIREV 526
AP ++ + + DVF+FGVVLLEL++G+K T++ ++ V W R +
Sbjct: 531 MGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEESLVEWARPRLI 590
Query: 527 LKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVF------ 580
+E+ + +DP LE+ Y + A +C +L RP M +VV
Sbjct: 591 EAIEKG---DISEVVDPRLENDYVESEVYKMIETAASCVRHSALKRPRMVQVVRALDTRD 647
Query: 581 NLSVLTQSTETLE-RSWTSGLEAEE 604
+LS LT + + R + SG + E
Sbjct: 648 DLSDLTNGVKVGQSRVYDSGQYSNE 672
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 615 | ||||||
| 255585150 | 620 | serine-threonine protein kinase, plant-t | 0.965 | 0.958 | 0.660 | 0.0 | |
| 359476733 | 608 | PREDICTED: probable receptor-like protei | 0.960 | 0.972 | 0.663 | 0.0 | |
| 297735222 | 590 | unnamed protein product [Vitis vinifera] | 0.931 | 0.971 | 0.655 | 0.0 | |
| 357966797 | 614 | Nod factor perception protein [Parasponi | 0.980 | 0.982 | 0.622 | 0.0 | |
| 224094680 | 601 | predicted protein [Populus trichocarpa] | 0.960 | 0.983 | 0.614 | 0.0 | |
| 299481062 | 598 | Nod-factor receptor 5A [Glycine max] | 0.946 | 0.973 | 0.583 | 0.0 | |
| 356537980 | 598 | PREDICTED: Nod factor receptor protein [ | 0.946 | 0.973 | 0.583 | 0.0 | |
| 299481064 | 598 | Nod-factor receptor 5A [Glycine max] | 0.946 | 0.973 | 0.581 | 0.0 | |
| 37651066 | 594 | SYM10 protein [Pisum sativum] gi|3765106 | 0.954 | 0.988 | 0.556 | 0.0 | |
| 37651070 | 594 | SYM10 protein [Pisum sativum] gi|3765107 | 0.954 | 0.988 | 0.554 | 0.0 |
| >gi|255585150|ref|XP_002533280.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223526905|gb|EEF29112.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 796 bits (2057), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 399/604 (66%), Positives = 476/604 (78%), Gaps = 10/604 (1%)
Query: 16 TIHITAQSPAANGTDFSCSADSLPS-CKTYVAYFAQSPEFLDLSNISDLFGVSRLSIARA 74
T ++TAQSP GT+FSCS D LPS C+TYVAY+AQ P FL+L NISDLF VSRLSIA A
Sbjct: 23 TTYVTAQSP--QGTNFSCSVD-LPSPCQTYVAYYAQPPNFLNLGNISDLFAVSRLSIASA 79
Query: 75 SNLVSEDTPLVPKQLLLVPIICGCTGNQYFANITYQIKKGDSYYLVSITSFENLTNWHAV 134
SNLVSED PL+P QLLLVPI CGCTGN FANITYQIK GDS+Y VS T FENL W AV
Sbjct: 80 SNLVSEDIPLMPNQLLLVPITCGCTGNSSFANITYQIKPGDSFYFVSTTYFENLAKWQAV 139
Query: 135 LEMNPGINPNLLQIGVKVTFPLFCKCPSKTNMEDGIENLITYVWQPGDDVSQVGAKLNAS 194
NP ++P LL G KV FPLFCKCPSK M+ GI+ LITYVWQP DD+ +VGAK NAS
Sbjct: 140 ESFNPNLDPTLLHPGDKVVFPLFCKCPSKNQMKHGIQYLITYVWQPEDDIFKVGAKFNAS 199
Query: 195 SAAIETENEYRNFSEAVSLPVLIPVSQLPSLSQSYPSTKRNGSKHHLTLIIPISAGGALL 254
I +N Y +FS AV P+LIPV+Q+P LSQ PS + S+HHL +II S GALL
Sbjct: 200 PHDIAIQNNYWDFSTAVHHPLLIPVTQMPILSQPSPSWPQR-SEHHLVIIIVTSVAGALL 258
Query: 255 ILLVAALVIYNH--HLQRKRVRILNRNGSSLESADLIPMKENSKSDRFEPKLAQNKLLPG 312
I L+ A +++ H ++K+ L+RNGS LE+ DL+ +KE K FEPK+ Q+KLLPG
Sbjct: 259 IFLLVAFLVHAHCSCKKKKKTMTLHRNGSCLETTDLLQIKEQGKYRSFEPKIIQDKLLPG 318
Query: 313 VSGYLGKPIVYEIEVIMESTMNLSEHYSIGKSVYRATIDGKVLAVKKIKEDVTEELRILQ 372
VSGYLGKPI+Y+I+ I+ +TM+L EHY IG SVYRA I+G+VLAVKK K D+TEEL ILQ
Sbjct: 319 VSGYLGKPIMYDIKEILLATMDLHEHYRIGGSVYRANINGQVLAVKKTKVDITEELNILQ 378
Query: 373 RINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLR 432
++NHANLVKLMG+SS++ G+ FLVYEYAENGSLDKWLHP K +SSS SV FL+WSQRL+
Sbjct: 379 KVNHANLVKLMGISSNADGDCFLVYEYAENGSLDKWLHP--KPASSSSSVAFLSWSQRLQ 436
Query: 433 VALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVMPKFDVF 492
+ALDVA+GLQYMHEH QP++VH DIRT+NI LDSRFKAKIANFS+A T+ ++ K DVF
Sbjct: 437 IALDVASGLQYMHEHIQPTVVHMDIRTSNILLDSRFKAKIANFSVAKLTTDSMLQKVDVF 496
Query: 493 AFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPID 552
AFGVVLLELL GKKA T ENG+ +LWKE++ V++V EKR ERL+ MDPNLE+FYPID
Sbjct: 497 AFGVVLLELLCGKKAMVTNENGEIVLLWKEMKGVMEVAEKRAERLKKRMDPNLENFYPID 556
Query: 553 GALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS-TETLERSWTSGLEAEEAFQFISP 611
ALSLA LAR CT++KS +RP+MAE+VFNL+VLTQS +ETLERSWTSGLEAEE Q SP
Sbjct: 557 SALSLANLARVCTLEKSSARPSMAEIVFNLTVLTQSCSETLERSWTSGLEAEEDIQITSP 616
Query: 612 VTAR 615
V AR
Sbjct: 617 VIAR 620
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359476733|ref|XP_002269472.2| PREDICTED: probable receptor-like protein kinase At1g49730 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 795 bits (2054), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 399/601 (66%), Positives = 477/601 (79%), Gaps = 10/601 (1%)
Query: 16 TIHITAQSPAANGTDFSCSADSLPSCKTYVAYFAQSPEFLDLSNISDLFGVSRLSIARAS 75
T HITAQSPA T+FSC+ DS SC+TYV Y AQ+P FLD+ NISDLFG+SRLSIA AS
Sbjct: 17 TNHITAQSPATPVTNFSCTTDSPASCQTYVIYRAQAPGFLDVGNISDLFGISRLSIAEAS 76
Query: 76 NLVSEDTPLVPKQLLLVPIICGCTGNQYFANITYQIKKGDSYYLVSITSFENLTNWHAVL 135
NL SE+ L P QLLLVPI+C CTGN YFANITY+IK DS+Y VS+T FENLTN++AV
Sbjct: 77 NLASEEARLSPDQLLLVPILCSCTGNHYFANITYKIKTDDSFYFVSVTVFENLTNYNAVE 136
Query: 136 EMNPGINPNLLQIGVKVTFPLFCKCPSKTNMEDGIENLITYVWQPGDDVSQVGAKLNASS 195
+NPG+ P LQ+GV+V FPLFCKCPSK++ + GI LITYVWQPGDDV VG L AS
Sbjct: 137 ALNPGLEPTTLQVGVEVVFPLFCKCPSKSHSDKGINYLITYVWQPGDDVLLVGTNLKASP 196
Query: 196 AAIETENEYRNFSEAVSLPVLIPVSQLPSLSQSYPSTKRNGSKHHLTLIIPISAGGALLI 255
I EN NFS +V PVLIPVSQ P L+Q +R SK L + +S GALLI
Sbjct: 197 VDIRDENNNLNFSASVDQPVLIPVSQPPLLTQP----ERRASKGRWILALVLST-GALLI 251
Query: 256 LLVAALVIYNHHLQRKRVRILNRNGSSLESADLIPMKENSKSDRFEPKLAQNKLLPGVSG 315
L+ +L++Y +++K+ L+ + SSLE+ DLI +K+ + + FE K+ Q+KLLPGVSG
Sbjct: 252 FLLVSLLVYTGLIRKKKT--LDHSESSLETTDLIKVKKAPEDENFELKIIQDKLLPGVSG 309
Query: 316 YLGKPIVYEIEVIMESTMNLSEHYSIGKSVYRATIDGKVLAVKKIKEDVTEELRILQRIN 375
YLGKPI+YE +VIME+TMNL+EHY IG SVYRATI+G+V+AVKK KED+TEELRILQ++N
Sbjct: 310 YLGKPIMYETKVIMEATMNLNEHYRIGGSVYRATINGQVVAVKKTKEDITEELRILQKVN 369
Query: 376 HANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVAL 435
H NLVKLMGVSSD+ GNRFLVYE+AENGSLDKWLHPK S SS SV FLTWSQR++VAL
Sbjct: 370 HGNLVKLMGVSSDADGNRFLVYEFAENGSLDKWLHPKPSSPSS--SVAFLTWSQRIQVAL 427
Query: 436 DVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVMPKFDVFAFG 495
DVANGLQYMHEH QPS+VHRDIR NNI LDSRFKAKIANFS+A PA N +MPK DVFAFG
Sbjct: 428 DVANGLQYMHEHTQPSVVHRDIRANNILLDSRFKAKIANFSMATPAMNSMMPKVDVFAFG 487
Query: 496 VVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGAL 555
VVLLELLSGKKA + NG+ +LWK+IRE+L+VE+KRE+R+R WMDP LE+FYP DGAL
Sbjct: 488 VVLLELLSGKKAMQMRANGEIVMLWKDIREILEVEDKREDRIRRWMDPTLENFYPFDGAL 547
Query: 556 SLATLARACTMDKSLSRPNMAEVVFNLSVLTQ-STETLERSWTSGLEAEEAFQFISPVTA 614
+LA LAR+CT +KS +RP+MAE+ FNLSVL+Q S+ETLERSWT G E EE Q I+PV A
Sbjct: 548 NLAGLARSCTQEKSSARPSMAEIAFNLSVLSQTSSETLERSWTQGFEPEETIQIINPVIA 607
Query: 615 R 615
R
Sbjct: 608 R 608
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297735222|emb|CBI17584.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 774 bits (1999), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 394/601 (65%), Positives = 466/601 (77%), Gaps = 28/601 (4%)
Query: 16 TIHITAQSPAANGTDFSCSADSLPSCKTYVAYFAQSPEFLDLSNISDLFGVSRLSIARAS 75
T HITAQSPA T+FSC+ DS SC+TYV Y AQ+P FLD+ NISDLFG+SRLSIA AS
Sbjct: 17 TNHITAQSPATPVTNFSCTTDSPASCQTYVIYRAQAPGFLDVGNISDLFGISRLSIAEAS 76
Query: 76 NLVSEDTPLVPKQLLLVPIICGCTGNQYFANITYQIKKGDSYYLVSITSFENLTNWHAVL 135
NL SE+ L P QLLLVPI+C CTGN YFANITY+IK DS+Y VS+T FENLTN++AV
Sbjct: 77 NLASEEARLSPDQLLLVPILCSCTGNHYFANITYKIKTDDSFYFVSVTVFENLTNYNAVE 136
Query: 136 EMNPGINPNLLQIGVKVTFPLFCKCPSKTNMEDGIENLITYVWQPGDDVSQVGAKLNASS 195
+NPG+ P LQ+GV+V FPLFCKCPSK++ + GI LITYVWQPGDDV VG L AS
Sbjct: 137 ALNPGLEPTTLQVGVEVVFPLFCKCPSKSHSDKGINYLITYVWQPGDDVLLVGTNLKASP 196
Query: 196 AAIETENEYRNFSEAVSLPVLIPVSQLPSLSQSYPSTKRNGSKHHLTLIIPISAGGALLI 255
I EN NFS +V PVLIPVSQ P L+Q +R SK L + +S GALLI
Sbjct: 197 VDIRDENNNLNFSASVDQPVLIPVSQPPLLTQP----ERRASKGRWILALVLST-GALLI 251
Query: 256 LLVAALVIYNHHLQRKRVRILNRNGSSLESADLIPMKENSKSDRFEPKLAQNKLLPGVSG 315
L+ +L++Y +++K+ L+ + SSLE+ DLI KLLPGVSG
Sbjct: 252 FLLVSLLVYTGLIRKKKT--LDHSESSLETTDLI------------------KLLPGVSG 291
Query: 316 YLGKPIVYEIEVIMESTMNLSEHYSIGKSVYRATIDGKVLAVKKIKEDVTEELRILQRIN 375
YLGKPI+YE +VIME+TMNL+EHY IG SVYRATI+G+V+AVKK KED+TEELRILQ++N
Sbjct: 292 YLGKPIMYETKVIMEATMNLNEHYRIGGSVYRATINGQVVAVKKTKEDITEELRILQKVN 351
Query: 376 HANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVAL 435
H NLVKLMGVSSD+ GNRFLVYE+AENGSLDKWLHPK S SS SV FLTWSQR++VAL
Sbjct: 352 HGNLVKLMGVSSDADGNRFLVYEFAENGSLDKWLHPKPSSPSS--SVAFLTWSQRIQVAL 409
Query: 436 DVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVMPKFDVFAFG 495
DVANGLQYMHEH QPS+VHRDIR NNI LDSRFKAKIANFS+A PA N +MPK DVFAFG
Sbjct: 410 DVANGLQYMHEHTQPSVVHRDIRANNILLDSRFKAKIANFSMATPAMNSMMPKVDVFAFG 469
Query: 496 VVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGAL 555
VVLLELLSGKKA + NG+ +LWK+IRE+L+VE+KRE+R+R WMDP LE+FYP DGAL
Sbjct: 470 VVLLELLSGKKAMQMRANGEIVMLWKDIREILEVEDKREDRIRRWMDPTLENFYPFDGAL 529
Query: 556 SLATLARACTMDKSLSRPNMAEVVFNLSVLTQ-STETLERSWTSGLEAEEAFQFISPVTA 614
+LA LAR+CT +KS +RP+MAE+ FNLSVL+Q S+ETLERSWT G E EE Q I+PV A
Sbjct: 530 NLAGLARSCTQEKSSARPSMAEIAFNLSVLSQTSSETLERSWTQGFEPEETIQIINPVIA 589
Query: 615 R 615
R
Sbjct: 590 R 590
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357966797|gb|AET97541.1| Nod factor perception protein [Parasponia andersonii] | Back alignment and taxonomy information |
|---|
Score = 742 bits (1916), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 380/610 (62%), Positives = 462/610 (75%), Gaps = 7/610 (1%)
Query: 11 LFLLMTIHITAQSPAANGTDFSCSADS-LPSCKTYVAYFAQSPEFLDLSNISDLFGVSRL 69
L L HI+AQSP T+FSCS +S PSCKTYVAYFAQ P F+DL +IS+LFGVS
Sbjct: 7 LLLFFITHISAQSPPTLATNFSCSTNSSQPSCKTYVAYFAQPPLFMDLKSISNLFGVSPS 66
Query: 70 SIARASNLVSEDTPLVPKQLLLVPIICGCTGNQYFANITYQIKKGDSYYLVSITSFENLT 129
SI+ ASNLVSE T L QLLL+P+ C C G+ YF+N+TY I GDSYYLVSI SFENLT
Sbjct: 67 SISEASNLVSESTKLTRGQLLLIPLSCSCNGSHYFSNVTYNITMGDSYYLVSIHSFENLT 126
Query: 130 NWHAVLEMNPGINPNLLQIGVKVTFPLFCKCPSKTNMEDGIENLITYVWQPGDDVSQVGA 189
NW V + NP +NPNLLQIG KV FPL+C CPSK++ ++GI+ LITYVWQP DD+ +V A
Sbjct: 127 NWPLVRDTNPTLNPNLLQIGTKVIFPLYCGCPSKSHSKNGIKYLITYVWQPSDDIYRVSA 186
Query: 190 KLNASSAAIETENEYRNFSEAVSLPVLIPVSQLPSLSQ-SYPSTKRNGS--KHHLTLIIP 246
NAS I EN Y++F AV PVLIPVS++P+LSQ YPS + S KH LI
Sbjct: 187 MFNASEVDIIIENNYQDFKAAVGYPVLIPVSRMPALSQPPYPSHSHHRSQLKHRWFLIAV 246
Query: 247 ISAGGALLILLVAALVIYNHHLQRKRVRILNRNGSSLESADLIPMKENSKSDRFEPKLAQ 306
IS+ GALLIL +A ++++ L K+ + L+ SSLE+ DLI +K SKSD E +
Sbjct: 247 ISSAGALLILFLATFLVHSIGLYEKK-KNLSHEESSLETTDLIQVKNFSKSDTLELQAKH 305
Query: 307 NKLLPGVSGYLGKPIVYEIEVIMESTMNLSEHYSIGKSVYRATIDGKVLAVKKIKEDVTE 366
+KLLPGVS YLGKPI+YEI++IME+TMN ++ Y IG SVYRA I+G LAVKK KE+VTE
Sbjct: 306 DKLLPGVSVYLGKPIMYEIKMIMEATMNFNDQYKIGGSVYRAMINGSFLAVKKAKENVTE 365
Query: 367 ELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLT 426
EL ILQ++NH NLVKLMG+S D GN F VYEYAENGSLDKWL+P+S +S+SS SV L+
Sbjct: 366 ELHILQKVNHGNLVKLMGISLDRDGNCFFVYEYAENGSLDKWLNPQSSTSTSS-SVGILS 424
Query: 427 WSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVM 486
WSQRL +ALDVANGLQYMHEH QPSIVH++IRT+NI LDSRFKAKIANFS+A A + M
Sbjct: 425 WSQRLNIALDVANGLQYMHEHTQPSIVHKEIRTSNILLDSRFKAKIANFSMARSAASAGM 484
Query: 487 PKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLE 546
K DVFAFGVVLL+LLSG+KA T ENG+ +LWKE + VL+ EEKR E++R W+DP LE
Sbjct: 485 TKVDVFAFGVVLLKLLSGRKAMATRENGEIVMLWKEAKAVLEEEEKRAEKVREWIDPKLE 544
Query: 547 SFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS-TETLERSWTSGLEAEEA 605
SFYPIDGALSL TLA+ACT +K+ +RP++ EVVF+L VLTQS +ETLE SWT LE E+
Sbjct: 545 SFYPIDGALSLMTLAKACTQEKASARPSIGEVVFSLCVLTQSFSETLEPSWTCTLEGEDV 604
Query: 606 FQFISPVTAR 615
Q SP+ AR
Sbjct: 605 VQITSPIVAR 614
|
Source: Parasponia andersonii Species: Parasponia andersonii Genus: Parasponia Family: Cannabaceae Order: Rosales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224094680|ref|XP_002310198.1| predicted protein [Populus trichocarpa] gi|222853101|gb|EEE90648.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 736 bits (1901), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 384/625 (61%), Positives = 463/625 (74%), Gaps = 34/625 (5%)
Query: 1 MAISSLS---LQALFLLMTI----HITAQSPAANGTDFSCSADSLPSCKTYVAYFAQSPE 53
MAIS LS QALF L+ + ++TAQ+P GT+FSC DS SC TY++Y AQ P+
Sbjct: 1 MAISLLSSFFTQALFFLVLVFFSTYVTAQAPP--GTNFSCPVDSPTSCPTYISYLAQPPD 58
Query: 54 FLDLSNISDLFGVSRLSIARASNLVSEDTPLVPKQLLLVPIICGCTGNQYFANITYQIKK 113
FLDL IS LFG+SR IA ASNLVSEDTPL P QLLLVPI CGCTG+Q F NITYQI++
Sbjct: 59 FLDLGKISHLFGISRTLIASASNLVSEDTPLFPNQLLLVPIRCGCTGSQSFVNITYQIQQ 118
Query: 114 GDSYYLVSITSFENLTNWHAVLEMNPGINPNLLQIGVKVTFPLFCKCPSKTNMEDGIENL 173
GDS Y VS SFENLT W V +N + P LL G +V FPLFCKCPS+T++E+GIE+L
Sbjct: 119 GDSIYSVSTISFENLTRWQEVEALNRSLTPTLLHAGDEVIFPLFCKCPSRTHLENGIEHL 178
Query: 174 ITYVWQPGDDVSQVGAKLNASSAAIETENEYRNFSEAVSLPVLIPVSQLPSLSQSYPSTK 233
ITYVWQPGDD+ +V A LNAS I EN Y NF+ AV P++IPVS+LP LSQ Y + +
Sbjct: 179 ITYVWQPGDDLKKVAAMLNASERNIVIENNYDNFNAAVYNPIVIPVSKLPVLSQPYLTPE 238
Query: 234 RNGSKHHLTLIIPISAGGALLILLVAALVIYNHHLQRKRVRILNRNGSSLESADLIPMKE 293
R GSKH +I+ S + A +I+ K + L+R GS LE++D
Sbjct: 239 RRGSKHLWIVIVAASIASTFFTCPLVAFLIHK-RCSYKATKALDRTGSCLETSD------ 291
Query: 294 NSKSDRFEPKLAQNKLLPGVSGYLGKPIVYEIEVIMESTMNLSEHYSIGKSVYRATIDGK 353
+KLLPGV G L K I+YE++ IME TM+L EHY IG SVYRA I+G
Sbjct: 292 ------------PDKLLPGVLGCLDKSIIYEVKAIMEGTMDLHEHYKIGGSVYRANINGC 339
Query: 354 VLAVKKIKEDVTEELRILQRINHANLVKLMGVS--SDSQGNRFLVYEYAENGSLDKWLHP 411
VLAVKK K+DVTEEL+ILQ+++HANLVKLMG+S SD +GNRFLVYEYAENGSLDKWLHP
Sbjct: 340 VLAVKKTKDDVTEELKILQKVSHANLVKLMGMSSESDREGNRFLVYEYAENGSLDKWLHP 399
Query: 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAK 471
KS+SSSS SV FLTW QR++VALDVANGLQY+HEH QP VH+DIRT+NI LDS F+AK
Sbjct: 400 KSESSSS--SVGFLTWKQRMQVALDVANGLQYLHEHTQPRTVHKDIRTSNILLDSTFRAK 457
Query: 472 IANFSLAAPATNDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEE 531
IANFS+A AT+ +MPK DVF FGVVLLELLSGKKA T E G+ +L +EI++VL++EE
Sbjct: 458 IANFSMARAATDSMMPKDDVFDFGVVLLELLSGKKAMVTKEKGEIVLLCREIKDVLEMEE 517
Query: 532 KREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQST-E 590
KREERLR WMDPNLE FYPID A+SLATLAR CT++KS RP+MAE+VFNL+VLTQS+ E
Sbjct: 518 KREERLRKWMDPNLERFYPIDSAMSLATLARLCTLEKSSERPSMAEIVFNLTVLTQSSPE 577
Query: 591 TLERSWTSGLEAEEAFQFISPVTAR 615
TLER WTS +E E+ + +SPVTAR
Sbjct: 578 TLER-WTSEVETEDFTRLVSPVTAR 601
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|299481062|gb|ADJ19106.1| Nod-factor receptor 5A [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 673 bits (1737), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 356/610 (58%), Positives = 447/610 (73%), Gaps = 28/610 (4%)
Query: 8 LQALFLLMTIHITAQSPAANGTDFSCSADSLPSCKTYVAYFAQSPEFLDLSNISDLFGVS 67
L + +L + +I AQS N T+FSC +DS PSC+TYV Y AQSP FL L+NIS++F S
Sbjct: 15 LCLVIMLFSTNIVAQSQQDNRTNFSCPSDSPPSCETYVTYIAQSPNFLSLTNISNIFDTS 74
Query: 68 RLSIARASNLVSEDTPLVPKQLLLVPIICGCTGNQYFANITYQIKKGDSYYLVSITSFEN 127
LSIARASNL D LV Q+LLVP+ CGCTGN+ FANI+Y+I +GDS+Y V+ TS+EN
Sbjct: 75 PLSIARASNLEPMDDKLVKDQVLLVPVTCGCTGNRSFANISYEINQGDSFYFVATTSYEN 134
Query: 128 LTNWHAVLEMNPGINPNLLQIGVKVTFPLFCKCPSKTNMEDGIENLITYVWQPGDDVSQV 187
LTNW AV+++NP ++PN L IG++V FPLFCKCPSK ++ I+ LITYVW+PGD+VS V
Sbjct: 135 LTNWRAVMDLNPVLSPNKLPIGIQVVFPLFCKCPSKNQLDKEIKYLITYVWKPGDNVSLV 194
Query: 188 GAKLNASSAAIETENEY-RNFSEAVSLPVLIPVSQLPSLSQSYPSTKRNGSKHHLTLIIP 246
K AS I +EN Y +NF+ A +LPVLIPV++LP L++S PS R G L +II
Sbjct: 195 SDKFGASPEDIMSENNYGQNFTAANNLPVLIPVTRLPVLARS-PSDGRKGG-IRLPVIIG 252
Query: 247 ISAGGALLILLVAALVIYNHHLQRKRVRILNRNGSSLESADLIPMKENSKSDRFEPKLAQ 306
IS G LL+L++A L++Y + L +++ LNR+ SS E+AD
Sbjct: 253 ISLGCTLLVLVLAVLLVYVYCL---KMKTLNRSASSAETAD------------------- 290
Query: 307 NKLLPGVSGYLGKPIVYEIEVIMESTMNLSEHYSIGKSVYRATIDGKVLAVKKIKEDVTE 366
KLL GVSGY+ KP +YE + IME+TMNLSE IG+SVY+A I+GKVLAVK+ KEDVTE
Sbjct: 291 -KLLSGVSGYVSKPTMYETDAIMEATMNLSEQCKIGESVYKANIEGKVLAVKRFKEDVTE 349
Query: 367 ELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLT 426
EL+ILQ++NH NLVKLMGVSSD+ GN F+VYEYAENGSLD+WL KS S +S S LT
Sbjct: 350 ELKILQKVNHGNLVKLMGVSSDNDGNCFVVYEYAENGSLDEWLFSKS-CSDTSNSRASLT 408
Query: 427 WSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVM 486
W QR+ +A+DVA GLQYMHEHA P IVHRDI ++NI LDS FKAKIANFS+A TN +M
Sbjct: 409 WCQRISMAVDVAMGLQYMHEHAYPRIVHRDITSSNILLDSNFKAKIANFSMARTFTNPMM 468
Query: 487 PKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLE 546
PK DVFAFGVVL+ELL+G+KA T ENG+ +LWK+I ++ EE REERL+ WMDP LE
Sbjct: 469 PKIDVFAFGVVLIELLTGRKAVTTKENGEVVMLWKDIWKIFDQEENREERLKKWMDPKLE 528
Query: 547 SFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQ-STETLERSWTSGLEAEEA 605
S+YPID ALSLA+LA CT DKSLSRP +AE+V +LS+LTQ S TLERS TS EA
Sbjct: 529 SYYPIDYALSLASLAVNCTADKSLSRPTIAEIVLSLSLLTQPSPATLERSLTSSGLDVEA 588
Query: 606 FQFISPVTAR 615
Q ++ + AR
Sbjct: 589 TQIVTSIAAR 598
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356537980|ref|XP_003537484.1| PREDICTED: Nod factor receptor protein [Glycine max] gi|148362061|gb|ABQ59609.1| NFR5a [Glycine max] gi|299481060|gb|ADJ19105.1| Nod-factor receptor 5A [Glycine max] gi|299481066|gb|ADJ19108.1| Nod-factor receptor 5A [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 673 bits (1737), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 356/610 (58%), Positives = 447/610 (73%), Gaps = 28/610 (4%)
Query: 8 LQALFLLMTIHITAQSPAANGTDFSCSADSLPSCKTYVAYFAQSPEFLDLSNISDLFGVS 67
L + +L + +I AQS N T+FSC +DS PSC+TYV Y AQSP FL L+NIS++F S
Sbjct: 15 LCLVIMLFSTNIVAQSQQDNRTNFSCPSDSPPSCETYVTYIAQSPNFLSLTNISNIFDTS 74
Query: 68 RLSIARASNLVSEDTPLVPKQLLLVPIICGCTGNQYFANITYQIKKGDSYYLVSITSFEN 127
LSIARASNL D LV Q+LLVP+ CGCTGN+ FANI+Y+I +GDS+Y V+ TS+EN
Sbjct: 75 PLSIARASNLEPMDDKLVKDQVLLVPVTCGCTGNRSFANISYEINQGDSFYFVATTSYEN 134
Query: 128 LTNWHAVLEMNPGINPNLLQIGVKVTFPLFCKCPSKTNMEDGIENLITYVWQPGDDVSQV 187
LTNW AV+++NP ++PN L IG++V FPLFCKCPSK ++ I+ LITYVW+PGD+VS V
Sbjct: 135 LTNWRAVMDLNPVLSPNKLPIGIQVVFPLFCKCPSKNQLDKEIKYLITYVWKPGDNVSLV 194
Query: 188 GAKLNASSAAIETENEY-RNFSEAVSLPVLIPVSQLPSLSQSYPSTKRNGSKHHLTLIIP 246
K AS I +EN Y +NF+ A +LPVLIPV++LP L++S PS R G L +II
Sbjct: 195 SDKFGASPEDIMSENNYGQNFTAANNLPVLIPVTRLPVLARS-PSDGRKGG-IRLPVIIG 252
Query: 247 ISAGGALLILLVAALVIYNHHLQRKRVRILNRNGSSLESADLIPMKENSKSDRFEPKLAQ 306
IS G LL+L++A L++Y + L +++ LNR+ SS E+AD
Sbjct: 253 ISLGCTLLVLVLAVLLVYVYCL---KMKTLNRSASSAETAD------------------- 290
Query: 307 NKLLPGVSGYLGKPIVYEIEVIMESTMNLSEHYSIGKSVYRATIDGKVLAVKKIKEDVTE 366
KLL GVSGY+ KP +YE + IME+TMNLSE IG+SVY+A I+GKVLAVK+ KEDVTE
Sbjct: 291 -KLLSGVSGYVSKPTMYETDAIMEATMNLSEQCKIGESVYKANIEGKVLAVKRFKEDVTE 349
Query: 367 ELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLT 426
EL+ILQ++NH NLVKLMGVSSD+ GN F+VYEYAENGSLD+WL KS S +S S LT
Sbjct: 350 ELKILQKVNHGNLVKLMGVSSDNDGNCFVVYEYAENGSLDEWLFSKS-CSDTSNSRASLT 408
Query: 427 WSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVM 486
W QR+ +A+DVA GLQYMHEHA P IVHRDI ++NI LDS FKAKIANFS+A TN +M
Sbjct: 409 WCQRISMAVDVAMGLQYMHEHAYPRIVHRDITSSNILLDSNFKAKIANFSMARTFTNPMM 468
Query: 487 PKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLE 546
PK DVFAFGVVL+ELL+G+KA T ENG+ +LWK+I ++ EE REERL+ WMDP LE
Sbjct: 469 PKIDVFAFGVVLIELLTGRKAMTTKENGEVVMLWKDIWKIFDQEENREERLKKWMDPKLE 528
Query: 547 SFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQ-STETLERSWTSGLEAEEA 605
S+YPID ALSLA+LA CT DKSLSRP +AE+V +LS+LTQ S TLERS TS EA
Sbjct: 529 SYYPIDYALSLASLAVNCTADKSLSRPTIAEIVLSLSLLTQPSPATLERSLTSSGLDVEA 588
Query: 606 FQFISPVTAR 615
Q ++ + AR
Sbjct: 589 TQIVTSIAAR 598
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|299481064|gb|ADJ19107.1| Nod-factor receptor 5A [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 672 bits (1733), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 355/610 (58%), Positives = 447/610 (73%), Gaps = 28/610 (4%)
Query: 8 LQALFLLMTIHITAQSPAANGTDFSCSADSLPSCKTYVAYFAQSPEFLDLSNISDLFGVS 67
L + +L + +I AQS N T+FSC +DS PSC+TYV Y AQSP FL L+NIS++F S
Sbjct: 15 LCLVIMLFSTNIVAQSQQDNRTNFSCPSDSPPSCETYVTYIAQSPNFLSLTNISNIFDTS 74
Query: 68 RLSIARASNLVSEDTPLVPKQLLLVPIICGCTGNQYFANITYQIKKGDSYYLVSITSFEN 127
LSIARASNL D LV Q+LLVP+ CGCTGN+ FANI+Y+I +GDS+Y V+ TS+EN
Sbjct: 75 PLSIARASNLEPMDDKLVKDQVLLVPVTCGCTGNRSFANISYEINQGDSFYFVATTSYEN 134
Query: 128 LTNWHAVLEMNPGINPNLLQIGVKVTFPLFCKCPSKTNMEDGIENLITYVWQPGDDVSQV 187
LTNW AV+++NP ++PN L IG++V FPLFCKCPSK ++ I+ LITYVW+PGD+VS V
Sbjct: 135 LTNWRAVMDLNPVLSPNKLPIGIQVVFPLFCKCPSKNQLDKEIKYLITYVWKPGDNVSLV 194
Query: 188 GAKLNASSAAIETENEY-RNFSEAVSLPVLIPVSQLPSLSQSYPSTKRNGSKHHLTLIIP 246
K AS I +EN Y +NF+ A +LPVLIPV++LP L++S PS R G L +II
Sbjct: 195 SDKFGASPEDIMSENNYGQNFTAANNLPVLIPVTRLPVLARS-PSDGRKGG-IRLPVIIG 252
Query: 247 ISAGGALLILLVAALVIYNHHLQRKRVRILNRNGSSLESADLIPMKENSKSDRFEPKLAQ 306
IS G LL+L++A L++Y + L +++ LNR+ SS E+AD
Sbjct: 253 ISLGCTLLVLVLAVLLVYVYCL---KMKTLNRSASSAETAD------------------- 290
Query: 307 NKLLPGVSGYLGKPIVYEIEVIMESTMNLSEHYSIGKSVYRATIDGKVLAVKKIKEDVTE 366
KLL GVSGY+ KP +YE + IME+TMNLSE IG+SVY+A I+GKVLAVK+ K+DVTE
Sbjct: 291 -KLLSGVSGYVSKPTMYETDAIMEATMNLSEQCKIGESVYKANIEGKVLAVKRFKKDVTE 349
Query: 367 ELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLT 426
EL+ILQ++NH NLVKLMGVSSD+ GN F+VYEYAENGSLD+WL KS S +S S LT
Sbjct: 350 ELKILQKVNHGNLVKLMGVSSDNDGNCFVVYEYAENGSLDEWLFSKS-CSDTSNSRASLT 408
Query: 427 WSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVM 486
W QR+ +A+DVA GLQYMHEHA P IVHRDI ++NI LDS FKAKIANFS+A TN +M
Sbjct: 409 WCQRISMAVDVAMGLQYMHEHAYPRIVHRDITSSNILLDSNFKAKIANFSMARTFTNPMM 468
Query: 487 PKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLE 546
PK DVFAFGVVL+ELL+G+KA T ENG+ +LWK+I ++ EE REERL+ WMDP LE
Sbjct: 469 PKIDVFAFGVVLIELLTGRKAVTTKENGEVVMLWKDIWKIFDQEENREERLKKWMDPKLE 528
Query: 547 SFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQ-STETLERSWTSGLEAEEA 605
S+YPID ALSLA+LA CT DKSLSRP +AE+V +LS+LTQ S TLERS TS EA
Sbjct: 529 SYYPIDYALSLASLAVNCTADKSLSRPTIAEIVLSLSLLTQPSPATLERSLTSSGLDVEA 588
Query: 606 FQFISPVTAR 615
Q ++ + AR
Sbjct: 589 TQIVTSIAAR 598
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|37651066|emb|CAE02593.1| SYM10 protein [Pisum sativum] gi|37651068|emb|CAE02594.1| SYM10 protein [Pisum sativum] | Back alignment and taxonomy information |
|---|
Score = 669 bits (1726), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 346/622 (55%), Positives = 443/622 (71%), Gaps = 35/622 (5%)
Query: 1 MAISSL--SLQALFLLMTIHIT---AQSPAANGTDFSCSADSLPSCKTYVAYFAQSPEFL 55
MAI L S ALFL + +T AQ +GT+FSC DS PSC+TYV YFA+SP FL
Sbjct: 1 MAIFFLPSSSHALFLALMFFVTNISAQPLQLSGTNFSCPVDSPPSCETYVTYFARSPNFL 60
Query: 56 DLSNISDLFGVSRLSIARASNLVSEDTPLVPKQLLLVPIICGCTGNQYFANITYQIKKGD 115
L+NISD+F +S LSIA+ASN+ ED LV Q+LL+P+ CGCT N+YFAN TY IK GD
Sbjct: 61 SLTNISDIFDMSPLSIAKASNIEDEDKKLVEGQVLLIPVTCGCTRNRYFANFTYTIKLGD 120
Query: 116 SYYLVSITSFENLTNWHAVLEMNPGINPNLLQIGVKVTFPLFCKCPSKTNMEDGIENLIT 175
+Y++VS TS++NLTN+ + NP ++PNLL +KV PLFCKCPSK + GI++LIT
Sbjct: 121 NYFIVSTTSYQNLTNYVEMENFNPNLSPNLLPPEIKVVVPLFCKCPSKNQLSKGIKHLIT 180
Query: 176 YVWQPGDDVSQVGAKLNASSAAIETENEYRNFSEAVSLPVLIPVSQLPSLSQSYPSTKRN 235
YVWQ D+V++V +K AS + TEN +NF+ + ++P+LIPV++LP + Q S R
Sbjct: 181 YVWQANDNVTRVSSKFGASQVDMFTENN-QNFTASTNVPILIPVTKLPVIDQP-SSNGRK 238
Query: 236 GSKHHLTLIIPISAGGALLILLVAALVIYNHHLQRKRVRILNRNGSSLESADLIPMKENS 295
S II IS G A ++++ ++Y + L+ KR LNR+ S E+AD
Sbjct: 239 NSTQKPAFIIGISLGCAFFVVVLTLSLVYVYCLKMKR---LNRSTSLAETAD-------- 287
Query: 296 KSDRFEPKLAQNKLLPGVSGYLGKPIVYEIEVIMESTMNLSEHYSIGKSVYRATIDGKVL 355
KLL GVSGY+ KP +YE++ IME+TMNLSE+ IG+SVY+A IDG+VL
Sbjct: 288 ------------KLLSGVSGYVSKPTMYEMDAIMEATMNLSENCKIGESVYKANIDGRVL 335
Query: 356 AVKKIKEDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKS 415
AVKKIK+D +EEL+ILQ++NH NLVKLMGVSSD+ GN FLVYEYAENGSLD+WL S+S
Sbjct: 336 AVKKIKKDASEELKILQKVNHGNLVKLMGVSSDNDGNCFLVYEYAENGSLDEWLF--SES 393
Query: 416 SSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANF 475
S +S SV+ LTWSQR+ VA+DVA GLQYMHEH P I+HRDI T+NI LDS FKAKIANF
Sbjct: 394 SKTSNSVVSLTWSQRITVAVDVAVGLQYMHEHTYPRIIHRDITTSNILLDSNFKAKIANF 453
Query: 476 SLAAPATNDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREE 535
S+A +TN +MPK DVFAFGVVL+ELL+GKKA T ENG+ +LWK+ ++ +E REE
Sbjct: 454 SMARTSTNSMMPKIDVFAFGVVLIELLTGKKAITTMENGEVVILWKDFWKIFDLEGNREE 513
Query: 536 RLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQSTE--TLE 593
LR WMDP LE+FYPID ALSLA+LA CT DKSLSRP++AE+V LS+L QS+ LE
Sbjct: 514 SLRKWMDPKLENFYPIDNALSLASLAVNCTADKSLSRPSIAEIVLCLSLLNQSSSEPMLE 573
Query: 594 RSWTSGLEAEEAFQFISPVTAR 615
RS TSGL+ EA ++ + AR
Sbjct: 574 RSLTSGLDV-EATHVVTSIVAR 594
|
Source: Pisum sativum Species: Pisum sativum Genus: Pisum Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|37651070|emb|CAE02595.1| SYM10 protein [Pisum sativum] gi|37651072|emb|CAE02596.1| SYM10 protein [Pisum sativum] gi|283855903|gb|ADB45277.1| Nod factor recognition protein [Pisum sativum] | Back alignment and taxonomy information |
|---|
Score = 667 bits (1721), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 345/622 (55%), Positives = 443/622 (71%), Gaps = 35/622 (5%)
Query: 1 MAISSL--SLQALFLLMTIHIT---AQSPAANGTDFSCSADSLPSCKTYVAYFAQSPEFL 55
MAI L S ALFL + +T AQ +GT+FSC DS PSC+TYV YFA+SP FL
Sbjct: 1 MAIFFLPSSSHALFLALMFFVTNISAQPLQLSGTNFSCPVDSPPSCETYVTYFARSPNFL 60
Query: 56 DLSNISDLFGVSRLSIARASNLVSEDTPLVPKQLLLVPIICGCTGNQYFANITYQIKKGD 115
L+NISD+F +S LSIA+ASN+ ED LV Q+LL+P+ CGCT N+YFAN TY IK GD
Sbjct: 61 SLTNISDIFDMSPLSIAKASNIEDEDKKLVEGQVLLIPVTCGCTRNRYFANFTYTIKLGD 120
Query: 116 SYYLVSITSFENLTNWHAVLEMNPGINPNLLQIGVKVTFPLFCKCPSKTNMEDGIENLIT 175
+Y++VS TS++NLTN+ + NP ++PNLL +KV PLFCKCPSK + GI++LIT
Sbjct: 121 NYFIVSTTSYQNLTNYVEMENFNPNLSPNLLPPEIKVVVPLFCKCPSKNQLSKGIKHLIT 180
Query: 176 YVWQPGDDVSQVGAKLNASSAAIETENEYRNFSEAVSLPVLIPVSQLPSLSQSYPSTKRN 235
YVWQ D+V++V +K AS + TEN +NF+ + ++P+LIPV++LP + Q S R
Sbjct: 181 YVWQANDNVTRVSSKFGASQVDMFTENN-QNFTASTNVPILIPVTKLPVIDQP-SSNGRK 238
Query: 236 GSKHHLTLIIPISAGGALLILLVAALVIYNHHLQRKRVRILNRNGSSLESADLIPMKENS 295
S II IS G A ++++ ++Y + L+ KR LNR+ S E+AD
Sbjct: 239 NSTQKPAFIIGISLGCAFFVVVLTLSLVYVYCLKMKR---LNRSTSLAETAD-------- 287
Query: 296 KSDRFEPKLAQNKLLPGVSGYLGKPIVYEIEVIMESTMNLSEHYSIGKSVYRATIDGKVL 355
KLL GVSGY+ KP +YE++ IME+TMNLSE+ IG+SVY+A IDG+VL
Sbjct: 288 ------------KLLSGVSGYVSKPTMYEMDAIMEATMNLSENCKIGESVYKANIDGRVL 335
Query: 356 AVKKIKEDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKS 415
AVKKIK+D +EEL+ILQ++NH NLVKLMGVSSD++GN FLVYEYAENGSLD+WL S+
Sbjct: 336 AVKKIKKDASEELKILQKVNHGNLVKLMGVSSDNEGNCFLVYEYAENGSLDEWLF--SEL 393
Query: 416 SSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANF 475
S +S SV+ LTWSQR+ VA+DVA GLQYMHEH P I+HRDI T+NI LDS FKAKIANF
Sbjct: 394 SKTSNSVVSLTWSQRITVAVDVAVGLQYMHEHTYPRIIHRDITTSNILLDSNFKAKIANF 453
Query: 476 SLAAPATNDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREE 535
S+A +TN +MPK DVFAFGVVL+ELL+GKKA T ENG+ +LWK+ ++ +E REE
Sbjct: 454 SMARTSTNSMMPKIDVFAFGVVLIELLTGKKAITTMENGEVVILWKDFWKIFDLEGNREE 513
Query: 536 RLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQSTE--TLE 593
LR WMDP LE+FYPID ALSLA+LA CT DKSLSRP++AE+V LS+L QS+ LE
Sbjct: 514 SLRKWMDPKLENFYPIDNALSLASLAVNCTADKSLSRPSIAEIVLCLSLLNQSSSEPMLE 573
Query: 594 RSWTSGLEAEEAFQFISPVTAR 615
RS TSGL+ EA ++ + AR
Sbjct: 574 RSLTSGLDV-EATHVVTSIVAR 594
|
Source: Pisum sativum Species: Pisum sativum Genus: Pisum Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 615 | ||||||
| TAIR|locus:2050987 | 664 | LYK5 "LysM-containing receptor | 0.256 | 0.237 | 0.398 | 7.8e-57 | |
| TAIR|locus:2049029 | 612 | LYK4 "LysM-containing receptor | 0.476 | 0.478 | 0.304 | 1.7e-46 | |
| TAIR|locus:2089860 | 617 | CERK1 "chitin elicitor recepto | 0.255 | 0.254 | 0.375 | 2.2e-44 | |
| UNIPROTKB|D7UPN3 | 605 | CERK1 "Chitin elicitor recepto | 0.243 | 0.247 | 0.386 | 1.3e-38 | |
| TAIR|locus:2195814 | 651 | LYK3 "LysM-containing receptor | 0.250 | 0.236 | 0.369 | 3.7e-35 | |
| TAIR|locus:2082359 | 654 | LYK2 "LysM-containing receptor | 0.299 | 0.281 | 0.302 | 2.2e-32 | |
| TAIR|locus:2054492 | 338 | AT2G30730 [Arabidopsis thalian | 0.247 | 0.449 | 0.365 | 2.6e-30 | |
| TAIR|locus:2132168 | 725 | AT4G02010 [Arabidopsis thalian | 0.243 | 0.206 | 0.378 | 3.5e-29 | |
| TAIR|locus:2183835 | 433 | AT5G11020 [Arabidopsis thalian | 0.278 | 0.394 | 0.345 | 4.4e-28 | |
| TAIR|locus:2081277 | 408 | AT3G59350 [Arabidopsis thalian | 0.245 | 0.370 | 0.375 | 6.5e-28 |
| TAIR|locus:2050987 LYK5 "LysM-containing receptor-like kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 325 (119.5 bits), Expect = 7.8e-57, Sum P(3) = 7.8e-57
Identities = 67/168 (39%), Positives = 100/168 (59%)
Query: 312 GVSGYLGKPIVYEIEVIMESTMNLSEHYSIGKSVYRATIDGKVLAVKKIKEDVTE-ELRI 370
G+ + +Y + +T N S+ I SVYRATI+G AVK IK DV+ E+ +
Sbjct: 349 GLKSAIESLTLYRFNDLQSATSNFSDENRIKGSVYRATINGDDAAVKVIKGDVSSSEINL 408
Query: 371 LQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPXXXXXXXXXXVIFLTWSQR 430
L+++NH+N+++L G +G +LV+EY+ENGS+ WLH LTW QR
Sbjct: 409 LKKLNHSNIIRLSGFCI-REGTSYLVFEYSENGSISDWLHSSGKKS--------LTWKQR 459
Query: 431 LRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA 478
+ +A DVA L Y+H + P +H+++ + NI LDS F+AKIANF +A
Sbjct: 460 VEIARDVAEALDYLHNYITPPHIHKNLESTNILLDSNFRAKIANFGVA 507
|
|
| TAIR|locus:2049029 LYK4 "LysM-containing receptor-like kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 336 (123.3 bits), Expect = 1.7e-46, Sum P(2) = 1.7e-46
Identities = 96/315 (30%), Positives = 154/315 (48%)
Query: 292 KENSKSDRF---EPKLAQNKLLP--GVSGYLGKPI-VYEIEVIMESTMNLSEHYSIGKSV 345
+E D F +P ++ + P G+SG + + + VY+ + +T + + SIG S
Sbjct: 307 EETGNLDSFMGKKPPMSDQEFDPLDGLSGMVVESLKVYKFHELQSATSDFTSSSSIGGSG 366
Query: 346 YRATIDGKVLAVKKIKEDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSL 405
Y I+G +KKI+ + +EE+ +L ++NH N+++L G +G+ +LVYE+A NGSL
Sbjct: 367 YIGKINGDGAMIKKIEGNASEEVNLLSKLNHLNIIRLSGFCFH-EGDWYLVYEHASNGSL 425
Query: 406 DKWLHPXXXXXXXXXXVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLD 465
+W+H L+ +Q+L++ALD+A GL Y+H A P VHRD+ +NN+ LD
Sbjct: 426 SEWIHTTKS---------LLSLTQKLQIALDIATGLNYLHNFADPPYVHRDLNSNNVFLD 476
Query: 466 SRFKAKIANFSLAAPATND-VMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEI 523
F+AKI + A T D V+ K G + E L G +T+ VL + +
Sbjct: 477 LEFRAKIGSLGSARSTTEDFVLTKHVEGTRGYLAPEYLEHGLVSTKLDVYAFGVVLLEIV 536
Query: 524 XXXXXXXXXXXXXXXNWMDPNL--ESFYPIDGALSLAT-LARACTMDKSLSRPNMAEVVF 580
+D L P +G S L C L+RP+M E V
Sbjct: 537 TGKEASELKKEIDEGKAIDEILIHGRLLP-EGLTSFVERLVVDCLKKDHLNRPSMDENVM 595
Query: 581 NLSVLTQSTETLERS 595
+LS + +T+ E S
Sbjct: 596 SLSKILAATQNWEES 610
|
|
| TAIR|locus:2089860 CERK1 "chitin elicitor receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 302 (111.4 bits), Expect = 2.2e-44, Sum P(3) = 2.2e-44
Identities = 66/176 (37%), Positives = 110/176 (62%)
Query: 311 PGVSGY-LGKPIVYEIEVIMESTMNLSEHYSIGK----SVYRATIDGKVLAVKKIKEDVT 365
PG++ + K + + +E + ++T N + + IG+ +VY A + G+ A+KK+ + +
Sbjct: 297 PGIAAISVDKSVEFSLEELAKATDNFNLSFKIGQGGFGAVYYAELRGEKAAIKKMDMEAS 356
Query: 366 E----ELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPXXXXXXXXXX 421
+ EL++L R++H NLV+L+G + G+ FLVYEY ENG+L + LH
Sbjct: 357 KQFLAELKVLTRVHHVNLVRLIGYCVE--GSLFLVYEYVENGNLGQHLHGSGREP----- 409
Query: 422 VIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSL 477
L W++R+++ALD A GL+Y+HEH P VHRDI++ NI +D +F+AK+A+F L
Sbjct: 410 ---LPWTKRVQIALDSARGLEYIHEHTVPVYVHRDIKSANILIDQKFRAKVADFGL 462
|
|
| UNIPROTKB|D7UPN3 CERK1 "Chitin elicitor receptor kinase 1" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 273 (101.2 bits), Expect = 1.3e-38, Sum P(3) = 1.3e-38
Identities = 65/168 (38%), Positives = 98/168 (58%)
Query: 319 KPIVYEIEVIMESTMNLSEHYSIGK----SVYRATIDGKVLAVKKIKEDVTEE----LRI 370
+ I + E I +T S + IG+ SVY A + G+ A+KK+ T+E L++
Sbjct: 301 RSIEFSYEEIFNATQGFSMEHKIGQGGFGSVYYAELRGEKTAIKKMGMQATQEFLAELKV 360
Query: 371 LQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPXXXXXXXXXXVIFLTWSQR 430
L ++H NLV+L+G ++ FLVYE+ +NG+L + L L+W+ R
Sbjct: 361 LTHVHHLNLVRLIGYCVENC--LFLVYEFIDNGNLSQHLQRTGYAP--------LSWATR 410
Query: 431 LRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA 478
+++ALD A GL+Y+HEH P VHRDI++ NI LD F+AKIA+F LA
Sbjct: 411 VQIALDSARGLEYLHEHVVPVYVHRDIKSANILLDKDFRAKIADFGLA 458
|
|
| TAIR|locus:2195814 LYK3 "LysM-containing receptor-like kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 260 (96.6 bits), Expect = 3.7e-35, Sum P(3) = 3.7e-35
Identities = 62/168 (36%), Positives = 97/168 (57%)
Query: 319 KPIVYEIEVIMESTMNLSEHYSIGK----SVYRATIDGKVLAVKKIKEDVTEE----LRI 370
KP+V+ E I +T S+ +G SVY + + +AVK++ T+E +++
Sbjct: 325 KPMVFTYEEIRAATDEFSDSNLLGHGNYGSVYFGLLREQEVAVKRMTATKTKEFAAEMKV 384
Query: 371 LQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPXXXXXXXXXXVIFLTWSQR 430
L +++H+NLV+L+G ++ + F+VYEY G L LH L+W R
Sbjct: 385 LCKVHHSNLVELIGYAA-TVDELFVVYEYVRKGMLKSHLHDPQSKGNTP-----LSWIMR 438
Query: 431 LRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA 478
++ALD A GL+Y+HEH + VHRDI+T+NI LD F+AKI++F LA
Sbjct: 439 NQIALDAARGLEYIHEHTKTHYVHRDIKTSNILLDEAFRAKISDFGLA 486
|
|
| TAIR|locus:2082359 LYK2 "LysM-containing receptor-like kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 249 (92.7 bits), Expect = 2.2e-32, Sum P(2) = 2.2e-32
Identities = 63/208 (30%), Positives = 111/208 (53%)
Query: 319 KPI--VYEIEVIMESTMNLSEHYSIGKSVYRATIDGKVLAVKKIKEDVTE--ELRILQRI 374
KP+ +Y E + ++T N S I SVY ++ GK LA+K++ D + + +L
Sbjct: 327 KPVLEIYAFEELEKATENFSSSNHIKGSVYFGSLKGKDLAIKQVNADEMKRFDFGLLNDQ 386
Query: 375 NHA---NLVKLMGVS-SDSQGNRFLVYEYAENGSLDKWLHPXXXXXXXXXX--VIFLTWS 428
+H N+++++G + + +LV+EYA NGSL W+ FL W
Sbjct: 387 SHYYNHNVIRVLGTCFREIDQDSYLVFEYARNGSLWDWIQNKLAIKNQFIESCYCFLAWK 446
Query: 429 QRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVM-- 486
QR+++ DVA L+YMH + + VH +I++ NI L+ + K+ NF ++ TN++
Sbjct: 447 QRIKICHDVAIALKYMH---RINYVHGNIKSRNIFLNEDLRGKVGNFGMSKCVTNELATE 503
Query: 487 ---------PKFDVFAFGVVLLELLSGK 505
P D+FA+G++++E+LSG+
Sbjct: 504 ENLIESSLSPASDIFAYGIIVMEVLSGQ 531
|
|
| TAIR|locus:2054492 AT2G30730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 249 (92.7 bits), Expect = 2.6e-30, Sum P(2) = 2.6e-30
Identities = 61/167 (36%), Positives = 96/167 (57%)
Query: 325 IEVIMESTMNLSEHYSIGKS----VYRATI-DGKVLAVKKIK---EDVTE-----ELRIL 371
++ + E T N + IG+ VY AT+ DGK +A+KK+ ED T ++ ++
Sbjct: 37 VDEVNEQTDNFGPNSLIGEGSYGRVYYATLNDGKAVALKKLDLAPEDETNTEFLSQVSMV 96
Query: 372 QRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPXXXXXXXXXXVIFLTWSQRL 431
R+ H NL++L+G D + R L YE+A GSL LH L W R+
Sbjct: 97 SRLKHENLIQLVGYCVD-ENLRVLAYEFATMGSLHDILHGRKGVQDALPGPT-LDWITRV 154
Query: 432 RVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA 478
++A++ A GL+Y+HE QP ++HRDIR++NI L ++AKIA+F+L+
Sbjct: 155 KIAVEAARGLEYLHEKVQPQVIHRDIRSSNILLFDDYQAKIADFNLS 201
|
|
| TAIR|locus:2132168 AT4G02010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 273 (101.2 bits), Expect = 3.5e-29, Sum P(2) = 3.5e-29
Identities = 64/169 (37%), Positives = 93/169 (55%)
Query: 326 EVIMESTMNLSEHYSIGKS----VYRATI-DGKVLAVKKIK-------EDVTEELRILQR 373
E + E+T N +G+ VYR + DG +A+KK+ ++ E+ +L R
Sbjct: 371 EELKEATSNFESASILGEGGFGKVYRGILADGTAVAIKKLTSGGPQGDKEFQVEIDMLSR 430
Query: 374 INHANLVKLMGV-SSDSQGNRFLVYEYAENGSLDKWLHPXXXXXXXXXXVIFLTWSQRLR 432
++H NLVKL+G SS L YE NGSL+ WLH L W R++
Sbjct: 431 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLEAWLHGPLGLNCP------LDWDTRMK 484
Query: 433 VALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA 481
+ALD A GL Y+HE +QPS++HRD + +NI L++ F AK+A+F LA A
Sbjct: 485 IALDAARGLAYLHEDSQPSVIHRDFKASNILLENNFNAKVADFGLAKQA 533
|
|
| TAIR|locus:2183835 AT5G11020 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 285 (105.4 bits), Expect = 4.4e-28, Sum P(2) = 4.4e-28
Identities = 66/191 (34%), Positives = 106/191 (55%)
Query: 300 FEPKLAQNKLLPGVSGYLGKPIVYEIEVIMESTMNLSEHYSIGKS----VYRATIDGKV- 354
F + +++K L + G + + ++ E T E +G+ VY AT++ +
Sbjct: 106 FLNRFSRSKTLDKRTTKQGTVSLIDYNILEEGTSGFKESNILGQGGFGCVYSATLENNIS 165
Query: 355 LAVKKI---KEDVTEELR----ILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407
AVKK+ ED +E + IL ++ H N++ L+G S++ RF+VYE N SL+
Sbjct: 166 AAVKKLDCANEDAAKEFKSEVEILSKLQHPNIISLLGYSTNDTA-RFIVYELMPNVSLES 224
Query: 408 WLHPXXXXXXXXXXVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSR 467
LH +TW R+++ALDV GL+Y+HEH P+I+HRD++++NI LDS
Sbjct: 225 HLHGSSQGSA-------ITWPMRMKIALDVTRGLEYLHEHCHPAIIHRDLKSSNILLDSN 277
Query: 468 FKAKIANFSLA 478
F AKI++F LA
Sbjct: 278 FNAKISDFGLA 288
|
|
| TAIR|locus:2081277 AT3G59350 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 249 (92.7 bits), Expect = 6.5e-28, Sum P(2) = 6.5e-28
Identities = 63/168 (37%), Positives = 91/168 (54%)
Query: 325 IEVIMESTMNLSEHYSIGKS----VYRATI-DGKVLAVKKIKEDVTEELRI--------L 371
++ + E T N IG+ Y AT+ DGK +AVKK+ E + +
Sbjct: 103 LDELKEKTDNFGSKSLIGEGSYGRAYYATLKDGKAVAVKKLDNAAEPESNVEFLTQVSRV 162
Query: 372 QRINHANLVKLMGVSSDSQGN-RFLVYEYAENGSLDKWLHPXXXXXXXXXXVIFLTWSQR 430
++ H N V+L G + GN R L YE+A GSL LH L W QR
Sbjct: 163 SKLKHDNFVELFGYCVE--GNFRILAYEFATMGSLHDILHGRKGVQGAQPGPT-LDWIQR 219
Query: 431 LRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA 478
+R+A+D A GL+Y+HE QP+++HRDIR++N+ L FKAKIA+F+L+
Sbjct: 220 VRIAVDAARGLEYLHEKVQPAVIHRDIRSSNVLLFEDFKAKIADFNLS 267
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 615 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-31 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-31 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-31 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-30 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-29 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-27 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-26 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-22 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-20 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-19 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-19 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-18 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-17 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-16 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-16 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 8e-15 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-14 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-14 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-14 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-14 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-14 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-14 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-14 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-13 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-13 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-13 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-13 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 9e-13 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-12 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-12 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-12 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-12 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-12 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-12 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-12 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-12 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-12 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-12 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-12 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-11 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-11 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-11 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-11 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-11 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-11 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-11 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-11 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-11 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-11 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-11 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-10 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-10 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-10 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-10 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-10 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-10 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-10 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-10 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-10 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-10 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-10 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-10 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-10 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 8e-10 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-10 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-09 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-09 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-09 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-09 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-09 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-09 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-09 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-09 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-09 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 8e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 9e-09 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-08 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-08 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-08 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-08 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-08 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-08 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-08 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-08 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-08 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-08 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-08 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-07 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-07 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-07 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-07 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-07 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-07 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-07 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-07 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-07 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-07 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-07 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 9e-07 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 9e-07 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-06 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-06 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-06 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-06 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-06 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-06 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-06 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-06 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-06 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 9e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-05 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-05 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-05 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-05 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-05 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-05 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-05 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-05 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-05 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-05 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-05 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-05 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-05 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-05 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-05 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-05 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-05 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-05 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-05 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-05 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-05 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-05 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-05 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-05 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-05 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-05 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-05 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 8e-05 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-05 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-04 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-04 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-04 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-04 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-04 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-04 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-04 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-04 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-04 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-04 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-04 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-04 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-04 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-04 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-04 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-04 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-04 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-04 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 5e-04 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-04 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-04 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-04 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-04 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-04 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-04 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 8e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.001 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 0.001 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 0.001 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 0.001 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 0.001 | |
| COG3858 | 423 | COG3858, COG3858, Predicted glycosyl hydrolase [Ge | 0.001 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 0.001 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 0.001 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 0.002 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 0.002 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 0.002 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 0.002 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 0.002 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 0.002 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 0.003 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 0.003 | |
| cd00118 | 45 | cd00118, LysM, Lysine Motif is a small domain invo | 0.003 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 0.003 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 0.003 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.003 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 0.003 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 0.004 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 0.004 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 0.004 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 0.004 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 0.004 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 3e-31
Identities = 67/276 (24%), Positives = 110/276 (39%), Gaps = 76/276 (27%)
Query: 345 VYRATIDGKVL------AVKKIKEDVTE--------ELRILQRINHANLVKLMGVSSDSQ 390
VY+ T+ GK AVK +KED +E E RI+++++H N+VKL+GV ++ +
Sbjct: 15 VYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTE-E 73
Query: 391 GNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQP 450
+V EY G L +L L+ S L AL +A G++Y+
Sbjct: 74 EPLMIVMEYMPGGDLLDYLRKNRPK--------ELSLSDLLSFALQIARGMEYLESK--- 122
Query: 451 SIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVM------------------------ 486
+ +HRD+ N + KI++F L+ +D
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFT 182
Query: 487 PKFDVFAFGVVLLELLSGKKATRTTENGKT---AVLWKEIREVLKVEEKREERLRNWMDP 543
K DV++FGV+L E+ + G+ + E+ E LK + R +
Sbjct: 183 SKSDVWSFGVLLWEIFT---------LGEEPYPGMSNAEVLEYLK-KGYRLPK------- 225
Query: 544 NLESFYPIDGALSLATLARACTMDKSLSRPNMAEVV 579
P + L L C + RP +E+V
Sbjct: 226 ------PPNCPPELYKLMLQCWAEDPEDRPTFSELV 255
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 4e-31
Identities = 68/276 (24%), Positives = 111/276 (40%), Gaps = 77/276 (27%)
Query: 345 VYRATIDGKVL------AVKKIKEDVTE--------ELRILQRINHANLVKLMGVSSDSQ 390
VY+ + GK AVK +KED +E E RI+++++H N+VKL+GV ++ +
Sbjct: 15 VYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTE-E 73
Query: 391 GNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQP 450
++V EY E G L +L L+ S L AL +A G++Y+
Sbjct: 74 EPLYIVMEYMEGGDLLSYLRKNRPK---------LSLSDLLSFALQIARGMEYLESK--- 121
Query: 451 SIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVM------------------------ 486
+ +HRD+ N + KI++F L+ +D
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFT 181
Query: 487 PKFDVFAFGVVLLELLSGKKATRTTENGKT---AVLWKEIREVLKVEEKREERLRNWMDP 543
K DV++FGV+L E+ + G+ + +E+ E L K RL
Sbjct: 182 SKSDVWSFGVLLWEIFT---------LGEQPYPGMSNEEVLEYL----KNGYRLPQ---- 224
Query: 544 NLESFYPIDGALSLATLARACTMDKSLSRPNMAEVV 579
P + L L C + RP +E+V
Sbjct: 225 ------PPNCPPELYDLMLQCWAEDPEDRPTFSELV 254
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 6e-31
Identities = 70/276 (25%), Positives = 113/276 (40%), Gaps = 69/276 (25%)
Query: 345 VYRATIDGKVL-----AVKKIKEDVTE--------ELRILQRINHANLVKLMGVSSDSQG 391
VY+ + GK AVK +KED +E E R+++++ H N+V+L+GV ++ +
Sbjct: 11 VYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-EE 69
Query: 392 NRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPS 451
+LV EY E G L +L KS+ S L+ L A+ +A G++Y+
Sbjct: 70 PLYLVLEYMEGGDLLDYLR-KSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---K 125
Query: 452 IVHRDIRTNNIQLDSRFKAKIANFSLA---------APATNDVMP------------KF- 489
VHRD+ N + KI++F L+ T +P F
Sbjct: 126 FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFT 185
Query: 490 ---DVFAFGVVLLELLSGKKATRTTENGKT---AVLWKEIREVLKVEEKREERLRNWMDP 543
DV++FGV+L E+ + G T + +E+ E L+ + R P
Sbjct: 186 SKSDVWSFGVLLWEIFT---------LGATPYPGLSNEEVLEYLR------KGYRL---P 227
Query: 544 NLESFYPIDGALSLATLARACTMDKSLSRPNMAEVV 579
E L L +C RP +E+V
Sbjct: 228 KPEYCPD-----ELYELMLSCWQLDPEDRPTFSELV 258
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 1e-30
Identities = 63/200 (31%), Positives = 96/200 (48%), Gaps = 52/200 (26%)
Query: 341 IGK----SVYRAT--IDGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVS 386
+G+ +VY A GK +A+K IK E++ E+ IL+++NH N+VKL GV
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 387 SDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHE 446
D + + +LV EY E GSL L L+ + LR+ L + GL+Y+H
Sbjct: 61 ED-ENHLYLVMEYCEGGSLKDLLKENEG---------KLSEDEILRILLQILEGLEYLHS 110
Query: 447 HAQPSIVHRDIRTNNIQLDSR-FKAKIANFSLAAPATNDVM------------------- 486
+ I+HRD++ NI LDS K K+A+F L+ T+D
Sbjct: 111 N---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLG 167
Query: 487 -----PKFDVFAFGVVLLEL 501
K D+++ GV+L EL
Sbjct: 168 KGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 6e-29
Identities = 53/200 (26%), Positives = 89/200 (44%), Gaps = 54/200 (27%)
Query: 345 VYRATIDG-------KVLAVKKIKEDVT--------EELRILQRINHANLVKLMGVSSDS 389
VY+ T+ G KV AVK +KE + EE I+++++H N+V+L+GV +
Sbjct: 15 VYKGTLKGDGEGTETKV-AVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQG 73
Query: 390 QGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQ 449
+ ++V EY G L +L + LT L++AL +A G++Y+
Sbjct: 74 EPL-YIVTEYMPGGDLLDFLRKHGEK---------LTLKDLLQMALQIAKGMEYLESK-- 121
Query: 450 PSIVHRDIRTNNIQLDSRFKAKIANFSLA---------APATNDVMP------------K 488
+ VHRD+ N + KI++F L+ +P K
Sbjct: 122 -NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGK 180
Query: 489 F----DVFAFGVVLLELLSG 504
F DV++FGV+L E+ +
Sbjct: 181 FTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 63/197 (31%), Positives = 96/197 (48%), Gaps = 49/197 (24%)
Query: 344 SVYRAT--IDGKVLAVKKIKEDVTE---------ELRILQRINHANLVKLMGVSSDSQGN 392
+VY+A GK++AVK +K+ + E+RIL+R++H N+V+L+ D +
Sbjct: 14 TVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDK-DH 72
Query: 393 RFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSI 452
+LV EY E G L +L L+ + ++AL + GL+Y+H + I
Sbjct: 73 LYLVMEYCEGGDLFDYLSRGGP----------LSEDEAKKIALQILRGLEYLHSN---GI 119
Query: 453 VHRDIRTNNIQLDSRFKAKIANFSLA--------------------AP----ATNDVMPK 488
+HRD++ NI LD KIA+F LA AP N PK
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPK 179
Query: 489 FDVFAFGVVLLELLSGK 505
DV++ GV+L ELL+GK
Sbjct: 180 VDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 55/201 (27%), Positives = 87/201 (43%), Gaps = 50/201 (24%)
Query: 341 IGK----SVYRAT--IDGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVS 386
+G+ VY A GK++A+K IK E + E++IL+++ H N+V+L V
Sbjct: 7 LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVF 66
Query: 387 SDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHE 446
D + +LV EY E G L L + + L+ + + + L+Y+H
Sbjct: 67 ED-EDKLYLVMEYCEGGDLFDLLKKRGR----------LSEDEARFYLRQILSALEYLHS 115
Query: 447 HAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVM-------------------- 486
IVHRD++ NI LD K+A+F LA
Sbjct: 116 K---GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKG 172
Query: 487 --PKFDVFAFGVVLLELLSGK 505
D+++ GV+L ELL+GK
Sbjct: 173 YGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 6e-22
Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 56/202 (27%)
Query: 344 SVYRA--TIDGKVLAVKKIKED-------VT--EELRILQRINHANLVKLMG-VSSDSQG 391
VY+A G+++A+KKI+ + +T E+++LQ++ H N+V+L V+S +G
Sbjct: 14 QVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKG 73
Query: 392 NRFLVYEYAE---NGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHA 448
+ ++V+EY + G LD P+ K T SQ + GLQY+H +
Sbjct: 74 SIYMVFEYMDHDLTGLLD---SPEVK----------FTESQIKCYMKQLLEGLQYLHSNG 120
Query: 449 QPSIVHRDIRTNNIQLDSRFKAKIANFSLA--------APATNDVM-------------- 486
I+HRDI+ +NI +++ K+A+F LA A TN V+
Sbjct: 121 ---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGAT 177
Query: 487 ---PKFDVFAFGVVLLELLSGK 505
P+ D+++ G +L EL GK
Sbjct: 178 RYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 3e-20
Identities = 54/206 (26%), Positives = 85/206 (41%), Gaps = 54/206 (26%)
Query: 341 IGK----SVYRAT--IDGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGV 385
+G+ SVY A G+++AVK ++ E + E+RIL + H N+V+ G
Sbjct: 8 LGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGS 67
Query: 386 SSDSQGNRFLVY-EYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYM 444
D + N ++ EY GSL L K VI R + + GL Y+
Sbjct: 68 ERDEEKNTLNIFLEYVSGGSLSSLLK---KFGKLPEPVI------R-KYTRQILEGLAYL 117
Query: 445 HEHAQPSIVHRDIRTNNIQLDSRFKAKIANF----SLAAPATNDVMPKF----------- 489
H + IVHRDI+ NI +DS K+A+F L T +
Sbjct: 118 HSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV 174
Query: 490 ----------DVFAFGVVLLELLSGK 505
D+++ G ++E+ +GK
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 1e-19
Identities = 59/201 (29%), Positives = 93/201 (46%), Gaps = 48/201 (23%)
Query: 340 SIGK----SVYRAT--IDGKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVS 386
IGK VY+A GK +A+K IK E + E++IL++ H N+VK G S
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYG-S 65
Query: 387 SDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHE 446
+ ++V E+ GSL L +++ LT SQ V ++ GL+Y+H
Sbjct: 66 YLKKDELWIVMEFCSGGSLKDLLKSTNQT---------LTESQIAYVCKELLKGLEYLHS 116
Query: 447 HAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAA-----PATNDVM--------------- 486
+ I+HRDI+ NI L S + K+ +F L+A A N ++
Sbjct: 117 N---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKP 173
Query: 487 --PKFDVFAFGVVLLELLSGK 505
K D+++ G+ +EL GK
Sbjct: 174 YDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 6e-19
Identities = 56/194 (28%), Positives = 92/194 (47%), Gaps = 42/194 (21%)
Query: 340 SIGK----SVYRATIDGKVLAVKKIKEDVTE------ELRILQRINHANLVKLMGVSSDS 389
+IGK V G+ +AVK +K+D T E ++ + H NLV+L+GV
Sbjct: 13 TIGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQG 72
Query: 390 QGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQ 449
++V EY GSL +L + ++ +T +Q+L ALDV G++Y+ E
Sbjct: 73 NP-LYIVTEYMAKGSLVDYLRSRGRA--------VITLAQQLGFALDVCEGMEYLEEK-- 121
Query: 450 PSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDV----MP----------------KF 489
+ VHRD+ N+ + AK+++F LA A+ +P K
Sbjct: 122 -NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWTAPEALREKKFSTKS 180
Query: 490 DVFAFGVVLLELLS 503
DV++FG++L E+ S
Sbjct: 181 DVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (209), Expect = 4e-18
Identities = 56/208 (26%), Positives = 88/208 (42%), Gaps = 54/208 (25%)
Query: 341 IGK----SVYRA--TIDGKVLAVKKI---------KEDVTEELRILQRINHANLVKLMGV 385
IGK VY DGK+ +K+I +ED E++IL+++NH N++K
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY-- 65
Query: 386 SSDS---QGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQ 442
+S +G +V EYA+ G L + K K G Q L + + L+
Sbjct: 66 --ESFEEKGKLCIVMEYADGGDLSQ----KIKKQKKEG--KPFPEEQILDWFVQLCLALK 117
Query: 443 YMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDV----------------- 485
Y+H I+HRDI+ NI L S K+ +F ++ ++ V
Sbjct: 118 YLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPEL 174
Query: 486 ---MP---KFDVFAFGVVLLELLSGKKA 507
P K D+++ G VL EL + K
Sbjct: 175 CQNKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 6e-17
Identities = 50/207 (24%), Positives = 79/207 (38%), Gaps = 56/207 (27%)
Query: 338 HYSIGKSVYRATID------GKVLAVKKIKEDVTE--------ELRILQRINHANLVKLM 383
H+ V D G+ +AVK + E E+ IL+ ++H N+VK
Sbjct: 16 HFG---KVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYK 72
Query: 384 GVSSDSQGNRF-LVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQ 442
GV G L+ EY +GSL +L + + + + L + + G+
Sbjct: 73 GVCEKPGGRSLRLIMEYLPSGSLRDYL-QRHRDQINLK--------RLLLFSSQICKGMD 123
Query: 443 YMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDV----------MPKF--- 489
Y+ +HRD+ NI ++S KI++F LA D P F
Sbjct: 124 YLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYA 180
Query: 490 -------------DVFAFGVVLLELLS 503
DV++FGV L EL +
Sbjct: 181 PECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 3e-16
Identities = 51/203 (25%), Positives = 89/203 (43%), Gaps = 52/203 (25%)
Query: 341 IGK----SVYRA--TIDGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGV 385
IG+ VY+ G +A+K+I + + +E+ +L+ + H N+VK +G
Sbjct: 8 IGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG- 66
Query: 386 SSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMH 445
S ++ + +++ EYAENGSL + + S +V Q L+ GL Y+H
Sbjct: 67 SIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYV---YQVLQ-------GLAYLH 116
Query: 446 EHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA--------------------APAT--- 482
E ++HRDI+ NI K+A+F +A AP
Sbjct: 117 EQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM 173
Query: 483 NDVMPKFDVFAFGVVLLELLSGK 505
+ D+++ G ++ELL+G
Sbjct: 174 SGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 5e-16
Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 49/207 (23%)
Query: 345 VYRATI-------DGKVLAVKKIKE--------DVTEELRILQRINHANLVKLMGVSSDS 389
V+ D +++AVK +KE D E +L H N+VK GV ++
Sbjct: 21 VFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG 80
Query: 390 QGNRFLVYEYAENGSLDKWLH---PKSKSSSSSGSVIF-LTWSQRLRVALDVANGLQYMH 445
+V+EY E+G L+K+L P + S S + LT SQ L++A+ +A+G+ Y+
Sbjct: 81 -DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYL- 138
Query: 446 EHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA-TNDV-------------MP---- 487
A VHRD+ T N + KI +F ++ T D MP
Sbjct: 139 --ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESI 196
Query: 488 ---KF----DVFAFGVVLLELLS-GKK 506
KF DV++FGVVL E+ + GK+
Sbjct: 197 MYRKFTTESDVWSFGVVLWEIFTYGKQ 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (193), Expect = 7e-16
Identities = 55/199 (27%), Positives = 93/199 (46%), Gaps = 55/199 (27%)
Query: 345 VYRAT--IDGKVLAVKKIKEDVTEE------LR---ILQRINHANLVKLMGV--SSDSQG 391
VY+A G+++A+KKI+ D EE LR +L+ + H N+VKL+ V +
Sbjct: 15 VYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKL- 73
Query: 392 NRFLVYEYAENGSLDKWLHPKSKSSSSSGSVI-FLTWSQRLRVALDVANGLQYMHEHAQP 450
+LV+EY + L K+L + S ++I + + Q LR GL Y H H
Sbjct: 74 --YLVFEYCDM-DLKKYL--DKRPGPLSPNLIKSIMY-QLLR-------GLAYCHSH--- 117
Query: 451 SIVHRDIRTNNIQLDSRFKAKIANFSLAAPA-------TNDVM----------------- 486
I+HRD++ NI ++ K+A+F LA T++V+
Sbjct: 118 RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYS 177
Query: 487 PKFDVFAFGVVLLELLSGK 505
D+++ G + E+++GK
Sbjct: 178 TAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 8e-15
Identities = 52/199 (26%), Positives = 85/199 (42%), Gaps = 52/199 (26%)
Query: 345 VYRA--TIDGKVLAVKKIKE------------DVTEELRILQRINHANLVKLMGVSSDSQ 390
VY+A G+++A+KKIK E+++LQ + H N++ L+ V +
Sbjct: 16 VYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFG-HK 74
Query: 391 GNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQP 450
N LV+E+ E L+K + KS I LT + L GL+Y+H +
Sbjct: 75 SNINLVFEFME-TDLEKVIKDKS---------IVLTPADIKSYMLMTLRGLEYLHSN--- 121
Query: 451 SIVHRDIRTNNIQLDSRFKAKIANFSLAA--PATNDVM---------------------- 486
I+HRD++ NN+ + S K+A+F LA + N M
Sbjct: 122 WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYG 181
Query: 487 PKFDVFAFGVVLLELLSGK 505
D+++ G + ELL
Sbjct: 182 VGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 53/188 (28%), Positives = 96/188 (51%), Gaps = 39/188 (20%)
Query: 351 DGKVL-AVKKIKEDVTE--------ELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAE 401
D VL AVK ++ D ++ E++IL R++ N+ +L+GV + ++ EY E
Sbjct: 44 DAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDP-PLCMIMEYME 102
Query: 402 NGSLDKWLHP-KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTN 460
NG L+++L +++S + + L++S L +A +A+G++Y+ + VHRD+ T
Sbjct: 103 NGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATR 159
Query: 461 NIQLDSRFKAKIANFSLAAPA-TND--------VMP------------KF----DVFAFG 495
N + + KIA+F ++ ++D +P KF DV+AFG
Sbjct: 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFG 219
Query: 496 VVLLELLS 503
V L E+L+
Sbjct: 220 VTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 44/152 (28%), Positives = 73/152 (48%), Gaps = 30/152 (19%)
Query: 345 VYRA--TIDGKVLAVKKIKEDVTEE------------LRILQRINHANLVKLMGVSSDSQ 390
VY+A G+ +A+KK++ ++EE L+ L+ H N+V+L+ V +
Sbjct: 15 VYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPR 74
Query: 391 GNR----FLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHE 446
+R LV+E+ + L +L K ++ L Q LR G+ ++H
Sbjct: 75 TDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMR-QLLR-------GVDFLHS 125
Query: 447 HAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA 478
H IVHRD++ NI + S + KIA+F LA
Sbjct: 126 HR---IVHRDLKPQNILVTSDGQVKIADFGLA 154
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 58/192 (30%), Positives = 84/192 (43%), Gaps = 57/192 (29%)
Query: 355 LAVKKIKEDVTE--------ELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLD 406
+AVK + E +E E I+ + NH N+V+L+GVS + RF++ E G L
Sbjct: 39 VAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL-PRFILLELMAGGDLK 97
Query: 407 KWL---HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQ 463
+L P+ + SS LT L A DVA G +Y+ E+ +HRDI N
Sbjct: 98 SFLRENRPRPERPSS------LTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCL 148
Query: 464 LDSRFK---AKIANFSLAAPATNDV------------------MP-----------KFDV 491
L + AKIA+F +A D+ MP K DV
Sbjct: 149 LTCKGPGRVAKIADFGMA----RDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDV 204
Query: 492 FAFGVVLLELLS 503
++FGV+L E+ S
Sbjct: 205 WSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 52/177 (29%), Positives = 87/177 (49%), Gaps = 36/177 (20%)
Query: 352 GKVLAVKKIKEDVTE-----ELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLD 406
G +AVK IK D T E ++ ++ H+NLV+L+GV + +G ++V EY GSL
Sbjct: 29 GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 88
Query: 407 KWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDS 466
+L + +S L L+ +LDV ++Y+ + + VHRD+ N+ +
Sbjct: 89 DYLRSRGRS--------VLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSE 137
Query: 467 RFKAKIANFSLA--APATNDV--MP----------------KFDVFAFGVVLLELLS 503
AK+++F L A +T D +P K DV++FG++L E+ S
Sbjct: 138 DNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 4e-14
Identities = 50/195 (25%), Positives = 79/195 (40%), Gaps = 46/195 (23%)
Query: 344 SVYRAT--IDGKVLAVKKIKEDVTE--------ELRILQRINHANLVKLMGVSSDSQGNR 393
VY+ GK+ A+KKI D E EL+ L+ +VK G +G
Sbjct: 16 VVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF-YKEGEI 74
Query: 394 FLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIV 453
+V EY + GSL L K + I Q + GL Y+H + I+
Sbjct: 75 SIVLEYMDGGSLADLLKKVGKIPEPVLAYIA---RQ-------ILKGLDYLH--TKRHII 122
Query: 454 HRDIRTNNIQLDSRFKAKIANFSLAAPATNDVMPKF-----------------------D 490
HRDI+ +N+ ++S+ + KIA+F ++ N + D
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAAD 182
Query: 491 VFAFGVVLLELLSGK 505
+++ G+ LLE GK
Sbjct: 183 IWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 5e-14
Identities = 70/280 (25%), Positives = 100/280 (35%), Gaps = 77/280 (27%)
Query: 342 GKSVYRA---TIDGKVL--AVK--------KIKEDVTEELRILQRINHANLVKLMGVSSD 388
V R T GKV+ AVK I +D +E I+ ++H NL++L GV
Sbjct: 8 FGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT 67
Query: 389 SQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHA 448
+V E A GSL L + S A+ +ANG++Y+
Sbjct: 68 HP--LMMVTELAPLGSLLDRLRKDALG--------HFLISTLCDYAVQIANGMRYLE--- 114
Query: 449 QPSIVHRDIRTNNIQLDSRFKAKIANFSL--AAPATND--VMP----------------- 487
+HRD+ NI L S K KI +F L A P D VM
Sbjct: 115 SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT 174
Query: 488 -KF----DVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIR--EVLKVEEKREERLRN 539
F DV+ FGV L E+ + G++ W + ++LK +K ERL
Sbjct: 175 RTFSHASDVWMFGVTLWEMFTYGEEP------------WAGLSGSQILKKIDKEGERLER 222
Query: 540 WMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVV 579
P + + C RP A +
Sbjct: 223 ----------PEACPQDIYNVMLQCWAHNPADRPTFAALR 252
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 7e-14
Identities = 49/191 (25%), Positives = 82/191 (42%), Gaps = 46/191 (24%)
Query: 346 YRATIDGKVLAVKKIKE------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEY 399
+R ID +A+K I+E D EE +++ +++H NLV+L GV + Q F+V EY
Sbjct: 25 WRGKID---VAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT-KQRPIFIVTEY 80
Query: 400 AENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRT 459
NG L +L + + L + DV ++Y+ + +HRD+
Sbjct: 81 MANGCLLNYLRERKGKLGT---------EWLLDMCSDVCEAMEYLESN---GFIHRDLAA 128
Query: 460 NNIQLDSRFKAKIANFSLAAPATND-----VMPKF-------------------DVFAFG 495
N + K+++F LA +D KF DV++FG
Sbjct: 129 RNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFG 188
Query: 496 VVLLELLSGKK 506
V++ E+ S K
Sbjct: 189 VLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 54/208 (25%), Positives = 88/208 (42%), Gaps = 52/208 (25%)
Query: 336 SEHYS----IGK----SVYRAT--IDGKVLAVKKI------KEDVTEELRILQRINHANL 379
E Y IG+ VY+AT GK +A+KK+ KE + E+ I++ H N+
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNI 77
Query: 380 VKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVAN 439
V S ++V EY + GSL + + Q V +V
Sbjct: 78 VDYYD-SYLVGDELWVVMEYMDGGSLTDIITQNFVR---------MNEPQIAYVCREVLQ 127
Query: 440 GLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDV------------M- 486
GL+Y+H +++HRDI+++NI L K+A+F AA T + M
Sbjct: 128 GLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMA 184
Query: 487 ----------PKFDVFAFGVVLLELLSG 504
PK D+++ G++ +E+ G
Sbjct: 185 PEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 5e-13
Identities = 42/147 (28%), Positives = 75/147 (51%), Gaps = 20/147 (13%)
Query: 344 SVYRAT--IDGKVLAVKK--IKEDVTE---ELRILQRINHANLVKLMGVSSDSQGNRFLV 396
SVY+A G+V+A+K ++ED+ E E+ IL++ + +VK G S + ++V
Sbjct: 18 SVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYG-SYFKNTDLWIV 76
Query: 397 YEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRD 456
EY GS+ + +K+ LT + + GL+Y+H + +HRD
Sbjct: 77 MEYCGAGSVSDIMKITNKT---------LTEEEIAAILYQTLKGLEYLHSN---KKIHRD 124
Query: 457 IRTNNIQLDSRFKAKIANFSLAAPATN 483
I+ NI L+ +AK+A+F ++ T+
Sbjct: 125 IKAGNILLNEEGQAKLADFGVSGQLTD 151
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 6e-13
Identities = 49/185 (26%), Positives = 96/185 (51%), Gaps = 39/185 (21%)
Query: 354 VLAVKKIKEDVT--------EELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSL 405
++AVK ++ DVT +E++I+ R+ + N+++L+GV ++ EY ENG L
Sbjct: 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDD-PLCMITEYMENGDL 104
Query: 406 DKWLHPKSKSS--SSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQ 463
+++L + S + + ++ ++ + L +A+ +A+G++Y+ A + VHRD+ T N
Sbjct: 105 NQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCL 161
Query: 464 LDSRFKAKIANFSLAAPATND---------VMP------------KF----DVFAFGVVL 498
+ + + KIA+F ++ + V+P KF DV+AFGV L
Sbjct: 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTL 221
Query: 499 LELLS 503
E+ +
Sbjct: 222 WEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 6e-13
Identities = 75/271 (27%), Positives = 121/271 (44%), Gaps = 63/271 (23%)
Query: 356 AVKKIKEDVTE--------ELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLD 406
A+K +KE +E EL +L ++ +H N++ L+G + +++G ++ EYA G+L
Sbjct: 33 AIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLG-ACENRGYLYIAIEYAPYGNLL 91
Query: 407 KWLHPKSKS-------SSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRT 459
+L KS+ + G+ LT Q L+ A DVA G+QY+ E +HRD+
Sbjct: 92 DFLR-KSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAA 147
Query: 460 NNIQLDSRFKAKIANFSLA------APATNDVMP----------------KFDVFAFGVV 497
N+ + +KIA+F L+ T +P K DV++FGV+
Sbjct: 148 RNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVL 207
Query: 498 LLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSL 557
L E++S T G T E+ E L + R E+ RN D E
Sbjct: 208 LWEIVS---LGGTPYCGMTCA---ELYEKLP-QGYRMEKPRNCDDEVYE----------- 249
Query: 558 ATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588
L R C D+ RP A++ LS + ++
Sbjct: 250 --LMRQCWRDRPYERPPFAQISVQLSRMLEA 278
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 6e-13
Identities = 59/203 (29%), Positives = 89/203 (43%), Gaps = 61/203 (30%)
Query: 345 VYRA--TIDGKVLAVKKIKED-------VT--EELRILQRINHANLVKLMGVSSDSQGNR 393
VYRA T G+++A+KK++ D ++ E+ +L + H N+V+L V G
Sbjct: 23 VYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVV---VGKH 79
Query: 394 ----FLVYEYAEN--GSL-DKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHE 446
FLV EY E SL D P + SQ + L + GLQY+HE
Sbjct: 80 LDSIFLVMEYCEQDLASLLDNMPTP-------------FSESQVKCLMLQLLRGLQYLHE 126
Query: 447 HAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA---APATNDVMPK--------------- 488
+ I+HRD++ +N+ L + KIA+F LA + PK
Sbjct: 127 NF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGC 183
Query: 489 ------FDVFAFGVVLLELLSGK 505
D++A G +L ELL+ K
Sbjct: 184 TTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 7e-13
Identities = 55/189 (29%), Positives = 91/189 (48%), Gaps = 38/189 (20%)
Query: 344 SVYRATIDGKVLAVKKIKEDVT-----EELRILQRINHANLVKLMGVSSDSQGNRFLVYE 398
+V + G+ +AVK IK DVT EE ++ +++H NLV+L+GV ++V E
Sbjct: 21 AVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVIL--HNGLYIVME 78
Query: 399 YAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIR 458
G+L +L + ++ S Q L+ +LDVA G++Y+ +VHRD+
Sbjct: 79 LMSKGNLVNFLRTRGRALVSV--------IQLLQFSLDVAEGMEYLESK---KLVHRDLA 127
Query: 459 TNNIQLDSRFKAKIANFSLAA----PATNDVMP----------------KFDVFAFGVVL 498
NI + AK+++F LA N +P K DV+++GV+L
Sbjct: 128 ARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLL 187
Query: 499 LELLSGKKA 507
E+ S +A
Sbjct: 188 WEVFSYGRA 196
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 9e-13
Identities = 68/265 (25%), Positives = 119/265 (44%), Gaps = 63/265 (23%)
Query: 356 AVKKIKEDVTE--------ELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLD 406
A+K++KE ++ EL +L ++ +H N++ L+G + + +G +L EYA +G+L
Sbjct: 26 AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLG-ACEHRGYLYLAIEYAPHGNLL 84
Query: 407 KWLHPKSKS-------SSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRT 459
+L KS+ + ++ + L+ Q L A DVA G+ Y+ + +HRD+
Sbjct: 85 DFLR-KSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAA 140
Query: 460 NNIQLDSRFKAKIANFSLA------APATNDVMP----------------KFDVFAFGVV 497
NI + + AKIA+F L+ T +P DV+++GV+
Sbjct: 141 RNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVL 200
Query: 498 LLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSL 557
L E++S T G T E+ E L + R E+ N D +
Sbjct: 201 LWEIVS---LGGTPYCGMTCA---ELYEKLP-QGYRLEKPLNCDDEVYD----------- 242
Query: 558 ATLARACTMDKSLSRPNMAEVVFNL 582
L R C +K RP+ A+++ +L
Sbjct: 243 --LMRQCWREKPYERPSFAQILVSL 265
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 43/144 (29%), Positives = 71/144 (49%), Gaps = 27/144 (18%)
Query: 344 SVYRA-TID-GKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVS-SDSQG 391
VY A +D G+++AVK+I+ +++ +E+++L+ + H NLVK GV +
Sbjct: 15 KVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKV 74
Query: 392 NRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPS 451
F+ EY G+L++ L G ++ + L + GL Y+H H
Sbjct: 75 YIFM--EYCSGGTLEELLE--------HGRILDEHVIRVY--TLQLLEGLAYLHSHG--- 119
Query: 452 IVHRDIRTNNIQLDSRFKAKIANF 475
IVHRDI+ NI LD K+ +F
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDF 143
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 49/181 (27%), Positives = 87/181 (48%), Gaps = 46/181 (25%)
Query: 356 AVKKIKEDVTEELR--------ILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407
A+K +K +++ R I+ + +H N+++L GV + S+ ++ EY ENGSLDK
Sbjct: 36 AIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSR-PVMIITEYMENGSLDK 94
Query: 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSR 467
+L T Q + + +A+G++Y+ E + VHRD+ NI ++S
Sbjct: 95 FLRENDGK---------FTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSN 142
Query: 468 FKAKIANFSLA-----APATNDVM----------P------KF----DVFAFGVVLLELL 502
K+++F L+ + AT P KF DV++FG+V+ E++
Sbjct: 143 LVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVM 202
Query: 503 S 503
S
Sbjct: 203 S 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 49/184 (26%), Positives = 86/184 (46%), Gaps = 41/184 (22%)
Query: 351 DGKVLAVKKIKEDVTE--------ELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAEN 402
GK++AVK I+ ++ E EL IL + N +V G + + G+ + EY +
Sbjct: 25 TGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG-AFYNNGDISICMEYMDG 83
Query: 403 GSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNI 462
GSLDK L G + ++A+ V GL Y+HE + I+HRD++ +NI
Sbjct: 84 GSLDKIL------KEVQGRIPERILG---KIAVAVLKGLTYLHE--KHKIIHRDVKPSNI 132
Query: 463 QLDSRFKAKIANFSLAAPATNDVMPKF---------------------DVFAFGVVLLEL 501
++SR + K+ +F ++ N + F D+++ G+ L+EL
Sbjct: 133 LVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIEL 192
Query: 502 LSGK 505
+G+
Sbjct: 193 ATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 52/195 (26%), Positives = 93/195 (47%), Gaps = 49/195 (25%)
Query: 354 VLAVKKIKEDVTEELR--------ILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSL 405
++AVK +KE+ + +++ ++ +H N+VKL+GV + L++EY G L
Sbjct: 37 MVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV-GKPMCLLFEYMAYGDL 95
Query: 406 DKWLH---PKSKSSSSSGSVIF---------LTWSQRLRVALDVANGLQYMHEHAQPSIV 453
+++L P+++ S S + L+ +++L +A VA G+ Y+ E V
Sbjct: 96 NEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFV 152
Query: 454 HRDIRTNNIQLDSRFKAKIANFSLA---------APATNDVMP------------KF--- 489
HRD+ T N + KIA+F L+ + ND +P ++
Sbjct: 153 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTE 212
Query: 490 -DVFAFGVVLLELLS 503
DV+A+GVVL E+ S
Sbjct: 213 SDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 50/182 (27%), Positives = 86/182 (47%), Gaps = 38/182 (20%)
Query: 356 AVKKIKEDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH----- 410
A K + D +E++IL R+ N+++L+GV D ++ EY ENG L+++L
Sbjct: 58 ANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDED-PLCMITEYMENGDLNQFLSSHHLD 116
Query: 411 ----PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDS 466
+ + + + +++S L VAL +A+G++Y+ + + VHRD+ T N +
Sbjct: 117 DKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGE 173
Query: 467 RFKAKIANFSLAAPA-TND--------------------VMPKF----DVFAFGVVLLEL 501
KIA+F ++ D +M KF DV+AFGV L E+
Sbjct: 174 NLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEI 233
Query: 502 LS 503
L
Sbjct: 234 LM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 4e-12
Identities = 54/201 (26%), Positives = 83/201 (41%), Gaps = 50/201 (24%)
Query: 340 SIGKSVY--RATIDGKVLAVKKIK----------EDVTEELRILQRINHANLVKLMGVSS 387
S GK V R GK+ A+K +K E E IL RINH +VKL +
Sbjct: 5 SFGK-VLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH-YAF 62
Query: 388 DSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEH 447
++ +LV EYA G L L + + F R A ++ L+Y+H
Sbjct: 63 QTEEKLYLVLEYAPGGELFSHLSKEGR---------FSEERARFYAA-EIVLALEYLHSL 112
Query: 448 AQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVM--------------------- 486
I++RD++ NI LD+ K+ +F LA +++
Sbjct: 113 ---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKG 169
Query: 487 --PKFDVFAFGVVLLELLSGK 505
D ++ GV+L E+L+GK
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 67.8 bits (164), Expect = 4e-12
Identities = 53/205 (25%), Positives = 85/205 (41%), Gaps = 56/205 (27%)
Query: 345 VYRATIDGKVLAVKKIKEDVTE----------ELRILQRINHA-NLVKLMGVSSDSQGNR 393
VY A D K++A+K + + + E++IL +NH N+VKL D +G+
Sbjct: 16 VYLA-RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD-EGSL 73
Query: 394 FLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIV 453
+LV EY + GSL+ L G L+ S+ L + + + L+Y+H I+
Sbjct: 74 YLVMEYVDGGSLEDLLK-------KIGRKGPLSESEALFILAQILSALEYLHSK---GII 123
Query: 454 HRDIRTNNIQLDS-RFKAKIANFSLAAPATNDVM-------------------------- 486
HRDI+ NI LD K+ +F LA +
Sbjct: 124 HRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGL 183
Query: 487 ------PKFDVFAFGVVLLELLSGK 505
D+++ G+ L ELL+G
Sbjct: 184 SLAYASSSSDIWSLGITLYELLTGL 208
|
Length = 384 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 5e-12
Identities = 46/174 (26%), Positives = 89/174 (51%), Gaps = 30/174 (17%)
Query: 356 AVKKIKEDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL-HPKSK 414
A K + D +E++I+ R+ N+++L+ V S ++ EY ENG L+++L + +
Sbjct: 58 ANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSD-PLCMITEYMENGDLNQFLSRHEPQ 116
Query: 415 SSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIAN 474
++ V+ +++S + +A +A+G++Y+ + + VHRD+ T N + + KIA+
Sbjct: 117 EAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIAD 173
Query: 475 FSLAAPATND---------VMP------------KF----DVFAFGVVLLELLS 503
F ++ + V+P KF DV+AFGV L E+L+
Sbjct: 174 FGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 5e-12
Identities = 72/286 (25%), Positives = 114/286 (39%), Gaps = 75/286 (26%)
Query: 339 YSIGKS----VYRAT--IDGKVLAVKKI---------KEDVTEELRILQRINHANLVKLM 383
IGK V++ D +V A+K+I +E+ +E R+L +++ + +++
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYY 65
Query: 384 GVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQY 443
D +G +V EYAENG L K L + V W R + + GL +
Sbjct: 66 ESFLD-KGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQV----W----RFFIQILLGLAH 116
Query: 444 MHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA--------------------APATN 483
+H I+HRDI++ N+ LD+ KI + +A +P
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELC 173
Query: 484 DVMP---KFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNW 540
+ P K DV+A GVVL E +GK G A++ K IR V
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG--ALILKIIRGV-------------- 217
Query: 541 MDPNLESFYPIDGALS--LATLARACTMDKSLSRPNMAEVVFNLSV 584
F P+ S LA L C RP+ +++ N S+
Sbjct: 218 -------FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 6e-12
Identities = 45/176 (25%), Positives = 80/176 (45%), Gaps = 35/176 (19%)
Query: 359 KIKEDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL-----HPKS 413
K++++ +E ++ + H N+V L+GV + Q L +EY +G L ++L H
Sbjct: 50 KVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCML-FEYLAHGDLHEFLVRNSPHSDV 108
Query: 414 KSSSSSGSVIFLTW-SQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKI 472
+ S +V S L +A+ +A G++Y+ H VHRD+ N + KI
Sbjct: 109 GAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKI 165
Query: 473 ANFSLAAPA---------TNDVMP------------KF----DVFAFGVVLLELLS 503
++F L+ + ++P KF D+++FGVVL E+ S
Sbjct: 166 SDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 6e-12
Identities = 51/188 (27%), Positives = 83/188 (44%), Gaps = 43/188 (22%)
Query: 345 VYRATIDGKV-LAVKKIK------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVY 397
V+ T +G +AVK +K E +E +I++++ H LV+L V S+ + ++V
Sbjct: 22 VWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEE-PIYIVT 80
Query: 398 EYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDI 457
EY GSL +L SG L Q + +A +A G+ Y+ + +HRD+
Sbjct: 81 EYMSKGSLLDFLK--------SGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDL 129
Query: 458 RTNNIQLDSRFKAKIANFSLAAPATNDV--------MP----------------KFDVFA 493
NI + KIA+F LA +D P K DV++
Sbjct: 130 AARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWS 189
Query: 494 FGVVLLEL 501
FG++L E+
Sbjct: 190 FGILLTEI 197
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 7e-12
Identities = 51/187 (27%), Positives = 88/187 (47%), Gaps = 47/187 (25%)
Query: 352 GKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRF-LVYEYAEN 402
G+ +AVK +K D+ +E+ IL+ + H N+VK G+ ++ GN L+ E+ +
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92
Query: 403 GSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNI 462
GSL ++L P++K+ + Q+L+ A+ + G+ Y+ VHRD+ N+
Sbjct: 93 GSLKEYL-PRNKNK--------INLKQQLKYAVQICKGMDYL---GSRQYVHRDLAARNV 140
Query: 463 QLDSRFKAKIANFSLAAPATND----------------------VMPKF----DVFAFGV 496
++S + KI +F L D + KF DV++FGV
Sbjct: 141 LVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGV 200
Query: 497 VLLELLS 503
L ELL+
Sbjct: 201 TLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 51/190 (26%), Positives = 87/190 (45%), Gaps = 44/190 (23%)
Query: 354 VLAVKKIKEDVTE--------ELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGS 404
+AVK +K+D TE E+ +++ I H N++ L+GV + +G ++V EYA +G+
Sbjct: 44 TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT-QEGPLYVVVEYAAHGN 102
Query: 405 LDKWLH---PKSKSSSSSGSVIF---LTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIR 458
L +L P + +S LT + A VA G++++ A +HRD+
Sbjct: 103 LRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFL---ASKKCIHRDLA 159
Query: 459 TNNIQLDSRFKAKIANFSLA---------APATNDVMP----------------KFDVFA 493
N+ + KIA+F LA TN +P + DV++
Sbjct: 160 ARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 219
Query: 494 FGVVLLELLS 503
FGV+L E+ +
Sbjct: 220 FGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 57/186 (30%), Positives = 81/186 (43%), Gaps = 46/186 (24%)
Query: 352 GKVLAVKKIKEDVTEELR-------ILQRINHANLVKLMGVS-SDSQGNRFLVYEYAENG 403
G+V+AVKK++ E LR IL+ + H N+VK GV S + N LV EY G
Sbjct: 33 GEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYG 92
Query: 404 SLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQ 463
SL +L K + L + L A + G++Y+ VHRD+ T NI
Sbjct: 93 SLRDYLQ-KHRER--------LDHRKLLLYASQICKGMEYL---GSKRYVHRDLATRNIL 140
Query: 464 LDSRFKAKIANFSLAA--PATNDVM--------PKF----------------DVFAFGVV 497
++S + KI +F L P + P F DV++FGVV
Sbjct: 141 VESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVV 200
Query: 498 LLELLS 503
L EL +
Sbjct: 201 LYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 45/213 (21%), Positives = 98/213 (46%), Gaps = 48/213 (22%)
Query: 334 NLSEHYSIGKS----VYRATIDG-------KVLAVKKIKE--------DVTEELRILQRI 374
NL E ++G+ V+ A G ++ VK +++ + EL + +++
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 375 NHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVA 434
+H N+V+L+G+ +++ + +++ EY + G L ++L +KS L+ Q++ +
Sbjct: 66 SHKNVVRLLGLCREAEPH-YMILEYTDLGDLKQFLR-ATKSKDEKLKPPPLSTKQKVALC 123
Query: 435 LDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATND--------VM 486
+A G+ ++ VHRD+ N + S+ + K++ SL+ N ++
Sbjct: 124 TQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI 180
Query: 487 P----------------KFDVFAFGVVLLELLS 503
P K DV++FGV++ E+ +
Sbjct: 181 PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 69/276 (25%), Positives = 126/276 (45%), Gaps = 67/276 (24%)
Query: 356 AVKKIKE--------DVTEELRILQRIN-HANLVKLMGVSSDSQGNRFLVYEYAENGSLD 406
A+K++KE D EL +L ++ H N++ L+G + + +G +L EYA +G+L
Sbjct: 38 AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLG-ACEHRGYLYLAIEYAPHGNLL 96
Query: 407 KWLH--------PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIR 458
+L P ++S+ S L+ Q L A DVA G+ Y+ +Q +HRD+
Sbjct: 97 DFLRKSRVLETDPAFAIANSTAST--LSSQQLLHFAADVARGMDYL---SQKQFIHRDLA 151
Query: 459 TNNIQLDSRFKAKIANFSLA------APATNDVMP----------------KFDVFAFGV 496
NI + + AKIA+F L+ T +P DV+++GV
Sbjct: 152 ARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGV 211
Query: 497 VLLELLSGKKATRTTENGKT-AVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGAL 555
+L E++S T G T A L++++ + ++E+ P++
Sbjct: 212 LLWEIVS---LGGTPYCGMTCAELYEKLPQGYRLEK------------------PLNCDD 250
Query: 556 SLATLARACTMDKSLSRPNMAEVVFNLSVLTQSTET 591
+ L R C +K RP+ A+++ +L+ + + +T
Sbjct: 251 EVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 286
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 49/202 (24%), Positives = 81/202 (40%), Gaps = 52/202 (25%)
Query: 338 HYSIGKSVYRATIDGKVLAVKKI----KED-----VTEELRILQRINHANLVKLMGVSSD 388
H + K+ R T G+ +A+KK+ E E++ LQ H +VKL+ V
Sbjct: 13 HGIVFKAKDRET--GETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH 70
Query: 389 SQGNRF-LVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEH 447
G+ F LV EY L + L + + L +Q + G+ YMH +
Sbjct: 71 --GSGFVLVMEYMP-SDLSEVLRDEERP---------LPEAQVKSYMRMLLKGVAYMHAN 118
Query: 448 AQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVMPKF------------------ 489
I+HRD++ N+ + + KIA+F LA + + +
Sbjct: 119 ---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175
Query: 490 -------DVFAFGVVLLELLSG 504
D++A G + ELL+G
Sbjct: 176 RKYDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-11
Identities = 53/194 (27%), Positives = 84/194 (43%), Gaps = 44/194 (22%)
Query: 355 LAVKKIKE------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKW 408
+A+K IKE + EE +++ +++H LV+L GV + Q ++V EY NG L +
Sbjct: 31 VAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT-KQRPIYIVTEYMSNGCLLNY 89
Query: 409 LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRF 468
L K SQ L + DV G+ Y+ +HRD+ N +D +
Sbjct: 90 LREHGKR---------FQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQG 137
Query: 469 KAKIANFSLAAPATND-----VMPKF-------------------DVFAFGVVLLELLS- 503
K+++F L+ +D V KF DV+AFGV++ E+ S
Sbjct: 138 CVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSL 197
Query: 504 GKKATRTTENGKTA 517
GK N +T
Sbjct: 198 GKMPYERFNNSETV 211
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (157), Expect = 3e-11
Identities = 54/196 (27%), Positives = 88/196 (44%), Gaps = 47/196 (23%)
Query: 344 SVYRATI--DGKVLAVKKIK------EDVTE--ELRILQRIN-HANLVKLMGVSSDSQGN 392
SVY A G+++A+KK+K E+ E++ L+++N H N+VKL V ++
Sbjct: 14 SVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREN-DE 72
Query: 393 RFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSI 452
+ V+EY E G+L + L K S SVI Q + GL ++H+H
Sbjct: 73 LYFVFEYME-GNLYQ-LMKDRKGKPFSESVIRSIIYQ-------ILQGLAHIHKHG---F 120
Query: 453 VHRDIRTNNIQLDSRFKAKIANFSLA------APATNDVM-----------------PKF 489
HRD++ N+ + KIA+F LA P T+ V
Sbjct: 121 FHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPV 180
Query: 490 DVFAFGVVLLELLSGK 505
D++A G ++ EL + +
Sbjct: 181 DIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 44/157 (28%), Positives = 67/157 (42%), Gaps = 26/157 (16%)
Query: 340 SIGK----SVYRA--TIDGKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVS 386
IG VY+A G+++A+K IK E + +E+ +L+ H N+V G S
Sbjct: 10 RIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFG-S 68
Query: 387 SDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHE 446
+ ++V EY GSL L+ Q V + GL Y+HE
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQDIYQVTRGP---------LSELQIAYVCRETLKGLAYLHE 119
Query: 447 HAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN 483
+HRDI+ NI L K+A+F ++A T
Sbjct: 120 T---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTA 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 55/188 (29%), Positives = 82/188 (43%), Gaps = 51/188 (27%)
Query: 352 GKVLAVKKIKEDVTE--------ELRILQRINHANLVKLMGVSSDSQGNR--FLVYEYAE 401
G+++AVK +K + + E+ IL+ + H N+VK G S+ QG + L+ EY
Sbjct: 33 GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSE-QGGKGLQLIMEYVP 91
Query: 402 NGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNN 461
GSL +L PK K L +Q L A + G+ Y+H +HRD+ N
Sbjct: 92 LGSLRDYL-PKHK----------LNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARN 137
Query: 462 IQLDSRFKAKIANFSLAAP----------ATNDVMPKF----------------DVFAFG 495
+ LD+ KI +F LA + P F DV++FG
Sbjct: 138 VLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFG 197
Query: 496 VVLLELLS 503
V L ELL+
Sbjct: 198 VTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 4e-11
Identities = 43/190 (22%), Positives = 74/190 (38%), Gaps = 41/190 (21%)
Query: 351 DGKVLAVKKI---------KEDVTEELRILQRINHANLVKLMGVSSDSQGNR-FLVYEYA 400
DGK+L K+I K+ + E+ IL+ + H N+V+ D ++V EY
Sbjct: 24 DGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYC 83
Query: 401 ENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMH--EHAQPSIVHRDIR 458
E G L + L K K ++ R+ + L H +++HRD++
Sbjct: 84 EGGDLAQ-LIQKCKKERK-----YIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLK 137
Query: 459 TNNIQLDSRFKAKIANFSLAAPATNDVM-----------------------PKFDVFAFG 495
NI LD+ K+ +F LA +D K D+++ G
Sbjct: 138 PANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLG 197
Query: 496 VVLLELLSGK 505
++ EL +
Sbjct: 198 CLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 5e-11
Identities = 45/161 (27%), Positives = 65/161 (40%), Gaps = 28/161 (17%)
Query: 340 SIGKSVYRAT--IDGKVLAVK---K---IKE----DVTEELRILQRIN-HANLVKLMGVS 386
S V A K A+K K IKE V E +L R+N H ++KL
Sbjct: 13 SFST-VVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF 71
Query: 387 SDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHE 446
D + N + V EYA NG L +++ K S ++ + L+Y+H
Sbjct: 72 QD-EENLYFVLEYAPNGELLQYIR---KYGSLDEKCTRFYAAE-------ILLALEYLHS 120
Query: 447 HAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVMP 487
I+HRD++ NI LD KI +F A + P
Sbjct: 121 K---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 6e-11
Identities = 52/202 (25%), Positives = 87/202 (43%), Gaps = 51/202 (25%)
Query: 341 IGK----SVYRATIDGKVL-AVKKIKEDVTEELR--------ILQRINHANLVKLMGVSS 387
IGK VY+ + G AVK + + +L+ IL++ +H N+VKL+GV
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 388 DSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEH 447
Q ++V E GSL +L K LT + L+++LD A G++Y+
Sbjct: 63 QKQ-PIYIVMELVPGGSLLTFLRKKKNR---------LTVKKLLQMSLDAAAGMEYLE-- 110
Query: 448 AQPSIVHRDIRTNNIQLDSRFKAKIANFSLA----------------------AP-ATN- 483
+ +HRD+ N + KI++F ++ AP A N
Sbjct: 111 -SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNY 169
Query: 484 -DVMPKFDVFAFGVVLLELLSG 504
+ DV+++G++L E S
Sbjct: 170 GRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 8e-11
Identities = 50/196 (25%), Positives = 88/196 (44%), Gaps = 51/196 (26%)
Query: 355 LAVKKIKE--------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLD 406
+AVK +KE D+ E +L+++NH +++KL G S G L+ EYA+ GSL
Sbjct: 33 VAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACS-QDGPLLLIVEYAKYGSLR 91
Query: 407 KWLHPKSK--------SSSSSGSVIF------LTWSQRLRVALDVANGLQYMHEHAQPSI 452
+L K + + S + LT + A ++ G+QY+ A+ +
Sbjct: 92 SFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYL---AEMKL 148
Query: 453 VHRDIRTNNIQLDSRFKAKIANFSLA---------APATNDVMP---------------- 487
VHRD+ N+ + K KI++F L+ + +P
Sbjct: 149 VHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTT 208
Query: 488 KFDVFAFGVVLLELLS 503
+ DV++FGV+L E+++
Sbjct: 209 QSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 42/196 (21%), Positives = 83/196 (42%), Gaps = 38/196 (19%)
Query: 341 IGKSVYRATIDGKVLAVKKIKEDVT--------EELRILQRINHANLVKLMGVSSDSQGN 392
+ K V + + +V A+K + E+ + E +++ N ++V+L+GV S Q
Sbjct: 26 LAKGVVKGEPETRV-AIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ-P 83
Query: 393 RFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSI 452
+V E G L +L + + ++ + T + +++A ++A+G+ Y+
Sbjct: 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KF 140
Query: 453 VHRDIRTNNIQLDSRFKAKIANFSLA---------APATNDVMP---------------- 487
VHRD+ N + KI +F + ++P
Sbjct: 141 VHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTT 200
Query: 488 KFDVFAFGVVLLELLS 503
K DV++FGVVL E+ +
Sbjct: 201 KSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 48/197 (24%), Positives = 90/197 (45%), Gaps = 49/197 (24%)
Query: 344 SVYRA--TIDGKVLAVKKIKEDVTE---------ELRILQRINHANLVKLMGVSSDSQGN 392
VY+A + G+++A+KKIK E+++L+ +NH N++KL+ V +G+
Sbjct: 14 VVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH-KGD 72
Query: 393 RFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSI 452
+LV+E+ + L K + + + S + + Q L+ GL + H H I
Sbjct: 73 LYLVFEFMDT-DLYKLIKDRQRGLPES-LIKSYLY-QLLQ-------GLAFCHSH---GI 119
Query: 453 VHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVMP------------------------K 488
+HRD++ N+ +++ K+A+F LA + V P
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTP 179
Query: 489 FDVFAFGVVLLELLSGK 505
D+++ G + ELLS +
Sbjct: 180 VDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 43/180 (23%), Positives = 83/180 (46%), Gaps = 42/180 (23%)
Query: 352 GKVLAVKKIKEDVTE------ELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSL 405
+AVK +KED E E +++ I H NLV+L+GV + + +++ E+ G+L
Sbjct: 31 SLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-REPPFYIITEFMTYGNL 89
Query: 406 DKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLD 465
+L ++ ++ ++++ A +++ ++Y+ + + +HRD+ N +
Sbjct: 90 LDYLRECNRQEVNAVVLLYM--------ATQISSAMEYLEKK---NFIHRDLAARNCLVG 138
Query: 466 SRFKAKIANFSLA---------------------AP---ATNDVMPKFDVFAFGVVLLEL 501
K+A+F L+ AP A N K DV+AFGV+L E+
Sbjct: 139 ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 55/201 (27%), Positives = 85/201 (42%), Gaps = 54/201 (26%)
Query: 340 SIGKSVYRATIDGKVL--AVKKIKED--------VTEELRILQRINHANLVKLMGVSSDS 389
S+ K VY GK + AVK +K++ E ++ +++H +V+L+GV
Sbjct: 10 SVVKGVYL-MKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVC--- 65
Query: 390 QGNRF-LVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHA 448
+G LV E A G L K+L + + S A VA G+ Y+
Sbjct: 66 KGEPLMLVMELAPLGPLLKYLKKRREIPVSD----LKEL------AHQVAMGMAYLESK- 114
Query: 449 QPSIVHRDIRTNNIQLDSRFKAKIANFSL--AAPATND--------------VMP----- 487
VHRD+ N+ L +R +AKI++F + A A +D P
Sbjct: 115 --HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 488 -KF----DVFAFGVVLLELLS 503
KF DV+++GV L E S
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 64/209 (30%)
Query: 345 VYRA--TIDGKVLAVKKIKED---------VTEELRILQRINHANLVKLMGVSSDSQ--- 390
VY+A G+++A+KK++ D E++IL+++NH N+V L + +D Q
Sbjct: 23 VYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82
Query: 391 ------GNRFLVYEYAEN---GSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGL 441
G +LV+EY ++ G L+ L S+ S ++ L+ GL
Sbjct: 83 DFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS----------FMKQLLE---GL 129
Query: 442 QYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA--------APATNDVM------- 486
Y H+ + +HRDI+ +NI L+++ + K+A+F LA P TN V+
Sbjct: 130 NYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPP 186
Query: 487 ----------PKFDVFAFGVVLLELLSGK 505
P DV++ G +L EL + K
Sbjct: 187 ELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 42/185 (22%), Positives = 79/185 (42%), Gaps = 48/185 (25%)
Query: 356 AVKKIKED--------VTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407
A+K ++E+ + +E ++ ++H ++V+L+G+ SQ L+ + G L
Sbjct: 40 AIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQ--VQLITQLMPLGCLLD 97
Query: 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSR 467
++ + GS L W + +A G+ Y+ E +VHRD+ N+ + +
Sbjct: 98 YVR---NHKDNIGSQYLLNWC------VQIAKGMSYLEEK---RLVHRDLAARNVLVKTP 145
Query: 468 FKAKIANFSLAA---------PATNDVMP----------------KFDVFAFGVVLLELL 502
KI +F LA A +P K DV+++GV + EL+
Sbjct: 146 QHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELM 205
Query: 503 S-GKK 506
+ G K
Sbjct: 206 TFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 49/196 (25%), Positives = 88/196 (44%), Gaps = 57/196 (29%)
Query: 352 GKVLAVKKIK-------------EDVTEELRILQRINHANLVKLMGVS-SDSQGNRFLVY 397
G ++AVK++ E + +E+R++ R+NH ++++++G + DS N F+
Sbjct: 25 GTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFV-- 82
Query: 398 EYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDI 457
E+ GS+ L K + +VI Q LR GL Y+HE+ I+HRD+
Sbjct: 83 EWMAGGSVSHLLS---KYGAFKEAVIINYTEQLLR-------GLSYLHEN---QIIHRDV 129
Query: 458 RTNNIQLDSRFK-AKIANFSLAAPATNDVM-----------------PKF---------- 489
+ N+ +DS + +IA+F AA P+
Sbjct: 130 KGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSC 189
Query: 490 DVFAFGVVLLELLSGK 505
DV++ G V++E+ + K
Sbjct: 190 DVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 50/192 (26%), Positives = 81/192 (42%), Gaps = 50/192 (26%)
Query: 347 RATIDGKVLAVKKIK-----EDVTE----ELRILQRINHANLVKLMGVSSDSQGNRFLVY 397
+AT G+++A+KK K EDV + E+++L+++ H N+V L +G +LV+
Sbjct: 23 KAT--GEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFR-RKGRLYLVF 79
Query: 398 EYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDI 457
EY E L+ L S +V W + + Y H H +I+HRDI
Sbjct: 80 EYVERTLLE--LLEASPGGLPPDAVRSYIWQ--------LLQAIAYCHSH---NIIHRDI 126
Query: 458 RTNNIQLDSRFKAKIANF----SLAAPATN-------------------DVM--PKFDVF 492
+ NI + K+ +F +L A + D DV+
Sbjct: 127 KPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVW 186
Query: 493 AFGVVLLELLSG 504
A G ++ ELL G
Sbjct: 187 AIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 4e-10
Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 56/207 (27%)
Query: 341 IGK----SVYRATI---DGKVL--AVKKIK-----EDVTEELR---ILQRINHANLVKLM 383
IGK VY T+ DG+ + AVK + E+V + L+ I++ +H N++ L+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 384 GVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQY 443
G+ S+G+ +V Y ++G L ++ ++ + + + F L VA G++Y
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGF---------GLQVAKGMEY 113
Query: 444 MHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA-----------TNDVMP----- 487
+ A VHRD+ N LD F K+A+F LA T +P
Sbjct: 114 L---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA 170
Query: 488 -----------KFDVFAFGVVLLELLS 503
K DV++FGV+L EL++
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 52/194 (26%), Positives = 89/194 (45%), Gaps = 42/194 (21%)
Query: 351 DGKVLAVKKIKE-------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENG 403
D ++AVK +KE D E +L + H ++V+ GV ++ + +V+EY +G
Sbjct: 34 DKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGR-PLLMVFEYMRHG 92
Query: 404 SLDKWLH---PKSKSSSSSGSVIF--LTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIR 458
L+++L P +K + V LT Q L +A +A+G+ Y+ A VHRD+
Sbjct: 93 DLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYL---ASLHFVHRDLA 149
Query: 459 TNNIQLDSRFKAKIANFSLA---------------------APATNDVMPKF----DVFA 493
T N + KI +F ++ P + + KF D+++
Sbjct: 150 TRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWS 209
Query: 494 FGVVLLELLS-GKK 506
FGVVL E+ + GK+
Sbjct: 210 FGVVLWEIFTYGKQ 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 6e-10
Identities = 47/198 (23%), Positives = 79/198 (39%), Gaps = 43/198 (21%)
Query: 341 IGKSVYRATI--DGKVLAVKKI--------KEDVTEELRILQRINHANLVKLMGV-SSDS 389
G SV + + G + A+K I ++ + EL I + +VK G +S
Sbjct: 13 AGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDES 72
Query: 390 QGNRFLVYEYAENGSLDKWLHP-KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHA 448
+ + EY E GSLD K + V+ ++A V GL Y+H
Sbjct: 73 SSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVL-------GKIAESVLKGLSYLHSR- 124
Query: 449 QPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVMPKF------------------- 489
I+HRDI+ +NI L + + K+ +F ++ N + F
Sbjct: 125 --KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQGKPYSI 182
Query: 490 --DVFAFGVVLLELLSGK 505
DV++ G+ LLE+ +
Sbjct: 183 TSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 6e-10
Identities = 50/190 (26%), Positives = 86/190 (45%), Gaps = 43/190 (22%)
Query: 345 VYRATIDGKV-LAVKKIK-------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLV 396
V+ +V +A+K +K +D +E++ L+R+ H +L+ L V S + +++
Sbjct: 22 VWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGE-PVYII 80
Query: 397 YEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRD 456
E E GSL +L S G V L + + +A VA G+ Y+ E + +HRD
Sbjct: 81 TELMEKGSLLAFL------RSPEGQV--LPVASLIDMACQVAEGMAYLEEQ---NSIHRD 129
Query: 457 IRTNNIQLDSRFKAKIANFSLAAPATNDV-------MP----------------KFDVFA 493
+ NI + K+A+F LA DV +P K DV++
Sbjct: 130 LAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWS 189
Query: 494 FGVVLLELLS 503
FG++L E+ +
Sbjct: 190 FGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 6e-10
Identities = 46/152 (30%), Positives = 71/152 (46%), Gaps = 29/152 (19%)
Query: 345 VYRA--TIDGKVLAVKKI------KEDVTEELRILQRI-NHANLVKLMGV--SSDSQGNR 393
VY+A G+++A+K + +E++ EE IL++ NH N+ G + GN
Sbjct: 22 VYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81
Query: 394 ---FLVYEYAENGS---LDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEH 447
+LV E GS L K L K K I + LR L GL Y+HE+
Sbjct: 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEE--WI----AYILRETL---RGLAYLHEN 132
Query: 448 AQPSIVHRDIRTNNIQLDSRFKAKIANFSLAA 479
++HRDI+ NI L + K+ +F ++A
Sbjct: 133 ---KVIHRDIKGQNILLTKNAEVKLVDFGVSA 161
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 7e-10
Identities = 53/187 (28%), Positives = 79/187 (42%), Gaps = 46/187 (24%)
Query: 352 GKVLAVKKI-KEDVTE---------ELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAE 401
K+ A+K + K+ E E RILQ +NH LV L D + N +LV +
Sbjct: 25 KKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEE-NMYLVVDLLL 83
Query: 402 NGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNN 461
G L ++ H K S V F W + +AL+ Y+H I+HRDI+ +N
Sbjct: 84 GGDL-RY-HLSQKVKFSEEQVKF--WICEIVLALE------YLHSK---GIIHRDIKPDN 130
Query: 462 IQLDSRFKAKIANFSLAAPATNDVM------------PKF----------DVFAFGVVLL 499
I LD + I +F++A T D + P+ D ++ GV
Sbjct: 131 ILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAY 190
Query: 500 ELLSGKK 506
E L GK+
Sbjct: 191 ECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 8e-10
Identities = 63/275 (22%), Positives = 119/275 (43%), Gaps = 67/275 (24%)
Query: 344 SVYRATIDGKVLAVK---------KIKEDVTE-ELRILQRINHANLVKLMGV---SSDSQ 390
S+Y+ + K + ++ K+ D+TE E++ L+RI+ N++K+ G D
Sbjct: 35 SIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 391 GNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQP 450
L+ EY G L + L K K L++ +L +A+D GL ++++
Sbjct: 95 PRLSLILEYCTRGYLREVLD-KEKD---------LSFKTKLDMAIDCCKGLYNLYKYT-- 142
Query: 451 SIVHRDIRTNNIQLDSRFKAKIANFSL----AAPATNDV------------------MPK 488
+ ++++ + + + +K KI L ++P +V K
Sbjct: 143 NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIK 202
Query: 489 FDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESF 548
D+++ GVVL E+ +GK EN T ++ I + + +L
Sbjct: 203 DDIYSLGVVLWEIFTGKIPF---ENLTTKEIYDLI-----INKNNSLKL----------- 243
Query: 549 YPIDGALSLATLARACTMDKSLSRPNMAEVVFNLS 583
P+D L + + ACT S+ RPN+ E+++NLS
Sbjct: 244 -PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 53/200 (26%), Positives = 88/200 (44%), Gaps = 49/200 (24%)
Query: 349 TIDGKVLAVKKIKE-------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAE 401
T D ++AVK +K+ D E +L + H ++VK GV D +V+EY +
Sbjct: 32 TKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD-PLIMVFEYMK 90
Query: 402 NGSLDKWLHPKSKSS---------SSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSI 452
+G L+K+L + + G L SQ L +A +A+G+ Y+ A
Sbjct: 91 HGDLNKFLRAHGPDAMILVDGQPRQAKGE---LGLSQMLHIASQIASGMVYL---ASQHF 144
Query: 453 VHRDIRTNNIQLDSRFKAKIANFSLA---------------------APATNDVMPKF-- 489
VHRD+ T N + + KI +F ++ P + + KF
Sbjct: 145 VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTT 204
Query: 490 --DVFAFGVVLLELLS-GKK 506
DV++FGV+L E+ + GK+
Sbjct: 205 ESDVWSFGVILWEIFTYGKQ 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 8e-10
Identities = 65/290 (22%), Positives = 123/290 (42%), Gaps = 65/290 (22%)
Query: 243 LIIPISAGGALLILLVAALVIY---NHHLQRKRVRILNRNGS-SLESADLIPMKENSKSD 298
I + G L++ LVA ++ ++L+ KRV N +G+ L+ D K + +D
Sbjct: 630 FYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVE--NEDGTWELQFFDSKVSKSITIND 687
Query: 299 RFEPKLAQNKLLPGVSG--YLGKPIVYEIEVIMESTMNLSEHYSIGKSVYRATIDGKVLA 356
+N + G G Y GK I ++ +++ ++
Sbjct: 688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVK----------------------EIND 725
Query: 357 VKKIKEDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSS 416
V I ++ LQ H N+VKL+G+ +G +L++EY E +L + L
Sbjct: 726 VNSIPSSEIADMGKLQ---HPNIVKLIGLCRSEKGA-YLIHEYIEGKNLSEVLRN----- 776
Query: 417 SSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFK------- 469
L+W +R ++A+ +A L+++H P++V ++ I +D + +
Sbjct: 777 --------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSL 828
Query: 470 --------AKIANFSLAAPAT---NDVMPKFDVFAFGVVLLELLSGKKAT 508
+ + AP T D+ K D++ FG++L+ELL+GK
Sbjct: 829 PGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPA 878
|
Length = 968 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 43/178 (24%), Positives = 80/178 (44%), Gaps = 42/178 (23%)
Query: 356 AVKKIK------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409
AVK +K +D E +I++++ H L++L V + + ++V E + GSL ++L
Sbjct: 34 AVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEE-PIYIVTELMKYGSLLEYL 92
Query: 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFK 469
+ + L Q + +A VA+G+ Y+ + +HRD+ N+ +
Sbjct: 93 QGGAGRA--------LKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNI 141
Query: 470 AKIANFSLA---------------------APAT---NDVMPKFDVFAFGVVLLELLS 503
K+A+F LA AP N K DV++FG++L E+++
Sbjct: 142 CKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 44/145 (30%), Positives = 79/145 (54%), Gaps = 24/145 (16%)
Query: 345 VYRA--TIDGKVLAVKKIKEDV-TE--------ELRILQRINHANLVKLMGVSSDSQGNR 393
VY+A + G+V+A+KKI+ D TE E+ +L+ +NH N+VKL+ V ++
Sbjct: 16 VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-TENKL 74
Query: 394 FLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIV 453
+LV+E+ + L K++ +S SG + L S ++ GL + H H ++
Sbjct: 75 YLVFEFL-HQDLKKFM----DASPLSGIPLPLIKSYLFQLL----QGLAFCHSH---RVL 122
Query: 454 HRDIRTNNIQLDSRFKAKIANFSLA 478
HRD++ N+ +++ K+A+F LA
Sbjct: 123 HRDLKPQNLLINTEGAIKLADFGLA 147
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 46/158 (29%), Positives = 75/158 (47%), Gaps = 38/158 (24%)
Query: 345 VYRA----TIDGKVLAVKKIKEDVTE----------ELRILQRINHANLVKLMGVS-SDS 389
VY+A DGK A+KK K D + E+ +L+ + H N+V L+ V +
Sbjct: 16 VYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHA 75
Query: 390 QGNRFLVYEYAENGSLDKW----LHPKSKSSSSSGSVI-FLTWSQRLRVALDVANGLQYM 444
+ +L+++YAE+ D W H ++K S S++ L W Q L NG+ Y+
Sbjct: 76 DKSVYLLFDYAEH---DLWQIIKFHRQAKRVSIPPSMVKSLLW-QIL-------NGVHYL 124
Query: 445 HEHAQPSIVHRDIRTNNIQL----DSRFKAKIANFSLA 478
H + ++HRD++ NI + R KI + LA
Sbjct: 125 HSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLA 159
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 42/143 (29%), Positives = 69/143 (48%), Gaps = 22/143 (15%)
Query: 345 VYRATIDGKV-LAVKKIKEDVTEEL--------RILQRINHANLVKLMGVSSDSQGNRFL 395
V++ T+ K +AVK KED+ +EL RIL++ +H N+VKL+GV + Q ++
Sbjct: 11 VFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQ-PIYI 69
Query: 396 VYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHR 455
V E G +L K L Q ++ ALD A G+ Y+ + +HR
Sbjct: 70 VMELVPGGDFLSFLRKKKDE---------LKTKQLVKFALDAAAGMAYLESK---NCIHR 117
Query: 456 DIRTNNIQLDSRFKAKIANFSLA 478
D+ N + KI++F ++
Sbjct: 118 DLAARNCLVGENNVLKISDFGMS 140
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 3e-09
Identities = 46/192 (23%), Positives = 86/192 (44%), Gaps = 44/192 (22%)
Query: 355 LAVKKIKE------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKW 408
+A+K I+E D EE +++ +++H LV+L GV ++ + LV+E+ E+G L +
Sbjct: 31 VAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE-RSPICLVFEFMEHGCLSDY 89
Query: 409 LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRF 468
L +++ S + L + LDV G+ Y+ +++HRD+ N +
Sbjct: 90 L--RAQRGKFSQETL-------LGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQ 137
Query: 469 KAKIANFSLA--------APATNDVMP----------------KFDVFAFGVVLLELLS- 503
K+++F + +T P K DV++FGV++ E+ S
Sbjct: 138 VVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSE 197
Query: 504 GKKATRTTENGK 515
GK N +
Sbjct: 198 GKTPYENRSNSE 209
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 45/174 (25%), Positives = 78/174 (44%), Gaps = 41/174 (23%)
Query: 355 LAVKKIKEDVTEELR--------ILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLD 406
+A+K +K TE+ R I+ + +H N+++L GV + + ++ EY ENG+LD
Sbjct: 36 VAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK-PAMIITEYMENGALD 94
Query: 407 KWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDS 466
K+L SS V L +A G++Y+ + + VHRD+ NI ++S
Sbjct: 95 KYLRDHDGEFSSYQLVGMLR---------GIAAGMKYL---SDMNYVHRDLAARNILVNS 142
Query: 467 RFKAKIANFSLAAPATNDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLW 520
+ K+++F L+ +D + T TT GK + W
Sbjct: 143 NLECKVSDFGLSRVLEDD--------------------PEGTYTTSGGKIPIRW 176
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 47/195 (24%), Positives = 83/195 (42%), Gaps = 44/195 (22%)
Query: 344 SVYRAT--IDGKVLAVKKI---------KEDVTEELRILQRINHANLVKLMGVSSDSQGN 392
SVY+ D + A+K++ +ED E+RIL +NH N++ D GN
Sbjct: 15 SVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD--GN 72
Query: 393 RF-LVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPS 451
+ +V EYA G L K + + K + + R+ + + GLQ +HE
Sbjct: 73 KLCIVMEYAPFGDLSKAISKRKKKRK------LIPEQEIWRIFIQLLRGLQALHEQ---K 123
Query: 452 IVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDV----------MP-----------KFD 490
I+HRD+++ NI L + KI + ++ ++ M K D
Sbjct: 124 ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSD 183
Query: 491 VFAFGVVLLELLSGK 505
+++ G +L E+ +
Sbjct: 184 IWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 49/175 (28%), Positives = 77/175 (44%), Gaps = 29/175 (16%)
Query: 314 SGYLGKPIVYEIEVIMESTMNLSEHYSIGKSVYRATIDGKVL---AVKKIKEDVTEELRI 370
+G GK ++E+T Y + KS + K+L A +E + EL+I
Sbjct: 45 AGAFGK--------VVEATA-----YGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKI 91
Query: 371 LQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQ 429
+ + NH N+V L+G + G ++ EY G L +L K +S FLT
Sbjct: 92 MSHLGNHENIVNLLGACTIG-GPILVITEYCCYGDLLNFLRRKRES--------FLTLED 142
Query: 430 RLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATND 484
L + VA G+ ++ A + +HRD+ N+ L KI +F LA ND
Sbjct: 143 LLSFSYQVAKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMND 194
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 5e-09
Identities = 48/177 (27%), Positives = 82/177 (46%), Gaps = 39/177 (22%)
Query: 353 KVLAVKKIKEDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412
K +K + D E I+ + +H N++ L GV + S+ +V EY ENGSLD +L
Sbjct: 41 KAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSK-PVMIVTEYMENGSLDAFL--- 96
Query: 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKI 472
+ +VI L R +A+G++Y+ + VHRD+ NI ++S K+
Sbjct: 97 -RKHDGQFTVIQLVGMLR-----GIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKV 147
Query: 473 ANFSLAAPATND----------------VMP------KF----DVFAFGVVLLELLS 503
++F L+ +D P KF DV+++G+V+ E++S
Sbjct: 148 SDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 5e-09
Identities = 52/192 (27%), Positives = 85/192 (44%), Gaps = 40/192 (20%)
Query: 351 DGKVLAVKKIKE-------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENG 403
D ++AVK +K+ D E +L + H ++VK GV + +V+EY ++G
Sbjct: 34 DKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD-PLIMVFEYMKHG 92
Query: 404 SLDKWLH---PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTN 460
L+K+L P + + LT SQ L +A +A G+ Y+ A VHRD+ T
Sbjct: 93 DLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATR 149
Query: 461 NIQLDSRFKAKIANFSLA---------------------APATNDVMPKF----DVFAFG 495
N + KI +F ++ P + + KF DV++ G
Sbjct: 150 NCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLG 209
Query: 496 VVLLELLS-GKK 506
VVL E+ + GK+
Sbjct: 210 VVLWEIFTYGKQ 221
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (140), Expect = 6e-09
Identities = 37/143 (25%), Positives = 69/143 (48%), Gaps = 27/143 (18%)
Query: 349 TIDGKVLAVKKIK---EDVTE------ELRILQRINHANLVKLMGVSSDSQGNRF----L 395
G+ +A+KKI +D+ + E+++L+ + H N++ L+ + F +
Sbjct: 22 KRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81
Query: 396 VYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHR 455
V E E L K + KS + + + + Q LR GL+Y+H +++HR
Sbjct: 82 VTELMET-DLHKVI--KSPQPLTDDHIQYFLY-QILR-------GLKYLHS---ANVIHR 127
Query: 456 DIRTNNIQLDSRFKAKIANFSLA 478
D++ +NI ++S KI +F LA
Sbjct: 128 DLKPSNILVNSNCDLKICDFGLA 150
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 7e-09
Identities = 50/154 (32%), Positives = 79/154 (51%), Gaps = 31/154 (20%)
Query: 343 KSVYRATIDGKVLAVKKI-----KE--DVT--EELRILQRINHANLVKL--MGV-----S 386
K+ T G+V+A+KKI K+ +T E++IL+++ H N+V L M V S
Sbjct: 26 KARQIKT--GRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKS 83
Query: 387 SDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHE 446
+G+ ++V Y ++ L L S + LT SQ L + G+ Y+HE
Sbjct: 84 KRKRGSVYMVTPYMDH-DLSGLLENPS---------VKLTESQIKCYMLQLLEGINYLHE 133
Query: 447 HAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAP 480
+ I+HRDI+ NI +D++ KIA+F LA P
Sbjct: 134 N---HILHRDIKAANILIDNQGILKIADFGLARP 164
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 8e-09
Identities = 38/140 (27%), Positives = 72/140 (51%), Gaps = 30/140 (21%)
Query: 341 IGK----SVYRA--TIDGKVLAVKKIK----------EDVTEELRILQRINHANLVK-LM 383
IGK VY+A +DG+V+A+KK++ +D +E+ +L++++H N++K L
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 384 GVSSDSQGNRFLVYEYAENGSLDKWL-HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQ 442
+++ N +V E A+ G L + + H K + I+ + Q + + L+
Sbjct: 70 SFIENNELN--IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQ-------LCSALE 120
Query: 443 YMHEHAQPSIVHRDIRTNNI 462
+MH I+HRDI+ N+
Sbjct: 121 HMHSK---RIMHRDIKPANV 137
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 9e-09
Identities = 49/216 (22%), Positives = 96/216 (44%), Gaps = 51/216 (23%)
Query: 340 SIGKSVYRATIDGKVLAVK---------KIKEDVTEELRILQRINHANLVKLMGVSSDSQ 390
++ K +Y+ K +AVK +K+++ E ++Q++++ +V+++G+
Sbjct: 10 TVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAE- 68
Query: 391 GNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQP 450
+ LV E AE G L+K+L K+K +T + V+ G++Y+ E
Sbjct: 69 -SWMLVMELAELGPLNKFLQ-KNKH---------VTEKNITELVHQVSMGMKYLEET--- 114
Query: 451 SIVHRDIRTNNIQLDSRFKAKIANFSLAAPATND-------------------------- 484
+ VHRD+ N+ L ++ AKI++F L+ D
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK 174
Query: 485 VMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVL 519
K DV++FGV++ E S G+K + + + +
Sbjct: 175 FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQM 210
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 40/143 (27%), Positives = 70/143 (48%), Gaps = 32/143 (22%)
Query: 343 KSVYRATIDGKVLAVKKI--------KEDVTEELRILQRINHANLVKLMGVSSDSQGNRF 394
K ++R T G++ A+K I + + E+ IL+ +NH N+VK + D G
Sbjct: 92 KVIHRPT--GRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-DHNGEIQ 148
Query: 395 LVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRL--RVALDVANGLQYMHEHAQPSI 452
++ E+ + GSL+ G+ I ++ VA + +G+ Y+H I
Sbjct: 149 VLLEFMDGGSLE-------------GTHI---ADEQFLADVARQILSGIAYLHRR---HI 189
Query: 453 VHRDIRTNNIQLDSRFKAKIANF 475
VHRDI+ +N+ ++S KIA+F
Sbjct: 190 VHRDIKPSNLLINSAKNVKIADF 212
|
Length = 353 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 33/158 (20%), Positives = 69/158 (43%), Gaps = 30/158 (18%)
Query: 371 LQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQR 430
L ++H N++ ++ V + F++Y Y G+L +L + + + L+ Q
Sbjct: 62 LYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFL--QQCRLGEANNPQALSTQQL 119
Query: 431 LRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIAN---------------- 474
+ +A+ +A G+ Y+H+ ++H+DI N +D + KI +
Sbjct: 120 VHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLG 176
Query: 475 ---------FSLAAPATNDVMPKFDVFAFGVVLLELLS 503
+L + + DV++FGV+L EL++
Sbjct: 177 DNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 53/190 (27%), Positives = 84/190 (44%), Gaps = 44/190 (23%)
Query: 345 VYRATIDGKV-LAVKKIK------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVY 397
V+ T +G +AVK +K E EE +I++++ H LV+L V S+ ++V
Sbjct: 22 VWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEEP--IYIVT 79
Query: 398 EYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDI 457
EY GSL +L G L + +A VA G+ Y+ + + +HRD+
Sbjct: 80 EYMSKGSLLDFL--------KDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDL 128
Query: 458 RTNNIQLDSRFKAKIANFSLA---------------------APAT---NDVMPKFDVFA 493
R+ NI + KIA+F LA AP K DV++
Sbjct: 129 RSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188
Query: 494 FGVVLLELLS 503
FG++L EL++
Sbjct: 189 FGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 45/205 (21%), Positives = 79/205 (38%), Gaps = 53/205 (25%)
Query: 344 SVYRATID------GKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVS-S 387
SV + KV AVK +K E+ E ++ +H N++KL+GV
Sbjct: 14 SVMEGQLSQDDGSQLKV-AVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFE 72
Query: 388 DSQGNRF----LVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQY 443
S + ++ + ++G L +L S G L L+ +D+A G++Y
Sbjct: 73 ASSLQKIPKPMVILPFMKHGDLHSFLL----YSRLGGLPEKLPLQTLLKFMVDIALGMEY 128
Query: 444 MHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA------------------------- 478
+ + + +HRD+ N L +A+F L+
Sbjct: 129 L---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIE 185
Query: 479 APATNDVMPKFDVFAFGVVLLELLS 503
+ A K DV+AFGV + E+ +
Sbjct: 186 SLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 47/179 (26%), Positives = 83/179 (46%), Gaps = 43/179 (24%)
Query: 355 LAVKKIKEDVTE------ELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKW 408
+A+K +K+ E +++++ H LV+L V + Q +++ EY ENGSL +
Sbjct: 33 VAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT--QEPIYIITEYMENGSLVDF 90
Query: 409 LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRF 468
L K+ LT ++ + +A +A G+ ++ + +HRD+R NI +
Sbjct: 91 L----KTPEGIK----LTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETL 139
Query: 469 KAKIANFSLA---------------------AP-ATN--DVMPKFDVFAFGVVLLELLS 503
KIA+F LA AP A N K DV++FG++L E+++
Sbjct: 140 CCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 36/142 (25%), Positives = 62/142 (43%), Gaps = 24/142 (16%)
Query: 347 RATIDGKVLAVKKIK----------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLV 396
R I A+K + + V E R+L+ ++H +++L D Q +++
Sbjct: 21 RDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD-QRFLYML 79
Query: 397 YEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRD 456
EY G L +L + S+S+G L A ++ L+Y+H IV+RD
Sbjct: 80 MEYVPGGELFSYLRNSGRFSNSTG----------LFYASEIVCALEYLHSK---EIVYRD 126
Query: 457 IRTNNIQLDSRFKAKIANFSLA 478
++ NI LD K+ +F A
Sbjct: 127 LKPENILLDKEGHIKLTDFGFA 148
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 2e-08
Identities = 47/152 (30%), Positives = 75/152 (49%), Gaps = 37/152 (24%)
Query: 345 VYRA----TIDGKVLAVKKIK-EDVTE--------ELRILQRINHANLVKL----MGVSS 387
VYRA T G+++A+KK+K E E E+ IL ++ H N+V + +G +
Sbjct: 21 VYRARDKKT--GEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNL 78
Query: 388 DSQGNRFLVYEYAENGSLD-KWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHE 446
D ++V EY E+ D K L K V L Q L G+ ++H+
Sbjct: 79 DKI---YMVMEYVEH---DLKSLMETMKQPFLQSEVKCLM-LQLLS-------GVAHLHD 124
Query: 447 HAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA 478
+ I+HRD++T+N+ L++R KI +F LA
Sbjct: 125 N---WILHRDLKTSNLLLNNRGILKICDFGLA 153
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 47/191 (24%), Positives = 85/191 (44%), Gaps = 46/191 (24%)
Query: 346 YRATIDGKVLAVKKIKE------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEY 399
+RA I +A+K I E D EE +++ +++H LV+L GV + Q ++V E+
Sbjct: 25 WRAQIK---VAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT-QQKPLYIVTEF 80
Query: 400 AENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRT 459
ENG L +L + + S ++ L + DV G++Y+ + S +HRD+
Sbjct: 81 MENGCLLNYL--RQRQGKLSKDML-------LSMCQDVCEGMEYLE---RNSFIHRDLAA 128
Query: 460 NNIQLDSRFKAKIANFSLAAPATND------------------------VMPKFDVFAFG 495
N + S K+++F + +D K DV++FG
Sbjct: 129 RNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFG 188
Query: 496 VVLLELLSGKK 506
V++ E+ + K
Sbjct: 189 VLMWEVFTEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 42/140 (30%), Positives = 67/140 (47%), Gaps = 26/140 (18%)
Query: 351 DGKVLAVKKIK---EDVT---------EELRILQRINHANLVKLMGVSSDSQGNRFLVYE 398
DG AVK++ + T +E+ +L ++ H N+V+ +G + + N ++ E
Sbjct: 24 DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLG-TEREEDNLYIFLE 82
Query: 399 YAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIR 458
GSL K L K S VI L Q L GL+Y+H+ + VHRDI+
Sbjct: 83 LVPGGSLAKLL---KKYGSFPEPVIRLYTRQILL-------GLEYLHDR---NTVHRDIK 129
Query: 459 TNNIQLDSRFKAKIANFSLA 478
NI +D+ K+A+F +A
Sbjct: 130 GANILVDTNGVVKLADFGMA 149
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 52/181 (28%), Positives = 88/181 (48%), Gaps = 34/181 (18%)
Query: 347 RATIDGKVLAVKKIK-EDVTE--------ELRILQRINHANLVKLMGV--SSDSQGNR-- 393
R +++A+KK+ E+ E E++ILQ + H N+V L+ + + + NR
Sbjct: 32 RHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91
Query: 394 ---FLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQP 450
+LV+E+ E+ L L S+ +V F T S+ +V + NGL Y+H +
Sbjct: 92 GSFYLVFEFCEH-DLAGLL--------SNKNVKF-TLSEIKKVMKMLLNGLYYIHRN--- 138
Query: 451 SIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVMPKFDVFAFGVVLL-----ELLSGK 505
I+HRD++ NI + K+A+F LA + K + + VV L ELL G+
Sbjct: 139 KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGE 198
Query: 506 K 506
+
Sbjct: 199 R 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 3e-08
Identities = 50/188 (26%), Positives = 85/188 (45%), Gaps = 44/188 (23%)
Query: 345 VYRATIDGKV-LAVKKIK------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVY 397
V+ T +G +A+K +K E +E ++++++ H LV+L V S+ ++V
Sbjct: 22 VWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP--IYIVT 79
Query: 398 EYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDI 457
EY GSL +L K + +L Q + +A +A+G+ Y+ + + VHRD+
Sbjct: 80 EYMSKGSLLDFL--KGEMGK------YLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 128
Query: 458 RTNNIQLDSRFKAKIANFSLA---------------------APAT---NDVMPKFDVFA 493
R NI + K+A+F LA AP K DV++
Sbjct: 129 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188
Query: 494 FGVVLLEL 501
FG++L EL
Sbjct: 189 FGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 47/192 (24%), Positives = 88/192 (45%), Gaps = 44/192 (22%)
Query: 352 GKVLAVKKIKE--------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENG 403
+++A+K +K+ + +E ++ ++H N+V L+GV + Q +++EY G
Sbjct: 34 AQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ-PVCMLFEYLNQG 92
Query: 404 SLDKWLHPKSK------SSSSSGSV-IFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRD 456
L ++L +S SS G+V L L +A+ +A G++Y+ H VH+D
Sbjct: 93 DLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKD 149
Query: 457 IRTNNIQLDSRFKAKIANFSLAAP---------ATNDVMP------------KF----DV 491
+ NI + + KI++ L+ ++P KF D+
Sbjct: 150 LAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDI 209
Query: 492 FAFGVVLLELLS 503
++FGVVL E+ S
Sbjct: 210 WSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 49/169 (28%), Positives = 74/169 (43%), Gaps = 39/169 (23%)
Query: 340 SIGKSVYRA--TIDGKVLAVKKIK-----EDVTE----------------ELRILQRINH 376
+ GK V +A T+ GK++A+KK+K DVT+ EL+I+ I H
Sbjct: 21 TYGK-VEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKH 79
Query: 377 ANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALD 436
N++ L+ V LV + L K + K I LT SQ + L
Sbjct: 80 ENIMGLVDVYV-EGDFINLVMDIMA-SDLKKVVDRK----------IRLTESQVKCILLQ 127
Query: 437 VANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDV 485
+ NGL +H+ +HRD+ NI ++S+ KIA+F LA
Sbjct: 128 ILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPP 173
|
Length = 335 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 7e-08
Identities = 49/187 (26%), Positives = 81/187 (43%), Gaps = 45/187 (24%)
Query: 355 LAVKKIKEDVT--------EELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLD 406
+AVK +++ T +E ++ NH N+VKL+GV ++ ++++ E E G L
Sbjct: 29 VAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNE-PQYIIMELMEGGDLL 87
Query: 407 KWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNI---- 462
+L LT + L + LDVA G Y+ Q +HRD+ N
Sbjct: 88 SYLRDARVERFGPP---LLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSE 141
Query: 463 -QLDSRFKAKIANFSLAAPA-TND--------VMP------------KF----DVFAFGV 496
D+ KI +F LA +D ++P KF DV++FGV
Sbjct: 142 KGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGV 201
Query: 497 VLLELLS 503
++ E+L+
Sbjct: 202 LMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 7e-08
Identities = 45/196 (22%), Positives = 76/196 (38%), Gaps = 46/196 (23%)
Query: 345 VYRATIDGKVLAVKKI---------KEDVTEELRILQRINHANLVKLMGVSSDSQGNRFL 395
+YR T D ++ K++ + D E+ IL + H N++ D +
Sbjct: 18 LYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDN-TLLI 76
Query: 396 VYEYAENGSL-DKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVH 454
EYA G+L DK + K + L + + + Y+H+ I+H
Sbjct: 77 EMEYANGGTLYDKIVRQKGQ---------LFEEEMVLWYLFQIVSAVSYIHKA---GILH 124
Query: 455 RDIRTNNIQLDSRFKAKIANFSLAAPATNDVM-------------P----------KFDV 491
RDI+T NI L K+ +F ++ ++ P K D+
Sbjct: 125 RDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDI 184
Query: 492 FAFGVVLLELLSGKKA 507
+A G VL ELL+ K+
Sbjct: 185 WALGCVLYELLTLKRT 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 38/132 (28%), Positives = 69/132 (52%), Gaps = 21/132 (15%)
Query: 355 LAVKKIKEDVTEELR--------ILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLD 406
+A+K +K TE+ R I+ + +H N++ L GV + S+ ++ E+ ENG+LD
Sbjct: 35 VAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSR-PVMIITEFMENGALD 93
Query: 407 KWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDS 466
+L + + +VI L R +A G++Y+ E + VHRD+ NI ++S
Sbjct: 94 SFL----RQNDGQFTVIQLVGMLR-----GIAAGMKYLSEM---NYVHRDLAARNILVNS 141
Query: 467 RFKAKIANFSLA 478
K+++F L+
Sbjct: 142 NLVCKVSDFGLS 153
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 42/147 (28%), Positives = 74/147 (50%), Gaps = 28/147 (19%)
Query: 345 VYRA--TIDGKVLAVKKIK-EDVTE--------ELRILQRINHANLVKLMGVSSDSQGNR 393
VY+A + G+++A+KKI+ E E E+ +L+ +NH N+V+L+ V N+
Sbjct: 15 VYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVV--HSENK 72
Query: 394 -FLVYEYAENGSLDKWLHPKSKSSSSSG-SVIFLTWSQRLRVALDVANGLQYMHEHAQPS 451
+LV+E+ + LD + S + +I Q L+ G+ Y H H
Sbjct: 73 LYLVFEFLD---LDLKKYMDSSPLTGLDPPLIKSYLYQLLQ-------GIAYCHSH---R 119
Query: 452 IVHRDIRTNNIQLDSRFKAKIANFSLA 478
++HRD++ N+ +D K+A+F LA
Sbjct: 120 VLHRDLKPQNLLIDREGALKLADFGLA 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 66/279 (23%), Positives = 112/279 (40%), Gaps = 69/279 (24%)
Query: 343 KSVYRATIDGKV-LAVKKIKEDVTEELR--------ILQRINHANLVKLMGVSSDSQGNR 393
+ VY + + K+ +AVK K + +R I+++ +H ++VKL+GV +++
Sbjct: 24 QGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENP--V 81
Query: 394 FLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIV 453
++V E A G L +L +K S S+I + ++ L Y+ V
Sbjct: 82 WIVMELAPLGELRSYLQ-VNKYSLDLASLILY--------SYQLSTALAYLESK---RFV 129
Query: 454 HRDIRTNNIQLDSRFKAKIANFSLAA--------PATNDVMP------------KF---- 489
HRDI N+ + S K+ +F L+ A+ +P +F
Sbjct: 130 HRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSAS 189
Query: 490 DVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESF 548
DV+ FGV + E+L G K + +N +V+ E ERL P +
Sbjct: 190 DVWMFGVCMWEILMLGVKPFQGVKN----------NDVIGRIEN-GERL-----PMPPNC 233
Query: 549 YPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQ 587
P +L +L C RP E+ LS + Q
Sbjct: 234 PP-----TLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 47/189 (24%), Positives = 84/189 (44%), Gaps = 44/189 (23%)
Query: 355 LAVKKIKEDVTE--------ELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSL 405
+AVK +K D TE E+ +++ I H N++ L+G + G +++ EYA G+L
Sbjct: 53 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT-QDGPLYVIVEYASKGNL 111
Query: 406 DKWLHPKSKS------SSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRT 459
++L + + + L++ + A VA G++Y+ A +HRD+
Sbjct: 112 REYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 168
Query: 460 NNIQLDSRFKAKIANFSLA---------APATNDVMP----------------KFDVFAF 494
N+ + KIA+F LA TN +P + DV++F
Sbjct: 169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 228
Query: 495 GVVLLELLS 503
GV+L E+ +
Sbjct: 229 GVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 43/189 (22%), Positives = 87/189 (46%), Gaps = 44/189 (23%)
Query: 355 LAVKKIKEDVTE--------ELRILQRIN-HANLVKLMGVSSDSQGNRFLVYEYAENGSL 405
+AVK +K++ T+ E+ +++ I H N++ L+GV + +G +++ EYA G+L
Sbjct: 47 VAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT-QEGPLYVIVEYAAKGNL 105
Query: 406 DKWLH---PKSKSSSSSGSVI---FLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRT 459
++L P + + + L++ + A VA G++Y+ +HRD+
Sbjct: 106 REFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYL---ESRRCIHRDLAA 162
Query: 460 NNIQLDSRFKAKIANFSLA---------APATNDVMP----------------KFDVFAF 494
N+ + KIA+F LA +N +P + DV++F
Sbjct: 163 RNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSF 222
Query: 495 GVVLLELLS 503
G+++ E+ +
Sbjct: 223 GILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 55/203 (27%), Positives = 84/203 (41%), Gaps = 55/203 (27%)
Query: 344 SVYRA-TIDGK-VLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNR 393
VY A + +A+K+I +++ +E++ + + NH N+VK S G+
Sbjct: 16 VVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT--SFVVGDE 73
Query: 394 -FLVYEYAENGSLDKWLHPKSKSSSSSG--SVIFLTWSQRLRVALDVANGLQYMHEHAQP 450
+LV Y GSL L S G I T V +V GL+Y+H + Q
Sbjct: 74 LWLVMPYLSGGSL---LDIMKSSYPRGGLDEAIIAT------VLKEVLKGLEYLHSNGQ- 123
Query: 451 SIVHRDIRTNNIQLDSRFKAKIANF----SLAAPATN-----------------DVMP-- 487
+HRDI+ NI L KIA+F SLA +VM
Sbjct: 124 --IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV 181
Query: 488 -----KFDVFAFGVVLLELLSGK 505
K D+++FG+ +EL +G
Sbjct: 182 HGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 46/189 (24%), Positives = 83/189 (43%), Gaps = 44/189 (23%)
Query: 355 LAVKKIKEDVTE--------ELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSL 405
+AVK +K+D TE E+ +++ I H N++ L+G + G +++ EYA G+L
Sbjct: 50 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD-GPLYVIVEYASKGNL 108
Query: 406 DKWLHPKSKSSSSSGSVIF------LTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRT 459
++L + I +T+ + VA G++Y+ A +HRD+
Sbjct: 109 REYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAA 165
Query: 460 NNIQLDSRFKAKIANFSLA---------APATNDVMP----------------KFDVFAF 494
N+ + KIA+F LA TN +P + DV++F
Sbjct: 166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 225
Query: 495 GVVLLELLS 503
GV++ E+ +
Sbjct: 226 GVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 46/189 (24%), Positives = 80/189 (42%), Gaps = 53/189 (28%)
Query: 352 GKVLAVKK---------IKEDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAEN 402
G+++A+KK IK+ E+R+L+++ H NLV L+ V + LV+EY ++
Sbjct: 26 GQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKR-KLHLVFEYCDH 84
Query: 403 ---GSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRT 459
L+K +P+ + + W + + H+H + +HRD++
Sbjct: 85 TVLNELEK--NPR---GVPEHLIKKIIWQ--------TLQAVNFCHKH---NCIHRDVKP 128
Query: 460 NNIQLDSRFKAKIANFSLA--------------------APA--TNDVM--PKFDVFAFG 495
NI + + + K+ +F A AP D P DV+A G
Sbjct: 129 ENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIG 188
Query: 496 VVLLELLSG 504
V ELL+G
Sbjct: 189 CVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 49/189 (25%), Positives = 85/189 (44%), Gaps = 44/189 (23%)
Query: 355 LAVKKIKEDVTE--------ELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSL 405
+AVK +K+D T+ E+ +++ I H N++ L+G + G +++ EYA G+L
Sbjct: 47 VAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD-GPLYVLVEYASKGNL 105
Query: 406 DKWLH---PKSKSSSSSGSVI---FLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRT 459
++L P S + LT+ + A VA G++Y+ A +HRD+
Sbjct: 106 REYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAA 162
Query: 460 NNIQLDSRFKAKIANFSLA---------APATNDVMP----------------KFDVFAF 494
N+ + KIA+F LA TN +P + DV++F
Sbjct: 163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 222
Query: 495 GVVLLELLS 503
GV+L E+ +
Sbjct: 223 GVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 48/185 (25%), Positives = 82/185 (44%), Gaps = 46/185 (24%)
Query: 355 LAVKKIKED-------VTEELRILQRINHANLVKLMGVSSDSQGNRFLVY-EYAENGSLD 406
+A+K+I E + EE+ + + H N+V+ +G SDS+ F ++ E GSL
Sbjct: 36 IAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLG--SDSENGFFKIFMEQVPGGSLS 93
Query: 407 KWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDS 466
L K + I Q L GL+Y+H++ IVHRDI+ +N+ +++
Sbjct: 94 ALLRSKWGPLKDNEQTIIFYTKQILE-------GLKYLHDN---QIVHRDIKGDNVLVNT 143
Query: 467 RFKA-KIANFS----LA----------------APATNDVMPK-----FDVFAFGVVLLE 500
KI++F LA AP D P+ D+++ G ++E
Sbjct: 144 YSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVE 203
Query: 501 LLSGK 505
+ +GK
Sbjct: 204 MATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 52/188 (27%), Positives = 83/188 (44%), Gaps = 38/188 (20%)
Query: 319 KPIVYEIEVIMESTMNLSEHYSIGK----SVYRAT--IDGKVLAVK------KIKEDVTE 366
+ +E + + T +IGK VY+ T DG + AVK + E++
Sbjct: 8 NSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEA 67
Query: 367 ELRILQRI-NHANLVKLMGV--SSD--SQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGS 421
E ILQ + NH N+VK G+ +D G +LV E GS+ + +
Sbjct: 68 EYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKG---------- 117
Query: 422 VIFLTWSQRLRVAL------DVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANF 475
L QRL A+ GLQ++H + I+HRD++ NNI L + K+ +F
Sbjct: 118 --LLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDF 172
Query: 476 SLAAPATN 483
++A T+
Sbjct: 173 GVSAQLTS 180
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 5e-07
Identities = 53/199 (26%), Positives = 84/199 (42%), Gaps = 51/199 (25%)
Query: 338 HYSIGKSVYRAT--IDGKVLAVKKIK----------EDVTEELRILQRINHANLVKLMGV 385
H S G +VY A +V+A+KK+ +D+ +E+R LQ++ H N ++ G
Sbjct: 25 HGSFG-AVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGC 83
Query: 386 SSDSQGNRFLVYEYAENGSLDKW-LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYM 444
+ +LV EY + D +H K L + + GL Y+
Sbjct: 84 YL-REHTAWLVMEYCLGSASDILEVHKKP-----------LQEVEIAAICHGALQGLAYL 131
Query: 445 HEHAQPSIVHRDIRTNNIQLDSRFKAKIANF---SLAAPATNDV-MP------------- 487
H H + +HRDI+ NI L K+A+F SL +PA + V P
Sbjct: 132 HSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVGTPYWMAPEVILAMDE 188
Query: 488 -----KFDVFAFGVVLLEL 501
K DV++ G+ +EL
Sbjct: 189 GQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 5e-07
Identities = 50/190 (26%), Positives = 85/190 (44%), Gaps = 44/190 (23%)
Query: 345 VYRATIDGKV-LAVKKIK------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVY 397
V+ T +G +A+K +K E +E +I++++ H LV L V S+ ++V
Sbjct: 22 VWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEP--IYIVT 79
Query: 398 EYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDI 457
E+ GSL +L G +L Q + +A +A+G+ Y+ + + +HRD+
Sbjct: 80 EFMGKGSLLDFL--------KEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDL 128
Query: 458 RTNNIQLDSRFKAKIANFSLA---------------------APAT---NDVMPKFDVFA 493
R NI + KIA+F LA AP K DV++
Sbjct: 129 RAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188
Query: 494 FGVVLLELLS 503
FG++L EL++
Sbjct: 189 FGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 7e-07
Identities = 51/188 (27%), Positives = 88/188 (46%), Gaps = 51/188 (27%)
Query: 352 GKVLAVKK---------IKEDVTEELRILQRINHANLVKLMGVSSDSQGNR-FLVYEYAE 401
G+++A+KK +K+ E+R+L+++ H NLV L+ V + R +LV+E+ +
Sbjct: 26 GQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF--RRKKRLYLVFEFVD 83
Query: 402 NGSLDKWLH-PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTN 460
+ LD P S +F Q LR G+++ H H +I+HRDI+
Sbjct: 84 HTVLDDLEKYPNGLDESRVRKYLF----QILR-------GIEFCHSH---NIIHRDIKPE 129
Query: 461 NIQLDSRFKAKIANF----SLAAPA---TNDVM-------------PKF----DVFAFGV 496
NI + K+ +F +LAAP T+ V K+ D++A G
Sbjct: 130 NILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGC 189
Query: 497 VLLELLSG 504
++ E+L+G
Sbjct: 190 LVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 9e-07
Identities = 39/147 (26%), Positives = 71/147 (48%), Gaps = 22/147 (14%)
Query: 340 SIGKSVYR---ATIDG--KVLAV---KKIKEDVTEELRILQRINHANLVKLMGVSSDSQG 391
+ K VY+ ID KVL K +++++ E I+ ++++ +V+++GV
Sbjct: 10 CVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAE-- 67
Query: 392 NRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPS 451
LV E A G L+K+L K + S V + V+ G++Y+ +
Sbjct: 68 ALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMH---------QVSMGMKYLEGK---N 115
Query: 452 IVHRDIRTNNIQLDSRFKAKIANFSLA 478
VHRD+ N+ L ++ AKI++F L+
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLS 142
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 9e-07
Identities = 50/201 (24%), Positives = 91/201 (45%), Gaps = 45/201 (22%)
Query: 340 SIGKSVY-RATIDGKVLAVKKI---------KEDVTEELRILQRINHANLVKLMGVSSDS 389
S GK++ ++ DGK +K+I +E+ +E+ +L + H N+V+ S +
Sbjct: 12 SFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE-SFEE 70
Query: 390 QGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQ 449
GN ++V +Y E G L K ++ + + L W ++ +AL +++H+
Sbjct: 71 NGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQI--LDWFVQICLAL------KHVHDR-- 120
Query: 450 PSIVHRDIRTNNIQLDSRFKAKIANFSLA--------------------APATNDVMP-- 487
I+HRDI++ NI L K+ +F +A +P + P
Sbjct: 121 -KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYN 179
Query: 488 -KFDVFAFGVVLLELLSGKKA 507
K D++A G VL E+ + K A
Sbjct: 180 NKSDIWALGCVLYEMCTLKHA 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 47/172 (27%), Positives = 77/172 (44%), Gaps = 38/172 (22%)
Query: 359 KIKEDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSS 418
K KE +E+ +L ++ H N+V S G F+V EY + G L K ++ +
Sbjct: 41 KEKEASKKEVILLAKMKHPNIVTFFA-SFQENGRLFIVMEYCDGGDLMKRINRQR----- 94
Query: 419 SGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFK-AKIANFSL 477
V+F + Q L + ++ GL+++H+ I+HRDI++ NI L AK+ +F +
Sbjct: 95 --GVLF-SEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGI 148
Query: 478 AAPATNDVMP------------------------KFDVFAFGVVLLELLSGK 505
A ND M K D+++ G VL EL + K
Sbjct: 149 AR-QLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 40/146 (27%), Positives = 64/146 (43%), Gaps = 26/146 (17%)
Query: 344 SVY--RATIDGKVLAVKKIKED----------VTEELRILQRINHANLVKLMGVSSDSQG 391
V+ + G + A+K IK+ V E IL + +VKL S +
Sbjct: 8 RVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSFQGKK 66
Query: 392 NRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPS 451
N +LV EY G L L + GS R+ +A ++ L+Y+H +
Sbjct: 67 NLYLVMEYLPGGDLASLLE-------NVGS--LDEDVARIYIA-EIVLALEYLHSN---G 113
Query: 452 IVHRDIRTNNIQLDSRFKAKIANFSL 477
I+HRD++ +NI +DS K+ +F L
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGL 139
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 55/215 (25%), Positives = 88/215 (40%), Gaps = 67/215 (31%)
Query: 341 IGKSVYR---ATID---GKVLAVKKIK---EDVTEELRILQRIN------HANLVKLMGV 385
IGK Y + ID G+ +A+KKI E V++ RIL+ I H ++V++ +
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67
Query: 386 SSDSQGNRF----LVYEYAENGSLDKWLHPKSKSS---SSSGSVIFLTWSQRLRVALDVA 438
F +V+E E+ LH K++ + FL Q LR
Sbjct: 68 MLPPSRREFKDIYVVFELMESD-----LHQVIKANDDLTPEHHQFFLY--QLLR------ 114
Query: 439 NGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDV------------- 485
L+Y+H ++ HRD++ NI ++ K KI +F LA A ND
Sbjct: 115 -ALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 486 ---------------MPKFDVFAFGVVLLELLSGK 505
P D+++ G + E+L+GK
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 45/179 (25%), Positives = 80/179 (44%), Gaps = 42/179 (23%)
Query: 355 LAVKKIK------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKW 408
+AVK +K + EE +++ + H LV+L V + + +++ EY GSL +
Sbjct: 33 VAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEE-PIYIITEYMAKGSLLDF 91
Query: 409 LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRF 468
L S G + L + + + +A G+ Y+ + + +HRD+R N+ +
Sbjct: 92 L------KSDEGGKVLL--PKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESL 140
Query: 469 KAKIANFSLA---------------------AP-ATN--DVMPKFDVFAFGVVLLELLS 503
KIA+F LA AP A N K DV++FG++L E+++
Sbjct: 141 MCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 48/188 (25%), Positives = 75/188 (39%), Gaps = 48/188 (25%)
Query: 352 GKVLAVKKIKEDVT----------EELRIL-QRINHANLVKLMGVSSDSQGNRFLVYEYA 400
++ AVK +K+DV E R+L H L +L ++ F V EY
Sbjct: 20 DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHS-CFQTKDRLFFVMEYV 78
Query: 401 ENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTN 460
G L H + F A ++ GLQ++HE I++RD++ +
Sbjct: 79 NGGDL--MFHIQRSGRFDEPRARFY--------AAEIVLGLQFLHERG---IIYRDLKLD 125
Query: 461 NIQLDSRFKAKIANFSLA--------------------AP---ATNDVMPKFDVFAFGVV 497
N+ LDS KIA+F + AP + P D +A GV+
Sbjct: 126 NVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVL 185
Query: 498 LLELLSGK 505
L E+L+G+
Sbjct: 186 LYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 4e-06
Identities = 57/236 (24%), Positives = 89/236 (37%), Gaps = 88/236 (37%)
Query: 353 KVLAVKKIKEDVT--------EELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENG 403
+ +AVK +KE T EL+IL I +H N+V L+G + G ++ EY + G
Sbjct: 38 RTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFG 97
Query: 404 SLDKWLHPK--------------------------------SKSSSSSGSV--------- 422
+L +L K S+SS+SSG +
Sbjct: 98 NLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVE 157
Query: 423 ----------IFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKI 472
LT + + VA G++++ A +HRD+ NI L KI
Sbjct: 158 EDEEGDELYKEPLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKI 214
Query: 473 ANFSLA----------------------APAT--NDVMP-KFDVFAFGVVLLELLS 503
+F LA AP + + V + DV++FGV+L E+ S
Sbjct: 215 CDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 7e-06
Identities = 31/117 (26%), Positives = 57/117 (48%), Gaps = 14/117 (11%)
Query: 362 EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGS 421
+++T+ + + ++HA +V+L+G+ + LV + + GSL L + S
Sbjct: 54 QEITDHMLAMGSLDHAYIVRLLGICPGASLQ--LVTQLSPLGSL---LDHVRQHRDSLDP 108
Query: 422 VIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA 478
L W + +A G+ Y+ EH +VHR++ NI L S +IA+F +A
Sbjct: 109 QRLLNW------CVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVA 156
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (115), Expect = 7e-06
Identities = 43/126 (34%), Positives = 58/126 (46%), Gaps = 15/126 (11%)
Query: 353 KVLAVKKIKEDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412
K++ +K++ E V E RILQ I H LV L G D N +LV EY G L L K
Sbjct: 38 KIVKLKQV-EHVLNEKRILQSIRHPFLVNLYGSFQDDS-NLYLVMEYVPGGELFSHLR-K 94
Query: 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKI 472
S + + A V L+Y+H IV+RD++ N+ LDS KI
Sbjct: 95 SGRFPEPVARFY---------AAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKI 142
Query: 473 ANFSLA 478
+F A
Sbjct: 143 TDFGFA 148
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 7e-06
Identities = 35/139 (25%), Positives = 67/139 (48%), Gaps = 23/139 (16%)
Query: 351 DGKVLAVKKIKEDVTEE------LR---ILQRINHANLVKLMGVSSDSQGNRFLVYEYAE 401
+++A+K+++ D +E LR +L+ + H N+V+L V S LV+EY +
Sbjct: 24 THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLH-SDKKLTLVFEYCD 82
Query: 402 NGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNN 461
L K+ S + ++ Q L+ GL + H H +++HRD++ N
Sbjct: 83 Q-DLKKYF--DSCNGDIDPEIVKSFMFQLLK-------GLAFCHSH---NVLHRDLKPQN 129
Query: 462 IQLDSRFKAKIANFSLAAP 480
+ ++ + K+A+F LA
Sbjct: 130 LLINKNGELKLADFGLARA 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 7e-06
Identities = 55/204 (26%), Positives = 85/204 (41%), Gaps = 49/204 (24%)
Query: 338 HYSIGKSVYRAT--IDGKVLAVKKIK----------EDVTEELRILQRINHANLVKLMGV 385
H S G +VY AT +V+AVKK+ +D+ +E++ LQ++ H N ++ G
Sbjct: 31 HGSFG-AVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGC 89
Query: 386 SSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMH 445
+LV EY GS L K L + + GL Y+H
Sbjct: 90 YLKEH-TAWLVMEYCL-GSASDLLEVHKKP---------LQEVEIAAITHGALQGLAYLH 138
Query: 446 EHAQPSIVHRDIRTNNIQLDSRFKAKIANF---SLAAPATNDV-MP-------------- 487
H ++HRDI+ NI L + K+A+F S ++PA + V P
Sbjct: 139 SHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTPYWMAPEVILAMDEG 195
Query: 488 ----KFDVFAFGVVLLELLSGKKA 507
K DV++ G+ +EL K
Sbjct: 196 QYDGKVDVWSLGITCIELAERKPP 219
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 8e-06
Identities = 42/185 (22%), Positives = 80/185 (43%), Gaps = 43/185 (23%)
Query: 343 KSVYRATIDGKVLAVKKIKEDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAEN 402
K V+ I K +++ + EL+I+ +V G + ++ N + E+ +
Sbjct: 36 KVVH---IGAK----SSVRKQILRELQIMHECRSPYIVSFYG-AFLNENNICMCMEFMDC 87
Query: 403 GSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMH-EHAQPSIVHRDIRTNN 461
GSLD+ K ++ ++A+ V GL Y++ H I+HRDI+ +N
Sbjct: 88 GSLDRIY---KKGGPIPVEILG-------KIAVAVVEGLTYLYNVH---RIMHRDIKPSN 134
Query: 462 IQLDSRFKAKIANFSLAAPATNDVMPKF---------------------DVFAFGVVLLE 500
I ++SR + K+ +F ++ N + F DV++ G+ ++E
Sbjct: 135 ILVNSRGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIE 194
Query: 501 LLSGK 505
L GK
Sbjct: 195 LALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 9e-06
Identities = 40/154 (25%), Positives = 73/154 (47%), Gaps = 34/154 (22%)
Query: 344 SVYRA--TIDGKVLAVKKIK----------------EDVTEELRILQRINHANLVKLMGV 385
SVY G+++AVK+++ + + E+ +L+ + H N+V+ +G
Sbjct: 15 SVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGS 74
Query: 386 SSDSQG-NRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYM 444
S D+ N FL EY GS+ L + + +++ Q L+ GL Y+
Sbjct: 75 SLDADHLNIFL--EYVPGGSVAALL---NNYGAFEETLVRNFVRQILK-------GLNYL 122
Query: 445 HEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA 478
H I+HRDI+ NI +D++ KI++F ++
Sbjct: 123 HNR---GIIHRDIKGANILVDNKGGIKISDFGIS 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 29/99 (29%), Positives = 49/99 (49%), Gaps = 14/99 (14%)
Query: 366 EELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFL 425
E ++ +++H +LVKL GV N +V EY + G LD +LH + + L
Sbjct: 50 ETASLMSQLSHKHLVKLYGVCV-RDEN-IMVEEYVKFGPLDVFLH-------REKNNVSL 100
Query: 426 TWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQL 464
W +L VA +A+ L Y+ + +VH ++ NI +
Sbjct: 101 HW--KLDVAKQLASALHYLEDK---KLVHGNVCGKNILV 134
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 50/185 (27%), Positives = 80/185 (43%), Gaps = 46/185 (24%)
Query: 353 KVLAVKKIK----------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAEN 402
+V+A+KK+ +D+ +E++ LQRI H N ++ G + +LV EY
Sbjct: 51 EVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYL-REHTAWLVMEYCL- 108
Query: 403 GSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNI 462
GS L K L + + GL Y+H H +++HRDI+ NI
Sbjct: 109 GSASDLLEVHKKP---------LQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNI 156
Query: 463 QLDSRFKAKIANF---SLAAPATNDV-MP------------------KFDVFAFGVVLLE 500
L + K+A+F S+A+PA + V P K DV++ G+ +E
Sbjct: 157 LLTEPGQVKLADFGSASIASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 216
Query: 501 LLSGK 505
L K
Sbjct: 217 LAERK 221
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 45/147 (30%), Positives = 73/147 (49%), Gaps = 27/147 (18%)
Query: 345 VYRAT--IDGKVLAVKKIK---ED------VTEELRILQRINHANLVKLMGVSSDSQGNR 393
VY+A + + +A+KKI+ ED E+ +L+ + H N+V+L V S+
Sbjct: 18 VYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH-SEKRL 76
Query: 394 FLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTW-SQRLRVALDVANGLQYMHEHAQPSI 452
+LV+EY + LD H S + + T+ Q LR G+ Y H H +
Sbjct: 77 YLVFEYLD---LDLKKHMDSSPDFAKNPRLIKTYLYQILR-------GIAYCHSH---RV 123
Query: 453 VHRDIRTNNIQLDSRFKA-KIANFSLA 478
+HRD++ N+ +D R A K+A+F LA
Sbjct: 124 LHRDLKPQNLLIDRRTNALKLADFGLA 150
|
Length = 294 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 44/170 (25%), Positives = 74/170 (43%), Gaps = 39/170 (22%)
Query: 359 KIKEDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSS 418
K + +E I+ ++H +LV+L+GV LV + +G L ++H + +
Sbjct: 51 KANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ--LVTQLMPHGCLLDYVH---EHKDN 105
Query: 419 SGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA 478
GS + L W + +A G+ Y+ E +VHRD+ N+ + S KI +F LA
Sbjct: 106 IGSQLLLNW------CVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLA 156
Query: 479 APATND---------VMP------------KF----DVFAFGVVLLELLS 503
D MP KF DV+++GV + EL++
Sbjct: 157 RLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 47/211 (22%), Positives = 94/211 (44%), Gaps = 60/211 (28%)
Query: 344 SVY--RATIDGKVLAVKKIKEDVTE--------ELRILQRINHANLVKLMGVSSDSQGNR 393
+VY R G+++A+K+I D E E+ +++ + H N+V+L V ++
Sbjct: 15 TVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI-HTENKL 73
Query: 394 FLVYEYAENGSLDKWL----HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQ 449
LV+EY + L K++ + ++ S + Q L+ G+ + HE+
Sbjct: 74 MLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTY----QLLK-------GIAFCHEN-- 119
Query: 450 PSIVHRDIRTNNIQLDSRFKAKIANFSLA--------------------APATNDVM--- 486
++HRD++ N+ ++ R + K+A+F LA AP DV+
Sbjct: 120 -RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAP---DVLLGS 175
Query: 487 ----PKFDVFAFGVVLLELLSGKKATRTTEN 513
D+++ G ++ E+++G+ T N
Sbjct: 176 RTYSTSIDIWSVGCIMAEMITGRPLFPGTNN 206
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 42/174 (24%), Positives = 72/174 (41%), Gaps = 37/174 (21%)
Query: 358 KKIKEDVTEELRILQRINHANLVKLM-GVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSS 416
K + E ++L+ ++H N+++ D +V EYA G+L +++ + S
Sbjct: 40 KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKA--LMIVMEYAPGGTLAEYIQKRCNS- 96
Query: 417 SSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSR-FKAKIANF 475
L L + + L ++H I+HRD++T NI LD KI +F
Sbjct: 97 -------LLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDF 146
Query: 476 SLA-------------------APATNDVMP---KFDVFAFGVVLLELLSGKKA 507
++ +P + P K D++A G VL EL S K+A
Sbjct: 147 GISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRA 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 39/167 (23%), Positives = 72/167 (43%), Gaps = 34/167 (20%)
Query: 360 IKEDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSS 419
I+ + EL++L N +V G S G + E+ + GSLD+ L +
Sbjct: 46 IRNQIIRELQVLHECNSPYIVGFYGAFY-SDGEISICMEHMDGGSLDQVLKEAKRIPEEI 104
Query: 420 GSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAA 479
+V++ V GL Y+ E Q I+HRD++ +NI ++SR + K+ +F ++
Sbjct: 105 LG----------KVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSG 152
Query: 480 PATNDVMPKF---------------------DVFAFGVVLLELLSGK 505
+ + F D+++ G+ L+EL G+
Sbjct: 153 QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 30/118 (25%), Positives = 52/118 (44%), Gaps = 13/118 (11%)
Query: 362 EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGS 421
ED E+ IL H N+V L + +++ E+ + G+LD + +
Sbjct: 47 EDFMVEIDILSECKHPNIVGLYEAYF-YENKLWILIEFCDGGALDSIMLELERG------ 99
Query: 422 VIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAA 479
LT Q V + L ++H H ++HRD++ NI L K+A+F ++A
Sbjct: 100 ---LTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSA 151
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 2e-05
Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 85/223 (38%)
Query: 341 IGKS----VYRATID---GKVLAVKKIKE---DVTE------ELRILQRI-NHANLVKLM 383
+GK V++A ID +V+A+KKI + + T+ E+ LQ + +H N+VKL+
Sbjct: 15 LGKGAYGIVWKA-IDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLL 73
Query: 384 GV-SSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVI-----------FLTWSQRL 431
V +++ + +LV+EY E D LH +VI ++ + Q L
Sbjct: 74 NVIKAENDKDIYLVFEYMET---D--LH----------AVIRANILEDVHKRYIMY-QLL 117
Query: 432 RVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA-------APATND 484
+ L+Y+H +++HRD++ +NI L+S + K+A+F LA N
Sbjct: 118 K-------ALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENP 167
Query: 485 VMPKF----------------------DVFAFGVVLLELLSGK 505
V+ + D+++ G +L E+L GK
Sbjct: 168 VLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 47/195 (24%), Positives = 73/195 (37%), Gaps = 50/195 (25%)
Query: 344 SVYRA--TIDGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQG 391
SVY A G A+K +K+ +V E I+ + V + S S+
Sbjct: 11 SVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKD 70
Query: 392 NRFLVYEYAENG---SLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHA 448
+LV EY G SL K L W+++ +V G++ +H
Sbjct: 71 YLYLVMEYLNGGDCASLIKTLGGLP-----------EDWAKQY--IAEVVLGVEDLH--- 114
Query: 449 QPSIVHRDIRTNNIQLDSRFKAKIANFSLA----------------APAT---NDVMPKF 489
Q I+HRDI+ N+ +D K+ +F L+ AP T
Sbjct: 115 QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPDYLAPETILGVGDDKMS 174
Query: 490 DVFAFGVVLLELLSG 504
D ++ G V+ E L G
Sbjct: 175 DWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 45/199 (22%), Positives = 84/199 (42%), Gaps = 51/199 (25%)
Query: 339 YSIGKSVYRA--TIDGKVLAVKKIKEDVT--------EELRILQRINHANLVKLMGVSSD 388
+ G +VY+A + ++LAVK I D+T EL IL + + ++ G
Sbjct: 11 HGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV 70
Query: 389 SQGNRF-LVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEH 447
NR + E+ + GSLD + + G R+A+ V GL Y+
Sbjct: 71 E--NRISICTEFMDGGSLDVY---RKIPEHVLG-----------RIAVAVVKGLTYLW-- 112
Query: 448 AQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVMPKF------------------ 489
I+HRD++ +N+ +++R + K+ +F ++ N + +
Sbjct: 113 -SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYG 171
Query: 490 ---DVFAFGVVLLELLSGK 505
DV++ G+ +EL G+
Sbjct: 172 IHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 32/140 (22%), Positives = 64/140 (45%), Gaps = 21/140 (15%)
Query: 347 RATIDGKVLAVKKIKEDVTEEL--------RILQRINHANLVKLMGVSSDSQGNRFLVYE 398
R D +AVK +E + +L RIL++ +H N+V+L+GV + Q ++V E
Sbjct: 15 RLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ-PIYIVME 73
Query: 399 YAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIR 458
+ G +L + L + +++ + A G++Y+ +HRD+
Sbjct: 74 LVQGGDFLTFLRTEGPR---------LKVKELIQMVENAAAGMEYLESK---HCIHRDLA 121
Query: 459 TNNIQLDSRFKAKIANFSLA 478
N + + KI++F ++
Sbjct: 122 ARNCLVTEKNVLKISDFGMS 141
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 32/145 (22%), Positives = 66/145 (45%), Gaps = 13/145 (8%)
Query: 341 IGKSVYRATIDGKVLAVKKIKEDVT--------EELRILQRINHANLVKLMGVSSDSQGN 392
I K V + + +V A+K + E + E +++ N ++V+L+GV S Q
Sbjct: 26 IAKGVVKDEPETRV-AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 84
Query: 393 RFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSI 452
++ E G L +L ++ + + +++A ++A+G+ Y++ +
Sbjct: 85 -LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KF 140
Query: 453 VHRDIRTNNIQLDSRFKAKIANFSL 477
VHRD+ N + F KI +F +
Sbjct: 141 VHRDLAARNCMVAEDFTVKIGDFGM 165
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 43/153 (28%), Positives = 71/153 (46%), Gaps = 30/153 (19%)
Query: 344 SVYRAT--IDGKVLAVKKIKEDVTEE------------LRILQRINHANLVKLMGVSSDS 389
+VY+A G +A+K ++ E+ L+ L+ +H N+V+LM V + S
Sbjct: 15 TVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATS 74
Query: 390 QGNR----FLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMH 445
+ +R LV+E+ + L +L K I Q LR GL ++H
Sbjct: 75 RTDRETKVTLVFEHVDQ-DLRTYLD-KVPPPGLPAETIKDLMRQFLR-------GLDFLH 125
Query: 446 EHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA 478
+ IVHRD++ NI + S + K+A+F LA
Sbjct: 126 ANC---IVHRDLKPENILVTSGGQVKLADFGLA 155
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 38/146 (26%), Positives = 66/146 (45%), Gaps = 34/146 (23%)
Query: 352 GKVLAVKKIKEDVTEE------------LRILQRINHANLVKLMGVSSDSQGNR----FL 395
G+ +A+K+++ EE LR L+ H N+V+L V + S+ +R L
Sbjct: 27 GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL 86
Query: 396 VYEYAENG---SLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSI 452
V+E+ + LDK P + + + + GL ++H H +
Sbjct: 87 VFEHVDQDLTTYLDKVPEPGVPTETIKD------------MMFQLLRGLDFLHSH---RV 131
Query: 453 VHRDIRTNNIQLDSRFKAKIANFSLA 478
VHRD++ NI + S + K+A+F LA
Sbjct: 132 VHRDLKPQNILVTSSGQIKLADFGLA 157
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 42/147 (28%), Positives = 65/147 (44%), Gaps = 23/147 (15%)
Query: 345 VYRA--TIDGKVLAVKKIKED-------VTEELRILQRINHANLVKLMGVSSDSQGNRFL 395
VY+A G++ AVK IK + + +E+ +++ H N+V G S S+ ++
Sbjct: 25 VYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFG-SYLSREKLWI 83
Query: 396 VYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHR 455
EY GSL H L+ Q V + GL Y+H + +HR
Sbjct: 84 CMEYCGGGSLQDIYHVTGP----------LSELQIAYVCRETLQGLAYLHSKGK---MHR 130
Query: 456 DIRTNNIQLDSRFKAKIANFSLAAPAT 482
DI+ NI L K+A+F +AA T
Sbjct: 131 DIKGANILLTDNGDVKLADFGVAAKIT 157
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 40/162 (24%), Positives = 71/162 (43%), Gaps = 39/162 (24%)
Query: 367 ELRILQRINHANLVKLMGVSSDSQGNRFL-VYEYAENGSLDKWLHPKSKSSSSSGSVIFL 425
E L + +H+N+V+L GV + +GN + V EY NG+LD +L L
Sbjct: 56 EALTLGQFDHSNIVRLEGVIT--RGNTMMIVTEYMSNGALDSFLRKHEGQ---------L 104
Query: 426 TWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFS--------- 476
Q + + +A+G++Y+ E VH+ + + + ++S KI+ F
Sbjct: 105 VAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161
Query: 477 ------------LAAPAT---NDVMPKFDVFAFGVVLLELLS 503
AAP + DV++FG+V+ E++S
Sbjct: 162 IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 38/142 (26%), Positives = 64/142 (45%), Gaps = 18/142 (12%)
Query: 345 VYRATIDGKVLAVKKIKEDVT--EELRILQR------INHANLVKLMGVSSDSQGNRFLV 396
+R +V+ VK+++ T E+L LQ +NH N+++ +G +S LV
Sbjct: 16 AHRGMSKARVV-VKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESI-PYLLV 73
Query: 397 YEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRD 456
E+ G L +L + L R+A +VA+GL ++H Q +H D
Sbjct: 74 LEFCPLGDLKNYLRSNRGMVAQMAQKDVL-----QRMACEVASGLLWLH---QADFIHSD 125
Query: 457 IRTNNIQLDSRFKAKIANFSLA 478
+ N QL + KI ++ LA
Sbjct: 126 LALRNCQLTADLSVKIGDYGLA 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 41/163 (25%), Positives = 78/163 (47%), Gaps = 22/163 (13%)
Query: 324 EIEVIMESTMNLSEHYSIGKSVYRATIDGKVLAVKKIKEDVTE--------ELRILQRIN 375
EIEV+ E + + S+ K ++R T G +A+K+I+ ++ E EL IL +
Sbjct: 2 EIEVLDE--LGKGNYGSVYKVLHRPT--GVTMAMKEIRLELDESKFNQIIMELDILHKAV 57
Query: 376 HANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVAL 435
+V G +G ++ EY + GSLDK + V+ R+
Sbjct: 58 SPYIVDFYGAFF-IEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVL-------RRITY 109
Query: 436 DVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA 478
V GL+++ E + +I+HRD++ N+ ++ + K+ +F ++
Sbjct: 110 AVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVS 150
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 44/145 (30%), Positives = 65/145 (44%), Gaps = 30/145 (20%)
Query: 346 YRATIDGKVLAVKKIK----------EDVTEELRILQRIN---HANLVKLMGVSSDSQGN 392
Y+ T G++ A+K +K E + E RI + N H LV L +
Sbjct: 20 YKKT--GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTED-H 76
Query: 393 RFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSI 452
V EYA G L +H + S +V + A V GLQY+HE+ I
Sbjct: 77 VCFVMEYAAGGDL--MMHIHTDVFSEPRAVFY---------AACVVLGLQYLHEN---KI 122
Query: 453 VHRDIRTNNIQLDSRFKAKIANFSL 477
V+RD++ +N+ LD+ KIA+F L
Sbjct: 123 VYRDLKLDNLLLDTEGFVKIADFGL 147
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 38/140 (27%), Positives = 71/140 (50%), Gaps = 22/140 (15%)
Query: 347 RATIDGKVLAVKKIKEDVTE--------ELRILQRINHANLVKLMGVSSDSQGNRFLVYE 398
R+ + ++A+K+I+ + E E+ +L+ + HAN+V L + ++ LV+E
Sbjct: 25 RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIH-TERCLTLVFE 83
Query: 399 YAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIR 458
Y ++ L ++L S IF+ Q LR GL Y H+ I+HRD++
Sbjct: 84 YLDS-DLKQYLDNCGNLMSMHNVKIFMF--QLLR-------GLSYCHKR---KILHRDLK 130
Query: 459 TNNIQLDSRFKAKIANFSLA 478
N+ ++ + + K+A+F LA
Sbjct: 131 PQNLLINEKGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 4e-05
Identities = 43/186 (23%), Positives = 86/186 (46%), Gaps = 49/186 (26%)
Query: 352 GKVLAVKKI-------KEDVTEELRILQRINHANLVKLMGVSSDSQGNR-FLVYEYAENG 403
G+ +AVKK+ +E + E+ I++ H N+V++ SS G+ ++V E+ E G
Sbjct: 44 GRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMY--SSYLVGDELWVVMEFLEGG 101
Query: 404 SL-DKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNI 462
+L D H + + Q V L V L ++H ++HRDI++++I
Sbjct: 102 ALTDIVTHTR------------MNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSI 146
Query: 463 QLDSRFKAKIANFSLAAPATNDV------------M-----------PKFDVFAFGVVLL 499
L S + K+++F A + +V M + D+++ G++++
Sbjct: 147 LLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVI 206
Query: 500 ELLSGK 505
E++ G+
Sbjct: 207 EMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 5e-05
Identities = 48/199 (24%), Positives = 78/199 (39%), Gaps = 56/199 (28%)
Query: 352 GKVLAVKKIKEDVTEELRILQR----------INHANLVKLMGVSSDSQGNRFLVYEYAE 401
G +A+K ++ D EE R + H N+V L+ G F V+EY
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 402 NGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNN 461
+L + L ++ G+ L + R+ L V + L H Q IVHRD++ N
Sbjct: 63 GRTLREVL-------AADGA---LPAGETGRLMLQVLDALA--CAHNQ-GIVHRDLKPQN 109
Query: 462 IQL---DSRFKAKIANFSLAA--PATND----------------------------VMPK 488
I + R AK+ +F + P D V P
Sbjct: 110 IMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPN 169
Query: 489 FDVFAFGVVLLELLSGKKA 507
D++A+G++ LE L+G++
Sbjct: 170 SDLYAWGLIFLECLTGQRV 188
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 45/187 (24%), Positives = 86/187 (45%), Gaps = 51/187 (27%)
Query: 352 GKVLAVKKI-------KEDVTEELRILQRINHANLVKLMGVSSDSQGNR-FLVYEYAENG 403
GK +AVKK+ +E + E+ I++ +H N+V + +S G+ ++V E+ E G
Sbjct: 47 GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMY--NSYLVGDELWVVMEFLEGG 104
Query: 404 SL-DKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNI 462
+L D H + + Q V L V L Y+H ++HRDI++++I
Sbjct: 105 ALTDIVTHTR------------MNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSI 149
Query: 463 QLDSRFKAKIANFSLAAPATNDVMPK------------------------FDVFAFGVVL 498
L S + K+++F A + +V PK D+++ G+++
Sbjct: 150 LLTSDGRIKLSDFGFCAQVSKEV-PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMV 208
Query: 499 LELLSGK 505
+E++ G+
Sbjct: 209 IEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 56/244 (22%), Positives = 86/244 (35%), Gaps = 98/244 (40%)
Query: 353 KVLAVKKIKEDVT--------EELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENG 403
+ +AVK +KE T EL+IL I +H N+V L+G + G ++ E+ + G
Sbjct: 38 RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 97
Query: 404 SLDKWLHPK-------------------------------------SKSSSSSGSV---- 422
+L +L K S+SS+SSG V
Sbjct: 98 NLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKS 157
Query: 423 ----------------IFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDS 466
LT + + VA G++++ A +HRD+ NI L
Sbjct: 158 LSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSE 214
Query: 467 RFKAKIANFSLAAPATNDVMPKF---------------------------DVFAFGVVLL 499
KI +F LA D P + DV++FGV+L
Sbjct: 215 NNVVKICDFGLARDIYKD--PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 272
Query: 500 ELLS 503
E+ S
Sbjct: 273 EIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 47/217 (21%), Positives = 94/217 (43%), Gaps = 59/217 (27%)
Query: 340 SIGKSVYRATIDGKV--------LAVKKIK---------EDVTEELRILQRINHANLVKL 382
++G+ + + ++G++ +AVK +K ED E ++ +H N+++L
Sbjct: 6 TLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRL 65
Query: 383 MGV---SSDSQG--NRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDV 437
+GV + +S+G + ++ + ++G L +L S +L ++ D+
Sbjct: 66 IGVCLQTVESEGYPSPVVILPFMKHGDLHSFL----LYSRLGDCPQYLPTQMLVKFMTDI 121
Query: 438 ANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN---------DVMP- 487
A+G++Y+ + S +HRD+ N L+ +A+F L+ N MP
Sbjct: 122 ASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV 178
Query: 488 ---------------KFDVFAFGVVLLELLSGKKATR 509
K DV++FGV + E+ ATR
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEI-----ATR 210
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 41/175 (23%), Positives = 79/175 (45%), Gaps = 35/175 (20%)
Query: 360 IKEDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL---HPKSKSS 416
++E+ E + R+ H N+V L+GV + Q +++ Y + L ++L P S
Sbjct: 51 LREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS-MIFSYCSHSDLHEFLVMRSPHSDVG 109
Query: 417 SSSGSVIF---LTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIA 473
S+ L + + + +A G++++ H +VH+D+ T N+ + + KI+
Sbjct: 110 STDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKIS 166
Query: 474 NFSL-----AAP----ATNDVMP------------KF----DVFAFGVVLLELLS 503
+ L AA N ++P KF D++++GVVL E+ S
Sbjct: 167 DLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 6e-05
Identities = 42/167 (25%), Positives = 79/167 (47%), Gaps = 34/167 (20%)
Query: 324 EIEVIMESTMNLSEHYSIGKSVYRATIDGKVLAVKKIKEDVTE---------ELRILQRI 374
+IE I E T + + K + T G+++A+KKI+ + E E+ +L+ +
Sbjct: 4 KIEKIGEGTYGV-----VYKGRNKKT--GQIVAMKKIRLESEEEGVPSTAIREISLLKEL 56
Query: 375 NHANLVKLMGVSSDSQGNR-FLVYEYAENGSLDKWLH--PKSKSSSSSGSVIFLTWSQRL 431
H N+V L V Q +R +L++E+ L K+L PK + + +L
Sbjct: 57 QHPNIVCLQDVLM--QESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYL------ 107
Query: 432 RVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA 478
+ G+ + H ++HRD++ N+ +D++ K+A+F LA
Sbjct: 108 ---YQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLA 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 53/237 (22%), Positives = 82/237 (34%), Gaps = 93/237 (39%)
Query: 355 LAVKKIKEDVT--------EELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSL 405
+AVK +KE T EL+IL I NH N+V L+G + G ++ E+ + G+L
Sbjct: 40 VAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNL 99
Query: 406 DKWLHPK----------------------------SKSSSSSGSVIF------------- 424
+L K + + SV+F
Sbjct: 100 SNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP 159
Query: 425 -----------LTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIA 473
LT + + VA G++++ A +HRD+ NI L KI
Sbjct: 160 PQETDDLWKSPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKIC 216
Query: 474 NFSLAAPATNDVMPKF---------------------------DVFAFGVVLLELLS 503
+F LA D P + DV++FGV+L E+ S
Sbjct: 217 DFGLARDIYKD--PDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 6e-05
Identities = 46/167 (27%), Positives = 74/167 (44%), Gaps = 45/167 (26%)
Query: 367 ELRILQRINHANLVKLMGV-SSDSQGNRF----LVYEYAENGSLDKWLHPKSKSSSSSGS 421
ELR+L+ ++H N++ L+ V + S F LV L+ K S
Sbjct: 64 ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-----GADLNNIVKCQKLSDD 118
Query: 422 VI-FLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAP 480
I FL + Q LR GL+Y+H I+HRD++ +NI ++ + KI +F LA
Sbjct: 119 HIQFLVY-QILR-------GLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARH 167
Query: 481 ATNDVMPKF----------------------DVFAFGVVLLELLSGK 505
T+D M + D+++ G ++ ELL+GK
Sbjct: 168 -TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 6e-05
Identities = 47/179 (26%), Positives = 80/179 (44%), Gaps = 43/179 (24%)
Query: 355 LAVKKIK------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKW 408
+AVK +K E E +++ + H LVKL V + +++ E+ GSL +
Sbjct: 33 VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEP--IYIITEFMAKGSLLDF 90
Query: 409 LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRF 468
L S GS L + + + +A G+ ++ Q + +HRD+R NI + +
Sbjct: 91 L------KSDEGSKQPL--PKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASL 139
Query: 469 KAKIANFSLA---------------------AP-ATN--DVMPKFDVFAFGVVLLELLS 503
KIA+F LA AP A N K DV++FG++L+E+++
Sbjct: 140 VCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 8e-05
Identities = 40/150 (26%), Positives = 66/150 (44%), Gaps = 22/150 (14%)
Query: 345 VYRA-TIDGKVLAVKKI--------KEDVTEELRILQRINHANLVKLMGVSSDSQGNRFL 395
VY+A + VLA K+ ED E+ IL +H N+VKL+ + N ++
Sbjct: 21 VYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY-YENNLWI 79
Query: 396 VYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHR 455
+ E+ G++D + + LT Q V L Y+HE+ I+HR
Sbjct: 80 LIEFCAGGAVDAVMLELERP---------LTEPQIRVVCKQTLEALNYLHEN---KIIHR 127
Query: 456 DIRTNNIQLDSRFKAKIANFSLAAPATNDV 485
D++ NI K+A+F ++A T +
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVSAKNTRTI 157
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 9e-05
Identities = 42/186 (22%), Positives = 85/186 (45%), Gaps = 49/186 (26%)
Query: 352 GKVLAVKKI-------KEDVTEELRILQRINHANLVKLMGVSSDSQGNR-FLVYEYAENG 403
GK++AVKK+ +E + E+ I++ H N+V++ +S G+ ++V E+ E G
Sbjct: 45 GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMY--NSYLVGDELWVVMEFLEGG 102
Query: 404 SL-DKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNI 462
+L D H + + Q V L V L +H ++HRDI++++I
Sbjct: 103 ALTDIVTHTR------------MNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSI 147
Query: 463 QLDSRFKAKIANFSLAAPATNDVM-----------------------PKFDVFAFGVVLL 499
L + K+++F A + +V P+ D+++ G++++
Sbjct: 148 LLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVI 207
Query: 500 ELLSGK 505
E++ G+
Sbjct: 208 EMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 41/196 (20%), Positives = 80/196 (40%), Gaps = 38/196 (19%)
Query: 341 IGKSVYRATIDGKVLAVKKIKEDVT--------EELRILQRINHANLVKLMGVSSDSQGN 392
+ + + + +V AVK + E + E +++ ++V+L+GV S Q
Sbjct: 26 NARDIIKGEAETRV-AVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84
Query: 393 RFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSI 452
+V E +G L +L + ++ T + +++A ++A+G+ Y++
Sbjct: 85 -LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KF 140
Query: 453 VHRDIRTNNIQLDSRFKAKIANFSLA----------------------APAT---NDVMP 487
VHRD+ N + F KI +F + AP +
Sbjct: 141 VHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTT 200
Query: 488 KFDVFAFGVVLLELLS 503
D+++FGVVL E+ S
Sbjct: 201 SSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 47/192 (24%), Positives = 83/192 (43%), Gaps = 48/192 (25%)
Query: 352 GKVLAVKKIK------EDVTEELR---ILQRINHANLVKLMGVSSDSQGNRFL-----VY 397
+ +AVK +K D+ E LR ++ +H N++KL+GVS S+ L +
Sbjct: 27 FQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVIL 86
Query: 398 EYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRL-RVALDVANGLQYMHEHAQPSIVHRD 456
+ ++G L +L S G F Q L R +D+A+G++Y+ + + +HRD
Sbjct: 87 PFMKHGDLHTFL-----LMSRIGEEPFTLPLQTLVRFMIDIASGMEYL---SSKNFIHRD 138
Query: 457 IRTNNIQLDSRFKAKIANFSLA-------------------------APATNDVMPKFDV 491
+ N L+ +A+F L+ + A N DV
Sbjct: 139 LAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDV 198
Query: 492 FAFGVVLLELLS 503
+AFGV + E+++
Sbjct: 199 WAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 53/223 (23%), Positives = 93/223 (41%), Gaps = 68/223 (30%)
Query: 334 NLSEHYS----IGKSVYR---ATID---GKVLAVKKIK--EDVT------EELRILQRIN 375
++ Y IG+ Y + G +A+KKI E T E++IL+R
Sbjct: 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFK 61
Query: 376 HANLVKLMGV----SSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVI--FLTWSQ 429
H N++ ++ + S +S + ++V E E L+ K+ S I FL Q
Sbjct: 62 HENIIGILDIIRPPSFESFNDVYIVQELMETD-----LYKLIKTQHLSNDHIQYFLY--Q 114
Query: 430 RLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATND----- 484
LR GL+Y+H +++HRD++ +N+ L++ KI +F LA A +
Sbjct: 115 ILR-------GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTG 164
Query: 485 ---------------VMPKF-------DVFAFGVVLLELLSGK 505
+M D+++ G +L E+LS +
Sbjct: 165 FLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 49/183 (26%), Positives = 80/183 (43%), Gaps = 28/183 (15%)
Query: 318 GKPIVYEIEVIMESTMNLSEHYSIGKSVYRAT------IDGKVLAVK------KIKEDVT 365
GK I+++ T + E +IGK Y +G AVK I E++
Sbjct: 5 GKTIIFDSFPDPSDTWEIIE--TIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIE 62
Query: 366 EELRILQRI-NHANLVKLMGV---SSDSQGNR-FLVYEYAENGSLDKWLHPKSKSSSSSG 420
E IL+ + +H N+VK G+ G++ +LV E GS+ + K
Sbjct: 63 AEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERME 122
Query: 421 SVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAP 480
I + L AL GLQ++H + +HRD++ NNI L + K+ +F ++A
Sbjct: 123 EPII---AYILHEAL---MGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQ 173
Query: 481 ATN 483
T+
Sbjct: 174 LTS 176
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 1e-04
Identities = 39/168 (23%), Positives = 74/168 (44%), Gaps = 36/168 (21%)
Query: 360 IKEDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSS 419
I+ + EL++L N +V G S G + E+ + GSLD+ L +
Sbjct: 46 IRNQIIRELQVLHECNSPYIVGFYGAFY-SDGEISICMEHMDGGSLDQVLKKAGRIPE-- 102
Query: 420 GSVIFLTWSQRL-RVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA 478
Q L +V++ V GL Y+ E + I+HRD++ +NI ++SR + K+ +F ++
Sbjct: 103 ---------QILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS 151
Query: 479 APATNDVMPKF---------------------DVFAFGVVLLELLSGK 505
+ + F D+++ G+ L+E+ G+
Sbjct: 152 GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 30/145 (20%), Positives = 55/145 (37%), Gaps = 27/145 (18%)
Query: 344 SVYRATIDGKVLAVKKI------KEDVTE---ELRILQRINHANLVKLMGVSSDSQGNRF 394
+ + ++AVKKI KED+ E+ +++ H N++ + +
Sbjct: 17 HLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDS-ELY 75
Query: 395 LVYEYAENGSLDKWLHPKSKSSSSSG---SVIFLTWSQRLRVALDVANGLQYMHEHAQPS 451
+V GS + L K+ G I L+ DV N L Y+H
Sbjct: 76 VVSPLMAYGSCEDLL----KTHFPEGLPELAIAFI----LK---DVLNALDYIH---SKG 121
Query: 452 IVHRDIRTNNIQLDSRFKAKIANFS 476
+HR ++ ++I L K ++
Sbjct: 122 FIHRSVKASHILLSGDGKVVLSGLR 146
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 48/211 (22%), Positives = 90/211 (42%), Gaps = 63/211 (29%)
Query: 341 IGKSVY------RATIDGKVLAVKKIK---EDVTE------ELRILQRINHANLVKL--- 382
IG+ Y + + + +A+KKI ++ + E+++L+ ++H N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 383 -MGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSS---SSSGSVIFLTWSQRLRVALDVA 438
++ + ++VYE +D LH +SS S FL Q LR
Sbjct: 73 MPPPHREAFNDVYIVYEL-----MDTDLHQIIRSSQTLSDDHCQYFLY--QLLR------ 119
Query: 439 NGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAP--ATNDVMPKF------- 489
GL+Y+H +++HRD++ +N+ L++ KI +F LA D M ++
Sbjct: 120 -GLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYR 175
Query: 490 ---------------DVFAFGVVLLELLSGK 505
DV++ G + ELL K
Sbjct: 176 APELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 42/147 (28%), Positives = 68/147 (46%), Gaps = 23/147 (15%)
Query: 345 VYRA--TIDGKVLAVKKIK----ED---VTEELRILQRINHANLVKLMGVSSDSQGNRFL 395
VY+A G++ A+K IK ED V +E+ +++ H+N+V G S + ++
Sbjct: 25 VYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFG-SYLRRDKLWI 83
Query: 396 VYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHR 455
E+ GSL H L+ SQ V+ + GL Y+H + +HR
Sbjct: 84 CMEFCGGGSLQDIYHVTGP----------LSESQIAYVSRETLQGLYYLHSKGK---MHR 130
Query: 456 DIRTNNIQLDSRFKAKIANFSLAAPAT 482
DI+ NI L K+A+F ++A T
Sbjct: 131 DIKGANILLTDNGHVKLADFGVSAQIT 157
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 46/159 (28%), Positives = 63/159 (39%), Gaps = 38/159 (23%)
Query: 378 NLVKLMG--VSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVAL 435
N+V L VS DS FLV ++AE G L W H + V W+ + VAL
Sbjct: 46 NMVCLHKYIVSEDSV---FLVLQHAEGGKL--WSHISKFLNIPEECV--KRWAAEMVVAL 98
Query: 436 DVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFS-----------------LA 478
D +H IV RD+ NNI LD R ++ FS
Sbjct: 99 DA------LHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYC 149
Query: 479 AP---ATNDVMPKFDVFAFGVVLLELLSGKKATRTTENG 514
AP ++ D ++ G +L ELL+GK +G
Sbjct: 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG 188
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 40/175 (22%), Positives = 79/175 (45%), Gaps = 39/175 (22%)
Query: 355 LAVK-KIKEDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKS 413
L +K I+ + EL++L N +V G + S G + E+ + GSLD+ L
Sbjct: 36 LEIKPAIRNQIIRELKVLHECNSPYIVGFYG-AFYSDGEISICMEHMDGGSLDQVL---- 90
Query: 414 KSSSSSGSV--IFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAK 471
+G + L ++++ V GL Y+ E + I+HRD++ +NI ++SR + K
Sbjct: 91 ---KKAGRIPENILG-----KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIK 140
Query: 472 IANFSLAAPATNDVMPKF---------------------DVFAFGVVLLELLSGK 505
+ +F ++ + + F D+++ G+ L+E+ G+
Sbjct: 141 LCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 20/100 (20%), Positives = 48/100 (48%), Gaps = 28/100 (28%)
Query: 432 RVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDV------ 485
++A+ + L+Y+H + S++HRD++ +N+ ++ + K+ +F ++ + V
Sbjct: 107 KIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA 164
Query: 486 -----MP---------------KFDVFAFGVVLLELLSGK 505
M K DV++ G+ ++EL +G+
Sbjct: 165 GCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 42/167 (25%), Positives = 73/167 (43%), Gaps = 52/167 (31%)
Query: 367 ELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLT 426
E +LQ +NH +++++ LV G++ + P S + +LT
Sbjct: 107 EAMLLQNVNHPSVIRMKDT---------LVS-----GAITCMVLPHYSSDLYT----YLT 148
Query: 427 WSQRLRVALDVA--------NGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKI-----A 473
R + +D A GL+Y+H I+HRD++T NI ++ + I A
Sbjct: 149 KRSR-PLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAA 204
Query: 474 NFSLAAPA---------TN--DVMP------KFDVFAFGVVLLELLS 503
F + APA TN +V+ K D+++ G+VL E+L+
Sbjct: 205 QFPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 62/244 (25%), Positives = 101/244 (41%), Gaps = 51/244 (20%)
Query: 338 HYSIGKSVY--RATIDGKVLAVKKIK----------EDVTEELRILQRINHANLVKLMGV 385
H S G +VY R + +V+A+KK+ +D+ +E+R LQ++ H N ++ G
Sbjct: 25 HGSFG-AVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGC 83
Query: 386 SSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMH 445
+ +LV EY GS L K L + V GL Y+H
Sbjct: 84 YL-REHTAWLVMEYCL-GSASDLLEVHKKP---------LQEVEIAAVTHGALQGLAYLH 132
Query: 446 EHAQPSIVHRDIRTNNIQLDSRFKAKIANF---SLAAPATNDV-MP-------------- 487
H +++HRD++ NI L K+ +F S+ APA V P
Sbjct: 133 SH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDEG 189
Query: 488 ----KFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKR-EERLRNWMD 542
K DV++ G+ +E L+ +K N +A+ E ++ E RN++D
Sbjct: 190 QYDGKVDVWSLGITCIE-LAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD 248
Query: 543 PNLE 546
L+
Sbjct: 249 SCLQ 252
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 37/148 (25%), Positives = 72/148 (48%), Gaps = 26/148 (17%)
Query: 345 VYRAT--IDGKVLAVKKI----------KEDVTEELRILQRINHANLVKLMG-VSSDSQG 391
VYRAT +DG +A+KK+ + D +E+ +L+++NH N++K D++
Sbjct: 18 VYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL 77
Query: 392 NRFLVYEYAENGSLDKWL-HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQP 450
N +V E A+ G L + + H K + ++ + Q + + L++MH
Sbjct: 78 N--IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQ-------LCSALEHMHSR--- 125
Query: 451 SIVHRDIRTNNIQLDSRFKAKIANFSLA 478
++HRDI+ N+ + + K+ + L
Sbjct: 126 RVMHRDIKPANVFITATGVVKLGDLGLG 153
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 35/144 (24%), Positives = 62/144 (43%), Gaps = 20/144 (13%)
Query: 344 SVYRATIDGKVLAVKKI---------KEDVTEELRILQRINHANLVKLMGVSSDSQGNRF 394
S+ R DGK +KK+ ++ +E ++L ++ H N+V G +
Sbjct: 17 SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLY 76
Query: 395 LVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVH 454
+V + E G L L + L +Q + + +A LQY+HE I+H
Sbjct: 77 IVMGFCEGGDLYHKLKEQKGK--------LLPENQVVEWFVQIAMALQYLHEK---HILH 125
Query: 455 RDIRTNNIQLDSRFKAKIANFSLA 478
RD++T N+ L K+ + +A
Sbjct: 126 RDLKTQNVFLTRTNIIKVGDLGIA 149
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 4e-04
Identities = 39/157 (24%), Positives = 66/157 (42%), Gaps = 29/157 (18%)
Query: 341 IGKSVYRATIDG------KVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVS 386
IGK + G KV+A+K I ED+ +E+ +L + + + K G S
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG-S 70
Query: 387 SDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHE 446
+++ EY GS L P L +Q + ++ GL Y+H
Sbjct: 71 YLKDTKLWIIMEYLGGGSALDLLEPGP-----------LDETQIATILREILKGLDYLHS 119
Query: 447 HAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN 483
+ +HRDI+ N+ L + K+A+F +A T+
Sbjct: 120 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD 153
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 36/148 (24%), Positives = 74/148 (50%), Gaps = 26/148 (17%)
Query: 345 VYRAT--IDGKVLAVKKI----------KEDVTEELRILQRINHANLVK-LMGVSSDSQG 391
VYRAT +D K +A+KK+ ++D +E+ +L+++NH N++K L D++
Sbjct: 18 VYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNEL 77
Query: 392 NRFLVYEYAENGSLDKWL-HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQP 450
N +V E A+ G L + + + K + ++ + Q + + +++MH
Sbjct: 78 N--IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQ-------LCSAVEHMHSR--- 125
Query: 451 SIVHRDIRTNNIQLDSRFKAKIANFSLA 478
++HRDI+ N+ + + K+ + L
Sbjct: 126 RVMHRDIKPANVFITATGVVKLGDLGLG 153
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 40/145 (27%), Positives = 74/145 (51%), Gaps = 24/145 (16%)
Query: 344 SVY--RATIDGKVLAVKKIKEDVTE--------ELRILQRINHANLVKLMGVSSDSQGNR 393
+VY R+ + ++A+K+I+ + E E+ +L+ + HAN+V L + ++ +
Sbjct: 21 TVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-TEKSL 79
Query: 394 FLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIV 453
LV+EY + L ++L S + +FL Q LR GL Y H ++
Sbjct: 80 TLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLF--QLLR-------GLNYCHRR---KVL 126
Query: 454 HRDIRTNNIQLDSRFKAKIANFSLA 478
HRD++ N+ ++ R + K+A+F LA
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLA 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 51/190 (26%), Positives = 89/190 (46%), Gaps = 50/190 (26%)
Query: 367 ELRILQRINHANLVKLMGV-SSDSQGNRF----LVYEYAENGSLDKWL-HPKSKSSSSSG 420
EL +L+ + H N++ L+ V +S G+ F LV Y + L K + HP S+
Sbjct: 64 ELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHPLSEDK---- 118
Query: 421 SVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA-- 478
V +L + Q L GL+Y+H I+HRD++ N+ ++ + KI +F LA
Sbjct: 119 -VQYLVY-QMLC-------GLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARH 166
Query: 479 --APATNDVMPKF-----------------DVFAFGVVLLELLSGKKATRTTENGKTAVL 519
A T V+ ++ D+++ G ++ E+L+GK T GK +
Sbjct: 167 ADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK----TLFKGKDYL- 221
Query: 520 WKEIREVLKV 529
++ ++LKV
Sbjct: 222 -DQLTQILKV 230
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 38/153 (24%), Positives = 74/153 (48%), Gaps = 27/153 (17%)
Query: 342 GKSVYRAT--IDGKVLAVKKIKEDVTEE------LR---ILQRINHAN-LVKLMGV---- 385
GK VY+A GK++A+KK + ++ EE LR +LQ ++ + +V+L+ V
Sbjct: 15 GK-VYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVE 73
Query: 386 SSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMH 445
+ + + +LV+EY ++ L K++ + L + G+ + H
Sbjct: 74 EKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRP-----LPAKTIKSFMYQLLKGVAHCH 127
Query: 446 EHAQPSIVHRDIRTNNIQLD-SRFKAKIANFSL 477
+H ++HRD++ N+ +D + KIA+ L
Sbjct: 128 KHG---VMHRDLKPQNLLVDKQKGLLKIADLGL 157
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 5e-04
Identities = 44/157 (28%), Positives = 70/157 (44%), Gaps = 29/157 (18%)
Query: 341 IGK----SVYRATID--GKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVS 386
IGK VY+A +V+A+K I ED+ +E++ L + + K G S
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYG-S 67
Query: 387 SDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHE 446
+++ EY GS L P K + + I LR +V GL+Y+HE
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLDLLKP-GKLDETYIAFI-------LR---EVLLGLEYLHE 116
Query: 447 HAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN 483
+ +HRDI+ NI L K+A+F ++ T+
Sbjct: 117 EGK---IHRDIKAANILLSEEGDVKLADFGVSGQLTS 150
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 5e-04
Identities = 25/124 (20%), Positives = 46/124 (37%), Gaps = 23/124 (18%)
Query: 345 VYRATIDGKVLAVKKI-----KEDVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYE 398
VY + +K D E+ ILQ + V + S +S G +L+ E
Sbjct: 14 VYLLGTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLME 73
Query: 399 YAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIR 458
+ E +LD+ ++ ++ +A +A L +H+ + H D+
Sbjct: 74 WIEGETLDE-----------------VSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLH 116
Query: 459 TNNI 462
NI
Sbjct: 117 PGNI 120
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 6e-04
Identities = 45/157 (28%), Positives = 76/157 (48%), Gaps = 34/157 (21%)
Query: 341 IGK----SVYRA--TIDGKVLAVKKIK--------EDVTEELRILQRINHA---NLVKLM 383
IG+ +VYR G+V+A+K I D+ E+ +L ++ + N+ K
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 384 GVSSDSQGNR-FLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQ 442
G S +G R +++ EYAE GS+ + + SVI +R L VA L+
Sbjct: 69 G--SYLKGPRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVI-------IREVL-VA--LK 115
Query: 443 YMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAA 479
Y+H + ++HRDI+ NI + + K+ +F +AA
Sbjct: 116 YIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAA 149
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 6e-04
Identities = 52/201 (25%), Positives = 83/201 (41%), Gaps = 49/201 (24%)
Query: 340 SIGKSVYRATIDG--KVLAVKKIKEDVT----------EELRILQRINHANLVKLMGVSS 387
S GK V+ A + G + A+K +K+DV E R+L + + +
Sbjct: 7 SFGK-VFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTF 65
Query: 388 DSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEH 447
++ N F V EY G L H +S F A ++ GLQ++H
Sbjct: 66 QTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATFY--------AAEIICGLQFLHSK 115
Query: 448 AQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAP------------ATND-VMPKF----- 489
IV+RD++ +NI LD+ KIA+F + T D + P+
Sbjct: 116 G---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQK 172
Query: 490 -----DVFAFGVVLLELLSGK 505
D ++FGV+L E+L G+
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 7e-04
Identities = 35/126 (27%), Positives = 62/126 (49%), Gaps = 16/126 (12%)
Query: 354 VLAVKKIKEDVTEELRILQRINHANLVKLMGVS-SDSQGNRFLVYEYAENGSLDKWLHPK 412
VLA +K E + EE+ +L+ + H N+V+ +G D+ + F+ E+ GS+
Sbjct: 39 VLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM--EFVPGGSI------- 89
Query: 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKI 472
S + G + + + + LD G+ Y+H + +VHRDI+ NN+ L K+
Sbjct: 90 SSILNRFGPLPEPVFCKYTKQILD---GVAYLHNN---CVVHRDIKGNNVMLMPNGIIKL 143
Query: 473 ANFSLA 478
+F A
Sbjct: 144 IDFGCA 149
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 7e-04
Identities = 48/217 (22%), Positives = 89/217 (41%), Gaps = 66/217 (30%)
Query: 341 IGKSVYRATI------DGKVLAVKKIK-----------------EDVTEELRILQRINHA 377
IGK Y G+++AVK+++ + + E+ L+ ++H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 378 NLVKLMGV-SSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALD 436
N+V+ +G +++ + FL EY GS+ L + V F T Q L
Sbjct: 69 NIVQYLGFETTEEYLSIFL--EYVPGGSIGSCLRTYGRFEEQL--VRFFT-EQVLE---- 119
Query: 437 VANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA------------------ 478
GL Y+H I+HRD++ +N+ +D+ KI++F ++
Sbjct: 120 ---GLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGS 173
Query: 479 ----APATNDVM-----PKFDVFAFGVVLLELLSGKK 506
AP K D+++ G V+LE+ +G++
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 8e-04
Identities = 48/187 (25%), Positives = 71/187 (37%), Gaps = 47/187 (25%)
Query: 352 GKVLAVKKIKEDVT----------EELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAE 401
GK A+K +K++V E R+LQ H L L S + V EYA
Sbjct: 20 GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK-YSFQTHDRLCFVMEYAN 78
Query: 402 NGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNN 461
G L + H S +F R A ++ + L Y+H +V+RD++ N
Sbjct: 79 GGEL--FFH-------LSRERVFSEDRARFYGA-EIVSALGYLHSC---DVVYRDLKLEN 125
Query: 462 IQLDSRFKAKIANFSLA--------------------APAT---NDVMPKFDVFAFGVVL 498
+ LD KI +F L AP ND D + GVV+
Sbjct: 126 LMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVM 185
Query: 499 LELLSGK 505
E++ G+
Sbjct: 186 YEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 8e-04
Identities = 27/100 (27%), Positives = 47/100 (47%), Gaps = 26/100 (26%)
Query: 429 QRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA---------- 478
Q + A +++ GL ++H I++RD++ +N+ LDS KIA+F +
Sbjct: 102 QAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTT 158
Query: 479 ----------APATNDVMP---KFDVFAFGVVLLELLSGK 505
AP P D +A+GV+L E+L+G+
Sbjct: 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 8e-04
Identities = 48/202 (23%), Positives = 80/202 (39%), Gaps = 51/202 (25%)
Query: 340 SIGKSVYRATIDGK--VLAVKKIKEDVT----------EELRILQ-RINHANLVKLMGVS 386
S GK V A + G V A+K +K+DV E RIL H L L
Sbjct: 7 SFGK-VMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHC-C 64
Query: 387 SDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHE 446
++ F V EY G L + +S+ S + A +V L ++H
Sbjct: 65 FQTKDRLFFVMEYVNGGDLMFQIQ-RSRKFDEPRSRFY---------AAEVTLALMFLHR 114
Query: 447 HAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVM-------------------- 486
H +++RD++ +NI LD+ K+A+F + + +
Sbjct: 115 HG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQEL 171
Query: 487 ---PKFDVFAFGVVLLELLSGK 505
P D +A GV++ E+++G+
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 40/193 (20%), Positives = 74/193 (38%), Gaps = 48/193 (24%)
Query: 342 GKSVYRATIDGKVLAVKKIKEDVTEELRILQRINHANLVKLMGV--SSD-----SQGNRF 394
GK I +V A + + E+ L R+NH N++K+ + S +Q F
Sbjct: 188 GKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF 247
Query: 395 LVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVH 454
+Y + + + D W K L R + + ++Y+H+ ++H
Sbjct: 248 DLYSFMYDEAFD-W-----KDRP-------LLKQTR-AIMKQLLCAVEYIHDKK---LIH 290
Query: 455 RDIRTNNIQLDSRFKAKIANFSLAAPATNDVMPK------------------------FD 490
RDI+ NI L+ K + +F A P + D
Sbjct: 291 RDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITD 350
Query: 491 VFAFGVVLLELLS 503
+++ G++LL++LS
Sbjct: 351 IWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 43/164 (26%), Positives = 78/164 (47%), Gaps = 31/164 (18%)
Query: 329 MESTMNLSEHYSIGKSVYRATIDGK------VLAVKKIKEDVTE--------ELRILQRI 374
ME+ + L + +G+ Y G+ ++A+K+I+ + E E+ +L+ +
Sbjct: 5 METYIKLEK---LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDL 61
Query: 375 NHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVA 434
HAN+V L + + + LV+EY + L +++ S IFL Q LR
Sbjct: 62 KHANIVTLHDIVHTDK-SLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLY--QILR-- 115
Query: 435 LDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA 478
GL Y H ++HRD++ N+ ++ R + K+A+F LA
Sbjct: 116 -----GLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLA 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 51/201 (25%), Positives = 81/201 (40%), Gaps = 51/201 (25%)
Query: 340 SIGKSVY-RATIDGKVLAVKKIKEDV----------TEELRILQRI-NHANLVKLMGVSS 387
S GK + R G++ AVK +K+DV E RIL NH L +L
Sbjct: 7 SFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY-CCF 65
Query: 388 DSQGNRFLVYEYAENGSLDKWLH-PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHE 446
+ F V E+ G L H KS+ + + + A ++ + L ++H+
Sbjct: 66 QTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFY---------AAEITSALMFLHD 114
Query: 447 HAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA--------------------APATNDVM 486
I++RD++ +N+ LD K+A+F + AP M
Sbjct: 115 KG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEM 171
Query: 487 ---PKFDVFAFGVVLLELLSG 504
P D +A GV+L E+L G
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 42/167 (25%), Positives = 74/167 (44%), Gaps = 35/167 (20%)
Query: 362 EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGS 421
ED +E +L ++ H N+V S ++ G+ ++V EY + G L + + K +
Sbjct: 43 EDSRKEAVLLAKMKHPNIVAFKE-SFEADGHLYIVMEYCDGGDLMQKI--KLQRGKLFPE 99
Query: 422 VIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA 481
L W ++ + G+Q++HE ++HRDI++ NI L K K+ +F A
Sbjct: 100 DTILQWFVQMCL------GVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLL 150
Query: 482 TNDV--------------------MP---KFDVFAFGVVLLELLSGK 505
T+ MP K D+++ G +L EL + K
Sbjct: 151 TSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 28/95 (29%), Positives = 45/95 (47%), Gaps = 26/95 (27%)
Query: 434 ALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA--------------- 478
A ++A GL ++H I++RD++ +N+ LDS KIA+F +
Sbjct: 107 AAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCG 163
Query: 479 -----APATNDVMP---KFDVFAFGVVLLELLSGK 505
AP P D +AFGV+L E+L+G+
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|226376 COG3858, COG3858, Predicted glycosyl hydrolase [General function prediction only] | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 21/112 (18%), Positives = 38/112 (33%), Gaps = 17/112 (15%)
Query: 44 YVAYFAQSPEFLDLSNISDLFGVSRLSIARASNLVSEDTPLVPKQLLLVPIICGCTGNQY 103
+ + I+ F + I ++ ++D LV Q +VP
Sbjct: 1 MSIHLVGPGDSR--LIIAVYFPYTNNRIVNGNDYTNDD--LVDGQTFVVPP--------- 47
Query: 104 FANITYQIKKGDSYYLVSITSFENLTNWHAVLEMNPGINPNLLQIGVKVTFP 155
+ Y + GD+ ++ T + MN I P LQ G+ + P
Sbjct: 48 -SGHFYDVGPGDTLTSIARTVGVTQDSA---AIMNFVICPGYLQYGLNLYIP 95
|
Length = 423 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 40/143 (27%), Positives = 67/143 (46%), Gaps = 28/143 (19%)
Query: 347 RATIDGKVLAVKKIKEDVTE--------ELRILQRINHANLVKLMGVSSDSQGNRFLVYE 398
++ ++GK++A+K I+ E E +L+ + HAN+V L + + LV+E
Sbjct: 25 KSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKE-TLTLVFE 83
Query: 399 YAENG---SLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHR 455
Y +DK HP + +F Q LR GL Y+H Q I+HR
Sbjct: 84 YVHTDLCQYMDK--HPGGLHPENVKLFLF----QLLR-------GLSYIH---QRYILHR 127
Query: 456 DIRTNNIQLDSRFKAKIANFSLA 478
D++ N+ + + K+A+F LA
Sbjct: 128 DLKPQNLLISDTGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 32/120 (26%), Positives = 59/120 (49%), Gaps = 14/120 (11%)
Query: 362 EDVTEELRIL-QRINHANLVKLMGVSSDSQGNR-FLVYEYAENGSL-DKWLHPKSKSSSS 418
D+ E+ I+ +++ H N+V+ + + +R ++V + E L + + K K
Sbjct: 53 GDIVSEVTIIKEQLRHPNIVRYY--KTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRF 110
Query: 419 SGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA 478
+ I W+ +++ L L+Y+H+ + IVHRD+ NNI L K I +F LA
Sbjct: 111 TEERI---WNIFVQMVL----ALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLA 161
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 47/196 (23%), Positives = 78/196 (39%), Gaps = 39/196 (19%)
Query: 354 VLAVKKIKEDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKS 413
++A ++ +TE R+LQ H L L S + V EYA G L + H
Sbjct: 33 IVAKDEVAHTLTEN-RVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGEL--FFHLSR 88
Query: 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIA 473
+ S F ++ + L Y+H ++ ++V+RD++ N+ LD KI
Sbjct: 89 ERVFSEDRARFY--------GAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKIT 138
Query: 474 NFSLA--------------------APAT---NDVMPKFDVFAFGVVLLELLSGKKATRT 510
+F L AP ND D + GVV+ E++ G+
Sbjct: 139 DFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 198
Query: 511 TENGK--TAVLWKEIR 524
++ K +L +EIR
Sbjct: 199 QDHEKLFELILMEEIR 214
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 35/136 (25%), Positives = 61/136 (44%), Gaps = 26/136 (19%)
Query: 352 GKVLAVKKIKED------------VTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEY 399
G+ LAVK++ D + E+++L+ + H +V+ G D + + EY
Sbjct: 27 GRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDE-TLSIFMEY 85
Query: 400 AENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRT 459
GS+ L + G+ LT + + + G++Y+H + IVHRDI+
Sbjct: 86 MPGGSVKDQL-------KAYGA---LTETVTRKYTRQILEGVEYLHSN---MIVHRDIKG 132
Query: 460 NNIQLDSRFKAKIANF 475
NI DS K+ +F
Sbjct: 133 ANILRDSAGNVKLGDF 148
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.002
Identities = 27/95 (28%), Positives = 45/95 (47%), Gaps = 26/95 (27%)
Query: 434 ALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA--------------- 478
A ++A GL ++H I++RD++ +N+ LD+ KIA+F +
Sbjct: 107 AAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCG 163
Query: 479 -----APATNDVMP---KFDVFAFGVVLLELLSGK 505
AP P D +AFGV+L E+L+G+
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 35/137 (25%), Positives = 60/137 (43%), Gaps = 26/137 (18%)
Query: 352 GKVLAVKKIKEDVTE------------ELRILQRINHANLVKLMGVSSDSQGNRFLVY-E 398
G+ LAVK+++ D E+++L+ + H +V+ G D ++ E
Sbjct: 27 GRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME 86
Query: 399 YAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIR 458
+ GS+ L S G+ LT + + + G+ Y+H + IVHRDI+
Sbjct: 87 HMPGGSIKDQL-------KSYGA---LTENVTRKYTRQILEGVSYLHSNM---IVHRDIK 133
Query: 459 TNNIQLDSRFKAKIANF 475
NI DS K+ +F
Sbjct: 134 GANILRDSVGNVKLGDF 150
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 32/118 (27%), Positives = 54/118 (45%), Gaps = 13/118 (11%)
Query: 362 EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGS 421
ED E+ IL NH +VKL+G G +++ E+ G++D + +
Sbjct: 54 EDYMVEIEILATCNHPYIVKLLGAFY-WDGKLWIMIEFCPGGAVDAIMLELDRG------ 106
Query: 422 VIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAA 479
LT Q + + LQY+H I+HRD++ N+ L K+A+F ++A
Sbjct: 107 ---LTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSA 158
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 45/175 (25%), Positives = 69/175 (39%), Gaps = 38/175 (21%)
Query: 354 VLAVKKIKEDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKS 413
++A ++ VTE R+LQ H L L + + V EYA G L + H
Sbjct: 33 IIAKDEVAHTVTES-RVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGEL--FFH--- 85
Query: 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIA 473
S +F R A ++ + L+Y+H +V+RDI+ N+ LD KI
Sbjct: 86 ----LSRERVFTEERARFYGA-EIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKIT 137
Query: 474 NFSLA--------------------APAT---NDVMPKFDVFAFGVVLLELLSGK 505
+F L AP ND D + GVV+ E++ G+
Sbjct: 138 DFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.003
Identities = 40/146 (27%), Positives = 71/146 (48%), Gaps = 26/146 (17%)
Query: 344 SVYRA--TIDGKVLAVKKIKEDVTE--------ELRILQRINHANLVKLMG-VSSDSQGN 392
+VY+ + G+++A+K+I+ + E E +L+ + HAN+V L + +
Sbjct: 20 TVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLT 79
Query: 393 RFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSI 452
LV+EY + L +++ S +FL Q LR GL Y H Q +
Sbjct: 80 --LVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLF--QLLR-------GLAYCH---QRRV 124
Query: 453 VHRDIRTNNIQLDSRFKAKIANFSLA 478
+HRD++ N+ + R + K+A+F LA
Sbjct: 125 LHRDLKPQNLLISERGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 37/137 (27%), Positives = 63/137 (45%), Gaps = 26/137 (18%)
Query: 352 GKVLAVKKI------KEDVTE------ELRILQRINHANLVKLMGVSSDSQGNRFLVY-E 398
G+ LAVK++ +E E E+++L+ + H +V+ G D + + ++ E
Sbjct: 27 GRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVE 86
Query: 399 YAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIR 458
Y GS+ L + G+ LT + R + G+ Y+H + IVHRDI+
Sbjct: 87 YMPGGSIKDQL-------KAYGA---LTENVTRRYTRQILQGVSYLHSNM---IVHRDIK 133
Query: 459 TNNIQLDSRFKAKIANF 475
NI DS K+ +F
Sbjct: 134 GANILRDSAGNVKLGDF 150
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|212030 cd00118, LysM, Lysine Motif is a small domain involved in binding peptidoglycan | Back alignment and domain information |
|---|
Score = 35.5 bits (83), Expect = 0.003
Identities = 14/47 (29%), Positives = 23/47 (48%), Gaps = 3/47 (6%)
Query: 107 ITYQIKKGDSYYLVSITSFENLTNWHAVLEMNPGINPNLLQIGVKVT 153
TY +K GD+ + SI + + + NP INP+ + G K+
Sbjct: 1 KTYTVKPGDTLW--SI-AKKYGVTVEELAAANPLINPDCIYPGQKLK 44
|
LysM, a small globular domain with approximately 40 amino acids, is a widespread protein module involved in binding peptidoglycan in bacteria and chitin in eukaryotes. The domain was originally identified in enzymes that degrade bacterial cell walls, but proteins involved in many other biological functions also contain this domain. It has been reported that the LysM domain functions as a signal for specific plant-bacteria recognition in bacterial pathogenesis. Many of these enzymes are modular and are composed of catalytic units linked to one or several repeats of LysM domains. LysM domains are found in bacteria and eukaryotes. Length = 45 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.003
Identities = 44/189 (23%), Positives = 76/189 (40%), Gaps = 45/189 (23%)
Query: 347 RATIDGKVLAVKKIKEDVT---------EELRILQRINHANLVKLMGVSSDSQGNRFLVY 397
R + G+ +A+KKI + + EL++L+ + H N++ L + + + V
Sbjct: 30 RDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVT 89
Query: 398 EYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDI 457
E L LH S I Q LR GL+Y+H +VHRD+
Sbjct: 90 EL-----LGTDLHRLLTSRPLEKQFIQYFLYQILR-------GLKYVH---SAGVVHRDL 134
Query: 458 RTNNIQLDSRFKAKIANFSLAAPATN--------------DVM-------PKFDVFAFGV 496
+ +NI ++ KI +F LA ++M + D+++ G
Sbjct: 135 KPSNILINENCDLKICDFGLARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGC 194
Query: 497 VLLELLSGK 505
+ E+L GK
Sbjct: 195 IFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 39.5 bits (93), Expect = 0.003
Identities = 33/143 (23%), Positives = 54/143 (37%), Gaps = 34/143 (23%)
Query: 351 DGKVLAVKKIK----------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYA 400
+ A+K +K E + E IL+ NH +VKL D + L+ EY
Sbjct: 17 KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLM-EYC 75
Query: 401 ENGSL-----DKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHR 455
G L D+ L + + V+ +Y+H I++R
Sbjct: 76 LGGELWTILRDRGLFDEYTARFYIACVV---------------LAFEYLHNR---GIIYR 117
Query: 456 DIRTNNIQLDSRFKAKIANFSLA 478
D++ N+ LDS K+ +F A
Sbjct: 118 DLKPENLLLDSNGYVKLVDFGFA 140
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 29/99 (29%), Positives = 50/99 (50%), Gaps = 13/99 (13%)
Query: 366 EELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFL 425
E ++++++H ++V L GV N +V E+ E G LD ++H KS L
Sbjct: 53 ETASMMRQVSHKHIVLLYGVCVRDVEN-IMVEEFVEFGPLDLFMHRKSD---------VL 102
Query: 426 TWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQL 464
T + +VA +A+ L Y+ + +VH ++ T NI L
Sbjct: 103 TTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILL 138
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 45/167 (26%), Positives = 78/167 (46%), Gaps = 45/167 (26%)
Query: 367 ELRILQRINHANLVKLMGV-SSDSQGNRF----LVYEY--AENGSLDKWLHPKSKSSSSS 419
ELR+L+ + H N++ L+ V + D +RF LV + + G L K H K S
Sbjct: 64 ELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK--HEKL----SE 117
Query: 420 GSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAA 479
+ FL + Q L+ GL+Y+H I+HRD++ N+ ++ + KI +F LA
Sbjct: 118 DRIQFLVY-QMLK-------GLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR 166
Query: 480 PA----TNDVMPKF-----------------DVFAFGVVLLELLSGK 505
T V+ ++ D+++ G ++ E+L+GK
Sbjct: 167 QTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 51/202 (25%), Positives = 83/202 (41%), Gaps = 51/202 (25%)
Query: 340 SIGKSVYRATIDGK--VLAVKKIKEDV------TEELRILQRI-----NHANLVKLMGVS 386
S GK V A + G A+K +K+DV E + +R+ H L L +
Sbjct: 7 SFGK-VMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF-CT 64
Query: 387 SDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHE 446
++ + F V EY G L H +S F A ++ GLQ++H+
Sbjct: 65 FQTKEHLFFVMEYLNGGDL--MFHIQSSGRFDEARARFY--------AAEIICGLQFLHK 114
Query: 447 HAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAP------------ATNDVM-PKF---- 489
I++RD++ +N+ LD KIA+F + T D + P+
Sbjct: 115 K---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQ 171
Query: 490 ------DVFAFGVVLLELLSGK 505
D ++FGV+L E+L G+
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.004
Identities = 38/185 (20%), Positives = 80/185 (43%), Gaps = 47/185 (25%)
Query: 352 GKVLAVKKI-------KEDVTEELRILQRINHANLVKLMGVSSDSQGNR-FLVYEYAENG 403
G+ +A+K+I KE + E+ +++ + + N+V + S G+ F+V EY G
Sbjct: 44 GQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFL--DSFLVGDELFVVMEYLAGG 101
Query: 404 SLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQ 463
SL + + + +Q V + L+++H + ++HRDI+++N+
Sbjct: 102 SL-----------TDVVTETCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVL 147
Query: 464 LDSRFKAKIANFSLAAPATNDVM-----------------------PKFDVFAFGVVLLE 500
L K+ +F A T + PK D+++ G++ +E
Sbjct: 148 LGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIE 207
Query: 501 LLSGK 505
++ G+
Sbjct: 208 MVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.004
Identities = 34/145 (23%), Positives = 64/145 (44%), Gaps = 23/145 (15%)
Query: 347 RATIDGKVLAVKKIKEDVTEELRILQRIN-------HANLVKLMG--VSSDSQG---NRF 394
R G++ A+K + EE I Q IN H N+ G + + G +
Sbjct: 26 RHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 85
Query: 395 LVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVH 454
LV E+ GS+ + ++ G+ + W + ++ GL ++H+H ++H
Sbjct: 86 LVMEFCGAGSVTDLI------KNTKGNTLKEEWIAY--ICREILRGLSHLHQH---KVIH 134
Query: 455 RDIRTNNIQLDSRFKAKIANFSLAA 479
RDI+ N+ L + K+ +F ++A
Sbjct: 135 RDIKGQNVLLTENAEVKLVDFGVSA 159
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.004
Identities = 51/223 (22%), Positives = 88/223 (39%), Gaps = 50/223 (22%)
Query: 347 RATIDGKVLAVKK-----IKEDVTE-----ELRILQRINHANLVKLMGVSSDSQGNRFLV 396
RAT GK+ A KK IK+ E E +IL+++N +V L + +++ LV
Sbjct: 22 RAT--GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-AYAYETKDALCLV 78
Query: 397 YEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRD 456
G L ++ +F A ++ GL+ +H IV+RD
Sbjct: 79 LTLMNGGDLKFHIYNMGNPGFDEERAVFY--------AAEITCGLEDLHRE---RIVYRD 127
Query: 457 IRTNNIQLDSRFKAKIANFSLAAPATND------------VMPKF----------DVFAF 494
++ NI LD +I++ LA + P+ D +
Sbjct: 128 LKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGL 187
Query: 495 GVVLLELLSGKKATRTTENGKTAVLWKEI-REVLKVEEKREER 536
G ++ E++ GK R K V +E+ R V + +E+ E+
Sbjct: 188 GCLIYEMIEGKSPFRQR---KEKVKREEVERRVKEDQEEYSEK 227
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.004
Identities = 38/147 (25%), Positives = 68/147 (46%), Gaps = 18/147 (12%)
Query: 335 LSEHYSIGKSVYRATI-DGKVLAVKKIKEDVT---EELRILQRINHANLVKLMGVSSDSQ 390
LSE Y+ V R + + K A K + + + RILQ H N+++ +G ++
Sbjct: 13 LSEIYT-DTGVARVVVKELKANASSKEQNEFLQQGDPYRILQ---HPNILQCLGQCVEAI 68
Query: 391 GNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQP 450
LV+EY E G L +L + +S + R+A ++A G+ +MH+H
Sbjct: 69 -PYLLVFEYCELGDLKSYLSQEQWHRRNSQLL------LLQRMACEIAAGVTHMHKH--- 118
Query: 451 SIVHRDIRTNNIQLDSRFKAKIANFSL 477
+ +H D+ N L S K+ ++ +
Sbjct: 119 NFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 615 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.98 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.98 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.98 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.98 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.98 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.98 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.98 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.98 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.97 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.97 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.97 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.97 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.97 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.97 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.97 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.97 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.97 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.97 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.97 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.97 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.97 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.97 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.97 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.97 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.97 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.97 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 99.97 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.97 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.97 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.97 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.97 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.97 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.97 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.97 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.97 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.97 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.97 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.97 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.97 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.97 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.97 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.97 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.97 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.97 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.97 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.97 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.97 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.97 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.97 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.97 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.97 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.97 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.97 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.97 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.97 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.97 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.97 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.97 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.97 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.97 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.97 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.97 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.97 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.97 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.97 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.97 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.96 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.96 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.96 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.96 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.96 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.96 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.96 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.96 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.96 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.96 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.96 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.96 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.96 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.96 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.96 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.96 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.96 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.96 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.96 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.96 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.96 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.96 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.96 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.96 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.96 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.96 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.96 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.96 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.96 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.96 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.96 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.96 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.96 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.96 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.96 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.96 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.96 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.96 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.96 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.96 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.96 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.96 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.96 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.96 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.96 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.96 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.96 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.96 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.96 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.96 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.96 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.96 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.96 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.96 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.96 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.96 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.95 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.95 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.95 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.95 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.95 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.95 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.95 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.95 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.95 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.95 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.95 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.95 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.95 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.95 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.95 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.95 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.95 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.95 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.95 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.95 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.95 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.95 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.95 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.95 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.95 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.94 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.94 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.94 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.94 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.94 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.94 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.94 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.94 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.94 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.94 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.94 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.94 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.94 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.94 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.93 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.93 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.93 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.93 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.93 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.93 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.92 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.92 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.92 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.92 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.92 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.91 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.91 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.91 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.91 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.9 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.9 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.89 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.89 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.89 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.89 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.88 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.88 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.88 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.88 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.87 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.87 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.86 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.85 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.84 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.84 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.84 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.83 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.83 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.83 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.82 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.79 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.78 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.77 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.7 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.68 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.67 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.65 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.61 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.59 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.59 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.57 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.57 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.56 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.54 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.54 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.54 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.51 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.48 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.47 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.45 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.43 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.37 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.36 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.32 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.32 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.25 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.25 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.23 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.19 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.1 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.0 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.95 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.93 | |
| PRK10783 | 456 | mltD membrane-bound lytic murein transglycosylase | 98.87 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.82 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.8 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.78 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 98.77 | |
| PRK06347 | 592 | autolysin; Reviewed | 98.76 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.75 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.73 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.69 | |
| PRK06347 | 592 | autolysin; Reviewed | 98.69 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.68 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.59 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.54 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.52 | |
| PRK10783 | 456 | mltD membrane-bound lytic murein transglycosylase | 98.33 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.24 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.2 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.02 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.97 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 97.86 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 97.85 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 97.75 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.6 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.56 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.53 | |
| PF01476 | 44 | LysM: LysM domain; InterPro: IPR018392 This domain | 97.33 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.22 | |
| PF01476 | 44 | LysM: LysM domain; InterPro: IPR018392 This domain | 97.14 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 96.99 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 96.96 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 96.94 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 96.81 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.71 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.45 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.42 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 96.39 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 96.38 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.27 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 96.18 | |
| PRK13914 | 481 | invasion associated secreted endopeptidase; Provis | 95.98 | |
| TIGR02899 | 44 | spore_safA spore coat assembly protein SafA. in wh | 95.98 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 95.79 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 95.73 | |
| PRK14125 | 103 | cell division suppressor protein YneA; Provisional | 95.72 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 95.58 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 95.41 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.39 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 95.35 | |
| cd00118 | 46 | LysM Lysin domain, found in a variety of enzymes i | 95.28 | |
| COG1388 | 124 | LytE FOG: LysM repeat [Cell envelope biogenesis, o | 95.17 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 94.98 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.93 | |
| PRK14125 | 103 | cell division suppressor protein YneA; Provisional | 94.58 | |
| PRK11198 | 147 | LysM domain/BON superfamily protein; Provisional | 94.37 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 94.3 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 94.09 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 93.87 | |
| cd00118 | 46 | LysM Lysin domain, found in a variety of enzymes i | 93.79 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 93.39 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 93.12 | |
| PRK10871 | 319 | nlpD lipoprotein NlpD; Provisional | 93.03 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 92.92 | |
| PLN02236 | 344 | choline kinase | 92.85 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-51 Score=430.69 Aligned_cols=257 Identities=39% Similarity=0.647 Sum_probs=219.8
Q ss_pred CceeeeHHHHHHHccccccccccc----ceEEEEEE-CCeEEEEEEcc-------HHHHHHHHHHHhcCCCCcccEEEEE
Q 047629 319 KPIVYEIEVIMESTMNLSEHYSIG----KSVYRATI-DGKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVS 386 (615)
Q Consensus 319 ~~~~~~~~~l~~at~~~~~~~~iG----~~Vy~~~~-~g~~vAvK~~~-------~~~~~Ei~~l~~l~H~niv~l~g~~ 386 (615)
....|+|+++.+||++|++.+.+| |.||+|.+ +|+.||||++. .+|.+|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 457899999999999999999988 47999999 56999999874 3599999999999999999999999
Q ss_pred EcCCCcEEEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCC
Q 047629 387 SDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDS 466 (615)
Q Consensus 387 ~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~ 466 (615)
.+.+++.+||||||+||+|.++|+..... .|+|.+|++||.++|+||+|||+.+.|+|||||||++|||||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--------~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~ 212 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--------PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDE 212 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC--------CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECC
Confidence 87543499999999999999999986531 3899999999999999999999999999999999999999999
Q ss_pred CCcEEEeecCCCCCCCC------------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHH
Q 047629 467 RFKAKIANFSLAAPATN------------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKE 522 (615)
Q Consensus 467 ~~~~kl~DFGla~~~~~------------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 522 (615)
++++||+|||+|+.... ..+.|+|||||||+|+||+||++|.+.........+..|
T Consensus 213 ~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w 292 (361)
T KOG1187|consen 213 DFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEW 292 (361)
T ss_pred CCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHH
Confidence 99999999999865532 145699999999999999999999886542222224455
Q ss_pred HHHHHhHHHHHHHHHhhhcCCcCC-CCCCh-HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 523 IREVLKVEEKREERLRNWMDPNLE-SFYPI-DGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~~dp~l~-~~~~~-~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
....+. ...+.+++||++. ++++. +++.++..++.+|++.+|.+||+|.||+++|+.+...
T Consensus 293 ~~~~~~-----~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 293 AKPLLE-----EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHHHH-----CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 544432 3378999999997 77775 7889999999999999999999999999999655443
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=357.62 Aligned_cols=214 Identities=29% Similarity=0.466 Sum_probs=182.7
Q ss_pred ceEEEEEECCe-EEEEEEcc------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCC
Q 047629 343 KSVYRATIDGK-VLAVKKIK------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKS 415 (615)
Q Consensus 343 ~~Vy~~~~~g~-~vAvK~~~------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~ 415 (615)
|.||.|.++|. .||||.++ ++|.+|+++|++++|+|||+|+|+|...+ .++||||||++|+|.+||......
T Consensus 220 G~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~-piyIVtE~m~~GsLl~yLr~~~~~ 298 (468)
T KOG0197|consen 220 GEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE-PIYIVTEYMPKGSLLDYLRTREGG 298 (468)
T ss_pred ceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCC-ceEEEEEecccCcHHHHhhhcCCC
Confidence 69999999876 89999886 46899999999999999999999998644 799999999999999999873332
Q ss_pred CCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCCC-----------
Q 047629 416 SSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATND----------- 484 (615)
Q Consensus 416 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~----------- 484 (615)
.+...+.+.++.|||.||+||++++ +|||||.++|||++++..+||+||||||...++
T Consensus 299 --------~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfP 367 (468)
T KOG0197|consen 299 --------LLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFP 367 (468)
T ss_pred --------ccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCCC
Confidence 3889999999999999999999998 999999999999999999999999999965322
Q ss_pred -------------CCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 485 -------------VMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 485 -------------~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
++.|||||||||+||||+| |+.|+....+.+. .+.++..-+-..|
T Consensus 368 IkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev---------------------~~~le~GyRlp~P 426 (468)
T KOG0197|consen 368 IKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV---------------------LELLERGYRLPRP 426 (468)
T ss_pred ceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH---------------------HHHHhccCcCCCC
Confidence 5679999999999999999 9999877654221 1122233333457
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccch
Q 047629 551 IDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQST 589 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~ 589 (615)
..|+..+.+|++.||+.+|++|||++.+...|+.+....
T Consensus 427 ~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 427 EGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred CCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 788889999999999999999999999999988776543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=350.40 Aligned_cols=216 Identities=32% Similarity=0.524 Sum_probs=180.5
Q ss_pred ceEEEEEECCeE-EEEEEccH---------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATIDGKV-LAVKKIKE---------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~~g~~-vAvK~~~~---------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
|.||+|.|.|+. ||||++.. +|.+|+.+|.+++|||||+++|+|.+..+.+.+|||||++|+|.++|+..
T Consensus 55 g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~ 134 (362)
T KOG0192|consen 55 GTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKK 134 (362)
T ss_pred eeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhc
Confidence 699999999988 99999973 79999999999999999999999987554689999999999999999874
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCC-cEEEeecCCCCCCC---------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRF-KAKIANFSLAAPAT--------- 482 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~-~~kl~DFGla~~~~--------- 482 (615)
.. ..|+|..+++|+.|||+||+|||+++. |||||||++|||++.++ .+||+|||+++...
T Consensus 135 ~~--------~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~ 204 (362)
T KOG0192|consen 135 RK--------RKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSMTSV 204 (362)
T ss_pred cc--------CCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeeccccccccCC
Confidence 21 149999999999999999999999863 99999999999999997 99999999995431
Q ss_pred ----------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCC
Q 047629 483 ----------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLE 546 (615)
Q Consensus 483 ----------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~ 546 (615)
..++.|+|||||||+||||+||+.||..... .... ...... ...
T Consensus 205 ~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~---------------~~v~~~----~~R 264 (362)
T KOG0192|consen 205 AGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVA---------------SAVVVG----GLR 264 (362)
T ss_pred CCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHH---------------HHHHhc----CCC
Confidence 1267899999999999999999999987653 1110 001111 222
Q ss_pred CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 547 SFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 547 ~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
...|.++...+..|+.+||+.||+.||++.|++..|+.+...
T Consensus 265 p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~ 306 (362)
T KOG0192|consen 265 PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH 306 (362)
T ss_pred CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence 333445667789999999999999999999999999977654
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=360.69 Aligned_cols=231 Identities=28% Similarity=0.452 Sum_probs=191.3
Q ss_pred cccccccc--ceEEEEEEC-------CeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEE
Q 047629 335 LSEHYSIG--KSVYRATID-------GKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVY 397 (615)
Q Consensus 335 ~~~~~~iG--~~Vy~~~~~-------g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~ 397 (615)
|.++.+-| |.||+|... .+.||||.++ .+|++|+++|..++|+|||+|+|+|.+.+ .+++|+
T Consensus 490 ~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~-P~~MvF 568 (774)
T KOG1026|consen 490 FKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD-PLCMVF 568 (774)
T ss_pred ehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC-eeEEEE
Confidence 44444444 689999863 3679999997 46999999999999999999999998755 789999
Q ss_pred eecCCCCHHHhhccCCCCCCCCCc----ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEe
Q 047629 398 EYAENGSLDKWLHPKSKSSSSSGS----VIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIA 473 (615)
Q Consensus 398 E~~~~GsL~~~L~~~~~~~~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~ 473 (615)
|||..|||.+||...........+ +.+|+..+.+.||.|||.||+||-++. +|||||..+|+|+.++..+||+
T Consensus 569 EYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~VKIs 645 (774)
T KOG1026|consen 569 EYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVVKIS 645 (774)
T ss_pred EecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEEEec
Confidence 999999999999876543222111 234999999999999999999999998 9999999999999999999999
Q ss_pred ecCCCCCC-------------------------CCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHH
Q 047629 474 NFSLAAPA-------------------------TNDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVL 527 (615)
Q Consensus 474 DFGla~~~-------------------------~~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 527 (615)
||||+|.. .+.++++||||||||||||+++ |+.|+....+++....
T Consensus 646 DfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~-------- 717 (774)
T KOG1026|consen 646 DFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC-------- 717 (774)
T ss_pred ccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHH--------
Confidence 99999753 2347899999999999999999 9999988776443221
Q ss_pred hHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccchh
Q 047629 528 KVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQSTE 590 (615)
Q Consensus 528 ~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~~ 590 (615)
+-+.++ -+.|..++.++..|+..||+++|++||+++||-..|+...+..+
T Consensus 718 ------------i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 718 ------------IRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred ------------HHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 122233 35688899999999999999999999999999999988776543
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=357.29 Aligned_cols=219 Identities=27% Similarity=0.475 Sum_probs=186.9
Q ss_pred ceEEEEEE--CC---eEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATI--DG---KVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~--~g---~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
|.||+|.+ .| ..||||.+| .+|..|..||.++.||||++|.|+....+ ..++|.|||+||+|+.||
T Consensus 643 GEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~-PvMIiTEyMENGsLDsFL 721 (996)
T KOG0196|consen 643 GEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK-PVMIITEYMENGSLDSFL 721 (996)
T ss_pred cceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc-eeEEEhhhhhCCcHHHHH
Confidence 58999998 34 679999997 47999999999999999999999987544 689999999999999999
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCCC-----
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATND----- 484 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~----- 484 (615)
+.+..+ ++|.|+..++++||.||.||.+.+ +|||||.++|||++.|..+||+||||+|.+.++
T Consensus 722 R~~DGq---------ftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~y 789 (996)
T KOG0196|consen 722 RQNDGQ---------FTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAY 789 (996)
T ss_pred hhcCCc---------eEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCCCccc
Confidence 987753 899999999999999999999998 999999999999999999999999999866322
Q ss_pred ---------------------CCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcC
Q 047629 485 ---------------------VMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMD 542 (615)
Q Consensus 485 ---------------------~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~d 542 (615)
++.++|||||||||||.++ |.+|+.+..+++... .++
T Consensus 790 tt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIk---------------------aIe 848 (996)
T KOG0196|consen 790 TTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIK---------------------AIE 848 (996)
T ss_pred cccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHH---------------------HHH
Confidence 5678999999999999988 999988766533211 111
Q ss_pred CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccchhhhhhc
Q 047629 543 PNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQSTETLERS 595 (615)
Q Consensus 543 p~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~~~~~~~ 595 (615)
...+-.-|.+|+..+.+|++.||+.|..+||.+.||+..|.++.....+++..
T Consensus 849 ~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~~ 901 (996)
T KOG0196|consen 849 QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKTI 901 (996)
T ss_pred hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhccc
Confidence 22223457789999999999999999999999999999999998776665443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=309.59 Aligned_cols=211 Identities=26% Similarity=0.390 Sum_probs=172.2
Q ss_pred ccceEEEEEE--CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 341 IGKSVYRATI--DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 341 iG~~Vy~~~~--~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
-||.|||+.. +++.+|+|.+. +++.+|++++++.+||+||+++|.|........++||||.+|||++++.
T Consensus 91 ~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k 170 (364)
T KOG0581|consen 91 NGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILK 170 (364)
T ss_pred CCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHh
Confidence 3479999998 68999999983 4578999999999999999999998754324999999999999999998
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHE-HAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA-------- 481 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~-------- 481 (615)
..+. +++..+-+|+.+|++||.|||+ ++ ||||||||+|||++..+.+||+|||.++.+
T Consensus 171 ~~g~----------i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS~a~tf 237 (364)
T KOG0581|consen 171 RVGR----------IPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNSIANTF 237 (364)
T ss_pred hcCC----------CCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhhhcccc
Confidence 7542 8899999999999999999996 55 999999999999999999999999998543
Q ss_pred -------------CCCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcC---CcC
Q 047629 482 -------------TNDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMD---PNL 545 (615)
Q Consensus 482 -------------~~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~d---p~l 545 (615)
...++.++||||||+.++|+.+|+.|+......... | -+.+..+++ |++
T Consensus 238 vGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~--~-------------~~Ll~~Iv~~ppP~l 302 (364)
T KOG0581|consen 238 VGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLD--I-------------FELLCAIVDEPPPRL 302 (364)
T ss_pred cccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCC--H-------------HHHHHHHhcCCCCCC
Confidence 223667999999999999999999999764211110 1 112233333 333
Q ss_pred CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047629 546 ESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNL 582 (615)
Q Consensus 546 ~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L 582 (615)
... ....++..++..|++.||.+||+++|++++=
T Consensus 303 P~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp 336 (364)
T KOG0581|consen 303 PEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQHP 336 (364)
T ss_pred Ccc---cCCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 322 3566789999999999999999999999863
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=319.54 Aligned_cols=210 Identities=25% Similarity=0.474 Sum_probs=179.6
Q ss_pred ceEEEEEECCeEEEEEEccHHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCCCCCCCcc
Q 047629 343 KSVYRATIDGKVLAVKKIKEDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSV 422 (615)
Q Consensus 343 ~~Vy~~~~~g~~vAvK~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~ 422 (615)
|.||.|.+.++.||||++++--..+|+-|++|+|+||+.+.|+|.... .++||||||+.|-|...|+..+.
T Consensus 138 GAVF~Grl~netVAVKKV~elkETdIKHLRkLkH~NII~FkGVCtqsP-cyCIiMEfCa~GqL~~VLka~~~-------- 208 (904)
T KOG4721|consen 138 GAVFLGRLHNETVAVKKVRELKETDIKHLRKLKHPNIITFKGVCTQSP-CYCIIMEFCAQGQLYEVLKAGRP-------- 208 (904)
T ss_pred cceeeeeccCceehhHHHhhhhhhhHHHHHhccCcceeeEeeeecCCc-eeEEeeeccccccHHHHHhccCc--------
Confidence 689999999999999999998889999999999999999999998654 68999999999999999987653
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------------------
Q 047629 423 IFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------------------- 482 (615)
Q Consensus 423 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------------------- 482 (615)
++-..+..|..+||.||+|||.+. |||||||+-||||..+..+||+|||-++...
T Consensus 209 --itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvI 283 (904)
T KOG4721|consen 209 --ITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVI 283 (904)
T ss_pred --cCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHh
Confidence 778889999999999999999998 9999999999999999999999999876432
Q ss_pred --CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHH
Q 047629 483 --NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATL 560 (615)
Q Consensus 483 --~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l 560 (615)
...+.|+||||||||||||+||..|+...+.. ...| . .-...|.-..|..++.-+.-|
T Consensus 284 rnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss--AIIw----G--------------VGsNsL~LpvPstcP~GfklL 343 (904)
T KOG4721|consen 284 RNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS--AIIW----G--------------VGSNSLHLPVPSTCPDGFKLL 343 (904)
T ss_pred hcCCcccccceehhHHHHHHHHhcCCCccccchh--eeEE----e--------------ccCCcccccCcccCchHHHHH
Confidence 23567999999999999999999998764421 1111 1 111223345677788889999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHhcc
Q 047629 561 ARACTMDKSLSRPNMAEVVFNLSVLT 586 (615)
Q Consensus 561 ~~~C~~~dP~~RPsm~ev~~~L~~l~ 586 (615)
++.||+..|..||++++|+.+|.-..
T Consensus 344 ~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 344 LKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred HHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 99999999999999999999997443
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=320.40 Aligned_cols=222 Identities=25% Similarity=0.404 Sum_probs=186.0
Q ss_pred ccccccccc----ceEEEEEEC--CeEEEEEEccH------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecC
Q 047629 334 NLSEHYSIG----KSVYRATID--GKVLAVKKIKE------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAE 401 (615)
Q Consensus 334 ~~~~~~~iG----~~Vy~~~~~--g~~vAvK~~~~------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~ 401 (615)
++.-+.++| |.||.|+|. .-.||||.+++ +|..|..+|+.++|||+|+|+|+|.. +..+|||.|||.
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~-EpPFYIiTEfM~ 346 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTH-EPPFYIITEFMC 346 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhcc-CCCeEEEEeccc
Confidence 445556666 489999994 57899999985 58899999999999999999999985 457999999999
Q ss_pred CCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCC
Q 047629 402 NGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA 481 (615)
Q Consensus 402 ~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~ 481 (615)
+|+|.+||++.... .++-..++.++.||+.||+||..+. +|||||.++|+|+.++..+||+||||++++
T Consensus 347 yGNLLdYLRecnr~--------ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 347 YGNLLDYLRECNRS--------EVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred CccHHHHHHHhchh--------hcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhh
Confidence 99999999987653 3667778999999999999999988 999999999999999999999999999987
Q ss_pred CCC------------------------CCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHH
Q 047629 482 TND------------------------VMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREER 536 (615)
Q Consensus 482 ~~~------------------------~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 536 (615)
+.+ ++-|+|||+|||+|||+.| |..|+...+- ..+...
T Consensus 416 tgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl-------SqVY~L---------- 478 (1157)
T KOG4278|consen 416 TGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-------SQVYGL---------- 478 (1157)
T ss_pred cCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH-------HHHHHH----------
Confidence 543 4569999999999999999 8899876541 111111
Q ss_pred HhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 537 LRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 537 ~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
+....+-+.|..|+.++.+|++.||+++|.+||+++|+-+.++.+.++
T Consensus 479 ----LEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 479 ----LEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred ----HhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 112222345778899999999999999999999999999999987655
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=341.72 Aligned_cols=220 Identities=30% Similarity=0.425 Sum_probs=183.0
Q ss_pred ceEEEEEE---CCe----EEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATI---DGK----VLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~---~g~----~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~ 407 (615)
|.||+|.+ +|. .||||.++ .+|.+|..+|++++|||||+++|+|.+ .+..+|++|||++|+|..
T Consensus 706 G~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~-~~~~~i~leyM~gGDL~s 784 (1025)
T KOG1095|consen 706 GEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD-SGPPLILLEYMEGGDLLS 784 (1025)
T ss_pred cceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC-CCCcEEEehhcccCcHHH
Confidence 68999998 443 48999986 368999999999999999999999997 558999999999999999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----- 482 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----- 482 (615)
||++.+..... ...|+..+++.++.|||+|+.||++++ +|||||.++|+||+....+||+|||||+...
T Consensus 785 flr~~r~~~~~---~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yy 858 (1025)
T KOG1095|consen 785 FLRESRPAPFQ---PSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYY 858 (1025)
T ss_pred HHHhcccccCC---CCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccchhHhhhhchhe
Confidence 99987543211 235999999999999999999999998 9999999999999999999999999998321
Q ss_pred --------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhc
Q 047629 483 --------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWM 541 (615)
Q Consensus 483 --------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 541 (615)
..++.|+|||||||+|||++| |..|+....+.+....+ ..
T Consensus 859 r~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~------~~------------- 919 (1025)
T KOG1095|consen 859 RKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDV------LE------------- 919 (1025)
T ss_pred eccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHH------Hh-------------
Confidence 226789999999999999999 88999876643222111 10
Q ss_pred CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccchh
Q 047629 542 DPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQSTE 590 (615)
Q Consensus 542 dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~~ 590 (615)
+.+ -+.|..|+.++.+|++.||+.+|++||+++.|++.+..+.+...
T Consensus 920 ggR--L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 920 GGR--LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred CCc--cCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 112 24577888999999999999999999999999999887765543
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=304.60 Aligned_cols=212 Identities=24% Similarity=0.432 Sum_probs=171.0
Q ss_pred ceEEEEEECCeEEEEEEcc----------HHHHHHHHHHHhcCCCCcccEEEEEEc--C-CCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATIDGKVLAVKKIK----------EDVTEELRILQRINHANLVKLMGVSSD--S-QGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~~g~~vAvK~~~----------~~~~~Ei~~l~~l~H~niv~l~g~~~~--~-~~~~~lV~E~~~~GsL~~~L 409 (615)
+.||+|.++|+.||||+++ +.+.+|+.+|.+++||||++++|++.+ . ....++||||+++|+|.+++
T Consensus 34 ~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l 113 (283)
T PHA02988 34 NSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL 113 (283)
T ss_pred eEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHH
Confidence 4799999999999999985 235689999999999999999999865 2 23578999999999999999
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEH-AQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------ 482 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------ 482 (615)
.... .++|....+++.|++.||.|||+. + ++||||||+|||+++++.+||+|||+++...
T Consensus 114 ~~~~----------~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~~~~ 180 (283)
T PHA02988 114 DKEK----------DLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKN 180 (283)
T ss_pred hhCC----------CCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhccccccc
Confidence 7643 288999999999999999999985 5 7799999999999999999999999986311
Q ss_pred ----------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCC
Q 047629 483 ----------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLE 546 (615)
Q Consensus 483 ----------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~ 546 (615)
..++.++|||||||++|||++|+.||......+ ... . .......+
T Consensus 181 ~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~---~~~---~----------i~~~~~~~--- 241 (283)
T PHA02988 181 VNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE---IYD---L----------IINKNNSL--- 241 (283)
T ss_pred cCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH---HHH---H----------HHhcCCCC---
Confidence 235679999999999999999999997543211 110 0 00111111
Q ss_pred CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 047629 547 SFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQ 587 (615)
Q Consensus 547 ~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~ 587 (615)
..+......+.+++.+||+.||++|||++|+++.|+.+.+
T Consensus 242 -~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 242 -KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred -CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 2233455678999999999999999999999999987653
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=345.40 Aligned_cols=243 Identities=26% Similarity=0.493 Sum_probs=188.0
Q ss_pred eeHHHHHHHccccccccccc----ceEEEEEE--CCeEEEEEEccH---HHHHHHHHHHhcCCCCcccEEEEEEcCCCcE
Q 047629 323 YEIEVIMESTMNLSEHYSIG----KSVYRATI--DGKVLAVKKIKE---DVTEELRILQRINHANLVKLMGVSSDSQGNR 393 (615)
Q Consensus 323 ~~~~~l~~at~~~~~~~~iG----~~Vy~~~~--~g~~vAvK~~~~---~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 393 (615)
++++++..+ +.+...+| |.||+|.. +|+.||||+++. ...+|++.+++++|||||+++|+|.+.+ ..
T Consensus 683 ~~~~~~~~~---~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~~-~~ 758 (968)
T PLN00113 683 ITINDILSS---LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEK-GA 758 (968)
T ss_pred hhHHHHHhh---CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcCC-CC
Confidence 345555543 44444555 58999996 789999999863 2356899999999999999999998654 78
Q ss_pred EEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEe
Q 047629 394 FLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIA 473 (615)
Q Consensus 394 ~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~ 473 (615)
++||||+++|+|.++++. ++|.++.+|+.|+|.||+|||+++.++|+||||||+||+++.++.+++.
T Consensus 759 ~lv~Ey~~~g~L~~~l~~-------------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~ 825 (968)
T PLN00113 759 YLIHEYIEGKNLSEVLRN-------------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR 825 (968)
T ss_pred EEEEeCCCCCcHHHHHhc-------------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE
Confidence 999999999999999952 8899999999999999999998777779999999999999999888775
Q ss_pred ecCCCCCC-------------------CCCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHH
Q 047629 474 NFSLAAPA-------------------TNDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKRE 534 (615)
Q Consensus 474 DFGla~~~-------------------~~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 534 (615)
||.+... ...++.|+|||||||++|||++|+.|++...... ....+|.+.... .
T Consensus 826 -~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~-~~~~~~~~~~~~-----~ 898 (968)
T PLN00113 826 -LSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVH-GSIVEWARYCYS-----D 898 (968)
T ss_pred -eccccccccCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCC-CcHHHHHHHhcC-----c
Confidence 5543211 1236779999999999999999999986433211 112223322211 1
Q ss_pred HHHhhhcCCcCCCC--CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccch
Q 047629 535 ERLRNWMDPNLESF--YPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQST 589 (615)
Q Consensus 535 ~~~~~~~dp~l~~~--~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~ 589 (615)
.....++||.+... .+.++..++.+++.+||+.||++||+|+||++.|+.+.+..
T Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 899 CHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred cchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 23456778777543 34567778999999999999999999999999999886654
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=302.78 Aligned_cols=232 Identities=25% Similarity=0.411 Sum_probs=182.9
Q ss_pred HHHHHHHccccccccccc--ceEEEEEECC-eEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcE
Q 047629 325 IEVIMESTMNLSEHYSIG--KSVYRATIDG-KVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNR 393 (615)
Q Consensus 325 ~~~l~~at~~~~~~~~iG--~~Vy~~~~~g-~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 393 (615)
.+|..+..--|.++.+-| |.|..+..+| ..||||.++ .+|.+|+++|.+++|||||+|+|+|...+ .+
T Consensus 532 l~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De-Pi 610 (807)
T KOG1094|consen 532 LVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD-PL 610 (807)
T ss_pred hhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC-ch
Confidence 344444444455555555 5788888866 999999997 46899999999999999999999998654 78
Q ss_pred EEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEe
Q 047629 394 FLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIA 473 (615)
Q Consensus 394 ~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~ 473 (615)
++++|||++|+|.+||..+... .+.-....+|+.|||.||+||.+.. +|||||.++|||+|.++++||+
T Consensus 611 cmI~EYmEnGDLnqFl~aheap--------t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKia 679 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELP--------TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIA 679 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCc--------ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEec
Confidence 9999999999999999887542 1355567789999999999999998 9999999999999999999999
Q ss_pred ecCCCCCCC-------------------------CCCCCcccchhHHHHHHHHHc--CCCCCCCCCCChhHHHHHHHHHH
Q 047629 474 NFSLAAPAT-------------------------NDVMPKFDVFAFGVVLLELLS--GKKATRTTENGKTAVLWKEIREV 526 (615)
Q Consensus 474 DFGla~~~~-------------------------~~~~~k~DV~SfGvvl~Ellt--G~~p~~~~~~~~~~~l~~~~~~~ 526 (615)
|||+++-+. +.+++++|||+|||+|||+++ ...|+....+....
T Consensus 680 dfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vv--------- 750 (807)
T KOG1094|consen 680 DFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVV--------- 750 (807)
T ss_pred CcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHH---------
Confidence 999998432 237899999999999999866 67788654432111
Q ss_pred HhHHHHHHHHHhhhcCC---cCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 047629 527 LKVEEKREERLRNWMDP---NLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVL 585 (615)
Q Consensus 527 ~~~~~~~~~~~~~~~dp---~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l 585 (615)
+...++.+. ..--..|.-++.++.+++.+||..|-++||+++++...|+..
T Consensus 751 --------en~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 751 --------ENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred --------HhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 111222221 112334667888899999999999999999999999888653
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=307.98 Aligned_cols=202 Identities=28% Similarity=0.433 Sum_probs=169.1
Q ss_pred eEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 344 SVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 344 ~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
.+|+++. .|+.||+|++.+ .+.+||+|.++|+|||||++++++.+.+ +.|+|.|+|++|+|.++++.
T Consensus 33 ~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~-nVYivLELC~~~sL~el~Kr 111 (592)
T KOG0575|consen 33 RCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSN-NVYIVLELCHRGSLMELLKR 111 (592)
T ss_pred EEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCC-ceEEEEEecCCccHHHHHHh
Confidence 7999987 799999999853 4678999999999999999999988755 89999999999999999985
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCCC-------
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATND------- 484 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~------- 484 (615)
.. .|++.+...++.||+.||.|||+++ |+|||||..|++|++++++||+|||||.....+
T Consensus 112 rk----------~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~Tl 178 (592)
T KOG0575|consen 112 RK----------PLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKTL 178 (592)
T ss_pred cC----------CCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCccccccee
Confidence 44 3999999999999999999999998 999999999999999999999999999765321
Q ss_pred ----------------CCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCC
Q 047629 485 ----------------VMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESF 548 (615)
Q Consensus 485 ----------------~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~ 548 (615)
.+..+||||+|||||.|+.|++||+...- .+.+.. -+..+ -.
T Consensus 179 CGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v----------kety~~-----Ik~~~-------Y~ 236 (592)
T KOG0575|consen 179 CGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV----------KETYNK-----IKLNE-------YS 236 (592)
T ss_pred cCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH----------HHHHHH-----HHhcC-------cc
Confidence 34578999999999999999999986541 111110 01111 12
Q ss_pred CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 549 YPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 549 ~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
+|.....+..+|+...++.||.+|||+++|+..
T Consensus 237 ~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 237 MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred cccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 344555667899999999999999999999985
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=301.24 Aligned_cols=226 Identities=25% Similarity=0.319 Sum_probs=171.4
Q ss_pred ceEEEEEE--CCeEEEEEEccHH---------HHHHHHHHHhcCCCCcccEEEEEEcC-CCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKED---------VTEELRILQRINHANLVKLMGVSSDS-QGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~~---------~~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~~lV~E~~~~GsL~~~L~ 410 (615)
+.||++.. +|+.||+|+++-+ ..+||.||++|+||||++|.+...+. .+.+|||+|||++ +|.-++.
T Consensus 131 g~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~ 209 (560)
T KOG0600|consen 131 GQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLS 209 (560)
T ss_pred hheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhc
Confidence 58999997 8999999999732 56899999999999999999998765 4579999999987 9999887
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC-------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------- 483 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------- 483 (615)
...- .++..++..++.|++.||+|+|+++ |+|||||.+|||||.+|.+||+|||||+....
T Consensus 210 ~p~v---------kft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T 277 (560)
T KOG0600|consen 210 SPGV---------KFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYT 277 (560)
T ss_pred CCCc---------ccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCCCCcccc
Confidence 6542 3999999999999999999999998 99999999999999999999999999985421
Q ss_pred ------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcC
Q 047629 484 ------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNL 545 (615)
Q Consensus 484 ------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l 545 (615)
.+++++|+||.||||.||+.|++.+....+-+....+-.+........+...++....-...
T Consensus 278 ~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp 357 (560)
T KOG0600|consen 278 SRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKP 357 (560)
T ss_pred cceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCC
Confidence 26789999999999999999999988765433332221111111111111111111100011
Q ss_pred CCCCCh-------HHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 546 ESFYPI-------DGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 546 ~~~~~~-------~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
...|.. ......++|+...+..||.+|.|+.++++.
T Consensus 358 ~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 358 QQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred CCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 111111 223356889999999999999999998874
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=296.15 Aligned_cols=209 Identities=25% Similarity=0.321 Sum_probs=163.9
Q ss_pred eEEEEEE--CCeEEEEEEccH--------------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHH
Q 047629 344 SVYRATI--DGKVLAVKKIKE--------------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407 (615)
Q Consensus 344 ~Vy~~~~--~g~~vAvK~~~~--------------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~ 407 (615)
.|-.|.- +|+.||||.+.+ ++.+|+++|++++|||||++.+++...+ ..|+|||||++|+|.+
T Consensus 187 ~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d-s~YmVlE~v~GGeLfd 265 (475)
T KOG0615|consen 187 LVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD-SSYMVLEYVEGGELFD 265 (475)
T ss_pred EEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC-ceEEEEEEecCccHHH
Confidence 5666654 799999999863 2468999999999999999999987654 7899999999999999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCC---CcEEEeecCCCCCCCCC
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSR---FKAKIANFSLAAPATND 484 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~---~~~kl~DFGla~~~~~~ 484 (615)
++-.+.. +.+..-..++.|++.|+.|||+++ |+||||||+|||+..+ ..+||+|||+|+.....
T Consensus 266 ~vv~nk~----------l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~ 332 (475)
T KOG0615|consen 266 KVVANKY----------LREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEG 332 (475)
T ss_pred HHHhccc----------cccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccchhhccccc
Confidence 9987653 666677889999999999999999 9999999999999766 78999999999875321
Q ss_pred -------------------------CCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhh
Q 047629 485 -------------------------VMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRN 539 (615)
Q Consensus 485 -------------------------~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 539 (615)
+..|+|+||+|||||-+++|.+||........ +.+.+. .++.
T Consensus 333 sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s--l~eQI~---------~G~y-- 399 (475)
T KOG0615|consen 333 SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS--LKEQIL---------KGRY-- 399 (475)
T ss_pred eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc--HHHHHh---------cCcc--
Confidence 22388999999999999999999976543221 111110 0000
Q ss_pred hcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047629 540 WMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLS 583 (615)
Q Consensus 540 ~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~ 583 (615)
.. ...+..+...+..+|+.+++..||++|||+.|++++-.
T Consensus 400 ~f----~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW 439 (475)
T KOG0615|consen 400 AF----GPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPW 439 (475)
T ss_pred cc----cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence 00 01112244557899999999999999999999998643
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=292.04 Aligned_cols=157 Identities=29% Similarity=0.516 Sum_probs=139.9
Q ss_pred ceEEEEEE--CCeEEEEEEccHH---------HHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIKED---------VTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~~---------~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
+.||+|+. +|..||||.+... ...|+.+|+.++|+|||+|++++...+ .+|||||||.+|+|.+||+.
T Consensus 24 avVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~-~i~lVMEyC~gGDLs~yi~~ 102 (429)
T KOG0595|consen 24 AVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD-FIYLVMEYCNGGDLSDYIRR 102 (429)
T ss_pred EEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC-eEEEEEEeCCCCCHHHHHHH
Confidence 48999998 7899999988533 467999999999999999999987654 89999999999999999998
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCC------CcEEEeecCCCCCCCC--
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSR------FKAKIANFSLAAPATN-- 483 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~------~~~kl~DFGla~~~~~-- 483 (615)
.+. +++.....++.|+|.||++||+++ ||||||||.||||+.. -.+||+|||+|+.+..
T Consensus 103 ~~~----------l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~ 169 (429)
T KOG0595|consen 103 RGR----------LPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGS 169 (429)
T ss_pred cCC----------CCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchh
Confidence 753 899999999999999999999998 9999999999999875 4689999999987643
Q ss_pred --------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCC
Q 047629 484 --------------------DVMPKFDVFAFGVVLLELLSGKKATRTTEN 513 (615)
Q Consensus 484 --------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~ 513 (615)
.|..|+|+||.|++|||+++|+.||+....
T Consensus 170 ~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 170 MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 367799999999999999999999986553
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=302.87 Aligned_cols=222 Identities=25% Similarity=0.394 Sum_probs=177.1
Q ss_pred ceEEEEEE--CCeEEEEEEccHHH--------HHHHHHHHhcC-CCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIKEDV--------TEELRILQRIN-HANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~~~--------~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
|+||+|+- +|+.||||+|++.| .+|+..|++|+ |||||+|..++.+.+..+++|||||+. +|++.++.
T Consensus 24 GsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~-NLYqLmK~ 102 (538)
T KOG0661|consen 24 GSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC-NLYQLMKD 102 (538)
T ss_pred eeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhhh-hHHHHHhh
Confidence 58999986 79999999999754 47999999998 999999999998877689999999975 99999988
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC--------
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN-------- 483 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~-------- 483 (615)
++. .+++..+..|+.||..||+|+|.+| +.|||+||+|||+..+..+||+||||||....
T Consensus 103 R~r---------~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPYTeYV 170 (538)
T KOG0661|consen 103 RNR---------LFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRSKPPYTEYV 170 (538)
T ss_pred cCC---------cCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccccCCCcchhh
Confidence 743 5999999999999999999999999 99999999999999999999999999986532
Q ss_pred ---------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHH---HHH-HHHhhhcCCc
Q 047629 484 ---------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEE---KRE-ERLRNWMDPN 544 (615)
Q Consensus 484 ---------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~-~~~~~~~dp~ 544 (615)
.++.+.||||+|||++|+.+=++-|.+..+-+.. + .+.+++.... ..+ ..+...|.=+
T Consensus 171 STRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi--~-KIc~VLGtP~~~~~~eg~~La~~mnf~ 247 (538)
T KOG0661|consen 171 STRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQI--Y-KICEVLGTPDKDSWPEGYNLASAMNFR 247 (538)
T ss_pred hcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHH--H-HHHHHhCCCccccchhHHHHHHHhccC
Confidence 2567899999999999999999888765543322 2 2344432211 111 1222222211
Q ss_pred --------CCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 545 --------LESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 545 --------l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
+..-.+. ...+.++|+.+|+.+||.+|||+.|.+++
T Consensus 248 ~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 248 FPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred CCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1122222 56678999999999999999999999986
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=309.24 Aligned_cols=220 Identities=28% Similarity=0.485 Sum_probs=179.4
Q ss_pred ceEEEEEECCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATIDGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
|+||||.|.|. ||||.++ +.|.+|+.++++-+|.||+-++|||... .+.||..+|++-+|+.+||..+
T Consensus 406 GtV~Rg~whGd-VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p--~~AIiTqwCeGsSLY~hlHv~e 482 (678)
T KOG0193|consen 406 GTVYRGRWHGD-VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP--PLAIITQWCEGSSLYTHLHVQE 482 (678)
T ss_pred cceeecccccc-eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC--ceeeeehhccCchhhhhccchh
Confidence 69999999885 8999996 4589999999999999999999999753 4599999999999999999865
Q ss_pred CCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCC------------
Q 047629 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA------------ 481 (615)
Q Consensus 414 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~------------ 481 (615)
. .|+..+.+.||.|||.|+.|||.++ |||||||+.||+|++++++||+||||+...
T Consensus 483 t---------kfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp 550 (678)
T KOG0193|consen 483 T---------KFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQP 550 (678)
T ss_pred h---------hhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCC
Confidence 3 3999999999999999999999998 999999999999999999999999998431
Q ss_pred ----------------CCCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcC
Q 047629 482 ----------------TNDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNL 545 (615)
Q Consensus 482 ----------------~~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l 545 (615)
.+.++..+||||||+|+|||++|..|+. ....+. .+|. + -+....|++
T Consensus 551 ~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dq-Iifm----V----------GrG~l~pd~ 614 (678)
T KOG0193|consen 551 HGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQ-IIFM----V----------GRGYLMPDL 614 (678)
T ss_pred ccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhh-eEEE----e----------cccccCccc
Confidence 2347889999999999999999999998 332221 1111 0 011111222
Q ss_pred CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccchhhhhh
Q 047629 546 ESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQSTETLER 594 (615)
Q Consensus 546 ~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~~~~~~ 594 (615)
. ....++...|.+|+..||..++++||.+.+|+..|+.+..+...+.|
T Consensus 615 s-~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki~R 662 (678)
T KOG0193|consen 615 S-KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKINR 662 (678)
T ss_pred h-hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhccccccc
Confidence 1 11235667899999999999999999999999999888776544444
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=310.21 Aligned_cols=215 Identities=29% Similarity=0.499 Sum_probs=176.4
Q ss_pred ceEEEEEE---CC--eE-EEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHH
Q 047629 343 KSVYRATI---DG--KV-LAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLD 406 (615)
Q Consensus 343 ~~Vy~~~~---~g--~~-vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~ 406 (615)
|.||+|.+ ++ .. ||||..+. +|.+|.++|++++|+|||+++|++...+ .++||||+|+||+|.
T Consensus 171 GeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~-Pl~ivmEl~~gGsL~ 249 (474)
T KOG0194|consen 171 GEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE-PLMLVMELCNGGSLD 249 (474)
T ss_pred cEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC-ccEEEEEecCCCcHH
Confidence 68999998 22 23 89998872 4788999999999999999999998654 799999999999999
Q ss_pred HhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC----
Q 047629 407 KWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT---- 482 (615)
Q Consensus 407 ~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~---- 482 (615)
+||..... .++..+++.++.+.|.||+|||++. ++||||.++|+|++.++.+||+||||++...
T Consensus 250 ~~L~k~~~---------~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~ 317 (474)
T KOG0194|consen 250 DYLKKNKK---------SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVM 317 (474)
T ss_pred HHHHhCCC---------CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCCcceee
Confidence 99987654 2899999999999999999999998 9999999999999999999999999986542
Q ss_pred -------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcC
Q 047629 483 -------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMD 542 (615)
Q Consensus 483 -------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~d 542 (615)
.-++.++|||||||++||+++ |..|+.+....+ +.. ++ +-
T Consensus 318 ~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~-------v~~----------kI---~~ 377 (474)
T KOG0194|consen 318 KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE-------VKA----------KI---VK 377 (474)
T ss_pred ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH-------HHH----------HH---Hh
Confidence 125789999999999999999 888987654211 111 11 01
Q ss_pred CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccchh
Q 047629 543 PNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQSTE 590 (615)
Q Consensus 543 p~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~~ 590 (615)
.......+...+..+..++..||..+|++||+|.++.+.|+.+....+
T Consensus 378 ~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 378 NGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred cCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 111223344566678899999999999999999999999998876644
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=291.70 Aligned_cols=238 Identities=24% Similarity=0.389 Sum_probs=186.3
Q ss_pred ceEEEEEECCeEEEEEEcc----HHHHHHHHHHHh--cCCCCcccEEEEEEcCC---CcEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATIDGKVLAVKKIK----EDVTEELRILQR--INHANLVKLMGVSSDSQ---GNRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~~g~~vAvK~~~----~~~~~Ei~~l~~--l~H~niv~l~g~~~~~~---~~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
|.||||.++++.||||++. ..|.+|-+|.+. ++|+||++++++-...+ -+.+||+||.++|||.+||..+
T Consensus 224 g~V~KaqL~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~n- 302 (534)
T KOG3653|consen 224 GCVWKAQLDNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKAN- 302 (534)
T ss_pred ceeehhhccCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhc-
Confidence 5899999999999999996 458888888775 58999999999854322 2589999999999999999875
Q ss_pred CCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhC------CCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCCC---
Q 047629 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEH------AQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATND--- 484 (615)
Q Consensus 414 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~--- 484 (615)
.++|....+|+..+++||+|||+. .+|+|+|||||++|||+.+++.+.|+|||||..+...
T Consensus 303 ----------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~ 372 (534)
T KOG3653|consen 303 ----------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQ 372 (534)
T ss_pred ----------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCC
Confidence 389999999999999999999974 4788999999999999999999999999999654211
Q ss_pred ----------------------------CCCcccchhHHHHHHHHHcCCCCCCCCC-CChhHHHHHHHHHHHhHHHHHHH
Q 047629 485 ----------------------------VMPKFDVFAFGVVLLELLSGKKATRTTE-NGKTAVLWKEIREVLKVEEKREE 535 (615)
Q Consensus 485 ----------------------------~~~k~DV~SfGvvl~ElltG~~p~~~~~-~~~~~~l~~~~~~~~~~~~~~~~ 535 (615)
.-.+.||||+|.|||||+++....+... ..-......++......++.+.-
T Consensus 373 ~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~ 452 (534)
T KOG3653|consen 373 GDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQEL 452 (534)
T ss_pred cchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHH
Confidence 1136899999999999999887664322 11122222234444444555555
Q ss_pred HHhhhcCCcCCCCCCh-HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccchhh
Q 047629 536 RLRNWMDPNLESFYPI-DGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQSTET 591 (615)
Q Consensus 536 ~~~~~~dp~l~~~~~~-~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~~~ 591 (615)
.+++...|.+...+-. ..+..+.+.+..||..||+.|-|+.-|.+++..+....+.
T Consensus 453 VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 453 VVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred HHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 6666677776543332 3456689999999999999999999999999888766543
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=299.63 Aligned_cols=222 Identities=27% Similarity=0.406 Sum_probs=170.2
Q ss_pred ceEEEEEE-------CCeEEEEEEcc--------HHHHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCHH
Q 047629 343 KSVYRATI-------DGKVLAVKKIK--------EDVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLD 406 (615)
Q Consensus 343 ~~Vy~~~~-------~g~~vAvK~~~--------~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~ 406 (615)
|.||+|.. .++.||||+++ ..+.+|+.++.++ +||||++++|+|...++..++||||+++|+|.
T Consensus 21 g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~ 100 (338)
T cd05102 21 GKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLS 100 (338)
T ss_pred ceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHH
Confidence 58999974 24679999985 2467899999999 89999999999876555689999999999999
Q ss_pred HhhccCCCCCCC----------------------------------------------------CCcccccCHHHHHHHH
Q 047629 407 KWLHPKSKSSSS----------------------------------------------------SGSVIFLTWSQRLRVA 434 (615)
Q Consensus 407 ~~L~~~~~~~~~----------------------------------------------------~~~~~~l~~~~~~~i~ 434 (615)
+++......... ......+++..+..++
T Consensus 101 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 180 (338)
T cd05102 101 NFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYS 180 (338)
T ss_pred HHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHH
Confidence 999753210000 0001248899999999
Q ss_pred HHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------------------------CCCCCcc
Q 047629 435 LDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------------------------NDVMPKF 489 (615)
Q Consensus 435 ~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------------------------~~~~~k~ 489 (615)
.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++... ..++.++
T Consensus 181 ~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~s 257 (338)
T cd05102 181 FQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQS 257 (338)
T ss_pred HHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCccc
Confidence 99999999999988 9999999999999999999999999986421 1246789
Q ss_pred cchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcC
Q 047629 490 DVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDK 568 (615)
Q Consensus 490 DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~d 568 (615)
|||||||+||||++ |+.||......+. .. . .+..-..+. .+......+.+|+.+||+.|
T Consensus 258 DiwslG~il~el~~~g~~pf~~~~~~~~--~~----~----------~~~~~~~~~----~~~~~~~~l~~li~~cl~~d 317 (338)
T cd05102 258 DVWSFGVLLWEIFSLGASPYPGVQINEE--FC----Q----------RLKDGTRMR----APENATPEIYRIMLACWQGD 317 (338)
T ss_pred CHHHHHHHHHHHHhCCCCCCCCCCccHH--HH----H----------HHhcCCCCC----CCCCCCHHHHHHHHHHccCC
Confidence 99999999999997 9999875432211 00 0 011101111 12233456889999999999
Q ss_pred CCCCCCHHHHHHHHHhccc
Q 047629 569 SLSRPNMAEVVFNLSVLTQ 587 (615)
Q Consensus 569 P~~RPsm~ev~~~L~~l~~ 587 (615)
|++||++.|+++.|+.+.+
T Consensus 318 p~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 318 PKERPTFSALVEILGDLLQ 336 (338)
T ss_pred hhhCcCHHHHHHHHHHHHh
Confidence 9999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=287.43 Aligned_cols=207 Identities=34% Similarity=0.584 Sum_probs=161.6
Q ss_pred ceEEEEEEC------CeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHh
Q 047629 343 KSVYRATID------GKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKW 408 (615)
Q Consensus 343 ~~Vy~~~~~------g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~ 408 (615)
|.||+|.+. +..|+||.++ +++.+|++.+++++|+||++++|+|.+. +..++|+||+++|+|.++
T Consensus 13 g~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~-~~~~lv~e~~~~g~L~~~ 91 (259)
T PF07714_consen 13 GKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIEN-EPLFLVMEYCPGGSLDDY 91 (259)
T ss_dssp EEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESS-SSEEEEEE--TTEBHHHH
T ss_pred cEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccc-cccccccccccccccccc
Confidence 589999997 6889999994 3578899999999999999999999854 469999999999999999
Q ss_pred hccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC-----
Q 047629 409 LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN----- 483 (615)
Q Consensus 409 L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~----- 483 (615)
|...... .+++.++.+|+.|++.||.|||+++ ++|+||+++||++++++.+||+|||+++....
T Consensus 92 L~~~~~~--------~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~ 160 (259)
T PF07714_consen 92 LKSKNKE--------PLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK 160 (259)
T ss_dssp HHHTCTT--------TSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred ccccccc--------ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 9886221 3899999999999999999999997 99999999999999999999999999876511
Q ss_pred --------------------CCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcC
Q 047629 484 --------------------DVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMD 542 (615)
Q Consensus 484 --------------------~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~d 542 (615)
..+.++||||||+++|||++ |+.|+......+ .. ..+.+
T Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~---~~--------------~~~~~--- 220 (259)
T PF07714_consen 161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE---II--------------EKLKQ--- 220 (259)
T ss_dssp ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH---HH--------------HHHHT---
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc---cc--------------ccccc---
Confidence 13568999999999999999 678876543111 00 01111
Q ss_pred CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047629 543 PNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNL 582 (615)
Q Consensus 543 p~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L 582 (615)
.. ....+......+.+++..||+.||++||+|+|+++.|
T Consensus 221 ~~-~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 221 GQ-RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TE-ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cc-cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 11 1122334456688999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=275.25 Aligned_cols=221 Identities=23% Similarity=0.333 Sum_probs=165.9
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
|.|||++. +|+.||||++. +-..+|+.+|++++|+|+|.|+.+|.. .+.++||+||++.--|. -|..
T Consensus 16 GvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr-krklhLVFE~~dhTvL~-eLe~ 93 (396)
T KOG0593|consen 16 GVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR-KRKLHLVFEYCDHTVLH-ELER 93 (396)
T ss_pred eEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh-cceeEEEeeecchHHHH-HHHh
Confidence 57999887 79999999985 236789999999999999999999875 45899999999874444 4443
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC--------
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN-------- 483 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~-------- 483 (615)
... .++.....+++.|++.|+.|+|+++ +|||||||+|||+..++.+||+|||+|+.+..
T Consensus 94 ~p~---------G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTDY 161 (396)
T KOG0593|consen 94 YPN---------GVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTDY 161 (396)
T ss_pred ccC---------CCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCcchhhhh
Confidence 332 2888899999999999999999998 99999999999999999999999999987641
Q ss_pred ----------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHH-H------HHHhhh
Q 047629 484 ----------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKR-E------ERLRNW 540 (615)
Q Consensus 484 ----------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~-~------~~~~~~ 540 (615)
.+.+.+||||.||++.||++|.+-|.+..+-+...+.. ..+..--.+ . +.+..+
T Consensus 162 VATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~---ktLG~L~prhq~iF~~N~~F~Gv 238 (396)
T KOG0593|consen 162 VATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIR---KTLGNLIPRHQSIFSSNPFFHGV 238 (396)
T ss_pred hhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHH---HHHcccCHHHHHHhccCCceeee
Confidence 25578999999999999999998887765543333221 111100000 0 001111
Q ss_pred cCCc------CCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 541 MDPN------LESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 541 ~dp~------l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.=|. +...||. ...-++++++.|++.||.+|++-+|++..
T Consensus 239 ~lP~~~~~epLe~k~p~-~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 239 RLPEPEHPEPLERKYPK-ISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred ecCCCCCccchhhhccc-chHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 1111 1222332 23368999999999999999999998763
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=289.87 Aligned_cols=204 Identities=25% Similarity=0.369 Sum_probs=168.4
Q ss_pred ceEEEEEE--CCeEEEEEEccHH----------HHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATI--DGKVLAVKKIKED----------VTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~~----------~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
..||+++- .++.+|||++.+. +..|-++|.+| +||.|++|+--+.+. ..+|+|+||++||+|.++|
T Consensus 87 StV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~-~sLYFvLe~A~nGdll~~i 165 (604)
T KOG0592|consen 87 STVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDE-ESLYFVLEYAPNGDLLDLI 165 (604)
T ss_pred eeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecc-cceEEEEEecCCCcHHHHH
Confidence 37999987 7899999999754 45799999999 899999999888764 4899999999999999999
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------ 483 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------ 483 (615)
+..+. |+......++.+|+.||+|||+++ ||||||||+|||||++|++||+|||-|+.+..
T Consensus 166 ~K~Gs----------fde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~ 232 (604)
T KOG0592|consen 166 KKYGS----------FDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQE 232 (604)
T ss_pred HHhCc----------chHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCChhhcccc
Confidence 87653 888999999999999999999999 99999999999999999999999999976521
Q ss_pred ------------------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHH
Q 047629 484 ------------------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKR 533 (615)
Q Consensus 484 ------------------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 533 (615)
..++.+|+|+|||+||+|+.|++||....+ +..+...
T Consensus 233 ~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne------yliFqkI------- 299 (604)
T KOG0592|consen 233 NPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE------YLIFQKI------- 299 (604)
T ss_pred CccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH------HHHHHHH-------
Confidence 134578999999999999999999976442 1111111
Q ss_pred HHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047629 534 EERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNL 582 (615)
Q Consensus 534 ~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L 582 (615)
++ +.-++|......+.+|++..+..||.+|++..||-++.
T Consensus 300 -------~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 300 -------QA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred -------HH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 11 12234445556688999999999999999999988753
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=293.72 Aligned_cols=211 Identities=27% Similarity=0.408 Sum_probs=179.4
Q ss_pred ceEEEEEEC----C--eEEEEEEccH--------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHh
Q 047629 343 KSVYRATID----G--KVLAVKKIKE--------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKW 408 (615)
Q Consensus 343 ~~Vy~~~~~----g--~~vAvK~~~~--------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~ 408 (615)
|.||+|++. | -.||||..+. .|..|..+|++++|||||+|+|+|.+ ...|+|||.++-|.|.+|
T Consensus 403 GdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e--~P~WivmEL~~~GELr~y 480 (974)
T KOG4257|consen 403 GDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE--QPMWIVMELAPLGELREY 480 (974)
T ss_pred cceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec--cceeEEEecccchhHHHH
Confidence 689999983 2 3589998873 58999999999999999999999975 368999999999999999
Q ss_pred hccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCCC----
Q 047629 409 LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATND---- 484 (615)
Q Consensus 409 L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~---- 484 (615)
|..+.. .|+...+..++.||..+|.|||+.. +|||||.++|||+...-.+|++||||+|...++
T Consensus 481 Lq~nk~---------sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYk 548 (974)
T KOG4257|consen 481 LQQNKD---------SLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYK 548 (974)
T ss_pred HHhccc---------cchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccccchhh
Confidence 987764 3899999999999999999999998 999999999999999999999999999865332
Q ss_pred --------------------CCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCC
Q 047629 485 --------------------VMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDP 543 (615)
Q Consensus 485 --------------------~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp 543 (615)
+++++|||-|||.+||+++ |.+||....+.+... .+..
T Consensus 549 aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~---------------------~iEn 607 (974)
T KOG4257|consen 549 ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG---------------------HIEN 607 (974)
T ss_pred ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE---------------------EecC
Confidence 5789999999999999998 999998766543210 1111
Q ss_pred cCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 544 NLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 544 ~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
.-+-..|..|+..+..|+..||..+|.+||.+.|+...|+.+.+.
T Consensus 608 GeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe 652 (974)
T KOG4257|consen 608 GERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE 652 (974)
T ss_pred CCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence 112245778888899999999999999999999999999988764
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=275.90 Aligned_cols=210 Identities=25% Similarity=0.409 Sum_probs=169.2
Q ss_pred ceEEEEEE--CCeEEEEEEccH------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCC
Q 047629 343 KSVYRATI--DGKVLAVKKIKE------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSK 414 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~ 414 (615)
+.||+|.. .++.||+|.++. ++.+|++++++++|+||+++++++.. ++..+++|||+++|+|.+++.....
T Consensus 20 ~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~ 98 (263)
T cd05052 20 GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-EPPFYIITEFMTYGNLLDYLRECNR 98 (263)
T ss_pred ceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcC-CCCcEEEEEeCCCCcHHHHHHhCCC
Confidence 58999987 588999998863 47789999999999999999999875 4478999999999999999975432
Q ss_pred CCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC------------
Q 047629 415 SSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------------ 482 (615)
Q Consensus 415 ~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------------ 482 (615)
. .+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 99 ~--------~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~ 167 (263)
T cd05052 99 Q--------EVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 167 (263)
T ss_pred C--------CCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceeeccCCCCC
Confidence 1 3899999999999999999999987 9999999999999999999999999875432
Q ss_pred ------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCC
Q 047629 483 ------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFY 549 (615)
Q Consensus 483 ------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~ 549 (615)
...+.++||||||+++|||++ |..|+...... ..+. .+.. ......
T Consensus 168 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---~~~~--------------~~~~----~~~~~~ 226 (263)
T cd05052 168 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYE--------------LLEK----GYRMER 226 (263)
T ss_pred ccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH--------------HHHC----CCCCCC
Confidence 113457999999999999998 88888653311 1111 0111 111122
Q ss_pred ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 047629 550 PIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVL 585 (615)
Q Consensus 550 ~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l 585 (615)
+...+..+.+++.+||+.||++||++.|+++.|+.+
T Consensus 227 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 227 PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 334456689999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=277.74 Aligned_cols=209 Identities=22% Similarity=0.377 Sum_probs=166.9
Q ss_pred ceEEEEEE-----CCeEEEEEEccH--------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATI-----DGKVLAVKKIKE--------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~-----~g~~vAvK~~~~--------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
|.||+|.+ .+..||+|.++. .+.+|+.++.+++||||++++|++... +..++||||+++|+|.+++
T Consensus 19 g~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l 97 (266)
T cd05064 19 GELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG-NTMMIVTEYMSNGALDSFL 97 (266)
T ss_pred CeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC-CCcEEEEEeCCCCcHHHHH
Confidence 58999976 257899998762 467899999999999999999998754 4799999999999999999
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------- 482 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------- 482 (615)
..... .++|.+++.++.|++.||+|||+++ ++||||||+|||++.++.+|++|||.+....
T Consensus 98 ~~~~~---------~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 165 (266)
T cd05064 98 RKHEG---------QLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTT 165 (266)
T ss_pred HhCCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccccchhcc
Confidence 76432 3899999999999999999999998 9999999999999999999999999764321
Q ss_pred -----------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCc
Q 047629 483 -----------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPN 544 (615)
Q Consensus 483 -----------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~ 544 (615)
..++.++|||||||++||+++ |+.|+......+ ... .+.+...+
T Consensus 166 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~~--------------~~~~~~~~- 227 (266)
T cd05064 166 MSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VIK--------------AVEDGFRL- 227 (266)
T ss_pred cCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHH--------------HHHCCCCC-
Confidence 124568999999999999775 999987543211 000 11111111
Q ss_pred CCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 047629 545 LESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVL 585 (615)
Q Consensus 545 l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l 585 (615)
..+...+..+.+++..||+.+|.+||+++||.+.|.++
T Consensus 228 ---~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 ---PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 12334556789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=284.88 Aligned_cols=211 Identities=28% Similarity=0.394 Sum_probs=168.5
Q ss_pred ceEEEEEE--CCeEEEEEEccHH-------HHHHHHHHHhcCCCCcccEEEEEEcCCC-cEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATI--DGKVLAVKKIKED-------VTEELRILQRINHANLVKLMGVSSDSQG-NRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~~-------~~~Ei~~l~~l~H~niv~l~g~~~~~~~-~~~lV~E~~~~GsL~~~L~~~ 412 (615)
|.||.+.. +|+..|||.+... +.+|+.+|++++|||||+.+|.....++ .+++.|||+++|+|.+++.+.
T Consensus 31 G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~ 110 (313)
T KOG0198|consen 31 GSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRY 110 (313)
T ss_pred eEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHc
Confidence 58999988 4899999998643 6899999999999999999997443343 588999999999999999876
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCC-CCcEEEeecCCCCCCCC--------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDS-RFKAKIANFSLAAPATN-------- 483 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~-~~~~kl~DFGla~~~~~-------- 483 (615)
.. .|+...+..+..||++||.|||+++ |+||||||+|||++. ++.+||+|||+++....
T Consensus 111 g~---------~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~ 178 (313)
T KOG0198|consen 111 GG---------KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSE 178 (313)
T ss_pred CC---------CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccccccccccc
Confidence 53 2899999999999999999999998 999999999999999 79999999998864321
Q ss_pred -----------------CCC--CcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCc
Q 047629 484 -----------------DVM--PKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPN 544 (615)
Q Consensus 484 -----------------~~~--~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~ 544 (615)
... .++||||+||++.||+||+.||....... ... +......
T Consensus 179 ~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~--------~~~----------~~ig~~~- 239 (313)
T KOG0198|consen 179 LSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEA--------EAL----------LLIGRED- 239 (313)
T ss_pred ccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchH--------HHH----------HHHhccC-
Confidence 011 38999999999999999999987531100 000 0011111
Q ss_pred CCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 047629 545 LESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSV 584 (615)
Q Consensus 545 l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~ 584 (615)
....+|........+++..|++.||++|||+.|+++....
T Consensus 240 ~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 240 SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 1114455566678999999999999999999999997643
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=300.56 Aligned_cols=211 Identities=25% Similarity=0.396 Sum_probs=176.9
Q ss_pred ceEEEEEE--CC----eEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHh
Q 047629 343 KSVYRATI--DG----KVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKW 408 (615)
Q Consensus 343 ~~Vy~~~~--~g----~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~ 408 (615)
|.||||.| .| -+||||++. .++.+|.-+|.+++|+|++||+|+|..+ .+.||++|||.|+|.+|
T Consensus 710 GtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s--~~qlvtq~mP~G~LlDy 787 (1177)
T KOG1025|consen 710 GTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS--TLQLVTQLMPLGCLLDY 787 (1177)
T ss_pred eeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc--hHHHHHHhcccchHHHH
Confidence 69999998 44 468999885 3588999999999999999999999753 48899999999999999
Q ss_pred hccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC-----
Q 047629 409 LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN----- 483 (615)
Q Consensus 409 L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~----- 483 (615)
++.++. .+.-...+.|..|||+||.|||++. ++||||.++|+|+.+-..+||.|||+++....
T Consensus 788 vr~hr~---------~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey 855 (1177)
T KOG1025|consen 788 VREHRD---------NIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY 855 (1177)
T ss_pred HHHhhc---------cccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence 998764 3788899999999999999999997 99999999999999999999999999987632
Q ss_pred --------------------CCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcC
Q 047629 484 --------------------DVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMD 542 (615)
Q Consensus 484 --------------------~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~d 542 (615)
.++.++|||||||++||++| |.+|++...- +++...+ .
T Consensus 856 ~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~-------~eI~dll--------------e 914 (1177)
T KOG1025|consen 856 SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA-------EEIPDLL--------------E 914 (1177)
T ss_pred cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH-------HHhhHHH--------------h
Confidence 25779999999999999999 9999886542 1122222 1
Q ss_pred CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 543 PNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 543 p~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
...+-..|.-+...+..++.+||..|+..||+++++...+.++...
T Consensus 915 ~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 915 KGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred ccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 1112245777888899999999999999999999999988766543
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=284.88 Aligned_cols=211 Identities=21% Similarity=0.408 Sum_probs=166.9
Q ss_pred ceEEEEEE--CCe----EEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHh
Q 047629 343 KSVYRATI--DGK----VLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKW 408 (615)
Q Consensus 343 ~~Vy~~~~--~g~----~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~ 408 (615)
|.||+|.+ +|+ .||+|.++ +++.+|+.+++.++|+||++++|+|.. ...++++||+++|+|.++
T Consensus 21 g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~--~~~~~v~e~~~~g~l~~~ 98 (316)
T cd05108 21 GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT--STVQLITQLMPFGCLLDY 98 (316)
T ss_pred ceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC--CCceeeeecCCCCCHHHH
Confidence 58999986 444 48999975 247789999999999999999999874 357899999999999999
Q ss_pred hccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC------
Q 047629 409 LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------ 482 (615)
Q Consensus 409 L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------ 482 (615)
+..... .+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 99 l~~~~~---------~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 166 (316)
T cd05108 99 VREHKD---------NIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEY 166 (316)
T ss_pred HHhccc---------cCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccCCCcce
Confidence 986542 3889999999999999999999998 9999999999999999999999999986431
Q ss_pred -------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcC
Q 047629 483 -------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMD 542 (615)
Q Consensus 483 -------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~d 542 (615)
..++.++|||||||++|||++ |+.|+......+ +... +....
T Consensus 167 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-------~~~~----------~~~~~- 228 (316)
T cd05108 167 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSI----------LEKGE- 228 (316)
T ss_pred eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHH----------HhCCC-
Confidence 113568999999999999998 999986432110 1111 00000
Q ss_pred CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 543 PNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 543 p~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
.+ ..+..+...+.+++..||+.+|.+||++.|++..|..+...
T Consensus 229 -~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 229 -RL--PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred -CC--CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 01 11223345678999999999999999999999999877654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=291.85 Aligned_cols=219 Identities=25% Similarity=0.394 Sum_probs=166.1
Q ss_pred ceEEEEEE-------CCeEEEEEEccH--------HHHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCHH
Q 047629 343 KSVYRATI-------DGKVLAVKKIKE--------DVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLD 406 (615)
Q Consensus 343 ~~Vy~~~~-------~g~~vAvK~~~~--------~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~ 406 (615)
|.||++.. .+..||||+++. .+.+|+.+|..+ +||||++++|+|.+. +..++||||+++|+|.
T Consensus 49 G~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~-~~~~lv~E~~~~g~L~ 127 (375)
T cd05104 49 GKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG-GPTLVITEYCCYGDLL 127 (375)
T ss_pred ceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC-CcceeeehhccCCcHH
Confidence 58999874 356899999862 367899999999 899999999998754 4789999999999999
Q ss_pred HhhccCCCCCCC-----------------------------------------------------------------CCc
Q 047629 407 KWLHPKSKSSSS-----------------------------------------------------------------SGS 421 (615)
Q Consensus 407 ~~L~~~~~~~~~-----------------------------------------------------------------~~~ 421 (615)
+++......... ...
T Consensus 128 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (375)
T cd05104 128 NFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEED 207 (375)
T ss_pred HHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhcc
Confidence 999753210000 000
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------------------
Q 047629 422 VIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------------------- 482 (615)
Q Consensus 422 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------------------- 482 (615)
...++|..+++++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 208 ~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 284 (375)
T cd05104 208 ELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMA 284 (375)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeC
Confidence 124889999999999999999999987 9999999999999999999999999985321
Q ss_pred ------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHH
Q 047629 483 ------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGAL 555 (615)
Q Consensus 483 ------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~ 555 (615)
..++.++|||||||++|||++ |+.|+........ .+.. + .+ ......+.....
T Consensus 285 PE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~--~~~~----~----------~~----~~~~~~~~~~~~ 344 (375)
T cd05104 285 PESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK--FYKM----I----------KE----GYRMLSPECAPS 344 (375)
T ss_pred hhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH--HHHH----H----------Hh----CccCCCCCCCCH
Confidence 124568999999999999998 8888865432111 1111 0 00 000011122234
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 047629 556 SLATLARACTMDKSLSRPNMAEVVFNLSVL 585 (615)
Q Consensus 556 ~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l 585 (615)
++.+|+.+||+.||++||+|+||++.|++.
T Consensus 345 ~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 345 EMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 688999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-32 Score=272.78 Aligned_cols=210 Identities=24% Similarity=0.405 Sum_probs=168.3
Q ss_pred ceEEEEEE-CCeEEEEEEcc------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCC
Q 047629 343 KSVYRATI-DGKVLAVKKIK------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKS 415 (615)
Q Consensus 343 ~~Vy~~~~-~g~~vAvK~~~------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~ 415 (615)
+.||+|.. +++.||+|.++ +++.+|++++++++|+||+++.+++... +..+++|||+++|+|.+++.....
T Consensus 20 ~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~- 97 (261)
T cd05068 20 GEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE-EPIYIVTELMKYGSLLEYLQGGAG- 97 (261)
T ss_pred ccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecC-CCeeeeeecccCCcHHHHHhccCC-
Confidence 48999987 56789999886 3578899999999999999999988754 478999999999999999976432
Q ss_pred CCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------------
Q 047629 416 SSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------------- 482 (615)
Q Consensus 416 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------------- 482 (615)
..++|.++..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 98 -------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 167 (261)
T cd05068 98 -------RALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFP 167 (261)
T ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCCCcCc
Confidence 13899999999999999999999988 9999999999999999999999999875321
Q ss_pred -----------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 483 -----------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 483 -----------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
...+.++||||||+++|||++ |+.|+....... ... .+.. ......+
T Consensus 168 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~--------------~~~~----~~~~~~~ 226 (261)
T cd05068 168 IKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---VLQ--------------QVDQ----GYRMPCP 226 (261)
T ss_pred eeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHH--------------HHHc----CCCCCCC
Confidence 113558999999999999999 888886533211 110 0111 0011122
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 047629 551 IDGALSLATLARACTMDKSLSRPNMAEVVFNLSVL 585 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l 585 (615)
......+.+++.+|++.+|.+||+|.++++.|+.+
T Consensus 227 ~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 227 PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 33456789999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-32 Score=271.84 Aligned_cols=207 Identities=25% Similarity=0.430 Sum_probs=165.0
Q ss_pred ceEEEEEE-CCeEEEEEEcc------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCC
Q 047629 343 KSVYRATI-DGKVLAVKKIK------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKS 415 (615)
Q Consensus 343 ~~Vy~~~~-~g~~vAvK~~~------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~ 415 (615)
+.||++.+ ++..+|+|.++ .++.+|++++++++|+||+++++++.+. ...++||||+++|+|.++++....
T Consensus 18 ~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~iv~e~~~~~~L~~~~~~~~~- 95 (256)
T cd05114 18 GVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ-KPLYIVTEFMENGCLLNYLRQRQG- 95 (256)
T ss_pred ceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccC-CCEEEEEEcCCCCcHHHHHHhCcc-
Confidence 48999988 56689999875 3578899999999999999999998754 479999999999999999975432
Q ss_pred CCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------------
Q 047629 416 SSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------------- 482 (615)
Q Consensus 416 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------------- 482 (615)
.++|..+..++.|++.||+|||+++ ++||||||+||++++++.+|++|||+++...
T Consensus 96 --------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~ 164 (256)
T cd05114 96 --------KLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFP 164 (256)
T ss_pred --------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCCCc
Confidence 2899999999999999999999998 9999999999999999999999999885321
Q ss_pred -----------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 483 -----------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 483 -----------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
...+.++||||||+++|||++ |+.|+......+. ... +.+...+ ..+
T Consensus 165 ~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~---~~~--------------i~~~~~~----~~~ 223 (256)
T cd05114 165 VKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV---VEM--------------ISRGFRL----YRP 223 (256)
T ss_pred hhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HHH--------------HHCCCCC----CCC
Confidence 113568999999999999999 8889865432111 100 0000000 112
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047629 551 IDGALSLATLARACTMDKSLSRPNMAEVVFNLS 583 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~ 583 (615)
......+.+++.+||+.+|.+||+|.|+++.|.
T Consensus 224 ~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 224 KLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 223346899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=277.77 Aligned_cols=215 Identities=21% Similarity=0.306 Sum_probs=167.8
Q ss_pred ceEEEEEE--CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATI--DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
..||+|.. .++.||||++. ..+.+|+..|+.++||||+++...|... ..+|+||.||..||+.+.++..
T Consensus 40 a~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~-~~LWvVmpfMa~GS~ldIik~~ 118 (516)
T KOG0582|consen 40 AVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVD-SELWVVMPFMAGGSLLDIIKTY 118 (516)
T ss_pred eEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEec-ceeEEeehhhcCCcHHHHHHHH
Confidence 47999997 78999999996 3467899999999999999999887754 4899999999999999999875
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCC-----------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA----------- 481 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~----------- 481 (615)
-.. .+.+..+..|.+++++||.|||.++ .||||||+.|||||.+|.+||+|||.+..+
T Consensus 119 ~~~--------Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf 187 (516)
T KOG0582|consen 119 YPD--------GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRF 187 (516)
T ss_pred ccc--------cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEee
Confidence 442 3899999999999999999999998 999999999999999999999999876322
Q ss_pred ------------------CCCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCC
Q 047629 482 ------------------TNDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDP 543 (615)
Q Consensus 482 ------------------~~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp 543 (615)
...|..|+||||||++..||.+|..||.....-... ...+... .....-.
T Consensus 188 ~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL--l~tLqn~----------pp~~~t~ 255 (516)
T KOG0582|consen 188 NTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL--LLTLQND----------PPTLLTS 255 (516)
T ss_pred ccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH--HHHhcCC----------CCCcccc
Confidence 112567999999999999999999999876542211 1101000 0000000
Q ss_pred cCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 544 NLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 544 ~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.+..+........+.+++..|+..||.+|||++++++.
T Consensus 256 ~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 256 GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 11111112233478999999999999999999999874
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=270.83 Aligned_cols=211 Identities=26% Similarity=0.429 Sum_probs=170.0
Q ss_pred ceEEEEEECCeEEEEEEccH-----HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCCCC
Q 047629 343 KSVYRATIDGKVLAVKKIKE-----DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSS 417 (615)
Q Consensus 343 ~~Vy~~~~~g~~vAvK~~~~-----~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~~ 417 (615)
+.||++...|+.+|+|.++. .+.+|+.++++++|+|++++++++...++..++++||+++|+|.+++......
T Consensus 20 ~~v~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-- 97 (256)
T cd05082 20 GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-- 97 (256)
T ss_pred CeEEEEEEcCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCC--
Confidence 48999999999999998863 47789999999999999999998765555789999999999999999764431
Q ss_pred CCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC---------------
Q 047629 418 SSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT--------------- 482 (615)
Q Consensus 418 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~--------------- 482 (615)
.++|..++.++.|++.||+|||+++ ++||||||+||++++++.+|++|||+++...
T Consensus 98 ------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aP 168 (256)
T cd05082 98 ------VLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAP 168 (256)
T ss_pred ------CCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccCCCCccceeecCH
Confidence 3889999999999999999999998 9999999999999999999999999986431
Q ss_pred -----CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHH
Q 047629 483 -----NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALS 556 (615)
Q Consensus 483 -----~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~ 556 (615)
...+.++||||||+++|||++ |+.|+...... . +.. .+..-.. ...+...+..
T Consensus 169 E~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~---~----~~~----------~~~~~~~----~~~~~~~~~~ 227 (256)
T cd05082 169 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---D----VVP----------RVEKGYK----MDAPDGCPPV 227 (256)
T ss_pred HHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---H----HHH----------HHhcCCC----CCCCCCCCHH
Confidence 124568999999999999998 88888643210 0 000 0111011 1222334556
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 047629 557 LATLARACTMDKSLSRPNMAEVVFNLSVL 585 (615)
Q Consensus 557 l~~l~~~C~~~dP~~RPsm~ev~~~L~~l 585 (615)
+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 228 ~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 228 VYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 88999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=270.51 Aligned_cols=213 Identities=23% Similarity=0.366 Sum_probs=168.8
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCc-EEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGN-RFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~-~~lV~E~~~~GsL~~~L~ 410 (615)
|.|||+.. +|..+|.|.++ .+...|+.+|++++|||||+++++....+.+ ++||||||..|+|.+.++
T Consensus 33 g~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk 112 (375)
T KOG0591|consen 33 GEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIK 112 (375)
T ss_pred hheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHH
Confidence 58999885 99999999885 3567899999999999999999965545545 899999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCceeeCCCCcEEEeecCCCCCCCC-----
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPS--IVHRDIRTNNIQLDSRFKAKIANFSLAAPATN----- 483 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDlk~~NILld~~~~~kl~DFGla~~~~~----- 483 (615)
.-+... ..+++..++++..|++.||.++|+.. |+ |+||||||.||+|+.++.+||+||||++.+..
T Consensus 113 ~~K~qk------r~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA 185 (375)
T KOG0591|consen 113 HFKKQK------RLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTFA 185 (375)
T ss_pred HHHhcc------ccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhHhcchhHHH
Confidence 654322 24899999999999999999999942 33 99999999999999999999999999976532
Q ss_pred ------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcC
Q 047629 484 ------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNL 545 (615)
Q Consensus 484 ------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l 545 (615)
.+..|+||||+||++|||..=+.||.... ...+. .++..---|.+
T Consensus 186 ~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n---~~~L~--------------~KI~qgd~~~~ 248 (375)
T KOG0591|consen 186 HSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN---LLSLC--------------KKIEQGDYPPL 248 (375)
T ss_pred HhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc---HHHHH--------------HHHHcCCCCCC
Confidence 36679999999999999999999997642 11111 12222111112
Q ss_pred CCCCC-hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047629 546 ESFYP-IDGALSLATLARACTMDKSLSRPNMAEVVFNLS 583 (615)
Q Consensus 546 ~~~~~-~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~ 583 (615)
| ......+..|+..|+..||+.||+...+++.+.
T Consensus 249 ----p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 249 ----PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred ----cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 2 345567899999999999999999655555544
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=261.06 Aligned_cols=221 Identities=24% Similarity=0.335 Sum_probs=171.6
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
+.||+|.. +|+.||||+++ ....+||+.|+.++|+||+.|++++... +.+-||+|||+. +|...++.
T Consensus 16 gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~-~~l~lVfEfm~t-dLe~vIkd 93 (318)
T KOG0659|consen 16 GVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHK-SNLSLVFEFMPT-DLEVVIKD 93 (318)
T ss_pred EEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCC-CceEEEEEeccc-cHHHHhcc
Confidence 47999987 79999999996 2467899999999999999999998754 479999999986 99999987
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC--------
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN-------- 483 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~-------- 483 (615)
... .|+-.++..++.++.+||+|+|+++ |+||||||.|+|++.++.+||+|||+|+....
T Consensus 94 ~~i---------~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~ 161 (318)
T KOG0659|consen 94 KNI---------ILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQ 161 (318)
T ss_pred ccc---------ccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCcccccc
Confidence 653 5999999999999999999999998 99999999999999999999999999987532
Q ss_pred ----------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHH---HH-------HHHH
Q 047629 484 ----------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEE---KR-------EERL 537 (615)
Q Consensus 484 ----------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~-------~~~~ 537 (615)
.++..+||||.|||+.||+-|.+-+.+..+-+.. ..+.+.+.... +. -.++
T Consensus 162 V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL---~~If~~LGTP~~~~WP~~~~lpdY~~~ 238 (318)
T KOG0659|consen 162 VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQL---SKIFRALGTPTPDQWPEMTSLPDYVKI 238 (318)
T ss_pred eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHH---HHHHHHcCCCCcccCccccccccHHHH
Confidence 2567899999999999999998777665443322 12222221110 00 0111
Q ss_pred hhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 538 RNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 538 ~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
...=.|.+..-+ ..+....++|+..++..||.+|.+++|++++
T Consensus 239 ~~~P~~~~~~lf-~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 239 QQFPKPPLNNLF-PAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred hcCCCCcccccc-ccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 111112222222 3344456999999999999999999999886
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=275.13 Aligned_cols=217 Identities=25% Similarity=0.446 Sum_probs=169.2
Q ss_pred ceEEEEEEC--C-----eEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATID--G-----KVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~~--g-----~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~ 407 (615)
+.||+|... + ..||+|.++ ..+.+|+.++.+++|+||+++++++.+. +..+++|||+++|+|.+
T Consensus 19 g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~-~~~~~~~e~~~~~~L~~ 97 (283)
T cd05048 19 GKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE-QPTCMLFEYLAHGDLHE 97 (283)
T ss_pred CcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC-CceEEEEecCCCCcHHH
Confidence 589999862 2 579999885 2477899999999999999999998754 47899999999999999
Q ss_pred hhccCCCCCCC------CCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCC
Q 047629 408 WLHPKSKSSSS------SGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA 481 (615)
Q Consensus 408 ~L~~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~ 481 (615)
++......... ......+++..++.++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++..
T Consensus 98 ~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~ 174 (283)
T cd05048 98 FLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDI 174 (283)
T ss_pred HHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCCcEEECCCcceeec
Confidence 99764321110 000124889999999999999999999998 999999999999999999999999988542
Q ss_pred C-------------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHH
Q 047629 482 T-------------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREE 535 (615)
Q Consensus 482 ~-------------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 535 (615)
. ..++.++|||||||++|||++ |+.|+......+ +..
T Consensus 175 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~-------~~~---------- 237 (283)
T cd05048 175 YSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE-------VIE---------- 237 (283)
T ss_pred cccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHH----------
Confidence 1 124568999999999999998 999987543211 000
Q ss_pred HHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 047629 536 RLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSV 584 (615)
Q Consensus 536 ~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~ 584 (615)
.+. .......+...+.++.+|+.+||+.||.+||+++||+++|+.
T Consensus 238 ~i~----~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 238 MIR----SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHH----cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 011 111112344556778999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-31 Score=277.72 Aligned_cols=223 Identities=26% Similarity=0.436 Sum_probs=165.1
Q ss_pred ceEEEEEE------------------CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEE
Q 047629 343 KSVYRATI------------------DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLV 396 (615)
Q Consensus 343 ~~Vy~~~~------------------~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV 396 (615)
|.||++.+ ++..||+|.++ .++.+|++++.+++|+||+++++++.+. ...++|
T Consensus 19 g~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv 97 (304)
T cd05096 19 GEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDE-DPLCMI 97 (304)
T ss_pred eEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEecC-CceEEE
Confidence 47998875 23479999875 2577899999999999999999998764 478999
Q ss_pred EeecCCCCHHHhhccCCCCCCC---------CCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCC
Q 047629 397 YEYAENGSLDKWLHPKSKSSSS---------SGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSR 467 (615)
Q Consensus 397 ~E~~~~GsL~~~L~~~~~~~~~---------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~ 467 (615)
|||+++|+|.+++......... ......++|.++++++.|++.||.|||+++ |+||||||+|||++.+
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH~dlkp~Nill~~~ 174 (304)
T cd05096 98 TEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVHRDLATRNCLVGEN 174 (304)
T ss_pred EecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccccCcchhheEEcCC
Confidence 9999999999998654211100 011124889999999999999999999998 9999999999999999
Q ss_pred CcEEEeecCCCCCCC-------------------------CCCCCcccchhHHHHHHHHHc--CCCCCCCCCCChhHHHH
Q 047629 468 FKAKIANFSLAAPAT-------------------------NDVMPKFDVFAFGVVLLELLS--GKKATRTTENGKTAVLW 520 (615)
Q Consensus 468 ~~~kl~DFGla~~~~-------------------------~~~~~k~DV~SfGvvl~Ellt--G~~p~~~~~~~~~~~l~ 520 (615)
+.+||+|||+++... ..++.++||||||+++|||++ |..|+......+ ..
T Consensus 175 ~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~---~~ 251 (304)
T cd05096 175 LTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQ---VI 251 (304)
T ss_pred ccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHH---HH
Confidence 999999999986421 124568999999999999987 455665433211 11
Q ss_pred HHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047629 521 KEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLS 583 (615)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~ 583 (615)
..+...+ .... .......+..++..+.+++.+||+.||++||||.||...|+
T Consensus 252 ~~~~~~~----------~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 252 ENAGEFF----------RDQG-RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred HHHHHHh----------hhcc-ccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 1111111 0000 00001112334557899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-31 Score=270.00 Aligned_cols=207 Identities=26% Similarity=0.422 Sum_probs=165.6
Q ss_pred ceEEEEEE----CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATI----DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~----~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
+.||+|.+ +++.+|+|+++ +++.+|+.++++++|+||++++|++.. ...++||||+++|+|.+++
T Consensus 9 g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~lv~e~~~~~~L~~~l 86 (257)
T cd05116 9 GTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA--ESWMLVMELAELGPLNKFL 86 (257)
T ss_pred cceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC--CCcEEEEecCCCCcHHHHH
Confidence 47999875 47889999875 247789999999999999999998753 3679999999999999999
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------ 483 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------ 483 (615)
.... .+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++....
T Consensus 87 ~~~~----------~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 87 QKNK----------HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred HhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 7543 2889999999999999999999998 99999999999999999999999999854311
Q ss_pred --------------------CCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcC
Q 047629 484 --------------------DVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMD 542 (615)
Q Consensus 484 --------------------~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~d 542 (615)
..+.++||||||+++|||++ |+.||......+ ... .+.+
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~--------------~i~~--- 213 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE---VTQ--------------MIES--- 213 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH--------------HHHC---
Confidence 12347999999999999998 999986543211 110 0111
Q ss_pred CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 047629 543 PNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVL 585 (615)
Q Consensus 543 p~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l 585 (615)
......+......+.+++.+||+.||++||++.+|++.|++.
T Consensus 214 -~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 214 -GERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred -CCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 111122334456688999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=287.38 Aligned_cols=205 Identities=23% Similarity=0.405 Sum_probs=169.4
Q ss_pred ceEEEEEE--CCeEEEEEEcc-------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
|.||.+.- +++.||||++. +-+.+|+.+|+..+|+|||+++.-+... .++|+|||||++|+|.+.+...
T Consensus 287 G~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~-deLWVVMEym~ggsLTDvVt~~- 364 (550)
T KOG0578|consen 287 GGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG-DELWVVMEYMEGGSLTDVVTKT- 364 (550)
T ss_pred cceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc-ceeEEEEeecCCCchhhhhhcc-
Confidence 58998876 78999999995 2367999999999999999999987755 4899999999999999998654
Q ss_pred CCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC----------
Q 047629 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN---------- 483 (615)
Q Consensus 414 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~---------- 483 (615)
.+++.++..|+++++.||+|||.++ |+|||||.+|||++.++.+||+|||++.....
T Consensus 365 ----------~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~TmVG 431 (550)
T KOG0578|consen 365 ----------RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTMVG 431 (550)
T ss_pred ----------cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccCccccccC
Confidence 3899999999999999999999998 99999999999999999999999999865422
Q ss_pred -------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 484 -------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 484 -------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
.+.+|+||||||++.+||+-|.+||-.... ...++ .+..--.|.+ ..+
T Consensus 432 TPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P--lrAly---------------LIa~ng~P~l--k~~ 492 (550)
T KOG0578|consen 432 TPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP--LRALY---------------LIATNGTPKL--KNP 492 (550)
T ss_pred CCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh--HHHHH---------------HHhhcCCCCc--CCc
Confidence 256899999999999999999999875322 11111 1111122333 234
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 551 IDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
......+.++..+|++.|+++||++.|++++
T Consensus 493 ~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 493 EKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred cccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 4556678999999999999999999999986
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-31 Score=270.87 Aligned_cols=210 Identities=23% Similarity=0.401 Sum_probs=166.8
Q ss_pred ceEEEEEE-CCeEEEEEEcc------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCC
Q 047629 343 KSVYRATI-DGKVLAVKKIK------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKS 415 (615)
Q Consensus 343 ~~Vy~~~~-~g~~vAvK~~~------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~ 415 (615)
+.||+|.. +++.||+|.++ +.+.+|+.++++++|+||+++++++.+ ++..+++|||+++|+|.++++.....
T Consensus 20 g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~ 98 (261)
T cd05072 20 GEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK-EEPIYIITEYMAKGSLLDFLKSDEGG 98 (261)
T ss_pred ceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCCcEEEEecCCCCcHHHHHHHhcCC
Confidence 48999987 66789999875 357789999999999999999998765 44789999999999999999764321
Q ss_pred CCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC------------
Q 047629 416 SSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------------ 483 (615)
Q Consensus 416 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------------ 483 (615)
.+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 99 --------~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 167 (261)
T cd05072 99 --------KVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFP 167 (261)
T ss_pred --------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCceeccCCCccc
Confidence 3889999999999999999999987 99999999999999999999999999864321
Q ss_pred ------------CCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 484 ------------DVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 484 ------------~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
..+.++|||||||++|||++ |+.|+....... ... .+........ .
T Consensus 168 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~--------------~~~~~~~~~~----~ 226 (261)
T cd05072 168 IKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMS--------------ALQRGYRMPR----M 226 (261)
T ss_pred eecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHH--------------HHHcCCCCCC----C
Confidence 13457999999999999998 898986533211 010 0111111111 1
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 047629 551 IDGALSLATLARACTMDKSLSRPNMAEVVFNLSVL 585 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l 585 (615)
......+.+++.+|++.+|++||+++++.+.|+.+
T Consensus 227 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 227 ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 12334578999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.8e-32 Score=274.33 Aligned_cols=237 Identities=27% Similarity=0.422 Sum_probs=177.6
Q ss_pred cccccccccc--ceEEEEEECCeEEEEEEcc----HHHHHHHHHHHh--cCCCCcccEEEEEEcCCC---cEEEEEeecC
Q 047629 333 MNLSEHYSIG--KSVYRATIDGKVLAVKKIK----EDVTEELRILQR--INHANLVKLMGVSSDSQG---NRFLVYEYAE 401 (615)
Q Consensus 333 ~~~~~~~~iG--~~Vy~~~~~g~~vAvK~~~----~~~~~Ei~~l~~--l~H~niv~l~g~~~~~~~---~~~lV~E~~~ 401 (615)
.-+.+..+-| |.||+|.|.|+.||||.+. ..+.+|.+|.+. |+|+||..+++.-..+.+ ++|||.+|.+
T Consensus 213 I~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe 292 (513)
T KOG2052|consen 213 IVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHE 292 (513)
T ss_pred eEEEEEecCccccceeeccccCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeeccc
Confidence 3344444444 6899999999999999995 458889999886 499999999986432233 3799999999
Q ss_pred CCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHh-----CCCCCeEecCCCCCceeeCCCCcEEEeecC
Q 047629 402 NGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHE-----HAQPSIVHRDIRTNNIQLDSRFKAKIANFS 476 (615)
Q Consensus 402 ~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-----~~~~~ivHrDlk~~NILld~~~~~kl~DFG 476 (615)
+|||.|||... .++-...++++..+|.||+|||. +++|.|.|||||+.|||+..++.+-|+|+|
T Consensus 293 ~GSL~DyL~r~-----------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 293 HGSLYDYLNRN-----------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred CCcHHHHHhhc-----------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 99999999863 38999999999999999999995 579999999999999999999999999999
Q ss_pred CCCCCCCC----------------C-----------------CCcccchhHHHHHHHHHcCC----------CCCCCCCC
Q 047629 477 LAAPATND----------------V-----------------MPKFDVFAFGVVLLELLSGK----------KATRTTEN 513 (615)
Q Consensus 477 la~~~~~~----------------~-----------------~~k~DV~SfGvvl~ElltG~----------~p~~~~~~ 513 (615)
||...... + ...+||||||.|+||+..+. .||....+
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 98432111 1 12589999999999997642 34433221
Q ss_pred ChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC-hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccchhh
Q 047629 514 GKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP-IDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQSTET 591 (615)
Q Consensus 514 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~-~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~~~ 591 (615)
.+.. .+.++.+. -.+.+.|.+...+. .+....+.+|++.||..+|..|-|+=-|-+.|.++.++.+.
T Consensus 442 ~DPs--~eeMrkVV---------Cv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~ek 509 (513)
T KOG2052|consen 442 SDPS--FEEMRKVV---------CVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSDEK 509 (513)
T ss_pred CCCC--HHHHhcce---------eecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcChhh
Confidence 1110 11111111 11223444444333 35667899999999999999999999999999888765543
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=268.93 Aligned_cols=207 Identities=23% Similarity=0.402 Sum_probs=165.9
Q ss_pred ceEEEEEE--CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATI--DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
+.||+|.. +|+.+|+|..+ ..+.+|++++++++|+||+++++++... ...++|+||+++|+|.+++...
T Consensus 9 g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~ 87 (252)
T cd05084 9 GEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-QPIYIVMELVQGGDFLTFLRTE 87 (252)
T ss_pred ccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCeEEEEeeccCCcHHHHHHhC
Confidence 48999987 78999999764 2477899999999999999999998754 4789999999999999999754
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC----------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT---------- 482 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~---------- 482 (615)
.. .++|.+++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++...
T Consensus 88 ~~---------~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 88 GP---------RLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred CC---------CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 32 3889999999999999999999998 9999999999999999999999999875321
Q ss_pred ---------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCC
Q 047629 483 ---------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLE 546 (615)
Q Consensus 483 ---------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~ 546 (615)
...+.++||||||+++|||++ |..|+....... .. ..+.. ...
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-------~~----------~~~~~----~~~ 214 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-------TR----------EAIEQ----GVR 214 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-------HH----------HHHHc----CCC
Confidence 113457899999999999998 888875432110 00 01111 111
Q ss_pred CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047629 547 SFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLS 583 (615)
Q Consensus 547 ~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~ 583 (615)
...+......+.+++.+|++.+|++||++.|+.+.|.
T Consensus 215 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 215 LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 1223334557899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=270.11 Aligned_cols=209 Identities=28% Similarity=0.468 Sum_probs=167.4
Q ss_pred ceEEEEEEC-----CeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATID-----GKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~~-----g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
+.||+|.+. ...||||.++ .++.+|+.++.+++|+||+++++++.+. +..+++|||+++|+|.+++
T Consensus 18 g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~iv~e~~~~~~L~~~~ 96 (266)
T cd05033 18 GEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS-RPVMIITEYMENGSLDKFL 96 (266)
T ss_pred ceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC-CceEEEEEcCCCCCHHHHH
Confidence 489999872 3579999875 2467899999999999999999988754 4789999999999999999
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------- 482 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------- 482 (615)
..... .++|.++.+++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++...
T Consensus 97 ~~~~~---------~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (266)
T cd05033 97 RENDG---------KFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYT 164 (266)
T ss_pred HhccC---------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccccccccee
Confidence 76442 3899999999999999999999987 9999999999999999999999999886542
Q ss_pred ------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCC
Q 047629 483 ------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDP 543 (615)
Q Consensus 483 ------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp 543 (615)
..++.++||||||+++|||++ |+.|+......+ ... .+.+..
T Consensus 165 ~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~~~--------------~~~~~~-- 225 (266)
T cd05033 165 TKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VIK--------------AVEDGY-- 225 (266)
T ss_pred ccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---HHH--------------HHHcCC--
Confidence 113568999999999999998 999986433211 111 111100
Q ss_pred cCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 047629 544 NLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVL 585 (615)
Q Consensus 544 ~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l 585 (615)
....+.+....+.+++.+||+.+|++||++.||++.|.++
T Consensus 226 --~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 --RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred --CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0111233455689999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.8e-32 Score=288.18 Aligned_cols=220 Identities=24% Similarity=0.376 Sum_probs=167.0
Q ss_pred ceEEEEEE-------CCeEEEEEEccH--------HHHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCHH
Q 047629 343 KSVYRATI-------DGKVLAVKKIKE--------DVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLD 406 (615)
Q Consensus 343 ~~Vy~~~~-------~g~~vAvK~~~~--------~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~ 406 (615)
|.||++.. +++.||||+++. .+.+|+++++++ +|+||++++|+|.+. +..++||||+++|+|.
T Consensus 52 g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~-~~~~lv~ey~~~g~L~ 130 (374)
T cd05106 52 GKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG-GPVLVITEYCCYGDLL 130 (374)
T ss_pred ccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC-CCeEEeHhhccCCcHH
Confidence 47998874 235799999852 467899999999 899999999998754 4799999999999999
Q ss_pred HhhccCCCCC------------------------------------------------------------CCCCcccccC
Q 047629 407 KWLHPKSKSS------------------------------------------------------------SSSGSVIFLT 426 (615)
Q Consensus 407 ~~L~~~~~~~------------------------------------------------------------~~~~~~~~l~ 426 (615)
+++....... ........++
T Consensus 131 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 210 (374)
T cd05106 131 NFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLD 210 (374)
T ss_pred HHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchhccCCCCCcC
Confidence 9986432100 0000112488
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC------------------------
Q 047629 427 WSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------------------------ 482 (615)
Q Consensus 427 ~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------------------------ 482 (615)
+.++++++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 211 ~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 287 (374)
T cd05106 211 LDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIF 287 (374)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhc
Confidence 9999999999999999999988 9999999999999999999999999985321
Q ss_pred -CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHH
Q 047629 483 -NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATL 560 (615)
Q Consensus 483 -~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l 560 (615)
..++.++|||||||++|||++ |+.||........ .. .. +.....+. .+......+.++
T Consensus 288 ~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~~----~~----------~~~~~~~~----~~~~~~~~l~~l 347 (374)
T cd05106 288 DCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--FY----KM----------VKRGYQMS----RPDFAPPEIYSI 347 (374)
T ss_pred CCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--HH----HH----------HHcccCcc----CCCCCCHHHHHH
Confidence 124568999999999999997 9999875432111 00 00 00001111 112223568899
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHhcc
Q 047629 561 ARACTMDKSLSRPNMAEVVFNLSVLT 586 (615)
Q Consensus 561 ~~~C~~~dP~~RPsm~ev~~~L~~l~ 586 (615)
+.+||+.||++||++.||++.|+++.
T Consensus 348 i~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 348 MKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 99999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=272.80 Aligned_cols=211 Identities=23% Similarity=0.386 Sum_probs=163.9
Q ss_pred ceEEEEEE--CCe----EEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHh
Q 047629 343 KSVYRATI--DGK----VLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKW 408 (615)
Q Consensus 343 ~~Vy~~~~--~g~----~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~ 408 (615)
+.||+|.+ +|+ .+++|.+. .++..|+..+.+++|+||++++|++.. ...++++||+++|+|.++
T Consensus 21 ~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~--~~~~~i~e~~~~gsL~~~ 98 (279)
T cd05111 21 GTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG--ASLQLVTQLSPLGSLLDH 98 (279)
T ss_pred cceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC--CccEEEEEeCCCCcHHHH
Confidence 48999998 454 47888774 235567778899999999999998753 357899999999999999
Q ss_pred hccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC------
Q 047629 409 LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------ 482 (615)
Q Consensus 409 L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------ 482 (615)
+..... .++|..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 99 l~~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~ 166 (279)
T cd05111 99 VRQHRD---------SLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKY 166 (279)
T ss_pred HHhccc---------CCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccCCCccc
Confidence 976443 3899999999999999999999988 9999999999999999999999999985421
Q ss_pred -------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcC
Q 047629 483 -------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMD 542 (615)
Q Consensus 483 -------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~d 542 (615)
..++.++||||||+++|||++ |+.|+....... +... +..-..
T Consensus 167 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-------~~~~----------~~~~~~ 229 (279)
T cd05111 167 FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-------VPDL----------LEKGER 229 (279)
T ss_pred ccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHH----------HHCCCc
Confidence 113567899999999999998 999986543211 1111 110000
Q ss_pred CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 543 PNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 543 p~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
+. .+..+...+.+++.+||..||++|||+.|+++.|..+...
T Consensus 230 ~~----~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 230 LA----QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred CC----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 11 1112234568899999999999999999999999876643
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=273.05 Aligned_cols=224 Identities=26% Similarity=0.386 Sum_probs=169.7
Q ss_pred ceEEEEEE------CCeEEEEEEccH--------HHHHHHHHHHhcCCCCcccEEEEEEcCC-CcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATI------DGKVLAVKKIKE--------DVTEELRILQRINHANLVKLMGVSSDSQ-GNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~------~g~~vAvK~~~~--------~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~~lV~E~~~~GsL~~ 407 (615)
|.||.+.+ +++.||+|.++. .+.+|++++++++|+||+++++++...+ ...+++|||+++|+|.+
T Consensus 18 g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~ 97 (283)
T cd05080 18 GKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRD 97 (283)
T ss_pred cEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHH
Confidence 46766543 577899998852 3678999999999999999999886543 24789999999999999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----- 482 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----- 482 (615)
++... .++|.++..++.|++.||+|||+++ ++||||||+|||+++++.+||+|||+++...
T Consensus 98 ~~~~~-----------~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 163 (283)
T cd05080 98 YLPKH-----------KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 163 (283)
T ss_pred HHHHc-----------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCCcchh
Confidence 99653 2899999999999999999999998 9999999999999999999999999986431
Q ss_pred ---------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhc
Q 047629 483 ---------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWM 541 (615)
Q Consensus 483 ---------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 541 (615)
...+.++||||||+++|||++|+.|+......... ...... .......+.+.+
T Consensus 164 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~~-----~~~~~~~~~~~~ 237 (283)
T cd05080 164 YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE-MIGPKQ-----GQMTVVRLIELL 237 (283)
T ss_pred hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhh-hhcccc-----cccchhhhhhhh
Confidence 12456899999999999999999997653321100 000000 000011122222
Q ss_pred CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 047629 542 DPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLT 586 (615)
Q Consensus 542 dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~ 586 (615)
+.......+......+.+++..||+.+|++||+++++++.|+.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 222222234445567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-31 Score=267.98 Aligned_cols=208 Identities=24% Similarity=0.415 Sum_probs=165.9
Q ss_pred ceEEEEEE----CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI----DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~----~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
+.||+|.+ ++..||+|.++ +.+.+|+.++++++|+||+++++++. . ...++||||+++|+|.+++.
T Consensus 9 g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~-~~~~lv~e~~~~~~L~~~l~ 86 (257)
T cd05115 9 GCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-A-EALMLVMEMASGGPLNKFLS 86 (257)
T ss_pred ccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-C-CCeEEEEEeCCCCCHHHHHH
Confidence 47999876 35679999885 24778999999999999999999874 3 36899999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
.... .+++.++++++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+++...
T Consensus 87 ~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 87 GKKD---------EITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred hCCC---------CCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 5432 3899999999999999999999998 9999999999999999999999999885321
Q ss_pred ------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCC
Q 047629 483 ------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDP 543 (615)
Q Consensus 483 ------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp 543 (615)
...+.++||||||+++||+++ |+.|+......+. .. .+..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~--------------~~~~---- 213 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV---MS--------------FIEQ---- 213 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH---HH--------------HHHC----
Confidence 113458999999999999996 9999875432110 00 0111
Q ss_pred cCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 047629 544 NLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVL 585 (615)
Q Consensus 544 ~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l 585 (615)
......+..+...+.+++..||..||++||++.+|.+.|+.+
T Consensus 214 ~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 214 GKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 111123344556788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-31 Score=272.58 Aligned_cols=220 Identities=28% Similarity=0.422 Sum_probs=168.6
Q ss_pred ceEEEEEEC-------CeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATID-------GKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~~-------g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~ 407 (615)
|.||+|... ...+|+|.+. .++.+|++++++++||||+++++.+... +..++++||+++|+|.+
T Consensus 14 g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~ 92 (290)
T cd05045 14 GKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQD-GPLLLIVEYAKYGSLRS 92 (290)
T ss_pred cceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecC-CCcEEEEEecCCCCHHH
Confidence 479999862 2578999875 2477899999999999999999998754 47899999999999999
Q ss_pred hhccCCCCCCC--------------CCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEe
Q 047629 408 WLHPKSKSSSS--------------SGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIA 473 (615)
Q Consensus 408 ~L~~~~~~~~~--------------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~ 473 (615)
++......... ......+++.+++.++.|++.||.|||+++ ++||||||+|||+++++.+||+
T Consensus 93 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~nill~~~~~~kl~ 169 (290)
T cd05045 93 FLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKIS 169 (290)
T ss_pred HHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhheEEEcCCCcEEec
Confidence 98753211000 001124899999999999999999999988 9999999999999999999999
Q ss_pred ecCCCCCCC-------------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHH
Q 047629 474 NFSLAAPAT-------------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVL 527 (615)
Q Consensus 474 DFGla~~~~-------------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 527 (615)
|||+++... ...+.++||||||+++|||++ |+.|+...... .++..
T Consensus 170 dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~----- 241 (290)
T cd05045 170 DFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE---RLFNL----- 241 (290)
T ss_pred cccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHH-----
Confidence 999986421 113567899999999999999 99888643311 11111
Q ss_pred hHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 047629 528 KVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQ 587 (615)
Q Consensus 528 ~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~ 587 (615)
+.+... ...+......+.+++.+||+.+|++||+++|+++.|+.+..
T Consensus 242 ---------~~~~~~----~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 242 ---------LKTGYR----MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred ---------HhCCCC----CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 111111 11233344568899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-31 Score=269.22 Aligned_cols=209 Identities=27% Similarity=0.491 Sum_probs=166.5
Q ss_pred ceEEEEEE--CC---eEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATI--DG---KVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~--~g---~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
+.||+|.. ++ ..+|+|.++ .++..|++++++++|+|++++.+++.+. +..++||||+++|+|.+++
T Consensus 19 g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~ 97 (268)
T cd05063 19 GEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF-KPAMIITEYMENGALDKYL 97 (268)
T ss_pred ccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC-CCcEEEEEcCCCCCHHHHH
Confidence 47999987 33 379999875 2467899999999999999999998754 4789999999999999999
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------- 482 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------- 482 (615)
..... .++|.++..++.|++.||+|||+.+ ++||||||+||+++.++.+|++|||++....
T Consensus 98 ~~~~~---------~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 165 (268)
T cd05063 98 RDHDG---------EFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTY 165 (268)
T ss_pred HhcCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecccccccce
Confidence 75432 3899999999999999999999998 9999999999999999999999999885331
Q ss_pred -------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcC
Q 047629 483 -------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMD 542 (615)
Q Consensus 483 -------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~d 542 (615)
..++.++|||||||++|||++ |+.|+......+ ... .+..
T Consensus 166 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~---~~~--------------~i~~--- 225 (268)
T cd05063 166 TTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE---VMK--------------AIND--- 225 (268)
T ss_pred eccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHH--------------HHhc---
Confidence 113457899999999999997 999986433211 110 0110
Q ss_pred CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 047629 543 PNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVL 585 (615)
Q Consensus 543 p~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l 585 (615)
......+.+....+.+++.+||+.+|++||+|.+|++.|.++
T Consensus 226 -~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 226 -GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 011112233456689999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-31 Score=268.68 Aligned_cols=215 Identities=24% Similarity=0.413 Sum_probs=164.0
Q ss_pred ceEEEEEEC--Ce--EEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCC-----CcEEEEEeecCCCC
Q 047629 343 KSVYRATID--GK--VLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQ-----GNRFLVYEYAENGS 404 (615)
Q Consensus 343 ~~Vy~~~~~--g~--~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~~lV~E~~~~Gs 404 (615)
|.||+|.+. ++ .+|+|.++ +.+.+|++++++++|+||++++++|.... ...++++||+++|+
T Consensus 13 g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~ 92 (272)
T cd05075 13 GSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGD 92 (272)
T ss_pred ceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCc
Confidence 489999973 32 68999764 24678999999999999999999875321 13689999999999
Q ss_pred HHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--
Q 047629 405 LDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-- 482 (615)
Q Consensus 405 L~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-- 482 (615)
|.+++....... ....++|.....++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 93 l~~~~~~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 165 (272)
T cd05075 93 LHSFLLYSRLGD----CPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNG 165 (272)
T ss_pred HHHHHHHhcccC----CcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCcccccCcc
Confidence 999985432111 1124899999999999999999999987 9999999999999999999999999986431
Q ss_pred -----------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHh
Q 047629 483 -----------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLR 538 (615)
Q Consensus 483 -----------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 538 (615)
..++.++||||||+++|||++ |+.|+...... ..+. . +.
T Consensus 166 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~----~----------~~ 228 (272)
T cd05075 166 DYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---EIYD----Y----------LR 228 (272)
T ss_pred cceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH----H----------HH
Confidence 113568999999999999999 78888653321 1111 0 01
Q ss_pred hhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 047629 539 NWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVL 585 (615)
Q Consensus 539 ~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l 585 (615)
.. ... ..+......+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 229 ~~--~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 229 QG--NRL--KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred cC--CCC--CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 000 11223445689999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-31 Score=267.80 Aligned_cols=207 Identities=26% Similarity=0.430 Sum_probs=164.4
Q ss_pred ceEEEEEEC-CeEEEEEEccH------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCC
Q 047629 343 KSVYRATID-GKVLAVKKIKE------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKS 415 (615)
Q Consensus 343 ~~Vy~~~~~-g~~vAvK~~~~------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~ 415 (615)
+.||.|.+. +..+|||.++. ++.+|+.++.+++||||+++++++.+. ...++||||+++|+|.+++.....
T Consensus 18 ~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~l~~~i~~~~~- 95 (256)
T cd05113 18 GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ-RPIYIVTEYMSNGCLLNYLREHGK- 95 (256)
T ss_pred ceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccC-CCcEEEEEcCCCCcHHHHHHhcCC-
Confidence 589999884 45699998863 478899999999999999999998754 468999999999999999975432
Q ss_pred CCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------------
Q 047629 416 SSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------------- 482 (615)
Q Consensus 416 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------------- 482 (615)
.++|.+++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++...
T Consensus 96 --------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~ 164 (256)
T cd05113 96 --------RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFP 164 (256)
T ss_pred --------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCCccC
Confidence 3899999999999999999999998 9999999999999999999999999876321
Q ss_pred -----------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 483 -----------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 483 -----------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
..++.++||||||+++|||++ |+.|+......+ ... .+.....+ ..+
T Consensus 165 ~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~--------------~~~~~~~~----~~~ 223 (256)
T cd05113 165 VRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVE--------------KVSQGLRL----YRP 223 (256)
T ss_pred hhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHH--------------HHhcCCCC----CCC
Confidence 113568999999999999999 999986543211 010 01110011 112
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047629 551 IDGALSLATLARACTMDKSLSRPNMAEVVFNLS 583 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~ 583 (615)
......+.+++.+||+.||.+||++.+++..|+
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 223456899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-31 Score=270.43 Aligned_cols=216 Identities=22% Similarity=0.381 Sum_probs=164.4
Q ss_pred ceEEEEEEC-------CeEEEEEEccH--------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATID-------GKVLAVKKIKE--------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~~-------g~~vAvK~~~~--------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~ 407 (615)
+.||+|... +..||||+++. ++.+|+.++++++|+||+++++++.+. ...++||||+++|+|.+
T Consensus 20 g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~ 98 (277)
T cd05062 20 GMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG-QPTLVIMELMTRGDLKS 98 (277)
T ss_pred CeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-CCeEEEEecCCCCCHHH
Confidence 479988753 46799998752 367899999999999999999998654 47899999999999999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----- 482 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----- 482 (615)
++...............++|.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 175 (277)
T cd05062 99 YLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 175 (277)
T ss_pred HHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEECCCCCccccCCccee
Confidence 99754321110001124789999999999999999999987 9999999999999999999999999875321
Q ss_pred --------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhc
Q 047629 483 --------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWM 541 (615)
Q Consensus 483 --------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 541 (615)
...+.++|||||||++|||++ |..|+......+. .. . ..
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~---~~----~-------------~~ 235 (277)
T cd05062 176 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV---LR----F-------------VM 235 (277)
T ss_pred ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HH----H-------------HH
Confidence 124568999999999999999 6778764332110 00 0 00
Q ss_pred CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047629 542 DPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLS 583 (615)
Q Consensus 542 dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~ 583 (615)
.... ...+......+.+++.+|++.||++||++.|+++.|+
T Consensus 236 ~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 236 EGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred cCCc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 0000 1122334456899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=280.77 Aligned_cols=222 Identities=27% Similarity=0.404 Sum_probs=169.4
Q ss_pred ceEEEEEE-------CCeEEEEEEcc--------HHHHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCHH
Q 047629 343 KSVYRATI-------DGKVLAVKKIK--------EDVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLD 406 (615)
Q Consensus 343 ~~Vy~~~~-------~g~~vAvK~~~--------~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~ 406 (615)
|.||+|.. .++.||+|+++ +.+..|++++.++ +|+||++++++|...+...++++||+++|+|.
T Consensus 21 g~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~ 100 (337)
T cd05054 21 GKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLS 100 (337)
T ss_pred ceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHH
Confidence 58999864 24789999875 2356799999999 89999999999876666789999999999999
Q ss_pred HhhccCCCCCCC---------------------------------------------------CCcccccCHHHHHHHHH
Q 047629 407 KWLHPKSKSSSS---------------------------------------------------SGSVIFLTWSQRLRVAL 435 (615)
Q Consensus 407 ~~L~~~~~~~~~---------------------------------------------------~~~~~~l~~~~~~~i~~ 435 (615)
+++......... ......++|..+..++.
T Consensus 101 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 180 (337)
T cd05054 101 NYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSF 180 (337)
T ss_pred HHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHH
Confidence 998653210000 00012589999999999
Q ss_pred HHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------------------------CCCCCccc
Q 047629 436 DVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------------------------NDVMPKFD 490 (615)
Q Consensus 436 ~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------------------------~~~~~k~D 490 (615)
||+.||+|||+++ |+||||||+|||++.++.+||+|||+++... ..++.++|
T Consensus 181 qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 257 (337)
T cd05054 181 QVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSD 257 (337)
T ss_pred HHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCcccc
Confidence 9999999999987 9999999999999999999999999986431 12456899
Q ss_pred chhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCC
Q 047629 491 VFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKS 569 (615)
Q Consensus 491 V~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP 569 (615)
||||||++|||++ |+.|+......+. +. . .+.+...+ ..+.....++.+++.+||+.+|
T Consensus 258 i~SlGv~l~el~t~g~~p~~~~~~~~~--~~----~----------~~~~~~~~----~~~~~~~~~~~~l~~~cl~~~p 317 (337)
T cd05054 258 VWSFGVLLWEIFSLGASPYPGVQIDEE--FC----R----------RLKEGTRM----RAPEYATPEIYSIMLDCWHNNP 317 (337)
T ss_pred HHHHHHHHHHHHHcCCCCCCCCCccHH--HH----H----------HHhccCCC----CCCccCCHHHHHHHHHHccCCh
Confidence 9999999999998 9999865332211 11 0 11111111 1122334568999999999999
Q ss_pred CCCCCHHHHHHHHHhccc
Q 047629 570 LSRPNMAEVVFNLSVLTQ 587 (615)
Q Consensus 570 ~~RPsm~ev~~~L~~l~~ 587 (615)
++||++.||+++|+.+.+
T Consensus 318 ~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 318 EDRPTFSELVEILGDLLQ 335 (337)
T ss_pred hhCcCHHHHHHHHHHHHh
Confidence 999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-31 Score=266.32 Aligned_cols=210 Identities=27% Similarity=0.463 Sum_probs=169.4
Q ss_pred ceEEEEEECCeEEEEEEccH------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCCC
Q 047629 343 KSVYRATIDGKVLAVKKIKE------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSS 416 (615)
Q Consensus 343 ~~Vy~~~~~g~~vAvK~~~~------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~ 416 (615)
|.||++...|+.||+|.++. .+.+|+.++++++|+||+++++++.+ +...++||||+++|+|.+++......
T Consensus 20 g~v~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~- 97 (256)
T cd05039 20 GDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ-GNPLYIVTEYMAKGSLVDYLRSRGRA- 97 (256)
T ss_pred ceEEEEEecCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcC-CCCeEEEEEecCCCcHHHHHHhcCCC-
Confidence 58999999999999999863 46789999999999999999999875 45789999999999999999765421
Q ss_pred CCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------------
Q 047629 417 SSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------------- 482 (615)
Q Consensus 417 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------------- 482 (615)
.++|..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++...
T Consensus 98 -------~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~a 167 (256)
T cd05039 98 -------VITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWTA 167 (256)
T ss_pred -------CCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccccCCCcccccC
Confidence 3899999999999999999999998 9999999999999999999999999876432
Q ss_pred ------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHH
Q 047629 483 ------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGAL 555 (615)
Q Consensus 483 ------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~ 555 (615)
...+.++||||||+++||+++ |+.|+......+ +... +.. ......+...+.
T Consensus 168 pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~----------~~~----~~~~~~~~~~~~ 226 (256)
T cd05039 168 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPH----------VEK----GYRMEAPEGCPP 226 (256)
T ss_pred chhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHH----------Hhc----CCCCCCccCCCH
Confidence 123457999999999999997 998886443110 1100 110 001112223345
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 047629 556 SLATLARACTMDKSLSRPNMAEVVFNLSVL 585 (615)
Q Consensus 556 ~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l 585 (615)
.+.+++.+||+.+|++||++.|+++.|+.+
T Consensus 227 ~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 227 EVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred HHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 688999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-32 Score=286.87 Aligned_cols=204 Identities=26% Similarity=0.370 Sum_probs=167.2
Q ss_pred ceEEEEEE--CCeEEEEEEccHH----------HHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKED----------VTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~~----------~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.|-.|+. +|+.+|||.+.+. +.+||-+|+-+.|||+++|++++.+.. ++|||.||+++|.|.++|.
T Consensus 26 g~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~-~lylvlEyv~gGELFdylv 104 (786)
T KOG0588|consen 26 GCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQ-HLYLVLEYVPGGELFDYLV 104 (786)
T ss_pred ceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCc-eEEEEEEecCCchhHHHHH
Confidence 35666665 8999999998643 678999999999999999999987654 8999999999999999998
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCCC------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATND------ 484 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~------ 484 (615)
.++. |+..+..+++.||..|+.|+|..+ |+||||||+|+|||.+.++||+|||+|.+...+
T Consensus 105 ~kG~----------l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeTS 171 (786)
T KOG0588|consen 105 RKGP----------LPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLETS 171 (786)
T ss_pred hhCC----------CCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCCcccccc
Confidence 7764 889999999999999999999998 999999999999999999999999999765322
Q ss_pred -----------------CCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCC
Q 047629 485 -----------------VMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLES 547 (615)
Q Consensus 485 -----------------~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~ 547 (615)
-..++||||+|||||-|+||+.||++.. ...+...++ .+. -
T Consensus 172 CGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN---ir~LLlKV~---------~G~----------f 229 (786)
T KOG0588|consen 172 CGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN---IRVLLLKVQ---------RGV----------F 229 (786)
T ss_pred CCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc---HHHHHHHHH---------cCc----------c
Confidence 2358999999999999999999998432 111111111 110 1
Q ss_pred CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047629 548 FYPIDGALSLATLARACTMDKSLSRPNMAEVVFNL 582 (615)
Q Consensus 548 ~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L 582 (615)
+.|.....+..+|+.+++..||++|.|++||+++-
T Consensus 230 ~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 230 EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 22344445568999999999999999999999974
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=268.07 Aligned_cols=210 Identities=24% Similarity=0.423 Sum_probs=169.1
Q ss_pred ceEEEEEE-CCeEEEEEEcc-------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCC
Q 047629 343 KSVYRATI-DGKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSK 414 (615)
Q Consensus 343 ~~Vy~~~~-~g~~vAvK~~~-------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~ 414 (615)
+.||+|.. +++.+|+|.++ .++..|+.++++++|+||+++++++.+. ...++||||+++|+|.+++.....
T Consensus 20 ~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~ 98 (261)
T cd05148 20 GEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVG-EPVYIITELMEKGSLLAFLRSPEG 98 (261)
T ss_pred ccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecC-CCeEEEEeecccCCHHHHHhcCCC
Confidence 48999998 67889999876 3467899999999999999999998754 478999999999999999976432
Q ss_pred CCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC------------
Q 047629 415 SSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------------ 482 (615)
Q Consensus 415 ~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------------ 482 (615)
. .+++.++..++.|++.||.|||+++ ++||||||+||++++++.+||+|||++....
T Consensus 99 ~--------~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~ 167 (261)
T cd05148 99 Q--------VLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIP 167 (261)
T ss_pred C--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccccccCCCCc
Confidence 1 3899999999999999999999988 9999999999999999999999999885431
Q ss_pred -----------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 483 -----------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 483 -----------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
...+.++||||||+++|||++ |+.|+......+. ... +. .......+
T Consensus 168 ~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~---~~~--------------~~----~~~~~~~~ 226 (261)
T cd05148 168 YKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV---YDQ--------------IT----AGYRMPCP 226 (261)
T ss_pred eEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH---HHH--------------HH----hCCcCCCC
Confidence 124568999999999999998 8888865432111 000 00 01111223
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 047629 551 IDGALSLATLARACTMDKSLSRPNMAEVVFNLSVL 585 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l 585 (615)
......+.+++.+||+.||.+|||++++++.|+.+
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 227 AKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 34455688999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=269.30 Aligned_cols=213 Identities=29% Similarity=0.395 Sum_probs=166.4
Q ss_pred ceEEEEEEC-------CeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATID-------GKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~~-------g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~ 407 (615)
+.||+|... +..||+|.+. .++..|+.++++++|+||+++++++.+. ...++||||+++|+|.+
T Consensus 20 g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~g~~L~~ 98 (277)
T cd05036 20 GEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER-LPRFILLELMAGGDLKS 98 (277)
T ss_pred CcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC-CCcEEEEecCCCCCHHH
Confidence 489999883 4679999875 2478899999999999999999988754 47899999999999999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCC---cEEEeecCCCCCCC--
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRF---KAKIANFSLAAPAT-- 482 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~---~~kl~DFGla~~~~-- 482 (615)
++........ ....++|.++++++.||+.||+|||+++ ++||||||+||+++.++ .+||+|||+++...
T Consensus 99 ~i~~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~ 172 (277)
T cd05036 99 FLRENRPRPE---RPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRA 172 (277)
T ss_pred HHHHhCCCCC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEeccCccccccCCc
Confidence 9976542211 1124899999999999999999999998 99999999999998754 69999999986431
Q ss_pred -----------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHh
Q 047629 483 -----------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLR 538 (615)
Q Consensus 483 -----------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 538 (615)
..++.++|||||||++|||++ |+.||......+. ..
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~---~~----------------- 232 (277)
T cd05036 173 SYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV---ME----------------- 232 (277)
T ss_pred cceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HH-----------------
Confidence 124568999999999999997 9889875432111 00
Q ss_pred hhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047629 539 NWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLS 583 (615)
Q Consensus 539 ~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~ 583 (615)
.+........+...+..+.+++.+|++.+|++||++.||++.|.
T Consensus 233 -~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 233 -FVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -HHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 01011111233444567899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=272.03 Aligned_cols=222 Identities=26% Similarity=0.410 Sum_probs=170.6
Q ss_pred ceEEEEEE-------CCeEEEEEEcc-------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHh
Q 047629 343 KSVYRATI-------DGKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKW 408 (615)
Q Consensus 343 ~~Vy~~~~-------~g~~vAvK~~~-------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~ 408 (615)
+.||++.. ++..+++|.++ +.+.+|++++++++|+||+++++++... ...++||||+++|+|.++
T Consensus 19 g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~ 97 (291)
T cd05094 19 GKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDG-DPLIMVFEYMKHGDLNKF 97 (291)
T ss_pred CeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC-CceEEEEecCCCCcHHHH
Confidence 47998874 34679999986 3577899999999999999999998754 478999999999999999
Q ss_pred hccCCCCCC------CCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC
Q 047629 409 LHPKSKSSS------SSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT 482 (615)
Q Consensus 409 L~~~~~~~~------~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~ 482 (615)
+........ .......++|.+++.++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++...
T Consensus 98 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~ 174 (291)
T cd05094 98 LRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVY 174 (291)
T ss_pred HHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEECCCCcccccC
Confidence 976432100 0000113899999999999999999999998 9999999999999999999999999985321
Q ss_pred -------------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHH
Q 047629 483 -------------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREER 536 (615)
Q Consensus 483 -------------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 536 (615)
..++.++||||||+++|||++ |+.|+......+ .+..
T Consensus 175 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~-------------- 237 (291)
T cd05094 175 STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---VIEC-------------- 237 (291)
T ss_pred CCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH--------------
Confidence 113568999999999999999 999986543211 1100
Q ss_pred HhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccch
Q 047629 537 LRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQST 589 (615)
Q Consensus 537 ~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~ 589 (615)
+..... ...+...+..+.+++.+||+.||++||++++|++.|..+....
T Consensus 238 ---~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~ 286 (291)
T cd05094 238 ---ITQGRV-LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKAT 286 (291)
T ss_pred ---HhCCCC-CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhc
Confidence 001000 1112233456889999999999999999999999999886653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=279.40 Aligned_cols=203 Identities=20% Similarity=0.300 Sum_probs=162.6
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
+.||++.. +|+.||||.++. .+.+|+.++++++||||+++++++.+. +..++||||+++|+|.+++.
T Consensus 32 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~ 110 (329)
T PTZ00263 32 GRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE-NRVYFLLEFVVGGELFTHLR 110 (329)
T ss_pred eEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC-CEEEEEEcCCCCChHHHHHH
Confidence 58999998 689999998863 356899999999999999999998754 47999999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC-------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------- 483 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------- 483 (615)
... .+++.....++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 111 ~~~----------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~g 177 (329)
T PTZ00263 111 KAG----------RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLCG 177 (329)
T ss_pred HcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCCcceecC
Confidence 643 2788899999999999999999998 99999999999999999999999999864321
Q ss_pred -------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 484 -------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 484 -------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
..+.++|||||||++|||++|+.||..... .... . .+ ....+ .++
T Consensus 178 t~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~---~-----------~i---~~~~~--~~p 235 (329)
T PTZ00263 178 TPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP---FRIY---E-----------KI---LAGRL--KFP 235 (329)
T ss_pred ChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH---HHHH---H-----------HH---hcCCc--CCC
Confidence 245689999999999999999999965331 1111 0 01 11111 122
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 047629 551 IDGALSLATLARACTMDKSLSRPN-----MAEVVFN 581 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RPs-----m~ev~~~ 581 (615)
......+.+++..||+.||.+||+ ++|++.+
T Consensus 236 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 236 NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 223345789999999999999997 6777755
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=271.83 Aligned_cols=209 Identities=21% Similarity=0.292 Sum_probs=164.3
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||++.. +|+.||+|.+.. .+.+|+.++.+++|+||+++.+++.+. +..++|+||+++|+|.+++.
T Consensus 14 g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~-~~~~lv~e~~~~g~L~~~~~ 92 (285)
T cd05631 14 GEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETK-DALCLVLTIMNGGDLKFHIY 92 (285)
T ss_pred EEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC-CeEEEEEEecCCCcHHHHHH
Confidence 48999987 789999998752 256799999999999999999988754 47999999999999998886
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
..... .+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++....
T Consensus 93 ~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 161 (285)
T cd05631 93 NMGNP--------GFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR 161 (285)
T ss_pred hhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecCC
Confidence 43321 3899999999999999999999998 9999999999999999999999999985421
Q ss_pred --------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCC
Q 047629 483 --------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESF 548 (615)
Q Consensus 483 --------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~ 548 (615)
..++.++|||||||++|||++|+.||......... ..+.. .+. ++ ...
T Consensus 162 ~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~----------~~~---~~--~~~ 223 (285)
T cd05631 162 VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR---EEVDR----------RVK---ED--QEE 223 (285)
T ss_pred CCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH---HHHHH----------Hhh---cc--ccc
Confidence 12456899999999999999999999765432111 00100 010 00 112
Q ss_pred CChHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 047629 549 YPIDGALSLATLARACTMDKSLSRPN-----MAEVVFN 581 (615)
Q Consensus 549 ~~~~~~~~l~~l~~~C~~~dP~~RPs-----m~ev~~~ 581 (615)
++.+....+.+|+..||+.||++||+ +.|+++.
T Consensus 224 ~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 224 YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 33334456789999999999999997 7888774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=266.74 Aligned_cols=206 Identities=26% Similarity=0.416 Sum_probs=165.3
Q ss_pred ceEEEEEE-CCeEEEEEEccH------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCC
Q 047629 343 KSVYRATI-DGKVLAVKKIKE------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKS 415 (615)
Q Consensus 343 ~~Vy~~~~-~g~~vAvK~~~~------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~ 415 (615)
+.||++.. ++..+|+|.+++ ++.+|++++++++|+||+++++++... +..++|+||+++++|.+++.....
T Consensus 18 ~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~- 95 (256)
T cd05059 18 GVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ-RPIFIVTEYMANGCLLNYLRERKG- 95 (256)
T ss_pred ceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCC-CceEEEEecCCCCCHHHHHHhccc-
Confidence 48999987 456899998752 577899999999999999999988654 478999999999999999975432
Q ss_pred CCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------------
Q 047629 416 SSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------------- 482 (615)
Q Consensus 416 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------------- 482 (615)
.++|..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 96 --------~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 164 (256)
T cd05059 96 --------KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFP 164 (256)
T ss_pred --------CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccccCCCCCC
Confidence 3899999999999999999999998 9999999999999999999999999875321
Q ss_pred -----------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 483 -----------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 483 -----------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
..++.++||||||+++|||++ |+.|+......+ ... .+.....+ ..+
T Consensus 165 ~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~--------------~~~~~~~~----~~~ 223 (256)
T cd05059 165 VKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VVE--------------SVSAGYRL----YRP 223 (256)
T ss_pred ccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HHH--------------HHHcCCcC----CCC
Confidence 123458999999999999999 788886543211 110 11111111 122
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047629 551 IDGALSLATLARACTMDKSLSRPNMAEVVFNL 582 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L 582 (615)
......+.+++.+||+.+|++||+|.|+++.|
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 224 KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 23455689999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-32 Score=267.35 Aligned_cols=229 Identities=22% Similarity=0.285 Sum_probs=173.0
Q ss_pred cccccccc----ceEEEEEE--CCeEEEEEEccHH---------HHHHHHHHHhcCCCCcccEEEEEEcCC-CcEEEEEe
Q 047629 335 LSEHYSIG----KSVYRATI--DGKVLAVKKIKED---------VTEELRILQRINHANLVKLMGVSSDSQ-GNRFLVYE 398 (615)
Q Consensus 335 ~~~~~~iG----~~Vy~~~~--~g~~vAvK~~~~~---------~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~~lV~E 398 (615)
|...++|+ |.||||.. +++.||+|+++.+ ..+||.+|.+++|||||.+..+....+ ...|+|||
T Consensus 78 fe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe 157 (419)
T KOG0663|consen 78 FEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVME 157 (419)
T ss_pred HHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHH
Confidence 33444554 58999997 7899999999743 468999999999999999988865432 35899999
Q ss_pred ecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCC
Q 047629 399 YAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA 478 (615)
Q Consensus 399 ~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla 478 (615)
||+. +|...++.-.. .+...+...++.|+++|+.|||+++ |+|||||++|+|+...|.+||+|||||
T Consensus 158 ~~Eh-DLksl~d~m~q---------~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLA 224 (419)
T KOG0663|consen 158 YVEH-DLKSLMETMKQ---------PFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLA 224 (419)
T ss_pred HHHh-hHHHHHHhccC---------CCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchh
Confidence 9987 99999987653 3888999999999999999999999 999999999999999999999999999
Q ss_pred CCCCCC------------------------CCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHH
Q 047629 479 APATND------------------------VMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKRE 534 (615)
Q Consensus 479 ~~~~~~------------------------~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 534 (615)
|..... +++..|+||+|||+.||+++++-|.+..+-+.. +.+...+.... +
T Consensus 225 R~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl---~~If~llGtPt--e 299 (419)
T KOG0663|consen 225 REYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQL---DKIFKLLGTPS--E 299 (419)
T ss_pred hhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHH---HHHHHHhCCCc--c
Confidence 876432 567899999999999999999888765542222 22222221100 0
Q ss_pred HHHhhhc--------------CCcCCCCCChH-HHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 535 ERLRNWM--------------DPNLESFYPID-GALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 535 ~~~~~~~--------------dp~l~~~~~~~-~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.....+- -..+...++.. ....-.+|....+..||.+|-|+.|.+++
T Consensus 300 ~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 300 AIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred ccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 0000000 01122222222 33556889999999999999999998875
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=277.65 Aligned_cols=224 Identities=21% Similarity=0.295 Sum_probs=165.4
Q ss_pred ceEEEEEE--CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATI--DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
|.||++.. +|..+|+|.++ ..+.+|+++|++++|+||+++++++... +..++||||+++|+|.+++...
T Consensus 19 g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~ 97 (331)
T cd06649 19 GVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-GEISICMEHMDGGSLDQVLKEA 97 (331)
T ss_pred EEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-CEEEEEeecCCCCcHHHHHHHc
Confidence 58999988 58899999875 3477899999999999999999998754 4799999999999999999764
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC----------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT---------- 482 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~---------- 482 (615)
. .+++..+..++.|++.||.|||+.+ .|+||||||+|||++.++.+||+|||+++...
T Consensus 98 ~----------~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~g~ 165 (331)
T cd06649 98 K----------RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGT 165 (331)
T ss_pred C----------CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccccccCCCC
Confidence 3 2889999999999999999999853 39999999999999999999999999985431
Q ss_pred -----------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHH-hHH--------------------
Q 047629 483 -----------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVL-KVE-------------------- 530 (615)
Q Consensus 483 -----------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~-~~~-------------------- 530 (615)
..++.++|||||||++|||++|+.||......+ +...+.... ...
T Consensus 166 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (331)
T cd06649 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSG 242 (331)
T ss_pred cCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccCcccccccccccc
Confidence 124568999999999999999999996543211 111000000 000
Q ss_pred --------HHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047629 531 --------EKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNL 582 (615)
Q Consensus 531 --------~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L 582 (615)
.........+................+.+++.+||+.||++|||++|++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 243 HGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred cccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0000000001110000000112334589999999999999999999999874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=274.78 Aligned_cols=237 Identities=22% Similarity=0.303 Sum_probs=174.4
Q ss_pred cccccccc----ceEEEEEE--CCeEEEEEEccHH---HHHHHHHHHhcCCCCcccEEEEEEcCCCc----EEEEEeecC
Q 047629 335 LSEHYSIG----KSVYRATI--DGKVLAVKKIKED---VTEELRILQRINHANLVKLMGVSSDSQGN----RFLVYEYAE 401 (615)
Q Consensus 335 ~~~~~~iG----~~Vy~~~~--~g~~vAvK~~~~~---~~~Ei~~l~~l~H~niv~l~g~~~~~~~~----~~lV~E~~~ 401 (615)
+.....+| |.||+|.. +++.||||+.-.+ -.+|+++|+++.|||||+|+-++....+. ..|||||||
T Consensus 26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP 105 (364)
T KOG0658|consen 26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP 105 (364)
T ss_pred EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhch
Confidence 34444555 58999998 6789999998644 45799999999999999999887643322 358999999
Q ss_pred CCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCC-CcEEEeecCCCCC
Q 047629 402 NGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSR-FKAKIANFSLAAP 480 (615)
Q Consensus 402 ~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~-~~~kl~DFGla~~ 480 (615)
. +|.++++.....+ ..++...+.-+..|+.+||.|||+++ |+||||||.|+|+|.+ +.+||+|||.|+.
T Consensus 106 ~-tL~~~~r~~~~~~------~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 106 E-TLYRVIRHYTRAN------QRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred H-HHHHHHHHHhhcC------CCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCccee
Confidence 7 9999998521111 12677778889999999999999988 9999999999999987 9999999999976
Q ss_pred CCC-----------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHH
Q 047629 481 ATN-----------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERL 537 (615)
Q Consensus 481 ~~~-----------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 537 (615)
... .++.+.||||.|||+.||+-|+.-|.+....+...+.-.+......++...-..
T Consensus 176 L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~ 255 (364)
T KOG0658|consen 176 LVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNP 255 (364)
T ss_pred eccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCc
Confidence 522 267899999999999999999998887554444433332322222222111111
Q ss_pred --hhhcCCcCCC-----CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 538 --RNWMDPNLES-----FYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 538 --~~~~dp~l~~-----~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.+.-.|.+.. .+......+.++|+.+++..+|.+|.++.|++.+
T Consensus 256 ~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 256 NYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred ccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 1222233321 1333455578999999999999999999998874
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=278.26 Aligned_cols=203 Identities=23% Similarity=0.305 Sum_probs=163.4
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||++.. +|+.||+|.++. .+.+|++++++++|+||+++.+++... +..++||||+++|+|.+++.
T Consensus 9 g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~ 87 (323)
T cd05571 9 GKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTH-DRLCFVMEYANGGELFFHLS 87 (323)
T ss_pred eEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcC-CEEEEEEeCCCCCcHHHHHH
Confidence 58999987 689999998863 245799999999999999999988754 47999999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
... .+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 88 ~~~----------~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 154 (323)
T cd05571 88 RER----------VFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred HcC----------CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccc
Confidence 643 3899999999999999999999998 9999999999999999999999999986421
Q ss_pred ---------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCC
Q 047629 483 ---------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLES 547 (615)
Q Consensus 483 ---------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~ 547 (615)
..++.++|||||||++|||++|+.||...... .... . ... -+.
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~----~---------~~~--~~~---- 212 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFE----L---------ILM--EEI---- 212 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH---HHHH----H---------HHc--CCC----
Confidence 12456899999999999999999999653311 0000 0 000 011
Q ss_pred CCChHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 047629 548 FYPIDGALSLATLARACTMDKSLSRP-----NMAEVVFN 581 (615)
Q Consensus 548 ~~~~~~~~~l~~l~~~C~~~dP~~RP-----sm~ev~~~ 581 (615)
.++......+.+++.+|++.||++|| ++.|++++
T Consensus 213 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 213 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 22333445678999999999999999 79998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=275.64 Aligned_cols=203 Identities=21% Similarity=0.307 Sum_probs=162.8
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||++.. +|+.||+|+++. .+.+|++++++++||||+++++++.+. ...++||||+++|+|.+++.
T Consensus 15 g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~ 93 (291)
T cd05612 15 GRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQ-RFLYMLMEYVPGGELFSYLR 93 (291)
T ss_pred eEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccC-CeEEEEEeCCCCCCHHHHHH
Confidence 48999987 589999999852 356799999999999999999987654 47899999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC-------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------- 483 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------- 483 (615)
... .+++.....++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++....
T Consensus 94 ~~~----------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~g 160 (291)
T cd05612 94 NSG----------RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCG 160 (291)
T ss_pred HcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCCcccccC
Confidence 654 2889999999999999999999998 99999999999999999999999999864321
Q ss_pred -------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 484 -------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 484 -------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
..+.++|||||||++|||++|+.||......+ .. ... .... ..++
T Consensus 161 t~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~---~~---~~i--------------~~~~--~~~~ 218 (291)
T cd05612 161 TPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG---IY---EKI--------------LAGK--LEFP 218 (291)
T ss_pred ChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH---HHH--------------HhCC--cCCC
Confidence 24568999999999999999999987543211 11 000 0000 1122
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 047629 551 IDGALSLATLARACTMDKSLSRPN-----MAEVVFN 581 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RPs-----m~ev~~~ 581 (615)
......+.+++++|++.||.+||+ +.|++++
T Consensus 219 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 219 RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 223446789999999999999995 7887765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=268.91 Aligned_cols=212 Identities=22% Similarity=0.377 Sum_probs=166.5
Q ss_pred ceEEEEEE--CCe----EEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHh
Q 047629 343 KSVYRATI--DGK----VLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKW 408 (615)
Q Consensus 343 ~~Vy~~~~--~g~----~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~ 408 (615)
+.||+|.+ +|+ .||+|.++ ..+.+|+.++..++|+||+++++++.. ...++++||+++|+|.++
T Consensus 21 g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~l~~~~~~~g~l~~~ 98 (279)
T cd05109 21 GTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT--STVQLVTQLMPYGCLLDY 98 (279)
T ss_pred ceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC--CCcEEEEEcCCCCCHHHH
Confidence 58999986 554 48999875 246789999999999999999999864 357899999999999999
Q ss_pred hccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC------
Q 047629 409 LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------ 482 (615)
Q Consensus 409 L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------ 482 (615)
++.... .+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 99 l~~~~~---------~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~ 166 (279)
T cd05109 99 VRENKD---------RIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEY 166 (279)
T ss_pred HhhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeeccccccee
Confidence 976432 3899999999999999999999998 9999999999999999999999999986431
Q ss_pred -------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcC
Q 047629 483 -------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMD 542 (615)
Q Consensus 483 -------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~d 542 (615)
..++.++||||||+++|||++ |+.|+....... . .. .+.....
T Consensus 167 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~----~~----------~~~~~~~ 229 (279)
T cd05109 167 HADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---I----PD----------LLEKGER 229 (279)
T ss_pred ecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---H----HH----------HHHCCCc
Confidence 113457899999999999998 888886433211 0 00 1111111
Q ss_pred CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccch
Q 047629 543 PNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQST 589 (615)
Q Consensus 543 p~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~ 589 (615)
+ ..+......+.+++..||+.||++||++.|+++.|..+....
T Consensus 230 ~----~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 230 L----PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred C----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 1 112233456889999999999999999999999998775443
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=269.68 Aligned_cols=217 Identities=24% Similarity=0.432 Sum_probs=166.4
Q ss_pred ceEEEEEE------CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHh
Q 047629 343 KSVYRATI------DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKW 408 (615)
Q Consensus 343 ~~Vy~~~~------~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~ 408 (615)
+.||+|.. .++.+|+|.++ ..+.+|++++++++|+||+++++++... ...++||||+++|+|.++
T Consensus 19 g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~~~L~~~ 97 (283)
T cd05090 19 GKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE-QPVCMLFEYLNQGDLHEF 97 (283)
T ss_pred cceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC-CceEEEEEcCCCCcHHHH
Confidence 48999985 45789999986 3577899999999999999999998754 478999999999999999
Q ss_pred hccCCCCCC-------CCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCC
Q 047629 409 LHPKSKSSS-------SSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA 481 (615)
Q Consensus 409 L~~~~~~~~-------~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~ 481 (615)
+........ .......+++.+++.++.|++.||.|||+++ ++||||||+|||+++++.+||+|||+++..
T Consensus 98 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~ 174 (283)
T cd05090 98 LIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREI 174 (283)
T ss_pred HHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCCcEEeccccccccc
Confidence 864321100 0000124889999999999999999999998 999999999999999999999999998542
Q ss_pred C-------------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHH
Q 047629 482 T-------------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREE 535 (615)
Q Consensus 482 ~-------------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 535 (615)
. ...+.++||||||+++|||++ |..|+...... . +.+
T Consensus 175 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---~----~~~---------- 237 (283)
T cd05090 175 YSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---E----VIE---------- 237 (283)
T ss_pred cCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---H----HHH----------
Confidence 1 124568999999999999999 88888643311 0 000
Q ss_pred HHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 047629 536 RLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSV 584 (615)
Q Consensus 536 ~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~ 584 (615)
.+.....+ ..+......+.+++.+||+.||++||++.+|.+.|..
T Consensus 238 ~~~~~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 238 MVRKRQLL----PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHcCCcC----CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 01100011 1223334568899999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=270.03 Aligned_cols=226 Identities=27% Similarity=0.395 Sum_probs=167.3
Q ss_pred ceEEEEEE------CCeEEEEEEcc-------HHHHHHHHHHHhcCCCCcccEEEEEEcCC-CcEEEEEeecCCCCHHHh
Q 047629 343 KSVYRATI------DGKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVSSDSQ-GNRFLVYEYAENGSLDKW 408 (615)
Q Consensus 343 ~~Vy~~~~------~g~~vAvK~~~-------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~~lV~E~~~~GsL~~~ 408 (615)
|.||++.+ +++.||+|+++ +.+.+|++++++++|+||+++.+++...+ ...++|+||+++|+|.++
T Consensus 18 g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 97 (284)
T cd05081 18 GSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDY 97 (284)
T ss_pred ceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHH
Confidence 58999874 47899999985 25778999999999999999999875433 358999999999999999
Q ss_pred hccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC------
Q 047629 409 LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------ 482 (615)
Q Consensus 409 L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------ 482 (615)
+..... .++|..+..++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++...
T Consensus 98 l~~~~~---------~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~ 165 (284)
T cd05081 98 LQKHRE---------RLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYY 165 (284)
T ss_pred HHhcCc---------CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccccCCCcce
Confidence 975432 3899999999999999999999998 9999999999999999999999999986431
Q ss_pred --------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcC
Q 047629 483 --------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMD 542 (615)
Q Consensus 483 --------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~d 542 (615)
...+.++|||||||++|||++|..+....... ....+...... ......+.+.+.
T Consensus 166 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----~~~~~~~~~~~-~~~~~~~~~~~~ 240 (284)
T cd05081 166 KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE----FMRMMGNDKQG-QMIVYHLIELLK 240 (284)
T ss_pred eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh----hhhhccccccc-ccchHHHHHHHh
Confidence 11345799999999999999988765432210 00000000000 000001111111
Q ss_pred CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 047629 543 PNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVL 585 (615)
Q Consensus 543 p~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l 585 (615)
.......+......+.+++.+||+.+|++||||+||++.|+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 241 NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 1111112233445689999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-31 Score=266.13 Aligned_cols=215 Identities=25% Similarity=0.385 Sum_probs=166.9
Q ss_pred ceEEEEEE--C---CeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCC-----cEEEEEeecCCC
Q 047629 343 KSVYRATI--D---GKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQG-----NRFLVYEYAENG 403 (615)
Q Consensus 343 ~~Vy~~~~--~---g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-----~~~lV~E~~~~G 403 (615)
|.||+|.. + +..||||+++ ..+.+|++.+++++|+||+++++++...+. ..++++||+++|
T Consensus 13 g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~ 92 (273)
T cd05035 13 GSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHG 92 (273)
T ss_pred ceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCC
Confidence 48999987 2 3679999875 246789999999999999999998865332 268999999999
Q ss_pred CHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-
Q 047629 404 SLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT- 482 (615)
Q Consensus 404 sL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~- 482 (615)
+|..++........ ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 93 ~l~~~l~~~~~~~~----~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 165 (273)
T cd05035 93 DLHSFLLYSRLGGL----PEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKKIYS 165 (273)
T ss_pred CHHHHHHHhhccCC----cccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCccceeeccc
Confidence 99999865432111 124899999999999999999999987 9999999999999999999999999986421
Q ss_pred ------------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHH
Q 047629 483 ------------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERL 537 (615)
Q Consensus 483 ------------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 537 (615)
...+.++||||||+++|||++ |..|+....+.+ ..+ .+
T Consensus 166 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~--------------~~ 228 (273)
T cd05035 166 GDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYD--------------YL 228 (273)
T ss_pred cccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHH--------------HH
Confidence 124568999999999999999 888886533211 000 01
Q ss_pred hhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 047629 538 RNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVL 585 (615)
Q Consensus 538 ~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l 585 (615)
.....+ ..+......+.+++.+||+.||++||++.|+++.|+.+
T Consensus 229 ~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 229 RHGNRL----KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HcCCCC----CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111111 12334455789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=267.43 Aligned_cols=219 Identities=22% Similarity=0.377 Sum_probs=170.7
Q ss_pred ceEEEEEE-C-----CeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHh
Q 047629 343 KSVYRATI-D-----GKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKW 408 (615)
Q Consensus 343 ~~Vy~~~~-~-----g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~ 408 (615)
+.||+|.. + +..|++|+++ ..+.+|+.++++++|+||+++++++...+...++++||+++|+|.++
T Consensus 20 g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~ 99 (280)
T cd05043 20 GRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLF 99 (280)
T ss_pred ceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHH
Confidence 48999997 3 5889999885 23678999999999999999999987655578999999999999999
Q ss_pred hccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC------
Q 047629 409 LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------ 482 (615)
Q Consensus 409 L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------ 482 (615)
+........ .....+++.++..++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++...
T Consensus 100 l~~~~~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 174 (280)
T cd05043 100 LQQCRLGEA--NNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHC 174 (280)
T ss_pred HHhcccccc--ccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCCCCcccccCCceEE
Confidence 976432110 01124899999999999999999999987 9999999999999999999999999987431
Q ss_pred -------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcC
Q 047629 483 -------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMD 542 (615)
Q Consensus 483 -------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~d 542 (615)
...+.++||||||+++||+++ |+.|+...... .... .+..-..
T Consensus 175 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~--------------~~~~~~~ 237 (280)
T cd05043 175 LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---EMAA--------------YLKDGYR 237 (280)
T ss_pred eCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH---HHHH--------------HHHcCCC
Confidence 113568999999999999999 99998653311 1111 0111011
Q ss_pred CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 047629 543 PNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQ 587 (615)
Q Consensus 543 p~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~ 587 (615)
+. .+......+.+++.+||+.||++|||+.|+++.|+.+.+
T Consensus 238 ~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 238 LA----QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CC----CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11 122234568999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=283.88 Aligned_cols=221 Identities=24% Similarity=0.352 Sum_probs=168.1
Q ss_pred ceEEEEEEC-------CeEEEEEEcc--------HHHHHHHHHHHhcC-CCCcccEEEEEEcCCCcEEEEEeecCCCCHH
Q 047629 343 KSVYRATID-------GKVLAVKKIK--------EDVTEELRILQRIN-HANLVKLMGVSSDSQGNRFLVYEYAENGSLD 406 (615)
Q Consensus 343 ~~Vy~~~~~-------g~~vAvK~~~--------~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~ 406 (615)
|.||+|+.. +..||||+++ +.+.+|+++|++++ ||||++++|+|.+. +..++||||+++|+|.
T Consensus 51 G~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~-~~~~lv~Ey~~~g~L~ 129 (400)
T cd05105 51 GKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS-GPIYIITEYCFYGDLV 129 (400)
T ss_pred ceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC-CceEEEEEecCCCcHH
Confidence 489999852 3469999985 34778999999996 99999999998754 4799999999999999
Q ss_pred HhhccCCCCCC-------------------------------------------C-------------------------
Q 047629 407 KWLHPKSKSSS-------------------------------------------S------------------------- 418 (615)
Q Consensus 407 ~~L~~~~~~~~-------------------------------------------~------------------------- 418 (615)
++|+....... .
T Consensus 130 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (400)
T cd05105 130 NYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYD 209 (400)
T ss_pred HHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCccc
Confidence 99875321000 0
Q ss_pred ------------------CCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCC
Q 047629 419 ------------------SGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAP 480 (615)
Q Consensus 419 ------------------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~ 480 (615)
......+++.+++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.
T Consensus 210 ~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~~~~~kL~DfGla~~ 286 (400)
T cd05105 210 RPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARD 286 (400)
T ss_pred ccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeCCCEEEEEeCCccee
Confidence 000124889999999999999999999988 99999999999999999999999999853
Q ss_pred CC-------------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHH
Q 047629 481 AT-------------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKRE 534 (615)
Q Consensus 481 ~~-------------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 534 (615)
.. ..++.++|||||||++|||++ |+.|+........ ...
T Consensus 287 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~--~~~------------- 351 (400)
T cd05105 287 IMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST--FYN------------- 351 (400)
T ss_pred ccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH--HHH-------------
Confidence 21 124568999999999999997 8888865332111 000
Q ss_pred HHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 047629 535 ERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQ 587 (615)
Q Consensus 535 ~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~ 587 (615)
.+..-..+ ..+......+.+++.+||+.||++||++.+|.+.|+.+.+
T Consensus 352 -~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 352 -KIKSGYRM----AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred -HHhcCCCC----CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 01111111 1223344568999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=261.71 Aligned_cols=207 Identities=26% Similarity=0.407 Sum_probs=166.2
Q ss_pred ceEEEEEE-CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATI-DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~-~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
+.||+|.. +++.+|+|.++ ..+.+|++++++++|+||+++++++... +..++||||+++|+|.+++....
T Consensus 9 g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~ 87 (250)
T cd05085 9 GEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQR-QPIYIVMELVPGGDFLSFLRKKK 87 (250)
T ss_pred ceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC-CccEEEEECCCCCcHHHHHHhcC
Confidence 48999987 67889999875 2467899999999999999999998754 47899999999999999997543
Q ss_pred CCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----------
Q 047629 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----------- 482 (615)
Q Consensus 414 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----------- 482 (615)
. .++|.++..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++....
T Consensus 88 ~---------~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 88 D---------ELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred C---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 2 3889999999999999999999988 9999999999999999999999999885321
Q ss_pred -------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCC
Q 047629 483 -------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESF 548 (615)
Q Consensus 483 -------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~ 548 (615)
...+.++||||||+++||+++ |+.|+........ . ..+..... ..
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~---~--------------~~~~~~~~----~~ 214 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA---R--------------EQVEKGYR----MS 214 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH---H--------------HHHHcCCC----CC
Confidence 113457999999999999999 9989865432110 0 01111111 12
Q ss_pred CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047629 549 YPIDGALSLATLARACTMDKSLSRPNMAEVVFNLS 583 (615)
Q Consensus 549 ~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~ 583 (615)
.+......+.+++.+|++.+|++||++.|+++.|.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 215 CPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 23334567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=274.61 Aligned_cols=203 Identities=19% Similarity=0.252 Sum_probs=161.1
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||++.. +++.||+|.++. .+.+|+.++.+++||||+++++++.+. +..++||||+++|+|.+++.
T Consensus 7 g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~ 85 (312)
T cd05585 7 GKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSP-EKLYLVLAFINGGELFHHLQ 85 (312)
T ss_pred eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecC-CeEEEEEcCCCCCcHHHHHH
Confidence 48999987 578999998863 245799999999999999999988754 47999999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 86 ~~~----------~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 152 (312)
T cd05585 86 REG----------RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT 152 (312)
T ss_pred hcC----------CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCCcccc
Confidence 643 2889999999999999999999998 9999999999999999999999999986421
Q ss_pred ---------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCC
Q 047629 483 ---------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLES 547 (615)
Q Consensus 483 ---------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~ 547 (615)
..++.++|||||||++|||++|+.||...... .. ... .... ..
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~---~~---~~~----------~~~~--~~---- 210 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN---EM---YRK----------ILQE--PL---- 210 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH---HH---HHH----------HHcC--CC----
Confidence 11456899999999999999999999753310 00 010 0110 11
Q ss_pred CCChHHHHHHHHHHHHhhhcCCCCCCC---HHHHHHH
Q 047629 548 FYPIDGALSLATLARACTMDKSLSRPN---MAEVVFN 581 (615)
Q Consensus 548 ~~~~~~~~~l~~l~~~C~~~dP~~RPs---m~ev~~~ 581 (615)
.++......+.+++..||+.||.+||+ +.|++.+
T Consensus 211 ~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 211 RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 123333456789999999999999985 5666553
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=263.96 Aligned_cols=211 Identities=27% Similarity=0.404 Sum_probs=163.4
Q ss_pred ceEEEEEE-----CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATI-----DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~-----~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
+.||+|.. ++..+|+|++. ..+.+|+.++++++|+||+++++++...++..++++||+++|+|.+++
T Consensus 9 g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 88 (262)
T cd05058 9 GCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFI 88 (262)
T ss_pred ceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHH
Confidence 48999986 23579999874 246679999999999999999998876566689999999999999999
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------- 482 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------- 482 (615)
..... .+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 89 ~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 89 RSETH---------NPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred HhcCC---------CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 75432 2678889999999999999999987 9999999999999999999999999986321
Q ss_pred --------------------CCCCCcccchhHHHHHHHHHcCCC-CCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhc
Q 047629 483 --------------------NDVMPKFDVFAFGVVLLELLSGKK-ATRTTENGKTAVLWKEIREVLKVEEKREERLRNWM 541 (615)
Q Consensus 483 --------------------~~~~~k~DV~SfGvvl~ElltG~~-p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 541 (615)
...+.++||||||+++|||++|+. |+..... .... . .+....
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~---~-----------~~~~~~ 219 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---FDIT---V-----------YLLQGR 219 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHH---H-----------HHhcCC
Confidence 113458999999999999999654 5543221 1111 0 011111
Q ss_pred CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 047629 542 DPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLT 586 (615)
Q Consensus 542 dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~ 586 (615)
.+.. +...+..+.+++..||+.+|++||++.||++.|+.+.
T Consensus 220 ~~~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 220 RLLQ----PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CCCC----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 1111 1222346889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=277.19 Aligned_cols=211 Identities=19% Similarity=0.279 Sum_probs=165.2
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||+|.. +|+.||||+++. .+.+|++++.+++|+||+++++++.+. ...++||||+++|+|.+++.
T Consensus 15 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-~~~~lv~e~~~g~~L~~~l~ 93 (333)
T cd05600 15 GQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDD-EYLYLAMEYVPGGDFRTLLN 93 (333)
T ss_pred eEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcC-CEEEEEEeCCCCCCHHHHHH
Confidence 58999998 589999999863 256799999999999999999998754 47999999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
... .+++.+...++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 94 ~~~----------~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~~~~~g 160 (333)
T cd05600 94 NLG----------VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVG 160 (333)
T ss_pred HcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCcccccccCCccc
Confidence 543 3889999999999999999999998 9999999999999999999999999986431
Q ss_pred ------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 483 ------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 483 ------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
..++.++|||||||++|||++|+.||......+ .+..+.. ....+.........
T Consensus 161 t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~~~~i~~-----------~~~~~~~~~~~~~~ 226 (333)
T cd05600 161 SPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE---TWENLKY-----------WKETLQRPVYDDPR 226 (333)
T ss_pred CccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH---HHHHHHh-----------ccccccCCCCCccc
Confidence 124678999999999999999999997543211 1111100 00111110000001
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 551 IDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
......+.+++.+|+..+|.+||+++|++++
T Consensus 227 ~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 227 FNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 1234567899999999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=280.22 Aligned_cols=203 Identities=24% Similarity=0.370 Sum_probs=158.8
Q ss_pred ceEEEEEE--CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATI--DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
|.||++.. +|+.||||.+. ..+.+|++++++++|+||+++++++.+ ++..++||||+++|+|.+..
T Consensus 88 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~~--- 163 (353)
T PLN00034 88 GTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDH-NGEIQVLLEFMDGGSLEGTH--- 163 (353)
T ss_pred eEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEecc-CCeEEEEEecCCCCcccccc---
Confidence 58999987 68999999884 347789999999999999999999865 45799999999999986432
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCCC--------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATND-------- 484 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~-------- 484 (615)
.+.+..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 164 -----------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 229 (353)
T PLN00034 164 -----------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV 229 (353)
T ss_pred -----------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccccccccc
Confidence 2567788899999999999999998 999999999999999999999999998642110
Q ss_pred --------------------CCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCc
Q 047629 485 --------------------VMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPN 544 (615)
Q Consensus 485 --------------------~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~ 544 (615)
.+.++|||||||++|||++|+.||......+...+. .. +.....+
T Consensus 230 gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~----~~----------~~~~~~~- 294 (353)
T PLN00034 230 GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLM----CA----------ICMSQPP- 294 (353)
T ss_pred cCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHH----HH----------HhccCCC-
Confidence 123799999999999999999999743322111110 00 0000011
Q ss_pred CCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 545 LESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 545 l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
..+......+.+|+.+||+.||++||++.|++++
T Consensus 295 ---~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 295 ---EAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ---CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1222344568999999999999999999999986
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=269.72 Aligned_cols=219 Identities=26% Similarity=0.442 Sum_probs=168.2
Q ss_pred ceEEEEEEC-------CeEEEEEEccH--------HHHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCHH
Q 047629 343 KSVYRATID-------GKVLAVKKIKE--------DVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLD 406 (615)
Q Consensus 343 ~~Vy~~~~~-------g~~vAvK~~~~--------~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~ 406 (615)
|.||++... ...+|+|.++. ++.+|++++.++ +|+||+++++++.. ++..+++|||+++|+|.
T Consensus 26 g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-~~~~~li~e~~~~~~L~ 104 (293)
T cd05053 26 GQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ-EGPLYVVVEYAAHGNLR 104 (293)
T ss_pred ccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC-CCCeEEEEEeCCCCcHH
Confidence 489998862 26799998752 367899999999 89999999999875 45799999999999999
Q ss_pred HhhccCCCCCCCC------CcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCC
Q 047629 407 KWLHPKSKSSSSS------GSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAP 480 (615)
Q Consensus 407 ~~L~~~~~~~~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~ 480 (615)
+++.......... .....++|..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 105 ~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~ 181 (293)
T cd05053 105 DFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLARD 181 (293)
T ss_pred HHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcCCCeEEeCccccccc
Confidence 9997542110000 01124899999999999999999999987 99999999999999999999999999864
Q ss_pred CC-------------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHH
Q 047629 481 AT-------------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKRE 534 (615)
Q Consensus 481 ~~-------------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 534 (615)
.. ...+.++|||||||++|||++ |..|+......+ .. .
T Consensus 182 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~----~--------- 245 (293)
T cd05053 182 IHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---LF----K--------- 245 (293)
T ss_pred cccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH---HH----H---------
Confidence 21 113457999999999999998 888886433111 00 0
Q ss_pred HHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 047629 535 ERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLT 586 (615)
Q Consensus 535 ~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~ 586 (615)
.+. .......+......+.+|+.+||+.||++||||.|+++.|+.+.
T Consensus 246 -~~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 246 -LLK----EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -HHH----cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 000 11111233344567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=264.10 Aligned_cols=208 Identities=27% Similarity=0.410 Sum_probs=166.7
Q ss_pred ceEEEEEE-CCeEEEEEEcc------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCC
Q 047629 343 KSVYRATI-DGKVLAVKKIK------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKS 415 (615)
Q Consensus 343 ~~Vy~~~~-~g~~vAvK~~~------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~ 415 (615)
|.||++.. +++.||+|.+. .++.+|+.++++++|+|++++++++. +...++++||+++|+|.+++......
T Consensus 20 g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~~~~~ 97 (260)
T cd05067 20 GEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT--QEPIYIITEYMENGSLVDFLKTPEGI 97 (260)
T ss_pred ceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc--cCCcEEEEEcCCCCCHHHHHHhcCCC
Confidence 58999988 77999999886 36789999999999999999999864 34689999999999999998654321
Q ss_pred CCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------------
Q 047629 416 SSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------------- 482 (615)
Q Consensus 416 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------------- 482 (615)
.+++.++..++.|++.||+|||+.+ ++||||||+||++++++.++++|||++....
T Consensus 98 --------~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 166 (260)
T cd05067 98 --------KLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFP 166 (260)
T ss_pred --------CCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccCCccc
Confidence 3899999999999999999999987 9999999999999999999999999985432
Q ss_pred -----------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 483 -----------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 483 -----------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
...+.++||||||+++||+++ |+.|+......+. .. .+.....+ ..+
T Consensus 167 ~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~--------------~~~~~~~~----~~~ 225 (260)
T cd05067 167 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV---IQ--------------NLERGYRM----PRP 225 (260)
T ss_pred ccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH---HH--------------HHHcCCCC----CCC
Confidence 113458999999999999999 9999865432111 10 01111111 112
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 047629 551 IDGALSLATLARACTMDKSLSRPNMAEVVFNLSV 584 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~ 584 (615)
......+.+++.+|++.+|++||++++++..|+.
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 226 DNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 2334568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=265.16 Aligned_cols=219 Identities=29% Similarity=0.500 Sum_probs=166.6
Q ss_pred ceEEEEEE--CCe--EEEEEEcc--------HHHHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATI--DGK--VLAVKKIK--------EDVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~--~g~--~vAvK~~~--------~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
+.||+|.. +|. .+|+|.++ ..+.+|++++.++ +|+||+++++++... +..++||||+++|+|.+++
T Consensus 9 g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~i 87 (270)
T cd05047 9 GQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-GYLYLAIEYAPHGNLLDFL 87 (270)
T ss_pred ceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC-CCceEEEEeCCCCcHHHHH
Confidence 48999987 343 57888875 2466899999999 899999999998754 4789999999999999999
Q ss_pred ccCCCCCCC------CCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCC--
Q 047629 410 HPKSKSSSS------SGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA-- 481 (615)
Q Consensus 410 ~~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~-- 481 (615)
......... ......+++.++..++.|++.||+|||+++ ++||||||+||++++++.+|++|||+++..
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfgl~~~~~~ 164 (270)
T cd05047 88 RKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEV 164 (270)
T ss_pred HhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCCCccccch
Confidence 764321000 011124889999999999999999999987 999999999999999999999999998421
Q ss_pred --------------------CCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhh
Q 047629 482 --------------------TNDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNW 540 (615)
Q Consensus 482 --------------------~~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 540 (615)
....+.++||||||+++|||++ |+.||......+ ... .+.
T Consensus 165 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~--------------~~~-- 225 (270)
T cd05047 165 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYE--------------KLP-- 225 (270)
T ss_pred hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---HHH--------------HHh--
Confidence 1124568999999999999997 999986433111 000 010
Q ss_pred cCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 047629 541 MDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLT 586 (615)
Q Consensus 541 ~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~ 586 (615)
.....+.+......+.+++.+||+.||.+||++.|++..|..+.
T Consensus 226 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 226 --QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred --CCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 11111122233446889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=270.97 Aligned_cols=212 Identities=27% Similarity=0.348 Sum_probs=163.4
Q ss_pred ceEEEEEE--CCeEEEEEEccH---------------------HHHHHHHHHHhcCCCCcccEEEEEEcCC-CcEEEEEe
Q 047629 343 KSVYRATI--DGKVLAVKKIKE---------------------DVTEELRILQRINHANLVKLMGVSSDSQ-GNRFLVYE 398 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~---------------------~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~~lV~E 398 (615)
|.|-.+.. +|+.||||.+.+ .+.+||.+|++++|+|||+|+.+..+.. ..+|||+|
T Consensus 111 GkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVle 190 (576)
T KOG0585|consen 111 GKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLE 190 (576)
T ss_pred ceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEE
Confidence 45655654 799999998842 4678999999999999999999865432 35899999
Q ss_pred ecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCC
Q 047629 399 YAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA 478 (615)
Q Consensus 399 ~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla 478 (615)
||..|.+... .... ..|+..+.++++.++..||+|||.++ ||||||||+|+||++++++||+|||.+
T Consensus 191 y~s~G~v~w~-p~d~---------~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~VKIsDFGVs 257 (576)
T KOG0585|consen 191 YCSKGEVKWC-PPDK---------PELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTVKISDFGVS 257 (576)
T ss_pred eccCCccccC-CCCc---------ccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcEEeecccee
Confidence 9999887432 1111 12899999999999999999999998 999999999999999999999999987
Q ss_pred CCCCC--------------------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHH
Q 047629 479 APATN--------------------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREV 526 (615)
Q Consensus 479 ~~~~~--------------------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 526 (615)
..... ....+.||||+||+||-|+.|+.||..... ..
T Consensus 258 ~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~---~~-------- 326 (576)
T KOG0585|consen 258 NEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE---LE-------- 326 (576)
T ss_pred eecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH---HH--------
Confidence 53300 013478999999999999999999975331 11
Q ss_pred HhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 047629 527 LKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQ 587 (615)
Q Consensus 527 ~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~ 587 (615)
...+++...|.-.-..+....+.+|++++++.||+.|.+..+|..+...-..
T Consensus 327 ---------l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 327 ---------LFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred ---------HHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 1223333333211122456678999999999999999999999988765544
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=270.27 Aligned_cols=222 Identities=31% Similarity=0.499 Sum_probs=169.0
Q ss_pred ceEEEEEE--CCe--EEEEEEccH--------HHHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATI--DGK--VLAVKKIKE--------DVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~--~g~--~vAvK~~~~--------~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
|.||+|.. +|. .+++|.++. .+.+|++++.++ +||||+++++++.+ .+..++|+||+++|+|.+++
T Consensus 16 g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l 94 (297)
T cd05089 16 GQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN-RGYLYIAIEYAPYGNLLDFL 94 (297)
T ss_pred ceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc-CCcceEEEEecCCCcHHHHH
Confidence 48999987 333 478888762 477899999999 79999999999865 44789999999999999999
Q ss_pred ccCCCCCCC------CCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-
Q 047629 410 HPKSKSSSS------SGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT- 482 (615)
Q Consensus 410 ~~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~- 482 (615)
......... ......+++.++..++.|++.||+|||+++ ++||||||+|||+++++.+||+|||++....
T Consensus 95 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 171 (297)
T cd05089 95 RKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSRGEEV 171 (297)
T ss_pred HhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeEEECCcCCCccccc
Confidence 764321100 001124899999999999999999999987 9999999999999999999999999874221
Q ss_pred ---------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhh
Q 047629 483 ---------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNW 540 (615)
Q Consensus 483 ---------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 540 (615)
..++.++|||||||++|||++ |+.||......+ ... .+..-
T Consensus 172 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~---~~~--------------~~~~~ 234 (297)
T cd05089 172 YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE---LYE--------------KLPQG 234 (297)
T ss_pred eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH--------------HHhcC
Confidence 124568999999999999998 999986543211 010 01111
Q ss_pred cCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccch
Q 047629 541 MDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQST 589 (615)
Q Consensus 541 ~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~ 589 (615)
..+ ..+......+.+++.+||+.+|.+||++.++++.|..+.+..
T Consensus 235 ~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 235 YRM----EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred CCC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 111 122333456889999999999999999999999998777543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=268.23 Aligned_cols=222 Identities=26% Similarity=0.410 Sum_probs=169.9
Q ss_pred ceEEEEEE-------CCeEEEEEEcc-------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHh
Q 047629 343 KSVYRATI-------DGKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKW 408 (615)
Q Consensus 343 ~~Vy~~~~-------~g~~vAvK~~~-------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~ 408 (615)
+.||++.. ++..+|+|.++ +.+.+|++++++++|+||+++++++... +..++||||+++|+|.++
T Consensus 19 ~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~ 97 (288)
T cd05093 19 GKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG-DPLIMVFEYMKHGDLNKF 97 (288)
T ss_pred eeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC-CccEEEEEcCCCCCHHHH
Confidence 47998874 34668999885 2477899999999999999999998754 478999999999999999
Q ss_pred hccCCCCCC---CCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC---
Q 047629 409 LHPKSKSSS---SSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT--- 482 (615)
Q Consensus 409 L~~~~~~~~---~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~--- 482 (615)
+........ .......++|.+++.++.|++.||+|||+++ ++||||||+|||+++++.+||+|||+++...
T Consensus 98 i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 174 (288)
T cd05093 98 LRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD 174 (288)
T ss_pred HHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEeccCCccccccCCc
Confidence 975432100 0011124899999999999999999999998 9999999999999999999999999986321
Q ss_pred ----------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhh
Q 047629 483 ----------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRN 539 (615)
Q Consensus 483 ----------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 539 (615)
...+.++||||||+++|||++ |+.|+......+ ... .+..
T Consensus 175 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~~~--------------~i~~ 237 (288)
T cd05093 175 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIE--------------CITQ 237 (288)
T ss_pred eeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH--------------HHHc
Confidence 113568999999999999998 888886543211 000 0110
Q ss_pred hcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccch
Q 047629 540 WMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQST 589 (615)
Q Consensus 540 ~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~ 589 (615)
-..+.. +......+.+++.+||+.||.+|||+.|+...|+.+....
T Consensus 238 ~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 238 GRVLQR----PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred CCcCCC----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 001111 1223346899999999999999999999999999887553
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=284.44 Aligned_cols=206 Identities=25% Similarity=0.384 Sum_probs=172.3
Q ss_pred ceEEEEEEC---C--eEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATID---G--KVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~~---g--~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
|.|++|.|+ | -.||||.++ .+|.+|+.+|.+|+|+|+++|+|+..+ ....+|+|.++.|||.+.|
T Consensus 124 gvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~--qp~mMV~ELaplGSLldrL 201 (1039)
T KOG0199|consen 124 GVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD--QPAMMVFELAPLGSLLDRL 201 (1039)
T ss_pred eeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc--chhhHHhhhcccchHHHHH
Confidence 589999993 4 458999987 479999999999999999999999875 3688999999999999999
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------ 483 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------ 483 (615)
+..... .|-...+..++.|||.||.||.+++ +|||||.++|+||-..-.+||+||||.+.+..
T Consensus 202 rka~~~--------~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yv 270 (1039)
T KOG0199|consen 202 RKAKKA--------ILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYV 270 (1039)
T ss_pred hhcccc--------ceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcceE
Confidence 873221 3778889999999999999999998 99999999999999999999999999987632
Q ss_pred --------------------CCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcC
Q 047629 484 --------------------DVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMD 542 (615)
Q Consensus 484 --------------------~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~d 542 (615)
.++.++|||+|||+||||+| |..||.+.... .+.+.+|
T Consensus 271 m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~---------------------qIL~~iD 329 (1039)
T KOG0199|consen 271 MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI---------------------QILKNID 329 (1039)
T ss_pred ecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH---------------------HHHHhcc
Confidence 25679999999999999999 77898764421 1222333
Q ss_pred CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047629 543 PNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNL 582 (615)
Q Consensus 543 p~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L 582 (615)
.+-.-.-|..|.+.+.++++.||..+|.+||++..|.+.+
T Consensus 330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 3222345778899999999999999999999999998654
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=263.71 Aligned_cols=216 Identities=22% Similarity=0.326 Sum_probs=168.6
Q ss_pred ceEEEEEE--CCeEEEEEEcc----------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIK----------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~----------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
+.||+|.. +|+.||||.++ ..+.+|++++++++|+||+++++++.+. +..++|+||+++|+|.+++.
T Consensus 16 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~ 94 (267)
T cd08228 16 SEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED-NELNIVLELADAGDLSQMIK 94 (267)
T ss_pred eeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC-CeEEEEEEecCCCcHHHHHH
Confidence 47999987 78999999763 2467899999999999999999988754 47899999999999999886
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
...... ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++....
T Consensus 95 ~~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~ 165 (267)
T cd08228 95 YFKKQK------RLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS 165 (267)
T ss_pred Hhhhcc------CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccchhHHHhc
Confidence 432211 13789999999999999999999998 9999999999999999999999999875421
Q ss_pred ---------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCC
Q 047629 483 ---------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLES 547 (615)
Q Consensus 483 ---------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~ 547 (615)
...+.++||||||+++|||++|+.|+....... .... ..+.....+.+
T Consensus 166 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~--------------~~~~~~~~~~~-- 228 (267)
T cd08228 166 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-FSLC--------------QKIEQCDYPPL-- 228 (267)
T ss_pred CCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH-HHHH--------------HHHhcCCCCCC--
Confidence 123567999999999999999999986433110 0000 11111111211
Q ss_pred CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 047629 548 FYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLT 586 (615)
Q Consensus 548 ~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~ 586 (615)
.+......+.+++.+||+.+|++||++.||++.|+.+.
T Consensus 229 -~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 229 -PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred -ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 12234456899999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=262.11 Aligned_cols=208 Identities=25% Similarity=0.375 Sum_probs=165.9
Q ss_pred ceEEEEEE--C---CeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATI--D---GKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~--~---g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
|.||+|.+ . +..+|+|.++ +++.+|++++++++|+||+++++++.. ...++||||+++|+|.+++
T Consensus 9 g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~~~~~~L~~~l 86 (257)
T cd05060 9 GSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG--EPLMLVMELAPLGPLLKYL 86 (257)
T ss_pred eeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC--CceEEEEEeCCCCcHHHHH
Confidence 48999986 2 2689999875 246789999999999999999998753 3689999999999999999
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------- 482 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------- 482 (615)
.... .+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++...
T Consensus 87 ~~~~----------~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 87 KKRR----------EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred HhCC----------CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 7654 2899999999999999999999998 9999999999999999999999999985331
Q ss_pred -------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcC
Q 047629 483 -------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMD 542 (615)
Q Consensus 483 -------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~d 542 (615)
...+.++||||||+++|||++ |+.|+...... .....+. ...
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~~~--------------~~~- 215 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAMLE--------------SGE- 215 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHH--------------cCC-
Confidence 113458999999999999998 99998654321 1111110 000
Q ss_pred CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 047629 543 PNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLT 586 (615)
Q Consensus 543 p~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~ 586 (615)
....+......+.+++.+||+.+|++||++.|+++.|+.+.
T Consensus 216 ---~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 216 ---RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred ---cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 01123334456889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=270.33 Aligned_cols=211 Identities=26% Similarity=0.418 Sum_probs=165.7
Q ss_pred ceEEEEEE-------CCeEEEEEEccH--------HHHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCHH
Q 047629 343 KSVYRATI-------DGKVLAVKKIKE--------DVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLD 406 (615)
Q Consensus 343 ~~Vy~~~~-------~g~~vAvK~~~~--------~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~ 406 (615)
+.||++.. .+..+|||.++. .+.+|+++++++ +|+||+++++++... +..++||||+++|+|.
T Consensus 49 g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~ 127 (302)
T cd05055 49 GKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG-GPILVITEYCCYGDLL 127 (302)
T ss_pred eeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC-CceEEEEEcCCCCcHH
Confidence 47898864 345799998752 477899999999 899999999998754 4799999999999999
Q ss_pred HhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC---
Q 047629 407 KWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN--- 483 (615)
Q Consensus 407 ~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~--- 483 (615)
+++...... .+++.++..++.|++.||.|||+++ ++|+||||+|||++.++.+|++|||+++....
T Consensus 128 ~~i~~~~~~--------~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~ 196 (302)
T cd05055 128 NFLRRKRES--------FLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSN 196 (302)
T ss_pred HHHHhCCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccccccCCCc
Confidence 999754321 3899999999999999999999987 99999999999999999999999999864211
Q ss_pred ----------------------CCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhh
Q 047629 484 ----------------------DVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNW 540 (615)
Q Consensus 484 ----------------------~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 540 (615)
..+.++|||||||++|||++ |+.|+........ +.. .
T Consensus 197 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~------~~~--------------~ 256 (302)
T cd05055 197 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK------FYK--------------L 256 (302)
T ss_pred eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH------HHH--------------H
Confidence 13457899999999999998 9999865432111 000 0
Q ss_pred cCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 047629 541 MDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVL 585 (615)
Q Consensus 541 ~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l 585 (615)
++.......+......+.+++.+|++.+|++||++.|+++.|.++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 257 IKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 111111111222345689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-31 Score=271.46 Aligned_cols=223 Identities=29% Similarity=0.499 Sum_probs=169.2
Q ss_pred ceEEEEEE--CCe--EEEEEEccH--------HHHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATI--DGK--VLAVKKIKE--------DVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~--~g~--~vAvK~~~~--------~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
|.||+|.. +|. .+|+|.++. .+.+|++++.++ +|+||+++++++.. ++..++|+||+++|+|.+++
T Consensus 21 g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l 99 (303)
T cd05088 21 GQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-RGYLYLAIEYAPHGNLLDFL 99 (303)
T ss_pred ceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC-CCCceEEEEeCCCCcHHHHH
Confidence 48999987 453 468887652 467899999999 89999999999865 45799999999999999999
Q ss_pred ccCCCCCCC------CCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-
Q 047629 410 HPKSKSSSS------SGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT- 482 (615)
Q Consensus 410 ~~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~- 482 (615)
+........ ......+++.+++.++.|++.||+|||+++ ++||||||+|||+++++.+||+|||+++...
T Consensus 100 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 176 (303)
T cd05088 100 RKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEV 176 (303)
T ss_pred HhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcEEeCccccCcccch
Confidence 764321100 001124899999999999999999999998 9999999999999999999999999985321
Q ss_pred ---------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhh
Q 047629 483 ---------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNW 540 (615)
Q Consensus 483 ---------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 540 (615)
...+.++|||||||++|||+| |..||......+ .. . .+...
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~---~-----------~~~~~ 239 (303)
T cd05088 177 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LY---E-----------KLPQG 239 (303)
T ss_pred hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH---HH---H-----------HHhcC
Confidence 124578999999999999998 999986433211 00 0 01110
Q ss_pred cCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccchh
Q 047629 541 MDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQSTE 590 (615)
Q Consensus 541 ~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~~ 590 (615)
.....+......+.+++.+||+.+|++||++.++++.|..+.+...
T Consensus 240 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 240 ----YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred ----CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 1111122233467899999999999999999999999987765543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=261.82 Aligned_cols=206 Identities=30% Similarity=0.435 Sum_probs=164.8
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
+.||++.. +|+.|++|.+. ..+.+|++++++++|+|++++++++.+. +..++||||+++++|.+++..
T Consensus 14 ~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~ 92 (256)
T cd08529 14 GVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK-GKLNIVMEYAENGDLHKLLKM 92 (256)
T ss_pred eEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC-CEEEEEEEeCCCCcHHHHHHH
Confidence 48999987 68999999874 2467899999999999999999998754 479999999999999999976
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC---------
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT--------- 482 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~--------- 482 (615)
.... .+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++...
T Consensus 93 ~~~~--------~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~ 161 (256)
T cd08529 93 QRGR--------PLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI 161 (256)
T ss_pred hcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccchhhcc
Confidence 4221 3899999999999999999999987 9999999999999999999999999876431
Q ss_pred --------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCC
Q 047629 483 --------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESF 548 (615)
Q Consensus 483 --------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~ 548 (615)
...+.++||||||+++|||++|+.|+...... .... ....... +.+
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~-------------~~~~~~~-~~~--- 221 (256)
T cd08529 162 VGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---ALIL-------------KIIRGVF-PPV--- 221 (256)
T ss_pred ccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHHH-------------HHHcCCC-CCC---
Confidence 11356899999999999999999998654311 1000 0011111 111
Q ss_pred CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 549 YPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 549 ~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
+......+.+++.+||+.+|++||+|.|+++.
T Consensus 222 -~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 222 -SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 22334568999999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=265.93 Aligned_cols=205 Identities=23% Similarity=0.347 Sum_probs=161.6
Q ss_pred ccccccccc----ceEEEEEE--CCeEEEEEEccHH----------HHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEE
Q 047629 334 NLSEHYSIG----KSVYRATI--DGKVLAVKKIKED----------VTEELRILQRINHANLVKLMGVSSDSQGNRFLVY 397 (615)
Q Consensus 334 ~~~~~~~iG----~~Vy~~~~--~g~~vAvK~~~~~----------~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~ 397 (615)
+|.-...+| |.||.... +|+.+|+|+|++. ..+|..+|.+++||.||+|+-.+.+ .+.+|||+
T Consensus 26 dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt-~~kLylVl 104 (357)
T KOG0598|consen 26 DFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQT-EEKLYLVL 104 (357)
T ss_pred heeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEeccc-CCeEEEEE
Confidence 344444555 47887775 7899999999743 5679999999999999999977664 45899999
Q ss_pred eecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCC
Q 047629 398 EYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSL 477 (615)
Q Consensus 398 E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGl 477 (615)
||+.||.|..+|.+... +++....-++..|+.||.|||+++ ||||||||+|||||.+|.++|+||||
T Consensus 105 d~~~GGeLf~hL~~eg~----------F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL 171 (357)
T KOG0598|consen 105 DYLNGGELFYHLQREGR----------FSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGL 171 (357)
T ss_pred eccCCccHHHHHHhcCC----------cchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEecccc
Confidence 99999999999987653 888888999999999999999998 99999999999999999999999999
Q ss_pred CCCCC-----------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHH
Q 047629 478 AAPAT-----------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKRE 534 (615)
Q Consensus 478 a~~~~-----------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 534 (615)
++... ..++..+|.||+|+++|||++|.+||....... .+...
T Consensus 172 ~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~------~~~~I-------- 237 (357)
T KOG0598|consen 172 CKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK------MYDKI-------- 237 (357)
T ss_pred chhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH------HHHHH--------
Confidence 97431 125678999999999999999999997644211 11111
Q ss_pred HHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCC
Q 047629 535 ERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRP 573 (615)
Q Consensus 535 ~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RP 573 (615)
...++ ...+.-......++++..+..||++|-
T Consensus 238 ------~~~k~-~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 238 ------LKGKL-PLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ------hcCcC-CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 11111 112222334568999999999999995
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=270.16 Aligned_cols=224 Identities=20% Similarity=0.262 Sum_probs=161.9
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
+.||++.. +++.||+|+++ +.+.+|++++++++|+||+++++++.. ++..++||||++++.+..+...
T Consensus 15 ~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~l~~~~~~ 93 (287)
T cd07848 15 GVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR-RGKLYLVFEYVEKNMLELLEEM 93 (287)
T ss_pred EEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec-CCEEEEEEecCCCCHHHHHHhc
Confidence 47999998 57899999875 236789999999999999999998865 4579999999998877655433
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC---------
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT--------- 482 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~--------- 482 (615)
.. .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 94 ~~----------~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (287)
T cd07848 94 PN----------GVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTE 160 (287)
T ss_pred CC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccc
Confidence 22 3889999999999999999999998 9999999999999999999999999986431
Q ss_pred ---------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHH----HHHHhhhcCC
Q 047629 483 ---------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKR----EERLRNWMDP 543 (615)
Q Consensus 483 ---------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~----~~~~~~~~dp 543 (615)
..++.++|||||||++|||++|+.||......+...........+...... .........|
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (287)
T cd07848 161 YVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFP 240 (287)
T ss_pred cccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccC
Confidence 124568999999999999999999997644322111111000000000000 0000000001
Q ss_pred cCCC------CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047629 544 NLES------FYPIDGALSLATLARACTMDKSLSRPNMAEVVF 580 (615)
Q Consensus 544 ~l~~------~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~ 580 (615)
.... .+.......+.++++.|++.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 241 AVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1100 111123346899999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=263.45 Aligned_cols=209 Identities=26% Similarity=0.456 Sum_probs=165.8
Q ss_pred ceEEEEEE--CC---eEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATI--DG---KVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~--~g---~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
+.||+|.. +| ..||||.++ .++..|+.++++++||||+++.+++.+ ++..++||||+++|+|.+++
T Consensus 18 g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l 96 (269)
T cd05065 18 GEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-SRPVMIITEFMENGALDSFL 96 (269)
T ss_pred CeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECC-CCceEEEEecCCCCcHHHHH
Confidence 58999987 33 369999975 257789999999999999999998764 44789999999999999999
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------- 482 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------- 482 (615)
..... .+++.+++.++.|++.||+|||+++ ++||||||+||+++.++.+|++|||+++...
T Consensus 97 ~~~~~---------~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 164 (269)
T cd05065 97 RQNDG---------QFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT 164 (269)
T ss_pred hhCCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccCccccc
Confidence 76432 2899999999999999999999998 9999999999999999999999999875321
Q ss_pred ---------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhh
Q 047629 483 ---------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNW 540 (615)
Q Consensus 483 ---------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 540 (615)
..++.++||||||+++||+++ |+.|+......+ ... .+...
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~--------------~i~~~ 227 (269)
T cd05065 165 YTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VIN--------------AIEQD 227 (269)
T ss_pred cccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHH--------------HHHcC
Confidence 113457999999999999887 999986543211 110 11111
Q ss_pred cCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 047629 541 MDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVL 585 (615)
Q Consensus 541 ~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l 585 (615)
.. -..+.+.+..+.+++..||+.+|.+||+|++|+..|+.+
T Consensus 228 ~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 YR----LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred Cc----CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11 111234455688999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=264.02 Aligned_cols=216 Identities=22% Similarity=0.330 Sum_probs=168.9
Q ss_pred ceEEEEEE--CCeEEEEEEcc----------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIK----------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~----------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
+.||++.. +|+.+|||.+. .++.+|+.++++++|+||+++++++.+. +..+++|||+++++|.+++.
T Consensus 16 g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~ 94 (267)
T cd08229 16 SEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED-NELNIVLELADAGDLSRMIK 94 (267)
T ss_pred eEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeC-CeEEEEEEecCCCCHHHHHH
Confidence 47999986 78999999764 2467899999999999999999998754 47899999999999999986
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
...... ..++|.++..++.|++.||.|||+++ ++|+||||+||+++.++.++++|||++....
T Consensus 95 ~~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 165 (267)
T cd08229 95 HFKKQK------RLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS 165 (267)
T ss_pred HhhccC------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccccCCccccc
Confidence 432211 13899999999999999999999998 9999999999999999999999999875321
Q ss_pred ---------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCC
Q 047629 483 ---------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLES 547 (615)
Q Consensus 483 ---------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~ 547 (615)
...+.++||||||+++|||++|..|+....... ... ...+.....+.+.
T Consensus 166 ~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~-----------~~~~~~~~~~~~~- 229 (267)
T cd08229 166 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YSL-----------CKKIEQCDYPPLP- 229 (267)
T ss_pred ccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH----HHH-----------hhhhhcCCCCCCC-
Confidence 123457999999999999999999986432210 000 0111111222221
Q ss_pred CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 047629 548 FYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLT 586 (615)
Q Consensus 548 ~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~ 586 (615)
+......+.+++.+||+.||++||||.+|++.++++.
T Consensus 230 --~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 230 --SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred --cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 1234456889999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=280.55 Aligned_cols=220 Identities=24% Similarity=0.404 Sum_probs=168.6
Q ss_pred ceEEEEEEC-------CeEEEEEEccH--------HHHHHHHHHHhcC-CCCcccEEEEEEcCCCcEEEEEeecCCCCHH
Q 047629 343 KSVYRATID-------GKVLAVKKIKE--------DVTEELRILQRIN-HANLVKLMGVSSDSQGNRFLVYEYAENGSLD 406 (615)
Q Consensus 343 ~~Vy~~~~~-------g~~vAvK~~~~--------~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~ 406 (615)
|.||+|.+. ++.||||+++. .+.+|+++|.++. |+||++++|+|... +..++|+||+++|+|.
T Consensus 51 G~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~-~~~~iv~E~~~~g~L~ 129 (401)
T cd05107 51 GRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG-GPIYIITEYCRYGDLV 129 (401)
T ss_pred eeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC-CCcEEEEeccCCCcHH
Confidence 489999863 36899999862 4678999999997 99999999998754 4789999999999999
Q ss_pred HhhccCCCCC----------------------------------------------------------------------
Q 047629 407 KWLHPKSKSS---------------------------------------------------------------------- 416 (615)
Q Consensus 407 ~~L~~~~~~~---------------------------------------------------------------------- 416 (615)
++++......
T Consensus 130 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (401)
T cd05107 130 DYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNY 209 (401)
T ss_pred HHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCc
Confidence 9997543100
Q ss_pred ------------------CCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCC
Q 047629 417 ------------------SSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA 478 (615)
Q Consensus 417 ------------------~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla 478 (615)
........++|.+++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl~~~~~~kL~DfGla 286 (401)
T cd05107 210 ESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLA 286 (401)
T ss_pred CCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEEeCCCEEEEEecCcc
Confidence 00011134789999999999999999999887 999999999999999999999999998
Q ss_pred CCCC-------------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHH
Q 047629 479 APAT-------------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEK 532 (615)
Q Consensus 479 ~~~~-------------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 532 (615)
+... ..++.++|||||||++|||++ |+.|+......+. .. .
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~--~~----~------- 353 (401)
T cd05107 287 RDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ--FY----N------- 353 (401)
T ss_pred eecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH--HH----H-------
Confidence 6421 113567999999999999998 8888865432111 00 0
Q ss_pred HHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 047629 533 REERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLT 586 (615)
Q Consensus 533 ~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~ 586 (615)
.+ ........+......+.+++..||+.+|.+||+++||++.|+.+.
T Consensus 354 ---~~----~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 354 ---AI----KRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred ---HH----HcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 00 111111223334567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=261.41 Aligned_cols=208 Identities=27% Similarity=0.417 Sum_probs=165.0
Q ss_pred ceEEEEEE-CCeEEEEEEcc------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCC
Q 047629 343 KSVYRATI-DGKVLAVKKIK------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKS 415 (615)
Q Consensus 343 ~~Vy~~~~-~g~~vAvK~~~------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~ 415 (615)
+.||++.. .+..+|+|.+. +.+.+|+.++++++|+|++++++++. ++..+++|||+++|+|.+++......
T Consensus 20 ~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~~~~~ 97 (260)
T cd05069 20 GEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS--EEPIYIVTEFMGKGSLLDFLKEGDGK 97 (260)
T ss_pred CeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc--CCCcEEEEEcCCCCCHHHHHhhCCCC
Confidence 48999988 44579999875 35788999999999999999999874 34689999999999999999764321
Q ss_pred CCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------------
Q 047629 416 SSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------------- 482 (615)
Q Consensus 416 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------------- 482 (615)
.++|..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 98 --------~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 166 (260)
T cd05069 98 --------YLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFP 166 (260)
T ss_pred --------CCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCCccc
Confidence 3889999999999999999999987 9999999999999999999999999985421
Q ss_pred -----------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 483 -----------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 483 -----------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
...+.++||||||+++|||++ |+.|+......+ ... .+.....+ ..+
T Consensus 167 ~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~--------------~~~~~~~~----~~~ 225 (260)
T cd05069 167 IKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLE--------------QVERGYRM----PCP 225 (260)
T ss_pred hhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH--------------HHHcCCCC----CCC
Confidence 113457899999999999999 888886543211 110 01111111 122
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 047629 551 IDGALSLATLARACTMDKSLSRPNMAEVVFNLSV 584 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~ 584 (615)
.+....+.+++.+||+.||++||++++|++.|+.
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 226 QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 3345568999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=275.49 Aligned_cols=222 Identities=26% Similarity=0.377 Sum_probs=167.6
Q ss_pred ceEEEEEE-------CCeEEEEEEccH--------HHHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCHH
Q 047629 343 KSVYRATI-------DGKVLAVKKIKE--------DVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLD 406 (615)
Q Consensus 343 ~~Vy~~~~-------~g~~vAvK~~~~--------~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~ 406 (615)
|.||+|.. +++.||||+++. .+.+|++++.++ +|+||++++++|...+...+++|||+++|+|.
T Consensus 21 g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~ 100 (343)
T cd05103 21 GQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLS 100 (343)
T ss_pred ceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHH
Confidence 58999873 468899999852 366899999999 78999999998876555689999999999999
Q ss_pred HhhccCCCCCCC---------------------------------------------------------CCcccccCHHH
Q 047629 407 KWLHPKSKSSSS---------------------------------------------------------SGSVIFLTWSQ 429 (615)
Q Consensus 407 ~~L~~~~~~~~~---------------------------------------------------------~~~~~~l~~~~ 429 (615)
+++......... ......++|.+
T Consensus 101 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (343)
T cd05103 101 NYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLED 180 (343)
T ss_pred HHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHH
Confidence 998753210000 00012378999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------------------------CC
Q 047629 430 RLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------------------------ND 484 (615)
Q Consensus 430 ~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------------------------~~ 484 (615)
+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++... ..
T Consensus 181 ~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 257 (343)
T cd05103 181 LICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV 257 (343)
T ss_pred HHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCC
Confidence 9999999999999999998 9999999999999999999999999885421 12
Q ss_pred CCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHH
Q 047629 485 VMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARA 563 (615)
Q Consensus 485 ~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~ 563 (615)
++.++||||||+++|||++ |..|+........ +... +.+-..+.. +......+.+++..
T Consensus 258 ~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~------~~~~----------~~~~~~~~~----~~~~~~~~~~~~~~ 317 (343)
T cd05103 258 YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRR----------LKEGTRMRA----PDYTTPEMYQTMLD 317 (343)
T ss_pred CCchhhHHHHHHHHHHHHHCCCCCCCCccccHH------HHHH----------HhccCCCCC----CCCCCHHHHHHHHH
Confidence 3568999999999999997 8888865432111 0000 000001111 11122357899999
Q ss_pred hhhcCCCCCCCHHHHHHHHHhccc
Q 047629 564 CTMDKSLSRPNMAEVVFNLSVLTQ 587 (615)
Q Consensus 564 C~~~dP~~RPsm~ev~~~L~~l~~ 587 (615)
||+.||++||++.||++.|+.+.+
T Consensus 318 cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 318 CWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=267.03 Aligned_cols=217 Identities=22% Similarity=0.374 Sum_probs=166.7
Q ss_pred ceEEEEEEC-------CeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATID-------GKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~~-------g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~ 407 (615)
+.||+|... ++.||+|+++ ..+.+|+.++.+++|+||+++++++... ...++++||+++++|.+
T Consensus 19 g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~-~~~~~~~e~~~~~~l~~ 97 (283)
T cd05091 19 GKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE-QPLSMIFSYCSHSDLHE 97 (283)
T ss_pred CeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC-CceEEEEEcCCCCcHHH
Confidence 479999862 4789999986 2367899999999999999999998754 47899999999999999
Q ss_pred hhccCCCCCC------CCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCC
Q 047629 408 WLHPKSKSSS------SSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA 481 (615)
Q Consensus 408 ~L~~~~~~~~------~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~ 481 (615)
++........ .......+++..+..++.|++.||.|||+++ ++||||||+||++++++.+||+|||+++..
T Consensus 98 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 174 (283)
T cd05091 98 FLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREV 174 (283)
T ss_pred HHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCceEeccccccccc
Confidence 9864321100 0001124889999999999999999999998 999999999999999999999999987542
Q ss_pred C-------------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHH
Q 047629 482 T-------------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREE 535 (615)
Q Consensus 482 ~-------------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 535 (615)
. ...+.++||||||+++|||++ |..|+......+ .
T Consensus 175 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~---------------- 235 (283)
T cd05091 175 YAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---V---------------- 235 (283)
T ss_pred ccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH---H----------------
Confidence 1 123568999999999999998 777876533211 0
Q ss_pred HHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 047629 536 RLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSV 584 (615)
Q Consensus 536 ~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~ 584 (615)
+....++.. ..++.+.+..+.+++..||+.+|++||+++||+..|+.
T Consensus 236 -~~~i~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 -IEMIRNRQV-LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -HHHHHcCCc-CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 011111111 12344556668999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=270.28 Aligned_cols=222 Identities=21% Similarity=0.373 Sum_probs=163.0
Q ss_pred ceEEEEEE--CCeEEEEEEccH--------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATI--DGKVLAVKKIKE--------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~--------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
+.||+|.. +++.||+|.++. .+.+|+.++++++|+||+++++++.. ++..++||||++ |+|.+++...
T Consensus 19 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~-~~l~~~l~~~ 96 (288)
T cd07871 19 ATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHT-ERCLTLVFEYLD-SDLKQYLDNC 96 (288)
T ss_pred EEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcC-CCeEEEEEeCCC-cCHHHHHHhc
Confidence 48999987 689999998752 46689999999999999999999865 447899999997 5999998654
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC----------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT---------- 482 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~---------- 482 (615)
.. .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 97 ~~---------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~~~ 164 (288)
T cd07871 97 GN---------LMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEV 164 (288)
T ss_pred CC---------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCccccCce
Confidence 32 3789999999999999999999998 9999999999999999999999999985321
Q ss_pred --------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhH--HHHH-----HHHHhhhc
Q 047629 483 --------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKV--EEKR-----EERLRNWM 541 (615)
Q Consensus 483 --------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~--~~~~-----~~~~~~~~ 541 (615)
..++.++||||+||++|||++|+.||......+.... +...... .... ........
T Consensus 165 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (288)
T cd07871 165 VTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHL---IFRLLGTPTEETWPGITSNEEFRSYL 241 (288)
T ss_pred ecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhCCCChHHhhccccchhhhccc
Confidence 1245679999999999999999999975443222111 1111100 0000 00111111
Q ss_pred CCcCCCC----CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 542 DPNLESF----YPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 542 dp~l~~~----~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.|..... ..........+|+.+|++.||.+|||++|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 242 FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred cCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 1111000 001123457899999999999999999999853
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=273.62 Aligned_cols=221 Identities=22% Similarity=0.361 Sum_probs=162.2
Q ss_pred ceEEEEEE--CCeEEEEEEccH---------HHHHHHHHHHhcCCCCcccEEEEEEcCC----CcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATI--DGKVLAVKKIKE---------DVTEELRILQRINHANLVKLMGVSSDSQ----GNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~---------~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~~lV~E~~~~GsL~~ 407 (615)
+.||+|.. +|+.||||+++. .+.+|++++++++||||+++++++.... ...++||||++ ++|.+
T Consensus 14 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~ 92 (338)
T cd07859 14 GVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQ 92 (338)
T ss_pred eEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHH
Confidence 58999987 689999998752 3668999999999999999999875432 23799999996 68999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----- 482 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----- 482 (615)
++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~l~~~~----------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 159 (338)
T cd07859 93 VIKAND----------DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 159 (338)
T ss_pred HHHhcc----------cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence 987543 2899999999999999999999998 9999999999999999999999999986321
Q ss_pred -----------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhH---------H
Q 047629 483 -----------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKV---------E 530 (615)
Q Consensus 483 -----------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~---------~ 530 (615)
..++.++|||||||++|||++|+.||......... ..+...... .
T Consensus 160 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~i~ 236 (338)
T cd07859 160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL---DLITDLLGTPSPETISRVR 236 (338)
T ss_pred cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHH---HHHHHHhCCCCHHHHHHhh
Confidence 12356899999999999999999998654321111 111110000 0
Q ss_pred HHHHHHHhhhcCCcC----CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 531 EKREERLRNWMDPNL----ESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 531 ~~~~~~~~~~~dp~l----~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
..........+.+.. ...++ .....+.+++.+||+.||++||+++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 237 NEKARRYLSSMRKKQPVPFSQKFP-NADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhHHHHHHhhcccCCCchHHhcC-CCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000111111111 01111 123457899999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=262.04 Aligned_cols=208 Identities=27% Similarity=0.462 Sum_probs=166.2
Q ss_pred ceEEEEEECCeEEEEEEcc-----HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCCCC
Q 047629 343 KSVYRATIDGKVLAVKKIK-----EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSS 417 (615)
Q Consensus 343 ~~Vy~~~~~g~~vAvK~~~-----~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~~ 417 (615)
|.||+|...++.+|+|..+ ..+.+|+.++++++|+|++++++++.. + ..+++|||+++|+|.+++......
T Consensus 20 g~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~-~~~~v~e~~~~~~L~~~l~~~~~~-- 95 (254)
T cd05083 20 GAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH-N-GLYIVMELMSKGNLVNFLRTRGRA-- 95 (254)
T ss_pred CceEecccCCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcC-C-CcEEEEECCCCCCHHHHHHhcCcC--
Confidence 4799999999999999886 357789999999999999999998764 3 579999999999999999764321
Q ss_pred CCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC---------------
Q 047629 418 SSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT--------------- 482 (615)
Q Consensus 418 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~--------------- 482 (615)
.+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 96 ------~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~y~~p 166 (254)
T cd05083 96 ------LVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTAP 166 (254)
T ss_pred ------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccCCCCCCCceecCH
Confidence 3789999999999999999999987 9999999999999999999999999885421
Q ss_pred -----CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHH
Q 047629 483 -----NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALS 556 (615)
Q Consensus 483 -----~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~ 556 (615)
..++.++||||||+++|||++ |+.|+......+ ... .+.... ....+...+..
T Consensus 167 e~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~~~----------~~~~~~----~~~~~~~~~~~ 225 (254)
T cd05083 167 EALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-------VKE----------CVEKGY----RMEPPEGCPAD 225 (254)
T ss_pred HHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH-------HHH----------HHhCCC----CCCCCCcCCHH
Confidence 224568999999999999998 888886543211 000 011101 11112233456
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 047629 557 LATLARACTMDKSLSRPNMAEVVFNLSV 584 (615)
Q Consensus 557 l~~l~~~C~~~dP~~RPsm~ev~~~L~~ 584 (615)
+.+++.+||+.+|++||+++++++.|++
T Consensus 226 ~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 226 VYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 7899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=261.48 Aligned_cols=208 Identities=29% Similarity=0.433 Sum_probs=166.3
Q ss_pred ceEEEEEE-CCeEEEEEEcc------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCC
Q 047629 343 KSVYRATI-DGKVLAVKKIK------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKS 415 (615)
Q Consensus 343 ~~Vy~~~~-~g~~vAvK~~~------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~ 415 (615)
+.||++.. ++..+|+|.++ .++.+|+.++++++|+|++++++++. +...+++|||+++|+|.+++......
T Consensus 20 ~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~ 97 (260)
T cd05070 20 GEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS--EEPIYIVTEYMSKGSLLDFLKDGEGR 97 (260)
T ss_pred ceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC--CCCcEEEEEecCCCcHHHHHHhcCCC
Confidence 48999987 56789999886 45789999999999999999999874 34689999999999999999764321
Q ss_pred CCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------------
Q 047629 416 SSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------------- 482 (615)
Q Consensus 416 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------------- 482 (615)
.+++.++..++.|++.||.|||+++ ++||||||+||++++++.+||+|||++....
T Consensus 98 --------~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 166 (260)
T cd05070 98 --------ALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFP 166 (260)
T ss_pred --------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccccccCCCCC
Confidence 3899999999999999999999998 9999999999999999999999999975321
Q ss_pred -----------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 483 -----------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 483 -----------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
...+.++||||||+++|||++ |+.|+......+. .. .+. .......+
T Consensus 167 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~---~~--------------~~~----~~~~~~~~ 225 (260)
T cd05070 167 IKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREV---LE--------------QVE----RGYRMPCP 225 (260)
T ss_pred ccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH---HH--------------HHH----cCCCCCCC
Confidence 113458999999999999999 8888865332110 00 011 11111223
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 047629 551 IDGALSLATLARACTMDKSLSRPNMAEVVFNLSV 584 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~ 584 (615)
.+....+.+++.+|++.+|.+|||++++.+.|+.
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 226 QDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 3445678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-31 Score=274.28 Aligned_cols=203 Identities=24% Similarity=0.327 Sum_probs=162.6
Q ss_pred ceEEEEEE--CCeEEEEEEccHH----------HHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKED----------VTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~~----------~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||++.. +|+.||+|.++.+ +.+|+.++++++||||+++++++... +..++||||+++|+|..++.
T Consensus 9 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~-~~~~lv~E~~~~~~L~~~l~ 87 (323)
T cd05595 9 GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-DRLCFVMEYANGGELFFHLS 87 (323)
T ss_pred EEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecC-CEEEEEEeCCCCCcHHHHHH
Confidence 58999886 6899999998642 45799999999999999999988754 47999999999999999987
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCC---------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA--------- 481 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~--------- 481 (615)
... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 88 ~~~----------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 154 (323)
T cd05595 88 RER----------VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred HcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcccc
Confidence 543 2899999999999999999999998 999999999999999999999999987532
Q ss_pred --------------CCCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCC
Q 047629 482 --------------TNDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLES 547 (615)
Q Consensus 482 --------------~~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~ 547 (615)
...++.++|||||||++|||++|+.||....... ... ....+ +.
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~---~~~-------------~~~~~--~~---- 212 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFE-------------LILME--EI---- 212 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH---HHH-------------HHhcC--CC----
Confidence 0124568999999999999999999997543211 000 00000 11
Q ss_pred CCChHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 047629 548 FYPIDGALSLATLARACTMDKSLSRP-----NMAEVVFN 581 (615)
Q Consensus 548 ~~~~~~~~~l~~l~~~C~~~dP~~RP-----sm~ev~~~ 581 (615)
.++......+.+++..|++.||++|| ++.++++.
T Consensus 213 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 213 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 12333345678999999999999998 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=261.61 Aligned_cols=205 Identities=24% Similarity=0.352 Sum_probs=163.4
Q ss_pred ceEEEEEE--CCeEEEEEEcc------------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHh
Q 047629 343 KSVYRATI--DGKVLAVKKIK------------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKW 408 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~------------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~ 408 (615)
+.||++.. +|+.+|+|.+. ..+.+|++++++++|+||+++++++.+.+ ..++|+||+++++|.++
T Consensus 16 ~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~~v~e~~~~~~l~~~ 94 (263)
T cd06625 16 GRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDE-TLSIFMEYMPGGSVKDQ 94 (263)
T ss_pred eEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC-eEEEEEEECCCCcHHHH
Confidence 47999976 68999999864 23667999999999999999999987544 89999999999999999
Q ss_pred hccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC------
Q 047629 409 LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------ 482 (615)
Q Consensus 409 L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------ 482 (615)
+.... .+++.....++.|++.||.|||+.+ ++||||||+||++++++++||+|||+++...
T Consensus 95 ~~~~~----------~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 95 LKAYG----------ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred HHHhC----------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 97543 2788999999999999999999998 9999999999999999999999999875321
Q ss_pred --------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcC
Q 047629 483 --------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMD 542 (615)
Q Consensus 483 --------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~d 542 (615)
...+.++||||||+++|||++|+.|+........ .. ....
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~--------------~~~~ 221 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA------IF--------------KIAT 221 (263)
T ss_pred ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH------HH--------------HHhc
Confidence 1134689999999999999999999865332100 00 0011
Q ss_pred CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 543 PNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 543 p~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.......+......+.+++..||+.+|.+||++.|+++.
T Consensus 222 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 222 QPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred cCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 111122333444568899999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=264.53 Aligned_cols=216 Identities=23% Similarity=0.371 Sum_probs=166.2
Q ss_pred ceEEEEEEC-------CeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATID-------GKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~~-------g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~ 407 (615)
+.||+|... +..||+|.+. ..+.+|+.++.+++|+||+++++++... ...++||||+++|+|.+
T Consensus 20 g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~~v~e~~~~~~L~~ 98 (277)
T cd05032 20 GMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG-QPTLVVMELMAKGDLKS 98 (277)
T ss_pred ceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC-CCcEEEEecCCCCCHHH
Confidence 479998863 2679999975 2467899999999999999999998754 47899999999999999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----- 482 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----- 482 (615)
++...............++|..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 99 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~ 175 (277)
T cd05032 99 YLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYY 175 (277)
T ss_pred HHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEECCcccchhhccCccc
Confidence 99764321110001123789999999999999999999987 9999999999999999999999999875321
Q ss_pred --------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhc
Q 047629 483 --------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWM 541 (615)
Q Consensus 483 --------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 541 (615)
...+.++|||||||++||+++ |+.|+......+ ... .+....
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~--------------~~~~~~ 238 (277)
T cd05032 176 RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---VLK--------------FVIDGG 238 (277)
T ss_pred ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---HHH--------------HHhcCC
Confidence 124568999999999999998 888886433211 110 001000
Q ss_pred CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047629 542 DPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLS 583 (615)
Q Consensus 542 dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~ 583 (615)
.+ ..+......+.+++.+||+.+|++|||+.|++..|+
T Consensus 239 ~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 239 HL----DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CC----CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 11 123334567899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=273.54 Aligned_cols=203 Identities=24% Similarity=0.338 Sum_probs=162.9
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||++.. +|+.||+|.++. .+.+|+.++++++|+||+++.+++... +..++||||+++|+|.+++.
T Consensus 9 g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~Ey~~~g~L~~~l~ 87 (328)
T cd05593 9 GKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTK-DRLCFVMEYVNGGELFFHLS 87 (328)
T ss_pred EEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC-CEEEEEEeCCCCCCHHHHHH
Confidence 58999886 689999999863 245799999999999999999988754 47999999999999999987
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
... .+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 88 ~~~----------~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~ 154 (328)
T cd05593 88 RER----------VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT 154 (328)
T ss_pred hcC----------CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCccccccc
Confidence 643 3899999999999999999999998 9999999999999999999999999986421
Q ss_pred ---------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCC
Q 047629 483 ---------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLES 547 (615)
Q Consensus 483 ---------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~ 547 (615)
..++.++|||||||++|||++|+.||......+ .. .. .. ..+..
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~---~~----~~---------~~--~~~~~--- 213 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LF----EL---------IL--MEDIK--- 213 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH---HH----HH---------hc--cCCcc---
Confidence 124568999999999999999999996543211 00 00 00 01111
Q ss_pred CCChHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 047629 548 FYPIDGALSLATLARACTMDKSLSRP-----NMAEVVFN 581 (615)
Q Consensus 548 ~~~~~~~~~l~~l~~~C~~~dP~~RP-----sm~ev~~~ 581 (615)
++......+.+++.+|++.||++|| ++.|++++
T Consensus 214 -~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 214 -FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred -CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 2333345678999999999999997 89998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=264.89 Aligned_cols=216 Identities=26% Similarity=0.431 Sum_probs=167.4
Q ss_pred ceEEEEEE-C------CeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATI-D------GKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~-~------g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~ 407 (615)
+.||+|.. + ++.||||.++ +.+.+|+++|++++|+||+++++++... ...++||||+++|+|.+
T Consensus 19 ~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~ 97 (280)
T cd05049 19 GKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG-DPPIMVFEYMEHGDLNK 97 (280)
T ss_pred ceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC-CCeEEEEecCCCCCHHH
Confidence 48999875 2 4789999875 3577899999999999999999998764 47999999999999999
Q ss_pred hhccCCCCCCC----CCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-
Q 047629 408 WLHPKSKSSSS----SGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT- 482 (615)
Q Consensus 408 ~L~~~~~~~~~----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~- 482 (615)
++......... ......+++.++..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++...
T Consensus 98 ~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~ 174 (280)
T cd05049 98 FLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYT 174 (280)
T ss_pred HHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeEEECCcccceeccc
Confidence 99764321000 011124899999999999999999999998 9999999999999999999999999885320
Q ss_pred ------------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHH
Q 047629 483 ------------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERL 537 (615)
Q Consensus 483 ------------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 537 (615)
..+++++|||||||++|||++ |+.|+......+ .... +
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~~~--------------~ 237 (280)
T cd05049 175 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VIEC--------------I 237 (280)
T ss_pred CcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHH--------------H
Confidence 124568999999999999999 999986543211 1100 0
Q ss_pred hhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047629 538 RNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLS 583 (615)
Q Consensus 538 ~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~ 583 (615)
. ... ....+......+.+++.+||+.||++||++.||++.|+
T Consensus 238 ~---~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 238 T---QGR-LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred H---cCC-cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 0 000 11122334456899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=261.51 Aligned_cols=215 Identities=22% Similarity=0.341 Sum_probs=162.3
Q ss_pred ceEEEEEEC----CeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATID----GKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~~----g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||+|... +..+|+|.++ ..+.+|+.++++++|+||++++|++.+. ...++||||+++|+|.+++.
T Consensus 9 g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~ 87 (269)
T cd05087 9 GKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEV-TPYLLVMEFCPLGDLKGYLR 87 (269)
T ss_pred ceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC-CCcEEEEECCCCCcHHHHHH
Confidence 479999862 3579999885 2467899999999999999999998754 47899999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC-------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------- 483 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------- 483 (615)
...... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+|++|||+++....
T Consensus 88 ~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05087 88 SCRKAE-----LMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTP 159 (269)
T ss_pred Hhhhcc-----cccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceeecC
Confidence 543211 013678888999999999999999998 99999999999999999999999998853210
Q ss_pred -------------------------CCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHH
Q 047629 484 -------------------------DVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERL 537 (615)
Q Consensus 484 -------------------------~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 537 (615)
..+.++||||||+++|||++ |+.||......+... ... .+..
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~------~~~------~~~~ 227 (269)
T cd05087 160 DQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT------YTV------REQQ 227 (269)
T ss_pred CCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH------HHh------hccc
Confidence 12568999999999999996 999986544221100 000 0111
Q ss_pred hhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047629 538 RNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLS 583 (615)
Q Consensus 538 ~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~ 583 (615)
....+|.+.. .....+.+++..|| .+|++|||++||+..|+
T Consensus 228 ~~~~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 228 LKLPKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1222233221 22334778999999 58999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=261.61 Aligned_cols=209 Identities=27% Similarity=0.448 Sum_probs=165.4
Q ss_pred ceEEEEEE--C---CeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATI--D---GKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~--~---g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
+.||+|.. + +..+|+|.++ +.+.+|+.++.+++||||+++.+++... +..++||||+++|+|.+++
T Consensus 18 g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~ 96 (267)
T cd05066 18 GEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS-KPVMIVTEYMENGSLDAFL 96 (267)
T ss_pred CceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC-CccEEEEEcCCCCCHHHHH
Confidence 47999986 2 3479999875 2477899999999999999999998654 4789999999999999999
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------- 482 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------- 482 (615)
..... .+++.++..++.|++.||+|||+++ ++||||||+|||++.++.+|++|||+++...
T Consensus 97 ~~~~~---------~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd05066 97 RKHDG---------QFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAY 164 (267)
T ss_pred HhcCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccccccceee
Confidence 76432 3899999999999999999999998 9999999999999999999999999875421
Q ss_pred -------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcC
Q 047629 483 -------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMD 542 (615)
Q Consensus 483 -------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~d 542 (615)
...+.++||||||+++||+++ |+.|+......+ ... .+.+...
T Consensus 165 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~--------------~~~~~~~ 227 (267)
T cd05066 165 TTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIK--------------AIEEGYR 227 (267)
T ss_pred ecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHH--------------HHhCCCc
Confidence 123558999999999999887 999986543211 111 0111111
Q ss_pred CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 047629 543 PNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVL 585 (615)
Q Consensus 543 p~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l 585 (615)
+ ..+...+..+.+++.+|++.+|.+||+|.++++.|.++
T Consensus 228 ~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 L----PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred C----CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 1 11223345678999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=259.72 Aligned_cols=215 Identities=22% Similarity=0.370 Sum_probs=168.6
Q ss_pred ceEEEEEE--CCeEEEEEEcc----------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIK----------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~----------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
+.||+|.. +|+.||+|.++ +.+.+|++++++++|+|++++++++.+. +..++||||+++|+|.+++.
T Consensus 16 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~ 94 (267)
T cd08224 16 SVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN-NELNIVLELADAGDLSRMIK 94 (267)
T ss_pred eEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC-CeEEEEEecCCCCCHHHHHH
Confidence 48999998 68999999774 2467899999999999999999998764 47899999999999999986
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
...... ..+++.++..++.+++.||.|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 95 ~~~~~~------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 165 (267)
T cd08224 95 HFKKQK------RLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS 165 (267)
T ss_pred HhcccC------CCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccCCCcccce
Confidence 532211 13899999999999999999999998 9999999999999999999999999875321
Q ss_pred ---------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCC
Q 047629 483 ---------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLES 547 (615)
Q Consensus 483 ---------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~ 547 (615)
..++.++|||||||++|||++|+.|+...... ..+... .+....-+
T Consensus 166 ~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~-----------~~~~~~~~---- 226 (267)
T cd08224 166 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCK-----------KIEKCDYP---- 226 (267)
T ss_pred ecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHHHh-----------hhhcCCCC----
Confidence 11345789999999999999999998643311 010000 01110111
Q ss_pred CCCh-HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 047629 548 FYPI-DGALSLATLARACTMDKSLSRPNMAEVVFNLSVLT 586 (615)
Q Consensus 548 ~~~~-~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~ 586 (615)
..+. .....+.+++.+||+.+|++||++.+|++.|+.+.
T Consensus 227 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 227 PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 1122 33456889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=272.03 Aligned_cols=157 Identities=25% Similarity=0.439 Sum_probs=135.2
Q ss_pred ceEEEEEE--CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATI--DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
+.||++.. +|+.+|+|.++ ..+.+|++++++++|+||+++++++.+. +..++||||+++|+|.+++...
T Consensus 19 g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~ 97 (333)
T cd06650 19 GVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-GEISICMEHMDGGSLDQVLKKA 97 (333)
T ss_pred EEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC-CEEEEEEecCCCCcHHHHHHHc
Confidence 58999988 58899999764 2477899999999999999999998764 5899999999999999999764
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC----------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT---------- 482 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~---------- 482 (615)
. .+++.....++.+++.||.|||+.. .++||||||+|||++.++.+||+|||++....
T Consensus 98 ~----------~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 165 (333)
T cd06650 98 G----------RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGT 165 (333)
T ss_pred C----------CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhccccCCCC
Confidence 3 2788999999999999999999742 39999999999999999999999999985321
Q ss_pred -----------CCCCCcccchhHHHHHHHHHcCCCCCCCCC
Q 047629 483 -----------NDVMPKFDVFAFGVVLLELLSGKKATRTTE 512 (615)
Q Consensus 483 -----------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~ 512 (615)
..++.++|||||||++|||++|+.|+....
T Consensus 166 ~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 206 (333)
T cd06650 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206 (333)
T ss_pred ccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence 124568999999999999999999987543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=265.88 Aligned_cols=225 Identities=24% Similarity=0.375 Sum_probs=170.3
Q ss_pred ceEEEEEEC------CeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCC-CcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATID------GKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQ-GNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~~------g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~~lV~E~~~~GsL~~ 407 (615)
+.||++.++ ++.+|||.++ ..+.+|++++++++|+||+++.+++.... ...+++|||+++|+|.+
T Consensus 18 ~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~ 97 (284)
T cd05038 18 GKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRD 97 (284)
T ss_pred eeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHH
Confidence 489999863 6789999885 24778999999999999999999886522 25899999999999999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----- 482 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----- 482 (615)
++..... .++|.++..++.|++.||+|||+.+ ++||||||+||+++.++.+|++|||++....
T Consensus 98 ~l~~~~~---------~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 165 (284)
T cd05038 98 YLQRHRD---------QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDY 165 (284)
T ss_pred HHHhCcc---------ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccccccCCcc
Confidence 9976542 3899999999999999999999998 9999999999999999999999999986542
Q ss_pred ---------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhc
Q 047629 483 ---------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWM 541 (615)
Q Consensus 483 ---------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 541 (615)
...+.++||||||+++|||++|+.|+.......... ... .. .......+.+.+
T Consensus 166 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~-~~~-~~----~~~~~~~~~~~~ 239 (284)
T cd05038 166 YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRM-IGI-AQ----GQMIVTRLLELL 239 (284)
T ss_pred eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccc-ccc-cc----ccccHHHHHHHH
Confidence 113457999999999999999999876432211000 000 00 000001111122
Q ss_pred CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 047629 542 DPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVL 585 (615)
Q Consensus 542 dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l 585 (615)
........+..+...+.+++.+||+.+|++||+|.||+++|+.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 240 KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 22111122333446789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=265.49 Aligned_cols=219 Identities=23% Similarity=0.350 Sum_probs=165.9
Q ss_pred ceEEEEEEC-------CeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATID-------GKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~~-------g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~ 407 (615)
+.||+|... +..||+|.++ ..+.+|+.++++++|+||+++++++.+. ...++||||+++|+|.+
T Consensus 20 g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~g~L~~ 98 (288)
T cd05061 20 GMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG-QPTLVVMELMAHGDLKS 98 (288)
T ss_pred cEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-CCcEEEEeCCCCCCHHH
Confidence 489998642 4579999874 2366799999999999999999998754 47899999999999999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----- 482 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----- 482 (615)
++...............+++..+..++.|++.||.|||+++ ++||||||+||++++++.+|++|||+++...
T Consensus 99 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~ 175 (288)
T cd05061 99 YLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYY 175 (288)
T ss_pred HHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEECcCCccccccccccc
Confidence 99754321111111123678899999999999999999998 9999999999999999999999999876320
Q ss_pred --------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhc
Q 047629 483 --------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWM 541 (615)
Q Consensus 483 --------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 541 (615)
..++.++|||||||++|||++ |+.|+......+ +. ....
T Consensus 176 ~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~-------~~-------------~~~~ 235 (288)
T cd05061 176 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ-------VL-------------KFVM 235 (288)
T ss_pred cccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HH-------------HHHH
Confidence 124568999999999999999 677876433110 00 0011
Q ss_pred CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 047629 542 DPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLT 586 (615)
Q Consensus 542 dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~ 586 (615)
+... ...+......+.+++.+|++.||++||+|.|+++.|.+..
T Consensus 236 ~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 236 DGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred cCCC-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 1111 1122333457899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=273.97 Aligned_cols=203 Identities=21% Similarity=0.267 Sum_probs=161.8
Q ss_pred ceEEEEEEC---CeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATID---GKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~~---g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
|.||+|... +..||+|++.. .+.+|+.++..++||||+++++++.+. +..++||||+++|+|.+++
T Consensus 44 g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-~~~~lv~Ey~~~g~L~~~i 122 (340)
T PTZ00426 44 GRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE-SYLYLVLEFVIGGEFFTFL 122 (340)
T ss_pred eEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC-CEEEEEEeCCCCCcHHHHH
Confidence 589999862 36899998852 355799999999999999999998754 4799999999999999999
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------ 483 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------ 483 (615)
.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 123 ~~~~----------~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~~~~~ 189 (340)
T PTZ00426 123 RRNK----------RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLC 189 (340)
T ss_pred HHcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCCCcceec
Confidence 7654 2889999999999999999999998 99999999999999999999999999864321
Q ss_pred --------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCC
Q 047629 484 --------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFY 549 (615)
Q Consensus 484 --------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~ 549 (615)
..+.++|||||||++|||++|+.||..... ...... + .+.. ..+
T Consensus 190 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~---~~~~~~--------------i---~~~~--~~~ 247 (340)
T PTZ00426 190 GTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP---LLIYQK--------------I---LEGI--IYF 247 (340)
T ss_pred CChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH---HHHHHH--------------H---hcCC--CCC
Confidence 245689999999999999999999975432 111110 0 1100 112
Q ss_pred ChHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 047629 550 PIDGALSLATLARACTMDKSLSRP-----NMAEVVFN 581 (615)
Q Consensus 550 ~~~~~~~l~~l~~~C~~~dP~~RP-----sm~ev~~~ 581 (615)
+......+.+++++|++.||++|+ +++|++++
T Consensus 248 p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 248 PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 223334578999999999999995 88888775
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=259.15 Aligned_cols=209 Identities=26% Similarity=0.400 Sum_probs=167.5
Q ss_pred ceEEEEEE-CCeEEEEEEcc------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCC
Q 047629 343 KSVYRATI-DGKVLAVKKIK------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKS 415 (615)
Q Consensus 343 ~~Vy~~~~-~g~~vAvK~~~------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~ 415 (615)
+.||++.. +++.+|||.++ +++.+|++++++++|+||+++++++.. +...++||||+++|+|.+++......
T Consensus 20 ~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~L~~~i~~~~~~ 98 (261)
T cd05034 20 GEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE-EEPIYIVTEYMSKGSLLDFLKSGEGK 98 (261)
T ss_pred eEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeec-CCceEEEEeccCCCCHHHHHhccccC
Confidence 58999987 55789999886 358899999999999999999998764 34789999999999999999764321
Q ss_pred CCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------------
Q 047629 416 SSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------------- 482 (615)
Q Consensus 416 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------------- 482 (615)
.+++.++..++.+++.||.|||+++ ++|+||||+||++++++.+|++|||++....
T Consensus 99 --------~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 167 (261)
T cd05034 99 --------KLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFP 167 (261)
T ss_pred --------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhhhhhccCCC
Confidence 3899999999999999999999998 9999999999999999999999999875432
Q ss_pred -----------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 483 -----------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 483 -----------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
...+.++||||||+++|||++ |+.|+....... ... .+..... ...+
T Consensus 168 ~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~--------------~~~~~~~----~~~~ 226 (261)
T cd05034 168 IKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VLE--------------QVERGYR----MPRP 226 (261)
T ss_pred ccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH--------------HHHcCCC----CCCC
Confidence 124568999999999999999 999986433211 000 0110011 1112
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 047629 551 IDGALSLATLARACTMDKSLSRPNMAEVVFNLSV 584 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~ 584 (615)
.+.+..+.+++.+|++.+|++||+++|+.+.|+.
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 227 PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 2334568999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=263.15 Aligned_cols=221 Identities=22% Similarity=0.322 Sum_probs=169.6
Q ss_pred HHHccccccccccc----ceEEEEEE--CCeEEEEEEcc-------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEE
Q 047629 329 MESTMNLSEHYSIG----KSVYRATI--DGKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFL 395 (615)
Q Consensus 329 ~~at~~~~~~~~iG----~~Vy~~~~--~g~~vAvK~~~-------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~l 395 (615)
..++.++.....+| +.||+|.. ++..||+|.+. +.+.+|++++++++|+||+++++++... +..++
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~l 82 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN-GFFKI 82 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC-CEEEE
Confidence 34556666656665 48999986 57889999875 2477899999999999999999998754 47899
Q ss_pred EEeecCCCCHHHhhccCCCCCCCCCccccc--CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCC-CCcEEE
Q 047629 396 VYEYAENGSLDKWLHPKSKSSSSSGSVIFL--TWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDS-RFKAKI 472 (615)
Q Consensus 396 V~E~~~~GsL~~~L~~~~~~~~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~-~~~~kl 472 (615)
|+||+++++|.+++..... .+ ++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||
T Consensus 83 v~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l 150 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWG---------PLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKI 150 (268)
T ss_pred EEecCCCCCHHHHHHHhcc---------cCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEE
Confidence 9999999999999976432 14 78889999999999999999987 999999999999986 679999
Q ss_pred eecCCCCCCC-------------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHH
Q 047629 473 ANFSLAAPAT-------------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVL 527 (615)
Q Consensus 473 ~DFGla~~~~-------------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 527 (615)
+|||++.... ...+.++||||||+++|||++|+.|+......... .+.
T Consensus 151 ~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~-~~~------ 223 (268)
T cd06624 151 SDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA-MFK------ 223 (268)
T ss_pred ecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh-Hhh------
Confidence 9999874321 01456899999999999999999998653321110 000
Q ss_pred hHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 528 KVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 528 ~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.... ...+ ..+......+.+++.+||+.+|.+||++.|++.+
T Consensus 224 -------~~~~-~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 224 -------VGMF-KIHP----EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred -------hhhh-ccCC----CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 0000 0111 2233344567899999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=264.37 Aligned_cols=217 Identities=30% Similarity=0.444 Sum_probs=165.7
Q ss_pred ceEEEEEE-------CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATI-------DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~-------~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~ 407 (615)
+.||++.. ++..+|+|.++ .++.+|+.++++++|+||+++++++.+. ...++++||+++|+|.+
T Consensus 19 g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~ 97 (288)
T cd05050 19 GRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVG-KPMCLLFEYMAYGDLNE 97 (288)
T ss_pred ccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-CccEEEEecCCCCCHHH
Confidence 47999875 35789999875 3477899999999999999999998754 47899999999999999
Q ss_pred hhccCCCCCCC------------CCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeec
Q 047629 408 WLHPKSKSSSS------------SGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANF 475 (615)
Q Consensus 408 ~L~~~~~~~~~------------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DF 475 (615)
++......... ......+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 98 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~df 174 (288)
T cd05050 98 FLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADF 174 (288)
T ss_pred HHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhheEecCCCceEECcc
Confidence 99753211000 011124889999999999999999999987 999999999999999999999999
Q ss_pred CCCCCCC-------------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhH
Q 047629 476 SLAAPAT-------------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKV 529 (615)
Q Consensus 476 Gla~~~~-------------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 529 (615)
|+++... ..++.++|||||||++|||++ |..|+......+ . ..
T Consensus 175 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~---~---~~----- 243 (288)
T cd05050 175 GLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE---V---IY----- 243 (288)
T ss_pred ccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---H---HH-----
Confidence 9875321 123567999999999999998 888875433110 0 00
Q ss_pred HHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 047629 530 EEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSV 584 (615)
Q Consensus 530 ~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~ 584 (615)
...+.... ..+......+.+++.+|++.||.+||++.|+++.|++
T Consensus 244 ---------~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 244 ---------YVRDGNVL-SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ---------HHhcCCCC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 00111110 1122344568999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=264.29 Aligned_cols=208 Identities=19% Similarity=0.369 Sum_probs=162.3
Q ss_pred ceEEEEEE--CCeEEEEEEcc------HHHHHHHHHHHhc-CCCCcccEEEEEEcCC-----CcEEEEEeecCCCCHHHh
Q 047629 343 KSVYRATI--DGKVLAVKKIK------EDVTEELRILQRI-NHANLVKLMGVSSDSQ-----GNRFLVYEYAENGSLDKW 408 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~------~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~-----~~~~lV~E~~~~GsL~~~ 408 (615)
+.||+|.. +++.||+|.+. ..+..|+.++.++ +|+||+++++++...+ ...+++|||+++|+|.++
T Consensus 20 g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~ 99 (272)
T cd06637 20 GQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL 99 (272)
T ss_pred eEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHH
Confidence 47999987 67899999984 3577899999998 7999999999986432 247899999999999999
Q ss_pred hccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC------
Q 047629 409 LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------ 482 (615)
Q Consensus 409 L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------ 482 (615)
+...... .++|..+..++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++...
T Consensus 100 l~~~~~~--------~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~~~ 168 (272)
T cd06637 100 IKNTKGN--------TLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR 168 (272)
T ss_pred HHhccCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCceecccccccC
Confidence 9764321 3899999999999999999999997 9999999999999999999999999985321
Q ss_pred ----------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhh
Q 047629 483 ----------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNW 540 (615)
Q Consensus 483 ----------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 540 (615)
..++.++|||||||++|||++|+.|+......... ......
T Consensus 169 ~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~-----------------~~~~~~ 231 (272)
T cd06637 169 NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL-----------------FLIPRN 231 (272)
T ss_pred CcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH-----------------HHHhcC
Confidence 01344799999999999999999998643311000 000000
Q ss_pred cCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 541 MDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 541 ~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
..+.+ .+......+.+++.+||..||.+||++.|+++.
T Consensus 232 ~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 232 PAPRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CCCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 11111 111233467899999999999999999999763
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=267.62 Aligned_cols=211 Identities=26% Similarity=0.432 Sum_probs=165.2
Q ss_pred ceEEEEEE--CCe----EEEEEEccH--------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHh
Q 047629 343 KSVYRATI--DGK----VLAVKKIKE--------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKW 408 (615)
Q Consensus 343 ~~Vy~~~~--~g~----~vAvK~~~~--------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~ 408 (615)
+.||+|.. +|+ .+|+|.+.. .+.+|+.++++++|+||++++|+|... ..++++||+++|+|.++
T Consensus 21 g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--~~~~v~e~~~~g~l~~~ 98 (303)
T cd05110 21 GTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP--TIQLVTQLMPHGCLLDY 98 (303)
T ss_pred ccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC--CceeeehhcCCCCHHHH
Confidence 48999987 454 578987752 467899999999999999999998642 56799999999999999
Q ss_pred hccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC------
Q 047629 409 LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------ 482 (615)
Q Consensus 409 L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------ 482 (615)
+..... .+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++...
T Consensus 99 ~~~~~~---------~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 166 (303)
T cd05110 99 VHEHKD---------NIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEY 166 (303)
T ss_pred HHhccc---------CCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccCccccc
Confidence 976432 3889999999999999999999987 9999999999999999999999999986431
Q ss_pred -------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcC
Q 047629 483 -------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMD 542 (615)
Q Consensus 483 -------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~d 542 (615)
...+.++||||||+++|||++ |+.|+......+ +.... ...
T Consensus 167 ~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-------~~~~~----------~~~-- 227 (303)
T cd05110 167 NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-------IPDLL----------EKG-- 227 (303)
T ss_pred ccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHH----------HCC--
Confidence 113457999999999999997 888886432110 11111 000
Q ss_pred CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 543 PNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 543 p~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
..+ ..+......+.+++..||..+|++||+|+|+++.|..+...
T Consensus 228 ~~~--~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 228 ERL--PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred CCC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 001 11122345688999999999999999999999999887544
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-30 Score=259.78 Aligned_cols=215 Identities=22% Similarity=0.348 Sum_probs=160.7
Q ss_pred ceEEEEEE-C---CeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI-D---GKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~-~---g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||+|.. + ...+|+|.++ ..+.+|+++++.++|+||+++++.+.+. ...++||||+++|+|.+++.
T Consensus 9 g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~ 87 (269)
T cd05042 9 GKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES-IPYLLVLEFCPLGDLKNYLR 87 (269)
T ss_pred ceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCC-CceEEEEEeCCCCcHHHHHH
Confidence 47999875 2 3578999774 2467899999999999999999998754 47999999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
....... ...++.....++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 88 ~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05042 88 SNRGMVA-----QMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK 159 (269)
T ss_pred hcccccc-----ccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheecc
Confidence 6543110 12578889999999999999999998 9999999999999999999999999975310
Q ss_pred ------------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHH
Q 047629 483 ------------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERL 537 (615)
Q Consensus 483 ------------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 537 (615)
...+.++|||||||++|||++ |+.|+....+.+. ..... ....
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~------~~~~~------~~~~ 227 (269)
T cd05042 160 DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV------LKQVV------REQD 227 (269)
T ss_pred CCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH------HHHHh------hccC
Confidence 013458999999999999999 7778765432111 01000 0011
Q ss_pred hhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047629 538 RNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLS 583 (615)
Q Consensus 538 ~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~ 583 (615)
..+.+|.+. ......+.+++..|| .||++||+++||++.|+
T Consensus 228 ~~~~~~~~~----~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 228 IKLPKPQLD----LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred ccCCCCccc----ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 112223222 233345677888998 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-30 Score=258.84 Aligned_cols=209 Identities=27% Similarity=0.409 Sum_probs=165.2
Q ss_pred ceEEEEEE-CCeEEEEEEcc------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCC
Q 047629 343 KSVYRATI-DGKVLAVKKIK------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKS 415 (615)
Q Consensus 343 ~~Vy~~~~-~g~~vAvK~~~------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~ 415 (615)
+.||+|.. ++..||+|+++ +.+.+|++++++++|+||+++++++. +...++||||+++|+|.+++......
T Consensus 20 ~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~ 97 (262)
T cd05071 20 GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS--EEPIYIVTEYMSKGSLLDFLKGEMGK 97 (262)
T ss_pred CcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC--CCCcEEEEEcCCCCcHHHHHhhcccc
Confidence 48999987 44579999886 35788999999999999999999864 34689999999999999999754321
Q ss_pred CCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------------
Q 047629 416 SSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------------- 482 (615)
Q Consensus 416 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------------- 482 (615)
.++|.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 98 --------~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~ 166 (262)
T cd05071 98 --------YLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 166 (262)
T ss_pred --------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccccccCCccc
Confidence 3899999999999999999999987 9999999999999999999999999885321
Q ss_pred -----------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 483 -----------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 483 -----------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
..++.++||||||+++|||++ |+.|+......+ ... .+...... ..+
T Consensus 167 ~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~---~~~--------------~~~~~~~~----~~~ 225 (262)
T cd05071 167 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLD--------------QVERGYRM----PCP 225 (262)
T ss_pred ceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH---HHH--------------HHhcCCCC----CCc
Confidence 113458999999999999999 777876443211 000 00000111 122
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 047629 551 IDGALSLATLARACTMDKSLSRPNMAEVVFNLSVL 585 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l 585 (615)
.+....+.+++.+|++.||++||++.++++.|+..
T Consensus 226 ~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 226 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred cccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 34456689999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=272.78 Aligned_cols=203 Identities=25% Similarity=0.384 Sum_probs=164.4
Q ss_pred ceEEEEEE--CCeEEEEEEccHH------------HHHHHHHHHhcC-CCCcccEEEEEEcCCCcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATI--DGKVLAVKKIKED------------VTEELRILQRIN-HANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~~------------~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~ 407 (615)
+.|+.|.. +|+.||||.+.++ +.+|+.++++++ ||||++++.++.... ..++||||+.+|+|.+
T Consensus 31 gkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~-~~~ivmEy~~gGdL~~ 109 (370)
T KOG0583|consen 31 GKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT-KIYIVMEYCSGGDLFD 109 (370)
T ss_pred eeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC-eEEEEEEecCCccHHH
Confidence 58999976 7899999976542 347999999998 999999999987654 6999999999999999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCC-CcEEEeecCCCCCCC-CC-
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSR-FKAKIANFSLAAPAT-ND- 484 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~-~~~kl~DFGla~~~~-~~- 484 (615)
++.... .+.+.....++.|++.|++|+|+++ |+||||||+|||+|.+ +++||+|||++.... ..
T Consensus 110 ~i~~~g----------~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~ 176 (370)
T KOG0583|consen 110 YIVNKG----------RLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAISPGEDG 176 (370)
T ss_pred HHHHcC----------CCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccccccCCCCC
Confidence 998843 3888999999999999999999998 9999999999999999 999999999997651 11
Q ss_pred ----------------------C-CCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhc
Q 047629 485 ----------------------V-MPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWM 541 (615)
Q Consensus 485 ----------------------~-~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 541 (615)
+ ..++||||+||+||.|++|+.||+.... ..+... +.
T Consensus 177 ~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~---~~l~~k-----------------i~ 236 (370)
T KOG0583|consen 177 LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV---PNLYRK-----------------IR 236 (370)
T ss_pred cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH---HHHHHH-----------------Hh
Confidence 1 3589999999999999999999986331 111110 01
Q ss_pred CCcCCCCCChHH-HHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 542 DPNLESFYPIDG-ALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 542 dp~l~~~~~~~~-~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
... -.+|... ..++..|+.+|+..||.+|+++.||++.
T Consensus 237 ~~~--~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 237 KGE--FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred cCC--ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence 000 1122222 5567999999999999999999999953
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=266.28 Aligned_cols=222 Identities=22% Similarity=0.337 Sum_probs=161.4
Q ss_pred ceEEEEEE--CCeEEEEEEccH--------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATI--DGKVLAVKKIKE--------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~--------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
+.||+|.. +|+.||||.++. .+.+|+.++++++|+||+++++++.+. ...++||||++ |+|.+++...
T Consensus 19 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~-~~l~~~~~~~ 96 (303)
T cd07869 19 ATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTK-ETLTLVFEYVH-TDLCQYMDKH 96 (303)
T ss_pred EEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecC-CeEEEEEECCC-cCHHHHHHhC
Confidence 48999987 689999998852 367899999999999999999998754 47899999996 6888888654
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC----------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT---------- 482 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~---------- 482 (615)
.. .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 97 ~~---------~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 164 (303)
T cd07869 97 PG---------GLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEV 164 (303)
T ss_pred CC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCCCc
Confidence 32 3888999999999999999999998 9999999999999999999999999875321
Q ss_pred --------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHH--HHH--HHHhhhcCCc
Q 047629 483 --------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEE--KRE--ERLRNWMDPN 544 (615)
Q Consensus 483 --------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~--~~~--~~~~~~~dp~ 544 (615)
..++.++|||||||++|||++|+.||....+... ....+...+.... ... .... ..++.
T Consensus 165 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 241 (303)
T cd07869 165 VTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD--QLERIFLVLGTPNEDTWPGVHSLP-HFKPE 241 (303)
T ss_pred ccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhCCCChhhccchhhcc-ccccc
Confidence 1134578999999999999999999976432111 1111111110000 000 0000 00000
Q ss_pred -CCCCCCh---------HHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 545 -LESFYPI---------DGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 545 -l~~~~~~---------~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.....+. .....+.+|+..|++.||++|||+.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 242 RFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred cccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 0000000 112356799999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-30 Score=256.37 Aligned_cols=207 Identities=27% Similarity=0.443 Sum_probs=166.2
Q ss_pred ceEEEEEE-CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATI-DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~-~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
+.||++.. +|+.||+|.++ ..+.+|++++++++|+||+++++++.+. ...++|+||+++++|.+++....
T Consensus 9 g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e~~~~~~l~~~l~~~~ 87 (251)
T cd05041 9 GDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQK-QPIYIVMELVPGGSLLTFLRKKK 87 (251)
T ss_pred ceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecC-CCeEEEEEcCCCCcHHHHHHhcC
Confidence 47999988 48999999875 2477899999999999999999998754 47899999999999999997543
Q ss_pred CCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----------
Q 047629 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----------- 482 (615)
Q Consensus 414 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----------- 482 (615)
. .+++..+..++.+++.||.|||+++ ++||||||+||+++.++.+||+|||+++...
T Consensus 88 ~---------~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 88 N---------RLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred C---------CCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 2 3789999999999999999999998 9999999999999999999999999886432
Q ss_pred --------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCC
Q 047629 483 --------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLES 547 (615)
Q Consensus 483 --------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~ 547 (615)
...+.++|||||||++|||++ |..|+........ . ..+.. ....
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~-------~----------~~~~~----~~~~ 214 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT-------R----------ERIES----GYRM 214 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH-------H----------HHHhc----CCCC
Confidence 123467999999999999999 7778755432110 0 01111 1111
Q ss_pred CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047629 548 FYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLS 583 (615)
Q Consensus 548 ~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~ 583 (615)
..+......+.+++.+|++.+|.+||++.|+++.|.
T Consensus 215 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 215 PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 123344557899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=266.19 Aligned_cols=221 Identities=23% Similarity=0.404 Sum_probs=168.4
Q ss_pred ceEEEEEE---------CCeEEEEEEccH--------HHHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCC
Q 047629 343 KSVYRATI---------DGKVLAVKKIKE--------DVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGS 404 (615)
Q Consensus 343 ~~Vy~~~~---------~g~~vAvK~~~~--------~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~Gs 404 (615)
|.||++.. ++..||+|.++. ++.+|+.+++.+ +|+||+++++++... +..+++|||+++|+
T Consensus 29 g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~ 107 (304)
T cd05101 29 GQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD-GPLYVIVEYASKGN 107 (304)
T ss_pred ceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC-CceEEEEecCCCCc
Confidence 48998864 245799998852 367899999999 899999999998754 47899999999999
Q ss_pred HHHhhccCCCCCCCC------CcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCC
Q 047629 405 LDKWLHPKSKSSSSS------GSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA 478 (615)
Q Consensus 405 L~~~L~~~~~~~~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla 478 (615)
|.+++.......... .....++|.++..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++
T Consensus 108 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili~~~~~~kl~D~g~~ 184 (304)
T cd05101 108 LREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLA 184 (304)
T ss_pred HHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEEcCCCcEEECCCccc
Confidence 999997643211000 00124899999999999999999999998 999999999999999999999999998
Q ss_pred CCCC-------------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHH
Q 047629 479 APAT-------------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEK 532 (615)
Q Consensus 479 ~~~~-------------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 532 (615)
+... ..++.++||||||+++|||++ |..|+..... .. +...
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~----~~~~------ 251 (304)
T cd05101 185 RDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---EE----LFKL------ 251 (304)
T ss_pred eecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---HH----HHHH------
Confidence 5321 113568999999999999998 7777754321 01 1110
Q ss_pred HHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 533 REERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 533 ~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
+.... ....+......+.+++.+||+.+|.+||+|.|+++.|.++...
T Consensus 252 ----~~~~~----~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 252 ----LKEGH----RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred ----HHcCC----cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 11000 0112334456688999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=269.92 Aligned_cols=203 Identities=22% Similarity=0.337 Sum_probs=160.9
Q ss_pred ceEEEEEE-----CCeEEEEEEccH-----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHH
Q 047629 343 KSVYRATI-----DGKVLAVKKIKE-----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLD 406 (615)
Q Consensus 343 ~~Vy~~~~-----~g~~vAvK~~~~-----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~ 406 (615)
|.||++.. .|+.||||.++. .+.+|+++|++++||||+++++++.. ++..++||||+++|+|.
T Consensus 10 g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~~~~L~ 88 (323)
T cd05584 10 GKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT-GGKLYLILEYLSGGELF 88 (323)
T ss_pred eEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec-CCeEEEEEeCCCCchHH
Confidence 47998874 578999999863 24579999999999999999998875 45799999999999999
Q ss_pred HhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC----
Q 047629 407 KWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT---- 482 (615)
Q Consensus 407 ~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~---- 482 (615)
+++.... .+.+..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 89 ~~~~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 89 MHLEREG----------IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred HHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 9997643 2788888999999999999999998 9999999999999999999999999975320
Q ss_pred -------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCC
Q 047629 483 -------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDP 543 (615)
Q Consensus 483 -------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp 543 (615)
...+.++|||||||++|||++|+.||....... .+. .+...
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~------~~~--------------~~~~~ 215 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK------TID--------------KILKG 215 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH------HHH--------------HHHcC
Confidence 113468999999999999999999997543210 001 11111
Q ss_pred cCCCCCChHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 047629 544 NLESFYPIDGALSLATLARACTMDKSLSRP-----NMAEVVFN 581 (615)
Q Consensus 544 ~l~~~~~~~~~~~l~~l~~~C~~~dP~~RP-----sm~ev~~~ 581 (615)
.. ..+......+.+++.+|++.||++|| ++.++++.
T Consensus 216 ~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 216 KL--NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CC--CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 11 12333345678999999999999999 78887764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-30 Score=262.96 Aligned_cols=223 Identities=21% Similarity=0.344 Sum_probs=159.5
Q ss_pred ceEEEEEE---CCeEEEEEEccH---------HHHHHHHHHHhc---CCCCcccEEEEEEc----CCCcEEEEEeecCCC
Q 047629 343 KSVYRATI---DGKVLAVKKIKE---------DVTEELRILQRI---NHANLVKLMGVSSD----SQGNRFLVYEYAENG 403 (615)
Q Consensus 343 ~~Vy~~~~---~g~~vAvK~~~~---------~~~~Ei~~l~~l---~H~niv~l~g~~~~----~~~~~~lV~E~~~~G 403 (615)
|.||++.. .|+.||||+++. .+.+|+++++++ +||||++++++|.. .....++|+||++ |
T Consensus 15 g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~ 93 (290)
T cd07862 15 GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-Q 93 (290)
T ss_pred eEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-C
Confidence 58999986 468899998752 356788887766 69999999998852 2335899999996 6
Q ss_pred CHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-
Q 047629 404 SLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT- 482 (615)
Q Consensus 404 sL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~- 482 (615)
+|.+++...... .+++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 94 ~l~~~~~~~~~~--------~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T cd07862 94 DLTTYLDKVPEP--------GVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF 162 (290)
T ss_pred CHHHHHHhCCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccceEeccC
Confidence 999999754321 3899999999999999999999998 9999999999999999999999999985421
Q ss_pred ---------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhH--HHHHHHHH--
Q 047629 483 ---------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKV--EEKREERL-- 537 (615)
Q Consensus 483 ---------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~-- 537 (615)
..++.++|||||||++|||++|+.||......+.. ..+...... ........
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~ 239 (290)
T cd07862 163 QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL---GKILDVIGLPGEEDWPRDVAL 239 (290)
T ss_pred CcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHH---HHHHHHhCCCChhhchhhhcc
Confidence 12456899999999999999999999765432111 111111100 00000000
Q ss_pred -hhhcCCcCC---CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047629 538 -RNWMDPNLE---SFYPIDGALSLATLARACTMDKSLSRPNMAEVVF 580 (615)
Q Consensus 538 -~~~~dp~l~---~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~ 580 (615)
.....+... .....+....+.+++.+|++.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 240 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred cchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000000000 0001122345689999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=262.97 Aligned_cols=195 Identities=22% Similarity=0.369 Sum_probs=151.4
Q ss_pred eEEEEEEccH-------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCCCCCCCccccc
Q 047629 353 KVLAVKKIKE-------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFL 425 (615)
Q Consensus 353 ~~vAvK~~~~-------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l 425 (615)
..||+|.+.. .+.+|+.++++++|+||++++|+|.+. ...++||||+++|+|..++..... .+
T Consensus 45 ~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~~~~~~~~-~~~~lv~ey~~~g~L~~~l~~~~~---------~~ 114 (274)
T cd05076 45 LRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRG-SENIMVEEFVEHGPLDVCLRKEKG---------RV 114 (274)
T ss_pred eeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeEEEEEEeC-CceEEEEecCCCCcHHHHHHhcCC---------CC
Confidence 4589998853 466789999999999999999999864 478999999999999999975432 38
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCC-------cEEEeecCCCCCC-----------------
Q 047629 426 TWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRF-------KAKIANFSLAAPA----------------- 481 (615)
Q Consensus 426 ~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~-------~~kl~DFGla~~~----------------- 481 (615)
++..+..++.|++.||+|||+++ |+||||||+|||++..+ .+|++|||++...
T Consensus 115 ~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~ 191 (274)
T cd05076 115 PVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVERIPWIAPEC 191 (274)
T ss_pred CHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcccCccceeeecCCccccccccccccccCCcccCchh
Confidence 89999999999999999999987 99999999999997643 3799999987421
Q ss_pred ---CCCCCCcccchhHHHHHHHHH-cCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHH
Q 047629 482 ---TNDVMPKFDVFAFGVVLLELL-SGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSL 557 (615)
Q Consensus 482 ---~~~~~~k~DV~SfGvvl~Ell-tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l 557 (615)
...++.++||||||+++|||+ +|+.|+......+.. ..+ .. ...+ +......+
T Consensus 192 ~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~----------~~--~~~~----~~~~~~~~ 248 (274)
T cd05076 192 VPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE-------RFY----------EK--KHRL----PEPSCKEL 248 (274)
T ss_pred hcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH-------HHH----------Hh--ccCC----CCCCChHH
Confidence 012467899999999999995 688888654321110 000 00 0111 11122357
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047629 558 ATLARACTMDKSLSRPNMAEVVFNLS 583 (615)
Q Consensus 558 ~~l~~~C~~~dP~~RPsm~ev~~~L~ 583 (615)
.+++.+||+.+|++||+|.||++.|+
T Consensus 249 ~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 249 ATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHHHHHcccChhhCcCHHHHHHhhC
Confidence 89999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=267.03 Aligned_cols=222 Identities=25% Similarity=0.408 Sum_probs=169.2
Q ss_pred ceEEEEEEC---------CeEEEEEEccH--------HHHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCC
Q 047629 343 KSVYRATID---------GKVLAVKKIKE--------DVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGS 404 (615)
Q Consensus 343 ~~Vy~~~~~---------g~~vAvK~~~~--------~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~Gs 404 (615)
+.||++... +..+|+|.++. ++.+|++++.++ +|+||+++++++... +..++||||+++|+
T Consensus 32 g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~ 110 (307)
T cd05098 32 GQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD-GPLYVIVEYASKGN 110 (307)
T ss_pred eeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC-CceEEEEecCCCCc
Confidence 479988752 24699998862 366799999999 799999999998754 47999999999999
Q ss_pred HHHhhccCCCCCC------CCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCC
Q 047629 405 LDKWLHPKSKSSS------SSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA 478 (615)
Q Consensus 405 L~~~L~~~~~~~~------~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla 478 (615)
|.+++........ .......++|.++++++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++
T Consensus 111 L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~a 187 (307)
T cd05098 111 LREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLA 187 (307)
T ss_pred HHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEcCCCcEEECCCccc
Confidence 9999976432110 0000124899999999999999999999987 999999999999999999999999998
Q ss_pred CCCC-------------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHH
Q 047629 479 APAT-------------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEK 532 (615)
Q Consensus 479 ~~~~-------------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 532 (615)
+... ...+.++|||||||++|||++ |+.|+..... ..+...
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~-------~~~~~~------ 254 (307)
T cd05098 188 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-------EELFKL------ 254 (307)
T ss_pred ccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-------HHHHHH------
Confidence 5321 113567999999999999998 8888754321 001111
Q ss_pred HHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccch
Q 047629 533 REERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQST 589 (615)
Q Consensus 533 ~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~ 589 (615)
+.. ....+.+......+.+++.+||+.+|.+||+|.||++.|..+....
T Consensus 255 ----~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 255 ----LKE----GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred ----HHc----CCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 110 0111223344557889999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-30 Score=257.82 Aligned_cols=206 Identities=25% Similarity=0.473 Sum_probs=164.5
Q ss_pred ceEEEEEE-CCeEEEEEEcc------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCC
Q 047629 343 KSVYRATI-DGKVLAVKKIK------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKS 415 (615)
Q Consensus 343 ~~Vy~~~~-~g~~vAvK~~~------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~ 415 (615)
|.||++.+ +++.+|+|.++ .++.+|++++++++|+|++++++++... ...++|+||+++|+|.+++.....
T Consensus 18 g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~- 95 (256)
T cd05112 18 GLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTER-SPICLVFEFMEHGCLSDYLRAQRG- 95 (256)
T ss_pred ceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccC-CceEEEEEcCCCCcHHHHHHhCcc-
Confidence 48999987 57899999876 3588999999999999999999997654 478999999999999999975432
Q ss_pred CCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------------
Q 047629 416 SSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------------- 482 (615)
Q Consensus 416 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------------- 482 (615)
.++|..+..++.+++.||+|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 96 --------~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 164 (256)
T cd05112 96 --------KFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFP 164 (256)
T ss_pred --------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccccCCCccc
Confidence 3889999999999999999999998 9999999999999999999999999875321
Q ss_pred -----------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 483 -----------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 483 -----------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
...+.++||||||+++|||++ |+.|+......+ ... .+.+...+ ..+
T Consensus 165 ~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~--------------~~~~~~~~----~~~ 223 (256)
T cd05112 165 VKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---VVE--------------TINAGFRL----YKP 223 (256)
T ss_pred hhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---HHH--------------HHhCCCCC----CCC
Confidence 123457999999999999998 898886533211 110 01110000 011
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047629 551 IDGALSLATLARACTMDKSLSRPNMAEVVFNL 582 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L 582 (615)
......+.+++.+||+.+|++||++.|+++.|
T Consensus 224 ~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 224 RLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 12235689999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=262.93 Aligned_cols=211 Identities=20% Similarity=0.279 Sum_probs=162.5
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||++.. +|+.+|+|.+.. .+..|++++++++|+||+++.+++.. +...++||||+++|+|.+++.
T Consensus 7 g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~g~L~~~~~ 85 (280)
T cd05608 7 GEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT-KTDLCLVMTIMNGGDLRYHIY 85 (280)
T ss_pred eeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC-CCeEEEEEeCCCCCCHHHHHH
Confidence 48999887 689999999853 24579999999999999999998764 447999999999999998885
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
...... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 86 ~~~~~~------~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 156 (280)
T cd05608 86 NVDEEN------PGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKG 156 (280)
T ss_pred hccccC------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccc
Confidence 432211 13899999999999999999999998 9999999999999999999999999985321
Q ss_pred ---------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCC
Q 047629 483 ---------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLES 547 (615)
Q Consensus 483 ---------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~ 547 (615)
..++.++|||||||++|||++|+.||......... ... ........ .
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~---~~~-------------~~~~~~~~--~ 218 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN---KEL-------------KQRILNDS--V 218 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH---HHH-------------HHhhcccC--C
Confidence 12356899999999999999999999754321110 000 01111111 1
Q ss_pred CCChHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 047629 548 FYPIDGALSLATLARACTMDKSLSRP-----NMAEVVFN 581 (615)
Q Consensus 548 ~~~~~~~~~l~~l~~~C~~~dP~~RP-----sm~ev~~~ 581 (615)
.++......+.+++..|++.||++|| +++|++++
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 219 TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 22334455688999999999999999 66777654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=262.93 Aligned_cols=203 Identities=23% Similarity=0.371 Sum_probs=163.8
Q ss_pred ceEEEEEE--CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATI--DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
+.||+|.. +|+.||+|.++ +.+.+|++++++++|+||+++++++... ...++|+||+++|+|.+++...
T Consensus 18 ~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~ 96 (277)
T cd06642 18 GEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKG-TKLWIIMEYLGGGSALDLLKPG 96 (277)
T ss_pred eeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccC-CceEEEEEccCCCcHHHHhhcC
Confidence 58999987 67899999875 2467899999999999999999998754 4799999999999999998642
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC---------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN--------- 483 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~--------- 483 (615)
.+++..+..++.|++.||.|||+++ ++|+||+|+||++++++.+|++|||++.....
T Consensus 97 -----------~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 162 (277)
T cd06642 97 -----------PLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV 162 (277)
T ss_pred -----------CCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcchhhhccc
Confidence 2889999999999999999999987 99999999999999999999999998854311
Q ss_pred --------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCC
Q 047629 484 --------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFY 549 (615)
Q Consensus 484 --------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~ 549 (615)
..+.++||||||+++|||++|+.|+......... . .+.....+.+
T Consensus 163 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~------~-----------~~~~~~~~~~---- 221 (277)
T cd06642 163 GTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL------F-----------LIPKNSPPTL---- 221 (277)
T ss_pred CcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH------h-----------hhhcCCCCCC----
Confidence 1356899999999999999999998643321100 0 0111112222
Q ss_pred ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 550 PIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 550 ~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
+......+.+++.+||+.+|++||+|.|++.+
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 222 EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 22344568899999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=283.73 Aligned_cols=208 Identities=20% Similarity=0.294 Sum_probs=162.2
Q ss_pred ceEEEEEE--C-CeEEEEEEcc-------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATI--D-GKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~--~-g~~vAvK~~~-------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
+.||++.. + ++.||+|.+. ..+.+|+.+|++++|||||++++++... +..+|||||+++|+|.++|+..
T Consensus 81 g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~-~~~~lv~E~~~gg~L~~~l~~~ 159 (478)
T PTZ00267 81 TAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSD-DKLLLIMEYGSGGDLNKQIKQR 159 (478)
T ss_pred cEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC-CEEEEEEECCCCCCHHHHHHHH
Confidence 58999876 3 6788998763 2367799999999999999999998754 5899999999999999988653
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC----------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT---------- 482 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~---------- 482 (615)
.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 160 ~~~~------~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~ 230 (478)
T PTZ00267 160 LKEH------LPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230 (478)
T ss_pred Hhcc------CCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccc
Confidence 2110 14889999999999999999999997 9999999999999999999999999986431
Q ss_pred ---------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCC
Q 047629 483 ---------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLES 547 (615)
Q Consensus 483 ---------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~ 547 (615)
..++.++|||||||++|||++|+.|+...... .. +.. .+....+
T Consensus 231 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~---~~---~~~----------~~~~~~~----- 289 (478)
T PTZ00267 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR---EI---MQQ----------VLYGKYD----- 289 (478)
T ss_pred cCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---HH---HHH----------HHhCCCC-----
Confidence 11456899999999999999999998653311 00 010 0111111
Q ss_pred CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 548 FYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 548 ~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
..+......+.+++..||+.||++||++.|++..
T Consensus 290 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 290 PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 1222334568999999999999999999998753
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-30 Score=257.47 Aligned_cols=208 Identities=27% Similarity=0.388 Sum_probs=164.6
Q ss_pred ceEEEEEEC---C--eEEEEEEccH--------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATID---G--KVLAVKKIKE--------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~~---g--~~vAvK~~~~--------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
+.||+|.+. + ..||||.++. ++.+|+.++++++|+||+++++++.+ ...++|+||+++|+|.+++
T Consensus 9 ~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~~~~~~L~~~l 86 (257)
T cd05040 9 GVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT--HPLMMVTELAPLGSLLDRL 86 (257)
T ss_pred ccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC--CeEEEEEEecCCCcHHHHH
Confidence 489999872 2 3699998863 46689999999999999999999875 5789999999999999999
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------ 483 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------ 483 (615)
...... .++|..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 87 ~~~~~~--------~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 87 RKDALG--------HFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred Hhcccc--------cCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 765421 3899999999999999999999998 99999999999999999999999998864321
Q ss_pred --------------------CCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcC
Q 047629 484 --------------------DVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMD 542 (615)
Q Consensus 484 --------------------~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~d 542 (615)
.++.++||||||+++|||++ |+.|+......+ ... . +.. ..
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~---~-----------~~~-~~ 217 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---ILK---K-----------IDK-EG 217 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHH---H-----------HHh-cC
Confidence 13457999999999999999 999986433211 000 0 000 00
Q ss_pred CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047629 543 PNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLS 583 (615)
Q Consensus 543 p~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~ 583 (615)
..+ ..+...+..+.+++.+|++.+|++||++.|+++.|.
T Consensus 218 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 218 ERL--ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CcC--CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 011 112233456889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=276.61 Aligned_cols=214 Identities=21% Similarity=0.236 Sum_probs=165.1
Q ss_pred cccccccccc----ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEE
Q 047629 333 MNLSEHYSIG----KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLV 396 (615)
Q Consensus 333 ~~~~~~~~iG----~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV 396 (615)
.+|.....+| |.||++.. +|+.||+|.+++ .+.+|+.+++.++|+||+++++++.+. ...++|
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~-~~~~lv 121 (370)
T cd05596 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD-KYLYMV 121 (370)
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC-CEEEEE
Confidence 3444444454 48999887 688999999853 256799999999999999999987654 479999
Q ss_pred EeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecC
Q 047629 397 YEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFS 476 (615)
Q Consensus 397 ~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFG 476 (615)
|||+++|+|.+++.... ++...+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 122 ~Ey~~gg~L~~~l~~~~-----------l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG 187 (370)
T cd05596 122 MEYMPGGDLVNLMSNYD-----------IPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 187 (370)
T ss_pred EcCCCCCcHHHHHHhcC-----------CCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEecc
Confidence 99999999999986532 677888889999999999999998 9999999999999999999999999
Q ss_pred CCCCCCC----------------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHh
Q 047629 477 LAAPATN----------------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLK 528 (615)
Q Consensus 477 la~~~~~----------------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~ 528 (615)
+++.... .++.++|||||||++|||++|+.||...... ...
T Consensus 188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~-------- 256 (370)
T cd05596 188 TCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---GTY-------- 256 (370)
T ss_pred ceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH---HHH--------
Confidence 9753210 1356899999999999999999999754321 001
Q ss_pred HHHHHHHHHhhhcCCcCCCCCCh--HHHHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 047629 529 VEEKREERLRNWMDPNLESFYPI--DGALSLATLARACTMDKSLS--RPNMAEVVFN 581 (615)
Q Consensus 529 ~~~~~~~~~~~~~dp~l~~~~~~--~~~~~l~~l~~~C~~~dP~~--RPsm~ev~~~ 581 (615)
.++++..-.-.++. .....+.+++..|++.+|.+ ||++.|++++
T Consensus 257 ---------~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 257 ---------SKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ---------HHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 11111000001111 23456789999999999988 9999999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=285.82 Aligned_cols=211 Identities=25% Similarity=0.379 Sum_probs=171.8
Q ss_pred eEEEEEE-C-CeEEEEEEcc-------HHHHHHHHHHHhcC-CCCcccEEEE-EEcC--C---CcEEEEEeecCCCCHHH
Q 047629 344 SVYRATI-D-GKVLAVKKIK-------EDVTEELRILQRIN-HANLVKLMGV-SSDS--Q---GNRFLVYEYAENGSLDK 407 (615)
Q Consensus 344 ~Vy~~~~-~-g~~vAvK~~~-------~~~~~Ei~~l~~l~-H~niv~l~g~-~~~~--~---~~~~lV~E~~~~GsL~~ 407 (615)
.||.+.. . |..+|+|++- +.+.+||++|++|+ |+|||.+++. .... + -+.+|.||||++|+|-+
T Consensus 52 ~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd 131 (738)
T KOG1989|consen 52 QVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVD 131 (738)
T ss_pred EEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHH
Confidence 7999998 3 4899999984 34789999999996 9999999993 2211 1 24789999999999999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCC------
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA------ 481 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~------ 481 (615)
++...... .|++.++++|+.|+++|+.+||.. .|+|||||||.+||||+.++..||||||.|...
T Consensus 132 ~mn~Rlq~--------~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~ 202 (738)
T KOG1989|consen 132 FMNTRLQT--------RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTS 202 (738)
T ss_pred HHHHHHhc--------cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccccCCCcc
Confidence 99865432 399999999999999999999998 688999999999999999999999999988421
Q ss_pred -----------------------------CCCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHH
Q 047629 482 -----------------------------TNDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEK 532 (615)
Q Consensus 482 -----------------------------~~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 532 (615)
...+++|+||||+||+||-|+....||+....
T Consensus 203 ~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~------------------- 263 (738)
T KOG1989|consen 203 AQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK------------------- 263 (738)
T ss_pred HHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-------------------
Confidence 11256899999999999999999999976421
Q ss_pred HHHHHhhhcCCcCCCCCC--hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccch
Q 047629 533 REERLRNWMDPNLESFYP--IDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQST 589 (615)
Q Consensus 533 ~~~~~~~~~dp~l~~~~~--~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~ 589 (615)
..+++.+. .+| ......+.+|++.||+.||++||++-||++.+.++....
T Consensus 264 -----laIlng~Y--~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 264 -----LAILNGNY--SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred -----eeEEeccc--cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 01122111 122 356678999999999999999999999999998887653
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=262.98 Aligned_cols=225 Identities=24% Similarity=0.391 Sum_probs=165.9
Q ss_pred ceEEEEEE------CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCC-CcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATI------DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQ-GNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~------~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~~lV~E~~~~GsL~~ 407 (615)
+.||.+.+ +++.||+|.++ ..+.+|++++++++|+|++++.+++.+.+ ...++||||+++|+|.+
T Consensus 18 g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~ 97 (284)
T cd05079 18 GKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKE 97 (284)
T ss_pred eeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHH
Confidence 47998874 47889999986 34778999999999999999999987542 35899999999999999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----- 482 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----- 482 (615)
++..... .++|.++..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++...
T Consensus 98 ~l~~~~~---------~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 165 (284)
T cd05079 98 YLPRNKN---------KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY 165 (284)
T ss_pred HHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccccccCccc
Confidence 9965432 3899999999999999999999998 9999999999999999999999999885321
Q ss_pred ---------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhc
Q 047629 483 ---------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWM 541 (615)
Q Consensus 483 ---------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 541 (615)
..++.++||||||+++|||++++.|....... ..+..... ..+.. .....+.+
T Consensus 166 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~----~~~~~~~~-~~~~~-~~~~~~~~ 239 (284)
T cd05079 166 YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTL----FLKMIGPT-HGQMT-VTRLVRVL 239 (284)
T ss_pred eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccch----hhhhcccc-ccccc-HHHHHHHH
Confidence 12456899999999999999988764321110 00000000 00000 00000000
Q ss_pred CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 047629 542 DPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVL 585 (615)
Q Consensus 542 dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l 585 (615)
........+......+.+++.+|++.||++||++.|+++.|+.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 240 EEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00001111233456789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=260.92 Aligned_cols=209 Identities=25% Similarity=0.362 Sum_probs=163.0
Q ss_pred ceEEEEEE--CCeEEEEEEccH-------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATI--DGKVLAVKKIKE-------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~-------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
+.||+|.. +|+.||+|+++. .+.+|+.++++++|+||+++++++... +..++|+||+++|+|.++++...
T Consensus 23 g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~-~~~~iv~e~~~~~~L~~~~~~~~ 101 (267)
T cd06646 23 GDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR-EKLWICMEYCGGGSLQDIYHVTG 101 (267)
T ss_pred eEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC-CEEEEEEeCCCCCcHHHHHHhcC
Confidence 48999997 789999998852 366899999999999999999998754 47899999999999999987543
Q ss_pred CCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----------
Q 047629 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----------- 482 (615)
Q Consensus 414 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----------- 482 (615)
.+++.++..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 102 ----------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 168 (267)
T cd06646 102 ----------PLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIG 168 (267)
T ss_pred ----------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccccccCcccc
Confidence 2889999999999999999999987 9999999999999999999999999875321
Q ss_pred ---------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCC
Q 047629 483 ---------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLES 547 (615)
Q Consensus 483 ---------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~ 547 (615)
...+.++|||||||++|||++|+.|+......+....+ ....+..+.+..
T Consensus 169 ~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~---------------~~~~~~~~~~~~ 233 (267)
T cd06646 169 TPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM---------------SKSNFQPPKLKD 233 (267)
T ss_pred CccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee---------------ecCCCCCCCCcc
Confidence 01345799999999999999999998543211100000 000111111111
Q ss_pred CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047629 548 FYPIDGALSLATLARACTMDKSLSRPNMAEVVFNL 582 (615)
Q Consensus 548 ~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L 582 (615)
.......+.+++.+||+.+|++||+++++++.|
T Consensus 234 --~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 234 --KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred --ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 112235688999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-30 Score=261.06 Aligned_cols=216 Identities=24% Similarity=0.411 Sum_probs=165.5
Q ss_pred ceEEEEEE-------CCeEEEEEEcc-------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHh
Q 047629 343 KSVYRATI-------DGKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKW 408 (615)
Q Consensus 343 ~~Vy~~~~-------~g~~vAvK~~~-------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~ 408 (615)
|.||++.. ++..+|+|.++ .++.+|++++++++|+||+++++++.+. +..++++||+++|+|.++
T Consensus 19 g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~ 97 (280)
T cd05092 19 GKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEG-RPLLMVFEYMRHGDLNRF 97 (280)
T ss_pred CeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC-CceEEEEecCCCCCHHHH
Confidence 48998863 35689999875 3588899999999999999999998754 478999999999999999
Q ss_pred hccCCCCCC-----CCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-
Q 047629 409 LHPKSKSSS-----SSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT- 482 (615)
Q Consensus 409 L~~~~~~~~-----~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~- 482 (615)
+........ .......+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 98 i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~ 174 (280)
T cd05092 98 LRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS 174 (280)
T ss_pred HHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCEEECCCCceeEcCC
Confidence 976432100 0001124899999999999999999999998 9999999999999999999999999875320
Q ss_pred ------------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHH
Q 047629 483 ------------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERL 537 (615)
Q Consensus 483 ------------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 537 (615)
...+.++|||||||++|||++ |+.|+......+. +. ..
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~------~~-----------~~ 237 (280)
T cd05092 175 TDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA------IE-----------CI 237 (280)
T ss_pred CceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH------HH-----------HH
Confidence 124568999999999999998 8888864332111 00 01
Q ss_pred hhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047629 538 RNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLS 583 (615)
Q Consensus 538 ~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~ 583 (615)
.....+ ..+......+.+++.+||+.||.+||++.||.+.|+
T Consensus 238 ~~~~~~----~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 238 TQGREL----ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HcCccC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 111111 112233456789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=261.39 Aligned_cols=214 Identities=25% Similarity=0.433 Sum_probs=159.5
Q ss_pred CeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCCCCC-CCcc
Q 047629 352 GKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSS-SGSV 422 (615)
Q Consensus 352 g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~~~-~~~~ 422 (615)
+..+|+|.++ .++.+|++++++++|+||+++++++... +..++||||+++|+|.+++......... ....
T Consensus 46 ~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 124 (296)
T cd05095 46 PVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITS-DPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124 (296)
T ss_pred eeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC-CccEEEEEeCCCCcHHHHHHhcCcccccccccc
Confidence 3568999886 2477899999999999999999998754 4789999999999999999764422111 1112
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------------------
Q 047629 423 IFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------------------- 482 (615)
Q Consensus 423 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------------------- 482 (615)
..+++.++..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++...
T Consensus 125 ~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p 201 (296)
T cd05095 125 VTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSW 201 (296)
T ss_pred cccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCH
Confidence 34889999999999999999999998 9999999999999999999999999986421
Q ss_pred -----CCCCCcccchhHHHHHHHHHc--CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHH
Q 047629 483 -----NDVMPKFDVFAFGVVLLELLS--GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGAL 555 (615)
Q Consensus 483 -----~~~~~k~DV~SfGvvl~Ellt--G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~ 555 (615)
..++.++|||||||++|||++ |..|+......+. +......+. ........ ..+..+..
T Consensus 202 e~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~---~~~~~~~~~------~~~~~~~~-----~~~~~~~~ 267 (296)
T cd05095 202 ESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV---IENTGEFFR------DQGRQVYL-----PKPALCPD 267 (296)
T ss_pred HHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH---HHHHHHHHh------hccccccC-----CCCCCCCH
Confidence 113568999999999999998 6677754332111 111111000 00000000 11223346
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047629 556 SLATLARACTMDKSLSRPNMAEVVFNLS 583 (615)
Q Consensus 556 ~l~~l~~~C~~~dP~~RPsm~ev~~~L~ 583 (615)
.+.+++.+||+.||++||+|.||++.|+
T Consensus 268 ~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 268 SLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 7899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=257.35 Aligned_cols=208 Identities=25% Similarity=0.402 Sum_probs=165.0
Q ss_pred ceEEEEEE-CCeEEEEEEcc------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCC
Q 047629 343 KSVYRATI-DGKVLAVKKIK------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKS 415 (615)
Q Consensus 343 ~~Vy~~~~-~g~~vAvK~~~------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~ 415 (615)
+.||++.. ++..+|+|.++ ..+.+|++++++++|+||+++.+++.+ ...+++|||+++|+|.+++......
T Consensus 20 ~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~v~e~~~~~~L~~~~~~~~~~ 97 (260)
T cd05073 20 GEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK--EPIYIITEFMAKGSLLDFLKSDEGS 97 (260)
T ss_pred eEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC--CCeEEEEEeCCCCcHHHHHHhCCcc
Confidence 58999987 56789999875 347789999999999999999998765 4689999999999999999764321
Q ss_pred CCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------------
Q 047629 416 SSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------------- 482 (615)
Q Consensus 416 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------------- 482 (615)
.++|.++..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 98 --------~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 166 (260)
T cd05073 98 --------KQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP 166 (260)
T ss_pred --------ccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccCCccc
Confidence 3789999999999999999999987 9999999999999999999999999875321
Q ss_pred -----------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 483 -----------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 483 -----------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
...+.++|||||||++||+++ |+.|+....... +.. .+..-.. ...+
T Consensus 167 ~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~--------------~~~~~~~----~~~~ 225 (260)
T cd05073 167 IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIR--------------ALERGYR----MPRP 225 (260)
T ss_pred ccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---HHH--------------HHhCCCC----CCCc
Confidence 113457999999999999999 888886543211 110 0111001 1112
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 047629 551 IDGALSLATLARACTMDKSLSRPNMAEVVFNLSV 584 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~ 584 (615)
......+.+++.+|++.+|++||++.++.+.|+.
T Consensus 226 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 226 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 2334568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=265.15 Aligned_cols=221 Identities=25% Similarity=0.438 Sum_probs=168.4
Q ss_pred ceEEEEEE---------CCeEEEEEEccH--------HHHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCC
Q 047629 343 KSVYRATI---------DGKVLAVKKIKE--------DVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGS 404 (615)
Q Consensus 343 ~~Vy~~~~---------~g~~vAvK~~~~--------~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~Gs 404 (615)
+.||++.. .+..+|+|.++. ++..|+++++++ +|+||+++++++.+ ++..++++||+++|+
T Consensus 26 g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~~~~~lv~e~~~~g~ 104 (314)
T cd05099 26 GQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ-EGPLYVIVEYAAKGN 104 (314)
T ss_pred ccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc-CCceEEEEecCCCCc
Confidence 47998864 245799998762 467899999999 69999999999875 447899999999999
Q ss_pred HHHhhccCCCCCCC------CCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCC
Q 047629 405 LDKWLHPKSKSSSS------SGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA 478 (615)
Q Consensus 405 L~~~L~~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla 478 (615)
|.+++......... ......++|.++..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++
T Consensus 105 L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~~~kL~Dfg~~ 181 (314)
T cd05099 105 LREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLA 181 (314)
T ss_pred HHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEcCCCcEEEcccccc
Confidence 99999764321000 001124899999999999999999999988 999999999999999999999999998
Q ss_pred CCCC-------------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHH
Q 047629 479 APAT-------------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEK 532 (615)
Q Consensus 479 ~~~~-------------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 532 (615)
+... ..++.++|||||||++|||++ |+.|+......+ .. .
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~----~------- 247 (314)
T cd05099 182 RGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE---LF----K------- 247 (314)
T ss_pred ccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH---HH----H-------
Confidence 6431 113568999999999999999 888885433110 11 0
Q ss_pred HHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 533 REERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 533 ~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
.+.... ....+......+.+++.+||+.+|++||++.|+++.|..+...
T Consensus 248 ---~~~~~~----~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 248 ---LLREGH----RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred ---HHHcCC----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 011100 1122334445688999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=270.55 Aligned_cols=203 Identities=24% Similarity=0.340 Sum_probs=161.4
Q ss_pred ceEEEEEE--CCeEEEEEEccHH----------HHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKED----------VTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~~----------~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||++.. +|+.||+|.++.. +..|++++.+++|+||+++.+++... +..++||||+++|+|..++.
T Consensus 9 g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~-~~~~lv~E~~~~~~L~~~l~ 87 (325)
T cd05594 9 GKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH-DRLCFVMEYANGGELFFHLS 87 (325)
T ss_pred EEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcC-CEEEEEEeCCCCCcHHHHHH
Confidence 58999886 7899999998642 45688999999999999999987654 47999999999999999987
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHE-HAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------- 482 (615)
... .+++.++..++.|++.||.|||+ .+ |+||||||+|||++.++.+||+|||+++...
T Consensus 88 ~~~----------~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (325)
T cd05594 88 RER----------VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 154 (325)
T ss_pred hcC----------CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccc
Confidence 543 38999999999999999999997 56 9999999999999999999999999875321
Q ss_pred ----------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCC
Q 047629 483 ----------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLE 546 (615)
Q Consensus 483 ----------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~ 546 (615)
..++.++|||||||++|||++|+.||....... .. ... .. ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~---~~----~~i---------~~--~~~~-- 214 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LF----ELI---------LM--EEIR-- 214 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH---HH----HHH---------hc--CCCC--
Confidence 124568999999999999999999996543211 00 000 00 0111
Q ss_pred CCCChHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 047629 547 SFYPIDGALSLATLARACTMDKSLSRP-----NMAEVVFN 581 (615)
Q Consensus 547 ~~~~~~~~~~l~~l~~~C~~~dP~~RP-----sm~ev~~~ 581 (615)
++......+.+++.+|++.||++|+ ++.|++++
T Consensus 215 --~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 215 --FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred --CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 2223344578999999999999996 89999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=257.91 Aligned_cols=204 Identities=21% Similarity=0.360 Sum_probs=156.6
Q ss_pred ceEEEEEEC--------------CeEEEEEEccH-------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecC
Q 047629 343 KSVYRATID--------------GKVLAVKKIKE-------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAE 401 (615)
Q Consensus 343 ~~Vy~~~~~--------------g~~vAvK~~~~-------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~ 401 (615)
+.||+|.+. ...||+|.+.. .+.+|+.++++++||||+++++++.+. ...++||||++
T Consensus 9 ~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~ 87 (262)
T cd05077 9 TQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRD-VENIMVEEFVE 87 (262)
T ss_pred ceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CCCEEEEeccc
Confidence 478888752 23589998752 467789999999999999999998754 47899999999
Q ss_pred CCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCc-------EEEee
Q 047629 402 NGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFK-------AKIAN 474 (615)
Q Consensus 402 ~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~-------~kl~D 474 (615)
+|+|..++..... .+++..+++++.|++.||+|||+++ |+||||||+|||++.++. +|++|
T Consensus 88 ~~~l~~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 88 FGPLDLFMHRKSD---------VLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred CCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 9999999875432 3899999999999999999999988 999999999999987654 89999
Q ss_pred cCCCCCCC--------------------CCCCCcccchhHHHHHHHHH-cCCCCCCCCCCChhHHHHHHHHHHHhHHHHH
Q 047629 475 FSLAAPAT--------------------NDVMPKFDVFAFGVVLLELL-SGKKATRTTENGKTAVLWKEIREVLKVEEKR 533 (615)
Q Consensus 475 FGla~~~~--------------------~~~~~k~DV~SfGvvl~Ell-tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 533 (615)
||++.... ..++.++|||||||++|||+ .|+.|+......+. ..
T Consensus 156 ~g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-------~~-------- 220 (262)
T cd05077 156 PGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-------ER-------- 220 (262)
T ss_pred CCCCccccCcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-------HH--------
Confidence 99875321 12456799999999999998 57777654321110 00
Q ss_pred HHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047629 534 EERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNL 582 (615)
Q Consensus 534 ~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L 582 (615)
+. ..... ........+.+|+..||+.||.+||++.||++.+
T Consensus 221 ---~~---~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 221 ---FY---EGQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred ---HH---hcCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 00 00000 0111234678999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=258.79 Aligned_cols=211 Identities=22% Similarity=0.395 Sum_probs=167.5
Q ss_pred ceEEEEEE--CCe----EEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHh
Q 047629 343 KSVYRATI--DGK----VLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKW 408 (615)
Q Consensus 343 ~~Vy~~~~--~g~----~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~ 408 (615)
+.||+|.. +|+ .+|+|.++ ..+.+|+.++++++|+||++++++|.. ...++|+||+++|+|.++
T Consensus 21 g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~v~e~~~~g~L~~~ 98 (279)
T cd05057 21 GTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS--SQVQLITQLMPLGCLLDY 98 (279)
T ss_pred ccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--CceEEEEecCCCCcHHHH
Confidence 48999986 343 68999875 246789999999999999999999875 478999999999999999
Q ss_pred hccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC------
Q 047629 409 LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------ 482 (615)
Q Consensus 409 L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------ 482 (615)
+..... .+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++...
T Consensus 99 l~~~~~---------~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 166 (279)
T cd05057 99 VRNHKD---------NIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY 166 (279)
T ss_pred HHhccC---------CCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccCcccce
Confidence 976543 3899999999999999999999987 9999999999999999999999999886431
Q ss_pred -------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcC
Q 047629 483 -------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMD 542 (615)
Q Consensus 483 -------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~d 542 (615)
...+.++||||||+++||+++ |+.|+......+ +.. .+....
T Consensus 167 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~----------~~~~~~- 228 (279)
T cd05057 167 HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-------IPD----------LLEKGE- 228 (279)
T ss_pred ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHH----------HHhCCC-
Confidence 123457999999999999999 999986543111 111 111100
Q ss_pred CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 543 PNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 543 p~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
....+..+...+.+++..||..||.+||++.++++.|..+...
T Consensus 229 ---~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 229 ---RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 0111222335678999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-30 Score=260.79 Aligned_cols=212 Identities=18% Similarity=0.244 Sum_probs=162.4
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||++.. +|+.+|+|++.. .+..|++++++++|+||+++.+++.+ +...++||||+++|+|.+++.
T Consensus 7 g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~-~~~~~lv~e~~~g~~L~~~~~ 85 (277)
T cd05607 7 GEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES-KTHLCLVMSLMNGGDLKYHIY 85 (277)
T ss_pred eEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec-CCeEEEEEecCCCCCHHHHHH
Confidence 48999887 689999998853 23459999999999999999998765 447899999999999999886
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
.... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 86 ~~~~--------~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 154 (277)
T cd05607 86 NVGE--------RGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQR 154 (277)
T ss_pred hccc--------cCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeecc
Confidence 5432 13889999999999999999999998 9999999999999999999999999875321
Q ss_pred --------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCC
Q 047629 483 --------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESF 548 (615)
Q Consensus 483 --------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~ 548 (615)
..++.++|||||||++|||++|+.|+.......... . +. ...+...+...
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~--~-~~---------~~~~~~~~~~~---- 218 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE--E-LK---------RRTLEDEVKFE---- 218 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHH--H-HH---------HHhhccccccc----
Confidence 124568999999999999999999986543211100 0 00 00111111100
Q ss_pred CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047629 549 YPIDGALSLATLARACTMDKSLSRPNMAEVVFNLS 583 (615)
Q Consensus 549 ~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~ 583 (615)
.......+.+++..|++.||++||+++|+++.+.
T Consensus 219 -~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 219 -HQNFTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred -cccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 0122345789999999999999999988765443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-30 Score=268.09 Aligned_cols=203 Identities=24% Similarity=0.375 Sum_probs=160.7
Q ss_pred ceEEEEEE--CCeEEEEEEccHH----------HHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATI--DGKVLAVKKIKED----------VTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~~----------~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
|.||+|.. +|+.||||.++.+ +..|.+++..+ +|+||+++++++.+. +..++||||+++|+|..++
T Consensus 9 g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~-~~~~lv~E~~~~~~L~~~l 87 (321)
T cd05591 9 GKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK-DRLFFVMEYVNGGDLMFQI 87 (321)
T ss_pred eEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC-CeEEEEEeCCCCCcHHHHH
Confidence 58999987 5789999998642 45688888876 899999999998754 4799999999999999998
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------- 482 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------- 482 (615)
.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 88 ~~~~----------~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05591 88 QRSR----------KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTT 154 (321)
T ss_pred HHcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCcccc
Confidence 7543 2889999999999999999999998 9999999999999999999999999875321
Q ss_pred ----------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCC
Q 047629 483 ----------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLE 546 (615)
Q Consensus 483 ----------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~ 546 (615)
..++.++|||||||++|||++|+.||......+ ... .. ... +.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~---~~~---~i----------~~~--~~--- 213 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD---LFE---SI----------LHD--DV--- 213 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH---HHH---HH----------HcC--CC---
Confidence 124568999999999999999999997543211 110 00 000 00
Q ss_pred CCCChHHHHHHHHHHHHhhhcCCCCCC-------CHHHHHHH
Q 047629 547 SFYPIDGALSLATLARACTMDKSLSRP-------NMAEVVFN 581 (615)
Q Consensus 547 ~~~~~~~~~~l~~l~~~C~~~dP~~RP-------sm~ev~~~ 581 (615)
.++......+.+++..|++.||++|| ++.+++++
T Consensus 214 -~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 214 -LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred -CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 12222334578999999999999999 78888765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=273.45 Aligned_cols=206 Identities=23% Similarity=0.285 Sum_probs=162.8
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||++.. +|+.||||+++. .+.+|++++..++|+||+++++++.+. ...++||||+++|+|.+++.
T Consensus 15 g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~ 93 (350)
T cd05573 15 GEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDE-EHLYLVMEYMPGGDLMNLLI 93 (350)
T ss_pred EEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecC-CeEEEEEcCCCCCCHHHHHH
Confidence 58999998 589999999863 356799999999999999999988754 47999999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC-------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------- 483 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------- 483 (615)
... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~~~----------~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 94 RKD----------VFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred HcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 653 3889999999999999999999988 99999999999999999999999999864311
Q ss_pred ---------------------------------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHH
Q 047629 484 ---------------------------------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAV 518 (615)
Q Consensus 484 ---------------------------------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~ 518 (615)
.++.++|||||||++|||++|+.||......+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~--- 237 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE--- 237 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH---
Confidence 13568999999999999999999997544211
Q ss_pred HHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCC-HHHHHHH
Q 047629 519 LWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPN-MAEVVFN 581 (615)
Q Consensus 519 l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPs-m~ev~~~ 581 (615)
.+ . .+..+. ..+.-.........+.+++..|+. ||.+||+ +.|+++.
T Consensus 238 ~~---~-----------~i~~~~-~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 238 TY---N-----------KIINWK-ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HH---H-----------HHhccC-CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 01 0 011100 001000001124567899999997 9999999 9999985
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=271.07 Aligned_cols=199 Identities=22% Similarity=0.303 Sum_probs=157.8
Q ss_pred ceEEEEEE-----CCeEEEEEEccH---------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHh
Q 047629 343 KSVYRATI-----DGKVLAVKKIKE---------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKW 408 (615)
Q Consensus 343 ~~Vy~~~~-----~g~~vAvK~~~~---------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~ 408 (615)
|.||++.. +|+.+|+|+++. .+..|++++++++|+||+++++++.+ ++..++||||+++|+|.++
T Consensus 10 g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~~~L~~~ 88 (318)
T cd05582 10 GKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT-EGKLYLILDFLRGGDLFTR 88 (318)
T ss_pred EEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc-CCEEEEEEcCCCCCcHHHH
Confidence 47887753 578999999863 24569999999999999999999875 4579999999999999999
Q ss_pred hccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC------
Q 047629 409 LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------ 482 (615)
Q Consensus 409 L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------ 482 (615)
+.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 89 l~~~~----------~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 155 (318)
T cd05582 89 LSKEV----------MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 155 (318)
T ss_pred HHHcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCce
Confidence 96543 3899999999999999999999998 9999999999999999999999999986431
Q ss_pred -----------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcC
Q 047629 483 -----------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNL 545 (615)
Q Consensus 483 -----------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l 545 (615)
...+.++|||||||++|||++|+.||......+ .. .. +....
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~---~~--------------i~~~~- 214 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE---TM---TM--------------ILKAK- 214 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH---HH---HH--------------HHcCC-
Confidence 123568999999999999999999997543211 00 00 00000
Q ss_pred CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHH
Q 047629 546 ESFYPIDGALSLATLARACTMDKSLSRPNMAE 577 (615)
Q Consensus 546 ~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~e 577 (615)
...+......+.+++.+||+.||++||++.+
T Consensus 215 -~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 215 -LGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred -CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1122233445789999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=262.23 Aligned_cols=204 Identities=24% Similarity=0.409 Sum_probs=164.8
Q ss_pred ceEEEEEE--CCeEEEEEEccHH----------HHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKED----------VTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~~----------~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.|-++.- .|+.||||.++++ +.+||+||+.++||||+.++.+|.+.+ .+.|||||..+|.|++|+.
T Consensus 67 GKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkd-KIvivMEYaS~GeLYDYiS 145 (668)
T KOG0611|consen 67 GKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKD-KIVIVMEYASGGELYDYIS 145 (668)
T ss_pred cceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCc-eEEEEEEecCCccHHHHHH
Confidence 34555543 6899999998753 578999999999999999999987654 8999999999999999998
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCCC------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATND------ 484 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~------ 484 (615)
..+. |++.....+++||..++.|+|.++ ++|||||.+|||||.|+++||+||||+......
T Consensus 146 er~~----------LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLqTF 212 (668)
T KOG0611|consen 146 ERGS----------LSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQTF 212 (668)
T ss_pred Hhcc----------ccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccccHHHHh
Confidence 8663 999999999999999999999998 999999999999999999999999998654211
Q ss_pred -----------------CCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCC
Q 047629 485 -----------------VMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLES 547 (615)
Q Consensus 485 -----------------~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~ 547 (615)
-.+.+|-||+||+||.|+.|..||++.+... ++..+. .+..+
T Consensus 213 CGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~---lvrQIs---------~GaYr--------- 271 (668)
T KOG0611|consen 213 CGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR---LVRQIS---------RGAYR--------- 271 (668)
T ss_pred cCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH---HHHHhh---------ccccc---------
Confidence 2468999999999999999999998765211 111110 11111
Q ss_pred CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047629 548 FYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLS 583 (615)
Q Consensus 548 ~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~ 583 (615)
..+.+....-|+++++..||++|.|..+|..+..
T Consensus 272 --EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 272 --EPETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred --CCCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 1122233578899999999999999999998754
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-30 Score=265.17 Aligned_cols=224 Identities=21% Similarity=0.315 Sum_probs=164.6
Q ss_pred ceEEEEEE--CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATI--DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
+.||++.. +|+.+|+|.++ .++.+|++++.+++|+||+++++++.+ ++..++|+||+++|+|.+++...
T Consensus 15 g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ey~~~~~L~~~l~~~ 93 (308)
T cd06615 15 GVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYS-DGEISICMEHMDGGSLDQVLKKA 93 (308)
T ss_pred eEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-CCEEEEEeeccCCCcHHHHHHhc
Confidence 48999987 67889999874 236789999999999999999999875 45899999999999999999765
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC---------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEH-AQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT--------- 482 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~--------- 482 (615)
. .+++..+..++.|++.||.|||+. + ++||||||+|||++.++.+||+|||++....
T Consensus 94 ~----------~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 160 (308)
T cd06615 94 G----------RIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVG 160 (308)
T ss_pred C----------CCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccccccccCCC
Confidence 3 288999999999999999999984 5 9999999999999999999999999875421
Q ss_pred ------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHH----------------HHHH
Q 047629 483 ------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVE----------------EKRE 534 (615)
Q Consensus 483 ------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~----------------~~~~ 534 (615)
..++.++||||||+++|||++|+.|+...........+.......... ....
T Consensus 161 ~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (308)
T cd06615 161 TRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIF 240 (308)
T ss_pred CcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHH
Confidence 124568999999999999999999986433211111000000000000 0000
Q ss_pred HHHhhhc---CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047629 535 ERLRNWM---DPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLS 583 (615)
Q Consensus 535 ~~~~~~~---dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~ 583 (615)
......+ .|.+.. ......+.+++.+|++.||++||++.||++..-
T Consensus 241 ~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 289 (308)
T cd06615 241 ELLDYIVNEPPPKLPS---GAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289 (308)
T ss_pred HHHHHHhcCCCccCcC---cccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 0011111 111111 012345889999999999999999999998754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-30 Score=262.73 Aligned_cols=209 Identities=21% Similarity=0.275 Sum_probs=164.0
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||++.. +|+.||+|++.. .+.+|+.++++++|+||+++++++... ...++||||+++|+|.+++.
T Consensus 14 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~ 92 (285)
T cd05605 14 GEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK-DALCLVLTLMNGGDLKFHIY 92 (285)
T ss_pred eEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCC-CeEEEEEeccCCCcHHHHHH
Confidence 58999987 689999998853 245799999999999999999988654 47999999999999999886
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
..... .+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++....
T Consensus 93 ~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 161 (285)
T cd05605 93 NMGNP--------GFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR 161 (285)
T ss_pred hcCcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCCccccc
Confidence 53321 3899999999999999999999998 9999999999999999999999999886431
Q ss_pred --------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCC
Q 047629 483 --------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESF 548 (615)
Q Consensus 483 --------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~ 548 (615)
...+.++|||||||++|||++|+.||........ ...+.. .+.. ....
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~---~~~~~~----------~~~~-----~~~~ 223 (285)
T cd05605 162 VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK---REEVER----------RVKE-----DQEE 223 (285)
T ss_pred cCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH---HHHHHH----------Hhhh-----cccc
Confidence 1135679999999999999999999975432111 111110 1110 0112
Q ss_pred CChHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 047629 549 YPIDGALSLATLARACTMDKSLSRP-----NMAEVVFN 581 (615)
Q Consensus 549 ~~~~~~~~l~~l~~~C~~~dP~~RP-----sm~ev~~~ 581 (615)
++......+.+|+..||+.||++|| ++++++++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 224 YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 2333445678999999999999999 78888665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=256.88 Aligned_cols=215 Identities=24% Similarity=0.393 Sum_probs=164.6
Q ss_pred ceEEEEEE-----CCeEEEEEEccH---------HHHHHHHHHHhcCCCCcccEEEEEEcCCC-----cEEEEEeecCCC
Q 047629 343 KSVYRATI-----DGKVLAVKKIKE---------DVTEELRILQRINHANLVKLMGVSSDSQG-----NRFLVYEYAENG 403 (615)
Q Consensus 343 ~~Vy~~~~-----~g~~vAvK~~~~---------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-----~~~lV~E~~~~G 403 (615)
+.||+|.+ +|+.||||.++. ++.+|++++++++|+||+++++++...+. ..++++||+++|
T Consensus 13 g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 92 (273)
T cd05074 13 GSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHG 92 (273)
T ss_pred CCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCC
Confidence 48999986 368899998752 36789999999999999999998764321 247899999999
Q ss_pred CHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC
Q 047629 404 SLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN 483 (615)
Q Consensus 404 sL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~ 483 (615)
+|.+++........ ...+++..+.+++.|++.||+|||+.+ |+||||||+||+++.++.+|++|||+++....
T Consensus 93 ~l~~~~~~~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg~~~~~~~ 165 (273)
T cd05074 93 DLHTFLLMSRIGEE----PFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYS 165 (273)
T ss_pred cHHHHHHHhcccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcccccccccC
Confidence 99998864321111 123889999999999999999999987 99999999999999999999999999864311
Q ss_pred -------------------------CCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHH
Q 047629 484 -------------------------DVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERL 537 (615)
Q Consensus 484 -------------------------~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 537 (615)
..+.++||||||+++|||++ |+.|+......+ .... +
T Consensus 166 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~~~~--------------~ 228 (273)
T cd05074 166 GDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYNY--------------L 228 (273)
T ss_pred CcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---HHHH--------------H
Confidence 13457999999999999999 888876433211 1100 0
Q ss_pred hhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 047629 538 RNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVL 585 (615)
Q Consensus 538 ~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l 585 (615)
...... ..+.+....+.+++.+||+.+|++||++.|+++.|+.+
T Consensus 229 ~~~~~~----~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 229 IKGNRL----KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HcCCcC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000111 11223445789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-30 Score=272.97 Aligned_cols=206 Identities=20% Similarity=0.316 Sum_probs=158.4
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||++.. +|+.||||+++. .+.+|++++.+++|+||+++++++.+. ...++||||+++|+|.+++.
T Consensus 15 g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~-~~~~lv~E~~~gg~L~~~l~ 93 (381)
T cd05626 15 GEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDK-DNLYFVMDYIPGGDMMSLLI 93 (381)
T ss_pred EEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecC-CEEEEEEecCCCCcHHHHHH
Confidence 58999987 688999999853 256799999999999999999998764 47999999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCC---------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA--------- 481 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~--------- 481 (615)
... .+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 94 ~~~----------~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 94 RME----------VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred hcC----------CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 643 2888999999999999999999998 999999999999999999999999986421
Q ss_pred -------------------------------------------------------------CCCCCCcccchhHHHHHHH
Q 047629 482 -------------------------------------------------------------TNDVMPKFDVFAFGVVLLE 500 (615)
Q Consensus 482 -------------------------------------------------------------~~~~~~k~DV~SfGvvl~E 500 (615)
...++.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~e 240 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHH
Confidence 0124568999999999999
Q ss_pred HHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhc-CCcCCCCCChHHHHHHHHHHHH--hhhcCCCCCCCHHH
Q 047629 501 LLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWM-DPNLESFYPIDGALSLATLARA--CTMDKSLSRPNMAE 577 (615)
Q Consensus 501 lltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~-dp~l~~~~~~~~~~~l~~l~~~--C~~~dP~~RPsm~e 577 (615)
|++|+.||......+.. . .+..+. ...... .......+.+++.. |+..+|..||++.|
T Consensus 241 lltG~~Pf~~~~~~~~~------~-----------~i~~~~~~~~~~~--~~~~s~~~~dli~~ll~~~~~~~~R~~~~~ 301 (381)
T cd05626 241 MLVGQPPFLAPTPTETQ------L-----------KVINWENTLHIPP--QVKLSPEAVDLITKLCCSAEERLGRNGADD 301 (381)
T ss_pred HHhCCCCCcCCCHHHHH------H-----------HHHccccccCCCC--CCCCCHHHHHHHHHHccCcccccCCCCHHH
Confidence 99999999754421110 0 000000 001111 01122345566665 66777778999999
Q ss_pred HHHH
Q 047629 578 VVFN 581 (615)
Q Consensus 578 v~~~ 581 (615)
++.+
T Consensus 302 ~l~h 305 (381)
T cd05626 302 IKAH 305 (381)
T ss_pred HhcC
Confidence 9885
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=261.04 Aligned_cols=213 Identities=26% Similarity=0.423 Sum_probs=158.8
Q ss_pred eEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCCCCC-CCccc
Q 047629 353 KVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSS-SGSVI 423 (615)
Q Consensus 353 ~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~~~-~~~~~ 423 (615)
..||+|.+. +++.+|++++.+++|+||+++++++... +..++++||+++++|.+++......... .....
T Consensus 47 ~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 125 (296)
T cd05051 47 VLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVD-PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125 (296)
T ss_pred eeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEecC-CCcEEEEecCCCCCHHHHHHhcccccccccccCC
Confidence 568999885 2467899999999999999999998754 5789999999999999999765421000 00112
Q ss_pred ccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC---------------------
Q 047629 424 FLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT--------------------- 482 (615)
Q Consensus 424 ~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~--------------------- 482 (615)
.+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++...
T Consensus 126 ~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 202 (296)
T cd05051 126 SLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWE 202 (296)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHH
Confidence 4899999999999999999999998 9999999999999999999999999986321
Q ss_pred ----CCCCCcccchhHHHHHHHHHc--CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHH
Q 047629 483 ----NDVMPKFDVFAFGVVLLELLS--GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALS 556 (615)
Q Consensus 483 ----~~~~~k~DV~SfGvvl~Ellt--G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~ 556 (615)
...+.++||||||+++|||++ |..|+...... ..+......+ ...+.......+...+.+
T Consensus 203 ~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~---~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~ 268 (296)
T cd05051 203 SVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ---QVIENAGHFF-----------RDDGRQIYLPRPPNCPKD 268 (296)
T ss_pred HhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH---HHHHHHHhcc-----------ccccccccCCCccCCCHH
Confidence 124568999999999999998 56676543321 1111111100 000111111122233457
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047629 557 LATLARACTMDKSLSRPNMAEVVFNLS 583 (615)
Q Consensus 557 l~~l~~~C~~~dP~~RPsm~ev~~~L~ 583 (615)
+.+++.+|++.||.+||++.||++.|+
T Consensus 269 l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 269 IYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-30 Score=258.58 Aligned_cols=213 Identities=25% Similarity=0.406 Sum_probs=164.0
Q ss_pred ceEEEEEEC--------CeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHH
Q 047629 343 KSVYRATID--------GKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLD 406 (615)
Q Consensus 343 ~~Vy~~~~~--------g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~ 406 (615)
+.||+|... ++.+|||.+. ..+.+|++++++++|+||+++++++... +..++||||+++|+|.
T Consensus 9 g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e~~~~~~L~ 87 (269)
T cd05044 9 GEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLN-EPQYIIMELMEGGDLL 87 (269)
T ss_pred eeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCC-CCeEEEEeccCCCcHH
Confidence 479998862 2678999774 2467899999999999999999998754 4789999999999999
Q ss_pred HhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCC-----cEEEeecCCCCCC
Q 047629 407 KWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRF-----KAKIANFSLAAPA 481 (615)
Q Consensus 407 ~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~-----~~kl~DFGla~~~ 481 (615)
+++........ ....++|.+++.++.|++.||.|||+.+ ++|+||||+||+++.+. .+|++|||+++..
T Consensus 88 ~~l~~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~ 161 (269)
T cd05044 88 SYLRDARVERF---GPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI 161 (269)
T ss_pred HHHHHhhhccc---CCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccccccc
Confidence 99975432110 0124899999999999999999999987 99999999999999877 8999999997532
Q ss_pred C-------------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHH
Q 047629 482 T-------------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREE 535 (615)
Q Consensus 482 ~-------------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 535 (615)
. ...+.++|||||||++|||++ |+.|+......+ ....
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~~~------------- 225 (269)
T cd05044 162 YKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VLQH------------- 225 (269)
T ss_pred ccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HHHH-------------
Confidence 1 124568999999999999998 999986433211 1100
Q ss_pred HHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047629 536 RLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLS 583 (615)
Q Consensus 536 ~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~ 583 (615)
++....-..+...+..+.+++.+||+.+|.+||+++++.+.|+
T Consensus 226 -----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 226 -----VTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred -----HhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 0000011122334556889999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=270.68 Aligned_cols=156 Identities=24% Similarity=0.343 Sum_probs=135.9
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||++.. +|+.||||.+++ .+.+|+.++.+++|+||+++++.+.+. ...++||||+++|+|.+++.
T Consensus 15 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~-~~~~lv~E~~~gg~L~~~l~ 93 (363)
T cd05628 15 GEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDK-LNLYLIMEFLPGGDMMTLLM 93 (363)
T ss_pred EEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecC-CeEEEEEcCCCCCcHHHHHH
Confidence 58999987 689999999863 356799999999999999999988754 47999999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
... .+++.+...++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 94 ~~~----------~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 94 KKD----------TLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred hcC----------CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 643 3899999999999999999999998 9999999999999999999999999975321
Q ss_pred --------------------------------------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCC
Q 047629 483 --------------------------------------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTE 512 (615)
Q Consensus 483 --------------------------------------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~ 512 (615)
..++.++|||||||++|||++|+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~ 240 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCC
Confidence 124568999999999999999999997543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-30 Score=261.99 Aligned_cols=231 Identities=26% Similarity=0.384 Sum_probs=174.8
Q ss_pred eeHHHHHHHccccccccccc----ceEEEEEE--CCeEEEEEEcc------HHHHHHHHHHHhc-CCCCcccEEEEEEcC
Q 047629 323 YEIEVIMESTMNLSEHYSIG----KSVYRATI--DGKVLAVKKIK------EDVTEELRILQRI-NHANLVKLMGVSSDS 389 (615)
Q Consensus 323 ~~~~~l~~at~~~~~~~~iG----~~Vy~~~~--~g~~vAvK~~~------~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 389 (615)
+..+++..++++|.....+| +.||++.. +|+.+|+|.+. ..+.+|+.++.++ +|+|++++++++...
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 34455555667776666666 48999987 68999999885 3466899999999 899999999998643
Q ss_pred C----CcEEEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeC
Q 047629 390 Q----GNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLD 465 (615)
Q Consensus 390 ~----~~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld 465 (615)
+ +..++|+||+++|+|.++++...... ..++|..+..++.|++.||+|||+++ ++||||||+||+++
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~------~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~ 162 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICG------QRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLT 162 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcC------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEc
Confidence 3 35899999999999999986432111 13899999999999999999999987 99999999999999
Q ss_pred CCCcEEEeecCCCCCCCC----------------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhH
Q 047629 466 SRFKAKIANFSLAAPATN----------------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTA 517 (615)
Q Consensus 466 ~~~~~kl~DFGla~~~~~----------------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~ 517 (615)
.++.+||+|||+++.... ..+.++|||||||++|||++|+.|+.........
T Consensus 163 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~ 242 (291)
T cd06639 163 TEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL 242 (291)
T ss_pred CCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH
Confidence 999999999998753210 1356899999999999999999998754321110
Q ss_pred HHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 518 VLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 518 ~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
. .+.....+.+ ..+.+....+.+++.+||+.+|++||++.|++++
T Consensus 243 ------~-----------~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 243 ------F-----------KIPRNPPPTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred ------H-----------HHhcCCCCCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0 0111111111 1122333468999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-30 Score=272.47 Aligned_cols=206 Identities=22% Similarity=0.314 Sum_probs=160.0
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||++.. +|+.||||+++. .+.+|+++|..++|+||+++++++.+. ...++||||+++|+|.+++.
T Consensus 15 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~-~~~~lv~E~~~~g~L~~~l~ 93 (364)
T cd05599 15 GEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDE-NYLYLIMEYLPGGDMMTLLM 93 (364)
T ss_pred EEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC-CeEEEEECCCCCcHHHHHHH
Confidence 48999987 689999999863 246799999999999999999998754 47999999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 94 ~~~----------~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 94 KKD----------TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred HcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 643 2899999999999999999999998 9999999999999999999999999875321
Q ss_pred -----------------------------------------------------CCCCCcccchhHHHHHHHHHcCCCCCC
Q 047629 483 -----------------------------------------------------NDVMPKFDVFAFGVVLLELLSGKKATR 509 (615)
Q Consensus 483 -----------------------------------------------------~~~~~k~DV~SfGvvl~ElltG~~p~~ 509 (615)
..++.++|||||||++|||++|+.||.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~ 240 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCC
Confidence 124568999999999999999999997
Q ss_pred CCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCC---HHHHHHH
Q 047629 510 TTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPN---MAEVVFN 581 (615)
Q Consensus 510 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPs---m~ev~~~ 581 (615)
.....+. ... +..+. ..+...........+.+++.+|+. +|.+|++ ++|++.+
T Consensus 241 ~~~~~~~------~~~-----------i~~~~-~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 241 SDNPQET------YRK-----------IINWK-ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCHHHH------HHH-----------HHcCC-CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 5432110 010 11110 011000011123356788888886 8999998 8888774
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=258.17 Aligned_cols=210 Identities=27% Similarity=0.391 Sum_probs=166.4
Q ss_pred ceEEEEEEC-----CeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATID-----GKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~~-----g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
|.||+|... ...||||... +.+.+|+.++++++|+||+++++++.+ ...++||||+++|+|.+++
T Consensus 20 g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~lv~e~~~~~~L~~~l 97 (270)
T cd05056 20 GDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE--NPVWIVMELAPLGELRSYL 97 (270)
T ss_pred eeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC--CCcEEEEEcCCCCcHHHHH
Confidence 589999872 2468999875 247789999999999999999998864 3678999999999999999
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------- 482 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------- 482 (615)
..... .+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+|++|||+++...
T Consensus 98 ~~~~~---------~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~ 165 (270)
T cd05056 98 QVNKY---------SLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKA 165 (270)
T ss_pred HhCCC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecccccceec
Confidence 76432 3899999999999999999999988 9999999999999999999999999875321
Q ss_pred -----------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCc
Q 047629 483 -----------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPN 544 (615)
Q Consensus 483 -----------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~ 544 (615)
...+.++||||||+++||+++ |+.||......+.. . .+.....+
T Consensus 166 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~---~--------------~~~~~~~~- 227 (270)
T cd05056 166 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI---G--------------RIENGERL- 227 (270)
T ss_pred CCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH---H--------------HHHcCCcC-
Confidence 123567999999999999986 99998754421110 0 01100011
Q ss_pred CCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 047629 545 LESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQ 587 (615)
Q Consensus 545 l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~ 587 (615)
..+......+.+++.+|+..+|.+||++.|++..|..+..
T Consensus 228 ---~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 228 ---PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1123344568999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=266.30 Aligned_cols=202 Identities=26% Similarity=0.358 Sum_probs=156.9
Q ss_pred ceEEEEEE--CCeEEEEEEccHH----------HHHHHHHH---HhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATI--DGKVLAVKKIKED----------VTEELRIL---QRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~~----------~~~Ei~~l---~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~ 407 (615)
|.||++.. +|+.||||.++.. +.+|+.++ ++++|+||+++++++... +..++||||+++|+|..
T Consensus 13 g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~-~~~~lv~E~~~~~~L~~ 91 (324)
T cd05589 13 GKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE-DHVCFVMEYAAGGDLMM 91 (324)
T ss_pred EEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC-CEEEEEEcCCCCCcHHH
Confidence 58999987 6899999998632 34455544 566899999999998754 47999999999999999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----- 482 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----- 482 (615)
+++.. .+++.++..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++...
T Consensus 92 ~~~~~-----------~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05589 92 HIHTD-----------VFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR 157 (324)
T ss_pred HhhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCc
Confidence 88642 2899999999999999999999998 9999999999999999999999999875321
Q ss_pred ------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCc
Q 047629 483 ------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPN 544 (615)
Q Consensus 483 ------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~ 544 (615)
..++.++|||||||++|||++|+.||......+ .. . .+.. ..+
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~---~~---~-----------~i~~-~~~- 218 (324)
T cd05589 158 TSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE---VF---D-----------SIVN-DEV- 218 (324)
T ss_pred ccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH---HH---H-----------HHHh-CCC-
Confidence 124568999999999999999999997543211 00 0 0000 011
Q ss_pred CCCCCChHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 047629 545 LESFYPIDGALSLATLARACTMDKSLSRP-----NMAEVVFN 581 (615)
Q Consensus 545 l~~~~~~~~~~~l~~l~~~C~~~dP~~RP-----sm~ev~~~ 581 (615)
.++......+.+++.+|++.||.+|| ++.++++.
T Consensus 219 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 219 ---RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 12333445678999999999999999 46666653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=272.66 Aligned_cols=224 Identities=19% Similarity=0.247 Sum_probs=162.5
Q ss_pred ceEEEEEE--CCeEEEEEEccH-HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCCCCCC
Q 047629 343 KSVYRATI--DGKVLAVKKIKE-DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSS 419 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~-~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~~~~ 419 (615)
|.||++.. +++.||+|.... .+.+|+++|++++||||+++++++... ...++|+|++. ++|.+++....
T Consensus 106 g~V~~~~d~~~~~~vaiK~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~lv~e~~~-~~L~~~l~~~~------ 177 (391)
T PHA03212 106 GFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYN-KFTCLILPRYK-TDLYCYLAAKR------ 177 (391)
T ss_pred eEEEEEEECCCCCEEEEechhhhhhHHHHHHHHhCCCCCCCCEeEEEEEC-CeeEEEEecCC-CCHHHHHHhcC------
Confidence 58999987 689999998763 578899999999999999999988754 47899999995 78999886543
Q ss_pred CcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----------------
Q 047629 420 GSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----------------- 482 (615)
Q Consensus 420 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----------------- 482 (615)
.+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 178 ----~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~ 250 (391)
T PHA03212 178 ----NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATN 250 (391)
T ss_pred ----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccccCccCCC
Confidence 2889999999999999999999998 9999999999999999999999999985321
Q ss_pred -------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCC----hhHHHHHHHHHHHhH---------HHHHHHHH---hh
Q 047629 483 -------NDVMPKFDVFAFGVVLLELLSGKKATRTTENG----KTAVLWKEIREVLKV---------EEKREERL---RN 539 (615)
Q Consensus 483 -------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~----~~~~l~~~~~~~~~~---------~~~~~~~~---~~ 539 (615)
..++.++|||||||++|||++|+.|+...... ........+...... ........ ..
T Consensus 251 aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~ 330 (391)
T PHA03212 251 APELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAK 330 (391)
T ss_pred ChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHh
Confidence 12456899999999999999999887543211 000011111110000 00000000 00
Q ss_pred --hcCCcCCCCC--ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 540 --WMDPNLESFY--PIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 540 --~~dp~l~~~~--~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
...+...... ..+....+.+|+.+|++.||++|||++|+++.
T Consensus 331 ~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 331 KSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred ccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0011100000 01234568899999999999999999999874
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-29 Score=255.03 Aligned_cols=214 Identities=21% Similarity=0.337 Sum_probs=159.7
Q ss_pred ceEEEEEE-CC---eEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI-DG---KVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~-~g---~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||+|.. ++ ..+++|.++ +.+.+|+.+++.++||||+++++.|.+. ...++||||+++|+|.+++.
T Consensus 9 g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~ 87 (268)
T cd05086 9 GKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEA-IPYLLVFEYCELGDLKSYLS 87 (268)
T ss_pred ceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCC-CccEEEEecCCCCcHHHHHH
Confidence 47999875 32 346677654 3577899999999999999999998754 47899999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
...... ..+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++....
T Consensus 88 ~~~~~~------~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 88 QEQWHR------RNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred hhhccc------ccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 643211 13677888899999999999999987 9999999999999999999999999874210
Q ss_pred ------------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHH
Q 047629 483 ------------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERL 537 (615)
Q Consensus 483 ------------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 537 (615)
...+.++|||||||++|||++ |+.|+....+.+ . +...+ .+..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~---~~~~~------~~~~ 226 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE---V---LNHVI------KDQQ 226 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH---H---HHHHH------hhcc
Confidence 012457999999999999997 466775433211 1 11111 1112
Q ss_pred hhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047629 538 RNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLS 583 (615)
Q Consensus 538 ~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~ 583 (615)
....+|.+...+. ..+.+++..|| .+|++||+++||++.|.
T Consensus 227 ~~~~~~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 227 VKLFKPQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cccCCCccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 2334455443333 34678889999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=261.57 Aligned_cols=205 Identities=20% Similarity=0.330 Sum_probs=163.4
Q ss_pred ceEEEEEE--CCeEEEEEEcc-------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
+.||+|.. +|+.+|+|.+. ..+.+|+.++++++|+|++++++.+... ...++||||+++|+|.+++...
T Consensus 34 ~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~- 111 (296)
T cd06654 34 GTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-DELWVVMEYLAGGSLTDVVTET- 111 (296)
T ss_pred eEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeC-CEEEEeecccCCCCHHHHHHhc-
Confidence 58999986 68899999885 3467899999999999999999988754 4799999999999999998642
Q ss_pred CCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----------
Q 047629 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----------- 482 (615)
Q Consensus 414 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----------- 482 (615)
.+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 112 ----------~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 178 (296)
T cd06654 112 ----------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG 178 (296)
T ss_pred ----------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccccccCcccC
Confidence 2789999999999999999999998 9999999999999999999999999875321
Q ss_pred ------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 483 ------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 483 ------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
...+.++|||||||++|||++|+.||.......... . ...++......+
T Consensus 179 ~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~------~-------------~~~~~~~~~~~~ 239 (296)
T cd06654 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY------L-------------IATNGTPELQNP 239 (296)
T ss_pred CccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH------H-------------HhcCCCCCCCCc
Confidence 113568999999999999999999996543211100 0 000110001122
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 551 IDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
......+.+++.+||..||++||++.|++..
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred cccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 2334567899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=265.67 Aligned_cols=224 Identities=17% Similarity=0.245 Sum_probs=162.5
Q ss_pred eEEEEEE--CCeEEEEEEccH---------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 344 SVYRATI--DGKVLAVKKIKE---------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 344 ~Vy~~~~--~g~~vAvK~~~~---------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
.||++.. +|+.||+|+++. .+.+|+++++.++||||+++++++... +..++|+||+++|+|.+++...
T Consensus 15 ~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-~~~~lv~e~~~~~~l~~~~~~~ 93 (327)
T cd08227 15 TVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-NELWVVTSFMAYGSAKDLICTH 93 (327)
T ss_pred EEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC-CEEEEEEeccCCCcHHHHHHhh
Confidence 6888887 789999999863 255799999999999999999998764 4799999999999999999654
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCC-----------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA----------- 481 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~----------- 481 (615)
... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.++++|||.....
T Consensus 94 ~~~--------~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 162 (327)
T cd08227 94 FMD--------GMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVH 162 (327)
T ss_pred ccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccccccccc
Confidence 321 3899999999999999999999998 999999999999999999999999753110
Q ss_pred -------------------C--CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHH----hHHHHHHHH
Q 047629 482 -------------------T--NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVL----KVEEKREER 536 (615)
Q Consensus 482 -------------------~--~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~----~~~~~~~~~ 536 (615)
. ..++.++|||||||++|||++|+.||........ ......... .......+.
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 240 (327)
T cd08227 163 DFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPCLLDTTTIPAEE 240 (327)
T ss_pred cccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHhcCCccccccccchhhhh
Confidence 0 1245789999999999999999999975432111 111000000 000000000
Q ss_pred Hh-----hhcCCcC-----------------CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 537 LR-----NWMDPNL-----------------ESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 537 ~~-----~~~dp~l-----------------~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
+. ...+... ...+.......+.+++.+||+.||++|||++|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred cccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 00 0000000 001112233468899999999999999999999875
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=261.48 Aligned_cols=212 Identities=23% Similarity=0.411 Sum_probs=156.1
Q ss_pred EEEEEEccH--------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCCCC--CCCccc
Q 047629 354 VLAVKKIKE--------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSS--SSGSVI 423 (615)
Q Consensus 354 ~vAvK~~~~--------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~~--~~~~~~ 423 (615)
.||+|.++. .+.+|++++++++|+|++++++++... ...++||||+++|+|.+++........ ......
T Consensus 46 ~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 124 (295)
T cd05097 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSD-DPLCMITEYMENGDLNQFLSQREIESTFTHANNIP 124 (295)
T ss_pred EEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CccEEEEecCCCCcHHHHHHhccccccccccccCC
Confidence 589998752 477899999999999999999998754 478999999999999999965321100 000112
Q ss_pred ccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC---------------------
Q 047629 424 FLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT--------------------- 482 (615)
Q Consensus 424 ~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~--------------------- 482 (615)
.++|.+++.++.|++.||.|||+++ ++||||||+||++++++.+||+|||+++...
T Consensus 125 ~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 201 (295)
T cd05097 125 SVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWE 201 (295)
T ss_pred cccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChh
Confidence 3789999999999999999999998 9999999999999999999999999985321
Q ss_pred ----CCCCCcccchhHHHHHHHHHc--CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHH
Q 047629 483 ----NDVMPKFDVFAFGVVLLELLS--GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALS 556 (615)
Q Consensus 483 ----~~~~~k~DV~SfGvvl~Ellt--G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~ 556 (615)
..++.++|||||||++|||++ |..|+......+.. ....... . ..+.......+...+..
T Consensus 202 ~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~---~~~~~~~----------~-~~~~~~~~~~~~~~~~~ 267 (295)
T cd05097 202 SILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVI---ENTGEFF----------R-NQGRQIYLSQTPLCPSP 267 (295)
T ss_pred hhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHH---HHHHHhh----------h-hccccccCCCCCCCCHH
Confidence 123568999999999999998 45566543321111 0011000 0 00000001112223457
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047629 557 LATLARACTMDKSLSRPNMAEVVFNLS 583 (615)
Q Consensus 557 l~~l~~~C~~~dP~~RPsm~ev~~~L~ 583 (615)
+.+++.+||+.||++||+|.+|++.|.
T Consensus 268 l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 268 VFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=282.93 Aligned_cols=209 Identities=22% Similarity=0.272 Sum_probs=162.8
Q ss_pred ceEEEEEE--CCeEEEEEEccH---------HHHHHHHHHHhcCCCCcccEEEEEEcCCC-------cEEEEEeecCCCC
Q 047629 343 KSVYRATI--DGKVLAVKKIKE---------DVTEELRILQRINHANLVKLMGVSSDSQG-------NRFLVYEYAENGS 404 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~---------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-------~~~lV~E~~~~Gs 404 (615)
|.||++.. +|+.||||.++. .+.+|+.++..++|+|++++.+.+...+. ..++||||+++|+
T Consensus 46 G~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gs 125 (496)
T PTZ00283 46 GTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGD 125 (496)
T ss_pred EEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCc
Confidence 58999986 789999998842 36679999999999999998876543221 2579999999999
Q ss_pred HHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--
Q 047629 405 LDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-- 482 (615)
Q Consensus 405 L~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-- 482 (615)
|.++++...... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 126 L~~~l~~~~~~~------~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~ 196 (496)
T PTZ00283 126 LRQEIKSRAKTN------RTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDFGFSKMYAAT 196 (496)
T ss_pred HHHHHHHhhccC------CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEecccCeecccc
Confidence 999997543211 24889999999999999999999987 9999999999999999999999999986421
Q ss_pred -----------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhh
Q 047629 483 -----------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRN 539 (615)
Q Consensus 483 -----------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 539 (615)
..++.++|||||||++|||++|+.||...... .. +.. .+..
T Consensus 197 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~---~~---~~~----------~~~~ 260 (496)
T PTZ00283 197 VSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME---EV---MHK----------TLAG 260 (496)
T ss_pred ccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH---HH---HHH----------HhcC
Confidence 12456899999999999999999999653310 00 110 1111
Q ss_pred hcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 540 WMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 540 ~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
..+ ..+......+.+++..||+.||.+||++.+++.+
T Consensus 261 ~~~-----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 261 RYD-----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCC-----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111 1233344568999999999999999999999864
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=270.31 Aligned_cols=207 Identities=20% Similarity=0.262 Sum_probs=161.5
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
+.||++.. +|+.||+|+++. .+.+|+.+++.++|+||+++.+++.+. ...++||||+++|+|.+++.
T Consensus 15 g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~ 93 (330)
T cd05601 15 GEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDK-DNLYLVMEYQPGGDLLSLLN 93 (330)
T ss_pred EEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecC-CeEEEEECCCCCCCHHHHHH
Confidence 48999887 689999999863 256799999999999999999988754 47999999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 94 ~~~~---------~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 161 (330)
T cd05601 94 RYED---------QFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSK 161 (330)
T ss_pred HhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCceeee
Confidence 6532 3899999999999999999999998 9999999999999999999999999985321
Q ss_pred ----------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhh
Q 047629 483 ----------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNW 540 (615)
Q Consensus 483 ----------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 540 (615)
..++.++|||||||++|||++|+.||....... .+..... ....
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~~i~~--------~~~~ 227 (330)
T cd05601 162 LPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK------TYNNIMN--------FQRF 227 (330)
T ss_pred cccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH------HHHHHHc--------CCCc
Confidence 113467999999999999999999997543211 0111100 0000
Q ss_pred cCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 541 MDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 541 ~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.. .. ........+.+|+..|++ +|.+||++.+++..
T Consensus 228 ~~--~~--~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 228 LK--FP--EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred cC--CC--CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 00 00 011233457889999997 99999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-30 Score=266.64 Aligned_cols=203 Identities=23% Similarity=0.366 Sum_probs=159.5
Q ss_pred ceEEEEEE--CCeEEEEEEccHH----------HHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATI--DGKVLAVKKIKED----------VTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~~----------~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
|.||++.. +|+.||||.++.+ +..|..++..+ +|+||+++++++... +..++||||+++|+|.+++
T Consensus 9 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~-~~~~iv~Ey~~~g~L~~~i 87 (320)
T cd05590 9 GKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTP-DRLFFVMEFVNGGDLMFHI 87 (320)
T ss_pred eEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcC-CEEEEEEcCCCCchHHHHH
Confidence 58999987 6889999998642 34688888876 799999999988754 4799999999999999998
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------- 482 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------- 482 (615)
.... .+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++...
T Consensus 88 ~~~~----------~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (320)
T cd05590 88 QKSR----------RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTS 154 (320)
T ss_pred HHcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccc
Confidence 7654 2889999999999999999999998 9999999999999999999999999876421
Q ss_pred ----------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCC
Q 047629 483 ----------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLE 546 (615)
Q Consensus 483 ----------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~ 546 (615)
..++.++|||||||++|||++|+.||......+ ... . +....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~---~~~---~--------------i~~~~-- 212 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD---LFE---A--------------ILNDE-- 212 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH---HHH---H--------------HhcCC--
Confidence 123568999999999999999999997543211 110 0 00000
Q ss_pred CCCChHHHHHHHHHHHHhhhcCCCCCCCH------HHHHHH
Q 047629 547 SFYPIDGALSLATLARACTMDKSLSRPNM------AEVVFN 581 (615)
Q Consensus 547 ~~~~~~~~~~l~~l~~~C~~~dP~~RPsm------~ev~~~ 581 (615)
..++......+.+++.+|++.||++||++ ++++++
T Consensus 213 ~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 213 VVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred CCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 01222234457899999999999999998 555543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=253.55 Aligned_cols=215 Identities=28% Similarity=0.448 Sum_probs=167.9
Q ss_pred ceEEEEEEC-----CeEEEEEEccH--------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATID-----GKVLAVKKIKE--------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~~-----g~~vAvK~~~~--------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
+.||++... +..+|+|.++. .+.+|++.+.+++|+|++++++++.+ +...++||||+++|+|.+++
T Consensus 9 g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l 87 (262)
T cd00192 9 GEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-EEPLYLVLEYMEGGDLLDYL 87 (262)
T ss_pred eEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-CCceEEEEEeccCCcHHHHH
Confidence 589999984 78999998862 46679999999999999999999876 45799999999999999999
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------ 483 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------ 483 (615)
....... .......+++.++..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||.+.....
T Consensus 88 ~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 163 (262)
T cd00192 88 RKSRPVF-PSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRK 163 (262)
T ss_pred hhccccc-cccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccccccccc
Confidence 8752110 0000014899999999999999999999987 99999999999999999999999999865422
Q ss_pred -------------------CCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCC
Q 047629 484 -------------------DVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDP 543 (615)
Q Consensus 484 -------------------~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp 543 (615)
..+.++||||+|++++||++ |+.|+...... ..+. .+.....
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~--------------~~~~~~~- 225 (262)
T cd00192 164 KTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE---EVLE--------------YLRKGYR- 225 (262)
T ss_pred ccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH---HHHH--------------HHHcCCC-
Confidence 13457999999999999999 68888765321 1110 1111111
Q ss_pred cCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047629 544 NLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLS 583 (615)
Q Consensus 544 ~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~ 583 (615)
...+......+.+++.+||+.+|.+|||+.|++..|+
T Consensus 226 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 ---LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1223334567899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-29 Score=257.08 Aligned_cols=204 Identities=22% Similarity=0.337 Sum_probs=165.3
Q ss_pred ceEEEEEE--CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATI--DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
+.||+|.. +++.||+|.++ ..+.+|++++++++|+||+++++++.+. ...++||||+++|+|.+++...
T Consensus 18 ~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~i~~~ 96 (277)
T cd06640 18 GEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG-TKLWIIMEYLGGGSALDLLRAG 96 (277)
T ss_pred eEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-CEEEEEEecCCCCcHHHHHhcC
Confidence 58999987 58899999875 2467899999999999999999998764 4799999999999999998643
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC----------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT---------- 482 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~---------- 482 (615)
.+++.+...++.|++.||+|||+.+ ++|+||+|+||+++.++.++++|||++....
T Consensus 97 -----------~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 162 (277)
T cd06640 97 -----------PFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV 162 (277)
T ss_pred -----------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcccccccc
Confidence 2788899999999999999999987 9999999999999999999999999984431
Q ss_pred -------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCC
Q 047629 483 -------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFY 549 (615)
Q Consensus 483 -------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~ 549 (615)
...+.++|||||||++|||++|+.|+......... ..+........
T Consensus 163 ~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---------------------~~~~~~~~~~~ 221 (277)
T cd06640 163 GTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL---------------------FLIPKNNPPTL 221 (277)
T ss_pred CcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh---------------------hhhhcCCCCCC
Confidence 12356899999999999999999998654321100 00111111223
Q ss_pred ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047629 550 PIDGALSLATLARACTMDKSLSRPNMAEVVFNL 582 (615)
Q Consensus 550 ~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L 582 (615)
+......+.+++.+||+.+|++||++.|++..-
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06640 222 TGEFSKPFKEFIDACLNKDPSFRPTAKELLKHK 254 (277)
T ss_pred chhhhHHHHHHHHHHcccCcccCcCHHHHHhCh
Confidence 445566789999999999999999999998863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=257.35 Aligned_cols=225 Identities=22% Similarity=0.309 Sum_probs=167.9
Q ss_pred ceEEEEEE--CCeEEEEEEccH---------HHHHHHHHHHhcCCCC-cccEEEEEEcCCC-----cEEEEEeecCCCCH
Q 047629 343 KSVYRATI--DGKVLAVKKIKE---------DVTEELRILQRINHAN-LVKLMGVSSDSQG-----NRFLVYEYAENGSL 405 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~---------~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~~-----~~~lV~E~~~~GsL 405 (615)
+.||+|+. +|+.||+|+++- ...+|+.+|++++|+| ||+|.+++...+. .+++|+||+.. +|
T Consensus 25 g~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~-DL 103 (323)
T KOG0594|consen 25 GVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDR-DL 103 (323)
T ss_pred eEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEeecc-cH
Confidence 58999997 799999999873 2468999999999999 9999999876542 68899999976 99
Q ss_pred HHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC---
Q 047629 406 DKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT--- 482 (615)
Q Consensus 406 ~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~--- 482 (615)
.+++....... ..++-..+..++.|++.||+|||+++ |+||||||.|||+++++.+||+|||+|+...
T Consensus 104 ~~ymd~~~~~~------~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~ 174 (323)
T KOG0594|consen 104 KKYMDSLPKKP------QGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLARAFSIPM 174 (323)
T ss_pred HHHHHhccccc------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchHHHhcCCc
Confidence 99998765321 13666889999999999999999998 9999999999999999999999999997542
Q ss_pred ---------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHH--HHHHHHhh
Q 047629 483 ---------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEE--KREERLRN 539 (615)
Q Consensus 483 ---------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~--~~~~~~~~ 539 (615)
..+++..||||+||++.||++++.-|....+.+ ....+.+.+.... ..+ .+..
T Consensus 175 ~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~---ql~~If~~lGtP~e~~Wp-~v~~ 250 (323)
T KOG0594|consen 175 RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID---QLFRIFRLLGTPNEKDWP-GVSS 250 (323)
T ss_pred ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH---HHHHHHHHcCCCCccCCC-Cccc
Confidence 125678999999999999999998887655422 1222333322110 000 0000
Q ss_pred hcCCc--CCC-----CCChHHH---HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 540 WMDPN--LES-----FYPIDGA---LSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 540 ~~dp~--l~~-----~~~~~~~---~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
..|-. ... .+..... ....+++..|++.+|.+|.|++..+.+
T Consensus 251 ~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 251 LPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 00100 000 0000011 257899999999999999999999886
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=253.52 Aligned_cols=207 Identities=25% Similarity=0.434 Sum_probs=164.8
Q ss_pred ceEEEEEE--CCeEEEEEEcc-----HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK-----EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKS 415 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-----~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~ 415 (615)
+.||+|.. +++.+++|.++ +++.+|++++++++|+||+++++++... ...++++||+++++|.+++.....
T Consensus 17 ~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~l~~e~~~~~~L~~~l~~~~~- 94 (256)
T cd06612 17 GSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKN-TDLWIVMEYCGAGSVSDIMKITNK- 94 (256)
T ss_pred eEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC-CcEEEEEecCCCCcHHHHHHhCcc-
Confidence 48999998 47899999886 3578899999999999999999998754 479999999999999999965432
Q ss_pred CCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC------------
Q 047629 416 SSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------------ 483 (615)
Q Consensus 416 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------------ 483 (615)
.++|..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++.....
T Consensus 95 --------~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 163 (256)
T cd06612 95 --------TLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTP 163 (256)
T ss_pred --------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCccccccccCCc
Confidence 3899999999999999999999998 99999999999999999999999998764321
Q ss_pred -----------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChH
Q 047629 484 -----------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPID 552 (615)
Q Consensus 484 -----------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~ 552 (615)
..+.++||||||+++|||++|+.|+.......... .......+.+ ..+..
T Consensus 164 ~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~-----------------~~~~~~~~~~--~~~~~ 224 (256)
T cd06612 164 FWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF-----------------MIPNKPPPTL--SDPEK 224 (256)
T ss_pred cccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh-----------------hhccCCCCCC--Cchhh
Confidence 13468999999999999999999987543211100 0000111111 11222
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 553 GALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 553 ~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
....+.+++.+||+.||++||++.||++.
T Consensus 225 ~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 225 WSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred cCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 33468899999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=256.06 Aligned_cols=204 Identities=24% Similarity=0.422 Sum_probs=163.8
Q ss_pred ceEEEEEE--CCeEEEEEEcc----------------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK----------------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGS 404 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~----------------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~Gs 404 (615)
+.||+|.. +++.+|+|.+. +.+.+|++++++++|+||+++++++.+. +..++++||+++++
T Consensus 14 ~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~ 92 (267)
T cd06628 14 GSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA-DHLNIFLEYVPGGS 92 (267)
T ss_pred eEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-CccEEEEEecCCCC
Confidence 48999986 67899999774 2367899999999999999999998754 47899999999999
Q ss_pred HHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--
Q 047629 405 LDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-- 482 (615)
Q Consensus 405 L~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-- 482 (615)
|.+++.... .+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 93 L~~~l~~~~----------~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06628 93 VAALLNNYG----------AFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEAN 159 (267)
T ss_pred HHHHHHhcc----------CccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence 999997643 2889999999999999999999988 9999999999999999999999999875432
Q ss_pred ---------------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHH
Q 047629 483 ---------------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREE 535 (615)
Q Consensus 483 ---------------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 535 (615)
...+.++||||||+++|||++|+.|+....... .+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~----------- 222 (267)
T cd06628 160 SLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ------AIF----------- 222 (267)
T ss_pred cccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH------HHH-----------
Confidence 013457999999999999999999997533210 010
Q ss_pred HHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 536 RLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 536 ~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.+.....+.+ +......+.+++.+||+.||.+||++.||++.
T Consensus 223 ~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 223 KIGENASPEI----PSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred HHhccCCCcC----CcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 1111222333 23344567899999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=267.07 Aligned_cols=210 Identities=18% Similarity=0.311 Sum_probs=161.7
Q ss_pred ceEEEEEE--CCeEEEEEEccHH----------HHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATI--DGKVLAVKKIKED----------VTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~~----------~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
|.||++.. +|+.||+|.++.+ +..|..++.++ +||||+++++++.+. ...++||||+++|+|.+++
T Consensus 9 g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~-~~~~lv~e~~~~g~L~~~~ 87 (329)
T cd05588 9 AKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE-SRLFFVIEFVSGGDLMFHM 87 (329)
T ss_pred eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC-CEEEEEEeCCCCCCHHHHH
Confidence 58999987 6899999998742 45788899888 799999999988754 4799999999999999998
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCC--------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA-------- 481 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~-------- 481 (615)
.... .+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++..
T Consensus 88 ~~~~----------~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (329)
T cd05588 88 QRQR----------KLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTS 154 (329)
T ss_pred HHcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCCCccc
Confidence 6543 2899999999999999999999998 999999999999999999999999998631
Q ss_pred ---------------CCCCCCcccchhHHHHHHHHHcCCCCCCCCCCCh--hHHHHHHHHHHHhHHHHHHHHHhhhcCCc
Q 047629 482 ---------------TNDVMPKFDVFAFGVVLLELLSGKKATRTTENGK--TAVLWKEIREVLKVEEKREERLRNWMDPN 544 (615)
Q Consensus 482 ---------------~~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~~~~~~dp~ 544 (615)
...++.++|||||||++|||++|+.||......+ .....++.... + ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~----------~---~~~~ 221 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV----------I---LEKQ 221 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHH----------H---HcCC
Confidence 0124568999999999999999999996422111 00000111110 1 1111
Q ss_pred CCCCCChHHHHHHHHHHHHhhhcCCCCCCC------HHHHHHH
Q 047629 545 LESFYPIDGALSLATLARACTMDKSLSRPN------MAEVVFN 581 (615)
Q Consensus 545 l~~~~~~~~~~~l~~l~~~C~~~dP~~RPs------m~ev~~~ 581 (615)
. ..|......+.+++..|++.||.+||+ +.|++++
T Consensus 222 ~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 222 I--RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred C--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 1 123333456789999999999999997 6777654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=265.71 Aligned_cols=203 Identities=24% Similarity=0.365 Sum_probs=161.7
Q ss_pred ceEEEEEE--CCeEEEEEEccHH----------HHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATI--DGKVLAVKKIKED----------VTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~~----------~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
|.||++.. +++.||||.++++ +..|.+++..+ +|+||+++++++... +..++||||+++|+|..++
T Consensus 9 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~ 87 (318)
T cd05570 9 GKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTK-DRLFFVMEYVNGGDLMFHI 87 (318)
T ss_pred eEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC-CEEEEEEcCCCCCCHHHHH
Confidence 48999988 5789999998742 34688888887 799999999988754 4799999999999999998
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCC--------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA-------- 481 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~-------- 481 (615)
.... .+++.++..++.|++.||.|||+++ ++||||||+|||+++++.+||+|||+++..
T Consensus 88 ~~~~----------~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (318)
T cd05570 88 QRSG----------RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTS 154 (318)
T ss_pred HHcC----------CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccc
Confidence 7653 2899999999999999999999998 999999999999999999999999987531
Q ss_pred ---------------CCCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCC
Q 047629 482 ---------------TNDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLE 546 (615)
Q Consensus 482 ---------------~~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~ 546 (615)
...++.++|||||||++|||++|+.||...... .... . + ....
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~---~~~~----~----------i---~~~~-- 212 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED---ELFQ----S----------I---LEDE-- 212 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH---HHHH----H----------H---HcCC--
Confidence 112456899999999999999999999654311 1110 0 0 0000
Q ss_pred CCCChHHHHHHHHHHHHhhhcCCCCCCCH-----HHHHHH
Q 047629 547 SFYPIDGALSLATLARACTMDKSLSRPNM-----AEVVFN 581 (615)
Q Consensus 547 ~~~~~~~~~~l~~l~~~C~~~dP~~RPsm-----~ev~~~ 581 (615)
..++......+.+++.+||+.||.+||++ .+++..
T Consensus 213 ~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 213 VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 11233344567899999999999999999 887764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-30 Score=272.61 Aligned_cols=222 Identities=23% Similarity=0.319 Sum_probs=163.2
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCC----CcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQ----GNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~~lV~E~~~~GsL~~ 407 (615)
|.||++.. +|+.||||++. +.+.+|+++++.++|+||+++++++...+ ...++|+||+. ++|.+
T Consensus 14 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~ 92 (372)
T cd07853 14 GVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHK 92 (372)
T ss_pred EEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHH
Confidence 58999986 78999999875 24678999999999999999999886433 15799999997 58888
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----- 482 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----- 482 (615)
++.... .+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++...
T Consensus 93 ~~~~~~----------~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~ 159 (372)
T cd07853 93 IIVSPQ----------PLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK 159 (372)
T ss_pred HHhcCC----------CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecccCccc
Confidence 886543 3899999999999999999999998 9999999999999999999999999985321
Q ss_pred --------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhH---HHH--HHHHH
Q 047629 483 --------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKV---EEK--REERL 537 (615)
Q Consensus 483 --------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~--~~~~~ 537 (615)
..++.++|||||||++|||++|+.||......+.. ..+...+.. +.. .....
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i~~~~g~~~~~~~~~~~~~~ 236 (372)
T cd07853 160 HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQL---DLITDLLGTPSLEAMRSACEGA 236 (372)
T ss_pred cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHH---HHHHHHcCCCCHHHHHHhhHHH
Confidence 11356789999999999999999999764432211 111111100 000 00001
Q ss_pred hhhc-----CCc-CCC--CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 538 RNWM-----DPN-LES--FYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 538 ~~~~-----dp~-l~~--~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
...+ .+. ... ....+....+.+|+.+|++.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 1111 010 000 1112234567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=258.03 Aligned_cols=210 Identities=20% Similarity=0.325 Sum_probs=161.4
Q ss_pred ceEEEEEE--CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATI--DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
+.||+|.. +++.||+|.+. .++.+|++++.+++|+||+++++++... ...++||||+++|+|..+.
T Consensus 15 ~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~l~~~~--- 90 (279)
T cd06619 15 GTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE-NRISICTEFMDGGSLDVYR--- 90 (279)
T ss_pred eEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC-CEEEEEEecCCCCChHHhh---
Confidence 48999986 78999999874 2467899999999999999999998764 4789999999999997652
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC----------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT---------- 482 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~---------- 482 (615)
.+++..+..++.|++.||.|||+.+ ++|+||||+|||++.++.+||+|||++....
T Consensus 91 -----------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 156 (279)
T cd06619 91 -----------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGT 156 (279)
T ss_pred -----------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccccccCCCCC
Confidence 2678889999999999999999998 9999999999999999999999999985321
Q ss_pred -----------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCCh
Q 047629 483 -----------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPI 551 (615)
Q Consensus 483 -----------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~ 551 (615)
...+.++||||||+++|||++|+.|+................ ..+.....+.+. ..
T Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~---~~ 223 (279)
T cd06619 157 NAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLL----------QCIVDEDPPVLP---VG 223 (279)
T ss_pred hhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHH----------HHHhccCCCCCC---CC
Confidence 124568999999999999999999986533221111000000 011111112221 11
Q ss_pred HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047629 552 DGALSLATLARACTMDKSLSRPNMAEVVFNLS 583 (615)
Q Consensus 552 ~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~ 583 (615)
.....+.+++.+|++.+|++||+++|++..-.
T Consensus 224 ~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~ 255 (279)
T cd06619 224 QFSEKFVHFITQCMRKQPKERPAPENLMDHPF 255 (279)
T ss_pred cCCHHHHHHHHHHhhCChhhCCCHHHHhcCcc
Confidence 22345789999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-30 Score=272.46 Aligned_cols=205 Identities=20% Similarity=0.280 Sum_probs=158.1
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||++.. +|+.||||++.. .+.+|++++.+++|+||+++++++.+. ...++||||+++|+|.+++.
T Consensus 15 g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~-~~~~lv~E~~~gg~L~~~l~ 93 (377)
T cd05629 15 GEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDA-QYLYLIMEFLPGGDLMTMLI 93 (377)
T ss_pred EEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC-CeeEEEEeCCCCCcHHHHHH
Confidence 58999887 789999998852 256799999999999999999998754 47999999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCC---------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA--------- 481 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~--------- 481 (615)
... .+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 94 ~~~----------~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 94 KYD----------TFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred hcC----------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 543 3888899999999999999999998 999999999999999999999999998411
Q ss_pred -------------------------------------------------------------CCCCCCcccchhHHHHHHH
Q 047629 482 -------------------------------------------------------------TNDVMPKFDVFAFGVVLLE 500 (615)
Q Consensus 482 -------------------------------------------------------------~~~~~~k~DV~SfGvvl~E 500 (615)
...++.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhh
Confidence 0124568999999999999
Q ss_pred HHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcC-CcCCCCCChHHHHHHHHHHHHhhhcCCCC---CCCHH
Q 047629 501 LLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMD-PNLESFYPIDGALSLATLARACTMDKSLS---RPNMA 576 (615)
Q Consensus 501 lltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~d-p~l~~~~~~~~~~~l~~l~~~C~~~dP~~---RPsm~ 576 (615)
|++|+.||......+ .. .. +..+.+ ..+.. .......+.+++..|+. +|.+ |+++.
T Consensus 241 lltG~~Pf~~~~~~~---~~---~~-----------i~~~~~~~~~p~--~~~~s~~~~dli~~lL~-~~~~r~~r~~~~ 300 (377)
T cd05629 241 CLIGWPPFCSENSHE---TY---RK-----------IINWRETLYFPD--DIHLSVEAEDLIRRLIT-NAENRLGRGGAH 300 (377)
T ss_pred hhcCCCCCCCCCHHH---HH---HH-----------HHccCCccCCCC--CCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence 999999997543211 01 10 000000 00111 01123457889999997 6665 46999
Q ss_pred HHHHH
Q 047629 577 EVVFN 581 (615)
Q Consensus 577 ev~~~ 581 (615)
|++.+
T Consensus 301 ~~l~h 305 (377)
T cd05629 301 EIKSH 305 (377)
T ss_pred HHhcC
Confidence 98886
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=266.74 Aligned_cols=207 Identities=21% Similarity=0.277 Sum_probs=161.4
Q ss_pred ceEEEEEE-----CCeEEEEEEccH-----------HHHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCH
Q 047629 343 KSVYRATI-----DGKVLAVKKIKE-----------DVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSL 405 (615)
Q Consensus 343 ~~Vy~~~~-----~g~~vAvK~~~~-----------~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL 405 (615)
|.||++.. +|+.||+|.+++ .+..|+.++.++ +|+||+++++++.. ++..++||||+++|+|
T Consensus 14 g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~~~lv~e~~~~g~L 92 (332)
T cd05614 14 GKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT-EAKLHLILDYVSGGEM 92 (332)
T ss_pred EEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec-CCEEEEEEeCCCCCcH
Confidence 47998765 578999998853 245799999999 59999999998764 4478999999999999
Q ss_pred HHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC---
Q 047629 406 DKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT--- 482 (615)
Q Consensus 406 ~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~--- 482 (615)
.+++.... .+++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~ 159 (332)
T cd05614 93 FTHLYQRD----------NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE 159 (332)
T ss_pred HHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence 99997643 2889999999999999999999998 9999999999999999999999999986421
Q ss_pred ----------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhh
Q 047629 483 ----------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNW 540 (615)
Q Consensus 483 ----------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 540 (615)
...+.++|||||||++|||++|+.||.......... .+. ..+. .
T Consensus 160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~---~~~----------~~~~-~ 225 (332)
T cd05614 160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS---EVS----------RRIL-K 225 (332)
T ss_pred CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH---HHH----------HHHh-c
Confidence 013468999999999999999999997543221111 011 0111 1
Q ss_pred cCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 047629 541 MDPNLESFYPIDGALSLATLARACTMDKSLSRP-----NMAEVVFN 581 (615)
Q Consensus 541 ~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RP-----sm~ev~~~ 581 (615)
.++.+ +......+.+++.+|++.||++|| +++|+++.
T Consensus 226 ~~~~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 226 CDPPF----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCCCC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 22333 223344578999999999999999 77788764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=267.06 Aligned_cols=210 Identities=20% Similarity=0.319 Sum_probs=161.0
Q ss_pred ceEEEEEE--CCeEEEEEEccHH----------HHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATI--DGKVLAVKKIKED----------VTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~~----------~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
|.||++.. +++.+|+|.+++. +..|+.++.++ +||||+++++++... +..++||||+++|+|..++
T Consensus 9 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~-~~~~lv~E~~~~~~L~~~~ 87 (329)
T cd05618 9 AKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-SRLFFVIEYVNGGDLMFHM 87 (329)
T ss_pred eEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC-CEEEEEEeCCCCCCHHHHH
Confidence 48999987 6789999998642 45688888777 899999999988754 4799999999999999988
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------- 482 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------- 482 (615)
.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 88 ~~~~----------~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (329)
T cd05618 88 QRQR----------KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS 154 (329)
T ss_pred HHcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccc
Confidence 6543 2889999999999999999999998 9999999999999999999999999986421
Q ss_pred ----------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChh--HHHHHHHHHHHhHHHHHHHHHhhhcCCc
Q 047629 483 ----------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKT--AVLWKEIREVLKVEEKREERLRNWMDPN 544 (615)
Q Consensus 483 ----------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~--~~l~~~~~~~~~~~~~~~~~~~~~~dp~ 544 (615)
..++.++|||||||++|||++|+.||........ .....++... +....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~-------------i~~~~ 221 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV-------------ILEKQ 221 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHH-------------HhcCC
Confidence 1245689999999999999999999963221110 0000001100 01111
Q ss_pred CCCCCChHHHHHHHHHHHHhhhcCCCCCCC------HHHHHHH
Q 047629 545 LESFYPIDGALSLATLARACTMDKSLSRPN------MAEVVFN 581 (615)
Q Consensus 545 l~~~~~~~~~~~l~~l~~~C~~~dP~~RPs------m~ev~~~ 581 (615)
..+|......+.+++.+|++.||++||+ +.|++++
T Consensus 222 --~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 222 --IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred --CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 1233344556789999999999999998 5676654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-30 Score=271.72 Aligned_cols=214 Identities=21% Similarity=0.234 Sum_probs=163.4
Q ss_pred cccccccccc----ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEE
Q 047629 333 MNLSEHYSIG----KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLV 396 (615)
Q Consensus 333 ~~~~~~~~iG----~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV 396 (615)
.+|.....+| |.||++.. +++.+|+|.+++ .+.+|+.+++.++||||+++++++.+. ...++|
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~-~~~~lv 121 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD-KYLYMV 121 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-CEEEEE
Confidence 4444444455 48999987 678999998853 256899999999999999999988754 479999
Q ss_pred EeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecC
Q 047629 397 YEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFS 476 (615)
Q Consensus 397 ~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFG 476 (615)
|||+++|+|.+++... .+++.+...++.|++.||+|||+++ |+||||||+|||+++++.+||+|||
T Consensus 122 ~Ey~~gg~L~~~l~~~-----------~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG 187 (370)
T cd05621 122 MEYMPGGDLVNLMSNY-----------DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFG 187 (370)
T ss_pred EcCCCCCcHHHHHHhc-----------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecc
Confidence 9999999999999643 2788899999999999999999998 9999999999999999999999999
Q ss_pred CCCCCCC----------------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHh
Q 047629 477 LAAPATN----------------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLK 528 (615)
Q Consensus 477 la~~~~~----------------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~ 528 (615)
+++.... .++.++|||||||++|||++|+.||....... .
T Consensus 188 ~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~---~--------- 255 (370)
T cd05621 188 TCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG---T--------- 255 (370)
T ss_pred cceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH---H---------
Confidence 9854210 13468999999999999999999997543110 0
Q ss_pred HHHHHHHHHhhhcCCcCCCCCCh--HHHHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 047629 529 VEEKREERLRNWMDPNLESFYPI--DGALSLATLARACTMDKSLS--RPNMAEVVFN 581 (615)
Q Consensus 529 ~~~~~~~~~~~~~dp~l~~~~~~--~~~~~l~~l~~~C~~~dP~~--RPsm~ev~~~ 581 (615)
..++++....-.++. .....+.+++..|+..++.+ ||++.|++++
T Consensus 256 --------~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 256 --------YSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred --------HHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 111111110011111 22345678888898755544 8999999886
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=265.46 Aligned_cols=222 Identities=25% Similarity=0.409 Sum_probs=168.2
Q ss_pred ceEEEEEEC---------CeEEEEEEcc--------HHHHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCC
Q 047629 343 KSVYRATID---------GKVLAVKKIK--------EDVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGS 404 (615)
Q Consensus 343 ~~Vy~~~~~---------g~~vAvK~~~--------~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~Gs 404 (615)
+.||++... +..||+|.++ +++.+|++++.++ +|+||++++++|.+. +..++++||+++|+
T Consensus 26 g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~~~~lv~e~~~~g~ 104 (334)
T cd05100 26 GQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD-GPLYVLVEYASKGN 104 (334)
T ss_pred CcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC-CceEEEEecCCCCc
Confidence 478988641 2368999875 2467899999999 899999999998754 47899999999999
Q ss_pred HHHhhccCCCCCCC------CCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCC
Q 047629 405 LDKWLHPKSKSSSS------SGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA 478 (615)
Q Consensus 405 L~~~L~~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla 478 (615)
|.+++......... ......++|.+++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++
T Consensus 105 L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~~~~~~kL~Dfg~~ 181 (334)
T cd05100 105 LREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVTEDNVMKIADFGLA 181 (334)
T ss_pred HHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCcccc
Confidence 99999764321000 001124899999999999999999999998 999999999999999999999999998
Q ss_pred CCCC-------------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHH
Q 047629 479 APAT-------------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEK 532 (615)
Q Consensus 479 ~~~~-------------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 532 (615)
+... ...+.++||||||+++|||++ |+.|+...... ... .
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~----~------- 247 (334)
T cd05100 182 RDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE---ELF----K------- 247 (334)
T ss_pred eecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH---HHH----H-------
Confidence 6321 113458999999999999998 88887643311 000 0
Q ss_pred HHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccch
Q 047629 533 REERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQST 589 (615)
Q Consensus 533 ~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~ 589 (615)
.+.. ......+......+.+++.+||+.+|++||+|.|+++.|..+....
T Consensus 248 ---~~~~----~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 248 ---LLKE----GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred ---HHHc----CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 0100 0111223344456889999999999999999999999999887443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=264.40 Aligned_cols=202 Identities=23% Similarity=0.344 Sum_probs=157.2
Q ss_pred ceEEEEEE--CCeEEEEEEccHH----------HHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATI--DGKVLAVKKIKED----------VTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~~----------~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
|.||++.. +++.||||.++.+ +..|..++... +|+||+++++++... +..++||||+++|+|.+++
T Consensus 9 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~-~~~~lv~e~~~gg~L~~~~ 87 (316)
T cd05592 9 GKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTK-EHLFFVMEYLNGGDLMFHI 87 (316)
T ss_pred eEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcC-CEEEEEEcCCCCCcHHHHH
Confidence 58999987 5789999998643 23466666654 899999999988654 4799999999999999999
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------- 482 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------- 482 (615)
.... .+++.+...++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 88 ~~~~----------~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 154 (316)
T cd05592 88 QSSG----------RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAS 154 (316)
T ss_pred HHcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccc
Confidence 7543 2888999999999999999999998 9999999999999999999999999986421
Q ss_pred ----------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCC
Q 047629 483 ----------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLE 546 (615)
Q Consensus 483 ----------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~ 546 (615)
..++.++|||||||++|||++|+.||......+ ... .+.. ..+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~---~~~--------------~i~~-~~~--- 213 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE---LFD--------------SILN-DRP--- 213 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH---HHH--------------HHHc-CCC---
Confidence 124568999999999999999999997543211 000 0110 111
Q ss_pred CCCChHHHHHHHHHHHHhhhcCCCCCCCHH-HHHH
Q 047629 547 SFYPIDGALSLATLARACTMDKSLSRPNMA-EVVF 580 (615)
Q Consensus 547 ~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~-ev~~ 580 (615)
.++......+.+++..||+.||.+||++. ++.+
T Consensus 214 -~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 214 -HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred -CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 12333344578999999999999999975 4543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-30 Score=266.79 Aligned_cols=198 Identities=23% Similarity=0.316 Sum_probs=154.9
Q ss_pred ceEEEEEE--CCeEEEEEEccHH----------HHHHHH-HHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATI--DGKVLAVKKIKED----------VTEELR-ILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~~----------~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
|.||++.. +|+.||+|.+... +..|.. +++.++||||+++++++.+. ...++||||+++|+|..++
T Consensus 9 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~g~L~~~l 87 (323)
T cd05575 9 GKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTA-DKLYFVLDYVNGGELFFHL 87 (323)
T ss_pred eEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeC-CEEEEEEcCCCCCCHHHHH
Confidence 48999998 6899999998632 233444 45778999999999988754 4789999999999999999
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------- 482 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------- 482 (615)
.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 88 ~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (323)
T cd05575 88 QRER----------SFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTS 154 (323)
T ss_pred HhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccc
Confidence 7643 2889999999999999999999998 9999999999999999999999999985421
Q ss_pred ----------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCC
Q 047629 483 ----------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLE 546 (615)
Q Consensus 483 ----------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~ 546 (615)
..++.++|||||||++|||++|+.||...... ... .. .+.. ...+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~---~~~---~~----------i~~~--~~~~- 215 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA---EMY---DN----------ILNK--PLRL- 215 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH---HHH---HH----------HHcC--CCCC-
Confidence 12456899999999999999999999754311 111 00 0111 0111
Q ss_pred CCCChHHHHHHHHHHHHhhhcCCCCCCCHH
Q 047629 547 SFYPIDGALSLATLARACTMDKSLSRPNMA 576 (615)
Q Consensus 547 ~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ 576 (615)
+......+.+++.+|++.||.+||+++
T Consensus 216 ---~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 216 ---KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred ---CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 122244578999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=258.54 Aligned_cols=224 Identities=19% Similarity=0.321 Sum_probs=163.3
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
+.||+|.. +|+.||||+++ ..+.+|+.++++++|+||+++++++.+ ++..++|+||++ |+|.+++..
T Consensus 14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~-~~l~~~~~~ 91 (285)
T cd07861 14 GVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ-ESRLYLIFEFLS-MDLKKYLDS 91 (285)
T ss_pred eEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee-CCeEEEEEecCC-CCHHHHHhc
Confidence 48999987 68999999875 246789999999999999999999875 447999999997 689998865
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC---------
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT--------- 482 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~--------- 482 (615)
.... ..+++.++..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++....
T Consensus 92 ~~~~-------~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (285)
T cd07861 92 LPKG-------QYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHE 161 (285)
T ss_pred CCCC-------CcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcccccCC
Confidence 4321 13899999999999999999999998 9999999999999999999999999875321
Q ss_pred ---------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHH----------hHHHHHHHHH
Q 047629 483 ---------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVL----------KVEEKREERL 537 (615)
Q Consensus 483 ---------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~----------~~~~~~~~~~ 537 (615)
...+.++||||||+++|||++|+.|+....... .......... ..........
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
T cd07861 162 VVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID--QLFRIFRILGTPTEDVWPGVTSLPDYKNTF 239 (285)
T ss_pred cccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhcchhhHHHHhhc
Confidence 113567999999999999999999987543211 1111110000 0000000011
Q ss_pred hhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 538 RNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 538 ~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
..+..+.+. ........++.+++.+|++.||.+|||+.||++.
T Consensus 240 ~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 240 PKWKKGSLR-SAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred cccCcchhH-HhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 111111110 0111233456899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=280.25 Aligned_cols=226 Identities=19% Similarity=0.290 Sum_probs=160.6
Q ss_pred ceEEEEEE--CCeEEEEEEccH---HHHHHHHHHHhcCCCCcccEEEEEEcC-----C--CcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE---DVTEELRILQRINHANLVKLMGVSSDS-----Q--GNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~---~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~--~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||+|.. +++.||||++.. ...+|+.+|++++|+||+++.+++... . ..+++||||+++ +|.+++.
T Consensus 80 g~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~ 158 (440)
T PTZ00036 80 GVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMK 158 (440)
T ss_pred EEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCc-cHHHHHH
Confidence 58999987 689999998853 356799999999999999999876421 1 135689999984 7877775
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCC-cEEEeecCCCCCCC-------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRF-KAKIANFSLAAPAT------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~-~~kl~DFGla~~~~------- 482 (615)
...... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||+++...
T Consensus 159 ~~~~~~------~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~ 229 (440)
T PTZ00036 159 HYARNN------HALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVS 229 (440)
T ss_pred HHhhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccccchhccCCCCccc
Confidence 322110 13889999999999999999999998 99999999999999764 79999999986321
Q ss_pred ----------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHH--HHHH---HHHhhh-
Q 047629 483 ----------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVE--EKRE---ERLRNW- 540 (615)
Q Consensus 483 ----------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~--~~~~---~~~~~~- 540 (615)
..++.++|||||||++|||++|+.||......+... .+...+... .... ....+.
T Consensus 230 ~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~---~i~~~~~~p~~~~~~~~~~~~~~~~ 306 (440)
T PTZ00036 230 YICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLV---RIIQVLGTPTEDQLKEMNPNYADIK 306 (440)
T ss_pred CCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHhCCCCHHHHHHhchhhhccc
Confidence 125678999999999999999999997544322111 111111000 0000 000000
Q ss_pred ----cCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 541 ----MDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 541 ----~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
....+...++.....++.+|+.+||+.||.+|||+.|++++
T Consensus 307 ~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 307 FPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00111112233344568999999999999999999999875
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-29 Score=255.24 Aligned_cols=205 Identities=25% Similarity=0.373 Sum_probs=158.2
Q ss_pred ceEEEEEE--CCeEEEEEEcc------------HHHHHHHHHHHhcCCCCcccEEEEEEcC-CCcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATI--DGKVLAVKKIK------------EDVTEELRILQRINHANLVKLMGVSSDS-QGNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~------------~~~~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~~lV~E~~~~GsL~~ 407 (615)
+.||++.. +|+.||+|+++ ..+.+|+.++++++|+||+++++++.+. +...++++||+++++|.+
T Consensus 16 g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~ 95 (266)
T cd06651 16 GRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKD 95 (266)
T ss_pred EEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHH
Confidence 47999986 68899999874 2367799999999999999999987653 335789999999999999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----- 482 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----- 482 (615)
++.... .+++.....++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 96 ~l~~~~----------~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd06651 96 QLKAYG----------ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS 162 (266)
T ss_pred HHHHcC----------CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcccccccccc
Confidence 997543 2889999999999999999999987 9999999999999999999999999885321
Q ss_pred ---------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhc
Q 047629 483 ---------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWM 541 (615)
Q Consensus 483 ---------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 541 (615)
...+.++|||||||++|||++|+.|+....... .+. .......
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~------~~~----------~~~~~~~ 226 (266)
T cd06651 163 GTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA------AIF----------KIATQPT 226 (266)
T ss_pred CCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH------HHH----------HHhcCCC
Confidence 113467999999999999999999987543110 000 0011111
Q ss_pred CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 542 DPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 542 dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.+.+ +......+.+++ +||..+|++||+|+||+++
T Consensus 227 ~~~~----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 227 NPQL----PSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred CCCC----chhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 2222 222233445555 7888999999999999763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=262.77 Aligned_cols=222 Identities=20% Similarity=0.353 Sum_probs=162.9
Q ss_pred ceEEEEEE--CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATI--DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
+.||+|.. +++.||+|+++ ..+.+|++++++++|+||+++++++... +..++||||+++ +|.+++...
T Consensus 20 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~-~l~~~~~~~ 97 (309)
T cd07872 20 ATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTD-KSLTLVFEYLDK-DLKQYMDDC 97 (309)
T ss_pred EEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeC-CeEEEEEeCCCC-CHHHHHHhc
Confidence 48999987 67899999886 2467899999999999999999998754 479999999975 898888654
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC----------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT---------- 482 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~---------- 482 (615)
.. .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 98 ~~---------~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 165 (309)
T cd07872 98 GN---------IMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEV 165 (309)
T ss_pred CC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcccccccc
Confidence 32 3789999999999999999999998 9999999999999999999999999985321
Q ss_pred --------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHH--HHHH-----HHHhhhc
Q 047629 483 --------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVE--EKRE-----ERLRNWM 541 (615)
Q Consensus 483 --------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~--~~~~-----~~~~~~~ 541 (615)
..++.++|||||||++|||++|+.||......+.... +...+... .... ......-
T Consensus 166 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (309)
T cd07872 166 VTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHL---IFRLLGTPTEETWPGISSNDEFKNYN 242 (309)
T ss_pred ccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHhCCCCHHHHhhhcchhhhhhhh
Confidence 1235679999999999999999999976543222111 11111000 0000 0000000
Q ss_pred CCcCCC----CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 542 DPNLES----FYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 542 dp~l~~----~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.+.... .........+.+++.+|++.||.+|||++|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 243 FPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred cCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 010000 0001123456899999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=253.99 Aligned_cols=206 Identities=23% Similarity=0.341 Sum_probs=162.6
Q ss_pred ceEEEEEE--CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATI--DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
+.||++.. +++.+|+|.++ +.+..|+.++++++|+||+++++.+.+. +..+++|||+++|+|.+++...
T Consensus 14 g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~l~~~~~~~ 92 (255)
T cd08219 14 GRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEAD-GHLYIVMEYCDGGDLMQKIKLQ 92 (255)
T ss_pred eEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEEC-CEEEEEEeeCCCCcHHHHHHhc
Confidence 47888876 68999999874 3467899999999999999999988754 4899999999999999998653
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC---------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN--------- 483 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~--------- 483 (615)
... .+++.....++.|++.||.|||+++ ++|+||||+||++++++.++++|||+++....
T Consensus 93 ~~~--------~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 161 (255)
T cd08219 93 RGK--------LFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV 161 (255)
T ss_pred cCC--------CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccccccccc
Confidence 321 3789999999999999999999998 99999999999999999999999999854321
Q ss_pred --------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCC
Q 047629 484 --------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFY 549 (615)
Q Consensus 484 --------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~ 549 (615)
..+.++||||||+++|||++|+.||........ .. .+.. ... ...
T Consensus 162 ~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~------~~-----------~~~~---~~~-~~~ 220 (255)
T cd08219 162 GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL------IL-----------KVCQ---GSY-KPL 220 (255)
T ss_pred CCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH------HH-----------HHhc---CCC-CCC
Confidence 135689999999999999999999975331000 00 0000 000 111
Q ss_pred ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 550 PIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 550 ~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
+......+.+++.+||+.||++||++.|++..
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 22334457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=247.54 Aligned_cols=218 Identities=21% Similarity=0.292 Sum_probs=168.6
Q ss_pred eEEEEEE--CCeEEEEEEcc-------HHHHHHHHHHHhcCCCCcccEEEEEEcC----CCcEEEEEeecCCCCHHHhhc
Q 047629 344 SVYRATI--DGKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVSSDS----QGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 344 ~Vy~~~~--~g~~vAvK~~~-------~~~~~Ei~~l~~l~H~niv~l~g~~~~~----~~~~~lV~E~~~~GsL~~~L~ 410 (615)
-||.+.- +++.+|+|++. +...+|++..++++|||++++++++... ..+.||++.|...|+|.+.+.
T Consensus 36 fv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~ 115 (302)
T KOG2345|consen 36 FVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIE 115 (302)
T ss_pred eeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHH
Confidence 5666653 78999999985 3467899999999999999999886432 224899999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
...... ..+++.+.++|+.+|++||++||+. .|++.||||||.|||+.+.+.+++.|||.+....
T Consensus 116 ~~k~kg------~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~ 188 (302)
T KOG2345|consen 116 RLKIKG------NFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQ 188 (302)
T ss_pred HHhhcC------CccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccccceEeechHH
Confidence 654321 2599999999999999999999998 5789999999999999999999999999885431
Q ss_pred ---------------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHH
Q 047629 483 ---------------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREE 535 (615)
Q Consensus 483 ---------------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 535 (615)
..+++++|||||||+||+|+.|..||+...+.....
T Consensus 189 a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl----------------- 251 (302)
T KOG2345|consen 189 ALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL----------------- 251 (302)
T ss_pred HHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE-----------------
Confidence 114679999999999999999999997543211100
Q ss_pred HHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 047629 536 RLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLT 586 (615)
Q Consensus 536 ~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~ 586 (615)
......+.+.-.-..-....+.+++++|++.||.+||+..|++..+..+.
T Consensus 252 -aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 252 -ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred -EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 00111111110000113446899999999999999999999999987653
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-30 Score=257.78 Aligned_cols=205 Identities=20% Similarity=0.356 Sum_probs=157.8
Q ss_pred ceEEEEEEC---------CeEEEEEEcc-------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHH
Q 047629 343 KSVYRATID---------GKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLD 406 (615)
Q Consensus 343 ~~Vy~~~~~---------g~~vAvK~~~-------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~ 406 (615)
+.||+|... ...+|+|.+. +.+.+|+.++++++|+|++++++++... ...++||||+++|+|.
T Consensus 9 ~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-~~~~lv~e~~~~g~L~ 87 (258)
T cd05078 9 TKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG-DESIMVQEYVKFGSLD 87 (258)
T ss_pred hhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC-CCcEEEEecCCCCcHH
Confidence 479988762 2348888875 2467899999999999999999998764 4789999999999999
Q ss_pred HhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCc--------EEEeecCCC
Q 047629 407 KWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFK--------AKIANFSLA 478 (615)
Q Consensus 407 ~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~--------~kl~DFGla 478 (615)
+++..... .++|..++.++.|++.||+|||+++ |+||||||+||+++.++. +|++|||++
T Consensus 88 ~~l~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 88 TYLKKNKN---------LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred HHHhcCCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 99976543 3899999999999999999999998 999999999999987765 699999987
Q ss_pred CCCC--------------------CCCCCcccchhHHHHHHHHHcCCC-CCCCCCCChhHHHHHHHHHHHhHHHHHHHHH
Q 047629 479 APAT--------------------NDVMPKFDVFAFGVVLLELLSGKK-ATRTTENGKTAVLWKEIREVLKVEEKREERL 537 (615)
Q Consensus 479 ~~~~--------------------~~~~~k~DV~SfGvvl~ElltG~~-p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 537 (615)
.... ...+.++||||||+++|||++|.. |+........ ... .
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-------~~~----------~ 218 (258)
T cd05078 156 ITVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-------LQF----------Y 218 (258)
T ss_pred cccCCchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-------HHH----------H
Confidence 5321 124568999999999999999964 4432221000 000 0
Q ss_pred hhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047629 538 RNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLS 583 (615)
Q Consensus 538 ~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~ 583 (615)
.. . ..++.....++.+++..||+.||++|||++|+++.|+
T Consensus 219 ~~--~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 219 ED--R----HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred Hc--c----ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 0 1122223356899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-29 Score=253.36 Aligned_cols=207 Identities=24% Similarity=0.347 Sum_probs=162.9
Q ss_pred ceEEEEEE--CCeEEEEEEccH---------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE---------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~---------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
+.||++.. +++.+|+|++.. .+.+|++++++++|+|++++.+.+...++..+++|||+++++|.+++..
T Consensus 14 ~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~ 93 (257)
T cd08223 14 GEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKE 93 (257)
T ss_pred eEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHH
Confidence 47998887 678999998752 3667999999999999999998875445467999999999999999976
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC---------
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT--------- 482 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~--------- 482 (615)
.... .+++.++..++.+++.||+|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 94 ~~~~--------~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~ 162 (257)
T cd08223 94 QKGK--------LLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTL 162 (257)
T ss_pred hcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccCCccccc
Confidence 4321 3899999999999999999999998 9999999999999999999999999875331
Q ss_pred --------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCC
Q 047629 483 --------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESF 548 (615)
Q Consensus 483 --------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~ 548 (615)
...+.++||||||++++||++|+.|+....... .... ...... + .
T Consensus 163 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~------~~~~----------~~~~~~-~----~ 221 (257)
T cd08223 163 IGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS------LVYR----------IIEGKL-P----P 221 (257)
T ss_pred cCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH------HHHH----------HHhcCC-C----C
Confidence 113468999999999999999999986433110 0000 011111 1 1
Q ss_pred CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 549 YPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 549 ~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.+......+.+++.+|++.||++||++.|++++
T Consensus 222 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 222 MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 223344568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=285.82 Aligned_cols=220 Identities=28% Similarity=0.423 Sum_probs=175.4
Q ss_pred ceEEEEEEC---------CeEEEEEEcc--------HHHHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCC
Q 047629 343 KSVYRATID---------GKVLAVKKIK--------EDVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGS 404 (615)
Q Consensus 343 ~~Vy~~~~~---------g~~vAvK~~~--------~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~Gs 404 (615)
|.|++|... ...||||.++ +++..|+++|+.+ +|+||+.++|+|.. ++..++|.||+++|+
T Consensus 310 G~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~-~~~~~~v~Ey~~~G~ 388 (609)
T KOG0200|consen 310 GQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ-DGPLYVIVEYAEHGD 388 (609)
T ss_pred cceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc-CCceEEEEEeccCCc
Confidence 578888752 3569999987 4578899999999 79999999999986 568999999999999
Q ss_pred HHHhhccCCCCCCCCCc------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCC
Q 047629 405 LDKWLHPKSKSSSSSGS------VIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA 478 (615)
Q Consensus 405 L~~~L~~~~~~~~~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla 478 (615)
|.+||+..+........ ...|+..+++.++.|||.|++||++.. +|||||.++|||+.++..+||+|||+|
T Consensus 389 L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~~~~~~kIaDFGla 465 (609)
T KOG0200|consen 389 LLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLITKNKVIKIADFGLA 465 (609)
T ss_pred HHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEecCCCEEEEccccce
Confidence 99999887610000000 023899999999999999999999987 999999999999999999999999999
Q ss_pred CCCC--------------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHH
Q 047629 479 APAT--------------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEE 531 (615)
Q Consensus 479 ~~~~--------------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 531 (615)
+... ..++.|+|||||||+|||++| |..|+........ +++
T Consensus 466 r~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~--l~~---------- 533 (609)
T KOG0200|consen 466 RDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEE--LLE---------- 533 (609)
T ss_pred eccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHH--HHH----------
Confidence 7421 125679999999999999999 8888865221111 111
Q ss_pred HHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 047629 532 KREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLT 586 (615)
Q Consensus 532 ~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~ 586 (615)
.+.+.-+-+.|..+..++.++++.||+.+|++||++.|+++.++.+.
T Consensus 534 --------~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 534 --------FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred --------HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 11222223456677788999999999999999999999999998854
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-29 Score=257.50 Aligned_cols=223 Identities=21% Similarity=0.358 Sum_probs=164.2
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
+.||++.. +|+.||+|++. +.+.+|++++++++|+|++++++++... ...++||||++++.|..++..
T Consensus 15 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~~v~e~~~~~~l~~~~~~ 93 (286)
T cd07847 15 GVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRK-RKLHLVFEYCDHTVLNELEKN 93 (286)
T ss_pred eEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeC-CEEEEEEeccCccHHHHHHhC
Confidence 48999987 58999999874 2367899999999999999999998754 478999999999989888754
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC---------
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT--------- 482 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~--------- 482 (615)
.. .++|.++..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 94 ~~----------~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 160 (286)
T cd07847 94 PR----------GVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDY 160 (286)
T ss_pred CC----------CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcccccCc
Confidence 33 2899999999999999999999987 9999999999999999999999999986421
Q ss_pred ---------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHH------HHhhhc
Q 047629 483 ---------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREE------RLRNWM 541 (615)
Q Consensus 483 ---------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~------~~~~~~ 541 (615)
...+.++||||||+++|||++|+.||......+...... ............ ......
T Consensus 161 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07847 161 VATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIR--KTLGDLIPRHQQIFSTNQFFKGLS 238 (286)
T ss_pred ccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH--HHhCCCChHHhhhccccccccccc
Confidence 113468999999999999999999997654322211110 000000000000 000111
Q ss_pred CCcCCCCCCh-----HHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 542 DPNLESFYPI-----DGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 542 dp~l~~~~~~-----~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.|......+. .....+.+++.+||+.+|++||++.|++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 239 IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred CCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 1111111111 123567899999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=258.75 Aligned_cols=229 Identities=22% Similarity=0.342 Sum_probs=170.3
Q ss_pred HHHHHHccccccccccc----ceEEEEEE--CCeEEEEEEcc------HHHHHHHHHHHhc-CCCCcccEEEEEEc----
Q 047629 326 EVIMESTMNLSEHYSIG----KSVYRATI--DGKVLAVKKIK------EDVTEELRILQRI-NHANLVKLMGVSSD---- 388 (615)
Q Consensus 326 ~~l~~at~~~~~~~~iG----~~Vy~~~~--~g~~vAvK~~~------~~~~~Ei~~l~~l-~H~niv~l~g~~~~---- 388 (615)
+.+..++++|.-...+| +.||++.. +|+.+|+|.++ ..+.+|+.+++++ +|+||+++++++..
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 34444555555545555 48999987 68899999875 3467899999999 79999999998753
Q ss_pred CCCcEEEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCC
Q 047629 389 SQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRF 468 (615)
Q Consensus 389 ~~~~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~ 468 (615)
.++..++||||+++|+|.+++....... ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~ 161 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKRG------ERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEG 161 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhccC------ccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCC
Confidence 2235899999999999999886432111 13889999999999999999999987 99999999999999999
Q ss_pred cEEEeecCCCCCCC----------------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHH
Q 047629 469 KAKIANFSLAAPAT----------------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLW 520 (615)
Q Consensus 469 ~~kl~DFGla~~~~----------------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 520 (615)
.+||+|||+++... ..++.++|||||||++|||++|+.|+........
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~---- 237 (286)
T cd06638 162 GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA---- 237 (286)
T ss_pred CEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH----
Confidence 99999999875321 1135589999999999999999999865432110
Q ss_pred HHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047629 521 KEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNL 582 (615)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L 582 (615)
+. .......+.+. .+......+.+++.+||+.||++||++.|+++.+
T Consensus 238 --~~-----------~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 238 --LF-----------KIPRNPPPTLH--QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred --Hh-----------hccccCCCccc--CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 00 00001111110 1111234588999999999999999999999764
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=258.42 Aligned_cols=219 Identities=22% Similarity=0.347 Sum_probs=166.2
Q ss_pred ceEEEEEE--CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATI--DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
+.||++.. +|+.+|+|.+. +.+.+|+++++.++|+||+++++++... +..++||||+++|+|.+++...
T Consensus 19 g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~ 97 (284)
T cd06620 19 GSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNE-NNICMCMEFMDCGSLDRIYKKG 97 (284)
T ss_pred eEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecC-CEEEEEEecCCCCCHHHHHHhc
Confidence 58999987 58999999764 3477899999999999999999998765 4799999999999999998754
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC---------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHE-HAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT--------- 482 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~--------- 482 (615)
. .+++..+..++.+++.||.|||+ ++ ++||||||+||++++++.++|+|||++....
T Consensus 98 ~----------~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~~~~~~ 164 (284)
T cd06620 98 G----------PIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVG 164 (284)
T ss_pred c----------CCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhccCcccc
Confidence 3 38899999999999999999997 45 9999999999999999999999999875321
Q ss_pred ------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 483 ------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 483 ------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
...+.++|||||||++|||++|+.||......+... ...... .+.+...+.........
T Consensus 165 ~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~--~~~~~~-------~~~~~~~~~~~~~~~~~ 235 (284)
T cd06620 165 TSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ--DDPMGI-------LDLLQQIVQEPPPRLPS 235 (284)
T ss_pred CcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhh--hhhhHH-------HHHHHHHhhccCCCCCc
Confidence 123568999999999999999999997543211100 000000 00111111111111111
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 047629 551 IDGALSLATLARACTMDKSLSRPNMAEVVFNLSV 584 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~ 584 (615)
.+....+.+++.+|++.||++||++.|++++..-
T Consensus 236 ~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~ 269 (284)
T cd06620 236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269 (284)
T ss_pred hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 1244568899999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-29 Score=252.85 Aligned_cols=204 Identities=23% Similarity=0.390 Sum_probs=159.4
Q ss_pred ceEEEEEEC--C----------eEEEEEEcc------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCC
Q 047629 343 KSVYRATID--G----------KVLAVKKIK------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGS 404 (615)
Q Consensus 343 ~~Vy~~~~~--g----------~~vAvK~~~------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~Gs 404 (615)
+.||+|... + ..+++|.++ ..+.+|+.++++++|+||++++|++.. ...++|+||+++|+
T Consensus 9 ~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~lv~e~~~~~~ 86 (259)
T cd05037 9 TNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR--DENIMVEEYVKFGP 86 (259)
T ss_pred ceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec--CCcEEEEEcCCCCc
Confidence 479999883 3 247888765 346789999999999999999999876 46899999999999
Q ss_pred HHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCC-------cEEEeecCC
Q 047629 405 LDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRF-------KAKIANFSL 477 (615)
Q Consensus 405 L~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~-------~~kl~DFGl 477 (615)
|.+++..... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++ .+|++|||+
T Consensus 87 L~~~l~~~~~---------~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 87 LDVFLHREKN---------NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred HHHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 9999986542 3889999999999999999999987 99999999999999887 799999999
Q ss_pred CCCCC-------------------C--CCCCcccchhHHHHHHHHHcC-CCCCCCCCCChhHHHHHHHHHHHhHHHHHHH
Q 047629 478 AAPAT-------------------N--DVMPKFDVFAFGVVLLELLSG-KKATRTTENGKTAVLWKEIREVLKVEEKREE 535 (615)
Q Consensus 478 a~~~~-------------------~--~~~~k~DV~SfGvvl~ElltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 535 (615)
+.... . ..+.++||||||+++|||++| ..|+......+...
T Consensus 155 a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~----------------- 217 (259)
T cd05037 155 PITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER----------------- 217 (259)
T ss_pred ccccccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH-----------------
Confidence 86521 1 245679999999999999994 66665433111000
Q ss_pred HHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047629 536 RLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLS 583 (615)
Q Consensus 536 ~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~ 583 (615)
... ++. ..+......+.+++..||..+|.+||++.||++.|.
T Consensus 218 ~~~---~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 218 FYQ---DQH---RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred HHh---cCC---CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 000 011111256889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=252.45 Aligned_cols=218 Identities=24% Similarity=0.371 Sum_probs=174.7
Q ss_pred ceEEEEEEC-------CeEEEEEEccHH--------HHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATID-------GKVLAVKKIKED--------VTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~~-------g~~vAvK~~~~~--------~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~ 407 (615)
|.||+|.|. .+.|-||.++.. +..|--.+..+.|||+..+.|++.+.....++.|.++.-|+|..
T Consensus 298 Gri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~ 377 (563)
T KOG1024|consen 298 GRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKS 377 (563)
T ss_pred hheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHH
Confidence 579999762 355778887743 55677788888999999999999876667899999999999999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----- 482 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----- 482 (615)
||...+..+. .....++-.+...++.|++.|++|||.++ +||.||.++|+++|+..++||+|-.++|.+-
T Consensus 378 FL~~Cr~~~~--~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYh 452 (563)
T KOG1024|consen 378 FLQICRGDDP--SYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYH 452 (563)
T ss_pred HHHHhccCCC--ccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEeccchhccccCccccc
Confidence 9985543221 12245888999999999999999999998 9999999999999999999999999987541
Q ss_pred --------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhc
Q 047629 483 --------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWM 541 (615)
Q Consensus 483 --------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 541 (615)
+.++..+|||||||+||||+| |+.|+...+.-+... .+.
T Consensus 453 cLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~-------ylk------------- 512 (563)
T KOG1024|consen 453 CLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEH-------YLK------------- 512 (563)
T ss_pred ccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHH-------HHh-------------
Confidence 125678999999999999999 999987655422211 110
Q ss_pred CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 047629 542 DPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLT 586 (615)
Q Consensus 542 dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~ 586 (615)
| .-+-..|..|+.++..++..||..+|++||+++|++.-|+++.
T Consensus 513 d-GyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 513 D-GYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred c-cceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 0 0111246678889999999999999999999999999998764
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=260.09 Aligned_cols=222 Identities=22% Similarity=0.338 Sum_probs=163.4
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
+.||++.. .|+.+|+|++. +.+.+|++++++++|+||+++++++.+ ++..++|+||+++++|..+...
T Consensus 15 ~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~l~~~~~~ 93 (286)
T cd07846 15 GMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR-KKRLYLVFEFVDHTVLDDLEKY 93 (286)
T ss_pred eEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc-CCeEEEEEecCCccHHHHHHhc
Confidence 47999998 57999999874 246789999999999999999999865 4579999999999999888764
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC---------
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT--------- 482 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~--------- 482 (615)
.. .++|.++..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++....
T Consensus 94 ~~----------~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 160 (286)
T cd07846 94 PN----------GLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDY 160 (286)
T ss_pred cC----------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCcc
Confidence 32 2899999999999999999999997 9999999999999999999999999875321
Q ss_pred ---------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHH-HHHH------HHHhhh
Q 047629 483 ---------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVE-EKRE------ERLRNW 540 (615)
Q Consensus 483 ---------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~-~~~~------~~~~~~ 540 (615)
...+.++||||||+++|||++|+.|+...... ..+..+....... .... ......
T Consensus 161 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 161 VATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI---DQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred cceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH---HHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 11345799999999999999999888643321 1111111111000 0000 000011
Q ss_pred cCCcCCCCC-----ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 541 MDPNLESFY-----PIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 541 ~dp~l~~~~-----~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
..+...... .......+.+++.+||+.+|++||+|.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 111111000 11234568999999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-29 Score=262.65 Aligned_cols=202 Identities=25% Similarity=0.370 Sum_probs=158.7
Q ss_pred ceEEEEEE--CCeEEEEEEccHH----------HHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATI--DGKVLAVKKIKED----------VTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~~----------~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
|.||+|.. +++.||||.++.+ ...|..++... +||||+++++++.+. +..++||||+++|+|.+++
T Consensus 9 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~-~~~~lv~ey~~~g~L~~~l 87 (316)
T cd05619 9 GKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK-ENLFFVMEYLNGGDLMFHI 87 (316)
T ss_pred EEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC-CEEEEEEeCCCCCcHHHHH
Confidence 58999987 5789999998743 34577777764 999999999998754 4799999999999999999
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCC--------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA-------- 481 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~-------- 481 (615)
.... .+++.+...++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++..
T Consensus 88 ~~~~----------~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05619 88 QSCH----------KFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTC 154 (316)
T ss_pred HHcC----------CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCcee
Confidence 7543 2889999999999999999999998 999999999999999999999999987531
Q ss_pred ---------------CCCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCC
Q 047629 482 ---------------TNDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLE 546 (615)
Q Consensus 482 ---------------~~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~ 546 (615)
...++.++|||||||++|||++|+.||...... .+... +. ...+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~~~--------------i~-~~~~~-- 214 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---ELFQS--------------IR-MDNPC-- 214 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HHHHH--------------HH-hCCCC--
Confidence 112456899999999999999999999754321 11110 00 01111
Q ss_pred CCCChHHHHHHHHHHHHhhhcCCCCCCCHH-HHHH
Q 047629 547 SFYPIDGALSLATLARACTMDKSLSRPNMA-EVVF 580 (615)
Q Consensus 547 ~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~-ev~~ 580 (615)
++......+.+++.+|++.||++||++. ++.+
T Consensus 215 --~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 215 --YPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred --CCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 1222334578999999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-29 Score=263.69 Aligned_cols=202 Identities=23% Similarity=0.342 Sum_probs=158.2
Q ss_pred ceEEEEEE--CCeEEEEEEccHH----------HHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATI--DGKVLAVKKIKED----------VTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~~----------~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
|.||++.. +++.||||.++++ +..|..++..+ +|++|+++.+++.+. +..++||||+++|+|.+++
T Consensus 14 g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-~~~~lv~E~~~~g~L~~~~ 92 (323)
T cd05616 14 GKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM-DRLYFVMEYVNGGDLMYQI 92 (323)
T ss_pred eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecC-CEEEEEEcCCCCCCHHHHH
Confidence 58999987 5789999988642 34577777777 588899999987654 4799999999999999998
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------- 482 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------- 482 (615)
.... .+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~~~~----------~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~ 159 (323)
T cd05616 93 QQVG----------RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK 159 (323)
T ss_pred HHcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccc
Confidence 7543 2889999999999999999999998 9999999999999999999999999986321
Q ss_pred ----------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCC
Q 047629 483 ----------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLE 546 (615)
Q Consensus 483 ----------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~ 546 (615)
..++.++|||||||++|||++|+.||......+ +.. .+.+..
T Consensus 160 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---~~~-----------------~i~~~~-- 217 (323)
T cd05616 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQ-----------------SIMEHN-- 217 (323)
T ss_pred cCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH---HHH-----------------HHHhCC--
Confidence 124578999999999999999999997543211 110 011111
Q ss_pred CCCChHHHHHHHHHHHHhhhcCCCCCCCH-----HHHHH
Q 047629 547 SFYPIDGALSLATLARACTMDKSLSRPNM-----AEVVF 580 (615)
Q Consensus 547 ~~~~~~~~~~l~~l~~~C~~~dP~~RPsm-----~ev~~ 580 (615)
..++......+.+++.+|++.||.+|++. .++.+
T Consensus 218 ~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 218 VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 12333444567899999999999999984 56654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=247.44 Aligned_cols=204 Identities=27% Similarity=0.399 Sum_probs=160.8
Q ss_pred eEEEEEE--CCeEEEEEEcc---------------HHHHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCH
Q 047629 344 SVYRATI--DGKVLAVKKIK---------------EDVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSL 405 (615)
Q Consensus 344 ~Vy~~~~--~g~~vAvK~~~---------------~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL 405 (615)
.|-++.. .|+..|+|++. +.-.+|++||+++ .||+|+++.+++. .+...++|+|.|+.|.|
T Consensus 32 ~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye-s~sF~FlVFdl~prGEL 110 (411)
T KOG0599|consen 32 VVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE-SDAFVFLVFDLMPRGEL 110 (411)
T ss_pred hhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc-CcchhhhhhhhcccchH
Confidence 3444444 57888888774 3356799999998 7999999999976 45589999999999999
Q ss_pred HHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC--
Q 047629 406 DKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN-- 483 (615)
Q Consensus 406 ~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~-- 483 (615)
.++|...- .++++...+|+.|+..|++|||... ||||||||+|||+|+++++||+|||+|.....
T Consensus 111 FDyLts~V----------tlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa~~l~~Ge 177 (411)
T KOG0599|consen 111 FDYLTSKV----------TLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFACQLEPGE 177 (411)
T ss_pred HHHhhhhe----------eecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccceeeccCCch
Confidence 99997643 4999999999999999999999998 99999999999999999999999999965421
Q ss_pred --------------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHH
Q 047629 484 --------------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERL 537 (615)
Q Consensus 484 --------------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 537 (615)
.++..+|+||.||+||.|+.|.+||..... ..+ +
T Consensus 178 kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ---mlM-----------------L 237 (411)
T KOG0599|consen 178 KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ---MLM-----------------L 237 (411)
T ss_pred hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH---HHH-----------------H
Confidence 256789999999999999999999864321 100 1
Q ss_pred hhhcCCcC--CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 538 RNWMDPNL--ESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 538 ~~~~dp~l--~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
+-++.... ...--.+....+.+|+.+|++.||.+|-|++|++.+
T Consensus 238 R~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 238 RMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 11111111 111112334467899999999999999999999875
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-29 Score=265.36 Aligned_cols=163 Identities=22% Similarity=0.335 Sum_probs=135.6
Q ss_pred cccccccccc----ceEEEEEE--CCeEEEEEEcc-HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCH
Q 047629 333 MNLSEHYSIG----KSVYRATI--DGKVLAVKKIK-EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSL 405 (615)
Q Consensus 333 ~~~~~~~~iG----~~Vy~~~~--~g~~vAvK~~~-~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL 405 (615)
.+|.....+| |.||+|.. .++.||+|... .....|+.++++++|+||+++++++... ...++|+||+. |+|
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~-~~l 143 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSG-AITCMVLPHYS-SDL 143 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccccHHHHHHHHhCCCCCCcChhheEEeC-CeeEEEEEccC-CcH
Confidence 3455555555 58999998 56789999865 3456799999999999999999998764 47899999995 699
Q ss_pred HHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC---
Q 047629 406 DKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT--- 482 (615)
Q Consensus 406 ~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~--- 482 (615)
.+++..... .++|..+..|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 144 ~~~l~~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 144 YTYLTKRSR---------PLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred HHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 999875432 3899999999999999999999998 9999999999999999999999999986321
Q ss_pred -------------------CCCCCcccchhHHHHHHHHHcCCCCCC
Q 047629 483 -------------------NDVMPKFDVFAFGVVLLELLSGKKATR 509 (615)
Q Consensus 483 -------------------~~~~~k~DV~SfGvvl~ElltG~~p~~ 509 (615)
..++.++|||||||++|||+++..++.
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 124578999999999999999766553
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-29 Score=258.94 Aligned_cols=207 Identities=26% Similarity=0.375 Sum_probs=163.0
Q ss_pred ceEEEEEE--CCeEEEEEEcc----------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIK----------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~----------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
+.||+|.. +|+.||+|.+. .++.+|++++++++|+||+++.++|.+. +..++|+||++ |+|.+++.
T Consensus 29 g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~-g~l~~~~~ 106 (307)
T cd06607 29 GAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE-HTAWLVMEYCL-GSASDILE 106 (307)
T ss_pred eEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC-CeEEEEHHhhC-CCHHHHHH
Confidence 58999987 68999999874 2467899999999999999999998864 47899999997 68888775
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
.... .+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++....
T Consensus 107 ~~~~---------~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~~~~~~ 174 (307)
T cd06607 107 VHKK---------PLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVGT 174 (307)
T ss_pred Hccc---------CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCCCCccCC
Confidence 4332 3899999999999999999999998 9999999999999999999999999875321
Q ss_pred --------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCC
Q 047629 483 --------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESF 548 (615)
Q Consensus 483 --------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~ 548 (615)
..++.++||||||+++|||++|+.|+........ .. .+.....+.+
T Consensus 175 ~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~------~~-----------~~~~~~~~~~--- 234 (307)
T cd06607 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LY-----------HIAQNDSPTL--- 234 (307)
T ss_pred ccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH------HH-----------HHhcCCCCCC---
Confidence 1245689999999999999999999864331100 00 0000011111
Q ss_pred CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047629 549 YPIDGALSLATLARACTMDKSLSRPNMAEVVFNLS 583 (615)
Q Consensus 549 ~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~ 583 (615)
.+......+.+++.+||+.||++||+|.+|+.+..
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 269 (307)
T cd06607 235 SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF 269 (307)
T ss_pred CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 12234456899999999999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-29 Score=253.54 Aligned_cols=209 Identities=22% Similarity=0.389 Sum_probs=163.3
Q ss_pred ceEEEEEE--CCeEEEEEEcc-----------------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK-----------------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENG 403 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-----------------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~G 403 (615)
+.||+|.. +|+.+|+|.++ +.+.+|++++++++|+|++++++++... ...++|+||+++|
T Consensus 15 ~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~ 93 (272)
T cd06629 15 GRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE-EYLSIFLEYVPGG 93 (272)
T ss_pred eEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC-CceEEEEecCCCC
Confidence 48999986 68999999764 1356799999999999999999998754 4789999999999
Q ss_pred CHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC
Q 047629 404 SLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN 483 (615)
Q Consensus 404 sL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~ 483 (615)
+|.+++.... .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+|++|||+++....
T Consensus 94 ~L~~~l~~~~----------~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 160 (272)
T cd06629 94 SIGSCLRTYG----------RFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDD 160 (272)
T ss_pred cHHHHHhhcc----------CCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence 9999997653 3889999999999999999999987 99999999999999999999999998853210
Q ss_pred ---------------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHH
Q 047629 484 ---------------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREER 536 (615)
Q Consensus 484 ---------------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 536 (615)
..+.++||||||+++||+++|+.|+......+ . ....
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~----~~~~---------- 224 (272)
T cd06629 161 IYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA--A----MFKL---------- 224 (272)
T ss_pred cccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH--H----HHHh----------
Confidence 13567999999999999999999986432111 0 0000
Q ss_pred HhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 537 LRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 537 ~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
......+.+......+....+.+++..||+.+|.+||+|.||+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 225 GNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred hccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 000111111111222334568899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-29 Score=254.33 Aligned_cols=205 Identities=22% Similarity=0.377 Sum_probs=162.7
Q ss_pred ceEEEEEE-CCeEEEEEEcc-------------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHh
Q 047629 343 KSVYRATI-DGKVLAVKKIK-------------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKW 408 (615)
Q Consensus 343 ~~Vy~~~~-~g~~vAvK~~~-------------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~ 408 (615)
+.||+|.. +|+.+|||.++ ..+.+|++++++++|+||+++.+++.+. +..++++||+++|+|.++
T Consensus 14 ~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~ 92 (265)
T cd06631 14 GTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD-NTISIFMEFVPGGSISSI 92 (265)
T ss_pred eEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC-CeEEEEEecCCCCcHHHH
Confidence 48999987 78899999774 2367899999999999999999998764 478999999999999999
Q ss_pred hccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC------
Q 047629 409 LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------ 482 (615)
Q Consensus 409 L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------ 482 (615)
+.... .+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++....
T Consensus 93 l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 93 LNRFG----------PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred HHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 97543 2789999999999999999999988 9999999999999999999999999875320
Q ss_pred -----------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhh
Q 047629 483 -----------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRN 539 (615)
Q Consensus 483 -----------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 539 (615)
...+.++||||||+++|||++|+.|+......... .. ... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~---------~~-----~~~-~~ 224 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM---------FY-----IGA-HR 224 (265)
T ss_pred cccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH---------HH-----hhh-cc
Confidence 11346899999999999999999999754321100 00 000 00
Q ss_pred hcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047629 540 WMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVF 580 (615)
Q Consensus 540 ~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~ 580 (615)
...+.+. ......+.+++.+||+.+|.+||++.|+++
T Consensus 225 ~~~~~~~----~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 225 GLMPRLP----DSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCCCCC----CCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1112222 233445789999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=252.86 Aligned_cols=212 Identities=22% Similarity=0.322 Sum_probs=163.9
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCC-CcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQ-GNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~~lV~E~~~~GsL~~~L~ 410 (615)
+.||++.. +|+.+|+|.++ +.+..|++++++++|+||+++++++...+ ...+++|||+++|+|.+++.
T Consensus 14 ~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~ 93 (265)
T cd08217 14 GTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQ 93 (265)
T ss_pred eEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHH
Confidence 48999986 67899999874 23667999999999999999999876433 34789999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC-----
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHA--QPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN----- 483 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~----- 483 (615)
...... ..+++..++.++.|++.||.|||..+ ...++|+||||+||+++.++.+|++|||++.....
T Consensus 94 ~~~~~~------~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 167 (265)
T cd08217 94 KCKKER------KYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA 167 (265)
T ss_pred HHhhcc------cCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCCcccc
Confidence 642211 14899999999999999999999332 23399999999999999999999999998865321
Q ss_pred ------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcC
Q 047629 484 ------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNL 545 (615)
Q Consensus 484 ------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l 545 (615)
..+.++||||||+++|||++|+.|+...... ... ..+.....
T Consensus 168 ~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~--------------~~~~~~~~--- 227 (265)
T cd08217 168 KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLA--------------SKIKEGKF--- 227 (265)
T ss_pred cccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHH--------------HHHhcCCC---
Confidence 1345789999999999999999998754311 100 01111111
Q ss_pred CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 546 ESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 546 ~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
...+......+.+++.+|++.+|++||++.||+++
T Consensus 228 -~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 -RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 12333445568999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=277.17 Aligned_cols=233 Identities=21% Similarity=0.306 Sum_probs=164.4
Q ss_pred cccccccc----ceEEEEEE--CCeEEEEEEcc-HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHH
Q 047629 335 LSEHYSIG----KSVYRATI--DGKVLAVKKIK-EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407 (615)
Q Consensus 335 ~~~~~~iG----~~Vy~~~~--~g~~vAvK~~~-~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~ 407 (615)
|.....+| |.||++.. .++.||||... ..+.+|+++|++++|+|||++++++... +..++|||++. |+|.+
T Consensus 171 y~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~~~~~E~~iL~~L~HpnIv~l~~~~~~~-~~~~lv~e~~~-~~L~~ 248 (461)
T PHA03211 171 FAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYASSVHEARLLRRLSHPAVLALLDVRVVG-GLTCLVLPKYR-SDLYT 248 (461)
T ss_pred eEEEEEEccCCCeEEEEEEECCCCCEEEEecccccCHHHHHHHHHHCCCCCCCcEEEEEEEC-CEEEEEEEccC-CCHHH
Confidence 44444454 47999998 57899999754 4577899999999999999999998754 47899999995 79999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----- 482 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----- 482 (615)
++..... .++|.+++.|+.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 249 ~l~~~~~---------~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 249 YLGARLR---------PLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred HHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 9865432 3899999999999999999999998 9999999999999999999999999986421
Q ss_pred --------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCC-----hhHHHHHHHHHHHh-H-------
Q 047629 483 --------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENG-----KTAVLWKEIREVLK-V------- 529 (615)
Q Consensus 483 --------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~-----~~~~l~~~~~~~~~-~------- 529 (615)
..++.++|||||||+||||++|..++...... ....+...+...-. .
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 11456899999999999999988765432211 01111111111000 0
Q ss_pred HHHHHHHHhhh----cCCcCC-CCCC--hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 530 EEKREERLRNW----MDPNLE-SFYP--IDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 530 ~~~~~~~~~~~----~dp~l~-~~~~--~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.......+... ..+... ..+. ......+.+|+.+|++.||.+|||+.|++++
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000000000 000000 0000 0112357889999999999999999999875
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=262.51 Aligned_cols=201 Identities=23% Similarity=0.335 Sum_probs=157.9
Q ss_pred ceEEEEEE--CCeEEEEEEccHH----------HHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATI--DGKVLAVKKIKED----------VTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~~----------~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
|.||++.. +|+.||+|.++.. ...|..++... +|+||+++++++.+. +..++||||+++|+|.+++
T Consensus 9 g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-~~~~lv~E~~~~g~L~~~i 87 (316)
T cd05620 9 GKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTK-EHLFFVMEFLNGGDLMFHI 87 (316)
T ss_pred eEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeC-CEEEEEECCCCCCcHHHHH
Confidence 48999988 6889999998643 34577777654 899999999998754 4799999999999999998
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCC--------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA-------- 481 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~-------- 481 (615)
.... .+++.+...++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 88 ~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05620 88 QDKG----------RFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAS 154 (316)
T ss_pred HHcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCCCcee
Confidence 7643 2889999999999999999999998 999999999999999999999999987531
Q ss_pred ---------------CCCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCC
Q 047629 482 ---------------TNDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLE 546 (615)
Q Consensus 482 ---------------~~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~ 546 (615)
...++.++|||||||++|||++|+.||..... ..++.. +. ...+.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~---~~~~~~--------------~~-~~~~~~- 215 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE---DELFES--------------IR-VDTPHY- 215 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHH--------------HH-hCCCCC-
Confidence 01245689999999999999999999975431 111110 00 011222
Q ss_pred CCCChHHHHHHHHHHHHhhhcCCCCCCCHH-HHH
Q 047629 547 SFYPIDGALSLATLARACTMDKSLSRPNMA-EVV 579 (615)
Q Consensus 547 ~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~-ev~ 579 (615)
+......+.+++..|++.||++||++. ++.
T Consensus 216 ---~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 216 ---PRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred ---CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 222334578999999999999999984 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=258.39 Aligned_cols=205 Identities=21% Similarity=0.367 Sum_probs=163.2
Q ss_pred ceEEEEEE--CCeEEEEEEcc-------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
+.||+|.. +|+.||+|.+. +.+.+|++++++++|+|++++++++... ...++|+||+++|+|.+++...
T Consensus 33 g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~- 110 (296)
T cd06655 33 GTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVG-DELFVVMEYLAGGSLTDVVTET- 110 (296)
T ss_pred eEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecC-ceEEEEEEecCCCcHHHHHHhc-
Confidence 58999985 78999999875 3467899999999999999999998754 4799999999999999998643
Q ss_pred CCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----------
Q 047629 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----------- 482 (615)
Q Consensus 414 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----------- 482 (615)
.+++.++..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++....
T Consensus 111 ----------~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 177 (296)
T cd06655 111 ----------CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVG 177 (296)
T ss_pred ----------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCcCC
Confidence 2899999999999999999999998 9999999999999999999999999875321
Q ss_pred ------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 483 ------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 483 ------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
...+.++|||||||++|||++|+.||.......... . +.....+.+ ..+
T Consensus 178 ~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~------~-----------~~~~~~~~~--~~~ 238 (296)
T cd06655 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------L-----------IATNGTPEL--QNP 238 (296)
T ss_pred CccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------H-----------HHhcCCccc--CCc
Confidence 113567999999999999999999997544211100 0 000000111 112
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 551 IDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.+....+.+++.+||..||.+||++.+++..
T Consensus 239 ~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 239 EKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred ccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 2334457899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=262.46 Aligned_cols=198 Identities=22% Similarity=0.304 Sum_probs=154.6
Q ss_pred ceEEEEEE--CCeEEEEEEccHH----------HHHHHH-HHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATI--DGKVLAVKKIKED----------VTEELR-ILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~~----------~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
+.||++.. +|+.||+|.+.+. +..|.. +++.++|+||+++++++.+. +..++||||+++|+|..++
T Consensus 9 g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l 87 (321)
T cd05603 9 GKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTA-EKLYFVLDYVNGGELFFHL 87 (321)
T ss_pred EEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcC-CEEEEEEcCCCCCCHHHHH
Confidence 48999987 6899999998532 334443 57789999999999988754 4799999999999999988
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------- 482 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------- 482 (615)
.... .+++.++..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 88 ~~~~----------~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05603 88 QRER----------CFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTS 154 (321)
T ss_pred HHcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccc
Confidence 6543 2788889999999999999999998 9999999999999999999999999876421
Q ss_pred ----------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCC
Q 047629 483 ----------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLE 546 (615)
Q Consensus 483 ----------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~ 546 (615)
..++.++|||||||++|||++|+.||...... ... . .+ ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~---~-----------~i---~~~~-- 212 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS---QMY---D-----------NI---LHKP-- 212 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH---HHH---H-----------HH---hcCC--
Confidence 12456899999999999999999999754310 000 0 00 1111
Q ss_pred CCCChHHHHHHHHHHHHhhhcCCCCCCCHH
Q 047629 547 SFYPIDGALSLATLARACTMDKSLSRPNMA 576 (615)
Q Consensus 547 ~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ 576 (615)
...+......+.+++.+|++.||.+||+..
T Consensus 213 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 213 LQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 112333445688999999999999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=254.39 Aligned_cols=204 Identities=25% Similarity=0.385 Sum_probs=163.9
Q ss_pred ceEEEEEE--CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATI--DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
+.||+|.. +|+.+|+|.+. ..+.+|++++++++|+|++++.+++.+. ...++|+||+++|+|.+++...
T Consensus 15 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~ 93 (274)
T cd06609 15 GEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG-SKLWIIMEYCGGGSCLDLLKPG 93 (274)
T ss_pred eEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC-CeEEEEEEeeCCCcHHHHHhhc
Confidence 48999987 68999999875 2467899999999999999999988754 4789999999999999999754
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC---------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN--------- 483 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~--------- 483 (615)
.+++..+..++.|++.||.|||+++ ++||||+|+||++++++.++++|||+++....
T Consensus 94 -----------~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 159 (274)
T cd06609 94 -----------KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV 159 (274)
T ss_pred -----------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccccccccc
Confidence 2889999999999999999999988 99999999999999999999999998754311
Q ss_pred --------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCC
Q 047629 484 --------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFY 549 (615)
Q Consensus 484 --------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~ 549 (615)
..+.++||||||+++|||++|+.|+........ . ..+.....+.+...
T Consensus 160 ~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~------~-----------~~~~~~~~~~~~~~- 221 (274)
T cd06609 160 GTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV------L-----------FLIPKNNPPSLEGN- 221 (274)
T ss_pred CCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH------H-----------HHhhhcCCCCCccc-
Confidence 135689999999999999999999865432110 0 01111122222211
Q ss_pred ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 550 PIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 550 ~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.....+.+++.+||..+|++||+++++++.
T Consensus 222 --~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 222 --KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred --ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 033457899999999999999999999885
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-30 Score=255.80 Aligned_cols=224 Identities=24% Similarity=0.396 Sum_probs=166.5
Q ss_pred ceEEEEEE--CCeEEEEEEccHH---------HHHHHHHHHhcCCCCcccEEEEEEcC----CCcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATI--DGKVLAVKKIKED---------VTEELRILQRINHANLVKLMGVSSDS----QGNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~~---------~~~Ei~~l~~l~H~niv~l~g~~~~~----~~~~~lV~E~~~~GsL~~ 407 (615)
|.|..+.. +|+.||||++..- ..+|+++|+.++|+||+.+.+....+ -...|+|+|+|+ -+|.+
T Consensus 36 GvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elMe-tDL~~ 114 (359)
T KOG0660|consen 36 GVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELME-TDLHQ 114 (359)
T ss_pred eeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHHh-hHHHH
Confidence 46666666 7899999999743 45799999999999999999987541 124899999995 48999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC----
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN---- 483 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~---- 483 (615)
.++... .|+.....-+..|+++||.|+|+-+ ++||||||+|+|++.+...||+|||+|+....
T Consensus 115 iik~~~----------~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~ 181 (359)
T KOG0660|consen 115 IIKSQQ----------DLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFED 181 (359)
T ss_pred HHHcCc----------cccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeeccccCcc
Confidence 998754 2888899999999999999999998 99999999999999999999999999987731
Q ss_pred ----------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHH---HHHHHHh
Q 047629 484 ----------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEE---KREERLR 538 (615)
Q Consensus 484 ----------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~~~~~ 538 (615)
.+++..||||.||++.||++|++-|.+.+.-+...+.-.+......+. ...++.+
T Consensus 182 ~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar 261 (359)
T KOG0660|consen 182 GFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKAR 261 (359)
T ss_pred cchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHH
Confidence 156789999999999999999998876654333222211111111000 0001111
Q ss_pred hhcC--CcC-----CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 539 NWMD--PNL-----ESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 539 ~~~d--p~l-----~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
..+. |.. ...+| ......++|..+++..||.+|+|++|.+++
T Consensus 262 ~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 262 PYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1111 111 11122 333457899999999999999999999985
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-29 Score=253.66 Aligned_cols=216 Identities=23% Similarity=0.407 Sum_probs=164.7
Q ss_pred ceEEEEEE-------CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATI-------DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~-------~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~ 407 (615)
+.||++.. +.+.+|+|.+. ..+.+|++++++++|+||+++++++.+. ...++||||+++|+|.+
T Consensus 19 g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~ 97 (275)
T cd05046 19 GEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREA-EPHYMILEYTDLGDLKQ 97 (275)
T ss_pred eEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCC-CcceEEEEecCCCcHHH
Confidence 48999885 24679999874 3478899999999999999999998654 47899999999999999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----- 482 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----- 482 (615)
++........ ......+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.+|++|||+++...
T Consensus 98 ~i~~~~~~~~-~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~ 173 (275)
T cd05046 98 FLRATKSKDE-KLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYY 173 (275)
T ss_pred HHHhcccccc-cccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEcccccccccCccccc
Confidence 9976542110 011124899999999999999999999998 9999999999999999999999999975321
Q ss_pred -------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcC
Q 047629 483 -------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMD 542 (615)
Q Consensus 483 -------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~d 542 (615)
...+.++||||||+++|||++ |..|+....... ..... ..
T Consensus 174 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~~~-----------------~~ 233 (275)
T cd05046 174 KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLNRL-----------------QA 233 (275)
T ss_pred ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHHHH-----------------Hc
Confidence 123557999999999999999 777875432211 01000 00
Q ss_pred CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047629 543 PNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLS 583 (615)
Q Consensus 543 p~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~ 583 (615)
..+....+......+.+++.+||+.+|.+||++.|++..|+
T Consensus 234 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 GKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 01111112233456899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-30 Score=267.39 Aligned_cols=202 Identities=25% Similarity=0.406 Sum_probs=168.0
Q ss_pred ceEEEEEE--CCeEEEEEEccH---------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE---------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~---------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
|.||||+- +++.||+|.+.+ .+.+|++|+++++|||||.+++++.. ..++|+|.||+.+ +|..+|..
T Consensus 16 g~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt-~~~~~vVte~a~g-~L~~il~~ 93 (808)
T KOG0597|consen 16 GRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET-SAHLWVVTEYAVG-DLFTILEQ 93 (808)
T ss_pred ceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc-cceEEEEehhhhh-hHHHHHHh
Confidence 58999986 679999998852 37889999999999999999999864 4589999999976 99999987
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC--------
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN-------- 483 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~-------- 483 (615)
... |++.++..|+.|+..||.|||+++ |+|||+||+|||++.++.+|++|||+|+..+.
T Consensus 94 d~~----------lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsi 160 (808)
T KOG0597|consen 94 DGK----------LPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTSI 160 (808)
T ss_pred ccC----------CCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCceeeeec
Confidence 654 999999999999999999999998 99999999999999999999999999986532
Q ss_pred ---------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCC
Q 047629 484 ---------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESF 548 (615)
Q Consensus 484 ---------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~ 548 (615)
.++..+|.||+||++||+.+|++||.... +.+.. +..+ -||. .
T Consensus 161 kGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s----------i~~Lv------~~I~---~d~v---~ 218 (808)
T KOG0597|consen 161 KGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS----------ITQLV------KSIL---KDPV---K 218 (808)
T ss_pred cCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH----------HHHHH------HHHh---cCCC---C
Confidence 24557999999999999999999996422 11111 0011 1221 2
Q ss_pred CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 549 YPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 549 ~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
+|......+..+....+..||..|-+..+++.+
T Consensus 219 ~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 219 PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred CcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 455666778999999999999999999998875
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=262.67 Aligned_cols=202 Identities=22% Similarity=0.341 Sum_probs=157.1
Q ss_pred ceEEEEEE--CCeEEEEEEccHH----------HHHHHHHHHhcCCC-CcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATI--DGKVLAVKKIKED----------VTEELRILQRINHA-NLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~~----------~~~Ei~~l~~l~H~-niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
|.||+|.. +++.||||.++.+ +..|..++..++|+ +|+++.+++.+ ++..++||||+++|+|.+++
T Consensus 14 g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv~E~~~~g~L~~~~ 92 (324)
T cd05587 14 GKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-MDRLYFVMEYVNGGDLMYHI 92 (324)
T ss_pred eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc-CCEEEEEEcCCCCCcHHHHH
Confidence 58999987 5689999988632 45688899999765 57788887764 44799999999999999999
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------- 482 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------- 482 (615)
.... .+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~~~~----------~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (324)
T cd05587 93 QQVG----------KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR 159 (324)
T ss_pred HHcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCcee
Confidence 7543 2889999999999999999999998 9999999999999999999999999875320
Q ss_pred ----------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCC
Q 047629 483 ----------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLE 546 (615)
Q Consensus 483 ----------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~ 546 (615)
..++.++|||||||++|||++|+.||......+ ... .+... .
T Consensus 160 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~-----------------~i~~~--~ 217 (324)
T cd05587 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---LFQ-----------------SIMEH--N 217 (324)
T ss_pred eecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHH-----------------HHHcC--C
Confidence 124568999999999999999999997543211 000 00111 1
Q ss_pred CCCChHHHHHHHHHHHHhhhcCCCCCCCH-----HHHHH
Q 047629 547 SFYPIDGALSLATLARACTMDKSLSRPNM-----AEVVF 580 (615)
Q Consensus 547 ~~~~~~~~~~l~~l~~~C~~~dP~~RPsm-----~ev~~ 580 (615)
..++......+.+++.+|++.||.+|++. +++.+
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 218 VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 12233344567899999999999999986 55554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=253.16 Aligned_cols=208 Identities=25% Similarity=0.352 Sum_probs=163.0
Q ss_pred ceEEEEEE--CCeEEEEEEcc-------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
+.||+|.. ++..+|+|.+. ..+.+|++++++++|+|++++++++... +..++|+||+++|+|..++....
T Consensus 19 g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-~~~~~v~e~~~~~~l~~~~~~~~ 97 (282)
T cd06643 19 GKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-NNLWILIEFCAGGAVDAVMLELE 97 (282)
T ss_pred eEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC-CEEEEEEEecCCCcHHHHHHhcC
Confidence 48999988 57889999874 2467899999999999999999998754 47899999999999999886533
Q ss_pred CCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC----------
Q 047629 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN---------- 483 (615)
Q Consensus 414 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~---------- 483 (615)
. .++|..+..++.|++.||.|||+.+ ++||||||+||+++.++.+|++|||++.....
T Consensus 98 ~---------~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 165 (282)
T cd06643 98 R---------PLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIG 165 (282)
T ss_pred C---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccccccccccc
Confidence 2 3899999999999999999999998 99999999999999999999999998753210
Q ss_pred ------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcC
Q 047629 484 ------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNL 545 (615)
Q Consensus 484 ------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l 545 (615)
..+.++|||||||++|||++|+.|+......+. +.. ......+.+
T Consensus 166 ~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~~~-----------~~~~~~~~~ 228 (282)
T cd06643 166 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV------LLK-----------IAKSEPPTL 228 (282)
T ss_pred cccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH------HHH-----------HhhcCCCCC
Confidence 123479999999999999999999865332110 000 000011111
Q ss_pred CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047629 546 ESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNL 582 (615)
Q Consensus 546 ~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L 582 (615)
..+......+.+++..||+.||.+||++.++++.-
T Consensus 229 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 229 --AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred --CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 11222335688999999999999999999988753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=264.17 Aligned_cols=202 Identities=23% Similarity=0.311 Sum_probs=156.2
Q ss_pred ceEEEEEE--CCeEEEEEEccHH----------HHHHHH-HHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATI--DGKVLAVKKIKED----------VTEELR-ILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~~----------~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
|.||++.. +|+.+|+|+++.. +..|.. +++.++|+||+++++++... +..++||||+++|+|..++
T Consensus 9 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l 87 (325)
T cd05604 9 GKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTT-EKLYFVLDFVNGGELFFHL 87 (325)
T ss_pred eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecC-CEEEEEEcCCCCCCHHHHH
Confidence 48999987 7899999998632 234444 46778999999999988754 4799999999999999998
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------- 482 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------- 482 (615)
.... .+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 88 ~~~~----------~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (325)
T cd05604 88 QRER----------SFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTT 154 (325)
T ss_pred HHcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcc
Confidence 7543 3889999999999999999999998 9999999999999999999999999986421
Q ss_pred ----------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCC
Q 047629 483 ----------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLE 546 (615)
Q Consensus 483 ----------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~ 546 (615)
..++.++|||||||++|||++|+.||......+ .. ... ... ...+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~---~~~----------~~~--~~~~- 215 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE---MY---DNI----------LHK--PLVL- 215 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH---HH---HHH----------HcC--CccC-
Confidence 124568999999999999999999997543111 11 110 010 0111
Q ss_pred CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047629 547 SFYPIDGALSLATLARACTMDKSLSRPNMAEVVF 580 (615)
Q Consensus 547 ~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~ 580 (615)
+......+.+++..|++.+|.+||++++.++
T Consensus 216 ---~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 216 ---RPGASLTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred ---CCCCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 1123345789999999999999998864333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-29 Score=250.12 Aligned_cols=207 Identities=22% Similarity=0.275 Sum_probs=161.6
Q ss_pred ceEEEEE--ECCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRAT--IDGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~--~~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
+.||.+. .+|+.+++|.+. .++.+|++++++++|+||+++++++.+. +..+++|||+++|+|.+++..
T Consensus 14 g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~~~~e~~~~~~L~~~~~~ 92 (256)
T cd08221 14 GEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD-NTLLIEMEYANGGTLYDKIVR 92 (256)
T ss_pred ceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC-CeEEEEEEecCCCcHHHHHHh
Confidence 3455444 478999999764 2477899999999999999999998764 478999999999999999976
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC--------
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN-------- 483 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~-------- 483 (615)
... ..+++.++..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++.....
T Consensus 93 ~~~--------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (256)
T cd08221 93 QKG--------QLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV 161 (256)
T ss_pred ccc--------cCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccccccccccc
Confidence 532 13899999999999999999999988 99999999999999999999999998754311
Q ss_pred ---------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCC
Q 047629 484 ---------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESF 548 (615)
Q Consensus 484 ---------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~ 548 (615)
..+.++||||||+++|||++|+.|+......+. ... ....... .
T Consensus 162 ~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~------~~~--------------~~~~~~~-~ 220 (256)
T cd08221 162 VGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL------VVK--------------IVQGNYT-P 220 (256)
T ss_pred CCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH------HHH--------------HHcCCCC-C
Confidence 134579999999999999999999865331110 000 0001110 1
Q ss_pred CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047629 549 YPIDGALSLATLARACTMDKSLSRPNMAEVVFNL 582 (615)
Q Consensus 549 ~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L 582 (615)
.+......+.+++..||+.+|.+||++.|+++.+
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 221 VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 1123345688999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=254.64 Aligned_cols=207 Identities=26% Similarity=0.392 Sum_probs=164.1
Q ss_pred ceEEEEEE--CCeEEEEEEcc-------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
+.||++.. +++.+|+|..+ +.+.+|++++++++|+||+++++++.. +...++||||+++|+|.+++....
T Consensus 19 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~ 97 (280)
T cd06611 19 GKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFY-ENKLWILIEFCDGGALDSIMLELE 97 (280)
T ss_pred ceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEec-CCeEEEEeeccCCCcHHHHHHHhc
Confidence 58999987 58999999875 247789999999999999999999875 447899999999999999987643
Q ss_pred CCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----------
Q 047629 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----------- 482 (615)
Q Consensus 414 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----------- 482 (615)
. .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 98 ~---------~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 165 (280)
T cd06611 98 R---------GLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIG 165 (280)
T ss_pred C---------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccccccceeec
Confidence 2 3899999999999999999999998 9999999999999999999999999874321
Q ss_pred -----------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcC
Q 047629 483 -----------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNL 545 (615)
Q Consensus 483 -----------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l 545 (615)
...+.++||||||+++|||++|+.|+........ +. .+.....+.+
T Consensus 166 ~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~------~~-----------~~~~~~~~~~ 228 (280)
T cd06611 166 TPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV------LL-----------KILKSEPPTL 228 (280)
T ss_pred chhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH------HH-----------HHhcCCCCCc
Confidence 1134579999999999999999999865432110 00 0111011111
Q ss_pred CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 546 ESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 546 ~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
..+......+.+++..||+.+|.+||++.++++.
T Consensus 229 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 229 --DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred --CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 1122233457899999999999999999999886
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=259.19 Aligned_cols=220 Identities=21% Similarity=0.333 Sum_probs=163.2
Q ss_pred ceEEEEEE--CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATI--DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
|.||+|.. +++.||+|.++ ..+.+|+.++++++|+||+++++++... +..++|+||++ ++|.+++...
T Consensus 20 g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~-~~~~lv~e~~~-~~l~~~l~~~ 97 (301)
T cd07873 20 ATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE-KSLTLVFEYLD-KDLKQYLDDC 97 (301)
T ss_pred EEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecC-CeEEEEEeccc-cCHHHHHHhc
Confidence 48999987 57899999875 2466899999999999999999998754 47999999997 6999998764
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC----------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT---------- 482 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~---------- 482 (615)
.. .+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 98 ~~---------~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 165 (301)
T cd07873 98 GN---------SINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEV 165 (301)
T ss_pred CC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcccccc
Confidence 32 3789999999999999999999998 9999999999999999999999999885421
Q ss_pred --------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhc-------
Q 047629 483 --------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWM------- 541 (615)
Q Consensus 483 --------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~------- 541 (615)
...+.++|||||||++|||++|+.||......+ .+..+...+.... ......++
T Consensus 166 ~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~---~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 240 (301)
T cd07873 166 VTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE---QLHFIFRILGTPT--EETWPGILSNEEFKS 240 (301)
T ss_pred eeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCC--hhhchhhhccccccc
Confidence 113457899999999999999999997544211 1111111110000 00001110
Q ss_pred --CCcCCCCC----ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 542 --DPNLESFY----PIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 542 --dp~l~~~~----~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
-|...... .......+.+|+.+|++.||.+|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 01110000 11223357899999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=258.51 Aligned_cols=205 Identities=20% Similarity=0.328 Sum_probs=163.0
Q ss_pred ceEEEEEE--CCeEEEEEEcc-------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
+.||++.. +|+.||+|.+. +.+.+|+.+++.++|+||+++++++... +..++||||+++|+|.+++...
T Consensus 33 g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~- 110 (297)
T cd06656 33 GTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-DELWVVMEYLAGGSLTDVVTET- 110 (297)
T ss_pred eEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CEEEEeecccCCCCHHHHHHhC-
Confidence 58999986 78999999885 3467899999999999999999998754 4799999999999999998642
Q ss_pred CCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----------
Q 047629 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----------- 482 (615)
Q Consensus 414 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----------- 482 (615)
.+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 111 ----------~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 177 (297)
T cd06656 111 ----------CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG 177 (297)
T ss_pred ----------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCcccC
Confidence 2789999999999999999999987 9999999999999999999999999875321
Q ss_pred ------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 483 ------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 483 ------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
...+.++|||||||++|||++|+.||.......... ............+
T Consensus 178 ~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~-------------------~~~~~~~~~~~~~ 238 (297)
T cd06656 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-------------------LIATNGTPELQNP 238 (297)
T ss_pred CccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee-------------------eeccCCCCCCCCc
Confidence 113468999999999999999999996543211100 0000000001122
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 551 IDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
......+.+++.+||+.+|++||++.|+++.
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 239 ERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2334457899999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=269.41 Aligned_cols=206 Identities=20% Similarity=0.269 Sum_probs=157.7
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
+.||++.. +|+.||||.+.+ .+.+|+++|.+++|+||+++++.+.+ ++..++||||+++|+|.+++.
T Consensus 15 g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-~~~~~lv~E~~~~g~L~~~i~ 93 (376)
T cd05598 15 GEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD-KDNLYFVMDYIPGGDMMSLLI 93 (376)
T ss_pred eEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc-CCEEEEEEeCCCCCcHHHHHH
Confidence 58999987 689999999853 25679999999999999999999875 458999999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCC---------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA--------- 481 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~--------- 481 (615)
... .+++.....++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 94 ~~~----------~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 94 RLG----------IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred hcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 643 2788888999999999999999998 999999999999999999999999986311
Q ss_pred ---------------------------------------------------------CCCCCCcccchhHHHHHHHHHcC
Q 047629 482 ---------------------------------------------------------TNDVMPKFDVFAFGVVLLELLSG 504 (615)
Q Consensus 482 ---------------------------------------------------------~~~~~~k~DV~SfGvvl~ElltG 504 (615)
...++.++|||||||++|||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G 240 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhC
Confidence 01245689999999999999999
Q ss_pred CCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCC---CHHHHHHH
Q 047629 505 KKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRP---NMAEVVFN 581 (615)
Q Consensus 505 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RP---sm~ev~~~ 581 (615)
+.||......+.. .. +..+ ...+...........+.+++.+|+ .+|.+|+ ++.|++++
T Consensus 241 ~~Pf~~~~~~~~~------~~-----------i~~~-~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 241 QPPFLADTPAETQ------LK-----------VINW-ETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred CCCCCCCCHHHHH------HH-----------Hhcc-CccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 9999764421110 00 0000 000100011122334566777765 4999999 88998876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-29 Score=249.57 Aligned_cols=206 Identities=24% Similarity=0.354 Sum_probs=163.4
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
+.+|++.. +|+.+|+|++. .++.+|+.++++++|+||+++.+++.+ ++..++|+||+++++|.+++..
T Consensus 14 g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~l~~~~~~ 92 (256)
T cd08218 14 GKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE-NGNLYIVMDYCEGGDLYKKINA 92 (256)
T ss_pred eEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC-CCeEEEEEecCCCCcHHHHHHh
Confidence 36888776 78999999874 247789999999999999999998765 4579999999999999999975
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC---------
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT--------- 482 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~--------- 482 (615)
.... .+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||++....
T Consensus 93 ~~~~--------~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 161 (256)
T cd08218 93 QRGV--------LFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTC 161 (256)
T ss_pred ccCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhhc
Confidence 4321 3789999999999999999999988 9999999999999999999999999885431
Q ss_pred --------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCC
Q 047629 483 --------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESF 548 (615)
Q Consensus 483 --------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~ 548 (615)
...+.++|||||||+++||++|+.|+......+ .+.. .+... .+ .
T Consensus 162 ~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~~~----------~~~~~-~~----~ 220 (256)
T cd08218 162 IGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN------LVLK----------IIRGS-YP----P 220 (256)
T ss_pred cCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH------HHHH----------HhcCC-CC----C
Confidence 123568999999999999999999986432110 0100 11111 11 1
Q ss_pred CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 549 YPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 549 ~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.+......+.+++.+||+.+|.+||+|+||++.
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 221 VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 223344568999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-29 Score=253.57 Aligned_cols=203 Identities=25% Similarity=0.395 Sum_probs=162.8
Q ss_pred ceEEEEEE--CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATI--DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
+.||+|.. +++.+|+|... ..+.+|++++.+++|+||+++++++.+. ...++||||+++|+|.+++...
T Consensus 18 ~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~l~~~i~~~ 96 (277)
T cd06641 18 GEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-TKLWIIMEYLGGGSALDLLEPG 96 (277)
T ss_pred eEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC-CeEEEEEEeCCCCcHHHHHhcC
Confidence 58999986 67899999864 2477899999999999999999998754 4799999999999999998642
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC----------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT---------- 482 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~---------- 482 (615)
.+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++++|||++....
T Consensus 97 -----------~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 162 (277)
T cd06641 97 -----------PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV 162 (277)
T ss_pred -----------CCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchhhhcccc
Confidence 2889999999999999999999988 9999999999999999999999999875321
Q ss_pred -------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCC
Q 047629 483 -------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFY 549 (615)
Q Consensus 483 -------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~ 549 (615)
...+.++|||||||++|||++|+.|+....... . .. .+...-.+.+
T Consensus 163 ~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~---~~-----------~~~~~~~~~~---- 221 (277)
T cd06641 163 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK---V---LF-----------LIPKNNPPTL---- 221 (277)
T ss_pred CCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH---H---HH-----------HHhcCCCCCC----
Confidence 113457999999999999999999986432110 0 00 0111111122
Q ss_pred ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 550 PIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 550 ~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
+......+.+++.+||+.+|.+||++.|++++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 22334557899999999999999999999995
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-30 Score=242.49 Aligned_cols=206 Identities=27% Similarity=0.375 Sum_probs=166.4
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||.|.. ++-.||+|++.+ ++.+|++|.+.++||||.+++||+.+.. ..||++||.++|+|...|.
T Consensus 36 G~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~-riyLilEya~~gel~k~L~ 114 (281)
T KOG0580|consen 36 GNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK-RIYLILEYAPRGELYKDLQ 114 (281)
T ss_pred ccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccc-eeEEEEEecCCchHHHHHH
Confidence 48999998 578899999853 4678999999999999999999998755 7999999999999999998
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
..... .++......+..|+|.||.|+|..+ ++||||||+|+|++..+..|++|||.+....
T Consensus 115 ~~~~~--------~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~kR~tlc 183 (281)
T KOG0580|consen 115 EGRMK--------RFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSNKRKTLC 183 (281)
T ss_pred hcccc--------cccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecCCCCceeee
Confidence 54432 2777778889999999999999987 9999999999999999999999999874431
Q ss_pred -------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCC
Q 047629 483 -------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFY 549 (615)
Q Consensus 483 -------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~ 549 (615)
.....++|+|++||+.||++.|.+||.....++. .+.+.. +| -.+
T Consensus 184 gt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et---YkrI~k---------------~~----~~~ 241 (281)
T KOG0580|consen 184 GTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET---YKRIRK---------------VD----LKF 241 (281)
T ss_pred cccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH---HHHHHH---------------cc----ccC
Confidence 1245689999999999999999999986542221 111110 11 122
Q ss_pred ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047629 550 PIDGALSLATLARACTMDKSLSRPNMAEVVFNL 582 (615)
Q Consensus 550 ~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L 582 (615)
|........+++..|+..+|.+|.+..|++..-
T Consensus 242 p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 242 PSTISGGAADLISRLLVKNPIERLALTEVMDHP 274 (281)
T ss_pred CcccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence 333444578999999999999999999998763
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=268.00 Aligned_cols=156 Identities=22% Similarity=0.326 Sum_probs=135.1
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||++.. +++.+|+|.+.. .+.+|++++++++|+||+++++.+.+. ...++||||+++|+|.+++.
T Consensus 15 g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~-~~~~lv~E~~~gg~L~~~l~ 93 (382)
T cd05625 15 GEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDK-DNLYFVMDYIPGGDMMSLLI 93 (382)
T ss_pred EEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeC-CEEEEEEeCCCCCcHHHHHH
Confidence 58999987 688999999863 356799999999999999999998754 47999999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCC---------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA--------- 481 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~--------- 481 (615)
... .+++.....++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 94 ~~~----------~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 94 RMG----------IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred hcC----------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 643 2788889999999999999999998 999999999999999999999999986311
Q ss_pred -------------------------------------------------------------CCCCCCcccchhHHHHHHH
Q 047629 482 -------------------------------------------------------------TNDVMPKFDVFAFGVVLLE 500 (615)
Q Consensus 482 -------------------------------------------------------------~~~~~~k~DV~SfGvvl~E 500 (615)
...++.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 240 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHH
Confidence 0124568999999999999
Q ss_pred HHcCCCCCCCCC
Q 047629 501 LLSGKKATRTTE 512 (615)
Q Consensus 501 lltG~~p~~~~~ 512 (615)
|++|+.||....
T Consensus 241 lltG~~Pf~~~~ 252 (382)
T cd05625 241 MLVGQPPFLAQT 252 (382)
T ss_pred HHhCCCCCCCCC
Confidence 999999997543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-29 Score=255.56 Aligned_cols=209 Identities=21% Similarity=0.285 Sum_probs=163.1
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||++.. +++.+|||.+.. .+.+|+.++++++|+|++++.+.+.+. ...++||||+++|+|.+++.
T Consensus 14 g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~g~~L~~~l~ 92 (285)
T cd05630 14 GEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETK-DALCLVLTLMNGGDLKFHIY 92 (285)
T ss_pred eEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC-CEEEEEEEecCCCcHHHHHH
Confidence 48999887 688999998752 245799999999999999999988754 47899999999999999986
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
..... .+++.++..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 93 ~~~~~--------~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 161 (285)
T cd05630 93 HMGEA--------GFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR 161 (285)
T ss_pred Hhccc--------CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccCC
Confidence 53321 3889999999999999999999987 9999999999999999999999999885421
Q ss_pred --------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCC
Q 047629 483 --------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESF 548 (615)
Q Consensus 483 --------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~ 548 (615)
..++.++||||||+++|||++|+.||......... ....... .... ..
T Consensus 162 ~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~---~~~~~~~-------~~~~--------~~ 223 (285)
T cd05630 162 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR---EEVERLV-------KEVQ--------EE 223 (285)
T ss_pred CCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH---HHHHhhh-------hhhh--------hh
Confidence 12456899999999999999999999764322111 0011000 0000 11
Q ss_pred CChHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 047629 549 YPIDGALSLATLARACTMDKSLSRPN-----MAEVVFN 581 (615)
Q Consensus 549 ~~~~~~~~l~~l~~~C~~~dP~~RPs-----m~ev~~~ 581 (615)
++......+.+|+..||+.||++||| +.|++++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 224 YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 12223345789999999999999999 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=244.24 Aligned_cols=194 Identities=23% Similarity=0.357 Sum_probs=158.5
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.|...+. +|..+|+|++++ ...+|..+|+.+.||.+++|.+-+.+.+ .+++||||+++|.|..+|+
T Consensus 58 GrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~-~lymvmeyv~GGElFS~Lr 136 (355)
T KOG0616|consen 58 GRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNS-NLYMVMEYVPGGELFSYLR 136 (355)
T ss_pred ceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCC-eEEEEEeccCCccHHHHHH
Confidence 46766665 789999999974 2457999999999999999999887654 8999999999999999999
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC-------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------- 483 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------- 483 (615)
+.+. ++.....-+|.+|+.||+|||+.. |++|||||+|||||.+|.+||+|||+|+...+
T Consensus 137 k~~r----------F~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~rT~TlCG 203 (355)
T KOG0616|consen 137 KSGR----------FSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGRTWTLCG 203 (355)
T ss_pred hcCC----------CCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCcEEEecC
Confidence 8664 889999999999999999999998 99999999999999999999999999976532
Q ss_pred -------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 484 -------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 484 -------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
++..++|.|||||++|||+.|.+||..... ... ..+++...+ .+|
T Consensus 204 TPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~---~~i-----------------Y~KI~~~~v--~fP 261 (355)
T KOG0616|consen 204 TPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP---IQI-----------------YEKILEGKV--KFP 261 (355)
T ss_pred CccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh---HHH-----------------HHHHHhCcc--cCC
Confidence 245689999999999999999999976442 111 111222222 245
Q ss_pred hHHHHHHHHHHHHhhhcCCCCC
Q 047629 551 IDGALSLATLARACTMDKSLSR 572 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~R 572 (615)
.-....+.+|++..++.|-.+|
T Consensus 262 ~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 262 SYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred cccCHHHHHHHHHHHhhhhHhh
Confidence 5555567888888898888888
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=261.94 Aligned_cols=210 Identities=18% Similarity=0.294 Sum_probs=160.7
Q ss_pred ceEEEEEE--CCeEEEEEEccHH----------HHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATI--DGKVLAVKKIKED----------VTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~~----------~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
|.||++.. +++.+|+|.++.. +..|+.++.++ +|+||+++++++.+. ...++||||+++|+|.+++
T Consensus 9 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~ 87 (327)
T cd05617 9 AKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT-SRLFLVIEYVNGGDLMFHM 87 (327)
T ss_pred eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC-CEEEEEEeCCCCCcHHHHH
Confidence 48999987 6789999999742 45788888888 699999999987654 4799999999999999988
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCC--------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA-------- 481 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~-------- 481 (615)
.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 88 ~~~~----------~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (327)
T cd05617 88 QRQR----------KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTS 154 (327)
T ss_pred HHcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCCcee
Confidence 6543 2899999999999999999999998 999999999999999999999999988632
Q ss_pred ---------------CCCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCC
Q 047629 482 ---------------TNDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLE 546 (615)
Q Consensus 482 ---------------~~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~ 546 (615)
...++.++|||||||++|||++|+.||..............+... + ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~----------~---~~~~-- 219 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV----------I---LEKP-- 219 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHH----------H---HhCC--
Confidence 112456899999999999999999999643321111001111110 0 0111
Q ss_pred CCCChHHHHHHHHHHHHhhhcCCCCCCCH------HHHHHH
Q 047629 547 SFYPIDGALSLATLARACTMDKSLSRPNM------AEVVFN 581 (615)
Q Consensus 547 ~~~~~~~~~~l~~l~~~C~~~dP~~RPsm------~ev~~~ 581 (615)
...|......+.+++.+|++.||.+|+++ .++..+
T Consensus 220 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 220 IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 11233334557899999999999999984 566553
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=253.17 Aligned_cols=217 Identities=24% Similarity=0.331 Sum_probs=165.0
Q ss_pred ceEEEEEE--CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCC-CcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQ-GNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~~lV~E~~~~GsL~~~L~~ 411 (615)
+.||++.. +++.+|+|.+. ..+.+|++++++++|+||+++++++.+.+ +..++||||+++|+|.+++..
T Consensus 15 ~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 94 (287)
T cd06621 15 GSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKK 94 (287)
T ss_pred eEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHH
Confidence 58999998 67999999875 24778999999999999999999886433 358999999999999998764
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC---------
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT--------- 482 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~--------- 482 (615)
..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 95 ~~~~~------~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 165 (287)
T cd06621 95 VKKRG------GRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTG 165 (287)
T ss_pred HHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccccccccccC
Confidence 22111 13889999999999999999999998 9999999999999999999999999975321
Q ss_pred ------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCC--hhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCC
Q 047629 483 ------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENG--KTAVLWKEIREVLKVEEKREERLRNWMDPNLESF 548 (615)
Q Consensus 483 ------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~--~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~ 548 (615)
..++.++||||||+++|||++|+.|+...... ....+..+ +...-.+.+...
T Consensus 166 ~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~ 231 (287)
T cd06621 166 TSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY--------------IVNMPNPELKDE 231 (287)
T ss_pred CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHH--------------HhcCCchhhccC
Confidence 12456899999999999999999998754321 11111110 111011111111
Q ss_pred CC--hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047629 549 YP--IDGALSLATLARACTMDKSLSRPNMAEVVFNL 582 (615)
Q Consensus 549 ~~--~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L 582 (615)
.. ......+.+++.+||+.+|.+||||.|+++.-
T Consensus 232 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~ 267 (287)
T cd06621 232 PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP 267 (287)
T ss_pred CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence 11 12345688999999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=262.27 Aligned_cols=202 Identities=23% Similarity=0.289 Sum_probs=155.4
Q ss_pred ceEEEEEE--CCeEEEEEEccHH----------HHHHH-HHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATI--DGKVLAVKKIKED----------VTEEL-RILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~~----------~~~Ei-~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
|.||++.. +++.+|+|.+... +..|. .+++.++|+||+++++++... +..++||||+++|+|.+++
T Consensus 9 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~~ 87 (325)
T cd05602 9 GKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA-DKLYFVLDYINGGELFYHL 87 (325)
T ss_pred eEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcC-CeEEEEEeCCCCCcHHHHH
Confidence 48999987 6788999998632 22333 346778999999999988754 4799999999999999999
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------- 482 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------- 482 (615)
.... .+.+.....++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 88 ~~~~----------~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~ 154 (325)
T cd05602 88 QRER----------CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTS 154 (325)
T ss_pred HhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcc
Confidence 7643 2778888899999999999999998 9999999999999999999999999986421
Q ss_pred ----------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCC
Q 047629 483 ----------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLE 546 (615)
Q Consensus 483 ----------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~ 546 (615)
..++.++|||||||++|||++|+.||...... ..+..+ ... .+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i-------------~~~----~~- 213 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EMYDNI-------------LNK----PL- 213 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH---HHHHHH-------------HhC----Cc-
Confidence 12456899999999999999999999754321 111100 000 00
Q ss_pred CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047629 547 SFYPIDGALSLATLARACTMDKSLSRPNMAEVVF 580 (615)
Q Consensus 547 ~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~ 580 (615)
..+.+....+.+++..|++.||.+||++.+.+.
T Consensus 214 -~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 214 -QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred -CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 112233445789999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=248.31 Aligned_cols=208 Identities=25% Similarity=0.365 Sum_probs=163.3
Q ss_pred ceEEEEEE--CCeEEEEEEcc-------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
+.||++.. +++.+|+|.+. +.+.+|++++++++|+||+++++++.+. +..+++|||+++++|.+++....
T Consensus 17 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~l~~e~~~~~~l~~~~~~~~ 95 (262)
T cd06613 17 GDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRR-DKLWIVMEYCGGGSLQDIYQVTR 95 (262)
T ss_pred eEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeC-CEEEEEEeCCCCCcHHHHHHhhc
Confidence 48999987 57889999875 3477899999999999999999988754 47999999999999999987652
Q ss_pred CCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----------
Q 047629 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----------- 482 (615)
Q Consensus 414 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----------- 482 (615)
. .+++.++..++.|++.||.|||+++ ++|+||||+||++++++.+||+|||++....
T Consensus 96 ~---------~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 163 (262)
T cd06613 96 G---------PLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIG 163 (262)
T ss_pred c---------CCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhhccccccC
Confidence 2 3889999999999999999999998 9999999999999999999999999874321
Q ss_pred ------------C---CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCC
Q 047629 483 ------------N---DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLES 547 (615)
Q Consensus 483 ------------~---~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~ 547 (615)
. ..+.++||||||+++|||++|+.|+.......... . ......-.+.+
T Consensus 164 ~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~------~---------~~~~~~~~~~~-- 226 (262)
T cd06613 164 TPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF------L---------ISKSNFPPPKL-- 226 (262)
T ss_pred CccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH------H---------HHhccCCCccc--
Confidence 1 23457899999999999999999987543211110 0 00000011111
Q ss_pred CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047629 548 FYPIDGALSLATLARACTMDKSLSRPNMAEVVF 580 (615)
Q Consensus 548 ~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~ 580 (615)
..+......+.+++.+||+.+|.+||++.||+.
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 227 KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 112233456899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-29 Score=254.42 Aligned_cols=209 Identities=19% Similarity=0.260 Sum_probs=161.9
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||++.. +|+.+|+|.++. .+.+|+++|++++|+|++++.+++... ...+++|||+++|+|.+++.
T Consensus 14 g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~ 92 (285)
T cd05632 14 GEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK-DALCLVLTIMNGGDLKFHIY 92 (285)
T ss_pred eEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC-CEEEEEEEeccCccHHHHHH
Confidence 58999988 689999998752 256799999999999999999887654 47899999999999999986
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
..... .+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++....
T Consensus 93 ~~~~~--------~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 161 (285)
T cd05632 93 NMGNP--------GFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR 161 (285)
T ss_pred HhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccCC
Confidence 54321 3899999999999999999999998 9999999999999999999999999884321
Q ss_pred --------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCC
Q 047629 483 --------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESF 548 (615)
Q Consensus 483 --------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~ 548 (615)
..++.++|+||||+++|||++|+.||....+...... +. ..+.+. . ..
T Consensus 162 ~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~---~~----------~~~~~~-~----~~ 223 (285)
T cd05632 162 VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE---VD----------RRVLET-E----EV 223 (285)
T ss_pred CCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HH----------Hhhhcc-c----cc
Confidence 1245689999999999999999999975432111100 00 011110 0 11
Q ss_pred CChHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 047629 549 YPIDGALSLATLARACTMDKSLSRPN-----MAEVVFN 581 (615)
Q Consensus 549 ~~~~~~~~l~~l~~~C~~~dP~~RPs-----m~ev~~~ 581 (615)
++......+.+|+..|++.||++||+ ++|++..
T Consensus 224 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 224 YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 22233445789999999999999999 5666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=250.35 Aligned_cols=205 Identities=22% Similarity=0.304 Sum_probs=159.7
Q ss_pred ceEEEEEE--CCeEEEEEEcc------------HHHHHHHHHHHhcCCCCcccEEEEEEcCC-CcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATI--DGKVLAVKKIK------------EDVTEELRILQRINHANLVKLMGVSSDSQ-GNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~------------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~~lV~E~~~~GsL~~ 407 (615)
+.||+|.. +|+.||||.++ +.+.+|+.++++++|+||+++++++.+.. ...++++||+++|+|.+
T Consensus 16 g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~ 95 (265)
T cd06652 16 GRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKD 95 (265)
T ss_pred eEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHH
Confidence 47999987 68999999874 13567999999999999999999876543 34789999999999999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----- 482 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----- 482 (615)
++.... .+++....+++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||+++...
T Consensus 96 ~l~~~~----------~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~ 162 (265)
T cd06652 96 QLKSYG----------ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLS 162 (265)
T ss_pred HHHHcC----------CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccccccccccc
Confidence 997543 2788889999999999999999998 9999999999999999999999999885321
Q ss_pred ---------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhc
Q 047629 483 ---------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWM 541 (615)
Q Consensus 483 ---------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 541 (615)
...+.++||||||+++|||++|+.|+....... .+. .......
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~~----------~~~~~~~ 226 (265)
T cd06652 163 GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA------AIF----------KIATQPT 226 (265)
T ss_pred ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH------HHH----------HHhcCCC
Confidence 113467999999999999999999986432110 000 0001111
Q ss_pred CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 542 DPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 542 dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
. ...+......+.+++.+|+. +|++||+++||++.
T Consensus 227 ~----~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 227 N----PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred C----CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 1 22344444567788899985 99999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=254.56 Aligned_cols=207 Identities=20% Similarity=0.373 Sum_probs=160.5
Q ss_pred ceEEEEEE--CCeEEEEEEcc------HHHHHHHHHHHhc-CCCCcccEEEEEEcC-----CCcEEEEEeecCCCCHHHh
Q 047629 343 KSVYRATI--DGKVLAVKKIK------EDVTEELRILQRI-NHANLVKLMGVSSDS-----QGNRFLVYEYAENGSLDKW 408 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~------~~~~~Ei~~l~~l-~H~niv~l~g~~~~~-----~~~~~lV~E~~~~GsL~~~ 408 (615)
+.||+|.. +++.+|+|.+. .++..|+.++.++ +|+||+++++++... ....+++|||+++|+|.++
T Consensus 30 ~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~ 109 (282)
T cd06636 30 GQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDL 109 (282)
T ss_pred eEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHH
Confidence 48999997 68899999874 2467789999998 799999999987532 2357999999999999999
Q ss_pred hccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC------
Q 047629 409 LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------ 482 (615)
Q Consensus 409 L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------ 482 (615)
+...... .+++..+..++.|++.||.|||+++ ++||||||+||++++++.+||+|||++....
T Consensus 110 ~~~~~~~--------~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~~~ 178 (282)
T cd06636 110 VKNTKGN--------ALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR 178 (282)
T ss_pred HHHccCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCcchhhhhccccCC
Confidence 9754321 3788899999999999999999998 9999999999999999999999999874321
Q ss_pred ----------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhh
Q 047629 483 ----------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNW 540 (615)
Q Consensus 483 ----------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 540 (615)
..++.++|||||||++|||++|+.|+......... . .+...
T Consensus 179 ~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~------~-----------~~~~~ 241 (282)
T cd06636 179 NTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL------F-----------LIPRN 241 (282)
T ss_pred CcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh------h-----------hHhhC
Confidence 11345799999999999999999998653321100 0 00111
Q ss_pred cCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047629 541 MDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVF 580 (615)
Q Consensus 541 ~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~ 580 (615)
..+.+. .......+.+++.+||+.||.+||++.|+++
T Consensus 242 ~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 242 PPPKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred CCCCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 111111 1123346899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=275.89 Aligned_cols=238 Identities=19% Similarity=0.246 Sum_probs=165.1
Q ss_pred HHccccccccccc----ceEEEEEE--CCeEEEEEEccH------HHHHHHHHHHhcCCC------CcccEEEEEEcCCC
Q 047629 330 ESTMNLSEHYSIG----KSVYRATI--DGKVLAVKKIKE------DVTEELRILQRINHA------NLVKLMGVSSDSQG 391 (615)
Q Consensus 330 ~at~~~~~~~~iG----~~Vy~~~~--~g~~vAvK~~~~------~~~~Ei~~l~~l~H~------niv~l~g~~~~~~~ 391 (615)
..+.+|.....+| |.||++.. .++.||||+++. +...|++++.+++|. +++++++++....+
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~ 205 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETG 205 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCc
Confidence 3445565555565 58999987 678999999852 456688888887654 58889998876555
Q ss_pred cEEEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCceeeCCCC--
Q 047629 392 NRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEH-AQPSIVHRDIRTNNIQLDSRF-- 468 (615)
Q Consensus 392 ~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDlk~~NILld~~~-- 468 (615)
..++|||++ +++|.+++.... .+++..+..|+.||+.||+|||++ + |+||||||+|||++.++
T Consensus 206 ~~~iv~~~~-g~~l~~~l~~~~----------~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~ 271 (467)
T PTZ00284 206 HMCIVMPKY-GPCLLDWIMKHG----------PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTV 271 (467)
T ss_pred eEEEEEecc-CCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcc
Confidence 789999988 678999987543 389999999999999999999974 6 99999999999998765
Q ss_pred --------------cEEEeecCCCCCCC--------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCC
Q 047629 469 --------------KAKIANFSLAAPAT--------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENG 514 (615)
Q Consensus 469 --------------~~kl~DFGla~~~~--------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~ 514 (615)
.+||+|||++.... ..++.++|||||||++|||++|+.||......
T Consensus 272 ~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 272 VDPVTNRALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred cccccccccCCCCceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 49999999864321 12566899999999999999999999765432
Q ss_pred hhHHHHHHHHHHHhHHHHH---HHHHhhhc------CCcCC--------CCCC---hHHHHHHHHHHHHhhhcCCCCCCC
Q 047629 515 KTAVLWKEIREVLKVEEKR---EERLRNWM------DPNLE--------SFYP---IDGALSLATLARACTMDKSLSRPN 574 (615)
Q Consensus 515 ~~~~l~~~~~~~~~~~~~~---~~~~~~~~------dp~l~--------~~~~---~~~~~~l~~l~~~C~~~dP~~RPs 574 (615)
+...........+..+... .....++. ++... ...+ ......+.+|+..|++.||++|||
T Consensus 352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t 431 (467)
T PTZ00284 352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN 431 (467)
T ss_pred HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence 2222111110000000000 00000000 00000 0000 011245789999999999999999
Q ss_pred HHHHHHH
Q 047629 575 MAEVVFN 581 (615)
Q Consensus 575 m~ev~~~ 581 (615)
++|++++
T Consensus 432 a~e~L~H 438 (467)
T PTZ00284 432 ARQMTTH 438 (467)
T ss_pred HHHHhcC
Confidence 9999985
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-29 Score=252.25 Aligned_cols=211 Identities=23% Similarity=0.368 Sum_probs=160.5
Q ss_pred ceEEEEEEC---CeEEEEEEcc-----------------HHHHHHHHHHHh-cCCCCcccEEEEEEcCCCcEEEEEeecC
Q 047629 343 KSVYRATID---GKVLAVKKIK-----------------EDVTEELRILQR-INHANLVKLMGVSSDSQGNRFLVYEYAE 401 (615)
Q Consensus 343 ~~Vy~~~~~---g~~vAvK~~~-----------------~~~~~Ei~~l~~-l~H~niv~l~g~~~~~~~~~~lV~E~~~ 401 (615)
+.||+|... ++.+|+|.+. .++..|+.++.+ ++|+||+++++++.+ ++..+++|||++
T Consensus 14 ~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~ 92 (269)
T cd08528 14 GCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE-NDRLYIVMDLIE 92 (269)
T ss_pred ceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc-CCeEEEEEecCC
Confidence 489999983 5889999764 125678888875 799999999999875 458999999999
Q ss_pred CCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCceeeCCCCcEEEeecCCCCC
Q 047629 402 NGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHE-HAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAP 480 (615)
Q Consensus 402 ~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~ 480 (615)
+++|.+++....... ..+++..+++++.|++.||.|||+ .+ ++|+||||+||+++.++.+||+|||++..
T Consensus 93 ~~~l~~~l~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~ 163 (269)
T cd08528 93 GAPLGEHFNSLKEKK------QRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITDFGLAKQ 163 (269)
T ss_pred CCcHHHHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEecccceee
Confidence 999999885422110 138899999999999999999996 44 99999999999999999999999998854
Q ss_pred CC----------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHh
Q 047629 481 AT----------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLR 538 (615)
Q Consensus 481 ~~----------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 538 (615)
.. ..++.++||||||+++|||++|+.|+....... .. .. ...
T Consensus 164 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~---~~---~~----------~~~ 227 (269)
T cd08528 164 KQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS---LA---TK----------IVE 227 (269)
T ss_pred cccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH---HH---HH----------Hhh
Confidence 32 113568999999999999999999986433110 00 00 000
Q ss_pred hhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047629 539 NWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLS 583 (615)
Q Consensus 539 ~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~ 583 (615)
....+.... .....+.+++.+||+.||++||++.|+..+++
T Consensus 228 ~~~~~~~~~----~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 228 AVYEPLPEG----MYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ccCCcCCcc----cCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 111111111 22345789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=265.46 Aligned_cols=223 Identities=19% Similarity=0.272 Sum_probs=162.4
Q ss_pred ceEEEEEE----CCeEEEEEEccH--HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCCC
Q 047629 343 KSVYRATI----DGKVLAVKKIKE--DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSS 416 (615)
Q Consensus 343 ~~Vy~~~~----~g~~vAvK~~~~--~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~ 416 (615)
|.||++.. .++.||||.+.. ...+|+++|++++|+||+++++++... ...++|||++. ++|.+++....
T Consensus 106 g~Vy~~~~~~~~~~~~v~vK~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~-~~l~~~l~~~~--- 180 (392)
T PHA03207 106 GEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRWK-STVCMVMPKYK-CDLFTYVDRSG--- 180 (392)
T ss_pred eEEEEEEEcCCccceeEEEEeccccccHHHHHHHHHhcCCCCccceeeeEeeC-CEEEEEehhcC-CCHHHHHHhcC---
Confidence 58999875 357899999863 467899999999999999999987653 47899999996 68999984332
Q ss_pred CCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------------
Q 047629 417 SSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------------- 482 (615)
Q Consensus 417 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------------- 482 (615)
.++|.+++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 181 -------~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt 250 (392)
T PHA03207 181 -------PLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGT 250 (392)
T ss_pred -------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccc
Confidence 3899999999999999999999998 9999999999999999999999999985431
Q ss_pred -----------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHH---------HHHHHHhhhcC
Q 047629 483 -----------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEE---------KREERLRNWMD 542 (615)
Q Consensus 483 -----------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---------~~~~~~~~~~d 542 (615)
..++.++|||||||++|||++|+.||..............+...+.... .....+... .
T Consensus 251 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 329 (392)
T PHA03207 251 LETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQY-A 329 (392)
T ss_pred cCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhh-c
Confidence 1245689999999999999999999876543221111111111110000 000000000 0
Q ss_pred CcCCCCCC-------hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 543 PNLESFYP-------IDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 543 p~l~~~~~-------~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
......+. ......+.++++.|+..||++||++.|++.+
T Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 330 IVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred ccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00111111 0123456789999999999999999999986
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=266.66 Aligned_cols=225 Identities=21% Similarity=0.205 Sum_probs=167.2
Q ss_pred HHHHHHHccccccccccc----ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEc
Q 047629 325 IEVIMESTMNLSEHYSIG----KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSD 388 (615)
Q Consensus 325 ~~~l~~at~~~~~~~~iG----~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~ 388 (615)
+.++.....+|.....+| |.||++.. +++.+|+|.+.. .+.+|+.+++.++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 334444445565555565 48999987 688999998852 25679999999999999999998875
Q ss_pred CCCcEEEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCC
Q 047629 389 SQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRF 468 (615)
Q Consensus 389 ~~~~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~ 468 (615)
+...++||||+++|+|.+++.... ++...+..++.|++.||+|||+++ |+||||||+|||++.++
T Consensus 115 -~~~~~lv~Ey~~gg~L~~~~~~~~-----------~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~ 179 (371)
T cd05622 115 -DRYLYMVMEYMPGGDLVNLMSNYD-----------VPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSG 179 (371)
T ss_pred -CCEEEEEEcCCCCCcHHHHHHhcC-----------CCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCC
Confidence 447999999999999999986532 778888899999999999999998 99999999999999999
Q ss_pred cEEEeecCCCCCCCC----------------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHH
Q 047629 469 KAKIANFSLAAPATN----------------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLW 520 (615)
Q Consensus 469 ~~kl~DFGla~~~~~----------------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 520 (615)
.+||+|||+++.... .++.++|||||||++|||++|+.||...... ..
T Consensus 180 ~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~- 255 (371)
T cd05622 180 HLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---GT- 255 (371)
T ss_pred CEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH---HH-
Confidence 999999999853210 1456899999999999999999999754311 00
Q ss_pred HHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCC--CCCHHHHHHHH
Q 047629 521 KEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLS--RPNMAEVVFNL 582 (615)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~--RPsm~ev~~~L 582 (615)
+.. +.... ..+.-....+....+.+++..|+..++.+ ||++.|++++.
T Consensus 256 --~~~-----------i~~~~-~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 256 --YSK-----------IMNHK-NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred --HHH-----------HHcCC-CcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 111 11000 00100011123445788999999844433 78999988864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=254.93 Aligned_cols=223 Identities=20% Similarity=0.343 Sum_probs=162.3
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
+.||+|.. +|+.||||+++ ..+.+|++++++++|+||+++++++.+. ...++||||+. ++|.+++..
T Consensus 14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e~~~-~~l~~~~~~ 91 (284)
T cd07860 14 GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE-NKLYLVFEFLH-QDLKKFMDA 91 (284)
T ss_pred eEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccC-CcEEEEeeccc-cCHHHHHHh
Confidence 48999987 68999999885 2467899999999999999999998654 47999999996 689999875
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC---------
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT--------- 482 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~--------- 482 (615)
.... .+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 92 ~~~~--------~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~ 160 (284)
T cd07860 92 SPLS--------GIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE 160 (284)
T ss_pred CCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCccccccc
Confidence 4321 3899999999999999999999998 9999999999999999999999999875321
Q ss_pred ---------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhH----------HHHHHHHH
Q 047629 483 ---------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKV----------EEKREERL 537 (615)
Q Consensus 483 ---------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~----------~~~~~~~~ 537 (615)
...+.++||||||+++|||+||+.|+....+... ....+...... ........
T Consensus 161 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07860 161 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTLGTPDEVVWPGVTSLPDYKPSF 238 (284)
T ss_pred cccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhhhhHHHHHHhhc
Confidence 0124579999999999999999999875432111 11111000000 00000011
Q ss_pred hhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 538 RNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 538 ~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
..+....+.. ........+.+++.+|++.||.+||+++|++++
T Consensus 239 ~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 239 PKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred ccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 1111111100 011122356899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=253.30 Aligned_cols=207 Identities=24% Similarity=0.377 Sum_probs=162.6
Q ss_pred ceEEEEEE--CCeEEEEEEcc-------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
+.||+|.. +|+.+|+|.+. +.+.+|++++++++|+|++++++.+.. ++..++||||+++|+|..++....
T Consensus 26 g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~l~~~~~~~~ 104 (292)
T cd06644 26 GKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYW-DGKLWIMIEFCPGGAVDAIMLELD 104 (292)
T ss_pred eEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe-CCeEEEEEecCCCCcHHHHHHhhc
Confidence 58999987 57999999985 246789999999999999999998765 457999999999999998886543
Q ss_pred CCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----------
Q 047629 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----------- 482 (615)
Q Consensus 414 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----------- 482 (615)
. .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++....
T Consensus 105 ~---------~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 172 (292)
T cd06644 105 R---------GLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIG 172 (292)
T ss_pred C---------CCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccccccceecC
Confidence 2 3899999999999999999999987 9999999999999999999999999874321
Q ss_pred -----------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcC
Q 047629 483 -----------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNL 545 (615)
Q Consensus 483 -----------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l 545 (615)
..++.++|||||||++|||++|+.|+....... .+. .+.....+.+
T Consensus 173 ~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~~-----------~~~~~~~~~~ 235 (292)
T cd06644 173 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLL-----------KIAKSEPPTL 235 (292)
T ss_pred CccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH------HHH-----------HHhcCCCccC
Confidence 012457999999999999999999986533110 000 0111111111
Q ss_pred CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 546 ESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 546 ~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
..+......+.+++.+||+.||++||++.|+++.
T Consensus 236 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 236 --SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred --CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 1122333467899999999999999999999874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-29 Score=252.03 Aligned_cols=208 Identities=24% Similarity=0.367 Sum_probs=161.8
Q ss_pred ceEEEEEE--CCeEEEEEEccH-------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATI--DGKVLAVKKIKE-------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~-------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
+.||++.. +++.||+|.++. .+.+|+.+++.++|+||+++++.+... +..++|+||+++|+|.+++....
T Consensus 23 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~ 101 (267)
T cd06645 23 GDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR-DKLWICMEFCGGGSLQDIYHVTG 101 (267)
T ss_pred eEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC-CEEEEEEeccCCCcHHHHHHhcC
Confidence 47999987 689999998752 366799999999999999999988754 47999999999999999987543
Q ss_pred CCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----------
Q 047629 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----------- 482 (615)
Q Consensus 414 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----------- 482 (615)
.+++.++..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++....
T Consensus 102 ----------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 168 (267)
T cd06645 102 ----------PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIG 168 (267)
T ss_pred ----------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcccccccccC
Confidence 2889999999999999999999998 9999999999999999999999999874221
Q ss_pred ---------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCC
Q 047629 483 ---------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLES 547 (615)
Q Consensus 483 ---------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~ 547 (615)
..++.++|||||||++|||++|+.|+......... .. . .......+....
T Consensus 169 ~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~--~~----~---------~~~~~~~~~~~~ 233 (267)
T cd06645 169 TPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--FL----M---------TKSNFQPPKLKD 233 (267)
T ss_pred cccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH--Hh----h---------hccCCCCCcccc
Confidence 11445799999999999999999998643321110 00 0 000111111111
Q ss_pred CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 548 FYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 548 ~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.......+.+++.+|++.+|++||++++|+++
T Consensus 234 --~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 234 --KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred --cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 01122357899999999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=254.42 Aligned_cols=223 Identities=19% Similarity=0.304 Sum_probs=162.9
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
+.||++.. +|+.+|+|+++ ..+.+|++++++++|+||+++++++.+. ...++++||++ |+|.+++..
T Consensus 14 ~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~-~~l~~~~~~ 91 (284)
T cd07839 14 GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD-KKLTLVFEYCD-QDLKKYFDS 91 (284)
T ss_pred eEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC-CceEEEEecCC-CCHHHHHHh
Confidence 47999998 68999999885 2467899999999999999999988654 47999999997 588888865
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC---------
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT--------- 482 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~--------- 482 (615)
... .+++..+..++.||+.||.|||+++ ++||||||+||+++.++.+||+|||+++...
T Consensus 92 ~~~---------~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (284)
T cd07839 92 CNG---------DIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAE 159 (284)
T ss_pred cCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCC
Confidence 432 3899999999999999999999998 9999999999999999999999999886421
Q ss_pred ---------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHH-HHHHHHHhhhcCCcCC
Q 047629 483 ---------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVE-EKREERLRNWMDPNLE 546 (615)
Q Consensus 483 ---------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~~~~~~dp~l~ 546 (615)
...+.++|||||||++|||++|+.|+....+... ....+...+... ...-..+....+....
T Consensus 160 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07839 160 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEESWPGVSKLPDYKPY 237 (284)
T ss_pred ccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH--HHHHHHHHhCCCChHHhHHhhhccccccc
Confidence 0135689999999999999999988654332211 111111111000 0000011111111110
Q ss_pred CCC---------ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 547 SFY---------PIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 547 ~~~---------~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
..+ .......+.+++..|++.||.+|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 238 PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 011 11233567899999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=256.86 Aligned_cols=222 Identities=24% Similarity=0.374 Sum_probs=163.1
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
+.||+|.. +++.||+|+++ +.+.+|++++++++|+||+++++++.. ++..++||||++++.+..++..
T Consensus 15 ~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~iv~e~~~~~~l~~~~~~ 93 (288)
T cd07833 15 GVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-KGRLYLVFEYVERTLLELLEAS 93 (288)
T ss_pred eeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-CCEEEEEEecCCCCHHHHHHhc
Confidence 47999987 57899999875 247789999999999999999999875 4479999999998777766544
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC--------
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN-------- 483 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~-------- 483 (615)
.. .+++.++..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++.....
T Consensus 94 ~~----------~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (288)
T cd07833 94 PG----------GLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD 160 (288)
T ss_pred CC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccC
Confidence 32 2889999999999999999999998 99999999999999999999999998754211
Q ss_pred -----------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHH-H------Hh-
Q 047629 484 -----------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREE-R------LR- 538 (615)
Q Consensus 484 -----------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~-~------~~- 538 (615)
..+.++||||||+++|||++|+.|+......+ .++. ....+........ . ..
T Consensus 161 ~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07833 161 YVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID--QLYL-IQKCLGPLPPSHQELFSSNPRFAG 237 (288)
T ss_pred cccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-HHHHhCCCCHHHhhhcccCccccc
Confidence 24568999999999999999999987543221 1111 1110000000000 0 00
Q ss_pred -hhcCCc----CCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 539 -NWMDPN----LESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 539 -~~~dp~----l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
+..+.. +...++.....++.++++.||+.+|++||+++++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000000 0011222335678999999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-29 Score=260.02 Aligned_cols=197 Identities=23% Similarity=0.350 Sum_probs=154.7
Q ss_pred ceEEEEEE--CCeEEEEEEccHH----------HHHHHHHHHhcC-CCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATI--DGKVLAVKKIKED----------VTEELRILQRIN-HANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~~----------~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
|.||++.. +|+.||+|.++++ +..|..++..+. |++|+++.+++.+ ++..++||||+++|+|.+++
T Consensus 14 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv~Ey~~~g~L~~~i 92 (323)
T cd05615 14 GKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT-VDRLYFVMEYVNGGDLMYHI 92 (323)
T ss_pred eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec-CCEEEEEEcCCCCCcHHHHH
Confidence 58999987 6899999998632 456888888885 5677788887764 44799999999999999999
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------- 482 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------- 482 (615)
.... .+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~~~~----------~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~ 159 (323)
T cd05615 93 QQVG----------KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTR 159 (323)
T ss_pred HHcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCCcccc
Confidence 7543 2899999999999999999999998 9999999999999999999999999876421
Q ss_pred ----------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCC
Q 047629 483 ----------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLE 546 (615)
Q Consensus 483 ----------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~ 546 (615)
..++.++|||||||++|||++|+.||...... ... . .++...
T Consensus 160 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~---~--------------~i~~~~-- 217 (323)
T cd05615 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED---ELF---Q--------------SIMEHN-- 217 (323)
T ss_pred CccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---HHH---H--------------HHHhCC--
Confidence 12456899999999999999999999754321 011 0 011111
Q ss_pred CCCChHHHHHHHHHHHHhhhcCCCCCCCH
Q 047629 547 SFYPIDGALSLATLARACTMDKSLSRPNM 575 (615)
Q Consensus 547 ~~~~~~~~~~l~~l~~~C~~~dP~~RPsm 575 (615)
..++......+.+++.+|++.+|.+|++.
T Consensus 218 ~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 218 VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 12233344567899999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=247.50 Aligned_cols=205 Identities=25% Similarity=0.402 Sum_probs=162.4
Q ss_pred ceEEEEEE--CCeEEEEEEcc------------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHh
Q 047629 343 KSVYRATI--DGKVLAVKKIK------------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKW 408 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~------------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~ 408 (615)
+.||+|.. +++.|++|.+. +.+.+|++++++++|+||+++.+++.+. ...++++||+++++|.++
T Consensus 14 ~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~ 92 (258)
T cd06632 14 GSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE-DNLYIFLELVPGGSLAKL 92 (258)
T ss_pred ceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC-CeEEEEEEecCCCcHHHH
Confidence 58999997 68999999763 2367899999999999999999998754 478999999999999999
Q ss_pred hccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC------
Q 047629 409 LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------ 482 (615)
Q Consensus 409 L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------ 482 (615)
+.... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 93 ~~~~~----------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~ 159 (258)
T cd06632 93 LKKYG----------SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAK 159 (258)
T ss_pred HHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecccccccc
Confidence 97543 2889999999999999999999998 9999999999999999999999999875321
Q ss_pred ----------------CC-CCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcC
Q 047629 483 ----------------ND-VMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNL 545 (615)
Q Consensus 483 ----------------~~-~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l 545 (615)
.. .+.++|+||||+++|||++|+.|+....... ..+ . .....+ .
T Consensus 160 ~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~--~~~----~-----------~~~~~~--~ 220 (258)
T cd06632 160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA--AVF----K-----------IGRSKE--L 220 (258)
T ss_pred ccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH--HHH----H-----------HHhccc--C
Confidence 11 4567999999999999999999986543110 000 0 000000 0
Q ss_pred CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 546 ESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 546 ~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
...+......+.+++.+||+.+|.+||++.|++..
T Consensus 221 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 221 -PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred -CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 11222334557899999999999999999999863
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-30 Score=271.08 Aligned_cols=214 Identities=22% Similarity=0.408 Sum_probs=168.2
Q ss_pred cccccc--ceEEEEEE--CCeEEEEEEcc-----------HHHHHHHHHHHhcCCCCcccEEEEEEcCCC-cEEEEEeec
Q 047629 337 EHYSIG--KSVYRATI--DGKVLAVKKIK-----------EDVTEELRILQRINHANLVKLMGVSSDSQG-NRFLVYEYA 400 (615)
Q Consensus 337 ~~~~iG--~~Vy~~~~--~g~~vAvK~~~-----------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-~~~lV~E~~ 400 (615)
+..+.| ++||||.. +|..||=-.++ +.|..|+.+|+.|+|+|||+++.++.+.+. ..-+|+|.|
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~ 125 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF 125 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence 333444 58999987 56666532221 357889999999999999999999876543 267899999
Q ss_pred CCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCC-CcEEEeecCCCC
Q 047629 401 ENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSR-FKAKIANFSLAA 479 (615)
Q Consensus 401 ~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~-~~~kl~DFGla~ 479 (615)
..|+|..|+++.+. ++.+.+..|++||++||.|||++ .|||||||||..||+++.+ |.+||+|+|||.
T Consensus 126 TSGtLr~Y~kk~~~----------vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAt 194 (632)
T KOG0584|consen 126 TSGTLREYRKKHRR----------VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLAT 194 (632)
T ss_pred cCCcHHHHHHHhcc----------CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHH
Confidence 99999999998764 78889999999999999999998 5889999999999999886 899999999996
Q ss_pred CCC--------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhh
Q 047629 480 PAT--------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRN 539 (615)
Q Consensus 480 ~~~--------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 539 (615)
... ..|...+||||||+.++||+|+..|+....+.- .. ++.+.. +.....+.+
T Consensus 195 l~r~s~aksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A--QI---YKKV~S--GiKP~sl~k 267 (632)
T KOG0584|consen 195 LLRKSHAKSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA--QI---YKKVTS--GIKPAALSK 267 (632)
T ss_pred HhhccccceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHH--HH---HHHHHc--CCCHHHhhc
Confidence 542 225678999999999999999999997654321 11 222221 112344455
Q ss_pred hcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 540 WMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 540 ~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
+-|| ++.+++..|+.. ..+|||+.|++..
T Consensus 268 V~dP------------evr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 268 VKDP------------EVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred cCCH------------HHHHHHHHHhcC-chhccCHHHHhhC
Confidence 4454 368999999999 9999999999985
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-29 Score=256.03 Aligned_cols=205 Identities=23% Similarity=0.381 Sum_probs=163.4
Q ss_pred ceEEEEEE--CCeEEEEEEcc-------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
+.||++.. +++.||||.+. +.+.+|+.++++++|+||+++++.+... +..++||||+++++|.+++...
T Consensus 36 g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~- 113 (292)
T cd06658 36 GIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVG-DELWVVMEFLEGGALTDIVTHT- 113 (292)
T ss_pred eEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecC-CeEEEEEeCCCCCcHHHHHhcC-
Confidence 57999886 68999999875 2467899999999999999999988754 4789999999999999998542
Q ss_pred CCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----------
Q 047629 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----------- 482 (615)
Q Consensus 414 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----------- 482 (615)
.+++.++..++.|++.||+|||+++ ++||||||+||++++++.+||+|||++....
T Consensus 114 ----------~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~ 180 (292)
T cd06658 114 ----------RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVG 180 (292)
T ss_pred ----------CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceeec
Confidence 2789999999999999999999998 9999999999999999999999999875321
Q ss_pred ------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 483 ------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 483 ------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
...+.++||||||+++|||++|+.|+........ +. .+...+.+.+....
T Consensus 181 ~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~~-----------~~~~~~~~~~~~~~- 242 (292)
T cd06658 181 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA------MR-----------RIRDNLPPRVKDSH- 242 (292)
T ss_pred CccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HH-----------HHHhcCCCcccccc-
Confidence 1245789999999999999999999865332110 00 11122222222211
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 551 IDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.....+.+++..||..||.+|||+.|+++.
T Consensus 243 -~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 243 -KVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred -ccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 223357889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=257.11 Aligned_cols=222 Identities=25% Similarity=0.306 Sum_probs=164.1
Q ss_pred ceEEEEEE--CCeEEEEEEccH------------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHh
Q 047629 343 KSVYRATI--DGKVLAVKKIKE------------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKW 408 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~------------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~ 408 (615)
+.||+|.. +|+.||||+++. .+..|++++++++|+||+++++++.+ +...++||||+ +|+|.++
T Consensus 14 ~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~~-~~~L~~~ 91 (298)
T cd07841 14 AVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-KSNINLVFEFM-ETDLEKV 91 (298)
T ss_pred cEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-CCEEEEEEccc-CCCHHHH
Confidence 48999987 689999999852 24579999999999999999999876 44789999999 8999999
Q ss_pred hccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC------
Q 047629 409 LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------ 482 (615)
Q Consensus 409 L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------ 482 (615)
+..... .+++..+..++.|+++||.|||+++ ++|+||||+||+++.++.+||+|||+++...
T Consensus 92 i~~~~~---------~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (298)
T cd07841 92 IKDKSI---------VLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM 159 (298)
T ss_pred HhccCC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence 976431 3899999999999999999999998 9999999999999999999999999885431
Q ss_pred ------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHH--HHH--HHHHhhh
Q 047629 483 ------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVE--EKR--EERLRNW 540 (615)
Q Consensus 483 ------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~--~~~--~~~~~~~ 540 (615)
...+.++|||||||++|||++|..++....+.+. .......+... ... ...+...
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T cd07841 160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ---LGKIFEALGTPTEENWPGVTSLPDY 236 (298)
T ss_pred cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH---HHHHHHHcCCCchhhhhhccccccc
Confidence 1134679999999999999999777764332111 11111111000 000 0001011
Q ss_pred cCCcCCCCC-----ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 541 MDPNLESFY-----PIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 541 ~dp~l~~~~-----~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
......... .......+.+++.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 237 VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 110001111 12234578899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-29 Score=282.21 Aligned_cols=223 Identities=20% Similarity=0.239 Sum_probs=167.4
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||+|.. +|+.||||+++. .+.+|++++++++||||+++++++.+. +..++||||+++|+|.+++.
T Consensus 16 G~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~-~~lyLVMEY~eGGSL~~lL~ 94 (932)
T PRK13184 16 GEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDG-DPVYYTMPYIEGYTLKSLLK 94 (932)
T ss_pred EEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC-CEEEEEEEcCCCCCHHHHHH
Confidence 58999987 689999998852 477899999999999999999998754 47899999999999999986
Q ss_pred cCCCCC-CCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------
Q 047629 411 PKSKSS-SSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------- 482 (615)
Q Consensus 411 ~~~~~~-~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------- 482 (615)
...... ........+++..+++++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 95 s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~ 171 (932)
T PRK13184 95 SVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLL 171 (932)
T ss_pred HhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecCcceeccccccccc
Confidence 532110 00011124778899999999999999999998 9999999999999999999999999986430
Q ss_pred ----------------------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHh
Q 047629 483 ----------------------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLK 528 (615)
Q Consensus 483 ----------------------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~ 528 (615)
...+.++|||||||++|||++|+.|+........ . .
T Consensus 172 ~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki-~-~-------- 241 (932)
T PRK13184 172 DIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI-S-Y-------- 241 (932)
T ss_pred ccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh-h-h--------
Confidence 1134578999999999999999999975332110 0 0
Q ss_pred HHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHhcccc
Q 047629 529 VEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRP-NMAEVVFNLSVLTQS 588 (615)
Q Consensus 529 ~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RP-sm~ev~~~L~~l~~~ 588 (615)
.. ...+|.-.. ...+.+..+.+++.+|++.||++|| +++++.+.|+...+.
T Consensus 242 -----~~---~i~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 242 -----RD---VILSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred -----hh---hccChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 00 001110000 0112334578999999999999996 577888888776554
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=255.86 Aligned_cols=212 Identities=27% Similarity=0.398 Sum_probs=165.1
Q ss_pred ceEEEEEE--CCeEEEEEEcc----------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIK----------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~----------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
+.||++.. +|+.+|+|++. ..+.+|++++++++|+|++++++++.+. ...++||||++ |+|.+++.
T Consensus 39 ~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~-g~l~~~~~ 116 (317)
T cd06635 39 GAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE-HTAWLVMEYCL-GSASDLLE 116 (317)
T ss_pred eEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC-CeEEEEEeCCC-CCHHHHHH
Confidence 48999987 68999999875 2467899999999999999999998754 47899999997 58888876
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
.... .++|.++..++.|++.||.|||+++ ++||||+|+||+++.++.+||+|||++....
T Consensus 117 ~~~~---------~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 184 (317)
T cd06635 117 VHKK---------PLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGT 184 (317)
T ss_pred HhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCcccccCC
Confidence 4432 3899999999999999999999998 9999999999999999999999999874321
Q ss_pred --------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCC
Q 047629 483 --------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESF 548 (615)
Q Consensus 483 --------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~ 548 (615)
...+.++|||||||++|||++|+.|+........ . .. +.....+..
T Consensus 185 ~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---~---~~-----------~~~~~~~~~--- 244 (317)
T cd06635 185 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---L---YH-----------IAQNESPTL--- 244 (317)
T ss_pred ccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---H---HH-----------HHhccCCCC---
Confidence 1245689999999999999999999865321110 0 00 000001111
Q ss_pred CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 549 YPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 549 ~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
........+.+++.+||+.+|.+||++.|+++.+..+...
T Consensus 245 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 245 QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 1122334688999999999999999999999976655444
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=250.97 Aligned_cols=204 Identities=23% Similarity=0.386 Sum_probs=162.6
Q ss_pred ceEEEEEE--CCeEEEEEEcc--------HHHHHHHHHHHhcC---CCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATI--DGKVLAVKKIK--------EDVTEELRILQRIN---HANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~--------~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
+.||+|.. +|+.+|+|.++ .++.+|++++++++ |+|++++++++.+. ...++||||+++++|.+++
T Consensus 15 g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~-~~~~lv~e~~~~~~L~~~~ 93 (277)
T cd06917 15 GAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG-PRLWIIMEYAEGGSVRTLM 93 (277)
T ss_pred ceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC-CEEEEEEecCCCCcHHHHH
Confidence 48999997 68999999874 24778999999997 99999999998754 4789999999999999998
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------- 482 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------- 482 (615)
... .+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.++++|||++....
T Consensus 94 ~~~-----------~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06917 94 KAG-----------PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRS 159 (277)
T ss_pred Hcc-----------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCccccc
Confidence 643 2889999999999999999999998 9999999999999999999999999875321
Q ss_pred -----------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcC
Q 047629 483 -----------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNL 545 (615)
Q Consensus 483 -----------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l 545 (615)
...+.++|||||||++|||++|+.|+........ . ..+.....+.+
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~------~-----------~~~~~~~~~~~ 222 (277)
T cd06917 160 TFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA------M-----------MLIPKSKPPRL 222 (277)
T ss_pred cccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh------h-----------hccccCCCCCC
Confidence 1135689999999999999999999865432110 0 00111111222
Q ss_pred CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 546 ESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 546 ~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
..+ .....+.+++.+||+.||++||++.|++.+
T Consensus 223 ~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 223 EDN---GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred Ccc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 211 133468899999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=252.29 Aligned_cols=224 Identities=22% Similarity=0.317 Sum_probs=160.2
Q ss_pred ceEEEEEE--CCeEEEEEEccH---------HHHHHHHHHHhc---CCCCcccEEEEEEcC----CCcEEEEEeecCCCC
Q 047629 343 KSVYRATI--DGKVLAVKKIKE---------DVTEELRILQRI---NHANLVKLMGVSSDS----QGNRFLVYEYAENGS 404 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~---------~~~~Ei~~l~~l---~H~niv~l~g~~~~~----~~~~~lV~E~~~~Gs 404 (615)
|.||++.. +|+.||+|.++. .+.+|+++++++ +|+||+++++++... ....++++||++ ++
T Consensus 14 g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~ 92 (288)
T cd07863 14 GTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVD-QD 92 (288)
T ss_pred eEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEcccc-cC
Confidence 58999987 689999998752 356788887766 799999999987532 224789999998 58
Q ss_pred HHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--
Q 047629 405 LDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-- 482 (615)
Q Consensus 405 L~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-- 482 (615)
|.+++...... .+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+++...
T Consensus 93 l~~~~~~~~~~--------~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd07863 93 LRTYLDKVPPP--------GLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQ 161 (288)
T ss_pred HHHHHHhcCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccccccCc
Confidence 99998754321 3899999999999999999999998 9999999999999999999999999986431
Q ss_pred --------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHH--HHHHHHH---
Q 047629 483 --------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVE--EKREERL--- 537 (615)
Q Consensus 483 --------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~--- 537 (615)
..++.++|||||||++|||++|+.||......+. ...+....... .......
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07863 162 MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ---LGKIFDLIGLPPEDDWPRDVTLP 238 (288)
T ss_pred ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH---HHHHHHHhCCCChhhCccccccc
Confidence 1245689999999999999999999865432111 11111111000 0000000
Q ss_pred hhhcCCcCC---CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 538 RNWMDPNLE---SFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 538 ~~~~dp~l~---~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.....+... .....+....+.+++.+|++.||++|||+.|++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 239 RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred ccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000000 01111234467899999999999999999998853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=251.01 Aligned_cols=211 Identities=25% Similarity=0.407 Sum_probs=162.9
Q ss_pred ceEEEEEE--CCeEEEEEEcc------HHHHHHHHHHHhc-CCCCcccEEEEEEcCC-----CcEEEEEeecCCCCHHHh
Q 047629 343 KSVYRATI--DGKVLAVKKIK------EDVTEELRILQRI-NHANLVKLMGVSSDSQ-----GNRFLVYEYAENGSLDKW 408 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~------~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~-----~~~~lV~E~~~~GsL~~~ 408 (615)
+.||+|.. +++.+++|.++ ..+.+|+++++++ +|+||+++++++.... ...++||||+++++|.++
T Consensus 20 ~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 99 (275)
T cd06608 20 GKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDL 99 (275)
T ss_pred eEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHH
Confidence 47999987 57899999875 4578899999999 7999999999986432 237999999999999999
Q ss_pred hccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC------
Q 047629 409 LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------ 482 (615)
Q Consensus 409 L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------ 482 (615)
+....... ..+++..+..++.|++.||.|||+++ ++|+||+|+||++++++.+||+|||++....
T Consensus 100 ~~~~~~~~------~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~ 170 (275)
T cd06608 100 VKGLRKKG------KRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRR 170 (275)
T ss_pred HHHHhhcC------CCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCccceecccchhhh
Confidence 87533111 13899999999999999999999998 9999999999999999999999999874321
Q ss_pred ----------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhh
Q 047629 483 ----------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNW 540 (615)
Q Consensus 483 ----------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 540 (615)
..++.++|||||||+++||++|+.|+........ ... +...
T Consensus 171 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~-----------~~~~ 233 (275)
T cd06608 171 NTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA------LFK-----------IPRN 233 (275)
T ss_pred cCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH------HHH-----------hhcc
Confidence 1134579999999999999999999864322110 000 1111
Q ss_pred cCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 541 MDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 541 ~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
..+.+ ..+.+....+.+++.+||..||++|||+.|+++.
T Consensus 234 ~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 234 PPPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred CCCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11111 1122244568899999999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-29 Score=263.62 Aligned_cols=220 Identities=23% Similarity=0.329 Sum_probs=159.9
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCC-----CcEEEEEeecCCCCHH
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQ-----GNRFLVYEYAENGSLD 406 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~~lV~E~~~~GsL~ 406 (615)
|.||++.. .++.||||+++ ..+.+|+.+++.++|+||+++++++.... ...++||||+++ +|.
T Consensus 31 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~ 109 (355)
T cd07874 31 GIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLC 109 (355)
T ss_pred EEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhcc-cHH
Confidence 47999876 68899999885 23567999999999999999999875332 246999999965 777
Q ss_pred HhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC---
Q 047629 407 KWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN--- 483 (615)
Q Consensus 407 ~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~--- 483 (615)
+++.. .+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 110 ~~~~~------------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 174 (355)
T cd07874 110 QVIQM------------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 174 (355)
T ss_pred HHHhh------------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccccCCCccc
Confidence 77642 2788999999999999999999998 99999999999999999999999999865321
Q ss_pred -------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhH---H--HHHHHHHhh
Q 047629 484 -------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKV---E--EKREERLRN 539 (615)
Q Consensus 484 -------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~---~--~~~~~~~~~ 539 (615)
.++.++|||||||++|||++|+.||......+ .+..+...+.. + ......+..
T Consensus 175 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (355)
T cd07874 175 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID---QWNKVIEQLGTPCPEFMKKLQPTVRN 251 (355)
T ss_pred cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHHHhhcHHHHH
Confidence 24568999999999999999999997543211 11111111000 0 000001111
Q ss_pred hcC----------CcC--------CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 540 WMD----------PNL--------ESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 540 ~~d----------p~l--------~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
+++ +.. ....+......+.+|+.+|++.||++|||+.|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 111 000 001111224567899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-29 Score=264.49 Aligned_cols=156 Identities=22% Similarity=0.346 Sum_probs=135.4
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||++.. +|+.||+|.++. .+.+|+.++.+++|+||+++++.+.+. +..++||||+++|+|.+++.
T Consensus 15 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-~~~~lv~E~~~gg~L~~~l~ 93 (360)
T cd05627 15 GEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDK-RNLYLIMEFLPGGDMMTLLM 93 (360)
T ss_pred EEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-CEEEEEEeCCCCccHHHHHH
Confidence 58999987 689999999863 256799999999999999999988754 47999999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
... .+++.....++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 94 ~~~----------~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 94 KKD----------TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred hcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 643 2889999999999999999999998 9999999999999999999999999875321
Q ss_pred --------------------------------------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCC
Q 047629 483 --------------------------------------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTE 512 (615)
Q Consensus 483 --------------------------------------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~ 512 (615)
..++.++|||||||++|||++|+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~ 240 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCC
Confidence 124568999999999999999999997543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=254.09 Aligned_cols=209 Identities=21% Similarity=0.225 Sum_probs=162.1
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
+.||++.. .++.||+|.+.. .+.+|+++++.++|+||+++++.+.. ++..++||||+++|+|.+++.
T Consensus 15 ~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~g~~L~~~l~ 93 (305)
T cd05609 15 GAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET-KRHLCMVMEYVEGGDCATLLK 93 (305)
T ss_pred eeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec-CCEEEEEEecCCCCcHHHHHH
Confidence 47999887 578999998753 35579999999999999999998865 447899999999999999996
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCC---------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA--------- 481 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~--------- 481 (615)
... .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+|++|||+++..
T Consensus 94 ~~~----------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 94 NIG----------ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred HcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 543 3889999999999999999999987 999999999999999999999999987521
Q ss_pred -----------------------------CCCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHH
Q 047629 482 -----------------------------TNDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEK 532 (615)
Q Consensus 482 -----------------------------~~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 532 (615)
....+.++|+||||+++|||++|+.|+......+ +. ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~---~~---~~------- 227 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---LF---GQ------- 227 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH---HH-------
Confidence 0123568999999999999999999986433211 00 00
Q ss_pred HHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 047629 533 REERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSV 584 (615)
Q Consensus 533 ~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~ 584 (615)
........|.... .....+.+++.+||+.||++||++.++.+.|+.
T Consensus 228 --~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 228 --VISDDIEWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred --HHhcccCCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 0001111122111 233457899999999999999997666666553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=254.51 Aligned_cols=164 Identities=24% Similarity=0.416 Sum_probs=131.2
Q ss_pred ceEEEEEE----CCeEEEEEEcc-----HHHHHHHHHHHhcCCCCcccEEEEEEcC-CCcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATI----DGKVLAVKKIK-----EDVTEELRILQRINHANLVKLMGVSSDS-QGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~----~g~~vAvK~~~-----~~~~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
|.||+|.. +++.+|+|.++ ..+.+|+++|++++|+||+++++++... +...++++||+. ++|.+++...
T Consensus 15 g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~ 93 (317)
T cd07868 15 GHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFH 93 (317)
T ss_pred eEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-CCHHHHHHhc
Confidence 58999985 35789999886 3578899999999999999999987543 335789999996 5888887643
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceee----CCCCcEEEeecCCCCCCC------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQL----DSRFKAKIANFSLAAPAT------ 482 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl----d~~~~~kl~DFGla~~~~------ 482 (615)
..... ......+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 94 ~~~~~-~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~ 169 (317)
T cd07868 94 RASKA-NKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 169 (317)
T ss_pred ccccc-cCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccc
Confidence 22110 011124889999999999999999999998 9999999999999 456789999999985421
Q ss_pred ---------------------CCCCCcccchhHHHHHHHHHcCCCCCCCC
Q 047629 483 ---------------------NDVMPKFDVFAFGVVLLELLSGKKATRTT 511 (615)
Q Consensus 483 ---------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~ 511 (615)
..++.++||||+||++|||++|+.||...
T Consensus 170 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 170 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 11355799999999999999999998653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=252.69 Aligned_cols=222 Identities=23% Similarity=0.361 Sum_probs=161.2
Q ss_pred ceEEEEEE--CCeEEEEEEccH--------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATI--DGKVLAVKKIKE--------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~--------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
+.||+|.. +|+.||||.++. .+.+|++++++++|+||+++++++.+. ...++||||++ ++|.+++...
T Consensus 19 ~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~-~~L~~~~~~~ 96 (291)
T cd07844 19 ATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTK-KTLTLVFEYLD-TDLKQYMDDC 96 (291)
T ss_pred eEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecC-CeEEEEEecCC-CCHHHHHHhC
Confidence 48999987 689999998852 356799999999999999999998754 47999999998 5999998754
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC----------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT---------- 482 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~---------- 482 (615)
.. .+++.....++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 97 ~~---------~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 164 (291)
T cd07844 97 GG---------GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEV 164 (291)
T ss_pred CC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCccccccc
Confidence 32 3889999999999999999999998 9999999999999999999999999875321
Q ss_pred --------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhH--HHHHH--HHHhhhc---
Q 047629 483 --------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKV--EEKRE--ERLRNWM--- 541 (615)
Q Consensus 483 --------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~--~~~~~--~~~~~~~--- 541 (615)
...+.++||||||+++|||++|+.|+........ ....+...+.. ..... ....+..
T Consensus 165 ~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (291)
T cd07844 165 VTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED--QLHKIFRVLGTPTEETWPGVSSNPEFKPYS 242 (291)
T ss_pred cccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHhcCCCChhhhhhhhhcccccccc
Confidence 1135678999999999999999999865432111 11111111100 00000 0000000
Q ss_pred -----CCcCCCCCC-hHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047629 542 -----DPNLESFYP-IDGALSLATLARACTMDKSLSRPNMAEVVF 580 (615)
Q Consensus 542 -----dp~l~~~~~-~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~ 580 (615)
...+....+ ......+.+++..|++.+|++||++.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 243 FPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000000000 111246789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=256.07 Aligned_cols=164 Identities=25% Similarity=0.426 Sum_probs=131.1
Q ss_pred ceEEEEEE----CCeEEEEEEccH-----HHHHHHHHHHhcCCCCcccEEEEEEcC-CCcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATI----DGKVLAVKKIKE-----DVTEELRILQRINHANLVKLMGVSSDS-QGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~----~g~~vAvK~~~~-----~~~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
|.||+|.. ++..||+|.++. .+.+|++++++++|+||+++++++... +...++|+||+++ +|.+++...
T Consensus 15 g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~ 93 (317)
T cd07867 15 GHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFH 93 (317)
T ss_pred eeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-cHHHHHHhh
Confidence 58999986 347899998863 577899999999999999999987543 3457999999875 788887543
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceee----CCCCcEEEeecCCCCCCC------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQL----DSRFKAKIANFSLAAPAT------ 482 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl----d~~~~~kl~DFGla~~~~------ 482 (615)
..... ......+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 94 ~~~~~-~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~ 169 (317)
T cd07867 94 RASKA-NKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 169 (317)
T ss_pred hcccc-CCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccc
Confidence 21110 011124889999999999999999999998 9999999999999 566899999999985421
Q ss_pred ---------------------CCCCCcccchhHHHHHHHHHcCCCCCCCC
Q 047629 483 ---------------------NDVMPKFDVFAFGVVLLELLSGKKATRTT 511 (615)
Q Consensus 483 ---------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~ 511 (615)
..++.++|||||||++|||++|+.||...
T Consensus 170 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 170 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 11356799999999999999999998654
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=247.04 Aligned_cols=206 Identities=27% Similarity=0.453 Sum_probs=162.2
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
+.||+|.. +++.+|+|.++ ..+.+|++++++++|+||+++++++... ...++|+||+++++|.+++..
T Consensus 14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~ 92 (264)
T cd06626 14 GKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR-EKVYIFMEYCSGGTLEELLEH 92 (264)
T ss_pred cEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecC-CEEEEEEecCCCCcHHHHHhh
Confidence 48999987 68899999875 2467899999999999999999987654 478999999999999999976
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC--------
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN-------- 483 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~-------- 483 (615)
.. .+++..+..++.+++.||.|||+.+ ++|+||||+||++++++.+||+|||++.....
T Consensus 93 ~~----------~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 159 (264)
T cd06626 93 GR----------ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159 (264)
T ss_pred cC----------CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence 43 2788999999999999999999998 99999999999999999999999998754210
Q ss_pred ----------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhc
Q 047629 484 ----------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWM 541 (615)
Q Consensus 484 ----------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 541 (615)
..+.++||||||+++||+++|+.||......... .. .+....
T Consensus 160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~-----~~-----------~~~~~~ 223 (264)
T cd06626 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQI-----MF-----------HVGAGH 223 (264)
T ss_pred ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHH-----HH-----------HHhcCC
Confidence 1456789999999999999999999654321110 00 001111
Q ss_pred CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047629 542 DPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVF 580 (615)
Q Consensus 542 dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~ 580 (615)
.+.+... ......+.+++.+||+.+|.+||++.|++.
T Consensus 224 ~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 KPPIPDS--LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCCcc--cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1222111 112455789999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=247.37 Aligned_cols=206 Identities=23% Similarity=0.330 Sum_probs=161.3
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
+.||++.. +++.+|||.+. ..+.+|++++++++|+|++++++.+.. ++..++|+||+++|+|.+++..
T Consensus 14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~ 92 (256)
T cd08220 14 GIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE-DKALMIVMEYAPGGTLAEYIQK 92 (256)
T ss_pred eEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec-CCEEEEEEecCCCCCHHHHHHH
Confidence 47898876 68899999874 247789999999999999999998764 4479999999999999999976
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCC-CcEEEeecCCCCCCC--------
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSR-FKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~-~~~kl~DFGla~~~~-------- 482 (615)
.... .+++..+.+++.+++.||+|||+++ ++|+||||+||+++++ ..+|++|||++....
T Consensus 93 ~~~~--------~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~ 161 (256)
T cd08220 93 RCNS--------LLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTV 161 (256)
T ss_pred hccc--------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcccccc
Confidence 4321 3899999999999999999999998 9999999999999865 568999999885432
Q ss_pred --------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCC
Q 047629 483 --------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESF 548 (615)
Q Consensus 483 --------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~ 548 (615)
...+.++||||||+++|||++|+.|+........ .... ... ..+ .
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~------~~~~----------~~~-~~~----~ 220 (256)
T cd08220 162 VGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL------VLKI----------MSG-TFA----P 220 (256)
T ss_pred ccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH------HHHH----------Hhc-CCC----C
Confidence 1135689999999999999999999865432110 0000 000 001 1
Q ss_pred CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 549 YPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 549 ~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.+......+.+++..||+.+|.+|||+.|++..
T Consensus 221 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 221 ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 122234457899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=261.54 Aligned_cols=221 Identities=23% Similarity=0.326 Sum_probs=160.0
Q ss_pred ceEEEEEE--CCeEEEEEEccH---------HHHHHHHHHHhcCCCCcccEEEEEEcCC-----CcEEEEEeecCCCCHH
Q 047629 343 KSVYRATI--DGKVLAVKKIKE---------DVTEELRILQRINHANLVKLMGVSSDSQ-----GNRFLVYEYAENGSLD 406 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~---------~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~~lV~E~~~~GsL~ 406 (615)
|.||++.. +|+.||||+++. .+.+|+.+++.++|+||+++++++...+ ...++||||+++ +|.
T Consensus 35 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~ 113 (359)
T cd07876 35 GIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLC 113 (359)
T ss_pred EEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHH
Confidence 48999986 689999999852 3568999999999999999999875432 236999999975 676
Q ss_pred HhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC----
Q 047629 407 KWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT---- 482 (615)
Q Consensus 407 ~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~---- 482 (615)
+.+.. .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 114 ~~~~~------------~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 178 (359)
T cd07876 114 QVIHM------------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM 178 (359)
T ss_pred HHHhc------------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCccccccCcc
Confidence 66642 2788889999999999999999998 9999999999999999999999999985421
Q ss_pred ------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHH-----HHHHHHHhh
Q 047629 483 ------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVE-----EKREERLRN 539 (615)
Q Consensus 483 ------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~-----~~~~~~~~~ 539 (615)
..++.++|||||||++|||++|+.||...+... .+..+...+... ......+..
T Consensus 179 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (359)
T cd07876 179 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID---QWNKVIEQLGTPSAEFMNRLQPTVRN 255 (359)
T ss_pred CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence 124568999999999999999999997654211 121111111000 000001111
Q ss_pred hcC--CcCCC----------------CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047629 540 WMD--PNLES----------------FYPIDGALSLATLARACTMDKSLSRPNMAEVVFNL 582 (615)
Q Consensus 540 ~~d--p~l~~----------------~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L 582 (615)
... +...+ .........+.+|+.+|++.||++|||+.|++++-
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 256 YVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 111 11000 00111234578999999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=248.03 Aligned_cols=208 Identities=24% Similarity=0.400 Sum_probs=163.2
Q ss_pred ceEEEEEE--CCeEEEEEEcc-------------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATI--DGKVLAVKKIK-------------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-------------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~ 407 (615)
+.||++.. +|+.+|+|.++ +.+.+|++++++++|+||+++++++.+. +..++|+||+++++|.+
T Consensus 14 ~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~v~e~~~~~~L~~ 92 (268)
T cd06630 14 SSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCED-SHFNLFVEWMAGGSVSH 92 (268)
T ss_pred eEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccC-CeEEEEEeccCCCcHHH
Confidence 47998876 78999999884 2467899999999999999999998754 47899999999999999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCC-cEEEeecCCCCCCC----
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRF-KAKIANFSLAAPAT---- 482 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~-~~kl~DFGla~~~~---- 482 (615)
++.... .+++..+..++.|++.||+|||+++ ++||||||+||+++.++ .+||+|||++....
T Consensus 93 ~l~~~~----------~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~ 159 (268)
T cd06630 93 LLSKYG----------AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT 159 (268)
T ss_pred HHHHhC----------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence 997543 3889999999999999999999998 99999999999998775 59999999875321
Q ss_pred -----------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhh
Q 047629 483 -----------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRN 539 (615)
Q Consensus 483 -----------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 539 (615)
...+.++||||+|++++||++|+.|+...........+ .. ....
T Consensus 160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~~----------~~~~ 226 (268)
T cd06630 160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI---FK----------IASA 226 (268)
T ss_pred cCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHH---HH----------Hhcc
Confidence 12346799999999999999999998644321111100 00 0000
Q ss_pred hcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 540 WMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 540 ~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.. ....+......+.+++..|+..+|.+||++.|+++.
T Consensus 227 ~~----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 227 TT----APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred CC----CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 11 122334445668899999999999999999999853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=251.31 Aligned_cols=210 Identities=21% Similarity=0.378 Sum_probs=164.0
Q ss_pred ceEEEEEE--CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATI--DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
|.||++.. .|+.+|+|.++ ..+.+|++++++++|+||+++++.+.. ++..++|+||+++++|.+++...
T Consensus 15 g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~l~~~~~~~ 93 (286)
T cd06622 15 GSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI-EGAVYMCMEYMDAGSLDKLYAGG 93 (286)
T ss_pred eEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec-CCeEEEEEeecCCCCHHHHHHhc
Confidence 48999988 58999999875 246789999999999999999998775 45799999999999999998764
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC--------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEH-AQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN-------- 483 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~-------- 483 (615)
... ..+++..+..++.+++.||.|||+. + ++||||||+||+++.++.+||+|||++.....
T Consensus 94 ~~~-------~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 163 (286)
T cd06622 94 VAT-------EGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIG 163 (286)
T ss_pred ccc-------CCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCccccCCC
Confidence 211 1389999999999999999999974 5 99999999999999999999999998753210
Q ss_pred -------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCc
Q 047629 484 -------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPN 544 (615)
Q Consensus 484 -------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~ 544 (615)
.++.++|||||||++|||++|+.||........ ...+ ..+.....+.
T Consensus 164 ~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~-----------~~~~~~~~~~ 229 (286)
T cd06622 164 CQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI---FAQL-----------SAIVDGDPPT 229 (286)
T ss_pred ccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH---HHHH-----------HHHhhcCCCC
Confidence 125689999999999999999999865332110 0000 0111111122
Q ss_pred CCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 545 LESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 545 l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.+.+....+.+++.+||+.+|++||++.|++..
T Consensus 230 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 230 ----LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred ----CCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 233345567899999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=252.13 Aligned_cols=222 Identities=22% Similarity=0.343 Sum_probs=159.5
Q ss_pred ceEEEEEE--CCeEEEEEEccH--------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATI--DGKVLAVKKIKE--------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~--------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
+.||+|.. +|+.||+|.++. .+.+|++++++++|+||+++.+++... +..++|+||+. ++|.+++...
T Consensus 19 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~~~~lv~e~~~-~~l~~~~~~~ 96 (291)
T cd07870 19 ATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTK-ETLTFVFEYMH-TDLAQYMIQH 96 (291)
T ss_pred EEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecC-CeEEEEEeccc-CCHHHHHHhC
Confidence 48999986 689999998752 467899999999999999999998754 47899999996 6888777543
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC----------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT---------- 482 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~---------- 482 (615)
.. .+.+.++..++.|++.||.|||+++ ++||||||+||+++.++++||+|||+++...
T Consensus 97 ~~---------~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 164 (291)
T cd07870 97 PG---------GLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEV 164 (291)
T ss_pred CC---------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCCcc
Confidence 32 2788889999999999999999998 9999999999999999999999999875321
Q ss_pred --------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHH--HH--HHHHHhhhcCCc
Q 047629 483 --------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVE--EK--REERLRNWMDPN 544 (615)
Q Consensus 483 --------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~--~~--~~~~~~~~~dp~ 544 (615)
...+.++|||||||++|||++|+.||........ ........+... .. ....+.+.....
T Consensus 165 ~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (291)
T cd07870 165 VTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE--QLEKIWTVLGVPTEDTWPGVSKLPNYKPEW 242 (291)
T ss_pred ccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH--HHHHHHHHcCCCChhhhhhhhhcccccchh
Confidence 1134578999999999999999999975432111 111111110000 00 000000000000
Q ss_pred C----CCCC-----ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047629 545 L----ESFY-----PIDGALSLATLARACTMDKSLSRPNMAEVVF 580 (615)
Q Consensus 545 l----~~~~-----~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~ 580 (615)
. .... .......+.+++.+|++.||.+|||+.|++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 243 FLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0 0000 0012346789999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=250.43 Aligned_cols=209 Identities=19% Similarity=0.378 Sum_probs=157.7
Q ss_pred ceEEEEEE--CCeEEEEEEccH--------HHHHHHHH-HHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE--------DVTEELRI-LQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~--------~~~~Ei~~-l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
|.||++.. +|+.||+|+++. ++..|+.+ ++.++|+||+++++++... +..+++|||++ |+|.+++..
T Consensus 15 g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~-~~~~lv~e~~~-~~l~~~l~~ 92 (283)
T cd06617 15 GVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFRE-GDVWICMEVMD-TSLDKFYKK 92 (283)
T ss_pred eEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecC-CcEEEEhhhhc-ccHHHHHHH
Confidence 58999987 689999998752 24456665 5566999999999998754 47999999996 689888765
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEH-AQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
..... ..+++..+..++.|++.||+|||++ + ++||||||+||+++.++.+||+|||+++...
T Consensus 93 ~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 163 (283)
T cd06617 93 VYDKG------LTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTID 163 (283)
T ss_pred hccCC------CCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 32211 1489999999999999999999987 5 9999999999999999999999999875321
Q ss_pred ------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCc
Q 047629 483 ------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPN 544 (615)
Q Consensus 483 ------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~ 544 (615)
..++.++|+||||+++|||++|+.|+........ .+.. ......+.
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-----~~~~-----------~~~~~~~~ 227 (283)
T cd06617 164 AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ-----QLKQ-----------VVEEPSPQ 227 (283)
T ss_pred cCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHH-----HHHH-----------HHhcCCCC
Confidence 1135679999999999999999999864322110 0110 01111122
Q ss_pred CCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 545 LESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 545 l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
+.. ......+.+++..||..+|.+||++.|+++.
T Consensus 228 ~~~---~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 228 LPA---EKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred CCc---cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 211 1123457899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=256.24 Aligned_cols=225 Identities=18% Similarity=0.268 Sum_probs=163.6
Q ss_pred eEEEEEECCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCC
Q 047629 344 SVYRATIDGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSK 414 (615)
Q Consensus 344 ~Vy~~~~~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~ 414 (615)
.||++..+|+.||||+++ ..+.+|++++++++|+||+++++++.+. ...+++|||+++|+|.+++.....
T Consensus 17 ~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~-~~~~~~~e~~~~~~l~~~l~~~~~ 95 (314)
T cd08216 17 HLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD-SELYVVSPLMAYGSCEDLLKTHFP 95 (314)
T ss_pred EEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecC-CeEEEEEeccCCCCHHHHHHHhcc
Confidence 455555689999999875 2467899999999999999999988754 478999999999999999976432
Q ss_pred CCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC------------
Q 047629 415 SSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------------ 482 (615)
Q Consensus 415 ~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------------ 482 (615)
. .+++.....++.|++.||+|||+++ |+||||||+||+++.++.+|++|||.+....
T Consensus 96 ~--------~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~ 164 (314)
T cd08216 96 E--------GLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF 164 (314)
T ss_pred c--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccccc
Confidence 1 3788999999999999999999998 9999999999999999999999999764210
Q ss_pred --------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHh----HHH--HHHHH
Q 047629 483 --------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLK----VEE--KREER 536 (615)
Q Consensus 483 --------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~----~~~--~~~~~ 536 (615)
..++.++|||||||++|||++|+.||........ .......... ... .....
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 242 (314)
T cd08216 165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYPLYEDS 242 (314)
T ss_pred cccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchhhhcCC
Confidence 1245689999999999999999999976432211 1111100000 000 00000
Q ss_pred Hhh----hcCCcC----CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047629 537 LRN----WMDPNL----ESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNL 582 (615)
Q Consensus 537 ~~~----~~dp~l----~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L 582 (615)
... ..++.. ...+.......+.+++..||+.||++|||++|++++-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p 296 (314)
T cd08216 243 MSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS 296 (314)
T ss_pred cCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence 000 011111 0111223345688999999999999999999999853
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-30 Score=261.27 Aligned_cols=204 Identities=25% Similarity=0.388 Sum_probs=168.2
Q ss_pred ceEEEEEE--CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATI--DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
|.||||.. .++.||+|.+. +++.+|+.+|.+++++||.+++|.+... ..+|++||||.+|++.+.|...
T Consensus 27 G~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g-~~LwiiMey~~gGsv~~lL~~~ 105 (467)
T KOG0201|consen 27 GEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG-TKLWIIMEYCGGGSVLDLLKSG 105 (467)
T ss_pred ceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeec-ccHHHHHHHhcCcchhhhhccC
Confidence 58999998 68999999996 3577899999999999999999988754 3799999999999999999865
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC----------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT---------- 482 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~---------- 482 (615)
.. +++..+.-|++++..||.|||+++ .+|||||+.|||+..++.+|++|||.+...+
T Consensus 106 ~~----------~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tfv 172 (467)
T KOG0201|consen 106 NI----------LDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTFV 172 (467)
T ss_pred CC----------CccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhcccccc
Confidence 42 567777788999999999999998 9999999999999999999999999985432
Q ss_pred -------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCC
Q 047629 483 -------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFY 549 (615)
Q Consensus 483 -------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~ 549 (615)
..+..|+||||+|++.+||.+|.+|+.......... .+.+---|.+.+.
T Consensus 173 GTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf-----------------lIpk~~PP~L~~~- 234 (467)
T KOG0201|consen 173 GTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF-----------------LIPKSAPPRLDGD- 234 (467)
T ss_pred ccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE-----------------eccCCCCCccccc-
Confidence 236679999999999999999999987654311100 1222233455443
Q ss_pred ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 550 PIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 550 ~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
....+.+++..|++.||+.||++.+++++
T Consensus 235 ---~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 235 ---FSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ---cCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 34458899999999999999999999985
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=252.23 Aligned_cols=223 Identities=23% Similarity=0.324 Sum_probs=164.2
Q ss_pred ceEEEEEE--CCeEEEEEEccH---------HHHHHHHHHHhcCCCCcccEEEEEEcCC-CcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE---------DVTEELRILQRINHANLVKLMGVSSDSQ-GNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~---------~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~~lV~E~~~~GsL~~~L~ 410 (615)
+.||+|.. +|+.+|+|.++. .+.+|++++.+++|+||+++++++...+ ...++|+||++ ++|.+++.
T Consensus 19 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~ 97 (293)
T cd07843 19 GVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLME 97 (293)
T ss_pred eEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC-cCHHHHHH
Confidence 48999998 588999998852 3567999999999999999999887542 47999999997 59999887
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC-------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------- 483 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------- 483 (615)
.... .+++.++..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++....
T Consensus 98 ~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 165 (293)
T cd07843 98 TMKQ---------PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQ 165 (293)
T ss_pred hccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCcccccc
Confidence 6432 3899999999999999999999998 99999999999999999999999998764311
Q ss_pred -----------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHH-H-HHH----------
Q 047629 484 -----------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVE-E-KRE---------- 534 (615)
Q Consensus 484 -----------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~-~-~~~---------- 534 (615)
..+.++|+||||+++|||++|+.|+......... ..+....... . ...
T Consensus 166 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (293)
T cd07843 166 LVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQL---NKIFKLLGTPTEKIWPGFSELPGAKK 242 (293)
T ss_pred ccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCchHHHHHhhccchhcc
Confidence 1346799999999999999999998754421111 1111100000 0 000
Q ss_pred HHHhhhcCCcCCCCCChH-HHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 535 ERLRNWMDPNLESFYPID-GALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 535 ~~~~~~~dp~l~~~~~~~-~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
..........+...++.. ....+.++++.|++.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 243 KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000000011111222222 34567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=248.24 Aligned_cols=211 Identities=27% Similarity=0.458 Sum_probs=164.5
Q ss_pred ceEEEEEE--CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATI--DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
+.||++.. +++.+|+|.+. ..+.+|++++++++|+||+++++++... +..++++||+++++|.+++...
T Consensus 15 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~ 93 (265)
T cd06605 15 GVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNN-GDISICMEYMDGGSLDKILKEV 93 (265)
T ss_pred eEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecC-CEEEEEEEecCCCcHHHHHHHc
Confidence 57999988 58999999875 2467899999999999999999998754 5799999999999999999765
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC---------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHE-HAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT--------- 482 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~--------- 482 (615)
.. .+++..+.+++.|++.||+|||+ .+ ++|+||||+||++++++.+||+|||.+....
T Consensus 94 ~~---------~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 161 (265)
T cd06605 94 QG---------RIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVG 161 (265)
T ss_pred cC---------CCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhcccC
Confidence 32 38899999999999999999999 76 9999999999999999999999999875321
Q ss_pred ------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 483 ------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 483 ------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
...+.++||||||+++|||++|+.|+......... ....+. .+.....+.+...
T Consensus 162 ~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~-----------~~~~~~~~~~~~~-- 227 (265)
T cd06605 162 TSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG-IFELLQ-----------YIVNEPPPRLPSG-- 227 (265)
T ss_pred ChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc-HHHHHH-----------HHhcCCCCCCChh--
Confidence 12456899999999999999999998754321110 011111 1111111122111
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 551 IDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.....+.+++..||..||++||++.|++..
T Consensus 228 -~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 228 -KFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred -hcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 134458899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=260.81 Aligned_cols=203 Identities=17% Similarity=0.224 Sum_probs=155.5
Q ss_pred ceEEEEEE--CCeEEEEEEccHH----------HHHHHHHHHhc---CCCCcccEEEEEEcCCCcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATI--DGKVLAVKKIKED----------VTEELRILQRI---NHANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~~----------~~~Ei~~l~~l---~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~ 407 (615)
|.||++.. +|+.||||++... +..|..++.+. +||||+++++++.+. ...++||||+++|+|.+
T Consensus 7 g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~-~~~~lv~e~~~~g~L~~ 85 (330)
T cd05586 7 GQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD-SDLYLVTDYMSGGELFW 85 (330)
T ss_pred eEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC-CeEEEEEcCCCCChHHH
Confidence 48999987 6899999998532 23466666665 699999999988754 47999999999999999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----- 482 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----- 482 (615)
++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 86 ~l~~~~----------~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~ 152 (330)
T cd05586 86 HLQKEG----------RFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT 152 (330)
T ss_pred HHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC
Confidence 987543 2889999999999999999999998 9999999999999999999999999985420
Q ss_pred -------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCC
Q 047629 483 -------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDP 543 (615)
Q Consensus 483 -------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp 543 (615)
..++.++|||||||++|||++|+.||...... ..+. .. .. .+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~---~~~~---~i----------~~--~~~ 214 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ---QMYR---NI----------AF--GKV 214 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH---HHHH---HH----------Hc--CCC
Confidence 11456899999999999999999998654311 1110 00 00 011
Q ss_pred cCCCCCChHHHHHHHHHHHHhhhcCCCCCC----CHHHHHH
Q 047629 544 NLESFYPIDGALSLATLARACTMDKSLSRP----NMAEVVF 580 (615)
Q Consensus 544 ~l~~~~~~~~~~~l~~l~~~C~~~dP~~RP----sm~ev~~ 580 (615)
.+.. ......+.+++.+|++.||.+|| ++.|+++
T Consensus 215 ~~~~---~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 215 RFPK---NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CCCC---ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 1111 11234568999999999999998 4666655
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-28 Score=244.90 Aligned_cols=207 Identities=29% Similarity=0.500 Sum_probs=163.3
Q ss_pred ceEEEEEECC------eEEEEEEccH--------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHh
Q 047629 343 KSVYRATIDG------KVLAVKKIKE--------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKW 408 (615)
Q Consensus 343 ~~Vy~~~~~g------~~vAvK~~~~--------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~ 408 (615)
|.||++.... ..||+|.++. .+..|++++.+++|+||+++++++.+. +..+++|||+++++|.++
T Consensus 13 g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~i~e~~~~~~l~~~ 91 (258)
T smart00219 13 GEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE-EPLMIVMEYMEGGDLLDY 91 (258)
T ss_pred cceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-CeeEEEEeccCCCCHHHH
Confidence 5899999843 8899999862 467899999999999999999998764 479999999999999999
Q ss_pred hccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC------
Q 047629 409 LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------ 482 (615)
Q Consensus 409 L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------ 482 (615)
+...... .+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+|++|||+++...
T Consensus 92 ~~~~~~~--------~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (258)
T smart00219 92 LRKNRPK--------ELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK 160 (258)
T ss_pred HHhhhhc--------cCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccccccc
Confidence 9764321 1899999999999999999999998 9999999999999999999999999985331
Q ss_pred ------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCC
Q 047629 483 ------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDP 543 (615)
Q Consensus 483 ------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp 543 (615)
...+.++||||+|++++||++ |+.|+...... ..... +....-
T Consensus 161 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~---~~~~~--------------~~~~~~- 222 (258)
T smart00219 161 KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE---EVLEY--------------LKKGYR- 222 (258)
T ss_pred cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH--------------HhcCCC-
Confidence 113568999999999999998 77787643211 11100 000000
Q ss_pred cCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047629 544 NLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNL 582 (615)
Q Consensus 544 ~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L 582 (615)
...+......+.+++.+|++.||++|||+.|+++.|
T Consensus 223 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 ---LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111222445688999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=259.45 Aligned_cols=221 Identities=23% Similarity=0.341 Sum_probs=159.0
Q ss_pred ceEEEEEE--CCeEEEEEEccH---------HHHHHHHHHHhcCCCCcccEEEEEEcCC-----CcEEEEEeecCCCCHH
Q 047629 343 KSVYRATI--DGKVLAVKKIKE---------DVTEELRILQRINHANLVKLMGVSSDSQ-----GNRFLVYEYAENGSLD 406 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~---------~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~~lV~E~~~~GsL~ 406 (615)
|.||++.. +++.||||+++. .+.+|++++++++|+||+++++++.... ...++++|++ +++|.
T Consensus 29 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~ 107 (343)
T cd07878 29 GSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLN 107 (343)
T ss_pred eEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHH
Confidence 48999986 678999999852 3557999999999999999998765321 2468999988 67999
Q ss_pred HhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC---
Q 047629 407 KWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN--- 483 (615)
Q Consensus 407 ~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~--- 483 (615)
+++... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 108 ~~~~~~-----------~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 173 (343)
T cd07878 108 NIVKCQ-----------KLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMT 173 (343)
T ss_pred HHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccceecCCCcC
Confidence 888642 2889999999999999999999998 99999999999999999999999999864311
Q ss_pred ------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHH------HHHHHHHhh
Q 047629 484 ------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVE------EKREERLRN 539 (615)
Q Consensus 484 ------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~------~~~~~~~~~ 539 (615)
.++.++|||||||++|||++|+.||......+. ...+....... .........
T Consensus 174 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (343)
T cd07878 174 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ---LKRIMEVVGTPSPEVLKKISSEHARK 250 (343)
T ss_pred CccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHHhCCCCHHHHHhcchhhHHH
Confidence 245689999999999999999999865432111 11111100000 000000000
Q ss_pred hcC--CcCCCC----CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 540 WMD--PNLESF----YPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 540 ~~d--p~l~~~----~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.+. +..... ........+.+|+.+|++.||.+|||+.|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 251 YIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 000000 000112346899999999999999999999976
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=253.78 Aligned_cols=205 Identities=21% Similarity=0.342 Sum_probs=162.3
Q ss_pred ceEEEEEE--CCeEEEEEEcc-------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
+.||++.. +++.||+|.+. +.+.+|+.++.+++|+||+++++++... +..++|+||+++|+|..++...
T Consensus 35 g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-~~~~iv~e~~~~~~L~~~~~~~- 112 (297)
T cd06659 35 GIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVG-EELWVLMEFLQGGALTDIVSQT- 112 (297)
T ss_pred eeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeC-CeEEEEEecCCCCCHHHHHhhc-
Confidence 57999886 68999999974 3477899999999999999999988754 4799999999999999987542
Q ss_pred CCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----------
Q 047629 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----------- 482 (615)
Q Consensus 414 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----------- 482 (615)
.+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 113 ----------~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~ 179 (297)
T cd06659 113 ----------RLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVG 179 (297)
T ss_pred ----------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccccccceec
Confidence 2889999999999999999999998 9999999999999999999999999875321
Q ss_pred ------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 483 ------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 483 ------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
...+.++|||||||++|||++|+.|+......+. +. .+.....+... ..
T Consensus 180 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~-----------~~~~~~~~~~~--~~ 240 (297)
T cd06659 180 TPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA------MK-----------RLRDSPPPKLK--NA 240 (297)
T ss_pred CccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HH-----------HHhccCCCCcc--cc
Confidence 1245689999999999999999999875332111 00 01111111111 11
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 551 IDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
......+.+++..|++.+|++||++.|+++.
T Consensus 241 ~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 241 HKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 1223457899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-28 Score=253.17 Aligned_cols=206 Identities=23% Similarity=0.301 Sum_probs=160.7
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
+.||++.. +|+.+|+|.+.. .+..|++++.+++|+||+++++.+.+. ...++||||+++|+|.+++.
T Consensus 15 g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~ 93 (316)
T cd05574 15 GRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTE-TYLCLVMDYCPGGELFRLLQ 93 (316)
T ss_pred EEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecC-CEEEEEEEecCCCCHHHHHH
Confidence 48999987 579999998852 366799999999999999999998754 47899999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
..... .+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 94 ~~~~~--------~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 162 (316)
T cd05574 94 RQPGK--------CLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSK 162 (316)
T ss_pred hCCCC--------ccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccccccccc
Confidence 54321 3899999999999999999999998 9999999999999999999999999874321
Q ss_pred --------------------------------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHH
Q 047629 483 --------------------------------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAV 518 (615)
Q Consensus 483 --------------------------------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~ 518 (615)
...+.++||||||+++|||++|+.|+........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~-- 240 (316)
T cd05574 163 ALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET-- 240 (316)
T ss_pred ccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH--
Confidence 1134578999999999999999999875432111
Q ss_pred HHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCC----HHHHHH
Q 047629 519 LWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPN----MAEVVF 580 (615)
Q Consensus 519 l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPs----m~ev~~ 580 (615)
+.+..+....-.........+.+++.+||+.||++||+ +.|++.
T Consensus 241 ------------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 241 ------------------FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred ------------------HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 01111111110011113456899999999999999999 555554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=261.53 Aligned_cols=220 Identities=21% Similarity=0.315 Sum_probs=159.7
Q ss_pred ceEEEEEE--CCeEEEEEEccH---------HHHHHHHHHHhcCCCCcccEEEEEEcCC-----CcEEEEEeecCCCCHH
Q 047629 343 KSVYRATI--DGKVLAVKKIKE---------DVTEELRILQRINHANLVKLMGVSSDSQ-----GNRFLVYEYAENGSLD 406 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~---------~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~~lV~E~~~~GsL~ 406 (615)
|.||++.. .++.||||++.. .+.+|+.+++.++|+||+++++++...+ ...++||||+++ +|.
T Consensus 38 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~ 116 (364)
T cd07875 38 GIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLC 116 (364)
T ss_pred eEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCCC-CHH
Confidence 48999986 688999999852 3668999999999999999999875322 247999999975 787
Q ss_pred HhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC---
Q 047629 407 KWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN--- 483 (615)
Q Consensus 407 ~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~--- 483 (615)
+++.. .+++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 117 ~~~~~------------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~ 181 (364)
T cd07875 117 QVIQM------------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 181 (364)
T ss_pred HHHHh------------cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCccccCCCCc
Confidence 77742 2788999999999999999999998 99999999999999999999999999864321
Q ss_pred -------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhH-----HHHHHHHHhh
Q 047629 484 -------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKV-----EEKREERLRN 539 (615)
Q Consensus 484 -------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~-----~~~~~~~~~~ 539 (615)
.++.++|||||||++|||++|+.||......+ .+..+...+.. .......+..
T Consensus 182 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (364)
T cd07875 182 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID---QWNKVIEQLGTPCPEFMKKLQPTVRT 258 (364)
T ss_pred ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCHHHHHhhhHHHHH
Confidence 24568999999999999999999997544211 11111111000 0000000011
Q ss_pred hcC--CcCC----------------CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 540 WMD--PNLE----------------SFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 540 ~~d--p~l~----------------~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.+. |... ..........+.+++.+|++.||.+|||+.|++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 259 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 100 0000 00111123467899999999999999999999886
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=256.61 Aligned_cols=209 Identities=19% Similarity=0.225 Sum_probs=157.2
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||++.. .++.+|+|.+.+ .+.+|+.++..++|+||+++.+++.+. ...++||||+++|+|.+++.
T Consensus 15 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv~ey~~~g~L~~~l~ 93 (332)
T cd05623 15 GEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDE-NNLYLVMDYYVGGDLLTLLS 93 (332)
T ss_pred eEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecC-CEEEEEEeccCCCcHHHHHH
Confidence 58999988 578899999853 266789999999999999999988754 47999999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 94 ~~~~---------~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~ 161 (332)
T cd05623 94 KFED---------RLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSS 161 (332)
T ss_pred HhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCCcceec
Confidence 6432 3889999999999999999999998 9999999999999999999999999874310
Q ss_pred ---------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhc
Q 047629 483 ---------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWM 541 (615)
Q Consensus 483 ---------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 541 (615)
..++.++|||||||++|||++|+.||......+ .+.... ....
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~----------~~~~ 225 (332)
T cd05623 162 VAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIM----------NHKE 225 (332)
T ss_pred ccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH------HHHHHh----------CCCc
Confidence 113568999999999999999999997543111 011110 0000
Q ss_pred CCcCCCCCChHHHHHHHHHHHHhhhc--CCCCCCCHHHHHHH
Q 047629 542 DPNLESFYPIDGALSLATLARACTMD--KSLSRPNMAEVVFN 581 (615)
Q Consensus 542 dp~l~~~~~~~~~~~l~~l~~~C~~~--dP~~RPsm~ev~~~ 581 (615)
...... ...+....+.+++.+|+.. ++..|+++.|++++
T Consensus 226 ~~~~p~-~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 226 RFQFPA-QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred cccCCC-ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 000100 0112334567788887754 44447899999876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-28 Score=245.71 Aligned_cols=206 Identities=20% Similarity=0.287 Sum_probs=164.3
Q ss_pred ceEEEEEEC--CeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATID--GKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~~--g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
+.||++... ++.+|+|.+.. .+.+|++++++++|+||+++++.+.+. ...++++||+++|+|.+++.
T Consensus 7 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~ 85 (262)
T cd05572 7 GRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDK-KYIYMLMEYCLGGELWTILR 85 (262)
T ss_pred eEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcC-CccEEEEecCCCCcHHHHHh
Confidence 489999984 89999998752 367799999999999999999988754 47899999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC-------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------- 483 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------- 483 (615)
... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 86 ~~~----------~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~ 152 (262)
T cd05572 86 DRG----------LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTF 152 (262)
T ss_pred hcC----------CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccc
Confidence 643 2889999999999999999999987 99999999999999999999999999865422
Q ss_pred ---------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCC
Q 047629 484 ---------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESF 548 (615)
Q Consensus 484 ---------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~ 548 (615)
..+.++|+||||+++|||++|+.|+........ .. ..+..+......
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~-----------------~~~~~~~~~~~~ 214 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM-EI-----------------YNDILKGNGKLE 214 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH-HH-----------------HHHHhccCCCCC
Confidence 134679999999999999999999976542111 00 111111111223
Q ss_pred CChHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 047629 549 YPIDGALSLATLARACTMDKSLSRPN-----MAEVVF 580 (615)
Q Consensus 549 ~~~~~~~~l~~l~~~C~~~dP~~RPs-----m~ev~~ 580 (615)
++......+.+++..||+.+|++||+ ++|+++
T Consensus 215 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 215 FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 34334567899999999999999999 566554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-28 Score=255.46 Aligned_cols=156 Identities=23% Similarity=0.302 Sum_probs=134.4
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||++.. +++.||+|.+++ .+.+|+.++..++|+||+++++++.+. +..++||||+++|+|.+++.
T Consensus 15 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~g~~L~~~l~ 93 (331)
T cd05597 15 GEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDE-NNLYLVMDYYVGGDLLTLLS 93 (331)
T ss_pred eEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecC-CeEEEEEecCCCCcHHHHHH
Confidence 58999987 689999999853 256799999999999999999988754 47999999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 94 ~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 161 (331)
T cd05597 94 KFED---------RLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSN 161 (331)
T ss_pred HhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcccc
Confidence 5332 3889999999999999999999998 9999999999999999999999999874321
Q ss_pred ---------------------CCCCCcccchhHHHHHHHHHcCCCCCCCC
Q 047629 483 ---------------------NDVMPKFDVFAFGVVLLELLSGKKATRTT 511 (615)
Q Consensus 483 ---------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~ 511 (615)
..++.++|||||||++|||++|+.||...
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 211 (331)
T cd05597 162 VAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred ceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence 11345799999999999999999999653
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=256.20 Aligned_cols=216 Identities=21% Similarity=0.269 Sum_probs=166.6
Q ss_pred ccccccccccc----ceEEEEEE--CCeEEEEEEccHH----------HHHHHHHHHhcCCCCcccEEEEEEcCCCcEEE
Q 047629 332 TMNLSEHYSIG----KSVYRATI--DGKVLAVKKIKED----------VTEELRILQRINHANLVKLMGVSSDSQGNRFL 395 (615)
Q Consensus 332 t~~~~~~~~iG----~~Vy~~~~--~g~~vAvK~~~~~----------~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~l 395 (615)
.++|.-...|| |.||.+.- +|+.+|+|++++. +..|-++|...++++||+|+-.+.+.+ .+||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~-~LYL 218 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE-YLYL 218 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC-eeEE
Confidence 34555555565 58998886 7999999999743 568999999999999999998776554 8999
Q ss_pred EEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeec
Q 047629 396 VYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANF 475 (615)
Q Consensus 396 V~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DF 475 (615)
||||.|+|++..+|.... .|+......++.+.+.|++-||.++ +|||||||+|+|||..|.+||+||
T Consensus 219 iMEylPGGD~mTLL~~~~----------~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDF 285 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKD----------TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDF 285 (550)
T ss_pred EEEecCCccHHHHHHhcC----------cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccc
Confidence 999999999999998765 3899999999999999999999999 999999999999999999999999
Q ss_pred CCCCCCCC----------------------------------------------------------------------CC
Q 047629 476 SLAAPATN----------------------------------------------------------------------DV 485 (615)
Q Consensus 476 Gla~~~~~----------------------------------------------------------------------~~ 485 (615)
||+..... .+
T Consensus 286 GLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY 365 (550)
T KOG0605|consen 286 GLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGY 365 (550)
T ss_pred cccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCC
Confidence 99843200 02
Q ss_pred CCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhh
Q 047629 486 MPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACT 565 (615)
Q Consensus 486 ~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~ 565 (615)
...+|.||+|||+||||.|-+||......+ .|..+..+ +..+..-- ..+...+..+|+.+|+
T Consensus 366 ~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~---T~rkI~nw-------r~~l~fP~--------~~~~s~eA~DLI~rll 427 (550)
T KOG0605|consen 366 GKECDWWSLGCIMYEMLVGYPPFCSETPQE---TYRKIVNW-------RETLKFPE--------EVDLSDEAKDLITRLL 427 (550)
T ss_pred CccccHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHH-------hhhccCCC--------cCcccHHHHHHHHHHh
Confidence 346899999999999999999998765432 22222111 11111111 1122256789999999
Q ss_pred hcCCCCCCC---HHHHHH
Q 047629 566 MDKSLSRPN---MAEVVF 580 (615)
Q Consensus 566 ~~dP~~RPs---m~ev~~ 580 (615)
. ||++|-- +.||-.
T Consensus 428 ~-d~~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 428 C-DPENRLGSKGAEEIKK 444 (550)
T ss_pred c-CHHHhcCcccHHHHhc
Confidence 9 9999975 555544
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-28 Score=244.25 Aligned_cols=207 Identities=27% Similarity=0.412 Sum_probs=165.8
Q ss_pred ceEEEEEE--CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATI--DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
+.||++.. +|+.++||++. ..+.+|++.+.+++|+|++++++++... +..++|+||+++++|.+++...
T Consensus 15 ~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~ 93 (264)
T cd06623 15 GVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKE-GEISIVLEYMDGGSLADLLKKV 93 (264)
T ss_pred eEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC-CeEEEEEEecCCCcHHHHHHHc
Confidence 47999988 58999999865 3477899999999999999999998754 5799999999999999999764
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC--------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHE-HAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN-------- 483 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~-------- 483 (615)
. .+++..+..++.|++.||.|||+ .+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 94 ~----------~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~ 160 (264)
T cd06623 94 G----------KIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF 160 (264)
T ss_pred C----------CCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCcccce
Confidence 3 38999999999999999999999 87 99999999999999999999999998865321
Q ss_pred ---------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCC
Q 047629 484 ---------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESF 548 (615)
Q Consensus 484 ---------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~ 548 (615)
..+.++||||||+++|||++|+.|+............. .+.....+.+
T Consensus 161 ~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~--------------~~~~~~~~~~--- 223 (264)
T cd06623 161 VGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ--------------AICDGPPPSL--- 223 (264)
T ss_pred eecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHH--------------HHhcCCCCCC---
Confidence 13457999999999999999999987654211111110 1111111222
Q ss_pred CChH-HHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 549 YPID-GALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 549 ~~~~-~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
+.. ....+.+++..|++.+|++||++.|+++.
T Consensus 224 -~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 224 -PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 222 44568999999999999999999999885
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-28 Score=247.67 Aligned_cols=221 Identities=19% Similarity=0.353 Sum_probs=162.9
Q ss_pred ceEEEEEE--CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATI--DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
+.||+|.. +|+.||||+++ ..+.+|++++++++|+||+++++++.+. +..++||||+++ +|.+++...
T Consensus 14 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~-~l~~~~~~~ 91 (284)
T cd07836 14 ATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTE-NKLMLVFEYMDK-DLKKYMDTH 91 (284)
T ss_pred eEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeC-CcEEEEEecCCc-cHHHHHHhc
Confidence 48999997 68999999875 2456899999999999999999998764 478999999984 899988654
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC----------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT---------- 482 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~---------- 482 (615)
... ..+++.++..++.|++.||.|||+.+ ++||||||+||++++++.+|++|||+++...
T Consensus 92 ~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 161 (284)
T cd07836 92 GVR-------GALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEV 161 (284)
T ss_pred CCC-------CCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccccccc
Confidence 321 13899999999999999999999998 9999999999999999999999999885321
Q ss_pred --------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHH-HHHHHHHhhhcCCcCCC
Q 047629 483 --------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVE-EKREERLRNWMDPNLES 547 (615)
Q Consensus 483 --------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~~~~~~dp~l~~ 547 (615)
...+.++|||||||++|||++|+.|+......+.. ..+....... ...-..+... +.+..
T Consensus 162 ~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~--~~~~~ 236 (284)
T cd07836 162 VTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQL---LKIFRIMGTPTESTWPGISQL--PEYKP 236 (284)
T ss_pred ccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHH---HHHHHHhCCCChhhHHHHhcC--chhcc
Confidence 11356799999999999999999998755432211 1111110000 0000000000 01111
Q ss_pred CC-----------ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047629 548 FY-----------PIDGALSLATLARACTMDKSLSRPNMAEVVF 580 (615)
Q Consensus 548 ~~-----------~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~ 580 (615)
.+ .......+.+++..|++.||.+||++.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11 1122346789999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=247.09 Aligned_cols=210 Identities=29% Similarity=0.485 Sum_probs=162.7
Q ss_pred ceEEEEEE--CCeEEEEEEccH---------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE---------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~---------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
|.||++.. +++.+|+|.+.. ...+|+.++++++|+||+++++++.+. ...++||||+++++|.+++..
T Consensus 13 g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~~v~~~~~~~~L~~~l~~ 91 (260)
T PF00069_consen 13 GTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDD-NYLYIVMEYCPGGSLQDYLQK 91 (260)
T ss_dssp EEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEES-SEEEEEEEEETTEBHHHHHHH
T ss_pred EEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccc-ccccccccccccccccccccc
Confidence 58999998 578899999862 124589999999999999999998764 478999999999999999983
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCC----------
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA---------- 481 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~---------- 481 (615)
.. .+++..+..++.|++.||.|||+++ ++||||||+||++++++.++|+|||.+...
T Consensus 92 ~~----------~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 158 (260)
T PF00069_consen 92 NK----------PLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPF 158 (260)
T ss_dssp HS----------SBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSS
T ss_pred cc----------ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccccc
Confidence 22 3899999999999999999999998 999999999999999999999999998531
Q ss_pred --------------CCCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCC
Q 047629 482 --------------TNDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLES 547 (615)
Q Consensus 482 --------------~~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~ 547 (615)
....+.++||||+|+++|||++|+.|+........... +...... ..... .
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~---~~~~~~~------~~~~~----~-- 223 (260)
T PF00069_consen 159 VGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEI---IEKILKR------PLPSS----S-- 223 (260)
T ss_dssp SSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHH---HHHHHHT------HHHHH----T--
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccchhhhhh---hhhcccc------ccccc----c--
Confidence 01245689999999999999999999986521111111 1111100 00000 0
Q ss_pred CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 548 FYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 548 ~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.........+.+++..|++.||++||++.|+++.
T Consensus 224 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 224 QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000112578999999999999999999999863
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-29 Score=259.72 Aligned_cols=206 Identities=23% Similarity=0.357 Sum_probs=169.2
Q ss_pred eEEEEEECCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCC
Q 047629 344 SVYRATIDGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSK 414 (615)
Q Consensus 344 ~Vy~~~~~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~ 414 (615)
..++.+.+++.+++|++. .....|+.++++++|||||.+.+.+.+++...+|||+|++||+|.+.+...+.
T Consensus 21 ~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~ 100 (426)
T KOG0589|consen 21 LLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKG 100 (426)
T ss_pred hhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhh
Confidence 345566688899999885 35788999999999999999999987655338999999999999999987663
Q ss_pred CCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCCC----------
Q 047629 415 SSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATND---------- 484 (615)
Q Consensus 415 ~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~---------- 484 (615)
..++..++..|+.|++.|+.|||++. |+|||||+.||++..+..+||+|||+|+.....
T Consensus 101 --------~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a~tvvGT 169 (426)
T KOG0589|consen 101 --------VLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSLASTVVGT 169 (426)
T ss_pred --------ccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCchhhhheecCC
Confidence 24899999999999999999999887 999999999999999999999999999876332
Q ss_pred -------------CCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCCh
Q 047629 485 -------------VMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPI 551 (615)
Q Consensus 485 -------------~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~ 551 (615)
+..|+|+||+||++|||++=+++|...+-.. +.. ......++ ..|.
T Consensus 170 p~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---Li~-------------ki~~~~~~-----Plp~ 228 (426)
T KOG0589|consen 170 PYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---LIL-------------KINRGLYS-----PLPS 228 (426)
T ss_pred CcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---HHH-------------HHhhccCC-----CCCc
Confidence 4569999999999999999999997654211 111 11122222 2344
Q ss_pred HHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 552 DGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 552 ~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
....++..+++.|+..+|..||++.+++.+
T Consensus 229 ~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 229 MYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 556678999999999999999999999987
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-28 Score=246.87 Aligned_cols=222 Identities=23% Similarity=0.292 Sum_probs=161.8
Q ss_pred ceEEEEEE--CCeEEEEEEccHH--------HHHHHHHHHhcC-CCCcccEEEEEEcCC-CcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKED--------VTEELRILQRIN-HANLVKLMGVSSDSQ-GNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~~--------~~~Ei~~l~~l~-H~niv~l~g~~~~~~-~~~~lV~E~~~~GsL~~~L~ 410 (615)
+.||+|.. +++.+|+|+++.. ..+|+.++.++. |+|++++++++.+.. +..++|+||++ |+|.+++.
T Consensus 13 ~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~ 91 (282)
T cd07831 13 SEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIK 91 (282)
T ss_pred ceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHH
Confidence 58999987 6899999988642 346888999885 999999999987642 47899999997 68888887
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
.... .++|.++..++.|++.||+|||+.+ ++||||||+||+++. +.+||+|||+++...
T Consensus 92 ~~~~---------~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~~~ 158 (282)
T cd07831 92 GRKR---------PLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTEY 158 (282)
T ss_pred hccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCCCcCCC
Confidence 5432 3899999999999999999999998 999999999999999 999999999885431
Q ss_pred ---------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHH-HHHHH-----hhhc
Q 047629 483 ---------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEK-REERL-----RNWM 541 (615)
Q Consensus 483 ---------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~-----~~~~ 541 (615)
...+.++|||||||++|||++|+.|+......+ .............. ..... ....
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
T cd07831 159 ISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFRKSRHMNYN 235 (282)
T ss_pred CCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhccccccccc
Confidence 113568999999999999999999996543211 11111111110000 00000 0000
Q ss_pred CCcCCC----CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 542 DPNLES----FYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 542 dp~l~~----~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.+.... .........+.+++.+||+.+|++||++.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 236 FPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred CcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000000 0011235678999999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-28 Score=249.19 Aligned_cols=222 Identities=24% Similarity=0.302 Sum_probs=164.6
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
+.||+|.. +|+.||+|++. ..+.+|+.++++++|+||+++++++.+. ...++|+||+ +++|.+++..
T Consensus 14 ~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~~v~e~~-~~~L~~~~~~ 91 (286)
T cd07832 14 GIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHG-SGFVLVMEYM-PSDLSEVLRD 91 (286)
T ss_pred cEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecC-CeeEEEeccc-CCCHHHHHHh
Confidence 47999987 68999999885 3477899999999999999999998754 4789999999 9999999875
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC--------
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN-------- 483 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~-------- 483 (615)
... .+++.++..++.|++.||+|||+++ ++|+||||+||+++.++.++++|||++.....
T Consensus 92 ~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (286)
T cd07832 92 EER---------PLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH 159 (286)
T ss_pred cCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcccc
Confidence 442 3899999999999999999999998 99999999999999999999999998754311
Q ss_pred -----------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHH-HHHHHhh------
Q 047629 484 -----------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEK-REERLRN------ 539 (615)
Q Consensus 484 -----------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~------ 539 (615)
..+.++||||+|++++||++|+.++....+.+ .+..+...+..... ....+.+
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07832 160 QVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE---QLAIVFRTLGTPNEETWPGLTSLPDYNK 236 (286)
T ss_pred ccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH---HHHHHHHHcCCCChHHHhhccCcchhhc
Confidence 13568999999999999999977775433211 11111111110000 0000000
Q ss_pred hcCCcCC----CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 540 WMDPNLE----SFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 540 ~~dp~l~----~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
...+.-. .+...+....+.+++.+|++.+|++||++++++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 237 ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred ccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000 00111234678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=250.35 Aligned_cols=223 Identities=21% Similarity=0.360 Sum_probs=164.0
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
+.||+|.. +|+.||+|++. ..+.+|++++++++|+|++++++++.+. +..+++|||++ ++|.+++..
T Consensus 13 ~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~-~~~~iv~e~~~-~~l~~~~~~ 90 (283)
T cd07835 13 GVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSE-NKLYLVFEFLD-LDLKKYMDS 90 (283)
T ss_pred eEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccC-CeEEEEEeccC-cCHHHHHhh
Confidence 48999987 78999999875 3467899999999999999999998754 47999999995 699999876
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC---------
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT--------- 482 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~--------- 482 (615)
.... .+++..+..++.|++.||+|||+++ ++||||+|+||+++.++.+||+|||+++...
T Consensus 91 ~~~~--------~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~ 159 (283)
T cd07835 91 SPLT--------GLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHE 159 (283)
T ss_pred CCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCcc
Confidence 5421 3899999999999999999999987 9999999999999999999999999875321
Q ss_pred ---------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHH----------HHHHHH
Q 047629 483 ---------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEE----------KREERL 537 (615)
Q Consensus 483 ---------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~----------~~~~~~ 537 (615)
...+.++||||||+++|||++|+.||....... .+...+........ ......
T Consensus 160 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07835 160 VVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID--QLFRIFRTLGTPDEDVWPGVTSLPDYKPTF 237 (283)
T ss_pred ccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHHhhhhhhchhhhhhc
Confidence 013457999999999999999999987543211 11111110000000 000001
Q ss_pred hhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 538 RNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 538 ~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
..+..+.+ ..........+.+++.+|++.||.+||+++|+++.
T Consensus 238 ~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 238 PKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred ccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 11111111 11112233467899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-28 Score=244.94 Aligned_cols=206 Identities=23% Similarity=0.377 Sum_probs=161.8
Q ss_pred ceEEEEEE--CCeEEEEEEccH---------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE---------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~---------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
+.||++.. +|..+|+|.+.. .+.+|++++++++|+||+++++.+.+ ++..++|+||+++++|.+++..
T Consensus 14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~ 92 (257)
T cd08225 14 GKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE-NGRLFIVMEYCDGGDLMKRINR 92 (257)
T ss_pred ceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc-CCeEEEEEecCCCCcHHHHHHh
Confidence 58999998 688999998742 46689999999999999999998865 4478999999999999999976
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCC-cEEEeecCCCCCCC--------
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRF-KAKIANFSLAAPAT-------- 482 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~-~~kl~DFGla~~~~-------- 482 (615)
.... .++|..+..++.|++.||.|||+.+ ++|+||||+||++++++ .+|++|||.+....
T Consensus 93 ~~~~--------~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~ 161 (257)
T cd08225 93 QRGV--------LFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT 161 (257)
T ss_pred ccCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCcccccc
Confidence 4321 3799999999999999999999998 99999999999999885 56999999875431
Q ss_pred ---------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCC
Q 047629 483 ---------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLES 547 (615)
Q Consensus 483 ---------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~ 547 (615)
...+.++||||||+++|||++|+.|+...... +.+.. .......+
T Consensus 162 ~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~----------~~~~~~~~---- 221 (257)
T cd08225 162 CVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH------QLVLK----------ICQGYFAP---- 221 (257)
T ss_pred cCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHH----------HhcccCCC----
Confidence 11346899999999999999999998643211 01111 11111111
Q ss_pred CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 548 FYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 548 ~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.+......+.+++.+||+.+|++|||+.|++..
T Consensus 222 -~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 222 -ISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 111223458899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-28 Score=247.47 Aligned_cols=207 Identities=27% Similarity=0.422 Sum_probs=164.2
Q ss_pred ceEEEEEE--CCeEEEEEEcc------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSK 414 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~ 414 (615)
+.||++.. +++.+++|.++ ..+.+|++++++++|+|++++++++... ...++++||+++++|.+++.....
T Consensus 33 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~ 111 (286)
T cd06614 33 GEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVG-DELWVVMEYMDGGSLTDIITQNFV 111 (286)
T ss_pred eEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-CEEEEEEeccCCCcHHHHHHHhcc
Confidence 47999998 48999999885 3577899999999999999999998765 479999999999999999987541
Q ss_pred CCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC------------
Q 047629 415 SSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------------ 482 (615)
Q Consensus 415 ~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------------ 482 (615)
.+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 112 ---------~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 179 (286)
T cd06614 112 ---------RMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGT 179 (286)
T ss_pred ---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhccccCC
Confidence 3899999999999999999999987 9999999999999999999999999764321
Q ss_pred -----------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCCh
Q 047629 483 -----------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPI 551 (615)
Q Consensus 483 -----------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~ 551 (615)
...+.++|||||||++|||++|+.|+......... .. ...... +.+ ..+.
T Consensus 180 ~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~------~~----------~~~~~~-~~~--~~~~ 240 (286)
T cd06614 180 PYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL------FL----------ITTKGI-PPL--KNPE 240 (286)
T ss_pred cccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH------HH----------HHhcCC-CCC--cchh
Confidence 12456899999999999999999998643321100 00 000000 111 1111
Q ss_pred HHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 552 DGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 552 ~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.....+.+++.+|++.+|.+||++.|+++.
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 241 KWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred hCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 234568899999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-28 Score=247.77 Aligned_cols=205 Identities=23% Similarity=0.378 Sum_probs=162.8
Q ss_pred ceEEEEEE--CCeEEEEEEcc-------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
+.||++.. +++.+++|+++ +.+.+|+.++++++|+||+++++++... +..++++||+++++|.+++...
T Consensus 33 g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~- 110 (285)
T cd06648 33 GIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVG-DELWVVMEFLEGGALTDIVTHT- 110 (285)
T ss_pred eEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcC-CeEEEEEeccCCCCHHHHHHhC-
Confidence 58999986 67899999874 2467899999999999999999988754 4789999999999999998762
Q ss_pred CCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----------
Q 047629 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----------- 482 (615)
Q Consensus 414 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----------- 482 (615)
.+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+|++|||++....
T Consensus 111 ----------~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 177 (285)
T cd06648 111 ----------RMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVG 177 (285)
T ss_pred ----------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccccC
Confidence 2889999999999999999999998 9999999999999999999999999864321
Q ss_pred ------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 483 ------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 483 ------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
..++.++|||||||++|||++|+.|+..... .... . .+.....+.+.. +
T Consensus 178 ~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~---~~~~---~-----------~~~~~~~~~~~~--~ 238 (285)
T cd06648 178 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP---LQAM---K-----------RIRDNLPPKLKN--L 238 (285)
T ss_pred CccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH---HHHH---H-----------HHHhcCCCCCcc--c
Confidence 1245689999999999999999999864321 1000 0 111111112111 1
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 551 IDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
......+.+++.+||+.+|++||++.|+++.
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 239 HKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred ccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 1233568999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-28 Score=243.65 Aligned_cols=211 Identities=26% Similarity=0.350 Sum_probs=164.3
Q ss_pred ceEEEEEE--CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATI--DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
+.||+|.. +++.+|+|++. ..+.+|+++++.++|+|++++.+.+... ...++|+||+++++|.+++...
T Consensus 15 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~iv~e~~~~~~l~~~~~~~ 93 (267)
T cd06610 15 AVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG-DELWLVMPYLSGGSLLDIMKSS 93 (267)
T ss_pred eEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC-CEEEEEEeccCCCcHHHHHHHh
Confidence 48999987 67899999874 3477899999999999999999988754 4789999999999999999764
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC----------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT---------- 482 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~---------- 482 (615)
... ..+++.....++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++....
T Consensus 94 ~~~-------~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~ 163 (267)
T cd06610 94 YPR-------GGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVR 163 (267)
T ss_pred ccc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccccccc
Confidence 321 13899999999999999999999998 9999999999999999999999999863221
Q ss_pred -----------------C-CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCc
Q 047629 483 -----------------N-DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPN 544 (615)
Q Consensus 483 -----------------~-~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~ 544 (615)
. ..+.++|||||||++|||++|+.|+........ +.... ....+.
T Consensus 164 ~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~------~~~~~-----------~~~~~~ 226 (267)
T cd06610 164 KTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV------LMLTL-----------QNDPPS 226 (267)
T ss_pred ccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh------HHHHh-----------cCCCCC
Confidence 0 234579999999999999999999875432111 11100 001112
Q ss_pred CCCCCC-hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 545 LESFYP-IDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 545 l~~~~~-~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
+..... ......+.+++..||+.||++||++.|+++.
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 227 LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred cCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 211111 1334567899999999999999999999863
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-28 Score=247.73 Aligned_cols=203 Identities=26% Similarity=0.325 Sum_probs=161.7
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
+.||++.. +++.+|+|.++. .+.+|++++++++|+||+++++++.+. ...++||||+++|+|.+++.
T Consensus 15 ~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~ 93 (290)
T cd05580 15 GRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDD-SNLYLVMEYVPGGELFSHLR 93 (290)
T ss_pred eEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcC-CeEEEEEecCCCCCHHHHHH
Confidence 48999987 689999998852 356799999999999999999998754 47899999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC-------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------- 483 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------- 483 (615)
... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 94 ~~~----------~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 160 (290)
T cd05580 94 KSG----------RFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCG 160 (290)
T ss_pred HcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCCCCCCCC
Confidence 653 3889999999999999999999988 99999999999999999999999999865321
Q ss_pred -------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 484 -------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 484 -------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
..+.++||||||+++|||++|+.|+..... ..... ...... ..++
T Consensus 161 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~-----------------~~~~~~--~~~~ 218 (290)
T cd05580 161 TPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP---IQIYE-----------------KILEGK--VRFP 218 (290)
T ss_pred CccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH---HHHHH-----------------HHhcCC--ccCC
Confidence 134579999999999999999999865431 10000 000111 1122
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 047629 551 IDGALSLATLARACTMDKSLSRP-----NMAEVVFN 581 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RP-----sm~ev~~~ 581 (615)
......+.+++.+||..||.+|| +++|+++.
T Consensus 219 ~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 219 SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 23345678999999999999999 66777653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=250.18 Aligned_cols=221 Identities=27% Similarity=0.406 Sum_probs=164.0
Q ss_pred ceEEEEEE--CCeEEEEEEccH---------HHHHHHHHHHhcCCCCcccEEEEEEcC-CCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE---------DVTEELRILQRINHANLVKLMGVSSDS-QGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~---------~~~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~~lV~E~~~~GsL~~~L~ 410 (615)
+.||+|.. +|+.+|+|+++. ++.+|++++++++|+|++++++++.+. .+..++|+||+++ +|.+++.
T Consensus 13 ~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~ 91 (287)
T cd07840 13 GQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLD 91 (287)
T ss_pred eEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccc-cHHHHHh
Confidence 58999998 579999999863 367899999999999999999998765 2579999999974 8999887
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC-------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------- 483 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------- 483 (615)
.... .+++.++..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++.....
T Consensus 92 ~~~~---------~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (287)
T cd07840 92 SPEV---------KFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT 159 (287)
T ss_pred ccCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCccccc
Confidence 6432 3899999999999999999999998 99999999999999999999999998753311
Q ss_pred ------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhh-----
Q 047629 484 ------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNW----- 540 (615)
Q Consensus 484 ------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~----- 540 (615)
..+.++||||||+++|||++|+.|+........ ...+........ ......+
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~---~~~~~~~~~~~~--~~~~~~~~~~~~ 234 (287)
T cd07840 160 NRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ---LEKIFELCGSPT--DENWPGVSKLPW 234 (287)
T ss_pred ccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCc--hhhccccccchh
Confidence 135689999999999999999999875442111 111111100000 0000000
Q ss_pred ---------cCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 541 ---------MDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 541 ---------~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
....+...+...+...+.+++..||+.+|.+||++.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000011111125568999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=246.02 Aligned_cols=205 Identities=23% Similarity=0.315 Sum_probs=161.5
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
+.||++.. +|+.+|+|.+.. .+.+|++++++++|+||+++++.+.. +...++++||+++|+|.+++.
T Consensus 7 ~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~ 85 (265)
T cd05579 7 GRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG-KKNLYLVMEYLPGGDLASLLE 85 (265)
T ss_pred eEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec-CcEEEEEEecCCCCcHHHHHH
Confidence 47999998 489999998752 36679999999999999999998764 447899999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC-------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------- 483 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------- 483 (615)
... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 86 ~~~----------~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 152 (265)
T cd05579 86 NVG----------SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN 152 (265)
T ss_pred HcC----------CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence 643 2899999999999999999999998 99999999999999999999999998753211
Q ss_pred ------------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhh
Q 047629 484 ------------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRN 539 (615)
Q Consensus 484 ------------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 539 (615)
..+.++||||||+++|||++|+.|+......+. .. .+
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~------~~-----------~~-- 213 (265)
T cd05579 153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI------FQ-----------NI-- 213 (265)
T ss_pred cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH------HH-----------HH--
Confidence 124579999999999999999999865432110 00 00
Q ss_pred hcCCcCCCCCChH--HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047629 540 WMDPNLESFYPID--GALSLATLARACTMDKSLSRPNMAEVVFNLS 583 (615)
Q Consensus 540 ~~dp~l~~~~~~~--~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~ 583 (615)
..... ..+.. ....+.+++..||+.+|.+||++.++.+.|+
T Consensus 214 -~~~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 214 -LNGKI--EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred -hcCCc--CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 00000 11111 1456799999999999999999966665554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-28 Score=247.47 Aligned_cols=227 Identities=21% Similarity=0.331 Sum_probs=161.2
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhc-CCCCcccEEEEEEcCCC----cEEEEEeecCCCCHH
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRI-NHANLVKLMGVSSDSQG----NRFLVYEYAENGSLD 406 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~----~~~lV~E~~~~GsL~ 406 (615)
|.||+|.. +|+.||+|.++ ..+.+|+.+++++ +|+||+++++++...+. ..++||||+++ +|.
T Consensus 15 g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~ 93 (295)
T cd07837 15 GKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLK 93 (295)
T ss_pred eEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHH
Confidence 58999997 68999999875 2467899999999 56999999998765432 27999999985 899
Q ss_pred HhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCC-CCcEEEeecCCCCCCC---
Q 047629 407 KWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDS-RFKAKIANFSLAAPAT--- 482 (615)
Q Consensus 407 ~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~-~~~~kl~DFGla~~~~--- 482 (615)
+++....... ...+++..+..++.||+.||.|||+++ ++||||||+||+++. ++.+||+|||+++...
T Consensus 94 ~~~~~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~ 165 (295)
T cd07837 94 KFMDSNGRGP-----GRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPV 165 (295)
T ss_pred HHHHHhcccC-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecccceecCCCc
Confidence 9886543210 114899999999999999999999998 999999999999999 8999999999875321
Q ss_pred ---------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHH-HHH---HHHH
Q 047629 483 ---------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVE-EKR---EERL 537 (615)
Q Consensus 483 ---------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~-~~~---~~~~ 537 (615)
...+.++||||||+++|||++|+.|+....... .+.+.+ ..+... ... ....
T Consensus 166 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~ 242 (295)
T cd07837 166 KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ--QLLHIF-KLLGTPTEQVWPGVSKL 242 (295)
T ss_pred cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHH-HHhCCCChhhCcchhhc
Confidence 123568999999999999999999987543211 111111 100000 000 0000
Q ss_pred hhhcC-CcCC----CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 538 RNWMD-PNLE----SFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 538 ~~~~d-p~l~----~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
..... +... ..........+.+++.+|++.||.+||++.|++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 243 RDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred cchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000 0000 00011234567899999999999999999998863
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-28 Score=254.41 Aligned_cols=209 Identities=17% Similarity=0.199 Sum_probs=156.9
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||++.. +++.||+|.+++ .+.+|+.++..++|+||+++.+++.+. +..++||||+++|+|.+++.
T Consensus 15 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~-~~~~lv~Ey~~gg~L~~~l~ 93 (331)
T cd05624 15 GEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDE-NYLYLVMDYYVGGDLLTLLS 93 (331)
T ss_pred eEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-CEEEEEEeCCCCCcHHHHHH
Confidence 48999987 678999998853 256789999999999999999988754 47999999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 94 ~~~~---------~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 161 (331)
T cd05624 94 KFED---------RLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSS 161 (331)
T ss_pred HhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCceeec
Confidence 6432 3889999999999999999999998 9999999999999999999999999874321
Q ss_pred ---------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhc
Q 047629 483 ---------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWM 541 (615)
Q Consensus 483 ---------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 541 (615)
..++.++|||||||++|||++|+.||......+ . ..... ....
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~---~---~~~i~----------~~~~ 225 (331)
T cd05624 162 VAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE---T---YGKIM----------NHEE 225 (331)
T ss_pred cccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH---H---HHHHH----------cCCC
Confidence 123457899999999999999999997543110 0 00000 0000
Q ss_pred CCcCCCCCChHHHHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 047629 542 DPNLESFYPIDGALSLATLARACTMDKSLS--RPNMAEVVFN 581 (615)
Q Consensus 542 dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~--RPsm~ev~~~ 581 (615)
...+... ..+....+.+++.+|+..++.+ |+++++++.+
T Consensus 226 ~~~~p~~-~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 226 RFQFPSH-ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred cccCCCc-cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0001110 1123345778888888765544 5688888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-28 Score=254.27 Aligned_cols=226 Identities=15% Similarity=0.253 Sum_probs=165.3
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
+.||++.. +|+.||+|.++ +.+.+|+.+++.++|+||+++++++... +..++|+||+++|+|.+++..
T Consensus 14 ~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~~v~e~~~~~~l~~~l~~ 92 (328)
T cd08226 14 TSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTG-SWLWVISPFMAYGSANSLLKT 92 (328)
T ss_pred eeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecC-CceEEEEecccCCCHHHHHHh
Confidence 37999987 78999999875 2367899999999999999999998764 478999999999999999976
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCC----------
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA---------- 481 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~---------- 481 (615)
.... .+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+|++|||.+...
T Consensus 93 ~~~~--------~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 93 YFPE--------GMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred hccc--------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 4321 3889999999999999999999987 999999999999999999999999642100
Q ss_pred --------------------C--CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHH---------HHhH-
Q 047629 482 --------------------T--NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIRE---------VLKV- 529 (615)
Q Consensus 482 --------------------~--~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~---------~~~~- 529 (615)
. ..++.++|||||||++|||++|+.|+......... ...... ....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML--LQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH--HHHhcCCCCCCccccccchh
Confidence 0 11356889999999999999999998754322111 100000 0000
Q ss_pred HHHH---HHHH--------------hhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047629 530 EEKR---EERL--------------RNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNL 582 (615)
Q Consensus 530 ~~~~---~~~~--------------~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L 582 (615)
.... .... ....+..+....+......+.+|+++||+.||++|||+.|+++.-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~ 309 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA 309 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence 0000 0000 011111122222334556789999999999999999999998753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-28 Score=278.29 Aligned_cols=211 Identities=21% Similarity=0.319 Sum_probs=160.5
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCC-CcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQ-GNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~~lV~E~~~~GsL~~~L~ 410 (615)
+.||++.. .++.+|+|.+. ..+..|+.+|.+++|||||++++++.+.. ..+||||||+++|+|.++|.
T Consensus 27 GtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~ 106 (1021)
T PTZ00266 27 GEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQ 106 (1021)
T ss_pred eEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHH
Confidence 48999987 67889999875 24778999999999999999999876433 35899999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCC----CCeEecCCCCCceeeCC-----------------CCc
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQ----PSIVHRDIRTNNIQLDS-----------------RFK 469 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~ivHrDlk~~NILld~-----------------~~~ 469 (615)
...... ..+++..++.|+.||+.||.|||+.+. .+|+||||||+||||+. ...
T Consensus 107 k~~~~~------g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~i 180 (1021)
T PTZ00266 107 KCYKMF------GKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180 (1021)
T ss_pred HHhhcc------CCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCc
Confidence 532110 138999999999999999999998542 34999999999999964 245
Q ss_pred EEEeecCCCCCCC------------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHH
Q 047629 470 AKIANFSLAAPAT------------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIRE 525 (615)
Q Consensus 470 ~kl~DFGla~~~~------------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~ 525 (615)
+||+|||+++... ..++.++|||||||+||||++|+.||....... .+. .
T Consensus 181 VKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~--qli----~ 254 (1021)
T PTZ00266 181 AKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFS--QLI----S 254 (1021)
T ss_pred eEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHH--HHH----H
Confidence 8999999986431 114568999999999999999999997543211 000 0
Q ss_pred HHhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047629 526 VLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVF 580 (615)
Q Consensus 526 ~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~ 580 (615)
. +.. .|.+. .......+.+|+..||+.+|.+||++.|++.
T Consensus 255 ~----------lk~--~p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 255 E----------LKR--GPDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred H----------Hhc--CCCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 0 111 01111 0112345889999999999999999999985
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-27 Score=240.16 Aligned_cols=207 Identities=27% Similarity=0.388 Sum_probs=166.1
Q ss_pred ceEEEEEE--CCeEEEEEEccH---------HHHHHHHHHHhcCCCCcccEEEEEEcCC-CcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE---------DVTEELRILQRINHANLVKLMGVSSDSQ-GNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~---------~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~~lV~E~~~~GsL~~~L~ 410 (615)
+.||+|.. +|+.+++|.++. .+.+|++++++++|+||+++++.+.+.. ...++++||+++++|.+++.
T Consensus 14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 93 (260)
T cd06606 14 GSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLK 93 (260)
T ss_pred eEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHH
Confidence 58999998 489999998752 3678999999999999999999987541 46899999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC-------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------- 483 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------- 483 (615)
... .++|.++..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||.+.....
T Consensus 94 ~~~----------~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (260)
T cd06606 94 KFG----------KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT 160 (260)
T ss_pred HcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccccccccc
Confidence 654 2899999999999999999999987 99999999999999999999999998754321
Q ss_pred ------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcC
Q 047629 484 ------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNL 545 (615)
Q Consensus 484 ------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l 545 (615)
..+.++||||||++++||++|+.|+....+.. .. +........
T Consensus 161 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~------------------~~~~~~~~~ 221 (260)
T cd06606 161 GSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM-AA------------------LYKIGSSGE 221 (260)
T ss_pred cCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-HH------------------HHhccccCC
Confidence 13568999999999999999999987654111 00 001111111
Q ss_pred CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 546 ESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 546 ~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
....+......+.+++.+|++.||.+||++.|++..
T Consensus 222 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 222 PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 122333445678999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-27 Score=238.72 Aligned_cols=207 Identities=29% Similarity=0.469 Sum_probs=164.0
Q ss_pred ceEEEEEE--CCeEEEEEEcc-------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
+.||++.. +|+.+++|++. ..+.+|++.+++++|+|++++++++... ...++++||+++++|.+++....
T Consensus 14 ~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~l~~e~~~~~~L~~~~~~~~ 92 (253)
T cd05122 14 GEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKK-DELWIVMEFCSGGSLKDLLKSTN 92 (253)
T ss_pred eEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEEEEEecCCCCcHHHHHhhcC
Confidence 58999998 58999999875 2477899999999999999999988754 47899999999999999997653
Q ss_pred CCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCCC---------
Q 047629 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATND--------- 484 (615)
Q Consensus 414 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~--------- 484 (615)
. .+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.+||+|||.+......
T Consensus 93 ~---------~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 160 (253)
T cd05122 93 Q---------TLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGT 160 (253)
T ss_pred C---------CCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeeccccccccccccccceecC
Confidence 2 3899999999999999999999987 999999999999999999999999988554221
Q ss_pred -------------CCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCCh
Q 047629 485 -------------VMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPI 551 (615)
Q Consensus 485 -------------~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~ 551 (615)
.+.++||||||++++||++|+.|+.......... ......-+.+.. +.
T Consensus 161 ~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-----------------~~~~~~~~~~~~--~~ 221 (253)
T cd05122 161 PYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF-----------------KIATNGPPGLRN--PE 221 (253)
T ss_pred CcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH-----------------HHHhcCCCCcCc--cc
Confidence 3568999999999999999999987543211100 000000011111 11
Q ss_pred HHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 552 DGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 552 ~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.....+.+++.+||+.||++|||+.|+++.
T Consensus 222 ~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 222 KWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 113568999999999999999999999863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-28 Score=249.26 Aligned_cols=205 Identities=21% Similarity=0.348 Sum_probs=162.7
Q ss_pred ceEEEEEE--CCeEEEEEEcc-------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
+.||++.. +++.+|+|.+. +.+.+|+.++++++|+|++++++++... ...++|+||+++|+|.+++...
T Consensus 33 g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~- 110 (293)
T cd06647 33 GTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVG-DELWVVMEYLAGGSLTDVVTET- 110 (293)
T ss_pred eEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeC-CcEEEEEecCCCCcHHHHHhhc-
Confidence 58999986 68899999875 2467899999999999999999998754 4789999999999999999653
Q ss_pred CCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----------
Q 047629 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----------- 482 (615)
Q Consensus 414 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----------- 482 (615)
.+++.++..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++....
T Consensus 111 ----------~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~~~~ 177 (293)
T cd06647 111 ----------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG 177 (293)
T ss_pred ----------CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccccccccccC
Confidence 2789999999999999999999998 9999999999999999999999999864221
Q ss_pred ------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 483 ------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 483 ------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
...+.++||||||+++||+++|+.||.......... .. ...+......+
T Consensus 178 ~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~------~~-------------~~~~~~~~~~~ 238 (293)
T cd06647 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LI-------------ATNGTPELQNP 238 (293)
T ss_pred ChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee------eh-------------hcCCCCCCCCc
Confidence 124568999999999999999999997543211100 00 00111101112
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 551 IDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
......+.+++..||+.+|++||++.|++.+
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 239 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2234467899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-27 Score=247.97 Aligned_cols=220 Identities=25% Similarity=0.353 Sum_probs=161.5
Q ss_pred ceEEEEEE--CCeEEEEEEccH---------HHHHHHHHHHhcCCCCcccEEEEEEcCC---------CcEEEEEeecCC
Q 047629 343 KSVYRATI--DGKVLAVKKIKE---------DVTEELRILQRINHANLVKLMGVSSDSQ---------GNRFLVYEYAEN 402 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~---------~~~~Ei~~l~~l~H~niv~l~g~~~~~~---------~~~~lV~E~~~~ 402 (615)
+.||+|.. +|+.||+|+++. .+.+|++++++++|+|++++++++.+.+ +..++|+||+++
T Consensus 21 g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~ 100 (302)
T cd07864 21 GQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH 100 (302)
T ss_pred EEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc
Confidence 58999998 689999999852 3567999999999999999999876432 258999999986
Q ss_pred CCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC
Q 047629 403 GSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT 482 (615)
Q Consensus 403 GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~ 482 (615)
+|.+++..... .+++.++..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++....
T Consensus 101 -~l~~~l~~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 167 (302)
T cd07864 101 -DLMGLLESGLV---------HFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYN 167 (302)
T ss_pred -cHHHHHhcCCC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCccccccccc
Confidence 77777765422 3899999999999999999999998 9999999999999999999999999876421
Q ss_pred -------------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHH
Q 047629 483 -------------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERL 537 (615)
Q Consensus 483 -------------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 537 (615)
...+.++|||||||++|||++|+.|+......+... .+........ ....
T Consensus 168 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~---~~~~~~~~~~--~~~~ 242 (302)
T cd07864 168 SEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLE---LISRLCGSPC--PAVW 242 (302)
T ss_pred CCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHhCCCC--hhhc
Confidence 113567999999999999999999987543211111 1111100000 0000
Q ss_pred hhh--------cCC------cCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 538 RNW--------MDP------NLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 538 ~~~--------~dp------~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
..+ .++ .+...+ ...+..+.+++..||+.||.+||++.|++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 243 PDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred ccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 000 000001 1124568999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-28 Score=246.46 Aligned_cols=206 Identities=20% Similarity=0.250 Sum_probs=157.8
Q ss_pred ceEEEEEE--CCeEEEEEEccHH----------HHHHHHHHHh---cCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATI--DGKVLAVKKIKED----------VTEELRILQR---INHANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~~----------~~~Ei~~l~~---l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~ 407 (615)
|.||++.. +|+.+|+|.+... +.+|..++.. .+|+|++.+.+++... +..++||||+++|+|.+
T Consensus 8 g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~ 86 (279)
T cd05633 8 GEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP-DKLCFILDLMNGGDLHY 86 (279)
T ss_pred eEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC-CeEEEEEecCCCCCHHH
Confidence 48999887 6899999987421 2344443333 4799999999988754 47899999999999999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----- 482 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----- 482 (615)
++.... .++|.++..++.|++.||+|||+++ ++||||||+|||+++++.+|++|||++....
T Consensus 87 ~i~~~~----------~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 153 (279)
T cd05633 87 HLSQHG----------VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 153 (279)
T ss_pred HHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccCcc
Confidence 987543 3899999999999999999999998 9999999999999999999999999875321
Q ss_pred -----------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcC
Q 047629 483 -----------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNL 545 (615)
Q Consensus 483 -----------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l 545 (615)
...+.++|||||||++|||++|+.||.......... +.. .....++.
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----~~~-----------~~~~~~~~- 217 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDR-----------MTLTVNVE- 217 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH----HHH-----------HhhcCCcC-
Confidence 124568999999999999999999997543222111 000 00011222
Q ss_pred CCCCChHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 047629 546 ESFYPIDGALSLATLARACTMDKSLSRP-----NMAEVVFN 581 (615)
Q Consensus 546 ~~~~~~~~~~~l~~l~~~C~~~dP~~RP-----sm~ev~~~ 581 (615)
.+......+.+++..|++.||.+|| +++|++++
T Consensus 218 ---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 218 ---LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ---CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 2333445678999999999999999 59988876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-27 Score=248.53 Aligned_cols=212 Identities=25% Similarity=0.368 Sum_probs=164.6
Q ss_pred ceEEEEEE--CCeEEEEEEcc----------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIK----------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~----------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
+.||+|.. +++.+|+|.+. .++.+|++++++++|+|++++.+++... ...++|+||+. |+|.+++.
T Consensus 29 g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~-~~l~~~~~ 106 (308)
T cd06634 29 GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-HTAWLVMEYCL-GSASDLLE 106 (308)
T ss_pred EEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC-CeeEEEEEccC-CCHHHHHH
Confidence 58999987 67899999874 2356899999999999999999998764 47899999996 68888875
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
.... .+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 107 ~~~~---------~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 174 (308)
T cd06634 107 VHKK---------PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGT 174 (308)
T ss_pred HcCC---------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCcccccCC
Confidence 4332 3889999999999999999999987 9999999999999999999999999875321
Q ss_pred --------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCC
Q 047629 483 --------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESF 548 (615)
Q Consensus 483 --------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~ 548 (615)
...+.++|||||||++|||++|+.|+......+.. . .+.....+...
T Consensus 175 ~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~-----------~~~~~~~~~~~-- 235 (308)
T cd06634 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------Y-----------HIAQNESPALQ-- 235 (308)
T ss_pred ccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH------H-----------HHhhcCCCCcC--
Confidence 12456899999999999999999998643211100 0 00000111111
Q ss_pred CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 549 YPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 549 ~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
.......+.+++.+||+.+|++||++.++++........
T Consensus 236 -~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~ 274 (308)
T cd06634 236 -SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274 (308)
T ss_pred -cccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccC
Confidence 123345578999999999999999999999876544443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-28 Score=248.21 Aligned_cols=210 Identities=22% Similarity=0.372 Sum_probs=159.0
Q ss_pred ceEEEEEE--CCeEEEEEEccH--------HHHHHHHHHHhcC-CCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh--
Q 047629 343 KSVYRATI--DGKVLAVKKIKE--------DVTEELRILQRIN-HANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL-- 409 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~--------~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L-- 409 (615)
|.||++.. +|+.+|+|.+.. .+.+|+.++.++. |+||+++++++.. ++..+++|||++. +|.++.
T Consensus 18 g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-~~~~~~~~e~~~~-~l~~l~~~ 95 (288)
T cd06616 18 GTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-EGDCWICMELMDI-SLDKFYKY 95 (288)
T ss_pred eEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec-CCcEEEEEecccC-CHHHHHHH
Confidence 58999987 689999998852 4678999999996 9999999998875 4478999999864 554433
Q ss_pred -ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----
Q 047629 410 -HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEH-AQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----- 482 (615)
Q Consensus 410 -~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----- 482 (615)
..... ..+++..+..++.+++.||+|||+. + ++||||||+||+++.++.+||+|||+++...
T Consensus 96 ~~~~~~--------~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 164 (288)
T cd06616 96 VYEVLK--------SVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK 164 (288)
T ss_pred HHHhhc--------CCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhccCCcc
Confidence 22111 1389999999999999999999975 5 9999999999999999999999999874321
Q ss_pred --------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcC
Q 047629 483 --------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMD 542 (615)
Q Consensus 483 --------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~d 542 (615)
..++.++|||||||++|||++|+.||..... ....+. .......
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~-----------~~~~~~~ 228 (288)
T cd06616 165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLT-----------QVVKGDP 228 (288)
T ss_pred ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHh-----------hhcCCCC
Confidence 1246689999999999999999999864321 011000 0111112
Q ss_pred CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 543 PNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 543 p~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
|.+....+......+.+|+.+||+.||++||++.||+..
T Consensus 229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 229 PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 233322223345578999999999999999999999886
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=260.57 Aligned_cols=206 Identities=24% Similarity=0.362 Sum_probs=166.8
Q ss_pred cccccccccc----ceEEEEEE--CCeEEEEEEccHH----------HHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEE
Q 047629 333 MNLSEHYSIG----KSVYRATI--DGKVLAVKKIKED----------VTEELRILQRI-NHANLVKLMGVSSDSQGNRFL 395 (615)
Q Consensus 333 ~~~~~~~~iG----~~Vy~~~~--~g~~vAvK~~~~~----------~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~l 395 (615)
.+|.-...+| |.|+.+.+ +++.+|||.++++ ...|..|+... +||.|+.|+..+.. +.++|+
T Consensus 368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT-~~~l~f 446 (694)
T KOG0694|consen 368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT-KEHLFF 446 (694)
T ss_pred cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc-CCeEEE
Confidence 4455555555 58999988 6789999999853 45688888777 59999999987764 458999
Q ss_pred EEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeec
Q 047629 396 VYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANF 475 (615)
Q Consensus 396 V~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DF 475 (615)
||||+.+|++..+.+.. .++.....-++..|+.||.|||+++ ||+||||.+|||||.+|.+||+||
T Consensus 447 vmey~~Ggdm~~~~~~~-----------~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADF 512 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIHTD-----------VFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADF 512 (694)
T ss_pred EEEecCCCcEEEEEecc-----------cccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccc
Confidence 99999999976666543 2899999999999999999999998 999999999999999999999999
Q ss_pred CCCCCCC-----------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHH
Q 047629 476 SLAAPAT-----------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEK 532 (615)
Q Consensus 476 Gla~~~~-----------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 532 (615)
||++... ..|+..+|.|||||+||||+.|..||...++.+. .+
T Consensus 513 GlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~---Fd----------- 578 (694)
T KOG0694|consen 513 GLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV---FD----------- 578 (694)
T ss_pred ccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH---HH-----------
Confidence 9997542 2367789999999999999999999986553221 11
Q ss_pred HHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCH
Q 047629 533 REERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNM 575 (615)
Q Consensus 533 ~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm 575 (615)
.++.- .-.||.-...+.+.++++.+..+|++|--+
T Consensus 579 ------sI~~d--~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 579 ------SIVND--EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ------HHhcC--CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 11110 124777777888999999999999999987
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-28 Score=251.30 Aligned_cols=230 Identities=24% Similarity=0.329 Sum_probs=162.4
Q ss_pred ceEEEEEE----CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCC-CcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATI----DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQ-GNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~----~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~~lV~E~~~~GsL~~ 407 (615)
+.||+|.. +|+.||+|.+.. .+.+|+.++.+++||||+++++++.+.+ ...++||||+++ +|.+
T Consensus 14 g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~ 92 (316)
T cd07842 14 GRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQ 92 (316)
T ss_pred EEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCCc-CHHH
Confidence 58999997 478999998864 4578999999999999999999987652 368999999975 7777
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCC----CCcEEEeecCCCCCCC-
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDS----RFKAKIANFSLAAPAT- 482 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~----~~~~kl~DFGla~~~~- 482 (615)
++........ ..+++..+..++.|++.||+|||+.+ ++||||||+||+++. ++.+||+|||+++...
T Consensus 93 ~~~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~ 164 (316)
T cd07842 93 IIKFHRQAKR-----VSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNA 164 (316)
T ss_pred HHHhhccCCC-----cCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCccccccCC
Confidence 7654322110 14889999999999999999999998 999999999999999 8999999999876431
Q ss_pred --------------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChh------HHHHHHHHHHHhHH
Q 047629 483 --------------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKT------AVLWKEIREVLKVE 530 (615)
Q Consensus 483 --------------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~------~~l~~~~~~~~~~~ 530 (615)
...+.++||||||++++||++|+.|+........ ......+...+...
T Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 244 (316)
T cd07842 165 PLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTP 244 (316)
T ss_pred CcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCC
Confidence 1134579999999999999999999875443220 00001111111000
Q ss_pred HH-HH---HHH---hhhcCCcCCCCCC---------h--HHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 531 EK-RE---ERL---RNWMDPNLESFYP---------I--DGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 531 ~~-~~---~~~---~~~~dp~l~~~~~---------~--~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.. .. ..+ ....+......++ . .....+.+++.+|++.||++|||+.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 245 TEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred chhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00 00 000 0000000001111 0 233468899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=259.26 Aligned_cols=206 Identities=25% Similarity=0.391 Sum_probs=167.8
Q ss_pred ceEEEEEE--CCeEEEEEEcc----------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIK----------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~----------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||.+.. +.+.||||+|. .++..|+..|.+++|||+|.+.|++.. +...|||||||- ||-.+.|.
T Consensus 40 GAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr-e~TaWLVMEYCl-GSAsDlle 117 (948)
T KOG0577|consen 40 GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR-EHTAWLVMEYCL-GSASDLLE 117 (948)
T ss_pred ceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec-cchHHHHHHHHh-ccHHHHHH
Confidence 57888876 77999999995 468899999999999999999999885 447899999995 68888887
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCC---------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA--------- 481 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~--------- 481 (615)
-..+ +|....+..|+.+.+.||+|||+++ .||||||+.||||.+.+.+||+|||.|...
T Consensus 118 VhkK---------plqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAnsFvGT 185 (948)
T KOG0577|consen 118 VHKK---------PLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPANSFVGT 185 (948)
T ss_pred HHhc---------cchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCchhcccCC
Confidence 6654 4899999999999999999999998 999999999999999999999999988543
Q ss_pred -------------CCCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCC
Q 047629 482 -------------TNDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESF 548 (615)
Q Consensus 482 -------------~~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~ 548 (615)
.+.++-|+||||+|+++.||..+|+|.....- +...+. +..--.|.|.
T Consensus 186 PywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA---------MSALYH--------IAQNesPtLq-- 246 (948)
T KOG0577|consen 186 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---------MSALYH--------IAQNESPTLQ-- 246 (948)
T ss_pred ccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH---------HHHHHH--------HHhcCCCCCC--
Confidence 23367799999999999999999999865431 111111 1111234443
Q ss_pred CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047629 549 YPIDGALSLATLARACTMDKSLSRPNMAEVVFNL 582 (615)
Q Consensus 549 ~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L 582 (615)
..+-...+..++..|++.-|.+|||..+++..-
T Consensus 247 -s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 247 -SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred -CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence 235556789999999999999999999888753
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=254.15 Aligned_cols=204 Identities=23% Similarity=0.383 Sum_probs=167.1
Q ss_pred eEEEEEE-CCeEEEEEEcc---------HHHHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 344 SVYRATI-DGKVLAVKKIK---------EDVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 344 ~Vy~~~~-~g~~vAvK~~~---------~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
.||++.. +.+.+|+|++. ..+.+|++.|.++ .|.+||+|++|-. .++.+|+||||=+ -+|.++|...
T Consensus 376 kV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv-~d~~lYmvmE~Gd-~DL~kiL~k~ 453 (677)
T KOG0596|consen 376 KVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEV-TDGYLYMVMECGD-IDLNKILKKK 453 (677)
T ss_pred eeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeec-cCceEEEEeeccc-ccHHHHHHhc
Confidence 7999988 66888998875 2478999999999 5999999999965 4678999999874 4999999876
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCCC--------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATND-------- 484 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~-------- 484 (615)
... ...| .+..+..|++.++.++|.++ |||.||||.|+|+-. |.+||.|||+|.....+
T Consensus 454 ~~~--------~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI~kds 520 (677)
T KOG0596|consen 454 KSI--------DPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTSIVKDS 520 (677)
T ss_pred cCC--------CchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCccccceeecc
Confidence 542 2446 77889999999999999998 999999999999854 68999999999654211
Q ss_pred ----------------------------CCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHH
Q 047629 485 ----------------------------VMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREER 536 (615)
Q Consensus 485 ----------------------------~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 536 (615)
+++++||||+||+||+|+.|+.||....+ .-.+
T Consensus 521 QvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-------------------~~aK 581 (677)
T KOG0596|consen 521 QVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-------------------QIAK 581 (677)
T ss_pred ccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-------------------HHHH
Confidence 34689999999999999999999864221 1246
Q ss_pred HhhhcCCcCCCCCChH-HHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 537 LRNWMDPNLESFYPID-GALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 537 ~~~~~dp~l~~~~~~~-~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
+..++||...-+||.- ...++.++++.|+.+||++||+..|+++.
T Consensus 582 l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 582 LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 7788999876666652 23348999999999999999999999985
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-28 Score=243.54 Aligned_cols=204 Identities=26% Similarity=0.332 Sum_probs=162.4
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
+.||++.. +|+.+|+|.+.. .+.+|++++++++||||+++++++.+. ...++|+||+++++|.+++.
T Consensus 14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~ 92 (258)
T cd05578 14 GKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDE-ENMYLVVDLLLGGDLRYHLS 92 (258)
T ss_pred ceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCC-CeEEEEEeCCCCCCHHHHHH
Confidence 48999987 489999998852 467899999999999999999987654 47999999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC-------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------- 483 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------- 483 (615)
... .+++.++..++.|++.||.|||+++ ++|+||||+||++++++.++|+|||++.....
T Consensus 93 ~~~----------~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 159 (258)
T cd05578 93 QKV----------KFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST 159 (258)
T ss_pred hcC----------CcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCcccccc
Confidence 652 3889999999999999999999998 99999999999999999999999998754311
Q ss_pred ---------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCC
Q 047629 484 ---------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESF 548 (615)
Q Consensus 484 ---------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~ 548 (615)
..+.++||||||+++|||++|+.|+......... ++... ... . ...
T Consensus 160 ~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~----------~~~-~----~~~ 220 (258)
T cd05578 160 SGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRD----QIRAK----------QET-A----DVL 220 (258)
T ss_pred CCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHH----HHHHH----------hcc-c----ccc
Confidence 1356899999999999999999998765432111 11100 000 1 112
Q ss_pred CChHHHHHHHHHHHHhhhcCCCCCCCH--HHHH
Q 047629 549 YPIDGALSLATLARACTMDKSLSRPNM--AEVV 579 (615)
Q Consensus 549 ~~~~~~~~l~~l~~~C~~~dP~~RPsm--~ev~ 579 (615)
.+......+.+++.+||+.||.+||++ +|++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 221 YPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred CcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 233344678899999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-28 Score=255.40 Aligned_cols=228 Identities=21% Similarity=0.366 Sum_probs=166.3
Q ss_pred ceEEEEEE--CCeEEEEEEccH---------HHHHHHHHHHhcCCCCcccEEEEEEcCC----CcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATI--DGKVLAVKKIKE---------DVTEELRILQRINHANLVKLMGVSSDSQ----GNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~---------~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~~lV~E~~~~GsL~~ 407 (615)
+.||++.. +|+.||||.++. .+.+|+.++++++|+||+++++++.... ...++|+||+. ++|.+
T Consensus 19 ~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~ 97 (337)
T cd07858 19 GIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQ 97 (337)
T ss_pred eEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHH
Confidence 48999986 689999998752 3567999999999999999999875432 24799999996 68999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----- 482 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----- 482 (615)
++.... .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++...
T Consensus 98 ~~~~~~----------~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 164 (337)
T cd07858 98 IIRSSQ----------TLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDF 164 (337)
T ss_pred HHhcCC----------CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccccCCCccc
Confidence 987543 3899999999999999999999998 9999999999999999999999999986431
Q ss_pred -------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhH---HHH---HHHHH
Q 047629 483 -------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKV---EEK---REERL 537 (615)
Q Consensus 483 -------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~---~~~~~ 537 (615)
...+.++|||||||++|||++|+.||...+..+.... +...... ... .....
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07858 165 MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKL---ITELLGSPSEEDLGFIRNEKA 241 (337)
T ss_pred ccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHH---HHHHhCCCChHHhhhcCchhh
Confidence 1245689999999999999999999865432111111 1111100 000 00001
Q ss_pred hhh-------cCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHhcccc
Q 047629 538 RNW-------MDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN--LSVLTQS 588 (615)
Q Consensus 538 ~~~-------~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~--L~~l~~~ 588 (615)
.+. .++..... ..+....+.+++++|++.+|++|||++|+++. +..+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~ 300 (337)
T cd07858 242 RRYIRSLPYTPRQSFARL-FPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300 (337)
T ss_pred hHHHHhcCcccccCHHHH-cccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence 111 11111111 11334567899999999999999999999987 5554433
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.8e-28 Score=241.67 Aligned_cols=208 Identities=25% Similarity=0.364 Sum_probs=164.2
Q ss_pred ceEEEEEE--CCeEEEEEEccH---------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE---------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~---------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
+.||++.. +|+.+|+|.+.. .+.+|++++++++|+||+++.+++.+. ...++|+||+++++|.+++..
T Consensus 14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~ 92 (256)
T cd08530 14 GSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG-NKLCIVMEYAPFGDLSKAISK 92 (256)
T ss_pred eeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC-CEEEEEehhcCCCCHHHHHHH
Confidence 47999876 688999998752 356799999999999999999988754 479999999999999999876
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC--------
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN-------- 483 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~-------- 483 (615)
..... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+|++|||++.....
T Consensus 93 ~~~~~------~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 163 (256)
T cd08530 93 RKKKR------KLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIG 163 (256)
T ss_pred HHhhc------CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCCcccccC
Confidence 32211 13899999999999999999999998 99999999999999999999999998864321
Q ss_pred -------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 484 -------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 484 -------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
..+.++|+||||+++|||++|+.|+...+..+ + .. .... ......+
T Consensus 164 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~----~~----------~~~~----~~~~~~~ 222 (256)
T cd08530 164 TPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD---L----RY----------KVQR----GKYPPIP 222 (256)
T ss_pred CccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H----HH----------HHhc----CCCCCCc
Confidence 13458999999999999999999986543211 0 00 0000 0111122
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 551 IDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
......+.+++.+|++.+|++||++.|+++.
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 223 PIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred hhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 3444568999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=247.04 Aligned_cols=222 Identities=21% Similarity=0.322 Sum_probs=159.5
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
+.||+|.. +|+.||+|.++ ..+.+|++++++++|+||+++++++.+. ...++||||++ ++|.+++..
T Consensus 16 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~-~~l~~~~~~ 93 (294)
T PLN00009 16 GVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE-KRLYLVFEYLD-LDLKKHMDS 93 (294)
T ss_pred EEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecC-CeEEEEEeccc-ccHHHHHHh
Confidence 48999987 68899999875 2467899999999999999999998754 47999999996 588888765
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCC-CCcEEEeecCCCCCCC--------
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDS-RFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~-~~~~kl~DFGla~~~~-------- 482 (615)
.... .+++.....++.|++.||+|||+++ ++||||||+||+++. ++.+||+|||++....
T Consensus 94 ~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~~ 162 (294)
T PLN00009 94 SPDF--------AKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH 162 (294)
T ss_pred CCCC--------CcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCcccccc
Confidence 4321 2678889999999999999999997 999999999999985 5679999999885321
Q ss_pred ----------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHH--HHH---------HH
Q 047629 483 ----------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVE--EKR---------EE 535 (615)
Q Consensus 483 ----------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~--~~~---------~~ 535 (615)
...+.++|||||||++|||++|+.|+......+. ... +...+... ... ..
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 239 (294)
T PLN00009 163 EVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE--LFK-IFRILGTPNEETWPGVTSLPDYKS 239 (294)
T ss_pred CceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHHHhCCCChhhccccccchhhhh
Confidence 1135689999999999999999999875432111 111 11100000 000 00
Q ss_pred HHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 536 RLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 536 ~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
....+....+. .........+.+++.+|++.+|++||++.++++.
T Consensus 240 ~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 240 AFPKWPPKDLA-TVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hcccCCCCCHH-HhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000000 0111223457899999999999999999999874
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=240.36 Aligned_cols=205 Identities=23% Similarity=0.319 Sum_probs=161.3
Q ss_pred ceEEEEEE--CCeEEEEEEcc------------HHHHHHHHHHHhcCCCCcccEEEEEEcCC-CcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATI--DGKVLAVKKIK------------EDVTEELRILQRINHANLVKLMGVSSDSQ-GNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~------------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~~lV~E~~~~GsL~~ 407 (615)
+.||++.. +|+.+|+|.+. ..+.+|++++++++|+||+++++++.+.+ +..++++||+++++|.+
T Consensus 16 g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~ 95 (264)
T cd06653 16 GEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKD 95 (264)
T ss_pred eEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHH
Confidence 48999986 68999999863 24678999999999999999999886543 34789999999999999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----- 482 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----- 482 (615)
++.... .+++....+++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||+++...
T Consensus 96 ~~~~~~----------~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 162 (264)
T cd06653 96 QLKAYG----------ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMS 162 (264)
T ss_pred HHHHcC----------CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccccccccccc
Confidence 987543 2789999999999999999999998 9999999999999999999999999885321
Q ss_pred ---------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhc
Q 047629 483 ---------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWM 541 (615)
Q Consensus 483 ---------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 541 (615)
...+.++|||||||++|||++|+.||....... .+ .+..
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~--------------~~~~ 222 (264)
T cd06653 163 GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA------AI--------------FKIA 222 (264)
T ss_pred CccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH------HH--------------HHHH
Confidence 113467899999999999999999986432110 00 0111
Q ss_pred CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 542 DPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 542 dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
........+......+.+++..|++ +|.+||+..+++.+
T Consensus 223 ~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 223 TQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred cCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 1111123344455668999999999 57999999988753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.5e-29 Score=262.06 Aligned_cols=207 Identities=24% Similarity=0.362 Sum_probs=167.4
Q ss_pred ceEEEEEE--CCeEEEEEEccH-------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATI--DGKVLAVKKIKE-------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~-------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
|.||-|.. +...+|||.+.+ -..+||.+.++++|+|||+++|.|.+ +|.+-+.||.+|+|||.+.|+...
T Consensus 589 G~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~se-nGf~kIFMEqVPGGSLSsLLrskW 667 (1226)
T KOG4279|consen 589 GTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSE-NGFFKIFMEQVPGGSLSSLLRSKW 667 (1226)
T ss_pred eEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCC-CCeEEEEeecCCCCcHHHHHHhcc
Confidence 47887776 345689998863 26789999999999999999998764 568889999999999999998765
Q ss_pred CCCCCCCccccc--CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCC-CCcEEEeecCCCCCCC--------
Q 047629 414 KSSSSSGSVIFL--TWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDS-RFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 414 ~~~~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~-~~~~kl~DFGla~~~~-------- 482 (615)
+. | .+..+-.+.+||+.||.|||++. |||||||-.|+|++. .|.+||+|||-++.+.
T Consensus 668 GP---------lKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TET 735 (1226)
T KOG4279|consen 668 GP---------LKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTET 735 (1226)
T ss_pred CC---------CccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCCccccc
Confidence 42 4 67778889999999999999998 999999999999975 6899999999886541
Q ss_pred -----------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcC
Q 047629 483 -----------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNL 545 (615)
Q Consensus 483 -----------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l 545 (615)
..+.+++|||||||++.||.|||+||....+....... + + . -..
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk-----V---G-------m----yKv 796 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK-----V---G-------M----YKV 796 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh-----h---c-------c----eec
Confidence 23567899999999999999999999866543222110 0 0 0 011
Q ss_pred CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 546 ESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 546 ~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
....|.+...+...++++|..+||.+||+++++++.
T Consensus 797 HP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 797 HPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred CCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 234577777888999999999999999999999885
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-28 Score=255.19 Aligned_cols=219 Identities=23% Similarity=0.353 Sum_probs=160.6
Q ss_pred ceEEEEEE--CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCC----CcEEEEEeecCCCCHHHh
Q 047629 343 KSVYRATI--DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQ----GNRFLVYEYAENGSLDKW 408 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~~lV~E~~~~GsL~~~ 408 (615)
+.||+|.. +|+.||||+++ ..+.+|+.++++++|+||+++++++.... ...++++||+++ +|.++
T Consensus 19 g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~ 97 (336)
T cd07849 19 GMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKL 97 (336)
T ss_pred eEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhccc-CHHHH
Confidence 48999986 68999999875 23667999999999999999999875432 247999999974 88888
Q ss_pred hccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC------
Q 047629 409 LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------ 482 (615)
Q Consensus 409 L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------ 482 (615)
+... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 98 ~~~~-----------~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 163 (336)
T cd07849 98 IKTQ-----------HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHT 163 (336)
T ss_pred HhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeecccccccc
Confidence 7543 2889999999999999999999998 9999999999999999999999999875321
Q ss_pred ---------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhc
Q 047629 483 ---------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWM 541 (615)
Q Consensus 483 ---------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 541 (615)
...+.++|||||||++|||++|+.|+...... ..+..+...+.... .+.+....
T Consensus 164 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~---~~~~~~~~~~~~~~--~~~~~~~~ 238 (336)
T cd07849 164 GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL---HQLNLILGVLGTPS--QEDLNCII 238 (336)
T ss_pred CCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCC--HHHHHHhh
Confidence 11345789999999999999999998654321 11111211111000 00011111
Q ss_pred CCc-------C--CCCCC-----hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 542 DPN-------L--ESFYP-----IDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 542 dp~-------l--~~~~~-----~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
+.. + ....+ ......+.+++.+||+.||++||++.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred chhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 0 00000 1123458899999999999999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.9e-28 Score=248.03 Aligned_cols=198 Identities=22% Similarity=0.386 Sum_probs=163.9
Q ss_pred EECCeEEEEEEccH---------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCCCCCC
Q 047629 349 TIDGKVLAVKKIKE---------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSS 419 (615)
Q Consensus 349 ~~~g~~vAvK~~~~---------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~~~~ 419 (615)
++.|+.||||++.+ .+.+|+.+|+-++|||||+|+.+. +....+|||+|.-.+|+|.+|+-.+..
T Consensus 40 VFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi-DTQTKlyLiLELGD~GDl~DyImKHe~----- 113 (864)
T KOG4717|consen 40 VFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI-DTQTKLYLILELGDGGDLFDYIMKHEE----- 113 (864)
T ss_pred hcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh-cccceEEEEEEecCCchHHHHHHhhhc-----
Confidence 35899999999863 467899999999999999999985 456689999999999999999987664
Q ss_pred CcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCC-CcEEEeecCCCCCCC----------------
Q 047629 420 GSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSR-FKAKIANFSLAAPAT---------------- 482 (615)
Q Consensus 420 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~-~~~kl~DFGla~~~~---------------- 482 (615)
.|.+....+++.||..++.|.|... +|||||||+|+.+-+. |-+||.|||++..+.
T Consensus 114 ----Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSA 186 (864)
T KOG4717|consen 114 ----GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSA 186 (864)
T ss_pred ----cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcchhhcccchhhccC
Confidence 3889999999999999999999987 9999999999987665 889999999984431
Q ss_pred ------CC-CCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHH
Q 047629 483 ------ND-VMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGAL 555 (615)
Q Consensus 483 ------~~-~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~ 555 (615)
+. -.+++||||+||+||.|++|+.||....+.+.+ -.+||= +-..|.....
T Consensus 187 PEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL--------------------TmImDC--KYtvPshvS~ 244 (864)
T KOG4717|consen 187 PEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL--------------------TMIMDC--KYTVPSHVSK 244 (864)
T ss_pred chhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh--------------------hhhhcc--cccCchhhhH
Confidence 11 236899999999999999999999876654432 223432 1234556666
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 556 SLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 556 ~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
+..+|+..++..||++|.+..||+..
T Consensus 245 eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 245 ECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred HHHHHHHHHHhcCchhhccHHHHhcc
Confidence 78999999999999999999999875
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.9e-28 Score=249.38 Aligned_cols=221 Identities=28% Similarity=0.350 Sum_probs=161.9
Q ss_pred ceEEEEEE--CCeEEEEEEccH---------HHHHHHHHHHhcCCCCcccEEEEEEcCC-CcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE---------DVTEELRILQRINHANLVKLMGVSSDSQ-GNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~---------~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~~lV~E~~~~GsL~~~L~ 410 (615)
+.||+|.. +|+.||+|.++. .+.+|+.++++++|+||+++++++.+.+ +..++||||++ ++|.+++.
T Consensus 21 ~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~ 99 (309)
T cd07845 21 GIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE-QDLASLLD 99 (309)
T ss_pred EEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC-CCHHHHHH
Confidence 58999987 689999998852 2457999999999999999999986543 35899999997 58988887
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
.... .+++.++..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++....
T Consensus 100 ~~~~---------~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~ 167 (309)
T cd07845 100 NMPT---------PFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTP 167 (309)
T ss_pred hccc---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCccCCCCc
Confidence 5432 3899999999999999999999998 9999999999999999999999999875421
Q ss_pred ----------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCC---
Q 047629 483 ----------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDP--- 543 (615)
Q Consensus 483 ----------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp--- 543 (615)
...+.++||||||+++|||++|+.|+......+. ...+........ ......+.+.
T Consensus 168 ~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~---~~~~~~~~~~~~--~~~~~~~~~~~~~ 242 (309)
T cd07845 168 KVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ---LDLIIQLLGTPN--ESIWPGFSDLPLV 242 (309)
T ss_pred ccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCC--hhhchhhhccccc
Confidence 1135689999999999999999999875442211 111111110000 0000000000
Q ss_pred ---cCCC-CCC------hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 544 ---NLES-FYP------IDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 544 ---~l~~-~~~------~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.+.. .+. ......+.+++..|++.||++|||+.|++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 243 GKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred ccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000 000 0123456899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=251.48 Aligned_cols=220 Identities=25% Similarity=0.372 Sum_probs=161.4
Q ss_pred ceEEEEEE--CCeEEEEEEccH---------HHHHHHHHHHhc-CCCCcccEEEEEEcCCC-cEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATI--DGKVLAVKKIKE---------DVTEELRILQRI-NHANLVKLMGVSSDSQG-NRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~---------~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~-~~~lV~E~~~~GsL~~~L 409 (615)
+.||+|.. +|+.+|+|++.. .+.+|+.++.++ +|+||+++++++...++ ..++||||++ ++|..++
T Consensus 21 ~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~ 99 (337)
T cd07852 21 GIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVI 99 (337)
T ss_pred eeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHH
Confidence 48999987 689999998742 356799999999 99999999998864433 4799999997 5999998
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------- 482 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------- 482 (615)
... .++|..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 100 ~~~-----------~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~ 165 (337)
T cd07852 100 RAN-----------ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPE 165 (337)
T ss_pred hcC-----------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcccccccccc
Confidence 653 2789999999999999999999987 9999999999999999999999999885321
Q ss_pred ----------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhH---H---HHHH
Q 047629 483 ----------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKV---E---EKRE 534 (615)
Q Consensus 483 ----------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~---~---~~~~ 534 (615)
...+.++||||||+++|||++|+.|+......+... .+...... . ....
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 242 (337)
T cd07852 166 NPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLE---KIIEVIGPPSAEDIESIKS 242 (337)
T ss_pred CcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHhCCCCHHHHHHHHh
Confidence 113457999999999999999999986543221111 01000000 0 0000
Q ss_pred HHHhhhcC----C---cCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 535 ERLRNWMD----P---NLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 535 ~~~~~~~d----p---~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.....+++ . .+.... .+....+.+++.+||+.||.+|||+.++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 243 PFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred hhHHHhhhhcccccccchhhhc-cCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00011111 0 011111 1234568999999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=247.28 Aligned_cols=226 Identities=23% Similarity=0.339 Sum_probs=159.4
Q ss_pred ceEEEEEE--CCeEEEEEEccH---------HHHHHHHHHHhcCCCCcccEEEEEEcCC-------CcEEEEEeecCCCC
Q 047629 343 KSVYRATI--DGKVLAVKKIKE---------DVTEELRILQRINHANLVKLMGVSSDSQ-------GNRFLVYEYAENGS 404 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~---------~~~~Ei~~l~~l~H~niv~l~g~~~~~~-------~~~~lV~E~~~~Gs 404 (615)
+.||++.. +|+.||||.+.. .+.+|++++++++|+||++++++|...+ ...++||||++ ++
T Consensus 26 ~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~ 104 (310)
T cd07865 26 GEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HD 104 (310)
T ss_pred EEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCC-cC
Confidence 48999987 689999998742 3467999999999999999999986432 23599999997 48
Q ss_pred HHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--
Q 047629 405 LDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-- 482 (615)
Q Consensus 405 L~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-- 482 (615)
|.+++..... .+++.++..++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||++....
T Consensus 105 l~~~l~~~~~---------~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 172 (310)
T cd07865 105 LAGLLSNKNV---------KFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLS 172 (310)
T ss_pred HHHHHHhccc---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCcccccCC
Confidence 8888865432 3899999999999999999999998 9999999999999999999999999885321
Q ss_pred --------------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHH---
Q 047629 483 --------------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKR--- 533 (615)
Q Consensus 483 --------------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~--- 533 (615)
...++++||||||+++|||++|+.|+..............+......+...
T Consensus 173 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (310)
T cd07865 173 KNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVD 252 (310)
T ss_pred cccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccc
Confidence 013467999999999999999999987544322211111111000000000
Q ss_pred -HHHHhhhcCCc-----CCCCC-ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 534 -EERLRNWMDPN-----LESFY-PIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 534 -~~~~~~~~dp~-----l~~~~-~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.........+. ..... +......+.+++..||+.||.+|||++|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 253 KLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred chhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00000000000 00000 00112346799999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-28 Score=246.21 Aligned_cols=223 Identities=22% Similarity=0.350 Sum_probs=163.6
Q ss_pred ceEEEEEE--CCeEEEEEEccHH--------HHHHHHHHHhcC-CCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIKED--------VTEELRILQRIN-HANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~~--------~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
+.||+|.. +++.||||++... ..+|+..+.+++ |+|++++++++.+ ++..++||||+ +|+|.+++..
T Consensus 13 g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-~~~~~lv~e~~-~~~l~~~~~~ 90 (283)
T cd07830 13 GSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE-NDELYFVFEYM-EGNLYQLMKD 90 (283)
T ss_pred eEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc-CCcEEEEEecC-CCCHHHHHHh
Confidence 58999998 5789999998642 346899999998 9999999999876 45799999999 8899999876
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC--------
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN-------- 483 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~-------- 483 (615)
.... .++|.++..++.|++.+|.|||+++ ++|+||||+||++++++.++|+|||++.....
T Consensus 91 ~~~~--------~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 159 (283)
T cd07830 91 RKGK--------PFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYV 159 (283)
T ss_pred cccc--------cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCCC
Confidence 5421 3899999999999999999999998 99999999999999999999999998853311
Q ss_pred ---------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhH---HH-HHHHHHhhhcCCc
Q 047629 484 ---------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKV---EE-KREERLRNWMDPN 544 (615)
Q Consensus 484 ---------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~-~~~~~~~~~~dp~ 544 (615)
..+.++||||||+++|||++|+.|+......+... .....+.. .. .....+.+.++..
T Consensus 160 ~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07830 160 STRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLY---KICSVLGTPTKQDWPEGYKLASKLGFR 236 (283)
T ss_pred CcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHH---HHHHhcCCCChhhhhhHhhhhcccccc
Confidence 13468999999999999999999886543221110 01110000 00 0000011111111
Q ss_pred CC-------CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 545 LE-------SFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 545 l~-------~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
+. ..........+.+++.+||+.||++||+++|++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 237 FPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 10 00111123568999999999999999999999764
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=249.37 Aligned_cols=234 Identities=23% Similarity=0.319 Sum_probs=168.7
Q ss_pred HHccccccccccc----ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEE
Q 047629 330 ESTMNLSEHYSIG----KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRF 394 (615)
Q Consensus 330 ~at~~~~~~~~iG----~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~ 394 (615)
..+++|.....+| +.||++.. +|+.||||++. +.+.+|++++.+++||||+++.+++.......+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 3445555555554 48999876 78999999763 356789999999999999999998875555789
Q ss_pred EEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEee
Q 047629 395 LVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIAN 474 (615)
Q Consensus 395 lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~D 474 (615)
+++||+ +++|.+++... .+++.....++.|++.||.|||+.+ ++||||||+||++++++.+||+|
T Consensus 87 lv~e~~-~~~L~~~~~~~-----------~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~d 151 (328)
T cd07856 87 FVTELL-GTDLHRLLTSR-----------PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICD 151 (328)
T ss_pred EEeehh-ccCHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCc
Confidence 999998 56899888643 2778888899999999999999998 99999999999999999999999
Q ss_pred cCCCCCCC---------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhH--HH
Q 047629 475 FSLAAPAT---------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKV--EE 531 (615)
Q Consensus 475 FGla~~~~---------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~--~~ 531 (615)
||++.... ...+.++||||||+++|||++|+.|+.......... .+...+.. ++
T Consensus 152 fg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~---~~~~~~~~~~~~ 228 (328)
T cd07856 152 FGLARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFS---IITDLLGTPPDD 228 (328)
T ss_pred cccccccCCCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhCCCCHH
Confidence 99875321 124567999999999999999999986544211111 11111100 00
Q ss_pred H-----HHHHHhhhcCCcCCCCCCh-----HHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 532 K-----REERLRNWMDPNLESFYPI-----DGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 532 ~-----~~~~~~~~~dp~l~~~~~~-----~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
. ......-+.+-......+. .....+.+++.+|++.+|++||++.|++..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 229 VINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 0000000001011111111 234578999999999999999999999886
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=241.49 Aligned_cols=222 Identities=23% Similarity=0.356 Sum_probs=160.3
Q ss_pred ceEEEEEE--CCeEEEEEEccH---------HHHHHHHHHHhc---CCCCcccEEEEEEcCCC----cEEEEEeecCCCC
Q 047629 343 KSVYRATI--DGKVLAVKKIKE---------DVTEELRILQRI---NHANLVKLMGVSSDSQG----NRFLVYEYAENGS 404 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~---------~~~~Ei~~l~~l---~H~niv~l~g~~~~~~~----~~~lV~E~~~~Gs 404 (615)
+.||+|.. +|+.+|+|+++. .+.+|++++.++ +|+|++++++++...+. ..+++|||++ ++
T Consensus 13 ~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~-~~ 91 (287)
T cd07838 13 GTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QD 91 (287)
T ss_pred eEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhcc-cC
Confidence 58999998 489999999862 355788887766 59999999999876542 2899999997 58
Q ss_pred HHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--
Q 047629 405 LDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-- 482 (615)
Q Consensus 405 L~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-- 482 (615)
|.+++...... .++|.++..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 92 l~~~l~~~~~~--------~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~ 160 (287)
T cd07838 92 LATYLSKCPKP--------GLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160 (287)
T ss_pred HHHHHHHccCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcceeccCC
Confidence 99988754321 3899999999999999999999998 9999999999999999999999999885532
Q ss_pred --------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHH--------
Q 047629 483 --------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKRE-------- 534 (615)
Q Consensus 483 --------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~-------- 534 (615)
...+.++||||||+++|||++|+.|+......+. ...+...........
T Consensus 161 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07838 161 MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ---LDKIFDVIGLPSEEEWPRNVSLP 237 (287)
T ss_pred cccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH---HHHHHHHcCCCChHhcCCCcccc
Confidence 1134589999999999999999988875432211 111111100000000
Q ss_pred -HHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047629 535 -ERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVF 580 (615)
Q Consensus 535 -~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~ 580 (615)
........... .....+....+.+++.+||+.||.+||++.|++.
T Consensus 238 ~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 238 RSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred hhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000000000 1111133456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=240.00 Aligned_cols=208 Identities=20% Similarity=0.215 Sum_probs=156.9
Q ss_pred ceEEEEEE--CCeEEEEEEccHH----------HHHHHHHH-HhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATI--DGKVLAVKKIKED----------VTEELRIL-QRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~~----------~~~Ei~~l-~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
+.||++.. +|+.||||.++.. +..|..++ ...+|+|++++++++... ...++|+||+++|+|.+++
T Consensus 10 ~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l 88 (260)
T cd05611 10 GSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSK-DYLYLVMEYLNGGDCASLI 88 (260)
T ss_pred eeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcC-CeEEEEEeccCCCCHHHHH
Confidence 48999987 6899999988531 23344443 345899999999998754 4799999999999999999
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------- 482 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------- 482 (615)
.... .+++.++..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++...
T Consensus 89 ~~~~----------~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 155 (260)
T cd05611 89 KTLG----------GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVG 155 (260)
T ss_pred HHcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccccccCCC
Confidence 7543 2788999999999999999999987 9999999999999999999999999875421
Q ss_pred ------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 483 ------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 483 ------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
...+.++||||||+++|||++|+.|+...... ..+..+. ....+ ......
T Consensus 156 ~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~-------------~~~~~--~~~~~~ 217 (260)
T cd05611 156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD---AVFDNIL-------------SRRIN--WPEEVK 217 (260)
T ss_pred CcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHH-------------hcccC--CCCccc
Confidence 12356899999999999999999998654321 1111000 00000 011111
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047629 551 IDGALSLATLARACTMDKSLSRPNMAEVVFNL 582 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L 582 (615)
......+.+++..||+.+|++||++.++.+.|
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 12345689999999999999999876665544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-27 Score=244.50 Aligned_cols=205 Identities=27% Similarity=0.410 Sum_probs=160.5
Q ss_pred ceEEEEEE--CCeEEEEEEcc----------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIK----------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~----------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
+.||+|.. +|+.||+|++. ..+.+|++++++++|+|++++.+++.+. ...++||||+. |+|.+++.
T Consensus 35 g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~-~~l~~~l~ 112 (313)
T cd06633 35 GAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE-HTAWLVMEYCL-GSASDLLE 112 (313)
T ss_pred eEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC-CEEEEEEecCC-CCHHHHHH
Confidence 58999987 68999999875 2467899999999999999999998764 47899999996 68888876
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
.... .++|.++..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 113 ~~~~---------~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~~~~~~~ 180 (313)
T cd06633 113 VHKK---------PLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGT 180 (313)
T ss_pred hcCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCCCCCcccc
Confidence 5432 3899999999999999999999998 9999999999999999999999999875321
Q ss_pred --------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCC
Q 047629 483 --------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESF 548 (615)
Q Consensus 483 --------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~ 548 (615)
...+.++|||||||++|||++|+.|+........ ... ......+...
T Consensus 181 ~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~------~~~-----------~~~~~~~~~~-- 241 (313)
T cd06633 181 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYH-----------IAQNDSPTLQ-- 241 (313)
T ss_pred ccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH------HHH-----------HHhcCCCCCC--
Confidence 1245678999999999999999999865432110 000 0000011111
Q ss_pred CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 549 YPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 549 ~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.......+.+++.+||+.+|.+||++.+++..
T Consensus 242 -~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 242 -SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11122357899999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-27 Score=242.63 Aligned_cols=205 Identities=24% Similarity=0.387 Sum_probs=161.7
Q ss_pred ceEEEEEE--CCeEEEEEEcc-------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
+.||++.. +|+.||||++. ..+.+|+.++++++|+|++++++++...+ ..++||||+++++|.+++...
T Consensus 34 g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~- 111 (292)
T cd06657 34 GIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD-ELWVVMEFLEGGALTDIVTHT- 111 (292)
T ss_pred eEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCC-EEEEEEecCCCCcHHHHHhcC-
Confidence 58999987 78999999874 24778999999999999999999987644 789999999999999988542
Q ss_pred CCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----------
Q 047629 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----------- 482 (615)
Q Consensus 414 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----------- 482 (615)
.+++.....++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++....
T Consensus 112 ----------~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 178 (292)
T cd06657 112 ----------RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVG 178 (292)
T ss_pred ----------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccccccccccc
Confidence 2789999999999999999999998 9999999999999999999999999864321
Q ss_pred ------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 483 ------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 483 ------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
...+.++||||||+++|||++|+.|+......+. . . .+.....+.+.. .
T Consensus 179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~---~---~-----------~~~~~~~~~~~~--~ 239 (292)
T cd06657 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---M---K-----------MIRDNLPPKLKN--L 239 (292)
T ss_pred CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---H---H-----------HHHhhCCcccCC--c
Confidence 1235689999999999999999999864331110 0 0 011111122111 1
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 551 IDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
......+.+++.+||+.+|.+||++.|++.+
T Consensus 240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 240 HKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred ccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 1123357889999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=250.57 Aligned_cols=220 Identities=21% Similarity=0.310 Sum_probs=160.9
Q ss_pred ceEEEEEE--CCeEEEEEEccH---------HHHHHHHHHHhcCCCCcccEEEEEEcCC-----CcEEEEEeecCCCCHH
Q 047629 343 KSVYRATI--DGKVLAVKKIKE---------DVTEELRILQRINHANLVKLMGVSSDSQ-----GNRFLVYEYAENGSLD 406 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~---------~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~~lV~E~~~~GsL~ 406 (615)
+.||++.. +|+.||+|.+.. .+.+|+.++++++|+||+++++++.... ...++||||+. |+|.
T Consensus 30 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~ 108 (353)
T cd07850 30 GIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLC 108 (353)
T ss_pred EEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccC-CCHH
Confidence 47999986 789999998852 3567999999999999999999875322 24699999996 5888
Q ss_pred HhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC---
Q 047629 407 KWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN--- 483 (615)
Q Consensus 407 ~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~--- 483 (615)
+++.. .+++.++..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++....
T Consensus 109 ~~~~~------------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 173 (353)
T cd07850 109 QVIQM------------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 173 (353)
T ss_pred HHHhh------------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccceeCCCCCC
Confidence 88753 1778889999999999999999998 99999999999999999999999999864321
Q ss_pred -------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHH-----HHHHHHHhh
Q 047629 484 -------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVE-----EKREERLRN 539 (615)
Q Consensus 484 -------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~-----~~~~~~~~~ 539 (615)
.++.++|||||||++|||++|+.||...+.. ..+..+...+... .........
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (353)
T cd07850 174 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI---DQWNKIIEQLGTPSDEFMSRLQPTVRN 250 (353)
T ss_pred CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHHhcCCCCHHHHHHhhhhhhH
Confidence 2456899999999999999999998754321 1122111111000 000000111
Q ss_pred hcCC-------------------cCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 540 WMDP-------------------NLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 540 ~~dp-------------------~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.++. ......+......+.+++.+|++.||++|||+.|++..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 251 YVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1110 00011112335567899999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-27 Score=235.76 Aligned_cols=208 Identities=26% Similarity=0.393 Sum_probs=165.1
Q ss_pred ceEEEEEE--CCeEEEEEEccH---------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE---------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~---------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
+.||++.. +++.+|+|++.. .+.+|++++++++|+|++++.+.+... +..++|+||+++++|.+++..
T Consensus 14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~ 92 (258)
T cd08215 14 GKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK-GKLCIVMEYADGGDLSQKIKK 92 (258)
T ss_pred eEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC-CEEEEEEEecCCCcHHHHHHH
Confidence 48999998 489999999852 367899999999999999999988754 578999999999999999976
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC--------
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN-------- 483 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~-------- 483 (615)
..... ..+++.++..++.+++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 93 ~~~~~------~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 163 (258)
T cd08215 93 QKKEG------KPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTV 163 (258)
T ss_pred hhccC------CCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCcceecce
Confidence 53110 14899999999999999999999997 99999999999999999999999998754311
Q ss_pred ---------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCC
Q 047629 484 ---------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESF 548 (615)
Q Consensus 484 ---------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~ 548 (615)
..+.++||||+|++++||++|+.|+......+ +. ....... -+ .
T Consensus 164 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-------~~---------~~~~~~~-~~----~ 222 (258)
T cd08215 164 VGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE-------LA---------LKILKGQ-YP----P 222 (258)
T ss_pred eeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH-------HH---------HHHhcCC-CC----C
Confidence 23568999999999999999999986543110 00 0001111 11 1
Q ss_pred CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 549 YPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 549 ~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.+......+.+++.+||+.+|++||++.|+++.
T Consensus 223 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 223 IPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 222344568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=241.66 Aligned_cols=208 Identities=23% Similarity=0.300 Sum_probs=160.8
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
+.||++.. +|+.+|+|.+.. .+..|++++++++|+|++++.+++.. ++..++|+||+++|+|.+++.
T Consensus 7 g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~ 85 (277)
T cd05577 7 GEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET-KDDLCLVMTLMNGGDLKYHIY 85 (277)
T ss_pred eeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec-CCeEEEEEecCCCCcHHHHHH
Confidence 47999886 689999998752 24679999999999999999998865 447999999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
..... .+++.++..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++....
T Consensus 86 ~~~~~--------~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 154 (277)
T cd05577 86 NVGEP--------GFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR 154 (277)
T ss_pred HcCcC--------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccc
Confidence 64421 3899999999999999999999998 9999999999999999999999999875321
Q ss_pred --------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCC
Q 047629 483 --------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESF 548 (615)
Q Consensus 483 --------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~ 548 (615)
...+.++|||||||+++||++|+.||......... ..+.. .... . ...
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~----------~~~~-~----~~~ 216 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK---EELKR----------RTLE-M----AVE 216 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH---HHHHh----------cccc-c----ccc
Confidence 11355799999999999999999998754421110 00000 0000 0 112
Q ss_pred CChHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 047629 549 YPIDGALSLATLARACTMDKSLSRP-----NMAEVVF 580 (615)
Q Consensus 549 ~~~~~~~~l~~l~~~C~~~dP~~RP-----sm~ev~~ 580 (615)
++......+.+++..||+.||.+|| ++.+++.
T Consensus 217 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 217 YPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 2233345678999999999999999 5555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=255.10 Aligned_cols=226 Identities=21% Similarity=0.284 Sum_probs=166.0
Q ss_pred ceEEEEEE--CCeEEEEEEccH------HHHHHHHHHHhcC-C-----CCcccEEEEEEcCCCcEEEEEeecCCCCHHHh
Q 047629 343 KSVYRATI--DGKVLAVKKIKE------DVTEELRILQRIN-H-----ANLVKLMGVSSDSQGNRFLVYEYAENGSLDKW 408 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~------~~~~Ei~~l~~l~-H-----~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~ 408 (615)
|.|-|+.. +++.||||+++. +...|+.+|..++ | -|+|++++++... ++++||+|.+.. +|.++
T Consensus 200 GQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr-~HlciVfELL~~-NLYel 277 (586)
T KOG0667|consen 200 GQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR-NHLCIVFELLST-NLYEL 277 (586)
T ss_pred ceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc-cceeeeehhhhh-hHHHH
Confidence 47888876 689999999984 3457999999997 4 4899999998754 589999999976 99999
Q ss_pred hccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCC--CcEEEeecCCCCCCC----
Q 047629 409 LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSR--FKAKIANFSLAAPAT---- 482 (615)
Q Consensus 409 L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~--~~~kl~DFGla~~~~---- 482 (615)
|+.+... .|+...+..|+.||+.||.+||+.+ |||+||||+||||.+- ..+||.|||.|....
T Consensus 278 lK~n~f~--------Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vy 346 (586)
T KOG0667|consen 278 LKNNKFR--------GLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVY 346 (586)
T ss_pred HHhcCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccccCCcce
Confidence 9987764 4899999999999999999999998 9999999999999754 479999999996543
Q ss_pred ----------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHH-----hHHHHH--------
Q 047629 483 ----------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVL-----KVEEKR-------- 533 (615)
Q Consensus 483 ----------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~-----~~~~~~-------- 533 (615)
..+..+.||||||||+.||++|.+-|.+..+.+.....-++...+ ......
T Consensus 347 tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~ 426 (586)
T KOG0667|consen 347 TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLK 426 (586)
T ss_pred eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccC
Confidence 236789999999999999999977666544333222111111000 000000
Q ss_pred --------------------HHH----HhhhcCC-c---CCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 534 --------------------EER----LRNWMDP-N---LESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 534 --------------------~~~----~~~~~dp-~---l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
... ..+..-| . +....+...-..+++++++|++.||.+|+|..|.+++
T Consensus 427 ~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~H 502 (586)
T KOG0667|consen 427 GFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNH 502 (586)
T ss_pred CceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 000 0000011 0 1111122344568999999999999999999999886
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-27 Score=235.49 Aligned_cols=203 Identities=26% Similarity=0.446 Sum_probs=162.7
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
+.||++.. +++.+|+|.+. ..+.+|++++.+++|+|++++++++.+. +..++++||+++++|.+++..
T Consensus 14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~ 92 (254)
T cd06627 14 GVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS-DSLYIILEYAENGSLRQIIKK 92 (254)
T ss_pred eEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC-CEEEEEEecCCCCcHHHHHHh
Confidence 58999987 67899999875 2467899999999999999999988754 478999999999999999976
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC--------
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN-------- 483 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~-------- 483 (615)
.. .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 93 ~~----------~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 159 (254)
T cd06627 93 FG----------PFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV 159 (254)
T ss_pred cc----------CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccccccc
Confidence 53 3899999999999999999999998 99999999999999999999999998864321
Q ss_pred ---------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCC
Q 047629 484 ---------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESF 548 (615)
Q Consensus 484 ---------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~ 548 (615)
..+.++||||+|+++|||++|+.|+..... ....+. ......+.
T Consensus 160 ~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~--~~~~~~---------------~~~~~~~~---- 218 (254)
T cd06627 160 VGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP--MAALFR---------------IVQDDHPP---- 218 (254)
T ss_pred ccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH--HHHHHH---------------HhccCCCC----
Confidence 134679999999999999999999864331 111110 00011111
Q ss_pred CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047629 549 YPIDGALSLATLARACTMDKSLSRPNMAEVVF 580 (615)
Q Consensus 549 ~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~ 580 (615)
.+......+.+++.+|+..+|++||++.|++.
T Consensus 219 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 219 LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 22233456789999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=250.41 Aligned_cols=223 Identities=20% Similarity=0.321 Sum_probs=163.5
Q ss_pred ceEEEEEE--CCeEEEEEEccH---------HHHHHHHHHHhcCCCCcccEEEEEEcC---CCcEEEEEeecCCCCHHHh
Q 047629 343 KSVYRATI--DGKVLAVKKIKE---------DVTEELRILQRINHANLVKLMGVSSDS---QGNRFLVYEYAENGSLDKW 408 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~---------~~~~Ei~~l~~l~H~niv~l~g~~~~~---~~~~~lV~E~~~~GsL~~~ 408 (615)
+.||+|.. +|+.||+|++.. .+.+|+.+|++++|+||+++.+++... ....++|+||+. |+|.++
T Consensus 19 g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~ 97 (334)
T cd07855 19 GVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHI 97 (334)
T ss_pred eEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHH
Confidence 47999986 689999998753 356799999999999999999876532 235799999996 699999
Q ss_pred hccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC------
Q 047629 409 LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------ 482 (615)
Q Consensus 409 L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------ 482 (615)
+.... .+++..+..++.|++.||.|||+++ ++||||||+||++++++.+||+|||+++...
T Consensus 98 ~~~~~----------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 164 (334)
T cd07855 98 IHSDQ----------PLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEH 164 (334)
T ss_pred hccCC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeecccCcCC
Confidence 87543 2899999999999999999999988 9999999999999999999999999875321
Q ss_pred ----------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhH------HHHHH
Q 047629 483 ----------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKV------EEKRE 534 (615)
Q Consensus 483 ----------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~------~~~~~ 534 (615)
...+.++|||||||++|||++|+.||......... ..+...... +....
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~---~~~~~~~g~~~~~~~~~~~~ 241 (334)
T cd07855 165 KYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQL---KLILSVLGSPSEEVLNRIGS 241 (334)
T ss_pred CcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHH---HHHHHHhCCChhHhhhhhch
Confidence 11356899999999999999999999754322111 111111000 00001
Q ss_pred HHHhhhcCC-cCCCCCC-----hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047629 535 ERLRNWMDP-NLESFYP-----IDGALSLATLARACTMDKSLSRPNMAEVVFNL 582 (615)
Q Consensus 535 ~~~~~~~dp-~l~~~~~-----~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L 582 (615)
..+.+.++. ......+ .+....+.++++.|++.+|.+||++.|++..-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 111111110 0001111 22345689999999999999999999999863
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=250.76 Aligned_cols=225 Identities=22% Similarity=0.389 Sum_probs=161.1
Q ss_pred ceEEEEEE--CCeEEEEEEccH---------HHHHHHHHHHhcCCCCcccEEEEEEcCC-----CcEEEEEeecCCCCHH
Q 047629 343 KSVYRATI--DGKVLAVKKIKE---------DVTEELRILQRINHANLVKLMGVSSDSQ-----GNRFLVYEYAENGSLD 406 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~---------~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~~lV~E~~~~GsL~ 406 (615)
+.||+|.. +|+.||||+++. .+.+|+.++++++|+||+++++++.... ...++|+||+.. +|.
T Consensus 29 g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~ 107 (342)
T cd07879 29 GSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQ 107 (342)
T ss_pred eEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEeccccc-CHH
Confidence 58999986 689999998752 3678999999999999999999875432 236899999974 787
Q ss_pred HhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC----
Q 047629 407 KWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT---- 482 (615)
Q Consensus 407 ~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~---- 482 (615)
+++.. .+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++...
T Consensus 108 ~~~~~------------~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~~~ 172 (342)
T cd07879 108 KIMGH------------PLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMT 172 (342)
T ss_pred HHHcC------------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCCCCCCC
Confidence 76531 2789999999999999999999998 9999999999999999999999999986421
Q ss_pred -----------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHH-HHHHHH-----hh
Q 047629 483 -----------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEE-KREERL-----RN 539 (615)
Q Consensus 483 -----------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~-~~~~~~-----~~ 539 (615)
...+.++|||||||++|||++|+.||........ ...+........ .....+ ..
T Consensus 173 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (342)
T cd07879 173 GYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTGVPGPEFVQKLEDKAAKS 249 (342)
T ss_pred CceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCCHHHHHHhcccchHH
Confidence 1235689999999999999999999975432111 111111100000 000000 00
Q ss_pred hcC--C-----cCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHhccc
Q 047629 540 WMD--P-----NLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN--LSVLTQ 587 (615)
Q Consensus 540 ~~d--p-----~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~--L~~l~~ 587 (615)
..+ + .+...++ .....+.+++.+||+.||++||++.|++.+ ++.+.+
T Consensus 250 ~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 250 YIKSLPKYPRKDFSTLFP-KASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHhhcCCcccchHHHHhc-CCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 000 0 0000011 123457899999999999999999999975 555544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=244.34 Aligned_cols=208 Identities=21% Similarity=0.397 Sum_probs=157.1
Q ss_pred ceEEEEEEC--CeEEEEEEccH--------HHHHHHHHHHhcC-CCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATID--GKVLAVKKIKE--------DVTEELRILQRIN-HANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~~--g~~vAvK~~~~--------~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
+.||++... |+.||||.++. .+..|+.++.+.+ |+||+++++++.+. ...+++|||++ ++|.+++..
T Consensus 29 ~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-~~~~~v~e~~~-~~l~~l~~~ 106 (296)
T cd06618 29 GQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITD-SDVFICMELMS-TCLDKLLKR 106 (296)
T ss_pred eEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecC-CeEEEEeeccC-cCHHHHHHH
Confidence 489999984 89999999862 2456777777775 99999999998754 47999999985 477777654
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHE-HAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
... .+++..+..++.|++.||+|||+ .+ ++||||+|+||++++++.+||+|||++....
T Consensus 107 ~~~---------~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~~~~ 174 (296)
T cd06618 107 IQG---------PIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS 174 (296)
T ss_pred hcC---------CCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCCCcccCC
Confidence 332 38999999999999999999997 45 9999999999999999999999999875321
Q ss_pred ------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCc
Q 047629 483 ------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPN 544 (615)
Q Consensus 483 ------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~ 544 (615)
...+.++||||||+++|||++|+.|+...... .+..... +.. ..+.
T Consensus 175 ~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~----------~~~-~~~~ 238 (296)
T cd06618 175 AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKI----------LQE-EPPS 238 (296)
T ss_pred CCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHH----------hcC-CCCC
Confidence 11345799999999999999999998643211 0000000 000 0111
Q ss_pred CCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047629 545 LESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNL 582 (615)
Q Consensus 545 l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L 582 (615)
+. ........+.+++.+||+.||++||++.+++++.
T Consensus 239 ~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 239 LP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred CC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 11 1112345689999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-27 Score=247.66 Aligned_cols=218 Identities=27% Similarity=0.316 Sum_probs=162.7
Q ss_pred ceEEEEEE--CCeEEEEEEccH---------------------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEee
Q 047629 343 KSVYRATI--DGKVLAVKKIKE---------------------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEY 399 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~---------------------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~ 399 (615)
+.||++.. +|+.||||.++. .+.+|++++++++|+||+++++++... ...++||||
T Consensus 23 g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~ 101 (335)
T PTZ00024 23 GKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG-DFINLVMDI 101 (335)
T ss_pred eeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC-CcEEEEEec
Confidence 48999986 689999998752 256899999999999999999998754 478999999
Q ss_pred cCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCC
Q 047629 400 AENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAA 479 (615)
Q Consensus 400 ~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~ 479 (615)
++ |+|.+++.... .+++.....++.|++.||+|||+.+ ++||||||+||+++.++.+|++|||+++
T Consensus 102 ~~-~~l~~~l~~~~----------~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~dfg~~~ 167 (335)
T PTZ00024 102 MA-SDLKKVVDRKI----------RLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLAR 167 (335)
T ss_pred cc-cCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCcccee
Confidence 97 69999986543 3889999999999999999999998 9999999999999999999999999875
Q ss_pred CCC--------------------------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHH
Q 047629 480 PAT--------------------------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWK 521 (615)
Q Consensus 480 ~~~--------------------------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~ 521 (615)
... ...+.++||||||+++|||++|+.|+....+.+. ..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~---~~ 244 (335)
T PTZ00024 168 RYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ---LG 244 (335)
T ss_pred ecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HH
Confidence 432 1135678999999999999999999875543221 11
Q ss_pred HHHHHHhHHHHHHHHHhhh------------cCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 522 EIREVLKVEEKREERLRNW------------MDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~------------~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.+........ ....... ..+.+.. ........+.+++..|++.+|++||++.|++..
T Consensus 245 ~i~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 245 RIFELLGTPN--EDNWPQAKKLPLYTEFTPRKPKDLKT-IFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHhCCCc--hhhCcchhhcccccccCcCCcccHHH-hCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 1111110000 0000000 0000000 011223467899999999999999999999975
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-27 Score=239.26 Aligned_cols=206 Identities=19% Similarity=0.273 Sum_probs=157.0
Q ss_pred ceEEEEEE--CCeEEEEEEccHHHHH--HHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCCCC
Q 047629 343 KSVYRATI--DGKVLAVKKIKEDVTE--ELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSS 417 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~~~~~--Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~~ 417 (615)
|.||++.. +|+.+|+|........ |+.....+ +|+|++++++++...+ ..++||||+++|+|.+++....
T Consensus 30 g~v~~~~~~~~~~~~~~k~~~~~~~~~~e~~~~~~~~~h~~iv~~~~~~~~~~-~~~iv~e~~~~~~L~~~l~~~~---- 104 (267)
T PHA03390 30 GKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSVTTLK-GHVLIMDYIKDGDLFDLLKKEG---- 104 (267)
T ss_pred eEEEEEEEcCCCcEEEEEEEehhhcchhhHHHHHHhhcCCCEEEEEEEEecCC-eeEEEEEcCCCCcHHHHHHhcC----
Confidence 58998886 6889999998754322 44433333 7999999999987644 7999999999999999997653
Q ss_pred CCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCC-cEEEeecCCCCCCC--------------
Q 047629 418 SSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRF-KAKIANFSLAAPAT-------------- 482 (615)
Q Consensus 418 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~-~~kl~DFGla~~~~-------------- 482 (615)
.++|.++..++.|++.||.|||+.+ ++||||||+||+++.++ .++|+|||+++...
T Consensus 105 ------~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~y~aP 175 (267)
T PHA03390 105 ------KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTLDYFSP 175 (267)
T ss_pred ------CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecCCCccCCCCCcccCh
Confidence 2899999999999999999999998 99999999999999998 99999999875321
Q ss_pred -----CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHH
Q 047629 483 -----NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSL 557 (615)
Q Consensus 483 -----~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l 557 (615)
...+.++||||||+++|||++|+.|+....+... . ...+ ........ ..+......+
T Consensus 176 E~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~-~~~~--------------~~~~~~~~--~~~~~~~~~~ 237 (267)
T PHA03390 176 EKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL-D-LESL--------------LKRQQKKL--PFIKNVSKNA 237 (267)
T ss_pred hhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh-h-HHHH--------------HHhhcccC--CcccccCHHH
Confidence 2245689999999999999999999974432211 0 0000 00011111 1122344567
Q ss_pred HHHHHHhhhcCCCCCCC-HHHHHH
Q 047629 558 ATLARACTMDKSLSRPN-MAEVVF 580 (615)
Q Consensus 558 ~~l~~~C~~~dP~~RPs-m~ev~~ 580 (615)
.+++..|++.+|.+||+ ++|+++
T Consensus 238 ~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 238 NDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHHHHhccChhhCCchHHHHhc
Confidence 89999999999999996 688875
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-27 Score=244.31 Aligned_cols=223 Identities=26% Similarity=0.349 Sum_probs=160.0
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCC-------cEEEEEeecCCCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQG-------NRFLVYEYAENGS 404 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-------~~~lV~E~~~~Gs 404 (615)
+.||++.. +|+.+|||++. ..+.+|++++++++|+||+++++++.+... ..++|+||++. +
T Consensus 22 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~ 100 (311)
T cd07866 22 GEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-D 100 (311)
T ss_pred EEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCCc-C
Confidence 48999987 68899999874 246789999999999999999998754332 36999999975 7
Q ss_pred HHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--
Q 047629 405 LDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-- 482 (615)
Q Consensus 405 L~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-- 482 (615)
|..++..... .+++.++..++.|+++||+|||+++ ++||||||+||++++++.+||+|||+++...
T Consensus 101 l~~~~~~~~~---------~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 168 (311)
T cd07866 101 LSGLLENPSV---------KLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGP 168 (311)
T ss_pred HHHHHhcccc---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCccchhccCC
Confidence 8777765332 3899999999999999999999998 9999999999999999999999999885321
Q ss_pred ---------------------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhH
Q 047629 483 ---------------------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKV 529 (615)
Q Consensus 483 ---------------------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~ 529 (615)
...+.++||||||+++|||++|+.|+........... +......
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~---~~~~~~~ 245 (311)
T cd07866 169 PPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL---IFKLCGT 245 (311)
T ss_pred CcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhCC
Confidence 1134679999999999999999999865442211111 1111000
Q ss_pred ---HH-HHHHHHhhhcCCcCCCCCC-------hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 530 ---EE-KREERLRNWMDPNLESFYP-------IDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 530 ---~~-~~~~~~~~~~dp~l~~~~~-------~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.. .....+....+.......+ ......+.+++.+|++.||.+|||+.|++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 246 PTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred CChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 00 0000111111100000111 1122467899999999999999999998753
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-27 Score=240.76 Aligned_cols=207 Identities=22% Similarity=0.302 Sum_probs=158.9
Q ss_pred ceEEEEEE-----CCeEEEEEEccH-----------HHHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCH
Q 047629 343 KSVYRATI-----DGKVLAVKKIKE-----------DVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSL 405 (615)
Q Consensus 343 ~~Vy~~~~-----~g~~vAvK~~~~-----------~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL 405 (615)
+.||.+.. +|+.||+|+++. .+.+|+.++.++ +|+||+++.+++.. ++..++|+||+++|+|
T Consensus 14 g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L 92 (290)
T cd05613 14 GKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-DTKLHLILDYINGGEL 92 (290)
T ss_pred ceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec-CCeEEEEEecCCCCcH
Confidence 47888775 678999998853 356799999999 69999999988764 4478999999999999
Q ss_pred HHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC--
Q 047629 406 DKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN-- 483 (615)
Q Consensus 406 ~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~-- 483 (615)
.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++....
T Consensus 93 ~~~l~~~~----------~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 159 (290)
T cd05613 93 FTHLSQRE----------RFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE 159 (290)
T ss_pred HHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence 99997643 2889999999999999999999988 99999999999999999999999998854311
Q ss_pred ------------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhh
Q 047629 484 ------------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRN 539 (615)
Q Consensus 484 ------------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 539 (615)
..+.++||||||+++|||++|+.|+......... ..... .+..
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~--~~~~~-----------~~~~ 226 (290)
T cd05613 160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ--AEISR-----------RILK 226 (290)
T ss_pred ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccH--HHHHH-----------Hhhc
Confidence 1345799999999999999999998643221111 00000 0000
Q ss_pred hcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 047629 540 WMDPNLESFYPIDGALSLATLARACTMDKSLSRP-----NMAEVVFN 581 (615)
Q Consensus 540 ~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RP-----sm~ev~~~ 581 (615)
..+ .++......+.+++..||+.||++|| ++.+++..
T Consensus 227 -~~~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 227 -SEP----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred -cCC----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 111 22333445678999999999999997 66666553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-27 Score=238.89 Aligned_cols=206 Identities=21% Similarity=0.252 Sum_probs=157.7
Q ss_pred ceEEEEEE--CCeEEEEEEccHH----------HHHHHH---HHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATI--DGKVLAVKKIKED----------VTEELR---ILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~~----------~~~Ei~---~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~ 407 (615)
+.||++.. +|+.||+|.+... +..|.. .++..+|+||+++.+++.+. ...++||||+++|+|.+
T Consensus 8 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-~~~~~v~e~~~g~~L~~ 86 (278)
T cd05606 8 GEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP-DKLSFILDLMNGGDLHY 86 (278)
T ss_pred eEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC-CEEEEEEecCCCCcHHH
Confidence 47998876 6889999987521 233433 34445799999999987754 47899999999999999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----- 482 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----- 482 (615)
++.... .++|..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 87 ~l~~~~----------~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~ 153 (278)
T cd05606 87 HLSQHG----------VFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 153 (278)
T ss_pred HHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccCCc
Confidence 986543 3899999999999999999999987 9999999999999999999999999875321
Q ss_pred -----------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcC
Q 047629 483 -----------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNL 545 (615)
Q Consensus 483 -----------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l 545 (615)
..++.++|||||||++|||++|+.||........... . ......++.+
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~----~-----------~~~~~~~~~~ 218 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----D-----------RMTLTMAVEL 218 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH----H-----------HHhhccCCCC
Confidence 1245689999999999999999999975432111100 0 0011122222
Q ss_pred CCCCChHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 047629 546 ESFYPIDGALSLATLARACTMDKSLSRP-----NMAEVVFN 581 (615)
Q Consensus 546 ~~~~~~~~~~~l~~l~~~C~~~dP~~RP-----sm~ev~~~ 581 (615)
+......+.+++.+|+..+|.+|| ++.|+++.
T Consensus 219 ----~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 219 ----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred ----CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 222345688999999999999999 99998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.5e-27 Score=246.58 Aligned_cols=240 Identities=22% Similarity=0.290 Sum_probs=170.7
Q ss_pred eHHHHHHHccccccccccc----ceEEEEEE--CCeEEEEEEccH---------HHHHHHHHHHhcCCCCcccEEEEEEc
Q 047629 324 EIEVIMESTMNLSEHYSIG----KSVYRATI--DGKVLAVKKIKE---------DVTEELRILQRINHANLVKLMGVSSD 388 (615)
Q Consensus 324 ~~~~l~~at~~~~~~~~iG----~~Vy~~~~--~g~~vAvK~~~~---------~~~~Ei~~l~~l~H~niv~l~g~~~~ 388 (615)
..+++...+++|.....+| +.||++.. +|+.||+|+++. .+.+|++++++++|+||+++.+++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 3455666677777666665 47999986 689999998852 35679999999999999999998753
Q ss_pred CC-----CcEEEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcee
Q 047629 389 SQ-----GNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQ 463 (615)
Q Consensus 389 ~~-----~~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIL 463 (615)
.. ...+++++++ +++|.+++... .+++..+..++.|++.||+|||+.+ ++||||||+||+
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~-----------~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl 152 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ-----------KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLA 152 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEE
Confidence 21 2367888887 78999888643 2889999999999999999999998 999999999999
Q ss_pred eCCCCcEEEeecCCCCCCC---------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHH
Q 047629 464 LDSRFKAKIANFSLAAPAT---------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKE 522 (615)
Q Consensus 464 ld~~~~~kl~DFGla~~~~---------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 522 (615)
+++++.+||+|||+++... ...+.++|||||||++|||++|+.|+......... ..
T Consensus 153 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~---~~ 229 (345)
T cd07877 153 VNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL---KL 229 (345)
T ss_pred EcCCCCEEEecccccccccccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HH
Confidence 9999999999999986431 12356899999999999999999998654321111 11
Q ss_pred HHHHHhH---------HHHHHHHHhhhcCCcCCC---CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 523 IREVLKV---------EEKREERLRNWMDPNLES---FYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 523 ~~~~~~~---------~~~~~~~~~~~~dp~l~~---~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
+...... ...........++..... +........+.+++.+|++.||.+||++.|++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 230 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 1100000 000000000001100000 0001123457899999999999999999999886
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-27 Score=241.27 Aligned_cols=220 Identities=23% Similarity=0.347 Sum_probs=163.1
Q ss_pred ceEEEEEE--CCeEEEEEEccH---------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE---------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~---------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
+.||++.. +|+.+++|+++. .+..|++++++++|+||+++++++... ...++|+||+++ +|.+++..
T Consensus 13 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e~~~~-~l~~~l~~ 90 (283)
T cd05118 13 GVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK-GDLYLVFEFMDT-DLYKLIKD 90 (283)
T ss_pred ceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC-CCEEEEEeccCC-CHHHHHHh
Confidence 47999987 689999998752 366799999999999999999988754 479999999975 89888876
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC--------
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN-------- 483 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~-------- 483 (615)
... .+++.++..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||.+.....
T Consensus 91 ~~~---------~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~ 158 (283)
T cd05118 91 RQR---------GLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY 158 (283)
T ss_pred hcc---------cCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCc
Confidence 432 3899999999999999999999998 99999999999999999999999998743211
Q ss_pred ----------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcC-----
Q 047629 484 ----------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMD----- 542 (615)
Q Consensus 484 ----------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~d----- 542 (615)
..+.++||||||+++|||++|+.||......+. .......+... .......+.+
T Consensus 159 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~--~~~~~~~~~~~~~~~ 233 (283)
T cd05118 159 VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ---LFKIFRTLGTP--DPEVWPKFTSLARNY 233 (283)
T ss_pred cCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCC--chHhcccchhhhhhh
Confidence 245689999999999999999999865442111 11111110000 0000000000
Q ss_pred -CcCC-------CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 543 -PNLE-------SFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 543 -p~l~-------~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.... .....+....+.+++..||+.||.+||++.|++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000 01112345678999999999999999999999863
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-27 Score=240.93 Aligned_cols=221 Identities=24% Similarity=0.366 Sum_probs=163.2
Q ss_pred ceEEEEEE--CCeEEEEEEccH---------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE---------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~---------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
+.||+|.. +++.+|+|.++. .+..|++++++++|+|++++.+++.+. +..++|+||++ ++|.+++..
T Consensus 13 ~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~~v~e~~~-~~l~~~i~~ 90 (282)
T cd07829 13 GVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE-RKLYLVFEYCD-MDLKKYLDK 90 (282)
T ss_pred ceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC-CceEEEecCcC-cCHHHHHHh
Confidence 58999998 589999998763 356799999999999999999998754 47999999998 599999986
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC--------
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN-------- 483 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~-------- 483 (615)
... .+++..+..++.+++.||.|||+++ ++||||+|+||++++++.+||+|||+++....
T Consensus 91 ~~~---------~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (282)
T cd07829 91 RPG---------PLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE 158 (282)
T ss_pred hcc---------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCccccCcc
Confidence 532 3899999999999999999999998 99999999999999999999999998754211
Q ss_pred ----------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHH-HHHHhhh--cCCc
Q 047629 484 ----------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKR-EERLRNW--MDPN 544 (615)
Q Consensus 484 ----------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~--~dp~ 544 (615)
..+.++||||||+++|||++|+.|+......+. ...+...+...... -..+... .+..
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
T cd07829 159 VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ---LFKIFQILGTPTEESWPGVTKLPDYKPT 235 (282)
T ss_pred ccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHHHHhCCCcHHHHHhhccccccccc
Confidence 235579999999999999999988865432111 11111111000000 0000000 0000
Q ss_pred CC--------CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 545 LE--------SFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 545 l~--------~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.. ...+ .....+.+++.+||+.||++||++.|++..
T Consensus 236 ~~~~~~~~~~~~~~-~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 236 FPKFPPKDLEKVLP-RLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccccCccchHHhcc-cccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00 0011 124468999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.3e-27 Score=236.17 Aligned_cols=207 Identities=24% Similarity=0.310 Sum_probs=165.0
Q ss_pred ceEEEEEECC--eEEEEEEccHH----------HHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATIDG--KVLAVKKIKED----------VTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~~g--~~vAvK~~~~~----------~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|+||.+.+.| ..+|+|+|.++ ...|.+||+.++||.+.+|++.+.. +...+||||||++|+|...++
T Consensus 91 G~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet-~~~~cl~meyCpGGdL~~Lrq 169 (459)
T KOG0610|consen 91 GTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET-DKYSCLVMEYCPGGDLHSLRQ 169 (459)
T ss_pred eeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec-cceeEEEEecCCCccHHHHHh
Confidence 6999999955 88999999753 4569999999999999999998764 458999999999999999887
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
.+... .++.....-++..|.-||+|||-.| ||.|||||+|||+-++|.+.|+||.|+....
T Consensus 170 kQp~~--------~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s 238 (459)
T KOG0610|consen 170 KQPGK--------RFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKS 238 (459)
T ss_pred hCCCC--------ccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCCeeecc
Confidence 76543 4899999999999999999999999 9999999999999999999999998862110
Q ss_pred ----------------------------C-------------------------------------------CCCCcccc
Q 047629 483 ----------------------------N-------------------------------------------DVMPKFDV 491 (615)
Q Consensus 483 ----------------------------~-------------------------------------------~~~~k~DV 491 (615)
. ..+.++|.
T Consensus 239 ~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDW 318 (459)
T KOG0610|consen 239 SSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDW 318 (459)
T ss_pred CCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhH
Confidence 0 01136799
Q ss_pred hhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCC
Q 047629 492 FAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLS 571 (615)
Q Consensus 492 ~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~ 571 (615)
|+|||+||||+.|+.||.+..+.+. +..++-..+.=.-..+......+|++..+..||.+
T Consensus 319 WtfGIflYEmLyG~TPFKG~~~~~T--------------------l~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~k 378 (459)
T KOG0610|consen 319 WTFGIFLYEMLYGTTPFKGSNNKET--------------------LRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSK 378 (459)
T ss_pred HHHHHHHHHHHhCCCCcCCCCchhh--------------------HHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhh
Confidence 9999999999999999987665332 22222222211111134456899999999999999
Q ss_pred CCC----HHHHHHH
Q 047629 572 RPN----MAEVVFN 581 (615)
Q Consensus 572 RPs----m~ev~~~ 581 (615)
|-. +.||-++
T Consensus 379 Rlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 379 RLGSKRGAAEIKRH 392 (459)
T ss_pred hhccccchHHhhcC
Confidence 998 7777664
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-26 Score=238.66 Aligned_cols=211 Identities=21% Similarity=0.259 Sum_probs=161.8
Q ss_pred ceEEEEEE-----CCeEEEEEEccH-----------HHHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCH
Q 047629 343 KSVYRATI-----DGKVLAVKKIKE-----------DVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSL 405 (615)
Q Consensus 343 ~~Vy~~~~-----~g~~vAvK~~~~-----------~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL 405 (615)
+.||++.. +++.+|||.+++ .+.+|++++.++ +|+||+++++.+.. +...++||||+++|+|
T Consensus 14 ~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L 92 (288)
T cd05583 14 GKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT-DTKLHLILDYVNGGEL 92 (288)
T ss_pred ceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec-CCEEEEEEecCCCCcH
Confidence 47998874 468899998852 256799999999 69999999988764 4478999999999999
Q ss_pred HHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC--
Q 047629 406 DKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN-- 483 (615)
Q Consensus 406 ~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~-- 483 (615)
.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++++|||+++....
T Consensus 93 ~~~~~~~~----------~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (288)
T cd05583 93 FTHLYQRE----------HFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE 159 (288)
T ss_pred HHHHhhcC----------CcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence 99987543 2889999999999999999999987 99999999999999999999999998754210
Q ss_pred ------------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhh
Q 047629 484 ------------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRN 539 (615)
Q Consensus 484 ------------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 539 (615)
..+.++||||||+++|||++|+.|+......... ..+. . .+..
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---~~~~---------~-~~~~ 226 (288)
T cd05583 160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ---SEIS---------R-RILK 226 (288)
T ss_pred ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH---HHHH---------H-HHHc
Confidence 1345899999999999999999998643211110 0000 0 0100
Q ss_pred hcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 047629 540 WMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVL 585 (615)
Q Consensus 540 ~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l 585 (615)
.++.. +......+.+++.+||+.||++|||++++.+.|...
T Consensus 227 -~~~~~----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 227 -SKPPF----PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred -cCCCC----CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 11112 222334578999999999999999999888877653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-27 Score=235.89 Aligned_cols=194 Identities=21% Similarity=0.220 Sum_probs=153.1
Q ss_pred ceEEEEEE--CCeEEEEEEccH--HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCCCCC
Q 047629 343 KSVYRATI--DGKVLAVKKIKE--DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSS 418 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~--~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~~~ 418 (615)
+.||++.. +|+.+|+|+++. .+..|...+....||||+++++++.+. ...+++|||+++|+|.+++....
T Consensus 7 ~~v~~~~~~~~~~~~~~K~i~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~----- 80 (237)
T cd05576 7 DKVLLVMDTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSE-DSVFLVLQHAEGGKLWSHISKFL----- 80 (237)
T ss_pred ceEEEEEEccCCcEEEEEeecchhhhhhHHHHHHhcCCCceeehhhheecC-CeEEEEEecCCCCCHHHHHHHhc-----
Confidence 47898887 789999999975 355666666667899999999988754 47899999999999999986543
Q ss_pred CCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC----------------
Q 047629 419 SGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT---------------- 482 (615)
Q Consensus 419 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~---------------- 482 (615)
.+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++++|||++....
T Consensus 81 -----~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~aPE 152 (237)
T cd05576 81 -----NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPE 152 (237)
T ss_pred -----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccCCc
Confidence 2899999999999999999999988 9999999999999999999999999763221
Q ss_pred ----CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHHH
Q 047629 483 ----NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLA 558 (615)
Q Consensus 483 ----~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~ 558 (615)
...+.++||||+|+++|||++|+.|+...... ....... ..+......+.
T Consensus 153 ~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~----------------------~~~~~~~----~~~~~~~~~~~ 206 (237)
T cd05576 153 VGGISEETEACDWWSLGAILFELLTGKTLVECHPSG----------------------INTHTTL----NIPEWVSEEAR 206 (237)
T ss_pred ccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh----------------------ccccccc----CCcccCCHHHH
Confidence 22456899999999999999999876432110 0000000 11222334578
Q ss_pred HHHHHhhhcCCCCCCCHH
Q 047629 559 TLARACTMDKSLSRPNMA 576 (615)
Q Consensus 559 ~l~~~C~~~dP~~RPsm~ 576 (615)
+++.+|++.||++||++.
T Consensus 207 ~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 207 SLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHccCCHHHhcCCC
Confidence 999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-27 Score=239.12 Aligned_cols=202 Identities=26% Similarity=0.363 Sum_probs=162.3
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcC-CCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRIN-HANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
+.||++.. +|+.+|+|.+.. .+.+|.+++.+++ |+||+++++++.+. ...++||||+++|+|.+++
T Consensus 15 ~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l 93 (280)
T cd05581 15 STVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE-ENLYFVLEYAPNGELLQYI 93 (280)
T ss_pred eEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC-ceEEEEEcCCCCCcHHHHH
Confidence 48999987 789999998853 3567899999998 99999999987654 4789999999999999999
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------ 483 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------ 483 (615)
.... .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++++|||++.....
T Consensus 94 ~~~~----------~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 94 RKYG----------SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred HHcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 7653 3899999999999999999999998 99999999999999999999999998754211
Q ss_pred -------------------------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHH
Q 047629 484 -------------------------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREV 526 (615)
Q Consensus 484 -------------------------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 526 (615)
..+.++||||||++++|+++|+.|+...... ..+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~- 233 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY------LTFQK- 233 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHH-
Confidence 1245799999999999999999998754310 00100
Q ss_pred HhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCH----HHHHH
Q 047629 527 LKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNM----AEVVF 580 (615)
Q Consensus 527 ~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm----~ev~~ 580 (615)
.. + ....++......+.+++.+||+.+|.+||++ +|++.
T Consensus 234 ----------~~---~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 234 ----------IL---K--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred ----------HH---h--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 00 0 1112233335568999999999999999999 77664
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-26 Score=242.38 Aligned_cols=206 Identities=27% Similarity=0.335 Sum_probs=168.0
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcC-CCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRIN-HANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
+.||++.. +|+.+|+|.+.+ .+.+|+.+|+++. |||||.+.+.+.+.+ ..++|||++.+|.|.+.+
T Consensus 49 g~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~-~~~lvmEL~~GGeLfd~i 127 (382)
T KOG0032|consen 49 GVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD-SVYLVMELCEGGELFDRI 127 (382)
T ss_pred eEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC-eEEEEEEecCCchHHHHH
Confidence 58999987 699999998852 5678999999998 999999999987654 899999999999999999
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCC----CcEEEeecCCCCCCCC--
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSR----FKAKIANFSLAAPATN-- 483 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~----~~~kl~DFGla~~~~~-- 483 (615)
... . ++......++.|++.++.|||+.+ ++||||||+|+|+... +.+|++|||++.....
T Consensus 128 ~~~-~----------~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~ 193 (382)
T KOG0032|consen 128 VKK-H----------YSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGE 193 (382)
T ss_pred HHc-c----------CCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCc
Confidence 765 1 789999999999999999999998 9999999999999654 4799999999965422
Q ss_pred --------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCC
Q 047629 484 --------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDP 543 (615)
Q Consensus 484 --------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp 543 (615)
.++..+||||.||++|.|++|..||....+.+... ... . .+.
T Consensus 194 ~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------~i~----------~--~~~ 255 (382)
T KOG0032|consen 194 RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------AIL----------R--GDF 255 (382)
T ss_pred eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH------HHH----------c--CCC
Confidence 35678999999999999999999998655322111 110 0 111
Q ss_pred cCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 544 NLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 544 ~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.....+-......+.++++.++..||.+|+++.+++++
T Consensus 256 ~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 22233333445678899999999999999999999985
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=231.57 Aligned_cols=199 Identities=26% Similarity=0.339 Sum_probs=159.4
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
+.||++.. +|+.+|+|.++. .+..|++++++++|+||+++++.+.. +...+++|||+++++|.+++.
T Consensus 7 ~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~ 85 (250)
T cd05123 7 GKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT-EEKLYLVLEYAPGGELFSHLS 85 (250)
T ss_pred eEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec-CCeeEEEEecCCCCcHHHHHH
Confidence 47999987 589999998753 46789999999999999999998764 447899999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC-------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------- 483 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------- 483 (615)
... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 86 ~~~----------~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~ 152 (250)
T cd05123 86 KEG----------RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT 152 (250)
T ss_pred hcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccC
Confidence 653 2899999999999999999999987 99999999999999999999999998854321
Q ss_pred ----------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCC
Q 047629 484 ----------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLES 547 (615)
Q Consensus 484 ----------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~ 547 (615)
..+.++|+||||+++||+++|+.|+...+. .... ..+.. ...
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~--------------~~~~~-~~~---- 210 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIY--------------EKILK-DPL---- 210 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHH--------------HHHhc-CCC----
Confidence 134579999999999999999999965432 1000 00111 111
Q ss_pred CCChHHHHHHHHHHHHhhhcCCCCCCCHHH
Q 047629 548 FYPIDGALSLATLARACTMDKSLSRPNMAE 577 (615)
Q Consensus 548 ~~~~~~~~~l~~l~~~C~~~dP~~RPsm~e 577 (615)
.++......+.++++.||..||++||++.+
T Consensus 211 ~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 211 RFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 123333456789999999999999999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=242.40 Aligned_cols=223 Identities=22% Similarity=0.351 Sum_probs=159.6
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCC-----CcEEEEEeecCCCCHH
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQ-----GNRFLVYEYAENGSLD 406 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~~lV~E~~~~GsL~ 406 (615)
+.||++.. +|+.||||++. ..+.+|+++|++++|+||+++++++.... ...++||||+ +++|.
T Consensus 29 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~ 107 (343)
T cd07880 29 GTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLG 107 (343)
T ss_pred eEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHH
Confidence 47999986 68999999874 23668999999999999999999876432 1358999999 67999
Q ss_pred HhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC----
Q 047629 407 KWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT---- 482 (615)
Q Consensus 407 ~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~---- 482 (615)
+++... .+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+|++|||++....
T Consensus 108 ~~~~~~-----------~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 173 (343)
T cd07880 108 KLMKHE-----------KLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMT 173 (343)
T ss_pred HHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccccccccCcc
Confidence 888642 2889999999999999999999998 9999999999999999999999999986431
Q ss_pred -----------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHH-HH-------HHHHHHhHHHHH--HH
Q 047629 483 -----------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVL-WK-------EIREVLKVEEKR--EE 535 (615)
Q Consensus 483 -----------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l-~~-------~~~~~~~~~~~~--~~ 535 (615)
...+.++||||||+++|||++|+.||........... .. .+...+...... ..
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (343)
T cd07880 174 GYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVK 253 (343)
T ss_pred ccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHH
Confidence 1245679999999999999999999875432111000 00 000000000000 00
Q ss_pred HHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 536 RLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 536 ~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.+.......+ ..........+.+++.+|++.||.+|||+.+++..
T Consensus 254 ~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 254 KLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred hccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000 00111233457899999999999999999999964
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=242.76 Aligned_cols=222 Identities=23% Similarity=0.340 Sum_probs=163.6
Q ss_pred ceEEEEEE--CCeEEEEEEccH---------HHHHHHHHHHhcCCCCcccEEEEEEcCC----CcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATI--DGKVLAVKKIKE---------DVTEELRILQRINHANLVKLMGVSSDSQ----GNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~---------~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~~lV~E~~~~GsL~~ 407 (615)
+.||++.. +|+.+|||++.. .+.+|++++++++|+||+++.+++...+ ...+++|||++ ++|.+
T Consensus 14 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~ 92 (330)
T cd07834 14 GVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHK 92 (330)
T ss_pred eEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHH
Confidence 48999997 579999998752 4678999999999999999999886543 25899999998 58999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC----
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN---- 483 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~---- 483 (615)
++.... .+++..+..++.+++.||+|||+++ ++||||||+|||++.++.++|+|||++.....
T Consensus 93 ~l~~~~----------~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~ 159 (330)
T cd07834 93 VIKSPQ----------PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159 (330)
T ss_pred HHhCCC----------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeecccccc
Confidence 987643 3899999999999999999999998 99999999999999999999999998754311
Q ss_pred -----------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHH---H---HH
Q 047629 484 -----------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEE---K---RE 534 (615)
Q Consensus 484 -----------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~---~~ 534 (615)
..+.++||||||+++|||++|+.||......+. ...+........ . ..
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~ 236 (330)
T cd07834 160 KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ---LNLIVEVLGTPSEEDLKFITS 236 (330)
T ss_pred cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH---HHHHHHhcCCCChhHhhhccc
Confidence 234579999999999999999999876542111 111111100000 0 00
Q ss_pred HHHhhhcC---CcCC---CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 535 ERLRNWMD---PNLE---SFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 535 ~~~~~~~d---p~l~---~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
....+.+. +.-. ..........+.+++.+||+.+|.+||++.+++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00000000 0000 00111234567899999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=234.67 Aligned_cols=207 Identities=23% Similarity=0.315 Sum_probs=156.0
Q ss_pred ceEEEEEE--CCeEEEEEEccH------------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHh
Q 047629 343 KSVYRATI--DGKVLAVKKIKE------------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKW 408 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~------------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~ 408 (615)
+.||++.. .+..+++|.++. ++..|+.++++++||||+++++++.+. ...++|+||+++++|.++
T Consensus 14 g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~l~~~ 92 (260)
T cd08222 14 GTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER-DAFCIITEYCEGRDLDCK 92 (260)
T ss_pred ceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC-CceEEEEEeCCCCCHHHH
Confidence 48999887 334455554431 355789999999999999999988754 478999999999999999
Q ss_pred hccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC------
Q 047629 409 LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------ 482 (615)
Q Consensus 409 L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------ 482 (615)
+....... ..+++.++..++.|++.||.|||+.+ ++|+||||+||++++ ..+|++|||+++...
T Consensus 93 ~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~~~ 162 (260)
T cd08222 93 LEELKHTG------KTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCDLA 162 (260)
T ss_pred HHHHhhcc------cccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecCCCcccc
Confidence 86532111 13899999999999999999999988 999999999999976 469999999875431
Q ss_pred -----------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcC
Q 047629 483 -----------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNL 545 (615)
Q Consensus 483 -----------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l 545 (615)
...+.++||||||+++|||++|+.|+..... ..... ....-..+.
T Consensus 163 ~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~-----------~~~~~~~~~- 224 (260)
T cd08222 163 TTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVL-----------RIVEGPTPS- 224 (260)
T ss_pred cCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHH-----------HHHcCCCCC-
Confidence 1134579999999999999999999854321 10000 111111222
Q ss_pred CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 546 ESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 546 ~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.+......+.+++.+||+.+|++||++.|+++.
T Consensus 225 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 225 ---LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred ---CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 233444568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-27 Score=248.06 Aligned_cols=221 Identities=23% Similarity=0.358 Sum_probs=160.2
Q ss_pred ceEEEEEE--CCeEEEEEEccH---------HHHHHHHHHHhcCCCCcccEEEEEEcCCC-----cEEEEEeecCCCCHH
Q 047629 343 KSVYRATI--DGKVLAVKKIKE---------DVTEELRILQRINHANLVKLMGVSSDSQG-----NRFLVYEYAENGSLD 406 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~---------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-----~~~lV~E~~~~GsL~ 406 (615)
+.||+|.. +++.||||++.. .+.+|+.++++++|+|++++.+++...+. ..++|+||+ +++|.
T Consensus 29 g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~ 107 (343)
T cd07851 29 GQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLN 107 (343)
T ss_pred eEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHH
Confidence 58999988 578999998752 35579999999999999999987654331 379999999 56999
Q ss_pred HhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC---
Q 047629 407 KWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN--- 483 (615)
Q Consensus 407 ~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~--- 483 (615)
+++... .+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.....
T Consensus 108 ~~~~~~-----------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~ 173 (343)
T cd07851 108 NIVKCQ-----------KLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMT 173 (343)
T ss_pred HHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccccccccccc
Confidence 998652 2899999999999999999999998 99999999999999999999999999864321
Q ss_pred ------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhH--HH----HHHHHHhh
Q 047629 484 ------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKV--EE----KREERLRN 539 (615)
Q Consensus 484 ------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~--~~----~~~~~~~~ 539 (615)
..+.++|||||||++|||++|+.||......+.. ..+...... +. ........
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~~~~ 250 (343)
T cd07851 174 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQL---KRIMNLVGTPDEELLQKISSESARN 250 (343)
T ss_pred CCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHhcCCCCHHHHhhccchhHHH
Confidence 2346899999999999999999998754321111 111110000 00 00000000
Q ss_pred hcC---CcCCCCC---ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 540 WMD---PNLESFY---PIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 540 ~~d---p~l~~~~---~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
++. ..-...+ .......+.+++.+|++.||++|||+.||+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 251 YIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 110 0000000 01124568899999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.4e-28 Score=272.61 Aligned_cols=216 Identities=30% Similarity=0.423 Sum_probs=168.5
Q ss_pred ccccccccccc----ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEE
Q 047629 332 TMNLSEHYSIG----KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLV 396 (615)
Q Consensus 332 t~~~~~~~~iG----~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV 396 (615)
+......+.+| |.||-++. +|+..|+|.++ +.+.+|+.++..++|||+|+++|+-.+.+ ..+|.
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe-kv~IF 1312 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE-KVYIF 1312 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHH-HHHHH
Confidence 33344445555 47888876 78999999875 24678999999999999999999866543 78999
Q ss_pred EeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecC
Q 047629 397 YEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFS 476 (615)
Q Consensus 397 ~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFG 476 (615)
||||++|+|.+.+...+. +++.....+..|++.|+.|||+++ ||||||||.||+||.++.+|++|||
T Consensus 1313 MEyC~~GsLa~ll~~gri----------~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFG 1379 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRI----------EDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFG 1379 (1509)
T ss_pred HHHhccCcHHHHHHhcch----------hhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeeccc
Confidence 999999999999976542 566667778899999999999999 9999999999999999999999999
Q ss_pred CCCCCCCC------------------------------CCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHH
Q 047629 477 LAAPATND------------------------------VMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREV 526 (615)
Q Consensus 477 la~~~~~~------------------------------~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 526 (615)
.|....+. ...+.||||+|||++||+|||+||...++ .|..+..+
T Consensus 1380 sa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-----e~aIMy~V 1454 (1509)
T KOG4645|consen 1380 SAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-----EWAIMYHV 1454 (1509)
T ss_pred ceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-----hhHHHhHH
Confidence 98654322 12367999999999999999999987654 23322221
Q ss_pred HhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 527 LKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 527 ~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
-. .--| ..|.....+-.+++..|++.||++|-++.|+++.
T Consensus 1455 ~~-----------gh~P----q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1455 AA-----------GHKP----QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred hc-----------cCCC----CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 10 0112 2344455566899999999999999888887765
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.4e-26 Score=234.36 Aligned_cols=212 Identities=16% Similarity=0.210 Sum_probs=147.4
Q ss_pred ceEEEEEEC-----CeEEEEEEcc---HHH---------------HHHHHHHHhcCCCCcccEEEEEEcCCCc---EEEE
Q 047629 343 KSVYRATID-----GKVLAVKKIK---EDV---------------TEELRILQRINHANLVKLMGVSSDSQGN---RFLV 396 (615)
Q Consensus 343 ~~Vy~~~~~-----g~~vAvK~~~---~~~---------------~~Ei~~l~~l~H~niv~l~g~~~~~~~~---~~lV 396 (615)
|.||+|... +..+|+|... +.+ ..+...+..++|+|++++++++...... .+++
T Consensus 26 G~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 105 (294)
T PHA02882 26 GCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFIL 105 (294)
T ss_pred ceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEecCCceEEEEE
Confidence 589999973 3466777532 111 1223344566899999999976543322 3677
Q ss_pred EeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecC
Q 047629 397 YEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFS 476 (615)
Q Consensus 397 ~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFG 476 (615)
+|+... ++.+.+.... ..++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 106 ~~~~~~-~~~~~~~~~~----------~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~~l~DFG 171 (294)
T PHA02882 106 LEKLVE-NTKEIFKRIK----------CKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYIIDYG 171 (294)
T ss_pred Eehhcc-CHHHHHHhhc----------cCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcEEEEEcC
Confidence 777643 6666665432 2568888999999999999999997 9999999999999999999999999
Q ss_pred CCCCCC------------------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHH
Q 047629 477 LAAPAT------------------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREV 526 (615)
Q Consensus 477 la~~~~------------------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 526 (615)
+++... ..++.++|||||||++|||++|+.||............ ..
T Consensus 172 la~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~--~~-- 247 (294)
T PHA02882 172 IASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA--AK-- 247 (294)
T ss_pred CceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH--hH--
Confidence 985321 11356899999999999999999999765332221100 00
Q ss_pred HhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047629 527 LKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNL 582 (615)
Q Consensus 527 ~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L 582 (615)
.+.+..+..+.+. .......+.+++..|++.+|++||++.++.+.|
T Consensus 248 -------~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 248 -------CDFIKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred -------HHHHHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 0001111111110 112345689999999999999999999999876
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-28 Score=235.88 Aligned_cols=207 Identities=26% Similarity=0.403 Sum_probs=169.2
Q ss_pred ceEEEEEE--CCeEEEEEEcc-----HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK-----EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKS 415 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-----~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~ 415 (615)
|+||++.. .|+.+|||++. .++..|+.+|++.+.+++|+++|.++.. ..+|+|||||.-|++.+.++..++
T Consensus 47 GSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~-sDLWIVMEYCGAGSiSDI~R~R~K- 124 (502)
T KOG0574|consen 47 GSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKH-SDLWIVMEYCGAGSISDIMRARRK- 124 (502)
T ss_pred hHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccC-CceEeehhhcCCCcHHHHHHHhcC-
Confidence 57888876 79999999986 4578899999999999999999987644 479999999999999999987765
Q ss_pred CCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC------------
Q 047629 416 SSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------------ 483 (615)
Q Consensus 416 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------------ 483 (615)
+|++..+..++.+-++||+|||... -+|||||+.||||+.++.+||+|||.|..+++
T Consensus 125 --------~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTVIGTP 193 (502)
T KOG0574|consen 125 --------PLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTVIGTP 193 (502)
T ss_pred --------CccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCccccCc
Confidence 4999999999999999999999987 79999999999999999999999999866532
Q ss_pred -----------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChH
Q 047629 484 -----------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPID 552 (615)
Q Consensus 484 -----------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~ 552 (615)
.+..++||||+|+.-.||..||+|+.....- +..+ .---.|...-.-|.+
T Consensus 194 FWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM---------RAIF----------MIPT~PPPTF~KPE~ 254 (502)
T KOG0574|consen 194 FWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM---------RAIF----------MIPTKPPPTFKKPEE 254 (502)
T ss_pred ccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc---------ceeE----------eccCCCCCCCCChHh
Confidence 2567899999999999999999998754321 0000 000011111123455
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 553 GALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 553 ~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
-...+-++++.|+-.+|++|-|+-+++++
T Consensus 255 WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 255 WSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred hhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 56678999999999999999999888875
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=242.89 Aligned_cols=222 Identities=23% Similarity=0.333 Sum_probs=157.1
Q ss_pred ceEEEEEE--CCeEEEEEEcc-------HHHHHHHHHHHhcCCCCcccEEEEEEcCC-------------CcEEEEEeec
Q 047629 343 KSVYRATI--DGKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVSSDSQ-------------GNRFLVYEYA 400 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-------------~~~~lV~E~~ 400 (615)
+.||+|.. +|+.||+|++. +.+.+|++++++++|+||+++++++.... ...++|+||+
T Consensus 19 g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~ 98 (342)
T cd07854 19 GLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM 98 (342)
T ss_pred EEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeecc
Confidence 48999987 68999999874 34778999999999999999998755332 2468999999
Q ss_pred CCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCC-CCcEEEeecCCCC
Q 047629 401 ENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDS-RFKAKIANFSLAA 479 (615)
Q Consensus 401 ~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~-~~~~kl~DFGla~ 479 (615)
+ ++|.+++... .+++.....++.|++.||.|||+++ ++||||||+||+++. +..+|++|||+++
T Consensus 99 ~-~~L~~~~~~~-----------~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~dfg~~~ 163 (342)
T cd07854 99 E-TDLANVLEQG-----------PLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLAR 163 (342)
T ss_pred c-ccHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEECCcccce
Confidence 7 5999888542 2889999999999999999999998 999999999999974 5678999999885
Q ss_pred CCC---------------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHH-
Q 047629 480 PAT---------------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEE- 531 (615)
Q Consensus 480 ~~~---------------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~- 531 (615)
... ...+.++|||||||++|||++|+.||......+... ...........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~ 241 (342)
T cd07854 164 IVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ--LILESVPVVREE 241 (342)
T ss_pred ecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHhcCCCChH
Confidence 321 113457999999999999999999996543211110 00000000000
Q ss_pred HHH---HHHhhhcC-CcCCCC-----CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 532 KRE---ERLRNWMD-PNLESF-----YPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 532 ~~~---~~~~~~~d-p~l~~~-----~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
... ..+...+. ...... ........+.+++..|++.||++||++.|++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 242 DRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred HhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 000 00000000 000000 011223457899999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.5e-27 Score=246.88 Aligned_cols=212 Identities=26% Similarity=0.380 Sum_probs=164.4
Q ss_pred ccccccccc----eEEEEEE--CCeEEEEEEccH---------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEee
Q 047629 335 LSEHYSIGK----SVYRATI--DGKVLAVKKIKE---------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEY 399 (615)
Q Consensus 335 ~~~~~~iG~----~Vy~~~~--~g~~vAvK~~~~---------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~ 399 (615)
+.-...||. .|..+.. .|..||||.+.+ .+.+|+++|+.++|||||+|+.+... ...+|+||||
T Consensus 58 y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t-~~~lylV~ey 136 (596)
T KOG0586|consen 58 YVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET-EATLYLVMEY 136 (596)
T ss_pred eeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee-cceeEEEEEe
Confidence 333444553 5666654 789999998864 35689999999999999999998764 4489999999
Q ss_pred cCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCC
Q 047629 400 AENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAA 479 (615)
Q Consensus 400 ~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~ 479 (615)
+.+|.+.+||..+.. +.......+..|+..+++|+|+++ |+|||||++|||||.++++||+|||++.
T Consensus 137 a~~ge~~~yl~~~gr----------~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~ 203 (596)
T KOG0586|consen 137 ASGGELFDYLVKHGR----------MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFST 203 (596)
T ss_pred ccCchhHHHHHhccc----------chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccce
Confidence 999999999988764 555778888999999999999998 9999999999999999999999999985
Q ss_pred CCCC-----------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHH
Q 047629 480 PATN-----------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREER 536 (615)
Q Consensus 480 ~~~~-----------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 536 (615)
.+.. ...+++|+||+||+||-|++|..||+...-.+. . +..
T Consensus 204 ~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L---r-------------~rv 267 (596)
T KOG0586|consen 204 FFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL---R-------------PRV 267 (596)
T ss_pred eecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc---c-------------chh
Confidence 5421 135789999999999999999999986431110 0 011
Q ss_pred HhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047629 537 LRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNL 582 (615)
Q Consensus 537 ~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L 582 (615)
++. .++ .|.-.....-++++..+-.+|.+|++++++.+.-
T Consensus 268 l~g----k~r--Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 268 LRG----KYR--IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred eee----eec--ccceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence 111 111 1111222346889999999999999999998863
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-26 Score=225.69 Aligned_cols=205 Identities=30% Similarity=0.442 Sum_probs=163.3
Q ss_pred ceEEEEEE--CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATI--DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
|.||+|.. +|+.+|+|++. +.+.+|++.+++++|+|++++.+++... ...++++||+++++|.+++...
T Consensus 3 g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~l~~e~~~~~~L~~~~~~~ 81 (244)
T smart00220 3 GKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDE-DKLYLVMEYCDGGDLFDLLKKR 81 (244)
T ss_pred eEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeC-CEEEEEEeCCCCCCHHHHHHhc
Confidence 47999998 47999999984 4678999999999999999999998754 4789999999999999999764
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC---------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN--------- 483 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~--------- 483 (615)
.. +++.++..++.+++.++.|||+.+ ++|+||+|+||++++++.++++|||.+.....
T Consensus 82 ~~----------~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 148 (244)
T smart00220 82 GR----------LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVG 148 (244)
T ss_pred cC----------CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeeccccccccccC
Confidence 32 789999999999999999999997 99999999999999999999999999764322
Q ss_pred -------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCC-CCC
Q 047629 484 -------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLE-SFY 549 (615)
Q Consensus 484 -------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~-~~~ 549 (615)
..+.++||||||++++||++|+.|+....+.+. ... . +. ..... ...
T Consensus 149 ~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~--~~~----~----------~~---~~~~~~~~~ 209 (244)
T smart00220 149 TPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE--LFK----K----------IG---KPKPPFPPP 209 (244)
T ss_pred CcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH--HHH----H----------Hh---ccCCCCccc
Confidence 245689999999999999999999865322111 000 0 00 00000 000
Q ss_pred ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047629 550 PIDGALSLATLARACTMDKSLSRPNMAEVVF 580 (615)
Q Consensus 550 ~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~ 580 (615)
.......+.+++.+|+..+|++||++.++++
T Consensus 210 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 210 EWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred cccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 0003456889999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.7e-26 Score=237.43 Aligned_cols=221 Identities=22% Similarity=0.308 Sum_probs=158.0
Q ss_pred ceEEEEEE--C--CeEEEEEEccH---------HHHHHHHHHHhc-CCCCcccEEEEEEcC---CCcEEEEEeecCCCCH
Q 047629 343 KSVYRATI--D--GKVLAVKKIKE---------DVTEELRILQRI-NHANLVKLMGVSSDS---QGNRFLVYEYAENGSL 405 (615)
Q Consensus 343 ~~Vy~~~~--~--g~~vAvK~~~~---------~~~~Ei~~l~~l-~H~niv~l~g~~~~~---~~~~~lV~E~~~~GsL 405 (615)
+.||++.. . ++.||+|+++. .+.+|+++++++ +|+||+++++.+... ....++++||+. ++|
T Consensus 14 g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L 92 (332)
T cd07857 14 GIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADL 92 (332)
T ss_pred eEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCH
Confidence 48999997 3 67899998752 356799999999 599999999875422 124688889886 699
Q ss_pred HHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC---
Q 047629 406 DKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT--- 482 (615)
Q Consensus 406 ~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~--- 482 (615)
.+++.... .+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++...
T Consensus 93 ~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 93 HQIIRSGQ----------PLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred HHHHhcCC----------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 99986543 3899999999999999999999998 9999999999999999999999999885321
Q ss_pred -------------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHH-------
Q 047629 483 -------------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVE------- 530 (615)
Q Consensus 483 -------------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~------- 530 (615)
...+.++|||||||++|||++|+.|+....... ....+...+...
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~ 236 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD---QLNQILQVLGTPDEETLSR 236 (332)
T ss_pred ccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH---HHHHHHHHhCCCCHHHHHh
Confidence 113457899999999999999999986543211 111111111000
Q ss_pred --HHHHHHHhhhcC--C--cCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 531 --EKREERLRNWMD--P--NLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 531 --~~~~~~~~~~~d--p--~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
...........+ + .+.... ......+.+++.+|++.||++||++.|++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 237 IGSPKAQNYIRSLPNIPKKPFESIF-PNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred hhhhhHHHHHHhccccCCcchHhhC-CCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000000 0 000000 1123468899999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=7e-26 Score=251.01 Aligned_cols=209 Identities=19% Similarity=0.268 Sum_probs=140.3
Q ss_pred HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHH
Q 047629 363 DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQ 442 (615)
Q Consensus 363 ~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~ 442 (615)
.+.+|+.+|++++|+||+++++++... +..++|+|++. ++|.+++........ ......+...|+.|++.||.
T Consensus 209 ~~~~Ei~il~~l~HpnIv~l~~~~~~~-~~~~lv~e~~~-~~l~~~l~~~~~~~~-----~~~~~~~~~~i~~ql~~aL~ 281 (501)
T PHA03210 209 QLENEILALGRLNHENILKIEEILRSE-ANTYMITQKYD-FDLYSFMYDEAFDWK-----DRPLLKQTRAIMKQLLCAVE 281 (501)
T ss_pred HHHHHHHHHHhCCCCCcCcEeEEEEEC-CeeEEEEeccc-cCHHHHHhhcccccc-----ccccHHHHHHHHHHHHHHHH
Confidence 367899999999999999999998754 47899999985 588888765432100 01345667789999999999
Q ss_pred HHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC------------------------CCCCCcccchhHHHHH
Q 047629 443 YMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------------------------NDVMPKFDVFAFGVVL 498 (615)
Q Consensus 443 yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------------------------~~~~~k~DV~SfGvvl 498 (615)
|||+++ |+||||||+|||++.++.+||+|||+++... ..++.++|||||||++
T Consensus 282 yLH~~g---IiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 358 (501)
T PHA03210 282 YIHDKK---LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLIL 358 (501)
T ss_pred HHHhCC---eecCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHH
Confidence 999998 9999999999999999999999999986431 1145679999999999
Q ss_pred HHHHcCCCC-CCCCCCChhHHHHHHHHHHHhHHHH---HHHHHhhhcCCc-C---CCCCC-----hHHHHHHHHHHHHhh
Q 047629 499 LELLSGKKA-TRTTENGKTAVLWKEIREVLKVEEK---REERLRNWMDPN-L---ESFYP-----IDGALSLATLARACT 565 (615)
Q Consensus 499 ~ElltG~~p-~~~~~~~~~~~l~~~~~~~~~~~~~---~~~~~~~~~dp~-l---~~~~~-----~~~~~~l~~l~~~C~ 565 (615)
|||++|+.+ +..........+.+.+......... ....+.+.++.. + ....+ ......+.+++.+|+
T Consensus 359 ~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL 438 (501)
T PHA03210 359 LDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKML 438 (501)
T ss_pred HHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHh
Confidence 999998854 3322221111111111100000000 000111111100 0 00000 011234677899999
Q ss_pred hcCCCCCCCHHHHHHH
Q 047629 566 MDKSLSRPNMAEVVFN 581 (615)
Q Consensus 566 ~~dP~~RPsm~ev~~~ 581 (615)
+.||++|||+.|++.+
T Consensus 439 ~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 439 TFDWHLRPGAAELLAL 454 (501)
T ss_pred ccCcccCcCHHHHhhC
Confidence 9999999999999875
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-27 Score=230.79 Aligned_cols=161 Identities=28% Similarity=0.436 Sum_probs=136.8
Q ss_pred ceEEEEEE----C--CeEEEEEEccH---------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATI----D--GKVLAVKKIKE---------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~----~--g~~vAvK~~~~---------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~ 407 (615)
|.||+++- + .+.+|+|+++. ...+|+.+++.++|+|++.|..++...+...++++||++. +|.+
T Consensus 38 G~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~ 116 (438)
T KOG0666|consen 38 GKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWH 116 (438)
T ss_pred ceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhhh-hHHH
Confidence 58999965 1 24789999974 3679999999999999999999888767789999999987 9999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCC----CcEEEeecCCCCCCCC
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSR----FKAKIANFSLAAPATN 483 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~----~~~kl~DFGla~~~~~ 483 (615)
.++-++.... ..++-..+..|+.||+.|+.|||+++ |+||||||.|||+..+ |++||+|||+++...+
T Consensus 117 II~fHr~~~~-----~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~ 188 (438)
T KOG0666|consen 117 IIKFHRASKA-----KQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIADLGLARLFNN 188 (438)
T ss_pred HHHHhccchh-----ccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeecccHHHHhhc
Confidence 9876654322 13788899999999999999999999 9999999999999877 9999999999976532
Q ss_pred ---------------------------CCCCcccchhHHHHHHHHHcCCCCCCCCC
Q 047629 484 ---------------------------DVMPKFDVFAFGVVLLELLSGKKATRTTE 512 (615)
Q Consensus 484 ---------------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~ 512 (615)
.+|++.||||.||++.||++-++-|...+
T Consensus 189 plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 189 PLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred cccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 36789999999999999999887776543
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=221.72 Aligned_cols=208 Identities=19% Similarity=0.369 Sum_probs=156.5
Q ss_pred ceEEEEEE--CCeEEEEEEccH--------HHHHHHHHHHhcC-CCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE--------DVTEELRILQRIN-HANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~--------~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
|.|++..+ .|...|||.|++ .+...++++.+-+ .|.||+.+||+..+ ...++.||.|.- .++..|+.
T Consensus 106 G~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n-~dV~IcMelMs~-C~ekLlkr 183 (391)
T KOG0983|consen 106 GQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN-TDVFICMELMST-CAEKLLKR 183 (391)
T ss_pred cceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC-chHHHHHHHHHH-HHHHHHHH
Confidence 68999998 679999999963 3455666666554 79999999999854 468899999954 56666665
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC--------
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN-------- 483 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~-------- 483 (615)
-.. ++++.-+=++...+.+||.||.++. .|+|||+||+|||+|+.|++|++|||++..+.+
T Consensus 184 ik~---------piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAhtrsA 252 (391)
T KOG0983|consen 184 IKG---------PIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHTRSA 252 (391)
T ss_pred hcC---------CchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccccccccc
Confidence 443 3777777788899999999998865 599999999999999999999999999844321
Q ss_pred -----------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCC
Q 047629 484 -----------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLE 546 (615)
Q Consensus 484 -----------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~ 546 (615)
.+.-++||||||+.|+||.||+.|+.....+ .+.+..+ .+-.-|.|.
T Consensus 253 GC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-----Fe~ltkv-----------ln~ePP~L~ 316 (391)
T KOG0983|consen 253 GCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-----FEVLTKV-----------LNEEPPLLP 316 (391)
T ss_pred CCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-----HHHHHHH-----------HhcCCCCCC
Confidence 1334789999999999999999999764321 1111111 111224443
Q ss_pred CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 547 SFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 547 ~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
+.. .....+.++...|+..|+.+||...+++++
T Consensus 317 ~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 317 GHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred ccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 211 134468999999999999999999999885
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=246.82 Aligned_cols=162 Identities=30% Similarity=0.445 Sum_probs=135.5
Q ss_pred ceEEEEEE--CCeEEEEEEccH--------HHHHHHHHHHhcCCCCcccEEEEEEcCC-----CcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATI--DGKVLAVKKIKE--------DVTEELRILQRINHANLVKLMGVSSDSQ-----GNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~--------~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~~lV~E~~~~GsL~~ 407 (615)
|.||+|.. .|+.||||.++. ...+|+++|++++|+|||++++.-.+.. ....+|||||.+|||..
T Consensus 27 g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~ 106 (732)
T KOG4250|consen 27 GNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRK 106 (732)
T ss_pred ceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHH
Confidence 48999996 799999998864 3678999999999999999999732211 13689999999999999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCC--CC--cEEEeecCCCCCCCC
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDS--RF--KAKIANFSLAAPATN 483 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~--~~--~~kl~DFGla~~~~~ 483 (615)
.|.+.... ..|+..+.+.+..+++.||.|||+++ |+||||||.||++-. ++ --||+|||.||...+
T Consensus 107 ~L~~PEN~-------~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d 176 (732)
T KOG4250|consen 107 VLNSPENA-------YGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDD 176 (732)
T ss_pred HhcCcccc-------cCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccccccCCC
Confidence 99875432 35999999999999999999999998 999999999999842 23 469999999987533
Q ss_pred -----------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCC
Q 047629 484 -----------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENG 514 (615)
Q Consensus 484 -----------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~ 514 (615)
.++..+|.|||||++||.+||..||......
T Consensus 177 ~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 177 NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 2456789999999999999999999875543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-26 Score=244.76 Aligned_cols=203 Identities=23% Similarity=0.300 Sum_probs=160.5
Q ss_pred eEEEEEE--CCeEEEEEEccHH---HHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCCCC
Q 047629 344 SVYRATI--DGKVLAVKKIKED---VTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSS 417 (615)
Q Consensus 344 ~Vy~~~~--~g~~vAvK~~~~~---~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~~ 417 (615)
.|-++.. +++..+||.+.+. ..+|+.++.+. +|+||+++.+.+.+. .+.|+|||.+.+|-|.+.+.....
T Consensus 337 ~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~~~-~~~~~v~e~l~g~ell~ri~~~~~--- 412 (612)
T KOG0603|consen 337 AVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYEDG-KEIYLVMELLDGGELLRRIRSKPE--- 412 (612)
T ss_pred ceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeecceecCC-ceeeeeehhccccHHHHHHHhcch---
Confidence 4555554 6788999999765 77899887776 799999999998754 479999999999988887765442
Q ss_pred CCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceee-CCCCcEEEeecCCCCCCCC-------------
Q 047629 418 SSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQL-DSRFKAKIANFSLAAPATN------------- 483 (615)
Q Consensus 418 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl-d~~~~~kl~DFGla~~~~~------------- 483 (615)
.. ..+..|+.+++.++.|||+++ +|||||||+|||+ ++.+.++|+|||.++....
T Consensus 413 -------~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~tp~~t~~y~A 481 (612)
T KOG0603|consen 413 -------FC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSCDTPALTLQYVA 481 (612)
T ss_pred -------hH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchhhcccchhhcccC
Confidence 33 778889999999999999998 9999999999999 5889999999999865432
Q ss_pred -------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHH
Q 047629 484 -------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALS 556 (615)
Q Consensus 484 -------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~ 556 (615)
.+++++|+||||++||||++|+.|+.....+.. +... +-.+ .+.......
T Consensus 482 PEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e------i~~~-------------i~~~----~~s~~vS~~ 538 (612)
T KOG0603|consen 482 PEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE------IHTR-------------IQMP----KFSECVSDE 538 (612)
T ss_pred hhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHH------HHHh-------------hcCC----ccccccCHH
Confidence 257799999999999999999999987665411 1111 1111 112333345
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 047629 557 LATLARACTMDKSLSRPNMAEVVFNLSV 584 (615)
Q Consensus 557 l~~l~~~C~~~dP~~RPsm~ev~~~L~~ 584 (615)
..+|+..|++.||.+||+|.|+...=..
T Consensus 539 AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 539 AKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHHHHHHhccCChhhCcChhhhccCcch
Confidence 6899999999999999999999886433
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-26 Score=243.11 Aligned_cols=207 Identities=24% Similarity=0.403 Sum_probs=165.2
Q ss_pred ceEEEEEE--CCeEEEEEEcc-------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
|.||+++. .+-..|-|.+. +++.-||+||....||+||+|++.+.. ++.+|+..|||.+|-.+..+-...
T Consensus 46 GKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~-enkLwiliEFC~GGAVDaimlEL~ 124 (1187)
T KOG0579|consen 46 GKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYF-ENKLWILIEFCGGGAVDAIMLELG 124 (1187)
T ss_pred hhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhc-cCceEEEEeecCCchHhHHHHHhc
Confidence 57999887 34455777774 468889999999999999999997664 458999999999999999887655
Q ss_pred CCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCC------------
Q 047629 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA------------ 481 (615)
Q Consensus 414 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~------------ 481 (615)
. .|+..++.-++.|++.+|.|||++. |||||||+.|||+.-+|.++|+|||.+...
T Consensus 125 r---------~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsFIG 192 (1187)
T KOG0579|consen 125 R---------VLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSFIG 192 (1187)
T ss_pred c---------ccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhHHhhhccccC
Confidence 4 4999999999999999999999998 999999999999999999999999987432
Q ss_pred ----------------CCCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcC
Q 047629 482 ----------------TNDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNL 545 (615)
Q Consensus 482 ----------------~~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l 545 (615)
..+|..++||||||++|.||..+.+|...... ++-.+ ++.+--.|.|
T Consensus 193 TPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp---------MRVll--------KiaKSePPTL 255 (1187)
T KOG0579|consen 193 TPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP---------MRVLL--------KIAKSEPPTL 255 (1187)
T ss_pred CcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch---------HHHHH--------HHhhcCCCcc
Confidence 12255689999999999999999998754331 11111 1111122333
Q ss_pred CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 546 ESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 546 ~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
..|..-...+.++.+.|+..||..||++.+++++
T Consensus 256 --lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 256 --LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred --cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 2345566678999999999999999999999874
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.6e-27 Score=222.42 Aligned_cols=206 Identities=24% Similarity=0.335 Sum_probs=155.6
Q ss_pred eEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 344 SVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 344 ~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
.||++.. .|+.+|+|.+. +++.+|+.|.+.++|||||+|..-.. .++..|+|+|+|++|+|..=+-..
T Consensus 26 vVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~-~~~~~ylvFe~m~G~dl~~eIV~R 104 (355)
T KOG0033|consen 26 VVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-EESFHYLVFDLVTGGELFEDIVAR 104 (355)
T ss_pred HHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhc-ccceeEEEEecccchHHHHHHHHH
Confidence 4555554 67888887764 45778999999999999999999754 566899999999999997655433
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCC---CcEEEeecCCCCCCC-------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSR---FKAKIANFSLAAPAT------- 482 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~---~~~kl~DFGla~~~~------- 482 (615)
. .+++...-....||+++|.|.|.++ |||||+||+|+||... --+|++|||+|....
T Consensus 105 ~----------~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G 171 (355)
T KOG0033|consen 105 E----------FYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWHG 171 (355)
T ss_pred H----------HHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeCCcccccc
Confidence 1 4788888899999999999999998 9999999999999654 358999999986543
Q ss_pred ---------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCC
Q 047629 483 ---------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLES 547 (615)
Q Consensus 483 ---------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~ 547 (615)
+.++..+|||+.||+||-|+.|+.||...+.. .+.+.+ .....| +.+
T Consensus 172 ~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---rlye~I-------------~~g~yd--~~~ 233 (355)
T KOG0033|consen 172 FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYEQI-------------KAGAYD--YPS 233 (355)
T ss_pred ccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---HHHHHH-------------hccccC--CCC
Confidence 23567899999999999999999999764321 111111 111111 111
Q ss_pred CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 548 FYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 548 ~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.+-.....+..+|+++++..||.+|.|+.|.+++
T Consensus 234 ~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 234 PEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred cccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 1112233456899999999999999999988764
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.1e-26 Score=206.12 Aligned_cols=222 Identities=20% Similarity=0.322 Sum_probs=161.6
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
|+||+|.. .++.||+|+++ ....+|+-+|+.++|+|||+++++.. ++..+.||+|||.. +|..|...
T Consensus 16 gtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlh-sdkkltlvfe~cdq-dlkkyfds 93 (292)
T KOG0662|consen 16 GTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-SDKKLTLVFEFCDQ-DLKKYFDS 93 (292)
T ss_pred eeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhc-cCceeEEeHHHhhH-HHHHHHHh
Confidence 58999886 67999999986 34789999999999999999999864 45579999999975 89998876
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCCC-------
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATND------- 484 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~------- 484 (615)
..+ .++......++.|+.+||.+.|++. +.|||+||.|.|++.++..|++|||+++...-.
T Consensus 94 lng---------~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvrcysae 161 (292)
T KOG0662|consen 94 LNG---------DLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAE 161 (292)
T ss_pred cCC---------cCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceEeeece
Confidence 654 2888889999999999999999998 999999999999999999999999999765321
Q ss_pred -----------------CCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHH-HHHHHhhhcCCcC
Q 047629 485 -----------------VMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEK-REERLRNWMDPNL 545 (615)
Q Consensus 485 -----------------~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~dp~l 545 (615)
+++..|+||-||++.|+.. |++-|...+-.+. ...+...+..... .=..+.+.-|-..
T Consensus 162 vvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddq---lkrif~~lg~p~ed~wps~t~lpdyk~ 238 (292)
T KOG0662|consen 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ---LKRIFRLLGTPTEDQWPSMTKLPDYKP 238 (292)
T ss_pred eeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHH---HHHHHHHhCCCccccCCccccCCCCcc
Confidence 5678999999999999998 5555544332111 1122222211100 0011222223222
Q ss_pred CCCCChH---------HHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 546 ESFYPID---------GALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 546 ~~~~~~~---------~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
-..||.. ....-.++....+.-+|..|.++++.++.
T Consensus 239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 2223321 11234567777788899999998877653
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-24 Score=248.88 Aligned_cols=123 Identities=28% Similarity=0.444 Sum_probs=109.9
Q ss_pred ceEEEEEE--CCeEEEEEEcc----------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIK----------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~----------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
+.||+|.. +++.||||+++ ..+..|+.++..++|+||+++++++... ...++||||+++|+|.+++.
T Consensus 18 g~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-~~~~lVmEy~~g~~L~~li~ 96 (669)
T cd05610 18 GKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSA-NNVYLVMEYLIGGDVKSLLH 96 (669)
T ss_pred eEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEEC-CEEEEEEeCCCCCCHHHHHH
Confidence 48999998 48999999986 3467899999999999999999887654 47999999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCC
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAA 479 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~ 479 (615)
... .+++...+.|+.||+.||+|||.++ |+||||||+|||++.++.+||+|||+++
T Consensus 97 ~~~----------~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 97 IYG----------YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred hcC----------CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 543 2788999999999999999999987 9999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=251.23 Aligned_cols=154 Identities=27% Similarity=0.407 Sum_probs=109.6
Q ss_pred EEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEe
Q 047629 394 FLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIA 473 (615)
Q Consensus 394 ~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~ 473 (615)
||-||||+.-.|+++++.+... -.-...+++..+|+.||.|+|+.+ ||||||||.||+||++..+||+
T Consensus 672 YIQMEyCE~~ll~~iI~~N~~~---------~~~d~~wrLFreIlEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIG 739 (1351)
T KOG1035|consen 672 YIQMEYCEKTLLRDIIRRNHFN---------SQRDEAWRLFREILEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIG 739 (1351)
T ss_pred EEEHhhhhhhHHHHHHHhcccc---------hhhHHHHHHHHHHHHHHHHHHhCc---eeeccCCcceeEEcCCCCeeec
Confidence 5556666665555555443320 024456889999999999999998 9999999999999999999999
Q ss_pred ecCCCCCCC--------------------------------------------CCCCCcccchhHHHHHHHHHcCCCCCC
Q 047629 474 NFSLAAPAT--------------------------------------------NDVMPKFDVFAFGVVLLELLSGKKATR 509 (615)
Q Consensus 474 DFGla~~~~--------------------------------------------~~~~~k~DV~SfGvvl~ElltG~~p~~ 509 (615)
|||+|.... ..++.|+|+||+|||++||+. ||.
T Consensus 740 DFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~ 816 (1351)
T KOG1035|consen 740 DFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFG 816 (1351)
T ss_pred ccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCC
Confidence 999996510 014569999999999999986 344
Q ss_pred CCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCC--CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 510 TTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESF--YPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 510 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~--~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
+..+ . ...+..+-++.+..+ +..+....=.+++.+++++||.+|||+.|++..
T Consensus 817 TsME--R-----------------a~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 817 TSME--R-----------------ASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred chHH--H-----------------HHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhc
Confidence 3211 0 112222223433322 333444455899999999999999999999874
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-25 Score=218.09 Aligned_cols=211 Identities=18% Similarity=0.280 Sum_probs=161.9
Q ss_pred ceEEEEEE--CCeEEEEEEcc--HHHHHHHHHHHhc-CCCCcccEEEEEEcC---CCcEEEEEeecCCCCHHHhhccCCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK--EDVTEELRILQRI-NHANLVKLMGVSSDS---QGNRFLVYEYAENGSLDKWLHPKSK 414 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~--~~~~~Ei~~l~~l-~H~niv~l~g~~~~~---~~~~~lV~E~~~~GsL~~~L~~~~~ 414 (615)
|.|-.+.. +|+.+|+|.+. ...++|++..-+. .|+|||.+++++.+. ...+++|||.|++|.|.+.+..++.
T Consensus 76 GkV~~C~~k~T~ekfALKvL~Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~ 155 (400)
T KOG0604|consen 76 GKVVQCVHKRTQEKFALKVLLDSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGD 155 (400)
T ss_pred CceEEEEeccchhhhHHHHHhcCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHccc
Confidence 55665554 68899999996 4688999987766 699999999987532 2247899999999999999987654
Q ss_pred CCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCC---CCcEEEeecCCCCCCCCC-------
Q 047629 415 SSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDS---RFKAKIANFSLAAPATND------- 484 (615)
Q Consensus 415 ~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~---~~~~kl~DFGla~~~~~~------- 484 (615)
. .+++.+.-+|+.||+.|+.|||+.. |.||||||+|+|... |-..||+|||+|+.....
T Consensus 156 ~--------afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc 224 (400)
T KOG0604|consen 156 Q--------AFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPC 224 (400)
T ss_pred c--------cchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccccccccCCCccccCCc
Confidence 2 4999999999999999999999998 999999999999965 456899999999865421
Q ss_pred ---------------CCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCC
Q 047629 485 ---------------VMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFY 549 (615)
Q Consensus 485 ---------------~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~ 549 (615)
+....|+||+||++|-|++|.+||......- +...++. +++ .. .-+|
T Consensus 225 ~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a---ispgMk~----------rI~---~g--qy~F 286 (400)
T KOG0604|consen 225 FTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---ISPGMKR----------RIR---TG--QYEF 286 (400)
T ss_pred ccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc---CChhHHh----------Hhh---cc--CccC
Confidence 3456899999999999999999998654311 0000111 111 00 1123
Q ss_pred Ch----HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047629 550 PI----DGALSLATLARACTMDKSLSRPNMAEVVFNL 582 (615)
Q Consensus 550 ~~----~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L 582 (615)
|. ...+...++++..++.+|.+|-|..|++..-
T Consensus 287 P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hp 323 (400)
T KOG0604|consen 287 PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHP 323 (400)
T ss_pred CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCc
Confidence 33 2344567899999999999999999998763
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.6e-25 Score=245.24 Aligned_cols=239 Identities=15% Similarity=0.189 Sum_probs=147.7
Q ss_pred ccccccccccc----ceEEEEEE--C----CeEEEEEEccHHHHHHHHHHHhcC---CCCcccEEEEE-----EcCCCcE
Q 047629 332 TMNLSEHYSIG----KSVYRATI--D----GKVLAVKKIKEDVTEELRILQRIN---HANLVKLMGVS-----SDSQGNR 393 (615)
Q Consensus 332 t~~~~~~~~iG----~~Vy~~~~--~----g~~vAvK~~~~~~~~Ei~~l~~l~---H~niv~l~g~~-----~~~~~~~ 393 (615)
.++|.....+| |.||+|.. + +..||||+++.....|+.+..+++ +.++..+...+ ...+...
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDEY 210 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhcccccccCCce
Confidence 45566666666 58999998 4 789999998754444444444433 23333222211 1234468
Q ss_pred EEEEeecCCCCHHHhhccCCCCCC----------CCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcee
Q 047629 394 FLVYEYAENGSLDKWLHPKSKSSS----------SSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQ 463 (615)
Q Consensus 394 ~lV~E~~~~GsL~~~L~~~~~~~~----------~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIL 463 (615)
++||||+++|+|.+++........ .........+..+..++.|++.||+|||+++ |+||||||+|||
T Consensus 211 ~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP~NIL 287 (566)
T PLN03225 211 WLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNII 287 (566)
T ss_pred EEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCHHHEE
Confidence 999999999999999975431100 0000001223456689999999999999997 999999999999
Q ss_pred eCC-CCcEEEeecCCCCCCCC----------------------------------------------CCCCcccchhHHH
Q 047629 464 LDS-RFKAKIANFSLAAPATN----------------------------------------------DVMPKFDVFAFGV 496 (615)
Q Consensus 464 ld~-~~~~kl~DFGla~~~~~----------------------------------------------~~~~k~DV~SfGv 496 (615)
++. ++.+||+|||+|+.... .+..++|||||||
T Consensus 288 l~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGv 367 (566)
T PLN03225 288 FSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 367 (566)
T ss_pred EeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHH
Confidence 986 58999999999964210 0123459999999
Q ss_pred HHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcC----CCCCC--hHHHHHHHHHHHHhhhcCCC
Q 047629 497 VLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNL----ESFYP--IDGALSLATLARACTMDKSL 570 (615)
Q Consensus 497 vl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l----~~~~~--~~~~~~l~~l~~~C~~~dP~ 570 (615)
+||||+++..+.+.. ...+...+... ..........+++.. ...+. ........+|+.+|++.||+
T Consensus 368 iL~el~~~~~~~~~~----~~~~~~~l~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 368 IFLQMAFPNLRSDSN----LIQFNRQLKRN----DYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred HHHHHHhCcCCCchH----HHHHHHHHHhc----CCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 999999977654321 11111111000 000011111111111 00000 01122345899999999999
Q ss_pred CCCCHHHHHHH
Q 047629 571 SRPNMAEVVFN 581 (615)
Q Consensus 571 ~RPsm~ev~~~ 581 (615)
+|||++|++++
T Consensus 440 kR~ta~e~L~H 450 (566)
T PLN03225 440 QRISAKAALAH 450 (566)
T ss_pred cCCCHHHHhCC
Confidence 99999999986
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.7e-25 Score=217.14 Aligned_cols=235 Identities=23% Similarity=0.302 Sum_probs=167.5
Q ss_pred eHHHHHHHcccccccccccceEEEEE--ECCeEEEEEEccH-------HHHHHHHHHHhc-CCCCcccEEEEEEcCCCcE
Q 047629 324 EIEVIMESTMNLSEHYSIGKSVYRAT--IDGKVLAVKKIKE-------DVTEELRILQRI-NHANLVKLMGVSSDSQGNR 393 (615)
Q Consensus 324 ~~~~l~~at~~~~~~~~iG~~Vy~~~--~~g~~vAvK~~~~-------~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 393 (615)
+++|+.+-|.+...++.-+ +|--++ .+|.++|||++.+ .+.+|++++.+. .|+||++|+.++.+. ..+
T Consensus 74 ~F~d~YkLt~e~LGeGAya-sVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd-~~F 151 (463)
T KOG0607|consen 74 KFEDMYKLTSELLGEGAYA-SVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD-TRF 151 (463)
T ss_pred hHHHHHHhHHHHhcCccce-eeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc-ceE
Confidence 3567766665533222221 333333 3899999999863 477899999998 599999999998754 489
Q ss_pred EEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCC---cE
Q 047629 394 FLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRF---KA 470 (615)
Q Consensus 394 ~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~---~~ 470 (615)
|||||-|.+|+|..++..... +++....++..+||.||.|||.++ |.||||||+|||..... -+
T Consensus 152 YLVfEKm~GGplLshI~~~~~----------F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPv 218 (463)
T KOG0607|consen 152 YLVFEKMRGGPLLSHIQKRKH----------FNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPV 218 (463)
T ss_pred EEEEecccCchHHHHHHHhhh----------ccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCce
Confidence 999999999999999987653 899999999999999999999998 99999999999996643 47
Q ss_pred EEeecCCCCCCC--C---------------------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCCh
Q 047629 471 KIANFSLAAPAT--N---------------------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGK 515 (615)
Q Consensus 471 kl~DFGla~~~~--~---------------------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~ 515 (615)
||+||.|..-.. + .+..+.|.||+|||||-|++|..||.+..+.+
T Consensus 219 KiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d 298 (463)
T KOG0607|consen 219 KICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD 298 (463)
T ss_pred eeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc
Confidence 999998763210 0 13468999999999999999999998765422
Q ss_pred hHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChH----HHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047629 516 TAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPID----GALSLATLARACTMDKSLSRPNMAEVVF 580 (615)
Q Consensus 516 ~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~----~~~~l~~l~~~C~~~dP~~RPsm~ev~~ 580 (615)
--+...++.+.-+ ...+..+-+. .-+||.+ ...+..+++...+..|+.+|-++.+++.
T Consensus 299 CGWdrGe~Cr~CQ-----~~LFesIQEG--kYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 299 CGWDRGEVCRVCQ-----NKLFESIQEG--KYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CCccCCCccHHHH-----HHHHHHHhcc--CCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 1110001111100 0111111111 1234442 2345677888888899999999988887
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.7e-26 Score=219.37 Aligned_cols=210 Identities=24% Similarity=0.377 Sum_probs=154.2
Q ss_pred ceEEEEEE--CCeEEEEEEcc--------HHHHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc-
Q 047629 343 KSVYRATI--DGKVLAVKKIK--------EDVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH- 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~--------~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~- 410 (615)
|.|+|=.. .|+..|||+++ +.+..|.+...+- +.||||+++|.++ .+|..|+.||.|.- ||+.+-+
T Consensus 78 G~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F-~EGdcWiCMELMd~-SlDklYk~ 155 (361)
T KOG1006|consen 78 GTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALF-SEGDCWICMELMDI-SLDKLYKR 155 (361)
T ss_pred hhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhh-cCCceeeeHHHHhh-hHHHHHHH
Confidence 46666555 68999999996 2466677765554 7899999999987 46789999999964 7665432
Q ss_pred --cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCC-------
Q 047629 411 --PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA------- 481 (615)
Q Consensus 411 --~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~------- 481 (615)
...+ ..+++.-+-.|..-..+||+||-+.- .|||||+||+|||||..|.+||+|||++..+
T Consensus 156 vy~vq~--------~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT 225 (361)
T KOG1006|consen 156 VYSVQK--------SRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKT 225 (361)
T ss_pred HHHHHh--------ccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHHHhh
Confidence 2221 13777777788888899999998764 5999999999999999999999999987332
Q ss_pred -----------------CCCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCc
Q 047629 482 -----------------TNDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPN 544 (615)
Q Consensus 482 -----------------~~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~ 544 (615)
...+.-++||||+|++|+|+.||+.|+.. |..+.+.+.. --.-||.
T Consensus 226 ~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~---------w~svfeql~~--------Vv~gdpp 288 (361)
T KOG1006|consen 226 VDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK---------WDSVFEQLCQ--------VVIGDPP 288 (361)
T ss_pred hccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch---------HHHHHHHHHH--------HHcCCCC
Confidence 11245689999999999999999999864 3333222210 0112222
Q ss_pred -CCCCC-ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 545 -LESFY-PIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 545 -l~~~~-~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
|..+. ..+....+.+++..|+-.|..+||+..++.+.
T Consensus 289 ~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 289 ILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred eecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 22111 12355679999999999999999999998764
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.7e-26 Score=215.46 Aligned_cols=219 Identities=22% Similarity=0.385 Sum_probs=164.5
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcC-------CCcEEEEEeecCCCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDS-------QGNRFLVYEYAENGS 404 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~-------~~~~~lV~E~~~~Gs 404 (615)
|.||++.. .|+.||+|+.- ....+|+++|..++|+|++.++..|... .+.+++|+++|+. +
T Consensus 31 geVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-D 109 (376)
T KOG0669|consen 31 GEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-D 109 (376)
T ss_pred HHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-h
Confidence 36887776 57889998763 2467899999999999999999887532 1237999999987 8
Q ss_pred HHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--
Q 047629 405 LDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-- 482 (615)
Q Consensus 405 L~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-- 482 (615)
|.-.|.+... .++...+.+++.++..||.|+|... |+|||+|+.|+|++.++..||+|||+++.+.
T Consensus 110 LaGlLsn~~v---------r~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar~fs~~ 177 (376)
T KOG0669|consen 110 LAGLLSNRKV---------RFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLARAFSTS 177 (376)
T ss_pred HHHHhcCccc---------cccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccccceecc
Confidence 9888876542 3889999999999999999999998 9999999999999999999999999996542
Q ss_pred --------------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHH-----
Q 047629 483 --------------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEE----- 531 (615)
Q Consensus 483 --------------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~----- 531 (615)
..++++.|||.-|||+.||++|.+-+....+.....+...+...+..+.
T Consensus 178 ~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d 257 (376)
T KOG0669|consen 178 KNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVD 257 (376)
T ss_pred cccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcc
Confidence 1256789999999999999999988877666555444333222111110
Q ss_pred ---------------HHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 532 ---------------KREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 532 ---------------~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
....++.+.+.|-.+ + ...++|+...+..||.+|+.+++++.+
T Consensus 258 ~lpL~~sie~ePl~~~~~rkv~n~~kp~~k-----d--~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 258 NLPLYQSIELEPLPKGQKRKVKNRLKPYVK-----D--DEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred cchHHHhccCCCCCcchhhhhhhhcccccC-----C--hhHHHHHHHHhccCcccCcchHhhhch
Confidence 001112222221111 1 135788999999999999999998865
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-24 Score=221.34 Aligned_cols=208 Identities=24% Similarity=0.403 Sum_probs=160.9
Q ss_pred eEEEEEE--CCeEEEEEEcc--------------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHH
Q 047629 344 SVYRATI--DGKVLAVKKIK--------------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407 (615)
Q Consensus 344 ~Vy~~~~--~g~~vAvK~~~--------------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~ 407 (615)
.||++.. ..+.||||.-. +...+|..|.+.+.||.||++++|+.-....++-|+|||++.+|+-
T Consensus 478 EVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDF 557 (775)
T KOG1151|consen 478 EVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDF 557 (775)
T ss_pred HHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhH
Confidence 7999875 67899999642 2356799999999999999999998644457899999999999999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCC---CCcEEEeecCCCCCCCCC
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDS---RFKAKIANFSLAAPATND 484 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~---~~~~kl~DFGla~~~~~~ 484 (615)
||+.++ .++++....|..||+.+|.||.+. +|||||-||||.||||.+ .|.+||.||||++.+.++
T Consensus 558 YLKQhk----------lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMddd 626 (775)
T KOG1151|consen 558 YLKQHK----------LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDD 626 (775)
T ss_pred HHHhhh----------hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhhhccCC
Confidence 998765 389999999999999999999998 688999999999999954 378999999999876432
Q ss_pred ----------------------------------CCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHH
Q 047629 485 ----------------------------------VMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVE 530 (615)
Q Consensus 485 ----------------------------------~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 530 (615)
++.|+||||.||++|..+.|++||.......... .
T Consensus 627 Sy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdIL-----q------ 695 (775)
T KOG1151|consen 627 SYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDIL-----Q------ 695 (775)
T ss_pred ccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHH-----h------
Confidence 4568999999999999999999997643221110 0
Q ss_pred HHHHHHHhhhcCCcCCCCCCh--HHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047629 531 EKREERLRNWMDPNLESFYPI--DGALSLATLARACTMDKSLSRPNMAEVVF 580 (615)
Q Consensus 531 ~~~~~~~~~~~dp~l~~~~~~--~~~~~l~~l~~~C~~~dP~~RPsm~ev~~ 580 (615)
...+.+.-. -.||. -...+..+++++|++..-++|....++..
T Consensus 696 ---eNTIlkAtE----VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 696 ---ENTILKATE----VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred ---hhchhccee----ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 111111111 11221 12234578999999999999988777655
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=229.79 Aligned_cols=238 Identities=17% Similarity=0.211 Sum_probs=156.9
Q ss_pred ccccccccccc----ceEEEEEE------------------CCeEEEEEEccH-------HH--------------HHHH
Q 047629 332 TMNLSEHYSIG----KSVYRATI------------------DGKVLAVKKIKE-------DV--------------TEEL 368 (615)
Q Consensus 332 t~~~~~~~~iG----~~Vy~~~~------------------~g~~vAvK~~~~-------~~--------------~~Ei 368 (615)
.++|...+.|| |.||+|.. +++.||||+++. +| ..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 45777777777 48999964 346799999752 22 2367
Q ss_pred HHHHhcCCCCc-----ccEEEEEEcC-------CCcEEEEEeecCCCCHHHhhccCCCCCC--------------CCCcc
Q 047629 369 RILQRINHANL-----VKLMGVSSDS-------QGNRFLVYEYAENGSLDKWLHPKSKSSS--------------SSGSV 422 (615)
Q Consensus 369 ~~l~~l~H~ni-----v~l~g~~~~~-------~~~~~lV~E~~~~GsL~~~L~~~~~~~~--------------~~~~~ 422 (615)
.++.+++|.++ ++++++|... ++..+|||||+++|+|.++|+....... .....
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77788877654 6788887531 3468999999999999999975321100 00001
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC-------------C-----
Q 047629 423 IFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN-------------D----- 484 (615)
Q Consensus 423 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~-------------~----- 484 (615)
..++|..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.... .
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 13678899999999999999999987 99999999999999999999999999853210 0
Q ss_pred ----------------------------CCCcccchhHHHHHHHHHcCCC-CCCCCCCChhHHHHHHHHHHHhHHHHHHH
Q 047629 485 ----------------------------VMPKFDVFAFGVVLLELLSGKK-ATRTTENGKTAVLWKEIREVLKVEEKREE 535 (615)
Q Consensus 485 ----------------------------~~~k~DV~SfGvvl~ElltG~~-p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 535 (615)
...+.||||+||+++||++|.. |+.....- .......-. ...
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f-----~~~~~~~~~----~~~ 451 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLF-----NTELRQYDN----DLN 451 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhh-----hhHHhhccc----hHH
Confidence 0124699999999999999875 55432110 000000000 000
Q ss_pred HHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCC---CCCCCHHHHHHH
Q 047629 536 RLRNWMDPNLESFYPIDGALSLATLARACTMDKS---LSRPNMAEVVFN 581 (615)
Q Consensus 536 ~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP---~~RPsm~ev~~~ 581 (615)
..+........-...........+|+.+++..+| .+|+|++|++++
T Consensus 452 ~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 452 RWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred HHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 0111100011000111223456889999998766 689999999875
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.4e-24 Score=231.78 Aligned_cols=209 Identities=19% Similarity=0.353 Sum_probs=169.2
Q ss_pred ceEEEEEE--CCeEEEEEEcc------HHHHHHHHHHHhc-CCCCcccEEEEEEc----CCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATI--DGKVLAVKKIK------EDVTEELRILQRI-NHANLVKLMGVSSD----SQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~------~~~~~Ei~~l~~l-~H~niv~l~g~~~~----~~~~~~lV~E~~~~GsL~~~L 409 (615)
+.||+++- +|+.+|+|++. ++...|.++|+.. +|||++.++|++.. .++++|||||||.+||..+.+
T Consensus 33 gkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLV 112 (953)
T KOG0587|consen 33 GKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLV 112 (953)
T ss_pred eeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHH
Confidence 67777765 78899999875 4577788889887 79999999998753 234699999999999999999
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------ 483 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------ 483 (615)
++.... .+.|..+.-|+..++.||.+||.+. ++|||||-.||||+.++.+|+.|||.++.++.
T Consensus 113 Kn~~g~--------rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~grRn 181 (953)
T KOG0587|consen 113 KNTKGN--------RLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVGRRN 181 (953)
T ss_pred hhhccc--------chhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeeeeeeccccccc
Confidence 876532 4999999999999999999999987 99999999999999999999999999865421
Q ss_pred ----------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhc
Q 047629 484 ----------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWM 541 (615)
Q Consensus 484 ----------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 541 (615)
.+...+|+||+|++-.||.-|.+|+.+... ++..+ .-.-
T Consensus 182 T~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP---------mraLF----------~IpR 242 (953)
T KOG0587|consen 182 TFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP---------MRALF----------LIPR 242 (953)
T ss_pred CcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch---------hhhhc----------cCCC
Confidence 145589999999999999999999876542 11111 1112
Q ss_pred CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 542 DPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 542 dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.|...-.-|..-..++-+++..|+..|-++||++.+++++
T Consensus 243 NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 243 NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 2333334466777789999999999999999999998874
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.2e-25 Score=237.79 Aligned_cols=209 Identities=23% Similarity=0.389 Sum_probs=154.1
Q ss_pred cccceEEEEEECCeEEEEEEccHH----HHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCC
Q 047629 340 SIGKSVYRATIDGKVLAVKKIKED----VTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSK 414 (615)
Q Consensus 340 ~iG~~Vy~~~~~g~~vAvK~~~~~----~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~ 414 (615)
.-|..||+|.+.|+.||||++-.+ ..+|+..|+.- +|+|||++++.-. .+...||..|.|. .+|++++.....
T Consensus 521 s~Gt~Vf~G~ye~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~-d~qF~YIalELC~-~sL~dlie~~~~ 598 (903)
T KOG1027|consen 521 SNGTVVFRGVYEGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQ-DRQFLYIALELCA-CSLQDLIESSGL 598 (903)
T ss_pred CCCcEEEEEeeCCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeecc-CCceEEEEehHhh-hhHHHHHhcccc
Confidence 335689999999999999999765 45899999988 7999999987643 3457899999996 599999987511
Q ss_pred CCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCC-----CCcEEEeecCCCCCCCCC-----
Q 047629 415 SSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDS-----RFKAKIANFSLAAPATND----- 484 (615)
Q Consensus 415 ~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~-----~~~~kl~DFGla~~~~~~----- 484 (615)
.. . ...-...+.+..|++.||++||+.+ ||||||||.||||+. ..+++|+|||+++....+
T Consensus 599 d~-~-----~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~ 669 (903)
T KOG1027|consen 599 DV-E-----MQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFS 669 (903)
T ss_pred ch-h-----hcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhh
Confidence 10 0 1111345677889999999999987 999999999999976 268999999999765321
Q ss_pred ---------------------CCCcccchhHHHHHHHHHcC-CCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcC
Q 047629 485 ---------------------VMPKFDVFAFGVVLLELLSG-KKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMD 542 (615)
Q Consensus 485 ---------------------~~~k~DV~SfGvvl~ElltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~d 542 (615)
-+..+|+||+|||+|..++| +.||...-..+... +...-
T Consensus 670 r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NI------------------l~~~~- 730 (903)
T KOG1027|consen 670 RLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANI------------------LTGNY- 730 (903)
T ss_pred cccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhh------------------hcCcc-
Confidence 13468999999999999995 78987543211110 00000
Q ss_pred CcCCCCCC-hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 543 PNLESFYP-IDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 543 p~l~~~~~-~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.+..--+ .++ +..+|+.++++.+|..||++.+|+.+
T Consensus 731 -~L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 731 -TLVHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred -ceeeeccCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 0100001 111 56899999999999999999999853
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.8e-24 Score=216.88 Aligned_cols=212 Identities=21% Similarity=0.263 Sum_probs=164.1
Q ss_pred ccccccccc----ceEEEEEE--CCeEEEEEEccHH----------HHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEE
Q 047629 334 NLSEHYSIG----KSVYRATI--DGKVLAVKKIKED----------VTEELRILQRINHANLVKLMGVSSDSQGNRFLVY 397 (615)
Q Consensus 334 ~~~~~~~iG----~~Vy~~~~--~g~~vAvK~~~~~----------~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~ 397 (615)
.|.....+| |.||.+.. +|+.+|.|++.+. ...|-.+|.+++.+.||.|--.+. ....++||+
T Consensus 186 ~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfe-Tkd~LClVL 264 (591)
T KOG0986|consen 186 TFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFE-TKDALCLVL 264 (591)
T ss_pred ceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeec-CCCceEEEE
Confidence 355555555 47888776 7999999988532 457999999999999998865554 455899999
Q ss_pred eecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCC
Q 047629 398 EYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSL 477 (615)
Q Consensus 398 E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGl 477 (615)
..|.+|+|.-+|.+.... .+++...+-++.+|+.||++||... ||.||+||+|||||++|+++|+|.||
T Consensus 265 tlMNGGDLkfHiyn~g~~--------gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGL 333 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGNP--------GFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGL 333 (591)
T ss_pred EeecCCceeEEeeccCCC--------CCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccce
Confidence 999999999999876642 3899999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCC----------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHH
Q 047629 478 AAPATN----------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREE 535 (615)
Q Consensus 478 a~~~~~----------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 535 (615)
|..... .++...|.||+||+||||+.|+.||....+. +-++++.+...
T Consensus 334 Avei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK---vk~eEvdrr~~------- 403 (591)
T KOG0986|consen 334 AVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK---VKREEVDRRTL------- 403 (591)
T ss_pred EEecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh---hhHHHHHHHHh-------
Confidence 954321 2456789999999999999999999754422 11222221110
Q ss_pred HHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCH
Q 047629 536 RLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNM 575 (615)
Q Consensus 536 ~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm 575 (615)
-| ..+|+.....+...+...-+..||++|---
T Consensus 404 -----~~---~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 404 -----ED---PEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred -----cc---hhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 01 134555555567888889999999998744
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.6e-24 Score=237.08 Aligned_cols=227 Identities=22% Similarity=0.254 Sum_probs=172.0
Q ss_pred ceeeeHHHHHHHccccccccccc----ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEE
Q 047629 320 PIVYEIEVIMESTMNLSEHYSIG----KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLM 383 (615)
Q Consensus 320 ~~~~~~~~l~~at~~~~~~~~iG----~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~ 383 (615)
|++-...+++-...+|.-...|| |.|...+. .++.+|.|++.+ -|.+|-++|..-+.+.|+.|.
T Consensus 62 p~v~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~Lh 141 (1317)
T KOG0612|consen 62 PIVKKVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLH 141 (1317)
T ss_pred HHHHHHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHH
Confidence 44555666776677777777777 46766666 689999999874 278899999999999999998
Q ss_pred EEEEcCCCcEEEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcee
Q 047629 384 GVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQ 463 (615)
Q Consensus 384 g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIL 463 (615)
-.+.+ +.++|+|||||+||+|-..|..... ++......++..|..||.-||+.| +|||||||.|||
T Consensus 142 yAFQD-~~~LYlVMdY~pGGDlltLlSk~~~----------~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvL 207 (1317)
T KOG0612|consen 142 YAFQD-ERYLYLVMDYMPGGDLLTLLSKFDR----------LPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVL 207 (1317)
T ss_pred HHhcC-ccceEEEEecccCchHHHHHhhcCC----------ChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeE
Confidence 77665 4589999999999999999976542 788888888999999999999999 999999999999
Q ss_pred eCCCCcEEEeecCCCCCCC-----------------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCC
Q 047629 464 LDSRFKAKIANFSLAAPAT-----------------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENG 514 (615)
Q Consensus 464 ld~~~~~kl~DFGla~~~~-----------------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~ 514 (615)
||.+|.+||+|||.+-.+. +.+.+.+|.||+||++|||+.|..||....
T Consensus 208 ld~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads-- 285 (1317)
T KOG0612|consen 208 LDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS-- 285 (1317)
T ss_pred ecccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH--
Confidence 9999999999999752221 235678999999999999999999997432
Q ss_pred hhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC--hHHHHHHHHHHHHhhhcCCCCCCC---HHHHHHH
Q 047629 515 KTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP--IDGALSLATLARACTMDKSLSRPN---MAEVVFN 581 (615)
Q Consensus 515 ~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~--~~~~~~l~~l~~~C~~~dP~~RPs---m~ev~~~ 581 (615)
+.. ...++|+-.=.-.|| .+......+|+++-+. +|+.|-. ..|+-.+
T Consensus 286 ----lve--------------TY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 286 ----LVE--------------TYGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred ----HHH--------------HHHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 121 122223321111233 2344456677766554 6677776 8887765
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-23 Score=208.90 Aligned_cols=225 Identities=21% Similarity=0.257 Sum_probs=162.3
Q ss_pred eEEEEEE--CCeEEEEEEcc------HHHHHHHHHHHhcCC--C----CcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 344 SVYRATI--DGKVLAVKKIK------EDVTEELRILQRINH--A----NLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 344 ~Vy~~~~--~g~~vAvK~~~------~~~~~Ei~~l~~l~H--~----niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
.|-.+.. .+..||||+++ +...-|+++|.++.+ | -+|.+.+|+ +-.+..++|+|.+ +-|+.+||
T Consensus 104 kV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF-dyrghiCivfell-G~S~~dFl 181 (415)
T KOG0671|consen 104 KVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF-DYRGHICIVFELL-GLSTFDFL 181 (415)
T ss_pred ceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh-hccCceEEEEecc-ChhHHHHh
Confidence 3444433 47889999987 345679999999942 2 256777765 4567899999998 34999999
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCC--------------------CCc
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDS--------------------RFK 469 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~--------------------~~~ 469 (615)
..+.. .+++..++..|+.|++++++|||+.+ ++|-||||+|||+.+ +..
T Consensus 182 k~N~y--------~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~ 250 (415)
T KOG0671|consen 182 KENNY--------IPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTA 250 (415)
T ss_pred ccCCc--------cccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccceeccCCCcc
Confidence 88654 35889999999999999999999998 999999999999831 345
Q ss_pred EEEeecCCCCCCCC--------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhH
Q 047629 470 AKIANFSLAAPATN--------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKV 529 (615)
Q Consensus 470 ~kl~DFGla~~~~~--------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~ 529 (615)
+||.|||.|..... +.+.++||||+||||.||.+|...|...++.+.+.+.+.+...+..
T Consensus 251 I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~ 330 (415)
T KOG0671|consen 251 IKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPS 330 (415)
T ss_pred eEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcH
Confidence 89999999865422 3567899999999999999999999888766554443333221111
Q ss_pred HHHHHH---H--HhhhcC---------------Cc-C---CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 530 EEKREE---R--LRNWMD---------------PN-L---ESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 530 ~~~~~~---~--~~~~~d---------------p~-l---~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.-..+. + -..-+| +. . .-.....+...+.+|+++++..||.+|+|++|++.+
T Consensus 331 ~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 331 RMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred HHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcC
Confidence 000000 0 001111 10 0 011223567789999999999999999999999864
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-23 Score=205.63 Aligned_cols=195 Identities=27% Similarity=0.354 Sum_probs=152.7
Q ss_pred CCeEEEEEEccHHH----------HHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCCCCCCC
Q 047629 351 DGKVLAVKKIKEDV----------TEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSG 420 (615)
Q Consensus 351 ~g~~vAvK~~~~~~----------~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~~~~~ 420 (615)
.|+.+|+|.+++++ ..|-.+|+.-+||.+..|.-.+ +....+++||||+.+|.|.-+|.+.+
T Consensus 192 t~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF-Qt~drlCFVMeyanGGeLf~HLsrer------- 263 (516)
T KOG0690|consen 192 TGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF-QTQDRLCFVMEYANGGELFFHLSRER------- 263 (516)
T ss_pred cCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh-ccCceEEEEEEEccCceEeeehhhhh-------
Confidence 78999999998753 3477889999999988776444 44558999999999999999987754
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCC-------------------
Q 047629 421 SVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA------------------- 481 (615)
Q Consensus 421 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~------------------- 481 (615)
.+++....-+...|..+|.|||+++ ||.||||.+|.|||.+|.+||+||||.+..
T Consensus 264 ---~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAP 337 (516)
T KOG0690|consen 264 ---VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAP 337 (516)
T ss_pred ---cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcccccceeccccCChhhcCc
Confidence 3788888889999999999999988 999999999999999999999999998642
Q ss_pred ----CCCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHH
Q 047629 482 ----TNDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSL 557 (615)
Q Consensus 482 ----~~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l 557 (615)
.+++...+|.|..|||+|||++|+.||...+.+....+ +-.+ | -.+|.....+.
T Consensus 338 EVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeL-------Il~e-----------d----~kFPr~ls~eA 395 (516)
T KOG0690|consen 338 EVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFEL-------ILME-----------D----LKFPRTLSPEA 395 (516)
T ss_pred hhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHH-------HHhh-----------h----ccCCccCCHHH
Confidence 23466789999999999999999999987654322111 1100 0 12344444456
Q ss_pred HHHHHHhhhcCCCCCCC-----HHHHHHH
Q 047629 558 ATLARACTMDKSLSRPN-----MAEVVFN 581 (615)
Q Consensus 558 ~~l~~~C~~~dP~~RPs-----m~ev~~~ 581 (615)
..|....+..||.+|-- ++||.++
T Consensus 396 ktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 396 KTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred HHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 77888899999999963 5566543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.6e-22 Score=191.91 Aligned_cols=173 Identities=38% Similarity=0.603 Sum_probs=150.3
Q ss_pred ceEEEEEEC--CeEEEEEEccH--------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATID--GKVLAVKKIKE--------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~~--g~~vAvK~~~~--------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
+.||++... |+.+++|.... .+.+|++.+++++|++++++++++... ...++++||+++++|.+++...
T Consensus 7 ~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~~~~e~~~~~~l~~~~~~~ 85 (215)
T cd00180 7 GTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDE-NHLYLVMEYCEGGSLKDLLKEN 85 (215)
T ss_pred eEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecC-CeEEEEEecCCCCcHHHHHHhc
Confidence 489999985 89999998853 377899999999999999999998754 4789999999999999999765
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCC-CCcEEEeecCCCCCCCC--------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDS-RFKAKIANFSLAAPATN-------- 483 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~-~~~~kl~DFGla~~~~~-------- 483 (615)
.. .+++..+..++.+++.++.|||+.+ ++|+||+|.||+++. +..++++|||.+.....
T Consensus 86 ~~---------~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 153 (215)
T cd00180 86 EG---------KLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI 153 (215)
T ss_pred cC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcc
Confidence 31 3889999999999999999999997 999999999999999 89999999998753321
Q ss_pred ----------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCC
Q 047629 484 ----------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLES 547 (615)
Q Consensus 484 ----------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~ 547 (615)
..+.+.|+|++|++++||
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 234679999999999998
Q ss_pred CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 548 FYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 548 ~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
..+.+++..|++.+|.+||++.++++.
T Consensus 188 -------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 235788999999999999999999865
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-23 Score=211.11 Aligned_cols=206 Identities=25% Similarity=0.351 Sum_probs=157.7
Q ss_pred cccccccccc--ceEEEEEEC--CeEEEEEEccHHH----------HHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEE
Q 047629 333 MNLSEHYSIG--KSVYRATID--GKVLAVKKIKEDV----------TEELRILQRI-NHANLVKLMGVSSDSQGNRFLVY 397 (615)
Q Consensus 333 ~~~~~~~~iG--~~Vy~~~~~--g~~vAvK~~~~~~----------~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~ 397 (615)
.+|....+-| |.|-.+... .+.+|||++++++ ..|-.+|.-- +-|.+++|..++.. -..+|+||
T Consensus 351 FnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT-mDRLyFVM 429 (683)
T KOG0696|consen 351 FNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT-MDRLYFVM 429 (683)
T ss_pred cceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh-hhheeeEE
Confidence 4454433333 456666654 4779999998763 2466666655 56678888776654 44899999
Q ss_pred eecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCC
Q 047629 398 EYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSL 477 (615)
Q Consensus 398 E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGl 477 (615)
||+.+|+|.-++..-++ +.++...-+|..||-||-+||+++ |+.||||..|||||.++.+||+|||+
T Consensus 430 EyvnGGDLMyhiQQ~Gk----------FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGm 496 (683)
T KOG0696|consen 430 EYVNGGDLMYHIQQVGK----------FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGM 496 (683)
T ss_pred EEecCchhhhHHHHhcc----------cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccc
Confidence 99999999988876554 677788899999999999999998 99999999999999999999999999
Q ss_pred CCCC-----------------------CCCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHH
Q 047629 478 AAPA-----------------------TNDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKRE 534 (615)
Q Consensus 478 a~~~-----------------------~~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 534 (615)
.+.. ...+...+|.|||||+||||+.|+.||+..++.+
T Consensus 497 cKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e------------------- 557 (683)
T KOG0696|consen 497 CKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE------------------- 557 (683)
T ss_pred ccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH-------------------
Confidence 8642 1225568999999999999999999998755322
Q ss_pred HHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCC
Q 047629 535 ERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPN 574 (615)
Q Consensus 535 ~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPs 574 (615)
....+++.+. .||.....+...+.+.-+-..|.+|--
T Consensus 558 -lF~aI~ehnv--syPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 558 -LFQAIMEHNV--SYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred -HHHHHHHccC--cCcccccHHHHHHHHHHhhcCCccccC
Confidence 1122233222 477777777888999999999998853
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.3e-23 Score=192.48 Aligned_cols=157 Identities=23% Similarity=0.405 Sum_probs=127.3
Q ss_pred eEEEEEECCeEEEEEEccH--------HHHHHHHHHHh-cCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCC
Q 047629 344 SVYRATIDGKVLAVKKIKE--------DVTEELRILQR-INHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSK 414 (615)
Q Consensus 344 ~Vy~~~~~g~~vAvK~~~~--------~~~~Ei~~l~~-l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~ 414 (615)
.+|+-..+|+..|||+++. ...+|+++..+ ...|.+|.++|...+ ++..|+.||.|.- ||+.|-..--.
T Consensus 63 ekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r-egdvwIcME~M~t-Sldkfy~~v~~ 140 (282)
T KOG0984|consen 63 EKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR-EGDVWICMELMDT-SLDKFYRKVLK 140 (282)
T ss_pred hheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc-cccEEEeHHHhhh-hHHHHHHHHHh
Confidence 4666667999999999863 35567776554 478999999998764 5689999999964 88877543221
Q ss_pred CCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC------------
Q 047629 415 SSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------------ 482 (615)
Q Consensus 415 ~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------------ 482 (615)
.. ..+++..+=+|+..|.+||.|||++- .++|||+||+|||++.+|++|++|||++..+.
T Consensus 141 ~g------~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt~daGCk 212 (282)
T KOG0984|consen 141 KG------GTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKTMDAGCK 212 (282)
T ss_pred cC------CcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhhhHHHHhcCCC
Confidence 11 13788889999999999999999986 59999999999999999999999999974331
Q ss_pred --------------CCCCCcccchhHHHHHHHHHcCCCCCCC
Q 047629 483 --------------NDVMPKFDVFAFGVVLLELLSGKKATRT 510 (615)
Q Consensus 483 --------------~~~~~k~DV~SfGvvl~ElltG~~p~~~ 510 (615)
..++-|+||||+|+.+.||.+++.|++.
T Consensus 213 pYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 213 PYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred ccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 1356799999999999999999999874
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-22 Score=191.18 Aligned_cols=219 Identities=20% Similarity=0.308 Sum_probs=159.6
Q ss_pred eEEEEEE--CCeEEEEEEcc----HHHHHHHHHHHhcC-CCCcccEEEEEEcCCC-cEEEEEeecCCCCHHHhhccCCCC
Q 047629 344 SVYRATI--DGKVLAVKKIK----EDVTEELRILQRIN-HANLVKLMGVSSDSQG-NRFLVYEYAENGSLDKWLHPKSKS 415 (615)
Q Consensus 344 ~Vy~~~~--~g~~vAvK~~~----~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~-~~~lV~E~~~~GsL~~~L~~~~~~ 415 (615)
.||.|.. +++.+.||.++ +.+.+|+.||..+. |+||++|++...+... ...|++||+.|-+....-.
T Consensus 53 EVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~----- 127 (338)
T KOG0668|consen 53 EVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYP----- 127 (338)
T ss_pred hHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhh-----
Confidence 7888884 78899999986 56889999999996 9999999998766543 3679999999977665432
Q ss_pred CCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCC-CcEEEeecCCCCCCCC-----------
Q 047629 416 SSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSR-FKAKIANFSLAAPATN----------- 483 (615)
Q Consensus 416 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~-~~~kl~DFGla~~~~~----------- 483 (615)
.|+-..+..++.++++||.|+|+.| |.|||+||.|+++|.. -..+|.|+|||.....
T Consensus 128 --------tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnVRVASR 196 (338)
T KOG0668|consen 128 --------TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR 196 (338)
T ss_pred --------hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCCCceeeeeeehh
Confidence 3777888999999999999999999 9999999999999975 5689999999954321
Q ss_pred ------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCC-hhHHHHHHHHHHHhHHHHHH--HHHhhhcCCcCCC-
Q 047629 484 ------------DVMPKFDVFAFGVVLLELLSGKKATRTTENG-KTAVLWKEIREVLKVEEKRE--ERLRNWMDPNLES- 547 (615)
Q Consensus 484 ------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~-~~~~l~~~~~~~~~~~~~~~--~~~~~~~dp~l~~- 547 (615)
.+.-.-|+|||||+|.+|+..++||....+. +..+- +..++..++... .+..--+||+..+
T Consensus 197 yfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVk---IakVLGt~el~~Yl~KY~i~Ldp~~~~i 273 (338)
T KOG0668|consen 197 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVK---IAKVLGTDELYAYLNKYQIDLDPQFEDI 273 (338)
T ss_pred hcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHH---HHHHhChHHHHHHHHHHccCCChhHhhH
Confidence 1344679999999999999999998765432 22221 222222111100 1111112332210
Q ss_pred --C---------CC---hH-HHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 548 --F---------YP---ID-GALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 548 --~---------~~---~~-~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
. .+ .. ...+.++++...+..|-.+|||++|.+.+
T Consensus 274 ~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 274 LGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred hhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 0 00 01 12457899999999999999999998764
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.4e-23 Score=211.18 Aligned_cols=205 Identities=22% Similarity=0.289 Sum_probs=154.1
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
|.||.|.. +|+.||||.+. ..+++|+.||.+++||.||.|.-.|...+ ..++|||-+ +|+..+.+-.
T Consensus 578 G~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~e-rvFVVMEKl-~GDMLEMILS 655 (888)
T KOG4236|consen 578 GTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPE-RVFVVMEKL-HGDMLEMILS 655 (888)
T ss_pred eeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCc-eEEEEehhh-cchHHHHHHH
Confidence 58999987 79999999885 34789999999999999999998887554 799999999 5676666654
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCC---CcEEEeecCCCCCCCCC----
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSR---FKAKIANFSLAAPATND---- 484 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~---~~~kl~DFGla~~~~~~---- 484 (615)
..+. .|+...-..+..||+.+|.|||.++ |+|+||||+||||.+. -++||+|||+|+.....
T Consensus 656 sEkg--------RL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRr 724 (888)
T KOG4236|consen 656 SEKG--------RLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRR 724 (888)
T ss_pred hhcc--------cchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhhh
Confidence 4432 3888888888999999999999998 9999999999999654 57999999999876432
Q ss_pred ------------------CCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCC
Q 047629 485 ------------------VMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLE 546 (615)
Q Consensus 485 ------------------~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~ 546 (615)
+...-|+||.||++|--++|..||...++-... +.. ..+|=|.-
T Consensus 725 sVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQ-----IQN------------AaFMyPp~- 786 (888)
T KOG4236|consen 725 SVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQ-----IQN------------AAFMYPPN- 786 (888)
T ss_pred hhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHH-----hhc------------cccccCCC-
Confidence 345679999999999999999999866542111 110 11121111
Q ss_pred CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047629 547 SFYPIDGALSLATLARACTMDKSLSRPNMAEVVF 580 (615)
Q Consensus 547 ~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~ 580 (615)
--.+.....++|+...++..-.+|-|.+.-+.
T Consensus 787 --PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 787 --PWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred --chhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 01122334567777777777777877765543
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.7e-22 Score=210.67 Aligned_cols=160 Identities=22% Similarity=0.334 Sum_probs=131.2
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.|..+.- +...+|.|.+++ .+.+|.+||..-.++.||+|+--+.+. ..+|+||||+++|++..+|.
T Consensus 643 GeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDk-dnLYFVMdYIPGGDmMSLLI 721 (1034)
T KOG0608|consen 643 GEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDK-DNLYFVMDYIPGGDMMSLLI 721 (1034)
T ss_pred ceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccC-CceEEEEeccCCccHHHHHH
Confidence 45555443 456789998864 256799999999999999999776654 48999999999999999998
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
+.+ .+.+.....++..+..++++.|..+ +|||||||.|||||.+|.+||+||||..-+.
T Consensus 722 rmg----------IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYY 788 (1034)
T KOG0608|consen 722 RMG----------IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 788 (1034)
T ss_pred Hhc----------cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceeccccccc
Confidence 755 2667777778889999999999998 9999999999999999999999999973210
Q ss_pred ---------------------------------------------------------CCCCCcccchhHHHHHHHHHcCC
Q 047629 483 ---------------------------------------------------------NDVMPKFDVFAFGVVLLELLSGK 505 (615)
Q Consensus 483 ---------------------------------------------------------~~~~~k~DV~SfGvvl~ElltG~ 505 (615)
..++..+|.||.|||||||+.|+
T Consensus 789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~ 868 (1034)
T KOG0608|consen 789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQ 868 (1034)
T ss_pred cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCC
Confidence 00234689999999999999999
Q ss_pred CCCCCCCCChh
Q 047629 506 KATRTTENGKT 516 (615)
Q Consensus 506 ~p~~~~~~~~~ 516 (615)
.||.....++.
T Consensus 869 ~pf~~~tp~~t 879 (1034)
T KOG0608|consen 869 PPFLADTPGET 879 (1034)
T ss_pred CCccCCCCCcc
Confidence 99987765544
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.1e-23 Score=197.60 Aligned_cols=226 Identities=22% Similarity=0.310 Sum_probs=161.0
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCC----CcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQ----GNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~~lV~E~~~~GsL~~ 407 (615)
|.||..+. +|+.||.|++. +.+.+|+++|.-++|.|+...++.-.... .++|++.|.|.. +|..
T Consensus 67 GVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQS-DLHK 145 (449)
T KOG0664|consen 67 GVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQS-DLHK 145 (449)
T ss_pred eEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHHh-hhhh
Confidence 46666665 79999999986 34668999999999999999988754222 136788999864 7887
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC----
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN---- 483 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~---- 483 (615)
.+-... .|+-..+.-+..||.+||.|||+.+ |.||||||.|.|++.|...||+|||+++....
T Consensus 146 IIVSPQ----------~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~ 212 (449)
T KOG0664|consen 146 IIVSPQ----------ALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL 212 (449)
T ss_pred eeccCC----------CCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchhhhh
Confidence 775433 4788888889999999999999998 99999999999999999999999999986532
Q ss_pred ---------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHH-------HH
Q 047629 484 ---------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKR-------EE 535 (615)
Q Consensus 484 ---------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~-------~~ 535 (615)
.++...||||.||++.||+-+|--|.....-+...+...+......+..+ ..
T Consensus 213 hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H 292 (449)
T KOG0664|consen 213 NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNH 292 (449)
T ss_pred hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHH
Confidence 26778999999999999999888777655444443332222211111111 11
Q ss_pred HHhhh-cCCcCCCCCC----hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047629 536 RLRNW-MDPNLESFYP----IDGALSLATLARACTMDKSLSRPNMAEVVFNL 582 (615)
Q Consensus 536 ~~~~~-~dp~l~~~~~----~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L 582 (615)
.++.- -.|.+..-|. .+.-.+...+....+..||++|.+..+.+..+
T Consensus 293 ~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 293 VLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 11111 1222222121 12223456777788899999999988887654
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2e-22 Score=198.62 Aligned_cols=212 Identities=20% Similarity=0.315 Sum_probs=154.6
Q ss_pred CCeEEEEEEccH---------HHHHHHHHHHhcCCCCcccEEEEEEcCC-----CcEEEEEeecCCCCHHHhhccCCCCC
Q 047629 351 DGKVLAVKKIKE---------DVTEELRILQRINHANLVKLMGVSSDSQ-----GNRFLVYEYAENGSLDKWLHPKSKSS 416 (615)
Q Consensus 351 ~g~~vAvK~~~~---------~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~~lV~E~~~~GsL~~~L~~~~~~~ 416 (615)
.++.||+|++.. ...+|..++..++|+||++++.++...+ .+.|+|||+|. ++|.+.+...
T Consensus 40 ~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~-~nl~~vi~~e---- 114 (369)
T KOG0665|consen 40 LGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMD-ANLCQVILME---- 114 (369)
T ss_pred ccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhh-hHHHHHHHHh----
Confidence 578999998853 4568999999999999999999875322 13689999996 5999888731
Q ss_pred CCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC-------------
Q 047629 417 SSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------------- 483 (615)
Q Consensus 417 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------------- 483 (615)
++-..+..|..|++.|+.|||+.+ |+||||||+||++..+..+||.|||+|+....
T Consensus 115 --------lDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyy 183 (369)
T KOG0665|consen 115 --------LDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDFMMTPYVVTRYY 183 (369)
T ss_pred --------cchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcccCcccccCchhheeec
Confidence 677788899999999999999998 99999999999999999999999999975421
Q ss_pred ---------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHH-----HHHHHh-----------
Q 047629 484 ---------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEK-----REERLR----------- 538 (615)
Q Consensus 484 ---------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~-----~~~~~~----------- 538 (615)
.+.+++||||.||++.||++|+--|.+.+ ....|..+.+.++..+. .....+
T Consensus 184 rapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d---~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~ 260 (369)
T KOG0665|consen 184 RAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD---HIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQA 260 (369)
T ss_pred cCchheeccCCcccchhhhhhhHHHHHhhceEEecCch---HHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhc
Confidence 24578999999999999999998776432 22233322222211000 000000
Q ss_pred ----hhc-CCcC--CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 539 ----NWM-DPNL--ESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 539 ----~~~-dp~l--~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
+.+ |... ..+.+.-......+++.+++-.||++|-|.++++.+
T Consensus 261 ~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 261 ISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred cchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 000 0000 011122234457899999999999999999999875
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2e-22 Score=235.57 Aligned_cols=174 Identities=16% Similarity=0.236 Sum_probs=124.0
Q ss_pred HhcCC-CCcccEEEEEEc------CCCcEEEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHH
Q 047629 372 QRINH-ANLVKLMGVSSD------SQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYM 444 (615)
Q Consensus 372 ~~l~H-~niv~l~g~~~~------~~~~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yL 444 (615)
+.++| .||+++++++.. .+..+++++||+ .++|.++|..... .+++.+++.++.||+.||+||
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~---------~~~~~~~~~i~~qi~~al~~l 96 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDR---------SVDAFECFHVFRQIVEIVNAA 96 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccc---------cccHHHHHHHHHHHHHHHHHH
Confidence 34556 688888887621 112467788988 5699999975332 389999999999999999999
Q ss_pred HhCCCCCeEecCCCCCceeeC-------------------CCCcEEEeecCCCCCC------------------------
Q 047629 445 HEHAQPSIVHRDIRTNNIQLD-------------------SRFKAKIANFSLAAPA------------------------ 481 (615)
Q Consensus 445 H~~~~~~ivHrDlk~~NILld-------------------~~~~~kl~DFGla~~~------------------------ 481 (615)
|+++ |+||||||+||||+ .++.+|++|||+++..
T Consensus 97 H~~g---IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (793)
T PLN00181 97 HSQG---IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQI 173 (793)
T ss_pred HhCC---eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCccccc
Confidence 9998 99999999999994 4566788888887531
Q ss_pred ---------------CCCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCC
Q 047629 482 ---------------TNDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLE 546 (615)
Q Consensus 482 ---------------~~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~ 546 (615)
...++.++|||||||+||||++|..|+.... ..+... ......+...
T Consensus 174 ~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--------~~~~~~----------~~~~~~~~~~ 235 (793)
T PLN00181 174 LAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--------RTMSSL----------RHRVLPPQIL 235 (793)
T ss_pred ccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--------HHHHHH----------HHhhcChhhh
Confidence 1124578999999999999999988754211 000000 0001111111
Q ss_pred CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 547 SFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 547 ~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
........++.+||+.+|.+||+|.|++++
T Consensus 236 -----~~~~~~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 236 -----LNWPKEASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred -----hcCHHHHHHHHHhCCCChhhCcChHHHhhc
Confidence 112235678899999999999999999875
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.9e-22 Score=206.23 Aligned_cols=197 Identities=22% Similarity=0.297 Sum_probs=154.5
Q ss_pred eEEEEEECCeE--EEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 344 SVYRATIDGKV--LAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 344 ~Vy~~~~~g~~--vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
.|-....+++. +|+|.+++ .+..|-.||...+.+.||+|+.-+.+.+ ..|+.||-|-+|.|...|+.
T Consensus 435 RVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~k-yvYmLmEaClGGElWTiLrd 513 (732)
T KOG0614|consen 435 RVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSK-YVYMLMEACLGGELWTILRD 513 (732)
T ss_pred eEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccch-hhhhhHHhhcCchhhhhhhh
Confidence 55555555544 78888863 3567999999999999999999887654 78999999999999999987
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCCC-------
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATND------- 484 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~------- 484 (615)
.+. ++......++..+..|++|||+++ ||.|||||+|.+||.+|-+||.|||+|+.....
T Consensus 514 Rg~----------Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTwTFc 580 (732)
T KOG0614|consen 514 RGS----------FDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTWTFC 580 (732)
T ss_pred cCC----------cccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCCceeeec
Confidence 653 777777888999999999999998 999999999999999999999999999765322
Q ss_pred ---------------CCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCC
Q 047629 485 ---------------VMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFY 549 (615)
Q Consensus 485 ---------------~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~ 549 (615)
....+|.||+|++++||++|++||...+.-... ...+. -+| .-.+
T Consensus 581 GTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktY------n~ILk-----------Gid---~i~~ 640 (732)
T KOG0614|consen 581 GTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTY------NLILK-----------GID---KIEF 640 (732)
T ss_pred CCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHH------HHHHh-----------hhh---hhhc
Confidence 234789999999999999999999876642211 11111 011 0124
Q ss_pred ChHHHHHHHHHHHHhhhcCCCCCCC
Q 047629 550 PIDGALSLATLARACTMDKSLSRPN 574 (615)
Q Consensus 550 ~~~~~~~l~~l~~~C~~~dP~~RPs 574 (615)
|........+|++..+..+|.+|--
T Consensus 641 Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 641 PRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred ccccchhHHHHHHHHHhcCcHhhhc
Confidence 5555556788999999999999875
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-21 Score=188.32 Aligned_cols=214 Identities=21% Similarity=0.357 Sum_probs=165.1
Q ss_pred ceEEEEEECCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATIDGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
|..|+|.|.|..+.+|.++ .+|..|.--|+-+.||||+.++|.|... .++.++..||+.|||+..|++..
T Consensus 204 gelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp-pnlv~isq~mp~gslynvlhe~t 282 (448)
T KOG0195|consen 204 GELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP-PNLVIISQYMPFGSLYNVLHEQT 282 (448)
T ss_pred cccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC-CCceEeeeeccchHHHHHHhcCc
Confidence 5799999988888778764 5788999999999999999999999755 47899999999999999999765
Q ss_pred CCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEe--ecCCCCCCCC--------
Q 047629 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIA--NFSLAAPATN-------- 483 (615)
Q Consensus 414 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~--DFGla~~~~~-------- 483 (615)
. ...+-.|..+++.++|+|++|||+.. |-|..-.|.++.+++|++..++|+ |--++....+
T Consensus 283 ~--------vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsfqe~gr~y~pawm 353 (448)
T KOG0195|consen 283 S--------VVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQEVGRAYSPAWM 353 (448)
T ss_pred c--------EEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeeeeccccccCcccC
Confidence 3 24788899999999999999999984 545555799999999999988875 3222211111
Q ss_pred -----------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChH
Q 047629 484 -----------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPID 552 (615)
Q Consensus 484 -----------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~ 552 (615)
.--..+|+|||.++||||.|+..||....+-+--. ++.=..|+-..|..
T Consensus 354 spealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm--------------------kialeglrv~ippg 413 (448)
T KOG0195|consen 354 SPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM--------------------KIALEGLRVHIPPG 413 (448)
T ss_pred CHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh--------------------hhhhccccccCCCC
Confidence 01236899999999999999999997654321110 00001222334555
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 047629 553 GALSLATLARACTMDKSLSRPNMAEVVFNLSVLT 586 (615)
Q Consensus 553 ~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~ 586 (615)
....+.+|+.-|+++||.+||.++.|+-.|+++.
T Consensus 414 is~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 414 ISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 5667899999999999999999999999998764
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.8e-20 Score=178.12 Aligned_cols=151 Identities=20% Similarity=0.190 Sum_probs=109.3
Q ss_pred CCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC
Q 047629 403 GSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT 482 (615)
Q Consensus 403 GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~ 482 (615)
|+|.+++..... .++|.+++.|+.|++.||.|||+++ ||+|||++.++.+|+ ||+++...
T Consensus 1 GsL~~~l~~~~~---------~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~ 60 (176)
T smart00750 1 VSLADILEVRGR---------PLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKT 60 (176)
T ss_pred CcHHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeec
Confidence 789999976432 3999999999999999999999885 999999999999999 99886431
Q ss_pred ------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCc
Q 047629 483 ------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPN 544 (615)
Q Consensus 483 ------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~ 544 (615)
..++.++|||||||++|||++|+.|+........ . +.... ..... .++.
T Consensus 61 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-~----~~~~~-------~~~~~-~~~~ 127 (176)
T smart00750 61 PEQSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA-I----LEILL-------NGMPA-DDPR 127 (176)
T ss_pred cccCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH-H----HHHHH-------HHhcc-CCcc
Confidence 2356789999999999999999999864332111 0 00000 00000 0000
Q ss_pred CCCCCChHHH--HHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 047629 545 LESFYPIDGA--LSLATLARACTMDKSLSRPNMAEVVFNLSVLTQ 587 (615)
Q Consensus 545 l~~~~~~~~~--~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~ 587 (615)
- ...+.... ..+.+++.+||+.||.+||++.|+++++..+..
T Consensus 128 ~-~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 128 D-RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred c-cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 0 01111222 258999999999999999999999999876643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.3e-20 Score=180.75 Aligned_cols=155 Identities=35% Similarity=0.521 Sum_probs=134.0
Q ss_pred ceEEEEEE--CCeEEEEEEccH--------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATI--DGKVLAVKKIKE--------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~--------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
+.||++.. +++.+|+|.... .+.+|++.+.+++|+|++++++++... ...++++||+++++|.+++...
T Consensus 13 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~ 91 (225)
T smart00221 13 GKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDP-EPLYLVMEYCEGGDLFDYLRKK 91 (225)
T ss_pred eEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecC-CceEEEEeccCCCCHHHHHHhc
Confidence 48999998 369999998852 466799999999999999999998754 4789999999999999999764
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC---------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN--------- 483 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~--------- 483 (615)
.. .+++..+..++.+++.++.|||+++ ++|+||+++||+++.++.++|+|||++.....
T Consensus 92 ~~---------~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 159 (225)
T smart00221 92 GG---------KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTV 159 (225)
T ss_pred cc---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccce
Confidence 32 1789999999999999999999997 99999999999999999999999998754321
Q ss_pred ----------------CCCCcccchhHHHHHHHHHcCCCCCCC
Q 047629 484 ----------------DVMPKFDVFAFGVVLLELLSGKKATRT 510 (615)
Q Consensus 484 ----------------~~~~k~DV~SfGvvl~ElltG~~p~~~ 510 (615)
..+.++|||+||++++||++|+.||..
T Consensus 160 ~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 160 KGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred eccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 123579999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.6e-21 Score=184.87 Aligned_cols=203 Identities=17% Similarity=0.277 Sum_probs=144.9
Q ss_pred CCeEEEEEEcc------HHHHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCCCCCCCccc
Q 047629 351 DGKVLAVKKIK------EDVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVI 423 (615)
Q Consensus 351 ~g~~vAvK~~~------~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~ 423 (615)
..+.+++|.+. .+|.+|..---.| .|.||+.-+....+..+..++++||+|.|+|..-+...+
T Consensus 48 s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~G---------- 117 (378)
T KOG1345|consen 48 SKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEAAG---------- 117 (378)
T ss_pred CceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCccc----------
Confidence 45789999885 4677777654444 699999887776666667889999999999998876532
Q ss_pred ccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeC--CCCcEEEeecCCCCCCCCC-----------------
Q 047629 424 FLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLD--SRFKAKIANFSLAAPATND----------------- 484 (615)
Q Consensus 424 ~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld--~~~~~kl~DFGla~~~~~~----------------- 484 (615)
+.+....+++.|++.|++|+|++. +||||||.+|||+- +..++||+|||+++..+..
T Consensus 118 -igE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~~~~~~~y~~pe~~~ 193 (378)
T KOG1345|consen 118 -IGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKYLEYVNNYHAPELCD 193 (378)
T ss_pred -ccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCceehhhhhhcccCCcHHHh
Confidence 778888999999999999999998 99999999999993 3458999999998764211
Q ss_pred --------CCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHH
Q 047629 485 --------VMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALS 556 (615)
Q Consensus 485 --------~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~ 556 (615)
..+.+|||.||++++.++||+.|+....-. ....|.|... .+-..+++...+.. ...+
T Consensus 194 ~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~-d~~Y~~~~~w------------~~rk~~~~P~~F~~-fs~~ 259 (378)
T KOG1345|consen 194 TVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM-DKPYWEWEQW------------LKRKNPALPKKFNP-FSEK 259 (378)
T ss_pred hccccceEecccccchheeeeeeeeecCCCcchhhhcc-CchHHHHHHH------------hcccCccCchhhcc-cCHH
Confidence 246789999999999999999999843211 1122332211 11112222222211 1234
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 557 LATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 557 l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
+.++-++-+.++|++|-...++-++
T Consensus 260 a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 260 ALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred HHHHHHHhcCCcccccchhHHHHHH
Confidence 5677788888899888555554443
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.4e-19 Score=187.01 Aligned_cols=117 Identities=24% Similarity=0.384 Sum_probs=95.7
Q ss_pred cccccc----ceEEEEEE--CCeEEEEEEccH------HHHHHHHHHHhcC-----C---CCcccEEEEEEcCC---CcE
Q 047629 337 EHYSIG----KSVYRATI--DGKVLAVKKIKE------DVTEELRILQRIN-----H---ANLVKLMGVSSDSQ---GNR 393 (615)
Q Consensus 337 ~~~~iG----~~Vy~~~~--~g~~vAvK~~~~------~~~~Ei~~l~~l~-----H---~niv~l~g~~~~~~---~~~ 393 (615)
...++| .+||.+.. +.+.||+|+.+. ....||++|++++ | .+||+|++.|.... .+.
T Consensus 82 v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HV 161 (590)
T KOG1290|consen 82 VQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHV 161 (590)
T ss_pred EEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEE
Confidence 344566 38998876 578999999983 3668999999983 3 36999999986432 247
Q ss_pred EEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceee
Q 047629 394 FLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQL 464 (615)
Q Consensus 394 ~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl 464 (615)
++|+|+. +-+|..++...... .++...+.+|+.||+.||.|||.++ .|||-||||+|||+
T Consensus 162 CMVfEvL-GdnLLklI~~s~Yr--------Glpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 162 CMVFEVL-GDNLLKLIKYSNYR--------GLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred EEEehhh-hhHHHHHHHHhCCC--------CCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 9999999 45899999876543 3899999999999999999999998 69999999999999
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.1e-20 Score=195.97 Aligned_cols=249 Identities=20% Similarity=0.253 Sum_probs=173.1
Q ss_pred eeeeHHHHHHHccccccccccc--ceEEEEEE--CCeEEEEEEccH------HHHHHHHHHHhcC------CCCcccEEE
Q 047629 321 IVYEIEVIMESTMNLSEHYSIG--KSVYRATI--DGKVLAVKKIKE------DVTEELRILQRIN------HANLVKLMG 384 (615)
Q Consensus 321 ~~~~~~~l~~at~~~~~~~~iG--~~Vy~~~~--~g~~vAvK~~~~------~~~~Ei~~l~~l~------H~niv~l~g 384 (615)
-.+.+.|+...........+-| +.|-+|.. .|+.||||+++. .-..|++||++|+ -.|+++|+-
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r 501 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFR 501 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence 3445666665544433332323 24445554 578999999973 2357999999995 347888888
Q ss_pred EEEcCCCcEEEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceee
Q 047629 385 VSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQL 464 (615)
Q Consensus 385 ~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl 464 (615)
.|... .++|||+|-+. -+|.+.|+.-+.. ..|....+..++.|+..+|.+|-..+ |+|.||||.|||+
T Consensus 502 ~F~hk-nHLClVFE~Ls-lNLRevLKKyG~n-------vGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLV 569 (752)
T KOG0670|consen 502 HFKHK-NHLCLVFEPLS-LNLREVLKKYGRN-------VGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILV 569 (752)
T ss_pred Hhhhc-ceeEEEehhhh-chHHHHHHHhCcc-------cceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEe
Confidence 76644 48999999885 4899999875542 34888999999999999999999988 9999999999999
Q ss_pred CCC-CcEEEeecCCCCCCCC---------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHH
Q 047629 465 DSR-FKAKIANFSLAAPATN---------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKE 522 (615)
Q Consensus 465 d~~-~~~kl~DFGla~~~~~---------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 522 (615)
++. ...||||||.|..... .+....|+||.||.||||.||+--|.+..+...+-+.-.
T Consensus 570 NE~k~iLKLCDfGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me 649 (752)
T KOG0670|consen 570 NESKNILKLCDFGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFME 649 (752)
T ss_pred ccCcceeeeccCccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHH
Confidence 986 5679999999855422 245578999999999999999999988776555444322
Q ss_pred HHHHHhHHHHHHHH-HhhhcC--------------------------C------cCC--CCCChH---HHHHHHHHHHHh
Q 047629 523 IREVLKVEEKREER-LRNWMD--------------------------P------NLE--SFYPID---GALSLATLARAC 564 (615)
Q Consensus 523 ~~~~~~~~~~~~~~-~~~~~d--------------------------p------~l~--~~~~~~---~~~~l~~l~~~C 564 (615)
+...+...-.+.+. ....+| | .|. ..++.+ ....+.+|...|
T Consensus 650 ~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkm 729 (752)
T KOG0670|consen 650 LKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKM 729 (752)
T ss_pred hcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHH
Confidence 22111111000000 011111 1 011 123443 345688999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 047629 565 TMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 565 ~~~dP~~RPsm~ev~~~ 581 (615)
+..||++|-|..|.+.+
T Consensus 730 l~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 730 LILDPEKRITVNQALKH 746 (752)
T ss_pred hccChhhcCCHHHHhcC
Confidence 99999999999988764
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.3e-20 Score=181.75 Aligned_cols=193 Identities=19% Similarity=0.342 Sum_probs=145.8
Q ss_pred CCeEEEEEEccHHH----------HHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCCCCCC
Q 047629 351 DGKVLAVKKIKEDV----------TEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSS 419 (615)
Q Consensus 351 ~g~~vAvK~~~~~~----------~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~~~~ 419 (615)
+.+.+|+|++++++ ..|-.+..+. +||.+|-|..++. .+..+++|.||+++|+|.-++.+.++
T Consensus 274 t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfq-tesrlffvieyv~ggdlmfhmqrqrk----- 347 (593)
T KOG0695|consen 274 TDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQ-TESRLFFVIEYVNGGDLMFHMQRQRK----- 347 (593)
T ss_pred cceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhc-ccceEEEEEEEecCcceeeehhhhhc-----
Confidence 56889999998753 3466666665 8999999987654 45579999999999999888776654
Q ss_pred CcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----------------
Q 047629 420 GSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----------------- 482 (615)
Q Consensus 420 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----------------- 482 (615)
|++.....+...|..+|.|||+++ ||.||||..|+|+|..+.+|++|+|+.+..-
T Consensus 348 -----lpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~~gd~tstfcgtpnyia 419 (593)
T KOG0695|consen 348 -----LPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIA 419 (593)
T ss_pred -----CcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCCCCcccccccCCCcccc
Confidence 889999999999999999999999 9999999999999999999999999986421
Q ss_pred ------CCCCCcccchhHHHHHHHHHcCCCCCCCCC--CChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHH
Q 047629 483 ------NDVMPKFDVFAFGVVLLELLSGKKATRTTE--NGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGA 554 (615)
Q Consensus 483 ------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~--~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~ 554 (615)
..+.-.+|.|++||+++||+.|+.||+-.. +.+... -+.+.+++ +.+ .+ ..|....
T Consensus 420 peilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~nt-edylfqvi---------lek----qi--riprsls 483 (593)
T KOG0695|consen 420 PEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNT-EDYLFQVI---------LEK----QI--RIPRSLS 483 (593)
T ss_pred hhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccch-hHHHHHHH---------hhh----cc--cccceee
Confidence 124457899999999999999999997532 111110 01111111 111 11 1344444
Q ss_pred HHHHHHHHHhhhcCCCCCC
Q 047629 555 LSLATLARACTMDKSLSRP 573 (615)
Q Consensus 555 ~~l~~l~~~C~~~dP~~RP 573 (615)
.+...+.+.-++.||.+|-
T Consensus 484 vkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 484 VKASHVLKGFLNKDPKERL 502 (593)
T ss_pred hhhHHHHHHhhcCCcHHhc
Confidence 5567888999999999885
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.6e-20 Score=193.08 Aligned_cols=153 Identities=25% Similarity=0.369 Sum_probs=129.5
Q ss_pred ceEEEEEE--CCeEEEEEEccHH---------------HHHHHHHHHhcC---CCCcccEEEEEEcCCCcEEEEEeecC-
Q 047629 343 KSVYRATI--DGKVLAVKKIKED---------------VTEELRILQRIN---HANLVKLMGVSSDSQGNRFLVYEYAE- 401 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~~---------------~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~~lV~E~~~- 401 (615)
|.|+.++. +...|.||.+.++ +..||.||..++ |+||+|+++++.+ ++..||++|-..
T Consensus 575 GkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd-dd~yyl~te~hg~ 653 (772)
T KOG1152|consen 575 GKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED-DDYYYLETEVHGE 653 (772)
T ss_pred ceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec-CCeeEEEecCCCC
Confidence 56777776 5678999988643 346999999997 9999999999875 458999999764
Q ss_pred CCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCC
Q 047629 402 NGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA 481 (615)
Q Consensus 402 ~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~ 481 (615)
+-+|.+++..+.. +++....-|..||+.|+++||+++ |||||||-+|+.+|.+|-+||.|||.|...
T Consensus 654 gIDLFd~IE~kp~----------m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgsaa~~ 720 (772)
T KOG1152|consen 654 GIDLFDFIEFKPR----------MDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGSAAYT 720 (772)
T ss_pred CcchhhhhhccCc----------cchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccchhhh
Confidence 4589999976543 899999999999999999999998 999999999999999999999999988654
Q ss_pred CCC----------------------CCCcccchhHHHHHHHHHcCCCCCC
Q 047629 482 TND----------------------VMPKFDVFAFGVVLLELLSGKKATR 509 (615)
Q Consensus 482 ~~~----------------------~~~k~DV~SfGvvl~ElltG~~p~~ 509 (615)
... ....-|||++|++||.++....|+.
T Consensus 721 ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 721 KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 221 2346799999999999998888875
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4e-19 Score=190.20 Aligned_cols=194 Identities=23% Similarity=0.384 Sum_probs=149.5
Q ss_pred HHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCC
Q 047629 371 LQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQP 450 (615)
Q Consensus 371 l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 450 (615)
|+.+.|.|+.+++|.+.+. +..+.|.+|+..|+|.+.+..... .++|.....+.++++.||+|||+..
T Consensus 1 l~~l~h~n~~~f~g~~~~~-~~~~~i~~~c~rGsl~D~i~~~~~---------~~d~~F~~s~~rdi~~Gl~ylh~s~-- 68 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-PEMIVIWEYCSRGSLLDILSNEDI---------KLDYFFILSFIRDISKGLAYLHNSP-- 68 (484)
T ss_pred CcccchhhhhhheeeEecC-CceEEEEeeecCccHHhHHhcccc---------CccHHHHHHHHHHHHHHHHHHhcCc--
Confidence 4568999999999999976 578999999999999999987443 4999999999999999999999753
Q ss_pred CeEecCCCCCceeeCCCCcEEEeecCCCCCCCC--------------------------------CCCCcccchhHHHHH
Q 047629 451 SIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN--------------------------------DVMPKFDVFAFGVVL 498 (615)
Q Consensus 451 ~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~--------------------------------~~~~k~DV~SfGvvl 498 (615)
-..|+.++++|+++|..+.+|++|||+...... ..+.+.||||||+++
T Consensus 69 i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~ 148 (484)
T KOG1023|consen 69 IGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIM 148 (484)
T ss_pred ceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHH
Confidence 349999999999999999999999999765521 035679999999999
Q ss_pred HHHHcCCCCCCCCCCChhH-HHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHH
Q 047629 499 LELLSGKKATRTTENGKTA-VLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAE 577 (615)
Q Consensus 499 ~ElltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~e 577 (615)
+|+++.+.||+........ .....+. ........|.+.... +....+..++..||.++|++||++++
T Consensus 149 ~ei~~r~~~~~~~~~~~~~~eii~~~~----------~~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~ 216 (484)
T KOG1023|consen 149 YEILFRSGPFDLRNLVEDPDEIILRVK----------KGGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQ 216 (484)
T ss_pred HHHHhccCccccccccCChHHHHHHHH----------hcCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHH
Confidence 9999999999874432221 1111111 011222333332111 33336899999999999999999999
Q ss_pred HHHHHHhcccc
Q 047629 578 VVFNLSVLTQS 588 (615)
Q Consensus 578 v~~~L~~l~~~ 588 (615)
|-..++.+...
T Consensus 217 i~~~~~~~~~~ 227 (484)
T KOG1023|consen 217 IRSKLLTINKG 227 (484)
T ss_pred HHhhhhhhccc
Confidence 99988876653
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=8.5e-20 Score=194.62 Aligned_cols=207 Identities=24% Similarity=0.366 Sum_probs=160.6
Q ss_pred ceEEEEEE--CCeEEEEEEccH-------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATI--DGKVLAVKKIKE-------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~-------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
|.|||++. .|+..|||.++- -...|+-+++.-+|+|||.++|-+...+ .+|+.||||.+|+|++.-+...
T Consensus 29 gdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~d-klwicMEycgggslQdiy~~Tg 107 (829)
T KOG0576|consen 29 GDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRD-KLWICMEYCGGGSLQDIYHVTG 107 (829)
T ss_pred cchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhc-CcEEEEEecCCCcccceeeecc
Confidence 57999887 789999999983 2567999999999999999999887544 7999999999999999776544
Q ss_pred CCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----------
Q 047629 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----------- 482 (615)
Q Consensus 414 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----------- 482 (615)
+|++.++..+++...+||+|||+.+ =+|||||-.|||+.+.+.+|++|||.+...+
T Consensus 108 ----------plselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati~KrksfiG 174 (829)
T KOG0576|consen 108 ----------PLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKSFIG 174 (829)
T ss_pred ----------cchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhhhhhhcccC
Confidence 3899999999999999999999998 7899999999999999999999999875432
Q ss_pred ---------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCC
Q 047629 483 ---------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLES 547 (615)
Q Consensus 483 ---------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~ 547 (615)
..+..++|||+.|+.-.|+-.-+.|...........+ +. -...-.|.+++
T Consensus 175 tpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~L-------mT--------kS~~qpp~lkD 239 (829)
T KOG0576|consen 175 TPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFL-------MT--------KSGFQPPTLKD 239 (829)
T ss_pred CccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHH-------hh--------ccCCCCCcccC
Confidence 1255689999999999999877777543322111100 00 01111223322
Q ss_pred CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047629 548 FYPIDGALSLATLARACTMDKSLSRPNMAEVVF 580 (615)
Q Consensus 548 ~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~ 580 (615)
+..-...+-++++.|+-.+|++||++..++.
T Consensus 240 --k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 240 --KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred --CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 2233345789999999999999999987665
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1e-18 Score=178.57 Aligned_cols=232 Identities=24% Similarity=0.326 Sum_probs=163.8
Q ss_pred cccccccccc----ceEEEEEE-----CCeEEEEEEcc-----HHHHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEE
Q 047629 333 MNLSEHYSIG----KSVYRATI-----DGKVLAVKKIK-----EDVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVY 397 (615)
Q Consensus 333 ~~~~~~~~iG----~~Vy~~~~-----~g~~vAvK~~~-----~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~ 397 (615)
+.+...+++| ++||+++. ..+.||+|.+. ..+.+|+++|..+ -+.||+++.++... ++...+|+
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rn-nd~v~ivl 114 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRN-NDQVAIVL 114 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhcc-CCeeEEEe
Confidence 4455555666 37888876 35789999986 4578999999999 59999999997654 45899999
Q ss_pred eecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCC-CcEEEeecC
Q 047629 398 EYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSR-FKAKIANFS 476 (615)
Q Consensus 398 E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~-~~~kl~DFG 476 (615)
||++.-...++... ++..++..++..+..||.++|.++ ||||||||+|+|.+.. .+-.|.|||
T Consensus 115 p~~~H~~f~~l~~~-------------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFg 178 (418)
T KOG1167|consen 115 PYFEHDRFRDLYRS-------------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFG 178 (418)
T ss_pred cccCccCHHHHHhc-------------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEech
Confidence 99999998888763 778889999999999999999998 9999999999999876 678999999
Q ss_pred CCCCC-----------------CC---------------------------------------------------CCCCc
Q 047629 477 LAAPA-----------------TN---------------------------------------------------DVMPK 488 (615)
Q Consensus 477 la~~~-----------------~~---------------------------------------------------~~~~k 488 (615)
||... .. .-+++
T Consensus 179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta 258 (418)
T KOG1167|consen 179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA 258 (418)
T ss_pred hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence 98410 00 02457
Q ss_pred ccchhHHHHHHHHHcCCCCCCCCCCChhH--HH-----HHHHHHHHhHHHH-----------HHHHHhhh--cC-CcC-C
Q 047629 489 FDVFAFGVVLLELLSGKKATRTTENGKTA--VL-----WKEIREVLKVEEK-----------REERLRNW--MD-PNL-E 546 (615)
Q Consensus 489 ~DV~SfGvvl~ElltG~~p~~~~~~~~~~--~l-----~~~~~~~~~~~~~-----------~~~~~~~~--~d-p~l-~ 546 (615)
+||||-||+++-+++++.||....++-.. .+ +..++..-...+. ..+....+ ++ ..+ .
T Consensus 259 iDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~ 338 (418)
T KOG1167|consen 259 IDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYK 338 (418)
T ss_pred cceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccc
Confidence 99999999999999999999765433211 10 0111111000000 00000000 10 000 0
Q ss_pred CCC-------ChH-HHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 547 SFY-------PID-GALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 547 ~~~-------~~~-~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.+. ..+ ....+++|..+|++.||.+|-|++|.+++
T Consensus 339 ~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 339 SRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred ccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 011 111 22367899999999999999999999875
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.5e-16 Score=167.44 Aligned_cols=115 Identities=22% Similarity=0.267 Sum_probs=93.0
Q ss_pred ceEEEEEE---CCeEEEEEEcc------------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATI---DGKVLAVKKIK------------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~---~g~~vAvK~~~------------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~ 407 (615)
|.||+|.. +|+.+|||++. ..+.+|+++|++++|+|++..+..+ +..++||||+++++|..
T Consensus 32 g~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~~~LVmE~~~G~~L~~ 107 (365)
T PRK09188 32 STVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GKDGLVRGWTEGVPLHL 107 (365)
T ss_pred EEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CCcEEEEEccCCCCHHH
Confidence 58999986 57888999852 2378999999999999999643221 35799999999999963
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCCceeeCCCCcEEEeecCCCCCC
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDI-RTNNIQLDSRFKAKIANFSLAAPA 481 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDl-k~~NILld~~~~~kl~DFGla~~~ 481 (615)
. .. .. ...++.+++.+|.|||+++ |+|||| ||+|||++.++++||+|||+|+..
T Consensus 108 ~-~~-------------~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~ 162 (365)
T PRK09188 108 A-RP-------------HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLASVF 162 (365)
T ss_pred h-Cc-------------cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence 2 11 11 1356789999999999998 999999 999999999999999999999754
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.9e-16 Score=152.78 Aligned_cols=122 Identities=22% Similarity=0.244 Sum_probs=95.7
Q ss_pred ceEEEEEE-CCeEEEEEEccHH----------------H-----------------HHHHHHHHhcCCCCcccEEEEEEc
Q 047629 343 KSVYRATI-DGKVLAVKKIKED----------------V-----------------TEELRILQRINHANLVKLMGVSSD 388 (615)
Q Consensus 343 ~~Vy~~~~-~g~~vAvK~~~~~----------------~-----------------~~Ei~~l~~l~H~niv~l~g~~~~ 388 (615)
+.||+|.. +|+.||||+++.+ | ..|++.+.++.|+++.....+..
T Consensus 11 ~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~~p~~~~~- 89 (190)
T cd05147 11 ANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIPCPEPILL- 89 (190)
T ss_pred eEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCcEEEe-
Confidence 48999987 7999999998532 1 23999999998887744333322
Q ss_pred CCCcEEEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHH-HhCCCCCeEecCCCCCceeeCCC
Q 047629 389 SQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYM-HEHAQPSIVHRDIRTNNIQLDSR 467 (615)
Q Consensus 389 ~~~~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrDlk~~NILld~~ 467 (615)
. ..+|||||++++++........ .+++.+..+++.|++.+|.|+ |+.+ |+||||||+|||++ +
T Consensus 90 ~--~~~iVmE~i~g~~l~~~~~~~~----------~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~ 153 (190)
T cd05147 90 K--SHVLVMEFIGDDGWAAPRLKDA----------PLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-D 153 (190)
T ss_pred c--CCEEEEEEeCCCCCcchhhhcC----------CCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-C
Confidence 2 2489999999887765432221 388999999999999999999 6777 99999999999998 4
Q ss_pred CcEEEeecCCCCCC
Q 047629 468 FKAKIANFSLAAPA 481 (615)
Q Consensus 468 ~~~kl~DFGla~~~ 481 (615)
+.++|.|||+|...
T Consensus 154 ~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 GKLYIIDVSQSVEH 167 (190)
T ss_pred CcEEEEEccccccC
Confidence 78999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=7.5e-16 Score=148.88 Aligned_cols=123 Identities=24% Similarity=0.258 Sum_probs=98.6
Q ss_pred ceEEEEEE-CCeEEEEEEccHH---------------------------------HHHHHHHHHhcCCCCcccEEEEEEc
Q 047629 343 KSVYRATI-DGKVLAVKKIKED---------------------------------VTEELRILQRINHANLVKLMGVSSD 388 (615)
Q Consensus 343 ~~Vy~~~~-~g~~vAvK~~~~~---------------------------------~~~Ei~~l~~l~H~niv~l~g~~~~ 388 (615)
+.||+|.. +|+.||||.++.. +..|.+.+.++.|+++.....+...
T Consensus 11 ~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 90 (190)
T cd05145 11 ANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVPVPEPILLK 90 (190)
T ss_pred cEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCCCceEEEec
Confidence 48999987 6999999987631 1368899999999988655544332
Q ss_pred CCCcEEEEEeecCCCCHHHh-hccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCceeeCC
Q 047629 389 SQGNRFLVYEYAENGSLDKW-LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHE-HAQPSIVHRDIRTNNIQLDS 466 (615)
Q Consensus 389 ~~~~~~lV~E~~~~GsL~~~-L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~NILld~ 466 (615)
..+|||||++++++... +.. . .++..+..+++.+++.++.++|+ .+ |+||||||+|||++
T Consensus 91 ---~~~lVmE~~~g~~~~~~~l~~-~----------~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 91 ---KNVLVMEFIGDDGSPAPRLKD-V----------PLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred ---CCEEEEEEecCCCchhhhhhh-c----------cCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 24899999998855433 322 1 26778899999999999999999 87 99999999999999
Q ss_pred CCcEEEeecCCCCCCCC
Q 047629 467 RFKAKIANFSLAAPATN 483 (615)
Q Consensus 467 ~~~~kl~DFGla~~~~~ 483 (615)
++.++|+|||+++....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 78999999999887654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=9.6e-16 Score=150.45 Aligned_cols=137 Identities=16% Similarity=0.155 Sum_probs=109.2
Q ss_pred ceEEEEEECCeEEEEEEccH------H----------HHHHHHHHHhcCCCCcccEEEEEEcC-------CCcEEEEEee
Q 047629 343 KSVYRATIDGKVLAVKKIKE------D----------VTEELRILQRINHANLVKLMGVSSDS-------QGNRFLVYEY 399 (615)
Q Consensus 343 ~~Vy~~~~~g~~vAvK~~~~------~----------~~~Ei~~l~~l~H~niv~l~g~~~~~-------~~~~~lV~E~ 399 (615)
+.||....++..+|||.++. . +.+|+..+.+++|++|.....+.... .+..+|||||
T Consensus 45 ~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEy 124 (232)
T PRK10359 45 TKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEY 124 (232)
T ss_pred eEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEE
Confidence 47888666778899999862 1 46889999999999999998875532 2357899999
Q ss_pred cCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCC
Q 047629 400 AENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAA 479 (615)
Q Consensus 400 ~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~ 479 (615)
+++.+|.++.. ++. ....+++.+|..+|+.+ ++|||+||+||+++.++ +++.|||..+
T Consensus 125 i~G~tL~~~~~--------------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~liDfg~~~ 182 (232)
T PRK10359 125 IEGVELNDMPE--------------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LRIIDLSGKR 182 (232)
T ss_pred ECCccHHHhhh--------------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EEEEECCCcc
Confidence 99999988732 222 23558899999999998 99999999999999988 9999999886
Q ss_pred CCCC-----------CCCCcccchhHHHHHHHH
Q 047629 480 PATN-----------DVMPKFDVFAFGVVLLEL 501 (615)
Q Consensus 480 ~~~~-----------~~~~k~DV~SfGvvl~El 501 (615)
.... .+..++|+||||+.+.-+
T Consensus 183 ~~~e~~a~d~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 183 CTAQRKAKDRIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred cccchhhHHHHHHHhHhcccccccceeEeehHH
Confidence 5422 234689999999987643
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.9e-14 Score=143.77 Aligned_cols=217 Identities=28% Similarity=0.381 Sum_probs=156.6
Q ss_pred ceEEEEEECCeEEEEEEccH----------HHHHHHHHHHhcCCC-CcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATIDGKVLAVKKIKE----------DVTEELRILQRINHA-NLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~-niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
+.||++... ..+++|.+.. .+.+|+.++..+.|+ +++++.+.+.. .+..+++++++.++++.+++..
T Consensus 14 ~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~~ 91 (384)
T COG0515 14 GEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD-EGSLYLVMEYVDGGSLEDLLKK 91 (384)
T ss_pred eEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec-CCEEEEEEecCCCCcHHHHHHh
Confidence 478888776 7788888752 367899999999988 79999998853 3357999999999999977765
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCC-cEEEeecCCCCCCC--------
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRF-KAKIANFSLAAPAT-------- 482 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~-~~kl~DFGla~~~~-------- 482 (615)
.... ..+.......+..+++.++.|+|+.+ ++|||+||+||+++... .+++.|||+++...
T Consensus 92 ~~~~-------~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 161 (384)
T COG0515 92 IGRK-------GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSI 161 (384)
T ss_pred cccc-------cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccc
Confidence 4311 13788899999999999999999998 99999999999999998 79999999875221
Q ss_pred ------------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCC-hhHHHHHHHHHHHhHHHHHHHHH
Q 047629 483 ------------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENG-KTAVLWKEIREVLKVEEKREERL 537 (615)
Q Consensus 483 ------------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~-~~~~l~~~~~~~~~~~~~~~~~~ 537 (615)
.......|+||+|++++++++|+.|+...... .....+..+... .
T Consensus 162 ~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~----------~ 231 (384)
T COG0515 162 PALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL----------P 231 (384)
T ss_pred cccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhc----------C
Confidence 12344689999999999999999996544321 011111111100 0
Q ss_pred hhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 538 RNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 538 ~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.....+.............+.+++..|+..+|..|.++.+....
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 232 TPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred CcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00001111111111223467899999999999999999887764
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.1e-14 Score=142.24 Aligned_cols=119 Identities=12% Similarity=0.260 Sum_probs=90.4
Q ss_pred ceEEEEEECCeEEEEEEcc-------HHHHHHHHHHHhc-----CCCCcccEEEEEEcCCC--cEE-EEEee--cCCCCH
Q 047629 343 KSVYRATIDGKVLAVKKIK-------EDVTEELRILQRI-----NHANLVKLMGVSSDSQG--NRF-LVYEY--AENGSL 405 (615)
Q Consensus 343 ~~Vy~~~~~g~~vAvK~~~-------~~~~~Ei~~l~~l-----~H~niv~l~g~~~~~~~--~~~-lV~E~--~~~GsL 405 (615)
+.||....++.. +||++. +++.+|+.+++++ .||||++++|++.+..+ ..+ +|+|| +++|+|
T Consensus 16 ~~Vy~hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL 94 (210)
T PRK10345 16 RKCYAHPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITL 94 (210)
T ss_pred eEEEECCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhH
Confidence 367752224444 688765 3578999999999 57999999999876543 333 78999 668999
Q ss_pred HHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHH-HHHHhCCCCCeEecCCCCCceeeCC----CCcEEEeecCCC
Q 047629 406 DKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGL-QYMHEHAQPSIVHRDIRTNNIQLDS----RFKAKIANFSLA 478 (615)
Q Consensus 406 ~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~ivHrDlk~~NILld~----~~~~kl~DFGla 478 (615)
.+++.+.. +++. ..++.+++.++ +|||+++ |+||||||+|||++. +.+++|+||+.+
T Consensus 95 ~~~l~~~~-----------~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 95 TEFAEQCR-----------YEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred HHHHHccc-----------ccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 99996532 4444 35577888888 9999998 999999999999974 348999995543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.3e-14 Score=142.23 Aligned_cols=120 Identities=23% Similarity=0.305 Sum_probs=102.0
Q ss_pred ceEEEEEECCeEEEEEEcc---------------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATIDGKVLAVKKIK---------------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~~g~~vAvK~~~---------------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~ 407 (615)
+.||+|.++|..++||+.. ..+.+|++++.+++|+|+.....++.+. ...+++|||+++++|.+
T Consensus 10 ~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-~~~~lv~e~~~G~~L~~ 88 (211)
T PRK14879 10 AEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP-ENFIIVMEYIEGEPLKD 88 (211)
T ss_pred EEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC-CCCEEEEEEeCCcCHHH
Confidence 5899999999999999743 1356799999999999988777766544 36789999999999999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCC
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA 481 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~ 481 (615)
++... .+ .+..++.+++.+|.++|+.+ ++|+|++|+|||++ ++.+++.|||+++..
T Consensus 89 ~~~~~-------------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 89 LINSN-------------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred HHHhc-------------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 98532 22 78899999999999999998 99999999999999 788999999998764
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.1e-13 Score=144.93 Aligned_cols=217 Identities=19% Similarity=0.228 Sum_probs=156.2
Q ss_pred ceEEEEEECC---eEEEEEEccH-------HHHHHHHHHHhcCC----CCcccEEEEEEcCCCcEEEEEeecCCCCHHHh
Q 047629 343 KSVYRATIDG---KVLAVKKIKE-------DVTEELRILQRINH----ANLVKLMGVSSDSQGNRFLVYEYAENGSLDKW 408 (615)
Q Consensus 343 ~~Vy~~~~~g---~~vAvK~~~~-------~~~~Ei~~l~~l~H----~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~ 408 (615)
|.||.+.... +.+|+|.... .+..|+.++..+.+ +++.++++.....+...++||+.. +.+|.+.
T Consensus 32 G~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl 110 (322)
T KOG1164|consen 32 GAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDL 110 (322)
T ss_pred ceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-CccHHHH
Confidence 5899998732 4788887653 46789999999873 578888877532344689999988 5699997
Q ss_pred hccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCC-----CcEEEeecCCCC--CC
Q 047629 409 LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSR-----FKAKIANFSLAA--PA 481 (615)
Q Consensus 409 L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~-----~~~kl~DFGla~--~~ 481 (615)
....... .++....++|+.|+..+|++||+.+ ++||||||.|+++... ..+.+.|||+++ ..
T Consensus 111 ~~~~~~~--------~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~ 179 (322)
T KOG1164|consen 111 RKRNPPG--------RFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKY 179 (322)
T ss_pred HHhCCCC--------CcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCCccccc
Confidence 7554411 3899999999999999999999998 9999999999999865 468999999998 21
Q ss_pred ---C------C----------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHH
Q 047629 482 ---T------N----------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVE 530 (615)
Q Consensus 482 ---~------~----------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 530 (615)
. . ..+.+.|+||++-++.|++.|..|+........... +..
T Consensus 180 ~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~---~~~----- 251 (322)
T KOG1164|consen 180 VGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSK---FEK----- 251 (322)
T ss_pred cCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHH---HHH-----
Confidence 0 0 023578999999999999999999866543222111 110
Q ss_pred HHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 531 EKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 531 ~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
........+ +....+..+.++...+-..+...+|....+...|+.....
T Consensus 252 ----~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 252 ----DPRKLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred ----Hhhhhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 000111111 1222334566777777779999999999999988766544
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.57 E-value=3e-14 Score=137.18 Aligned_cols=145 Identities=13% Similarity=0.151 Sum_probs=108.8
Q ss_pred ceEEEEEECCeEEEEEEccH-----------HHHHHHHHHHhcC-CCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATIDGKVLAVKKIKE-----------DVTEELRILQRIN-HANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~~g~~vAvK~~~~-----------~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
+.||...-++..++.+.+.. -+.+|+++|++++ |+++.+++++ ...+++|||+++.+|.+.+.
T Consensus 16 ~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~-----~~~~lvmeyI~G~~L~~~~~ 90 (218)
T PRK12274 16 GRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW-----DGRHLDRSYLAGAAMYQRPP 90 (218)
T ss_pred ceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE-----cCEEEEEeeecCccHHhhhh
Confidence 35665555778888776642 2678999999995 5889999886 24699999999988875432
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCCceeeCCCCcEEEeecCCCCCCCCC-----
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDI-RTNNIQLDSRFKAKIANFSLAAPATND----- 484 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDl-k~~NILld~~~~~kl~DFGla~~~~~~----- 484 (615)
. ....+..+++.+|.++|+++ |+|||| ||+|||++.++.++|.|||+|......
T Consensus 91 ~-----------------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 91 R-----------------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred h-----------------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence 1 01246778999999999998 999999 799999999999999999999743211
Q ss_pred ---------------------CC------------CcccchhHHHHHHHHHcCCCCCCCCC
Q 047629 485 ---------------------VM------------PKFDVFAFGVVLLELLSGKKATRTTE 512 (615)
Q Consensus 485 ---------------------~~------------~k~DV~SfGvvl~ElltG~~p~~~~~ 512 (615)
.+ ...+.++-|.-+|.++||+.+.....
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 01 12466788888888888887765443
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.4e-14 Score=138.04 Aligned_cols=130 Identities=22% Similarity=0.278 Sum_probs=101.8
Q ss_pred ceEEEEEECCeEEEEEEcc---------------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATIDGKVLAVKKIK---------------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~~g~~vAvK~~~---------------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~ 407 (615)
+.||+|.++|..+++|... ..+.+|++++.+++|+++.....++... ...++||||+++++|.+
T Consensus 8 ~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-~~~~lv~e~~~g~~l~~ 86 (199)
T TIGR03724 8 AIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP-DNKTIVMEYIEGKPLKD 86 (199)
T ss_pred EEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC-CCCEEEEEEECCccHHH
Confidence 5899999999999999843 2245799999999988765544444433 35789999999999999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCCCCCC
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVMP 487 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 487 (615)
++.... . .++.+++.+|.+||+.+ ++|+|+||+||+++ ++.+++.|||+++........
T Consensus 87 ~~~~~~-----------~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~~~~~~ 145 (199)
T TIGR03724 87 VIEEGN-----------D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYSDEIEDK 145 (199)
T ss_pred HHhhcH-----------H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCCCcHHhh
Confidence 875321 1 77899999999999998 99999999999999 889999999998875443333
Q ss_pred cccchhH
Q 047629 488 KFDVFAF 494 (615)
Q Consensus 488 k~DV~Sf 494 (615)
..|++.+
T Consensus 146 ~~~~~~~ 152 (199)
T TIGR03724 146 AVDLHVL 152 (199)
T ss_pred hchHHHH
Confidence 4455443
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.5e-15 Score=169.90 Aligned_cols=189 Identities=14% Similarity=0.177 Sum_probs=137.1
Q ss_pred HHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHH
Q 047629 364 VTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQY 443 (615)
Q Consensus 364 ~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~y 443 (615)
+..|+.+-..++|+|++..+..+.+.+ ...-+|||+++ +|..++.... .++-..+-.+..|+..|+.|
T Consensus 368 i~sE~~i~~~l~h~~~~e~l~~~~~~~-~~~~~mE~~~~-Dlf~~~~~~~----------~~~~~e~~c~fKqL~~Gv~y 435 (601)
T KOG0590|consen 368 ITSEFCIGSSLSHPNIIETLDIVQEID-GILQSMEYCPY-DLFSLVMSNG----------KLTPLEADCFFKQLLRGVKY 435 (601)
T ss_pred hhhheeecccccCCchhhhHHHHhhcc-cchhhhhcccH-HHHHHHhccc----------ccchhhhhHHHHHHHHHHHH
Confidence 445666777789999987776665544 33344999999 9999997653 27788888999999999999
Q ss_pred HHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC----------------C-----------C-CCcccchhHH
Q 047629 444 MHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN----------------D-----------V-MPKFDVFAFG 495 (615)
Q Consensus 444 LH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~----------------~-----------~-~~k~DV~SfG 495 (615)
+|+.+ +.|||+|++|+++..++.+||+|||.+..... . + ....||||.|
T Consensus 436 ~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ 512 (601)
T KOG0590|consen 436 LHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCG 512 (601)
T ss_pred HHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhcc
Confidence 99999 99999999999999999999999998743211 0 1 1357999999
Q ss_pred HHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcC-CCCCChHHHHHHHHHHHHhhhcCCCCCCC
Q 047629 496 VVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNL-ESFYPIDGALSLATLARACTMDKSLSRPN 574 (615)
Q Consensus 496 vvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l-~~~~~~~~~~~l~~l~~~C~~~dP~~RPs 574 (615)
+++..|++|+.||......+... . .........-.. ......+.+.....++.++++.||.+|-+
T Consensus 513 ii~~~m~~~~~~Wk~a~~~~~~~-~-------------~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~t 578 (601)
T KOG0590|consen 513 IIYICMILGRFPWKVAKKSDNSF-K-------------TNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRIT 578 (601)
T ss_pred ceEEEEecCCCccccccccccch-h-------------hhccccccccccChHHHHHhchhhHHHHHHHHccCChhheec
Confidence 99999999999987654322110 0 000000000000 00111244556788999999999999999
Q ss_pred HHHHHHH
Q 047629 575 MAEVVFN 581 (615)
Q Consensus 575 m~ev~~~ 581 (615)
|.+|++.
T Consensus 579 i~~i~~d 585 (601)
T KOG0590|consen 579 IEQILND 585 (601)
T ss_pred HHHHhhC
Confidence 9999875
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.2e-14 Score=143.50 Aligned_cols=174 Identities=19% Similarity=0.249 Sum_probs=121.4
Q ss_pred CCCCcccEEEEEEcC--------------------------CCcEEEEEeecCCCCHHHhhccCCCCCCCCCcccccCHH
Q 047629 375 NHANLVKLMGVSSDS--------------------------QGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWS 428 (615)
Q Consensus 375 ~H~niv~l~g~~~~~--------------------------~~~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~ 428 (615)
+|||||++.+++.++ ...+|+||.-.+. +|.++|.... .+..
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-----------~s~r 341 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-----------RSYR 341 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-----------CchH
Confidence 688888887765431 1136899987765 8999997653 4555
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceee--CCC--CcEEEeecCCCCCCCC----------C----------
Q 047629 429 QRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQL--DSR--FKAKIANFSLAAPATN----------D---------- 484 (615)
Q Consensus 429 ~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl--d~~--~~~kl~DFGla~~~~~----------~---------- 484 (615)
...-|..|+.+|..|||.++ |.|||+|++|||+ |++ -...|+|||.+-.... .
T Consensus 342 ~~~~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lm 418 (598)
T KOG4158|consen 342 TGRVILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLM 418 (598)
T ss_pred HHHHHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceec
Confidence 66678889999999999999 9999999999998 333 4578999997632111 0
Q ss_pred ---------------CCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCC
Q 047629 485 ---------------VMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFY 549 (615)
Q Consensus 485 ---------------~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~ 549 (615)
-..|+|.|+.|-+-||++....||....+ ..... + ...+--=|.+.+
T Consensus 419 APEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe--m~L~~---r-----------~Yqe~qLPalp~-- 480 (598)
T KOG4158|consen 419 APEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE--MLLDT---R-----------TYQESQLPALPS-- 480 (598)
T ss_pred chhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccch--heech---h-----------hhhhhhCCCCcc--
Confidence 12489999999999999999999976321 11000 0 011111233433
Q ss_pred ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047629 550 PIDGALSLATLARACTMDKSLSRPNMAEVVFNLS 583 (615)
Q Consensus 550 ~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~ 583 (615)
.++..+.+|+...++.||.+|++..=....|.
T Consensus 481 --~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 481 --RVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred --cCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 33344688999999999999999765555443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.54 E-value=5.9e-15 Score=165.64 Aligned_cols=201 Identities=21% Similarity=0.312 Sum_probs=146.4
Q ss_pred eEEEEEECCeEEEEEEcc--------HHHHH---HHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 344 SVYRATIDGKVLAVKKIK--------EDVTE---ELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 344 ~Vy~~~~~g~~vAvK~~~--------~~~~~---Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
.|.|++.+.-.|.||++- ..+.+ |++ ...++|||.+.+.-+- ..+...|||-+|..+ +|+|.|..+
T Consensus 38 Kv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~-~t~kAAylvRqyvkh-nLyDRlSTR 114 (1431)
T KOG1240|consen 38 KVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL-VTDKAAYLVRQYVKH-NLYDRLSTR 114 (1431)
T ss_pred hhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH-HhhHHHHHHHHHHhh-hhhhhhccc
Confidence 466777754458888773 22443 444 4456999999887663 234356888899876 899998765
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC----------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT---------- 482 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~---------- 482 (615)
. +|...+..-|+.|+..||.-.|..+ |.|+|||.+|||+..-..+.|+||.--++..
T Consensus 115 P----------FL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~ 181 (1431)
T KOG1240|consen 115 P----------FLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFT 181 (1431)
T ss_pred h----------HHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCCcccce
Confidence 4 4888899999999999999999998 9999999999999999899999997655431
Q ss_pred ------------------------------CC-CCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHH
Q 047629 483 ------------------------------ND-VMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVE 530 (615)
Q Consensus 483 ------------------------------~~-~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 530 (615)
.. .+++.||||.|||+.||++ |+++|.-.. +.. ++.. ..
T Consensus 182 fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ------L~a-Yr~~--~~ 252 (1431)
T KOG1240|consen 182 FFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ------LLA-YRSG--NA 252 (1431)
T ss_pred EEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH------HHh-Hhcc--Cc
Confidence 01 4578899999999999999 677775210 110 1100 01
Q ss_pred HHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 531 EKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 531 ~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
...+..++++-|+. +..+++.+++.||.+|-++++.++.
T Consensus 253 ~~~e~~Le~Ied~~------------~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 253 DDPEQLLEKIEDVS------------LRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred cCHHHHHHhCcCcc------------HHHHHHHHHccCchhccCHHHHHHh
Confidence 11123344444443 5789999999999999999999987
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.51 E-value=8.9e-14 Score=155.64 Aligned_cols=117 Identities=20% Similarity=0.274 Sum_probs=96.8
Q ss_pred ceEEEEEECCeEEEEEEcc---------------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATIDGKVLAVKKIK---------------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~~g~~vAvK~~~---------------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~ 407 (615)
+.||+|.+.+..+++|+.. +.+.+|++++.+++|++++....++.+.+ ..++||||+++++|.+
T Consensus 347 g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-~~~lv~E~~~g~~L~~ 425 (535)
T PRK09605 347 ADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE-EKTIVMEYIGGKDLKD 425 (535)
T ss_pred EEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC-CCEEEEEecCCCcHHH
Confidence 4899999976666555321 23568999999999999998877766543 6789999999999998
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT 482 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~ 482 (615)
++. ....++.+++.+|.|||+.+ ++||||||+|||+ +++.++|+|||+++...
T Consensus 426 ~l~------------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~~~ 478 (535)
T PRK09605 426 VLE------------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKYSD 478 (535)
T ss_pred HHH------------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccccCC
Confidence 874 23568899999999999998 9999999999999 67899999999998753
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=4.2e-13 Score=128.20 Aligned_cols=156 Identities=19% Similarity=0.263 Sum_probs=123.4
Q ss_pred ceEEEEEE--CCeEEEEEEccH-----HHHHHHHHHHhcCCC-CcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCC
Q 047629 343 KSVYRATI--DGKVLAVKKIKE-----DVTEELRILQRINHA-NLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSK 414 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~-----~~~~Ei~~l~~l~H~-niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~ 414 (615)
|.+|.|.. +|+.||||.-+. ...-|..+...++|- .|-.+..|..+ ...-.+|||.. +.||.+...-...
T Consensus 29 GdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e-~~ynvlVMdLL-GPsLEdLfnfC~R 106 (341)
T KOG1163|consen 29 GDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTE-KDYNVLVMDLL-GPSLEDLFNFCSR 106 (341)
T ss_pred hheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccc-cccceeeeecc-CccHHHHHHHHhh
Confidence 57898886 899999998764 466799999999764 34444444443 33578999998 5689888765443
Q ss_pred CCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCC---CcEEEeecCCCCCCCCC-------
Q 047629 415 SSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSR---FKAKIANFSLAAPATND------- 484 (615)
Q Consensus 415 ~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~---~~~kl~DFGla~~~~~~------- 484 (615)
.++.++.+-++-|+..-++|+|.++ ++||||||+|.|..-+ .++.+.|||||+...+.
T Consensus 107 ---------~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIp 174 (341)
T KOG1163|consen 107 ---------RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIP 174 (341)
T ss_pred ---------hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhccccccccCc
Confidence 3889999999999999999999998 9999999999998643 56889999999754211
Q ss_pred -----------------------CCCcccchhHHHHHHHHHcCCCCCCCCC
Q 047629 485 -----------------------VMPKFDVFAFGVVLLELLSGKKATRTTE 512 (615)
Q Consensus 485 -----------------------~~~k~DV~SfGvvl~ElltG~~p~~~~~ 512 (615)
.+..-|+=|.|-||....-|..||....
T Consensus 175 yre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk 225 (341)
T KOG1163|consen 175 YREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK 225 (341)
T ss_pred cccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc
Confidence 1346799999999999999999998754
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.47 E-value=3.3e-13 Score=134.82 Aligned_cols=123 Identities=23% Similarity=0.228 Sum_probs=95.6
Q ss_pred ceEEEEE--E-CCeEEEEEEccH-------------------------------HHHHHHHHHHhcCCCC--cccEEEEE
Q 047629 343 KSVYRAT--I-DGKVLAVKKIKE-------------------------------DVTEELRILQRINHAN--LVKLMGVS 386 (615)
Q Consensus 343 ~~Vy~~~--~-~g~~vAvK~~~~-------------------------------~~~~Ei~~l~~l~H~n--iv~l~g~~ 386 (615)
+.||+|. . +|+.||||.++. .+..|++++.++.+.+ +.+.+++
T Consensus 42 g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~i~~p~~~~~- 120 (237)
T smart00090 42 ANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAGVPVPKPIAW- 120 (237)
T ss_pred eeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCeeeEe-
Confidence 4899998 3 799999998752 1347999999997643 3344442
Q ss_pred EcCCCcEEEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCC
Q 047629 387 SDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDS 466 (615)
Q Consensus 387 ~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~ 466 (615)
. ..++||||+++++|..++.... .+...+...++.|++.++.+||+++ .++||||||+||+++
T Consensus 121 --~--~~~lV~E~~~g~~L~~~~~~~~----------~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NIli~- 183 (237)
T smart00090 121 --R--RNVLVMEFIGGDGLPAPRLKDV----------EPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNILVH- 183 (237)
T ss_pred --c--CceEEEEEecCCcccccccccC----------CcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhEEEE-
Confidence 1 3589999999988876653222 1455667889999999999999885 499999999999999
Q ss_pred CCcEEEeecCCCCCCCC
Q 047629 467 RFKAKIANFSLAAPATN 483 (615)
Q Consensus 467 ~~~~kl~DFGla~~~~~ 483 (615)
++++++.|||++.....
T Consensus 184 ~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 184 DGKVVIIDVSQSVELDH 200 (237)
T ss_pred CCCEEEEEChhhhccCC
Confidence 88999999999876544
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.45 E-value=6.8e-13 Score=129.02 Aligned_cols=116 Identities=21% Similarity=0.237 Sum_probs=92.0
Q ss_pred ceEEEEEE-CCeEEEEEEccH-----------------------------HHHHHHHHHHhcCCCC--cccEEEEEEcCC
Q 047629 343 KSVYRATI-DGKVLAVKKIKE-----------------------------DVTEELRILQRINHAN--LVKLMGVSSDSQ 390 (615)
Q Consensus 343 ~~Vy~~~~-~g~~vAvK~~~~-----------------------------~~~~Ei~~l~~l~H~n--iv~l~g~~~~~~ 390 (615)
+.||++.. +|+.||||+++. ....|..++.++.|++ +.+.++.
T Consensus 29 g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~~~~~~----- 103 (198)
T cd05144 29 SDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVPKPIDW----- 103 (198)
T ss_pred eEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCCceeec-----
Confidence 47999988 799999997431 2456888999998874 4444432
Q ss_pred CcEEEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcE
Q 047629 391 GNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKA 470 (615)
Q Consensus 391 ~~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~ 470 (615)
...++||||+++++|...... .....++.+++.++.++|+.+ ++||||||+||++++++.+
T Consensus 104 ~~~~lv~e~~~g~~L~~~~~~----------------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~~~~ 164 (198)
T cd05144 104 NRHAVVMEYIDGVELYRVRVL----------------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDDEKI 164 (198)
T ss_pred CCceEEEEEeCCcchhhcccc----------------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCCCcE
Confidence 245899999999998765321 123567889999999999987 9999999999999999999
Q ss_pred EEeecCCCCCCC
Q 047629 471 KIANFSLAAPAT 482 (615)
Q Consensus 471 kl~DFGla~~~~ 482 (615)
+|+|||++....
T Consensus 165 ~liDfg~~~~~~ 176 (198)
T cd05144 165 YIIDWPQMVSTD 176 (198)
T ss_pred EEEECCccccCC
Confidence 999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.4e-12 Score=130.56 Aligned_cols=122 Identities=18% Similarity=0.230 Sum_probs=95.9
Q ss_pred ceEEEEEECCeEEEEEEccH--------------------HHHHHHHHHHhcCCCCc--ccEEEEEEcCCCc---EEEEE
Q 047629 343 KSVYRATIDGKVLAVKKIKE--------------------DVTEELRILQRINHANL--VKLMGVSSDSQGN---RFLVY 397 (615)
Q Consensus 343 ~~Vy~~~~~g~~vAvK~~~~--------------------~~~~Ei~~l~~l~H~ni--v~l~g~~~~~~~~---~~lV~ 397 (615)
++||+....|..++||+.+. .+.+|++++.+++|+++ .+.+++.....+. .++|+
T Consensus 46 gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~ 125 (239)
T PRK01723 46 GTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILI 125 (239)
T ss_pred ccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEE
Confidence 48998888888999987631 24569999999998885 6777765433322 35999
Q ss_pred eecCC-CCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecC
Q 047629 398 EYAEN-GSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFS 476 (615)
Q Consensus 398 E~~~~-GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFG 476 (615)
|++++ .+|.+++.... ++.. .+.+++.+|.+||+.+ |+||||||.|||++.++.++|.|||
T Consensus 126 e~l~G~~~L~~~l~~~~-----------l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LIDfg 187 (239)
T PRK01723 126 ERIEGARDLVALLQEAP-----------LSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLIDFD 187 (239)
T ss_pred EecCCCCCHHHHHhcCC-----------CCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEECC
Confidence 99997 69999886421 4433 2568899999999998 9999999999999998999999999
Q ss_pred CCCCCC
Q 047629 477 LAAPAT 482 (615)
Q Consensus 477 la~~~~ 482 (615)
.+....
T Consensus 188 ~~~~~~ 193 (239)
T PRK01723 188 RGELRT 193 (239)
T ss_pred CcccCC
Confidence 877643
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.37 E-value=2.4e-12 Score=130.29 Aligned_cols=144 Identities=21% Similarity=0.279 Sum_probs=96.0
Q ss_pred EEEEEeecCCCCHHHhhcc---CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCc
Q 047629 393 RFLVYEYAENGSLDKWLHP---KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFK 469 (615)
Q Consensus 393 ~~lV~E~~~~GsL~~~L~~---~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~ 469 (615)
.+++|+-+ .++|.+++.. .... ...+....++.+..|+.+-+++||+++ ++|+||||+|++++.+|.
T Consensus 114 ~~~l~P~~-~~dL~~~~~~l~~~~~~------~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi~~~nfll~~~G~ 183 (288)
T PF14531_consen 114 RFLLMPRA-QGDLQDLVEALFSRAQT------HSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDIKPENFLLDQDGG 183 (288)
T ss_dssp EEEEEE---SEEHHHHHHHHHHHTTT------SHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEE-TTS-
T ss_pred hhhccchh-hhcHHHHHHHHhhcccc------cchhHHHHHHHHHHHHHHHHHHHhhcc---eEecccceeeEEEcCCCC
Confidence 36778877 4688887543 2110 113566778888899999999999999 999999999999999999
Q ss_pred EEEeecCCCCCCCC----------------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHH
Q 047629 470 AKIANFSLAAPATN----------------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWK 521 (615)
Q Consensus 470 ~kl~DFGla~~~~~----------------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~ 521 (615)
++|+||+....... .++.+.|.|++|+++|.|++|+.|+..........
T Consensus 184 v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~--- 260 (288)
T PF14531_consen 184 VFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPE--- 260 (288)
T ss_dssp EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSG---
T ss_pred EEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCcccccc---
Confidence 99999986532110 13557799999999999999999998654211100
Q ss_pred HHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCC
Q 047629 522 EIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSR 572 (615)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~R 572 (615)
+.. ..+. +.++.+..|+...++.||.+|
T Consensus 261 ---------------------~~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 261 ---------------------WDF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp ---------------------GGG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ---------------------ccc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 011 1233 666778999999999999988
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.36 E-value=4.7e-13 Score=143.91 Aligned_cols=133 Identities=25% Similarity=0.320 Sum_probs=112.5
Q ss_pred HHHHHHHHHhcC-CCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHH
Q 047629 364 VTEELRILQRIN-HANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQ 442 (615)
Q Consensus 364 ~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~ 442 (615)
...|..++..++ |+.+|++.-. .+.++..+++++|..+|.|...+..... ++......+...++-+++
T Consensus 43 t~~er~il~~~~~~~f~v~lhya-fqt~~kl~l~ld~~rgg~lft~l~~~~~----------f~~~~~~~~~aelaLald 111 (612)
T KOG0603|consen 43 TKQERIILAFVHNTPFLVKLHYA-FQTDGKLYLILDFLRGGDLFTRLSKEVM----------FDELDVAFYLAELALALD 111 (612)
T ss_pred cccHHHHHhhccCCCceeeeeee-eccccchhHhhhhcccchhhhccccCCc----------hHHHHHHHHHHHHHHHHh
Confidence 345788888886 9999998755 4567789999999999999988876543 666677777888999999
Q ss_pred HHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----------------CCCCCcccchhHHHHHHHHHcCC
Q 047629 443 YMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-----------------NDVMPKFDVFAFGVVLLELLSGK 505 (615)
Q Consensus 443 yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-----------------~~~~~k~DV~SfGvvl~ElltG~ 505 (615)
++|+.+ ++|||+|++||+++.+|.+|+.|||+++... +.....+|.||||++++||+||-
T Consensus 112 ~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~cgt~eymApEI~~gh~~a~D~ws~gvl~felltg~ 188 (612)
T KOG0603|consen 112 HLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIACGTYEYRAPEIINGHLSAADWWSFGVLAFELLTGT 188 (612)
T ss_pred hcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhcccchhhhhhHhhhccCCcccchhhhhhHHHHhhCC
Confidence 999998 9999999999999999999999999986531 12456799999999999999999
Q ss_pred CCCCC
Q 047629 506 KATRT 510 (615)
Q Consensus 506 ~p~~~ 510 (615)
.||..
T Consensus 189 ~pf~~ 193 (612)
T KOG0603|consen 189 LPFGG 193 (612)
T ss_pred CCCch
Confidence 99875
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.3e-11 Score=113.01 Aligned_cols=121 Identities=21% Similarity=0.287 Sum_probs=100.8
Q ss_pred ceEEEEEECCeEEEEEEccH-----HHHHHHHHHHhcCC--CCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCC
Q 047629 343 KSVYRATIDGKVLAVKKIKE-----DVTEELRILQRINH--ANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKS 415 (615)
Q Consensus 343 ~~Vy~~~~~g~~vAvK~~~~-----~~~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~ 415 (615)
+.||++..++..+++|..+. ++..|+..+..++| .++.+++++... .+..++++||++++.+..+
T Consensus 12 ~~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~-~~~~~~v~e~~~g~~~~~~------- 83 (155)
T cd05120 12 NRVYLLGTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGES-DGWSYLLMEWIEGETLDEV------- 83 (155)
T ss_pred cceEEEEecCCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCC-CCccEEEEEecCCeecccC-------
Confidence 47999999888999998863 57899999999976 588898887654 3578999999988766543
Q ss_pred CCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCC
Q 047629 416 SSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA 481 (615)
Q Consensus 416 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~ 481 (615)
++.....++.+++.+|.++|......++|+|+||+||+++..+.+++.|||.++..
T Consensus 84 ----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 84 ----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 34566778899999999999875556999999999999999899999999987653
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.32 E-value=3.5e-11 Score=120.09 Aligned_cols=162 Identities=17% Similarity=0.257 Sum_probs=124.1
Q ss_pred cccccc----ceEEEEEE--CCeEEEEEEcc-----HHHHHHHHHHHhcC-CCCcccEEEEEEcCCCcEEEEEeecCCCC
Q 047629 337 EHYSIG----KSVYRATI--DGKVLAVKKIK-----EDVTEELRILQRIN-HANLVKLMGVSSDSQGNRFLVYEYAENGS 404 (615)
Q Consensus 337 ~~~~iG----~~Vy~~~~--~g~~vAvK~~~-----~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~~lV~E~~~~Gs 404 (615)
...+|| |..+.|+. +++.||||.-. .++..|....+.|. .++|-..+-+-.+. -.-.||+|.. +-|
T Consensus 32 VGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG-~~NiLVidLL-GPS 109 (449)
T KOG1165|consen 32 VGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEG-KYNILVIDLL-GPS 109 (449)
T ss_pred eccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeecccc-chhhhhhhhh-CcC
Confidence 334555 35666663 89999999753 25778888888885 56776655332222 2357999998 558
Q ss_pred HHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCC-----CcEEEeecCCCC
Q 047629 405 LDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSR-----FKAKIANFSLAA 479 (615)
Q Consensus 405 L~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~-----~~~kl~DFGla~ 479 (615)
|.+...-+.. .++.+....+|.|+..-++|+|++. +|.|||||+|+||..- ..+.+.|||+|+
T Consensus 110 LEDLFD~CgR---------~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 110 LEDLFDLCGR---------RFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred HHHHHHHhcC---------cccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 8887765543 3899999999999999999999998 9999999999999653 458999999997
Q ss_pred CCCCC------------------------------CCCcccchhHHHHHHHHHcCCCCCCCCC
Q 047629 480 PATND------------------------------VMPKFDVFAFGVVLLELLSGKKATRTTE 512 (615)
Q Consensus 480 ~~~~~------------------------------~~~k~DV~SfGvvl~ElltG~~p~~~~~ 512 (615)
...+. -+..-|+=|+|-|++..+-|..||....
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 64322 1346799999999999999999998755
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.25 E-value=2.7e-11 Score=116.36 Aligned_cols=119 Identities=24% Similarity=0.281 Sum_probs=85.8
Q ss_pred ceEEEEEE-CCeEEEEEEccHH---------H----------------------HHHHHHHHhcCCCC--cccEEEEEEc
Q 047629 343 KSVYRATI-DGKVLAVKKIKED---------V----------------------TEELRILQRINHAN--LVKLMGVSSD 388 (615)
Q Consensus 343 ~~Vy~~~~-~g~~vAvK~~~~~---------~----------------------~~Ei~~l~~l~H~n--iv~l~g~~~~ 388 (615)
+.||++.. +|+.||||+++.. . ..|.+.+.++++.. +.+.+++
T Consensus 11 g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~--- 87 (187)
T cd05119 11 ADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVPKPIDL--- 87 (187)
T ss_pred eeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCCceEec---
Confidence 48999988 5999999987521 1 24555666664443 3444432
Q ss_pred CCCcEEEEEeecCCCCHHHh-hccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCceeeCC
Q 047629 389 SQGNRFLVYEYAENGSLDKW-LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHE-HAQPSIVHRDIRTNNIQLDS 466 (615)
Q Consensus 389 ~~~~~~lV~E~~~~GsL~~~-L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~NILld~ 466 (615)
...++||||+++|.+... +.... .. .+...++.+++.++.++|. .+ |+||||||+||+++
T Consensus 88 --~~~~lv~e~~~g~~~~~~~l~~~~-----------~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 88 --NRHVLVMEFIGGDGIPAPRLKDVR-----------LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred --CCCEEEEEEeCCCCccChhhhhhh-----------hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 145899999999654321 11100 11 5567889999999999999 76 99999999999999
Q ss_pred CCcEEEeecCCCCCCC
Q 047629 467 RFKAKIANFSLAAPAT 482 (615)
Q Consensus 467 ~~~~kl~DFGla~~~~ 482 (615)
++.+++.|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8999999999986554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.25 E-value=4.1e-11 Score=137.54 Aligned_cols=123 Identities=21% Similarity=0.303 Sum_probs=92.2
Q ss_pred ceEEEEEE-CCeEEEEEEccHH----HHHHHHHHHhcC---CCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCC
Q 047629 343 KSVYRATI-DGKVLAVKKIKED----VTEELRILQRIN---HANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSK 414 (615)
Q Consensus 343 ~~Vy~~~~-~g~~vAvK~~~~~----~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~ 414 (615)
++||+|.- +|+.||+|.-+.. |--=.+++.||+ -+-|..+.......+ .-+||+||.+.|+|.+++...+
T Consensus 712 ~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~-~S~lv~ey~~~Gtlld~~N~~~- 789 (974)
T KOG1166|consen 712 GSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQN-ASVLVSEYSPYGTLLDLINTNK- 789 (974)
T ss_pred eEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCC-cceeeeeccccccHHHhhccCC-
Confidence 48999997 8999999987632 222234455555 112222222222223 4689999999999999998433
Q ss_pred CCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeC-------CCCcEEEeecCCCC
Q 047629 415 SSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLD-------SRFKAKIANFSLAA 479 (615)
Q Consensus 415 ~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld-------~~~~~kl~DFGla~ 479 (615)
.++|.-...+..|+++-+++||..+ |||+||||+|.||- ++..++|.|||-+-
T Consensus 790 ---------~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si 849 (974)
T KOG1166|consen 790 ---------VMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI 849 (974)
T ss_pred ---------CCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecccce
Confidence 3899999999999999999999998 99999999999993 23568999999873
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.23 E-value=7.6e-12 Score=132.28 Aligned_cols=150 Identities=23% Similarity=0.386 Sum_probs=109.7
Q ss_pred cEEEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEE
Q 047629 392 NRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAK 471 (615)
Q Consensus 392 ~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~k 471 (615)
.+++.|+++..++|.+||...... ...+|...+.+..|++.|++| ++ .+|||+||.||....+..+|
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~-------e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~k 396 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTG-------EERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLK 396 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcc-------cccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhh
Confidence 478999999999999999765432 137889999999999999999 55 89999999999999999999
Q ss_pred EeecCCCCCCC-----------------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHH
Q 047629 472 IANFSLAAPAT-----------------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWK 521 (615)
Q Consensus 472 l~DFGla~~~~-----------------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~ 521 (615)
|+|||+..... ..++.|+|+||+|++|+||+. =..+++...
T Consensus 397 IgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~--------- 467 (516)
T KOG1033|consen 397 IGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA--------- 467 (516)
T ss_pred hhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH---------
Confidence 99999964321 225679999999999999987 222221100
Q ss_pred HHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHH
Q 047629 522 EIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEV 578 (615)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev 578 (615)
.. .+.-...++|....++|.+ ..+..+.+...|.+||+..++
T Consensus 468 ------t~----~d~r~g~ip~~~~~d~p~e-----~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 468 ------TL----TDIRDGIIPPEFLQDYPEE-----YTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred ------hh----hhhhcCCCChHHhhcCcHH-----HHHHHHhcCCCcccCchHHHH
Confidence 00 0011122333333455544 578899999999999954443
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.2e-10 Score=126.72 Aligned_cols=126 Identities=22% Similarity=0.233 Sum_probs=89.1
Q ss_pred ceEEEEEE-CCeEEEEEEccH----H-------------------------------------------HHHHHHHHHhc
Q 047629 343 KSVYRATI-DGKVLAVKKIKE----D-------------------------------------------VTEELRILQRI 374 (615)
Q Consensus 343 ~~Vy~~~~-~g~~vAvK~~~~----~-------------------------------------------~~~Ei~~l~~l 374 (615)
|.||+|++ +|+.||||+.+. . +..|...+.++
T Consensus 131 gQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~Ea~n~~~~ 210 (437)
T TIGR01982 131 AQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRREAANASEL 210 (437)
T ss_pred hheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHHHHHHHHHH
Confidence 48999998 899999998751 1 22344444444
Q ss_pred ----CCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHH-HHHHHHhCCC
Q 047629 375 ----NHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVAN-GLQYMHEHAQ 449 (615)
Q Consensus 375 ----~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~~~~ 449 (615)
+|.+-+.+-.++.+..+..+|||||+++++|.++...... .. .+.+++..++. .+..+|..+
T Consensus 211 ~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~---------~~---~~~~ia~~~~~~~l~ql~~~g- 277 (437)
T TIGR01982 211 GENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA---------GL---DRKALAENLARSFLNQVLRDG- 277 (437)
T ss_pred HHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc---------CC---CHHHHHHHHHHHHHHHHHhCC-
Confidence 2333344434443333457999999999999887653221 12 23456666665 468889887
Q ss_pred CCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC
Q 047629 450 PSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN 483 (615)
Q Consensus 450 ~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~ 483 (615)
++|+|+||.||+++.++++++.|||++.....
T Consensus 278 --~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 278 --FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred --ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 99999999999999999999999999877643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=7.5e-11 Score=117.69 Aligned_cols=184 Identities=21% Similarity=0.340 Sum_probs=125.0
Q ss_pred HHHHHhcCCCCcccEEEEEEcCCC----cEEEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHH
Q 047629 368 LRILQRINHANLVKLMGVSSDSQG----NRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQY 443 (615)
Q Consensus 368 i~~l~~l~H~niv~l~g~~~~~~~----~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~y 443 (615)
..-|-++-|.|||++..|+.+.+. +..++.|||+.|+|.+||++..... ..+......+|+-||..||.|
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~------~a~~~~~wkkw~tqIlsal~y 191 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQ------KALFQKAWKKWCTQILSALSY 191 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhh------hhhhHHHHHHHHHHHHhhhhh
Confidence 344556789999999998765432 3678999999999999998755421 237777888999999999999
Q ss_pred HHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCC------------------------CCCC---CCCCCcccchhHHH
Q 047629 444 MHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA------------------------APAT---NDVMPKFDVFAFGV 496 (615)
Q Consensus 444 LH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla------------------------~~~~---~~~~~k~DV~SfGv 496 (615)
||+. .|+|+|+++..+.|.+..++-+|++--... +... ...+..+|||+||+
T Consensus 192 Lhs~-~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgm 270 (458)
T KOG1266|consen 192 LHSC-DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGM 270 (458)
T ss_pred hhcc-CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhH
Confidence 9997 688999999999999999888887632111 0000 11245789999999
Q ss_pred HHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHH
Q 047629 497 VLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMA 576 (615)
Q Consensus 497 vl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ 576 (615)
..+||..|.--....+..... ...+.. .+.. ....+. +.++..|++..|..||+|+
T Consensus 271 cAlemailEiq~tnseS~~~~--ee~ia~----------~i~~-len~lq-----------r~~i~kcl~~eP~~rp~ar 326 (458)
T KOG1266|consen 271 CALEMAILEIQSTNSESKVEV--EENIAN----------VIIG-LENGLQ-----------RGSITKCLEGEPNGRPDAR 326 (458)
T ss_pred HHHHHHHheeccCCCcceeeh--hhhhhh----------heee-ccCccc-----------cCcCcccccCCCCCCcchh
Confidence 999998876322111110000 000000 0000 001111 3556899999999999999
Q ss_pred HHHHHH
Q 047629 577 EVVFNL 582 (615)
Q Consensus 577 ev~~~L 582 (615)
+++.+.
T Consensus 327 ~llfHp 332 (458)
T KOG1266|consen 327 LLLFHP 332 (458)
T ss_pred hhhcCc
Confidence 987653
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.8e-09 Score=100.38 Aligned_cols=129 Identities=18% Similarity=0.180 Sum_probs=94.4
Q ss_pred ceEEEEEECCeEEEEEEccH------HHHHHHHHHHhcCCCCcc-cEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCC
Q 047629 343 KSVYRATIDGKVLAVKKIKE------DVTEELRILQRINHANLV-KLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKS 415 (615)
Q Consensus 343 ~~Vy~~~~~g~~vAvK~~~~------~~~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~ 415 (615)
+.||+....|+.+++|.... ++..|..++..+.+.+++ +++++. .+ ..++||||+++.++.+. ..
T Consensus 12 ~~vy~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~-~~~lv~e~i~G~~l~~~----~~- 83 (170)
T cd05151 12 NKNYRVEVANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PE-TGVLITEFIEGSELLTE----DF- 83 (170)
T ss_pred CceEEEEECCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CC-CCeEEEEecCCCccccc----cc-
Confidence 47999988899999998743 357899999999766655 455442 22 35899999999877543 00
Q ss_pred CCCCCcccccCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCCCCCCcccchh
Q 047629 416 SSSSGSVIFLTWSQRLRVALDVANGLQYMHEHA--QPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVMPKFDVFA 493 (615)
Q Consensus 416 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~k~DV~S 493 (615)
. ...++.+++++|..||... ...++|+|++|.||+++ ++.+++.|||.+.... -.|-
T Consensus 84 ---------~----~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~~-------~~~D 142 (170)
T cd05151 84 ---------S----DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMND-------PLFD 142 (170)
T ss_pred ---------c----CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCCC-------hHHH
Confidence 1 1234678999999999986 23469999999999999 6689999999876432 1455
Q ss_pred HHHHHHH
Q 047629 494 FGVVLLE 500 (615)
Q Consensus 494 fGvvl~E 500 (615)
++.++.+
T Consensus 143 la~~~~~ 149 (170)
T cd05151 143 LANFFSE 149 (170)
T ss_pred HHHHHHh
Confidence 6766654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.6e-08 Score=111.57 Aligned_cols=123 Identities=15% Similarity=0.163 Sum_probs=79.7
Q ss_pred ceEEEEEE-C-CeEEEEEEccHH-----------------------------------------------HHHHHHHHHh
Q 047629 343 KSVYRATI-D-GKVLAVKKIKED-----------------------------------------------VTEELRILQR 373 (615)
Q Consensus 343 ~~Vy~~~~-~-g~~vAvK~~~~~-----------------------------------------------~~~Ei~~l~~ 373 (615)
+.||++++ + |+.||||+.+.. +.+|...+.+
T Consensus 133 aQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~~Ea~N~~~ 212 (537)
T PRK04750 133 AQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLMREAANASQ 212 (537)
T ss_pred cEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHHHHHHHHHH
Confidence 58999998 5 999999988511 2234444444
Q ss_pred c----CCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh--ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhC
Q 047629 374 I----NHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL--HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEH 447 (615)
Q Consensus 374 l----~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L--~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~ 447 (615)
+ .+.+.+.+-.++.+-....+|||||+++++|.++- ...+.. ...+.......++ .-++..
T Consensus 213 ~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d------~~~la~~~v~~~~-------~Qif~~ 279 (537)
T PRK04750 213 LRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTD------MKLLAERGVEVFF-------TQVFRD 279 (537)
T ss_pred HHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCC------HHHHHHHHHHHHH-------HHHHhC
Confidence 4 24455555455544444678999999999998752 221100 0012222222222 334456
Q ss_pred CCCCeEecCCCCCceeeCCCC----cEEEeecCCCCCC
Q 047629 448 AQPSIVHRDIRTNNIQLDSRF----KAKIANFSLAAPA 481 (615)
Q Consensus 448 ~~~~ivHrDlk~~NILld~~~----~~kl~DFGla~~~ 481 (615)
+ ++|+|+||.||+++.++ ++++.|||++...
T Consensus 280 G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 280 G---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred C---eeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 6 99999999999999888 9999999998654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.2e-09 Score=123.65 Aligned_cols=117 Identities=21% Similarity=0.374 Sum_probs=83.9
Q ss_pred HHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC----------------------------------
Q 047629 437 VANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT---------------------------------- 482 (615)
Q Consensus 437 ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~---------------------------------- 482 (615)
++.+++|||+.+ |+|||+||+|.|+..-+.+|++|||+++..-
T Consensus 152 mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPe 228 (1205)
T KOG0606|consen 152 MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPE 228 (1205)
T ss_pred hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChh
Confidence 378999999998 9999999999999999999999999985320
Q ss_pred ----CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHHH
Q 047629 483 ----NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLA 558 (615)
Q Consensus 483 ----~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~ 558 (615)
..|...+|.|++|+++||.+-|+.||......+ +...+ +. ...+|.+. ...++ .+..
T Consensus 229 VilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee---lfg~v---is-------d~i~wpE~--dea~p----~Ea~ 289 (1205)
T KOG0606|consen 229 VILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---LFGQV---IS-------DDIEWPEE--DEALP----PEAQ 289 (1205)
T ss_pred hhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH---HHhhh---hh-------hhcccccc--CcCCC----HHHH
Confidence 114567999999999999999999998765322 11111 10 01111111 11222 3467
Q ss_pred HHHHHhhhcCCCCCCCH
Q 047629 559 TLARACTMDKSLSRPNM 575 (615)
Q Consensus 559 ~l~~~C~~~dP~~RPsm 575 (615)
+++...++.+|..|---
T Consensus 290 dli~~LL~qnp~~Rlgt 306 (1205)
T KOG0606|consen 290 DLIEQLLRQNPLCRLGT 306 (1205)
T ss_pred HHHHHHHHhChHhhccc
Confidence 88889999999988643
|
|
| >PRK10783 mltD membrane-bound lytic murein transglycosylase D; Provisional | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.8e-08 Score=107.87 Aligned_cols=160 Identities=14% Similarity=0.160 Sum_probs=113.9
Q ss_pred CCCCCHHHHHHhhCCChHHHHhhcCCCCCCCCCCCC-ccEEeeeeeccC------C-------Cc------eeeeeeEEe
Q 047629 52 PEFLDLSNISDLFGVSRLSIARASNLVSEDTPLVPK-QLLLVPIICGCT------G-------NQ------YFANITYQI 111 (615)
Q Consensus 52 ~~~~~l~~i~~lf~~~~~~i~~~n~~~~~~~~~~~~-~~~~vP~~C~C~------~-------~~------~~~~~~y~v 111 (615)
+...+|..||.++|++..+|...|+........+.| +.++||..-.=. . +. ......|+|
T Consensus 269 ~~~i~L~~iA~~~gvs~~eL~~LNP~~kr~~t~p~g~~~llvP~~~~~~f~~~l~~~~~~~~~p~~~~~~~~~~~~~y~V 348 (456)
T PRK10783 269 GQQIELAQAAEMAGMSLTKLKTFNAGYKRSTTAPSGPHYIMVPKKHADQLRESLASGEIAAVQSTLVADNTPLNSRSYKV 348 (456)
T ss_pred CCCcCHHHHHHHcCCCHHHHHHhCccccCCCcCCCCCeEEEecCchhhHHHHhhhhhhhhhcccccccccCcCCceEEEE
Confidence 445699999999999999999999854332222233 677788842100 0 00 012357999
Q ss_pred ecCCchhhhhhhhcCCcchHHHHHHhCCCCCCCCcCCCcEEEEEeeccCCCCCCCCCCeeEEEEEecCCCCchhHHHHHh
Q 047629 112 KKGDSYYLVSITSFENLTNWHAVLEMNPGINPNLLQIGVKVTFPLFCKCPSKTNMEDGIENLITYVWQPGDDVSQVGAKL 191 (615)
Q Consensus 112 ~~gdt~~~ia~~~~~~L~t~~~~~~~n~~~~~~~l~~G~~~~vpl~c~C~~~~~~s~~~~~l~ty~~~~gd~~~~ia~~F 191 (615)
++|||+..||... |++. .++...|+..+ +.+.+|+++.+|..|.|.... ......+|.|+.||++..||.+|
T Consensus 349 k~GDTL~sIA~r~--gvs~-~~L~~~N~l~~-~~L~~Gq~L~Ip~~~~~~~~~----~~~~~~~Y~Vr~GDTL~sIA~ky 420 (456)
T PRK10783 349 RSGDTLSGIASRL--NVST-KDLQQWNNLRG-SKLKVGQTLTIGAGSSAQRLA----NNSDSITYRVRKGDSLSSIAKRH 420 (456)
T ss_pred CCCCcHHHHHHHH--CcCH-HHHHHHcCCCc-ccCCCCCEEEecCCccccccc----ccccceeEEeCCCCCHHHHHHHh
Confidence 9999999999875 5554 67888898654 789999999999766553211 11223689999999999999999
Q ss_pred cCChhhHhhhccccCccccCccceeccc
Q 047629 192 NASSAAIETENEYRNFSEAVSLPVLIPV 219 (615)
Q Consensus 192 ~~s~~~i~~~n~~~~~~~~~~~~~l~p~ 219 (615)
|++...+...|+.......+|..+-+++
T Consensus 421 gVtv~~L~~~N~l~~~~L~pGq~L~l~v 448 (456)
T PRK10783 421 GVNIKDVMRWNSDTAKNLQPGDKLTLFV 448 (456)
T ss_pred CCCHHHHHHhcCCCCCcCCCCCEEEEec
Confidence 9999999999987322555666655544
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.82 E-value=9.1e-08 Score=101.43 Aligned_cols=162 Identities=17% Similarity=0.269 Sum_probs=125.9
Q ss_pred ceEEEEEE--CCeEEEEEEccH-------HHHHHHHHHHhcCCCCcccEEEEEEc---CCCcEEEEEeecCC-CCHHHhh
Q 047629 343 KSVYRATI--DGKVLAVKKIKE-------DVTEELRILQRINHANLVKLMGVSSD---SQGNRFLVYEYAEN-GSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~-------~~~~Ei~~l~~l~H~niv~l~g~~~~---~~~~~~lV~E~~~~-GsL~~~L 409 (615)
.+.||+.- ||..+..|++.. ....-++.++++.|.|+|++..++.. .+..+++||+|.|+ ++|.++-
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 47888886 899999999942 23356889999999999999988652 23358999999986 5777765
Q ss_pred ccCCCCCCC-----CCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCCC
Q 047629 410 HPKSKSSSS-----SGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATND 484 (615)
Q Consensus 410 ~~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 484 (615)
......... .......++..++.++.|+..||.++|+.| +.-+-|.+++||++.+.+++|+..|.......+
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 543322100 112234778899999999999999999998 888999999999999999999988887655433
Q ss_pred C------CCcccchhHHHHHHHHHcCCCC
Q 047629 485 V------MPKFDVFAFGVVLLELLSGKKA 507 (615)
Q Consensus 485 ~------~~k~DV~SfGvvl~ElltG~~p 507 (615)
- -.+-|.=.||.+++-|.||..-
T Consensus 447 ~~~~le~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 447 PTEPLESQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCcchhHHhhhhHHHHHHHHHHHhhcccc
Confidence 2 2467999999999999999765
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.80 E-value=8.5e-08 Score=92.38 Aligned_cols=97 Identities=16% Similarity=0.193 Sum_probs=71.5
Q ss_pred HHHHHHHhcCC--CCcccEEEEEEcCCCcEEEEEeecCCCCHHH-hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHH
Q 047629 366 EELRILQRINH--ANLVKLMGVSSDSQGNRFLVYEYAENGSLDK-WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQ 442 (615)
Q Consensus 366 ~Ei~~l~~l~H--~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~-~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~ 442 (615)
+|...|.+++. -++-+.+++ ...+|||||+.++.+.. .|+.. .++..+...+..+++.+|.
T Consensus 75 kE~r~L~rl~~~Gv~vP~pi~~-----~~~~lvME~Ig~~~~~~~~Lkd~-----------~~~~~~~~~i~~~i~~~l~ 138 (197)
T cd05146 75 KEMHNLKRMQKAGIPCPEVVVL-----KKHVLVMSFIGDDQVPAPKLKDA-----------KLNDEEMKNAYYQVLSMMK 138 (197)
T ss_pred HHHHHHHHHHHcCCCCCeEEEe-----cCCEEEEEEcCCCCccchhhhcc-----------ccCHHHHHHHHHHHHHHHH
Confidence 79999999854 355566654 14589999997654422 22211 1445566778899999999
Q ss_pred HH-HhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC
Q 047629 443 YM-HEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT 482 (615)
Q Consensus 443 yL-H~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~ 482 (615)
.| |..+ ++|+||++.|||++ ++.+.+.|||.+....
T Consensus 139 ~l~H~~g---lVHGDLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 139 QLYKECN---LVHADLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHHHhCC---eecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 99 7777 99999999999997 4679999999876554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.3e-07 Score=96.08 Aligned_cols=128 Identities=18% Similarity=0.220 Sum_probs=96.4
Q ss_pred cceEEEEEECCeEEEEEEcc--------H----------HHHHHHHHHHhcCCCCc--ccEEEEEEcC----CCcEEEEE
Q 047629 342 GKSVYRATIDGKVLAVKKIK--------E----------DVTEELRILQRINHANL--VKLMGVSSDS----QGNRFLVY 397 (615)
Q Consensus 342 G~~Vy~~~~~g~~vAvK~~~--------~----------~~~~Ei~~l~~l~H~ni--v~l~g~~~~~----~~~~~lV~ 397 (615)
|+.|++..++|+.+.||+.. + .+.+|...+.++...+| .+.+++.... ...-+||+
T Consensus 35 ~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 35 GRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred CceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 34577888899999999652 1 36789999988854443 4555554322 12468999
Q ss_pred eecCCC-CHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCC-------CCc
Q 047629 398 EYAENG-SLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDS-------RFK 469 (615)
Q Consensus 398 E~~~~G-sL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~-------~~~ 469 (615)
|++++- +|.+++...... ..+...+..++.+++..+.-||+.+ |+|+|++++|||++. +..
T Consensus 115 e~l~~~~sL~~~~~~~~~~--------~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 115 EDLAPTISLEDYCADWATN--------PPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred eeCCCCccHHHHHHhhccc--------CCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence 999876 799988532111 1445667789999999999999999 999999999999975 478
Q ss_pred EEEeecCCCCC
Q 047629 470 AKIANFSLAAP 480 (615)
Q Consensus 470 ~kl~DFGla~~ 480 (615)
+.+.||+.++.
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998854
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.77 E-value=8.1e-10 Score=124.11 Aligned_cols=184 Identities=26% Similarity=0.369 Sum_probs=130.4
Q ss_pred HHHHHHHhcC-CCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh-ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHH
Q 047629 366 EELRILQRIN-HANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL-HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQY 443 (615)
Q Consensus 366 ~Ei~~l~~l~-H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L-~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~y 443 (615)
.|..+-..+. |+|++++++...+.+ ..+++.||..+|++...+ +.... ..+-...-.+..|+..++.|
T Consensus 69 ~e~~~~~~~s~h~n~~~~~~~~~~~~-~~~~~~~~s~g~~~f~~i~~~~~~---------~~~~~~~~~~~~ql~s~l~~ 138 (601)
T KOG0590|consen 69 TETDIQKKLSKHSNTVHMIEPSSSPR-SYLLSLSYSDGGSLFSKISHPDST---------GTSSSSASRYLPQLNSGLSY 138 (601)
T ss_pred ccccccccccccccccccCCccCCCc-ccccccCcccccccccccccCCcc---------CCCCcchhhhhhhhccCccc
Confidence 4566666665 999999999876543 689999999999998888 33221 13344455678899999999
Q ss_pred HH-hCCCCCeEecCCCCCceeeCCCC-cEEEeecCCCCCCCC----------------------------CCCCcccchh
Q 047629 444 MH-EHAQPSIVHRDIRTNNIQLDSRF-KAKIANFSLAAPATN----------------------------DVMPKFDVFA 493 (615)
Q Consensus 444 LH-~~~~~~ivHrDlk~~NILld~~~-~~kl~DFGla~~~~~----------------------------~~~~k~DV~S 493 (615)
+| +.+ +.|||+||+|.+++..+ ..|++|||+|..... ...+..|+||
T Consensus 139 ~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S 215 (601)
T KOG0590|consen 139 LHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWS 215 (601)
T ss_pred cCcccc---cccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCccccc
Confidence 99 777 99999999999999999 999999999854322 0135689999
Q ss_pred HHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcC--CCCCChHHHHHHHHHHHHhhhcCCCC
Q 047629 494 FGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNL--ESFYPIDGALSLATLARACTMDKSLS 571 (615)
Q Consensus 494 fGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l--~~~~~~~~~~~l~~l~~~C~~~dP~~ 571 (615)
.|+++.-+++|..|+......... ...+++... .............++...++..+|..
T Consensus 216 ~g~~l~~~~~g~~p~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~ 276 (601)
T KOG0590|consen 216 LGIVLSAMLTGELPWDFPSRKDGR-------------------YSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSN 276 (601)
T ss_pred ccccccccccCCCCcccccccccc-------------------ceeecccccccccCccccCChhhhhcccccccCCchh
Confidence 999999999999998765432211 001111100 00011122234567778888899999
Q ss_pred CCCHHHHHHH
Q 047629 572 RPNMAEVVFN 581 (615)
Q Consensus 572 RPsm~ev~~~ 581 (615)
|.+.+++...
T Consensus 277 r~s~~~~~~d 286 (601)
T KOG0590|consen 277 RLSIEELKLD 286 (601)
T ss_pred cccccccccc
Confidence 9998877653
|
|
| >PRK06347 autolysin; Reviewed | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.1e-07 Score=105.45 Aligned_cols=153 Identities=16% Similarity=0.155 Sum_probs=110.8
Q ss_pred eeecccCCCCCCHHHHHHhhCCChHHHHhhcCCCCCCCCCCCCccEEeeeeeccCCC----------------ceeeeee
Q 047629 45 VAYFAQSPEFLDLSNISDLFGVSRLSIARASNLVSEDTPLVPKQLLLVPIICGCTGN----------------QYFANIT 108 (615)
Q Consensus 45 ~~y~~~~~~~~~l~~i~~lf~~~~~~i~~~n~~~~~~~~~~~~~~~~vP~~C~C~~~----------------~~~~~~~ 108 (615)
..|+++.. .+|..|+..||++..+|..+|++. .+.+.+||.+.||..=.=... .......
T Consensus 406 ~~ytVk~G--DTL~sIA~kygVSv~~L~~~N~l~--s~~L~~Gq~L~IP~~~~~~~~t~~~s~~~~~~k~~s~~~~~~~~ 481 (592)
T PRK06347 406 KVYTVVKG--DSLWRIANNNKVTIANLKSWNNLK--SDFIYPGQKLKVSAGSTSNTNTSKPSTNTNTSKPSTNTNTNAKV 481 (592)
T ss_pred eeEEecCC--CCHHHHHHHhCCCHHHHHHHhCCC--cceeccCcEEEEecCCccccccccccccccccccccccccccee
Confidence 46787654 599999999999999999999875 357999999999963100000 0012346
Q ss_pred EEeecCCchhhhhhhhcCCcchHHHHHHhCCCCCCCCcCCCcEEEEEeeccCCCCCC----CCCC-eeEEEEEecCCCCc
Q 047629 109 YQIKKGDSYYLVSITSFENLTNWHAVLEMNPGINPNLLQIGVKVTFPLFCKCPSKTN----MEDG-IENLITYVWQPGDD 183 (615)
Q Consensus 109 y~v~~gdt~~~ia~~~~~~L~t~~~~~~~n~~~~~~~l~~G~~~~vpl~c~C~~~~~----~s~~-~~~l~ty~~~~gd~ 183 (615)
|+|++|||++.||..++ + +..++...|+. ..+.|.+|++|.+|....-..... .... ..-...|.|+.||+
T Consensus 482 YtVk~GDTL~sIAkkyg--V-Sv~~L~~~N~l-~s~~L~~GQ~L~Ip~~~~~s~~~t~~~s~~~~~~~~~~~Y~Vk~GDT 557 (592)
T PRK06347 482 YTVAKGDSLWRIANNNK--V-TIANLKSWNNL-KSDFIYPGQKLKVSAGSTTNNTNTAKPSTNKPSNSTVKTYTVKKGDS 557 (592)
T ss_pred eeecCCCCHHHHHHHHC--C-CHHHHHHhcCC-CcccccCCcEEEEecCcccccccccCCccCCccCccceeeecCCCCc
Confidence 99999999999997653 3 34677888884 456899999999997542110000 0000 01135799999999
Q ss_pred hhHHHHHhcCChhhHhhhcccc
Q 047629 184 VSQVGAKLNASSAAIETENEYR 205 (615)
Q Consensus 184 ~~~ia~~F~~s~~~i~~~n~~~ 205 (615)
+..||.+||++...+...|++.
T Consensus 558 L~sIA~KygvSv~~L~~~N~L~ 579 (592)
T PRK06347 558 LWAISRQYKTTVDNIKAWNKLT 579 (592)
T ss_pred HHHHHHHhCCCHHHHHHhcCCC
Confidence 9999999999999999999873
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.2e-07 Score=88.80 Aligned_cols=129 Identities=25% Similarity=0.291 Sum_probs=93.1
Q ss_pred eEEEEEECCeEEEEEEc-c--------------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHh
Q 047629 344 SVYRATIDGKVLAVKKI-K--------------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKW 408 (615)
Q Consensus 344 ~Vy~~~~~g~~vAvK~~-~--------------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~ 408 (615)
.+|.+.+-|..+.+|.- + ....+|..++.+++--.|..-.=+..+.+ ...|+|||+++-.|.+.
T Consensus 11 ~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~-~~~I~me~I~G~~lkd~ 89 (204)
T COG3642 11 IIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPD-NGLIVMEYIEGELLKDA 89 (204)
T ss_pred eEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCC-CCEEEEEEeCChhHHHH
Confidence 56777666656666632 1 22457999999986555443333334443 57899999999888888
Q ss_pred hccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCCCCCCc
Q 047629 409 LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVMPK 488 (615)
Q Consensus 409 L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~k 488 (615)
+... +..++..+-.-+.-||..+ |+|+||.++||++..+. +.+.||||+......-...
T Consensus 90 l~~~-----------------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s~~~Ed~a 148 (204)
T COG3642 90 LEEA-----------------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFSDEVEDKA 148 (204)
T ss_pred HHhc-----------------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccccccHHhhh
Confidence 8653 2345667777788899998 99999999999997764 9999999998765555567
Q ss_pred ccchhH
Q 047629 489 FDVFAF 494 (615)
Q Consensus 489 ~DV~Sf 494 (615)
+|+|-|
T Consensus 149 VDl~Vl 154 (204)
T COG3642 149 VDLHVL 154 (204)
T ss_pred chHHHH
Confidence 788754
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.3e-07 Score=88.03 Aligned_cols=140 Identities=16% Similarity=0.234 Sum_probs=99.8
Q ss_pred eEEEEEECCeEEEEEEcc---------------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCC-CCHHH
Q 047629 344 SVYRATIDGKVLAVKKIK---------------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAEN-GSLDK 407 (615)
Q Consensus 344 ~Vy~~~~~g~~vAvK~~~---------------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~-GsL~~ 407 (615)
.|+++.+.|+...||.-- +...+|...|.+++--.|.--.=++.+.. .-.|+|||+++ -++.+
T Consensus 22 rv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~-~~~i~ME~~~g~~~vk~ 100 (229)
T KOG3087|consen 22 RVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY-GGQIYMEFIDGASTVKD 100 (229)
T ss_pred eEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC-CCeEEEEeccchhHHHH
Confidence 799999999998888431 23567999999886555542222333333 45789999975 37888
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCC---cEEEeecCCCCCCCCC
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRF---KAKIANFSLAAPATND 484 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~---~~kl~DFGla~~~~~~ 484 (615)
|+...-... -.-.....++..|-.-+.-||... |+|+||..+||+|..++ .+.+.|||++......
T Consensus 101 ~i~~~~~~~--------~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~s~~~ 169 (229)
T KOG3087|consen 101 FILSTMEDE--------SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSVSRLP 169 (229)
T ss_pred HHHHHccCc--------ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhcccCc
Confidence 886643321 112223677888888999999998 99999999999996653 4689999998776555
Q ss_pred CCCcccchhHH
Q 047629 485 VMPKFDVFAFG 495 (615)
Q Consensus 485 ~~~k~DV~SfG 495 (615)
-...+|.|=|-
T Consensus 170 EDKgVDLYVlE 180 (229)
T KOG3087|consen 170 EDKGVDLYVLE 180 (229)
T ss_pred ccccceeeeeh
Confidence 56678888543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.69 E-value=3.7e-07 Score=99.86 Aligned_cols=137 Identities=18% Similarity=0.338 Sum_probs=105.3
Q ss_pred CCeEEEEEEccH-------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCCCCCCCccc
Q 047629 351 DGKVLAVKKIKE-------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVI 423 (615)
Q Consensus 351 ~g~~vAvK~~~~-------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~ 423 (615)
++.+|.|...+. ...+-++-|+.++||||++++.... .++.+|||+|-+. .|..++++
T Consensus 36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e-~~~~~ylvTErV~--Pl~~~lk~------------ 100 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTE-EEGTLYLVTERVR--PLETVLKE------------ 100 (690)
T ss_pred cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhc-ccCceEEEeeccc--cHHHHHHH------------
Confidence 567777766542 2456678899999999999999754 5668999999884 57777764
Q ss_pred ccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCCC-------------CC----
Q 047629 424 FLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATND-------------VM---- 486 (615)
Q Consensus 424 ~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~-------------~~---- 486 (615)
+.-....--+.||+.||.|||+.+ .++|++|.-..|+++..|.-||++|-+....... ..
T Consensus 101 -l~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~ 177 (690)
T KOG1243|consen 101 -LGKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEI 177 (690)
T ss_pred -hHHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhc
Confidence 333344556789999999999776 5999999999999999999999999765322110 11
Q ss_pred Cc----ccchhHHHHHHHHHcCC
Q 047629 487 PK----FDVFAFGVVLLELLSGK 505 (615)
Q Consensus 487 ~k----~DV~SfGvvl~ElltG~ 505 (615)
.+ .|.|-||++++|++.|.
T Consensus 178 ~~s~~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 178 DPSEWSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred CccccchhhhhHHHHHHHHhCcc
Confidence 12 49999999999999993
|
|
| >PRK06347 autolysin; Reviewed | Back alignment and domain information |
|---|
Probab=98.69 E-value=2.3e-07 Score=102.89 Aligned_cols=169 Identities=16% Similarity=0.138 Sum_probs=118.5
Q ss_pred eeeecccCCCCCCHHHHHHhhCCChHHHHhhcCCCCCCCCCCCCccEEeeeeeccCC-----------------Cceeee
Q 047629 44 YVAYFAQSPEFLDLSNISDLFGVSRLSIARASNLVSEDTPLVPKQLLLVPIICGCTG-----------------NQYFAN 106 (615)
Q Consensus 44 ~~~y~~~~~~~~~l~~i~~lf~~~~~~i~~~n~~~~~~~~~~~~~~~~vP~~C~C~~-----------------~~~~~~ 106 (615)
...|.++.+ .+|..||..||+++.+|..+|++. .+.|.+||.|+||..=.=.. ......
T Consensus 330 ~~~Y~V~sG--DTL~~IA~rygvSv~eL~~~N~l~--~d~L~~Gq~L~VP~~~~~~~~~t~~~~~~~~~~~~~~~~~~~~ 405 (592)
T PRK06347 330 AKIYTVVKG--DSLWRIANNHKVTVANLKAWNNLK--SDFIYPGQKLKVSAGSTTSDTNTSKPSTGTSTSKPSTGTSTNA 405 (592)
T ss_pred ceEEEeCCC--CCHHHHHHHhCCCHHHHHHHhCCC--ccccccCcEEEEeccccccccccccccccccccccccccccCc
Confidence 446888654 599999999999999999999964 46899999999997300000 000123
Q ss_pred eeEEeecCCchhhhhhhhcCCcchHHHHHHhCCCCCCCCcCCCcEEEEEeecc------CCCCC-CC----CCCeeEEEE
Q 047629 107 ITYQIKKGDSYYLVSITSFENLTNWHAVLEMNPGINPNLLQIGVKVTFPLFCK------CPSKT-NM----EDGIENLIT 175 (615)
Q Consensus 107 ~~y~v~~gdt~~~ia~~~~~~L~t~~~~~~~n~~~~~~~l~~G~~~~vpl~c~------C~~~~-~~----s~~~~~l~t 175 (615)
..|+|++||+++.||...+-. ..++...|+ +..+.+.+|+.+.+|..-. .+... .. +....-...
T Consensus 406 ~~ytVk~GDTL~sIA~kygVS---v~~L~~~N~-l~s~~L~~Gq~L~IP~~~~~~~~t~~~s~~~~~~k~~s~~~~~~~~ 481 (592)
T PRK06347 406 KVYTVVKGDSLWRIANNNKVT---IANLKSWNN-LKSDFIYPGQKLKVSAGSTSNTNTSKPSTNTNTSKPSTNTNTNAKV 481 (592)
T ss_pred eeEEecCCCCHHHHHHHhCCC---HHHHHHHhC-CCcceeccCcEEEEecCCccccccccccccccccccccccccccee
Confidence 479999999999999766533 356677786 4456799999999996421 11000 00 000111257
Q ss_pred EecCCCCchhHHHHHhcCChhhHhhhccccCccccCccceecccc
Q 047629 176 YVWQPGDDVSQVGAKLNASSAAIETENEYRNFSEAVSLPVLIPVS 220 (615)
Q Consensus 176 y~~~~gd~~~~ia~~F~~s~~~i~~~n~~~~~~~~~~~~~l~p~~ 220 (615)
|.|+.||++..||.+||++...+...|++..-...+|..+.||..
T Consensus 482 YtVk~GDTL~sIAkkygVSv~~L~~~N~l~s~~L~~GQ~L~Ip~~ 526 (592)
T PRK06347 482 YTVAKGDSLWRIANNNKVTIANLKSWNNLKSDFIYPGQKLKVSAG 526 (592)
T ss_pred eeecCCCCHHHHHHHHCCCHHHHHHhcCCCcccccCCcEEEEecC
Confidence 999999999999999999999999999874333445666667653
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.68 E-value=2.6e-07 Score=90.71 Aligned_cols=128 Identities=24% Similarity=0.378 Sum_probs=97.0
Q ss_pred ceEEEEEEC-CeEEEEEEccH--------HHHHHHHHHHhcCCC--CcccEEEEEEcCC--CcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATID-GKVLAVKKIKE--------DVTEELRILQRINHA--NLVKLMGVSSDSQ--GNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~~-g~~vAvK~~~~--------~~~~Ei~~l~~l~H~--niv~l~g~~~~~~--~~~~lV~E~~~~GsL~~~L 409 (615)
..+|+.... |+.+++|.... .+..|.+++..+++. ++.+++.+..... +..++||||++++++.+.+
T Consensus 12 n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~ 91 (223)
T cd05154 12 NLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRL 91 (223)
T ss_pred ceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCC
Confidence 479998885 48899998652 467899999999764 4567787754321 2568999999998887765
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHA----------------------------------------- 448 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------------------- 448 (615)
.. . .++..++..++.++++.|.+||+..
T Consensus 92 ~~-~----------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 92 LR-P----------ELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CC-C----------CCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 32 1 2677788888888888888888521
Q ss_pred ------------CCCeEecCCCCCceeeCC--CCcEEEeecCCCCCC
Q 047629 449 ------------QPSIVHRDIRTNNIQLDS--RFKAKIANFSLAAPA 481 (615)
Q Consensus 449 ------------~~~ivHrDlk~~NILld~--~~~~kl~DFGla~~~ 481 (615)
...++|+|+++.||+++. +..+.+.||+.+...
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 245899999999999998 566899999987654
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.59 E-value=3.5e-08 Score=106.62 Aligned_cols=203 Identities=23% Similarity=0.297 Sum_probs=141.0
Q ss_pred ceEEEEEE----CCeEEEEEEccH---------HHHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHh
Q 047629 343 KSVYRATI----DGKVLAVKKIKE---------DVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKW 408 (615)
Q Consensus 343 ~~Vy~~~~----~g~~vAvK~~~~---------~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~ 408 (615)
+.||.+.. ++..+|+|+-+. .-.+|+....++ .|+|.++....+.+ .+..++-+|++. .+|.++
T Consensus 130 ~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~-~~~lfiqtE~~~-~sl~~~ 207 (524)
T KOG0601|consen 130 GSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG-SGILFIQTELCG-ESLQSY 207 (524)
T ss_pred ceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc-CCcceeeecccc-chhHHh
Confidence 57887765 578899998431 234677777777 49999997777654 457888899885 699999
Q ss_pred hccCCCCCCCCCcccccCHHHHHHHHHHHHH----HHHHHHhCCCCCeEecCCCCCceeeCCC-CcEEEeecCCCCCCCC
Q 047629 409 LHPKSKSSSSSGSVIFLTWSQRLRVALDVAN----GLQYMHEHAQPSIVHRDIRTNNIQLDSR-FKAKIANFSLAAPATN 483 (615)
Q Consensus 409 L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~ivHrDlk~~NILld~~-~~~kl~DFGla~~~~~ 483 (615)
.+.... .++....+....+... ||.++|+.. ++|-|+||.||++..+ ...+++|||+......
T Consensus 208 ~~~~~~---------~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~ 275 (524)
T KOG0601|consen 208 CHTPCN---------FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFGLVSKISD 275 (524)
T ss_pred hhcccc---------cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcceeEEccC
Confidence 886543 2444455555555556 999999987 9999999999999999 8899999998754321
Q ss_pred ---------------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHH
Q 047629 484 ---------------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREER 536 (615)
Q Consensus 484 ---------------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 536 (615)
-++.+.|+||+|.+..|..+|.......... .|...+..+
T Consensus 276 ~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~----~W~~~r~~~--------- 342 (524)
T KOG0601|consen 276 GNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNS----SWSQLRQGY--------- 342 (524)
T ss_pred CccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCC----Ccccccccc---------
Confidence 1346789999999999999987655433110 132222111
Q ss_pred HhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047629 537 LRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVF 580 (615)
Q Consensus 537 ~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~ 580 (615)
+..++...-..++......+++.+|..|++.+.+..
T Consensus 343 --------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 343 --------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred --------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 111122222223455888999999999998876654
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.54 E-value=5.8e-07 Score=86.19 Aligned_cols=118 Identities=27% Similarity=0.372 Sum_probs=77.6
Q ss_pred eEEEEEE-CCeEEEEEEccH---------------------------------HHHHHHHHHHhcCCCC--cccEEEEEE
Q 047629 344 SVYRATI-DGKVLAVKKIKE---------------------------------DVTEELRILQRINHAN--LVKLMGVSS 387 (615)
Q Consensus 344 ~Vy~~~~-~g~~vAvK~~~~---------------------------------~~~~Ei~~l~~l~H~n--iv~l~g~~~ 387 (615)
.||.|.. +|..+|||..+. ...+|.+.|.++...+ +-+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899987 789999997640 1357999999997764 45666542
Q ss_pred cCCCcEEEEEeecC--CCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHH-HHhCCCCCeEecCCCCCceee
Q 047629 388 DSQGNRFLVYEYAE--NGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQY-MHEHAQPSIVHRDIRTNNIQL 464 (615)
Q Consensus 388 ~~~~~~~lV~E~~~--~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~y-LH~~~~~~ivHrDlk~~NILl 464 (615)
...|||||++ +..+.. |.... ++......++.++...+.. +|..+ ++|+||.+.|||+
T Consensus 80 ----~~~ivME~I~~~G~~~~~-l~~~~-----------~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv 140 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPR-LKDVD-----------LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILV 140 (188)
T ss_dssp ----TTEEEEE--EETTEEGGC-HHHCG-----------GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEE
T ss_pred ----CCEEEEEecCCCccchhh-HHhcc-----------ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEe
Confidence 2479999998 444443 32211 1123345667777776666 46777 9999999999999
Q ss_pred CCCCcEEEeecCCCCCCC
Q 047629 465 DSRFKAKIANFSLAAPAT 482 (615)
Q Consensus 465 d~~~~~kl~DFGla~~~~ 482 (615)
+++ .+.+.|||.+....
T Consensus 141 ~~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 141 DDG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp ETT-CEEE--GTTEEETT
T ss_pred ecc-eEEEEecCcceecC
Confidence 988 99999999876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.52 E-value=6.4e-08 Score=104.65 Aligned_cols=212 Identities=21% Similarity=0.302 Sum_probs=143.3
Q ss_pred cccccccccc----ceEEEEEE---CCeEEEEEEccHH---H------HHHHHHHHhc-CCCCcccEEEEEEcCCCcEEE
Q 047629 333 MNLSEHYSIG----KSVYRATI---DGKVLAVKKIKED---V------TEELRILQRI-NHANLVKLMGVSSDSQGNRFL 395 (615)
Q Consensus 333 ~~~~~~~~iG----~~Vy~~~~---~g~~vAvK~~~~~---~------~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~l 395 (615)
..|.+...+| ..||+... ++..+++|.+.+. + ..|+-+...+ .|.++++....+...+ ..++
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r-~~~i 343 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR-QGYI 343 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc-cccC
Confidence 4455555555 24555544 5678899887642 1 2455555555 4777777655444333 5779
Q ss_pred EEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCC-CcEEEee
Q 047629 396 VYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSR-FKAKIAN 474 (615)
Q Consensus 396 V~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~-~~~kl~D 474 (615)
-.||++++++...+.-.. .++...++++..+++.++.++|+.. ++|+|+||+||++..+ +..+++|
T Consensus 344 p~e~~~~~s~~l~~~~~~----------~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~ 410 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSVTSQ----------MLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGD 410 (524)
T ss_pred chhhhcCcchhhhhHHHH----------hcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccc
Confidence 999999999887763221 3778888999999999999999887 9999999999999886 8889999
Q ss_pred cCCCCCCC----------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHH
Q 047629 475 FSLAAPAT----------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEK 532 (615)
Q Consensus 475 FGla~~~~----------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 532 (615)
||.+..+. .....+.|+||||.-+.|.++|..-.....+ |..+
T Consensus 411 ~~~~t~~~~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~------~~~i--------- 475 (524)
T KOG0601|consen 411 FGCWTRLAFSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ------SLTI--------- 475 (524)
T ss_pred cccccccceecccccccccccccchhhccccccccccccccccccccccccCcccCccccc------ceee---------
Confidence 99875321 1134589999999999999998754332211 1100
Q ss_pred HHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047629 533 REERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLS 583 (615)
Q Consensus 533 ~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~ 583 (615)
+.-.-|.+ +..- ..+..+++.....++..||.+.+...+.+
T Consensus 476 -----~~~~~p~~----~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 476 -----RSGDTPNL----PGLK-LQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred -----ecccccCC----CchH-HhhhhhhhhhcCCccccchhhhhhcccch
Confidence 00011111 1111 44667788889999999999887766544
|
|
| >PRK10783 mltD membrane-bound lytic murein transglycosylase D; Provisional | Back alignment and domain information |
|---|
Probab=98.33 E-value=2e-06 Score=93.47 Aligned_cols=104 Identities=26% Similarity=0.248 Sum_probs=84.9
Q ss_pred eeecccCCCCCCHHHHHHhhCCChHHHHhhcCCCCCCCCCCCCccEEeeeeeccCC-CceeeeeeEEeecCCchhhhhhh
Q 047629 45 VAYFAQSPEFLDLSNISDLFGVSRLSIARASNLVSEDTPLVPKQLLLVPIICGCTG-NQYFANITYQIKKGDSYYLVSIT 123 (615)
Q Consensus 45 ~~y~~~~~~~~~l~~i~~lf~~~~~~i~~~n~~~~~~~~~~~~~~~~vP~~C~C~~-~~~~~~~~y~v~~gdt~~~ia~~ 123 (615)
..|+++.. .|+..||..||++..+|...|+... +.+.+||.+.||.+|.|.. .......+|+|++|||++.||..
T Consensus 344 ~~y~Vk~G--DTL~sIA~r~gvs~~~L~~~N~l~~--~~L~~Gq~L~Ip~~~~~~~~~~~~~~~~Y~Vr~GDTL~sIA~k 419 (456)
T PRK10783 344 RSYKVRSG--DTLSGIASRLNVSTKDLQQWNNLRG--SKLKVGQTLTIGAGSSAQRLANNSDSITYRVRKGDSLSSIAKR 419 (456)
T ss_pred eEEEECCC--CcHHHHHHHHCcCHHHHHHHcCCCc--ccCCCCCEEEecCCcccccccccccceeEEeCCCCCHHHHHHH
Confidence 46888765 5999999999999999999999763 6799999999998887752 22234568999999999999976
Q ss_pred hcCCcchHHHHHHhCCCCCCCCcCCCcEEEEEe
Q 047629 124 SFENLTNWHAVLEMNPGINPNLLQIGVKVTFPL 156 (615)
Q Consensus 124 ~~~~L~t~~~~~~~n~~~~~~~l~~G~~~~vpl 156 (615)
.. ++..++...|+.... .+.+|+++.+++
T Consensus 420 yg---Vtv~~L~~~N~l~~~-~L~pGq~L~l~v 448 (456)
T PRK10783 420 HG---VNIKDVMRWNSDTAK-NLQPGDKLTLFV 448 (456)
T ss_pred hC---CCHHHHHHhcCCCCC-cCCCCCEEEEec
Confidence 54 456888999986554 899999998876
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.4e-05 Score=78.15 Aligned_cols=106 Identities=22% Similarity=0.264 Sum_probs=82.6
Q ss_pred HHHHHHHHHHhcCCC--CcccEEEEEEcCCC---cEEEEEeecCCC-CHHHhhccCCCCCCCCCcccccCHHHHHHHHHH
Q 047629 363 DVTEELRILQRINHA--NLVKLMGVSSDSQG---NRFLVYEYAENG-SLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALD 436 (615)
Q Consensus 363 ~~~~Ei~~l~~l~H~--niv~l~g~~~~~~~---~~~lV~E~~~~G-sL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ 436 (615)
...+|...+.++... ...+.+++.....+ ..+||+|++++- +|.+++..... ++......++.+
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~----------~~~~~~~~ll~~ 126 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ----------LDPSQRRELLRA 126 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc----------cchhhHHHHHHH
Confidence 467888888888544 34566676554322 248999999874 79999876332 445567888999
Q ss_pred HHHHHHHHHhCCCCCeEecCCCCCceeeCCCC---cEEEeecCCCCCC
Q 047629 437 VANGLQYMHEHAQPSIVHRDIRTNNIQLDSRF---KAKIANFSLAAPA 481 (615)
Q Consensus 437 ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~---~~kl~DFGla~~~ 481 (615)
++..+.-||+.+ |+|+|++++|||++.+. .+.+.||+-++..
T Consensus 127 l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 127 LARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999999999 99999999999999887 8999999976654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.20 E-value=4.5e-05 Score=73.91 Aligned_cols=125 Identities=19% Similarity=0.214 Sum_probs=94.9
Q ss_pred eEEEEEECCeEEEEEEcc-------------HHHHHHHHHHHhcCCCC--cccEEEEEE-cCCC---cEEEEEeecCC-C
Q 047629 344 SVYRATIDGKVLAVKKIK-------------EDVTEELRILQRINHAN--LVKLMGVSS-DSQG---NRFLVYEYAEN-G 403 (615)
Q Consensus 344 ~Vy~~~~~g~~vAvK~~~-------------~~~~~Ei~~l~~l~H~n--iv~l~g~~~-~~~~---~~~lV~E~~~~-G 403 (615)
+|++-.++|+.+-+|+-. ..|.+|+..|.++...+ +.+.. ++. ...+ .-+||+|-+++ -
T Consensus 33 gV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe~L~g~~ 111 (216)
T PRK09902 33 GVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTEDMAGFI 111 (216)
T ss_pred eEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEEeCCCCc
Confidence 799988888889999764 34789999999985433 33444 222 1111 25899998764 4
Q ss_pred CHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCc--EEEeecCCCCC
Q 047629 404 SLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFK--AKIANFSLAAP 480 (615)
Q Consensus 404 sL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~--~kl~DFGla~~ 480 (615)
+|.+++...... ..+..++..+..+++..+.-||+.+ +.|+|+.+.||+++.++. +++.||--++.
T Consensus 112 ~L~~~l~~~~~~--------~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 112 SIADWYAQHAVS--------PYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred cHHHHHhcCCcC--------CcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 899998654321 2567778899999999999999998 999999999999986666 99999986554
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.02 E-value=3.1e-05 Score=74.52 Aligned_cols=102 Identities=24% Similarity=0.320 Sum_probs=81.1
Q ss_pred HHHHHHHHhcCC-CCcccEEEEEEcCCCcEEEEEeecCCCCHHHh---hccCCCCCCCCCcccccCHHHHHHHHHHHHHH
Q 047629 365 TEELRILQRINH-ANLVKLMGVSSDSQGNRFLVYEYAENGSLDKW---LHPKSKSSSSSGSVIFLTWSQRLRVALDVANG 440 (615)
Q Consensus 365 ~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~---L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~g 440 (615)
..|.-+|+.+++ +++.+++|+|- .++|.||.+.+++... +... ..-+|.+|.+||.++++.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG-----~~~v~E~~~~~~~~~~~~~l~~~----------~~~~w~~R~~iA~~lL~~ 71 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG-----RFYVVEYVGAGSLYGIYRPLSQF----------LQSPWEQRAKIALQLLEL 71 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC-----CEEEEEeecCccccccccccccc----------cccCHHHHHHHHHHHHHH
Confidence 358888999976 68999999982 2679999987766422 1110 126899999999999999
Q ss_pred HHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCC
Q 047629 441 LQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA 481 (615)
Q Consensus 441 L~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~ 481 (615)
+++|++.....+.-.|++++|+-+++++++|+.|...+...
T Consensus 72 l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 72 LEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred HHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 99999865555888999999999999999999999876443
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.97 E-value=3.9e-05 Score=84.49 Aligned_cols=125 Identities=20% Similarity=0.207 Sum_probs=83.6
Q ss_pred ceEEEEEE-CCeEEEEEEccH-----------------------------------------------HHHHHHHHHHhc
Q 047629 343 KSVYRATI-DGKVLAVKKIKE-----------------------------------------------DVTEELRILQRI 374 (615)
Q Consensus 343 ~~Vy~~~~-~g~~vAvK~~~~-----------------------------------------------~~~~Ei~~l~~l 374 (615)
+.||+|++ +|+.||||+.+. ++..|..-+.++
T Consensus 139 aQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~EA~n~~~~ 218 (517)
T COG0661 139 AQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRREAANAERF 218 (517)
T ss_pred hhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHHHHHHHHHH
Confidence 47999999 699999998751 123455555554
Q ss_pred ----CCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHH-HHHHHhCCC
Q 047629 375 ----NHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANG-LQYMHEHAQ 449 (615)
Q Consensus 375 ----~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~g-L~yLH~~~~ 449 (615)
++..=+++-.++++-.+...|+|||++|-.+.+...-... .++-+. ++..+++. +..+-.++
T Consensus 219 ~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~---------g~d~k~---ia~~~~~~f~~q~~~dg- 285 (517)
T COG0661 219 RENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA---------GIDRKE---LAELLVRAFLRQLLRDG- 285 (517)
T ss_pred HHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc---------CCCHHH---HHHHHHHHHHHHHHhcC-
Confidence 3333344445555544567999999999888887432221 144222 33333322 23333355
Q ss_pred CCeEecCCCCCceeeCCCCcEEEeecCCCCCCC
Q 047629 450 PSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT 482 (615)
Q Consensus 450 ~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~ 482 (615)
++|.|.+|.||+++.+++.-+-|||+.....
T Consensus 286 --ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 286 --FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred --ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 9999999999999999999999999986653
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.86 E-value=9.6e-06 Score=92.78 Aligned_cols=169 Identities=17% Similarity=0.220 Sum_probs=109.2
Q ss_pred cCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 047629 374 INHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIV 453 (615)
Q Consensus 374 l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv 453 (615)
.+||-+++..--+. .....+||++|..+|+|...|+.... ++..-.......+...++|||... +.
T Consensus 861 p~~P~v~~~~~s~~-~rsP~~L~~~~~~~~~~~Skl~~~~~----------~saepaRs~i~~~vqs~e~L~s~~---r~ 926 (1205)
T KOG0606|consen 861 PRSPAVVRSFPSFP-CRSPLPLVGHYLNGGDLPSKLHNSGC----------LSAEPARSPILERVQSLESLHSSL---RK 926 (1205)
T ss_pred CCCCceecccCCCC-CCCCcchhhHHhccCCchhhhhcCCC----------cccccccchhHHHHhhhhccccch---hh
Confidence 34455554332211 12357999999999999999987653 222222233445667899999886 89
Q ss_pred ecCCCCCceeeCCCCcEEEeecCCCCCCC------C--------------------------------------------
Q 047629 454 HRDIRTNNIQLDSRFKAKIANFSLAAPAT------N-------------------------------------------- 483 (615)
Q Consensus 454 HrDlk~~NILld~~~~~kl~DFGla~~~~------~-------------------------------------------- 483 (615)
|||++|.|+|...++..+++|||...... .
T Consensus 927 h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~ 1006 (1205)
T KOG0606|consen 927 HRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEI 1006 (1205)
T ss_pred cccccccchhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcc
Confidence 99999999999999999999998432110 0
Q ss_pred ----CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCC-CCCChHHHHHHH
Q 047629 484 ----DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLE-SFYPIDGALSLA 558 (615)
Q Consensus 484 ----~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~-~~~~~~~~~~l~ 558 (615)
.....+|.|++|++++|.++|..|+.....+.. ++.+....+. ..-+.+......
T Consensus 1007 ~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~--------------------f~ni~~~~~~~p~g~~~~s~~aq 1066 (1205)
T KOG0606|consen 1007 LLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQI--------------------FENILNRDIPWPEGPEEGSYEAQ 1066 (1205)
T ss_pred cccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhh--------------------hhccccCCCCCCCCccccChhhh
Confidence 012367999999999999999999976543211 1111111110 112333444556
Q ss_pred HHHHHhhhcCCCCCCCHH
Q 047629 559 TLARACTMDKSLSRPNMA 576 (615)
Q Consensus 559 ~l~~~C~~~dP~~RPsm~ 576 (615)
++...-+..+|.+|-.|.
T Consensus 1067 ~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1067 DLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhhhhhccCchhccCcc
Confidence 677777777888887665
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.0001 Score=73.32 Aligned_cols=124 Identities=22% Similarity=0.274 Sum_probs=84.9
Q ss_pred cccccccc--ceEEEEEE-CCeEEEEEEcc-----------------------------HHHHHHHHHHHhcCCC--Ccc
Q 047629 335 LSEHYSIG--KSVYRATI-DGKVLAVKKIK-----------------------------EDVTEELRILQRINHA--NLV 380 (615)
Q Consensus 335 ~~~~~~iG--~~Vy~~~~-~g~~vAvK~~~-----------------------------~~~~~Ei~~l~~l~H~--niv 380 (615)
+....++| +.||.|.. .|.++|||.=+ ....+|.+.|.++.-. .+-
T Consensus 95 iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP 174 (304)
T COG0478 95 IGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVP 174 (304)
T ss_pred hccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCC
Confidence 34445566 37999998 69999999432 1245799999999655 666
Q ss_pred cEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 047629 381 KLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTN 460 (615)
Q Consensus 381 ~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~ 460 (615)
+.+++ +...+||||+++-.|...- ++-...-.++..|..-+.-+-..+ |||+|+..-
T Consensus 175 ~P~~~-----nRHaVvMe~ieG~eL~~~r---------------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSef 231 (304)
T COG0478 175 KPIAW-----NRHAVVMEYIEGVELYRLR---------------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEF 231 (304)
T ss_pred Ccccc-----ccceeeeehcccceeeccc---------------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchh
Confidence 66654 2468999999886554422 111222233344444444444555 999999999
Q ss_pred ceeeCCCCcEEEeecCCCCCC
Q 047629 461 NIQLDSRFKAKIANFSLAAPA 481 (615)
Q Consensus 461 NILld~~~~~kl~DFGla~~~ 481 (615)
||++++++.+.+.||--+...
T Consensus 232 NIlV~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 232 NILVTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred eEEEecCCCEEEEeCcccccC
Confidence 999999999999999766544
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.75 E-value=1.3e-05 Score=88.37 Aligned_cols=127 Identities=24% Similarity=0.371 Sum_probs=84.9
Q ss_pred HHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC-------------------------------
Q 047629 435 LDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------------------------------- 483 (615)
Q Consensus 435 ~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------------------------------- 483 (615)
.+++.||.|+|.+- .+||++|.|++|.++.++..|++.|+++.....
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 45569999999865 699999999999999999999999987632211
Q ss_pred -CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHH
Q 047629 484 -DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLAR 562 (615)
Q Consensus 484 -~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~ 562 (615)
..++++|+||+||+++-+..|..+.-...+..... . ... ...+-. .--+..+.+.++.+=+.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~--~-~~~-------------~~~~~~-~~~~s~~~p~el~~~l~ 246 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY--S-FSR-------------NLLNAG-AFGYSNNLPSELRESLK 246 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchh--h-hhh-------------cccccc-cccccccCcHHHHHHHH
Confidence 13468999999999999996555543322211100 0 000 000100 01122344556777788
Q ss_pred HhhhcCCCCCCCHHHHHH
Q 047629 563 ACTMDKSLSRPNMAEVVF 580 (615)
Q Consensus 563 ~C~~~dP~~RPsm~ev~~ 580 (615)
+.+..++..||++.++..
T Consensus 247 k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 247 KLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HHhcCCcccCcchhhhhc
Confidence 899999999998877654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.0008 Score=67.39 Aligned_cols=145 Identities=15% Similarity=0.152 Sum_probs=87.5
Q ss_pred ceEEEEEECCeEEEEEEccH----HHHHHHHHHHhcC-CCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh--------
Q 047629 343 KSVYRATIDGKVLAVKKIKE----DVTEELRILQRIN-HANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL-------- 409 (615)
Q Consensus 343 ~~Vy~~~~~g~~vAvK~~~~----~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L-------- 409 (615)
..||+...++..+.||.... +..+|++++..+. +--+.+++++.... +..++|||++++.+|.+..
T Consensus 13 ~~v~~~~~~~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~-~~~~lv~e~i~G~~l~~~~~~~~~~~~ 91 (244)
T cd05150 13 ATVYRLDGKNPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSDD-GRAWLLTSAVPGVPAAALWEELEPERL 91 (244)
T ss_pred CeEEEEcCCCCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEecC-CccEEEEEeeCCccHhHhhcccCHHHH
Confidence 47898877777888888765 4788999999884 43344777766533 4678999999987776442
Q ss_pred -----------ccCCCCCCCCCcccccC--HHHHHHHHH--------------------HHHHHHHHHHh----CCCCCe
Q 047629 410 -----------HPKSKSSSSSGSVIFLT--WSQRLRVAL--------------------DVANGLQYMHE----HAQPSI 452 (615)
Q Consensus 410 -----------~~~~~~~~~~~~~~~l~--~~~~~~i~~--------------------~ia~gL~yLH~----~~~~~i 452 (615)
|..... .. .+. +..+..... .+...+..|-. ...+.+
T Consensus 92 ~~~l~~~l~~lH~i~~~-----~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l 165 (244)
T cd05150 92 VDALAEALRRLHALPVA-----DC-PFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDLVV 165 (244)
T ss_pred HHHHHHHHHHHhcCCcc-----cC-CcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCceEE
Confidence 111100 00 010 001110000 01111222211 124569
Q ss_pred EecCCCCCceeeCCCCcEEEeecCCCCCCCCCCCCcccchhHHHHHHHH
Q 047629 453 VHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVMPKFDVFAFGVVLLEL 501 (615)
Q Consensus 453 vHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~k~DV~SfGvvl~El 501 (615)
+|+|+.+.|||++++....|.||+.+..... .|-|+.++..+
T Consensus 166 ~HgD~~~~Nil~~~~~~~~iIDwe~a~~gdp-------~~Dla~~~~~~ 207 (244)
T cd05150 166 THGDACLPNIIVDPGKFSGFIDLGRLGVADR-------YQDLALAVRSL 207 (244)
T ss_pred ECCCCCCccEEEeCCcEEEEEEccccccccH-------HHHHHHHHHHh
Confidence 9999999999999987788999997654322 34566655544
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.0013 Score=64.26 Aligned_cols=115 Identities=17% Similarity=0.226 Sum_probs=75.9
Q ss_pred eEEEEEECCeEEEEEEccHH----------------HHHHHHHHHhcCCC---CcccEEEEEEcCC----CcEEEEEeec
Q 047629 344 SVYRATIDGKVLAVKKIKED----------------VTEELRILQRINHA---NLVKLMGVSSDSQ----GNRFLVYEYA 400 (615)
Q Consensus 344 ~Vy~~~~~g~~vAvK~~~~~----------------~~~Ei~~l~~l~H~---niv~l~g~~~~~~----~~~~lV~E~~ 400 (615)
.|.+-..+|+.+.+|..+.. ..+++..+.+++.. ....++.+..... ...+++|||+
T Consensus 46 ~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~EYI 125 (229)
T PF06176_consen 46 YVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSSYVLLMEYI 125 (229)
T ss_pred EEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccceeEEEEEEEEe
Confidence 45555668999999987632 23445545555322 2233333222111 1356899999
Q ss_pred CCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCC
Q 047629 401 ENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAP 480 (615)
Q Consensus 401 ~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~ 480 (615)
++-.|.+... ++. .++..+...+.-||..| ++|+|..|+|+++.++ .+++.||+..+.
T Consensus 126 eG~~l~d~~~--------------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~i~iID~~~k~~ 183 (229)
T PF06176_consen 126 EGVELNDIED--------------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-GIRIIDTQGKRM 183 (229)
T ss_pred cCeecccchh--------------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-cEEEEECccccc
Confidence 9987766532 221 24456778899999999 9999999999999865 499999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00043 Score=76.21 Aligned_cols=126 Identities=21% Similarity=0.219 Sum_probs=79.5
Q ss_pred ceEEEEEE-CCeEEEEEEccH--------------------------------------------HHHHHHHHHHh----
Q 047629 343 KSVYRATI-DGKVLAVKKIKE--------------------------------------------DVTEELRILQR---- 373 (615)
Q Consensus 343 ~~Vy~~~~-~g~~vAvK~~~~--------------------------------------------~~~~Ei~~l~~---- 373 (615)
+.||++++ +|+.||||+-+. +|..|.+-..+
T Consensus 175 aQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~ 254 (538)
T KOG1235|consen 175 AQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFREN 254 (538)
T ss_pred hheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHH
Confidence 48999999 899999997641 13344443333
Q ss_pred cCCCCc---ccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCC
Q 047629 374 INHANL---VKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQP 450 (615)
Q Consensus 374 l~H~ni---v~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 450 (615)
+.|-+. |++-.++++......|+||||+|..+.+...-... .++-..+..-+.+... +-+-..|
T Consensus 255 f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~---------gi~~~~i~~~l~~~~~--~qIf~~G-- 321 (538)
T KOG1235|consen 255 FKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR---------GISPHDILNKLVEAYL--EQIFKTG-- 321 (538)
T ss_pred HHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc---------CCCHHHHHHHHHHHHH--HHHHhcC--
Confidence 356662 23444455544578999999999877655322211 1443433333333221 2222334
Q ss_pred CeEecCCCCCceeeCC----CCcEEEeecCCCCCCC
Q 047629 451 SIVHRDIRTNNIQLDS----RFKAKIANFSLAAPAT 482 (615)
Q Consensus 451 ~ivHrDlk~~NILld~----~~~~kl~DFGla~~~~ 482 (615)
++|.|-.|.||++.. +.++.+-|||+.+...
T Consensus 322 -ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 322 -FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred -CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 999999999999983 6789999999986653
|
|
| >PF01476 LysM: LysM domain; InterPro: IPR018392 This domain is about 40 residues long and is found in a variety of enzymes involved in bacterial cell wall degradation [] | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0002 Score=51.28 Aligned_cols=44 Identities=27% Similarity=0.540 Sum_probs=34.7
Q ss_pred EEeecCCchhhhhhhhcCCcchHHHHHHhCCCCCCCCcCCCcEEEEE
Q 047629 109 YQIKKGDSYYLVSITSFENLTNWHAVLEMNPGINPNLLQIGVKVTFP 155 (615)
Q Consensus 109 y~v~~gdt~~~ia~~~~~~L~t~~~~~~~n~~~~~~~l~~G~~~~vp 155 (615)
|+|++|||++.||... -.++.++...|+.++...+.+|+++.+|
T Consensus 1 y~V~~gDtl~~IA~~~---~~~~~~l~~~N~~~~~~~l~~G~~l~iP 44 (44)
T PF01476_consen 1 YTVQPGDTLWSIAKRY---GISVDELMELNPNIDSDNLQPGQKLCIP 44 (44)
T ss_dssp EEE-TT--HHHHHHHT---TS-HHHHHHHCCTTHGGCGGTTEEEEEC
T ss_pred CEECcCCcHHHHHhhh---hhhHhHHHHhcCCCCcccCCCCCEEEeC
Confidence 8999999999999765 3457889999988877779999999887
|
This domain may have a general peptidoglycan binding function.; GO: 0016998 cell wall macromolecule catabolic process; PDB: 2DJP_A 3ZQD_A 1Y7M_B 4A52_A 2L9Y_A 1E0G_A. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0058 Score=60.65 Aligned_cols=127 Identities=13% Similarity=0.158 Sum_probs=72.1
Q ss_pred eEEEEEECCeEEEEEEcc-----HHHHHHHHHHHhcCCCCc--ccEEEEEEcCCCcEEEEEeecCCCC-HHHh-------
Q 047629 344 SVYRATIDGKVLAVKKIK-----EDVTEELRILQRINHANL--VKLMGVSSDSQGNRFLVYEYAENGS-LDKW------- 408 (615)
Q Consensus 344 ~Vy~~~~~g~~vAvK~~~-----~~~~~Ei~~l~~l~H~ni--v~l~g~~~~~~~~~~lV~E~~~~Gs-L~~~------- 408 (615)
.||+. .|..+++|... .+..+|.+++..+..-.+ .+.+++..+. +...+|||++++.. +...
T Consensus 16 ~~y~~--~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~-~~~glv~e~i~G~~~~~~~~~~~~~~ 92 (226)
T TIGR02172 16 ESYTH--KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDG-GRLGLIYELIVGKRSFSRIISDNPSR 92 (226)
T ss_pred ceeEe--cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecC-CeeeeeeeecCCccchhhhhcCCHHH
Confidence 57873 24456677754 357889999999865444 5667766543 35688999998853 2211
Q ss_pred --------------hccCCCCCCCCCcccccC--HHHHHHHHH-------HHHH-HHHHHHhC-CCCCeEecCCCCCcee
Q 047629 409 --------------LHPKSKSSSSSGSVIFLT--WSQRLRVAL-------DVAN-GLQYMHEH-AQPSIVHRDIRTNNIQ 463 (615)
Q Consensus 409 --------------L~~~~~~~~~~~~~~~l~--~~~~~~i~~-------~ia~-gL~yLH~~-~~~~ivHrDlk~~NIL 463 (615)
||..... . ..+. +........ ++.. ...+|... ..+.++|+|+.|.||+
T Consensus 93 ~~~l~~~la~~l~~lH~~~~~----~--~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~Nii 166 (226)
T TIGR02172 93 LEEIAKIFAEMAKKLHSTKCD----T--STFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIGNLI 166 (226)
T ss_pred HHHHHHHHHHHHHHHhCCCCC----C--CcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCCcEE
Confidence 2211100 0 0011 000000000 0111 12233222 2345789999999999
Q ss_pred eCCCCcEEEeecCCCCC
Q 047629 464 LDSRFKAKIANFSLAAP 480 (615)
Q Consensus 464 ld~~~~~kl~DFGla~~ 480 (615)
+++++ ..+.||+.+..
T Consensus 167 ~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 167 TSGKG-TYWIDLGDFGY 182 (226)
T ss_pred EcCCC-cEEEechhcCc
Confidence 99887 99999997654
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01476 LysM: LysM domain; InterPro: IPR018392 This domain is about 40 residues long and is found in a variety of enzymes involved in bacterial cell wall degradation [] | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.00039 Score=49.69 Aligned_cols=44 Identities=27% Similarity=0.376 Sum_probs=33.3
Q ss_pred ecccCCCCCCHHHHHHhhCCChHHHHhhcCCCCCCCCCCCCccEEee
Q 047629 47 YFAQSPEFLDLSNISDLFGVSRLSIARASNLVSEDTPLVPKQLLLVP 93 (615)
Q Consensus 47 y~~~~~~~~~l~~i~~lf~~~~~~i~~~n~~~~~~~~~~~~~~~~vP 93 (615)
|+.++. .|+..||..|+++..+|..+|+....+. +.+||.|+||
T Consensus 1 y~V~~g--Dtl~~IA~~~~~~~~~l~~~N~~~~~~~-l~~G~~l~iP 44 (44)
T PF01476_consen 1 YTVQPG--DTLWSIAKRYGISVDELMELNPNIDSDN-LQPGQKLCIP 44 (44)
T ss_dssp EEE-TT----HHHHHHHTTS-HHHHHHHCCTTHGGC-GGTTEEEEEC
T ss_pred CEECcC--CcHHHHHhhhhhhHhHHHHhcCCCCccc-CCCCCEEEeC
Confidence 566655 4999999999999999999994333444 9999999998
|
This domain may have a general peptidoglycan binding function.; GO: 0016998 cell wall macromolecule catabolic process; PDB: 2DJP_A 3ZQD_A 1Y7M_B 4A52_A 2L9Y_A 1E0G_A. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.012 Score=57.61 Aligned_cols=132 Identities=23% Similarity=0.307 Sum_probs=74.8
Q ss_pred ceEEEEEECCeEEEEEEccH-----HHHHHHHHHHhcCCCC--cccEEEEEEcC--CCcEEEEEeecCCCCHHH------
Q 047629 343 KSVYRATIDGKVLAVKKIKE-----DVTEELRILQRINHAN--LVKLMGVSSDS--QGNRFLVYEYAENGSLDK------ 407 (615)
Q Consensus 343 ~~Vy~~~~~g~~vAvK~~~~-----~~~~Ei~~l~~l~H~n--iv~l~g~~~~~--~~~~~lV~E~~~~GsL~~------ 407 (615)
..||+...++..+++|.... .+..|..++..+.... +.+++.++... .+..+++|+++++..+..
T Consensus 11 n~~~~v~~~~~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~~~~~~~ 90 (239)
T PF01636_consen 11 NRVYRVTTDDGRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDDELSPEQ 90 (239)
T ss_dssp SEEEEEEETTSEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHHTSTHHH
T ss_pred eeEEEEEECCcEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccccccccccc
Confidence 46999998778999998853 4678999998885443 45677654322 223689999999888877
Q ss_pred ----------h---hccCCCCCCCCCcccccCH-H--------HHHHH------------HHHHHH-HHHHHHh----CC
Q 047629 408 ----------W---LHPKSKSSSSSGSVIFLTW-S--------QRLRV------------ALDVAN-GLQYMHE----HA 448 (615)
Q Consensus 408 ----------~---L~~~~~~~~~~~~~~~l~~-~--------~~~~i------------~~~ia~-gL~yLH~----~~ 448 (615)
. |+....... .+.+ . ..... ...+.. .+..+++ ..
T Consensus 91 ~~~~~~~~~~~l~~lh~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (239)
T PF01636_consen 91 RPELLRQLGRALAQLHQVPPPFS------PFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALLPKPL 164 (239)
T ss_dssp HHHHHHHHHHHHHHHHHSHTTCC------CHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCS
T ss_pred cccccccchhhhhhccccccccc------ccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhhccCC
Confidence 1 111110000 0111 1 00000 111222 3333433 23
Q ss_pred CCCeEecCCCCCceeeC-CCCcEEEeecCCCCC
Q 047629 449 QPSIVHRDIRTNNIQLD-SRFKAKIANFSLAAP 480 (615)
Q Consensus 449 ~~~ivHrDlk~~NILld-~~~~~kl~DFGla~~ 480 (615)
...++|+|+.++|||++ +++++-|.||+.+..
T Consensus 165 ~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 165 PPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp CEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred CcEEEEeccccccceeeeccceeEEEecccceE
Confidence 45699999999999999 666668999987654
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.011 Score=69.86 Aligned_cols=61 Identities=21% Similarity=0.443 Sum_probs=42.2
Q ss_pred eEEEEEECC----eEEEEEEcc--------HHHHHHHHHHHhcC-CCCc--ccEEEEEEcCC--CcEEEEEeecCCCC
Q 047629 344 SVYRATIDG----KVLAVKKIK--------EDVTEELRILQRIN-HANL--VKLMGVSSDSQ--GNRFLVYEYAENGS 404 (615)
Q Consensus 344 ~Vy~~~~~g----~~vAvK~~~--------~~~~~Ei~~l~~l~-H~ni--v~l~g~~~~~~--~~~~lV~E~~~~Gs 404 (615)
.+|+-...+ ..+++|+.. ..+.+|.++|+.+. |.++ .+++++|.+.. +..|+||||+++..
T Consensus 53 ~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~ 130 (822)
T PLN02876 53 PTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRI 130 (822)
T ss_pred ceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCcc
Confidence 466655532 356666642 35789999999995 6665 68888876532 45789999998754
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0032 Score=66.08 Aligned_cols=157 Identities=18% Similarity=0.241 Sum_probs=99.7
Q ss_pred ccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeec---CCC-------------CCC------
Q 047629 424 FLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANF---SLA-------------APA------ 481 (615)
Q Consensus 424 ~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DF---Gla-------------~~~------ 481 (615)
...|...++.++.+|.+.+-||+++ .+-+|+.++|+|+.++..+.+.|= -+. ...
T Consensus 113 ~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ng~~~~cpVg~~eftPPElQ~ 189 (637)
T COG4248 113 HCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQINANGTLHLCPVGVSEFTPPELQT 189 (637)
T ss_pred ccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceeeccCCceEecccCccccCCHHHhc
Confidence 4789999999999999999999998 889999999999999888888763 221 000
Q ss_pred -----CCCCCCcccchhHHHHHHHHHcC-CCCCCCCCCC----hhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCCh
Q 047629 482 -----TNDVMPKFDVFAFGVVLLELLSG-KKATRTTENG----KTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPI 551 (615)
Q Consensus 482 -----~~~~~~k~DV~SfGvvl~ElltG-~~p~~~~~~~----~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~ 551 (615)
..+.+...|-|.+||++++|+.| +.|+.+.... .... -+.....+.... ..-.... |. ..+.|.
T Consensus 190 ~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E-~~Ia~g~f~ya~---~~~~g~~-p~-P~~~P~ 263 (637)
T COG4248 190 LPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE-TDIAHGRFAYAS---DQRRGLK-PP-PRSIPL 263 (637)
T ss_pred cccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch-hhhhcceeeech---hccCCCC-CC-CCCCCh
Confidence 11235678999999999999986 8898753211 0000 000000000000 0000000 00 122333
Q ss_pred H-HHHHHHHHHHHhhhcC--CCCCCCHHHHHHHHHhcccch
Q 047629 552 D-GALSLATLARACTMDK--SLSRPNMAEVVFNLSVLTQST 589 (615)
Q Consensus 552 ~-~~~~l~~l~~~C~~~d--P~~RPsm~ev~~~L~~l~~~~ 589 (615)
+ ....+-.|-..|.... +.-|||++.-+..|..+.++.
T Consensus 264 ~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 264 SMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred hhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 2 2335667778888653 567999998888887776553
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.016 Score=57.47 Aligned_cols=120 Identities=23% Similarity=0.300 Sum_probs=80.5
Q ss_pred eEEEEEE-CCeEEEEEEccHH-------------------------------HHHHHHHHHhcC--CCCcccEEEEEEcC
Q 047629 344 SVYRATI-DGKVLAVKKIKED-------------------------------VTEELRILQRIN--HANLVKLMGVSSDS 389 (615)
Q Consensus 344 ~Vy~~~~-~g~~vAvK~~~~~-------------------------------~~~Ei~~l~~l~--H~niv~l~g~~~~~ 389 (615)
.||+|.- ++..+|||+.+.. ..+|..-|.++. +-.+-+-+++.
T Consensus 63 ~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~--- 139 (268)
T COG1718 63 NVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFR--- 139 (268)
T ss_pred EEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCCceeec---
Confidence 7999886 7899999988521 135777777774 33344445432
Q ss_pred CCcEEEEEeecCCCC-HHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCceeeCCC
Q 047629 390 QGNRFLVYEYAENGS-LDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHE-HAQPSIVHRDIRTNNIQLDSR 467 (615)
Q Consensus 390 ~~~~~lV~E~~~~Gs-L~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~NILld~~ 467 (615)
.-.|||||+.... -.-.|+. ..+.......+..++.+++.-|-. .+ +||+||..=|||++ +
T Consensus 140 --~nVLvMEfIg~~g~pAP~LkD-----------v~~e~~e~~~~~~~~v~~~~~l~~~a~---LVHgDLSEyNiL~~-~ 202 (268)
T COG1718 140 --NNVLVMEFIGDDGLPAPRLKD-----------VPLELEEAEGLYEDVVEYMRRLYKEAG---LVHGDLSEYNILVH-D 202 (268)
T ss_pred --CCeEEEEeccCCCCCCCCccc-----------CCcCchhHHHHHHHHHHHHHHHHHhcC---cccccchhhheEEE-C
Confidence 2379999996531 1111111 112333456666777788877766 44 99999999999999 8
Q ss_pred CcEEEeecCCCCCCCC
Q 047629 468 FKAKIANFSLAAPATN 483 (615)
Q Consensus 468 ~~~kl~DFGla~~~~~ 483 (615)
+.+.+.|||-|....+
T Consensus 203 ~~p~iID~~QaV~~~h 218 (268)
T COG1718 203 GEPYIIDVSQAVTIDH 218 (268)
T ss_pred CeEEEEECccccccCC
Confidence 8999999998765543
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.037 Score=57.32 Aligned_cols=62 Identities=13% Similarity=0.103 Sum_probs=43.7
Q ss_pred eEEEEEECCeEEEEEEcc-----HHHHHHHHHHHhcCC---CCcccEEEEEEcC--CCcEEEEEeecCCCCH
Q 047629 344 SVYRATIDGKVLAVKKIK-----EDVTEELRILQRINH---ANLVKLMGVSSDS--QGNRFLVYEYAENGSL 405 (615)
Q Consensus 344 ~Vy~~~~~g~~vAvK~~~-----~~~~~Ei~~l~~l~H---~niv~l~g~~~~~--~~~~~lV~E~~~~GsL 405 (615)
.||+-...+..+.+|..+ ..+..|.+.|+.+.. -.+-+++++|... .+..+||||+++++++
T Consensus 29 ~vy~~~~~~~~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 29 ALWALYDSQGNPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSV 100 (297)
T ss_pred eEEEEEcCCCCEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEec
Confidence 688776543345556544 257889999999853 3567888887532 3568999999998765
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.03 Score=56.53 Aligned_cols=140 Identities=16% Similarity=0.209 Sum_probs=80.3
Q ss_pred ceEEEEEECCeEEEEEEccH-------HHHHHHHHHHhcCCCCcc-cEEEEEEcCCCcEEEEEeecCCCCHHHh------
Q 047629 343 KSVYRATIDGKVLAVKKIKE-------DVTEELRILQRINHANLV-KLMGVSSDSQGNRFLVYEYAENGSLDKW------ 408 (615)
Q Consensus 343 ~~Vy~~~~~g~~vAvK~~~~-------~~~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~~lV~E~~~~GsL~~~------ 408 (615)
..+|+...+|+.+.+|.... +..+|.++++.+....++ ++++.. . -++||||+++..+...
T Consensus 10 n~~y~~~~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~---~~~v~e~i~G~~~~~~~~~~~~ 84 (256)
T TIGR02721 10 NRSWRIEHPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E---HWLLVEWLEGEVITLDQFVALD 84 (256)
T ss_pred CCeEEEEeCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C---CEEEEEeccCcccccccccCch
Confidence 36787777787888887542 356899999999655454 444432 2 2689999998665421
Q ss_pred -----------hccCCCCCCCCCcccccCHHHH-HHHHHH---------HHHHHHHHHhC-----CCCCeEecCCCCCce
Q 047629 409 -----------LHPKSKSSSSSGSVIFLTWSQR-LRVALD---------VANGLQYMHEH-----AQPSIVHRDIRTNNI 462 (615)
Q Consensus 409 -----------L~~~~~~~~~~~~~~~l~~~~~-~~i~~~---------ia~gL~yLH~~-----~~~~ivHrDlk~~NI 462 (615)
||...... ..++...+ ..+..+ +..-+..+-.. ..+.++|+|+.+.||
T Consensus 85 ~~~~la~~l~~lH~~~~~~------~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 85 LLLELAALLHQLHSQPRFG------YPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred hHHHHHHHHHHHhCCCCCC------CCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 22221100 01222211 111111 11112222222 123589999999999
Q ss_pred eeCCCCcEEEeecCCCCCCCCCCCCcccchhHHHHHHHH
Q 047629 463 QLDSRFKAKIANFSLAAPATNDVMPKFDVFAFGVVLLEL 501 (615)
Q Consensus 463 Lld~~~~~kl~DFGla~~~~~~~~~k~DV~SfGvvl~El 501 (615)
++++++ +.+.||..+..... .|-+|.++.+.
T Consensus 159 l~~~~~-~~lIDwE~a~~gdp-------~~DLa~~~~~~ 189 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASDGDI-------ALELAAIIRAN 189 (256)
T ss_pred EEeCCC-CEEEeccccCcCCH-------HHHHHHHHHhC
Confidence 999876 78999997765432 34556666553
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.42 E-value=0.005 Score=72.13 Aligned_cols=175 Identities=18% Similarity=0.212 Sum_probs=118.2
Q ss_pred HHHHHHHHhcCCCCcccEEEEEEcCCCc---EEEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHH
Q 047629 365 TEELRILQRINHANLVKLMGVSSDSQGN---RFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGL 441 (615)
Q Consensus 365 ~~Ei~~l~~l~H~niv~l~g~~~~~~~~---~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL 441 (615)
.-|++.+.++.|+|++.+++|-.+.... ..+..|++..-++...+.... ..+....+.+..+...||
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~----------~i~~~~~r~~~~~~~~GL 299 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG----------SIPLETLRILHQKLLEGL 299 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc----------ccCHHHHHHHHHHHhhhH
Confidence 3477788899999999999987643321 224457777777777775543 377788888999999999
Q ss_pred HHHHhCCCCCeEecCCCCC---ceeeCCCCcEEEe--ecCCCCCCCCC------------------------CCCcccch
Q 047629 442 QYMHEHAQPSIVHRDIRTN---NIQLDSRFKAKIA--NFSLAAPATND------------------------VMPKFDVF 492 (615)
Q Consensus 442 ~yLH~~~~~~ivHrDlk~~---NILld~~~~~kl~--DFGla~~~~~~------------------------~~~k~DV~ 492 (615)
.|+|+.. ..|.-+..+ +-..+..+....+ ||+..+...+. .....|+|
T Consensus 300 ~~~h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~ 376 (1351)
T KOG1035|consen 300 AYLHSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLW 376 (1351)
T ss_pred HHHHHhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHH
Confidence 9999985 556555554 4445556666666 88877654221 11236999
Q ss_pred hHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCC
Q 047629 493 AFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSR 572 (615)
Q Consensus 493 SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~R 572 (615)
.+|..+..+..|..+..... ....+++-. .. ..+.+....|+..++++|
T Consensus 377 ~lgll~~~~~~~~~i~~~~~-----------------------~~~~~l~~~----~~----~~~~d~~~~~~~~~~~~R 425 (1351)
T KOG1035|consen 377 CLGLLLLQLSQGEDISEKSA-----------------------VPVSLLDVL----ST----SELLDALPKCLDEDSEER 425 (1351)
T ss_pred HHHHHHhhhhhcCccccccc-----------------------chhhhhccc----cc----hhhhhhhhhhcchhhhhc
Confidence 99999999988865532111 001111110 01 135677889999999999
Q ss_pred CCHHHHHHHHH
Q 047629 573 PNMAEVVFNLS 583 (615)
Q Consensus 573 Psm~ev~~~L~ 583 (615)
++..+++....
T Consensus 426 l~~~~ll~~~f 436 (1351)
T KOG1035|consen 426 LSALELLTHPF 436 (1351)
T ss_pred cchhhhhhchh
Confidence 99999998754
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.084 Score=52.28 Aligned_cols=46 Identities=17% Similarity=0.238 Sum_probs=36.5
Q ss_pred CCeEecCCCCCceeeCC-CCcEEEeecCCCCCCCCCCCCcccchhHHHHHHHHH
Q 047629 450 PSIVHRDIRTNNIQLDS-RFKAKIANFSLAAPATNDVMPKFDVFAFGVVLLELL 502 (615)
Q Consensus 450 ~~ivHrDlk~~NILld~-~~~~kl~DFGla~~~~~~~~~k~DV~SfGvvl~Ell 502 (615)
..++|+|+.+.|||+++ +..+.+.||..|..... .|-+|.++.|+.
T Consensus 170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~~~~-------~~Dla~~~~e~~ 216 (235)
T cd05157 170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGYNYR-------AFDIANHFNEWA 216 (235)
T ss_pred EEEEcCCCCcCcEEEeCCCCCEEEEEcccCCcCch-------heeHHHHHHHHc
Confidence 45999999999999998 57899999987765433 456788888854
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.029 Score=55.82 Aligned_cols=33 Identities=15% Similarity=0.285 Sum_probs=26.8
Q ss_pred CCCeEecCCCCCceeeCCCCcEEEeecCCCCCC
Q 047629 449 QPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA 481 (615)
Q Consensus 449 ~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~ 481 (615)
.+.++|+|+.+.|||++++...-|.||+.+...
T Consensus 163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~g 195 (235)
T cd05155 163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGVG 195 (235)
T ss_pred CceEEeCCCCCCcEEEECCCEEEEEeCcccCcC
Confidence 345999999999999987765679999976543
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.0072 Score=65.23 Aligned_cols=162 Identities=17% Similarity=0.218 Sum_probs=88.4
Q ss_pred HHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHH
Q 047629 364 VTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQY 443 (615)
Q Consensus 364 ~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~y 443 (615)
+.....+++.+.|+|+...+.+.........+|+|++. -||.+.+..+... - ....+.+
T Consensus 29 ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~l~-----------~------~s~~~~~--- 87 (725)
T KOG1093|consen 29 ILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGNLK-----------D------ESLLAHG--- 87 (725)
T ss_pred HhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhcccc-----------h------hhhcccc---
Confidence 44556778889999999999987655445789999995 4999988764311 0 0000111
Q ss_pred HHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCCCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHH
Q 047629 444 MHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEI 523 (615)
Q Consensus 444 LH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~ 523 (615)
+.|-+ ++...+ ...|.+ .....+|+||||+|.++.|+.-|..-+....+.+... .+
T Consensus 88 --------~~~~~-----~~~~td---~~~t~~-----~~~~~pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~---~i 143 (725)
T KOG1093|consen 88 --------VLHLN-----IIYITD---HFLTKY-----PSPIGPKSDVWSLGFIILELYLGISLEAELTESEYLE---IL 143 (725)
T ss_pred --------cceeh-----hhhccc---cccccC-----CCCCCcchhhhhHHHHHHHHHHhhHHHHHHHHHHHHH---HH
Confidence 33321 211111 112222 2223479999999999999999876554332211111 01
Q ss_pred HHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHH
Q 047629 524 REVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAE 577 (615)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~e 577 (615)
...............+ ..+-.++...++++.+.|.-..|..||...+
T Consensus 144 ~k~~~~d~~~~~~a~e-------~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~ 190 (725)
T KOG1093|consen 144 LKYYTDDQELLSTAME-------HLIQLLADKKRLPLLKKCLWLEPIIRPLPME 190 (725)
T ss_pred HHhccCchhHHHHHHH-------HHHHHhhhHhHHHHhccCCccccccccchhH
Confidence 1111000000000000 0122344456788889999999988885443
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=96.18 E-value=0.091 Score=50.81 Aligned_cols=105 Identities=25% Similarity=0.393 Sum_probs=74.2
Q ss_pred ceEEEEEECCeEEEEEEcc----------------------------HHHHHHHHHHHhcC---CCCc--ccEEEEEEcC
Q 047629 343 KSVYRATIDGKVLAVKKIK----------------------------EDVTEELRILQRIN---HANL--VKLMGVSSDS 389 (615)
Q Consensus 343 ~~Vy~~~~~g~~vAvK~~~----------------------------~~~~~Ei~~l~~l~---H~ni--v~l~g~~~~~ 389 (615)
+.||+..++|+.+|+|..+ ..|..|.....+++ +.++ |+.+||..=.
T Consensus 52 ~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~ 131 (207)
T PF13095_consen 52 GYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGREGLWAVKCHGYLLLT 131 (207)
T ss_pred eEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccccCceEEEeeEEEEEc
Confidence 5799999999999999932 02567888877774 4566 8999986311
Q ss_pred -----------------CCcEEEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 047629 390 -----------------QGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSI 452 (615)
Q Consensus 390 -----------------~~~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 452 (615)
.....||.||++... .++-.++ .++.+-|..+|..+ |
T Consensus 132 ~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------------~~~~~~~----~~~~~dl~~~~k~g---I 185 (207)
T PF13095_consen 132 EDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------------PLQIRDI----PQMLRDLKILHKLG---I 185 (207)
T ss_pred hHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------------ccchhHH----HHHHHHHHHHHHCC---e
Confidence 011357888776533 0333333 35556678899998 9
Q ss_pred EecCCCCCceeeCCCCcEEEeecCCC
Q 047629 453 VHRDIRTNNIQLDSRFKAKIANFSLA 478 (615)
Q Consensus 453 vHrDlk~~NILld~~~~~kl~DFGla 478 (615)
+-+|+|+.|.. ..||+|||.+
T Consensus 186 ~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 186 VPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred eeccCcccccc-----CCEEEecccC
Confidence 99999999985 5689999964
|
|
| >PRK13914 invasion associated secreted endopeptidase; Provisional | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.042 Score=59.49 Aligned_cols=47 Identities=21% Similarity=0.154 Sum_probs=39.0
Q ss_pred EEEecCCCCchhHHHHHhcCChhhHhhhccccCccccCccceecccc
Q 047629 174 ITYVWQPGDDVSQVGAKLNASSAAIETENEYRNFSEAVSLPVLIPVS 220 (615)
Q Consensus 174 ~ty~~~~gd~~~~ia~~F~~s~~~i~~~n~~~~~~~~~~~~~l~p~~ 220 (615)
.+|.|+.||++..||.+|+++...+...|++.+....+|..+.+|..
T Consensus 200 ~tytVq~GDTL~sIAkrYgVtv~eI~~~N~l~s~~L~pGQ~L~Ip~s 246 (481)
T PRK13914 200 TTHAVKSGDTIWALSVKYGVSVQDIMSWNNLSSSSIYVGQKLAIKQT 246 (481)
T ss_pred eEEEECCCCCHHHHHHHHCCCHHHHHHhcCCCccccCCCCEEEecCC
Confidence 57999999999999999999999999999885444556776777653
|
|
| >TIGR02899 spore_safA spore coat assembly protein SafA | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.013 Score=41.31 Aligned_cols=40 Identities=20% Similarity=0.260 Sum_probs=34.6
Q ss_pred CCHHHHHHhhCCChHHHHhhcCCCCCCCCCCCCccEEeee
Q 047629 55 LDLSNISDLFGVSRLSIARASNLVSEDTPLVPKQLLLVPI 94 (615)
Q Consensus 55 ~~l~~i~~lf~~~~~~i~~~n~~~~~~~~~~~~~~~~vP~ 94 (615)
.|+..||..|+++..+|..+|+...+++.+.+|+.+.||.
T Consensus 5 dtl~~IA~~~~~~~~~l~~~N~~~~~~~~~~~g~~l~ip~ 44 (44)
T TIGR02899 5 DTLWKIAKKYGVDFDELIQANPQLSNPNLIYPGMKIKIPS 44 (44)
T ss_pred CCHHHHHHHHCcCHHHHHHHhhcCCCCCCcCCCCEEecCC
Confidence 5999999999999999999998544556788999999983
|
in which one of which is found in most examples of endospore-forming bacteria. Lysin motifs are repeated in many proteins. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.79 E-value=0.084 Score=49.72 Aligned_cols=112 Identities=19% Similarity=0.254 Sum_probs=74.6
Q ss_pred ceEEEEEECCeEEEEEEcc-----HHHHHHHHHHHhcCCCCcc-cEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCCC
Q 047629 343 KSVYRATIDGKVLAVKKIK-----EDVTEELRILQRINHANLV-KLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSS 416 (615)
Q Consensus 343 ~~Vy~~~~~g~~vAvK~~~-----~~~~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~ 416 (615)
+.||.|.+.|..+|+|.-+ ..+..|.++|..++-.++. +++.|- +-++.|||+.+-+|.++-...
T Consensus 36 s~Vyl~~~~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg-----~~~i~me~i~G~~L~~~~~~~---- 106 (201)
T COG2112 36 SVVYLGEWRGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYG-----EDFIRMEYIDGRPLGKLEIGG---- 106 (201)
T ss_pred cEEEEeeccCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEec-----hhhhhhhhhcCcchhhhhhcc----
Confidence 3799999999999999876 4578899999999887776 455542 235669999887887765421
Q ss_pred CCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC-C-CceeeCCCCcEEEeecCCCCC
Q 047629 417 SSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIR-T-NNIQLDSRFKAKIANFSLAAP 480 (615)
Q Consensus 417 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk-~-~NILld~~~~~kl~DFGla~~ 480 (615)
+-.++. .++..---|-..+ |-|..|. | +||++.+ ..+.|.||.-|+.
T Consensus 107 ---------~rk~l~----~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~-~~~~iIDFd~At~ 155 (201)
T COG2112 107 ---------DRKHLL----RVLEKAYKLDRLG---IEHGELSRPWKNVLVND-RDVYIIDFDSATF 155 (201)
T ss_pred ---------cHHHHH----HHHHHHHHHHHhc---cchhhhcCCceeEEecC-CcEEEEEccchhh
Confidence 112222 3333322233334 7777775 3 4555544 4999999988763
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=95.73 E-value=0.09 Score=54.12 Aligned_cols=137 Identities=18% Similarity=0.261 Sum_probs=78.6
Q ss_pred eEEEEEECCeEEEEEEcc----HHHHHHHHHHHhcCCCC--cccEEEE-----EEcCCCcEEEEEeecCCCCHHH-----
Q 047629 344 SVYRATIDGKVLAVKKIK----EDVTEELRILQRINHAN--LVKLMGV-----SSDSQGNRFLVYEYAENGSLDK----- 407 (615)
Q Consensus 344 ~Vy~~~~~g~~vAvK~~~----~~~~~Ei~~l~~l~H~n--iv~l~g~-----~~~~~~~~~lV~E~~~~GsL~~----- 407 (615)
.+|+...++..+++|... .....|++++..+++.+ +.+.+.. ....++..++|++|+++..+..
T Consensus 29 ~~y~v~~~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~ 108 (296)
T cd05153 29 TNYFVTTDSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLAGEHLTRPTAAH 108 (296)
T ss_pred ceEEEEeCCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCCCCCCCCCCHHH
Confidence 688877777778889865 34567899988885443 4444432 1112235689999998866532
Q ss_pred ---------hhccCCCC-CCCCCcccccCHHHHHH----------HHHHHHHHHHHHHhC----CCCCeEecCCCCCcee
Q 047629 408 ---------WLHPKSKS-SSSSGSVIFLTWSQRLR----------VALDVANGLQYMHEH----AQPSIVHRDIRTNNIQ 463 (615)
Q Consensus 408 ---------~L~~~~~~-~~~~~~~~~l~~~~~~~----------i~~~ia~gL~yLH~~----~~~~ivHrDlk~~NIL 463 (615)
.||..... ...........|..... ....+...+.++... ....++|+|+.|.|+|
T Consensus 109 ~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil 188 (296)
T cd05153 109 CRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGVIHADLFRDNVL 188 (296)
T ss_pred HHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcCCccCcCcccEE
Confidence 01111100 00000011133433211 111233445555431 1235999999999999
Q ss_pred eCCCCcEEEeecCCCCC
Q 047629 464 LDSRFKAKIANFSLAAP 480 (615)
Q Consensus 464 ld~~~~~kl~DFGla~~ 480 (615)
++++....|.||+.+..
T Consensus 189 ~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 189 FDGDELSGVIDFYFACT 205 (296)
T ss_pred EeCCceEEEeehhhhcC
Confidence 99987778999997654
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK14125 cell division suppressor protein YneA; Provisional | Back alignment and domain information |
|---|
Probab=95.72 E-value=0.043 Score=47.10 Aligned_cols=51 Identities=18% Similarity=0.271 Sum_probs=40.4
Q ss_pred ccceeeecccCCCCCCHHHHHHhhCCC--------hHHHHhhcCCCCCCCCCCCCccEEeeee
Q 047629 41 CKTYVAYFAQSPEFLDLSNISDLFGVS--------RLSIARASNLVSEDTPLVPKQLLLVPII 95 (615)
Q Consensus 41 C~~~~~y~~~~~~~~~l~~i~~lf~~~--------~~~i~~~n~~~~~~~~~~~~~~~~vP~~ 95 (615)
+..|..|+.++++ ||.+||..|+.+ ...|...|++. ++.+.+|+.++||..
T Consensus 33 ~~~~~~~tV~~GD--TLW~IA~~y~~~~~l~~~~~v~~I~~~N~l~--~~~I~~Gq~L~IP~~ 91 (103)
T PRK14125 33 KNQYVEITVQEGD--TLWALADQYAGKHHMAKNEFIEWVEDVNNLP--SGHIKAGDKLVIPVL 91 (103)
T ss_pred CCCcEEEEECCCC--CHHHHHHHhCCCcCCCHHHHHHHHHHhcCCC--CCcCCCCCEEEEecC
Confidence 4577789998665 999999999865 34667788865 346999999999985
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=95.58 E-value=0.21 Score=48.46 Aligned_cols=93 Identities=23% Similarity=0.356 Sum_probs=63.1
Q ss_pred HHHHHHHHHHhcC------CCCcccEEEEEEcCCCcEEEEEeecCC--C----CHHHhhccCCCCCCCCCcccccCHHHH
Q 047629 363 DVTEELRILQRIN------HANLVKLMGVSSDSQGNRFLVYEYAEN--G----SLDKWLHPKSKSSSSSGSVIFLTWSQR 430 (615)
Q Consensus 363 ~~~~Ei~~l~~l~------H~niv~l~g~~~~~~~~~~lV~E~~~~--G----sL~~~L~~~~~~~~~~~~~~~l~~~~~ 430 (615)
+..+|+.-...+. +.+|.+++|+...+. -.-+|+|.+.+ | +|.+++.... ++. ..
T Consensus 57 ~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~-G~Glv~e~I~d~dG~~s~TL~~~l~~~~-----------~~~-~~ 123 (199)
T PF10707_consen 57 QNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNL-GLGLVVELIRDADGNISPTLEDYLKEGG-----------LTE-EL 123 (199)
T ss_pred HHHHHHHHHHHHhhccCCcccccccEeEEEecCC-ceEEEEEEEECCCCCcCccHHHHHHcCC-----------ccH-HH
Confidence 3456777666665 889999999976544 47888888643 2 5778875432 444 33
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCC---C-cEEEee
Q 047629 431 LRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSR---F-KAKIAN 474 (615)
Q Consensus 431 ~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~---~-~~kl~D 474 (615)
.+.+.+ =..||-++. |+.+|++|+||++... . .+.|.|
T Consensus 124 ~~~L~~---f~~~l~~~~---Iv~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 124 RQALDE---FKRYLLDHH---IVIRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred HHHHHH---HHHHHHHcC---CeecCCCcccEEEEecCCCceEEEEEe
Confidence 333333 346666666 9999999999999543 2 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=95.41 E-value=0.27 Score=50.97 Aligned_cols=152 Identities=15% Similarity=0.277 Sum_probs=82.7
Q ss_pred ceEEEEEECCeEEEEEEcc-----HHHHHHHHHHHhcCCCC--cccEEEEE-----EcCCCcEEEEEeecCCCCHHH---
Q 047629 343 KSVYRATIDGKVLAVKKIK-----EDVTEELRILQRINHAN--LVKLMGVS-----SDSQGNRFLVYEYAENGSLDK--- 407 (615)
Q Consensus 343 ~~Vy~~~~~g~~vAvK~~~-----~~~~~Ei~~l~~l~H~n--iv~l~g~~-----~~~~~~~~lV~E~~~~GsL~~--- 407 (615)
..+|+...++..+.+|..+ .....|.+++..+.... +.+.+... ...++..++++||+++..+..
T Consensus 36 n~~y~v~t~~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~ 115 (307)
T TIGR00938 36 NSNYLLTTDVGRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFLQGLSVGRPTA 115 (307)
T ss_pred cceEEEEeCCCcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeCCCCCCCCCCH
Confidence 3688876655567778653 34567888888874322 34444421 112345789999998754321
Q ss_pred -----------hhccCCCCC-CC-CCcccccCHHHHHH------------HHHHHHHHHHHHHh----CCCCCeEecCCC
Q 047629 408 -----------WLHPKSKSS-SS-SGSVIFLTWSQRLR------------VALDVANGLQYMHE----HAQPSIVHRDIR 458 (615)
Q Consensus 408 -----------~L~~~~~~~-~~-~~~~~~l~~~~~~~------------i~~~ia~gL~yLH~----~~~~~ivHrDlk 458 (615)
.+|.....- .. ......-.|..... ....+...++++.. .....++|+|++
T Consensus 116 ~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~ 195 (307)
T TIGR00938 116 MHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDLPRGVIHADLF 195 (307)
T ss_pred HHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcCCCccCCCCCC
Confidence 122211100 00 00000112322111 11223345555543 223469999999
Q ss_pred CCceeeCCCCcEEEeecCCCCCCCCCCCCcccchhHHHHHHHH
Q 047629 459 TNNIQLDSRFKAKIANFSLAAPATNDVMPKFDVFAFGVVLLEL 501 (615)
Q Consensus 459 ~~NILld~~~~~kl~DFGla~~~~~~~~~k~DV~SfGvvl~El 501 (615)
+.|++++.+....|.||+.+.... -+|-++.++...
T Consensus 196 ~~Nvl~~~~~~~~vIDfd~~~~~~-------~~~DLA~~~~~~ 231 (307)
T TIGR00938 196 PDNVLFDGDSVKGVIDFYFACTDA-------RAYDLAITVNAW 231 (307)
T ss_pred cCcEEEECCceEEEeecccccCcc-------hHHHHHHHHHHH
Confidence 999999988777899999765432 255566655433
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.39 E-value=0.18 Score=52.36 Aligned_cols=131 Identities=20% Similarity=0.374 Sum_probs=73.3
Q ss_pred CCeEEEEEEc--------cHHHHHHHHHHHhcCC--CCcccEEEEEEcCC-CcEEEEEeecCCCCHHHhhccC-------
Q 047629 351 DGKVLAVKKI--------KEDVTEELRILQRINH--ANLVKLMGVSSDSQ-GNRFLVYEYAENGSLDKWLHPK------- 412 (615)
Q Consensus 351 ~g~~vAvK~~--------~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~-~~~~lV~E~~~~GsL~~~L~~~------- 412 (615)
+++.+.+.+- -.+..+|..+|+.+.- --.-+.+++|.+.. +..|.||+|.++..+...+...
T Consensus 47 ~~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~ 126 (321)
T COG3173 47 TGQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFA 126 (321)
T ss_pred CCceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHH
Confidence 4666666611 1345678888887743 22345677776554 5679999999873222221110
Q ss_pred --------------CCCCC-CCC------cccccCHHHHHHHHH--------HHHHHHHHHHhCC-----CCCeEecCCC
Q 047629 413 --------------SKSSS-SSG------SVIFLTWSQRLRVAL--------DVANGLQYMHEHA-----QPSIVHRDIR 458 (615)
Q Consensus 413 --------------~~~~~-~~~------~~~~l~~~~~~~i~~--------~ia~gL~yLH~~~-----~~~ivHrDlk 458 (615)
..... ..+ ....-.|...++.+. ....-..||+++. .+.++|+|+.
T Consensus 127 ~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~ 206 (321)
T COG3173 127 LDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYR 206 (321)
T ss_pred HHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcc
Confidence 00000 000 000112222221111 1122345555543 4579999999
Q ss_pred CCceeeCCCCcEEEeecCCCCCC
Q 047629 459 TNNIQLDSRFKAKIANFSLAAPA 481 (615)
Q Consensus 459 ~~NILld~~~~~kl~DFGla~~~ 481 (615)
+.|++++...-.-|.||+++...
T Consensus 207 ~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 207 PGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred cCCEEEeCCCeeEEEeccccccC
Confidence 99999999888999999987664
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.35 E-value=0.22 Score=51.38 Aligned_cols=47 Identities=21% Similarity=0.240 Sum_probs=36.8
Q ss_pred CCCeEecCCCCCceeeCCC----CcEEEeecCCCCCCCCCCCCcccchhHHHHHHHHH
Q 047629 449 QPSIVHRDIRTNNIQLDSR----FKAKIANFSLAAPATNDVMPKFDVFAFGVVLLELL 502 (615)
Q Consensus 449 ~~~ivHrDlk~~NILld~~----~~~kl~DFGla~~~~~~~~~k~DV~SfGvvl~Ell 502 (615)
...++|+|+.+.|||++++ ..+++.||..+..... .|-+|..+-|+.
T Consensus 178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~~p-------~~DlA~~~~e~~ 228 (302)
T cd05156 178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYNYR-------GFDIANHFCEWM 228 (302)
T ss_pred CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCCCc-------HHHHHHHHHHHH
Confidence 4568999999999999985 7899999998765433 355677777765
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd00118 LysM Lysin domain, found in a variety of enzymes involved in bacterial cell wall degradation | Back alignment and domain information |
|---|
Probab=95.28 E-value=0.036 Score=38.65 Aligned_cols=44 Identities=25% Similarity=0.352 Sum_probs=36.6
Q ss_pred ecccCCCCCCHHHHHHhhCCChHHHHhhcCCCCCCCCCCCCccEEee
Q 047629 47 YFAQSPEFLDLSNISDLFGVSRLSIARASNLVSEDTPLVPKQLLLVP 93 (615)
Q Consensus 47 y~~~~~~~~~l~~i~~lf~~~~~~i~~~n~~~~~~~~~~~~~~~~vP 93 (615)
|+.+.. .|+..|+..|+++..+|...|+.. ....+.+|+.+.||
T Consensus 3 ~~v~~g--dt~~~ia~~~~~~~~~~~~~N~~~-~~~~~~~g~~l~ip 46 (46)
T cd00118 3 YTVKKG--DTLSSIAQRYGISVEELLKLNGLS-DPDNLQVGQKLKIP 46 (46)
T ss_pred EEECCC--CCHHHHHHHHCcCHHHHHHHcCCC-CccccCCCCEEecC
Confidence 555544 599999999999999999999973 45678899999887
|
This domain may have a general peptidoglycan binding function. |
| >COG1388 LytE FOG: LysM repeat [Cell envelope biogenesis, outer membrane] | Back alignment and domain information |
|---|
Probab=95.17 E-value=0.034 Score=49.49 Aligned_cols=111 Identities=21% Similarity=0.329 Sum_probs=73.1
Q ss_pred HHHhhCCChHHHHhhcCCCCCCCCCCCCccEEeeeeeccCCCceeeeeeEEeecCCchhhhhhhhcCCcchHHHHHHhCC
Q 047629 60 ISDLFGVSRLSIARASNLVSEDTPLVPKQLLLVPIICGCTGNQYFANITYQIKKGDSYYLVSITSFENLTNWHAVLEMNP 139 (615)
Q Consensus 60 i~~lf~~~~~~i~~~n~~~~~~~~~~~~~~~~vP~~C~C~~~~~~~~~~y~v~~gdt~~~ia~~~~~~L~t~~~~~~~n~ 139 (615)
|+.-|+++..++..+|+.....+.+.+||.+.+|-. ..+....+++....+......-.
T Consensus 1 ia~~~~~~v~~l~~~n~~~~~s~~i~~gq~l~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~---------- 59 (124)
T COG1388 1 IASKYGVSVKALKKANALTGKSDAIKPGQVLKIPGD-----------ISSTVNAGQTLSSLSNKVSDSSS---------- 59 (124)
T ss_pred CcccccccHHHHHHHhcccCCCCccccCceEEccCC-----------cccccccccccccccceeecccc----------
Confidence 456688888999999986534677889999988764 22333344444443332221111
Q ss_pred CCCCCCcCCCcEEEEEeeccCCCCCCCCCCeeEEEEEecCCCCchhHHHHHhcCChhhHhhhccccCccccCccceecc
Q 047629 140 GINPNLLQIGVKVTFPLFCKCPSKTNMEDGIENLITYVWQPGDDVSQVGAKLNASSAAIETENEYRNFSEAVSLPVLIP 218 (615)
Q Consensus 140 ~~~~~~l~~G~~~~vpl~c~C~~~~~~s~~~~~l~ty~~~~gd~~~~ia~~F~~s~~~i~~~n~~~~~~~~~~~~~l~p 218 (615)
.....+..+|.+..||++..||.+|+.+...+...|++.++....+..+-++
T Consensus 60 ---------------------------~~~~~~~~~~~V~~gdtL~~Ia~~~~~tv~~l~~~n~l~~~~i~~gq~l~~~ 111 (124)
T COG1388 60 ---------------------------ASKAPPVVTYTVKKGDTLSKIARKYGVTVAELKQLNNLSSDKIKVGQKLKLP 111 (124)
T ss_pred ---------------------------ccccCCCceEEEecCCCHHHHHHHhCCCHHHHHHHhccCCCceecCcEEEEe
Confidence 0111223579999999999999999999999999998855555555544443
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.98 E-value=0.76 Score=49.47 Aligned_cols=58 Identities=21% Similarity=0.176 Sum_probs=39.8
Q ss_pred eEEEEEE-CC-eEEEEEEcc--------------HHHHHHHHHHHhcC---CCCcccEEEEEEcCCCcEEEEEeecCCCC
Q 047629 344 SVYRATI-DG-KVLAVKKIK--------------EDVTEELRILQRIN---HANLVKLMGVSSDSQGNRFLVYEYAENGS 404 (615)
Q Consensus 344 ~Vy~~~~-~g-~~vAvK~~~--------------~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~~lV~E~~~~Gs 404 (615)
.||+... +| +.+.||.-. .....|.+.|..+. -.++.+++.+ +. ...++||||+++..
T Consensus 41 ~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~-~~~~lVME~L~~~~ 117 (401)
T PRK09550 41 LVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DE-ELAVTVMEDLSDHK 117 (401)
T ss_pred EEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CC-CCCEEEEecCCCcc
Confidence 6899888 44 489999732 22466888888762 2456677776 22 35789999998744
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.93 E-value=0.39 Score=49.71 Aligned_cols=63 Identities=21% Similarity=0.343 Sum_probs=39.0
Q ss_pred ceEEEEEECCeEEEEEEcc---HHHHHHHHHHHhcCCC--CcccEEEE-----EEcCCCcEEEEEeecCCCCH
Q 047629 343 KSVYRATIDGKVLAVKKIK---EDVTEELRILQRINHA--NLVKLMGV-----SSDSQGNRFLVYEYAENGSL 405 (615)
Q Consensus 343 ~~Vy~~~~~g~~vAvK~~~---~~~~~Ei~~l~~l~H~--niv~l~g~-----~~~~~~~~~lV~E~~~~GsL 405 (615)
..||+...++..+++|+.. .....|+..+..+... .+.+++.. +...++..++++||+++.++
T Consensus 10 ~~v~~v~t~~g~~~LK~~~~~~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~~~ 82 (313)
T TIGR02906 10 RNVYKVETDSGNKCLKKINYPPERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEGREC 82 (313)
T ss_pred ccEEEEEeCCCCeEEEEcCCCHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccCcCC
Confidence 3688877755578899875 2355677777777433 33444432 11113457899999987544
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK14125 cell division suppressor protein YneA; Provisional | Back alignment and domain information |
|---|
Probab=94.58 E-value=0.078 Score=45.51 Aligned_cols=50 Identities=14% Similarity=0.345 Sum_probs=38.4
Q ss_pred eeEEeecCCchhhhhhhhcC--Ccch---HHHHHHhCCCCCCCCcCCCcEEEEEee
Q 047629 107 ITYQIKKGDSYYLVSITSFE--NLTN---WHAVLEMNPGINPNLLQIGVKVTFPLF 157 (615)
Q Consensus 107 ~~y~v~~gdt~~~ia~~~~~--~L~t---~~~~~~~n~~~~~~~l~~G~~~~vpl~ 157 (615)
..|+|++|||+..||....- +++. +.+++..|. ++.+.+.+|+.+.+|..
T Consensus 37 ~~~tV~~GDTLW~IA~~y~~~~~l~~~~~v~~I~~~N~-l~~~~I~~Gq~L~IP~~ 91 (103)
T PRK14125 37 VEITVQEGDTLWALADQYAGKHHMAKNEFIEWVEDVNN-LPSGHIKAGDKLVIPVL 91 (103)
T ss_pred EEEEECCCCCHHHHHHHhCCCcCCCHHHHHHHHHHhcC-CCCCcCCCCCEEEEecC
Confidence 56899999999999986543 3444 566777776 55567999999999964
|
|
| >PRK11198 LysM domain/BON superfamily protein; Provisional | Back alignment and domain information |
|---|
Probab=94.37 E-value=0.053 Score=49.88 Aligned_cols=50 Identities=20% Similarity=0.404 Sum_probs=43.0
Q ss_pred eeeEEeecCCchhhhhhhhcCCcchHHHHHHhCC--CCCCCCcCCCcEEEEE
Q 047629 106 NITYQIKKGDSYYLVSITSFENLTNWHAVLEMNP--GINPNLLQIGVKVTFP 155 (615)
Q Consensus 106 ~~~y~v~~gdt~~~ia~~~~~~L~t~~~~~~~n~--~~~~~~l~~G~~~~vp 155 (615)
..+|++++|||...||...|..-..|..+...|+ ..++..+++|+.+.+|
T Consensus 95 ~~~y~Vk~GDTL~~IA~~~~g~~~~~~~I~~~N~~~l~~~~~I~pGq~L~IP 146 (147)
T PRK11198 95 SQFYTVKSGDTLSAIAKKVYGNANKYNKIFEANKPMLKSPDKIYPGQVLRIP 146 (147)
T ss_pred CeEEEECCCCCHHHHHHHHcCChhhHHHHHHhhhhcCCCcCCcCcCCEEecC
Confidence 3569999999999999988777677999999997 4577889999999887
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=94.30 E-value=0.31 Score=50.12 Aligned_cols=59 Identities=25% Similarity=0.327 Sum_probs=37.8
Q ss_pred eEEEEEECCeEEEEEEccH----HHHHHHHHHHhcC---CCCcccEEEEEEcCCCcEEEEEeecCCC
Q 047629 344 SVYRATIDGKVLAVKKIKE----DVTEELRILQRIN---HANLVKLMGVSSDSQGNRFLVYEYAENG 403 (615)
Q Consensus 344 ~Vy~~~~~g~~vAvK~~~~----~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~~lV~E~~~~G 403 (615)
.+|+...+++.+.||.-.. .|..|.+-|+.|. --.+.+.+++-... +..+||+||++.+
T Consensus 32 ~a~~~~~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~-~~~fLlle~l~~~ 97 (288)
T PF03881_consen 32 EAYRLDTDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYD-DDAFLLLEFLEMG 97 (288)
T ss_dssp EEEEEETTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S-SCCEEEEE-----
T ss_pred heEEEECCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec-CCceEEEEeecCC
Confidence 6777766889999998764 3888999999884 33466888876543 3569999999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.09 E-value=1.1 Score=46.65 Aligned_cols=46 Identities=13% Similarity=0.301 Sum_probs=33.0
Q ss_pred CCeEecCCCCCceeeCCCCcEEEeecCCCCCCCCCCCCcccchhHHHHHHHHH
Q 047629 450 PSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVMPKFDVFAFGVVLLELL 502 (615)
Q Consensus 450 ~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~k~DV~SfGvvl~Ell 502 (615)
..++|+|+++.|||++.+...-|.||+.+.... =+|-+++.+....
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~~~-------~~~DlA~~~~~~~ 232 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACNDK-------LLYDVAITLNDWC 232 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccCCc-------hHHHHHHHHHHHH
Confidence 359999999999999977656899999875432 2455555554333
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=93.87 E-value=0.53 Score=48.15 Aligned_cols=33 Identities=18% Similarity=0.387 Sum_probs=27.0
Q ss_pred CCCeEecCCCCCceeeCCCCc-EEEeecCCCCCC
Q 047629 449 QPSIVHRDIRTNNIQLDSRFK-AKIANFSLAAPA 481 (615)
Q Consensus 449 ~~~ivHrDlk~~NILld~~~~-~kl~DFGla~~~ 481 (615)
.+.++|+|+++.|||++++++ .-|.||+.+...
T Consensus 184 ~~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 184 HTVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred CCeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 346999999999999997555 569999987664
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >cd00118 LysM Lysin domain, found in a variety of enzymes involved in bacterial cell wall degradation | Back alignment and domain information |
|---|
Probab=93.79 E-value=0.11 Score=36.02 Aligned_cols=45 Identities=31% Similarity=0.550 Sum_probs=35.4
Q ss_pred eEEeecCCchhhhhhhhcCCcchHHHHHHhCCCCCCCCcCCCcEEEEE
Q 047629 108 TYQIKKGDSYYLVSITSFENLTNWHAVLEMNPGINPNLLQIGVKVTFP 155 (615)
Q Consensus 108 ~y~v~~gdt~~~ia~~~~~~L~t~~~~~~~n~~~~~~~l~~G~~~~vp 155 (615)
.|++++|||+..|+... +. ++.++...|+..+...+.+|+.+.+|
T Consensus 2 ~~~v~~gdt~~~ia~~~--~~-~~~~~~~~N~~~~~~~~~~g~~l~ip 46 (46)
T cd00118 2 TYTVKKGDTLSSIAQRY--GI-SVEELLKLNGLSDPDNLQVGQKLKIP 46 (46)
T ss_pred EEEECCCCCHHHHHHHH--Cc-CHHHHHHHcCCCCccccCCCCEEecC
Confidence 58999999999999655 33 35678888887666788899987765
|
This domain may have a general peptidoglycan binding function. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=93.39 E-value=0.58 Score=49.19 Aligned_cols=122 Identities=27% Similarity=0.333 Sum_probs=82.2
Q ss_pred eEEEEEE-CCeEEEEEEccHH---------------------------------HHHHHHHHHhcCCCCcccEEEEEEcC
Q 047629 344 SVYRATI-DGKVLAVKKIKED---------------------------------VTEELRILQRINHANLVKLMGVSSDS 389 (615)
Q Consensus 344 ~Vy~~~~-~g~~vAvK~~~~~---------------------------------~~~Ei~~l~~l~H~niv~l~g~~~~~ 389 (615)
.||.++- +|..+|||+.+.. ...|+.-|.+++...|---.-...
T Consensus 159 NVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP~PePIlL-- 236 (520)
T KOG2270|consen 159 NVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIPCPEPILL-- 236 (520)
T ss_pred eeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCCCCCceee--
Confidence 7999987 8999999987511 235777888887665432111111
Q ss_pred CCcEEEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCc
Q 047629 390 QGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFK 469 (615)
Q Consensus 390 ~~~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~ 469 (615)
....|||+|+.. ..|-....+ ...|+......+-.+++.-+.-|-..+ .+||.||.==|+|+. +|.
T Consensus 237 -k~hVLVM~FlGr---dgw~aPkLK-------d~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh-dG~ 302 (520)
T KOG2270|consen 237 -KNHVLVMEFLGR---DGWAAPKLK-------DASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH-DGK 302 (520)
T ss_pred -ecceEeeeeccC---CCCcCcccc-------cccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE-CCE
Confidence 135799999853 122221111 123676677777788888888887666 599999999999885 468
Q ss_pred EEEeecCCCCCC
Q 047629 470 AKIANFSLAAPA 481 (615)
Q Consensus 470 ~kl~DFGla~~~ 481 (615)
+.+.|-+-+.-.
T Consensus 303 lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 303 LYIIDVSQSVEH 314 (520)
T ss_pred EEEEEccccccC
Confidence 899998876543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=93.12 E-value=0.037 Score=61.32 Aligned_cols=147 Identities=18% Similarity=0.162 Sum_probs=95.0
Q ss_pred eEEEEEE-CCeEEEEEEccH--HHHHHHHHHHhcCCCC-cccEEEEEEcCCCcEEEEEeecCCC-CHHHhhccCCCCCCC
Q 047629 344 SVYRATI-DGKVLAVKKIKE--DVTEELRILQRINHAN-LVKLMGVSSDSQGNRFLVYEYAENG-SLDKWLHPKSKSSSS 418 (615)
Q Consensus 344 ~Vy~~~~-~g~~vAvK~~~~--~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~~~~~lV~E~~~~G-sL~~~L~~~~~~~~~ 418 (615)
.+||.+- ..+...+|.+.. ...-++++|.+++||| .++.++-+. .+...+++++++..| +-..-..
T Consensus 257 knpKkRptaeklL~h~fvs~~l~~rl~~eLLdK~n~P~~~v~~~~d~~-~E~~~~i~~~i~s~~rs~~~~~~-------- 327 (829)
T KOG0576|consen 257 KNPKKRPTAEKLLQHPFVSQTLSRRLAIELLDKVNNPNPVVRYLEDYD-GEDYLWIPMRICSTGRSSALEMT-------- 327 (829)
T ss_pred CCCccCCChhhheeceeeccchhhHHHHHHHHHccCCCCcccccccCC-cccccchhhhhhcCCccccccCC--------
Confidence 4565543 122233444433 3456899999999999 566555443 344578999999876 2111110
Q ss_pred CCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCCC--------------
Q 047629 419 SGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATND-------------- 484 (615)
Q Consensus 419 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~-------------- 484 (615)
...+.+...+...+.+.-.++|+|+|+.. =+||| ||+..+ ...|.+||+.+..++..
T Consensus 328 -~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~ 398 (829)
T KOG0576|consen 328 -VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPRTAIGTPEPLA 398 (829)
T ss_pred -hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcccccccCCCCCCCCC
Confidence 11123555566667777789999999874 48998 777765 57899999987655332
Q ss_pred --------CCCcccchhHHHHHHHHHcCCCCC
Q 047629 485 --------VMPKFDVFAFGVVLLELLSGKKAT 508 (615)
Q Consensus 485 --------~~~k~DV~SfGvvl~ElltG~~p~ 508 (615)
+..+.|+|+.|+--.++--|-.|-
T Consensus 399 pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 399 PEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred chhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 234679999998766776676654
|
|
| >PRK10871 nlpD lipoprotein NlpD; Provisional | Back alignment and domain information |
|---|
Probab=93.03 E-value=0.1 Score=53.80 Aligned_cols=48 Identities=21% Similarity=0.364 Sum_probs=40.9
Q ss_pred eeeEEeecCCchhhhhhhhcCCcchHHHHHHhCCCCCCCCcCCCcEEEEEe
Q 047629 106 NITYQIKKGDSYYLVSITSFENLTNWHAVLEMNPGINPNLLQIGVKVTFPL 156 (615)
Q Consensus 106 ~~~y~v~~gdt~~~ia~~~~~~L~t~~~~~~~n~~~~~~~l~~G~~~~vpl 156 (615)
..+|+|++|||++.||..+. +.|.+|...|..-+|+.|.+||.|.+|.
T Consensus 60 ~~~y~Vk~GDTL~~IA~~~g---~~~~~La~~N~l~~p~~I~~GQ~L~i~~ 107 (319)
T PRK10871 60 GSTYTVKKGDTLFYIAWITG---NDFRDLAQRNNIQAPYSLNVGQTLQVGN 107 (319)
T ss_pred CCceEECCCCHHHHHHHHHC---cCHHHHHHhcCCCCCccccCCCEEEeCC
Confidence 45799999999999996443 3489999999888899999999999884
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=92.92 E-value=0.35 Score=50.63 Aligned_cols=55 Identities=16% Similarity=0.227 Sum_probs=46.7
Q ss_pred cCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC
Q 047629 425 LTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT 482 (615)
Q Consensus 425 l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~ 482 (615)
-.|.+.+.+..+.+.-+.-+..+- ++-|||+.-.||||| +|++.|.||-++|+..
T Consensus 318 ~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsRl~~ 372 (488)
T COG5072 318 DRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSRLSY 372 (488)
T ss_pred ccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeeeccc
Confidence 568999999999877666666543 589999999999999 9999999999998653
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=92.85 E-value=1.8 Score=45.85 Aligned_cols=142 Identities=18% Similarity=0.318 Sum_probs=81.5
Q ss_pred eEEEEEEC------CeEEEEEEccH------HHHHHHHHHHhcCCCCcc-cEEEEEEcCCCcEEEEEeecCCCCHHHh--
Q 047629 344 SVYRATID------GKVLAVKKIKE------DVTEELRILQRINHANLV-KLMGVSSDSQGNRFLVYEYAENGSLDKW-- 408 (615)
Q Consensus 344 ~Vy~~~~~------g~~vAvK~~~~------~~~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~~lV~E~~~~GsL~~~-- 408 (615)
.+|+..+. ++.+.+|.... +-.+|..++..+...++. ++++.+ ..+ .|+||+++.+|...
T Consensus 51 ~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~--~~g---~v~efi~g~~l~~~~l 125 (344)
T PLN02236 51 EVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRF--PNG---RVEEFIHARTLSAADL 125 (344)
T ss_pred eeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEE--CCc---eEEEeeCCCCCCHHHc
Confidence 57776542 25677776643 236799999998666655 566654 233 58999977666422
Q ss_pred ---------------hccCCCCCCCCCcccccCHHHHHHHHHH-----------------HHHHHHHHH----h-CCCCC
Q 047629 409 ---------------LHPKSKSSSSSGSVIFLTWSQRLRVALD-----------------VANGLQYMH----E-HAQPS 451 (615)
Q Consensus 409 ---------------L~~~~~~~~~~~~~~~l~~~~~~~i~~~-----------------ia~gL~yLH----~-~~~~~ 451 (615)
+|..... ....+..|.++.++..+ +..-+..|. . .....
T Consensus 126 ~~~~~~~~ia~~L~~lH~~~~~----~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~~~~ 201 (344)
T PLN02236 126 RDPEISALIAAKLREFHSLDMP----GPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQEIG 201 (344)
T ss_pred CChHHHHHHHHHHHHHhCCCCC----CCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCCCce
Confidence 2222111 00111223333333211 111222222 1 22335
Q ss_pred eEecCCCCCceeeCC-CCcEEEeecCCCCCCCCCCCCcccchhHHHHHHHH
Q 047629 452 IVHRDIRTNNIQLDS-RFKAKIANFSLAAPATNDVMPKFDVFAFGVVLLEL 501 (615)
Q Consensus 452 ivHrDlk~~NILld~-~~~~kl~DFGla~~~~~~~~~k~DV~SfGvvl~El 501 (615)
++|+|+++.|||+++ +..+.+.||..+..... .|-+|..+.|.
T Consensus 202 ~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~~~-------~~Dia~~~~e~ 245 (344)
T PLN02236 202 FCHNDLQYGNIMIDEETRAITIIDYEYASYNPV-------AYDIANHFCEM 245 (344)
T ss_pred EEeCCCCcCcEEEeCCCCcEEEEeehhccccch-------HHHHHHHHHHH
Confidence 899999999999986 46899999988765432 35677777664
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 615 | ||||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-24 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 9e-24 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-20 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-20 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-20 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-20 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-16 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-16 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-14 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-11 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-10 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-10 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-10 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-10 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-09 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-09 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-09 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-09 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-09 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-09 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-09 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-09 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-09 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-09 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-09 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-09 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-09 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-09 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-09 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-09 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-09 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-09 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-09 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-09 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 8e-09 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-09 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 8e-09 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-08 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-08 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-08 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-08 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-08 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-08 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-08 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-08 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-08 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-08 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-08 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-08 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-08 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-08 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-08 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-08 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-08 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-08 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-08 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-08 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-08 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-08 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-08 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-08 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-08 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-08 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 7e-08 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-08 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-08 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 7e-08 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-08 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-08 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-08 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-08 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-08 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-08 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 8e-08 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 9e-08 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 9e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-07 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-07 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-07 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-07 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-07 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-07 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-07 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-07 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-07 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-07 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-07 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-07 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-07 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-07 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-07 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-07 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-07 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-07 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-07 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-07 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-07 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-07 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-07 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-07 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-07 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-07 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-07 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-07 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-07 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-07 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-07 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-07 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-07 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-07 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-07 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-07 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-07 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-07 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-07 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-07 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-07 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-07 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-07 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-07 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-07 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-07 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-07 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-07 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-07 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-07 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 6e-07 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-07 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 7e-07 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 7e-07 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-07 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-07 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-07 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 8e-07 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-07 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 8e-07 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 8e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-07 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-07 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 9e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 9e-07 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-07 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 9e-07 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-06 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-06 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-06 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-06 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-06 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-06 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-06 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-06 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-06 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-06 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-06 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-06 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-06 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-06 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-06 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-06 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-06 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-06 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-06 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-06 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-06 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-06 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-06 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-06 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-06 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-06 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-06 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-06 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-06 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-06 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-06 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-06 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-06 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-06 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-06 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-06 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-06 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-06 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-06 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-06 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-06 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-06 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-06 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-06 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-06 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-06 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-06 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-06 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-06 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-06 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-06 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-06 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-06 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-06 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-06 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-06 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-06 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-06 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-06 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-06 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-06 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-06 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-06 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-06 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-06 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-06 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-06 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-06 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-06 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-06 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-06 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-06 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-06 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-06 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-06 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-06 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-06 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-06 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-06 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-06 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-06 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-06 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-06 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-06 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-06 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-06 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-06 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-06 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-06 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-06 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-06 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-06 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-06 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-06 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-06 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-06 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-06 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-06 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-06 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-06 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-06 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-06 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-06 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-06 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-06 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-06 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-06 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-06 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-06 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-06 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-06 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-06 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-06 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-06 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-06 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-06 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-06 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-06 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-06 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-06 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-06 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-06 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-06 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-06 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-06 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 9e-06 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-05 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-05 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-05 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-05 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-05 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-05 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-05 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-05 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-05 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-05 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-05 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-05 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-05 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-05 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-05 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-05 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-05 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-05 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-05 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-05 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-05 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-05 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-05 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-05 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-05 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-05 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-05 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-05 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-05 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-05 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-05 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-05 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-05 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-05 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-05 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-05 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-05 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-05 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-05 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-05 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-05 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-05 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-05 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-05 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-05 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-05 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-05 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-05 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-05 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-05 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-05 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-05 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-05 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-05 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-05 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-05 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-05 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-05 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-05 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-05 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-05 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-05 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-05 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-05 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-05 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-05 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 6e-05 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-05 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-05 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-05 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-05 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-05 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-05 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-05 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-05 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-05 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 7e-05 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-05 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-05 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-05 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-05 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-05 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-05 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-05 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-05 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-05 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-05 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-05 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-05 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-05 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-05 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-05 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 7e-05 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-05 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 8e-05 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-05 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 8e-05 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-05 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-05 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-05 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 9e-05 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 9e-05 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 9e-05 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-04 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-04 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-04 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-04 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-04 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-04 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-04 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-04 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-04 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-04 | ||
| 4eby_A | 212 | Crystal Structure Of The Ectodomain Of A Receptor L | 1e-04 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-04 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-04 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-04 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-04 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-04 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-04 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-04 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-04 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-04 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-04 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-04 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-04 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-04 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-04 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-04 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-04 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-04 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-04 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-04 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-04 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-04 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-04 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-04 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-04 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-04 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-04 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-04 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-04 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-04 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-04 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-04 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 5e-04 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-04 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-04 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-04 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-04 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-04 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-04 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-04 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-04 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-04 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 7e-04 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 8e-04 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 8e-04 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-04 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-04 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 9e-04 |
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4EBY|A Chain A, Crystal Structure Of The Ectodomain Of A Receptor Like Kinase Length = 212 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 615 | |||
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 9e-66 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 4e-64 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 3e-61 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 2e-51 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 1e-39 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 7e-39 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 2e-38 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 1e-36 | |
| 4eby_A | 212 | Chitin elicitor receptor kinase 1; pathogen-associ | 2e-36 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 1e-35 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 2e-35 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 5e-34 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 8e-34 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 4e-33 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 6e-33 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 1e-32 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 1e-32 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 2e-31 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 4e-30 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 3e-27 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 6e-27 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 1e-24 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 2e-24 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 4e-24 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 2e-23 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 2e-23 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 2e-23 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 4e-23 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 4e-23 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 5e-23 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 7e-23 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 7e-23 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 8e-23 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 8e-23 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 8e-23 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 1e-22 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 2e-22 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 2e-22 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 2e-22 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 2e-22 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 2e-22 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 3e-22 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 3e-22 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 3e-22 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 4e-22 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 6e-22 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 6e-22 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 8e-22 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 8e-22 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 1e-21 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 1e-21 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 2e-21 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 2e-21 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 3e-21 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 4e-21 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 5e-21 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 5e-21 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 6e-21 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 9e-21 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 9e-21 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 1e-20 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 1e-20 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 2e-20 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-20 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 2e-20 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 3e-20 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 5e-20 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 6e-20 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 9e-20 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 1e-19 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 1e-19 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 1e-19 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 2e-19 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 2e-19 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 2e-19 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 2e-19 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 3e-19 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 5e-19 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 9e-19 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 1e-18 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 4e-18 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 4e-18 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 2e-17 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 3e-17 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 4e-17 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 4e-17 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 5e-17 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 5e-17 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 6e-17 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 7e-17 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 9e-17 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 1e-16 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 2e-16 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 2e-16 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 2e-16 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 3e-16 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 3e-16 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 4e-16 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 4e-16 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 5e-16 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 6e-16 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 7e-16 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 7e-16 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 8e-16 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 1e-15 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 1e-15 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 1e-15 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 2e-15 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 2e-15 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 2e-15 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 2e-15 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-15 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 3e-15 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 3e-15 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 3e-15 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 3e-15 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 3e-15 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 4e-15 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 5e-15 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 5e-15 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 7e-15 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 7e-15 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 7e-15 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 8e-15 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 8e-15 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 1e-14 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 1e-14 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 1e-14 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 1e-14 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 1e-14 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 2e-14 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 3e-14 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 3e-14 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 3e-14 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 3e-14 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 3e-14 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 4e-14 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 4e-14 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 4e-14 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 5e-14 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 5e-14 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 6e-14 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 1e-13 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 1e-13 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 1e-13 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 2e-13 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 2e-13 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 3e-13 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 3e-13 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 3e-13 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 3e-13 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 4e-13 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 4e-13 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 5e-13 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 5e-13 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 9e-13 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 1e-12 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 2e-12 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 2e-12 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 2e-12 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 2e-12 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 3e-12 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 4e-12 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 4e-12 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 6e-12 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 9e-12 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 9e-12 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 1e-11 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 2e-11 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 2e-11 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 2e-11 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 2e-11 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 2e-11 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 2e-11 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 3e-11 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 3e-11 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 4e-11 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 1e-10 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 1e-10 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 1e-10 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 1e-10 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 3e-10 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 3e-10 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 4e-10 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 4e-10 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 4e-10 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-07 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 8e-07 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 7e-10 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 7e-10 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 9e-10 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 1e-09 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 1e-09 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 2e-09 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 3e-09 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 4e-09 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 1e-08 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 1e-08 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 2e-08 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 2e-08 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 2e-07 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 2e-07 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 4e-07 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 1e-06 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 2e-06 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 3e-06 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 4e-06 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 4e-06 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 6e-06 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 9e-06 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 1e-05 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 1e-05 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 2e-05 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 4e-05 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 4e-05 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 1e-04 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 2e-04 |
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 9e-66
Identities = 91/303 (30%), Positives = 146/303 (48%), Gaps = 51/303 (16%)
Query: 316 YLGKPIVYEIEVIMESTMNLSEHYSIGK----SVYRATI-DGKVLAVKKIKEDVTE---- 366
+LG+ + + + ++ N S +G+ VY+ + DG ++AVK++KE+ T+
Sbjct: 13 HLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGEL 72
Query: 367 ----ELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSV 422
E+ ++ H NL++L G R LVY Y NGS+ L + +S
Sbjct: 73 QFQTEVEMISMAVHRNLLRLRGFCMTPT-ERLLVYPYMANGSVASCLRERPESQPP---- 127
Query: 423 IFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA--AP 480
L W +R R+AL A GL Y+H+H P I+HRD++ NI LD F+A + +F LA
Sbjct: 128 --LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 185
Query: 481 ATN-----DVM-------P----------KFDVFAFGVVLLELLSGKKATRTT--ENGKT 516
+ V P K DVF +GV+LLEL++G++A N
Sbjct: 186 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 245
Query: 517 AVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMA 576
+L ++ +L +EK+ E L +D +L+ Y + L +A CT + RP M+
Sbjct: 246 VMLLDWVKGLL--KEKKLEAL---VDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS 300
Query: 577 EVV 579
EVV
Sbjct: 301 EVV 303
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 4e-64
Identities = 76/280 (27%), Positives = 130/280 (46%), Gaps = 53/280 (18%)
Query: 344 SVYRATIDGKVLAVKKIKEDVTE-----------ELRILQRINHANLVKLMGVSSDSQGN 392
VY+ ++ +AVKK+ V E++++ + H NLV+L+G SSD +
Sbjct: 46 VVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGD-D 104
Query: 393 RFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSI 452
LVY Y NGSL L + L+W R ++A ANG+ ++HE+
Sbjct: 105 LCLVYVYMPNGSLLDRLSCLDGTPP-------LSWHMRCKIAQGAANGINFLHEN---HH 154
Query: 453 VHRDIRTNNIQLDSRFKAKIANFSLA--APA------TNDVM----------------PK 488
+HRDI++ NI LD F AKI++F LA + T+ ++ PK
Sbjct: 155 IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPK 214
Query: 489 FDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESF 548
D+++FGVVLLE+++G A + + K E+ E+ + +++D +
Sbjct: 215 SDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK--EEIE----DEEKTIEDYIDKKMND- 267
Query: 549 YPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588
++ ++A C +K RP++ +V L +T S
Sbjct: 268 ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 3e-61
Identities = 78/301 (25%), Positives = 129/301 (42%), Gaps = 52/301 (17%)
Query: 328 IMESTMNLSEHYSIGK----SVYRATI-DGKVLAVKKIKED----VTE---ELRILQRIN 375
+ E+T N + IG VY+ + DG +A+K+ + + E E+ L
Sbjct: 34 LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCR 93
Query: 376 HANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVAL 435
H +LV L+G + + L+Y+Y ENG+L + L+ + S ++W QRL + +
Sbjct: 94 HPHLVSLIGFCDE-RNEMILIYKYMENGNLKRHLYGSDLPTMS------MSWEQRLEICI 146
Query: 436 DVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA--APATND------VM- 486
A GL Y+H +I+HRD+++ NI LD F KI +F ++ + V
Sbjct: 147 GAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKG 203
Query: 487 ------P----------KFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVE 530
P K DV++FGVVL E+L + A + + L + E
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN-- 261
Query: 531 EKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQSTE 590
+L +DPNL + A C S RP+M +V++ L + E
Sbjct: 262 ---NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318
Query: 591 T 591
+
Sbjct: 319 S 319
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 2e-51
Identities = 64/315 (20%), Positives = 120/315 (38%), Gaps = 62/315 (19%)
Query: 326 EVIMESTMNLSEHYSIGK----SVYRATIDGKVLAVKKIKEDVTE------ELRILQRIN 375
E + +M L + V++A + + +AVK + E+ L +
Sbjct: 17 ENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMK 76
Query: 376 HANLVKLMGV---SSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLR 432
H N+++ +G + + +L+ + E GSL +L ++W++
Sbjct: 77 HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-----------VSWNELCH 125
Query: 433 VALDVANGLQYMHEHAQ-------PSIVHRDIRTNNIQLDSRFKAKIANFSLA------- 478
+A +A GL Y+HE P+I HRDI++ N+ L + A IA+F LA
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 479 ---------------AP--------ATNDVMPKFDVFAFGVVLLELLSGKKATRTTENGK 515
AP D + D++A G+VL EL S A +
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 516 TAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALS-LATLARACTMDKSLSRPN 574
+EI + +E+ +E + P L ++ ++ L C + +R +
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 575 MAEVVFNLSVLTQST 589
V ++ + + T
Sbjct: 306 AGCVGERITQMQRLT 320
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 1e-39
Identities = 61/320 (19%), Positives = 110/320 (34%), Gaps = 73/320 (22%)
Query: 334 NLSEHYSIGK----SVYRATIDGKVLAVKKI----KEDVTEELRI--LQRINHANLVKLM 383
NL IG+ +VY+ ++D + +AVK +++ E I + + H N+ + +
Sbjct: 14 NLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFI 73
Query: 384 G----VSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVAN 439
V++D + LV EY NGSL K+L + W R+A V
Sbjct: 74 VGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-----------SDWVSSCRLAHSVTR 122
Query: 440 GLQYMHE------HAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA--------------- 478
GL Y+H H +P+I HRD+ + N+ + + I++F L+
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182
Query: 479 -------------AP----------ATNDVMPKFDVFAFGVVLLELLSGKKATRTTENGK 515
AP + + D++A G++ E+ E+
Sbjct: 183 NAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242
Query: 516 T--AVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGAL--SLATLARACTMDKSLS 571
E+ E+ + R P + + SL C + +
Sbjct: 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEA 302
Query: 572 RPNMAEVVFNLSVLTQSTET 591
R ++ L E
Sbjct: 303 RLTAQXAEERMAELMMIWER 322
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 7e-39
Identities = 65/270 (24%), Positives = 108/270 (40%), Gaps = 55/270 (20%)
Query: 345 VYRATIDGKVLAVKKIK-----EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEY 399
V +A K +A+K+I+ + ELR L R+NH N+VKL G + LV EY
Sbjct: 24 VCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLN---PVCLVMEY 80
Query: 400 AENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRT 459
AE GSL LH + + + T + + L + G+ Y+H +++HRD++
Sbjct: 81 AEGGSLYNVLH-------GAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKP 133
Query: 460 NNIQLDSRFK-AKIANFSLAAPATNDVM--------------------PKFDVFAFGVVL 498
N+ L + KI +F A + K DVF++G++L
Sbjct: 134 PNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIIL 193
Query: 499 LELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLA 558
E+++ +K ++W V R P L P +
Sbjct: 194 WEVITRRKPFDEIGGPAFRIMWA----VHN-------GTR----PPLIKNLPKP----IE 234
Query: 559 TLARACTMDKSLSRPNMAEVVFNLSVLTQS 588
+L C RP+M E+V ++ L +
Sbjct: 235 SLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 69/284 (24%), Positives = 116/284 (40%), Gaps = 62/284 (21%)
Query: 345 VYRATIDGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFL 395
V+RA G +AVK + + E+ I++R+ H N+V MG + N +
Sbjct: 53 VHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ-PPNLSI 111
Query: 396 VYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHR 455
V EY GSL + LH SG+ L +RL +A DVA G+ Y+H P IVHR
Sbjct: 112 VTEYLSRGSLYRLLH-------KSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHR 163
Query: 456 DIRTNNIQLDSRFKAKIANFSLA--------------------AP---ATNDVMPKFDVF 492
++++ N+ +D ++ K+ +F L+ AP K DV+
Sbjct: 164 NLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVY 223
Query: 493 AFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPID 552
+FGV+L EL + + W + V + R + P +
Sbjct: 224 SFGVILWELATLQ------------QPWGNLNPAQVVAAVGFKCKR----LEI----PRN 263
Query: 553 GALSLATLARACTMDKSLSRPNMAEVVFNL-SVLTQSTETLERS 595
+A + C ++ RP+ A ++ L ++ + RS
Sbjct: 264 LNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRS 307
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 1e-36
Identities = 51/269 (18%), Positives = 101/269 (37%), Gaps = 60/269 (22%)
Query: 345 VYRATIDGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRF- 394
+++ G + VK +K D EE L+ +H N++ ++G
Sbjct: 26 LWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT 85
Query: 395 LVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVH 454
L+ + GSL LH G+ + SQ ++ ALD+A G+ ++H +P I
Sbjct: 86 LITHWMPYGSLYNVLH--------EGTNFVVDQSQAVKFALDMARGMAFLHTL-EPLIPR 136
Query: 455 RDIRTNNIQLDSRFKAKIANFSLA---------------AP------ATNDVMPKFDVFA 493
+ + ++ +D A+I+ + AP + D+++
Sbjct: 137 HALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWS 196
Query: 494 FGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDG 553
F V+L EL++ + V + ++ + + E LR P + P
Sbjct: 197 FAVLLWELVTRE------------VPFADLSNMEIGMKVALEGLR----PTI----PPGI 236
Query: 554 ALSLATLARACTMDKSLSRPNMAEVVFNL 582
+ ++ L + C + RP +V L
Sbjct: 237 SPHVSKLMKICMNEDPAKRPKFDMIVPIL 265
|
| >4eby_A Chitin elicitor receptor kinase 1; pathogen-associated molecular patterns, pattern recognition receptors, LYSM, lysine chitin oligomer; HET: NAG BMA; 1.65A {Arabidopsis thaliana} PDB: 4ebz_A* Length = 212 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-36
Identities = 39/184 (21%), Positives = 82/184 (44%), Gaps = 4/184 (2%)
Query: 58 SNISDLFGVSRLSIARASNLVSEDTPLVPKQLLLVPIICGC-TGNQYFANITYQIKKGDS 116
S+I+ ++ I R ++ + + + +LVP C C G+ N +Y +++ D+
Sbjct: 29 SSIAPYDQINFDPILRYNSNIKDKDRIQMGSRVLVPFPCECQPGDFLGHNFSYSVRQEDT 88
Query: 117 YYLVSITSFENLTNWHAVLEMNPGINPNLLQIGVKVTFPLFCKCPSKTNMEDGIENLITY 176
Y V+I+++ NLT ++ NP + + + + C C ++ + +TY
Sbjct: 89 YERVAISNYANLTTMESLQARNP-FPATNIPLSATLNVLVNCSCGDES-VSKDFGLFVTY 146
Query: 177 VWQPGDDVSQVGAKLNASSAAIETENEYRNFSEAVSLPVLIPVSQLPSLSQSYPSTKRNG 236
+P D +S + S+ ++ N NF+ + V +P + S+K++G
Sbjct: 147 PLRPEDSLSSIARSSGVSADILQRYNPGVNFNSGNGI-VYVPGRDPNGAFPPFKSSKQDG 205
Query: 237 SKHH 240
HH
Sbjct: 206 VHHH 209
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 72/364 (19%), Positives = 124/364 (34%), Gaps = 88/364 (24%)
Query: 279 NGSSLESADLIPMKENSKSDRFEPKLAQNKLLPGVSGYLGKPIVYEIEVIMESTMNLSEH 338
G SL DLI ++S S P L Q + + + +
Sbjct: 7 PGESLR--DLIEQSQSSGSGSGLPLLVQR--------------------TIAKQIQMVK- 43
Query: 339 YSIGK----SVYRATIDGKVLAVKKIK-----EDVTE-ELRILQRINHANLVKLMGVSSD 388
IGK V+ G+ +AVK E E+ + H N++ +
Sbjct: 44 -QIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIK 102
Query: 389 SQGNR---FLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMH 445
G+ +L+ +Y ENGSL +L + L L++A +GL ++H
Sbjct: 103 GTGSWTQLYLITDYHENGSLYDYLKSTT-----------LDAKSMLKLAYSSVSGLCHLH 151
Query: 446 E-----HAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA-----------APATNDV---- 485
+P+I HRD+++ NI + IA+ LA P V
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211
Query: 486 -MP-----------------KFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVL 527
MP D+++FG++L E+ + E + +
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP-YHDLVPSDP 270
Query: 528 KVEEKREERLRNWMDPNLESFYPIDGAL-SLATLARACTMDKSLSRPNMAEVVFNLSVLT 586
E+ RE + P+ + + D L + L C SR V L+ ++
Sbjct: 271 SYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330
Query: 587 QSTE 590
+S +
Sbjct: 331 ESQD 334
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-35
Identities = 63/278 (22%), Positives = 105/278 (37%), Gaps = 72/278 (25%)
Query: 345 VYRATIDGKVLAVKKIK-----------EDVTEELRILQRINHANLVKLMGVSSDSQGNR 393
VYRA G +AVK + E+V +E ++ + H N++ L GV N
Sbjct: 23 VYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEP-NL 81
Query: 394 FLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIV 453
LV E+A G L++ L K + + A+ +A G+ Y+H+ A I+
Sbjct: 82 CLVMEFARGGPLNRVLSGKR-----------IPPDILVNWAVQIARGMNYLHDEAIVPII 130
Query: 454 HRDIRTNNIQLDSRFK--------AKIANFSLAAPATNDVM-----------P------- 487
HRD++++NI + + + KI +F LA P
Sbjct: 131 HRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASM 190
Query: 488 ---KFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPN 544
DV+++GV+L ELL+G+ V ++ I + +L
Sbjct: 191 FSKGSDVWSYGVLLWELLTGE------------VPFRGIDGLAVAYGVAMNKLA----LP 234
Query: 545 LESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNL 582
+ P A L C SRP+ ++ L
Sbjct: 235 I----PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQL 268
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-34
Identities = 69/283 (24%), Positives = 114/283 (40%), Gaps = 78/283 (27%)
Query: 345 VYRAT--IDGKVLAVKKIK--------------EDVTEELRILQRINHANLVKLMGVSSD 388
V++ D V+A+K + ++ E+ I+ +NH N+VKL G+ +
Sbjct: 35 VHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN 94
Query: 389 SQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHA 448
+V E+ G L L K+ + WS +LR+ LD+A G++YM
Sbjct: 95 ---PPRMVMEFVPCGDLYHRLLDKAHP---------IKWSVKLRLMLDIALGIEYMQNQN 142
Query: 449 QPSIVHRDIRTNNIQLDSR-----FKAKIANFSLAAPATNDVM----------P------ 487
P IVHRD+R+ NI L S AK+A+F L+ + + V P
Sbjct: 143 -PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPETIGAE 201
Query: 488 ------KFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIR--EVLKVEEKREERLRN 539
K D ++F ++L +L+G+ + E ++ + REE LR
Sbjct: 202 EESYTEKADTYSFAMILYTILTGE------------GPFDEYSYGKIKFINMIREEGLR- 248
Query: 540 WMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNL 582
P + P D L + C RP+ + +V L
Sbjct: 249 ---PTI----PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-33
Identities = 52/198 (26%), Positives = 82/198 (41%), Gaps = 52/198 (26%)
Query: 345 VYRATIDGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFL 395
VY+ G V AVK + + E+ +L++ H N++ MG S+ +
Sbjct: 40 VYKGKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST--APQLAI 96
Query: 396 VYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHR 455
V ++ E SL LH + + +A A G+ Y+H SI+HR
Sbjct: 97 VTQWCEGSSLYHHLHASETK---------FEMKKLIDIARQTARGMDYLH---AKSIIHR 144
Query: 456 DIRTNNIQLDSRFKAKIANFSLA----------------------AP------ATNDVMP 487
D+++NNI L KI +F LA AP +N
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 488 KFDVFAFGVVLLELLSGK 505
+ DV+AFG+VL EL++G+
Sbjct: 205 QSDVYAFGIVLYELMTGQ 222
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 65/301 (21%), Positives = 115/301 (38%), Gaps = 72/301 (23%)
Query: 341 IGK----SVYRATIDGKVLAVKKI-----KEDVTE-ELRILQRINHANLVKLMGVSSDSQ 390
+GK V+R + G+ +AVK K E EL + H N++ + S+
Sbjct: 16 VGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSR 75
Query: 391 GNR---FLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHE- 446
+ +L+ Y E GSL +L + L LR+ L +A+GL ++H
Sbjct: 76 HSSTQLWLITHYHEMGSLYDYLQLTT-----------LDTVSCLRIVLSIASGLAHLHIE 124
Query: 447 ----HAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA-----------APATNDV-----M 486
+P+I HRD+++ NI + + IA+ LA V M
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 487 P-----------------KFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKV 529
+ D++AFG+VL E+ + E+ K + +
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP-FYDVVPNDPSF 243
Query: 530 EEKRE----ERLRNWMDPNLESFYPIDGALS-LATLARACTMDKSLSRPNMAEVVFNLSV 584
E+ R+ ++ R PN+ + + D L+ LA L + C +R + L+
Sbjct: 244 EDMRKVVCVDQQR----PNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299
Query: 585 L 585
+
Sbjct: 300 I 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 69/304 (22%), Positives = 117/304 (38%), Gaps = 72/304 (23%)
Query: 341 IGK----SVYRATIDGKVLAVKKIK-----EDVTE-ELRILQRINHANLVKLMGVSSDSQ 390
IGK V+R G+ +AVK E E+ + H N++ + +
Sbjct: 50 IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN 109
Query: 391 GNR---FLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEH 447
G +LV +Y E+GSL +L+ + +T +++AL A+GL ++H
Sbjct: 110 GTWTQLWLVSDYHEHGSLFDYLNRYT-----------VTVEGMIKLALSTASGLAHLHME 158
Query: 448 AQ-----PSIVHRDIRTNNIQLDSRFKAKIANFSLA-----APATNDVMP---------- 487
P+I HRD+++ NI + IA+ LA A T D+ P
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 488 ------------------KFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKV 529
+ D++A G+V E+ E+ + + + V
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP-YYDLVPSDPSV 277
Query: 530 EEKR----EERLRNWMDPNLESFYPIDGALS-LATLARACTMDKSLSRPNMAEVVFNLSV 584
EE R E++LR PN+ + + AL +A + R C +R + LS
Sbjct: 278 EEMRKVVCEQKLR----PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333
Query: 585 LTQS 588
L+Q
Sbjct: 334 LSQQ 337
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 51/292 (17%), Positives = 98/292 (33%), Gaps = 78/292 (26%)
Query: 345 VYRAT--IDGKVLAVKKIKEDVTE-------ELRILQRINHANLVKLMGVSSDSQGNRFL 395
+ T G+V+ +K++ E E+++++ + H N++K +GV
Sbjct: 26 AIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK-DKRLNF 84
Query: 396 VYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHR 455
+ EY + G+L + WSQR+ A D+A+G+ Y+H +I+HR
Sbjct: 85 ITEYIKGGTLRGIIKSMDSQ---------YPWSQRVSFAKDIASGMAYLHSM---NIIHR 132
Query: 456 DIRTNNIQLDSRFKAKIANFSLAAPATNDVMP---------------------------- 487
D+ ++N + +A+F LA ++
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 488 ---------KFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLR 538
K DVF+FG+VL E++ A + + +
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEIIGRVNADPD---------YLPRTMDFGLNVRGFLDR- 242
Query: 539 NWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQSTE 590
+ P + S + C RP+ ++ L L
Sbjct: 243 ---------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 38/207 (18%), Positives = 72/207 (34%), Gaps = 61/207 (29%)
Query: 345 VYRATIDGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFL 395
VY G+V A++ I + E+ ++ H N+V MG + +
Sbjct: 49 VYHGRWHGEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS-PPHLAI 106
Query: 396 VYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHR 455
+ + +L + L ++ ++A ++ G+ Y+H I+H+
Sbjct: 107 ITSLCKGRTLYSVVRDAKIV---------LDVNKTRQIAQEIVKGMGYLH---AKGILHK 154
Query: 456 DIRTNNIQLDSRFKAKIANFSLA-------------------------AP---------A 481
D+++ N+ D+ K I +F L AP
Sbjct: 155 DLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDT 213
Query: 482 TNDVMP---KFDVFAFGVVLLELLSGK 505
D +P DVFA G + EL + +
Sbjct: 214 EEDKLPFSKHSDVFALGTIWYELHARE 240
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-27
Identities = 51/184 (27%), Positives = 86/184 (46%), Gaps = 36/184 (19%)
Query: 345 VYRATIDGKVLAVKKIKEDVTE-----ELRILQRINHANLVKLMGVSSDSQGNRFLVYEY 399
V G +AVK IK D T E ++ ++ H+NLV+L+GV + +G ++V EY
Sbjct: 209 VMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268
Query: 400 AENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRT 459
GSL +L + +S L L+ +LDV ++Y+ + + VHRD+
Sbjct: 269 MAKGSLVDYLRSRGRSV--------LGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAA 317
Query: 460 NNIQLDSRFKAKIANFSLA----APATNDVMP------------KF----DVFAFGVVLL 499
N+ + AK+++F L + +P KF DV++FG++L
Sbjct: 318 RNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLW 377
Query: 500 ELLS 503
E+ S
Sbjct: 378 EIYS 381
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-27
Identities = 53/186 (28%), Positives = 87/186 (46%), Gaps = 40/186 (21%)
Query: 345 VYRATIDGKVLAVKKIKEDVTE-----ELRILQRINHANLVKLMGVSSDSQGNRFLVYEY 399
V G +AVK IK D T E ++ ++ H+NLV+L+GV + +G ++V EY
Sbjct: 37 VMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96
Query: 400 AENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRT 459
GSL +L + +S L L+ +LDV ++Y+ + + VHRD+
Sbjct: 97 MAKGSLVDYLRSRGRSV--------LGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAA 145
Query: 460 NNIQLDSRFKAKIANFSLA-----------------AP-ATNDVMPKF----DVFAFGVV 497
N+ + AK+++F L AP A + KF DV++FG++
Sbjct: 146 RNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALRE--KKFSTKSDVWSFGIL 203
Query: 498 LLELLS 503
L E+ S
Sbjct: 204 LWEIYS 209
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 43/200 (21%), Positives = 84/200 (42%), Gaps = 46/200 (23%)
Query: 345 VYRATIDG--------KVLAVKKIKEDVTE--------ELRILQRINHANLVKLMGVSSD 388
VY G +V A+K + E + E +++ N ++V+L+GV S
Sbjct: 41 VYEGVAKGVVKDEPETRV-AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 99
Query: 389 SQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHA 448
Q ++ E G L +L + +++ + + S+ +++A ++A+G+ Y++ +
Sbjct: 100 GQ-PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN- 157
Query: 449 QPSIVHRDIRTNNIQLDSRFKAKIANFSLA---------APATNDVMP------------ 487
VHRD+ N + F KI +F + ++P
Sbjct: 158 --KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG 215
Query: 488 KF----DVFAFGVVLLELLS 503
F DV++FGVVL E+ +
Sbjct: 216 VFTTYSDVWSFGVVLWEIAT 235
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 53/232 (22%), Positives = 91/232 (39%), Gaps = 59/232 (25%)
Query: 316 YLGKPIVYEIEVIMESTMNLSEHYSIGK----SVYRATIDGK-----VLAVKKIKEDVTE 366
+ I ++ +E IG+ VY T+ AVK +
Sbjct: 11 LVQAVQHVVIG-PSSLIVHFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI 67
Query: 367 --------ELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSS 418
E I++ +H N++ L+G+ S+G+ +V Y ++G L ++ ++ +
Sbjct: 68 GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--- 124
Query: 419 SGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA 478
T + L VA G++Y+ VHRD+ N LD +F K+A+F LA
Sbjct: 125 ------PTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLA 175
Query: 479 -----------APATNDVMP------------KF----DVFAFGVVLLELLS 503
T +P KF DV++FGV+L EL++
Sbjct: 176 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 41/194 (21%), Positives = 77/194 (39%), Gaps = 48/194 (24%)
Query: 345 VYRATIDGKVL--AVKKIKEDVT--------EELRILQRINHANLVKLMGVSSDSQGNRF 394
V+ + AVK +E + +E RIL++ +H N+V+L+GV + Q +
Sbjct: 130 VFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ-PIY 188
Query: 395 LVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVH 454
+V E + G +L + L L++ D A G++Y+ +H
Sbjct: 189 IVMELVQGGDFLTFLRTEGAR---------LRVKTLLQMVGDAAAGMEYLESK---CCIH 236
Query: 455 RDIRTNNIQLDSRFKAKIANFSLAAPATNDVM-------------------------PKF 489
RD+ N + + KI++F ++ + V +
Sbjct: 237 RDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSES 296
Query: 490 DVFAFGVVLLELLS 503
DV++FG++L E S
Sbjct: 297 DVWSFGILLWETFS 310
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 46/205 (22%), Positives = 84/205 (40%), Gaps = 50/205 (24%)
Query: 345 VYRATIDGKVL-------AVKKIKEDVTE--------ELRILQRINHANLVKLMGVSSDS 389
VY+ + G A+K +K+ E + R+ H N+V L+GV +
Sbjct: 25 VYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD 84
Query: 390 QGNRFLVYEYAENGSLDKWLH---PKSKSSSSSGSVIF---LTWSQRLRVALDVANGLQY 443
Q +++ Y +G L ++L P S S+ L + + +A G++Y
Sbjct: 85 Q-PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEY 143
Query: 444 MHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA---------APATNDVMP------- 487
+ H +VH+D+ T N+ + + KI++ L N ++P
Sbjct: 144 LSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPE 200
Query: 488 -----KF----DVFAFGVVLLELLS 503
KF D++++GVVL E+ S
Sbjct: 201 AIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 63/294 (21%), Positives = 110/294 (37%), Gaps = 70/294 (23%)
Query: 265 NHHLQRKRVRILNRNGSSLESADLIPMKENSKSDRFEPKLAQNKLLPGVSG--------- 315
+H +R V D I E + ++ ++N G +
Sbjct: 13 HHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALN 72
Query: 316 --YLGKPIVYEIEVIMESTMNLSEHYSIGK----SVYRAT---IDGKVL--AVKKIKEDV 364
+ I ++ +E IG+ VY T DGK + AVK +
Sbjct: 73 PELVQAVQHVVIG-PSSLIVHFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT 129
Query: 365 TE--------ELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSS 416
E I++ +H N++ L+G+ S+G+ +V Y ++G L ++ ++ +
Sbjct: 130 DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN- 188
Query: 417 SSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFS 476
T + L VA G++++ VHRD+ N LD +F K+A+F
Sbjct: 189 --------PTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFG 237
Query: 477 LA-----------APATNDVMP------------KF----DVFAFGVVLLELLS 503
LA T +P KF DV++FGV+L EL++
Sbjct: 238 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 52/200 (26%), Positives = 82/200 (41%), Gaps = 52/200 (26%)
Query: 344 SVYRATIDGK------VLAVKKIKEDVTE-------ELRILQRINHANLVKLMGVSSDSQ 390
SV D ++AVK+++ + E++IL+ ++ +VK GVS
Sbjct: 38 SVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG 97
Query: 391 GN-RFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQ 449
LV EY +G L +L + ++ L S+ L + + G++Y+
Sbjct: 98 RQSLRLVMEYLPSGCLRDFL-QRHRAR--------LDASRLLLYSSQICKGMEYLGSR-- 146
Query: 450 PSIVHRDIRTNNIQLDSRFKAKIANFSLA--APATNDV--------MP------------ 487
VHRD+ NI ++S KIA+F LA P D P
Sbjct: 147 -RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 205
Query: 488 KF----DVFAFGVVLLELLS 503
F DV++FGVVL EL +
Sbjct: 206 IFSRQSDVWSFGVVLYELFT 225
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-23
Identities = 52/200 (26%), Positives = 91/200 (45%), Gaps = 45/200 (22%)
Query: 345 VYRATIDGKVL----AVKKIKEDVTE--------ELRILQRI-NHANLVKLMGVSSDSQG 391
V +A I L A+K++KE ++ EL +L ++ +H N++ L+G G
Sbjct: 41 VLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-G 99
Query: 392 NRFLVYEYAENGSLDKWL------HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMH 445
+L EYA +G+L +L + ++ + L+ Q L A DVA G+ Y+
Sbjct: 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS 159
Query: 446 EHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA------APATNDVMP------------ 487
+ +HRD+ NI + + AKIA+F L+ T +P
Sbjct: 160 QK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS 216
Query: 488 KF----DVFAFGVVLLELLS 503
+ DV+++GV+L E++S
Sbjct: 217 VYTTNSDVWSYGVLLWEIVS 236
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 4e-23
Identities = 53/201 (26%), Positives = 79/201 (39%), Gaps = 55/201 (27%)
Query: 344 SVYRATIDGK------VLAVKKIKEDVTE--------ELRILQRINHANLVKLMGVSSDS 389
V D ++AVK +K D E+ IL+ + H +++K G D+
Sbjct: 46 KVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA 105
Query: 390 QGN-RFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHA 448
LV EY GSL +L S + +Q L A + G+ Y+H
Sbjct: 106 GAASLQLVMEYVPLGSLRDYLPRHS-----------IGLAQLLLFAQQICEGMAYLHAQ- 153
Query: 449 QPSIVHRDIRTNNIQLDSRFKAKIANFSLA--APATNDV--------MP----------- 487
+HRD+ N+ LD+ KI +F LA P ++ P
Sbjct: 154 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 211
Query: 488 -KF----DVFAFGVVLLELLS 503
KF DV++FGV L ELL+
Sbjct: 212 YKFYYASDVWSFGVTLYELLT 232
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 5e-23
Identities = 52/201 (25%), Positives = 87/201 (43%), Gaps = 53/201 (26%)
Query: 344 SVYRATIDGK------VLAVKKIKEDVTE--------ELRILQRINHANLVKLMGVSSDS 389
V D + +AVK +K + E+ IL+ + H N+VK G+ ++
Sbjct: 36 KVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED 95
Query: 390 QGNR-FLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHA 448
GN L+ E+ +GSL ++L PK+K+ + Q+L+ A+ + G+ Y+
Sbjct: 96 GGNGIKLIMEFLPSGSLKEYL-PKNKNK--------INLKQQLKYAVQICKGMDYLGSR- 145
Query: 449 QPSIVHRDIRTNNIQLDSRFKAKIANFSLA----------APATNDVMP----------- 487
VHRD+ N+ ++S + KI +F L + P
Sbjct: 146 --QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ 203
Query: 488 -KF----DVFAFGVVLLELLS 503
KF DV++FGV L ELL+
Sbjct: 204 SKFYIASDVWSFGVTLHELLT 224
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 7e-23
Identities = 48/190 (25%), Positives = 75/190 (39%), Gaps = 44/190 (23%)
Query: 345 VYRATIDGKVL-AVKKIKEDVTE------ELRILQRINHANLVKLMGVSSDSQGNRFLVY 397
V G+ AVK IKE E + + +++H LVK GV S ++V
Sbjct: 24 VKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEY-PIYIVT 82
Query: 398 EYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDI 457
EY NG L +L K L SQ L + DV G+ ++ H +HRD+
Sbjct: 83 EYISNGCLLNYLRSHGKG---------LEPSQLLEMCYDVCEGMAFLESH---QFIHRDL 130
Query: 458 RTNNIQLDSRFKAKIANFSLAAPATNDV-------------MP-------KF----DVFA 493
N +D K+++F + +D K+ DV+A
Sbjct: 131 AARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWA 190
Query: 494 FGVVLLELLS 503
FG+++ E+ S
Sbjct: 191 FGILMWEVFS 200
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 7e-23
Identities = 45/199 (22%), Positives = 79/199 (39%), Gaps = 52/199 (26%)
Query: 345 VYRATIDGK-----VLAVKKIKEDVTE--------ELRILQRINHANLVKLMGVSSDSQG 391
VY + A+K + E +++ +NH N++ L+G+ +G
Sbjct: 37 VYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEG 96
Query: 392 NRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPS 451
++ Y +G L +++ ++ T + L VA G++Y+ E
Sbjct: 97 LPHVLLPYMCHGDLLQFIRSPQRN---------PTVKDLISFGLQVARGMEYLAEQ---K 144
Query: 452 IVHRDIRTNNIQLDSRFKAKIANFSLA-----------APATNDVMP------------K 488
VHRD+ N LD F K+A+F LA + +P +
Sbjct: 145 FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYR 204
Query: 489 F----DVFAFGVVLLELLS 503
F DV++FGV+L ELL+
Sbjct: 205 FTTKSDVWSFGVLLWELLT 223
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 8e-23
Identities = 41/203 (20%), Positives = 80/203 (39%), Gaps = 51/203 (25%)
Query: 345 VYRATIDGK-----VLAVKKIKEDVT---------EELRILQRINHANLVKLMGVSSDSQ 390
V A + + +AVK +K D+ E ++ +H ++ KL+GVS S+
Sbjct: 39 VREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98
Query: 391 GNR-----FLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMH 445
++ + ++G L +L +S + L +R +D+A G++Y+
Sbjct: 99 AKGRLPIPMVILPFMKHGDLHAFL----LASRIGENPFNLPLQTLVRFMVDIACGMEYLS 154
Query: 446 EHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA---------APATNDVMP--------- 487
+ +HRD+ N L +A+F L+ +P
Sbjct: 155 SR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESL 211
Query: 488 ---KF----DVFAFGVVLLELLS 503
+ DV+AFGV + E+++
Sbjct: 212 ADNLYTVHSDVWAFGVTMWEIMT 234
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 8e-23
Identities = 50/200 (25%), Positives = 78/200 (39%), Gaps = 52/200 (26%)
Query: 344 SVYRATIDGK------VLAVKKIKEDVTE-------ELRILQRINHANLVKLMGVSSDSQ 390
SV D V+AVKK++ E E+ IL+ + H N+VK GV +
Sbjct: 25 SVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 84
Query: 391 GNR-FLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQ 449
L+ EY GSL +L + + + L+ + G++Y+
Sbjct: 85 RRNLKLIMEYLPYGSLRDYLQKHKER---------IDHIKLLQYTSQICKGMEYLGTK-- 133
Query: 450 PSIVHRDIRTNNIQLDSRFKAKIANFSLA----------APATNDVMP------------ 487
+HRD+ T NI +++ + KI +F L P
Sbjct: 134 -RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES 192
Query: 488 KF----DVFAFGVVLLELLS 503
KF DV++FGVVL EL +
Sbjct: 193 KFSVASDVWSFGVVLYELFT 212
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 8e-23
Identities = 49/204 (24%), Positives = 82/204 (40%), Gaps = 49/204 (24%)
Query: 345 VYRATIDGKVL-------AVKKIKE-------DVTEELRILQRINHANLVKLMGVSSDSQ 390
V+ A AVK +K+ D E +L + H ++VK GV D
Sbjct: 31 VFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 90
Query: 391 GNRFLVYEYAENGSLDKWL------HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYM 444
+V+EY ++G L+K+L + L SQ L +A +A+G+ Y+
Sbjct: 91 -PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL 149
Query: 445 HEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA---------APATNDVMP-------- 487
VHRD+ T N + + KI +F ++ + ++P
Sbjct: 150 ASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPES 206
Query: 488 ----KF----DVFAFGVVLLELLS 503
KF DV++FGV+L E+ +
Sbjct: 207 IMYRKFTTESDVWSFGVILWEIFT 230
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-22
Identities = 46/224 (20%), Positives = 80/224 (35%), Gaps = 54/224 (24%)
Query: 329 MESTMNLSEHYSIGK--------SVYRAT--IDGKVLAVKKI---------KEDVTEELR 369
M S E Y + + DGK+L K++ K+ + E+
Sbjct: 1 MPSRA---EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVN 57
Query: 370 ILQRINHANLVKLMGVSSDSQGNRF-LVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWS 428
+L+ + H N+V+ D +V EY E G L + +K +L
Sbjct: 58 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQ------YLDEE 111
Query: 429 QRLRVALDVANGLQYMHE--HAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVM 486
LRV + L+ H +++HRD++ N+ LD + K+ +F LA +D
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS 171
Query: 487 -----------------------PKFDVFAFGVVLLELLSGKKA 507
K D+++ G +L EL +
Sbjct: 172 FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 50/203 (24%), Positives = 82/203 (40%), Gaps = 48/203 (23%)
Query: 345 VYRATIDGKVL-------AVKKIKE-------DVTEELRILQRINHANLVKLMGVSSDSQ 390
V+ A + AVK +KE D E +L + H ++V+ GV ++ +
Sbjct: 57 VFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR 116
Query: 391 GNRFLVYEYAENGSLDKWL-----HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMH 445
+V+EY +G L+++L K + + L Q L VA VA G+ Y+
Sbjct: 117 -PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA 175
Query: 446 EHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA---------APATNDVMP--------- 487
VHRD+ T N + KI +F ++ ++P
Sbjct: 176 GL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESI 232
Query: 488 ---KF----DVFAFGVVLLELLS 503
KF DV++FGVVL E+ +
Sbjct: 233 LYRKFTTESDVWSFGVVLWEIFT 255
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 50/200 (25%), Positives = 78/200 (39%), Gaps = 52/200 (26%)
Query: 344 SVYRATIDGK------VLAVKKIKEDVTE-------ELRILQRINHANLVKLMGVSSDSQ 390
SV D V+AVKK++ E E+ IL+ + H N+VK GV +
Sbjct: 56 SVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 115
Query: 391 GNR-FLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQ 449
L+ EY GSL +L + + + L+ + G++Y+
Sbjct: 116 RRNLKLIMEYLPYGSLRDYLQKHKER---------IDHIKLLQYTSQICKGMEYLGTK-- 164
Query: 450 PSIVHRDIRTNNIQLDSRFKAKIANFSLA----------APATNDVMP------------ 487
+HRD+ T NI +++ + KI +F L P
Sbjct: 165 -RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES 223
Query: 488 KF----DVFAFGVVLLELLS 503
KF DV++FGVVL EL +
Sbjct: 224 KFSVASDVWSFGVVLYELFT 243
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 2e-22
Identities = 41/190 (21%), Positives = 74/190 (38%), Gaps = 44/190 (23%)
Query: 345 VYRATIDGKVL-AVKKIKEDVTE------ELRILQRINHANLVKLMGVSSDSQGNRFLVY 397
V+ K A+K I+E E ++ +++H LV+L GV + LV
Sbjct: 24 VHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA-PICLVT 82
Query: 398 EYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDI 457
E+ E+G L +L + L + LDV G+ Y+ E ++HRD+
Sbjct: 83 EFMEHGCLSDYLRTQRGL---------FAAETLLGMCLDVCEGMAYLEEA---CVIHRDL 130
Query: 458 RTNNIQLDSRFKAKIANFSLAAPATNDV-------------MP-------KF----DVFA 493
N + K+++F + +D ++ DV++
Sbjct: 131 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 190
Query: 494 FGVVLLELLS 503
FGV++ E+ S
Sbjct: 191 FGVLMWEVFS 200
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 53/207 (25%), Positives = 83/207 (40%), Gaps = 52/207 (25%)
Query: 345 VYRATIDG--------KVLAVKKIKEDVTE--------ELRILQRI-NHANLVKLMGVSS 387
V A G V AVK +KE T EL+IL I +H N+V L+G +
Sbjct: 43 VIEADAFGIDKTATCRTV-AVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 101
Query: 388 DSQGNRFLVYEYAENGSLDKWL------HPKSKSSSSSGSVIFLTWSQRLRVALDVANGL 441
G ++ E+ + G+L +L K + FLT + + VA G+
Sbjct: 102 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGM 161
Query: 442 QYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA---------APATNDVMP----- 487
+++ A +HRD+ NI L + KI +F LA + +P
Sbjct: 162 EFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 218
Query: 488 -------KF----DVFAFGVVLLELLS 503
+ DV++FGV+L E+ S
Sbjct: 219 PETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 2e-22
Identities = 43/191 (22%), Positives = 80/191 (41%), Gaps = 44/191 (23%)
Query: 345 VYRATIDGKVL--AVKKIKEDVTE------ELRILQRINHANLVKLMGVSSDSQGNRFLV 396
VY L AVK +KED E E +++ I H NLV+L+GV + +++
Sbjct: 236 VYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP-PFYII 294
Query: 397 YEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRD 456
E+ G+L +L ++ ++ L +A +++ ++Y+ + + +HR+
Sbjct: 295 TEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAMEYLEKK---NFIHRN 343
Query: 457 IRTNNIQLDSRFKAKIANFSLA--------APATNDVMP----------------KFDVF 492
+ N + K+A+F L+ P K DV+
Sbjct: 344 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 403
Query: 493 AFGVVLLELLS 503
AFGV+L E+ +
Sbjct: 404 AFGVLLWEIAT 414
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 3e-22
Identities = 44/212 (20%), Positives = 80/212 (37%), Gaps = 57/212 (26%)
Query: 341 IGK----SVYRAT--IDGKVLAVKKI---KEDVTEELRILQRINHANLVKL--------- 382
IG V++A IDGK +K++ E E++ L +++H N+V
Sbjct: 19 IGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDY 78
Query: 383 ------MGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALD 436
S F+ E+ + G+L++W+ + L L +
Sbjct: 79 DPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE--------KLDKVLALELFEQ 130
Query: 437 VANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVM---------- 486
+ G+ Y+H +++RD++ +NI L + KI +F L ND
Sbjct: 131 ITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRY 187
Query: 487 ------------PKFDVFAFGVVLLELLSGKK 506
+ D++A G++L ELL
Sbjct: 188 MSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 38/202 (18%), Positives = 74/202 (36%), Gaps = 50/202 (24%)
Query: 345 VYRATIDGK-----VLAVKKIKEDVT---------EELRILQRINHANLVKLMGVSSDSQ 390
V + + +AVK +K D + E ++ +H N+++L+GV +
Sbjct: 50 VMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109
Query: 391 ----GNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHE 446
++ + + G L +L S + L+ +D+A G++Y+
Sbjct: 110 SQGIPKPMVILPFMKYGDLHTYL----LYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN 165
Query: 447 HAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA---------APATNDVMP---------- 487
+ +HRD+ N L +A+F L+ MP
Sbjct: 166 R---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLA 222
Query: 488 --KF----DVFAFGVVLLELLS 503
+ DV+AFGV + E+ +
Sbjct: 223 DRVYTSKSDVWAFGVTMWEIAT 244
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 3e-22
Identities = 44/190 (23%), Positives = 76/190 (40%), Gaps = 44/190 (23%)
Query: 345 VYRATIDGKVL-AVKKIKEDVTE------ELRILQRINHANLVKLMGVSSDSQGNRFLVY 397
V G+ A+K IKE E +++ ++H LV+L GV + + F++
Sbjct: 40 VKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR-PIFIIT 98
Query: 398 EYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDI 457
EY NG L +L Q L + DV ++Y+ +HRD+
Sbjct: 99 EYMANGCLLNYLREMRHR---------FQTQQLLEMCKDVCEAMEYLESK---QFLHRDL 146
Query: 458 RTNNIQLDSRFKAKIANFSLAAPATNDV-------------MP-------KF----DVFA 493
N ++ + K+++F L+ +D P KF D++A
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 206
Query: 494 FGVVLLELLS 503
FGV++ E+ S
Sbjct: 207 FGVLMWEIYS 216
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 4e-22
Identities = 47/191 (24%), Positives = 83/191 (43%), Gaps = 44/191 (23%)
Query: 345 VYRATIDGKVL--AVKKIKEDVTE------ELRILQRINHANLVKLMGVSSDSQGNRFLV 396
VY L AVK +KED E E +++ I H NLV+L+GV + +++
Sbjct: 29 VYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF-YII 87
Query: 397 YEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRD 456
E+ G+L +L ++ ++ L +A +++ ++Y+ + + +HRD
Sbjct: 88 TEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAMEYLEKK---NFIHRD 136
Query: 457 IRTNNIQLDSRFKAKIANFSLAAPATNDV--------MP------------KF----DVF 492
+ N + K+A+F L+ T D P KF DV+
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 196
Query: 493 AFGVVLLELLS 503
AFGV+L E+ +
Sbjct: 197 AFGVLLWEIAT 207
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 6e-22
Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 60/214 (28%)
Query: 345 VYRATIDG--------KVLAVKKIKEDVTE--------ELRILQRINHANLVKLMGVSSD 388
V +AT V AVK +KE+ + E +L+++NH +++KL G S
Sbjct: 39 VVKATAFHLKGRAGYTTV-AVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ 97
Query: 389 SQGNRFLVYEYAENGSLDKWL--------------HPKSKSSSSSGSVIFLTWSQRLRVA 434
G L+ EYA+ GSL +L ++ SS LT + A
Sbjct: 98 -DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFA 156
Query: 435 LDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA---------APATNDV 485
++ G+QY+ A+ +VHRD+ NI + K KI++F L+ +
Sbjct: 157 WQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGR 213
Query: 486 MP------------KF----DVFAFGVVLLELLS 503
+P + DV++FGV+L E+++
Sbjct: 214 IPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 6e-22
Identities = 50/205 (24%), Positives = 83/205 (40%), Gaps = 51/205 (24%)
Query: 345 VYRATIDG--------KVLAVKKIKEDVTE--------ELRILQRI-NHANLVKLMGVSS 387
V AT G KV AVK +K EL+I+ + H N+V L+G +
Sbjct: 62 VVEATAFGLGKEDAVLKV-AVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120
Query: 388 DSQGNRFLVYEYAENGSLDKWLHPKSKS----SSSSGSVIFLTWSQRLRVALDVANGLQY 443
G ++ EY G L +L KS+ + + + + L + VA G+ +
Sbjct: 121 H-GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAF 179
Query: 444 MHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA---------APATNDVMP------- 487
+ A + +HRD+ N+ L + AKI +F LA N +P
Sbjct: 180 L---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPE 236
Query: 488 -----KF----DVFAFGVVLLELLS 503
+ DV+++G++L E+ S
Sbjct: 237 SIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 8e-22
Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 60/214 (28%)
Query: 345 VYRATIDG--------KVLAVKKIKEDVTE--------ELRILQRINHANLVKLMGVSSD 388
V++A G V AVK +KE+ + E ++ ++ N+VKL+GV +
Sbjct: 63 VFQARAPGLLPYEPFTMV-AVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121
Query: 389 SQGNRFLVYEYAENGSLDKWL--------------HPKSKSSSSSGSVIFLTWSQRLRVA 434
+ L++EY G L+++L +++ SS L+ +++L +A
Sbjct: 122 GK-PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIA 180
Query: 435 LDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA---------APATNDV 485
VA G+ Y+ E VHRD+ T N + KIA+F L+ ND
Sbjct: 181 RQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDA 237
Query: 486 MP------------KF----DVFAFGVVLLELLS 503
+P ++ DV+A+GVVL E+ S
Sbjct: 238 IPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 8e-22
Identities = 56/203 (27%), Positives = 80/203 (39%), Gaps = 52/203 (25%)
Query: 345 VYRATIDG--------KVLAVKKIKEDVTE--------ELRILQRINHANLVKLMGVSSD 388
VY + G +V AVK + E +E E I+ + NH N+V+ +GVS
Sbjct: 46 VYEGQVSGMPNDPSPLQV-AVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104
Query: 389 SQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHA 448
S RF++ E G L +L S S L L VA D+A G QY+ E+
Sbjct: 105 SL-PRFILMELMAGGDLKSFLRETRPRPSQPSS---LAMLDLLHVARDIACGCQYLEEN- 159
Query: 449 QPSIVHRDIRTNNI---QLDSRFKAKIANFSLA---------APATNDVMP--------- 487
+HRDI N AKI +F +A ++P
Sbjct: 160 --HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF 217
Query: 488 ---KF----DVFAFGVVLLELLS 503
F D ++FGV+L E+ S
Sbjct: 218 MEGIFTSKTDTWSFGVLLWEIFS 240
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 34/185 (18%), Positives = 74/185 (40%), Gaps = 48/185 (25%)
Query: 356 AVKKIKEDVTE--------ELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407
A+K+++E + E ++ +++ ++ +L+G+ S L+ + G L
Sbjct: 48 AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLD 105
Query: 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSR 467
++ + + L + +A G+ Y+ + +VHRD+ N+ + +
Sbjct: 106 YVREHKDN---------IGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTP 153
Query: 468 FKAKIANFSLA---------APATNDVMP------------KF----DVFAFGVVLLELL 502
KI +F LA A +P + DV+++GV + EL+
Sbjct: 154 QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 213
Query: 503 S-GKK 506
+ G K
Sbjct: 214 TFGSK 218
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 51/209 (24%), Positives = 78/209 (37%), Gaps = 55/209 (26%)
Query: 345 VYRATIDG--------KVLAVKKIKEDVTE--------ELRILQRI-NHANLVKLMGVSS 387
V AT G V AVK +K EL++L + NH N+V L+G +
Sbjct: 39 VVEATAYGLIKSDAAMTV-AVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97
Query: 388 DSQGNRFLVYEYAENGSLDKWL--------HPKSKSSSSSGSVIFLTWSQRLRVALDVAN 439
G ++ EY G L +L K+ + + L L + VA
Sbjct: 98 I-GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAK 156
Query: 440 GLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA---------APATNDVMP--- 487
G+ ++ A + +HRD+ NI L KI +F LA N +P
Sbjct: 157 GMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKW 213
Query: 488 ---------KF----DVFAFGVVLLELLS 503
+ DV+++G+ L EL S
Sbjct: 214 MAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 51/214 (23%), Positives = 85/214 (39%), Gaps = 60/214 (28%)
Query: 345 VYRATIDG--------KVLAVKKIKEDVTE--------ELRILQRI-NHANLVKLMGVSS 387
V AT G +V AVK +KE EL+++ ++ +H N+V L+G +
Sbjct: 61 VMNATAYGISKTGVSIQV-AVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119
Query: 388 DSQGNRFLVYEYAENGSLDKWL-------------HPKSKSSSSSGSVIFLTWSQRLRVA 434
G +L++EY G L +L + K + LT+ L A
Sbjct: 120 L-SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFA 178
Query: 435 LDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA---------APATNDV 485
VA G++++ S VHRD+ N+ + KI +F LA N
Sbjct: 179 YQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNAR 235
Query: 486 MP------------KF----DVFAFGVVLLELLS 503
+P + DV+++G++L E+ S
Sbjct: 236 LPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 55/202 (27%), Positives = 79/202 (39%), Gaps = 50/202 (24%)
Query: 345 VYRATIDGKV-------LAVKKIKEDVTE--------ELRILQRINHANLVKLMGVSSDS 389
VY + G +AVK + E +E E I+ + NH N+V+ +GVS S
Sbjct: 87 VYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 146
Query: 390 QGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQ 449
RF++ E G L +L S S L L VA D+A G QY+ E+
Sbjct: 147 L-PRFILLELMAGGDLKSFLRETRPRPSQPSS---LAMLDLLHVARDIACGCQYLEEN-- 200
Query: 450 PSIVHRDIRTNNI---QLDSRFKAKIANFSLA---------APATNDVMP---------- 487
+HRDI N AKI +F +A ++P
Sbjct: 201 -HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFM 259
Query: 488 --KF----DVFAFGVVLLELLS 503
F D ++FGV+L E+ S
Sbjct: 260 EGIFTSKTDTWSFGVLLWEIFS 281
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 3e-21
Identities = 47/190 (24%), Positives = 81/190 (42%), Gaps = 44/190 (23%)
Query: 345 VYRATIDGKVL-AVKKIKEDVTE------ELRILQRINHANLVKLMGVSSDSQGNRFLVY 397
V+ T +G A+K +K E ++++++ H LV+L V S+ ++V
Sbjct: 200 VWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP--IYIVT 257
Query: 398 EYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDI 457
EY GSL +L ++ +L Q + +A +A+G+ Y+ + VHRD+
Sbjct: 258 EYMSKGSLLDFLKGETGK--------YLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 306
Query: 458 RTNNIQLDSRFKAKIANFSLA--------APATNDVMP----------------KFDVFA 493
R NI + K+A+F LA P K DV++
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 366
Query: 494 FGVVLLELLS 503
FG++L EL +
Sbjct: 367 FGILLTELTT 376
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 4e-21
Identities = 51/192 (26%), Positives = 85/192 (44%), Gaps = 48/192 (25%)
Query: 345 VYRATIDGKVL-AVKKIKEDVTE------ELRILQRINHANLVKLMGVSSDSQGNRFLVY 397
V+ +G AVK +K+ E +++++ H LV+L V + +++
Sbjct: 29 VWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP--IYIIT 86
Query: 398 EYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDI 457
EY ENGSL +L S LT ++ L +A +A G+ ++ E + +HRD+
Sbjct: 87 EYMENGSLVDFLKTPSGIK--------LTINKLLDMAAQIAEGMAFIEER---NYIHRDL 135
Query: 458 RTNNIQLDSRFKAKIANFSLA---------------------AP-ATNDVMPKF----DV 491
R NI + KIA+F LA AP A N F DV
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY--GTFTIKSDV 193
Query: 492 FAFGVVLLELLS 503
++FG++L E+++
Sbjct: 194 WSFGILLTEIVT 205
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 5e-21
Identities = 45/192 (23%), Positives = 80/192 (41%), Gaps = 48/192 (25%)
Query: 345 VYRATIDGKVL-AVKKIKEDVTE------ELRILQRINHANLVKLMGVSSDSQGNRFLVY 397
V+ AT + AVK +K E +++ + H LVKL V + +++
Sbjct: 204 VWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEP--IYIIT 261
Query: 398 EYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDI 457
E+ GSL +L S + + + +A G+ ++ + + +HRD+
Sbjct: 262 EFMAKGSLLDFLKSDEGS--------KQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDL 310
Query: 458 RTNNIQLDSRFKAKIANFSLA---------------------AP-ATNDVMPKF----DV 491
R NI + + KIA+F LA AP A N F DV
Sbjct: 311 RAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG--SFTIKSDV 368
Query: 492 FAFGVVLLELLS 503
++FG++L+E+++
Sbjct: 369 WSFGILLMEIVT 380
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 5e-21
Identities = 69/287 (24%), Positives = 113/287 (39%), Gaps = 72/287 (25%)
Query: 345 VYRATIDGKVL-AVKKIKEDVTE--------ELRILQRINHANLVKLMGVSSDSQGNRFL 395
R V A+K +K TE E I+ + +H N+++L GV + + +
Sbjct: 69 RLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA-MI 127
Query: 396 VYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHR 455
V EY ENGSLD +L T Q + + V G++Y+ + VHR
Sbjct: 128 VTEYMENGSLDTFLRTHDGQ---------FTIMQLVGMLRGVGAGMRYLSDL---GYVHR 175
Query: 456 DIRTNNIQLDSRFKAKIANFSLAAPATNDV----------MP------------KF---- 489
D+ N+ +DS K+++F L+ +D +P F
Sbjct: 176 DLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSAS 235
Query: 490 DVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLK-VEEKREERLRNWMDPNLES 547
DV++FGVV+ E+L+ G++ N R+V+ VE R +
Sbjct: 236 DVWSFGVVMWEVLAYGERPYWNMTN----------RDVISSVE--EGYR----LPA---- 275
Query: 548 FYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQSTETLER 594
P+ +L L C RP +++V L L +S E+L
Sbjct: 276 --PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRA 320
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 6e-21
Identities = 48/190 (25%), Positives = 81/190 (42%), Gaps = 44/190 (23%)
Query: 345 VYRATIDGKVL-AVKKIKEDVTE------ELRILQRINHANLVKLMGVSSDSQGNRFLVY 397
V+ T +G A+K +K E ++++++ H LV+L V S+ ++V
Sbjct: 283 VWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP--IYIVT 340
Query: 398 EYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDI 457
EY GSL +L +G +L Q + +A +A+G+ Y+ + VHRD+
Sbjct: 341 EYMSKGSLLDFLK------GETGK--YLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 389
Query: 458 RTNNIQLDSRFKAKIANFSLA--------APATNDVMP----------------KFDVFA 493
R NI + K+A+F LA P K DV++
Sbjct: 390 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 449
Query: 494 FGVVLLELLS 503
FG++L EL +
Sbjct: 450 FGILLTELTT 459
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 9e-21
Identities = 41/225 (18%), Positives = 78/225 (34%), Gaps = 64/225 (28%)
Query: 336 SEHYSIGK--------SVYRA--TIDGKVLAVKKI-------KEDVTEELRILQRINHAN 378
++HY + V DG A+K+I +E+ E + + NH N
Sbjct: 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPN 87
Query: 379 LVKLMGVSSDSQGNR---FLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVAL 435
+++L+ +G + +L+ + + G+L + + FLT Q L + L
Sbjct: 88 ILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGN------FLTEDQILWLLL 141
Query: 436 DVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVM--------- 486
+ GL+ +H HRD++ NI L + + + A V
Sbjct: 142 GICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQ 198
Query: 487 --------------------------PKFDVFAFGVVLLELLSGK 505
+ DV++ G VL ++ G+
Sbjct: 199 DWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 9e-21
Identities = 48/209 (22%), Positives = 86/209 (41%), Gaps = 55/209 (26%)
Query: 345 VYRATIDG----------KVLAVKKIKEDVTE--------ELRILQRI-NHANLVKLMGV 385
V A G V AVK +K+D TE E+ +++ I H N++ L+G
Sbjct: 97 VVMAEAVGIDKDKPKEAVTV-AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 155
Query: 386 SSDSQGNRFLVYEYAENGSLDKWL------HPKSKSSSSSGSVIFLTWSQRLRVALDVAN 439
+ G +++ EYA G+L ++L + + +T+ + +A
Sbjct: 156 CTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLAR 214
Query: 440 GLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA---------APATNDVMP--- 487
G++Y+ A +HRD+ N+ + KIA+F LA TN +P
Sbjct: 215 GMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKW 271
Query: 488 ---------KF----DVFAFGVVLLELLS 503
+ DV++FGV++ E+ +
Sbjct: 272 MAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 48/209 (22%), Positives = 86/209 (41%), Gaps = 55/209 (26%)
Query: 345 VYRATIDG----------KVLAVKKIKEDVTE--------ELRILQRI-NHANLVKLMGV 385
V A G V AVK +K+D TE E+ +++ I H N++ L+G
Sbjct: 51 VVMAEAVGIDKDKPKEAVTV-AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 109
Query: 386 SSDSQGNRFLVYEYAENGSLDKWL------HPKSKSSSSSGSVIFLTWSQRLRVALDVAN 439
+ G +++ EYA G+L ++L + + +T+ + +A
Sbjct: 110 CTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLAR 168
Query: 440 GLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA---------APATNDVMP--- 487
G++Y+ A +HRD+ N+ + KIA+F LA TN +P
Sbjct: 169 GMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKW 225
Query: 488 ---------KF----DVFAFGVVLLELLS 503
+ DV++FGV++ E+ +
Sbjct: 226 MAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 38/198 (19%), Positives = 73/198 (36%), Gaps = 46/198 (23%)
Query: 343 KSVYRA--TIDGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQG 391
K+VY+ T +A +++ + EE +L+ + H N+V+ +
Sbjct: 40 KTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 99
Query: 392 NRFLVY---EYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHA 448
+ + E +G+L +L + K + + GLQ++H
Sbjct: 100 GKKCIVLVTELMTSGTLKTYLK-RFKV---------MKIKVLRSWCRQILKGLQFLHTR- 148
Query: 449 QPSIVHRDIRTNNIQLDSRF-KAKIANFSLAAPATNDVM--------------------P 487
P I+HRD++ +NI + KI + LA
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKYDE 208
Query: 488 KFDVFAFGVVLLELLSGK 505
DV+AFG+ +LE+ + +
Sbjct: 209 SVDVYAFGMCMLEMATSE 226
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 64/275 (23%), Positives = 118/275 (42%), Gaps = 71/275 (25%)
Query: 356 AVKKIKEDVTEELR--------ILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407
A+K +K TE+ R I+ + +H N+++L GV S + ++ EY ENG+LDK
Sbjct: 77 AIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM-MIITEYMENGALDK 135
Query: 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSR 467
+L K + Q + + +A G++Y+ + VHRD+ NI ++S
Sbjct: 136 FLREKDGE---------FSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSN 183
Query: 468 FKAKIANFSLAAPATNDV----------MP------------KF----DVFAFGVVLLEL 501
K+++F L+ +D +P KF DV++FG+V+ E+
Sbjct: 184 LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEV 243
Query: 502 LS-GKKATRTTENGKTAVLWKEIREVLK-VEEKREERLRNWMDPNLESFYPIDGALSLAT 559
++ G++ N EV+K + R + P+D ++
Sbjct: 244 MTYGERPYWELSN----------HEVMKAIN--DGFR----LPT------PMDCPSAIYQ 281
Query: 560 LARACTMDKSLSRPNMAEVVFNLSVLTQSTETLER 594
L C + RP A++V L L ++ ++L+
Sbjct: 282 LMMQCWQQERARRPKFADIVSILDKLIRAPDSLKT 316
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 2e-20
Identities = 45/230 (19%), Positives = 80/230 (34%), Gaps = 63/230 (27%)
Query: 329 MESTMNLSEHYSIGK--------SVYRAT--IDGKVLAVKKIK--------EDVTEELRI 370
M S + + + +V+R G + A+K + E +
Sbjct: 1 MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEV 60
Query: 371 LQRINHANLVKLMGV-SSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQ 429
L+++NH N+VKL + + ++ L+ E+ GSL L + L S+
Sbjct: 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP-------SNAYGLPESE 113
Query: 430 RLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQL----DSRFKAKIANFSLAAPATNDV 485
L V DV G+ ++ E+ IVHR+I+ NI D + K+ +F A +D
Sbjct: 114 FLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170
Query: 486 M------------------------------PKFDVFAFGVVLLELLSGK 505
D+++ GV +G
Sbjct: 171 QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 47/184 (25%), Positives = 79/184 (42%), Gaps = 52/184 (28%)
Query: 356 AVKKIKEDVTE--------ELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407
A+K +K+ + E +I+ ++++ +V+L+GV LV E A G L K
Sbjct: 41 AIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA--LMLVMEMAGGGPLHK 98
Query: 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSR 467
+L K + + S + V+ G++Y+ E + VHRD+ N+ L +R
Sbjct: 99 FLVGKREE---------IPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNR 146
Query: 468 FKAKIANFSLA-----------------------AP-ATNDVMPKF----DVFAFGVVLL 499
AKI++F L+ AP N KF DV+++GV +
Sbjct: 147 HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMW 204
Query: 500 ELLS 503
E LS
Sbjct: 205 EALS 208
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-20
Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 55/209 (26%)
Query: 345 VYRATIDG----------KVLAVKKIKEDVTE--------ELRILQRI-NHANLVKLMGV 385
V A G KV AVK +K D TE E+ +++ I H N++ L+G
Sbjct: 85 VVLAEAIGLDKDKPNRVTKV-AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 143
Query: 386 SSDSQGNRFLVYEYAENGSLDKWL------HPKSKSSSSSGSVIFLTWSQRLRVALDVAN 439
+ G +++ EYA G+L ++L + + S L+ + A VA
Sbjct: 144 CTQ-DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVAR 202
Query: 440 GLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA---------APATNDVMP--- 487
G++Y+ A +HRD+ N+ + KIA+F LA TN +P
Sbjct: 203 GMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKW 259
Query: 488 ---------KF----DVFAFGVVLLELLS 503
+ DV++FGV+L E+ +
Sbjct: 260 MAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 5e-20
Identities = 32/181 (17%), Positives = 72/181 (39%), Gaps = 47/181 (25%)
Query: 356 AVKKIKEDVTE--------ELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407
A+K+++E + E ++ +++ ++ +L+G+ S L+ + G L
Sbjct: 48 AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLD 105
Query: 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSR 467
++ + + L + +A G+ Y+ + +VHRD+ N+ + +
Sbjct: 106 YVREHKDN---------IGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTP 153
Query: 468 FKAKIANFSLA---------APATNDVMP------------KF----DVFAFGVVLLELL 502
KI +F LA A +P + DV+++GV + EL+
Sbjct: 154 QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 213
Query: 503 S 503
+
Sbjct: 214 T 214
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 6e-20
Identities = 40/182 (21%), Positives = 73/182 (40%), Gaps = 50/182 (27%)
Query: 356 AVKKIKEDVTE--------ELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407
A+K K ++ E +++ +H ++VKL+GV +++ +++ E G L
Sbjct: 47 AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP--VWIIMELCTLGELRS 104
Query: 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSR 467
+L + S L + + A ++ L Y+ VHRDI N+ + S
Sbjct: 105 FLQVRKYS---------LDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSN 152
Query: 468 FKAKIANFSLA---------------------AP-ATNDVMPKF----DVFAFGVVLLEL 501
K+ +F L+ AP + N +F DV+ FGV + E+
Sbjct: 153 DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEI 210
Query: 502 LS 503
L
Sbjct: 211 LM 212
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 9e-20
Identities = 46/205 (22%), Positives = 82/205 (40%), Gaps = 50/205 (24%)
Query: 341 IGK----SVYRA--TIDGKVLAVKKI---------KEDVTEELRILQRINHANLVKLMGV 385
IG+ T DG+ +K+I +E+ E+ +L + H N+V+
Sbjct: 32 IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE- 90
Query: 386 SSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMH 445
S + G+ ++V +Y E G L K ++ + Q L + + L+++H
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKGV--------LFQEDQILDWFVQICLALKHVH 142
Query: 446 EHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVM------------------- 486
+ I+HRDI++ NI L ++ +F +A + V
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICEN 199
Query: 487 ----PKFDVFAFGVVLLELLSGKKA 507
K D++A G VL EL + K A
Sbjct: 200 KPYNNKSDIWALGCVLYELCTLKHA 224
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 42/182 (23%), Positives = 72/182 (39%), Gaps = 50/182 (27%)
Query: 356 AVKKIKEDVT--------EELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407
AVK K+D T E I++ ++H ++VKL+G+ + +++ E G L
Sbjct: 44 AVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEP--TWIIMELYPYGELGH 101
Query: 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSR 467
+L S L + +L + + Y+ + VHRDI NI + S
Sbjct: 102 YLERNKNS---------LKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASP 149
Query: 468 FKAKIANFSLA---------------------AP-ATNDVMPKF----DVFAFGVVLLEL 501
K+ +F L+ +P + N +F DV+ F V + E+
Sbjct: 150 ECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF--RRFTTASDVWMFAVCMWEI 207
Query: 502 LS 503
LS
Sbjct: 208 LS 209
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 38/181 (20%), Positives = 75/181 (41%), Gaps = 47/181 (25%)
Query: 356 AVKKIKEDVT--------EELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407
+K I++ + + + ++HA++V+L+G+ S LV +Y GSL
Sbjct: 46 CIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSS--LQLVTQYLPLGSLLD 103
Query: 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSR 467
+ + L L + +A G+ Y+ EH +VHR++ N+ L S
Sbjct: 104 HVRQHRGA---------LGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSP 151
Query: 468 FKAKIANFSLA---------APATNDVMP------------KF----DVFAFGVVLLELL 502
+ ++A+F +A + P K+ DV+++GV + EL+
Sbjct: 152 SQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELM 211
Query: 503 S 503
+
Sbjct: 212 T 212
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 52/219 (23%), Positives = 78/219 (35%), Gaps = 61/219 (27%)
Query: 356 AVKKIKEDVT----------EELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSL 405
AVK +K DV E+ + ++H NL++L GV +V E A GSL
Sbjct: 50 AVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP--MKMVTELAPLGSL 107
Query: 406 DKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLD 465
L R A+ VA G+ Y+ +HRD+ N+ L
Sbjct: 108 LDRLRKHQGH---------FLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLA 155
Query: 466 SRFKAKIANFSLA--APATNDV--------MP------------KF----DVFAFGVVLL 499
+R KI +F L P +D +P F D + FGV L
Sbjct: 156 TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLW 215
Query: 500 ELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERL 537
E+ + G++ ++L +K ERL
Sbjct: 216 EMFTYGQEPWIGLNG----------SQILHKIDKEGERL 244
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 38/222 (17%), Positives = 76/222 (34%), Gaps = 70/222 (31%)
Query: 341 IGK----SVYRAT--IDGKVLAVKKI--------KEDVTEELRILQRINHANLVKLMGVS 386
+G+ V+ A +D A+K+I +E V E++ L ++ H +V+
Sbjct: 13 LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 387 SDSQGNR-----------FLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVAL 435
+ ++ + +L W++ + SV L + L
Sbjct: 73 LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC-------LHIFL 125
Query: 436 DVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVM--------- 486
+A ++++H ++HRD++ +NI K+ +F L D
Sbjct: 126 QIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 487 --------------------------PKFDVFAFGVVLLELL 502
K D+F+ G++L ELL
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 45/199 (22%), Positives = 83/199 (41%), Gaps = 54/199 (27%)
Query: 344 SVYRATIDGKVL----AVKKIKEDVTE---------ELRILQRINHANLVKLMGVSSDSQ 390
+V + K + AVK +K + + E ++Q++++ +V+++G+
Sbjct: 32 TVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAES 91
Query: 391 GNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQP 450
LV E AE G L+K+L + + + V+ G++Y+ E
Sbjct: 92 --WMLVMEMAELGPLNKYLQQNRH----------VKDKNIIELVHQVSMGMKYLEES--- 136
Query: 451 SIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDV----------MP------------K 488
+ VHRD+ N+ L ++ AKI++F L+ D P K
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 196
Query: 489 F----DVFAFGVVLLELLS 503
F DV++FGV++ E S
Sbjct: 197 FSSKSDVWSFGVLMWEAFS 215
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 49/184 (26%), Positives = 82/184 (44%), Gaps = 51/184 (27%)
Query: 356 AVKKIKEDVTE--------ELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407
A+K +K TE E I+ + +H N+++L GV + S+ +V EY ENGSLD
Sbjct: 77 AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV-MIVTEYMENGSLDS 135
Query: 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSR 467
+L T Q + + +A+G++Y+ + VHRD+ NI ++S
Sbjct: 136 FLRKHDAQ---------FTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSN 183
Query: 468 FKAKIANFSLA-----------------------AP-ATNDVMPKF----DVFAFGVVLL 499
K+++F L +P A KF DV+++G+VL
Sbjct: 184 LVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLW 241
Query: 500 ELLS 503
E++S
Sbjct: 242 EVMS 245
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 32/183 (17%), Positives = 66/183 (36%), Gaps = 48/183 (26%)
Query: 356 AVKKIKEDVT-------EELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKW 408
+K + + E ++ +++H +LV GV N LV E+ + GSLD +
Sbjct: 44 LLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN-ILVQEFVKFGSLDTY 102
Query: 409 LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRF 468
L + +L VA +A + ++ E+ +++H ++ NI L
Sbjct: 103 LKKNKNC---------INILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREE 150
Query: 469 K--------AKIANFSLAAPATNDVMPKF--------------------DVFAFGVVLLE 500
K+++ ++ + + D ++FG L E
Sbjct: 151 DRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWE 210
Query: 501 LLS 503
+ S
Sbjct: 211 ICS 213
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 3e-19
Identities = 45/230 (19%), Positives = 80/230 (34%), Gaps = 63/230 (27%)
Query: 329 MESTMNLSEHYSIGK--------SVYRAT--IDGKVLAVKKIK--------EDVTEELRI 370
M S + + + +V+R G + A+K + E +
Sbjct: 1 MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEV 60
Query: 371 LQRINHANLVKLMGV-SSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQ 429
L+++NH N+VKL + + ++ L+ E+ GSL L + L S+
Sbjct: 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP-------SNAYGLPESE 113
Query: 430 RLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQL----DSRFKAKIANFSLAAPATNDV 485
L V DV G+ ++ E+ IVHR+I+ NI D + K+ +F A +D
Sbjct: 114 FLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170
Query: 486 M------------------------------PKFDVFAFGVVLLELLSGK 505
D+++ GV +G
Sbjct: 171 QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 40/206 (19%), Positives = 81/206 (39%), Gaps = 49/206 (23%)
Query: 341 IGK----SVYRA--TIDGKVLAVKKI----------KEDVTEELRILQRINHANLVKLMG 384
IG+ VYRA +DG +A+KK+ + D +E+ +L+++NH N++K
Sbjct: 40 IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 99
Query: 385 VSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYM 444
S +V E A+ G L + + K + + + + + L++M
Sbjct: 100 -SFIEDNELNIVLELADAGDLSRMIKHFKKQK------RLIPERTVWKYFVQLCSALEHM 152
Query: 445 HEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAA--PATNDVM---------------- 486
H ++HRDI+ N+ + + K+ + L +
Sbjct: 153 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 209
Query: 487 -----PKFDVFAFGVVLLELLSGKKA 507
K D+++ G +L E+ + +
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 89.2 bits (221), Expect = 9e-19
Identities = 48/198 (24%), Positives = 84/198 (42%), Gaps = 52/198 (26%)
Query: 344 SVYRAT--IDGKVL--AVKKIKEDVTE--------ELRILQRINHANLVKLMGVSSDSQG 391
SV + + K + A+K +K+ + E +I+ ++++ +V+L+GV
Sbjct: 351 SVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA- 409
Query: 392 NRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPS 451
LV E A G L K+L K + + S + V+ G++Y+ E +
Sbjct: 410 -LMLVMEMAGGGPLHKFLVGKREE---------IPVSNVAELLHQVSMGMKYLEEK---N 456
Query: 452 IVHRDIRTNNIQLDSRFKAKIANFSLAAPATND----------VMP------------KF 489
VHR++ N+ L +R AKI++F L+ D P KF
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 516
Query: 490 ----DVFAFGVVLLELLS 503
DV+++GV + E LS
Sbjct: 517 SSRSDVWSYGVTMWEALS 534
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 38/224 (16%), Positives = 77/224 (34%), Gaps = 60/224 (26%)
Query: 337 EHYSIGKS--------VYRATIDGKVLAVKKIK------------------------EDV 364
Y I ++ + D K A+KK + +D
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90
Query: 365 TEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIF 424
EL+I+ I + + G+ ++ +++YEY EN S+ K+ + F
Sbjct: 91 KNELQIITDIKNEYCLTCEGIITNYD-EVYIIYEYMENDSILKFDEYFFVLDKNYTC--F 147
Query: 425 LTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATND 484
+ + V N Y+H +I HRD++ +NI +D + K+++F + +
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK 205
Query: 485 VM-----------------------PKFDVFAFGVVLLELLSGK 505
+ K D+++ G+ L +
Sbjct: 206 KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 4e-18
Identities = 48/212 (22%), Positives = 84/212 (39%), Gaps = 56/212 (26%)
Query: 337 EHYSIGK--------SVYRAT--IDGKVLAVK----------KIKEDVTEELRILQRINH 376
E + +G VYRA G +A+K + + V E++I ++ H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 377 ANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALD 436
++++L DS +LV E NG ++++L + K S + + F+ Q
Sbjct: 71 PSILELYNYFEDSN-YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH--Q------- 120
Query: 437 VANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVM---------- 486
+ G+ Y+H H I+HRD+ +N+ L KIA+F LA
Sbjct: 121 IITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPN 177
Query: 487 -------------PKFDVFAFGVVLLELLSGK 505
+ DV++ G + LL G+
Sbjct: 178 YISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 4e-18
Identities = 41/198 (20%), Positives = 78/198 (39%), Gaps = 55/198 (27%)
Query: 345 VYRAT---IDGKVL--AVKKIKEDVTE--------ELRILQRINHANLVKLMGVSSDSQG 391
V++ + + A+K K ++ E +++ +H ++VKL+GV +++
Sbjct: 406 VHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP- 464
Query: 392 NRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPS 451
+++ E G L +L + S L + + A ++ L Y+
Sbjct: 465 -VWIIMELCTLGELRSFLQVRKFS---------LDLASLILYAYQLSTALAYLESK---R 511
Query: 452 IVHRDIRTNNIQLDSRFKAKIANFSLA---------------------AP-ATNDVMPKF 489
VHRDI N+ + S K+ +F L+ AP + N +F
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF--RRF 569
Query: 490 ----DVFAFGVVLLELLS 503
DV+ FGV + E+L
Sbjct: 570 TSASDVWMFGVCMWEILM 587
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 50/210 (23%), Positives = 85/210 (40%), Gaps = 55/210 (26%)
Query: 337 EHYSIGK--------SVYRA--TIDGKVLAVKKI-KEDVTE---------ELRILQRINH 376
E + IG+ +VY A +LA+K + K + + E+ I + H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 377 ANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALD 436
N+++L G D+ +L+ EYA G++ + L SK + ++
Sbjct: 69 PNILRLYGYFHDAT-RVYLILEYAPLGTVYRELQKLSKFDEQRTATYI---TE------- 117
Query: 437 VANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVM---------- 486
+AN L Y H ++HRDI+ N+ L S + KIA+F + A +
Sbjct: 118 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYL 174
Query: 487 -----------PKFDVFAFGVVLLELLSGK 505
K D+++ GV+ E L GK
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 41/226 (18%), Positives = 79/226 (34%), Gaps = 74/226 (32%)
Query: 341 IGK----SVYRAT--IDGKVLAVKKIK------EDVTEELRILQRINHANLVKLMGVSSD 388
+G+ V +A +D + A+KKI+ + E+ +L +NH +V+ +
Sbjct: 14 LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLE 73
Query: 389 SQGNR------------FLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALD 436
+ F+ EY ENG+L +H ++ + + R+
Sbjct: 74 RRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD---------EYWRLFRQ 124
Query: 437 VANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVM---------- 486
+ L Y+H I+HRD++ NI +D KI +F LA +
Sbjct: 125 ILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 487 ----------------------------PKFDVFAFGVVLLELLSG 504
K D+++ G++ E++
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 4e-17
Identities = 53/222 (23%), Positives = 88/222 (39%), Gaps = 58/222 (26%)
Query: 327 VIMESTMNLSEHYSIGK--------SVYRAT--IDGKVLAVKKIK----------EDVTE 366
+ ST S+ Y + V I G+ AVK I E +
Sbjct: 16 FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR 75
Query: 367 ELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLT 426
E+++L++++H N++KL D +LV E G L + + + S + I
Sbjct: 76 EVQLLKQLDHPNIMKLYEFFEDKG-YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQ 134
Query: 427 WSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSR---FKAKIANFSLAAP-AT 482
V +G+ YMH++ IVHRD++ N+ L+S+ +I +F L+
Sbjct: 135 ----------VLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181
Query: 483 NDVM--------------------PKFDVFAFGVVLLELLSG 504
+ M K DV++ GV+L LLSG
Sbjct: 182 SKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSG 223
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 4e-17
Identities = 38/202 (18%), Positives = 75/202 (37%), Gaps = 53/202 (26%)
Query: 342 GKSVYRATIDGKVLAVKKIK----EDVTEELRILQRIN-HANLVKLMGVSSDSQGNRFLV 396
G VYR D + +AVK+I E+++L+ + H N+++ D Q +++
Sbjct: 38 GTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQ-FQYIA 96
Query: 397 YEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRD 456
E +L +++ K + + + + +GL ++H +IVHRD
Sbjct: 97 IELCA-ATLQEYVEQKDFAHLG---------LEPITLLQQTTSGLAHLHSL---NIVHRD 143
Query: 457 IRTNNIQL-----DSRFKAKIANFSLAAPATNDVM------------------------- 486
++ +NI + + KA I++F L
Sbjct: 144 LKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCK 203
Query: 487 ----PKFDVFAFGVVLLELLSG 504
D+F+ G V ++S
Sbjct: 204 ENPTYTVDIFSAGCVFYYVISE 225
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 5e-17
Identities = 40/212 (18%), Positives = 73/212 (34%), Gaps = 57/212 (26%)
Query: 337 EHYSIGK--------SVYRAT--IDGKVLAVK----------KIKEDVTEELRILQRINH 376
Y G+ + + +V A K +E ++ E+ I + + H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 377 ANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALD 436
++V G D+ F+V E SL + + + Q
Sbjct: 75 QHVVGFHGFFEDND-FVFVVLELCRRRSLLELHKRRKALTEPEARYYL---RQ------- 123
Query: 437 VANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVM---------- 486
+ G QY+H + ++HRD++ N+ L+ + KI +F LA D
Sbjct: 124 IVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN 180
Query: 487 -------------PKFDVFAFGVVLLELLSGK 505
+ DV++ G ++ LL GK
Sbjct: 181 YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 5e-17
Identities = 55/222 (24%), Positives = 90/222 (40%), Gaps = 57/222 (25%)
Query: 327 VIMESTMNLSEHYSIGK--------SVYRAT--IDGKVLAVKKIK---------EDVTEE 367
I +LSE Y K V + A+K I+ + EE
Sbjct: 27 FITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEE 86
Query: 368 LRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTW 427
+ +L+ ++H N++KL D + N +LV E + G L + + K + +VI
Sbjct: 87 VAVLKLLDHPNIMKLYDFFEDKR-NYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQ- 144
Query: 428 SQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSR---FKAKIANFSLAAP-ATN 483
V +G+ Y+H+H +IVHRD++ N+ L+S+ KI +F L+A
Sbjct: 145 ---------VLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192
Query: 484 DVM--------------------PKFDVFAFGVVLLELLSGK 505
M K DV++ GV+L LL+G
Sbjct: 193 KKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGY 234
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 83.6 bits (206), Expect = 6e-17
Identities = 42/216 (19%), Positives = 78/216 (36%), Gaps = 58/216 (26%)
Query: 338 HYSIGK--------SVYRAT--IDGKVLAVKKIK--------EDVTEELRILQRINHANL 379
+ + + V R G+ +A+K+ + E E++I++++NH N+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 380 VKLMGV-----SSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVA 434
V V L EY E G L K+L+ + L +
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF-------ENCCGLKEGPIRTLL 127
Query: 435 LDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKA---KIANFSLAAPATNDVM----- 486
D+++ L+Y+HE+ I+HRD++ NI L + KI + A +
Sbjct: 128 SDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV 184
Query: 487 -----------------PKFDVFAFGVVLLELLSGK 505
D ++FG + E ++G
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 7e-17
Identities = 40/212 (18%), Positives = 73/212 (34%), Gaps = 57/212 (26%)
Query: 337 EHYSIGK--------SVYRAT--IDGKVLAVK----------KIKEDVTEELRILQRINH 376
Y G+ + + +V A K +E ++ E+ I + + H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 377 ANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALD 436
++V G D+ F+V E SL + + + Q
Sbjct: 101 QHVVGFHGFFEDND-FVFVVLELCRRRSLLELHKRRKALTEPEARYYLR---Q------- 149
Query: 437 VANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVM---------- 486
+ G QY+H + ++HRD++ N+ L+ + KI +F LA D
Sbjct: 150 IVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN 206
Query: 487 -------------PKFDVFAFGVVLLELLSGK 505
+ DV++ G ++ LL GK
Sbjct: 207 YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 9e-17
Identities = 48/198 (24%), Positives = 83/198 (41%), Gaps = 50/198 (25%)
Query: 344 SVYRA--TIDGKVLAVKKIKEDVTEELRILQR----------INHANLVKLMGVSSDSQG 391
+VY A TI +A+K I E+ L+R ++H N+V ++ V +
Sbjct: 26 TVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE-DD 84
Query: 392 NRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPS 451
+LV EY E +L +++ L+ + + +G+++ H+
Sbjct: 85 CYYLVMEYIEGPTLSEYIESHGP----------LSVDTAINFTNQILDGIKHAHDM---R 131
Query: 452 IVHRDIRTNNIQLDSRFKAKIANFSLAAPA-------TNDVM-----------------P 487
IVHRDI+ NI +DS KI +F +A TN V+
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDE 191
Query: 488 KFDVFAFGVVLLELLSGK 505
D+++ G+VL E+L G+
Sbjct: 192 CTDIYSIGIVLYEMLVGE 209
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 40/223 (17%), Positives = 73/223 (32%), Gaps = 59/223 (26%)
Query: 341 IGK----SVYRAT--IDGKVLAVKKIK---------EDVTEELRILQRI-NHANLVKLMG 384
+G V++ DG++ AVK+ E+ +++ H V+L
Sbjct: 65 LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ 124
Query: 385 VSSDSQGNR-FLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQY 443
+ +G +L E SL + L +Q D L +
Sbjct: 125 --AWEEGGILYLQTELCG-PSLQQHCEAWGA---------SLPEAQVWGYLRDTLLALAH 172
Query: 444 MHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVM----------------- 486
+H +VH D++ NI L R + K+ +F L
Sbjct: 173 LHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQ 229
Query: 487 ----PKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIRE 525
DVF+ G+ +LE+ + E W+++R+
Sbjct: 230 GSYGTAADVFSLGLTILEVACNMELPHGGEG------WQQLRQ 266
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 42/219 (19%), Positives = 81/219 (36%), Gaps = 54/219 (24%)
Query: 329 MESTMNLSEHYSIGK--------SVYRAT--IDGKVLAVKKI--------KEDVTEELRI 370
+ + + + + V+ G +K I E + E+ +
Sbjct: 14 LYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEV 73
Query: 371 LQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSL-DKWLHPKSKSSSSSGSVIFLTWSQ 429
L+ ++H N++K+ V D N ++V E E G L ++ + +++ + L+
Sbjct: 74 LKSLDHPNIIKIFEVFEDYH-NMYIVMETCEGGELLERIVSAQARGKA-------LSEGY 125
Query: 430 RLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKA---KIANFSLAAPATNDVM 486
+ + N L Y H +VH+D++ NI KI +F LA +D
Sbjct: 126 VAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH 182
Query: 487 ---------------------PKFDVFAFGVVLLELLSG 504
K D+++ GVV+ LL+G
Sbjct: 183 STNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTG 221
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 44/214 (20%), Positives = 83/214 (38%), Gaps = 55/214 (25%)
Query: 332 TMNLSEHYSIGK--------SVYRAT--IDGKVLAVKKIK-------EDVTEELRILQRI 374
T N+ + + + V+ + GK+ A+K IK + E+ +L++I
Sbjct: 4 TTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI 63
Query: 375 NHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVA 434
H N+V L + +S + +LV + G L + + + S++
Sbjct: 64 KHENIVTLEDI-YESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQ-------- 114
Query: 435 LDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRF---KAKIANFSLAAPATNDVM----- 486
V + ++Y+HE+ IVHRD++ N+ + K I +F L+ N +M
Sbjct: 115 --VLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACG 169
Query: 487 ----------------PKFDVFAFGVVLLELLSG 504
D ++ GV+ LL G
Sbjct: 170 TPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 53/219 (24%), Positives = 89/219 (40%), Gaps = 57/219 (26%)
Query: 329 MESTMNLSEHYSIGK--------SVYRAT--IDGKVLAVKKIK---------EDVTEELR 369
+ +E Y+I V + I + AVK I + E+
Sbjct: 14 LYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVE 73
Query: 370 ILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQ 429
+L++++H N++KL + DS + ++V E G L + + + S + I
Sbjct: 74 LLKKLDHPNIMKLFEILEDSS-SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQ--- 129
Query: 430 RLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKA---KIANFSLAAPATNDVM 486
V +G+ YMH+H +IVHRD++ NI L+S+ K KI +F L+ +
Sbjct: 130 -------VFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179
Query: 487 ---------------------PKFDVFAFGVVLLELLSG 504
K DV++ GV+L LLSG
Sbjct: 180 MKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSG 218
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 45/241 (18%), Positives = 88/241 (36%), Gaps = 73/241 (30%)
Query: 341 IGK----SVYRA--TIDGKVLAVKKIK---------EDVTEELRILQRI-NHANLVKLMG 384
IG SV++ +DG + A+K+ K ++ E+ + H+++V+
Sbjct: 19 IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFS 78
Query: 385 VSSDSQGNRFLVY-EYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQY 443
+ ++ + L+ EY GSL + + S + ++ + L V GL+Y
Sbjct: 79 --AWAEDDHMLIQNEYCNGGSLADAISENYRIMS------YFKEAELKDLLLQVGRGLRY 130
Query: 444 MHEHAQPSIVHRDIRTNNIQLD-------------------SRFKAKIANFSLAAPATN- 483
+H S+VH DI+ +NI + ++ KI + ++
Sbjct: 131 IHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP 187
Query: 484 -----DVM--------------PKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIR 524
D PK D+FA + ++ + R + W EIR
Sbjct: 188 QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD------QWHEIR 241
Query: 525 E 525
+
Sbjct: 242 Q 242
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 3e-16
Identities = 44/210 (20%), Positives = 81/210 (38%), Gaps = 55/210 (26%)
Query: 337 EHYSIGK--------SVYRA--TIDGKVLAVKKI------KEDVTE----ELRILQRINH 376
+ + IG+ +VY A + ++A+K + KE V E+ I + H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 377 ANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALD 436
N++++ D + +L+ E+A G L K L + + +
Sbjct: 74 PNILRMYNYFHDRK-RIYLMLEFAPRGELYKELQKHGRFDEQRSATFM---EE------- 122
Query: 437 VANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVM---------- 486
+A+ L Y HE ++HRDI+ N+ + + + KIA+F + A +
Sbjct: 123 LADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYL 179
Query: 487 -----------PKFDVFAFGVVLLELLSGK 505
K D++ GV+ E L G
Sbjct: 180 PPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 4e-16
Identities = 41/215 (19%), Positives = 80/215 (37%), Gaps = 55/215 (25%)
Query: 331 STMNLSEHYSIGK--------SVYRAT--IDGKVLAVKKI-------KEDVTEELRILQR 373
+ +++++Y++ V A A KKI + +E+ I++
Sbjct: 3 TKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKS 62
Query: 374 INHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRV 433
++H N+++L D+ + +LV E G L + + K S + I
Sbjct: 63 LDHPNIIRLYETFEDNT-DIYLVMELCTGGELFERVVHKRVFRESDAARIMKD------- 114
Query: 434 ALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKA---KIANFSLAAPATNDVM---- 486
V + + Y H+ ++ HRD++ N + K+ +F LAA M
Sbjct: 115 ---VLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK 168
Query: 487 -----------------PKFDVFAFGVVLLELLSG 504
P+ D ++ GV++ LL G
Sbjct: 169 VGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCG 203
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 45/205 (21%), Positives = 83/205 (40%), Gaps = 52/205 (25%)
Query: 341 IGK----SVYRA--TIDGKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVSS 387
+GK VY + +A+K+I + + EE+ + + + H N+V+ +G S
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG--S 87
Query: 388 DSQGNRFLVY-EYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHE 446
S+ ++ E GSL L K + I Q L GL+Y+H+
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILE-------GLKYLHD 140
Query: 447 HAQPSIVHRDIRTNNIQLDSRF-KAKIANFSLA--------------------AP----- 480
+ IVHRDI+ +N+ +++ KI++F + AP
Sbjct: 141 N---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDK 197
Query: 481 ATNDVMPKFDVFAFGVVLLELLSGK 505
D+++ G ++E+ +GK
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGK 222
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 5e-16
Identities = 55/286 (19%), Positives = 101/286 (35%), Gaps = 67/286 (23%)
Query: 272 RVRILNRNGSS--LESADLIPMKENSKSDRFEPKLAQNKLLPGVSG---------YLGKP 320
R+ N++G S E + + + + R + + + G
Sbjct: 81 RIIAENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIW 140
Query: 321 IVYEIEVIMESTMNLSEHYSIGK--------SVYRAT--IDGKVLAVKKI-------KED 363
Y + + ++ +HY I + V+R T G A K + KE
Sbjct: 141 KQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKET 200
Query: 364 VTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSL-DKWLHPKSKSSSSSGSV 422
V +E++ + + H LV L + ++YE+ G L +K +K
Sbjct: 201 VRKEIQTMSVLRHPTLVNLHDA-FEDDNEMVMIYEFMSGGELFEKVADEHNK-------- 251
Query: 423 IFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKA--KIANFSLA-- 478
++ + + V GL +MHE+ + VH D++ NI ++ K+ +F L
Sbjct: 252 --MSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 306
Query: 479 -----------------AP---ATNDVMPKFDVFAFGVVLLELLSG 504
AP V D+++ GV+ LLSG
Sbjct: 307 LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 6e-16
Identities = 37/155 (23%), Positives = 68/155 (43%), Gaps = 33/155 (21%)
Query: 345 VYRA----TIDGKVLAVKKIKEDVTE-----ELRILQRINHANLVKLMGVSSDSQGNR-F 394
VY+A D K A+K+I+ E+ +L+ + H N++ L V + +
Sbjct: 37 VYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96
Query: 395 LVYEYAENGSLDKWLHPKSKSSSSSGSVIF-------LTWSQRLRVALDVANGLQYMHEH 447
L+++YAE+ L + S ++ V L + Q L +G+ Y+H +
Sbjct: 97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLY-QIL-------DGIHYLHAN 147
Query: 448 AQPSIVHRDIRTNNI----QLDSRFKAKIANFSLA 478
++HRD++ NI + R + KIA+ A
Sbjct: 148 ---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 179
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 7e-16
Identities = 39/242 (16%), Positives = 84/242 (34%), Gaps = 69/242 (28%)
Query: 324 EIEVIMESTMNLSEHYSIGKS---------VYRATIDGKVLAVKKIK----EDVTEELRI 370
I I +L K V++ + G+ +AVK++ + E+++
Sbjct: 2 RIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKL 61
Query: 371 LQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQ 429
L +H N+++ + + ++ E +L + K+ S +
Sbjct: 62 LTESDDHPNVIRYYCSETTDR-FLYIALELCN-LNLQDLVESKNVSDENLKL---QKEYN 116
Query: 430 RLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDS-------------RFKAKIANFS 476
+ + +A+G+ ++H I+HRD++ NI + + + I++F
Sbjct: 117 PISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173
Query: 477 LA------------------------AP----ATNDVMPKF------DVFAFGVVLLELL 502
L AP +N++ K D+F+ G V +L
Sbjct: 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL 233
Query: 503 SG 504
S
Sbjct: 234 SK 235
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 7e-16
Identities = 45/202 (22%), Positives = 84/202 (41%), Gaps = 53/202 (26%)
Query: 345 VYRAT---IDGKVLAVKKIKEDVTEE------------LRILQRINHANLVKL----MGV 385
V++A G+ +A+K+++ EE LR L+ H N+V+L
Sbjct: 27 VFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 86
Query: 386 SSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMH 445
+D + LV+E+ + L +L + + ++ + + Q LR GL ++H
Sbjct: 87 RTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMF-QLLR-------GLDFLH 137
Query: 446 EHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA------APATNDVM------------- 486
H +VHRD++ NI + S + K+A+F LA T+ V+
Sbjct: 138 SH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS 194
Query: 487 ---PKFDVFAFGVVLLELLSGK 505
D+++ G + E+ K
Sbjct: 195 SYATPVDLWSVGCIFAEMFRRK 216
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 8e-16
Identities = 45/204 (22%), Positives = 76/204 (37%), Gaps = 55/204 (26%)
Query: 345 VYRA--TIDGKVLAVKKIKEDVTEE---------------LRILQRINHANLVKL----M 383
VY+A G +A+K ++ LR L+ H N+V+L
Sbjct: 25 VYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84
Query: 384 GVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQY 443
+D + LV+E+ + L +L + ++ L Q LR GL +
Sbjct: 85 TSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMR-QFLR-------GLDF 135
Query: 444 MHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA------APATNDVM----------- 486
+H + IVHRD++ NI + S K+A+F LA T V+
Sbjct: 136 LHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLL 192
Query: 487 -----PKFDVFAFGVVLLELLSGK 505
D+++ G + E+ K
Sbjct: 193 QSTYATPVDMWSVGCIFAEMFRRK 216
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 44/150 (29%), Positives = 74/150 (49%), Gaps = 32/150 (21%)
Query: 345 VYRA--TIDGKVLAVKKIKEDVTEE---------LR---ILQRINHANLVKLMGVSSDSQ 390
VY+A +++A+KKIK E LR +LQ ++H N++ L+ +
Sbjct: 26 VYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG-HK 84
Query: 391 GNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVI--FLTWSQRLRVALDVANGLQYMHEHA 448
N LV+++ E L+ + K S + S I ++ L+ GL+Y+H+H
Sbjct: 85 SNISLVFDFMET-DLEVII--KDNSLVLTPSHIKAYM--LMTLQ-------GLEYLHQH- 131
Query: 449 QPSIVHRDIRTNNIQLDSRFKAKIANFSLA 478
I+HRD++ NN+ LD K+A+F LA
Sbjct: 132 --WILHRDLKPNNLLLDENGVLKLADFGLA 159
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 1e-15
Identities = 40/145 (27%), Positives = 75/145 (51%), Gaps = 24/145 (16%)
Query: 345 VYRA--TIDGKVLAVKKIKEDVTEE------LR---ILQRINHANLVKLMGVSSDSQGNR 393
VY+A + G+V+A+KKI+ D E +R +L+ +NH N+VKL+ V ++
Sbjct: 19 VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-TENKL 77
Query: 394 FLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIV 453
+LV+E+ L K++ + + + + Q L+ GL + H H ++
Sbjct: 78 YLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLF-QLLQ-------GLAFCHSH---RVL 125
Query: 454 HRDIRTNNIQLDSRFKAKIANFSLA 478
HRD++ N+ +++ K+A+F LA
Sbjct: 126 HRDLKPQNLLINTEGAIKLADFGLA 150
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 1e-15
Identities = 37/147 (25%), Positives = 69/147 (46%), Gaps = 25/147 (17%)
Query: 345 VYRA--TIDGKVLAVKKIKEDVTE--------ELRILQRINHANLVKLMGVSSDSQGNRF 394
VY+ G +A+K++K D E E+ +++ + H N+V+L V ++
Sbjct: 21 VYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIH-TENKLT 79
Query: 395 LVYEYAEN---GSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPS 451
LV+E+ +N +D + V + W Q L+ GL + HE+
Sbjct: 80 LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQW-QLLQ-------GLAFCHEN---K 128
Query: 452 IVHRDIRTNNIQLDSRFKAKIANFSLA 478
I+HRD++ N+ ++ R + K+ +F LA
Sbjct: 129 ILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 18/220 (8%), Positives = 43/220 (19%), Gaps = 66/220 (30%)
Query: 345 VYRAT--IDGKVLAVKKIK----------EDVTEELRILQRINHANLVKLM--------- 383
V+ + A+K E + E R+ + +
Sbjct: 78 VFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPS 137
Query: 384 ----------------GVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTW 427
G + N L+ A L+ G
Sbjct: 138 DAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGD---EGI 193
Query: 428 SQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA------ 481
+ + + +VH +N+ + + + + S
Sbjct: 194 LALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPA 250
Query: 482 ---TNDVMP-------------KFDVFAFGVVLLELLSGK 505
P + + G+ + +
Sbjct: 251 SSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 48/231 (20%), Positives = 87/231 (37%), Gaps = 58/231 (25%)
Query: 318 GKPIVYEIEVIMESTMNLSEHYSIGK--------SVYRAT--IDGKVLAVKKIK------ 361
G+ + E +M ++ S++Y + + V R G A K I
Sbjct: 10 GQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA 69
Query: 362 ---EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSS 418
+ + E RI +++ H N+V+L + +LV++ G L + + + S +
Sbjct: 70 RDFQKLEREARICRKLQHPNIVRLHDSIQEE-SFHYLVFDLVTGGELFEDIVAREFYSEA 128
Query: 419 SGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKA---KIANF 475
S + + Y H + IVHR+++ N+ L S+ K K+A+F
Sbjct: 129 DASHCIQQ----------ILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADF 175
Query: 476 SLA-------------------AP---ATNDVMPKFDVFAFGVVLLELLSG 504
LA +P + D++A GV+L LL G
Sbjct: 176 GLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 58/294 (19%), Positives = 110/294 (37%), Gaps = 67/294 (22%)
Query: 264 YNHHLQRKRVRILNRNGSSLESADLIP-------MKENSKSDRFEPKLAQNKLLPGVSGY 316
++HH + N S++++ KE + ++
Sbjct: 5 HHHHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAV 64
Query: 317 --LGKPIVYEIEVIMESTMNLSEHYSIGKS----------VYRAT--IDGKVLAVKKI-- 360
P ++ ++ ++ Y++ K+ V++ G LA K I
Sbjct: 65 DIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKT 124
Query: 361 -----KEDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSL-DKWLHPKSK 414
KE+V E+ ++ +++HANL++L +S+ + LV EY + G L D+ +
Sbjct: 125 RGMKDKEEVKNEISVMNQLDHANLIQLYDA-FESKNDIVLVMEYVDGGELFDRIIDESYN 183
Query: 415 SSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKA--KI 472
LT + + G+++MH+ I+H D++ NI +R KI
Sbjct: 184 ----------LTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKI 230
Query: 473 ANFSLA-------------------AP---ATNDVMPKFDVFAFGVVLLELLSG 504
+F LA AP + V D+++ GV+ LLSG
Sbjct: 231 IDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 49/232 (21%), Positives = 90/232 (38%), Gaps = 68/232 (29%)
Query: 327 VIMESTMNLSEHYSIGK--------SVYRAT--IDGKVLAVKKIK--------------- 361
+ + + E Y + V A+K IK
Sbjct: 26 YVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKN 85
Query: 362 -----EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSS 416
E++ E+ +L+ ++H N++KL V D + +LV E+ E G L + + + K
Sbjct: 86 IEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKK-YFYLVTEFYEGGELFEQIINRHKFD 144
Query: 417 SSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSR---FKAKIA 473
+ I + +G+ Y+H+H +IVHRDI+ NI L+++ KI
Sbjct: 145 ECDAANIMKQ----------ILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIV 191
Query: 474 NFSLAAP-ATNDVM--------------------PKFDVFAFGVVLLELLSG 504
+F L++ + + + K DV++ GV++ LL G
Sbjct: 192 DFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCG 243
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 54/219 (24%), Positives = 89/219 (40%), Gaps = 57/219 (26%)
Query: 329 MESTMNLSEHYSIGK--------SVYRAT--IDGKVLAVKKIK---------EDVTEELR 369
+ +E Y+I V + I + AVK I + E+
Sbjct: 14 LYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVE 73
Query: 370 ILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQ 429
+L++++H N++KL + DS + ++V E G L + + + S + I
Sbjct: 74 LLKKLDHPNIMKLFEILEDSS-SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQ--- 129
Query: 430 RLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSR---FKAKIANFSLAAP-ATNDV 485
V +G+ YMH+H +IVHRD++ NI L+S+ KI +F L+ N
Sbjct: 130 -------VFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179
Query: 486 M--------------------PKFDVFAFGVVLLELLSG 504
M K DV++ GV+L LLSG
Sbjct: 180 MKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSG 218
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 3e-15
Identities = 45/217 (20%), Positives = 80/217 (36%), Gaps = 58/217 (26%)
Query: 332 TMNLSEHYSIGK--------SVYRAT--IDGKVLAVKKIK---------EDVTEELRILQ 372
+ S++Y + + V R G A K I + + E RI +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 373 RINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLR 432
++ H N+V+L + +LV++ G L + + + S + S
Sbjct: 61 KLQHPNIVRLHDSIQEE-SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ------ 113
Query: 433 VALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKA---KIANFSLA----------- 478
+ + Y H + IVHR+++ N+ L S+ K K+A+F LA
Sbjct: 114 ----ILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG 166
Query: 479 --------AP---ATNDVMPKFDVFAFGVVLLELLSG 504
+P + D++A GV+L LL G
Sbjct: 167 FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 3e-15
Identities = 50/223 (22%), Positives = 87/223 (39%), Gaps = 54/223 (24%)
Query: 323 YEIEVIMESTMNLSEHYSIGK--------SVYRAT--IDGKVLAVKKI-------KEDVT 365
Y + + ++ ++Y I + V+R G+V K I K V
Sbjct: 37 YVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK 96
Query: 366 EELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFL 425
E+ I+ +++H L+ L + + L+ E+ G L + + +
Sbjct: 97 NEISIMNQLHHPKLINLHDA-FEDKYEMVLILEFLSGGELFDRIAAEDYK---------M 146
Query: 426 TWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKA--KIANFSLA----- 478
+ ++ + GL++MHEH SIVH DI+ NI +++ + KI +F LA
Sbjct: 147 SEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203
Query: 479 --------------AP---ATNDVMPKFDVFAFGVVLLELLSG 504
AP V D++A GV+ LLSG
Sbjct: 204 DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 75.6 bits (187), Expect = 3e-15
Identities = 37/145 (25%), Positives = 69/145 (47%), Gaps = 25/145 (17%)
Query: 345 VYRA--TIDGKVLAVKKIKEDVTEE------LR---ILQRINHANLVKLMGVSSDSQGNR 393
V++A +++A+K+++ D +E LR +L+ + H N+V+L V S
Sbjct: 18 VFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-SDKKL 76
Query: 394 FLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIV 453
LV+E+ + L K+ + FL Q L+ GL + H +++
Sbjct: 77 TLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFL--FQLLK-------GLGFCHSR---NVL 123
Query: 454 HRDIRTNNIQLDSRFKAKIANFSLA 478
HRD++ N+ ++ + K+ANF LA
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLA 148
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 3e-15
Identities = 45/198 (22%), Positives = 82/198 (41%), Gaps = 53/198 (26%)
Query: 345 VYRA--TIDGKVLAVKKIKEDVTE---------ELRILQRINHANLVKLMGVSSDSQGNR 393
V++ G+++A+KK E + E+R+L+++ H NLV L+ V +
Sbjct: 19 VFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFR-RKRRL 77
Query: 394 FLVYEYAENGSLDKWL--HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPS 451
LV+EY ++ ++ L + + S+ + Q L+ + + H+H +
Sbjct: 78 HLVFEYCDH-TVLHELDRYQRGVPEHLVKSITW----QTLQ-------AVNFCHKH---N 122
Query: 452 IVHRDIRTNNIQLDSRFKAKIANFSLA-------APATNDVM-----------------P 487
+HRD++ NI + K+ +F A ++V P
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGP 182
Query: 488 KFDVFAFGVVLLELLSGK 505
DV+A G V ELLSG
Sbjct: 183 PVDVWAIGCVFAELLSGV 200
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 45/221 (20%), Positives = 83/221 (37%), Gaps = 55/221 (24%)
Query: 325 IEVIMESTMNLSEHYSIGK--------SVYRAT--IDGKVLAVKKI---KEDVTEELRIL 371
++ + +++ ++ Y + + R AVK I K D TEE+ IL
Sbjct: 10 VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEIL 69
Query: 372 QR-INHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQR 430
R H N++ L V D + ++V E + G L + + S S + T
Sbjct: 70 LRYGQHPNIITLKDVYDDGK-YVYVVTELMKGGELLDKILRQKFFSEREASAVLFT---- 124
Query: 431 LRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKA----KIANFSLAA--PATND 484
+ ++Y+H +VHRD++ +NI +I +F A A N
Sbjct: 125 ------ITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175
Query: 485 VM---------------------PKFDVFAFGVVLLELLSG 504
++ D+++ GV+L +L+G
Sbjct: 176 LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 4e-15
Identities = 42/219 (19%), Positives = 80/219 (36%), Gaps = 59/219 (26%)
Query: 331 STMNLSEHYSIGK--------SVYRAT--IDGKVLAVKKIK---------EDVTEELRIL 371
+ +E Y + + V R + G+ A I + + E RI
Sbjct: 5 TCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARIC 64
Query: 372 QRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRL 431
+ + H N+V+L S+ +G+ +L+++ G L + + + S + S
Sbjct: 65 RLLKHPNIVRLHDSISE-EGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQ----- 118
Query: 432 RVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKA---KIANFSLAA--PATNDVM 486
+ + + H+ +VHR+++ N+ L S+ K K+A+F LA
Sbjct: 119 -----ILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW 170
Query: 487 ---------------------PKFDVFAFGVVLLELLSG 504
D++A GV+L LL G
Sbjct: 171 FGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 5e-15
Identities = 33/198 (16%), Positives = 75/198 (37%), Gaps = 36/198 (18%)
Query: 336 SEHYSIGK--------SVYRAT--IDGKVLAVKKI-------KEDVTEELRILQRI-NHA 377
+ + VY A G+ A+K++ + +E+ ++++ H
Sbjct: 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHP 86
Query: 378 NLVKLMGVS----SDSQGNRFLVY---EYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQR 430
N+V+ + +S + E + ++ +S+ L+
Sbjct: 87 NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP--------LSCDTV 138
Query: 431 LRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVMPKFD 490
L++ +Q+MH +P I+HRD++ N+ L ++ K+ +F A ++ P +
Sbjct: 139 LKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHY--PDYS 195
Query: 491 VFAFGVVLLELLSGKKAT 508
A L+E + T
Sbjct: 196 WSAQRRALVEEEITRNTT 213
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 5e-15
Identities = 45/224 (20%), Positives = 80/224 (35%), Gaps = 68/224 (30%)
Query: 334 NLSEHYSIGK--------SVYRAT--IDGKVLAVKKIK---------------EDVTEEL 368
L + Y + K V A K +A++ I +V E+
Sbjct: 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEI 191
Query: 369 RILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWS 428
IL+++NH ++K+ + ++V E E G L + + ++ + F
Sbjct: 192 EILKKLNHPCIIKIKNFFDAE--DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ-- 247
Query: 429 QRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSR---FKAKIANFSLA------- 478
+ +QY+HE+ I+HRD++ N+ L S+ KI +F +
Sbjct: 248 --------MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS 296
Query: 479 ------------AP------ATNDVMPKFDVFAFGVVLLELLSG 504
AP T D ++ GV+L LSG
Sbjct: 297 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 7e-15
Identities = 38/144 (26%), Positives = 71/144 (49%), Gaps = 24/144 (16%)
Query: 345 VYRAT--IDGKVLAVKKIKEDVTE--------ELRILQRINHANLVKLMGVSSDSQGNRF 394
VY+ + ++A+K+I+ + E E+ +L+ + HAN+V L + ++ +
Sbjct: 18 VYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-TEKSLT 76
Query: 395 LVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVH 454
LV+EY + L ++L + +FL Q LR GL Y H ++H
Sbjct: 77 LVFEYLDK-DLKQYLDDCGNIINMHNVKLFL--FQLLR-------GLAYCHRQ---KVLH 123
Query: 455 RDIRTNNIQLDSRFKAKIANFSLA 478
RD++ N+ ++ R + K+A+F LA
Sbjct: 124 RDLKPQNLLINERGELKLADFGLA 147
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 7e-15
Identities = 52/230 (22%), Positives = 87/230 (37%), Gaps = 63/230 (27%)
Query: 324 EIEVIMESTMNLSEHYSIGK--------SVYRAT--IDGKVLAVK-----KIKED----- 363
E+E + S+ YS V+ A K + VK K+ ED
Sbjct: 11 ELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIED 70
Query: 364 -----VTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGS-LDKWLHPKSKSSS 417
VT E+ IL R+ HAN++K++ + ++QG LV E +G L ++ +
Sbjct: 71 PKLGKVTLEIAILSRVEHANIIKVLDIF-ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDE 129
Query: 418 SSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSL 477
S IF Q + + + Y+ I+HRDI+ NI + F K+ +F
Sbjct: 130 PLASYIF---RQ-------LVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGS 176
Query: 478 AAPATNDVM-----------------------PKFDVFAFGVVLLELLSG 504
AA + P+ ++++ GV L L+
Sbjct: 177 AAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFE 226
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 7e-15
Identities = 45/265 (16%), Positives = 79/265 (29%), Gaps = 87/265 (32%)
Query: 324 EIEVIMESTMNLSEHYSIGK--------SVYRAT--IDGKVLAVKKIK------------ 361
+ S + L + Y + V A + A+K +
Sbjct: 13 NLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDV 72
Query: 362 EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGS 421
E + E+R++++++H N+ +L V D Q LV E G L L+ S+ +
Sbjct: 73 ERIKTEVRLMKKLHHPNIARLYEVYEDEQ-YICLVMELCHGGHLLDKLNVFIDDSTGKCA 131
Query: 422 VIFLTWSQRL------------------------------RVALDVANGLQYMHEHAQPS 451
+ + + + + L Y+H
Sbjct: 132 MDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---G 188
Query: 452 IVHRDIRTNNIQLDSRFKA--KIANFSLAA------PATNDVM----------------- 486
I HRDI+ N + K+ +F L+ M
Sbjct: 189 ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT 248
Query: 487 ------PKFDVFAFGVVLLELLSGK 505
PK D ++ GV+L LL G
Sbjct: 249 TNESYGPKCDAWSAGVLLHLLLMGA 273
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 8e-15
Identities = 44/212 (20%), Positives = 72/212 (33%), Gaps = 55/212 (25%)
Query: 334 NLSEHYSIGK--------SVYRAT--IDGKVLAVKKIK------EDVTEELRILQRINHA 377
L E Y I + V+R K K +K V +E+ IL H
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHR 61
Query: 378 NLVKLMGVSSDSQGNRFLVYEYAENGSL-DKWLHPKSKSSSSSGSVIFLTWSQRLRVALD 436
N++ L +S +++E+ + ++ + +
Sbjct: 62 NILHLHES-FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQ---------- 110
Query: 437 VANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKA--KIANFSLA---------------- 478
V LQ++H H +I H DIR NI +R + KI F A
Sbjct: 111 VCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAP 167
Query: 479 ---AP---ATNDVMPKFDVFAFGVVLLELLSG 504
AP + V D+++ G ++ LLSG
Sbjct: 168 EYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 8e-15
Identities = 49/210 (23%), Positives = 88/210 (41%), Gaps = 65/210 (30%)
Query: 345 VYRA--TIDGKVLAVKKIKEDVTEE------LR---ILQRINHANLVKLMGV-------S 386
V++A G+ +A+KK+ + +E LR ILQ + H N+V L+ +
Sbjct: 33 VFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPY 92
Query: 387 SDSQGNRFLVYEYAEN---GSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQY 443
+ +G+ +LV+++ E+ G L + K T S+ RV + NGL Y
Sbjct: 93 NRCKGSIYLVFDFCEHDLAGLLS---NVLVK----------FTLSEIKRVMQMLLNGLYY 139
Query: 444 MHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA-----------APATNDVM------ 486
+H + I+HRD++ N+ + K+A+F LA TN V+
Sbjct: 140 IHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 196
Query: 487 -----------PKFDVFAFGVVLLELLSGK 505
P D++ G ++ E+ +
Sbjct: 197 PELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 43/198 (21%), Positives = 81/198 (40%), Gaps = 53/198 (26%)
Query: 345 VYRA--TIDGKVLAVKKIKEDVTE---------ELRILQRINHANLVKLMGVSSDSQGNR 393
V + G+++A+KK E + E+++L+++ H NLV L+ V +
Sbjct: 41 VMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK-KKKRW 99
Query: 394 FLVYEYAENGSLDKWL--HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPS 451
+LV+E+ ++ ++ L P +F Q + G+ + H H +
Sbjct: 100 YLVFEFVDH-TILDDLELFPNGLDYQVVQKYLF----QIIN-------GIGFCHSH---N 144
Query: 452 IVHRDIRTNNIQLDSRFKAKIANFSLA----APA---TNDVM-----------------P 487
I+HRDI+ NI + K+ +F A AP ++V
Sbjct: 145 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGK 204
Query: 488 KFDVFAFGVVLLELLSGK 505
DV+A G ++ E+ G+
Sbjct: 205 AVDVWAIGCLVTEMFMGE 222
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 42/202 (20%), Positives = 80/202 (39%), Gaps = 54/202 (26%)
Query: 345 VYRA--TIDGKVLAVKKIKEDVTEELRILQR----------INHANLVKL--MGVSSDSQ 390
V+ A D + +AVK ++ D+ + R +NH +V + G +
Sbjct: 28 VHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 87
Query: 391 GN-RFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQ 449
G ++V EY + +L +H + +T + + V D L + H++
Sbjct: 88 GPLPYIVMEYVDGVTLRDIVHTEGP----------MTPKRAIEVIADACQALNFSHQN-- 135
Query: 450 PSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA---------TNDVM-------------- 486
I+HRD++ NI + + K+ +F +A T V+
Sbjct: 136 -GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 194
Query: 487 ---PKFDVFAFGVVLLELLSGK 505
+ DV++ G VL E+L+G+
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGE 216
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 50/210 (23%), Positives = 88/210 (41%), Gaps = 56/210 (26%)
Query: 338 HYSIGKS--------VYRAT--IDGKVLAVK-----KIKED----VTEELRILQRINHAN 378
+Y + K+ V A + G+ +A+K ++ + E+RI++ +NH N
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 379 LVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVA 438
+VKL V +++ +L+ EYA G + +L + F Q +
Sbjct: 76 IVKLFEVI-ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKF---RQ-------IV 124
Query: 439 NGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVM------------ 486
+ +QY H+ IVHRD++ N+ LD+ KIA+F + T
Sbjct: 125 SAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAA 181
Query: 487 -----------PKFDVFAFGVVLLELLSGK 505
P+ DV++ GV+L L+SG
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 1e-14
Identities = 44/144 (30%), Positives = 74/144 (51%), Gaps = 24/144 (16%)
Query: 345 VYRAT-IDGKVLAVKKIKEDVTEE------LR---ILQRINHANLVKLMGVSSDSQGNRF 394
VY+A G+++A+K+I+ D +E +R +L+ ++H N+V L+ V S+
Sbjct: 37 VYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIH-SERCLT 95
Query: 395 LVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVH 454
LV+E+ E L K L S I+L Q LR G+ + H+H I+H
Sbjct: 96 LVFEFMEK-DLKKVLDENKTGLQDSQIKIYL--YQLLR-------GVAHCHQH---RILH 142
Query: 455 RDIRTNNIQLDSRFKAKIANFSLA 478
RD++ N+ ++S K+A+F LA
Sbjct: 143 RDLKPQNLLINSDGALKLADFGLA 166
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 49/350 (14%), Positives = 97/350 (27%), Gaps = 93/350 (26%)
Query: 280 GSSLESADLIPMKENSKSDRFEPKLAQNKLLPGVSGYLGK-PIVYE-------IEVIMES 331
+ S + + ++ KL KLL G+S + P +E I+ E
Sbjct: 2 SPQMSSLGTVDAPNFIVGNPWDDKL-IFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEF 60
Query: 332 TMNLSEHYSIGK--------SVYRAT-------IDGKVLAVKKIKED-------VTEELR 369
+ S+ + VY AT + + +K K T+ +
Sbjct: 61 QLG-SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLME 119
Query: 370 ILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQ 429
L+ +K Q LV E G+L ++ + +
Sbjct: 120 RLKPSMQHMFMKFYSAHLF-QNGSVLVGELYSYGTLLNAINLYKNTPEKV-----MPQGL 173
Query: 430 RLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKA-----------KIANFSLA 478
+ A+ + ++ +H+ I+H DI+ +N L + F + + +
Sbjct: 174 VISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQS 230
Query: 479 ----APATNDVMPKF---------------------DVFAFGVVLLELLSGKKATRTTEN 513
+ D F + +L G E
Sbjct: 231 IDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290
Query: 514 GKTAV-----------LWKEIREV-LKVEEK----REERLRNWMDPNLES 547
G+ +W E V L + + + LR + +
Sbjct: 291 GECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 2e-14
Identities = 33/194 (17%), Positives = 66/194 (34%), Gaps = 49/194 (25%)
Query: 345 VYRAT---IDGKVLAVKKIKEDVTE--------ELRILQRINHANLVKL--MGVSSDSQG 391
+Y A ++G+ + +K + E + L + H ++V++ +D G
Sbjct: 96 IYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG 155
Query: 392 NR--FLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQ 449
+ ++V EY SL + K L ++ + L++ L Y+H
Sbjct: 156 DPVGYIVMEYVGGQSLKRSKGQK------------LPVAEAIAYLLEILPALSYLHSI-- 201
Query: 450 PSIVHRDIRTNNIQLDSRFKAKIANFSLA----------------AP--ATNDVMPKFDV 491
+V+ D++ NI L + K+ + AP D+
Sbjct: 202 -GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYLYGTPGFQAPEIVRTGPTVATDI 259
Query: 492 FAFGVVLLELLSGK 505
+ G L L
Sbjct: 260 YTVGRTLAALTLDL 273
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 43/227 (18%), Positives = 81/227 (35%), Gaps = 66/227 (29%)
Query: 330 ESTMNLSEHYSIGK--------SVYRAT--IDGKVLAVKKIK------------EDVTEE 367
+ + + Y + + V R G+ AVK + ED+ E
Sbjct: 17 DDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKRE 76
Query: 368 LRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSL-DKWL---HPKSKSSSSSGSVI 423
I + H ++V+L+ S G ++V+E+ + L + + S + S
Sbjct: 77 ASICHMLKHPHIVELLETYSSD-GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY 135
Query: 424 FLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKA---KIANFSLAA- 479
+ L+Y H++ +I+HRD++ + + L S+ + K+ F +A
Sbjct: 136 MRQ----------ILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182
Query: 480 -PATNDVM---------------------PKFDVFAFGVVLLELLSG 504
+ V DV+ GV+L LLSG
Sbjct: 183 LGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 41/201 (20%), Positives = 83/201 (41%), Gaps = 51/201 (25%)
Query: 341 IGK----SVYRATI--DGKVLAVKKI-------KEDVTEELRILQRINHANLVKLMGVSS 387
IG+ +VY A G+ +A++++ KE + E+ +++ + N+V + S
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD-SY 86
Query: 388 DSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEH 447
++V EY GSL + + Q V + L+++H +
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETC-----------MDEGQIAAVCRECLQALEFLHSN 135
Query: 448 AQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDV------------M--------- 486
++HRDI+++NI L K+ +F A T + M
Sbjct: 136 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 487 --PKFDVFAFGVVLLELLSGK 505
PK D+++ G++ +E++ G+
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGE 213
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 46/223 (20%), Positives = 78/223 (34%), Gaps = 63/223 (28%)
Query: 331 STMNLSEHYSIGK--------SVYRAT--IDGKVLAVKKIK-------------EDVTEE 367
+ + Y IG+ V + G A K IK E++ E
Sbjct: 6 KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 368 LRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTW 427
+ IL+++ H N++ L V + + L+ E G L +L K S +
Sbjct: 66 VSILRQVLHHNVITLHDVYENRT-DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ- 123
Query: 428 SQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKA----KIANFSLA----- 478
+ +G+ Y+H I H D++ NI L + K+ +F LA
Sbjct: 124 ---------ILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171
Query: 479 --------------AP---ATNDVMPKFDVFAFGVVLLELLSG 504
AP + + D+++ GV+ LLSG
Sbjct: 172 GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 3e-14
Identities = 45/220 (20%), Positives = 79/220 (35%), Gaps = 63/220 (28%)
Query: 334 NLSEHYSIGK--------SVYRAT--IDGKVLAVKKIK-------------EDVTEELRI 370
+ +HY +G+ V + GK A K IK E++ E+ I
Sbjct: 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61
Query: 371 LQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQR 430
L+ I H N++ L + + + L+ E G L +L K + +
Sbjct: 62 LREIRHPNIITLHDIFENKT-DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQ---- 116
Query: 431 LRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKA----KIANFSLA-------- 478
+ +G+ Y+H I H D++ NI L + K+ +F +A
Sbjct: 117 ------ILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE 167
Query: 479 -----------AP---ATNDVMPKFDVFAFGVVLLELLSG 504
AP + + D+++ GV+ LLSG
Sbjct: 168 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 34/238 (14%), Positives = 78/238 (32%), Gaps = 56/238 (23%)
Query: 310 LPGVSGYLGKPIVYEIEVIMESTMNLSEHYSIGK---------SVYRAT--IDGKVLAVK 358
+ + + + +++ Y + K V G+ A+K
Sbjct: 1 MAHHHHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALK 60
Query: 359 KI--KEDVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVY---EYAENGSL-DKWLHP 411
+ +E+ + ++V ++ V + + + E E G L +
Sbjct: 61 LLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQER 120
Query: 412 KSKS-SSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKA 470
++ + + I + +Q++H H +I HRD++ N+ S+ K
Sbjct: 121 GDQAFTEREAAEIMRD----------IGTAIQFLHSH---NIAHRDVKPENLLYTSKEKD 167
Query: 471 ---KIANFSLAAPATNDVM---------------------PKFDVFAFGVVLLELLSG 504
K+ +F A T + + D+++ GV++ LL G
Sbjct: 168 AVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 4e-14
Identities = 39/145 (26%), Positives = 67/145 (46%), Gaps = 26/145 (17%)
Query: 345 VYRATID--GKVLAVKKIKEDVTEE------LR---ILQRINHANLVKLMGVSSDSQGNR 393
VY+A + G+ A+KKI+ + +E +R IL+ + H+N+VKL V ++
Sbjct: 18 VYKA-QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH-TKKRL 75
Query: 394 FLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIV 453
LV+E+ + L K L Q L G+ Y H+ ++
Sbjct: 76 VLVFEHLDQ-DLKKLL--DVCEGGLESVTAKSFLLQLLN-------GIAYCHDR---RVL 122
Query: 454 HRDIRTNNIQLDSRFKAKIANFSLA 478
HRD++ N+ ++ + KIA+F LA
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLA 147
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 45/218 (20%), Positives = 82/218 (37%), Gaps = 54/218 (24%)
Query: 327 VIMESTMNLSEHYSIGK--------SVYRAT--IDGKVLAVKKIK-----EDVTEELRIL 371
+ + LS+ + + VYR K A+K +K + V E+ +L
Sbjct: 43 IDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVL 102
Query: 372 QRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRL 431
R++H N++KL + ++ LV E G L + K S +
Sbjct: 103 LRLSHPNIIKLKEI-FETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQ----- 156
Query: 432 RVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKA---KIANFSLAAPATNDVM-- 486
+ + Y+HE+ IVHRD++ N+ + KIA+F L+ + V+
Sbjct: 157 -----ILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK 208
Query: 487 --------------------PKFDVFAFGVVLLELLSG 504
P+ D+++ G++ LL G
Sbjct: 209 TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 46/224 (20%), Positives = 80/224 (35%), Gaps = 68/224 (30%)
Query: 334 NLSEHYSIGK--------SVYRAT--IDGKVLAVKKIK---------------EDVTEEL 368
L + Y + K V A K +A+K I +V E+
Sbjct: 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEI 66
Query: 369 RILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWS 428
IL+++NH ++K+ + ++V E E G L + + ++ + F
Sbjct: 67 EILKKLNHPCIIKIKNFFDAE--DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ-- 122
Query: 429 QRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSR---FKAKIANFSLA------- 478
+ +QY+HE+ I+HRD++ N+ L S+ KI +F +
Sbjct: 123 --------MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS 171
Query: 479 ------------AP------ATNDVMPKFDVFAFGVVLLELLSG 504
AP T D ++ GV+L LSG
Sbjct: 172 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 48/227 (21%), Positives = 84/227 (37%), Gaps = 65/227 (28%)
Query: 329 MES--TMNLSEHYSIGK--------SVYRAT--IDGKVLAVKKIK-------------ED 363
ME+ + + Y IG+ V + G A K IK E+
Sbjct: 2 METFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREE 61
Query: 364 VTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVI 423
+ E+ IL+++ H N++ L V +++ + L+ E G L +L K
Sbjct: 62 IEREVSILRQVLHPNIITLHDV-YENRTDVVLILELVSGGELFDFLAQKE---------- 110
Query: 424 FLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSR----FKAKIANFSLA- 478
L+ + + +G+ Y+H I H D++ NI L + K+ +F LA
Sbjct: 111 SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167
Query: 479 ------------------AP---ATNDVMPKFDVFAFGVVLLELLSG 504
AP + + D+++ GV+ LLSG
Sbjct: 168 EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 5e-14
Identities = 42/203 (20%), Positives = 76/203 (37%), Gaps = 53/203 (26%)
Query: 341 IGK----SVYRA--TIDGKVLAVKKIKEDVT--EELRILQRINHANLVKLMGVSSDSQGN 392
+G+ V+R G AVKK++ +V EEL ++ +V L G + +G
Sbjct: 66 VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYG--AVREGP 123
Query: 393 RFLVY-EYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPS 451
++ E E GSL + + L + L GL+Y+H
Sbjct: 124 WVNIFMELLEGGSLGQLIKQMGC----------LPEDRALYYLGQALEGLEYLHTR---R 170
Query: 452 IVHRDIRTNNIQLDSR-FKAKIANFSLAAPATNDVM------------------------ 486
I+H D++ +N+ L S +A + +F A D +
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 487 ----PKFDVFAFGVVLLELLSGK 505
K D+++ ++L +L+G
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNGC 253
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 6e-14
Identities = 49/230 (21%), Positives = 84/230 (36%), Gaps = 69/230 (30%)
Query: 330 ESTMNLSEHYSIGK--------SVYRAT--IDGKVLAVKKI----------------KED 363
ST E+Y + V R K AVK I +E
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 364 VTEELRILQRIN-HANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSV 422
+E+ IL++++ H N+++L + FLV++ + G L +L K S
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNT-FFFLVFDLMKKGELFDYLTEKVTLSEKETRK 128
Query: 423 IFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA---- 478
I + + +H+ +IVHRD++ NI LD K+ +F +
Sbjct: 129 IMRA----------LLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175
Query: 479 ---------------AP-----ATNDVM----PKFDVFAFGVVLLELLSG 504
AP + ND + D+++ GV++ LL+G
Sbjct: 176 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 23/175 (13%), Positives = 51/175 (29%), Gaps = 34/175 (19%)
Query: 344 SVYRATID---GKVLAVKKIKEDVTE----------ELRILQRINHANLVKLMGVSSDSQ 390
++A D + +A+ + L RI+ + +++ V +
Sbjct: 46 QFWQAL-DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT-R 103
Query: 391 GNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQP 450
+V E+ GSL + + +R +A H
Sbjct: 104 AGGLVVAEWIRGGSLQEVADTS------------PSPVGAIRAMQSLAAAADAAHRAG-- 149
Query: 451 SIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVMPKFDVFAFGVVLLELLSGK 505
+ + +++ +A + A P+ D+ G L LL +
Sbjct: 150 -VALSIDHPSRVRVSIDGDVVLAYPATMPDAN----PQDDIRGIGASLYALLVNR 199
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 41/201 (20%), Positives = 83/201 (41%), Gaps = 51/201 (25%)
Query: 341 IGK----SVYRATI--DGKVLAVKKI-------KEDVTEELRILQRINHANLVKLMGVSS 387
IG+ V A G+ +AVK + +E + E+ I++ H N+V++ S
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYK-SY 111
Query: 388 DSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEH 447
+++ E+ + G+L + L Q V V L Y+H
Sbjct: 112 LVGEELWVLMEFLQGGALTDIVSQVR-----------LNEEQIATVCEAVLQALAYLHAQ 160
Query: 448 AQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDV------------M--------- 486
++HRDI++++I L + K+++F A + DV M
Sbjct: 161 ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSL 217
Query: 487 --PKFDVFAFGVVLLELLSGK 505
+ D+++ G++++E++ G+
Sbjct: 218 YATEVDIWSLGIMVIEMVDGE 238
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 45/238 (18%), Positives = 83/238 (34%), Gaps = 47/238 (19%)
Query: 267 HLQRKRVRILNRNGSSLESADLIPMKENSKSDRFEPKLAQNKLLPGVSGYLGKPIVYEIE 326
+L R++ R R+ S + E K + +PK +N Y +
Sbjct: 31 NLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENL-------YFQSMGPEDEL 83
Query: 327 VIMESTMNLSEHYSIGK--------SVYRAT--IDGKVLAVKKI---------------K 361
+ + Y V R G AVK + +
Sbjct: 84 PDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVR 143
Query: 362 EDVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSG 420
E E IL+++ H +++ L+ S FLV++ G L +L K S
Sbjct: 144 EATRRETHILRQVAGHPHIITLIDSYESSS-FMFLVFDLMRKGELFDYLTEKVALSEKET 202
Query: 421 SVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA 478
I + + + ++H + +IVHRD++ NI LD + ++++F +
Sbjct: 203 RSIMRS----------LLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFS 247
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 30/168 (17%), Positives = 56/168 (33%), Gaps = 36/168 (21%)
Query: 337 EHYSIGK--------SVYRAT-IDGKVLAVKKIK---------EDVTEELRILQRINHAN 378
YSI K V++ ++ A+K + + E+ L ++ +
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 379 L--VKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALD 436
++L Q ++V E N L+ WL K W
Sbjct: 69 DKIIRLYDYEITDQ-YIYMVMECG-NIDLNSWLKKKKSIDPW---ERKSYWKN------- 116
Query: 437 VANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATND 484
+ + +H+H IVH D++ N + K+ +F +A D
Sbjct: 117 MLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPD 160
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 50/223 (22%), Positives = 78/223 (34%), Gaps = 63/223 (28%)
Query: 331 STMNLSEHYSIGK--------SVYRAT--IDGKVLAVKKIK-------------EDVTEE 367
N+ ++Y G+ V + G A K IK ED+ E
Sbjct: 5 RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64
Query: 368 LRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTW 427
+ IL+ I H N++ L V + + L+ E G L +L K + +
Sbjct: 65 VSILKEIQHPNVITLHEVYENKT-DVILILELVAGGELFDFLAEKESLTEEEATEFLKQ- 122
Query: 428 SQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKA----KIANFSLA----- 478
+ NG+ Y+H I H D++ NI L R KI +F LA
Sbjct: 123 ---------ILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
Query: 479 --------------AP---ATNDVMPKFDVFAFGVVLLELLSG 504
AP + + D+++ GV+ LLSG
Sbjct: 171 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 37/150 (24%), Positives = 67/150 (44%), Gaps = 31/150 (20%)
Query: 345 VYRA--TIDGKVLAVKKIKEDVTEE------LR---ILQRINHANLVKLMGVSSDSQGNR 393
VY+A T+ + +A+K+I+ + EE +R +L+ + H N+++L V
Sbjct: 50 VYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH-HNHRL 108
Query: 394 FLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIV 453
L++EYAEN L K++ S + + Q + G+ + H +
Sbjct: 109 HLIFEYAEN-DLKKYMD--KNPDVSMRVIKSFLY-QLIN-------GVNFCHSR---RCL 154
Query: 454 HRDIRTNNIQLDSRFKA-----KIANFSLA 478
HRD++ N+ L + KI +F LA
Sbjct: 155 HRDLKPQNLLLSVSDASETPVLKIGDFGLA 184
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 40/225 (17%), Positives = 71/225 (31%), Gaps = 72/225 (32%)
Query: 337 EHYSIGK--------SVYRAT-IDGKVLAVKKIK---------EDVTEELRILQRINHAN 378
YSI K V++ ++ A+K + + E+ L ++ +
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 379 L--VKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALD 436
++L Q ++V E N L+ WL K W
Sbjct: 88 DKIIRLYDYEITDQ-YIYMVMECG-NIDLNSWLKKKKSIDPW---ERKSYWKN------- 135
Query: 437 VANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA---APATNDVM------- 486
+ + +H+H IVH D++ N + K+ +F +A P T V+
Sbjct: 136 MLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGT 191
Query: 487 --------------------------PKFDVFAFGVVLLELLSGK 505
PK DV++ G +L + GK
Sbjct: 192 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 42/225 (18%), Positives = 82/225 (36%), Gaps = 58/225 (25%)
Query: 326 EVIMESTMNLSEHYSIGK---------SVYRAT--IDGKVLAVKKIK---------EDVT 365
+ +S N + Y + V + G+ A K +K ++
Sbjct: 17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEIL 76
Query: 366 EELRILQRINHA-NLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIF 424
E+ +L+ ++ L V ++ L+ EYA G + P+ S VI
Sbjct: 77 HEIAVLELAKSCPRVINLHEVYENTS-EIILILEYAAGGEIFSLCLPELAEMVSENDVIR 135
Query: 425 LTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKA---KIANFSLA--- 478
L ++ + G+ Y+H++ +IVH D++ NI L S + KI +F ++
Sbjct: 136 L-----IK---QILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184
Query: 479 ----------------AP---ATNDVMPKFDVFAFGVVLLELLSG 504
AP + + D++ G++ LL+
Sbjct: 185 GHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 3e-13
Identities = 49/211 (23%), Positives = 85/211 (40%), Gaps = 57/211 (27%)
Query: 338 HYSIGKS--------VYRAT--IDGKVLAVKKI------KEDVTE----ELRILQRINHA 377
HY +G + V + G +AVK + DV E++ L+ H
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 378 NLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDV 437
+++KL V S + + F+V EY G L ++ + +F Q++
Sbjct: 72 HIIKLYQVIS-TPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLF----QQI------ 120
Query: 438 ANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVM----------- 486
+ + Y H H +VHRD++ N+ LD+ AKIA+F L+ ++
Sbjct: 121 LSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYA 177
Query: 487 ------------PKFDVFAFGVVLLELLSGK 505
P+ D+++ GV+L LL G
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 41/225 (18%), Positives = 72/225 (32%), Gaps = 72/225 (32%)
Query: 337 EHYSIGK--------SVYRAT-IDGKVLAVKKI-KEDVTE--------ELRILQRINHAN 378
YSI K V++ ++ A+K + E+ E+ L ++ +
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 379 L--VKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALD 436
++L Q ++V E N L+ WL K W
Sbjct: 116 DKIIRLYDYEITDQ-YIYMVMECG-NIDLNSWLKKKKSIDPW---ERKSYWKN------- 163
Query: 437 VANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA---APATNDVM------- 486
+ + +H+H IVH D++ N + K+ +F +A P T V+
Sbjct: 164 MLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGA 219
Query: 487 --------------------------PKFDVFAFGVVLLELLSGK 505
PK DV++ G +L + GK
Sbjct: 220 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 4e-13
Identities = 36/152 (23%), Positives = 65/152 (42%), Gaps = 26/152 (17%)
Query: 341 IGK----SVYRAT--IDGKVLAVKKI-------KEDVTEELRILQRINHANLVKLMGVSS 387
+G VY+A G + A K I ED E+ IL +H +VKL+G +
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLG-AY 85
Query: 388 DSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEH 447
G +++ E+ G++D + + LT Q V + L ++H
Sbjct: 86 YHDGKLWIMIEFCPGGAVDAIMLELDRG---------LTEPQIQVVCRQMLEALNFLHSK 136
Query: 448 AQPSIVHRDIRTNNIQLDSRFKAKIANFSLAA 479
I+HRD++ N+ + ++A+F ++A
Sbjct: 137 ---RIIHRDLKAGNVLMTLEGDIRLADFGVSA 165
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 5e-13
Identities = 32/204 (15%), Positives = 74/204 (36%), Gaps = 43/204 (21%)
Query: 327 VIMESTMNLSEHYSIGK--------SVYRAT--IDGKVLAVKKI--KEDVTEELRILQRI 374
+ ++ + ++ + V + + A+K + E+ + R
Sbjct: 8 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRA 67
Query: 375 -NHANLVKLMGVSSDSQGNR---FLVYEYAENGSL-DKWLHPKSKS-SSSSGSVIFLTWS 428
++V+++ V + R +V E + G L + ++ + S I +
Sbjct: 68 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS-- 125
Query: 429 QRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKA---KIANFSLAAPATNDV 485
+ +QY+H +I HRD++ N+ S+ K+ +F A +
Sbjct: 126 --------IGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF-AK---ET 170
Query: 486 M-----PKFDVFAFGVVLLELLSG 504
D+++ GV++ LL G
Sbjct: 171 TGEKYDKSCDMWSLGVIMYILLCG 194
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 5e-13
Identities = 40/179 (22%), Positives = 72/179 (40%), Gaps = 33/179 (18%)
Query: 319 KPIVYEIEVIMESTMNLSEHYS----IGK----SVYRA--TIDGKVLAVKKI-------- 360
P+ + + + E ++ IGK V++ KV+A+K I
Sbjct: 4 SPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE 63
Query: 361 KEDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSG 420
ED+ +E+ +L + + + K G S +++ EY GS L P
Sbjct: 64 IEDIQQEITVLSQCDSPYVTKYYG-SYLKDTKLWIIMEYLGGGSALDLLEPGP------- 115
Query: 421 SVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAA 479
L +Q + ++ GL Y+H +HRDI+ N+ L + K+A+F +A
Sbjct: 116 ----LDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAG 167
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 9e-13
Identities = 42/200 (21%), Positives = 83/200 (41%), Gaps = 48/200 (24%)
Query: 341 IGK----SVYRA--TIDGKVLAVKKIKEDVTE--------ELRILQRINHANLVKLMGVS 386
+G V++ G V+A K I ++ EL++L N +V G +
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG-A 99
Query: 387 SDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHE 446
S G + E+ + GSLD+ L + + ++ V GL Y+ E
Sbjct: 100 FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKV----------SIAVIKGLTYLRE 149
Query: 447 HAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDV----------MP--------- 487
+ I+HRD++ +NI ++SR + K+ +F ++ + + M
Sbjct: 150 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHY 207
Query: 488 --KFDVFAFGVVLLELLSGK 505
+ D+++ G+ L+E+ G+
Sbjct: 208 SVQSDIWSMGLSLVEMAVGR 227
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 32/197 (16%), Positives = 66/197 (33%), Gaps = 50/197 (25%)
Query: 345 VYRA--TIDGKVLAVKKIKEDVTE----------ELRILQRINHANLVKLMGVSSDSQGN 392
VY A T+ +++A+K + E ++ E R R+ ++V + G
Sbjct: 50 VYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI-DGQ 108
Query: 393 RFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSI 452
++ L L + L + + + + + L H
Sbjct: 109 LYVDMRLINGVDLAAMLRRQGP----------LAPPRAVAIVRQIGSALDAAHAAG---A 155
Query: 453 VHRDIRTNNIQLDSRFKAKIANFSLAAPA-------TNDVM-----------------PK 488
HRD++ NI + + A + +F +A+ + + +
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYR 215
Query: 489 FDVFAFGVVLLELLSGK 505
D++A VL E L+G
Sbjct: 216 ADIYALTCVLYECLTGS 232
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 32/176 (18%), Positives = 74/176 (42%), Gaps = 33/176 (18%)
Query: 326 EVIMESTMNLSEHYS----IGK----SVYRA--TIDGKVLAVKKIK------EDVTEELR 369
E+ + + + + + +G VY+ G++ A+K + E++ +E+
Sbjct: 13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEIN 72
Query: 370 ILQRI-NHANLVKLMG-----VSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVI 423
+L++ +H N+ G +LV E+ GS+ + ++
Sbjct: 73 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT------- 125
Query: 424 FLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAA 479
L + ++ GL ++H+H ++HRDI+ N+ L + K+ +F ++A
Sbjct: 126 -LKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA 177
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 43/218 (19%), Positives = 76/218 (34%), Gaps = 60/218 (27%)
Query: 332 TMNLSEHYSIGKS-----------VYRAT--IDGKVLAVKKI----KEDVTEELRILQRI 374
+HY + + + AVK I + + +E+ L+
Sbjct: 3 DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLC 62
Query: 375 -NHANLVKLMGVSSDSQGNRFLVYEYAENGSL-DKWLHPKSKSSSSSGSVIFLTWSQRLR 432
H N+VKL V D + FLV E G L ++ K S + + ++
Sbjct: 63 EGHPNIVKLHEVFHDQL-HTFLVMELLNGGELFERIKKKKHFSETEASYIM--------- 112
Query: 433 VALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKA---KIANFSLAA--PATNDVM- 486
+ + + +MH+ +VHRD++ N+ KI +F A P N +
Sbjct: 113 --RKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK 167
Query: 487 --------------------PKFDVFAFGVVLLELLSG 504
D+++ GV+L +LSG
Sbjct: 168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSG 205
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 38/143 (26%), Positives = 74/143 (51%), Gaps = 20/143 (13%)
Query: 344 SVYRAT--IDGKVLAVKKIK-----EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLV 396
SVY+A G+++A+K++ +++ +E+ I+Q+ + ++VK G S + ++V
Sbjct: 44 SVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYG-SYFKNTDLWIV 102
Query: 397 YEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRD 456
EY GS+ + ++K+ LT + + GL+Y+H +HRD
Sbjct: 103 MEYCGAGSVSDIIRLRNKT---------LTEDEIATILQSTLKGLEYLHFM---RKIHRD 150
Query: 457 IRTNNIQLDSRFKAKIANFSLAA 479
I+ NI L++ AK+A+F +A
Sbjct: 151 IKAGNILLNTEGHAKLADFGVAG 173
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 39/172 (22%), Positives = 73/172 (42%), Gaps = 43/172 (25%)
Query: 362 EDVTEELRILQRINHANLVKLMGVSSD-SQGNRFLVYEYAENGSL-DKWLHPKSKSSSSS 419
E V +E+ IL++++H N+VKL+ V D ++ + ++V+E G + +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP------- 133
Query: 420 GSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAA 479
L+ Q D+ G++Y+H I+HRDI+ +N+ + KIA+F ++
Sbjct: 134 -----LSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSN 185
Query: 480 -PATNDVM-------------------------PKFDVFAFGVVLLELLSGK 505
+D + DV+A GV L + G+
Sbjct: 186 EFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 55/256 (21%), Positives = 88/256 (34%), Gaps = 100/256 (39%)
Query: 345 VYRATIDG-------KVLAVKKIKEDVT--------EELRILQRI-NHANLVKLMGVSSD 388
V A G + +AVK +KE T EL+IL I +H N+V L+G +
Sbjct: 38 VIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 97
Query: 389 SQGNRFLVYEYAENGSLDKW-------------------------------LHPKSKSSS 417
G ++ E+ + G+L + L + S +
Sbjct: 98 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSIT 157
Query: 418 SSGSVI-------------------------FLTWSQRLRVALDVANGLQYMHEHAQPSI 452
SS S FLT + + VA G++++ A
Sbjct: 158 SSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKC 214
Query: 453 VHRDIRTNNIQLDSRFKAKIANFSLA---------APATNDVMP---------------- 487
+HRD+ NI L + KI +F LA + +P
Sbjct: 215 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 274
Query: 488 KFDVFAFGVVLLELLS 503
+ DV++FGV+L E+ S
Sbjct: 275 QSDVWSFGVLLWEIFS 290
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 46/204 (22%), Positives = 86/204 (42%), Gaps = 62/204 (30%)
Query: 345 VYRATI--DGKVLAVKKIKEDVTEELR---ILQRINHANLVKLMGV---SSDSQGNRFL- 395
VY+A + G+++A+KK+ +D + R I+++++H N+V+L S + + +L
Sbjct: 70 VYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129
Query: 396 -VYEYAENGSLDKWLHPKSKSSSSSGSVI------FLTWSQRLRVALDVANGLQYMHEHA 448
V +Y + + ++ ++ S + + + Q R L Y+H
Sbjct: 130 LVLDY-----VPETVYRVARHYSRAKQTLPVIYVKLYMY-QLFR-------SLAYIHSF- 175
Query: 449 QPSIVHRDIRTNNIQLDSR-FKAKIANFSLA-------------------APATNDVM-- 486
I HRDI+ N+ LD K+ +F A AP +++
Sbjct: 176 --GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP---ELIFG 230
Query: 487 -----PKFDVFAFGVVLLELLSGK 505
DV++ G VL ELL G+
Sbjct: 231 ATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 4e-12
Identities = 36/168 (21%), Positives = 64/168 (38%), Gaps = 38/168 (22%)
Query: 334 NLSEHYSIGK---------SVYRAT--IDGKVLAVKKI-------KEDVTEELRILQRI- 374
+ Y + + V I + AVK I + V E+ +L +
Sbjct: 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQ 68
Query: 375 NHANLVKLMGVSSDSQGNRFLVYEYAENGSL-DKWLHPKSKSSSSSGSVIFLTWSQRLRV 433
H N+++L+ + +LV+E GS+ +H + + SV+
Sbjct: 69 GHRNVLELIEFFEEED-RFYLVFEKMRGGSILSH-IHKRRHFNELEASVVVQ-------- 118
Query: 434 ALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKA---KIANFSLA 478
DVA+ L ++H I HRD++ NI + + KI +F L
Sbjct: 119 --DVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLG 161
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 66.9 bits (163), Expect = 6e-12
Identities = 29/172 (16%), Positives = 58/172 (33%), Gaps = 33/172 (19%)
Query: 329 MESTMNLSEHYS----IGK------SVYRA--TIDGKVLAVKKIK---------EDVTEE 367
M S + Y IGK +V A G+ + V++I + E
Sbjct: 17 MSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGE 76
Query: 368 LRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTW 427
L + + NH N+V + + ++V + GS + + ++ +
Sbjct: 77 LHVSKLFNHPNIVPYRA-TFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAY--- 132
Query: 428 SQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAA 479
+ V L Y+H VHR ++ ++I + K ++
Sbjct: 133 -----ILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNL 176
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 9e-12
Identities = 44/204 (21%), Positives = 81/204 (39%), Gaps = 63/204 (30%)
Query: 345 VYRATI--DGKVLAVKKIKEDVTEELR---ILQRINHANLVKLMGV--SSDSQGNR---F 394
V++A + +V A+KK+ +D + R I++ + H N+V L S+ + +
Sbjct: 56 VFQAKLVESDEV-AIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114
Query: 395 LVYEYAENGSLDKWLHPKSKSSSSSGSVI------FLTWSQRLRVALDVANGLQYMHEHA 448
LV EY + + ++ S+ + + + Q LR L Y+H
Sbjct: 115 LVLEY-----VPETVYRASRHYAKLKQTMPMLLIKLYMY-QLLR-------SLAYIHSI- 160
Query: 449 QPSIVHRDIRTNNIQLDSR-FKAKIANFSLA-------------------APATNDVM-- 486
I HRDI+ N+ LD K+ +F A AP +++
Sbjct: 161 --GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAP---ELIFG 215
Query: 487 -----PKFDVFAFGVVLLELLSGK 505
D+++ G V+ EL+ G+
Sbjct: 216 ATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 9e-12
Identities = 49/211 (23%), Positives = 84/211 (39%), Gaps = 57/211 (27%)
Query: 338 HYSIGKS--------VYRAT--IDGKVLAVKKI------KEDVTE----ELRILQRINHA 377
HY +G + V + G +AVK + DV E++ L+ H
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 378 NLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDV 437
+++KL V + + F+V EY G L ++ + +F Q +
Sbjct: 77 HIIKLYQV-ISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLF---QQ-------I 125
Query: 438 ANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVM----------- 486
+G+ Y H H +VHRD++ N+ LD+ AKIA+F L+ ++
Sbjct: 126 LSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYA 182
Query: 487 ------------PKFDVFAFGVVLLELLSGK 505
P+ D+++ GV+L LL G
Sbjct: 183 APEVISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 1e-11
Identities = 47/212 (22%), Positives = 78/212 (36%), Gaps = 58/212 (27%)
Query: 337 EHYSIGKS--------VYRAT--IDGKVLAVK--------KIKEDVTEELRILQRINHAN 378
E + + ++ V A + + +AVK E++ +E+ I + +NH N
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 379 LVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVA 438
+VK G ++L EY G L + P F +L
Sbjct: 67 VVKFYGHRR-EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF----HQL------M 115
Query: 439 NGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVMPKF--------- 489
G+ Y+H I HRDI+ N+ LD R KI++F LA + +
Sbjct: 116 AGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 490 -----------------DVFAFGVVLLELLSG 504
DV++ G+VL +L+G
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 46/224 (20%), Positives = 89/224 (39%), Gaps = 62/224 (27%)
Query: 328 IMESTMNLSEHYS----IGKSVY---RATID---GKVLAVKKIK---EDVTE------EL 368
I +ST + + Y IG A D + +A+KK+ ++ T EL
Sbjct: 16 IGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYREL 75
Query: 369 RILQRINHANLVKLMGV-----SSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVI 423
+++ +NH N++ L+ V S + + ++V E + + L + +
Sbjct: 76 VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA---N--LCQVIQMELDHERMS 130
Query: 424 FLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN 483
+L + Q L G++++H I+HRD++ +NI + S KI +F LA A
Sbjct: 131 YLLY-QMLC-------GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179
Query: 484 DVM----------------------PKFDVFAFGVVLLELLSGK 505
M D+++ G ++ E++ G
Sbjct: 180 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 46/220 (20%), Positives = 81/220 (36%), Gaps = 67/220 (30%)
Query: 338 HYSIGKS--------VYRAT--IDGKVLAVKKIK-----------EDVTEELRILQRINH 376
Y +G V AVK +K +V +E+++L+R+ H
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 377 ANLVKLMGV-SSDSQGNRFLVYEYAENGS---LDKWLHPKSKSSSSSGSVIFLTWSQRLR 432
N+++L+ V ++ + ++V EY G LD + + G F +L
Sbjct: 66 KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHG--YF----CQL- 118
Query: 433 VALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAA---PATNDVM--- 486
+GL+Y+H IVH+DI+ N+ L + KI+ +A P D
Sbjct: 119 -----IDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT 170
Query: 487 ---------------------PKFDVFAFGVVLLELLSGK 505
K D+++ GV L + +G
Sbjct: 171 SQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 35/231 (15%), Positives = 64/231 (27%), Gaps = 79/231 (34%)
Query: 345 VYRAT--IDGKVLAVK----------KIKEDVTEELRILQRI------------------ 374
AT G+ V + + EE+ L+ +
Sbjct: 89 YLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 148
Query: 375 -------NHANLVKLMGVSSD-SQGNRFLVYEYAE--NGSLDKWLHPKSKSSSSSGSVIF 424
++++ D +RF +Y + + + L S + S
Sbjct: 149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS------ 202
Query: 425 LTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA--- 481
L RL++ L V L +H + +VH +R +I LD R + F
Sbjct: 203 LVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR 259
Query: 482 -----TNDVMP----------------------KFDVFAFGVVLLELLSGK 505
+ P FD +A G+V+ +
Sbjct: 260 VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 46/223 (20%), Positives = 91/223 (40%), Gaps = 61/223 (27%)
Query: 328 IMESTMNLSEHYS----IGKSVYRA------TIDGKVLAVKKIK---EDVTE------EL 368
+ ++ L + Y +G Y + G+ +A+KK+ + EL
Sbjct: 15 VNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYREL 74
Query: 369 RILQRINHANLVKLMGV-----SSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVI 423
+L+ + H N++ L+ V S + + +LV + + D L S +
Sbjct: 75 LLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT---D--LQKIMGLKFSEEKIQ 129
Query: 424 FLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN 483
+L + Q L+ GL+Y+H +VHRD++ N+ ++ + KI +F LA A
Sbjct: 130 YLVY-QMLK-------GLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178
Query: 484 D--------------VM-------PKFDVFAFGVVLLELLSGK 505
+ V+ D+++ G ++ E+L+GK
Sbjct: 179 EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 51/220 (23%), Positives = 87/220 (39%), Gaps = 58/220 (26%)
Query: 329 MESTMNLSEHYSIGKS--------VYRAT--IDGKVLAVK-----KIKED-----VTEEL 368
M + Y I ++ V AT + +A+K +K+ V E+
Sbjct: 1 MAISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREI 60
Query: 369 RILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWS 428
L+ + H +++KL V + + +V EYA G L ++ K + + G F
Sbjct: 61 SYLKLLRHPHIIKLYDV-ITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFF---Q 115
Query: 429 QRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVM-- 486
Q + ++Y H H IVHRD++ N+ LD KIA+F L+ T+
Sbjct: 116 Q-------IICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLK 165
Query: 487 ---------------------PKFDVFAFGVVLLELLSGK 505
P+ DV++ G+VL +L G+
Sbjct: 166 TSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 40/178 (22%), Positives = 74/178 (41%), Gaps = 41/178 (23%)
Query: 326 EVIMESTMNLSEHYS----IGK----SVYRA--TIDGKVLAVKKIK---EDVTE------ 366
S + + Y IG V A ++ +V+A+KKI ED+ +
Sbjct: 42 MPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR 101
Query: 367 ELRILQRINHANLVKLMGVSSDSQGNRF----LVYEYAENGSLDKWLHP--KSKSSSSSG 420
E+ IL R+NH ++VK++ + +F +V E A+ D ++ +
Sbjct: 102 EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD---SD--FKKLFRTPVYLTEL 156
Query: 421 SVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA 478
+ L + L G++Y+H I+HRD++ N ++ K+ +F LA
Sbjct: 157 HIKTLLY-NLLV-------GVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 47/212 (22%), Positives = 78/212 (36%), Gaps = 58/212 (27%)
Query: 337 EHYSIGKS--------VYRAT--IDGKVLAVK--------KIKEDVTEELRILQRINHAN 378
E + + ++ V A + + +AVK E++ +E+ I + +NH N
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 379 LVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVA 438
+VK G ++L EY G L + P F +L
Sbjct: 67 VVKFYGHRR-EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF----HQL------M 115
Query: 439 NGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVMPKF--------- 489
G+ Y+H I HRDI+ N+ LD R KI++F LA + +
Sbjct: 116 AGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 490 -----------------DVFAFGVVLLELLSG 504
DV++ G+VL +L+G
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 34/153 (22%), Positives = 67/153 (43%), Gaps = 20/153 (13%)
Query: 341 IGK----SVYRATI--DGKVLAVKKI--------KEDVTEELRILQRINHANLVKLMGVS 386
IG V A + +A+K+I +++ +E++ + + +H N+V S
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT-S 81
Query: 387 SDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHE 446
+ +LV + GS+ + K + L S + +V GL+Y+H+
Sbjct: 82 FVVKDELWLVMKLLSGGSVLDII--KHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK 139
Query: 447 HAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAA 479
+ +HRD++ NI L +IA+F ++A
Sbjct: 140 N---GQIHRDVKAGNILLGEDGSVQIADFGVSA 169
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 63.2 bits (153), Expect = 1e-10
Identities = 35/228 (15%), Positives = 63/228 (27%), Gaps = 74/228 (32%)
Query: 345 VYRAT--IDGKVLAVKKIK----------EDVTEELRILQR------------------- 373
AT G+ V + + EE+ L+
Sbjct: 94 YLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 153
Query: 374 ---INHANLVKLMGVSSDSQG----NRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLT 426
+ K++ V D + +RF +Y + +L + SS+ S L
Sbjct: 154 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSSTHKS---LV 209
Query: 427 WSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA----- 481
RL++ L V L +H + +VH +R +I LD R + F
Sbjct: 210 HHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAV 266
Query: 482 ------------------------TNDVMPKFDVFAFGVVLLELLSGK 505
+ FD + G+ + +
Sbjct: 267 SPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 29/203 (14%), Positives = 68/203 (33%), Gaps = 51/203 (25%)
Query: 358 KKIKEDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSS 417
+ + ++R + + N V + S + ++ + +L W++ +
Sbjct: 102 PSPMDAPSVKIRRMDPFSTKNTVGQL-QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160
Query: 418 SSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSL 477
V L + + +A ++++H ++HRD++ +NI K+ +F L
Sbjct: 161 REHGVC-------LHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGL 210
Query: 478 AAPATNDVMP-----------------------------------KFDVFAFGVVLLELL 502
D K D+F+ G++L ELL
Sbjct: 211 VTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270
Query: 503 SGKKATRTTENGKTAVLWKEIRE 525
T+ + ++ ++R
Sbjct: 271 YSFS----TQMERVRII-TDVRN 288
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 44/213 (20%), Positives = 74/213 (34%), Gaps = 55/213 (25%)
Query: 333 MNLSEHYSIGKS--------VYRAT--IDGKVLAVK------KIKEDVTEELRILQRINH 376
M+ S+ Y K + +++AVK I E+V E+ + + H
Sbjct: 16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRH 75
Query: 377 ANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALD 436
N+V+ V + + ++ EYA G L + + + S F Q+L
Sbjct: 76 PNIVRFKEVI-LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFF----QQL----- 125
Query: 437 VANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKA--KIANFSLAAPATNDVM-------- 486
+G+ Y H I HRD++ N LD KI +F + +
Sbjct: 126 -LSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 181
Query: 487 ---------------PKFDVFAFGVVLLELLSG 504
DV++ GV L +L G
Sbjct: 182 AYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 214
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 39/155 (25%), Positives = 67/155 (43%), Gaps = 30/155 (19%)
Query: 341 IGK----SVYRA--TIDGKVLAVKKIK----------EDVTEELRILQRINHANLVKLMG 384
IG +VY A + +V+A+KK+ +D+ +E+R LQ++ H N ++ G
Sbjct: 62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 385 VSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYM 444
+ +LV EY + D K + + AL GL Y+
Sbjct: 122 -CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV-------THGAL---QGLAYL 170
Query: 445 HEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAA 479
H H +++HRD++ NI L K+ +F A+
Sbjct: 171 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSAS 202
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 43/224 (19%), Positives = 88/224 (39%), Gaps = 62/224 (27%)
Query: 328 IMESTMNLSEHYS----IGKSVY------RATIDGKVLAVKKIK---EDVTE------EL 368
+ +ST + + Y IG + + +A+KK+ ++ T EL
Sbjct: 53 VGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYREL 112
Query: 369 RILQRINHANLVKLMGV-----SSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVI 423
+++ +NH N++ L+ V + + + +LV E + + L + +
Sbjct: 113 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA---N--LCQVIQMELDHERMS 167
Query: 424 FLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN 483
+L + Q L G++++H I+HRD++ +NI + S KI +F LA A
Sbjct: 168 YLLY-QMLC-------GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216
Query: 484 DVM----------------------PKFDVFAFGVVLLELLSGK 505
M D+++ G ++ E++ K
Sbjct: 217 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 40/220 (18%), Positives = 78/220 (35%), Gaps = 44/220 (20%)
Query: 318 GKPIVYEIEVIMESTMNLSEHYS----IGK----SVYRA--TIDGKVLAVKKIK---EDV 364
G+ +Y +++ ++Y IG+ VY A K +A+KK+ ED+
Sbjct: 10 GRENLYFQG---IKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDL 66
Query: 365 TE------ELRILQRINHANLVKLMGVSSDSQGNRF----LVYEYAENGSLDKWLHP--K 412
+ E+ IL R+ +++L + +F +V E D L K
Sbjct: 67 IDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEI-----ADSDLKKLFK 121
Query: 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKI 472
+ + + + + L G ++HE I+HRD++ N L+ K+
Sbjct: 122 TPIFLTEEHIKTILY-NLLL-------GENFIHE---SGIIHRDLKPANCLLNQDCSVKV 170
Query: 473 ANFSLAAPATNDVMPKFDVFAFGVVLLELLSGKKATRTTE 512
+F LA ++ + + T
Sbjct: 171 CDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTS 210
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 4e-10
Identities = 47/224 (20%), Positives = 92/224 (41%), Gaps = 62/224 (27%)
Query: 328 IMESTMNLSEHYS----IGKSVY---RATID---GKVLAVKKIK---EDVTE------EL 368
+ ++ + Y +G Y + +D G +A+KK+ + EL
Sbjct: 16 VTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYREL 75
Query: 369 RILQRINHANLVKLMGV-----SSDSQGNRFLVYEYAENGSLDKWLHPKSKSSS-SSGSV 422
R+L+ + H N++ L+ V + D + +LV + D L K +
Sbjct: 76 RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT---D--LGKLMKHEKLGEDRI 130
Query: 423 IFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT 482
FL + Q L+ GL+Y+H I+HRD++ N+ ++ + KI +F LA A
Sbjct: 131 QFLVY-QMLK-------GLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179
Query: 483 ND--------------VM-------PKFDVFAFGVVLLELLSGK 505
++ V+ D+++ G ++ E+++GK
Sbjct: 180 SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 4e-10
Identities = 40/182 (21%), Positives = 79/182 (43%), Gaps = 39/182 (21%)
Query: 326 EVIMESTMNLSEHYS----IGKSVYRA------TIDGKVLAVKKIK--EDVTE------E 367
E++ ++ Y+ IG+ Y ++ +A+KKI E T E
Sbjct: 16 EMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLRE 75
Query: 368 LRILQRINHANLVKLMGVSSDSQGNRF----LVYEYAENGSLDKWLHPKSKSSS-SSGSV 422
++IL R H N++ + + + +V + ++ L+ K+ S+ +
Sbjct: 76 IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDL-----METDLYKLLKTQHLSNDHI 130
Query: 423 IFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT 482
+ + Q LR GL+Y+H +++HRD++ +N+ L++ KI +F LA A
Sbjct: 131 CYFLY-QILR-------GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179
Query: 483 ND 484
D
Sbjct: 180 PD 181
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 61.8 bits (149), Expect = 4e-10
Identities = 76/545 (13%), Positives = 155/545 (28%), Gaps = 144/545 (26%)
Query: 12 FLLMTIHITAQSPAANGTDFSCSADSLPSCKTYVAYFAQSPEFLDLSNISDLFGVSRLS- 70
FL+ I + P+ + D L + + F + VSRL
Sbjct: 93 FLMSPIKTEQRQPSMMTRMYIEQRDRL---------YNDNQVFAKYN-------VSRLQP 136
Query: 71 IARASNLVSEDTPLVPKQLLLVPIICGCTGNQYFANITYQIKK------GDSYYLVSITS 124
+ + E L P + +L+ + G G + A K ++L +
Sbjct: 137 YLKLRQALLE---LRPAKNVLIDGVLGS-GKTWVALDVCLSYKVQCKMDFKIFWL----N 188
Query: 125 FENLTNWHAVLEMNPGINPNLLQIGVKVTFPLFCKCPSKTNMEDGIENLITYVWQPG--- 181
+N + VLEM + L QI T K + L +
Sbjct: 189 LKNCNSPETVLEM---LQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYEN 245
Query: 182 -----DDV---------------------SQVGAKLNASSAA-IETENEYRNFSEAVSLP 214
+V QV L+A++ I ++ +
Sbjct: 246 CLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKS 305
Query: 215 VL-----IPVSQLPSLSQSYPSTKRNGSKHHLTLIIPISAGGALLILLVAALVI------ 263
+L LP + P + ++A +
Sbjct: 306 LLLKYLDCRPQDLPREVLT---------------TNP------RRLSIIAESIRDGLATW 344
Query: 264 --YNHHLQRKRVRILNRNGSSLESADLIPMKENSKSDRFEPKLA---QNKLLP-GVSGYL 317
+ H K I+ + + LE A+ F+ +L+ + +P + +
Sbjct: 345 DNWKHVNCDKLTTIIESSLNVLEPAEY--------RKMFD-RLSVFPPSAHIPTILLSLI 395
Query: 318 -GKPIVYEIEVIMESTMNLSEHYSIGKSVYRATI---DGKVLAVKKIKEDVTEELRILQR 373
I ++ V++ S + K +TI + K++ + I+
Sbjct: 396 WFDVIKSDVMVVVNKLHKYS---LVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDH 452
Query: 374 INHANLVKLMGVSSDSQGN---RFLVY-----EYAENGS------LD-KWLHPKSKSSSS 418
N + + + E+ E + LD ++L K + S+
Sbjct: 453 YNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDST 512
Query: 419 SGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA 478
+ W+ + L+ L++ + + + N I F KI +
Sbjct: 513 A-------WNASGSI-LNTLQQLKFYKPYICDNDPKYERLVNAIL---DFLPKIEENLIC 561
Query: 479 APATN 483
+ T+
Sbjct: 562 SKYTD 566
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.9 bits (126), Expect = 2e-07
Identities = 64/374 (17%), Positives = 112/374 (29%), Gaps = 94/374 (25%)
Query: 287 DLIPMKENSKSDRF-EPKLAQNKLLPGVSGYLGKPIVYEIEVIMESTMNLSEHYSIGKSV 345
+ K+ +F E L N +L PI E + +M + +
Sbjct: 69 WTLLSKQEEMVQKFVEEVLRIN------YKFLMSPIKTEQR---QPSMMTRMYIEQRDRL 119
Query: 346 YRATIDGKVLAVKKIKEDVT-----EELRI-LQRINHANLVKL--MGVSSDSQGNRFLVY 397
Y D +V A K +V+ +LR L + A V + + S G ++
Sbjct: 120 YN---DNQVFA----KYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGS----GKTWVAL 168
Query: 398 EYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDI 457
+ + + + + +L + LQ + P+ R
Sbjct: 169 DVCLSYKVQCKM---------DFKIFWLNLKNCNSPETVLEM-LQKLLYQIDPNWTSRSD 218
Query: 458 RTNNIQLDSR-FKAKIANFSLAAPATN------DVMPK--FDVFAFGV-VLL-------- 499
++NI+L +A++ + P N +V ++ F +LL
Sbjct: 219 HSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVT 278
Query: 500 ELLSGKKATR----------TTENGKT---AVLWKEI----REVLKV---------EEKR 533
+ LS T T + K+ L REVL E R
Sbjct: 279 DFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIR 338
Query: 534 EERLR--NWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAE-VVFNLSVLTQSTE 590
+ NW N + I SL L + + R VF S T
Sbjct: 339 DGLATWDNWKHVNCDKLTTII-ESSLNVL------EPAEYRKMFDRLSVFPPSAHI-PTI 390
Query: 591 TLERSWTSGLEAEE 604
L W ++++
Sbjct: 391 LLSLIWFDVIKSDV 404
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.4 bits (122), Expect = 8e-07
Identities = 68/433 (15%), Positives = 134/433 (30%), Gaps = 112/433 (25%)
Query: 8 LQALFLLMTIHITAQSPAANGTDFSCSA-DSLPSCKTYVAYFAQSPEF----LDLSNISD 62
LQ L + + T++S D S + + S + + +S + L L N+ +
Sbjct: 202 LQKLLYQIDPNWTSRS------DHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQN 255
Query: 63 L-----FGVS-R-LSIARASNLVSEDTPLVPKQLLLVPIICGCTGNQ---YFANIT---- 108
F +S + L R + + + L T ++
Sbjct: 256 AKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRP 315
Query: 109 ----YQIKKGDSYYLVSI--TSFEN----LTNW--------HAVLEMN-PGINPNLLQ-- 147
++ + +SI S + NW ++E + + P +
Sbjct: 316 QDLPREVLTT-NPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKM 374
Query: 148 ---IGVKVTFPLFCKCPSKTNMEDGIENLITYVWQ--PGDDVSQVGAKLNASSAAIETEN 202
+ V FP P+ ++ +W DV V KL+ S +
Sbjct: 375 FDRLSV---FPPSAHIPTIL---------LSLIWFDVIKSDVMVVVNKLHKYSLVEKQPK 422
Query: 203 EYRNFSEAVSLPVLIPVSQLPSLSQSYPSTKRNGSKHHLTLI----IPISAGGALLILLV 258
E +PS+ N H +++ IP + LI
Sbjct: 423 EST--------------ISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPY 468
Query: 259 AALVIYNH---HLQRKRVRILNRNGSSLESADLIPMKENSKSD-RF-EPKLAQNKLLPGV 313
Y+H HL ++E + + + D RF E K+ +
Sbjct: 469 LDQYFYSHIGHHL------------KNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNA 516
Query: 314 SGYLG---------KPIVYEIEVIMESTMNLSEHY--SIGKSVYRATIDGKV-LAVKKIK 361
SG + KP + + + E +N + I +++ + + +A+
Sbjct: 517 SGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMAED 576
Query: 362 EDVTEE-LRILQR 373
E + EE + +QR
Sbjct: 577 EAIFEEAHKQVQR 589
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 7e-10
Identities = 33/221 (14%), Positives = 77/221 (34%), Gaps = 56/221 (25%)
Query: 327 VIMESTMNLSEHYSIGK--------SVYRAT--IDGKVLAVKKI--KEDVTEELRILQRI 374
+ ++ + ++ + V + + A+K + E+ + R
Sbjct: 52 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRA 111
Query: 375 -NHANLVKLMGVSSDSQGNR---FLVYEYAENGSL-DKWLHPKSKS-SSSSGSVIFLTWS 428
++V+++ V + R +V E + G L + ++ + S I +
Sbjct: 112 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS-- 169
Query: 429 QRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKA---KIANFSLAAPAT-ND 484
+ +QY+H +I HRD++ N+ S+ K+ +F A T ++
Sbjct: 170 --------IGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218
Query: 485 VM---------------------PKFDVFAFGVVLLELLSG 504
+ D+++ GV++ LL G
Sbjct: 219 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 7e-10
Identities = 33/208 (15%), Positives = 73/208 (35%), Gaps = 64/208 (30%)
Query: 345 VYRATI--DGKVLAVKKIKEDVT------EELRILQRINHANLVKLMGVSSDSQGNRF-- 394
V G +A+KK+ +D + ++ L ++H N+V+L
Sbjct: 39 VQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD 98
Query: 395 ----LVYEYAENGSLDKWLHPKSKSSSSSGSVI------FLTWSQRLRVALDVANGLQYM 444
+V EY + LH ++ + Q +R + +
Sbjct: 99 IYLNVVMEY-----VPDTLHRCCRNYYRRQVAPPPILIKVFLF-QLIR-------SIGCL 145
Query: 445 HEHAQPSIVHRDIRTNNIQLD-SRFKAKIANFSLA-------------------APATND 484
H + ++ HRDI+ +N+ ++ + K+ +F A AP +
Sbjct: 146 HLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAP---E 201
Query: 485 VM-------PKFDVFAFGVVLLELLSGK 505
++ D+++ G + E++ G+
Sbjct: 202 LIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 9e-10
Identities = 51/229 (22%), Positives = 95/229 (41%), Gaps = 62/229 (27%)
Query: 323 YEIEVIMESTMNLSEHYS----IGKSVY------RATIDGKVLAVKKIK---EDVTE--- 366
+ + + ++ + E Y +G Y T G +AVKK+ + +
Sbjct: 15 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 74
Query: 367 ---ELRILQRINHANLVKLMGV-----SSDSQGNRFLVYEYAENGSLDKWLHPKSKSSS- 417
ELR+L+ + H N++ L+ V S + + +LV D L+ K
Sbjct: 75 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA---D--LNNIVKCQKL 129
Query: 418 SSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSL 477
+ V FL + Q LR GL+Y+H I+HRD++ +N+ ++ + KI +F L
Sbjct: 130 TDDHVQFLIY-QILR-------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGL 178
Query: 478 AAPATND--------------VM-------PKFDVFAFGVVLLELLSGK 505
A ++ +M D+++ G ++ ELL+G+
Sbjct: 179 ARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 37/221 (16%), Positives = 79/221 (35%), Gaps = 63/221 (28%)
Query: 334 NLSEHYSIGK--------SVYRAT--IDGKVLAVKKI-KEDVTE------------ELRI 370
L Y +G SVY D +A+K + K+ +++ E+ +
Sbjct: 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVL 99
Query: 371 LQRINHA--NLVKLMGVSSDSQGNRFLVYEYAEN-GSLDKWLHPKSKSSSSSGSVIFLTW 427
L++++ +++L+ + + L+ E E L ++ + F
Sbjct: 100 LKKVSSGFSGVIRLLDWF-ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF--- 155
Query: 428 SQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDS-RFKAKIANFSLAAPATNDVM 486
Q V +++ H ++HRDI+ NI +D R + K+ +F A + V
Sbjct: 156 WQ-------VLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 205
Query: 487 ----------------------PKFDVFAFGVVLLELLSGK 505
V++ G++L +++ G
Sbjct: 206 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 48/208 (23%), Positives = 84/208 (40%), Gaps = 54/208 (25%)
Query: 341 IGK----SVYRA--TIDGKVLAVKKIKEDVTE--------ELRILQR-INHANLVKLMGV 385
IG+ SV + G+++AVK+I+ V E +L ++ R + +V+ G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG- 88
Query: 386 SSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMH 445
+ +G+ ++ E + S DK+ L ++ L L ++
Sbjct: 89 ALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILG-----KITLATVKALNHLK 142
Query: 446 EHAQPSIVHRDIRTNNIQLDSRFKAKIANF--------SLAAPATNDV-----M-P---- 487
E I+HRDI+ +NI LD K+ +F S+A T D M P
Sbjct: 143 E--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA--KTRDAGCRPYMAPERID 198
Query: 488 ----------KFDVFAFGVVLLELLSGK 505
+ DV++ G+ L EL +G+
Sbjct: 199 PSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 42/211 (19%), Positives = 88/211 (41%), Gaps = 61/211 (28%)
Query: 341 IGK----SVYRA--TIDGKVLAVKKIKEDVTE--------ELRILQR-INHANLVKLMGV 385
+G+ V + G+++AVK+I+ V +L I R ++ V G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG- 73
Query: 386 SSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVI---FLTWSQRLRVALDVANGLQ 442
+ +G+ ++ E + SLDK+ K G I L ++A+ + L+
Sbjct: 74 ALFREGDVWICMELM-DTSLDKFY----KQVIDKGQTIPEDILG-----KIAVSIVKALE 123
Query: 443 YMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANF--------SLA-----------AP--- 480
++H + S++HRD++ +N+ +++ + K+ +F +A AP
Sbjct: 124 HLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERI 181
Query: 481 ------ATNDVMPKFDVFAFGVVLLELLSGK 505
V K D+++ G+ ++EL +
Sbjct: 182 NPELNQKGYSV--KSDIWSLGITMIELAILR 210
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 4e-09
Identities = 40/235 (17%), Positives = 74/235 (31%), Gaps = 73/235 (31%)
Query: 328 IMESTMNLSEHYS----IGK----SVYRAT-IDGKVLAVKKIKEDVTE------------ 366
++ + Y+ I +V +G +A+K++ V++
Sbjct: 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFL 72
Query: 367 ------ELRILQRINHANLVKLMGVSSDSQGNRF----LVYEYAENGSLDKWLHPKSKSS 416
E+R+L +H N++ L + + LV E D L
Sbjct: 73 CKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT---D--LAQVIHDQ 127
Query: 417 SSSGS---VIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIA 473
S + + + L GL +HE +VHRD+ NI L I
Sbjct: 128 RIVISPQHIQYFMY-HILL-------GLHVLHE---AGVVHRDLHPGNILLADNNDITIC 176
Query: 474 NFSLA-APATNDVM----------------------PKFDVFAFGVVLLELLSGK 505
+F+LA + D+++ G V+ E+ + K
Sbjct: 177 DFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 40/218 (18%), Positives = 74/218 (33%), Gaps = 65/218 (29%)
Query: 338 HYSIGK--------SVYRAT--IDGKVLAVKKI-KEDVTE------------ELRILQRI 374
Y +G +V+ D +A+K I + V E+ +L ++
Sbjct: 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 375 N----HANLVKLMGVSSDSQGNRFLVYEYAENGS-LDKWLHPKSKSSSSSGSVIFLTWSQ 429
H +++L+ ++Q LV E L ++ K F Q
Sbjct: 92 GAGGGHPGVIRLLDWF-ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFF---GQ 147
Query: 430 RLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDS-RFKAKIANFSLAAPATNDVM-- 486
V +Q+ H +VHRDI+ NI +D R AK+ +F A ++
Sbjct: 148 -------VVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD 197
Query: 487 --------------------PKFDVFAFGVVLLELLSG 504
V++ G++L +++ G
Sbjct: 198 FDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 1e-08
Identities = 27/143 (18%), Positives = 59/143 (41%), Gaps = 25/143 (17%)
Query: 345 VYRA--TIDGKVLAVKKIKEDVTE----ELRILQRI-NHANLVKLMGV-SSDSQGNRFLV 396
V+ A + + + VK +K + E++IL+ + N++ L + LV
Sbjct: 52 VFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111
Query: 397 YEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRD 456
+E+ N + + + F + + L+ L Y H I+HRD
Sbjct: 112 FEHVNNTDFKQLYQTLTDYD-----IRFYMY-EILK-------ALDYCHSM---GIMHRD 155
Query: 457 IRTNNIQLDSRFKA-KIANFSLA 478
++ +N+ +D + ++ ++ LA
Sbjct: 156 VKPHNVMIDHEHRKLRLIDWGLA 178
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 37/209 (17%), Positives = 80/209 (38%), Gaps = 59/209 (28%)
Query: 341 IGK----SVYRA--TIDGKVLAVKKIKEDVTE--------ELRILQR-INHANLVKLMGV 385
+G V++ G V+AVK+++ + +L ++ + + +V+ G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG- 91
Query: 386 SSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMH 445
+ + + F+ E +K + ++ + + L Y+
Sbjct: 92 TFITNTDVFIAMELM-GTCAEKLKKRMQGP---------IPERILGKMTVAIVKALYYLK 141
Query: 446 EHAQPSIVHRDIRTNNIQLDSRFKAKIANF--------SLA-----------AP------ 480
E + ++HRD++ +NI LD R + K+ +F A AP
Sbjct: 142 E--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPP 199
Query: 481 ----ATNDVMPKFDVFAFGVVLLELLSGK 505
D+ + DV++ G+ L+EL +G+
Sbjct: 200 DPTKPDYDI--RADVWSLGISLVELATGQ 226
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 2e-08
Identities = 34/168 (20%), Positives = 72/168 (42%), Gaps = 39/168 (23%)
Query: 334 NLSEHYS----IGK----SVYRA--TIDGKVLAVKKIK--EDVTE------ELRILQRIN 375
N+S + +G+ V A G+++A+KKI+ + E++IL+
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFK 67
Query: 376 HANLVKLMGVSSDSQGNRF----LVYEYAENGSLDKWLHPKSKSSS-SSGSVIFLTWSQR 430
H N++ + + F ++ E + D LH + S + + + Q
Sbjct: 68 HENIITIFNIQRPDSFENFNEVYIIQELMQT---D--LHRVISTQMLSDDHIQYFIY-QT 121
Query: 431 LRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA 478
LR ++ +H +++HRD++ +N+ ++S K+ +F LA
Sbjct: 122 LR-------AVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLA 159
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 2e-07
Identities = 38/151 (25%), Positives = 62/151 (41%), Gaps = 27/151 (17%)
Query: 340 SIGKSVYRAT--IDGKVLAVKKIK----------EDVTEELRILQRINHANLVKLMGVSS 387
S V A + A+K ++ VT E ++ R++H VKL
Sbjct: 42 SFST-VVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 100
Query: 388 DSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEH 447
D + + YA+NG L K++ K S F R A ++ + L+Y+H
Sbjct: 101 DDE-KLYFGLSYAKNGELLKYIR-KIGS--------FDETCTRFYTA-EIVSALEYLHGK 149
Query: 448 AQPSIVHRDIRTNNIQLDSRFKAKIANFSLA 478
I+HRD++ NI L+ +I +F A
Sbjct: 150 ---GIIHRDLKPENILLNEDMHIQITDFGTA 177
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 40/192 (20%), Positives = 75/192 (39%), Gaps = 46/192 (23%)
Query: 346 YRATIDGKVLAVKKIKEDV----------TEELRILQRINHANLVKLMGVSSDSQGNRFL 395
RAT GK+ A KK+++ E +IL+++N +V L + +++ L
Sbjct: 205 VRAT--GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY-AYETKDALCL 261
Query: 396 VYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHR 455
V G L ++ ++ +F A ++ GL+ +H IV+R
Sbjct: 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFY--------AAEICCGLEDLHRE---RIVYR 310
Query: 456 DIRTNNIQLDSRFKAKIANFSLAAPATNDVM-------PKF---------------DVFA 493
D++ NI LD +I++ LA + D +A
Sbjct: 311 DLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWA 370
Query: 494 FGVVLLELLSGK 505
G +L E+++G+
Sbjct: 371 LGCLLYEMIAGQ 382
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 34/138 (24%), Positives = 60/138 (43%), Gaps = 24/138 (17%)
Query: 351 DGKVLAVKKIK----------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYA 400
K+ A+K + +V +EL+I+Q + H LV L S + + F+V +
Sbjct: 39 TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY-SFQDEEDMFMVVDLL 97
Query: 401 ENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTN 460
G L L +V F + +L + ++ L Y+ I+HRD++ +
Sbjct: 98 LGGDLRYHL---------QQNVHFKEETVKLFIC-ELVMALDYLQNQ---RIIHRDMKPD 144
Query: 461 NIQLDSRFKAKIANFSLA 478
NI LD I +F++A
Sbjct: 145 NILLDEHGHVHITDFNIA 162
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 37/194 (19%), Positives = 76/194 (39%), Gaps = 47/194 (24%)
Query: 346 YRATIDGKVLAVKKIKEDV----------TEELRILQRINHANLVKLMGVSSDSQGNRFL 395
+AT GK+ A KK+ + E +IL +++ +V L + +++ + L
Sbjct: 206 MKAT--GKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY-AFETKTDLCL 262
Query: 396 VYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRV-ALDVANGLQYMHEHAQPSIVH 454
V G + ++ + + F R + +GL+++H+ +I++
Sbjct: 263 VMTIMNGGDIRYHIYNVDEDNP-----GFQE--PRAIFYTAQIVSGLEHLHQR---NIIY 312
Query: 455 RDIRTNNIQLDSRFKAKIANFSLA--APATNDVMPKF---------------------DV 491
RD++ N+ LD +I++ LA A + D
Sbjct: 313 RDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDY 372
Query: 492 FAFGVVLLELLSGK 505
FA GV L E+++ +
Sbjct: 373 FALGVTLYEMIAAR 386
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 41/171 (23%), Positives = 84/171 (49%), Gaps = 38/171 (22%)
Query: 330 ESTMNLSEHYS----IGK----SVYRA--TIDGKVLAVKKIK---EDVTE------ELRI 370
++ Y +GK V+++ G+V+AVKKI ++ T+ E+ I
Sbjct: 2 RVDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMI 61
Query: 371 LQRIN-HANLVKLMGV-SSDSQGNRFLVYEYAENGSLDKWLHPKSKSSS-SSGSVIFLTW 427
L ++ H N+V L+ V +D+ + +LV++Y E D LH +++ ++ +
Sbjct: 62 LTELSGHENIVNLLNVLRADNDRDVYLVFDYMET---D--LHAVIRANILEPVHKQYVVY 116
Query: 428 SQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA 478
Q ++ ++Y+H ++HRD++ +NI L++ K+A+F L+
Sbjct: 117 -QLIK-------VIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLS 156
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 36/193 (18%), Positives = 61/193 (31%), Gaps = 52/193 (26%)
Query: 351 DGKVLAVKKIKEDVT----------EELRILQRINHANLVKLMGVSSDSQGNRFLVYEYA 400
KV A+K + + EE +L + + L + N +LV +Y
Sbjct: 98 ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY-AFQDDNNLYLVMDYY 156
Query: 401 ENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTN 460
G L L S R +A ++ + +H+ VHRDI+ +
Sbjct: 157 VGGDLLTLL--------SKFEDRLPEEMARFYLA-EMVIAIDSVHQL---HYVHRDIKPD 204
Query: 461 NIQLDSRFKAKIANFSLAAPATNDVMPKFDVF---------------------------- 492
NI +D ++A+F D + V
Sbjct: 205 NILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDW 264
Query: 493 -AFGVVLLELLSG 504
+ GV + E+L G
Sbjct: 265 WSLGVCMYEMLYG 277
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 4e-06
Identities = 40/177 (22%), Positives = 69/177 (38%), Gaps = 48/177 (27%)
Query: 334 NLSEHYS----IGK----SVYRA--TIDGKVLAVKKIK-EDVTE------ELRILQRINH 376
+L Y +G V+ A K +A+KKI D E++I++R++H
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDH 67
Query: 377 ANLVKLMGV---------SSDSQGNRF----LVYEYAENGSLDKWLHPKSKSSS-SSGSV 422
N+VK+ + +V EY E D L +
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET---D--LANVLEQGPLLEEHA 122
Query: 423 IFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRF-KAKIANFSLA 478
+ Q LR GL+Y+H +++HRD++ N+ +++ KI +F LA
Sbjct: 123 RLFMY-QLLR-------GLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLA 168
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 38/220 (17%), Positives = 73/220 (33%), Gaps = 62/220 (28%)
Query: 345 VYRA--TIDGKVLAVKKIKEDVTE---ELRILQRINHANLVKLMGV-----SSDSQGNRF 394
V GK A+KK+ +D EL I++ ++H N++KL+ + + +
Sbjct: 23 VCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQP 82
Query: 395 LVYEYAENGSLDKWLHPKSKSSSSSGSVIFL---------TWSQRLRVALDVAN------ 439
G + + + +L T + L+ +
Sbjct: 83 PDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNL 142
Query: 440 ----------GLQYMHEHAQPSIVHRDIRTNNIQLDSR-FKAKIANFSLAAPATND---- 484
+ ++H I HRDI+ N+ ++S+ K+ +F A
Sbjct: 143 ISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSV 199
Query: 485 ------------VM-------PKFDVFAFGVVLLELLSGK 505
+M P D+++ G V EL+ GK
Sbjct: 200 AYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 6e-06
Identities = 36/138 (26%), Positives = 57/138 (41%), Gaps = 23/138 (16%)
Query: 351 DGKVLAVKKIKEDVT----------EELRILQRINHANLVKLMGVSSDSQGNRFLVYEYA 400
G+ A+K +K++V E R+LQ H L L S + V EYA
Sbjct: 172 TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY-SFQTHDRLCFVMEYA 230
Query: 401 ENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTN 460
G L L + F R A ++ + L Y+H ++ ++V+RD++
Sbjct: 231 NGGELFFHLSRERV---------FSEDRARFYGA-EIVSALDYLH--SEKNVVYRDLKLE 278
Query: 461 NIQLDSRFKAKIANFSLA 478
N+ LD KI +F L
Sbjct: 279 NLMLDKDGHIKITDFGLC 296
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 9e-06
Identities = 41/226 (18%), Positives = 73/226 (32%), Gaps = 51/226 (22%)
Query: 353 KVLAVKKIKEDVTEEL-----RILQRINHAN---LVKLMGVSSDSQGNRFLVYEYAENGS 404
K L K+IK E L +L ++ + +V + + + + + G
Sbjct: 220 KCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY-AFHTPDKLSFILDLMNGGD 278
Query: 405 LDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQL 464
L H S + F A ++ GL++MH +V+RD++ NI L
Sbjct: 279 L--HYHLSQHGVFSEADMRFY--------AAEIILGLEHMHNR---FVVYRDLKPANILL 325
Query: 465 DSRFKAKIANFSLAAPATNDVMPKF----------------------DVFAFGVVLLELL 502
D +I++ LA + D F+ G +L +LL
Sbjct: 326 DEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385
Query: 503 SGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESF 548
G R + + + + L + P L S
Sbjct: 386 RGHSPFRQHKTKDKHEIDRMTLTM-------AVELPDSFSPELRSL 424
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 28/145 (19%), Positives = 45/145 (31%), Gaps = 41/145 (28%)
Query: 352 GKVLAVKKIK----------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAE 401
KV A+K + EE I+ N +V+L + ++V EY
Sbjct: 94 RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY-AFQDDRYLYMVMEYMP 152
Query: 402 NGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVAN--------GLQYMHEHAQPSIV 453
G L + V A L +H +
Sbjct: 153 GGDL-------------------VNLMSNYDVPEKWARFYTAEVVLALDAIHSM---GFI 190
Query: 454 HRDIRTNNIQLDSRFKAKIANFSLA 478
HRD++ +N+ LD K+A+F
Sbjct: 191 HRDVKPDNMLLDKSGHLKLADFGTC 215
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 46.8 bits (110), Expect = 1e-05
Identities = 22/182 (12%), Positives = 43/182 (23%), Gaps = 66/182 (36%)
Query: 345 VYRATIDGKVLAVKKI---------------KEDVTEELRILQRI---------NHANLV 380
V++ D +A+K I E++ E+ I + + +
Sbjct: 36 VFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95
Query: 381 KLMGV-----------------------------SSDSQGNRFLVYEYAENGSLDKWLHP 411
L V F+V E+ G + +
Sbjct: 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT 155
Query: 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAK 471
K + + + + L HRD+ N+ L K
Sbjct: 156 K-----------LSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVLLKKTSLKK 202
Query: 472 IA 473
+
Sbjct: 203 LH 204
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 33/138 (23%), Positives = 58/138 (42%), Gaps = 24/138 (17%)
Query: 351 DGKVLAVKKI-KEDVTE---------ELRILQRINHANLVKLMGVSSDSQGNRFLVYEYA 400
G A+K + K+ V + E RILQ +N LVKL D+ N ++V EY
Sbjct: 65 SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS-NLYMVMEYV 123
Query: 401 ENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTN 460
G + + H + S F A + +Y+H +++RD++
Sbjct: 124 AGGEM--FSHLRRIGRFSEPHARF--------YAAQIVLTFEYLHSL---DLIYRDLKPE 170
Query: 461 NIQLDSRFKAKIANFSLA 478
N+ +D + ++ +F A
Sbjct: 171 NLLIDQQGYIQVTDFGFA 188
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 4e-05
Identities = 34/152 (22%), Positives = 57/152 (37%), Gaps = 23/152 (15%)
Query: 351 DGKVLAVKKIKEDVT----------EELRILQRINHANLVKLMGVSSDSQGNRFLVYEYA 400
G+V A+K + + EE +L + + +L + + +LV EY
Sbjct: 85 TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF-AFQDENYLYLVMEYY 143
Query: 401 ENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTN 460
G L L S G I + R +A ++ + +H VHRDI+ +
Sbjct: 144 VGGDLLTLL-------SKFGERIPAEMA-RFYLA-EIVMAIDSVHRL---GYVHRDIKPD 191
Query: 461 NIQLDSRFKAKIANFSLAAPATNDVMPKFDVF 492
NI LD ++A+F D + V
Sbjct: 192 NILLDRCGHIRLADFGSCLKLRADGTVRSLVA 223
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 33/138 (23%), Positives = 55/138 (39%), Gaps = 25/138 (18%)
Query: 352 GKVLAVKKIKEDV----------TEELRILQRIN-HANLVKLMGVSSDSQGNRFLVYEYA 400
++ AVK +K+DV E R+L L +L + + V EY
Sbjct: 366 DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHS-CFQTMDRLYFVMEYV 424
Query: 401 ENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTN 460
G L H + +F A ++A GL ++ I++RD++ +
Sbjct: 425 NGGDL--MYHIQQVGRFKEPHAVFY--------AAEIAIGLFFLQSK---GIIYRDLKLD 471
Query: 461 NIQLDSRFKAKIANFSLA 478
N+ LDS KIA+F +
Sbjct: 472 NVMLDSEGHIKIADFGMC 489
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 34/138 (24%), Positives = 54/138 (39%), Gaps = 24/138 (17%)
Query: 351 DGKVLAVKKI-KEDVTE---------ELRILQRINHANLVKLMGVSSDSQGNRFLVYEYA 400
G+ A+K + KE + E R+LQ H L L + + V EYA
Sbjct: 29 TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY-AFQTHDRLCFVMEYA 87
Query: 401 ENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTN 460
G L + H + + F ++ + L+Y+H +V+RDI+
Sbjct: 88 NGGEL--FFHLSRERVFTEERARFY--------GAEIVSALEYLHSR---DVVYRDIKLE 134
Query: 461 NIQLDSRFKAKIANFSLA 478
N+ LD KI +F L
Sbjct: 135 NLMLDKDGHIKITDFGLC 152
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 42.5 bits (101), Expect = 2e-04
Identities = 36/138 (26%), Positives = 59/138 (42%), Gaps = 24/138 (17%)
Query: 351 DGKVLAVKKI-KEDVTE---------ELRILQRINHANLVKLMGVSSDSQGNRFLVYEYA 400
+G+ A+K + KE V E +L + H ++++ G D+Q F++ +Y
Sbjct: 30 NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ-QIFMIMDYI 88
Query: 401 ENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTN 460
E G L L S F + A +V L+Y+H I++RD++
Sbjct: 89 EGGELFSLL---------RKSQRFPNPVAKFYAA-EVCLALEYLHSK---DIIYRDLKPE 135
Query: 461 NIQLDSRFKAKIANFSLA 478
NI LD KI +F A
Sbjct: 136 NILLDKNGHIKITDFGFA 153
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 615 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.98 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.98 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.98 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.98 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.98 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.98 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.98 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.98 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.98 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.98 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.98 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.98 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.98 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.98 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.98 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.98 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.98 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.98 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.98 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.98 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.98 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.98 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.98 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.98 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.98 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.98 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.98 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.98 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.98 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.98 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.98 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.98 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.98 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.98 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.98 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.98 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.98 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.97 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.97 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.97 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.97 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.97 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.97 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.97 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.97 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.97 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.97 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.97 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.97 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.97 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.97 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.97 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.97 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.97 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.97 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.97 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.97 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.97 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.97 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.97 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.97 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.97 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.97 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.97 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.97 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.97 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.97 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.97 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.97 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.97 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.97 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.97 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.97 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.97 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.97 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.97 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.97 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.97 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.97 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.97 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.97 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.97 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.97 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.97 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.97 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.97 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.97 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.97 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.97 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.97 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.97 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.97 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.97 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.97 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.97 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.97 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.97 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.97 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.97 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.97 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.97 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.97 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.97 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.96 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.96 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.96 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.96 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.96 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.96 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.95 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.95 | |
| 4eby_A | 212 | Chitin elicitor receptor kinase 1; pathogen-associ | 99.95 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.89 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.79 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.73 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.6 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.27 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.94 | |
| 4eby_A | 212 | Chitin elicitor receptor kinase 1; pathogen-associ | 98.85 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.75 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.71 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.28 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.02 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.98 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.98 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.83 | |
| 2l9y_A | 167 | CVNH-LYSM lectin; carbohydrate, sugar binding prot | 97.47 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.46 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.45 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.15 | |
| 2l9y_A | 167 | CVNH-LYSM lectin; carbohydrate, sugar binding prot | 97.03 | |
| 1e0g_A | 48 | Membrane-bound lytic murein transglycosylase D; ce | 96.87 | |
| 2djp_A | 77 | Hypothetical protein SB145; LYSM, structural genom | 96.86 | |
| 2djp_A | 77 | Hypothetical protein SB145; LYSM, structural genom | 96.75 | |
| 1e0g_A | 48 | Membrane-bound lytic murein transglycosylase D; ce | 96.72 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 95.99 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 95.97 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 95.81 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 95.72 | |
| 2gu1_A | 361 | Zinc peptidase; alpha/beta, beta barrel, structura | 95.49 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 94.59 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 94.5 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 94.5 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 94.41 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 94.3 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 94.19 | |
| 2gu1_A | 361 | Zinc peptidase; alpha/beta, beta barrel, structura | 94.08 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 93.67 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 93.21 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 93.19 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 93.1 | |
| 4a1k_A | 165 | Putative L, D-transpeptidase YKUD; transferase, pe | 92.29 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 90.89 | |
| 4a1k_A | 165 | Putative L, D-transpeptidase YKUD; transferase, pe | 90.86 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 90.46 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.2 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 86.49 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 83.48 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=388.44 Aligned_cols=232 Identities=23% Similarity=0.375 Sum_probs=182.5
Q ss_pred HHHccccccccccc--ceEEEEEE-------CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCC
Q 047629 329 MESTMNLSEHYSIG--KSVYRATI-------DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQG 391 (615)
Q Consensus 329 ~~at~~~~~~~~iG--~~Vy~~~~-------~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 391 (615)
..++..|.+..+-| |.||+|.+ +++.||||+++ ++|.+|+.+|++++|||||+++|+|.+. +
T Consensus 24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~-~ 102 (308)
T 4gt4_A 24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD-Q 102 (308)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-S
T ss_pred CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC-C
Confidence 33455666666666 69999997 35789999985 4689999999999999999999999754 4
Q ss_pred cEEEEEeecCCCCHHHhhccCCCCCCC------CCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeC
Q 047629 392 NRFLVYEYAENGSLDKWLHPKSKSSSS------SGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLD 465 (615)
Q Consensus 392 ~~~lV~E~~~~GsL~~~L~~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld 465 (615)
..+||||||++|+|.++|+........ ......|+|.++++|+.|||.||+|||+++ ||||||||+||||+
T Consensus 103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVY 179 (308)
T ss_dssp SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEEC
Confidence 789999999999999999764321100 001134999999999999999999999998 99999999999999
Q ss_pred CCCcEEEeecCCCCCCC-------------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHH
Q 047629 466 SRFKAKIANFSLAAPAT-------------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVL 519 (615)
Q Consensus 466 ~~~~~kl~DFGla~~~~-------------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l 519 (615)
+++.+||+|||+|+... ..++.++|||||||+||||+| |+.||......+ +
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---~ 256 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---V 256 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---H
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---H
Confidence 99999999999987431 125678999999999999999 899997644211 1
Q ss_pred HHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 047629 520 WKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVL 585 (615)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l 585 (615)
. . .+.. ......|.+++..+.+|+.+||+.||++||||+||++.|+..
T Consensus 257 ~----~----------~i~~----~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 257 V----E----------MIRN----RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp H----H----------HHHT----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred H----H----------HHHc----CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1 0 1111 111123556667789999999999999999999999999754
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=378.73 Aligned_cols=216 Identities=27% Similarity=0.461 Sum_probs=175.9
Q ss_pred ceEEEEEECCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATIDGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
|.||+|.+.+ .||||+++ +.|.+|+++|++++|||||+++|+|.+ +.++||||||++|+|.++|+...
T Consensus 50 G~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~--~~~~iVmEy~~gGsL~~~l~~~~ 126 (307)
T 3omv_A 50 GTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK--DNLAIVTQWCEGSSLYKHLHVQE 126 (307)
T ss_dssp SEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSCEEEEECCSSCBHHHHHHTSC
T ss_pred cEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC--CeEEEEEEcCCCCCHHHHHhhcC
Confidence 5899999866 48999985 358899999999999999999999853 46899999999999999997654
Q ss_pred CCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----------
Q 047629 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----------- 482 (615)
Q Consensus 414 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----------- 482 (615)
. .++|.+++.|+.|||.||+|||+++ ||||||||+||||++++.+||+|||+|+...
T Consensus 127 ~---------~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~ 194 (307)
T 3omv_A 127 T---------KFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQP 194 (307)
T ss_dssp C---------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC------------C
T ss_pred C---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeeccc
Confidence 3 3999999999999999999999987 9999999999999999999999999996431
Q ss_pred -----------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcC
Q 047629 483 -----------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNL 545 (615)
Q Consensus 483 -----------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l 545 (615)
..++.|+|||||||+||||+||+.||......... ... .......|.+
T Consensus 195 ~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~------~~~---------~~~~~~~p~~ 259 (307)
T 3omv_A 195 TGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQI------IFM---------VGRGYASPDL 259 (307)
T ss_dssp CCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH------HHH---------HHTTCCCCCS
T ss_pred ccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHH------HHH---------HhcCCCCCCc
Confidence 11456899999999999999999999764432111 100 1122233433
Q ss_pred CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccch
Q 047629 546 ESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQST 589 (615)
Q Consensus 546 ~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~ 589 (615)
. ..+.+++..+.+|+.+||+.||++||||.||++.|+.+..+.
T Consensus 260 ~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 260 S-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp T-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred c-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 2 334456667899999999999999999999999998876553
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=382.91 Aligned_cols=222 Identities=26% Similarity=0.404 Sum_probs=173.7
Q ss_pred ceEEEEEE-------CCeEEEEEEcc-------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHh
Q 047629 343 KSVYRATI-------DGKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKW 408 (615)
Q Consensus 343 ~~Vy~~~~-------~g~~vAvK~~~-------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~ 408 (615)
|.||+|.+ +|+.||||+++ ++|.+|+++|++++|||||+++|+|.+. +..+||||||++|+|.++
T Consensus 55 G~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~-~~~~lV~Ey~~~G~L~~~ 133 (329)
T 4aoj_A 55 GKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEG-RPLLMVFEYMRHGDLNRF 133 (329)
T ss_dssp EEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-SSEEEEEECCTTCBHHHH
T ss_pred cEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEEEcCCCCcHHHH
Confidence 58999986 36889999986 4588999999999999999999999764 479999999999999999
Q ss_pred hccCCCCCCC-----CCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-
Q 047629 409 LHPKSKSSSS-----SGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT- 482 (615)
Q Consensus 409 L~~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~- 482 (615)
|+........ ......|+|.+++.|+.|||.||+|||+++ |+||||||+||||++++.+||+|||+|+...
T Consensus 134 l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~ 210 (329)
T 4aoj_A 134 LRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS 210 (329)
T ss_dssp HHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred HHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcEEEcccccceeccC
Confidence 9865431100 001124999999999999999999999987 9999999999999999999999999997531
Q ss_pred ------------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHH
Q 047629 483 ------------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERL 537 (615)
Q Consensus 483 ------------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 537 (615)
..++.++|||||||+||||+| |+.||......+ ... .+
T Consensus 211 ~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~~--------------~i 273 (329)
T 4aoj_A 211 TDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE---AID--------------CI 273 (329)
T ss_dssp ---------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH---HHH--------------HH
T ss_pred CCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH---HHH--------------HH
Confidence 125678999999999999999 899997644211 111 01
Q ss_pred hhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccch
Q 047629 538 RNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQST 589 (615)
Q Consensus 538 ~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~ 589 (615)
.+-..+ ..|..++..+.+|+.+||+.||++||||+||++.|+.+.+..
T Consensus 274 ~~g~~~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p 321 (329)
T 4aoj_A 274 TQGREL----ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321 (329)
T ss_dssp HHTCCC----CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred HcCCCC----CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence 111112 234455567899999999999999999999999999887654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=381.35 Aligned_cols=221 Identities=26% Similarity=0.411 Sum_probs=175.4
Q ss_pred ceEEEEEE-------CCeEEEEEEcc-------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHh
Q 047629 343 KSVYRATI-------DGKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKW 408 (615)
Q Consensus 343 ~~Vy~~~~-------~g~~vAvK~~~-------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~ 408 (615)
|.||+|.+ +|+.||||+++ ++|.+|+++|++++|||||+++|+|.+. +..+||||||++|+|.++
T Consensus 27 G~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~-~~~~lV~Ey~~~G~L~~~ 105 (299)
T 4asz_A 27 GKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG-DPLIMVFEYMKHGDLNKF 105 (299)
T ss_dssp CCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-SSEEEEEECCTTCBHHHH
T ss_pred cEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC-CEEEEEEEcCCCCcHHHH
Confidence 58999986 36889999985 4588999999999999999999999764 479999999999999999
Q ss_pred hccCCCCC---CCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC---
Q 047629 409 LHPKSKSS---SSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT--- 482 (615)
Q Consensus 409 L~~~~~~~---~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~--- 482 (615)
|+...... ........|+|.++++|+.|||.||+|||+++ |+||||||+|||+++++.+||+|||+|+...
T Consensus 106 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 182 (299)
T 4asz_A 106 LRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD 182 (299)
T ss_dssp HHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGG
T ss_pred HHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEECCcccceecCCCC
Confidence 97643100 00001124999999999999999999999998 9999999999999999999999999986321
Q ss_pred ----------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhh
Q 047629 483 ----------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRN 539 (615)
Q Consensus 483 ----------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 539 (615)
..++.|+|||||||+||||+| |+.||......+ +.. . +.+
T Consensus 183 ~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~~----~----------i~~ 245 (299)
T 4asz_A 183 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIE----C----------ITQ 245 (299)
T ss_dssp CEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHH----H----------HHH
T ss_pred ceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----H----------HHc
Confidence 225679999999999999999 899997644211 111 0 111
Q ss_pred hcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 540 WMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 540 ~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
-.. ...|..++..+.+|+.+||+.||++||||+||++.|+.+.+.
T Consensus 246 ~~~----~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 246 GRV----LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp TCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCC----CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 011 123445566789999999999999999999999999887654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=374.06 Aligned_cols=234 Identities=24% Similarity=0.375 Sum_probs=174.5
Q ss_pred ceEEEEEECCeEEEEEEccH----HHH--HHHHHHHhcCCCCcccEEEEEEcCCC---cEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATIDGKVLAVKKIKE----DVT--EELRILQRINHANLVKLMGVSSDSQG---NRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~~g~~vAvK~~~~----~~~--~Ei~~l~~l~H~niv~l~g~~~~~~~---~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
|.||+|.++|+.||||+++. ++. .|+..+.+++|||||+++|+|.+.++ .++||||||++|+|.++|+..
T Consensus 17 G~Vy~~~~~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~- 95 (303)
T 3hmm_A 17 GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY- 95 (303)
T ss_dssp SEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC-
T ss_pred eEEEEEEECCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHhC-
Confidence 58999999999999999963 233 45556678899999999999976442 479999999999999999754
Q ss_pred CCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC-----
Q 047629 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEH-----AQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN----- 483 (615)
Q Consensus 414 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~----- 483 (615)
.++|.++++++.|+|.||+|||++ ..++|+||||||+|||||.++++||+|||+|+....
T Consensus 96 ----------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~ 165 (303)
T 3hmm_A 96 ----------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 165 (303)
T ss_dssp ----------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEE
T ss_pred ----------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCce
Confidence 289999999999999999999987 244699999999999999999999999999854210
Q ss_pred ----------------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHH
Q 047629 484 ----------------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREE 535 (615)
Q Consensus 484 ----------------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 535 (615)
.+++|+|||||||+||||+||+.|+......+... ..........+.....
T Consensus 166 ~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~-~~~~~~~~~~~~~~~~ 244 (303)
T 3hmm_A 166 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY-YDLVPSDPSVEEMRKV 244 (303)
T ss_dssp SCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT-TTTSCSSCCHHHHHHH
T ss_pred eeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccc-hhcccccchHHHHHHH
Confidence 02347999999999999999988765432211000 0000000000001111
Q ss_pred HHhhhcCCcCCCCC-ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 536 RLRNWMDPNLESFY-PIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 536 ~~~~~~dp~l~~~~-~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
...+..+|.+.... +.+....+.+|+.+||+.||++||||.||++.|+.+.+.
T Consensus 245 ~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 245 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 22334455553332 235667889999999999999999999999999988654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=373.40 Aligned_cols=224 Identities=26% Similarity=0.384 Sum_probs=176.0
Q ss_pred ceEEEEEEC-------CeEEEEEEcc--------HHHHHHHHHHHhcCC-CCcccEEEEEEcCCCcEEEEEeecCCCCHH
Q 047629 343 KSVYRATID-------GKVLAVKKIK--------EDVTEELRILQRINH-ANLVKLMGVSSDSQGNRFLVYEYAENGSLD 406 (615)
Q Consensus 343 ~~Vy~~~~~-------g~~vAvK~~~--------~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~~lV~E~~~~GsL~ 406 (615)
|.||+|.+. ++.||||+++ +.+.+|+++|.+++| ||||+++|+|.+.++.++||||||++|+|.
T Consensus 78 G~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~ 157 (353)
T 4ase_A 78 GQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLS 157 (353)
T ss_dssp EEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHH
T ss_pred eEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHH
Confidence 589999873 3689999985 347889999999955 899999999976555689999999999999
Q ss_pred HhhccCCCCCC------CCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCC
Q 047629 407 KWLHPKSKSSS------SSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAP 480 (615)
Q Consensus 407 ~~L~~~~~~~~------~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~ 480 (615)
++|+....... .......|+|.+++.++.|||.||+|||+++ ||||||||+|||+++++.+||+|||+|+.
T Consensus 158 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~vKi~DFGlar~ 234 (353)
T 4ase_A 158 TYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARD 234 (353)
T ss_dssp HHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSC
T ss_pred HHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccceeeCCCCCEEECcchhhhh
Confidence 99976432100 0001124999999999999999999999998 99999999999999999999999999975
Q ss_pred CCC-------------------------CCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHH
Q 047629 481 ATN-------------------------DVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKRE 534 (615)
Q Consensus 481 ~~~-------------------------~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 534 (615)
... .++.++|||||||+||||+| |+.||......+. +. .
T Consensus 235 ~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~--~~----~--------- 299 (353)
T 4ase_A 235 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FC----R--------- 299 (353)
T ss_dssp TTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--HH----H---------
T ss_pred cccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH--HH----H---------
Confidence 421 25678999999999999998 9999976543221 11 1
Q ss_pred HHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccch
Q 047629 535 ERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQST 589 (615)
Q Consensus 535 ~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~ 589 (615)
.+.+-..+ ..|..+..++.+++..||+.||++||||.||+++|+.+.++.
T Consensus 300 -~i~~g~~~----~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 300 -RLKEGTRM----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp -HHHHTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred -HHHcCCCC----CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 11111122 233444556899999999999999999999999999887543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=361.52 Aligned_cols=232 Identities=22% Similarity=0.286 Sum_probs=186.5
Q ss_pred cccccccc----ceEEEEEE--CCeEEEEEEccHH--HHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHH
Q 047629 335 LSEHYSIG----KSVYRATI--DGKVLAVKKIKED--VTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLD 406 (615)
Q Consensus 335 ~~~~~~iG----~~Vy~~~~--~g~~vAvK~~~~~--~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~ 406 (615)
|....+|| |.||+|.. +|+.||||+++.+ ..+|+.+|++++|||||++++++.+. +.+|||||||++|+|.
T Consensus 60 ~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~~~E~~il~~l~HpnIV~l~~~~~~~-~~~~ivmEy~~gg~L~ 138 (336)
T 4g3f_A 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREG-PWVNIFMELLEGGSLG 138 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCTHHHHTTTTCCCTTBCCEEEEEEET-TEEEEEECCCTTCBHH
T ss_pred eEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEEeccCCCcHH
Confidence 33344455 58999997 6899999999754 35799999999999999999998764 4799999999999999
Q ss_pred HhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCC-cEEEeecCCCCCCC---
Q 047629 407 KWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRF-KAKIANFSLAAPAT--- 482 (615)
Q Consensus 407 ~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~-~~kl~DFGla~~~~--- 482 (615)
++|+... .|++.+...++.||+.||+|||+++ |+||||||+||||+.++ .+||+|||+|+...
T Consensus 139 ~~l~~~~----------~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 139 QLIKQMG----------CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp HHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred HHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 9997654 3999999999999999999999998 99999999999999987 69999999996431
Q ss_pred -------------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHH
Q 047629 483 -------------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERL 537 (615)
Q Consensus 483 -------------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 537 (615)
..++.++|||||||+||||++|+.||......+.... +.
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~---i~------------- 269 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK---IA------------- 269 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHH---HH-------------
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHH---HH-------------
Confidence 1256789999999999999999999976543322110 00
Q ss_pred hhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccchhhhhhccccc
Q 047629 538 RNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQSTETLERSWTSG 599 (615)
Q Consensus 538 ~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~~~~~~~~~~~ 599 (615)
.+ .+.+ ...+.+....+.+++.+||+.||++|||+.|+++.|....+....+.+.|-.+
T Consensus 270 ~~--~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~ 328 (336)
T 4g3f_A 270 SE--PPPI-REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGE 328 (336)
T ss_dssp HS--CCGG-GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSS
T ss_pred cC--CCCc-hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCC
Confidence 00 0111 12334445568899999999999999999999999988877766677778654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=350.89 Aligned_cols=209 Identities=21% Similarity=0.373 Sum_probs=166.0
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcC---CCcEEEEEeecCCCCHHHh
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDS---QGNRFLVYEYAENGSLDKW 408 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~---~~~~~lV~E~~~~GsL~~~ 408 (615)
|.||+|.. +|+.||||++. +.|.+|+++|++++|||||++++++.+. +..++||||||++|+|.++
T Consensus 40 g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~ 119 (290)
T 3fpq_A 40 KTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTY 119 (290)
T ss_dssp EEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHH
T ss_pred cEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHH
Confidence 58999998 68999999985 2478999999999999999999987542 2347999999999999999
Q ss_pred hccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCC-CCcEEEeecCCCCCCC-----
Q 047629 409 LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDS-RFKAKIANFSLAAPAT----- 482 (615)
Q Consensus 409 L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~-~~~~kl~DFGla~~~~----- 482 (615)
|.... .+++..+..|+.||+.||+|||+++ ++|+||||||+||||+. ++.+||+|||+|+...
T Consensus 120 l~~~~----------~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~~~~ 188 (290)
T 3fpq_A 120 LKRFK----------VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK 188 (290)
T ss_dssp HHHHS----------SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBE
T ss_pred HHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCCCccC
Confidence 97643 3899999999999999999999985 45999999999999985 7999999999996532
Q ss_pred ---------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCC
Q 047629 483 ---------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLES 547 (615)
Q Consensus 483 ---------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~ 547 (615)
..++.++|||||||+||||+||+.||....+.. .+.. .+..-..|.
T Consensus 189 ~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~--~~~~--------------~i~~~~~~~--- 249 (290)
T 3fpq_A 189 AVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYR--------------RVTSGVKPA--- 249 (290)
T ss_dssp ESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHH--------------HHTTTCCCG---
T ss_pred CcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH--HHHH--------------HHHcCCCCC---
Confidence 125678999999999999999999997543211 1110 111111111
Q ss_pred CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 548 FYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 548 ~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.++......+.+|+.+||+.||++|||++|++++
T Consensus 250 ~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 250 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1122223457899999999999999999999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=351.13 Aligned_cols=205 Identities=24% Similarity=0.376 Sum_probs=169.2
Q ss_pred ceEEEEEE--CCeEEEEEEcc-------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
|.||+|.. +|+.||||+++ +.+.+|+++|++++|||||++++++.+. +.+|||||||++|+|.+++...
T Consensus 88 G~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-~~~~ivmEy~~gg~L~~~l~~~- 165 (346)
T 4fih_A 88 GIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-DELWVVMEFLEGGALTDIVTHT- 165 (346)
T ss_dssp CEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEECCCTTEEHHHHHHHS-
T ss_pred eEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEEeCCCCCcHHHHHHcC-
Confidence 58999998 69999999985 3478999999999999999999998764 4899999999999999999753
Q ss_pred CCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----------
Q 047629 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----------- 482 (615)
Q Consensus 414 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----------- 482 (615)
.+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+...
T Consensus 166 ----------~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~G 232 (346)
T 4fih_A 166 ----------RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVG 232 (346)
T ss_dssp ----------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCS
T ss_pred ----------CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCCccccccc
Confidence 2899999999999999999999998 9999999999999999999999999996532
Q ss_pred ------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 483 ------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 483 ------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
..++.++|||||||++|||++|+.||..... ..... .+.+...+.+. .+
T Consensus 233 Tp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~~--------------~i~~~~~~~~~--~~ 293 (346)
T 4fih_A 233 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMK--------------MIRDNLPPRLK--NL 293 (346)
T ss_dssp CGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHH--------------HHHHSSCCCCS--CG
T ss_pred CcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHHH--------------HHHcCCCCCCC--cc
Confidence 1256799999999999999999999975432 11111 11222222221 22
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 551 IDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
......+.+|+.+||+.||++|||+.|++++
T Consensus 294 ~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 294 HKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 3344568899999999999999999999875
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=352.47 Aligned_cols=206 Identities=23% Similarity=0.380 Sum_probs=168.3
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
|.||++.. +|+.||||+++ +.+.+|+++|++++|||||++++++.+. +.+|||||||++|+|.++|..
T Consensus 38 g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~-~~~yiVmEy~~gg~L~~~i~~ 116 (350)
T 4b9d_A 38 GKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEEN-GSLYIVMDYCEGGDLFKRINA 116 (350)
T ss_dssp -CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEECCTTCBHHHHHHH
T ss_pred eEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC-CEEEEEEeCCCCCcHHHHHHH
Confidence 58999997 69999999985 3478999999999999999999998764 589999999999999999976
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC---------
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT--------- 482 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~--------- 482 (615)
.... .+++.+.+.|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+...
T Consensus 117 ~~~~--------~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~ 185 (350)
T 4b9d_A 117 QKGV--------LFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARAC 185 (350)
T ss_dssp TTTC--------CCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHHHHH
T ss_pred cCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCccccccc
Confidence 4431 3789999999999999999999998 9999999999999999999999999997642
Q ss_pred --------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCC
Q 047629 483 --------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESF 548 (615)
Q Consensus 483 --------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~ 548 (615)
..++.++|||||||+||||++|+.||...... .+ +... +.... |.+
T Consensus 186 ~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~---~~---~~~i----------~~~~~-~~~--- 245 (350)
T 4b9d_A 186 IGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK---NL---VLKI----------ISGSF-PPV--- 245 (350)
T ss_dssp HSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HH---HHHH----------HHTCC-CCC---
T ss_pred CCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HH---HHHH----------HcCCC-CCC---
Confidence 23567999999999999999999999754321 11 1111 11111 122
Q ss_pred CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 549 YPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 549 ~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
+......+.+|+.+||+.||++|||+.|++++
T Consensus 246 -~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 246 -SLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 22334567899999999999999999999874
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=352.04 Aligned_cols=205 Identities=23% Similarity=0.373 Sum_probs=169.0
Q ss_pred ceEEEEEE--CCeEEEEEEcc-------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
|.||+|.. +|+.||||+++ +.+.+|+++|++++|||||++++++.+. +.+|||||||++|+|.+++...
T Consensus 165 G~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-~~~~iVmEy~~gG~L~~~i~~~- 242 (423)
T 4fie_A 165 GIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-DELWVVMEFLEGGALTDIVTHT- 242 (423)
T ss_dssp CEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEECCTTEEHHHHHHHS-
T ss_pred cEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEEC-CEEEEEEeCCCCCcHHHHHhcc-
Confidence 58999998 69999999985 3588999999999999999999998864 4899999999999999999753
Q ss_pred CCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----------
Q 047629 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----------- 482 (615)
Q Consensus 414 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----------- 482 (615)
.+++.++..|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+...
T Consensus 243 ----------~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~G 309 (423)
T 4fie_A 243 ----------RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVG 309 (423)
T ss_dssp ----------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCCEE
T ss_pred ----------CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCcccccccc
Confidence 2899999999999999999999998 9999999999999999999999999996532
Q ss_pred ------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 483 ------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 483 ------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
..++.++|||||||++|||++|+.||..... .... ..+.....+.+. .+
T Consensus 310 Tp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~--------------~~i~~~~~~~~~--~~ 370 (423)
T 4fie_A 310 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAM--------------KMIRDNLPPRLK--NL 370 (423)
T ss_dssp CTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHH--------------HHHHHSCCCCCS--CT
T ss_pred CcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHH--------------HHHHcCCCCCCc--cc
Confidence 1256799999999999999999999975432 1111 112222223332 12
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 551 IDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
......+.+|+.+||+.||++|||+.|++++
T Consensus 371 ~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 371 HKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp TSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 2334567899999999999999999999875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=331.58 Aligned_cols=202 Identities=26% Similarity=0.390 Sum_probs=162.9
Q ss_pred ceEEEEEE--CCeEEEEEEcc----------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIK----------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~----------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||++.. +|+.||||+++ ..+.+|+++|++++|||||++++++.+. +..|+||||+ +|+|.+++.
T Consensus 27 g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-~~~~ivmEy~-~g~L~~~l~ 104 (275)
T 3hyh_A 27 GKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSK-DEIIMVIEYA-GNELFDYIV 104 (275)
T ss_dssp CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEEECC-CEEHHHHHH
T ss_pred eEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-CEEEEEEeCC-CCCHHHHHH
Confidence 58999987 69999999884 2477899999999999999999998754 4899999999 689999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC-------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------- 483 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------- 483 (615)
... .+++.+...++.||+.||+|||+++ |+||||||+|||+++++++||+|||+|+....
T Consensus 105 ~~~----------~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 171 (275)
T 3hyh_A 105 QRD----------KMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS 171 (275)
T ss_dssp HSC----------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------------
T ss_pred HcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCCCccCCe
Confidence 654 3999999999999999999999998 99999999999999999999999999975321
Q ss_pred ---------------C-CCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCC
Q 047629 484 ---------------D-VMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLES 547 (615)
Q Consensus 484 ---------------~-~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~ 547 (615)
. .+.++||||+||++|||++|+.||..... ..+... +.. -.+.
T Consensus 172 ~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~---~~~~~~--------------i~~-~~~~--- 230 (275)
T 3hyh_A 172 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI---PVLFKN--------------ISN-GVYT--- 230 (275)
T ss_dssp ---CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHH--------------HHH-TCCC---
T ss_pred eECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH---HHHHHH--------------HHc-CCCC---
Confidence 1 24689999999999999999999975331 111110 100 0112
Q ss_pred CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 548 FYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 548 ~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
+|......+.+|+.+|++.||++|||++|++++
T Consensus 231 -~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 231 -LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp -CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred -CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 223334557899999999999999999999874
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=340.11 Aligned_cols=202 Identities=21% Similarity=0.355 Sum_probs=165.9
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||++.. +|+.||||++++ .+.+|+++|++++|||||++++++.+. +.+||||||+++|+|.++|.
T Consensus 46 g~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-~~~yivmEy~~gG~L~~~i~ 124 (311)
T 4aw0_A 46 STVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD-EKLYFGLSYAKNGELLKYIR 124 (311)
T ss_dssp EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEEECCCTTEEHHHHHH
T ss_pred eEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-CEEEEEEecCCCCCHHHHHH
Confidence 58999997 799999999863 367899999999999999999998754 48999999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC-------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------- 483 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------- 483 (615)
... .+++.+...++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 125 ~~~----------~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~ 191 (311)
T 4aw0_A 125 KIG----------SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 191 (311)
T ss_dssp HHS----------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCB
T ss_pred HcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccc
Confidence 654 3899999999999999999999998 99999999999999999999999999975421
Q ss_pred ------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcC
Q 047629 484 ------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNL 545 (615)
Q Consensus 484 ------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l 545 (615)
.++.++||||+||+||||++|+.||..... ..+.. .. .. .++.
T Consensus 192 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~~---~i----------~~--~~~~- 252 (311)
T 4aw0_A 192 NSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---GLIFA---KI----------IK--LEYD- 252 (311)
T ss_dssp CCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---HH----------HH--TCCC-
T ss_pred cCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHH---HH----------Hc--CCCC-
Confidence 145689999999999999999999975431 11111 11 01 1122
Q ss_pred CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047629 546 ESFYPIDGALSLATLARACTMDKSLSRPNMAEVVF 580 (615)
Q Consensus 546 ~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~ 580 (615)
+|......+.+|+.+|++.||++|||++|++.
T Consensus 253 ---~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 253 ---FPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp ---CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred ---CCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 23333446789999999999999999998754
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=336.43 Aligned_cols=202 Identities=22% Similarity=0.291 Sum_probs=158.9
Q ss_pred ceEEEEEE-----CCeEEEEEEccH---------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHh
Q 047629 343 KSVYRATI-----DGKVLAVKKIKE---------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKW 408 (615)
Q Consensus 343 ~~Vy~~~~-----~g~~vAvK~~~~---------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~ 408 (615)
|.||++.. .++.||||++++ .+.+|+++|++++|||||++++++.+. +..|+|||||++|+|.++
T Consensus 38 g~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-~~~~ivmEy~~gg~L~~~ 116 (304)
T 3ubd_A 38 GKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTE-GKLYLILDFLRGGDLFTR 116 (304)
T ss_dssp CEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEET-TEEEEEECCCTTCEEHHH
T ss_pred eEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-CEEEEEEEcCCCCCHHHH
Confidence 58999975 468999999852 478899999999999999999998764 589999999999999999
Q ss_pred hccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC------
Q 047629 409 LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------ 482 (615)
Q Consensus 409 L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------ 482 (615)
|.... .+++.+...++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 117 l~~~~----------~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 183 (304)
T 3ubd_A 117 LSKEV----------MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 183 (304)
T ss_dssp HHHHC----------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-----CCC
T ss_pred HHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccCCCccc
Confidence 97654 3899999999999999999999998 9999999999999999999999999996431
Q ss_pred -----------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcC
Q 047629 483 -----------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNL 545 (615)
Q Consensus 483 -----------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l 545 (615)
..++.++||||+||+||||++|+.||......+ +. ... ... .+
T Consensus 184 ~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~---~~i----------~~~--~~-- 243 (304)
T 3ubd_A 184 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE---TM---TMI----------LKA--KL-- 243 (304)
T ss_dssp CSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHH----------HHC--CC--
T ss_pred cccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH---HH---HHH----------HcC--CC--
Confidence 125678999999999999999999997543211 11 100 111 11
Q ss_pred CCCCChHHHHHHHHHHHHhhhcCCCCCCCH-----HHHHH
Q 047629 546 ESFYPIDGALSLATLARACTMDKSLSRPNM-----AEVVF 580 (615)
Q Consensus 546 ~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm-----~ev~~ 580 (615)
.+|......+.+|+.+||+.||++|||+ +|+++
T Consensus 244 --~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 244 --GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred --CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 2233344567899999999999999984 55554
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=323.03 Aligned_cols=203 Identities=21% Similarity=0.397 Sum_probs=156.5
Q ss_pred ceEEEEEE--CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCC-----------cEEEEEeecC
Q 047629 343 KSVYRATI--DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQG-----------NRFLVYEYAE 401 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-----------~~~lV~E~~~ 401 (615)
|.||+|.. +|+.||||+++ +.+.+|+++|++++|||||++++++.+.+. .+|+|||||+
T Consensus 19 g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~ 98 (299)
T 4g31_A 19 GVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCR 98 (299)
T ss_dssp -EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCC
T ss_pred eEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCC
Confidence 58999997 69999999985 347789999999999999999998864332 3689999999
Q ss_pred CCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCC
Q 047629 402 NGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA 481 (615)
Q Consensus 402 ~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~ 481 (615)
+|+|.+++...... ...++..++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 99 gg~L~~~l~~~~~~-------~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~DFGla~~~ 168 (299)
T 4g31_A 99 KENLKDWMNGRCTI-------EERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 168 (299)
T ss_dssp SCCHHHHHHTCCSG-------GGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCCCC---
T ss_pred CCcHHHHHHhcCCC-------ChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEccCccceec
Confidence 99999999865431 13677888999999999999999998 999999999999999999999999998643
Q ss_pred C-----------------------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHH
Q 047629 482 T-----------------------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREV 526 (615)
Q Consensus 482 ~-----------------------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 526 (615)
. ..++.++|||||||++|||++ ||.... +. ...+.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--~~---~~~~~-- 238 (299)
T 4g31_A 169 DQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--ER---VRTLT-- 238 (299)
T ss_dssp -----------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--HH---HHHHH--
T ss_pred CCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--HH---HHHHH--
Confidence 1 125678999999999999997 654211 00 00000
Q ss_pred HhHHHHHHHHHhhhcCCcCCCCCCh---HHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 527 LKVEEKREERLRNWMDPNLESFYPI---DGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 527 ~~~~~~~~~~~~~~~dp~l~~~~~~---~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.+.. ..+|. +......+|+.+||+.||++|||+.|++++
T Consensus 239 ---------~~~~-------~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 239 ---------DVRN-------LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp ---------HHHT-------TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---------HHhc-------CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0111 11221 222346789999999999999999999873
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=323.75 Aligned_cols=249 Identities=31% Similarity=0.529 Sum_probs=201.0
Q ss_pred HHHHHHccccccccccc----ceEEEEEE-CCeEEEEEEcc-------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcE
Q 047629 326 EVIMESTMNLSEHYSIG----KSVYRATI-DGKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVSSDSQGNR 393 (615)
Q Consensus 326 ~~l~~at~~~~~~~~iG----~~Vy~~~~-~g~~vAvK~~~-------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 393 (615)
.++...+++|.....+| |.||+|.. +|+.||||++. +.+.+|++++++++||||+++++++.+ ++..
T Consensus 32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~ 110 (321)
T 2qkw_B 32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE-RNEM 110 (321)
T ss_dssp SCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC-TTCC
T ss_pred HHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CCeE
Confidence 34455667777776776 58999998 68999999875 457899999999999999999999865 4478
Q ss_pred EEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEe
Q 047629 394 FLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIA 473 (615)
Q Consensus 394 ~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~ 473 (615)
++||||+++|+|.+++....... ..++|.+++.++.|++.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~ 181 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPT------MSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKIT 181 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCS------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEEC
T ss_pred EEEEEcCCCCcHHHHHhccCCCc------cccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEe
Confidence 99999999999999997654221 24899999999999999999999998 9999999999999999999999
Q ss_pred ecCCCCCCC-------------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHh
Q 047629 474 NFSLAAPAT-------------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLK 528 (615)
Q Consensus 474 DFGla~~~~-------------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~ 528 (615)
|||+++... ..++.++||||||+++|||++|+.|+......+......+....
T Consensus 182 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~-- 259 (321)
T 2qkw_B 182 DFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES-- 259 (321)
T ss_dssp CCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHH--
T ss_pred ecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhc--
Confidence 999986421 12456899999999999999999999765433322222221111
Q ss_pred HHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccch
Q 047629 529 VEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQST 589 (615)
Q Consensus 529 ~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~ 589 (615)
.....+...+++.+....+.+....+.+++.+||+.||++|||+.|+++.|+.+....
T Consensus 260 ---~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 260 ---HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp ---HTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred ---cccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 1123455667787777788889999999999999999999999999999999776543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=311.36 Aligned_cols=250 Identities=30% Similarity=0.527 Sum_probs=201.7
Q ss_pred ceeeeHHHHHHHccccccc------cccc----ceEEEEEECCeEEEEEEcc-----------HHHHHHHHHHHhcCCCC
Q 047629 320 PIVYEIEVIMESTMNLSEH------YSIG----KSVYRATIDGKVLAVKKIK-----------EDVTEELRILQRINHAN 378 (615)
Q Consensus 320 ~~~~~~~~l~~at~~~~~~------~~iG----~~Vy~~~~~g~~vAvK~~~-----------~~~~~Ei~~l~~l~H~n 378 (615)
...|+++++.+++.+|.+. ..+| |.||+|..+++.||||++. +.+.+|+.++++++|||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 3678999999999999987 5565 5899999999999999874 34778999999999999
Q ss_pred cccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 047629 379 LVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIR 458 (615)
Q Consensus 379 iv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk 458 (615)
|+++++++.+. +..++||||+++|+|.+++...... ..++|..++.++.|++.||.|||+++ ++|||||
T Consensus 92 i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlk 160 (307)
T 2nru_A 92 LVELLGFSSDG-DDLCLVYVYMPNGSLLDRLSCLDGT-------PPLSWHMRCKIAQGAANGINFLHENH---HIHRDIK 160 (307)
T ss_dssp BCCEEEEECSS-SSCEEEEECCTTCBHHHHHHTGGGC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCC
T ss_pred eEEEEEEEecC-CceEEEEEecCCCcHHHHHHhccCC-------CCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCC
Confidence 99999998754 4789999999999999999753321 14899999999999999999999998 9999999
Q ss_pred CCceeeCCCCcEEEeecCCCCCCCC------------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCC
Q 047629 459 TNNIQLDSRFKAKIANFSLAAPATN------------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENG 514 (615)
Q Consensus 459 ~~NILld~~~~~kl~DFGla~~~~~------------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~ 514 (615)
|+||+++.++.+||+|||+++.... .++.++||||||+++|||++|+.|+......
T Consensus 161 p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 240 (307)
T 2nru_A 161 SANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP 240 (307)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSS
T ss_pred HHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcch
Confidence 9999999999999999999854321 1356899999999999999999999765433
Q ss_pred hhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 047629 515 KTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQ 587 (615)
Q Consensus 515 ~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~ 587 (615)
.....+ ...... ....+.+++++.+ ...+......+.+++..||+.||.+|||++||++.|+.+..
T Consensus 241 ~~~~~~--~~~~~~----~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 241 QLLLDI--KEEIED----EEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp SBTTHH--HHHHHT----TSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHH--HHHhhh----hhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 221111 111100 0122445566555 34567778889999999999999999999999999998764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=321.68 Aligned_cols=256 Identities=34% Similarity=0.580 Sum_probs=206.7
Q ss_pred CceeeeHHHHHHHccccccccccc----ceEEEEEE-CCeEEEEEEccH--------HHHHHHHHHHhcCCCCcccEEEE
Q 047629 319 KPIVYEIEVIMESTMNLSEHYSIG----KSVYRATI-DGKVLAVKKIKE--------DVTEELRILQRINHANLVKLMGV 385 (615)
Q Consensus 319 ~~~~~~~~~l~~at~~~~~~~~iG----~~Vy~~~~-~g~~vAvK~~~~--------~~~~Ei~~l~~l~H~niv~l~g~ 385 (615)
....|+++++...+++|.....+| |.||+|.. +|+.||||+++. .+.+|++++++++|+||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 356788999999999999888887 58999987 689999999862 47899999999999999999999
Q ss_pred EEcCCCcEEEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeC
Q 047629 386 SSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLD 465 (615)
Q Consensus 386 ~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld 465 (615)
+.+. +..++||||+++|+|.+++....... ..++|..+..++.|++.||.|||++..++|+||||||+|||++
T Consensus 96 ~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~ 168 (326)
T 3uim_A 96 CMTP-TERLLVYPYMANGSVASCLRERPESQ------PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD 168 (326)
T ss_dssp ECCS-SCCEEEEECCTTCBHHHHHHCCSTTC------CCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEEC
T ss_pred EecC-CceEEEEEeccCCCHHHHHHhccccC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEEC
Confidence 8754 47899999999999999998754321 2489999999999999999999999333499999999999999
Q ss_pred CCCcEEEeecCCCCCCCC------------------------CCCCcccchhHHHHHHHHHcCCCCCCCCC--CChhHHH
Q 047629 466 SRFKAKIANFSLAAPATN------------------------DVMPKFDVFAFGVVLLELLSGKKATRTTE--NGKTAVL 519 (615)
Q Consensus 466 ~~~~~kl~DFGla~~~~~------------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~--~~~~~~l 519 (615)
.++.+||+|||+++.... .++.++||||||+++|||++|+.||.... .......
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 248 (326)
T 3uim_A 169 EEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 248 (326)
T ss_dssp TTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBH
T ss_pred CCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhH
Confidence 999999999999964321 13458999999999999999999996311 1111111
Q ss_pred HHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 047629 520 WKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLT 586 (615)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~ 586 (615)
..++..... ...+....++.+...++.+....+.+++.+||+.||.+|||++||+++|+...
T Consensus 249 ~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 249 LDWVKGLLK-----EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp HHHHTTTTS-----SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred HHHHHHHhh-----chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 222221111 22345666777777888899999999999999999999999999999998643
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=324.02 Aligned_cols=222 Identities=19% Similarity=0.282 Sum_probs=164.8
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcC-----CCcEEEEEeecCCCCHH
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDS-----QGNRFLVYEYAENGSLD 406 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~~~lV~E~~~~GsL~ 406 (615)
|.||+|.. +|+.||||+++ +.+.+|+++|++++|||||++++++... .+.+|||||||+ |+|.
T Consensus 68 G~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~ 146 (398)
T 4b99_A 68 GVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLH 146 (398)
T ss_dssp CEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHH
T ss_pred eEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHH
Confidence 58999997 69999999985 2367899999999999999999986532 246899999996 7899
Q ss_pred HhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC----
Q 047629 407 KWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT---- 482 (615)
Q Consensus 407 ~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~---- 482 (615)
+++.... .+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 147 ~~i~~~~----------~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~ 213 (398)
T 4b99_A 147 QIIHSSQ----------PLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPA 213 (398)
T ss_dssp HHHTSSS----------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCC-----
T ss_pred HHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeeecccCcc
Confidence 9997654 3999999999999999999999998 9999999999999999999999999996431
Q ss_pred ------------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhH---H---HH
Q 047629 483 ------------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKV---E---EK 532 (615)
Q Consensus 483 ------------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~---~---~~ 532 (615)
..++.++||||+||++|||++|+.||......+.. ..+...... . ..
T Consensus 214 ~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l---~~I~~~~g~p~~~~~~~~ 290 (398)
T 4b99_A 214 EHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQL---QLIMMVLGTPSPAVIQAV 290 (398)
T ss_dssp --CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHH---HHHHHHHCCCCGGGTC--
T ss_pred ccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHH---HHHHHhcCCCChHHhhhh
Confidence 11456899999999999999999999765432211 111111100 0 00
Q ss_pred HH---HHHhhhcCCcCCCC---CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 533 RE---ERLRNWMDPNLESF---YPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 533 ~~---~~~~~~~dp~l~~~---~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.. ......+.+..... ........+.+|+.+||..||++|||+.|++++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 291 GAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp ---CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 00000011100000 001123457899999999999999999999875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=316.83 Aligned_cols=232 Identities=25% Similarity=0.406 Sum_probs=174.9
Q ss_pred ceEEEEEECCeEEEEEEccH------HHHHHHHHHHhcCCCCcccEEEEEEcCCC---cEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATIDGKVLAVKKIKE------DVTEELRILQRINHANLVKLMGVSSDSQG---NRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~~g~~vAvK~~~~------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~---~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
|.||+|...|+.||||+++. ....|+.++.+++||||+++++++.+... ..++||||+++|+|.+++...
T Consensus 38 g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~- 116 (322)
T 3soc_A 38 GCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN- 116 (322)
T ss_dssp CEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC-
T ss_pred eEEEEEEECCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhc-
Confidence 58999999999999999862 34568888999999999999999876432 379999999999999999753
Q ss_pred CCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhC----------CCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC
Q 047629 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEH----------AQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN 483 (615)
Q Consensus 414 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~ 483 (615)
.++|..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++....
T Consensus 117 ----------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~ 183 (322)
T 3soc_A 117 ----------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIADFGLALKFEA 183 (322)
T ss_dssp ----------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECCCTTCEEECT
T ss_pred ----------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEccCCccccccc
Confidence 289999999999999999999998 6 99999999999999999999999999953211
Q ss_pred ------------------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHH
Q 047629 484 ------------------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKR 533 (615)
Q Consensus 484 ------------------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 533 (615)
.++.++|||||||++|||++|+.||.........................
T Consensus 184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (322)
T 3soc_A 184 GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQ 263 (322)
T ss_dssp TSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHH
T ss_pred ccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhh
Confidence 01235699999999999999999997654322111111000000001111
Q ss_pred HHHHhhhcCCcCCCCC-ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 534 EERLRNWMDPNLESFY-PIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 534 ~~~~~~~~dp~l~~~~-~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
.........|.+...+ .......+.+|+.+||+.||++|||+.||++.|+.+.+.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 264 EVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1112222333332222 124556799999999999999999999999999988653
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=313.68 Aligned_cols=162 Identities=25% Similarity=0.377 Sum_probs=137.0
Q ss_pred ccccccccc----ceEEEEEE-----CCeEEEEEEcc-----HHHHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEe
Q 047629 334 NLSEHYSIG----KSVYRATI-----DGKVLAVKKIK-----EDVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYE 398 (615)
Q Consensus 334 ~~~~~~~iG----~~Vy~~~~-----~g~~vAvK~~~-----~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E 398 (615)
.|.-...+| |.||+|.. .++.||||++. ..+.+|+++|.++ +|||||++++++.+. +..++|||
T Consensus 22 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~-~~~~lvmE 100 (361)
T 4f9c_A 22 VFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKN-DHVVIAMP 100 (361)
T ss_dssp TCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEET-TEEEEEEE
T ss_pred cEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEEC-CEEEEEEe
Confidence 344444455 58999975 36889999885 3477899999998 699999999988754 48999999
Q ss_pred ecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCC-CcEEEeecCC
Q 047629 399 YAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSR-FKAKIANFSL 477 (615)
Q Consensus 399 ~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~-~~~kl~DFGl 477 (615)
|+++|+|.+++.. +++.+...++.|++.||+|||+++ |+||||||+|||++.+ +.+||+|||+
T Consensus 101 ~~~g~~L~~~~~~-------------l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGl 164 (361)
T 4f9c_A 101 YLEHESFLDILNS-------------LSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGL 164 (361)
T ss_dssp CCCCCCHHHHHTT-------------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred CCCcccHHHHHcC-------------CCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence 9999999999841 889999999999999999999998 9999999999999887 7999999999
Q ss_pred CCCCC----------------------------------------------------CCCCCcccchhHHHHHHHHHcCC
Q 047629 478 AAPAT----------------------------------------------------NDVMPKFDVFAFGVVLLELLSGK 505 (615)
Q Consensus 478 a~~~~----------------------------------------------------~~~~~k~DV~SfGvvl~ElltG~ 505 (615)
|+... ..++.++||||+||++|||++|+
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~ 244 (361)
T 4f9c_A 165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244 (361)
T ss_dssp CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence 95210 11456889999999999999999
Q ss_pred CCCCCCC
Q 047629 506 KATRTTE 512 (615)
Q Consensus 506 ~p~~~~~ 512 (615)
.||....
T Consensus 245 ~Pf~~~~ 251 (361)
T 4f9c_A 245 YPFYKAS 251 (361)
T ss_dssp SSSSCCS
T ss_pred CCCCCCC
Confidence 9997544
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=324.24 Aligned_cols=214 Identities=26% Similarity=0.426 Sum_probs=178.3
Q ss_pred ceEEEEEECCeEEEEEEcc-----HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCCCC
Q 047629 343 KSVYRATIDGKVLAVKKIK-----EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSS 417 (615)
Q Consensus 343 ~~Vy~~~~~g~~vAvK~~~-----~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~~ 417 (615)
|.||+|.+.|+.||||.++ +.+.+|+.+|++++||||+++++++.+.++..++||||+++|+|.+++......
T Consensus 207 g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~-- 284 (450)
T 1k9a_A 207 GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-- 284 (450)
T ss_dssp EEEEEEEETTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTT--
T ss_pred eeEEEEEecCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCC--
Confidence 5899999999999999986 468899999999999999999999887665799999999999999999865421
Q ss_pred CCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC---------------
Q 047629 418 SSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT--------------- 482 (615)
Q Consensus 418 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~--------------- 482 (615)
.+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 285 ------~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~y~aP 355 (450)
T 1k9a_A 285 ------VLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAP 355 (450)
T ss_dssp ------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC------CCCTTTSCH
T ss_pred ------CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccccccCCCCCcceeCH
Confidence 3789999999999999999999998 9999999999999999999999999986431
Q ss_pred -----CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHH
Q 047629 483 -----NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALS 556 (615)
Q Consensus 483 -----~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~ 556 (615)
..++.++|||||||++|||++ |+.|+......+... .+..-.. ...+..+...
T Consensus 356 E~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~-----------------~i~~~~~----~~~p~~~~~~ 414 (450)
T 1k9a_A 356 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-----------------RVEKGYK----MDAPDGCPPA 414 (450)
T ss_dssp HHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHH-----------------HHHTTCC----CCCCTTCCHH
T ss_pred HHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-----------------HHHcCCC----CCCCCcCCHH
Confidence 124668999999999999999 999997654322110 1111111 1234445567
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 557 LATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 557 l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
+.+|+..||+.||.+|||+.|+++.|+.+...
T Consensus 415 l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 415 VYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 89999999999999999999999999987654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=308.35 Aligned_cols=216 Identities=27% Similarity=0.450 Sum_probs=174.1
Q ss_pred ceEEEEEE-----CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATI-----DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~-----~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
|.||+|.. .+..||||+++ +.+.+|++++++++|+||+++++++.+. +..++||||+++|+|.+++
T Consensus 63 g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l 141 (325)
T 3kul_A 63 GEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG-RLAMIVTEYMENGSLDTFL 141 (325)
T ss_dssp EEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG-GCCEEEEECCTTCBHHHHH
T ss_pred cEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-CccEEEeeCCCCCcHHHHH
Confidence 58999997 24569999986 2478899999999999999999998654 4789999999999999999
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------ 483 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------ 483 (615)
..... .+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 142 ~~~~~---------~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 209 (325)
T 3kul_A 142 RTHDG---------QFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAY 209 (325)
T ss_dssp HTTTT---------CSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC----CCE
T ss_pred Hhccc---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccccCcccee
Confidence 75433 3899999999999999999999998 99999999999999999999999999965421
Q ss_pred --------------------CCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcC
Q 047629 484 --------------------DVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMD 542 (615)
Q Consensus 484 --------------------~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~d 542 (615)
.++.++||||||+++|||++ |+.||......+ .. ..+.....
T Consensus 210 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~--------------~~~~~~~~ 272 (325)
T 3kul_A 210 TTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD---VI--------------SSVEEGYR 272 (325)
T ss_dssp ECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---HH--------------HHHHTTCC
T ss_pred eccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH---HH--------------HHHHcCCC
Confidence 13457899999999999999 999987544211 00 01111111
Q ss_pred CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccchhhh
Q 047629 543 PNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQSTETL 592 (615)
Q Consensus 543 p~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~~~~ 592 (615)
...+......+.+++..||+.||.+|||+.||++.|+.+....+..
T Consensus 273 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~ 318 (325)
T 3kul_A 273 ----LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESL 318 (325)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC--
T ss_pred ----CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcccc
Confidence 1223344566899999999999999999999999999988765543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=318.69 Aligned_cols=211 Identities=24% Similarity=0.403 Sum_probs=172.3
Q ss_pred ceEEEEEE--CCeEEEEEEccH--------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATI--DGKVLAVKKIKE--------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~--------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
|.||+|.. +|+.||||.++. .+.+|+++|++++||||++++|++.+. +..++||||+++|+|.+++...
T Consensus 128 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~ 206 (377)
T 3cbl_A 128 GEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-QPIYIVMELVQGGDFLTFLRTE 206 (377)
T ss_dssp EEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS-SSCEEEEECCTTCBHHHHHHHH
T ss_pred CeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC-CCcEEEEEcCCCCCHHHHHHhc
Confidence 58999998 689999999862 367899999999999999999998754 4789999999999999999754
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC---------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN--------- 483 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~--------- 483 (615)
.. .+++.+++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 207 ~~---------~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~ 274 (377)
T 3cbl_A 207 GA---------RLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGL 274 (377)
T ss_dssp GG---------GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSC
T ss_pred CC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCC
Confidence 32 3899999999999999999999998 99999999999999999999999999864321
Q ss_pred ----------------CCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCC
Q 047629 484 ----------------DVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLE 546 (615)
Q Consensus 484 ----------------~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~ 546 (615)
.++.++|||||||++|||++ |+.|+......+ +.. .+.... .
T Consensus 275 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~-------~~~----------~~~~~~----~ 333 (377)
T 3cbl_A 275 RQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-------TRE----------FVEKGG----R 333 (377)
T ss_dssp CEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH-------HHH----------HHHTTC----C
T ss_pred CCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHH----------HHHcCC----C
Confidence 13458999999999999999 999987544211 010 111111 1
Q ss_pred CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 047629 547 SFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQ 587 (615)
Q Consensus 547 ~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~ 587 (615)
...+..++..+.+|+..||+.||++|||+.|+++.|+.+..
T Consensus 334 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 334 LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 12233445568899999999999999999999999988754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=316.09 Aligned_cols=214 Identities=27% Similarity=0.450 Sum_probs=167.5
Q ss_pred ceEEEEEE-----CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATI-----DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~-----~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
|.||+|.. ++..||||+++ +++.+|+.+|++++||||+++++++.+. +..++||||+++|+|.+++
T Consensus 59 g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~~sL~~~l 137 (373)
T 2qol_A 59 GEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS-KPVMIVTEYMENGSLDSFL 137 (373)
T ss_dssp SEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-SSCEEEEECCTTCBHHHHH
T ss_pred eEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-CceEEEEeCCCCCcHHHHH
Confidence 58999986 36789999985 3578999999999999999999998754 4789999999999999999
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------ 483 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------ 483 (615)
..... .+++.+++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 138 ~~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 205 (373)
T 2qol_A 138 RKHDA---------QFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAY 205 (373)
T ss_dssp HTTTT---------CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------------
T ss_pred HhCCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccccCCccce
Confidence 76542 3899999999999999999999998 99999999999999999999999999865321
Q ss_pred --------------------CCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcC
Q 047629 484 --------------------DVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMD 542 (615)
Q Consensus 484 --------------------~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~d 542 (615)
.++.++||||||+++|||++ |+.|+......+ .. . .+.
T Consensus 206 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~---~~----~----------~i~---- 264 (373)
T 2qol_A 206 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD---VI----K----------AVD---- 264 (373)
T ss_dssp --------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH---HH----H----------HHH----
T ss_pred eccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----H----------HHH----
Confidence 13568999999999999998 999987543211 00 0 011
Q ss_pred CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccchh
Q 047629 543 PNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQSTE 590 (615)
Q Consensus 543 p~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~~ 590 (615)
.......+.+....+.+++..||+.||.+||+|.||++.|+.+.....
T Consensus 265 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~ 312 (373)
T 2qol_A 265 EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG 312 (373)
T ss_dssp TTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGG
T ss_pred cCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCcc
Confidence 111112233455678999999999999999999999999998876543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=302.74 Aligned_cols=218 Identities=28% Similarity=0.440 Sum_probs=171.6
Q ss_pred ceEEEEEECCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATIDGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
|.||++..+|+.||||++. +.+.+|++++++++|+||+++++++.+. +..++||||+++|+|.+++....
T Consensus 51 g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~ 129 (309)
T 3p86_A 51 GTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP-PNLSIVTEYLSRGSLYRLLHKSG 129 (309)
T ss_dssp EEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-TCCEEEEECCTTCBHHHHHHSTT
T ss_pred eEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-CceEEEEecCCCCcHHHHHhhcC
Confidence 5899999999999999984 2477899999999999999999998754 47899999999999999997643
Q ss_pred CCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----------
Q 047629 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----------- 482 (615)
Q Consensus 414 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----------- 482 (615)
.. ..+++..++.++.|++.||+|||+++ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 130 ~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~g 201 (309)
T 3p86_A 130 AR-------EQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAG 201 (309)
T ss_dssp HH-------HHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-----------------
T ss_pred CC-------CCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccccccccccCCC
Confidence 21 13899999999999999999999985 459999999999999999999999999985421
Q ss_pred ------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 483 ------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 483 ------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
...+.++||||||+++|||++|+.||......+. . . ........ ...+
T Consensus 202 t~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~---~---~----------~~~~~~~~----~~~~ 261 (309)
T 3p86_A 202 TPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV---V---A----------AVGFKCKR----LEIP 261 (309)
T ss_dssp CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH---H---H----------HHHHSCCC----CCCC
T ss_pred CccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---H---H----------HHHhcCCC----CCCC
Confidence 1245789999999999999999999975432110 0 0 00001111 1233
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccch
Q 047629 551 IDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQST 589 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~ 589 (615)
......+.+++.+||+.||.+|||+.|+++.|+.+.++.
T Consensus 262 ~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 262 RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 344456899999999999999999999999999887653
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=324.32 Aligned_cols=213 Identities=24% Similarity=0.398 Sum_probs=175.7
Q ss_pred ceEEEEEE--CCeEEEEEEcc------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSK 414 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~ 414 (615)
|.||+|.+ +++.||||.++ +++.+|+.+|++++||||++++|+|.+. +..++||||+++|+|.+++.....
T Consensus 234 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~ 312 (495)
T 1opk_A 234 GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-PPFYIITEFMTYGNLLDYLRECNR 312 (495)
T ss_dssp SSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSCEEEEECCTTCBHHHHHHHSCT
T ss_pred eEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecC-CcEEEEEEccCCCCHHHHHHhcCc
Confidence 58999998 48999999986 4688999999999999999999998754 478999999999999999976432
Q ss_pred CCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC-----------
Q 047629 415 SSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN----------- 483 (615)
Q Consensus 415 ~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~----------- 483 (615)
. .+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 313 ~--------~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~ 381 (495)
T 1opk_A 313 Q--------EVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 381 (495)
T ss_dssp T--------TSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCC
T ss_pred C--------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCceeecCCCcC
Confidence 1 3899999999999999999999998 99999999999999999999999999875421
Q ss_pred -------------CCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCC
Q 047629 484 -------------DVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFY 549 (615)
Q Consensus 484 -------------~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~ 549 (615)
.++.++|||||||+||||++ |+.|+......+. .. .+.. ......
T Consensus 382 ~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~---~~--------------~~~~----~~~~~~ 440 (495)
T 1opk_A 382 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---YE--------------LLEK----DYRMER 440 (495)
T ss_dssp CGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HH--------------HHHT----TCCCCC
T ss_pred CcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH---HH--------------HHHc----CCCCCC
Confidence 13458999999999999999 9999876543211 10 1111 111223
Q ss_pred ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 550 PIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 550 ~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
+..+...+.+|+.+||+.||++||||.||++.|+.+.+.
T Consensus 441 ~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 441 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred CCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 444556789999999999999999999999999988654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=310.41 Aligned_cols=222 Identities=23% Similarity=0.398 Sum_probs=173.7
Q ss_pred ceEEEEEE---------CCeEEEEEEcc--------HHHHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCC
Q 047629 343 KSVYRATI---------DGKVLAVKKIK--------EDVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGS 404 (615)
Q Consensus 343 ~~Vy~~~~---------~g~~vAvK~~~--------~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~Gs 404 (615)
|.||+|.. ++..||||+++ +.+.+|+++|+++ +||||+++++++.+. +..++||||+++|+
T Consensus 95 g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~-~~~~lv~e~~~~g~ 173 (370)
T 2psq_A 95 GQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD-GPLYVIVEYASKGN 173 (370)
T ss_dssp SEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS-SSCEEEEECCTTCB
T ss_pred eeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC-CCEEEEEEcCCCCC
Confidence 58999985 24679999986 2477899999999 899999999998754 47999999999999
Q ss_pred HHHhhccCCCCCCC------CCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCC
Q 047629 405 LDKWLHPKSKSSSS------SGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA 478 (615)
Q Consensus 405 L~~~L~~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla 478 (615)
|.+++......... ......+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 174 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a 250 (370)
T 2psq_A 174 LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLA 250 (370)
T ss_dssp HHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCSSC
T ss_pred HHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEECCCCCEEEccccCC
Confidence 99999865421000 000123899999999999999999999998 999999999999999999999999998
Q ss_pred CCCC-------------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHH
Q 047629 479 APAT-------------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEK 532 (615)
Q Consensus 479 ~~~~-------------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 532 (615)
+... ..++.++|||||||++|||++ |+.||......+.. .
T Consensus 251 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~---~----------- 316 (370)
T 2psq_A 251 RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF---K----------- 316 (370)
T ss_dssp EETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH---H-----------
T ss_pred cccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH---H-----------
Confidence 6431 114568999999999999999 99998764422111 0
Q ss_pred HHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccch
Q 047629 533 REERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQST 589 (615)
Q Consensus 533 ~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~ 589 (615)
.+..... ...+......+.+++..||+.||.+||++.|+++.|+.+....
T Consensus 317 ---~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 317 ---LLKEGHR----MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp ---HHHTTCC----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---HHhcCCC----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 1111111 1233444556899999999999999999999999999886543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=326.94 Aligned_cols=208 Identities=23% Similarity=0.305 Sum_probs=166.8
Q ss_pred ceEEEEEE--CCeEEEEEEcc-------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
|.||++.. +|+.||||.++ +.+.+|+++|++++|||||++++++.+. +.++||||||++|+|.++|....
T Consensus 171 g~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-~~~~iv~E~~~gg~L~~~i~~~~ 249 (573)
T 3uto_A 171 GVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD-NEMVMIYEFMSGGELFEKVADEH 249 (573)
T ss_dssp EEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECS-SEEEEEEECCCCCBHHHHHTCTT
T ss_pred eEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-CEEEEEEeecCCCcHHHHHHHhC
Confidence 58999997 79999999885 3477899999999999999999998754 58999999999999999997543
Q ss_pred CCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCC--CcEEEeecCCCCCCC---------
Q 047629 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSR--FKAKIANFSLAAPAT--------- 482 (615)
Q Consensus 414 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~--~~~kl~DFGla~~~~--------- 482 (615)
. .|++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+...
T Consensus 250 ~---------~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~~~ 317 (573)
T 3uto_A 250 N---------KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT 317 (573)
T ss_dssp S---------CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEEEC
T ss_pred C---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCCceeeeE
Confidence 3 3899999999999999999999998 9999999999999864 899999999997542
Q ss_pred -------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCC
Q 047629 483 -------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFY 549 (615)
Q Consensus 483 -------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~ 549 (615)
..++.++||||+||++|||++|+.||......+. . .. +.. .+..+....
T Consensus 318 GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~---~---~~-----------i~~-~~~~~~~~~ 379 (573)
T 3uto_A 318 GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET---L---RN-----------VKS-CDWNMDDSA 379 (573)
T ss_dssp SSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---H---HH-----------HHT-TCCCCCSGG
T ss_pred ECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---H---HH-----------HHh-CCCCCCccc
Confidence 1245689999999999999999999975442111 1 10 110 111111111
Q ss_pred ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 550 PIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 550 ~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.......+.+|+.+||+.||.+|||+.|++++
T Consensus 380 ~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 380 FSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 12233457899999999999999999999874
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-35 Score=294.80 Aligned_cols=212 Identities=25% Similarity=0.448 Sum_probs=173.7
Q ss_pred ceEEEEEE-CCeEEEEEEcc------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCC
Q 047629 343 KSVYRATI-DGKVLAVKKIK------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKS 415 (615)
Q Consensus 343 ~~Vy~~~~-~g~~vAvK~~~------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~ 415 (615)
|.||++.. +++.||||+++ +++.+|++++++++||||+++++++.+. +..++||||+++|+|.+++.....
T Consensus 24 g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~- 101 (269)
T 4hcu_A 24 GLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-APICLVFEFMEHGCLSDYLRTQRG- 101 (269)
T ss_dssp CEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSS-SSEEEEEECCTTCBHHHHHHTTTT-
T ss_pred cEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CceEEEEEeCCCCcHHHHHHhcCc-
Confidence 58999998 78899999986 4588999999999999999999998754 479999999999999999976443
Q ss_pred CCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------------
Q 047629 416 SSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------------- 482 (615)
Q Consensus 416 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------------- 482 (615)
.+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++...
T Consensus 102 --------~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 170 (269)
T 4hcu_A 102 --------LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP 170 (269)
T ss_dssp --------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCC
T ss_pred --------ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccccccCcccc
Confidence 3899999999999999999999998 9999999999999999999999999986431
Q ss_pred -----------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 483 -----------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 483 -----------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
..++.++||||||+++|||++ |+.|+......+ .. ..+.....+ ..+
T Consensus 171 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~---~~--------------~~~~~~~~~----~~~ 229 (269)
T 4hcu_A 171 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VV--------------EDISTGFRL----YKP 229 (269)
T ss_dssp GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HH--------------HHHHTTCCC----CCC
T ss_pred cccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH---HH--------------HHHhcCccC----CCC
Confidence 124568999999999999999 899987543211 00 011111111 122
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 551 IDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
......+.+++..||+.||++||++.|+++.|+.+.++
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 230 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 23345688999999999999999999999999988654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=293.72 Aligned_cols=211 Identities=29% Similarity=0.419 Sum_probs=167.0
Q ss_pred ceEEEEEECCeEEEEEEcc-----------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATIDGKVLAVKKIK-----------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~~g~~vAvK~~~-----------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
+.||+|...|+.||||.++ +.+.+|++++++++||||+++++++.+. +..++||||+++|+|.+++..
T Consensus 21 g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~ 99 (271)
T 3dtc_A 21 GKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE-PNLCLVMEFARGGPLNRVLSG 99 (271)
T ss_dssp EEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC---CEEEEECCTTEEHHHHHTS
T ss_pred eEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC-CceEEEEEcCCCCCHHHHhhc
Confidence 5899999999999999885 3467899999999999999999998754 478999999999999999964
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCC--------CCcEEEeecCCCCCCCC
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDS--------RFKAKIANFSLAAPATN 483 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~--------~~~~kl~DFGla~~~~~ 483 (615)
. .+++..+..++.|++.||.|||+++..+|+||||||+|||++. ++.+||+|||+++....
T Consensus 100 ~-----------~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~ 168 (271)
T 3dtc_A 100 K-----------RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR 168 (271)
T ss_dssp S-----------CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC------
T ss_pred C-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccccccc
Confidence 3 2899999999999999999999997666999999999999986 67899999999864321
Q ss_pred ---------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcC
Q 047629 484 ---------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMD 542 (615)
Q Consensus 484 ---------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~d 542 (615)
.++.++||||||+++|||++|+.||........ ......
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--------------------~~~~~~ 228 (271)
T 3dtc_A 169 TTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV--------------------AYGVAM 228 (271)
T ss_dssp -------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH--------------------HHHHHT
T ss_pred ccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--------------------HHhhhc
Confidence 245689999999999999999999975442110 000111
Q ss_pred CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 047629 543 PNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVL 585 (615)
Q Consensus 543 p~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l 585 (615)
.......+......+.+++.+||+.||.+|||+.|+++.|+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 229 NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 1122223444456789999999999999999999999999764
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=327.80 Aligned_cols=215 Identities=22% Similarity=0.264 Sum_probs=168.3
Q ss_pred ccccccccc----ceEEEEEE--CCeEEEEEEccHH----------HHHH---HHHHHhcCCCCcccEEEEEEcCCCcEE
Q 047629 334 NLSEHYSIG----KSVYRATI--DGKVLAVKKIKED----------VTEE---LRILQRINHANLVKLMGVSSDSQGNRF 394 (615)
Q Consensus 334 ~~~~~~~iG----~~Vy~~~~--~g~~vAvK~~~~~----------~~~E---i~~l~~l~H~niv~l~g~~~~~~~~~~ 394 (615)
+|.-...|| |.||++.. +|+.||||++++. +.+| +.+++.++|||||++++++.+. ..+|
T Consensus 190 df~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~-~~ly 268 (689)
T 3v5w_A 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP-DKLS 268 (689)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS-SEEE
T ss_pred HeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC-CEEE
Confidence 444444555 58999998 7999999999632 2333 5666778999999999998764 4899
Q ss_pred EEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEee
Q 047629 395 LVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIAN 474 (615)
Q Consensus 395 lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~D 474 (615)
|||||+++|+|.++|.... .+++.....++.||+.||+|||+++ ||||||||+|||||.++.+||+|
T Consensus 269 lVmEy~~GGdL~~~l~~~~----------~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~D 335 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHG----------VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISD 335 (689)
T ss_dssp EEECCCCSCBHHHHHHHHC----------CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred EEEecCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecc
Confidence 9999999999999997654 3899999999999999999999998 99999999999999999999999
Q ss_pred cCCCCCCC----------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHH
Q 047629 475 FSLAAPAT----------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEK 532 (615)
Q Consensus 475 FGla~~~~----------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 532 (615)
||+|+... ..++.++||||+||+||||++|+.||..........+.. .
T Consensus 336 FGlA~~~~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~---~------- 405 (689)
T 3v5w_A 336 LGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR---M------- 405 (689)
T ss_dssp CTTCEECSSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHH---H-------
T ss_pred cceeeecCCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH---h-------
Confidence 99996432 125678999999999999999999997644322211110 0
Q ss_pred HHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 047629 533 REERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPN-----MAEVVFN 581 (615)
Q Consensus 533 ~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPs-----m~ev~~~ 581 (615)
... ..+ .+|......+.+|+..|++.||.+|++ +.||.++
T Consensus 406 ---i~~--~~~----~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 406 ---TLT--MAV----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp ---HHH--CCC----CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred ---hcC--CCC----CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 001 111 233334456789999999999999998 6887764
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=298.68 Aligned_cols=228 Identities=21% Similarity=0.298 Sum_probs=180.8
Q ss_pred eeeeHHHHHHHccc----------cccccccc----ceEEEEEE--CCeEEEEEEcc-------HHHHHHHHHHHhcCCC
Q 047629 321 IVYEIEVIMESTMN----------LSEHYSIG----KSVYRATI--DGKVLAVKKIK-------EDVTEELRILQRINHA 377 (615)
Q Consensus 321 ~~~~~~~l~~at~~----------~~~~~~iG----~~Vy~~~~--~g~~vAvK~~~-------~~~~~Ei~~l~~l~H~ 377 (615)
..++++++..++.. |.....+| |.||+|.. +|+.||||+++ +.+.+|+.++++++|+
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45788888888865 33333455 58999997 69999999985 3478999999999999
Q ss_pred CcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 047629 378 NLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDI 457 (615)
Q Consensus 378 niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDl 457 (615)
||+++++++... +..++||||+++|+|.+++... .++|..+..++.|++.||.|||+++ |+||||
T Consensus 103 niv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~-----------~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dl 167 (321)
T 2c30_A 103 NVVEMYKSYLVG-EELWVLMEFLQGGALTDIVSQV-----------RLNEEQIATVCEAVLQALAYLHAQG---VIHRDI 167 (321)
T ss_dssp TBCCEEEEEEET-TEEEEEECCCCSCBHHHHHTTC-----------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred CcceEEEEEEEC-CEEEEEEecCCCCCHHHHHHhc-----------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCC
Confidence 999999998764 4799999999999999998743 2899999999999999999999998 999999
Q ss_pred CCCceeeCCCCcEEEeecCCCCCCC-----------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCC
Q 047629 458 RTNNIQLDSRFKAKIANFSLAAPAT-----------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENG 514 (615)
Q Consensus 458 k~~NILld~~~~~kl~DFGla~~~~-----------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~ 514 (615)
||+|||++.++.+||+|||+++... ..++.++||||||+++|||++|+.||......
T Consensus 168 kp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~ 247 (321)
T 2c30_A 168 KSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV 247 (321)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred CHHHEEECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999999999999999999985432 12456899999999999999999999754311
Q ss_pred hhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047629 515 KTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNL 582 (615)
Q Consensus 515 ~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L 582 (615)
... ..+.....+.+. .+......+.+++.+||+.||++|||+.|+++.-
T Consensus 248 ---~~~--------------~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp 296 (321)
T 2c30_A 248 ---QAM--------------KRLRDSPPPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLDHP 296 (321)
T ss_dssp ---HHH--------------HHHHHSSCCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred ---HHH--------------HHHhcCCCCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 111 112222222221 1223345688999999999999999999999864
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=321.30 Aligned_cols=214 Identities=24% Similarity=0.398 Sum_probs=174.5
Q ss_pred ceEEEEEE-CCeEEEEEEcc------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCC
Q 047629 343 KSVYRATI-DGKVLAVKKIK------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKS 415 (615)
Q Consensus 343 ~~Vy~~~~-~g~~vAvK~~~------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~ 415 (615)
|.||+|.+ +++.||||+++ +.+.+|+++|++++||||+++++++. +...++||||+++|+|.+++.....
T Consensus 202 g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~- 278 (454)
T 1qcf_A 202 GEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT--KEPIYIITEFMAKGSLLDFLKSDEG- 278 (454)
T ss_dssp EEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSSCEEEECCCTTCBHHHHHHSHHH-
T ss_pred eEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe--CCccEEEEeecCCCcHHHHHHhccC-
Confidence 58999999 57899999986 45889999999999999999999985 3468999999999999999975431
Q ss_pred CCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------------
Q 047629 416 SSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------------- 482 (615)
Q Consensus 416 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------------- 482 (615)
..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 279 -------~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~ 348 (454)
T 1qcf_A 279 -------SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP 348 (454)
T ss_dssp -------HTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSC
T ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCccc
Confidence 13889999999999999999999998 9999999999999999999999999997532
Q ss_pred -----------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 483 -----------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 483 -----------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
..++.++|||||||+||||++ |+.||......+ ... .+..-.. ...+
T Consensus 349 ~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~---~~~--------------~i~~~~~----~~~~ 407 (454)
T 1qcf_A 349 IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIR--------------ALERGYR----MPRP 407 (454)
T ss_dssp GGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHH--------------HHHHTCC----CCCC
T ss_pred ccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH---HHH--------------HHHcCCC----CCCC
Confidence 124568999999999999999 999997543211 110 0111111 1123
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccchh
Q 047629 551 IDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQSTE 590 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~~ 590 (615)
...+..+.+|+..||+.||++||||++|++.|+.+....+
T Consensus 408 ~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~ 447 (454)
T 1qcf_A 408 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATE 447 (454)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSC
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccc
Confidence 3445678999999999999999999999999998876543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=291.19 Aligned_cols=213 Identities=25% Similarity=0.406 Sum_probs=171.7
Q ss_pred ceEEEEEE-CCeEEEEEEcc------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCC
Q 047629 343 KSVYRATI-DGKVLAVKKIK------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKS 415 (615)
Q Consensus 343 ~~Vy~~~~-~g~~vAvK~~~------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~ 415 (615)
|.||++.. ++..||||.++ .++.+|++++.+++||||+++++++.+ ++..++||||+++|+|.+++.....
T Consensus 22 g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~- 99 (268)
T 3sxs_A 22 GVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK-EYPIYIVTEYISNGCLLNYLRSHGK- 99 (268)
T ss_dssp EEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSEEEEEECCTTCBHHHHHHHHGG-
T ss_pred ceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEcc-CCceEEEEEccCCCcHHHHHHHcCC-
Confidence 58999988 56789999985 458899999999999999999999865 4479999999999999999976432
Q ss_pred CCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC------------
Q 047629 416 SSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------------ 483 (615)
Q Consensus 416 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------------ 483 (615)
.+++.+++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++....
T Consensus 100 --------~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 168 (268)
T 3sxs_A 100 --------GLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFP 168 (268)
T ss_dssp --------GCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCCCC
T ss_pred --------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCCCcC
Confidence 3899999999999999999999998 99999999999999999999999999864321
Q ss_pred ------------CCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 484 ------------DVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 484 ------------~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
.++.++||||||+++|||++ |+.|+......+.. ..+.....+ ..+
T Consensus 169 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-----------------~~~~~~~~~----~~~ 227 (268)
T 3sxs_A 169 VKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV-----------------LKVSQGHRL----YRP 227 (268)
T ss_dssp GGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-----------------HHHHTTCCC----CCC
T ss_pred cccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHH-----------------HHHHcCCCC----CCC
Confidence 13568999999999999999 99998754421100 011111111 112
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccch
Q 047629 551 IDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQST 589 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~ 589 (615)
......+.+++..||+.||.+|||+.|+++.|+.+.+..
T Consensus 228 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 228 HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 223346889999999999999999999999999887653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=299.08 Aligned_cols=214 Identities=24% Similarity=0.411 Sum_probs=172.3
Q ss_pred ceEEEEEE--CCeEEEEEEcc-------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
|.||++.. +|+.||+|++. +.+.+|++++++++||||+++++++.+. +..++||||+++|+|.+++....
T Consensus 24 g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~ 102 (310)
T 3s95_A 24 GQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD-KRLNFITEYIKGGTLRGIIKSMD 102 (310)
T ss_dssp EEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-TEEEEEEECCTTCBHHHHHHHCC
T ss_pred EEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC-CeeEEEEEecCCCcHHHHHHhcc
Confidence 58999998 58999999874 3578999999999999999999998764 47999999999999999998744
Q ss_pred CCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----------
Q 047629 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----------- 482 (615)
Q Consensus 414 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----------- 482 (615)
. .++|.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 103 ~---------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 170 (310)
T 3s95_A 103 S---------QYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRS 170 (310)
T ss_dssp T---------TSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC-----------
T ss_pred C---------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccccccccccc
Confidence 3 3899999999999999999999998 9999999999999999999999999985421
Q ss_pred --------------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHH
Q 047629 483 --------------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREER 536 (615)
Q Consensus 483 --------------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 536 (615)
..++.++||||||+++|||++|+.|+............ .. ...
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~-~~----------~~~ 239 (310)
T 3s95_A 171 LKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL-NV----------RGF 239 (310)
T ss_dssp ---------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB-CH----------HHH
T ss_pred ccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh-hh----------hcc
Confidence 12467899999999999999999988654322110000 00 001
Q ss_pred HhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 537 LRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 537 ~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
..... +......+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 240 ~~~~~--------~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 240 LDRYC--------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp HHHTC--------CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccccC--------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 11111 122223478999999999999999999999999988755
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=300.90 Aligned_cols=229 Identities=24% Similarity=0.373 Sum_probs=173.5
Q ss_pred ceEEEEEE------CCeEEEEEEcc-------HHHHHHHHHHHhcCCCCcccEEEEEEcCC-CcEEEEEeecCCCCHHHh
Q 047629 343 KSVYRATI------DGKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVSSDSQ-GNRFLVYEYAENGSLDKW 408 (615)
Q Consensus 343 ~~Vy~~~~------~g~~vAvK~~~-------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~~lV~E~~~~GsL~~~ 408 (615)
|.||++.+ +|+.||||+++ +.+.+|++++++++||||+++++++...+ ...++||||+++|+|.++
T Consensus 24 g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 103 (295)
T 3ugc_A 24 GSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDY 103 (295)
T ss_dssp EEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHH
T ss_pred EEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHH
Confidence 58999985 58999999985 35788999999999999999999986432 358999999999999999
Q ss_pred hccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC-----
Q 047629 409 LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN----- 483 (615)
Q Consensus 409 L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~----- 483 (615)
+..... .+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 104 l~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 171 (295)
T 3ugc_A 104 LQKHKE---------RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF 171 (295)
T ss_dssp HHHCGG---------GCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC---------
T ss_pred HHhccc---------ccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccccccCCccee
Confidence 976542 3899999999999999999999998 99999999999999999999999999965321
Q ss_pred ---------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcC
Q 047629 484 ---------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMD 542 (615)
Q Consensus 484 ---------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~d 542 (615)
.++.++||||||+++|||++|+.|+...... ......... ........+.+.+.
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~~~~ 246 (295)
T 3ugc_A 172 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDK-QGQMIVFHLIELLK 246 (295)
T ss_dssp ----CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH----HHHHHCTTC-CTHHHHHHHHHHHH
T ss_pred eeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH----HHhhhcCcc-ccchhHHHHHHHHh
Confidence 1356899999999999999999987642210 000000000 00000011111111
Q ss_pred CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 543 PNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 543 p~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
.......+......+.+++..||+.||++|||++|+++.|+.+.+.
T Consensus 247 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 247 NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 1222233445556789999999999999999999999999988654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=309.22 Aligned_cols=235 Identities=26% Similarity=0.387 Sum_probs=180.7
Q ss_pred Hccccccccccc----ceEEEEEE-------CCeEEEEEEccH--------HHHHHHHHHHhc-CCCCcccEEEEEEcCC
Q 047629 331 STMNLSEHYSIG----KSVYRATI-------DGKVLAVKKIKE--------DVTEELRILQRI-NHANLVKLMGVSSDSQ 390 (615)
Q Consensus 331 at~~~~~~~~iG----~~Vy~~~~-------~g~~vAvK~~~~--------~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 390 (615)
..++|.....+| |.||+|.+ +++.||||+++. .+.+|++++.++ +||||+++++++.+.+
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 99 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 99 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC
Confidence 344555555555 58999984 358999999852 478899999999 8999999999988766
Q ss_pred CcEEEEEeecCCCCHHHhhccCCCCCCC----------------------------------------------------
Q 047629 391 GNRFLVYEYAENGSLDKWLHPKSKSSSS---------------------------------------------------- 418 (615)
Q Consensus 391 ~~~~lV~E~~~~GsL~~~L~~~~~~~~~---------------------------------------------------- 418 (615)
+..++||||+++|+|.+++.........
T Consensus 100 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (359)
T 3vhe_A 100 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179 (359)
T ss_dssp SCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------------
T ss_pred CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhc
Confidence 5689999999999999999865421000
Q ss_pred ----CCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC-----------
Q 047629 419 ----SGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN----------- 483 (615)
Q Consensus 419 ----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~----------- 483 (615)
......+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 180 ~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 256 (359)
T 3vhe_A 180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256 (359)
T ss_dssp ----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CE
T ss_pred ccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccC
Confidence 000112899999999999999999999998 99999999999999999999999999875311
Q ss_pred --------------CCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCC
Q 047629 484 --------------DVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESF 548 (615)
Q Consensus 484 --------------~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~ 548 (615)
.++.++||||||+++|||++ |+.||......+.. .. .+.....+.
T Consensus 257 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--~~--------------~~~~~~~~~---- 316 (359)
T 3vhe_A 257 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CR--------------RLKEGTRMR---- 316 (359)
T ss_dssp ECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH--HH--------------HHHHTCCCC----
T ss_pred CCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH--HH--------------HHHcCCCCC----
Confidence 13568999999999999999 99999765432211 10 111111122
Q ss_pred CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 549 YPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 549 ~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
.+......+.+++..||+.||.+|||+.|++++|+.+.+.
T Consensus 317 ~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 317 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 2233344688999999999999999999999999988754
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=295.10 Aligned_cols=218 Identities=25% Similarity=0.400 Sum_probs=167.9
Q ss_pred ceEEEEEECCeEEEEEEccH----HHHHHHHHHHh--cCCCCcccEEEEEEcC---CCcEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATIDGKVLAVKKIKE----DVTEELRILQR--INHANLVKLMGVSSDS---QGNRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~~g~~vAvK~~~~----~~~~Ei~~l~~--l~H~niv~l~g~~~~~---~~~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
|.||+|..+|+.||||+++. .+..|.+++.. ++||||+++++++... ....++||||+++|+|.+++...
T Consensus 22 g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~- 100 (301)
T 3q4u_A 22 GEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT- 100 (301)
T ss_dssp EEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTTC-
T ss_pred cEEEEEEECCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhhc-
Confidence 58999999999999999863 45667888777 7999999999987542 22479999999999999999643
Q ss_pred CCCCCCCcccccCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC--
Q 047629 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMH--------EHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN-- 483 (615)
Q Consensus 414 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~-- 483 (615)
.+++..++.++.|++.||+||| +++ |+||||||+|||++.++.+||+|||+++....
T Consensus 101 ----------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 167 (301)
T 3q4u_A 101 ----------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIADLGLAVMHSQST 167 (301)
T ss_dssp ----------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCCTTCEEEETTT
T ss_pred ----------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEeeCCCeeeccccc
Confidence 2899999999999999999999 665 99999999999999999999999999843210
Q ss_pred -------------------------------CCCCcccchhHHHHHHHHHcC----------CCCCCCCCCChhHHHHHH
Q 047629 484 -------------------------------DVMPKFDVFAFGVVLLELLSG----------KKATRTTENGKTAVLWKE 522 (615)
Q Consensus 484 -------------------------------~~~~k~DV~SfGvvl~ElltG----------~~p~~~~~~~~~~~l~~~ 522 (615)
.+++++|||||||++|||++| +.||.......... ..
T Consensus 168 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~--~~ 245 (301)
T 3q4u_A 168 NQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF--ED 245 (301)
T ss_dssp TEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH--HH
T ss_pred ccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcch--hh
Confidence 112478999999999999999 77776543221110 00
Q ss_pred HHHHHhHHHHHHHHHhhhcCCcCCC-CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 047629 523 IREVLKVEEKREERLRNWMDPNLES-FYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVL 585 (615)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~~dp~l~~-~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l 585 (615)
+.. ........+.+.. .++......+.+++.+||+.||++|||+.||++.|+.+
T Consensus 246 ~~~---------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 246 MRK---------VVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp HHH---------HHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred hhH---------HHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 110 1111112222221 12335677899999999999999999999999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-35 Score=304.25 Aligned_cols=212 Identities=20% Similarity=0.390 Sum_probs=169.7
Q ss_pred ceEEEEEE--CCe----EEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHh
Q 047629 343 KSVYRATI--DGK----VLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKW 408 (615)
Q Consensus 343 ~~Vy~~~~--~g~----~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~ 408 (615)
|.||+|.. +|+ .||+|.++ +.+.+|+.++++++||||++++++|.+. ..++|+||+++|+|.++
T Consensus 29 g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~v~e~~~~g~L~~~ 106 (327)
T 3poz_A 29 GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--TVQLITQLMPFGCLLDY 106 (327)
T ss_dssp EEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS--SEEEEEECCTTCBHHHH
T ss_pred eEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--CeEEEEEecCCCcHHHH
Confidence 58999997 444 36888874 3578899999999999999999999753 58899999999999999
Q ss_pred hccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC------
Q 047629 409 LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------ 482 (615)
Q Consensus 409 L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------ 482 (615)
+..... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 107 l~~~~~---------~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 174 (327)
T 3poz_A 107 VREHKD---------NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174 (327)
T ss_dssp HHHSTT---------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC--
T ss_pred HHhcCC---------CCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEccCCcccc
Confidence 987543 3899999999999999999999998 9999999999999999999999999985321
Q ss_pred -------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcC
Q 047629 483 -------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMD 542 (615)
Q Consensus 483 -------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~d 542 (615)
..++.++|||||||++|||++ |+.||......+.. . .+..
T Consensus 175 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-------~----------~~~~--- 234 (327)
T 3poz_A 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-------S----------ILEK--- 234 (327)
T ss_dssp -----CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-------H----------HHHT---
T ss_pred cccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH-------H----------HHHc---
Confidence 124568999999999999999 99999765432211 0 0111
Q ss_pred CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccch
Q 047629 543 PNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQST 589 (615)
Q Consensus 543 p~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~ 589 (615)
......+......+.+++.+||+.||.+||+|+|+++.|+.+....
T Consensus 235 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 280 (327)
T 3poz_A 235 -GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp -TCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred -CCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence 1111233445567899999999999999999999999999886553
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-35 Score=308.32 Aligned_cols=223 Identities=28% Similarity=0.384 Sum_probs=174.0
Q ss_pred ceEEEEEE-------CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATI-------DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~-------~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~ 407 (615)
|.||+|.+ +++.||||+++ ..+.+|+.++++++|+||+++++++.+. +..++||||+++|+|.+
T Consensus 85 g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~~lv~e~~~~g~L~~ 163 (367)
T 3l9p_A 85 GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS-LPRFILLELMAGGDLKS 163 (367)
T ss_dssp SCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSCEEEEECCTTEEHHH
T ss_pred EEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC-CCCEEEEEeCCCCCHHH
Confidence 58999985 35689999985 2477899999999999999999998754 47899999999999999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCC---cEEEeecCCCCCC---
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRF---KAKIANFSLAAPA--- 481 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~---~~kl~DFGla~~~--- 481 (615)
++........ ....+++.+++.++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||+++..
T Consensus 164 ~l~~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~ 237 (367)
T 3l9p_A 164 FLRETRPRPS---QPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 237 (367)
T ss_dssp HHHHHSCCSS---SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHH
T ss_pred HHHhhccccC---ccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEECCCccccccccc
Confidence 9976542111 1124899999999999999999999998 99999999999999554 5999999998521
Q ss_pred ----------------------CCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHh
Q 047629 482 ----------------------TNDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLR 538 (615)
Q Consensus 482 ----------------------~~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 538 (615)
...++.++|||||||++|||++ |+.||......+ .. ..+.
T Consensus 238 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~---~~--------------~~i~ 300 (367)
T 3l9p_A 238 GYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VL--------------EFVT 300 (367)
T ss_dssp SSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HH--------------HHHH
T ss_pred cccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH--------------HHHH
Confidence 1124668999999999999998 999987543211 00 0111
Q ss_pred hhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccchhhhh
Q 047629 539 NWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQSTETLE 593 (615)
Q Consensus 539 ~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~~~~~ 593 (615)
.... ...+......+.+|+..||+.||.+||++.||++.|+.+.+......
T Consensus 301 ~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~~~ 351 (367)
T 3l9p_A 301 SGGR----MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVIN 351 (367)
T ss_dssp TTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHHT
T ss_pred cCCC----CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhhcc
Confidence 1111 12233444568999999999999999999999999998887765443
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=292.78 Aligned_cols=211 Identities=25% Similarity=0.408 Sum_probs=172.3
Q ss_pred ceEEEEEE-CCeEEEEEEcc------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCC
Q 047629 343 KSVYRATI-DGKVLAVKKIK------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKS 415 (615)
Q Consensus 343 ~~Vy~~~~-~g~~vAvK~~~------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~ 415 (615)
|.||++.. ++..||||+++ +++.+|++++.+++|+||+++++++.+ ++..++||||+++|+|.+++.....
T Consensus 38 g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~- 115 (283)
T 3gen_A 38 GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK-QRPIFIITEYMANGCLLNYLREMRH- 115 (283)
T ss_dssp EEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSEEEEECCCTTCBHHHHHHCGGG-
T ss_pred ceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEec-CCCeEEEEeccCCCcHHHHHHHhcc-
Confidence 58999998 56789999986 458899999999999999999999865 4479999999999999999976432
Q ss_pred CCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------------
Q 047629 416 SSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------------- 482 (615)
Q Consensus 416 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------------- 482 (615)
.+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 116 --------~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 184 (283)
T 3gen_A 116 --------RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP 184 (283)
T ss_dssp --------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSC
T ss_pred --------CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccccccccCCccC
Confidence 3899999999999999999999998 9999999999999999999999999986431
Q ss_pred -----------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 483 -----------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 483 -----------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
..++.++||||||+++|||++ |+.||......+. ...+.....+ ..+
T Consensus 185 ~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~-----------------~~~~~~~~~~----~~~ 243 (283)
T 3gen_A 185 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-----------------AEHIAQGLRL----YRP 243 (283)
T ss_dssp GGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-----------------HHHHHTTCCC----CCC
T ss_pred cccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH-----------------HHHHhcccCC----CCC
Confidence 124568999999999999998 9999875442110 0111111111 122
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 047629 551 IDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQ 587 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~ 587 (615)
......+.+++.+||+.||.+|||++|+++.|..+..
T Consensus 244 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 244 HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 2334568899999999999999999999999987764
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=315.28 Aligned_cols=214 Identities=28% Similarity=0.424 Sum_probs=173.0
Q ss_pred ceEEEEEEC-CeEEEEEEcc------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCC
Q 047629 343 KSVYRATID-GKVLAVKKIK------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKS 415 (615)
Q Consensus 343 ~~Vy~~~~~-g~~vAvK~~~------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~ 415 (615)
|.||+|.+. +..||||+++ +++.+|+++|++++||||+++++++.+ +..++||||+++|+|.+++.....
T Consensus 198 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~iv~e~~~~gsL~~~l~~~~~- 274 (452)
T 1fmk_A 198 GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTEYMSKGSLLDFLKGETG- 274 (452)
T ss_dssp CEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEECCCTTCBHHHHHSHHHH-
T ss_pred eEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CceEEEehhhcCCCHHHHHHhcCC-
Confidence 589999994 5789999986 468899999999999999999999864 468999999999999999975321
Q ss_pred CCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC------------
Q 047629 416 SSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------------ 483 (615)
Q Consensus 416 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------------ 483 (615)
..+++.+++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 275 -------~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 344 (452)
T 1fmk_A 275 -------KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 344 (452)
T ss_dssp -------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------------CC
T ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCceecccCCccc
Confidence 13899999999999999999999998 99999999999999999999999999975421
Q ss_pred ------------CCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 484 ------------DVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 484 ------------~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
.++.++|||||||++|||++ |+.|+......+ .. . .+..-. ....+
T Consensus 345 ~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~----~----------~i~~~~----~~~~~ 403 (452)
T 1fmk_A 345 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VL----D----------QVERGY----RMPCP 403 (452)
T ss_dssp GGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HH----H----------HHHTTC----CCCCC
T ss_pred ccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH---HH----H----------HHHcCC----CCCCC
Confidence 24568999999999999999 999987543211 00 0 111111 11233
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccchh
Q 047629 551 IDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQSTE 590 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~~ 590 (615)
......+.+++..||+.||++|||++++++.|+.+..+.+
T Consensus 404 ~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 404 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443 (452)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence 4455678999999999999999999999999998876543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=291.28 Aligned_cols=216 Identities=21% Similarity=0.343 Sum_probs=173.3
Q ss_pred ceEEEEEECCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCC-CcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATIDGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQ-GNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
|.||+|..+|+.||||+++ +.+.+|+.++++++||||+++++++.+.+ +..++||||+++|+|.+++...
T Consensus 24 g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 103 (271)
T 3kmu_A 24 GELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEG 103 (271)
T ss_dssp EEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSC
T ss_pred ceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhc
Confidence 5899999999999999985 24788999999999999999999987542 4689999999999999999865
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCCC--------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATND-------- 484 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~-------- 484 (615)
... .+++.+++.++.|++.||.|||+++ ++++||||||+|||++.++.+|++|||++......
T Consensus 104 ~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~t~~y 174 (271)
T 3kmu_A 104 TNF--------VVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAPAW 174 (271)
T ss_dssp SSC--------CCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSCTTCBSCGGG
T ss_pred ccC--------CCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecccCccCCccc
Confidence 431 3899999999999999999999874 45999999999999999999999998886443111
Q ss_pred ----------C---CCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCCh
Q 047629 485 ----------V---MPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPI 551 (615)
Q Consensus 485 ----------~---~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~ 551 (615)
. +.++||||||+++|||++|+.||......+. . .........+.+ +.
T Consensus 175 ~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~----------~~~~~~~~~~~~----~~ 234 (271)
T 3kmu_A 175 VAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI------G----------MKVALEGLRPTI----PP 234 (271)
T ss_dssp SCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH------H----------HHHHHSCCCCCC----CT
T ss_pred cChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH------H----------HHHHhcCCCCCC----CC
Confidence 1 1269999999999999999999975432110 0 011112222322 33
Q ss_pred HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 047629 552 DGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQ 587 (615)
Q Consensus 552 ~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~ 587 (615)
.....+.+++..||+.||++|||++|+++.|+.+.+
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 235 GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 444568999999999999999999999999998764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-34 Score=292.69 Aligned_cols=205 Identities=20% Similarity=0.361 Sum_probs=167.0
Q ss_pred ceEEEEEE--CCeEEEEEEcc-------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
|.||++.. +|+.||||++. +.+.+|+.++++++||||+++++++... +..++||||+++|+|.+++...
T Consensus 34 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~- 111 (297)
T 3fxz_A 34 GTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-DELWVVMEYLAGGSLTDVVTET- 111 (297)
T ss_dssp EEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEECCTTCBHHHHHHHS-
T ss_pred eEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC-CEEEEEEECCCCCCHHHHHhhc-
Confidence 58999986 78999999985 3478899999999999999999998764 4799999999999999999754
Q ss_pred CCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----------
Q 047629 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----------- 482 (615)
Q Consensus 414 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----------- 482 (615)
.+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 112 ----------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 178 (297)
T 3fxz_A 112 ----------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG 178 (297)
T ss_dssp ----------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCS
T ss_pred ----------CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCCccC
Confidence 2889999999999999999999998 9999999999999999999999999985432
Q ss_pred ------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 483 ------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 483 ------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
..++.++|||||||++|||++|+.||........ ... +.....+.+ ..+
T Consensus 179 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~-----------~~~~~~~~~--~~~ 239 (297)
T 3fxz_A 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYL-----------IATNGTPEL--QNP 239 (297)
T ss_dssp CGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHH-----------HHHHCSCCC--SCG
T ss_pred CcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHH-----------HHhCCCCCC--CCc
Confidence 1246789999999999999999999975432111 000 000111111 223
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 551 IDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
......+.+++.+||+.||++|||+.|+++.
T Consensus 240 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 240 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 3445568999999999999999999999885
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=300.64 Aligned_cols=233 Identities=30% Similarity=0.448 Sum_probs=176.6
Q ss_pred cccccccccc----ceEEEEEECC-------eEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcE
Q 047629 333 MNLSEHYSIG----KSVYRATIDG-------KVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNR 393 (615)
Q Consensus 333 ~~~~~~~~iG----~~Vy~~~~~g-------~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 393 (615)
++|.....+| |.||+|...+ +.||||.++ +.+.+|++++++++||||+++++++.+. +..
T Consensus 47 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~ 125 (343)
T 1luf_A 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG-KPM 125 (343)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-SSC
T ss_pred HHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC-Cce
Confidence 3444444454 5899999743 889999985 2477899999999999999999998754 478
Q ss_pred EEEEeecCCCCHHHhhccCCCCCC--------------CCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 047629 394 FLVYEYAENGSLDKWLHPKSKSSS--------------SSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRT 459 (615)
Q Consensus 394 ~lV~E~~~~GsL~~~L~~~~~~~~--------------~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~ 459 (615)
++||||+++|+|.+++........ .......+++.+++.++.|++.||.|||+++ |+||||||
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp 202 (343)
T 1luf_A 126 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLAT 202 (343)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCc
Confidence 999999999999999976432100 0000124899999999999999999999998 99999999
Q ss_pred CceeeCCCCcEEEeecCCCCCCC-------------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCC
Q 047629 460 NNIQLDSRFKAKIANFSLAAPAT-------------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTEN 513 (615)
Q Consensus 460 ~NILld~~~~~kl~DFGla~~~~-------------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~ 513 (615)
+|||++.++.+||+|||+++... ..++.++||||||+++|||++ |+.|+.....
T Consensus 203 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 282 (343)
T 1luf_A 203 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 282 (343)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred ceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh
Confidence 99999999999999999874321 124568999999999999999 9999875432
Q ss_pred ChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccchh
Q 047629 514 GKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQSTE 590 (615)
Q Consensus 514 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~~ 590 (615)
.+ . .. .+.+ ... ...+......+.+++..||+.||.+||++.|+++.|+.+.+..+
T Consensus 283 ~~---~----~~----------~~~~---~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 283 EE---V----IY----------YVRD---GNI-LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp HH---H----HH----------HHHT---TCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred HH---H----HH----------HHhC---CCc-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 11 0 00 0111 111 12233444568999999999999999999999999998876543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=288.85 Aligned_cols=212 Identities=31% Similarity=0.498 Sum_probs=169.6
Q ss_pred ceEEEEEE--CCeEEEEEEcc--------------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHH
Q 047629 343 KSVYRATI--DGKVLAVKKIK--------------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLD 406 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~--------------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~ 406 (615)
|.||+|.. +++.||||++. +.+.+|++++++++|+||+++++++.+ ..++||||+++|+|.
T Consensus 33 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~lv~e~~~~~~L~ 109 (287)
T 4f0f_A 33 GLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN---PPRMVMEFVPCGDLY 109 (287)
T ss_dssp SCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT---TTEEEEECCTTCBHH
T ss_pred eeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC---CCeEEEEecCCCCHH
Confidence 58999998 78999999884 457889999999999999999998753 237999999999999
Q ss_pred HhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCc-----EEEeecCCCCCC
Q 047629 407 KWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFK-----AKIANFSLAAPA 481 (615)
Q Consensus 407 ~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~-----~kl~DFGla~~~ 481 (615)
+++..... .+++..++.++.|++.||+|||+++ ++|+||||||+|||++.++. +||+|||+++..
T Consensus 110 ~~l~~~~~---------~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~ 179 (287)
T 4f0f_A 110 HRLLDKAH---------PIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS 179 (287)
T ss_dssp HHHHCTTS---------CCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCC
T ss_pred HHHhcccC---------CccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCCccccc
Confidence 99876543 3899999999999999999999985 34999999999999988776 999999998643
Q ss_pred CC----------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhh
Q 047629 482 TN----------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRN 539 (615)
Q Consensus 482 ~~----------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 539 (615)
.. .++.++||||||+++|||++|+.||.......... .. .....
T Consensus 180 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~-------------~~~~~ 245 (287)
T 4f0f_A 180 VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF-IN-------------MIREE 245 (287)
T ss_dssp SSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH-HH-------------HHHHS
T ss_pred cccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH-HH-------------HHhcc
Confidence 21 13457899999999999999999997654332211 00 01111
Q ss_pred hcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 047629 540 WMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVL 585 (615)
Q Consensus 540 ~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l 585 (615)
...+ ..+......+.+++..||+.||.+|||+.|+++.|+.+
T Consensus 246 ~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 246 GLRP----TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CCCC----CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1222 23344455689999999999999999999999999864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-34 Score=303.51 Aligned_cols=223 Identities=25% Similarity=0.384 Sum_probs=174.2
Q ss_pred ceEEEEEEC---------CeEEEEEEcc--------HHHHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCC
Q 047629 343 KSVYRATID---------GKVLAVKKIK--------EDVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGS 404 (615)
Q Consensus 343 ~~Vy~~~~~---------g~~vAvK~~~--------~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~Gs 404 (615)
|.||+|... ++.||||+++ ..+.+|+++++++ +||||+++++++.+ ++..++||||+++|+
T Consensus 83 g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~-~~~~~lv~e~~~~g~ 161 (382)
T 3tt0_A 83 GQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-DGPLYVIVEYASKGN 161 (382)
T ss_dssp EEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEEEEECCTTCB
T ss_pred eEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc-CCceEEEEEecCCCc
Confidence 589999852 3679999985 3477899999999 99999999999875 447899999999999
Q ss_pred HHHhhccCCCCCC------CCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCC
Q 047629 405 LDKWLHPKSKSSS------SSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA 478 (615)
Q Consensus 405 L~~~L~~~~~~~~------~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla 478 (615)
|.+++........ .......+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 162 L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DFG~a 238 (382)
T 3tt0_A 162 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLA 238 (382)
T ss_dssp HHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSCSCC
T ss_pred HHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEEcCCCcEEEcccCcc
Confidence 9999976542110 0001124899999999999999999999998 999999999999999999999999998
Q ss_pred CCCCC-------------------------CCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHH
Q 047629 479 APATN-------------------------DVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEK 532 (615)
Q Consensus 479 ~~~~~-------------------------~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 532 (615)
+.... .++.++|||||||++|||++ |+.|+......+ +.
T Consensus 239 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~-------~~-------- 303 (382)
T 3tt0_A 239 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-------LF-------- 303 (382)
T ss_dssp CCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------HH--------
T ss_pred cccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HH--------
Confidence 74321 13558999999999999999 999987543111 11
Q ss_pred HHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccchh
Q 047629 533 REERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQSTE 590 (615)
Q Consensus 533 ~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~~ 590 (615)
..+.....+ ..+......+.+++.+||+.||++|||++||++.|+.+.....
T Consensus 304 --~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 355 (382)
T 3tt0_A 304 --KLLKEGHRM----DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 355 (382)
T ss_dssp --HHHHTTCCC----CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred --HHHHcCCCC----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 111111111 2233444568999999999999999999999999998875543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-34 Score=291.48 Aligned_cols=217 Identities=24% Similarity=0.350 Sum_probs=173.4
Q ss_pred ceEEEEEE--CCeEEEEEEcc----------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIK----------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~----------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||++.. +|+.||+|.+. +.+.+|+.++.+++||||+++++++.+. +..++||||+++|+|.+++.
T Consensus 25 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~g~~L~~~l~ 103 (294)
T 4eqm_A 25 STVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEED-DCYYLVMEYIEGPTLSEYIE 103 (294)
T ss_dssp EEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECS-SEEEEEEECCCSCBHHHHHH
T ss_pred EEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeC-CeEEEEEeCCCCCCHHHHHH
Confidence 58999986 68999999873 3577899999999999999999998754 47999999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC-------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------- 483 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------- 483 (615)
... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 104 ~~~----------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 170 (294)
T 4eqm_A 104 SHG----------PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTN 170 (294)
T ss_dssp HHC----------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC---------
T ss_pred hcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccccccccccC
Confidence 653 3899999999999999999999998 99999999999999999999999999864321
Q ss_pred -----------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCC
Q 047629 484 -----------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLE 546 (615)
Q Consensus 484 -----------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~ 546 (615)
..+.++||||||+++|||++|+.||........ .. ..+.+. .+.+.
T Consensus 171 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~----------~~~~~~-~~~~~ 233 (294)
T 4eqm_A 171 HVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI------AI----------KHIQDS-VPNVT 233 (294)
T ss_dssp ----CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH------HH----------HHHSSC-CCCHH
T ss_pred ccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HH----------HHhhcc-CCCcc
Confidence 245689999999999999999999975432110 00 001110 11111
Q ss_pred CCCChHHHHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHhcccchh
Q 047629 547 SFYPIDGALSLATLARACTMDKSLSRP-NMAEVVFNLSVLTQSTE 590 (615)
Q Consensus 547 ~~~~~~~~~~l~~l~~~C~~~dP~~RP-sm~ev~~~L~~l~~~~~ 590 (615)
...+.+.+..+.+++.+|++.||.+|| +++++.+.|+.+.....
T Consensus 234 ~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 234 TDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp HHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred hhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence 112233445689999999999999999 89999999998876544
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=319.81 Aligned_cols=214 Identities=28% Similarity=0.423 Sum_probs=174.3
Q ss_pred ceEEEEEEC-CeEEEEEEcc------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCC
Q 047629 343 KSVYRATID-GKVLAVKKIK------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKS 415 (615)
Q Consensus 343 ~~Vy~~~~~-g~~vAvK~~~------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~ 415 (615)
|.||+|.+. +..||||+++ +++.+|+++|++++|+||+++++++.+ +..++||||+++|+|.++|.....
T Consensus 281 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~- 357 (535)
T 2h8h_A 281 GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTEYMSKGSLLDFLKGETG- 357 (535)
T ss_dssp EEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEECCCTTEEHHHHHSHHHH-
T ss_pred eEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee--ccceEeeehhcCCcHHHHHhhcCC-
Confidence 589999994 5789999986 468899999999999999999999864 468999999999999999975321
Q ss_pred CCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC------------
Q 047629 416 SSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------------ 483 (615)
Q Consensus 416 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------------ 483 (615)
..+++.+++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 358 -------~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~ 427 (535)
T 2h8h_A 358 -------KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 427 (535)
T ss_dssp -------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSC
T ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCCcCc
Confidence 13899999999999999999999998 99999999999999999999999999975421
Q ss_pred ------------CCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 484 ------------DVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 484 ------------~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
.++.++|||||||+||||++ |+.||......+ .. . .+..... ...+
T Consensus 428 ~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~---~~----~----------~i~~~~~----~~~~ 486 (535)
T 2h8h_A 428 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VL----D----------QVERGYR----MPCP 486 (535)
T ss_dssp GGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH---HH----H----------HHHTTCC----CCCC
T ss_pred ccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----H----------HHHcCCC----CCCC
Confidence 24568999999999999999 899987543211 00 0 1111111 1223
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccchh
Q 047629 551 IDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQSTE 590 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~~ 590 (615)
..+...+.+|+..||+.||++|||+++|++.|+.+..+.+
T Consensus 487 ~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 487 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 3455678999999999999999999999999998876543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-34 Score=295.03 Aligned_cols=228 Identities=25% Similarity=0.374 Sum_probs=176.1
Q ss_pred ceEEEEEE------CCeEEEEEEccH--------HHHHHHHHHHhcCCCCcccEEEEEEcCC-CcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATI------DGKVLAVKKIKE--------DVTEELRILQRINHANLVKLMGVSSDSQ-GNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~------~g~~vAvK~~~~--------~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~~lV~E~~~~GsL~~ 407 (615)
|.||++.+ +|+.||||+++. .+.+|++++++++|+||+++++++.+.+ ...++||||+++|+|.+
T Consensus 45 g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~ 124 (318)
T 3lxp_A 45 GKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRD 124 (318)
T ss_dssp EEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHH
T ss_pred eEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHH
Confidence 58988875 578999999863 3788999999999999999999987643 35799999999999999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCCC---
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATND--- 484 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~--- 484 (615)
++.... +++.+++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 125 ~l~~~~-----------~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 190 (318)
T 3lxp_A 125 YLPRHS-----------IGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 190 (318)
T ss_dssp HGGGSC-----------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSE
T ss_pred HHhhCC-----------CCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccccccccc
Confidence 997542 889999999999999999999998 999999999999999999999999998654211
Q ss_pred -----------------------CCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhc
Q 047629 485 -----------------------VMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWM 541 (615)
Q Consensus 485 -----------------------~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 541 (615)
++.++||||||+++|||++|+.|+........ .... ..........+.+.+
T Consensus 191 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~-----~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 191 YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIG-----IAQGQMTVLRLTELL 264 (318)
T ss_dssp EEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHC-----SCCHHHHHHHHHHHH
T ss_pred cccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhc-----ccccchhHHHHHHHH
Confidence 23478999999999999999999864321100 0000 000000111222222
Q ss_pred CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccchh
Q 047629 542 DPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQSTE 590 (615)
Q Consensus 542 dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~~ 590 (615)
+.......+......+.+|+++||+.||++|||+.|+++.|+.+.+...
T Consensus 265 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 265 ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 2233333444555678999999999999999999999999998876543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-34 Score=297.23 Aligned_cols=203 Identities=27% Similarity=0.413 Sum_probs=165.6
Q ss_pred ceEEEEEE--CCeEEEEEEccH---------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE---------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~---------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
|.||+|.. +|+.||||++.. .+.+|+++|++++||||+++++++... +..++||||+++|+|.+++..
T Consensus 29 g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-~~~~lv~e~~~~~~L~~~l~~ 107 (328)
T 3fe3_A 29 AKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETE-KTLYLIMEYASGGEVFDYLVA 107 (328)
T ss_dssp EEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEECCCTTCBHHHHHHH
T ss_pred EEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-CEEEEEEECCCCCcHHHHHHH
Confidence 48999997 799999999852 367899999999999999999998754 479999999999999999976
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC--------
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN-------- 483 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~-------- 483 (615)
.. .+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 108 ~~----------~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 174 (328)
T 3fe3_A 108 HG----------RMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC 174 (328)
T ss_dssp HC----------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGGTTS
T ss_pred cC----------CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCCCcccccc
Confidence 54 2899999999999999999999998 99999999999999999999999999864321
Q ss_pred --------------C-CCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCC
Q 047629 484 --------------D-VMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESF 548 (615)
Q Consensus 484 --------------~-~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~ 548 (615)
. .++++|||||||++|||++|+.||...... .+ ... .... .. .
T Consensus 175 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~----~~~---------i~~~--~~----~ 232 (328)
T 3fe3_A 175 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK---EL----RER---------VLRG--KY----R 232 (328)
T ss_dssp SSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----HHH---------HHHC--CC----C
T ss_pred CCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH---HH----HHH---------HHhC--CC----C
Confidence 1 135899999999999999999999754311 10 000 0010 11 1
Q ss_pred CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 549 YPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 549 ~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.|......+.+|+.+||+.||.+|||+.|++++
T Consensus 233 ~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 233 IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 233334557899999999999999999999875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-34 Score=286.51 Aligned_cols=212 Identities=25% Similarity=0.438 Sum_probs=172.8
Q ss_pred ceEEEEEE-CCeEEEEEEcc------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCC
Q 047629 343 KSVYRATI-DGKVLAVKKIK------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKS 415 (615)
Q Consensus 343 ~~Vy~~~~-~g~~vAvK~~~------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~ 415 (615)
+.||++.. +++.||+|.++ +.+.+|++++++++||||+++++++.+. +..++||||+++|+|.+++.....
T Consensus 22 g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~- 99 (267)
T 3t9t_A 22 GLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-APICLVTEFMEHGCLSDYLRTQRG- 99 (267)
T ss_dssp EEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSS-SSCEEEECCCTTCBHHHHHHHTTT-
T ss_pred eeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccC-CCeEEEEeCCCCCcHHHHHhhCcc-
Confidence 58999998 78899999986 4588999999999999999999998754 478999999999999999976543
Q ss_pred CCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------------
Q 047629 416 SSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------------- 482 (615)
Q Consensus 416 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------------- 482 (615)
.+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++...
T Consensus 100 --------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 168 (267)
T 3t9t_A 100 --------LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP 168 (267)
T ss_dssp --------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCC
T ss_pred --------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccccccccccccc
Confidence 3899999999999999999999998 9999999999999999999999999986431
Q ss_pred -----------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 483 -----------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 483 -----------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
..++.++||||||+++|||++ |+.|+......+ .. ..+.....+ ..+
T Consensus 169 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~--------------~~i~~~~~~----~~~ 227 (267)
T 3t9t_A 169 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VV--------------EDISTGFRL----YKP 227 (267)
T ss_dssp GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HH--------------HHHHTTCCC----CCC
T ss_pred ccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH---HH--------------HHHhcCCcC----CCC
Confidence 124568999999999999999 898987543211 00 011111111 112
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 551 IDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
......+.+++.+||+.||++||++.|+++.|+.+.++
T Consensus 228 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 228 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 23345688999999999999999999999999988653
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=295.43 Aligned_cols=217 Identities=26% Similarity=0.462 Sum_probs=171.6
Q ss_pred ceEEEEEEC------CeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHh
Q 047629 343 KSVYRATID------GKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKW 408 (615)
Q Consensus 343 ~~Vy~~~~~------g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~ 408 (615)
|.||+|... +..||||.++ ..+.+|++++++++|+||+++++++.+ .+..++||||+++|+|.++
T Consensus 58 g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~ 136 (333)
T 1mqb_A 58 GEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-YKPMMIITEYMENGALDKF 136 (333)
T ss_dssp SEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSEEEEEECCTTEEHHHH
T ss_pred eEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec-CCCcEEEEeCCCCCcHHHH
Confidence 589999872 2469999985 247789999999999999999999865 4479999999999999999
Q ss_pred hccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC------
Q 047629 409 LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------ 482 (615)
Q Consensus 409 L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------ 482 (615)
+..... .+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 137 l~~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 204 (333)
T 1mqb_A 137 LREKDG---------EFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT 204 (333)
T ss_dssp HHHTTT---------CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----------
T ss_pred HHhCCC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhccccccc
Confidence 976533 3899999999999999999999998 9999999999999999999999999986431
Q ss_pred --------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhc
Q 047629 483 --------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWM 541 (615)
Q Consensus 483 --------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 541 (615)
..++.++||||||+++|||++ |+.||......+ .. ..+.+..
T Consensus 205 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~---~~--------------~~~~~~~ 267 (333)
T 1mqb_A 205 YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---VM--------------KAINDGF 267 (333)
T ss_dssp ------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HH--------------HHHHTTC
T ss_pred cccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH---HH--------------HHHHCCC
Confidence 123557999999999999999 999986543211 00 0111111
Q ss_pred CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccchhhhh
Q 047629 542 DPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQSTETLE 593 (615)
Q Consensus 542 dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~~~~~ 593 (615)
.+ ..+......+.+++.+||+.||.+||++.|+++.|+.+........
T Consensus 268 ~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~~ 315 (333)
T 1mqb_A 268 RL----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLK 315 (333)
T ss_dssp CC----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGGG
T ss_pred cC----CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhhh
Confidence 11 1233445568999999999999999999999999998877655443
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=292.57 Aligned_cols=214 Identities=25% Similarity=0.413 Sum_probs=171.6
Q ss_pred ceEEEEEECCeEEEEEEcc-----HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCCCC
Q 047629 343 KSVYRATIDGKVLAVKKIK-----EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSS 417 (615)
Q Consensus 343 ~~Vy~~~~~g~~vAvK~~~-----~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~~ 417 (615)
+.||++..+|+.||||.++ +.+.+|++++++++|+||+++++++.+.++..++||||+++|+|.+++.....
T Consensus 35 g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--- 111 (278)
T 1byg_A 35 GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR--- 111 (278)
T ss_dssp CEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHH---
T ss_pred ceEEEEEEcCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhccc---
Confidence 5899999999999999986 45789999999999999999999987655578999999999999999975432
Q ss_pred CCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC---------------
Q 047629 418 SSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT--------------- 482 (615)
Q Consensus 418 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~--------------- 482 (615)
..+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++...
T Consensus 112 -----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~y~aP 183 (278)
T 1byg_A 112 -----SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAP 183 (278)
T ss_dssp -----HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------------CCTTTSCH
T ss_pred -----ccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccccCCCccccccCH
Confidence 13789999999999999999999998 9999999999999999999999999986432
Q ss_pred -----CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHH
Q 047629 483 -----NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALS 556 (615)
Q Consensus 483 -----~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~ 556 (615)
..++.++||||||+++|||++ |+.|+......+. . ..+.....+ ..+......
T Consensus 184 E~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~--------------~~~~~~~~~----~~~~~~~~~ 242 (278)
T 1byg_A 184 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---V--------------PRVEKGYKM----DAPDGCPPA 242 (278)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---H--------------HHHTTTCCC----CCCTTCCHH
T ss_pred HHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH---H--------------HHHhcCCCC----CCcccCCHH
Confidence 124568999999999999998 9999875442111 0 011111122 223344456
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 557 LATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 557 l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
+.+++..||+.||.+||++.|+++.|+.+...
T Consensus 243 l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 243 VYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 89999999999999999999999999987643
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=292.13 Aligned_cols=225 Identities=23% Similarity=0.354 Sum_probs=169.9
Q ss_pred ceEEEEEECCeEEEEEEccH----HHHHHHHHHHhc--CCCCcccEEEEEEcCC---CcEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATIDGKVLAVKKIKE----DVTEELRILQRI--NHANLVKLMGVSSDSQ---GNRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~~g~~vAvK~~~~----~~~~Ei~~l~~l--~H~niv~l~g~~~~~~---~~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
|.||+|..+|+.||||++.. .+..|.+++..+ +|+||+++++++.... ...++||||+++|+|.+++...
T Consensus 51 g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~- 129 (337)
T 3mdy_A 51 GEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST- 129 (337)
T ss_dssp EEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC-
T ss_pred eEEEEEEECCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhcc-
Confidence 58999999999999999853 345666666655 9999999999987653 3689999999999999999653
Q ss_pred CCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCCC----
Q 047629 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHA-----QPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATND---- 484 (615)
Q Consensus 414 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~---- 484 (615)
.+++..++.++.|++.||.|||++. .++|+||||||+|||++.++.+||+|||+++.....
T Consensus 130 ----------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 199 (337)
T 3mdy_A 130 ----------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEV 199 (337)
T ss_dssp ----------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred ----------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccccc
Confidence 2899999999999999999999881 123999999999999999999999999998532110
Q ss_pred -----------------------CCC------cccchhHHHHHHHHHcC----------CCCCCCCCCChhHHHHHHHHH
Q 047629 485 -----------------------VMP------KFDVFAFGVVLLELLSG----------KKATRTTENGKTAVLWKEIRE 525 (615)
Q Consensus 485 -----------------------~~~------k~DV~SfGvvl~ElltG----------~~p~~~~~~~~~~~l~~~~~~ 525 (615)
... ++|||||||++|||++| +.|+......... .....
T Consensus 200 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~--~~~~~- 276 (337)
T 3mdy_A 200 DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS--YEDMR- 276 (337)
T ss_dssp ---CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC--HHHHH-
T ss_pred cCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCc--hhhhH-
Confidence 112 38999999999999999 5555443221111 00011
Q ss_pred HHhHHHHHHHHHhhhcCCcCCCCC-ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccch
Q 047629 526 VLKVEEKREERLRNWMDPNLESFY-PIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQST 589 (615)
Q Consensus 526 ~~~~~~~~~~~~~~~~dp~l~~~~-~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~ 589 (615)
.........+.+...+ +.++...+.+++.+||+.||.+|||+.||++.|+.+.++.
T Consensus 277 --------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 277 --------EIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp --------HHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred --------HHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 1111122233322221 1266778999999999999999999999999999887764
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-34 Score=321.26 Aligned_cols=212 Identities=26% Similarity=0.382 Sum_probs=174.5
Q ss_pred ceEEEEEE----CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI----DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~----~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||+|.+ ++..||||+++ +++.+|+++|++++|+|||+++++|.+ +..++||||+++|+|.+++.
T Consensus 350 G~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--~~~~lv~E~~~~g~L~~~l~ 427 (613)
T 2ozo_A 350 GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--EALMLVMEMAGGGPLHKFLV 427 (613)
T ss_dssp SEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES--SSEEEEEECCTTCBHHHHHT
T ss_pred cEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc--CCeEEEEEeCCCCcHHHHHh
Confidence 58999987 35679999985 358899999999999999999999874 36999999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
.... .+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 428 ~~~~---------~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 495 (613)
T 2ozo_A 428 GKRE---------EIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 495 (613)
T ss_dssp TCTT---------TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred hccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence 6533 3899999999999999999999998 9999999999999999999999999997542
Q ss_pred ------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCC
Q 047629 483 ------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDP 543 (615)
Q Consensus 483 ------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp 543 (615)
..++.++|||||||+||||++ |+.||......+. .. .+..-
T Consensus 496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~---~~--------------~i~~~--- 555 (613)
T 2ozo_A 496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---MA--------------FIEQG--- 555 (613)
T ss_dssp ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHH---HH--------------HHHTT---
T ss_pred ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH---HH--------------HHHcC---
Confidence 124568999999999999998 9999976543211 10 11111
Q ss_pred cCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccch
Q 047629 544 NLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQST 589 (615)
Q Consensus 544 ~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~ 589 (615)
.....+..+...+.+|+..||+.||++||++.+|++.|+.+..+.
T Consensus 556 -~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 556 -KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp -CCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred -CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 112234455567899999999999999999999999998876543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-34 Score=297.27 Aligned_cols=223 Identities=26% Similarity=0.390 Sum_probs=172.4
Q ss_pred ceEEEEEE-------CCeEEEEEEcc--------HHHHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCHH
Q 047629 343 KSVYRATI-------DGKVLAVKKIK--------EDVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLD 406 (615)
Q Consensus 343 ~~Vy~~~~-------~g~~vAvK~~~--------~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~ 406 (615)
|.||+|.. +++.||||.++ +.+.+|+.++.++ +||||+++++++... +..++||||+++|+|.
T Consensus 59 g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-~~~~lv~e~~~~g~L~ 137 (344)
T 1rjb_A 59 GKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS-GPIYLIFEYCCYGDLL 137 (344)
T ss_dssp EEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSCEEEEECCTTCBHH
T ss_pred ceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC-CccEEEEecCCCCcHH
Confidence 58999986 35689999985 3477999999999 999999999998754 4799999999999999
Q ss_pred HhhccCCCCCC-------------CCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEe
Q 047629 407 KWLHPKSKSSS-------------SSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIA 473 (615)
Q Consensus 407 ~~L~~~~~~~~-------------~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~ 473 (615)
+++........ .......+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 138 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~ 214 (344)
T 1rjb_A 138 NYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKIC 214 (344)
T ss_dssp HHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEETTTEEEEC
T ss_pred HHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEEcCCCcEEeC
Confidence 99976542100 0001123899999999999999999999998 9999999999999999999999
Q ss_pred ecCCCCCCC-------------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHH
Q 047629 474 NFSLAAPAT-------------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVL 527 (615)
Q Consensus 474 DFGla~~~~-------------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 527 (615)
|||+++... ..++.++||||||+++|||++ |+.||......... . .
T Consensus 215 Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~--~----~-- 286 (344)
T 1rjb_A 215 DFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF--Y----K-- 286 (344)
T ss_dssp CCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH--H----H--
T ss_pred CCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHH--H----H--
Confidence 999986431 124568999999999999998 99999765432211 0 0
Q ss_pred hHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccch
Q 047629 528 KVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQST 589 (615)
Q Consensus 528 ~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~ 589 (615)
.+.....+ ..+......+.+|+..||+.||.+|||+.|+++.|+.+....
T Consensus 287 --------~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 287 --------LIQNGFKM----DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp --------HHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred --------HHhcCCCC----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 11111122 223334556899999999999999999999999999877653
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-34 Score=289.96 Aligned_cols=214 Identities=25% Similarity=0.384 Sum_probs=175.5
Q ss_pred ceEEEEEE--CCeEEEEEEcc------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSK 414 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~ 414 (615)
|.||+|.. +++.||||.++ +.+.+|++++++++|+||+++++++.+ ++..++||||+++|+|.+++.....
T Consensus 27 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~ 105 (288)
T 3kfa_A 27 GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-EPPFYIITEFMTYGNLLDYLRECNR 105 (288)
T ss_dssp CSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSEEEEEECCTTEEHHHHHHHCCT
T ss_pred eeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc-CCCEEEEEEcCCCCcHHHHHHhccc
Confidence 58999998 48999999986 457899999999999999999999865 4479999999999999999976443
Q ss_pred CCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC-----------
Q 047629 415 SSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN----------- 483 (615)
Q Consensus 415 ~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~----------- 483 (615)
. .+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 106 ~--------~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~ 174 (288)
T 3kfa_A 106 Q--------EVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 174 (288)
T ss_dssp T--------TSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTEEE
T ss_pred C--------CccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCccccccCCcc
Confidence 2 3899999999999999999999998 99999999999999999999999999865421
Q ss_pred -------------CCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCC
Q 047629 484 -------------DVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFY 549 (615)
Q Consensus 484 -------------~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~ 549 (615)
.++.++||||||+++|||++ |+.|+......... ..+.....+ ..
T Consensus 175 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~-----------------~~~~~~~~~----~~ 233 (288)
T 3kfa_A 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-----------------ELLEKDYRM----ER 233 (288)
T ss_dssp CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-----------------HHHHTTCCC----CC
T ss_pred ccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-----------------HHHhccCCC----CC
Confidence 23558999999999999999 99998765422111 011111122 22
Q ss_pred ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccch
Q 047629 550 PIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQST 589 (615)
Q Consensus 550 ~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~ 589 (615)
+......+.+++..|++.||.+|||+.|+++.|+.+.+..
T Consensus 234 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 234 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 3344456899999999999999999999999999887653
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=289.88 Aligned_cols=218 Identities=29% Similarity=0.452 Sum_probs=170.6
Q ss_pred ceEEEEEECCeEEEEEEcc-----HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCCCC
Q 047629 343 KSVYRATIDGKVLAVKKIK-----EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSS 417 (615)
Q Consensus 343 ~~Vy~~~~~g~~vAvK~~~-----~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~~ 417 (615)
|.||++...++.||||+++ +.+.+|++++++++||||+++++++. +..++||||+++|+|.+++......
T Consensus 22 g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~-- 96 (307)
T 2eva_A 22 GVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL---NPVCLVMEYAEGGSLYNVLHGAEPL-- 96 (307)
T ss_dssp SEEEEEEETTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT---TTTEEEEECCTTCBHHHHHHCSSSE--
T ss_pred ceEEEEEECCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc---CCcEEEEEcCCCCCHHHHHhccCCC--
Confidence 5899999999999999985 35789999999999999999999874 2479999999999999999865421
Q ss_pred CCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCc-EEEeecCCCCCCC--------------
Q 047629 418 SSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFK-AKIANFSLAAPAT-------------- 482 (615)
Q Consensus 418 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~-~kl~DFGla~~~~-------------- 482 (615)
..+++..++.++.|++.||+|||+.+..+|+||||||+|||++.++. +||+|||+++...
T Consensus 97 -----~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~a 171 (307)
T 2eva_A 97 -----PYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMA 171 (307)
T ss_dssp -----ECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------------CCTTSSC
T ss_pred -----CccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccccccCCCCCceEC
Confidence 13789999999999999999999943234999999999999998876 7999999985431
Q ss_pred ------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHH
Q 047629 483 ------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALS 556 (615)
Q Consensus 483 ------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~ 556 (615)
..++.++||||||+++|||++|+.||...........+ .......+.+.. .....
T Consensus 172 PE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~---------------~~~~~~~~~~~~----~~~~~ 232 (307)
T 2eva_A 172 PEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMW---------------AVHNGTRPPLIK----NLPKP 232 (307)
T ss_dssp HHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHH---------------HHHTTCCCCCBT----TCCHH
T ss_pred hhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHH---------------HHhcCCCCCccc----ccCHH
Confidence 23567899999999999999999999754432211111 011111222222 33445
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHhcccch
Q 047629 557 LATLARACTMDKSLSRPNMAEVVFNLSVLTQST 589 (615)
Q Consensus 557 l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~ 589 (615)
+.+++.+||+.||.+|||++|+++.|+.+.+..
T Consensus 233 l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 233 IESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred HHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 789999999999999999999999999887653
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-34 Score=292.70 Aligned_cols=220 Identities=27% Similarity=0.406 Sum_probs=172.2
Q ss_pred ceEEEEEE-------CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATI-------DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~-------~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~ 407 (615)
|.||++.. +++.||||.++ +.+.+|++++++++||||+++++++.+. +..++||||+++|+|.+
T Consensus 37 g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~ 115 (314)
T 2ivs_A 37 GKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD-GPLLLIVEYAKYGSLRG 115 (314)
T ss_dssp SEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-SSCEEEEECCTTCBHHH
T ss_pred eeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC-CceEEEEeecCCCCHHH
Confidence 58999975 34889999985 3467899999999999999999998754 47899999999999999
Q ss_pred hhccCCCCCC--------------CCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEe
Q 047629 408 WLHPKSKSSS--------------SSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIA 473 (615)
Q Consensus 408 ~L~~~~~~~~--------------~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~ 473 (615)
++........ .......+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 116 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp~NIli~~~~~~kl~ 192 (314)
T 2ivs_A 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKIS 192 (314)
T ss_dssp HHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTEEEEC
T ss_pred HHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---CcccccchheEEEcCCCCEEEc
Confidence 9986542100 0001124899999999999999999999998 9999999999999999999999
Q ss_pred ecCCCCCCCC-------------------------CCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHH
Q 047629 474 NFSLAAPATN-------------------------DVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVL 527 (615)
Q Consensus 474 DFGla~~~~~-------------------------~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 527 (615)
|||+++.... .++.++||||||+++|||++ |+.|+......... .
T Consensus 193 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~---~------ 263 (314)
T 2ivs_A 193 DFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLF---N------ 263 (314)
T ss_dssp CCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH---H------
T ss_pred cccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---H------
Confidence 9999864311 13458999999999999999 99998765432111 0
Q ss_pred hHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 047629 528 KVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQ 587 (615)
Q Consensus 528 ~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~ 587 (615)
.+.....+ ..+......+.+++.+||+.||.+||++.|+++.|+.+..
T Consensus 264 --------~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 264 --------LLKTGHRM----ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp --------HHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------HhhcCCcC----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11111111 2233444568999999999999999999999999988754
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-33 Score=290.91 Aligned_cols=222 Identities=25% Similarity=0.400 Sum_probs=173.5
Q ss_pred ceEEEEEECCeEEEEEEcc----HHHHHHHHHHHh--cCCCCcccEEEEEEcCCC---cEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATIDGKVLAVKKIK----EDVTEELRILQR--INHANLVKLMGVSSDSQG---NRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~~g~~vAvK~~~----~~~~~Ei~~l~~--l~H~niv~l~g~~~~~~~---~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
|.||+|..+|+.||||.++ ..+.+|.+++.. ++||||+++++++...++ ..++||||+++|+|.+++...
T Consensus 56 g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~- 134 (342)
T 1b6c_B 56 GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY- 134 (342)
T ss_dssp EEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC-
T ss_pred cEEEEEEEcCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhcc-
Confidence 5899999999999999986 346789999988 799999999999876542 689999999999999999753
Q ss_pred CCCCCCCcccccCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCCC-
Q 047629 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMH--------EHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATND- 484 (615)
Q Consensus 414 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~- 484 (615)
.+++.+++.++.|++.||.||| +++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 135 ----------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 201 (342)
T 1b6c_B 135 ----------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 201 (342)
T ss_dssp ----------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEEECCCTTCEEEETTT
T ss_pred ----------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEEEEECCCceeccccc
Confidence 2899999999999999999999 666 999999999999999999999999998432110
Q ss_pred --------------------------------CCCcccchhHHHHHHHHHcC----------CCCCCCCCCChhHHHHHH
Q 047629 485 --------------------------------VMPKFDVFAFGVVLLELLSG----------KKATRTTENGKTAVLWKE 522 (615)
Q Consensus 485 --------------------------------~~~k~DV~SfGvvl~ElltG----------~~p~~~~~~~~~~~l~~~ 522 (615)
.+.++||||||+++|||++| +.||.......... ..
T Consensus 202 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~--~~ 279 (342)
T 1b6c_B 202 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV--EE 279 (342)
T ss_dssp TEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH--HH
T ss_pred cccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccH--HH
Confidence 11479999999999999999 66775543211100 00
Q ss_pred HHHHHhHHHHHHHHHhhhcCCcCCCCC-ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccch
Q 047629 523 IREVLKVEEKREERLRNWMDPNLESFY-PIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQST 589 (615)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~~dp~l~~~~-~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~ 589 (615)
+. .........+.+...+ ..+....+.+|+.+||+.||++|||+.||++.|+.+.+..
T Consensus 280 ~~---------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 280 MR---------KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp HH---------HHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred HH---------HHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 00 1111222333333222 2356678999999999999999999999999999887653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-34 Score=288.84 Aligned_cols=211 Identities=24% Similarity=0.375 Sum_probs=164.9
Q ss_pred ceEEEEEEC-----CeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATID-----GKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~~-----g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
|.||+|... +..||+|.++ +.+.+|+.++++++||||+++++++. ++..++||||+++|+|.+++
T Consensus 29 g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~lv~e~~~~~~L~~~l 106 (281)
T 1mp8_A 29 GDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT--ENPVWIIMELCTLGELRSFL 106 (281)
T ss_dssp SEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--SSSCEEEEECCTTEEHHHHH
T ss_pred eeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc--cCccEEEEecCCCCCHHHHH
Confidence 589999872 4679999975 34778999999999999999999974 34689999999999999999
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------ 483 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------ 483 (615)
..... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 107 ~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 174 (281)
T 1mp8_A 107 QVRKY---------SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA 174 (281)
T ss_dssp HHTTT---------TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------------
T ss_pred HhcCC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCccccccc
Confidence 76542 3899999999999999999999998 99999999999999999999999999865321
Q ss_pred ------------------CCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCc
Q 047629 484 ------------------DVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPN 544 (615)
Q Consensus 484 ------------------~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~ 544 (615)
.++.++||||||+++|||++ |+.||......+.. . .+.....+
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~---~--------------~i~~~~~~- 236 (281)
T 1mp8_A 175 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---G--------------RIENGERL- 236 (281)
T ss_dssp ----CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---H--------------HHHTTCCC-
T ss_pred ccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHH---H--------------HHHcCCCC-
Confidence 23557999999999999997 99998765432211 0 11111111
Q ss_pred CCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 545 LESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 545 l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
..+......+.+++..||+.||++|||+.|+++.|+.+.+.
T Consensus 237 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 237 ---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 12334445688999999999999999999999999988654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-34 Score=294.76 Aligned_cols=221 Identities=22% Similarity=0.379 Sum_probs=170.9
Q ss_pred ceEEEEEEC-------CeEEEEEEccH--------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATID-------GKVLAVKKIKE--------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~~-------g~~vAvK~~~~--------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~ 407 (615)
|.||+|... ++.||||.++. .+.+|++++++++|+||+++++++.+. +..++||||+++|+|.+
T Consensus 39 g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~ 117 (322)
T 1p4o_A 39 GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG-QPTLVIMELMTRGDLKS 117 (322)
T ss_dssp SEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS-SSCEEEEECCTTCBHHH
T ss_pred eEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC-CccEEEEEeCCCCcHHH
Confidence 589999763 67899999852 477899999999999999999998654 47899999999999999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----- 482 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----- 482 (615)
++...............+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 118 ~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~ 194 (322)
T 1p4o_A 118 YLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 194 (322)
T ss_dssp HHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCE
T ss_pred HHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEEECcCcccccccccccc
Confidence 99753210000000013789999999999999999999998 9999999999999999999999999986431
Q ss_pred --------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhc
Q 047629 483 --------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWM 541 (615)
Q Consensus 483 --------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 541 (615)
..++.++||||||+++|||++ |+.|+......+ .. . .+ .
T Consensus 195 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~----~----------~~---~ 254 (322)
T 1p4o_A 195 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---VL----R----------FV---M 254 (322)
T ss_dssp EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH---HH----H----------HH---H
T ss_pred ccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH---HH----H----------HH---H
Confidence 124568999999999999999 888886543211 00 0 01 1
Q ss_pred CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 542 DPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 542 dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
.... ...+......+.+++.+||+.||.+|||+.|+++.|+.+...
T Consensus 255 ~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 255 EGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp TTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred cCCc-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 1111 112334445689999999999999999999999999987665
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-33 Score=289.89 Aligned_cols=217 Identities=14% Similarity=0.194 Sum_probs=171.8
Q ss_pred ceEEEEEE--CCeEEEEEEcc-----HHHHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK-----EDVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSK 414 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-----~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~ 414 (615)
|.||+|.. +|+.||||.+. ..+.+|+++++++ +|+||+++++++... ...++||||+ +|+|.+++.....
T Consensus 23 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-~~~~lv~e~~-~~~L~~~~~~~~~ 100 (330)
T 2izr_A 23 GELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCG-KYNAMVLELL-GPSLEDLFDLCDR 100 (330)
T ss_dssp TSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEET-TEEEEEEECC-CCBHHHHHHHTTT
T ss_pred ceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecC-CccEEEEEeC-CCCHHHHHHHcCC
Confidence 58999996 79999999886 3488999999999 999999999998764 4789999999 8999999986432
Q ss_pred CCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCc-----EEEeecCCCCCCCC------
Q 047629 415 SSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFK-----AKIANFSLAAPATN------ 483 (615)
Q Consensus 415 ~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~-----~kl~DFGla~~~~~------ 483 (615)
.+++..++.++.|++.||+|||+++ |+||||||+|||++.++. +||+|||+++....
T Consensus 101 ---------~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~ 168 (330)
T 2izr_A 101 ---------TFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKH 168 (330)
T ss_dssp ---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCB
T ss_pred ---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCcc
Confidence 3899999999999999999999998 999999999999999887 99999999864211
Q ss_pred ------------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhh
Q 047629 484 ------------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRN 539 (615)
Q Consensus 484 ------------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 539 (615)
.++.++|||||||++|||++|+.||..............+... ......+
T Consensus 169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~------~~~~~~~ 242 (330)
T 2izr_A 169 IPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDT------KRATPIE 242 (330)
T ss_dssp CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHH------HHHSCHH
T ss_pred ccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhh------hccCCHH
Confidence 1345889999999999999999999875433322222111110 0000000
Q ss_pred hcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 540 WMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 540 ~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
. +.. ..+ .+.+++..||+.||.+||++++|.+.|+.+...
T Consensus 243 ~----~~~----~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~ 282 (330)
T 2izr_A 243 V----LCE----NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR 282 (330)
T ss_dssp H----HTT----TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred H----Hhc----cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence 0 001 122 689999999999999999999999999877654
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-34 Score=321.77 Aligned_cols=209 Identities=26% Similarity=0.412 Sum_probs=171.6
Q ss_pred ceEEEEEE----CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATI----DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~----~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
|.||+|.+ .++.||||+++ +++.+|+++|++++|+|||+++++|.+ +..++||||+++|+|.+++
T Consensus 383 G~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~lv~E~~~~g~L~~~l 460 (635)
T 4fl3_A 383 GTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA--ESWMLVMEMAELGPLNKYL 460 (635)
T ss_dssp EEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES--SSEEEEEECCTTEEHHHHH
T ss_pred EEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCEEEEEEccCCCCHHHHH
Confidence 58999976 45889999986 357899999999999999999999863 3689999999999999999
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------ 483 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------ 483 (615)
.... .+++.+++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 461 ~~~~----------~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 461 QQNR----------HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp HHCT----------TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred hhCC----------CCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 7643 3899999999999999999999998 99999999999999999999999999854311
Q ss_pred --------------------CCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcC
Q 047629 484 --------------------DVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMD 542 (615)
Q Consensus 484 --------------------~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~d 542 (615)
.++.++|||||||++|||++ |+.||......+ +. ..+.....
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~----------~~i~~~~~ 590 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VT----------AMLEKGER 590 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HH----------HHHHTTCC
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HH----------HHHHcCCC
Confidence 24568999999999999999 999997654211 11 01111111
Q ss_pred CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 047629 543 PNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQ 587 (615)
Q Consensus 543 p~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~ 587 (615)
...+..+...+.+|+..||+.||++||++.+|++.|+.+..
T Consensus 591 ----~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 591 ----MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 22344455678999999999999999999999999987653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=286.45 Aligned_cols=229 Identities=21% Similarity=0.298 Sum_probs=175.0
Q ss_pred ceEEEEEE--CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCC-cEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQG-NRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-~~~lV~E~~~~GsL~~~L~~ 411 (615)
|.||+|.. +|+.||||+++ +.+.+|++++++++||||+++++++...+. ..++||||+++|+|.+++..
T Consensus 23 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 102 (319)
T 4euu_A 23 ANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE 102 (319)
T ss_dssp EEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHS
T ss_pred eEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHH
Confidence 58999998 48999999986 346789999999999999999999875443 57999999999999999986
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceee----CCCCcEEEeecCCCCCCC-----
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQL----DSRFKAKIANFSLAAPAT----- 482 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl----d~~~~~kl~DFGla~~~~----- 482 (615)
.... ..+++.+++.++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 103 ~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~~ 172 (319)
T 4euu_A 103 PSNA-------YGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF 172 (319)
T ss_dssp GGGT-------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCCB
T ss_pred hccc-------cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCce
Confidence 4321 13899999999999999999999998 9999999999999 888899999999985431
Q ss_pred -------------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHH
Q 047629 483 -------------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERL 537 (615)
Q Consensus 483 -------------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 537 (615)
..++.++|||||||++|||++|+.||.......... ..+....... ....+
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~~~--p~~~~ 248 (319)
T 4euu_A 173 VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK--EVMYKIITGK--PSGAI 248 (319)
T ss_dssp CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCH--HHHHHHHHHC--CTTCC
T ss_pred eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhH--HHHHHHhcCC--Ccccc
Confidence 234568999999999999999999997544322211 1111111000 00000
Q ss_pred hhh---c--------CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 047629 538 RNW---M--------DPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVL 585 (615)
Q Consensus 538 ~~~---~--------dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l 585 (615)
..+ . +.......+......+.+++..||+.||++|||++|+++..+.-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 249 SGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp EEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred hhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 000 0 00111244567778899999999999999999999999988744
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=304.16 Aligned_cols=214 Identities=28% Similarity=0.439 Sum_probs=166.9
Q ss_pred ceEEEEEE---CC--eEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATI---DG--KVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~---~g--~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
|.||+|.. ++ ..||||.++ +.+.+|+.++++++||||++++++|.+.++..++||||+++|+|.+++
T Consensus 103 g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l 182 (373)
T 3c1x_A 103 GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 182 (373)
T ss_dssp SEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHH
T ss_pred eEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHH
Confidence 58999987 22 468999885 357889999999999999999999876666789999999999999999
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------- 482 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------- 482 (615)
..... .+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 183 ~~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~ 250 (373)
T 3c1x_A 183 RNETH---------NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 250 (373)
T ss_dssp HCTTC---------CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------------
T ss_pred hhccc---------CCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccccccccc
Confidence 76543 3889999999999999999999998 9999999999999999999999999986431
Q ss_pred --------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhc
Q 047629 483 --------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWM 541 (615)
Q Consensus 483 --------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 541 (615)
..++.++||||||+++|||++ |..|+......+... .+....
T Consensus 251 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~-----------------~~~~~~ 313 (373)
T 3c1x_A 251 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV-----------------YLLQGR 313 (373)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHH-----------------HHHTTC
T ss_pred cccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHH-----------------HHHcCC
Confidence 124568999999999999999 566776544322111 001101
Q ss_pred CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccch
Q 047629 542 DPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQST 589 (615)
Q Consensus 542 dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~ 589 (615)
.+ ..+......+.+++..||+.||++||++.|+++.|+.+....
T Consensus 314 ~~----~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~ 357 (373)
T 3c1x_A 314 RL----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357 (373)
T ss_dssp CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred CC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 11 112334456899999999999999999999999999887553
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=289.40 Aligned_cols=205 Identities=25% Similarity=0.310 Sum_probs=161.5
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------------------------------HHHHHHHHHHHhcCCCCcccEEEEEE
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------------------------------EDVTEELRILQRINHANLVKLMGVSS 387 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------------------------------~~~~~Ei~~l~~l~H~niv~l~g~~~ 387 (615)
|.||++.. +|+.||||+++ +.+.+|+++|++++||||+++++++.
T Consensus 27 g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 106 (298)
T 2zv2_A 27 GVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLD 106 (298)
T ss_dssp CEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred EEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 58999987 68999999874 23678999999999999999999987
Q ss_pred cC-CCcEEEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCC
Q 047629 388 DS-QGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDS 466 (615)
Q Consensus 388 ~~-~~~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~ 466 (615)
+. ++..++||||+++|+|.+++... .+++.++..++.|++.||+|||+++ |+||||||+|||++.
T Consensus 107 ~~~~~~~~lv~e~~~~~~l~~~~~~~-----------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~ 172 (298)
T 2zv2_A 107 DPNEDHLYMVFELVNQGPVMEVPTLK-----------PLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGE 172 (298)
T ss_dssp CSSSSEEEEEEECCTTCBSCCSSCSS-----------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECT
T ss_pred cCCCCEEEEEEecCCCCcHHHHhhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECC
Confidence 53 34689999999999998875432 3899999999999999999999998 999999999999999
Q ss_pred CCcEEEeecCCCCCCCCC--------------------------CCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHH
Q 047629 467 RFKAKIANFSLAAPATND--------------------------VMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLW 520 (615)
Q Consensus 467 ~~~~kl~DFGla~~~~~~--------------------------~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 520 (615)
++.+||+|||+++..... .+.++|||||||++|||++|+.||..... ..+.
T Consensus 173 ~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~ 249 (298)
T 2zv2_A 173 DGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI---MCLH 249 (298)
T ss_dssp TSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH
T ss_pred CCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH---HHHH
Confidence 999999999998643210 13467999999999999999999975331 1110
Q ss_pred HHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 521 KEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
. . .......... ..+....+.+++.+||+.||++|||+.|++++
T Consensus 250 ~----~---------~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 250 S----K---------IKSQALEFPD----QPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp H----H---------HHHCCCCCCS----SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred H----H---------HhcccCCCCC----ccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 0 0 0011111111 11233458899999999999999999998763
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=286.73 Aligned_cols=214 Identities=28% Similarity=0.471 Sum_probs=166.6
Q ss_pred ceEEEEEECCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATIDGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
|.||+|...+ .||||.++ +.+.+|++++++++|+||+++++++. ....++||||+++|+|.+++....
T Consensus 38 g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~ 114 (289)
T 3og7_A 38 GTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST--APQLAIVTQWCEGSSLYHHLHASE 114 (289)
T ss_dssp EEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSSCEEEEECCCEEEHHHHHTTC-
T ss_pred eEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc--CCccEEEEEecCCCcHHHHHhhcc
Confidence 5899998765 49999885 34788999999999999999999764 346899999999999999997654
Q ss_pred CCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----------
Q 047629 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----------- 482 (615)
Q Consensus 414 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----------- 482 (615)
. .+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 115 ~---------~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 182 (289)
T 3og7_A 115 T---------KFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQL 182 (289)
T ss_dssp -----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-----------------
T ss_pred C---------CCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccccccccccc
Confidence 3 3899999999999999999999998 9999999999999999999999999985321
Q ss_pred -----------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcC
Q 047629 483 -----------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNL 545 (615)
Q Consensus 483 -----------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l 545 (615)
..++.++||||||+++|||++|+.||......+.. ... .......+.+
T Consensus 183 ~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~---------~~~~~~~~~~ 247 (289)
T 3og7_A 183 SGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI------IEM---------VGRGSLSPDL 247 (289)
T ss_dssp -CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHH------HHH---------HHHTSCCCCT
T ss_pred CCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHH------HHH---------hcccccCcch
Confidence 12345899999999999999999999765432111 110 0111122222
Q ss_pred CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 047629 546 ESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQ 587 (615)
Q Consensus 546 ~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~ 587 (615)
..........+.+++..||+.||.+|||+.|+++.|+.+.+
T Consensus 248 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 248 -SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp -TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred -hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 12233445678999999999999999999999999998764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=286.67 Aligned_cols=213 Identities=26% Similarity=0.384 Sum_probs=173.6
Q ss_pred ceEEEEEE----CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI----DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~----~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||+|.+ +++.||||.++ +.+.+|++++++++||||+++++++. . +..++||||+++|+|.+++.
T Consensus 24 g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~-~~~~lv~e~~~~~~L~~~l~ 101 (287)
T 1u59_A 24 GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-A-EALMLVMEMAGGGPLHKFLV 101 (287)
T ss_dssp EEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-S-SSEEEEEECCTTEEHHHHHT
T ss_pred eeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-C-CCcEEEEEeCCCCCHHHHHH
Confidence 58999986 57889999985 24778999999999999999999984 3 36899999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC-------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------- 483 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------- 483 (615)
.... .+++.++..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++....
T Consensus 102 ~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 169 (287)
T 1u59_A 102 GKRE---------EIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 169 (287)
T ss_dssp TCTT---------TSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECC
T ss_pred hCCc---------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccCcceeec
Confidence 5432 3899999999999999999999998 99999999999999999999999999864311
Q ss_pred -------------------CCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCC
Q 047629 484 -------------------DVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDP 543 (615)
Q Consensus 484 -------------------~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp 543 (615)
.++.++||||||+++|||++ |+.||......+. .. .+.....+
T Consensus 170 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~--------------~i~~~~~~ 232 (287)
T 1u59_A 170 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---MA--------------FIEQGKRM 232 (287)
T ss_dssp CCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH---HH--------------HHHTTCCC
T ss_pred cccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH---HH--------------HHhcCCcC
Confidence 13457999999999999999 9999976543111 00 11111111
Q ss_pred cCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccchh
Q 047629 544 NLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQSTE 590 (615)
Q Consensus 544 ~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~~ 590 (615)
..+......+.+++..||+.||++||++.|+++.|+.+..+..
T Consensus 233 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 275 (287)
T 1u59_A 233 ----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275 (287)
T ss_dssp ----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ----CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 2334445678999999999999999999999999998877654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=284.43 Aligned_cols=212 Identities=27% Similarity=0.435 Sum_probs=170.7
Q ss_pred ceEEEEEE-CCeEEEEEEcc------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCC
Q 047629 343 KSVYRATI-DGKVLAVKKIK------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKS 415 (615)
Q Consensus 343 ~~Vy~~~~-~g~~vAvK~~~------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~ 415 (615)
|.||+|.. +++.||||.++ +.+.+|++++++++|+||+++++++.+ +..++||||+++|+|.+++.....
T Consensus 27 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~v~e~~~~~~L~~~l~~~~~- 103 (279)
T 1qpc_A 27 GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ--EPIYIITEYMENGSLVDFLKTPSG- 103 (279)
T ss_dssp EEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEEECCTTCBHHHHTTSHHH-
T ss_pred eEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC--CCcEEEEecCCCCCHHHHHhcCCC-
Confidence 58999998 56789999886 357899999999999999999998753 368999999999999999975321
Q ss_pred CCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC------------
Q 047629 416 SSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------------ 483 (615)
Q Consensus 416 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------------ 483 (615)
..+++.++..++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++....
T Consensus 104 -------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 173 (279)
T 1qpc_A 104 -------IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 173 (279)
T ss_dssp -------HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCC
T ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCCCCc
Confidence 13899999999999999999999998 99999999999999999999999999864321
Q ss_pred ------------CCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 484 ------------DVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 484 ------------~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
.++.++||||||+++|||++ |+.|+......+ .. ..+.....+ ..+
T Consensus 174 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~--------------~~~~~~~~~----~~~ 232 (279)
T 1qpc_A 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---VI--------------QNLERGYRM----VRP 232 (279)
T ss_dssp TTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HH--------------HHHHTTCCC----CCC
T ss_pred cCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH---HH--------------HHHhcccCC----CCc
Confidence 13457899999999999999 898987543211 00 011111111 122
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 551 IDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
......+.+++..|++.||++|||+.++++.|+.+...
T Consensus 233 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 33445689999999999999999999999999987654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-34 Score=296.79 Aligned_cols=212 Identities=22% Similarity=0.362 Sum_probs=169.1
Q ss_pred ceEEEEEE--CCeE----EEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHh
Q 047629 343 KSVYRATI--DGKV----LAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKW 408 (615)
Q Consensus 343 ~~Vy~~~~--~g~~----vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~ 408 (615)
|.||+|.. +|+. ||+|.+. ..+.+|+.++++++|+||+++++++.+ +..++|+||+++|+|.++
T Consensus 27 g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~~~~~~L~~~ 104 (325)
T 3kex_A 27 GTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG--SSLQLVTQYLPLGSLLDH 104 (325)
T ss_dssp CEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB--SSEEEEEECCTTCBSHHH
T ss_pred ceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CccEEEEEeCCCCCHHHH
Confidence 58999997 4543 8888774 236689999999999999999999853 468999999999999999
Q ss_pred hccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC-----
Q 047629 409 LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN----- 483 (615)
Q Consensus 409 L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~----- 483 (615)
+..... .+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 105 l~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~ 172 (325)
T 3kex_A 105 VRQHRG---------ALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQL 172 (325)
T ss_dssp HHSSGG---------GSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCC
T ss_pred HHHccc---------cCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCcccccc
Confidence 976532 3889999999999999999999998 99999999999999999999999999865311
Q ss_pred --------------------CCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcC
Q 047629 484 --------------------DVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMD 542 (615)
Q Consensus 484 --------------------~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~d 542 (615)
.++.++||||||+++|||++ |+.||......+... .+.....
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-----------------~~~~~~~ 235 (325)
T 3kex_A 173 LYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPD-----------------LLEKGER 235 (325)
T ss_dssp C-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHH-----------------HHHTTCB
T ss_pred cccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHH-----------------HHHcCCC
Confidence 13568999999999999999 999997654322110 0111111
Q ss_pred CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccch
Q 047629 543 PNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQST 589 (615)
Q Consensus 543 p~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~ 589 (615)
+ ..+......+.+++..||+.||.+||+++|+++.|+.+....
T Consensus 236 ~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 236 L----AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp C----CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred C----CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 1 112223334789999999999999999999999999887654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-34 Score=295.67 Aligned_cols=211 Identities=20% Similarity=0.288 Sum_probs=163.0
Q ss_pred ccccccccc----ceEEEEEE--CCeEEEEEEccH---------HHHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEE
Q 047629 334 NLSEHYSIG----KSVYRATI--DGKVLAVKKIKE---------DVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVY 397 (615)
Q Consensus 334 ~~~~~~~iG----~~Vy~~~~--~g~~vAvK~~~~---------~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~ 397 (615)
+|.....+| |.||+|.. +|+.||||++.. ....|+..+.++ +|+||++++++|.+. +..++||
T Consensus 58 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~-~~~~lv~ 136 (311)
T 3p1a_A 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG-GILYLQT 136 (311)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred heeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC-CEEEEEE
Confidence 455555555 58999998 689999998742 244566666655 999999999998754 4799999
Q ss_pred eecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCC
Q 047629 398 EYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSL 477 (615)
Q Consensus 398 E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGl 477 (615)
||+ +|+|.+++..... .++|..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 137 e~~-~~~L~~~~~~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~ 203 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGA---------SLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGL 203 (311)
T ss_dssp ECC-CCBHHHHHHHHCS---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTT
T ss_pred ecc-CCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEcccee
Confidence 999 6799999876543 3999999999999999999999998 99999999999999999999999999
Q ss_pred CCCCC---------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHH
Q 047629 478 AAPAT---------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREER 536 (615)
Q Consensus 478 a~~~~---------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 536 (615)
++... ..++.++|||||||++|||++|+.++.... .+..+
T Consensus 204 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~------~~~~~------------- 264 (311)
T 3p1a_A 204 LVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGE------GWQQL------------- 264 (311)
T ss_dssp CEECC------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHH------HHHHH-------------
T ss_pred eeecccCCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHH-------------
Confidence 85431 125678999999999999999987764311 01100
Q ss_pred HhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 537 LRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 537 ~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
......+ .++......+.+++.+||+.||++|||+.|+++.
T Consensus 265 ~~~~~~~----~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 265 RQGYLPP----EFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp TTTCCCH----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hccCCCc----ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 0001111 1112234568999999999999999999999864
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=292.10 Aligned_cols=222 Identities=25% Similarity=0.387 Sum_probs=173.2
Q ss_pred ceEEEEEE-------CCeEEEEEEcc--------HHHHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCHH
Q 047629 343 KSVYRATI-------DGKVLAVKKIK--------EDVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLD 406 (615)
Q Consensus 343 ~~Vy~~~~-------~g~~vAvK~~~--------~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~ 406 (615)
|.||+|.. +++.||||.++ +.+.+|+.+++++ +||||+++++++.+. +..++||||+++|+|.
T Consensus 37 g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~ 115 (313)
T 1t46_A 37 GKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG-GPTLVITEYCCYGDLL 115 (313)
T ss_dssp EEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSCEEEEECCTTEEHH
T ss_pred cceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC-CCcEEEEecCCCCCHH
Confidence 58999985 46899999985 3477899999999 999999999998754 4789999999999999
Q ss_pred HhhccCCCCCC--------CCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCC
Q 047629 407 KWLHPKSKSSS--------SSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA 478 (615)
Q Consensus 407 ~~L~~~~~~~~--------~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla 478 (615)
+++........ .......+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 116 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 192 (313)
T 1t46_A 116 NFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLA 192 (313)
T ss_dssp HHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEEEECCCGGG
T ss_pred HHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEcCCCCEEEcccccc
Confidence 99976542100 0000123899999999999999999999998 999999999999999999999999998
Q ss_pred CCCCC-------------------------CCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHH
Q 047629 479 APATN-------------------------DVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEK 532 (615)
Q Consensus 479 ~~~~~-------------------------~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 532 (615)
+.... .++.++||||||+++|||++ |+.|+......... . .
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--~----~------- 259 (313)
T 1t46_A 193 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF--Y----K------- 259 (313)
T ss_dssp SCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH--H----H-------
T ss_pred ccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH--H----H-------
Confidence 65421 13457999999999999999 99998765432211 1 0
Q ss_pred HHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 533 REERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 533 ~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
.+.+...+. .+......+.+++.+||+.||.+|||+.|+++.|+.+.+.
T Consensus 260 ---~~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 260 ---MIKEGFRML----SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp ---HHHHTCCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---HhccCCCCC----CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 111111111 1223345689999999999999999999999999877654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-33 Score=284.36 Aligned_cols=218 Identities=15% Similarity=0.166 Sum_probs=172.1
Q ss_pred ceEEEEEE--CCeEEEEEEcc-----HHHHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK-----EDVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSK 414 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-----~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~ 414 (615)
|.||+|.. +|+.||||.+. ..+.+|+.++.++ +|+|++++++++.+. ...++||||+ +|+|.+++.....
T Consensus 24 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-~~~~lv~e~~-~~~L~~~l~~~~~ 101 (298)
T 1csn_A 24 GVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEG-LHNVLVIDLL-GPSLEDLLDLCGR 101 (298)
T ss_dssp CEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEET-TEEEEEEECC-CCBHHHHHHHTTT
T ss_pred EEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCC-ceeEEEEEec-CCCHHHHHHHhcc
Confidence 58999995 79999999885 3588999999999 899999999998754 4789999999 9999999986542
Q ss_pred CCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCc-----EEEeecCCCCCCC-------
Q 047629 415 SSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFK-----AKIANFSLAAPAT------- 482 (615)
Q Consensus 415 ~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~-----~kl~DFGla~~~~------- 482 (615)
.+++.++..++.|++.||+|||+++ |+||||||+|||++.++. +||+|||+++...
T Consensus 102 ---------~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 169 (298)
T 1csn_A 102 ---------KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQH 169 (298)
T ss_dssp ---------CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCB
T ss_pred ---------CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccccccc
Confidence 3899999999999999999999998 999999999999987766 9999999985421
Q ss_pred -----------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhh
Q 047629 483 -----------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRN 539 (615)
Q Consensus 483 -----------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 539 (615)
..++.++||||||+++|||++|+.||..............+.... ......+
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-----~~~~~~~ 244 (298)
T 1csn_A 170 IPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK-----QSTPLRE 244 (298)
T ss_dssp CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH-----HHSCHHH
T ss_pred ccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc-----cCccHHH
Confidence 113568999999999999999999998755433322222111110 0000000
Q ss_pred hcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 540 WMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 540 ~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
+.. .....+.+++..||+.||++||++++|++.|+.+.+.
T Consensus 245 -----~~~----~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~ 284 (298)
T 1csn_A 245 -----LCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 284 (298)
T ss_dssp -----HTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred -----HHh----hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence 111 2234578999999999999999999999999988755
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=288.38 Aligned_cols=215 Identities=25% Similarity=0.353 Sum_probs=170.3
Q ss_pred ceEEEEEE--CC---eEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATI--DG---KVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~--~g---~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
|.||+|.. ++ ..+|+|.++ +.+.+|+.++++++||||+++++++.+.++..++|+||+.+|+|.+++
T Consensus 35 g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~ 114 (298)
T 3pls_A 35 GVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI 114 (298)
T ss_dssp EEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHH
T ss_pred ceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHH
Confidence 58999986 33 379999885 347789999999999999999999876655569999999999999999
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------ 483 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------ 483 (615)
..... .+++.++..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++....
T Consensus 115 ~~~~~---------~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 182 (298)
T 3pls_A 115 RSPQR---------NPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSV 182 (298)
T ss_dssp HCTTC---------CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCS
T ss_pred hcccc---------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCCccccc
Confidence 76433 3899999999999999999999998 99999999999999999999999999864311
Q ss_pred ---------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcC
Q 047629 484 ---------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMD 542 (615)
Q Consensus 484 ---------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~d 542 (615)
.++.++||||||+++|||++|+.|+....+.... . ..+.....
T Consensus 183 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~--~--------------~~~~~~~~ 246 (298)
T 3pls_A 183 QQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL--T--------------HFLAQGRR 246 (298)
T ss_dssp CCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGH--H--------------HHHHTTCC
T ss_pred ccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHH--H--------------HHhhcCCC
Confidence 2356899999999999999976665443322111 0 01111111
Q ss_pred CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccch
Q 047629 543 PNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQST 589 (615)
Q Consensus 543 p~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~ 589 (615)
+ ..+......+.+++..||+.||.+|||++|+++.|+.+....
T Consensus 247 ~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 247 L----PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred C----CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 1 122333456899999999999999999999999999886553
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=289.83 Aligned_cols=226 Identities=25% Similarity=0.397 Sum_probs=170.9
Q ss_pred ceEEEEEE------CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCC-CcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATI------DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQ-GNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~------~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~~lV~E~~~~GsL~~ 407 (615)
|.||++.+ +|+.||||+++ ..+.+|++++++++|+||+++++++.+.+ ...++||||+++|+|.+
T Consensus 35 g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~ 114 (302)
T 4e5w_A 35 GKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKE 114 (302)
T ss_dssp EEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHH
T ss_pred eEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHH
Confidence 58999984 68999999986 34788999999999999999999987643 35899999999999999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCCC---
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATND--- 484 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~--- 484 (615)
++..... .+++.+++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 115 ~l~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 182 (302)
T 4e5w_A 115 YLPKNKN---------KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY 182 (302)
T ss_dssp HHHHHTT---------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCE
T ss_pred HHHhccc---------cCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccccccCCCcc
Confidence 9965432 3899999999999999999999998 999999999999999999999999998643211
Q ss_pred -----------------------CCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhc
Q 047629 485 -----------------------VMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWM 541 (615)
Q Consensus 485 -----------------------~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 541 (615)
++.++||||||+++|||++|+.|+..... .... ........ .....+...+
T Consensus 183 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~-~~~~~~~~-~~~~~~~~~~ 256 (302)
T 4e5w_A 183 YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA----LFLK-MIGPTHGQ-MTVTRLVNTL 256 (302)
T ss_dssp EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH----HHHH-HHCSCCGG-GHHHHHHHHH
T ss_pred eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh----HHhh-ccCCcccc-cCHHHHHHHH
Confidence 23478999999999999999988643210 0000 00000000 0011111111
Q ss_pred CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 047629 542 DPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLT 586 (615)
Q Consensus 542 dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~ 586 (615)
........+......+.+++..||+.||.+|||+.|+++.|+.+.
T Consensus 257 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 257 KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 111222234445567899999999999999999999999998764
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=293.90 Aligned_cols=220 Identities=22% Similarity=0.349 Sum_probs=165.9
Q ss_pred ceEEEEEEC--Ce---EEEEEEccH---------HHHHHHHHHHhcCCCCcccEEEEEEcCCCc-----EEEEEeecCCC
Q 047629 343 KSVYRATID--GK---VLAVKKIKE---------DVTEELRILQRINHANLVKLMGVSSDSQGN-----RFLVYEYAENG 403 (615)
Q Consensus 343 ~~Vy~~~~~--g~---~vAvK~~~~---------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~-----~~lV~E~~~~G 403 (615)
|.||+|... ++ .||||.++. .+.+|++++++++||||+++++++...+.. .++||||+++|
T Consensus 37 g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~ 116 (323)
T 3qup_A 37 GSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHG 116 (323)
T ss_dssp EEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTC
T ss_pred eEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCC
Confidence 589999872 32 799999863 477899999999999999999998754321 38999999999
Q ss_pred CHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC
Q 047629 404 SLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN 483 (615)
Q Consensus 404 sL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~ 483 (615)
+|.+++....... ....+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 117 ~L~~~l~~~~~~~----~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~ 189 (323)
T 3qup_A 117 DLHAFLLASRIGE----NPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYS 189 (323)
T ss_dssp BHHHHHHHHHC-------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred cHHHHHHhhhccc----cccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEEeeccccccccc
Confidence 9999996543211 0113899999999999999999999998 99999999999999999999999999865311
Q ss_pred -------------------------CCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHH
Q 047629 484 -------------------------DVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERL 537 (615)
Q Consensus 484 -------------------------~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 537 (615)
.++.++||||||+++|||++ |+.|+......+.. . .+
T Consensus 190 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~---~--------------~~ 252 (323)
T 3qup_A 190 GDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY---N--------------YL 252 (323)
T ss_dssp -----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---H--------------HH
T ss_pred cccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHH---H--------------HH
Confidence 14568999999999999999 89998765432211 0 01
Q ss_pred hhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccchh
Q 047629 538 RNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQSTE 590 (615)
Q Consensus 538 ~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~~ 590 (615)
..... ...+......+.+++.+||+.||++|||+.|+++.|+.+.....
T Consensus 253 ~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 253 IGGNR----LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp HTTCC----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred hcCCC----CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 11111 12233444568999999999999999999999999998876653
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-34 Score=295.12 Aligned_cols=231 Identities=26% Similarity=0.348 Sum_probs=173.4
Q ss_pred ceEEEEEE------CCeEEEEEEcc-------HHHHHHHHHHHhcCCCCcccEEEEEEcC-CCcEEEEEeecCCCCHHHh
Q 047629 343 KSVYRATI------DGKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVSSDS-QGNRFLVYEYAENGSLDKW 408 (615)
Q Consensus 343 ~~Vy~~~~------~g~~vAvK~~~-------~~~~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~~lV~E~~~~GsL~~~ 408 (615)
|.||++.+ +|+.||||+++ +.+.+|++++++++|+||+++++++... +...++||||+++|+|.++
T Consensus 37 g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 116 (327)
T 3lxl_A 37 GSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDF 116 (327)
T ss_dssp EEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHH
T ss_pred eEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHH
Confidence 58999984 57899999985 3478999999999999999999998743 3358899999999999999
Q ss_pred hccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCCC----
Q 047629 409 LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATND---- 484 (615)
Q Consensus 409 L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~---- 484 (615)
+..... .+++.+++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 117 l~~~~~---------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 184 (327)
T 3lxl_A 117 LQRHRA---------RLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY 184 (327)
T ss_dssp HHHHGG---------GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEE
T ss_pred HHhccc---------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceecccCCccc
Confidence 976432 3899999999999999999999998 999999999999999999999999998643211
Q ss_pred ----------------------CCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcC
Q 047629 485 ----------------------VMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMD 542 (615)
Q Consensus 485 ----------------------~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~d 542 (615)
++.++||||||+++|||++|+.|+....... ........ .......+.+.+.
T Consensus 185 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~----~~~~~~~~--~~~~~~~~~~~~~ 258 (327)
T 3lxl_A 185 VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF----LRMMGCER--DVPALSRLLELLE 258 (327)
T ss_dssp ECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH----HHHCC------CCHHHHHHHHHH
T ss_pred eeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchh----hhhccccc--ccccHHHHHHHhh
Confidence 2458999999999999999999986432100 00000000 0000011222222
Q ss_pred CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccchhh
Q 047629 543 PNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQSTET 591 (615)
Q Consensus 543 p~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~~~ 591 (615)
.......+......+.+++..||+.||++|||++|+++.|+.+......
T Consensus 259 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 307 (327)
T 3lxl_A 259 EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG 307 (327)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC------
T ss_pred cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcC
Confidence 2222334455566789999999999999999999999999988766543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=286.26 Aligned_cols=211 Identities=26% Similarity=0.408 Sum_probs=171.5
Q ss_pred ceEEEEEE----CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATI----DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~----~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
|.||+|.+ .++.||||.++ +.+.+|++++++++||||+++++++. ++..++||||+++|+|.+++
T Consensus 31 g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~lv~e~~~~~~L~~~l 108 (291)
T 1xbb_A 31 GTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE--AESWMLVMEMAELGPLNKYL 108 (291)
T ss_dssp EEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE--SSSEEEEEECCTTEEHHHHH
T ss_pred eeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC--CCCcEEEEEeCCCCCHHHHH
Confidence 58999965 46889999985 24778999999999999999999984 34789999999999999999
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------ 483 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------ 483 (615)
.... .+++.+++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++....
T Consensus 109 ~~~~----------~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 175 (291)
T 1xbb_A 109 QQNR----------HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 175 (291)
T ss_dssp HHCT----------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred HhCc----------CCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCccc
Confidence 8653 2899999999999999999999998 99999999999999999999999999864321
Q ss_pred --------------------CCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcC
Q 047629 484 --------------------DVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMD 542 (615)
Q Consensus 484 --------------------~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~d 542 (615)
.++.++||||||+++|||++ |+.|+......+ +. ..+.....
T Consensus 176 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~----------~~~~~~~~ 238 (291)
T 1xbb_A 176 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VT----------AMLEKGER 238 (291)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HH----------HHHHTTCC
T ss_pred ccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HH----------HHHHcCCC
Confidence 12347999999999999999 999987543211 01 01111111
Q ss_pred CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccch
Q 047629 543 PNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQST 589 (615)
Q Consensus 543 p~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~ 589 (615)
+ ..+......+.+++..||+.||.+||++.|+++.|+.+....
T Consensus 239 ~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 239 M----GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp C----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred C----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 2 223344556899999999999999999999999999887654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=292.32 Aligned_cols=207 Identities=23% Similarity=0.333 Sum_probs=165.7
Q ss_pred ceEEEEEE--CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATI--DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
|.||++.. +|+.||||.+. +.+.+|+.++++++|+||+++++++.+. +..++||||+++|+|.+++...
T Consensus 21 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~ 99 (323)
T 3tki_A 21 GEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG-NIQYLFLEYCSGGELFDRIEPD 99 (323)
T ss_dssp EEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEEECCTTEEGGGGSBTT
T ss_pred EEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecC-CeEEEEEEcCCCCcHHHHHhhc
Confidence 58999987 68999999874 3477899999999999999999998754 4789999999999999999764
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC----------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT---------- 482 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~---------- 482 (615)
. .+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 100 ~----------~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 166 (323)
T 3tki_A 100 I----------GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166 (323)
T ss_dssp T----------BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCS
T ss_pred C----------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCC
Confidence 3 3899999999999999999999998 9999999999999999999999999986421
Q ss_pred ---------------CC-CCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCC
Q 047629 483 ---------------ND-VMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLE 546 (615)
Q Consensus 483 ---------------~~-~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~ 546 (615)
.. .+.++|||||||++|||++|+.||.......... .. +......
T Consensus 167 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-~~------------------~~~~~~~ 227 (323)
T 3tki_A 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-SD------------------WKEKKTY 227 (323)
T ss_dssp CCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHH-HH------------------HHTTCTT
T ss_pred CccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHH-HH------------------Hhccccc
Confidence 01 2457999999999999999999997654322110 00 0000000
Q ss_pred CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047629 547 SFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNL 582 (615)
Q Consensus 547 ~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L 582 (615)
..........+.+|+.+||+.||++|||+.|+++.-
T Consensus 228 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~ 263 (323)
T 3tki_A 228 LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDR 263 (323)
T ss_dssp STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 011123344578999999999999999999998863
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-34 Score=292.89 Aligned_cols=235 Identities=26% Similarity=0.388 Sum_probs=179.0
Q ss_pred ccccccccccc----ceEEEEEE-------CCeEEEEEEccH--------HHHHHHHHHHhc-CCCCcccEEEEEEcCCC
Q 047629 332 TMNLSEHYSIG----KSVYRATI-------DGKVLAVKKIKE--------DVTEELRILQRI-NHANLVKLMGVSSDSQG 391 (615)
Q Consensus 332 t~~~~~~~~iG----~~Vy~~~~-------~g~~vAvK~~~~--------~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 391 (615)
..+|.-...+| |.||++.. +++.||||.++. .+.+|+.++.++ +||||+++++++...++
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 105 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 105 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCC
Confidence 34444444554 58999984 458999999852 477899999999 79999999999876555
Q ss_pred cEEEEEeecCCCCHHHhhccCCCCCCC------CCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeC
Q 047629 392 NRFLVYEYAENGSLDKWLHPKSKSSSS------SGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLD 465 (615)
Q Consensus 392 ~~~lV~E~~~~GsL~~~L~~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld 465 (615)
..++||||+++|+|.+++......... ......+++..++.++.|++.||.|||+++ |+||||||+||+++
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~ 182 (316)
T 2xir_A 106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS 182 (316)
T ss_dssp CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEEC
Confidence 689999999999999999865431000 000112889999999999999999999998 99999999999999
Q ss_pred CCCcEEEeecCCCCCCCC-------------------------CCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHH
Q 047629 466 SRFKAKIANFSLAAPATN-------------------------DVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVL 519 (615)
Q Consensus 466 ~~~~~kl~DFGla~~~~~-------------------------~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l 519 (615)
.++.+||+|||+++.... .++.++||||||+++|||++ |+.|+.........
T Consensus 183 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~-- 260 (316)
T 2xir_A 183 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-- 260 (316)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH--
T ss_pred CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHH--
Confidence 999999999999865321 13568999999999999998 99998765432211
Q ss_pred HHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccch
Q 047629 520 WKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQST 589 (615)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~ 589 (615)
.. .+.....+.. +......+.+++..||+.||.+|||+.|+++.|+.+.+..
T Consensus 261 ~~--------------~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 261 CR--------------RLKEGTRMRA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp HH--------------HHHHTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HH--------------HhccCccCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 10 1111111112 2223446889999999999999999999999999887543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=286.90 Aligned_cols=213 Identities=26% Similarity=0.342 Sum_probs=170.3
Q ss_pred ceEEEEEEC-----CeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATID-----GKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~~-----g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
|.||+|... +..||||.++ +.+.+|+.++++++||||+++++++.+ +..++||||+++|+|.+++
T Consensus 26 g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~v~e~~~~~~L~~~l 103 (281)
T 3cc6_A 26 GEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE--EPTWIIMELYPYGELGHYL 103 (281)
T ss_dssp SEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS--SSCEEEEECCTTCBHHHHH
T ss_pred eeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC--CCCEEEEecCCCCCHHHHH
Confidence 589999862 2469999985 347789999999999999999999753 3579999999999999999
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------ 483 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------ 483 (615)
..... .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++....
T Consensus 104 ~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 171 (281)
T 3cc6_A 104 ERNKN---------SLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKA 171 (281)
T ss_dssp HHHTT---------TCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC--------
T ss_pred Hhccc---------cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccccccccccc
Confidence 76432 3899999999999999999999998 99999999999999999999999999864321
Q ss_pred ------------------CCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCc
Q 047629 484 ------------------DVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPN 544 (615)
Q Consensus 484 ------------------~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~ 544 (615)
.++.++||||||+++|||++ |+.||......+.. . .+.....+.
T Consensus 172 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~---~--------------~~~~~~~~~ 234 (281)
T 3cc6_A 172 SVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI---G--------------VLEKGDRLP 234 (281)
T ss_dssp -CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHH---H--------------HHHHTCCCC
T ss_pred ccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHH---H--------------HHhcCCCCC
Confidence 23557999999999999998 99999754432211 0 011111111
Q ss_pred CCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccchh
Q 047629 545 LESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQSTE 590 (615)
Q Consensus 545 l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~~ 590 (615)
.+......+.+++.+||+.||++||++.|+++.|+.+.+...
T Consensus 235 ----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 276 (281)
T 3cc6_A 235 ----KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEK 276 (281)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ----CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhh
Confidence 122334568899999999999999999999999998876544
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=287.19 Aligned_cols=213 Identities=27% Similarity=0.413 Sum_probs=169.0
Q ss_pred ceEEEEEEC-----CeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATID-----GKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~~-----g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
|.||+|... +..+|+|.++ +.+.+|+.++++++||||+++++++.+.++..++||||+++|+|.+++
T Consensus 39 g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l 118 (298)
T 3f66_A 39 GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 118 (298)
T ss_dssp EEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHH
T ss_pred ceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHH
Confidence 589999862 2368999875 347789999999999999999999876666789999999999999999
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------ 483 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------ 483 (615)
..... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 119 ~~~~~---------~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~ 186 (298)
T 3f66_A 119 RNETH---------NPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSV 186 (298)
T ss_dssp HCTTC---------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC
T ss_pred Hhccc---------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccccccchhcc
Confidence 76443 3899999999999999999999998 99999999999999999999999999864311
Q ss_pred ---------------------CCCCcccchhHHHHHHHHHcCC-CCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhc
Q 047629 484 ---------------------DVMPKFDVFAFGVVLLELLSGK-KATRTTENGKTAVLWKEIREVLKVEEKREERLRNWM 541 (615)
Q Consensus 484 ---------------------~~~~k~DV~SfGvvl~ElltG~-~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 541 (615)
.++.++||||||+++|||++|. .|+......+... .+....
T Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~-----------------~~~~~~ 249 (298)
T 3f66_A 187 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV-----------------YLLQGR 249 (298)
T ss_dssp -----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHH-----------------HHHTTC
T ss_pred ccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHH-----------------HHhcCC
Confidence 2356899999999999999955 4554433221110 011111
Q ss_pred CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 542 DPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 542 dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
.+ ..+......+.+++..||+.||++|||++|+++.|+.+...
T Consensus 250 ~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 250 RL----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CC----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11 11222344689999999999999999999999999988754
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=295.09 Aligned_cols=235 Identities=22% Similarity=0.351 Sum_probs=167.0
Q ss_pred ceEEEEEECCeEEEEEEcc----HHHHHHHHHH--HhcCCCCcccEEEEEEc----CCCcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATIDGKVLAVKKIK----EDVTEELRIL--QRINHANLVKLMGVSSD----SQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~~g~~vAvK~~~----~~~~~Ei~~l--~~l~H~niv~l~g~~~~----~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
|.||+|..+|+.||||+++ ..+..|.+++ ..++|+||+++++.+.. .....++||||+++|+|.+++...
T Consensus 27 g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~ 106 (336)
T 3g2f_A 27 GAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH 106 (336)
T ss_dssp EEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHC
T ss_pred eEEEEEEECCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhc
Confidence 5899999999999999986 3345555554 45899999999986532 122468999999999999999754
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCC------CCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC---
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHA------QPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN--- 483 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~--- 483 (615)
. ++|..+..++.|++.||.|||++. .++|+||||||+|||++.++.+||+|||+++....
T Consensus 107 ~-----------~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~ 175 (336)
T 3g2f_A 107 T-----------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175 (336)
T ss_dssp C-----------BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSC
T ss_pred c-----------cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeecccccc
Confidence 3 689999999999999999999981 11299999999999999999999999999964311
Q ss_pred -----------------------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChh--HHHHHHHHHH
Q 047629 484 -----------------------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKT--AVLWKEIREV 526 (615)
Q Consensus 484 -----------------------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~--~~l~~~~~~~ 526 (615)
.++.++|||||||++|||++|+.|+........ ..........
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 255 (336)
T 3g2f_A 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNH 255 (336)
T ss_dssp C---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSS
T ss_pred cCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCC
Confidence 012368999999999999999877654332111 0000000000
Q ss_pred HhHHHHHHHHHhhhcCCcCCCCCC--hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 527 LKVEEKREERLRNWMDPNLESFYP--IDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 527 ~~~~~~~~~~~~~~~dp~l~~~~~--~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
................+.+...++ ......+.+|+.+||+.||++|||++|+++.|+.+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 256 PTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred chHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 000000011111222233322222 23566799999999999999999999999999988754
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-33 Score=290.18 Aligned_cols=209 Identities=20% Similarity=0.233 Sum_probs=166.5
Q ss_pred ceEEEEEE--CCeEEEEEEcc------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSK 414 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~ 414 (615)
|.||++.. +|+.+|+|.++ ..+.+|+.+|++++||||+++++++.+. +..++||||+++|+|.+++.....
T Consensus 19 g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~~lv~e~~~g~~L~~~l~~~~~ 97 (321)
T 1tki_A 19 GIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESM-EELVMIFEFISGLDIFERINTSAF 97 (321)
T ss_dssp EEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEET-TEEEEEECCCCCCBHHHHHTSSSC
T ss_pred eEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecC-CEEEEEEEeCCCCCHHHHHHhcCC
Confidence 58999998 68999999885 3477899999999999999999998764 479999999999999999976432
Q ss_pred CCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCC--CCcEEEeecCCCCCCCC---------
Q 047629 415 SSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDS--RFKAKIANFSLAAPATN--------- 483 (615)
Q Consensus 415 ~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~--~~~~kl~DFGla~~~~~--------- 483 (615)
.+++.++..++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||+++....
T Consensus 98 ---------~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~g 165 (321)
T 1tki_A 98 ---------ELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT 165 (321)
T ss_dssp ---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEES
T ss_pred ---------CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccccC
Confidence 3899999999999999999999998 999999999999997 78999999999965421
Q ss_pred -------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 484 -------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 484 -------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
.++.++|||||||++|||++|+.||......+ .. ... .....+ ......
T Consensus 166 t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~---~~i----------~~~~~~--~~~~~~ 227 (321)
T 1tki_A 166 APEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---II---ENI----------MNAEYT--FDEEAF 227 (321)
T ss_dssp CGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH---HHH----------HHTCCC--CCHHHH
T ss_pred ChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH---HH---HHH----------HcCCCC--CChhhh
Confidence 13568999999999999999999997643211 11 110 000000 000000
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047629 551 IDGALSLATLARACTMDKSLSRPNMAEVVFNL 582 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L 582 (615)
.+....+.+++.+|++.||.+|||+.|++++-
T Consensus 228 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 228 KEISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 12234578999999999999999999999853
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=286.60 Aligned_cols=213 Identities=21% Similarity=0.348 Sum_probs=166.5
Q ss_pred ceEEEEEE--CC-------eEEEEEEcc-------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHH
Q 047629 343 KSVYRATI--DG-------KVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLD 406 (615)
Q Consensus 343 ~~Vy~~~~--~g-------~~vAvK~~~-------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~ 406 (615)
|.||+|.. +| +.||+|.++ +.+.+|++++++++||||+++++++.+. +..++||||+++|+|.
T Consensus 22 g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~ 100 (289)
T 4fvq_A 22 TKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG-DENILVQEFVKFGSLD 100 (289)
T ss_dssp EEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT-TCCEEEEECCTTCBHH
T ss_pred ceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC-CCCEEEEECCCCCCHH
Confidence 58999987 33 579999985 3578899999999999999999998754 4789999999999999
Q ss_pred HhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCc--------EEEeecCCC
Q 047629 407 KWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFK--------AKIANFSLA 478 (615)
Q Consensus 407 ~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~--------~kl~DFGla 478 (615)
+++..... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++. +||+|||++
T Consensus 101 ~~l~~~~~---------~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~ 168 (289)
T 4fvq_A 101 TYLKKNKN---------CINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS 168 (289)
T ss_dssp HHHHHTGG---------GCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSC
T ss_pred HHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeeeccCccc
Confidence 99986542 3899999999999999999999998 999999999999998887 999999998
Q ss_pred CCCC--------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHh
Q 047629 479 APAT--------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLR 538 (615)
Q Consensus 479 ~~~~--------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 538 (615)
+... ..++.++||||||+++|||++|..|+......... .. ...
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~------~~----------~~~ 232 (289)
T 4fvq_A 169 ITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK------LQ----------FYE 232 (289)
T ss_dssp TTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH------HH----------HHH
T ss_pred ccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH------HH----------Hhh
Confidence 6542 22567899999999999999966554433221110 00 000
Q ss_pred hhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccchh
Q 047629 539 NWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQSTE 590 (615)
Q Consensus 539 ~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~~ 590 (615)
..+.+ +......+.+++..||+.||++|||+.|+++.|+.+..+..
T Consensus 233 --~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~ 278 (289)
T 4fvq_A 233 --DRHQL----PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278 (289)
T ss_dssp --TTCCC----CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred --ccCCC----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 01111 11122347899999999999999999999999999987654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=284.78 Aligned_cols=222 Identities=22% Similarity=0.311 Sum_probs=166.4
Q ss_pred ceEEEEEE-CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATI-DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~-~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
|.||++.. +|+.||||+++ ..+.+|++++++++||||+++++++.+. ...++||||++ |+|.+++...
T Consensus 35 g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~-~~l~~~~~~~ 112 (311)
T 3niz_A 35 GVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSE-RCLTLVFEFME-KDLKKVLDEN 112 (311)
T ss_dssp CEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS-SCEEEEEECCS-EEHHHHHHTC
T ss_pred eEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC-CEEEEEEcCCC-CCHHHHHHhc
Confidence 58999998 78999999986 2467899999999999999999998654 47999999998 5888888765
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC----------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT---------- 482 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~---------- 482 (615)
.. .+++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 113 ~~---------~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 180 (311)
T 3niz_A 113 KT---------GLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEV 180 (311)
T ss_dssp TT---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---CCC
T ss_pred cC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCcccccCCc
Confidence 43 3899999999999999999999998 9999999999999999999999999985421
Q ss_pred --------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHH----HHHHHhhhcCCc
Q 047629 483 --------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEK----REERLRNWMDPN 544 (615)
Q Consensus 483 --------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~----~~~~~~~~~dp~ 544 (615)
..++.++|||||||++|||++|+.||......+.... +...+..... ....+..+.+..
T Consensus 181 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---i~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (311)
T 3niz_A 181 VTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPK---IFSILGTPNPREWPQVQELPLWKQRT 257 (311)
T ss_dssp CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHH---HHHHHCCCCTTTSGGGTTSHHHHSCC
T ss_pred ccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHHCCCChHHhhhhhccchhhhcc
Confidence 1246789999999999999999999986654332211 1111100000 000000000000
Q ss_pred C--CCCC-----ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 545 L--ESFY-----PIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 545 l--~~~~-----~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
. .... .......+.+|+.+|++.||++|||++|++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 258 FQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp CCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred cccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0 0000 11123467899999999999999999999874
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=293.77 Aligned_cols=212 Identities=21% Similarity=0.393 Sum_probs=168.8
Q ss_pred ceEEEEEE--CCeE----EEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHh
Q 047629 343 KSVYRATI--DGKV----LAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKW 408 (615)
Q Consensus 343 ~~Vy~~~~--~g~~----vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~ 408 (615)
|.||+|.. +|+. ||+|.++ ..+.+|+.++++++||||+++++++... ..++|+||+++|+|.++
T Consensus 29 g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~v~~~~~~g~L~~~ 106 (327)
T 3lzb_A 29 GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--TVQLITQLMPFGCLLDY 106 (327)
T ss_dssp EEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS--SEEEEECCCSSCBHHHH
T ss_pred eEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC--CceEEEEecCCCcHHHH
Confidence 58999997 4543 5778763 4588999999999999999999998753 58899999999999999
Q ss_pred hccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC-----
Q 047629 409 LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN----- 483 (615)
Q Consensus 409 L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~----- 483 (615)
+..... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 107 l~~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~ 174 (327)
T 3lzb_A 107 VREHKD---------NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174 (327)
T ss_dssp HHHTTT---------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-----------
T ss_pred HHhcCC---------CCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccc
Confidence 987543 3899999999999999999999998 99999999999999999999999999965311
Q ss_pred --------------------CCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcC
Q 047629 484 --------------------DVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMD 542 (615)
Q Consensus 484 --------------------~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~d 542 (615)
.++.++||||||+++|||++ |+.||......+... .+....
T Consensus 175 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~-----------------~~~~~~- 236 (327)
T 3lzb_A 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-----------------ILEKGE- 236 (327)
T ss_dssp -----CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH-----------------HHHTTC-
T ss_pred cccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH-----------------HHHcCC-
Confidence 14568999999999999999 999997654322110 111111
Q ss_pred CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccch
Q 047629 543 PNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQST 589 (615)
Q Consensus 543 p~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~ 589 (615)
....+......+.+++..||+.||.+||++.|+++.|+.+....
T Consensus 237 ---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 237 ---RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp ---CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred ---CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 11223334556899999999999999999999999999887654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-33 Score=288.70 Aligned_cols=207 Identities=25% Similarity=0.344 Sum_probs=165.5
Q ss_pred ceEEEEEE--CCeEEEEEEcc-------------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATI--DGKVLAVKKIK-------------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-------------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~ 407 (615)
|.||++.. +|+.||||.++ +.+.+|+.+|++++||||+++++++.+. ...++||||+++|+|.+
T Consensus 25 g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~ 103 (326)
T 2y0a_A 25 AVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK-TDVILILELVAGGELFD 103 (326)
T ss_dssp EEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEEECCCSCBHHH
T ss_pred eEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-CEEEEEEEcCCCCCHHH
Confidence 58999998 68999999874 3478999999999999999999998754 47999999999999999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCC----cEEEeecCCCCCCC-
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRF----KAKIANFSLAAPAT- 482 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~----~~kl~DFGla~~~~- 482 (615)
++.... .+++.++..++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||+++...
T Consensus 104 ~l~~~~----------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~ 170 (326)
T 2y0a_A 104 FLAEKE----------SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170 (326)
T ss_dssp HHTTSS----------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCT
T ss_pred HHHhcC----------CcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCC
Confidence 997543 3899999999999999999999998 99999999999999887 89999999986432
Q ss_pred ---------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhc
Q 047629 483 ---------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWM 541 (615)
Q Consensus 483 ---------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 541 (615)
..++.++|||||||++|||++|+.||......+. .. . +.. .
T Consensus 171 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~---~-----------~~~-~ 232 (326)
T 2y0a_A 171 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET---LA---N-----------VSA-V 232 (326)
T ss_dssp TSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HH---H-----------HHH-T
T ss_pred CCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH---HH---H-----------HHh-c
Confidence 1245689999999999999999999975432111 10 0 000 0
Q ss_pred CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 542 DPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 542 dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.......+.......+.+++.+||+.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 233 NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp CCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111111111223457899999999999999999999985
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-33 Score=290.20 Aligned_cols=222 Identities=24% Similarity=0.427 Sum_probs=171.7
Q ss_pred ceEEEEEE---------CCeEEEEEEccH--------HHHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCC
Q 047629 343 KSVYRATI---------DGKVLAVKKIKE--------DVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGS 404 (615)
Q Consensus 343 ~~Vy~~~~---------~g~~vAvK~~~~--------~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~Gs 404 (615)
|.||+|.. +++.||||+++. .+.+|+++++++ +||||+++++++.+. +..++||||+++|+
T Consensus 49 g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~ 127 (334)
T 2pvf_A 49 GQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD-GPLYVIVEYASKGN 127 (334)
T ss_dssp CEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCCEEEEECCTTCB
T ss_pred eeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC-CceEEEEECCCCCc
Confidence 58999986 357899999862 477899999999 999999999998754 47899999999999
Q ss_pred HHHhhccCCCCCCCC------CcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCC
Q 047629 405 LDKWLHPKSKSSSSS------GSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA 478 (615)
Q Consensus 405 L~~~L~~~~~~~~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla 478 (615)
|.+++.......... .....+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 128 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~ 204 (334)
T 2pvf_A 128 LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLA 204 (334)
T ss_dssp HHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred HHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEEcCCCCEEEcccccc
Confidence 999998654211000 00123899999999999999999999998 999999999999999999999999998
Q ss_pred CCCCC-------------------------CCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHH
Q 047629 479 APATN-------------------------DVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEK 532 (615)
Q Consensus 479 ~~~~~-------------------------~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 532 (615)
+.... .++.++||||||+++|||++ |+.|+......+ +. .
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~----~------- 270 (334)
T 2pvf_A 205 RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---LF----K------- 270 (334)
T ss_dssp EECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HH----H-------
T ss_pred ccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH---HH----H-------
Confidence 64321 13457999999999999999 999987543111 11 0
Q ss_pred HHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccch
Q 047629 533 REERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQST 589 (615)
Q Consensus 533 ~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~ 589 (615)
.+.....+. .+......+.+++.+||+.||.+||++.|+++.|+.+....
T Consensus 271 ---~~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 271 ---LLKEGHRMD----KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp ---HHHHTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---HHhcCCCCC----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 111111111 23334456899999999999999999999999999887653
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-33 Score=290.11 Aligned_cols=222 Identities=29% Similarity=0.497 Sum_probs=172.5
Q ss_pred ceEEEEEE--CCeEE--EEEEccH--------HHHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATI--DGKVL--AVKKIKE--------DVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~--~g~~v--AvK~~~~--------~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
|.||++.. +|+.+ |||.++. .+.+|++++.++ +||||+++++++.+. +..++||||+++|+|.+++
T Consensus 39 g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l 117 (327)
T 1fvr_A 39 GQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-GYLYLAIEYAPHGNLLDFL 117 (327)
T ss_dssp CEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-TEEEEEECCCTTCBHHHHH
T ss_pred ceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeC-CceEEEEecCCCCCHHHHH
Confidence 58999987 66654 9998852 477899999999 999999999998764 4799999999999999999
Q ss_pred ccCCCCCCC------CCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-
Q 047629 410 HPKSKSSSS------SGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT- 482 (615)
Q Consensus 410 ~~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~- 482 (615)
......... ......+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~ 194 (327)
T 1fvr_A 118 RKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEV 194 (327)
T ss_dssp HTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEESSCE
T ss_pred HhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeEEEcccCcCccccc
Confidence 765300000 000014899999999999999999999998 9999999999999999999999999985321
Q ss_pred ---------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhh
Q 047629 483 ---------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNW 540 (615)
Q Consensus 483 ---------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 540 (615)
..++.++||||||+++|||++ |+.||......+ +. ..+...
T Consensus 195 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-------~~----------~~~~~~ 257 (327)
T 1fvr_A 195 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LY----------EKLPQG 257 (327)
T ss_dssp ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HH----------HHGGGT
T ss_pred cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH-------HH----------HHhhcC
Confidence 113568999999999999998 999997543110 00 111111
Q ss_pred cCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccch
Q 047629 541 MDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQST 589 (615)
Q Consensus 541 ~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~ 589 (615)
..+ ..+......+.+++.+||+.||.+|||+.|+++.|..+.+..
T Consensus 258 ~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 258 YRL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp CCC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred CCC----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 111 223344456899999999999999999999999999876654
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-33 Score=294.96 Aligned_cols=222 Identities=17% Similarity=0.216 Sum_probs=167.9
Q ss_pred ceEEEEEEC-------CeEEEEEEccH---HHH---------------HHHHHHHhcCCCCcccEEEEEEcCC---CcEE
Q 047629 343 KSVYRATID-------GKVLAVKKIKE---DVT---------------EELRILQRINHANLVKLMGVSSDSQ---GNRF 394 (615)
Q Consensus 343 ~~Vy~~~~~-------g~~vAvK~~~~---~~~---------------~Ei~~l~~l~H~niv~l~g~~~~~~---~~~~ 394 (615)
|.||+|... ++.||||.+.. .+. .|+..+.+++|+||+++++++.... ...+
T Consensus 49 g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~ 128 (364)
T 3op5_A 49 GCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRF 128 (364)
T ss_dssp CEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEE
T ss_pred eEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeeeccCCcceEE
Confidence 589999872 47899999752 222 3455566678999999999986532 2379
Q ss_pred EEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeC--CCCcEEE
Q 047629 395 LVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLD--SRFKAKI 472 (615)
Q Consensus 395 lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld--~~~~~kl 472 (615)
+||||+ +|+|.+++..... .+++.+++.|+.|++.||+|||+++ |+||||||+|||++ .++.+||
T Consensus 129 lv~e~~-g~~L~~~~~~~~~---------~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~~~~~~kl 195 (364)
T 3op5_A 129 MIMDRF-GSDLQKIYEANAK---------RFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYL 195 (364)
T ss_dssp EEEECE-EEEHHHHHHHTTS---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESSCTTCEEE
T ss_pred EEEeCC-CCCHHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecCCCCeEEE
Confidence 999999 9999999976532 3999999999999999999999998 99999999999999 8899999
Q ss_pred eecCCCCCCC------------------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHH
Q 047629 473 ANFSLAAPAT------------------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKE 522 (615)
Q Consensus 473 ~DFGla~~~~------------------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 522 (615)
+|||+++... ..++.++|||||||++|||++|+.||............
T Consensus 196 ~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~-- 273 (364)
T 3op5_A 196 VDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRD-- 273 (364)
T ss_dssp CCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHH--
T ss_pred EECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHH--
Confidence 9999995321 11456889999999999999999999864433221111
Q ss_pred HHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 523 IREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
.... ....+.+++++.+.. ...+..+.+++..||+.||.+||++++|++.|+.+...
T Consensus 274 ~~~~------~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~ 330 (364)
T 3op5_A 274 SKIR------YRENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA 330 (364)
T ss_dssp HHHH------HHHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHH------hhhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence 1111 112233333333321 12234578999999999999999999999999877654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=294.48 Aligned_cols=216 Identities=25% Similarity=0.379 Sum_probs=170.1
Q ss_pred cccccccc----ceEEEEEE--CCeEEEEEEcc----------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEe
Q 047629 335 LSEHYSIG----KSVYRATI--DGKVLAVKKIK----------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYE 398 (615)
Q Consensus 335 ~~~~~~iG----~~Vy~~~~--~g~~vAvK~~~----------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E 398 (615)
|.....+| |.||+|.. +|+.||||++. +.+.+|++++++++||||+++++++.+. +..++|||
T Consensus 56 y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv~e 134 (348)
T 1u5q_A 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-HTAWLVME 134 (348)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEE
T ss_pred eeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-CeEEEEEe
Confidence 44444454 58999996 78999999884 2477899999999999999999998764 47999999
Q ss_pred ecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCC
Q 047629 399 YAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA 478 (615)
Q Consensus 399 ~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla 478 (615)
|++ |+|.+++..... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 135 ~~~-g~l~~~l~~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a 201 (348)
T 1u5q_A 135 YCL-GSASDLLEVHKK---------PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSA 201 (348)
T ss_dssp CCS-EEHHHHHHHHTS---------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTC
T ss_pred cCC-CCHHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCc
Confidence 997 788888864332 3899999999999999999999998 999999999999999999999999998
Q ss_pred CCCC----------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHH
Q 047629 479 APAT----------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREER 536 (615)
Q Consensus 479 ~~~~----------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 536 (615)
+... ..++.++|||||||++|||++|+.|+....... . +..
T Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~--~----~~~----------- 264 (348)
T 1u5q_A 202 SIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--A----LYH----------- 264 (348)
T ss_dssp BSSSSBCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--H----HHH-----------
T ss_pred eecCCCCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--H----HHH-----------
Confidence 6532 235678999999999999999999986543211 0 110
Q ss_pred HhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 047629 537 LRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSV 584 (615)
Q Consensus 537 ~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~ 584 (615)
+.....+.+. +......+.+++..||+.||++|||+.|+++...-
T Consensus 265 ~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~ 309 (348)
T 1u5q_A 265 IAQNESPALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 309 (348)
T ss_dssp HHHSCCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred HHhcCCCCCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhh
Confidence 1111122221 12233457899999999999999999999986543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-33 Score=290.11 Aligned_cols=203 Identities=24% Similarity=0.315 Sum_probs=166.1
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||++.. +|+.||+|.+++ .+.+|+.+|++++||||+++++++.+. +..++||||+++|+|.+++.
T Consensus 19 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~~lv~E~~~gg~L~~~l~ 97 (337)
T 1o6l_A 19 GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-DRLCFVMEYANGGELFFHLS 97 (337)
T ss_dssp EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS-SEEEEEEECCTTCBHHHHHH
T ss_pred eEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC-CEEEEEEeCCCCCcHHHHHH
Confidence 58999987 689999999864 356899999999999999999998754 47999999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
... .+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 98 ~~~----------~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~ 164 (337)
T 1o6l_A 98 RER----------VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 164 (337)
T ss_dssp HHS----------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCC
T ss_pred hcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccCCCcccc
Confidence 643 3899999999999999999999998 9999999999999999999999999986421
Q ss_pred ---------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCC
Q 047629 483 ---------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLES 547 (615)
Q Consensus 483 ---------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~ 547 (615)
..++.++|||||||++|||++|+.||...... .+.. . .... ..
T Consensus 165 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~---~----------i~~~--~~---- 222 (337)
T 1o6l_A 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFE---L----------ILME--EI---- 222 (337)
T ss_dssp CEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---H----------HHHC--CC----
T ss_pred cccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH---HHHH---H----------HHcC--CC----
Confidence 12467899999999999999999999754311 1110 0 0111 11
Q ss_pred CCChHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 047629 548 FYPIDGALSLATLARACTMDKSLSRP-----NMAEVVFN 581 (615)
Q Consensus 548 ~~~~~~~~~l~~l~~~C~~~dP~~RP-----sm~ev~~~ 581 (615)
.++......+.+++..||+.||++|| +++|++++
T Consensus 223 ~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 223 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 13333445678999999999999999 89999875
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-33 Score=287.15 Aligned_cols=219 Identities=23% Similarity=0.367 Sum_probs=168.1
Q ss_pred ceEEEEEE-----CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCC----cEEEEEeecCCCC
Q 047629 343 KSVYRATI-----DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQG----NRFLVYEYAENGS 404 (615)
Q Consensus 343 ~~Vy~~~~-----~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~----~~~lV~E~~~~Gs 404 (615)
|.||+|.. .++.||||.++ +.+.+|+.++++++||||+++++++.+.+. ..++||||+++|+
T Consensus 48 g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~ 127 (313)
T 3brb_A 48 GSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGD 127 (313)
T ss_dssp CCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCB
T ss_pred eEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCC
Confidence 58999986 24589999986 247789999999999999999999875432 3599999999999
Q ss_pred HHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--
Q 047629 405 LDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-- 482 (615)
Q Consensus 405 L~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-- 482 (615)
|.+++........ ...+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 128 L~~~l~~~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~ 200 (313)
T 3brb_A 128 LHTYLLYSRLETG----PKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSG 200 (313)
T ss_dssp HHHHHHHTTBTTS----CCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEECSCSCC------
T ss_pred HHHHHHHhhhhcC----CccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEEeecCcceecccc
Confidence 9999954321100 124899999999999999999999998 9999999999999999999999999986431
Q ss_pred -----------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHh
Q 047629 483 -----------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLR 538 (615)
Q Consensus 483 -----------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 538 (615)
..++.++||||||+++|||++ |+.|+......+.. . .+.
T Consensus 201 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---~--------------~~~ 263 (313)
T 3brb_A 201 DYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY---D--------------YLL 263 (313)
T ss_dssp ----------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH---H--------------HHH
T ss_pred cccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH---H--------------HHH
Confidence 113568899999999999999 88888754432111 0 011
Q ss_pred hhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccch
Q 047629 539 NWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQST 589 (615)
Q Consensus 539 ~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~ 589 (615)
....+ ..+......+.+++..||+.||.+||++.|+++.|+.+.+..
T Consensus 264 ~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 264 HGHRL----KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp TTCCC----CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred cCCCC----CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 11111 223334456899999999999999999999999999887654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=301.59 Aligned_cols=225 Identities=21% Similarity=0.244 Sum_probs=175.5
Q ss_pred HHHHHHHccccccccccc----ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEc
Q 047629 325 IEVIMESTMNLSEHYSIG----KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSD 388 (615)
Q Consensus 325 ~~~l~~at~~~~~~~~iG----~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~ 388 (615)
++++.....+|.....+| |.||++.. +|+.||+|++++ .+.+|+.++..++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 344555566677666676 58999998 689999999864 26689999999999999999999876
Q ss_pred CCCcEEEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCC
Q 047629 389 SQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRF 468 (615)
Q Consensus 389 ~~~~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~ 468 (615)
. ...++||||+++|+|.+++.... +++..+..++.|++.||+|||+++ |+||||||+|||++.++
T Consensus 141 ~-~~~~lV~E~~~gg~L~~~l~~~~-----------~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g 205 (410)
T 3v8s_A 141 D-RYLYMVMEYMPGGDLVNLMSNYD-----------VPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSG 205 (410)
T ss_dssp S-SEEEEEECCCTTEEHHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTS
T ss_pred C-CEEEEEEeCCCCCcHHHHHHcCC-----------CCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCC
Confidence 4 47999999999999999997532 889999999999999999999998 99999999999999999
Q ss_pred cEEEeecCCCCCCCCC----------------------------CCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHH
Q 047629 469 KAKIANFSLAAPATND----------------------------VMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLW 520 (615)
Q Consensus 469 ~~kl~DFGla~~~~~~----------------------------~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 520 (615)
.+||+|||+++..... ++.++|||||||++|||++|+.||......+ ..
T Consensus 206 ~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~ 282 (410)
T 3v8s_A 206 HLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG---TY 282 (410)
T ss_dssp CEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH
T ss_pred CEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh---HH
Confidence 9999999998543210 3468999999999999999999997543211 11
Q ss_pred HHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCC--CCCHHHHHHHH
Q 047629 521 KEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLS--RPNMAEVVFNL 582 (615)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~--RPsm~ev~~~L 582 (615)
...... .. ...-|. .......+.+|+.+|+..+|.+ ||++.||+++-
T Consensus 283 ---~~i~~~----~~---~~~~p~-----~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp 331 (410)
T 3v8s_A 283 ---SKIMNH----KN---SLTFPD-----DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 331 (410)
T ss_dssp ---HHHHTH----HH---HCCCCT-----TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred ---HHHHhc----cc---cccCCC-----cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence 111100 00 000010 1122345789999999999998 99999999863
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-33 Score=293.18 Aligned_cols=212 Identities=23% Similarity=0.354 Sum_probs=169.3
Q ss_pred ccccccccc----ceEEEEEE--CCeEEEEEEccHH----------HHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEE
Q 047629 334 NLSEHYSIG----KSVYRATI--DGKVLAVKKIKED----------VTEELRILQRI-NHANLVKLMGVSSDSQGNRFLV 396 (615)
Q Consensus 334 ~~~~~~~iG----~~Vy~~~~--~g~~vAvK~~~~~----------~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV 396 (615)
+|.....+| |.||++.. +|+.||||+++++ +.+|..++.++ +||||+++++++.+. +..++|
T Consensus 24 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~-~~~~lv 102 (353)
T 3txo_A 24 NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP-DRLFFV 102 (353)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEEEEE
T ss_pred heEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC-CEEEEE
Confidence 444444555 58999997 6899999998743 55799999988 799999999998754 479999
Q ss_pred EeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecC
Q 047629 397 YEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFS 476 (615)
Q Consensus 397 ~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFG 476 (615)
|||+++|+|.+++.... .+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 103 ~E~~~gg~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG 169 (353)
T 3txo_A 103 MEFVNGGDLMFHIQKSR----------RFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFG 169 (353)
T ss_dssp EECCCSCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred EeCCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEcccc
Confidence 99999999999997654 2899999999999999999999998 9999999999999999999999999
Q ss_pred CCCCCCC-----------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHH
Q 047629 477 LAAPATN-----------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKR 533 (615)
Q Consensus 477 la~~~~~-----------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 533 (615)
+++.... .++.++|||||||++|||++|+.||......+ +.. ..
T Consensus 170 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~~---~i------- 236 (353)
T 3txo_A 170 MCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD---LFE---AI------- 236 (353)
T ss_dssp TCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HH-------
T ss_pred ceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH---HHH---HH-------
Confidence 9875311 14578999999999999999999997543211 111 00
Q ss_pred HHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCH------HHHHHH
Q 047629 534 EERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNM------AEVVFN 581 (615)
Q Consensus 534 ~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm------~ev~~~ 581 (615)
.. .. ..++......+.+++..|++.||.+||++ .|++++
T Consensus 237 ---~~----~~--~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 237 ---LN----DE--VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp ---HH----CC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred ---Hc----CC--CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 01 11 12333344567899999999999999998 777663
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-33 Score=282.57 Aligned_cols=220 Identities=17% Similarity=0.213 Sum_probs=171.2
Q ss_pred ceEEEEEE--CCeEEEEEEcc-----HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK-----EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKS 415 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-----~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~ 415 (615)
|.||+|.. +|+.||||.+. ..+.+|++++.+++|+|++..++++...+...++||||+ +|+|.+++.....
T Consensus 23 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~- 100 (296)
T 4hgt_A 23 GDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSR- 100 (296)
T ss_dssp SEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTS-
T ss_pred eEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhcC-
Confidence 58999996 78999999764 357899999999999998888887765565789999999 8999999975432
Q ss_pred CCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceee---CCCCcEEEeecCCCCCCCC---------
Q 047629 416 SSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQL---DSRFKAKIANFSLAAPATN--------- 483 (615)
Q Consensus 416 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl---d~~~~~kl~DFGla~~~~~--------- 483 (615)
.+++.++..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||+++....
T Consensus 101 --------~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 169 (296)
T 4hgt_A 101 --------KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY 169 (296)
T ss_dssp --------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCC
T ss_pred --------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCC
Confidence 3899999999999999999999998 9999999999999 7889999999999864211
Q ss_pred ---------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcC
Q 047629 484 ---------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMD 542 (615)
Q Consensus 484 ---------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~d 542 (615)
.++.++|||||||++|||++|+.||..............+... ......
T Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------~~~~~~- 239 (296)
T 4hgt_A 170 RENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK---------KMSTPI- 239 (296)
T ss_dssp CCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH---------HHHSCH-
T ss_pred CcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcc---------cccchh-
Confidence 1345789999999999999999999865432221111111100 000000
Q ss_pred CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccch
Q 047629 543 PNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQST 589 (615)
Q Consensus 543 p~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~ 589 (615)
+.+...+ ...+.+++..||+.||++||++.|+++.|+.+.+..
T Consensus 240 ~~~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~ 282 (296)
T 4hgt_A 240 EVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp HHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred hhhhccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence 0011112 245889999999999999999999999999887654
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=283.82 Aligned_cols=222 Identities=23% Similarity=0.366 Sum_probs=167.8
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
|.||++.. +|+.||||++. +.+.+|++++++++|+||+++++++.+. +..++||||+++++|.+++..
T Consensus 17 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~l~~~~~~ 95 (311)
T 4agu_A 17 GVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK-RRLHLVFEYCDHTVLHELDRY 95 (311)
T ss_dssp EEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEECCSEEHHHHHHHT
T ss_pred eEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecC-CeEEEEEEeCCCchHHHHHhh
Confidence 58999998 58999999873 3467899999999999999999998764 478999999999999998875
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC---------
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT--------- 482 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~--------- 482 (615)
.. .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 96 ~~----------~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 162 (311)
T 4agu_A 96 QR----------GVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE 162 (311)
T ss_dssp SS----------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---------
T ss_pred hc----------CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCCC
Confidence 43 2899999999999999999999998 9999999999999999999999999985432
Q ss_pred ---------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHH-HHHHHH--Hhhhc---
Q 047629 483 ---------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVE-EKREER--LRNWM--- 541 (615)
Q Consensus 483 ---------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~--~~~~~--- 541 (615)
..++.++||||||+++|||++|+.||......+.... +...+... ...... .....
T Consensus 163 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
T 4agu_A 163 VATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYL---IRKTLGDLIPRHQQVFSTNQYFSGV 239 (311)
T ss_dssp ---GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCSCCHHHHHHHHTCGGGTTC
T ss_pred cCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhcccccccccccccccccccC
Confidence 2246789999999999999999999976543222111 11111000 000000 00000
Q ss_pred -CCcCCCCCC-----hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 542 -DPNLESFYP-----IDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 542 -dp~l~~~~~-----~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
-+......+ ......+.+++..||+.||.+|||++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 240 KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 011100001 1233457899999999999999999999975
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=291.07 Aligned_cols=207 Identities=21% Similarity=0.318 Sum_probs=164.9
Q ss_pred ceEEEEEE--CCeEEEEEEcc-------------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATI--DGKVLAVKKIK-------------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-------------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~ 407 (615)
|.||++.. +|+.||+|.++ +.+.+|+.+|++++||||+++++++.+. ...++||||+++|+|.+
T Consensus 26 g~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~~~lv~e~~~gg~L~~ 104 (361)
T 2yab_A 26 AIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR-TDVVLILELVSGGELFD 104 (361)
T ss_dssp EEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEEEECCCSCBHHH
T ss_pred EEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC-CEEEEEEEcCCCCcHHH
Confidence 58999998 68999999875 3478999999999999999999998754 47999999999999999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCC----cEEEeecCCCCCCC-
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRF----KAKIANFSLAAPAT- 482 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~----~~kl~DFGla~~~~- 482 (615)
++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++...
T Consensus 105 ~l~~~~----------~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~ 171 (361)
T 2yab_A 105 FLAQKE----------SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171 (361)
T ss_dssp HHTTCS----------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCT
T ss_pred HHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCC
Confidence 997643 3899999999999999999999998 99999999999998876 79999999986432
Q ss_pred ---------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhc
Q 047629 483 ---------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWM 541 (615)
Q Consensus 483 ---------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 541 (615)
..++.++|||||||++|||++|+.||......+ .. .. +.. .
T Consensus 172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~---~~---~~-----------i~~-~ 233 (361)
T 2yab_A 172 GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TL---AN-----------ITA-V 233 (361)
T ss_dssp TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HH---HH-----------HHT-T
T ss_pred CCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH---HH---HH-----------HHh-c
Confidence 125668999999999999999999997543211 11 00 000 0
Q ss_pred CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 542 DPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 542 dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.......+.......+.+++..|+..||.+|||+.|++++
T Consensus 234 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 234 SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000000011223457899999999999999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-33 Score=288.21 Aligned_cols=206 Identities=19% Similarity=0.361 Sum_probs=161.7
Q ss_pred ceEEEEEE--CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCC---------------------
Q 047629 343 KSVYRATI--DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQG--------------------- 391 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~--------------------- 391 (615)
|.||+|.. +|+.||||+++ +.+.+|+++|++++||||+++++++.+.+.
T Consensus 20 g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (332)
T 3qd2_B 20 GVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPL 99 (332)
T ss_dssp SEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC------------
T ss_pred eEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccc
Confidence 58999998 68999999985 457899999999999999999998864321
Q ss_pred -----------------------------------cEEEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHH
Q 047629 392 -----------------------------------NRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALD 436 (615)
Q Consensus 392 -----------------------------------~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ 436 (615)
..++||||+++|+|.+++...... ...++..++.++.|
T Consensus 100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~i~~q 172 (332)
T 3qd2_B 100 SSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL-------EDREHGVCLHIFIQ 172 (332)
T ss_dssp --------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG-------GGSCHHHHHHHHHH
T ss_pred cCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc-------cchhhHHHHHHHHH
Confidence 279999999999999999875431 23678889999999
Q ss_pred HHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC----------------------------------
Q 047629 437 VANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT---------------------------------- 482 (615)
Q Consensus 437 ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~---------------------------------- 482 (615)
++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 173 i~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 249 (332)
T 3qd2_B 173 IAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIH 249 (332)
T ss_dssp HHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHH
T ss_pred HHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhc
Confidence 999999999998 9999999999999999999999999986432
Q ss_pred -CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHH
Q 047629 483 -NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLA 561 (615)
Q Consensus 483 -~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~ 561 (615)
..++.++||||||+++|||++|..|+... .... ........|. ........+.+++
T Consensus 250 ~~~~~~~~Di~slG~il~el~~~~~~~~~~-----~~~~--------------~~~~~~~~~~----~~~~~~~~~~~li 306 (332)
T 3qd2_B 250 GNNYSHKVDIFSLGLILFELLYSFSTQMER-----VRII--------------TDVRNLKFPL----LFTQKYPQEHMMV 306 (332)
T ss_dssp CCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-----HHHH--------------HHHHTTCCCH----HHHHHCHHHHHHH
T ss_pred CCCCcchhhHHHHHHHHHHHHHcCCChhHH-----HHHH--------------HHhhccCCCc----ccccCChhHHHHH
Confidence 12467899999999999999987663210 0000 0011110010 0122334568999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 047629 562 RACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 562 ~~C~~~dP~~RPsm~ev~~~ 581 (615)
.+||+.||++|||+.|++++
T Consensus 307 ~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 307 QDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHCSSGGGSCCHHHHHHS
T ss_pred HHHccCCCCcCCCHHHHhhc
Confidence 99999999999999999874
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-33 Score=293.34 Aligned_cols=209 Identities=20% Similarity=0.246 Sum_probs=161.6
Q ss_pred ceEEEEEE--CCeEEEEEEcc------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSK 414 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~ 414 (615)
|.||++.. +|+.||||+++ +.+.+|+.++++++||||+++++++.+. +..++||||+++|+|.+++....
T Consensus 34 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~- 111 (361)
T 3uc3_A 34 GVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTP-THLAIIMEYASGGELYERICNAG- 111 (361)
T ss_dssp SSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEEECCCSCBHHHHHHHHS-
T ss_pred EEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeC-CEEEEEEEeCCCCCHHHHHHhcC-
Confidence 58999998 68999999985 4578999999999999999999998764 47999999999999999997643
Q ss_pred CCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCc--EEEeecCCCCCCCC---------
Q 047629 415 SSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFK--AKIANFSLAAPATN--------- 483 (615)
Q Consensus 415 ~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~--~kl~DFGla~~~~~--------- 483 (615)
.+++..+..++.|++.||.|||+++ |+||||||+|||++.++. +||+|||+++....
T Consensus 112 ---------~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~g 179 (361)
T 3uc3_A 112 ---------RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179 (361)
T ss_dssp ---------SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC--------------
T ss_pred ---------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCCCCcC
Confidence 2899999999999999999999998 999999999999987765 99999999863211
Q ss_pred -------------CCC-CcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCC
Q 047629 484 -------------DVM-PKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFY 549 (615)
Q Consensus 484 -------------~~~-~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~ 549 (615)
.+. .++|||||||++|||++|+.||.......... .. +..+.........
T Consensus 180 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~--~~--------------~~~~~~~~~~~~~ 243 (361)
T 3uc3_A 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYR--KT--------------IQRILSVKYSIPD 243 (361)
T ss_dssp -CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHH--HH--------------HHHHHTTCCCCCT
T ss_pred CCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHH--HH--------------HHHHhcCCCCCCC
Confidence 122 24899999999999999999997654322211 00 1111111111111
Q ss_pred ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 550 PIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 550 ~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.......+.+|+.+||+.||++|||+.|++++
T Consensus 244 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 244 DIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 11223457899999999999999999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=281.94 Aligned_cols=220 Identities=17% Similarity=0.203 Sum_probs=170.4
Q ss_pred ceEEEEEE--CCeEEEEEEcc-----HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK-----EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKS 415 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-----~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~ 415 (615)
|.||+|.. +|+.||||++. ..+.+|+.++.+++|++++..++++...+...++||||+ +|+|.+++.....
T Consensus 23 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~- 100 (296)
T 3uzp_A 23 GDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSR- 100 (296)
T ss_dssp EEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT-
T ss_pred eEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhcc-
Confidence 58999996 79999999875 468899999999999998877777765555789999999 8999999975432
Q ss_pred CCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceee---CCCCcEEEeecCCCCCCCC---------
Q 047629 416 SSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQL---DSRFKAKIANFSLAAPATN--------- 483 (615)
Q Consensus 416 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl---d~~~~~kl~DFGla~~~~~--------- 483 (615)
.+++.+++.++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||+++....
T Consensus 101 --------~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 169 (296)
T 3uzp_A 101 --------KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY 169 (296)
T ss_dssp --------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCC
T ss_pred --------CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccccccccc
Confidence 3899999999999999999999998 9999999999999 4889999999999854211
Q ss_pred ---------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcC
Q 047629 484 ---------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMD 542 (615)
Q Consensus 484 ---------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~d 542 (615)
.++.++|||||||++|||++|+.||..............+... ..... .
T Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------~~~~~-~ 239 (296)
T 3uzp_A 170 RENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK---------KMSTP-I 239 (296)
T ss_dssp CCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH---------HHHSC-H
T ss_pred ccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccc---------ccCCc-h
Confidence 1345889999999999999999999864422211111111110 00000 0
Q ss_pred CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccch
Q 047629 543 PNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQST 589 (615)
Q Consensus 543 p~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~ 589 (615)
+.+...+ ...+.+++..||+.||.+||++.||++.|+.+....
T Consensus 240 ~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 240 EVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp HHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHHhhC----CHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 0011122 245789999999999999999999999999886553
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=279.73 Aligned_cols=212 Identities=26% Similarity=0.469 Sum_probs=168.7
Q ss_pred ceEEEEEE--CCeEEEEEEcc---HHHHHHHHHHHhcCCCCcccEEEEEEc---------------CCCcEEEEEeecCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK---EDVTEELRILQRINHANLVKLMGVSSD---------------SQGNRFLVYEYAEN 402 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---~~~~~Ei~~l~~l~H~niv~l~g~~~~---------------~~~~~~lV~E~~~~ 402 (615)
|.||++.. +|+.||+|+++ ..+.+|++++++++||||+++++++.. .....++||||+++
T Consensus 25 g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~ 104 (284)
T 2a19_B 25 GQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDK 104 (284)
T ss_dssp CCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCS
T ss_pred eEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCC
Confidence 58999998 58999999986 468899999999999999999998753 12247999999999
Q ss_pred CCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC
Q 047629 403 GSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT 482 (615)
Q Consensus 403 GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~ 482 (615)
|+|.+++...... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 105 ~~L~~~l~~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 173 (284)
T 2a19_B 105 GTLEQWIEKRRGE--------KLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLK 173 (284)
T ss_dssp CBHHHHHHHGGGS--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEESS
T ss_pred CCHHHHHhhccCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCEEECcchhheecc
Confidence 9999999754321 3899999999999999999999998 9999999999999999999999999985432
Q ss_pred C----------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhh
Q 047629 483 N----------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNW 540 (615)
Q Consensus 483 ~----------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 540 (615)
. .++.++||||||+++|||++|+.|+.... .. ....
T Consensus 174 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-----~~-----------------~~~~ 231 (284)
T 2a19_B 174 NDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-----KF-----------------FTDL 231 (284)
T ss_dssp CCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-----HH-----------------HHHH
T ss_pred ccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-----HH-----------------HHHh
Confidence 1 24678999999999999999998863110 00 0111
Q ss_pred cCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccchhh
Q 047629 541 MDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQSTET 591 (615)
Q Consensus 541 ~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~~~ 591 (615)
.+..+...++ ..+.+++..||+.||.+||++.|+++.|..+..+.+.
T Consensus 232 ~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~ 278 (284)
T 2a19_B 232 RDGIISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278 (284)
T ss_dssp HTTCCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred hcccccccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence 1122222233 3478999999999999999999999999988776543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=290.14 Aligned_cols=208 Identities=23% Similarity=0.330 Sum_probs=159.6
Q ss_pred ceEEEEEE--CCeEEEEEEccH-----HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCC
Q 047629 343 KSVYRATI--DGKVLAVKKIKE-----DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKS 415 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~-----~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~ 415 (615)
|.||+|.. +++.||||+++. .+.+|++++++++|+||+++++++.+. +..++||||+++|+|.+++....
T Consensus 67 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~-- 143 (349)
T 2w4o_A 67 SIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETP-TEISLVLELVTGGELFDRIVEKG-- 143 (349)
T ss_dssp EEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECS-SEEEEEECCCCSCBHHHHHTTCS--
T ss_pred EEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecC-CeEEEEEEeCCCCCHHHHHHhcC--
Confidence 58999998 578999999863 467899999999999999999998764 47999999999999999997643
Q ss_pred CCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCC---CCcEEEeecCCCCCCC----------
Q 047629 416 SSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDS---RFKAKIANFSLAAPAT---------- 482 (615)
Q Consensus 416 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~---~~~~kl~DFGla~~~~---------- 482 (615)
.+++.++..++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||+++...
T Consensus 144 --------~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~g 212 (349)
T 2w4o_A 144 --------YYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCG 212 (349)
T ss_dssp --------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC----------------
T ss_pred --------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCcccccccccC
Confidence 3899999999999999999999998 999999999999975 8899999999986432
Q ss_pred ------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 483 ------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 483 ------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
..++.++|||||||++|||++|+.||........ ... . +... .........
T Consensus 213 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~---~-----------i~~~-~~~~~~~~~ 275 (349)
T 2w4o_A 213 TPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--MFR---R-----------ILNC-EYYFISPWW 275 (349)
T ss_dssp CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--HHH---H-----------HHTT-CCCCCTTTT
T ss_pred CCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--HHH---H-----------HHhC-CCccCCchh
Confidence 1256789999999999999999999975442111 110 0 1000 001111112
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 551 IDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.+....+.+|+.+||+.||++|||+.|+++.
T Consensus 276 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 276 DEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2344568899999999999999999999885
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-33 Score=301.79 Aligned_cols=229 Identities=18% Similarity=0.225 Sum_probs=178.5
Q ss_pred eeHHHHHHHccccccccccc----ceEEEEEE--CCeEEEEEEccHH----------HHHHHHHHHhcCCCCcccEEEEE
Q 047629 323 YEIEVIMESTMNLSEHYSIG----KSVYRATI--DGKVLAVKKIKED----------VTEELRILQRINHANLVKLMGVS 386 (615)
Q Consensus 323 ~~~~~l~~at~~~~~~~~iG----~~Vy~~~~--~g~~vAvK~~~~~----------~~~Ei~~l~~l~H~niv~l~g~~ 386 (615)
+.++++...+++|.....+| |.||++.. +|+.||||++++. +.+|+.++.+++|+||+++++++
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 34556666677787777777 58999998 5799999998641 67899999999999999999998
Q ss_pred EcCCCcEEEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCC
Q 047629 387 SDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDS 466 (615)
Q Consensus 387 ~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~ 466 (615)
.+. +..++||||+++|+|.+++..... .+++..+..++.|++.||+|||+++ |+||||||+|||++.
T Consensus 144 ~~~-~~~~lV~Ey~~gg~L~~~l~~~~~---------~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~ 210 (437)
T 4aw2_A 144 QDD-NNLYLVMDYYVGGDLLTLLSKFED---------RLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDM 210 (437)
T ss_dssp ECS-SEEEEEECCCTTCBHHHHHHTTTT---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred eeC-CEEEEEEecCCCCcHHHHHHHccC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcC
Confidence 764 479999999999999999976432 3899999999999999999999998 999999999999999
Q ss_pred CCcEEEeecCCCCCCC-----------------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhH
Q 047629 467 RFKAKIANFSLAAPAT-----------------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTA 517 (615)
Q Consensus 467 ~~~~kl~DFGla~~~~-----------------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~ 517 (615)
++.+||+|||+++... ..++.++|||||||++|||++|+.||......+
T Consensus 211 ~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~-- 288 (437)
T 4aw2_A 211 NGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE-- 288 (437)
T ss_dssp TSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--
T ss_pred CCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH--
Confidence 9999999999985321 124568999999999999999999997543211
Q ss_pred HHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 047629 518 VLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLS--RPNMAEVVFN 581 (615)
Q Consensus 518 ~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~--RPsm~ev~~~ 581 (615)
.. ...+.. . ....-|.... +....+.+|+++|+..+|++ ||++.|++++
T Consensus 289 -~~---~~i~~~----~---~~~~~p~~~~----~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 289 -TY---GKIMNH----K---ERFQFPTQVT----DVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp -HH---HHHHTH----H---HHCCCCSSCC----CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred -HH---Hhhhhc----c---ccccCCcccc----cCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 11 111100 0 0111111111 23345789999999888888 9999999885
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-33 Score=289.80 Aligned_cols=229 Identities=25% Similarity=0.384 Sum_probs=172.1
Q ss_pred ceEEEEEE------CCeEEEEEEcc-------HHHHHHHHHHHhcCCCCcccEEEEEEcCC-CcEEEEEeecCCCCHHHh
Q 047629 343 KSVYRATI------DGKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVSSDSQ-GNRFLVYEYAENGSLDKW 408 (615)
Q Consensus 343 ~~Vy~~~~------~g~~vAvK~~~-------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~~lV~E~~~~GsL~~~ 408 (615)
|.||++.+ +|+.||||+++ +.+.+|++++++++|+||+++++++...+ ...++||||+++|+|.++
T Consensus 55 g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 134 (326)
T 2w1i_A 55 GSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDY 134 (326)
T ss_dssp EEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHH
T ss_pred eEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHH
Confidence 58999985 58999999985 35789999999999999999999986533 257999999999999999
Q ss_pred hccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCCC----
Q 047629 409 LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATND---- 484 (615)
Q Consensus 409 L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~---- 484 (615)
+..... .+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 135 l~~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~ 202 (326)
T 2w1i_A 135 LQKHKE---------RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYY 202 (326)
T ss_dssp HHHSTT---------SSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEE
T ss_pred HHhccc---------CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhcccccccc
Confidence 986543 3899999999999999999999998 999999999999999999999999998653211
Q ss_pred ----------------------CCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcC
Q 047629 485 ----------------------VMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMD 542 (615)
Q Consensus 485 ----------------------~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~d 542 (615)
++.++||||||+++|||++|+.|+..... ......... .........+.+.+.
T Consensus 203 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~~~~~ 277 (326)
T 2w1i_A 203 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA----EFMRMIGND-KQGQMIVFHLIELLK 277 (326)
T ss_dssp ECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH----HHHHHHCTT-CCTHHHHHHHHHHHH
T ss_pred ccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH----HHHHhhccc-cchhhhHHHHHHHhh
Confidence 24579999999999999999988753210 000000000 000000011111111
Q ss_pred CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 543 PNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 543 p~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
.......+......+.+++..||+.||++|||+.|+++.|+.+.+.
T Consensus 278 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 278 NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 1111122344556789999999999999999999999999988654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=286.08 Aligned_cols=203 Identities=21% Similarity=0.324 Sum_probs=165.6
Q ss_pred ceEEEEEE--CCeEEEEEEccHH----------HHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKED----------VTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~~----------~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||++.. +|+.||+|.+++. +.+|+.++++++||||+++++++.+. ...++||||+++|+|.+++.
T Consensus 20 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-~~~~lv~e~~~gg~L~~~l~ 98 (318)
T 1fot_A 20 GRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA-QQIFMIMDYIEGGELFSLLR 98 (318)
T ss_dssp CEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS-SEEEEEECCCCSCBHHHHHH
T ss_pred EEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeC-CEEEEEEeCCCCCCHHHHHH
Confidence 58999987 6899999998642 55799999999999999999998754 47999999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 99 ~~~----------~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~~~~~g 165 (318)
T 1fot_A 99 KSQ----------RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCG 165 (318)
T ss_dssp HTS----------SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSCBCCCCS
T ss_pred HcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCccccccC
Confidence 654 2899999999999999999999998 9999999999999999999999999986432
Q ss_pred ------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 483 ------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 483 ------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
..++.++|||||||++|||++|+.||...... ... ... +.. .. .++
T Consensus 166 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~---~~i----------~~~--~~----~~p 223 (318)
T 1fot_A 166 TPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM---KTY---EKI----------LNA--EL----RFP 223 (318)
T ss_dssp CTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHH---HHH----------HHC--CC----CCC
T ss_pred CccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHH---HHH----------HhC--CC----CCC
Confidence 12467899999999999999999999754311 111 110 111 11 123
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 047629 551 IDGALSLATLARACTMDKSLSRP-----NMAEVVFN 581 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RP-----sm~ev~~~ 581 (615)
......+.+++.+|++.||.+|| ++.|++++
T Consensus 224 ~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 224 PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 33345678999999999999999 88888864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-32 Score=292.42 Aligned_cols=205 Identities=22% Similarity=0.309 Sum_probs=166.2
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||++.. +|+.||+|.++. .+.+|+++|++++||||+++++++.+. +..++||||+++|+|.+++.
T Consensus 29 G~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-~~~~lv~e~~~gg~L~~~l~ 107 (384)
T 4fr4_A 29 GKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE-EDMFMVVDLLLGGDLRYHLQ 107 (384)
T ss_dssp CCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEEEECCCTTEEHHHHHH
T ss_pred eEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-CEEEEEEecCCCCcHHHHHH
Confidence 58999987 689999999863 356899999999999999999998764 47999999999999999998
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 108 ~~~----------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~ 174 (384)
T 4fr4_A 108 QNV----------HFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTM 174 (384)
T ss_dssp TTC----------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTCCBCCC
T ss_pred hcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCCCceecc
Confidence 643 3899999999999999999999998 9999999999999999999999999986431
Q ss_pred -----------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcC
Q 047629 483 -----------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNL 545 (615)
Q Consensus 483 -----------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l 545 (615)
..++.++|||||||++|||++|+.||.............. +.. ..
T Consensus 175 ~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~--------------~~~-~~--- 236 (384)
T 4fr4_A 175 AGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT--------------FET-TV--- 236 (384)
T ss_dssp CSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHH--------------HHH-CC---
T ss_pred CCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHH--------------Hhh-cc---
Confidence 1246689999999999999999999975443322211110 000 01
Q ss_pred CCCCChHHHHHHHHHHHHhhhcCCCCCCC-HHHHHH
Q 047629 546 ESFYPIDGALSLATLARACTMDKSLSRPN-MAEVVF 580 (615)
Q Consensus 546 ~~~~~~~~~~~l~~l~~~C~~~dP~~RPs-m~ev~~ 580 (615)
..++......+.+|+..||+.||.+||+ +.++..
T Consensus 237 -~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 -VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp -CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred -cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 1234444556899999999999999999 777654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-32 Score=290.65 Aligned_cols=207 Identities=22% Similarity=0.314 Sum_probs=164.6
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
|.||++.. +|+.||+|.++ +.+.+|+.++++++||||+++++++.+. +..++||||+++|+|.+++..
T Consensus 43 g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-~~~~lv~e~~~gg~L~~~l~~ 121 (362)
T 2bdw_A 43 SVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-SFHYLVFDLVTGGELFEDIVA 121 (362)
T ss_dssp EEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEECCCCSCBHHHHHTT
T ss_pred eEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-CEEEEEEecCCCCCHHHHHHH
Confidence 58999997 68999999985 2467899999999999999999998754 478999999999999999976
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCC---CcEEEeecCCCCCCCC-----
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSR---FKAKIANFSLAAPATN----- 483 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~---~~~kl~DFGla~~~~~----- 483 (615)
.. .+++..+..++.|++.||.|||+++ |+||||||+|||++.+ +.+||+|||+++....
T Consensus 122 ~~----------~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~ 188 (362)
T 2bdw_A 122 RE----------FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH 188 (362)
T ss_dssp CS----------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCC
T ss_pred cC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcccc
Confidence 43 3899999999999999999999998 9999999999999865 4599999999865321
Q ss_pred -----------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCC
Q 047629 484 -----------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLE 546 (615)
Q Consensus 484 -----------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~ 546 (615)
.++.++|||||||++|||++|+.||..... ..++..+ .....+ ..
T Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~---~~~~~~i-------------~~~~~~--~~ 250 (362)
T 2bdw_A 189 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLYAQI-------------KAGAYD--YP 250 (362)
T ss_dssp CSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH-------------HHTCCC--CC
T ss_pred cCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHH-------------HhCCCC--CC
Confidence 256789999999999999999999975432 1111110 001111 00
Q ss_pred CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 547 SFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 547 ~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
..........+.+|+.+||+.||++||++.|++++
T Consensus 251 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 251 SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 01111234567899999999999999999999875
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-32 Score=293.25 Aligned_cols=224 Identities=16% Similarity=0.242 Sum_probs=165.1
Q ss_pred eEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 344 SVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 344 ~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
.||++.. +|+.||||+++ ..+.+|+.++++++|||||++++++.+. +..++||||+++|+|.+++...
T Consensus 42 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~ 120 (389)
T 3gni_B 42 TVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-NELWVVTSFMAYGSAKDLICTH 120 (389)
T ss_dssp EEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEECCTTCBHHHHHHHT
T ss_pred EEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC-CEEEEEEEccCCCCHHHHHhhh
Confidence 6999998 68999999985 2366799999999999999999998764 4799999999999999999765
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCC-----------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA----------- 481 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~----------- 481 (615)
... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 121 ~~~--------~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 189 (389)
T 3gni_B 121 FMD--------GMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVH 189 (389)
T ss_dssp CTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBC
T ss_pred ccc--------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccc
Confidence 321 3899999999999999999999998 999999999999999999999999986321
Q ss_pred -------------------C--CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHH----hHHHHHH--
Q 047629 482 -------------------T--NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVL----KVEEKRE-- 534 (615)
Q Consensus 482 -------------------~--~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~----~~~~~~~-- 534 (615)
. ..++.++|||||||++|||++|+.||.......... ..+.... .......
T Consensus 190 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 267 (389)
T 3gni_B 190 DFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL--EKLNGTVPCLLDTSTIPAEE 267 (389)
T ss_dssp CCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH--HC------------------
T ss_pred cccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH--HHhcCCCCcccccccccccc
Confidence 0 235678999999999999999999997654332211 0000000 0000000
Q ss_pred -----------HHHhhhcC---Cc------CCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 535 -----------ERLRNWMD---PN------LESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 535 -----------~~~~~~~d---p~------l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
..+.+.+. +. ....++......+.+|+.+||+.||++|||+.|++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 268 LTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp --------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00000000 00 0011223344568999999999999999999999875
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-32 Score=289.12 Aligned_cols=203 Identities=20% Similarity=0.282 Sum_probs=166.1
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||++.. +|+.||||.++. .+.+|+++|++++||||+++++++.+. ...++||||+++|+|.+++.
T Consensus 55 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~gg~L~~~l~ 133 (350)
T 1rdq_E 55 GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN-SNLYMVMEYVAGGEMFSHLR 133 (350)
T ss_dssp CEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEEEECCTTCBHHHHHH
T ss_pred cEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC-CEEEEEEcCCCCCcHHHHHH
Confidence 58999998 689999999853 356799999999999999999998754 47999999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
... .+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 134 ~~~----------~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~~~~~g 200 (350)
T 1rdq_E 134 RIG----------RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCG 200 (350)
T ss_dssp HHC----------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSCBCCCEE
T ss_pred HcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCCcccccC
Confidence 643 2899999999999999999999998 9999999999999999999999999986432
Q ss_pred ------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 483 ------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 483 ------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
..++.++|||||||++|||++|+.||...... ... ... ... .. .++
T Consensus 201 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~---~~i----------~~~--~~----~~p 258 (350)
T 1rdq_E 201 TPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI---QIY---EKI----------VSG--KV----RFP 258 (350)
T ss_dssp CGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HHH----------HHC--CC----CCC
T ss_pred CccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH---HHH---HHH----------HcC--CC----CCC
Confidence 22567899999999999999999999754311 111 000 010 11 223
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 047629 551 IDGALSLATLARACTMDKSLSRPN-----MAEVVFN 581 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RPs-----m~ev~~~ 581 (615)
......+.+++.+||+.||.+||+ ++||+++
T Consensus 259 ~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 259 SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 334456889999999999999998 8888764
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-32 Score=279.26 Aligned_cols=223 Identities=18% Similarity=0.267 Sum_probs=163.6
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
|.||++.. +|+.||||+++ ..+.+|+.++++++|+||+++++++.+. +..++||||+++ +|.+++..
T Consensus 16 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~-~l~~~~~~ 93 (292)
T 3o0g_A 16 GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-KKLTLVFEFCDQ-DLKKYFDS 93 (292)
T ss_dssp SEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-TEEEEEEECCSE-EHHHHHHH
T ss_pred eEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeC-CEEEEEEecCCC-CHHHHHHh
Confidence 58999998 68999999985 4577899999999999999999998764 479999999975 66666654
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC---------
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT--------- 482 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~--------- 482 (615)
... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 94 ~~~---------~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 161 (292)
T 3o0g_A 94 CNG---------DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE 161 (292)
T ss_dssp TTT---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCSC
T ss_pred CCC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCccccccCC
Confidence 332 3899999999999999999999998 9999999999999999999999999985421
Q ss_pred --------------C-CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHH-HHHHHhhhcCCc--
Q 047629 483 --------------N-DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEK-REERLRNWMDPN-- 544 (615)
Q Consensus 483 --------------~-~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~dp~-- 544 (615)
. .++.++|||||||++|||++|+.|+........ ....+......... .-....+..+..
T Consensus 162 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 239 (292)
T 3o0g_A 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239 (292)
T ss_dssp CSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred ccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHHhCCCChhhhhhhccccccccc
Confidence 1 146789999999999999999988654432111 11111111100000 000000000000
Q ss_pred -------CCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 545 -------LESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 545 -------l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
............+.+|+.+|++.||++|||++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0011112344567899999999999999999999864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-32 Score=288.17 Aligned_cols=205 Identities=21% Similarity=0.369 Sum_probs=167.0
Q ss_pred ceEEEEEE-CCeEEEEEEcc---------HHHHHHHHHHHhcCC--CCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI-DGKVLAVKKIK---------EDVTEELRILQRINH--ANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~-~g~~vAvK~~~---------~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||++.. +++.||||+++ ..+.+|+++|.+++| +||+++++++.+. ...++||| +.+|+|.+++.
T Consensus 23 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~-~~~~lv~e-~~~~~L~~~l~ 100 (343)
T 3dbq_A 23 SKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-QYIYMVME-CGNIDLNSWLK 100 (343)
T ss_dssp EEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEEEEEEC-CCSEEHHHHHH
T ss_pred eEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC-CEEEEEEe-CCCCCHHHHHH
Confidence 58999987 78999999885 347789999999976 9999999998754 47999999 56889999998
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
... .+++.++..++.|++.||.|||+++ |+||||||+|||++ ++.+||+|||+++...
T Consensus 101 ~~~----------~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~ 166 (343)
T 3dbq_A 101 KKK----------SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVK 166 (343)
T ss_dssp HSC----------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC---------
T ss_pred hcC----------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCcccccccC
Confidence 654 3899999999999999999999998 99999999999997 5789999999986431
Q ss_pred ----------------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHH
Q 047629 483 ----------------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKRE 534 (615)
Q Consensus 483 ----------------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 534 (615)
..++.++|||||||++|||++|+.||....+. .
T Consensus 167 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------------------~ 227 (343)
T 3dbq_A 167 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-------------------I 227 (343)
T ss_dssp ---CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-------------------H
T ss_pred CCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-------------------H
Confidence 12345789999999999999999999754321 0
Q ss_pred HHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047629 535 ERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNL 582 (615)
Q Consensus 535 ~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L 582 (615)
..+...+++.....++......+.+|+..||+.||.+|||+.|++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 228 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 112333444444455555556789999999999999999999999864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-33 Score=290.79 Aligned_cols=222 Identities=24% Similarity=0.367 Sum_probs=170.7
Q ss_pred ceEEEEEEC--C-----eEEEEEEcc--------HHHHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCHH
Q 047629 343 KSVYRATID--G-----KVLAVKKIK--------EDVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLD 406 (615)
Q Consensus 343 ~~Vy~~~~~--g-----~~vAvK~~~--------~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~ 406 (615)
|.||+|... | +.||+|.++ +.+.+|+.+++++ +||||+++++++.+. +..++||||+++|+|.
T Consensus 60 g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~~~~lv~e~~~~g~L~ 138 (333)
T 2i1m_A 60 GKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG-GPVLVITEYCCYGDLL 138 (333)
T ss_dssp EEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSCEEEEECCTTEEHH
T ss_pred cceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC-CceEEEEecCCCCcHH
Confidence 589999972 2 479999985 2477899999999 899999999998754 4799999999999999
Q ss_pred HhhccCCCCCCC----CCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC
Q 047629 407 KWLHPKSKSSSS----SGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT 482 (615)
Q Consensus 407 ~~L~~~~~~~~~----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~ 482 (615)
+++......... ......+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 139 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 215 (333)
T 2i1m_A 139 NFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIM 215 (333)
T ss_dssp HHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGGGEEEBCCCGGGCCGG
T ss_pred HHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCCCeEEECccccccccc
Confidence 999753210000 000013899999999999999999999998 9999999999999999999999999986431
Q ss_pred -------------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHH
Q 047629 483 -------------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREER 536 (615)
Q Consensus 483 -------------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 536 (615)
..++.++||||||+++|||++ |+.|+......... . . .
T Consensus 216 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~--~----~----------~ 279 (333)
T 2i1m_A 216 NDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF--Y----K----------L 279 (333)
T ss_dssp GCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH--H----H----------H
T ss_pred cccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH--H----H----------H
Confidence 124568999999999999999 88998765432211 1 0 0
Q ss_pred HhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 537 LRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 537 ~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
+.....+. .+......+.+++..||+.||.+|||+.|+++.|+.+.+.
T Consensus 280 ~~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 280 VKDGYQMA----QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp HHHTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HhcCCCCC----CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 11111111 1223345688999999999999999999999999877654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-33 Score=293.74 Aligned_cols=208 Identities=25% Similarity=0.306 Sum_probs=165.1
Q ss_pred ceEEEEEE--CCeEEEEEEcc-------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
|.||+|.. +|+.||+|+++ +.+.+|+++|++++||||+++++++.+. +..++||||+++|+|.+++....
T Consensus 103 g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~~lv~E~~~~~~L~~~l~~~~ 181 (373)
T 2x4f_A 103 GQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESK-NDIVLVMEYVDGGELFDRIIDES 181 (373)
T ss_dssp -CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEEEECCTTCEEHHHHHHTG
T ss_pred EEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-CEEEEEEeCCCCCcHHHHHHhcC
Confidence 58999987 68999999885 3578999999999999999999998764 47999999999999999997543
Q ss_pred CCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceee--CCCCcEEEeecCCCCCCCC--------
Q 047629 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQL--DSRFKAKIANFSLAAPATN-------- 483 (615)
Q Consensus 414 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl--d~~~~~kl~DFGla~~~~~-------- 483 (615)
. .+++..+..++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||+++....
T Consensus 182 ~---------~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~ 249 (373)
T 2x4f_A 182 Y---------NLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF 249 (373)
T ss_dssp G---------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCC
T ss_pred C---------CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccccccc
Confidence 2 3899999999999999999999998 9999999999999 6778999999999865321
Q ss_pred --------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCC
Q 047629 484 --------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFY 549 (615)
Q Consensus 484 --------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~ 549 (615)
.++.++|||||||++|||++|+.||......+ . +... +....+ +....
T Consensus 250 gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---~---~~~i----------~~~~~~--~~~~~ 311 (373)
T 2x4f_A 250 GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE---T---LNNI----------LACRWD--LEDEE 311 (373)
T ss_dssp SSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---H---HHHH----------HHTCCC--SCSGG
T ss_pred CCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH---H---HHHH----------HhccCC--CChhh
Confidence 13458999999999999999999997544211 0 1111 111111 11111
Q ss_pred ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 550 PIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 550 ~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.......+.+|+..|++.||.+||++.|+++.
T Consensus 312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 312 FQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11233467899999999999999999999984
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-32 Score=284.66 Aligned_cols=227 Identities=20% Similarity=0.347 Sum_probs=165.9
Q ss_pred ceEEEEEE--CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATI--DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
|.||+|.. +|+.||||+++ ..+.+|++++++++||||+++++++.+ ++..++||||++ |+|.+++...
T Consensus 19 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~-~~L~~~l~~~ 96 (317)
T 2pmi_A 19 ATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT-ENKLTLVFEFMD-NDLKKYMDSR 96 (317)
T ss_dssp CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC-TTEEEEEEECCC-CBHHHHHHHH
T ss_pred EEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE-CCeEEEEEEecC-CCHHHHHHhc
Confidence 58999987 68999999885 357899999999999999999999865 447999999998 6999998654
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC----------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT---------- 482 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~---------- 482 (615)
..... ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 97 ~~~~~----~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 169 (317)
T 2pmi_A 97 TVGNT----PRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEV 169 (317)
T ss_dssp HSSSC----CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCCCCCCC
T ss_pred ccccc----ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecCCCcccCCCCc
Confidence 32110 113899999999999999999999998 9999999999999999999999999985421
Q ss_pred --------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHH-HHHHHhh--hcCCcC
Q 047629 483 --------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEK-REERLRN--WMDPNL 545 (615)
Q Consensus 483 --------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~--~~dp~l 545 (615)
..++.++|||||||++|||++|+.||......+. ...+......... .-..... ..++.+
T Consensus 170 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (317)
T 2pmi_A 170 VTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ---LKLIFDIMGTPNESLWPSVTKLPKYNPNI 246 (317)
T ss_dssp SCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCTTTCGGGGGCTTCCTTC
T ss_pred ccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCChhHhhhhhhhhhccccc
Confidence 1246789999999999999999999976543211 1111111100000 0000000 000111
Q ss_pred CC------------CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 546 ES------------FYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 546 ~~------------~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.. ..+......+.+++.+||+.||++|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 247 QQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 00 0011223468899999999999999999999874
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-32 Score=283.54 Aligned_cols=218 Identities=22% Similarity=0.325 Sum_probs=166.7
Q ss_pred ceEEEEEE--CCeEEEEEEcc----------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIK----------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~----------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||+|.. +|+.||||+++ ..+.+|+.++++++|+||+++++++.+. +..++||||+++|+|.+++.
T Consensus 46 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~ 124 (310)
T 2wqm_A 46 SEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED-NELNIVLELADAGDLSRMIK 124 (310)
T ss_dssp CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEEEECCCSCBHHHHHH
T ss_pred ceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-CcEEEEEecCCCCCHHHHHH
Confidence 58999996 78999999875 2477899999999999999999998764 47999999999999999996
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
...... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++...
T Consensus 125 ~~~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 195 (310)
T 2wqm_A 125 HFKKQK------RLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS 195 (310)
T ss_dssp HHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC---------------
T ss_pred Hhcccc------cCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCccccc
Confidence 521110 13899999999999999999999998 9999999999999999999999999985431
Q ss_pred ---------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCC
Q 047629 483 ---------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLES 547 (615)
Q Consensus 483 ---------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~ 547 (615)
..++.++||||||+++|||++|+.||........ .+. ..+.....+.+.
T Consensus 196 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~--------------~~~~~~~~~~~~- 259 (310)
T 2wqm_A 196 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SLC--------------KKIEQCDYPPLP- 259 (310)
T ss_dssp ---CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH-HHH--------------HHHHTTCSCCCC-
T ss_pred cCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH-HHH--------------HHhhcccCCCCc-
Confidence 1245689999999999999999999865332111 000 011111111111
Q ss_pred CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 548 FYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 548 ~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
.......+.+++.+||+.||.+|||+.||++.|+.+...
T Consensus 260 --~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~ 298 (310)
T 2wqm_A 260 --SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC 298 (310)
T ss_dssp --TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 122334688999999999999999999999999988755
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-32 Score=279.22 Aligned_cols=222 Identities=22% Similarity=0.308 Sum_probs=164.3
Q ss_pred ceEEEEEE--CCeEEEEEEcc------------HHHHHHHHHHHhcC---CCCcccEEEEEEcCCC----cEEEEEeecC
Q 047629 343 KSVYRATI--DGKVLAVKKIK------------EDVTEELRILQRIN---HANLVKLMGVSSDSQG----NRFLVYEYAE 401 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~------------~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~----~~~lV~E~~~ 401 (615)
|.||++.. +|+.||||+++ ..+.+|++++++++ ||||+++++++..... ..++||||++
T Consensus 23 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~ 102 (308)
T 3g33_A 23 GTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD 102 (308)
T ss_dssp CCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC
T ss_pred eEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhh
Confidence 58999995 78999999985 35778888888774 9999999999875442 3789999997
Q ss_pred CCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCC
Q 047629 402 NGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA 481 (615)
Q Consensus 402 ~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~ 481 (615)
|+|.+++...... .+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 103 -~~L~~~~~~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 170 (308)
T 3g33_A 103 -QDLRTYLDKAPPP--------GLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY 170 (308)
T ss_dssp -CBHHHHHHTCCTT--------CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEECSCSCTTTS
T ss_pred -cCHHHHHhhccCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEeeCcccccc
Confidence 6999999865432 3899999999999999999999998 999999999999999999999999998653
Q ss_pred C----------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhh
Q 047629 482 T----------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRN 539 (615)
Q Consensus 482 ~----------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 539 (615)
. ..++.++|||||||++|||++|+.||......+. ...+........ ......
T Consensus 171 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~--~~~~~~ 245 (308)
T 3g33_A 171 SYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ---LGKIFDLIGLPP--EDDWPR 245 (308)
T ss_dssp TTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH---HHHHHHHHCCCC--TTTSCS
T ss_pred CCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCC--hhhccc
Confidence 2 1246789999999999999999999976442111 111111100000 000000
Q ss_pred -------hcCCcCC---CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 540 -------WMDPNLE---SFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 540 -------~~dp~l~---~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
...+... .....+....+.+|+.+|++.||++|||+.|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 246 DVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp SCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 0000000 00011234567899999999999999999999874
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-32 Score=295.82 Aligned_cols=207 Identities=21% Similarity=0.289 Sum_probs=165.5
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
|.||++.. +|+.+|+|.+. ..+.+|++++++++||||+++++++.+. +..++||||+++|+|.+++..
T Consensus 25 g~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~~~lv~E~~~gg~L~~~i~~ 103 (444)
T 3soa_A 25 SVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEE-GHHYLIFDLVTGGELFEDIVA 103 (444)
T ss_dssp CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECS-SEEEEEECCCBCCBHHHHHHH
T ss_pred eEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEEC-CEEEEEEEeCCCCCHHHHHHH
Confidence 58999987 79999999874 2477899999999999999999998754 479999999999999999976
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeC---CCCcEEEeecCCCCCCCC-----
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLD---SRFKAKIANFSLAAPATN----- 483 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld---~~~~~kl~DFGla~~~~~----- 483 (615)
.. .+++..+..++.|++.||.|||+++ |+||||||+|||++ .++.+||+|||+++....
T Consensus 104 ~~----------~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~ 170 (444)
T 3soa_A 104 RE----------YYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW 170 (444)
T ss_dssp CS----------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBC
T ss_pred cC----------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCcee
Confidence 54 3899999999999999999999998 99999999999998 457899999999964321
Q ss_pred ------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcC
Q 047629 484 ------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNL 545 (615)
Q Consensus 484 ------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l 545 (615)
.++.++||||+||++|||++|+.||...... .....+ .....+ .
T Consensus 171 ~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~---~~~~~i-------------~~~~~~--~ 232 (444)
T 3soa_A 171 FGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH---RLYQQI-------------KAGAYD--F 232 (444)
T ss_dssp CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHH-------------HHTCCC--C
T ss_pred ecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH---HHHHHH-------------HhCCCC--C
Confidence 2567899999999999999999999754321 111100 011111 1
Q ss_pred CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 546 ESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 546 ~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
...........+.+|+..||+.||.+|||+.|++++
T Consensus 233 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 233 PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 111111234467899999999999999999999875
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-32 Score=289.93 Aligned_cols=208 Identities=22% Similarity=0.291 Sum_probs=166.2
Q ss_pred ceEEEEEE--CCeEEEEEEcc-------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
|.||+|.. +|+.||+|.+. ..+.+|+++|++++|+||+++++++.+. ...++||||+++|+|.+++....
T Consensus 65 g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-~~~~lv~E~~~gg~L~~~l~~~~ 143 (387)
T 1kob_A 65 GVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK-YEMVLILEFLSGGELFDRIAAED 143 (387)
T ss_dssp EEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS-SEEEEEEECCCCCBHHHHTTCTT
T ss_pred EEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC-CEEEEEEEcCCCCcHHHHHHhhc
Confidence 58999998 68999999885 2477899999999999999999998754 47999999999999999997654
Q ss_pred CCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCC--CCcEEEeecCCCCCCCC--------
Q 047629 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDS--RFKAKIANFSLAAPATN-------- 483 (615)
Q Consensus 414 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~--~~~~kl~DFGla~~~~~-------- 483 (615)
. .+++.++..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+++....
T Consensus 144 ~---------~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~ 211 (387)
T 1kob_A 144 Y---------KMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT 211 (387)
T ss_dssp C---------CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEEC
T ss_pred C---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCCcceeeec
Confidence 2 3899999999999999999999998 999999999999974 47899999999965421
Q ss_pred --------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCC
Q 047629 484 --------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFY 549 (615)
Q Consensus 484 --------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~ 549 (615)
.++.++|||||||++|||++|+.||......+ .. .. +.. .+.......
T Consensus 212 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~---~~-----------i~~-~~~~~~~~~ 273 (387)
T 1kob_A 212 ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---TL---QN-----------VKR-CDWEFDEDA 273 (387)
T ss_dssp SSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HH---HH-----------HHH-CCCCCCSST
T ss_pred cCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH---HH---HH-----------HHh-CCCCCCccc
Confidence 24568999999999999999999997543211 00 00 000 011111112
Q ss_pred ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 550 PIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 550 ~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.......+.+++..||+.||.+|||+.|+++.
T Consensus 274 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 274 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 22334567899999999999999999999985
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-32 Score=277.53 Aligned_cols=204 Identities=25% Similarity=0.391 Sum_probs=164.2
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
+.||+|.. +|+.||||.+.. .+.+|++++++++||||+++++++.+. +..++||||+++|+|.+++.
T Consensus 25 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~ 103 (278)
T 3cok_A 25 AGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDS-NYVYLVLEMCHNGEMNRYLK 103 (278)
T ss_dssp EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS-SEEEEEEECCTTEEHHHHHH
T ss_pred eEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC-CeEEEEEecCCCCcHHHHHh
Confidence 48999997 789999999852 367899999999999999999998754 47899999999999999998
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
.... .+++.++..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++....
T Consensus 104 ~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 171 (278)
T 3cok_A 104 NRVK---------PFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT 171 (278)
T ss_dssp TCSS---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC--------
T ss_pred hccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCccee
Confidence 6532 3899999999999999999999998 9999999999999999999999999986432
Q ss_pred ---------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCC
Q 047629 483 ---------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLES 547 (615)
Q Consensus 483 ---------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~ 547 (615)
...+.++||||||+++|||++|+.|+......+. +....... .
T Consensus 172 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--------------------~~~~~~~~--~ 229 (278)
T 3cok_A 172 LCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT--------------------LNKVVLAD--Y 229 (278)
T ss_dssp --------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------------------CCSSC--C
T ss_pred ccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH--------------------HHHHhhcc--c
Confidence 1135689999999999999999999976442211 00111111 1
Q ss_pred CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 548 FYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 548 ~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
..+......+.+++.+||+.||++|||++|+++.
T Consensus 230 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 230 EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 1223334567899999999999999999999874
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=286.77 Aligned_cols=221 Identities=29% Similarity=0.383 Sum_probs=171.7
Q ss_pred ceEEEEEE-------CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATI-------DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~-------~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~ 407 (615)
|.||+|.. +++.||||.+. ..+.+|+.++++++||||+++++++.+. +..++||||+++|+|.+
T Consensus 44 g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~ 122 (327)
T 2yfx_A 44 GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS-LPRFILMELMAGGDLKS 122 (327)
T ss_dssp SCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSCEEEEECCTTEEHHH
T ss_pred eeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC-CCcEEEEecCCCCcHHH
Confidence 58999984 46789999984 3477899999999999999999998754 47899999999999999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCC---CCcEEEeecCCCCCC---
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDS---RFKAKIANFSLAAPA--- 481 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~---~~~~kl~DFGla~~~--- 481 (615)
++........ ....+++.+++.++.|++.||.|||+++ |+||||||+|||++. +..+||+|||+++..
T Consensus 123 ~l~~~~~~~~---~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~ 196 (327)
T 2yfx_A 123 FLRETRPRPS---QPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 196 (327)
T ss_dssp HHHHTSCCSS---STTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC-
T ss_pred HHHhhccccc---ccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEECccccccccccc
Confidence 9987543211 1124899999999999999999999998 999999999999994 456999999987421
Q ss_pred ----------------------CCCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHh
Q 047629 482 ----------------------TNDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLR 538 (615)
Q Consensus 482 ----------------------~~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 538 (615)
...++.++||||||+++|||++ |+.|+......+ .. ..+.
T Consensus 197 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~--------------~~~~ 259 (327)
T 2yfx_A 197 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VL--------------EFVT 259 (327)
T ss_dssp -----CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HH--------------HHHH
T ss_pred cccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH---HH--------------HHHh
Confidence 1124568999999999999998 888986543211 00 0111
Q ss_pred hhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccchhh
Q 047629 539 NWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQSTET 591 (615)
Q Consensus 539 ~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~~~ 591 (615)
....+ ..+......+.+++..||+.||.+||++.|+++.|+.+.+....
T Consensus 260 ~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 308 (327)
T 2yfx_A 260 SGGRM----DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 308 (327)
T ss_dssp TTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred cCCCC----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHHH
Confidence 11111 12233445688999999999999999999999999988776544
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-33 Score=284.50 Aligned_cols=222 Identities=23% Similarity=0.333 Sum_probs=165.8
Q ss_pred ceEEEEEE-CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATI-DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~-~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
|.||++.. +|+.||||+++ ..+.+|++++++++||||+++++++.+. +..++||||+++ +|.+++...
T Consensus 16 g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~-~l~~~~~~~ 93 (288)
T 1ob3_A 16 GVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-KRLVLVFEHLDQ-DLKKLLDVC 93 (288)
T ss_dssp EEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-SCEEEEEECCSE-EHHHHHHTS
T ss_pred EEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccC-CeEEEEEEecCC-CHHHHHHhc
Confidence 58999998 68999999884 3577999999999999999999998754 479999999985 999998764
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCC-----------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA----------- 481 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~----------- 481 (615)
.. .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 94 ~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 161 (288)
T 1ob3_A 94 EG---------GLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEI 161 (288)
T ss_dssp TT---------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------
T ss_pred cc---------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccccccccc
Confidence 33 3899999999999999999999998 999999999999999999999999987421
Q ss_pred -------------CCCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHH-HHHHHh--hhcCCcC
Q 047629 482 -------------TNDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEK-REERLR--NWMDPNL 545 (615)
Q Consensus 482 -------------~~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~--~~~dp~l 545 (615)
...++.++|||||||++|||++|+.||......+. +. .+......... .-.... ...++..
T Consensus 162 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T 1ob3_A 162 VTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--LM-RIFRILGTPNSKNWPNVTELPKYDPNF 238 (288)
T ss_dssp CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HH-HHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred ccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HH-HHHHHHCCCChhhchhhhccccccccc
Confidence 11256789999999999999999999976442111 11 11111000000 000000 0111111
Q ss_pred C-------CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 546 E-------SFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 546 ~-------~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
. ..+.......+.+|+.+||+.||++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1 01112234567899999999999999999999864
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-32 Score=297.88 Aligned_cols=203 Identities=26% Similarity=0.438 Sum_probs=165.9
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||+|.. +|+.||||+++. .+.+|+.+|++++||||+++++++... +..++||||+++|+|.+++.
T Consensus 30 g~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-~~~~lv~E~~~gg~L~~~l~ 108 (476)
T 2y94_A 30 GKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP-SDIFMVMEYVSGGELFDYIC 108 (476)
T ss_dssp SCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEEEECCSSEEHHHHTT
T ss_pred eEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEEeCCCCCcHHHHHH
Confidence 58999997 699999999853 367899999999999999999998764 47999999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCCC------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATND------ 484 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~------ 484 (615)
... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 109 ~~~----------~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~ 175 (476)
T 2y94_A 109 KNG----------RLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS 175 (476)
T ss_dssp SSS----------SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCBCCC
T ss_pred hcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccccccccc
Confidence 643 3899999999999999999999998 999999999999999999999999998653211
Q ss_pred -----------------CCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCC
Q 047629 485 -----------------VMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLES 547 (615)
Q Consensus 485 -----------------~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~ 547 (615)
.+.++|||||||++|||++|+.||....... +.. .+ .+...
T Consensus 176 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~---~~~--------------~i---~~~~~-- 233 (476)
T 2y94_A 176 CGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT---LFK--------------KI---CDGIF-- 233 (476)
T ss_dssp CSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH---HHH--------------HH---HTTCC--
T ss_pred CCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH---HHH--------------HH---hcCCc--
Confidence 2458999999999999999999997543211 110 01 11111
Q ss_pred CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 548 FYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 548 ~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
..+......+.+|+.+||+.||.+|||+.|++++
T Consensus 234 ~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 234 YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 1122233457899999999999999999999984
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-33 Score=290.13 Aligned_cols=203 Identities=26% Similarity=0.356 Sum_probs=165.4
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||+|.. +|+.||||.+.. .+.+|++++++++||||+++++++... +..++||||+ +|+|.+++.
T Consensus 23 g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-~~~~lv~E~~-~g~l~~~l~ 100 (336)
T 3h4j_B 23 GKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP-TDIVMVIEYA-GGELFDYIV 100 (336)
T ss_dssp EEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEEECCC-CEEHHHHHH
T ss_pred eEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-CEEEEEEECC-CCcHHHHHH
Confidence 58999997 789999999853 467899999999999999999998764 4799999999 789999987
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCCC------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATND------ 484 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~------ 484 (615)
... .+++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 101 ~~~----------~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~~~ 167 (336)
T 3h4j_B 101 EKK----------RMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS 167 (336)
T ss_dssp HHC----------SCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTCCC
T ss_pred HcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCCcccccc
Confidence 643 2899999999999999999999998 999999999999999999999999998653211
Q ss_pred -----------------CCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCC
Q 047629 485 -----------------VMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLES 547 (615)
Q Consensus 485 -----------------~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~ 547 (615)
.++++|||||||++|||++|+.||........ .+.+... ..
T Consensus 168 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---------------------~~~i~~~-~~ 225 (336)
T 3h4j_B 168 CGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL---------------------FKKVNSC-VY 225 (336)
T ss_dssp TTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC---------------------BCCCCSS-CC
T ss_pred cCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH---------------------HHHHHcC-CC
Confidence 14579999999999999999999975432110 0111110 11
Q ss_pred CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047629 548 FYPIDGALSLATLARACTMDKSLSRPNMAEVVFNL 582 (615)
Q Consensus 548 ~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L 582 (615)
..+......+.+|+.+||+.||.+|||+.|+++.-
T Consensus 226 ~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 260 (336)
T 3h4j_B 226 VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDP 260 (336)
T ss_dssp CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCH
T ss_pred CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhCh
Confidence 22333445678999999999999999999998853
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-32 Score=279.01 Aligned_cols=204 Identities=26% Similarity=0.371 Sum_probs=165.8
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||++.. +++.||||++.. .+.+|+.++++++||||+++++++.+. +..++||||+++|+|.+++.
T Consensus 23 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~l~~~l~ 101 (279)
T 3fdn_A 23 GNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-TRVYLILEYAPLGTVYRELQ 101 (279)
T ss_dssp EEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEEECCCTTEEHHHHHH
T ss_pred eEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC-CEEEEEEecCCCCcHHHHHH
Confidence 58999988 578999999852 367899999999999999999998754 47899999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 102 ~~~----------~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 168 (279)
T 3fdn_A 102 KLS----------KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC 168 (279)
T ss_dssp HHS----------SCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--------C
T ss_pred hcC----------CCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCcccccccC
Confidence 643 2899999999999999999999998 9999999999999999999999999875431
Q ss_pred -------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCC
Q 047629 483 -------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFY 549 (615)
Q Consensus 483 -------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~ 549 (615)
...+.++||||||+++|||++|+.||......+ ... .+.. ... .+
T Consensus 169 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~--------------~~~~-~~~----~~ 226 (279)
T 3fdn_A 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE---TYK--------------RISR-VEF----TF 226 (279)
T ss_dssp CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHH--------------HHHH-TCC----CC
T ss_pred CCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH---HHH--------------HHHh-CCC----CC
Confidence 124568999999999999999999997543111 110 0111 111 22
Q ss_pred ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047629 550 PIDGALSLATLARACTMDKSLSRPNMAEVVFNL 582 (615)
Q Consensus 550 ~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L 582 (615)
+......+.+++..||+.||.+||+++|++++-
T Consensus 227 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 227 PDFVTEGARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred CCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 333345678999999999999999999999864
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-32 Score=289.39 Aligned_cols=210 Identities=23% Similarity=0.327 Sum_probs=162.6
Q ss_pred ceEEEEEE--CCeEEEEEEcc------------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHh
Q 047629 343 KSVYRATI--DGKVLAVKKIK------------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKW 408 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~------------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~ 408 (615)
|.||++.. +|+.||||.++ +.+.+|+.++++++||||+++++++.+. +..++||||+++|+|.++
T Consensus 38 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~~lv~e~~~g~~L~~~ 116 (351)
T 3c0i_A 38 SVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD-GMLYMVFEFMDGADLCFE 116 (351)
T ss_dssp EEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEECCSSCBHHHH
T ss_pred EEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-CEEEEEEeCCCCCCHHHH
Confidence 58999987 68999999874 3477899999999999999999998764 479999999999999988
Q ss_pred hccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCc---EEEeecCCCCCCC---
Q 047629 409 LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFK---AKIANFSLAAPAT--- 482 (615)
Q Consensus 409 L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~---~kl~DFGla~~~~--- 482 (615)
+....... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++. +||+|||+++...
T Consensus 117 l~~~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 187 (351)
T 3c0i_A 117 IVKRADAG------FVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG 187 (351)
T ss_dssp HHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTS
T ss_pred HHHhcccC------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcceeEecCCC
Confidence 86532110 13899999999999999999999998 999999999999987654 9999999985432
Q ss_pred --------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcC
Q 047629 483 --------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMD 542 (615)
Q Consensus 483 --------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~d 542 (615)
..++.++|||||||++|||++|+.||.... ..+...+ ......
T Consensus 188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~i-------------~~~~~~ 250 (351)
T 3c0i_A 188 LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERLFEGI-------------IKGKYK 250 (351)
T ss_dssp CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHHHHHH-------------HHTCCC
T ss_pred eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHHHHHH-------------HcCCCC
Confidence 124678999999999999999999997532 1111100 000000
Q ss_pred CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 543 PNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 543 p~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
............+.+|+.+||+.||++|||+.|++++
T Consensus 251 --~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 251 --MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp --CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000001123457899999999999999999999874
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.98 E-value=3e-32 Score=278.70 Aligned_cols=209 Identities=21% Similarity=0.368 Sum_probs=164.6
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcC---CCcEEEEEeecCCCCHHHh
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDS---QGNRFLVYEYAENGSLDKW 408 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~---~~~~~lV~E~~~~GsL~~~ 408 (615)
|.||+|.. ++..||+|.+. ..+.+|+.++++++||||+++++++... +...++||||+++|+|.++
T Consensus 40 g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 119 (290)
T 1t4h_A 40 KTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTY 119 (290)
T ss_dssp EEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHH
T ss_pred eEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHH
Confidence 58999988 67899999875 2367899999999999999999987642 2347999999999999999
Q ss_pred hccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeC-CCCcEEEeecCCCCCCC-----
Q 047629 409 LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLD-SRFKAKIANFSLAAPAT----- 482 (615)
Q Consensus 409 L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld-~~~~~kl~DFGla~~~~----- 482 (615)
+.... .+++..+..++.|++.||.|||+++ ++|+||||||+|||++ .++.+||+|||++....
T Consensus 120 l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~ 188 (290)
T 1t4h_A 120 LKRFK----------VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK 188 (290)
T ss_dssp HHHHS----------SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBE
T ss_pred HHHcc----------CCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcccccccccc
Confidence 97643 3899999999999999999999984 3599999999999998 78999999999985432
Q ss_pred ---------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCC
Q 047629 483 ---------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLES 547 (615)
Q Consensus 483 ---------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~ 547 (615)
..++.++||||||+++|||++|+.||......... . ..+.....+ .
T Consensus 189 ~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~--------------~~~~~~~~~---~ 249 (290)
T 1t4h_A 189 AVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--Y--------------RRVTSGVKP---A 249 (290)
T ss_dssp ESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH--H--------------HHHTTTCCC---G
T ss_pred cccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH--H--------------HHHhccCCc---c
Confidence 12467899999999999999999999754431110 0 011111111 1
Q ss_pred CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 548 FYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 548 ~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.++......+.+++..||+.||.+|||+.|++++
T Consensus 250 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 250 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1122223458999999999999999999999864
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-32 Score=279.88 Aligned_cols=212 Identities=25% Similarity=0.336 Sum_probs=166.1
Q ss_pred ceEEEEEE---CC--eEEEEEEcc----------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATI---DG--KVLAVKKIK----------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~---~g--~~vAvK~~~----------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~ 407 (615)
+.||+|.+ ++ ..||||.++ +.+.+|++++++++|+||+++++++.+. ..++|+||+++|+|.+
T Consensus 32 g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~v~e~~~~~~L~~ 109 (291)
T 1u46_A 32 GVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--PMKMVTELAPLGSLLD 109 (291)
T ss_dssp CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SCEEEEECCTTCBHHH
T ss_pred eeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC--CceeeEecccCCCHHH
Confidence 58999986 23 368999885 2467899999999999999999998643 5899999999999999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC----
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN---- 483 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~---- 483 (615)
++..... .+++.++..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++....
T Consensus 110 ~l~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 177 (291)
T 1u46_A 110 RLRKHQG---------HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 177 (291)
T ss_dssp HHHHHGG---------GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCE
T ss_pred HHHhccC---------CcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccccccccc
Confidence 9976432 3899999999999999999999998 99999999999999999999999999865421
Q ss_pred ----------------------CCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhh
Q 047629 484 ----------------------DVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNW 540 (615)
Q Consensus 484 ----------------------~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 540 (615)
.++.++||||||+++|||++ |+.||......+ .. . ......
T Consensus 178 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~---~----------~~~~~~ 241 (291)
T 1u46_A 178 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---IL---H----------KIDKEG 241 (291)
T ss_dssp EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HH---H----------HHHTSC
T ss_pred hhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH---HH---H----------HHHccC
Confidence 12457999999999999999 999987543211 00 0 000111
Q ss_pred cCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 541 MDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 541 ~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
..+ ..+......+.+++.+||+.||.+||++.|+++.|+.+...
T Consensus 242 ~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 242 ERL----PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred CCC----CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 111 12233445689999999999999999999999999877654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=7.5e-33 Score=286.70 Aligned_cols=220 Identities=20% Similarity=0.284 Sum_probs=170.4
Q ss_pred ceEEEEEE--CCeEEEEEEcc-------HHHHHHHHHHHhcCCCCcccEEEEEEcC---CCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVSSDS---QGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-------~~~~~Ei~~l~~l~H~niv~l~g~~~~~---~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||++.. +|+.||||++. +.+.+|++++++++||||+++++++... ....++|+||+++|+|.+++.
T Consensus 43 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 122 (317)
T 2buj_A 43 SYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIE 122 (317)
T ss_dssp EEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHH
T ss_pred eEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHH
Confidence 48999996 78999999873 3577899999999999999999998632 235799999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
...... ..+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 123 ~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~ 193 (317)
T 2buj_A 123 RLKDKG------NFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQ 193 (317)
T ss_dssp HHHTTT------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHH
T ss_pred HHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccc
Confidence 632110 13899999999999999999999998 9999999999999999999999999864321
Q ss_pred ------------------------C---CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHH
Q 047629 483 ------------------------N---DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREE 535 (615)
Q Consensus 483 ------------------------~---~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 535 (615)
. .++.++||||||+++|||++|+.||.......... . .
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-----~----------~ 258 (317)
T 2buj_A 194 ALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV-----A----------L 258 (317)
T ss_dssp HHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCH-----H----------H
T ss_pred cccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchh-----h----------H
Confidence 0 13668999999999999999999985321100000 0 0
Q ss_pred HHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccchh
Q 047629 536 RLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQSTE 590 (615)
Q Consensus 536 ~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~~ 590 (615)
.+..... ...+......+.+++.+||+.||.+||++.|+++.|+.+.....
T Consensus 259 ~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 309 (317)
T 2buj_A 259 AVQNQLS----IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP 309 (317)
T ss_dssp HHHCC------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred HhhccCC----CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence 0111111 11112334568999999999999999999999999998876543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.8e-32 Score=290.85 Aligned_cols=219 Identities=19% Similarity=0.289 Sum_probs=168.3
Q ss_pred ccccccccc----ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEE
Q 047629 334 NLSEHYSIG----KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLV 396 (615)
Q Consensus 334 ~~~~~~~iG----~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV 396 (615)
+|.....+| |.||++.. +|+.||||++++ .+..|..++.++ +||||+++++++.+. +..++|
T Consensus 53 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~-~~~~lV 131 (396)
T 4dc2_A 53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-SRLFFV 131 (396)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS-SEEEEE
T ss_pred HcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC-CEEEEE
Confidence 344444555 58999998 689999999863 267899999887 899999999998754 479999
Q ss_pred EeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecC
Q 047629 397 YEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFS 476 (615)
Q Consensus 397 ~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFG 476 (615)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 132 ~E~~~gg~L~~~l~~~~----------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG 198 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQR----------KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYG 198 (396)
T ss_dssp EECCTTCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred EEcCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecc
Confidence 99999999999997643 2899999999999999999999998 9999999999999999999999999
Q ss_pred CCCCCC-----------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHH--HHHHHHHHHhHHH
Q 047629 477 LAAPAT-----------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAV--LWKEIREVLKVEE 531 (615)
Q Consensus 477 la~~~~-----------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~--l~~~~~~~~~~~~ 531 (615)
+++... ..++.++|||||||++|||++|+.||......+... ....+.
T Consensus 199 la~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~------- 271 (396)
T 4dc2_A 199 MCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF------- 271 (396)
T ss_dssp TCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHH-------
T ss_pred eeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHH-------
Confidence 997521 124568999999999999999999997533211100 000000
Q ss_pred HHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCH------HHHHHH
Q 047629 532 KREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNM------AEVVFN 581 (615)
Q Consensus 532 ~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm------~ev~~~ 581 (615)
..+.. ... .+|......+.+|+..||+.||.+||++ .||+++
T Consensus 272 ---~~i~~-~~~----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 272 ---QVILE-KQI----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp ---HHHHH-CCC----CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred ---HHHhc-ccc----CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 00110 111 2333444567899999999999999995 566653
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.98 E-value=9.4e-33 Score=288.05 Aligned_cols=212 Identities=22% Similarity=0.306 Sum_probs=162.2
Q ss_pred ceEEEEEE--CCeEEEEEEccH----HHHHHHHHHHhcC-CCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCC
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----DVTEELRILQRIN-HANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKS 415 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~ 415 (615)
|.||++.. +|+.||||++.. .+.+|+.++.++. ||||+++++++.+. ...++||||+++|+|.+++....
T Consensus 25 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~-- 101 (325)
T 3kn6_A 25 SICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQ-LHTFLVMELLNGGELFERIKKKK-- 101 (325)
T ss_dssp EEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEEEEEECCCCSCBHHHHHHHCS--
T ss_pred eEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC-CEEEEEEEccCCCcHHHHHHhcC--
Confidence 58999998 589999999863 4678999999997 99999999998754 47899999999999999998654
Q ss_pred CCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCC---cEEEeecCCCCCCC----------
Q 047629 416 SSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRF---KAKIANFSLAAPAT---------- 482 (615)
Q Consensus 416 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~---~~kl~DFGla~~~~---------- 482 (615)
.+++.++..++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||+++...
T Consensus 102 --------~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 170 (325)
T 3kn6_A 102 --------HFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC 170 (325)
T ss_dssp --------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC---------
T ss_pred --------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccC
Confidence 3899999999999999999999998 99999999999997665 89999999986431
Q ss_pred -------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcC--CC
Q 047629 483 -------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNL--ES 547 (615)
Q Consensus 483 -------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l--~~ 547 (615)
..++.++|||||||++|||++|+.||............. +.+..+..... ..
T Consensus 171 ~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~-------------~~~~~i~~~~~~~~~ 237 (325)
T 3kn6_A 171 FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAV-------------EIMKKIKKGDFSFEG 237 (325)
T ss_dssp -------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHH-------------HHHHHHTTTCCCCCS
T ss_pred CCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHH-------------HHHHHHHcCCCCCCc
Confidence 124568899999999999999999997643211000000 01111111111 11
Q ss_pred CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 548 FYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 548 ~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.........+.+|+..||+.||.+|||++|++++
T Consensus 238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 1111234568999999999999999999999865
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.2e-32 Score=279.34 Aligned_cols=211 Identities=17% Similarity=0.280 Sum_probs=166.3
Q ss_pred ceEEEEEE--CCeEEEEEEcc--HHHHHHHHHH-HhcCCCCcccEEEEEEc---CCCcEEEEEeecCCCCHHHhhccCCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK--EDVTEELRIL-QRINHANLVKLMGVSSD---SQGNRFLVYEYAENGSLDKWLHPKSK 414 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~--~~~~~Ei~~l-~~l~H~niv~l~g~~~~---~~~~~~lV~E~~~~GsL~~~L~~~~~ 414 (615)
|.||++.. +|+.||||+++ ..+.+|++++ +..+|+||+++++++.. .+...++||||+++|+|.+++.....
T Consensus 32 g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 111 (299)
T 3m2w_A 32 GKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD 111 (299)
T ss_dssp EEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTT
T ss_pred eEEEEEEEcCCCcEEEEEEecccHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccC
Confidence 58999987 78999999986 5678899998 55699999999998764 23358999999999999999987543
Q ss_pred CCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCC---CCcEEEeecCCCCCCC-CCCCCccc
Q 047629 415 SSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDS---RFKAKIANFSLAAPAT-NDVMPKFD 490 (615)
Q Consensus 415 ~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~---~~~~kl~DFGla~~~~-~~~~~k~D 490 (615)
. .+++.++..++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||+++... ..++.++|
T Consensus 112 ~--------~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~D 180 (299)
T 3m2w_A 112 Q--------AFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEKYDKSCD 180 (299)
T ss_dssp C--------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECTTCGGGGHHH
T ss_pred C--------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccccccccccCCchhh
Confidence 1 3899999999999999999999998 999999999999998 7899999999997654 45788999
Q ss_pred chhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC----hHHHHHHHHHHHHhhh
Q 047629 491 VFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP----IDGALSLATLARACTM 566 (615)
Q Consensus 491 V~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~----~~~~~~l~~l~~~C~~ 566 (615)
||||||++|||++|+.||........ ...+...+... ...++ ......+.+++.+||+
T Consensus 181 iwslG~il~el~tg~~pf~~~~~~~~-----------------~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~ 242 (299)
T 3m2w_A 181 MWSLGVIMYILLCGYPPFYSNHGLAI-----------------SPGMKTRIRMG-QYEFPNPEWSEVSEEVKMLIRNLLK 242 (299)
T ss_dssp HHHHHHHHHHHHHSSCSCCC------------------------CCSCCSSCTT-CCSSCHHHHTTSCHHHHHHHHHHTC
T ss_pred HHHHHHHHHHHHHCCCCCCCCcchhh-----------------hHHHHHHHhhc-cccCCchhcccCCHHHHHHHHHHcc
Confidence 99999999999999999965432100 00000000000 01111 1234568999999999
Q ss_pred cCCCCCCCHHHHHHHH
Q 047629 567 DKSLSRPNMAEVVFNL 582 (615)
Q Consensus 567 ~dP~~RPsm~ev~~~L 582 (615)
.||.+|||+.|++++-
T Consensus 243 ~dP~~Rps~~e~l~hp 258 (299)
T 3m2w_A 243 TEPTQRMTITEFMNHP 258 (299)
T ss_dssp SSTTTSCCHHHHHTSH
T ss_pred cChhhCCCHHHHhcCh
Confidence 9999999999999853
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=4.6e-32 Score=290.62 Aligned_cols=232 Identities=22% Similarity=0.328 Sum_probs=175.7
Q ss_pred ceEEEEEE--CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCC-cEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQG-NRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-~~~lV~E~~~~GsL~~~L~~ 411 (615)
|.||+|.. +|+.||||+++ +.+.+|++++++++|+||+++++++.+.++ ..++||||+++|+|.+++..
T Consensus 23 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 102 (396)
T 4eut_A 23 ANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE 102 (396)
T ss_dssp EEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTS
T ss_pred eEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHh
Confidence 58999998 58999999986 346789999999999999999999875443 57999999999999999976
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceee----CCCCcEEEeecCCCCCCCCC---
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQL----DSRFKAKIANFSLAAPATND--- 484 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl----d~~~~~kl~DFGla~~~~~~--- 484 (615)
.... ..+++..++.++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||+++.....
T Consensus 103 ~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~~ 172 (396)
T 4eut_A 103 PSNA-------YGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF 172 (396)
T ss_dssp GGGT-------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGGS
T ss_pred hhcc-------cCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCcc
Confidence 4321 13899999999999999999999998 9999999999999 88888999999999653211
Q ss_pred ---------------------------CCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHH
Q 047629 485 ---------------------------VMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERL 537 (615)
Q Consensus 485 ---------------------------~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 537 (615)
++.++|||||||++|||++|+.||.......... ..+....... ....+
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~--~~~~~~~~~~--p~~~~ 248 (396)
T 4eut_A 173 VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK--EVMYKIITGK--PSGAI 248 (396)
T ss_dssp SCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH--HHHHHHHHSC--CTTCC
T ss_pred ccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH--HHHHHHhcCC--Ccccc
Confidence 1247899999999999999999997544322111 0011111000 00000
Q ss_pred h---h-------hc-CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 538 R---N-------WM-DPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 538 ~---~-------~~-dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
. . +. +.......+......+.+++..||+.||++||+++|+++.+..+...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 249 SGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp EEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred hhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 0 0 00 00111234466777899999999999999999999999999877553
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.98 E-value=3.7e-32 Score=285.67 Aligned_cols=211 Identities=22% Similarity=0.299 Sum_probs=165.2
Q ss_pred ceEEEEEE--CCeEEEEEEccH---HHHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCCC
Q 047629 343 KSVYRATI--DGKVLAVKKIKE---DVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSS 416 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~---~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~ 416 (615)
|.||++.. +|+.||||.++. +..+|++++.++ +||||+++++++.+. ...++||||+++|+|.+++....
T Consensus 36 g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~-~~~~lv~E~~~gg~L~~~i~~~~--- 111 (342)
T 2qr7_A 36 SVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDG-KYVYVVTELMKGGELLDKILRQK--- 111 (342)
T ss_dssp EEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEECS-SEEEEEECCCCSCBHHHHHHTCT---
T ss_pred EEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEcC-CEEEEEEeCCCCCcHHHHHHHcC---
Confidence 58999998 689999999964 357899999998 799999999998754 47899999999999999997653
Q ss_pred CCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCC----CcEEEeecCCCCCCCCC--------
Q 047629 417 SSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSR----FKAKIANFSLAAPATND-------- 484 (615)
Q Consensus 417 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~----~~~kl~DFGla~~~~~~-------- 484 (615)
.+++..+..++.|++.||+|||+++ |+||||||+|||+.++ +.+||+|||+++.....
T Consensus 112 -------~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 181 (342)
T 2qr7_A 112 -------FFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC 181 (342)
T ss_dssp -------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSS
T ss_pred -------CCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccC
Confidence 3899999999999999999999998 9999999999998543 35999999998643211
Q ss_pred ---------------CCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCC
Q 047629 485 ---------------VMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFY 549 (615)
Q Consensus 485 ---------------~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~ 549 (615)
++.++|||||||++|||++|+.||..........+...+ ... ...+...+
T Consensus 182 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i-------------~~~--~~~~~~~~ 246 (342)
T 2qr7_A 182 YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI-------------GSG--KFSLSGGY 246 (342)
T ss_dssp CCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHH-------------HHC--CCCCCSTT
T ss_pred CCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHH-------------ccC--CcccCccc
Confidence 234789999999999999999999764322221111110 000 11122222
Q ss_pred ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047629 550 PIDGALSLATLARACTMDKSLSRPNMAEVVFNL 582 (615)
Q Consensus 550 ~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L 582 (615)
.......+.+|+..||+.||++||++.|++++-
T Consensus 247 ~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp 279 (342)
T 2qr7_A 247 WNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHP 279 (342)
T ss_dssp TTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCC
Confidence 333445688999999999999999999998853
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.98 E-value=4.8e-32 Score=284.03 Aligned_cols=227 Identities=21% Similarity=0.245 Sum_probs=167.6
Q ss_pred cccccccccc----ceEEEEEE--CCeEEEEEEccH------------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEE
Q 047629 333 MNLSEHYSIG----KSVYRATI--DGKVLAVKKIKE------------DVTEELRILQRINHANLVKLMGVSSDSQGNRF 394 (615)
Q Consensus 333 ~~~~~~~~iG----~~Vy~~~~--~g~~vAvK~~~~------------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~ 394 (615)
+.|.....+| |.||++.. +++.||+|+++. .+.+|++++++++||||+++++++.+. +..+
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~ 104 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE-QYIC 104 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC-CeEE
Confidence 3444444454 58999987 688999998852 367899999999999999999998754 4799
Q ss_pred EEEeecCCCCHHHhhccCCCCCC------------------------------CCCcccccCHHHHHHHHHHHHHHHHHH
Q 047629 395 LVYEYAENGSLDKWLHPKSKSSS------------------------------SSGSVIFLTWSQRLRVALDVANGLQYM 444 (615)
Q Consensus 395 lV~E~~~~GsL~~~L~~~~~~~~------------------------------~~~~~~~l~~~~~~~i~~~ia~gL~yL 444 (615)
+||||+++|+|.+++........ .......+++..+..++.|++.||+||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 99999999999999963110000 000011256778899999999999999
Q ss_pred HhCCCCCeEecCCCCCceeeCCCC--cEEEeecCCCCCCC-----------------------------CCCCCcccchh
Q 047629 445 HEHAQPSIVHRDIRTNNIQLDSRF--KAKIANFSLAAPAT-----------------------------NDVMPKFDVFA 493 (615)
Q Consensus 445 H~~~~~~ivHrDlk~~NILld~~~--~~kl~DFGla~~~~-----------------------------~~~~~k~DV~S 493 (615)
|+++ |+||||||+|||++.++ .+||+|||+++... ..++.++||||
T Consensus 185 H~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws 261 (345)
T 3hko_A 185 HNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261 (345)
T ss_dssp HHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred HHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence 9998 99999999999998766 89999999985320 22456899999
Q ss_pred HHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCC
Q 047629 494 FGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRP 573 (615)
Q Consensus 494 fGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RP 573 (615)
||+++|||++|+.||......+. +... +.... .............+.+++..||+.||.+||
T Consensus 262 lG~il~el~~g~~pf~~~~~~~~------~~~~----------~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 262 AGVLLHLLLMGAVPFPGVNDADT------ISQV----------LNKKL--CFENPNYNVLSPLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHH------HHHH----------HHCCC--CTTSGGGGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred HHHHHHHHHHCCCCCCCCChHHH------HHHH----------Hhccc--ccCCcccccCCHHHHHHHHHHcCCChhHCC
Confidence 99999999999999975442111 1111 11100 010111112345688999999999999999
Q ss_pred CHHHHHHH
Q 047629 574 NMAEVVFN 581 (615)
Q Consensus 574 sm~ev~~~ 581 (615)
++.|+++.
T Consensus 324 s~~~~l~h 331 (345)
T 3hko_A 324 DAMRALQH 331 (345)
T ss_dssp CHHHHHHS
T ss_pred CHHHHhcC
Confidence 99999885
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1e-32 Score=296.94 Aligned_cols=229 Identities=18% Similarity=0.221 Sum_probs=176.8
Q ss_pred eeeHHHHHHHccccccccccc----ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEE
Q 047629 322 VYEIEVIMESTMNLSEHYSIG----KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGV 385 (615)
Q Consensus 322 ~~~~~~l~~at~~~~~~~~iG----~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~ 385 (615)
.+.++++....++|.....+| |.||++.. +|+.||||++++ .+.+|..++.+++|+||++++++
T Consensus 50 ~~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~ 129 (412)
T 2vd5_A 50 VVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFA 129 (412)
T ss_dssp HHHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred hhhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence 345556666667777777776 58999998 689999999863 26789999999999999999999
Q ss_pred EEcCCCcEEEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeC
Q 047629 386 SSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLD 465 (615)
Q Consensus 386 ~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld 465 (615)
+.+. +..++||||+++|+|.+++..... .+++..+..++.||+.||+|||+++ |+||||||+|||++
T Consensus 130 ~~~~-~~~~lVmE~~~gg~L~~~l~~~~~---------~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld 196 (412)
T 2vd5_A 130 FQDE-NYLYLVMEYYVGGDLLTLLSKFGE---------RIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLD 196 (412)
T ss_dssp EECS-SEEEEEECCCCSCBHHHHHHHHSS---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred EeeC-CEEEEEEcCCCCCcHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeec
Confidence 8764 479999999999999999976432 3899999999999999999999998 99999999999999
Q ss_pred CCCcEEEeecCCCCCCC-------------------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCC
Q 047629 466 SRFKAKIANFSLAAPAT-------------------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENG 514 (615)
Q Consensus 466 ~~~~~kl~DFGla~~~~-------------------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~ 514 (615)
.++.+||+|||+++... ..++.++|||||||++|||++|+.||......
T Consensus 197 ~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~ 276 (412)
T 2vd5_A 197 RCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA 276 (412)
T ss_dssp TTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred CCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH
Confidence 99999999999985431 11456899999999999999999999764321
Q ss_pred hhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCC---CCHHHHHHH
Q 047629 515 KTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSR---PNMAEVVFN 581 (615)
Q Consensus 515 ~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~R---Psm~ev~~~ 581 (615)
+ .. ...... .. ...-|... ......+.+|+.+|+. +|.+| |++.|++++
T Consensus 277 ~---~~---~~i~~~----~~---~~~~p~~~----~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 277 E---TY---GKIVHY----KE---HLSLPLVD----EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp H---HH---HHHHTH----HH---HCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred H---HH---HHHHhc----cc---CcCCCccc----cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 1 11 111100 00 01112111 2233457899999999 99998 689998875
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.2e-32 Score=290.45 Aligned_cols=205 Identities=21% Similarity=0.364 Sum_probs=165.0
Q ss_pred ceEEEEEE-CCeEEEEEEcc---------HHHHHHHHHHHhcC--CCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI-DGKVLAVKKIK---------EDVTEELRILQRIN--HANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~-~g~~vAvK~~~---------~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||++.. +|+.||||+++ ..+.+|+++|.+++ |+||+++++++... ...++||| +.+|+|.+++.
T Consensus 70 g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~-~~~~lv~E-~~~~~L~~~l~ 147 (390)
T 2zmd_A 70 SKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-QYIYMVME-CGNIDLNSWLK 147 (390)
T ss_dssp EEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEEEEEEE-CCSEEHHHHHH
T ss_pred eEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC-CEEEEEEe-cCCCCHHHHHH
Confidence 58999987 68999999884 34788999999996 59999999998764 47999999 56889999998
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC-------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------- 483 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------- 483 (615)
... .+++.++..++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||+++....
T Consensus 148 ~~~----------~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~ 213 (390)
T 2zmd_A 148 KKK----------SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVK 213 (390)
T ss_dssp HCS----------SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---------
T ss_pred hcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccC
Confidence 654 2889999999999999999999998 99999999999996 57899999999864311
Q ss_pred -----------------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHH
Q 047629 484 -----------------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKRE 534 (615)
Q Consensus 484 -----------------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 534 (615)
.++.++|||||||++|||++|+.||....+..
T Consensus 214 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~------------------- 274 (390)
T 2zmd_A 214 DSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI------------------- 274 (390)
T ss_dssp CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-------------------
T ss_pred CCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH-------------------
Confidence 24457899999999999999999997543210
Q ss_pred HHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047629 535 ERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNL 582 (615)
Q Consensus 535 ~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L 582 (615)
..+..++++.....++......+.+|+.+||+.||.+||++.|+++.-
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 275 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 112233444443334444455688999999999999999999999763
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-31 Score=273.27 Aligned_cols=207 Identities=23% Similarity=0.326 Sum_probs=163.8
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
|.||++.. +|+.||+|++. ..+.+|++++++++|+||+++++++.+. +..++||||+++|+|.+++..
T Consensus 20 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e~~~~~~l~~~~~~ 98 (284)
T 3kk8_A 20 SVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-SFHYLVFDLVTGGELFEDIVA 98 (284)
T ss_dssp EEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEECCCCSCBHHHHHHH
T ss_pred eEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC-CEEEEEEecCCCCCHHHHHHh
Confidence 58999987 68999999985 2367899999999999999999998754 478999999999999999876
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCc---EEEeecCCCCCCC------
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFK---AKIANFSLAAPAT------ 482 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~---~kl~DFGla~~~~------ 482 (615)
.. .+++..+..++.|++.||.|||+++ |+||||||+||+++.++. +||+|||++....
T Consensus 99 ~~----------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (284)
T 3kk8_A 99 RE----------FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH 165 (284)
T ss_dssp HS----------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCC
T ss_pred cC----------CCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcccc
Confidence 53 3899999999999999999999998 999999999999987655 9999999985432
Q ss_pred ----------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCC
Q 047629 483 ----------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLE 546 (615)
Q Consensus 483 ----------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~ 546 (615)
..++.++||||||+++|||++|+.||....... ....+ .....+ ..
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---~~~~~-------------~~~~~~--~~ 227 (284)
T 3kk8_A 166 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---LYAQI-------------KAGAYD--YP 227 (284)
T ss_dssp CSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH-------------HHTCCC--CC
T ss_pred CCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH---HHHHH-------------Hhcccc--CC
Confidence 124678999999999999999999997543211 11000 001111 00
Q ss_pred CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 547 SFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 547 ~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
..........+.+++..|++.||++|||+.|+++.
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 228 SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred chhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 11112233457899999999999999999999985
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.9e-32 Score=288.19 Aligned_cols=212 Identities=25% Similarity=0.362 Sum_probs=168.2
Q ss_pred cccccccccc----ceEEEEEE--CCeEEEEEEccHH----------HHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEE
Q 047629 333 MNLSEHYSIG----KSVYRATI--DGKVLAVKKIKED----------VTEELRILQRI-NHANLVKLMGVSSDSQGNRFL 395 (615)
Q Consensus 333 ~~~~~~~~iG----~~Vy~~~~--~g~~vAvK~~~~~----------~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~l 395 (615)
.+|.....+| |.||++.. +|+.||||++++. +..|..++.++ +||||+++++++.+. ...++
T Consensus 17 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~-~~~~l 95 (345)
T 1xjd_A 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK-ENLFF 95 (345)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS-SEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC-CEEEE
Confidence 3444444454 58999998 6899999998743 45789999887 999999999998764 47999
Q ss_pred EEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeec
Q 047629 396 VYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANF 475 (615)
Q Consensus 396 V~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DF 475 (615)
||||+++|+|.+++.... .+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 96 v~E~~~gg~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DF 162 (345)
T 1xjd_A 96 VMEYLNGGDLMYHIQSCH----------KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADF 162 (345)
T ss_dssp EEECCTTCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCC
T ss_pred EEeCCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEC
Confidence 999999999999997643 2899999999999999999999998 999999999999999999999999
Q ss_pred CCCCCCC-----------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHH
Q 047629 476 SLAAPAT-----------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEK 532 (615)
Q Consensus 476 Gla~~~~-----------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 532 (615)
|+++... ..++.++|||||||++|||++|+.||...... .+...
T Consensus 163 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~---------- 229 (345)
T 1xjd_A 163 GMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELFHS---------- 229 (345)
T ss_dssp TTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH----------
T ss_pred hhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH---HHHHH----------
Confidence 9987431 12467899999999999999999999754321 11110
Q ss_pred HHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHH-HHHH
Q 047629 533 REERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMA-EVVF 580 (615)
Q Consensus 533 ~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~-ev~~ 580 (615)
+.. ..+. ++......+.+++.+||+.||.+||++. |+.+
T Consensus 230 ----i~~-~~~~----~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 230 ----IRM-DNPF----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp ----HHH-CCCC----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ----HHh-CCCC----CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 100 1122 2333345678999999999999999997 6654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.8e-32 Score=275.14 Aligned_cols=203 Identities=22% Similarity=0.312 Sum_probs=164.7
Q ss_pred ceEEEEEE--CCeEEEEEEcc-------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
|.||+|.. +++.+|+|++. +.+.+|++++++++||||+++++++.+. +..++||||+++|+|.+++....
T Consensus 23 g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~ 101 (277)
T 3f3z_A 23 GEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDN-TDIYLVMELCTGGELFERVVHKR 101 (277)
T ss_dssp EEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEEEEECCCSCBHHHHHHHHC
T ss_pred EEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeEEEEEeccCCCcHHHHHHHcC
Confidence 58999998 56799999985 3578999999999999999999998754 47899999999999999987643
Q ss_pred CCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceee---CCCCcEEEeecCCCCCCC--------
Q 047629 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQL---DSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 414 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl---d~~~~~kl~DFGla~~~~-------- 482 (615)
.+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++....
T Consensus 102 ----------~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 168 (277)
T 3f3z_A 102 ----------VFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK 168 (277)
T ss_dssp ----------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBCCC
T ss_pred ----------CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccchhcc
Confidence 3899999999999999999999998 9999999999999 788999999999985431
Q ss_pred -------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCC
Q 047629 483 -------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFY 549 (615)
Q Consensus 483 -------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~ 549 (615)
..++.++||||||+++|||++|+.||......+. ... +.+. . ..+
T Consensus 169 ~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~~--------------~~~~-~----~~~ 226 (277)
T 3f3z_A 169 VGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV---MLK--------------IREG-T----FTF 226 (277)
T ss_dssp CSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHH--------------HHHC-C----CCC
T ss_pred CCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHH---HHH--------------HHhC-C----CCC
Confidence 1246789999999999999999999976442111 100 0000 0 011
Q ss_pred Ch----HHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 550 PI----DGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 550 ~~----~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
+. .....+.+++..|++.||++|||+.|+++.
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 227 PEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11 223468899999999999999999999874
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4e-32 Score=285.76 Aligned_cols=210 Identities=20% Similarity=0.290 Sum_probs=163.8
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
|.||++.. +|+.||||++++ .+.+|..++.++ +||||+++++++.+. +..++||||+++|+|.+++
T Consensus 23 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~-~~~~lv~e~~~gg~L~~~l 101 (345)
T 3a8x_A 23 AKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-SRLFFVIEYVNGGDLMFHM 101 (345)
T ss_dssp EEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEEEEEECCCCSCBHHHHH
T ss_pred eEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC-CEEEEEEeCCCCCcHHHHH
Confidence 58999998 589999999863 256899999988 899999999998754 4799999999999999999
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------- 482 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------- 482 (615)
.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~~~~----------~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~~~ 168 (345)
T 3a8x_A 102 QRQR----------KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS 168 (345)
T ss_dssp HHHS----------SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCCBC
T ss_pred HHcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCCCCccc
Confidence 7643 2899999999999999999999998 9999999999999999999999999987421
Q ss_pred ----------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHH--HHHHHHHHHhHHHHHHHHHhhhcCCc
Q 047629 483 ----------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAV--LWKEIREVLKVEEKREERLRNWMDPN 544 (615)
Q Consensus 483 ----------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~--l~~~~~~~~~~~~~~~~~~~~~~dp~ 544 (615)
..++.++|||||||++|||++|+.||.......... ....+.. .+.. -..
T Consensus 169 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~----------~i~~-~~~- 236 (345)
T 3a8x_A 169 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ----------VILE-KQI- 236 (345)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHH----------HHHH-CCC-
T ss_pred ccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHH----------HHHc-CCC-
Confidence 124568999999999999999999997532211100 0000000 1111 011
Q ss_pred CCCCCChHHHHHHHHHHHHhhhcCCCCCCCH------HHHHHH
Q 047629 545 LESFYPIDGALSLATLARACTMDKSLSRPNM------AEVVFN 581 (615)
Q Consensus 545 l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm------~ev~~~ 581 (615)
.+|......+.+|+.+||+.||.+||++ .|++++
T Consensus 237 ---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 237 ---RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred ---CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 2333444568899999999999999995 566653
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.7e-32 Score=283.72 Aligned_cols=203 Identities=21% Similarity=0.322 Sum_probs=160.3
Q ss_pred ceEEEEEE-----CCeEEEEEEccH-----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHH
Q 047629 343 KSVYRATI-----DGKVLAVKKIKE-----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLD 406 (615)
Q Consensus 343 ~~Vy~~~~-----~g~~vAvK~~~~-----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~ 406 (615)
|.||++.. +|+.||+|++++ .+.+|+++|++++||||+++++++.+. +..++||||+++|+|.
T Consensus 31 g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~ 109 (327)
T 3a62_A 31 GKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG-GKLYLILEYLSGGELF 109 (327)
T ss_dssp EEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS-SCEEEEEECCTTEEHH
T ss_pred EEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC-CEEEEEEeCCCCCcHH
Confidence 58999986 689999998852 256799999999999999999998754 4799999999999999
Q ss_pred HhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC----
Q 047629 407 KWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT---- 482 (615)
Q Consensus 407 ~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~---- 482 (615)
+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 110 ~~l~~~~----------~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 176 (327)
T 3a62_A 110 MQLEREG----------IFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT 176 (327)
T ss_dssp HHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC--------
T ss_pred HHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccccccCCc
Confidence 9997643 2889999999999999999999998 9999999999999999999999999986421
Q ss_pred -------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCC
Q 047629 483 -------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDP 543 (615)
Q Consensus 483 -------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp 543 (615)
..++.++||||||+++|||++|+.||......+ .. ... ... ..
T Consensus 177 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~---~~i----------~~~--~~ 238 (327)
T 3a62_A 177 VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK---TI---DKI----------LKC--KL 238 (327)
T ss_dssp --CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HH---HHH----------HHT--CC
T ss_pred cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH---HH---HHH----------HhC--CC
Confidence 124568999999999999999999997543211 11 100 010 11
Q ss_pred cCCCCCChHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 047629 544 NLESFYPIDGALSLATLARACTMDKSLSRP-----NMAEVVFN 581 (615)
Q Consensus 544 ~l~~~~~~~~~~~l~~l~~~C~~~dP~~RP-----sm~ev~~~ 581 (615)
.++......+.+++.+||+.||.+|| ++.|++++
T Consensus 239 ----~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 239 ----NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp ----CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred ----CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 12333445688999999999999999 77788774
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.98 E-value=4.1e-32 Score=280.82 Aligned_cols=214 Identities=15% Similarity=0.229 Sum_probs=167.2
Q ss_pred ceEEEEEE--CCeEEEEEEcc----------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIK----------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~----------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
+.||++.. +|+.||||.++ +.+.+|+.++++++||||+++++++... +..++|+||+++|+|.+++.
T Consensus 48 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~ 126 (309)
T 2h34_A 48 GDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID-GQLYVDMRLINGVDLAAMLR 126 (309)
T ss_dssp SEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-TEEEEEEECCCCEEHHHHHH
T ss_pred eeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC-CeEEEEEEecCCCCHHHHHH
Confidence 58999997 68999999985 3467899999999999999999998764 47999999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
... .+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 127 ~~~----------~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 193 (309)
T 2h34_A 127 RQG----------PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLG 193 (309)
T ss_dssp HHC----------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-------------
T ss_pred hcC----------CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccccccccccc
Confidence 643 3899999999999999999999998 9999999999999999999999999975431
Q ss_pred ----------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCC
Q 047629 483 ----------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLE 546 (615)
Q Consensus 483 ----------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~ 546 (615)
..++.++||||||+++|||++|+.||..... . .+.. .+..... . .
T Consensus 194 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~----~~~~----------~~~~~~~-~-~ 254 (309)
T 2h34_A 194 NTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL---S----VMGA----------HINQAIP-R-P 254 (309)
T ss_dssp ---CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH---H----HHHH----------HHHSCCC-C-G
T ss_pred ccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH---H----HHHH----------HhccCCC-C-c
Confidence 1235689999999999999999999975321 0 0111 1111110 0 0
Q ss_pred CCCChHHHHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHhcccch
Q 047629 547 SFYPIDGALSLATLARACTMDKSLSRP-NMAEVVFNLSVLTQST 589 (615)
Q Consensus 547 ~~~~~~~~~~l~~l~~~C~~~dP~~RP-sm~ev~~~L~~l~~~~ 589 (615)
...+......+.+++.+||+.||++|| +++++++.|+.+....
T Consensus 255 ~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 255 STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 112223334578999999999999999 9999999998776553
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=8.8e-33 Score=280.68 Aligned_cols=214 Identities=23% Similarity=0.334 Sum_probs=166.2
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcC-CCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDS-QGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||++.. +|+.||+|.+. +.+.+|++++++++||||+++++++.+. ++..++||||+++|+|.+++.
T Consensus 20 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 99 (279)
T 2w5a_A 20 GRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVIT 99 (279)
T ss_dssp SEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHH
T ss_pred cEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHH
Confidence 58999998 68999999985 2477899999999999999999987542 346899999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHA--QPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------ 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------ 482 (615)
...... ..+++..++.++.|++.||+|||+++ ..+++||||||+||+++.++.+||+|||+++...
T Consensus 100 ~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~ 173 (279)
T 2w5a_A 100 KGTKER------QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA 173 (279)
T ss_dssp HHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---CHHH
T ss_pred hhcccC------CCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccccccc
Confidence 533211 13899999999999999999999975 2349999999999999999999999999875432
Q ss_pred -----------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcC
Q 047629 483 -----------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNL 545 (615)
Q Consensus 483 -----------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l 545 (615)
..++.++||||||+++|||++|+.|+...... .... .+....-+.+
T Consensus 174 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~--------------~i~~~~~~~~ 236 (279)
T 2w5a_A 174 KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELAG--------------KIREGKFRRI 236 (279)
T ss_dssp HHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH--------------HHHHTCCCCC
T ss_pred cccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH---HHHH--------------HHhhcccccC
Confidence 12456899999999999999999998754321 1110 1111111122
Q ss_pred CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047629 546 ESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLS 583 (615)
Q Consensus 546 ~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~ 583 (615)
+......+.+++.+||+.||.+||++.|+++.+.
T Consensus 237 ----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 237 ----PYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred ----CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 2333456899999999999999999999998764
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-32 Score=298.70 Aligned_cols=212 Identities=23% Similarity=0.313 Sum_probs=165.5
Q ss_pred ccccccccc----ceEEEEEE--CCeEEEEEEccHH----------HHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEE
Q 047629 334 NLSEHYSIG----KSVYRATI--DGKVLAVKKIKED----------VTEELRILQRINHANLVKLMGVSSDSQGNRFLVY 397 (615)
Q Consensus 334 ~~~~~~~iG----~~Vy~~~~--~g~~vAvK~~~~~----------~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~ 397 (615)
+|.....+| |.||++.. +|+.||||+++.+ +.+|+.++++++||||+++++++.+. +..++||
T Consensus 149 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~-~~~~lv~ 227 (446)
T 4ejn_A 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH-DRLCFVM 227 (446)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEET-TEEEEEE
T ss_pred HcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC-CEEEEEE
Confidence 344444555 58999987 6899999998743 45789999999999999999998764 4799999
Q ss_pred eecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCceeeCCCCcEEEeecC
Q 047629 398 EYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHE-HAQPSIVHRDIRTNNIQLDSRFKAKIANFS 476 (615)
Q Consensus 398 E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~NILld~~~~~kl~DFG 476 (615)
||+++|+|.+++.... .+++..+..++.|++.||+|||+ ++ |+||||||+|||++.++.+||+|||
T Consensus 228 e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG 294 (446)
T 4ejn_A 228 EYANGGELFFHLSRER----------VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFG 294 (446)
T ss_dssp CCCSSCBHHHHHHHHS----------CCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCC
T ss_pred eeCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCC
Confidence 9999999999997643 38999999999999999999998 77 9999999999999999999999999
Q ss_pred CCCCCC-----------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHH
Q 047629 477 LAAPAT-----------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKR 533 (615)
Q Consensus 477 la~~~~-----------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 533 (615)
+++... ..++.++|||||||++|||++|+.||....... +.. .
T Consensus 295 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~----~------- 360 (446)
T 4ejn_A 295 LCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFE----L------- 360 (446)
T ss_dssp CCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----H-------
T ss_pred CceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH---HHH----H-------
Confidence 987531 125678999999999999999999997543211 110 0
Q ss_pred HHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 047629 534 EERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRP-----NMAEVVFN 581 (615)
Q Consensus 534 ~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RP-----sm~ev~~~ 581 (615)
... -.. .++......+.+|+..||+.||.+|| +++|++++
T Consensus 361 --i~~--~~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 361 --ILM--EEI----RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp --HHH--CCC----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --HHh--CCC----CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 001 011 12333445688999999999999999 99999875
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=290.39 Aligned_cols=224 Identities=21% Similarity=0.231 Sum_probs=171.3
Q ss_pred ceEEEEEEC----------CeEEEEEEccH--HHHHHHHHHHhcCCCCccc---------------EEEEEEcCCCcEEE
Q 047629 343 KSVYRATID----------GKVLAVKKIKE--DVTEELRILQRINHANLVK---------------LMGVSSDSQGNRFL 395 (615)
Q Consensus 343 ~~Vy~~~~~----------g~~vAvK~~~~--~~~~Ei~~l~~l~H~niv~---------------l~g~~~~~~~~~~l 395 (615)
|.||+|... ++.||||.++. .+.+|++++++++|+||++ +++++...++..++
T Consensus 56 g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 135 (352)
T 2jii_A 56 GILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFL 135 (352)
T ss_dssp EEEEEEEECC-----------CEEEEEEETTSTHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEE
T ss_pred eEEEEEeecCCccccccccCceEEEEEecccchHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEE
Confidence 589999872 78999999975 4899999999999999998 67777654557899
Q ss_pred EEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCC--cEEEe
Q 047629 396 VYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRF--KAKIA 473 (615)
Q Consensus 396 V~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~--~~kl~ 473 (615)
||||+ +|+|.+++..... ..+++.+++.++.|++.||.|||+++ |+||||||+|||++.++ .+||+
T Consensus 136 v~e~~-~~~L~~~l~~~~~--------~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl~~~~~~~~~kl~ 203 (352)
T 2jii_A 136 VLPSL-GRSLQSALDVSPK--------HVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLA 203 (352)
T ss_dssp EEECC-CEEHHHHHHHSGG--------GCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEEEETTEEEEEEEC
T ss_pred EecCC-CcCHHHHHHhCCc--------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEEcCCCCceEEEe
Confidence 99999 9999999986521 13899999999999999999999998 99999999999999998 99999
Q ss_pred ecCCCCCCC------------------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHH
Q 047629 474 NFSLAAPAT------------------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEI 523 (615)
Q Consensus 474 DFGla~~~~------------------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~ 523 (615)
|||+++... ..++.++||||||+++|||++|+.||.......... ..
T Consensus 204 Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~-~~-- 280 (352)
T 2jii_A 204 GYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDI-MK-- 280 (352)
T ss_dssp CGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH-HH--
T ss_pred cCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHH-HH--
Confidence 999995421 123568999999999999999999998654222111 10
Q ss_pred HHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccch
Q 047629 524 REVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQST 589 (615)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~ 589 (615)
.. .........+.++... .......+.+++..||+.||++||++.|+++.|+.+.+..
T Consensus 281 --~~---~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 338 (352)
T 2jii_A 281 --QK---QKFVDKPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL 338 (352)
T ss_dssp --HH---HHHHHSCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred --HH---HhccCChhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence 00 0001111112211111 0122356899999999999999999999999999887553
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-32 Score=286.67 Aligned_cols=197 Identities=24% Similarity=0.336 Sum_probs=163.1
Q ss_pred ceEEEEEE--CCeEEEEEEccH---------------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCC-C
Q 047629 343 KSVYRATI--DGKVLAVKKIKE---------------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENG-S 404 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~---------------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~G-s 404 (615)
|.||++.. +|+.||||.++. .+.+|++++++++|+||+++++++.+. +..++||||+.+| +
T Consensus 38 g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~-~~~~lv~e~~~~g~~ 116 (335)
T 3dls_A 38 GFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ-GFFQLVMEKHGSGLD 116 (335)
T ss_dssp CSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS-SEEEEEEECCTTSCB
T ss_pred EEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC-CEEEEEEEeCCCCcc
Confidence 58999986 789999998863 245799999999999999999998754 4789999999877 9
Q ss_pred HHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC-
Q 047629 405 LDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN- 483 (615)
Q Consensus 405 L~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~- 483 (615)
|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 117 l~~~~~~~~----------~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 183 (335)
T 3dls_A 117 LFAFIDRHP----------RLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG 183 (335)
T ss_dssp HHHHHHTCC----------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred HHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccceECCCC
Confidence 999997654 2899999999999999999999998 99999999999999999999999999864321
Q ss_pred ---------------------C-CCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhc
Q 047629 484 ---------------------D-VMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWM 541 (615)
Q Consensus 484 ---------------------~-~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 541 (615)
. .+.++||||||+++|||++|+.||..... ......
T Consensus 184 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------------------~~~~~~ 241 (335)
T 3dls_A 184 KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------------------TVEAAI 241 (335)
T ss_dssp CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG----------------------GTTTCC
T ss_pred CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH----------------------HHhhcc
Confidence 1 25678999999999999999999964221 001111
Q ss_pred CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 542 DPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 542 dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
. .+......+.+|+..||+.||++|||+.|+++.
T Consensus 242 ~------~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 242 H------PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp C------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred C------CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 112233457899999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.4e-32 Score=278.62 Aligned_cols=205 Identities=25% Similarity=0.402 Sum_probs=167.4
Q ss_pred ceEEEEEE--CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATI--DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
|.||+|.. +|+.||||.++ +.+.+|+.++++++|+||+++++++.+. +..++||||+++|+|.+++...
T Consensus 36 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~ 114 (303)
T 3a7i_A 36 GEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-TKLWIIMEYLGGGSALDLLEPG 114 (303)
T ss_dssp SEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEECCTTEEHHHHHTTS
T ss_pred eEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEEEEEEeCCCCcHHHHHhcC
Confidence 58999987 68999999985 4578999999999999999999998764 4789999999999999999642
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC----------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT---------- 482 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~---------- 482 (615)
.+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++....
T Consensus 115 -----------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 180 (303)
T 3a7i_A 115 -----------PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV 180 (303)
T ss_dssp -----------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCCCC
T ss_pred -----------CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccccccCccC
Confidence 2899999999999999999999998 9999999999999999999999999985421
Q ss_pred -------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCC
Q 047629 483 -------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFY 549 (615)
Q Consensus 483 -------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~ 549 (615)
..++.++||||||+++|||++|+.|+....... .. ..+.....+.+...+
T Consensus 181 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~--------------~~~~~~~~~~~~~~~ 243 (303)
T 3a7i_A 181 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK---VL--------------FLIPKNNPPTLEGNY 243 (303)
T ss_dssp SCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HH--------------HHHHHSCCCCCCSSC
T ss_pred CCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH---HH--------------HHhhcCCCCCCcccc
Confidence 124568999999999999999999987543211 00 011111223333333
Q ss_pred ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047629 550 PIDGALSLATLARACTMDKSLSRPNMAEVVFNLS 583 (615)
Q Consensus 550 ~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~ 583 (615)
...+.+++..||+.||.+|||+.|+++...
T Consensus 244 ----~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 244 ----SKPLKEFVEACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp ----CHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred ----CHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence 345789999999999999999999998643
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=6.3e-32 Score=275.44 Aligned_cols=203 Identities=23% Similarity=0.332 Sum_probs=166.0
Q ss_pred ceEEEEEE--CCeEEEEEEcc----------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIK----------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~----------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||++.. +++.||||.+. ..+.+|++++++++|+||+++++++.+. +..++||||+++|+|.+++.
T Consensus 28 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~ 106 (284)
T 2vgo_A 28 GNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDR-KRIYLMLEFAPRGELYKELQ 106 (284)
T ss_dssp EEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEEEECCCTTEEHHHHHH
T ss_pred eEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC-CEEEEEEEeCCCCcHHHHHH
Confidence 58999998 57899999985 2467899999999999999999998754 47899999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
... .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++....
T Consensus 107 ~~~----------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 173 (284)
T 2vgo_A 107 KHG----------RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC 173 (284)
T ss_dssp HHS----------SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSSCBCCCC
T ss_pred hcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccccccccc
Confidence 643 2899999999999999999999998 9999999999999999999999999885321
Q ss_pred -------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCC
Q 047629 483 -------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFY 549 (615)
Q Consensus 483 -------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~ 549 (615)
..++.++||||||+++|||++|+.||......+ .. . .+.. .+. .+
T Consensus 174 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~---~-----------~~~~-~~~----~~ 231 (284)
T 2vgo_A 174 GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE---TH---R-----------RIVN-VDL----KF 231 (284)
T ss_dssp SCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH---H-----------HHHT-TCC----CC
T ss_pred CCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH---HH---H-----------HHhc-ccc----CC
Confidence 124678999999999999999999997543211 00 0 0110 111 22
Q ss_pred ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 550 PIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 550 ~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
+......+.+++..|++.||.+||++.|++++
T Consensus 232 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 232 PPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 33334567899999999999999999999875
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.98 E-value=4.5e-32 Score=286.27 Aligned_cols=233 Identities=20% Similarity=0.245 Sum_probs=170.4
Q ss_pred cccccccccc----ceEEEEEE--CCeEEEEEEcc------HHHHHHHHHHHhcC-----CCCcccEEEEEEcCCCcEEE
Q 047629 333 MNLSEHYSIG----KSVYRATI--DGKVLAVKKIK------EDVTEELRILQRIN-----HANLVKLMGVSSDSQGNRFL 395 (615)
Q Consensus 333 ~~~~~~~~iG----~~Vy~~~~--~g~~vAvK~~~------~~~~~Ei~~l~~l~-----H~niv~l~g~~~~~~~~~~l 395 (615)
++|.....+| |.||++.. +|+.||||+++ ..+..|++++.+++ |+||+++++++... +..++
T Consensus 35 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~-~~~~l 113 (360)
T 3llt_A 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY-DHMCL 113 (360)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET-TEEEE
T ss_pred CEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC-CeeEE
Confidence 3444444555 58999998 78999999986 34677999999996 99999999998764 47999
Q ss_pred EEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCC---------
Q 047629 396 VYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDS--------- 466 (615)
Q Consensus 396 V~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~--------- 466 (615)
||||+ +|+|.+++...... .+++..+..++.|++.||+|||+++ |+||||||+|||++.
T Consensus 114 v~e~~-~~~L~~~~~~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~ 181 (360)
T 3llt_A 114 IFEPL-GPSLYEIITRNNYN--------GFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLIT 181 (360)
T ss_dssp EECCC-CCBHHHHHHHTTTC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEE
T ss_pred EEcCC-CCCHHHHHHhcCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccc
Confidence 99999 89999999865432 3899999999999999999999998 999999999999986
Q ss_pred ----------------CCcEEEeecCCCCCCC--------------------CCCCCcccchhHHHHHHHHHcCCCCCCC
Q 047629 467 ----------------RFKAKIANFSLAAPAT--------------------NDVMPKFDVFAFGVVLLELLSGKKATRT 510 (615)
Q Consensus 467 ----------------~~~~kl~DFGla~~~~--------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~ 510 (615)
++.+||+|||+++... ..++.++|||||||++|||++|+.||..
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 182 VRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp EECTTTCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred hhcccccccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCC
Confidence 7899999999986432 2356799999999999999999999976
Q ss_pred CCCChhHHHHHHHHHHHhH--HHHHHHH----HhhhcC-CcCCCCCCh--------------------HHHHHHHHHHHH
Q 047629 511 TENGKTAVLWKEIREVLKV--EEKREER----LRNWMD-PNLESFYPI--------------------DGALSLATLARA 563 (615)
Q Consensus 511 ~~~~~~~~l~~~~~~~~~~--~~~~~~~----~~~~~d-p~l~~~~~~--------------------~~~~~l~~l~~~ 563 (615)
....+... .+...... ....... ....++ ..+...++. .....+.+|+.+
T Consensus 262 ~~~~~~~~---~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 338 (360)
T 3llt_A 262 HEHMEHLA---MMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYS 338 (360)
T ss_dssp SSHHHHHH---HHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHH
T ss_pred CcHHHHHH---HHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHH
Confidence 54322111 11111100 0000000 000000 000001110 011457799999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 047629 564 CTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 564 C~~~dP~~RPsm~ev~~~ 581 (615)
||+.||++|||++|+++.
T Consensus 339 ~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 339 ILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HCCSSGGGSCCHHHHTTS
T ss_pred HhcCChhhCCCHHHHhcC
Confidence 999999999999999753
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=4.5e-32 Score=285.08 Aligned_cols=221 Identities=19% Similarity=0.205 Sum_probs=166.9
Q ss_pred ceEEEEEE-----CCeEEEEEEccH------------------HHHHHHHHHHhcCCCCcccEEEEEEcC---CCcEEEE
Q 047629 343 KSVYRATI-----DGKVLAVKKIKE------------------DVTEELRILQRINHANLVKLMGVSSDS---QGNRFLV 396 (615)
Q Consensus 343 ~~Vy~~~~-----~g~~vAvK~~~~------------------~~~~Ei~~l~~l~H~niv~l~g~~~~~---~~~~~lV 396 (615)
|.||+|.. ++..+|||++.. .+.+|+..+..++|+||+++++++... +...++|
T Consensus 51 g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv 130 (345)
T 2v62_A 51 GLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMV 130 (345)
T ss_dssp -CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEE
T ss_pred eEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccccCCCcEEEEE
Confidence 58999998 468899998742 245677888889999999999998752 3468999
Q ss_pred EeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCC--cEEEee
Q 047629 397 YEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRF--KAKIAN 474 (615)
Q Consensus 397 ~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~--~~kl~D 474 (615)
|||+ +|+|.+++.... .+++.+++.++.|++.||+|||+++ |+||||||+|||++.++ .+||+|
T Consensus 131 ~e~~-~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kL~D 196 (345)
T 2v62_A 131 MERL-GIDLQKISGQNG----------TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLAD 196 (345)
T ss_dssp EECE-EEEHHHHCBGGG----------BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTTSEEECC
T ss_pred Eecc-CCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCCcEEEEe
Confidence 9999 999999997643 3899999999999999999999998 99999999999999887 999999
Q ss_pred cCCCCCCC------------------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHH
Q 047629 475 FSLAAPAT------------------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIR 524 (615)
Q Consensus 475 FGla~~~~------------------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~ 524 (615)
||+++... ..++.++|||||||++|||++|+.||............ ..
T Consensus 197 fg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~--~~ 274 (345)
T 2v62_A 197 YGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT--AK 274 (345)
T ss_dssp CTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH--HH
T ss_pred CCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH--HH
Confidence 99995321 11456899999999999999999999653322211111 11
Q ss_pred HHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 525 EVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 525 ~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
.... ......+.+... .......+.+++..||+.||++||++.||++.|+.+...
T Consensus 275 ~~~~--~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 329 (345)
T 2v62_A 275 TNLL--DELPQSVLKWAP-------SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIP 329 (345)
T ss_dssp HHHH--HTTTHHHHHHSC-------TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCC
T ss_pred Hhhc--ccccHHHHhhcc-------ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCc
Confidence 0000 000011111111 012334689999999999999999999999999876543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.98 E-value=9.1e-32 Score=274.84 Aligned_cols=210 Identities=24% Similarity=0.354 Sum_probs=162.8
Q ss_pred ceEEEEEE--CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATI--DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
|.||++.. +|+.+|+|++. +.+.+|++++++++||||+++++++.+. ...++||||+++|+|.+++...
T Consensus 36 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~ 114 (285)
T 3is5_A 36 GDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY-HNMYIVMETCEGGELLERIVSA 114 (285)
T ss_dssp CEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEEEECCCSCCBHHHHHHHH
T ss_pred eEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecC-CeEEEEEEeCCCCcHHHHHHhh
Confidence 58999997 68999999885 3478999999999999999999998754 4789999999999999998643
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceee---CCCCcEEEeecCCCCCCC-------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQL---DSRFKAKIANFSLAAPAT------- 482 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl---d~~~~~kl~DFGla~~~~------- 482 (615)
.... ..+++..+..++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 115 ~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~ 185 (285)
T 3is5_A 115 QARG------KALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN 185 (285)
T ss_dssp HHHT------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---------
T ss_pred hhcc------cCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcccCcC
Confidence 2100 13899999999999999999999998 9999999999999 456889999999996532
Q ss_pred --------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCC
Q 047629 483 --------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESF 548 (615)
Q Consensus 483 --------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~ 548 (615)
..++.++||||||+++|||++|+.||......+ +.. .. ....+.....
T Consensus 186 ~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~-------~~~----------~~-~~~~~~~~~~ 247 (285)
T 3is5_A 186 AAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE-------VQQ----------KA-TYKEPNYAVE 247 (285)
T ss_dssp -CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHH----------HH-HHCCCCCCC-
T ss_pred cccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH-------HHh----------hh-ccCCcccccc
Confidence 124568999999999999999999997543111 000 00 0111111111
Q ss_pred CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 549 YPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 549 ~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.......+.+++..||+.||++|||+.|+++.
T Consensus 248 -~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 248 -CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp --CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred -cCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01123457899999999999999999999863
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=5.7e-32 Score=274.06 Aligned_cols=206 Identities=23% Similarity=0.331 Sum_probs=164.6
Q ss_pred ceEEEEEE--CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATI--DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
|.||++.. +|+.||||.++ +.+.+|+.++++++|+||+++++++.+. +..++|+||+++|+|.+++...
T Consensus 21 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~ 99 (276)
T 2yex_A 21 GEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG-NIQYLFLEYCSGGELFDRIEPD 99 (276)
T ss_dssp SEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEEEECCTTEEGGGGSBTT
T ss_pred cEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcC-CEEEEEEEecCCCcHHHHHhhc
Confidence 58999998 68999999985 3477899999999999999999998754 4789999999999999999754
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC----------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT---------- 482 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~---------- 482 (615)
. .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++....
T Consensus 100 ~----------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 166 (276)
T 2yex_A 100 I----------GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166 (276)
T ss_dssp T----------BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCC
T ss_pred c----------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccC
Confidence 3 3899999999999999999999998 9999999999999999999999999985321
Q ss_pred ---------------CC-CCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCC
Q 047629 483 ---------------ND-VMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLE 546 (615)
Q Consensus 483 ---------------~~-~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~ 546 (615)
.. .+.++||||||+++|||++|+.||......... .. . + ......
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~---~-----------~---~~~~~~ 227 (276)
T 2yex_A 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YS---D-----------W---KEKKTY 227 (276)
T ss_dssp CCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH--HH---H-----------H---HTTCTT
T ss_pred CccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH--HH---H-----------h---hhcccc
Confidence 01 135799999999999999999999765432211 00 0 0 000000
Q ss_pred CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 547 SFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 547 ~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
..........+.+++..||+.||.+|||+.|+++.
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 228 LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 01112234467899999999999999999999874
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=8e-32 Score=275.71 Aligned_cols=209 Identities=21% Similarity=0.324 Sum_probs=166.9
Q ss_pred ceEEEEEE--CCeEEEEEEcc-------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
|.||+|.. +++.||||.++ +.+.+|+.++++++|+||+++++++.+. +..++||||+++|+|.+++....
T Consensus 36 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~ 114 (295)
T 2clq_A 36 GIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN-GFIKIFMEQVPGGSLSALLRSKW 114 (295)
T ss_dssp SEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEEEECCSEEEHHHHHHHTT
T ss_pred EEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC-CcEEEEEEeCCCCCHHHHHHhhc
Confidence 58999997 68899999874 4578999999999999999999998754 47899999999999999997653
Q ss_pred CCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCC-CCcEEEeecCCCCCCCC---------
Q 047629 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDS-RFKAKIANFSLAAPATN--------- 483 (615)
Q Consensus 414 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~-~~~~kl~DFGla~~~~~--------- 483 (615)
.. ..+++..+..++.|++.||.|||+++ ++||||||+||+++. ++.+||+|||+++....
T Consensus 115 ~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 184 (295)
T 2clq_A 115 GP-------LKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT 184 (295)
T ss_dssp CC-------CTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CCCC
T ss_pred cC-------CCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCCcccccC
Confidence 21 13779999999999999999999998 999999999999987 89999999999864321
Q ss_pred ----------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCC
Q 047629 484 ----------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLES 547 (615)
Q Consensus 484 ----------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~ 547 (615)
.++.++||||||+++|||++|+.||......... .. . .......+.+
T Consensus 185 ~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~-------------~-~~~~~~~~~~-- 247 (295)
T 2clq_A 185 GTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA-MF-------------K-VGMFKVHPEI-- 247 (295)
T ss_dssp CCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH-HH-------------H-HHHHCCCCCC--
T ss_pred CCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH-HH-------------h-hccccccccc--
Confidence 1456899999999999999999999754321110 00 0 0011122333
Q ss_pred CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 548 FYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 548 ~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
+......+.+++.+||+.||++||++.|+++.
T Consensus 248 --~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 248 --PESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp --CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred --cccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 33344567899999999999999999999874
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.98 E-value=8e-32 Score=280.09 Aligned_cols=207 Identities=21% Similarity=0.309 Sum_probs=165.2
Q ss_pred ceEEEEEE--CCeEEEEEEcc-------------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATI--DGKVLAVKKIK-------------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-------------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~ 407 (615)
|.||++.. +|+.||||.++ +.+.+|+.++++++||||+++++++.+. +..++||||+++|+|.+
T Consensus 26 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~ 104 (321)
T 2a2a_A 26 AIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR-TDVVLILELVSGGELFD 104 (321)
T ss_dssp EEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEECCCCSCBHHH
T ss_pred EEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC-CEEEEEEEcCCCCcHHH
Confidence 58999998 68999999874 3478999999999999999999998754 47999999999999999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCC----cEEEeecCCCCCCC-
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRF----KAKIANFSLAAPAT- 482 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~----~~kl~DFGla~~~~- 482 (615)
++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||+++...
T Consensus 105 ~l~~~~----------~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~ 171 (321)
T 2a2a_A 105 FLAQKE----------SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171 (321)
T ss_dssp HHHTCS----------CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCT
T ss_pred HHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCccceecCc
Confidence 997643 3899999999999999999999998 99999999999999887 79999999986432
Q ss_pred ---------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhc
Q 047629 483 ---------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWM 541 (615)
Q Consensus 483 ---------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 541 (615)
..++.++||||||+++|||++|+.||......+ .. .. +...
T Consensus 172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~---~~-----------i~~~- 233 (321)
T 2a2a_A 172 GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TL---AN-----------ITSV- 233 (321)
T ss_dssp TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HH---HH-----------HHTT-
T ss_pred cccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH---HH---HH-----------HHhc-
Confidence 124668999999999999999999997543211 11 00 0000
Q ss_pred CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 542 DPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 542 dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
...............+.+++..||+.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 234 SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp CCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred ccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000011223457899999999999999999999985
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-32 Score=285.04 Aligned_cols=212 Identities=21% Similarity=0.340 Sum_probs=164.4
Q ss_pred ceEEEEEECCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATIDGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
|.||+|...+. +|+|.++ +.+.+|+.++++++|+||+++++++.+. +..++|+||+++|+|.+++....
T Consensus 47 g~V~~~~~~~~-~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~iv~e~~~~~~L~~~l~~~~ 124 (319)
T 2y4i_B 47 GQVYHGRWHGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP-PHLAIITSLCKGRTLYSVVRDAK 124 (319)
T ss_dssp SEEEEEEESSS-EEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS-SCEEEECBCCCSEEHHHHTTSSC
T ss_pred eEEEEEEEcCe-EEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC-CceEEEeecccCCcHHHHHHhcC
Confidence 58999998664 8999885 2367899999999999999999998864 47999999999999999997654
Q ss_pred CCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----------
Q 047629 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----------- 482 (615)
Q Consensus 414 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----------- 482 (615)
. .+++.++..++.|++.||+|||+++ ++||||||+|||++ ++.+||+|||+++...
T Consensus 125 ~---------~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 191 (319)
T 2y4i_B 125 I---------VLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKL 191 (319)
T ss_dssp C---------CCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC----------CCSC
T ss_pred C---------CCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccccccccccccccc
Confidence 2 3889999999999999999999998 99999999999998 6799999999865321
Q ss_pred --------------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHH
Q 047629 483 --------------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREER 536 (615)
Q Consensus 483 --------------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 536 (615)
..++.++||||||+++|||++|+.||....... . . ..
T Consensus 192 ~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~-~--------------~~ 254 (319)
T 2y4i_B 192 RIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA--I-I--------------WQ 254 (319)
T ss_dssp BCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH--H-H--------------HH
T ss_pred ccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--H-H--------------HH
Confidence 113557999999999999999999997543211 0 0 01
Q ss_pred HhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccch
Q 047629 537 LRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQST 589 (615)
Q Consensus 537 ~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~ 589 (615)
+.....+.+.. ......+.+++..||+.||++|||+.|+++.|+.+....
T Consensus 255 ~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 255 MGTGMKPNLSQ---IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp HHTTCCCCCCC---SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred hccCCCCCCCc---CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 11112222211 112234789999999999999999999999999887664
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-31 Score=277.39 Aligned_cols=221 Identities=20% Similarity=0.288 Sum_probs=166.4
Q ss_pred ceEEEEEE--CCeEEEEEEcc----HHHHHHHHHHHhcC-CCCcccEEEEEEcC-CCcEEEEEeecCCCCHHHhhccCCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK----EDVTEELRILQRIN-HANLVKLMGVSSDS-QGNRFLVYEYAENGSLDKWLHPKSK 414 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~----~~~~~Ei~~l~~l~-H~niv~l~g~~~~~-~~~~~lV~E~~~~GsL~~~L~~~~~ 414 (615)
|.||+|.. +|+.||||.++ +.+.+|++++++++ |+||+++++++.+. ....++||||+++|+|.+++..
T Consensus 50 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--- 126 (330)
T 3nsz_A 50 SEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT--- 126 (330)
T ss_dssp EEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGG---
T ss_pred eEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHh---
Confidence 58999987 78999999986 56889999999997 99999999998763 3458999999999999999842
Q ss_pred CCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCC-cEEEeecCCCCCCC-----------
Q 047629 415 SSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRF-KAKIANFSLAAPAT----------- 482 (615)
Q Consensus 415 ~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~-~~kl~DFGla~~~~----------- 482 (615)
+++.++..++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||+++...
T Consensus 127 ----------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 193 (330)
T 3nsz_A 127 ----------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS 193 (330)
T ss_dssp ----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSC
T ss_pred ----------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCcccccccc
Confidence 788999999999999999999998 99999999999999776 89999999996421
Q ss_pred ------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHH--HHHhhhcCCc----
Q 047629 483 ------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKRE--ERLRNWMDPN---- 544 (615)
Q Consensus 483 ------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~--~~~~~~~dp~---- 544 (615)
..++.++|||||||++|||++|+.|+........ .+ ..+...+....... .......++.
T Consensus 194 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~l-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (330)
T 3nsz_A 194 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QL-VRIAKVLGTEDLYDYIDKYNIELDPRFNDI 271 (330)
T ss_dssp GGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH-HH-HHHHHHHCHHHHHHHHHHTTCCCCTHHHHH
T ss_pred ccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH-HH-HHHHHhcCCchhhhHHHHhccccccchhhh
Confidence 2256789999999999999999999965443211 11 11111111111000 0000001110
Q ss_pred ------------CCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 545 ------------LESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 545 ------------l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.....+......+.+|+.+||+.||++|||++|++++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 272 LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0111122235578999999999999999999999874
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1e-31 Score=273.12 Aligned_cols=205 Identities=21% Similarity=0.389 Sum_probs=161.9
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||++.. +|+.||||+++ ..+.+|+..+.++ +||||+++++++.+. +..++||||+++|+|.+++.
T Consensus 25 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~ 103 (289)
T 1x8b_A 25 GSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED-DHMLIQNEYCNGGSLADAIS 103 (289)
T ss_dssp EEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET-TEEEEEEECCTTCBHHHHHH
T ss_pred eEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC-CeEEEEEEecCCCcHHHHHH
Confidence 58999998 68999999885 2467899999999 999999999998764 47999999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCC-------------------CCcEE
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDS-------------------RFKAK 471 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~-------------------~~~~k 471 (615)
...... ..+++..+..++.|++.||.|||+++ |+||||||+|||++. ...+|
T Consensus 104 ~~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~k 174 (289)
T 1x8b_A 104 ENYRIM------SYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 174 (289)
T ss_dssp HHHHHT------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC--------------------CCCEE
T ss_pred hhcccc------cCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccccCCceEEE
Confidence 642100 13899999999999999999999998 999999999999984 45899
Q ss_pred EeecCCCCCCCC--------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHH
Q 047629 472 IANFSLAAPATN--------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEE 531 (615)
Q Consensus 472 l~DFGla~~~~~--------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 531 (615)
|+|||++..... ..++++||||||+++|||++|+.++.... .+.
T Consensus 175 l~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~------~~~---------- 238 (289)
T 1x8b_A 175 IGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD------QWH---------- 238 (289)
T ss_dssp ECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH------HHH----------
T ss_pred EcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh------HHH----------
Confidence 999999865421 13358999999999999999987764321 011
Q ss_pred HHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 532 KREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 532 ~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.+.....+.+ +......+.+++.+||+.||++|||+.|++++
T Consensus 239 ----~~~~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 239 ----EIRQGRLPRI----PQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp ----HHHTTCCCCC----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ----HHHcCCCCCC----CcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 1111112222 23334568899999999999999999999875
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.98 E-value=6.7e-32 Score=279.42 Aligned_cols=218 Identities=22% Similarity=0.312 Sum_probs=163.6
Q ss_pred ceEEEEEE--CCeEEEEEEcc-------HHHHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATI--DGKVLAVKKIK-------EDVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-------~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
|.||++.. +|+.||||+++ ..+.+|++++.++ +||||+++++++.+. +..++||||+++|+|.+++...
T Consensus 27 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~ 105 (316)
T 2ac3_A 27 ARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE-DRFYLVFEKMRGGSILSHIHKR 105 (316)
T ss_dssp EEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEEEECCTTCBHHHHHHHH
T ss_pred EEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC-CEEEEEEEcCCCCcHHHHHhcc
Confidence 58999986 78999999984 4578999999995 799999999998764 4799999999999999999764
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCc---EEEeecCCCCCCC-------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFK---AKIANFSLAAPAT------- 482 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~---~kl~DFGla~~~~------- 482 (615)
. .+++..+..++.|++.||+|||+++ |+||||||+|||++.++. +||+|||+++...
T Consensus 106 ~----------~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 172 (316)
T 2ac3_A 106 R----------HFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSP 172 (316)
T ss_dssp S----------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC----------
T ss_pred C----------CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcccc
Confidence 3 3899999999999999999999998 999999999999998766 9999999986431
Q ss_pred ----------------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHH
Q 047629 483 ----------------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKRE 534 (615)
Q Consensus 483 ----------------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 534 (615)
..++.++|||||||++|||++|+.||......+.. |....... ....
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~---~~~~ 247 (316)
T 2ac3_A 173 ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG--WDRGEACP---ACQN 247 (316)
T ss_dssp ---------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSC--C----CCH---HHHH
T ss_pred ccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccc--ccccccch---hHHH
Confidence 01356889999999999999999999765422110 00000000 0000
Q ss_pred HHHhhhcCCcCCCCCCh----HHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 535 ERLRNWMDPNLESFYPI----DGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 535 ~~~~~~~dp~l~~~~~~----~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.....+..... .++. .....+.+|+.+||+.||.+|||+.|++++
T Consensus 248 ~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 248 MLFESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00001111111 1121 123468899999999999999999999875
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6.2e-32 Score=285.18 Aligned_cols=212 Identities=22% Similarity=0.331 Sum_probs=167.5
Q ss_pred ccccccccc----ceEEEEEE--CCeEEEEEEccHH----------HHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEE
Q 047629 334 NLSEHYSIG----KSVYRATI--DGKVLAVKKIKED----------VTEELRILQRI-NHANLVKLMGVSSDSQGNRFLV 396 (615)
Q Consensus 334 ~~~~~~~iG----~~Vy~~~~--~g~~vAvK~~~~~----------~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV 396 (615)
+|.....+| |.||++.. +|+.||||+++.. +..|..++..+ +||||+++++++.+. +..++|
T Consensus 21 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~-~~~~lv 99 (353)
T 2i0e_A 21 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM-DRLYFV 99 (353)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS-SEEEEE
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC-CEEEEE
Confidence 344444454 58999998 4789999998743 56799999888 899999999998754 479999
Q ss_pred EeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecC
Q 047629 397 YEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFS 476 (615)
Q Consensus 397 ~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFG 476 (615)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 100 ~E~~~gg~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG 166 (353)
T 2i0e_A 100 MEYVNGGDLMYHIQQVG----------RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFG 166 (353)
T ss_dssp EECCCSCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred EeCCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCC
Confidence 99999999999997643 2899999999999999999999998 9999999999999999999999999
Q ss_pred CCCCCC-----------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHH
Q 047629 477 LAAPAT-----------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKR 533 (615)
Q Consensus 477 la~~~~-----------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 533 (615)
+++... ..++.++|||||||++|||++|+.||...... .+. ..
T Consensus 167 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~---~~-------- 232 (353)
T 2i0e_A 167 MCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELF---QS-------- 232 (353)
T ss_dssp TCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HH--------
T ss_pred cccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH---HHH---HH--------
Confidence 987521 12456899999999999999999999754321 111 00
Q ss_pred HHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 047629 534 EERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPN-----MAEVVFN 581 (615)
Q Consensus 534 ~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPs-----m~ev~~~ 581 (615)
+ +... ..+|......+.+|+.+|++.||.+||+ ++|++++
T Consensus 233 ---i---~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 233 ---I---MEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp ---H---HHCC--CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred ---H---HhCC--CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1 1111 1233344556889999999999999995 5777654
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.98 E-value=6.2e-32 Score=291.84 Aligned_cols=216 Identities=20% Similarity=0.255 Sum_probs=165.9
Q ss_pred ccccccccc----ceEEEEEE--CCeEEEEEEccH---------------HHHHHHHHHHhcCCCCcccEEEEEEcCCCc
Q 047629 334 NLSEHYSIG----KSVYRATI--DGKVLAVKKIKE---------------DVTEELRILQRINHANLVKLMGVSSDSQGN 392 (615)
Q Consensus 334 ~~~~~~~iG----~~Vy~~~~--~g~~vAvK~~~~---------------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 392 (615)
.|.....+| |.||+|.. +|+.||||.+.. .+.+|+++|++++||||+++++++.. +.
T Consensus 136 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~ 213 (419)
T 3i6u_A 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA--ED 213 (419)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES--SE
T ss_pred cEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec--Cc
Confidence 344444444 58999987 679999999853 26789999999999999999999753 35
Q ss_pred EEEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCC---Cc
Q 047629 393 RFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSR---FK 469 (615)
Q Consensus 393 ~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~---~~ 469 (615)
.++||||+++|+|.+++.... .+++.++..++.|++.||+|||+++ |+||||||+|||++.+ +.
T Consensus 214 ~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~ 280 (419)
T 3i6u_A 214 YYIVLELMEGGELFDKVVGNK----------RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCL 280 (419)
T ss_dssp EEEEEECCTTCBGGGGTSSSC----------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCC
T ss_pred eEEEEEcCCCCcHHHHHhccC----------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcce
Confidence 899999999999999997654 3899999999999999999999998 9999999999999754 45
Q ss_pred EEEeecCCCCCCCC-------------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHH
Q 047629 470 AKIANFSLAAPATN-------------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIR 524 (615)
Q Consensus 470 ~kl~DFGla~~~~~-------------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~ 524 (615)
+||+|||+++.... .++.++|||||||++|||++|+.||.......... ..+.
T Consensus 281 ~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~--~~i~ 358 (419)
T 3i6u_A 281 IKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK--DQIT 358 (419)
T ss_dssp EEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHH--HHHH
T ss_pred EEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHH--HHHh
Confidence 99999999965321 13357899999999999999999997644322211 0000
Q ss_pred HHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 525 EVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 525 ~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
..... ............+.+++.+||+.||++||++.|++++
T Consensus 359 -------------~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 359 -------------SGKYN--FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp -------------TTCCC--CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -------------cCCCC--CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00000 0000001223467899999999999999999999875
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.98 E-value=7.9e-32 Score=274.22 Aligned_cols=207 Identities=22% Similarity=0.344 Sum_probs=165.0
Q ss_pred ceEEEEEE--CCeEEEEEEcc-------------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATI--DGKVLAVKKIK-------------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-------------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~ 407 (615)
|.||++.. +|+.||+|.++ +.+.+|++++++++||||+++++++.+. ...++||||+++++|.+
T Consensus 19 g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~ 97 (283)
T 3bhy_A 19 AIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK-TDVVLILELVSGGELFD 97 (283)
T ss_dssp EEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEEECCCSCBHHH
T ss_pred eEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC-CeEEEEEeecCCCcHHH
Confidence 58999998 58999999874 3478999999999999999999998764 47899999999999999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCC----cEEEeecCCCCCCC-
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRF----KAKIANFSLAAPAT- 482 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~----~~kl~DFGla~~~~- 482 (615)
++.... .+++.++..++.|++.||.|||+++ ++||||||+||+++.++ .+||+|||++....
T Consensus 98 ~l~~~~----------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~ 164 (283)
T 3bhy_A 98 FLAEKE----------SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164 (283)
T ss_dssp HHHHHS----------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred HHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence 997543 3899999999999999999999998 99999999999998877 89999999986431
Q ss_pred ---------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhc
Q 047629 483 ---------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWM 541 (615)
Q Consensus 483 ---------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 541 (615)
..++.++||||||+++|||++|+.|+......+ ... . +.. .
T Consensus 165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~---~-----------~~~-~ 226 (283)
T 3bhy_A 165 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE---TLT---N-----------ISA-V 226 (283)
T ss_dssp -------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHH---H-----------HHT-T
T ss_pred CCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH---HHH---H-----------hHh-c
Confidence 224568999999999999999999997543211 010 0 000 0
Q ss_pred CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 542 DPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 542 dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
...............+.+++.+||+.||.+||++.|+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 227 NYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp CCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred ccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 1111000111223457899999999999999999999984
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1e-31 Score=284.76 Aligned_cols=218 Identities=21% Similarity=0.326 Sum_probs=168.8
Q ss_pred ccccccccccc----ceEEEEEE--CCeEEEEEEcc---------------HHHHHHHHHHHhc-CCCCcccEEEEEEcC
Q 047629 332 TMNLSEHYSIG----KSVYRATI--DGKVLAVKKIK---------------EDVTEELRILQRI-NHANLVKLMGVSSDS 389 (615)
Q Consensus 332 t~~~~~~~~iG----~~Vy~~~~--~g~~vAvK~~~---------------~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 389 (615)
..+|.....+| |.||++.. +|+.||||+++ +.+.+|+.++.++ +||||+++++++...
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 34455445555 58999998 58999999874 2367899999999 899999999998754
Q ss_pred CCcEEEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCc
Q 047629 390 QGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFK 469 (615)
Q Consensus 390 ~~~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~ 469 (615)
+..++||||+++|+|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.
T Consensus 173 -~~~~lv~e~~~g~~L~~~l~~~~----------~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ 238 (365)
T 2y7j_A 173 -SFMFLVFDLMRKGELFDYLTEKV----------ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQ 238 (365)
T ss_dssp -SEEEEEECCCTTCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCC
T ss_pred -CEEEEEEEeCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCC
Confidence 47999999999999999997543 3899999999999999999999998 999999999999999999
Q ss_pred EEEeecCCCCCCCC----------------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHH
Q 047629 470 AKIANFSLAAPATN----------------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWK 521 (615)
Q Consensus 470 ~kl~DFGla~~~~~----------------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~ 521 (615)
+||+|||++..... .++.++|||||||++|||++|+.||...... ....
T Consensus 239 ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~~~~ 315 (365)
T 2y7j_A 239 IRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI---LMLR 315 (365)
T ss_dssp EEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH
T ss_pred EEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH---HHHH
Confidence 99999998854311 2456899999999999999999999754321 1111
Q ss_pred HHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 522 EIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.+. ......... ...+....+.+++.+||+.||++|||+.|+++.
T Consensus 316 ~i~-------------~~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 316 MIM-------------EGQYQFSSP--EWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHH-------------HTCCCCCHH--HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHH-------------hCCCCCCCc--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 000 000000000 000123457899999999999999999999874
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-32 Score=289.69 Aligned_cols=214 Identities=17% Similarity=0.263 Sum_probs=164.8
Q ss_pred ceEEEEEE--CCeEEEEEEcc--HHHHHHHHHHHh-cCCCCcccEEEEEEc---CCCcEEEEEeecCCCCHHHhhccCCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK--EDVTEELRILQR-INHANLVKLMGVSSD---SQGNRFLVYEYAENGSLDKWLHPKSK 414 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~--~~~~~Ei~~l~~-l~H~niv~l~g~~~~---~~~~~~lV~E~~~~GsL~~~L~~~~~ 414 (615)
|.||++.. +|+.||||+++ ..+.+|++++.+ .+|+||+++++++.. .+...++||||+++|+|.+++.....
T Consensus 76 g~V~~~~~~~~~~~vAiK~~~~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~ 155 (400)
T 1nxk_A 76 GKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD 155 (400)
T ss_dssp EEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC--
T ss_pred eEEEEEEECCCCCEEEEEEeCcchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCC
Confidence 58999988 68999999986 467889998855 489999999998753 23358999999999999999986532
Q ss_pred CCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCC---CCcEEEeecCCCCCCC---------
Q 047629 415 SSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDS---RFKAKIANFSLAAPAT--------- 482 (615)
Q Consensus 415 ~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~---~~~~kl~DFGla~~~~--------- 482 (615)
. .+++.++..|+.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+++...
T Consensus 156 ~--------~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~ 224 (400)
T 1nxk_A 156 Q--------AFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC 224 (400)
T ss_dssp ---------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC---------
T ss_pred C--------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccccccCCCCccccCC
Confidence 1 3899999999999999999999998 999999999999998 7899999999986432
Q ss_pred -------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhH-HHHHHHHHHHhHHHHHHHHHhhhcCCcCCCC
Q 047629 483 -------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTA-VLWKEIREVLKVEEKREERLRNWMDPNLESF 548 (615)
Q Consensus 483 -------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~ 548 (615)
..++.++|||||||++|||++|+.||......... .....+ .... .+ +...
T Consensus 225 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i------------~~~~-~~--~~~~ 289 (400)
T 1nxk_A 225 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI------------RMGQ-YE--FPNP 289 (400)
T ss_dssp --CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH------------HHTC-CC--CCTT
T ss_pred CCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH------------HcCc-cc--CCCc
Confidence 22567899999999999999999999764422110 000000 0001 10 1111
Q ss_pred CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047629 549 YPIDGALSLATLARACTMDKSLSRPNMAEVVFNL 582 (615)
Q Consensus 549 ~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L 582 (615)
........+.+|+..||+.||++|||+.|++++-
T Consensus 290 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 290 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 1122345678999999999999999999999864
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.8e-32 Score=281.81 Aligned_cols=222 Identities=23% Similarity=0.370 Sum_probs=167.2
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
|.||++.. +|+.||||++. +.+.+|++++++++|+||+++++++.+. +..++||||+++++|.+++..
T Consensus 39 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~l~~~~~~ 117 (331)
T 4aaa_A 39 GMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK-KRWYLVFEFVDHTILDDLELF 117 (331)
T ss_dssp SSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEECCSEEHHHHHHHS
T ss_pred EEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC-CEEEEEEecCCcchHHHHHhh
Confidence 58999998 58999999873 2367899999999999999999998754 478999999999999988765
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC---------
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT--------- 482 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~--------- 482 (615)
.. .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 118 ~~----------~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 184 (331)
T 4aaa_A 118 PN----------GLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE 184 (331)
T ss_dssp TT----------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------------C
T ss_pred cc----------CCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCccccCCC
Confidence 43 2899999999999999999999998 9999999999999999999999999985421
Q ss_pred ---------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhH-HHH------HHHHHhhh
Q 047629 483 ---------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKV-EEK------REERLRNW 540 (615)
Q Consensus 483 ---------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~-~~~------~~~~~~~~ 540 (615)
..++.++||||||+++|||++|+.||......+.. .. +...... ... ........
T Consensus 185 ~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (331)
T 4aaa_A 185 VATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQL--YH-IMMCLGNLIPRHQELFNKNPVFAGV 261 (331)
T ss_dssp CCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HH-HHHHHCSCCHHHHHHHHHCGGGTTC
T ss_pred cCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHH--HH-HHHHhCCCChhhhhHhhhccccccc
Confidence 12467899999999999999999999765432211 11 1111000 000 00111112
Q ss_pred cCCcCCCCCCh-----HHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 541 MDPNLESFYPI-----DGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 541 ~dp~l~~~~~~-----~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
..+.+....+. .....+.+|+.+||+.||++|||+.|+++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 262 RLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp CCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 22222222221 234568999999999999999999999885
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-32 Score=283.46 Aligned_cols=213 Identities=22% Similarity=0.324 Sum_probs=163.8
Q ss_pred ceEEEEEE--CCeEEEEEEcc-------HHHHHHHHHHHhcC-CCCcccEEEEEEc-------CCCcEEEEEeecCCCCH
Q 047629 343 KSVYRATI--DGKVLAVKKIK-------EDVTEELRILQRIN-HANLVKLMGVSSD-------SQGNRFLVYEYAENGSL 405 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-------~~~~~Ei~~l~~l~-H~niv~l~g~~~~-------~~~~~~lV~E~~~~GsL 405 (615)
|.||++.. +|+.||||++. ..+.+|+.++.++. |+||+++++++.. .....++|+||+. |+|
T Consensus 42 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L 120 (337)
T 3ll6_A 42 AFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQL 120 (337)
T ss_dssp EEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEH
T ss_pred eEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecC-CCH
Confidence 48999998 78999999883 35778999999995 9999999999842 2234799999996 799
Q ss_pred HHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC---
Q 047629 406 DKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT--- 482 (615)
Q Consensus 406 ~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~--- 482 (615)
.+++...... ..+++.+++.++.|++.||.|||+++ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 121 ~~~l~~~~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 192 (337)
T 3ll6_A 121 VEFLKKMESR-------GPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYP 192 (337)
T ss_dssp HHHHHHHHTT-------CSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC
T ss_pred HHHHHHhhcc-------CCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCccceeccccC
Confidence 9998652211 13899999999999999999999874 459999999999999999999999999986431
Q ss_pred -----------------------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHH
Q 047629 483 -----------------------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVL 527 (615)
Q Consensus 483 -----------------------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 527 (615)
..++.++||||||+++|||++|+.||.......
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------------ 260 (337)
T 3ll6_A 193 DYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR------------ 260 (337)
T ss_dssp -------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------------------
T ss_pred cccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH------------
Confidence 113458999999999999999999986432100
Q ss_pred hHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 528 KVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 528 ~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
.+........... ....+.+++..||+.||.+||++.|+++.|+.+...
T Consensus 261 --------~~~~~~~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 261 --------IVNGKYSIPPHDT----QYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp -------------CCCCTTCC----SSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------hhcCcccCCcccc----cchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 0001111111111 223368999999999999999999999999988654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-32 Score=287.39 Aligned_cols=226 Identities=20% Similarity=0.346 Sum_probs=167.0
Q ss_pred ceEEEEEE--CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATI--DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
|.||++.. +|+.||+|.++ ..+.+|+.++++++|+||+++++++.+. +..++||||+++|+|.+++...
T Consensus 47 g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~ 125 (360)
T 3eqc_A 47 GVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-GEISICMEHMDGGSLDQVLKKA 125 (360)
T ss_dssp CEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET-TEEEEEECCCTTCBHHHHHHHH
T ss_pred eEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC-CEEEEEEECCCCCCHHHHHHHc
Confidence 58999998 58999999985 3477899999999999999999998764 4799999999999999999764
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCceeeCCCCcEEEeecCCCCCC----------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEH-AQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA---------- 481 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~---------- 481 (615)
. .+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++..
T Consensus 126 ~----------~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~g 192 (360)
T 3eqc_A 126 G----------RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVG 192 (360)
T ss_dssp S----------SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC----CC
T ss_pred C----------CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccccccCCCC
Confidence 3 289999999999999999999985 6 999999999999999999999999998421
Q ss_pred -----------CCCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHH-HHHH-----------------HhHHH-
Q 047629 482 -----------TNDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKE-IREV-----------------LKVEE- 531 (615)
Q Consensus 482 -----------~~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~-~~~~-----------------~~~~~- 531 (615)
...++.++||||||+++|||++|+.||......+....... .... .....
T Consensus 193 t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (360)
T 3eqc_A 193 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSR 272 (360)
T ss_dssp CCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------------------
T ss_pred CCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCC
Confidence 12356789999999999999999999976442211110000 0000 00000
Q ss_pred ---HHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047629 532 ---KREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNL 582 (615)
Q Consensus 532 ---~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L 582 (615)
.....+...................+.+|+.+||+.||++|||++|++++-
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 326 (360)
T 3eqc_A 273 PPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 326 (360)
T ss_dssp -CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred CcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence 000000111111111111112344688999999999999999999999853
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-32 Score=276.89 Aligned_cols=209 Identities=12% Similarity=0.105 Sum_probs=165.4
Q ss_pred ceEEEEEE--CCeEEEEEEcc----------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIK----------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~----------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||+|.. +|+.||||.++ +.+.+|+.++.+++|+||+++++++.+. +..++||||+++|+|.+++.
T Consensus 45 g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~g~~L~~~l~ 123 (286)
T 3uqc_A 45 LQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR-AGGLVVAEWIRGGSLQEVAD 123 (286)
T ss_dssp CEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEEEECCCEEEHHHHHT
T ss_pred eEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC-CcEEEEEEecCCCCHHHHHh
Confidence 58999998 48999999985 3478899999999999999999998764 47999999999999999995
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCCCCCCccc
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVMPKFD 490 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~k~D 490 (615)
.. ....+..+++.|++.||+|||+++ |+||||||+|||++.++.+||+++|... ..+.++|
T Consensus 124 ~~------------~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~~~~----~~~~~~D 184 (286)
T 3uqc_A 124 TS------------PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPATMP----DANPQDD 184 (286)
T ss_dssp TC------------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCCCCT----TCCHHHH
T ss_pred cC------------CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEeccccC----CCCchhH
Confidence 42 344568889999999999999998 9999999999999999999999887643 4788999
Q ss_pred chhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcC--CCCCChHHHHHHHHHHHHhhhcC
Q 047629 491 VFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNL--ESFYPIDGALSLATLARACTMDK 568 (615)
Q Consensus 491 V~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l--~~~~~~~~~~~l~~l~~~C~~~d 568 (615)
||||||++|||++|+.||......+.... ....+.... ......+....+.+++.+||+.|
T Consensus 185 i~slG~il~elltg~~Pf~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 247 (286)
T 3uqc_A 185 IRGIGASLYALLVNRWPLPEAGVRSGLAP-----------------AERDTAGQPIEPADIDRDIPFQISAVAARSVQGD 247 (286)
T ss_dssp HHHHHHHHHHHHHSEECSCCCSBCCCSEE-----------------CCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTT
T ss_pred HHHHHHHHHHHHHCCCCCCcCCcchhhHH-----------------HHHHhccCCCChhhcccCCCHHHHHHHHHHcccC
Confidence 99999999999999999976543211000 000000000 00011223345889999999999
Q ss_pred CCCCCCHHHHHHHHHhcccch
Q 047629 569 SLSRPNMAEVVFNLSVLTQST 589 (615)
Q Consensus 569 P~~RPsm~ev~~~L~~l~~~~ 589 (615)
|++| |+.|+++.|+.+....
T Consensus 248 P~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 248 GGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp SSCC-CHHHHHHHHHHHHC--
T ss_pred CccC-CHHHHHHHHHHHhccC
Confidence 9999 9999999999887654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-32 Score=283.46 Aligned_cols=212 Identities=22% Similarity=0.318 Sum_probs=161.7
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCC---cEEEEEeecCCCCHHH
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQG---NRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~---~~~lV~E~~~~GsL~~ 407 (615)
|.||++.. +|+.||||+++. .+.+|++++.+++||||+++++++..... ..++||||+++|+|.+
T Consensus 26 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~ 105 (311)
T 3ork_A 26 SEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD 105 (311)
T ss_dssp EEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHH
T ss_pred EEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHH
Confidence 58999996 789999999852 46789999999999999999998764332 2499999999999999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----- 482 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----- 482 (615)
++.... .+++.+++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 106 ~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 172 (311)
T 3ork_A 106 IVHTEG----------PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172 (311)
T ss_dssp HHHHHC----------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC---------
T ss_pred HHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcccccccccc
Confidence 997643 3899999999999999999999998 9999999999999999999999999986431
Q ss_pred ---------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhc
Q 047629 483 ---------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWM 541 (615)
Q Consensus 483 ---------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 541 (615)
..++.++||||||+++|||++|+.||......+ .... ......
T Consensus 173 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~--~~~~--------------~~~~~~ 236 (311)
T 3ork_A 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS--VAYQ--------------HVREDP 236 (311)
T ss_dssp ---------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHH--------------HHHCCC
T ss_pred cccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH--HHHH--------------HhcCCC
Confidence 124568999999999999999999997543211 1000 001000
Q ss_pred CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHH-HHHhc
Q 047629 542 DPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVF-NLSVL 585 (615)
Q Consensus 542 dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~-~L~~l 585 (615)
.+. ..........+.+++.+||+.||++||++.+++. .|..+
T Consensus 237 ~~~--~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 237 IPP--SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp CCH--HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCc--ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 000 0001123345789999999999999997666554 45444
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=294.37 Aligned_cols=219 Identities=18% Similarity=0.233 Sum_probs=166.9
Q ss_pred ceEEEEEE--CCeEEEEEEcc-----HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK-----EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKS 415 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-----~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~ 415 (615)
|.||+|.. +|+.||||.++ .++..|++++..++|.+.+..+.++.......+|||||+ +|+|.+++.....
T Consensus 21 G~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~- 98 (483)
T 3sv0_A 21 GEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSR- 98 (483)
T ss_dssp CEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT-
T ss_pred EEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhcC-
Confidence 58999997 68999999875 358899999999987555544444433445789999999 8999999975433
Q ss_pred CCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceee---CCCCcEEEeecCCCCCCCC---------
Q 047629 416 SSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQL---DSRFKAKIANFSLAAPATN--------- 483 (615)
Q Consensus 416 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl---d~~~~~kl~DFGla~~~~~--------- 483 (615)
.+++.+++.|+.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++....
T Consensus 99 --------~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~ 167 (483)
T 3sv0_A 99 --------KLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPY 167 (483)
T ss_dssp --------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCC
T ss_pred --------CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcccccccc
Confidence 3899999999999999999999998 9999999999999 6889999999999864311
Q ss_pred ---------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcC
Q 047629 484 ---------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMD 542 (615)
Q Consensus 484 ---------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~d 542 (615)
.++.++|||||||+||||++|+.||..............+... .+...++
T Consensus 168 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~---------~~~~~~~ 238 (483)
T 3sv0_A 168 RENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK---------KVATSIE 238 (483)
T ss_dssp CCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH---------HHHSCHH
T ss_pred ccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc---------cccccHH
Confidence 1345789999999999999999999876543332222211111 1110000
Q ss_pred CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 543 PNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 543 p~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
.+...+ ..++.+++..||+.||++||++.+|++.|+.+...
T Consensus 239 -~l~~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 239 -ALCRGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp -HHHTTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred -HHhcCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 000122 34579999999999999999999999999887553
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.8e-32 Score=306.21 Aligned_cols=211 Identities=24% Similarity=0.377 Sum_probs=171.0
Q ss_pred ceEEEEEEC-----CeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATID-----GKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~~-----g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
|.||+|.+. +..||||+++ +.+.+|+.+|++++||||++++|++.+ +..++||||+++|+|.+++
T Consensus 404 G~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~lv~E~~~~g~L~~~l 481 (656)
T 2j0j_A 404 GDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--NPVWIIMELCTLGELRSFL 481 (656)
T ss_dssp CCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEEECCTTCBHHHHH
T ss_pred EEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec--CceEEEEEcCCCCcHHHHH
Confidence 589999872 4679999875 457889999999999999999999843 4689999999999999999
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------ 483 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------ 483 (615)
..... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 482 ~~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 549 (656)
T 2j0j_A 482 QVRKF---------SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA 549 (656)
T ss_dssp HHTTT---------TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC------
T ss_pred HhccC---------CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecCCCcceec
Confidence 76542 3899999999999999999999998 99999999999999999999999999975421
Q ss_pred ------------------CCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCc
Q 047629 484 ------------------DVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPN 544 (615)
Q Consensus 484 ------------------~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~ 544 (615)
.++.++|||||||++|||++ |+.||......+ ... .+.....+
T Consensus 550 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---~~~--------------~i~~~~~~- 611 (656)
T 2j0j_A 550 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIG--------------RIENGERL- 611 (656)
T ss_dssp ----CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHH--------------HHHHTCCC-
T ss_pred cCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH---HHH--------------HHHcCCCC-
Confidence 13557999999999999997 999987543211 110 11111111
Q ss_pred CCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 545 LESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 545 l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
..+......+.+++..||+.||.+||++.|+++.|+.+.+.
T Consensus 612 ---~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 612 ---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 12334445689999999999999999999999999987643
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=274.99 Aligned_cols=204 Identities=23% Similarity=0.351 Sum_probs=165.5
Q ss_pred ceEEEEEE--CCeEEEEEEcc----------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIK----------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~----------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||++.. +|+.+|+|.+. +.+.+|+.++++++|+||+++++++.+. +..++||||+++|+|.+++.
T Consensus 29 g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~ 107 (294)
T 2rku_A 29 AKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN-DFVFVVLELCRRRSLLELHK 107 (294)
T ss_dssp EEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEEEEECCTTCBHHHHHH
T ss_pred EEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC-CEEEEEEecCCCCCHHHHHH
Confidence 48999998 58899999874 2467899999999999999999998754 47899999999999999987
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
... .+++.++..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++...
T Consensus 108 ~~~----------~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 174 (294)
T 2rku_A 108 RRK----------ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV 174 (294)
T ss_dssp HHC----------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred hcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccCcccccc
Confidence 643 3899999999999999999999998 9999999999999999999999999986431
Q ss_pred ---------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCC
Q 047629 483 ---------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLES 547 (615)
Q Consensus 483 ---------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~ 547 (615)
...+.++||||||+++|||++|+.|+......+. + . .+.. ....
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~---~-----------~~~~-~~~~--- 233 (294)
T 2rku_A 175 LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET---Y---L-----------RIKK-NEYS--- 233 (294)
T ss_dssp CCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---H---H-----------HHHT-TCCC---
T ss_pred ccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---H---H-----------HHhh-ccCC---
Confidence 1145689999999999999999999975432110 0 0 0000 0111
Q ss_pred CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047629 548 FYPIDGALSLATLARACTMDKSLSRPNMAEVVFNL 582 (615)
Q Consensus 548 ~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L 582 (615)
.+......+.+++.+||+.||++|||+.|+++.-
T Consensus 234 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~ 267 (294)
T 2rku_A 234 -IPKHINPVAASLIQKMLQTDPTARPTINELLNDE 267 (294)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred -CccccCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 2233345678999999999999999999998853
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.1e-32 Score=288.18 Aligned_cols=221 Identities=23% Similarity=0.370 Sum_probs=163.3
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcC-CCCcccEEEEEEcCC-CcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRIN-HANLVKLMGVSSDSQ-GNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~-~~~~lV~E~~~~GsL~~~L 409 (615)
|.||+|.. +|+.||||++. ..+.+|+.++.++. |+||+++++++...+ ...++||||++ |+|.+++
T Consensus 23 g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~ 101 (388)
T 3oz6_A 23 GIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVI 101 (388)
T ss_dssp -CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHH
T ss_pred eEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHH
Confidence 58999987 68999999884 23568999999997 999999999987543 35899999997 6999999
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------- 482 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------- 482 (615)
... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~~~-----------~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 167 (388)
T 3oz6_A 102 RAN-----------ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTN 167 (388)
T ss_dssp HHT-----------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCC
T ss_pred HcC-----------CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccccccccccccc
Confidence 753 2889999999999999999999998 9999999999999999999999999986321
Q ss_pred --------------------------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHH
Q 047629 483 --------------------------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIR 524 (615)
Q Consensus 483 --------------------------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~ 524 (615)
..++.++|||||||++|||++|+.||......+. ...+.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~---~~~i~ 244 (388)
T 3oz6_A 168 NIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ---LERII 244 (388)
T ss_dssp CGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHH
T ss_pred cccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHH
Confidence 2256789999999999999999999976542211 11111
Q ss_pred HHHhHHHHH-------------HHHHhhhc---CCcCCCCC------------ChHHHHHHHHHHHHhhhcCCCCCCCHH
Q 047629 525 EVLKVEEKR-------------EERLRNWM---DPNLESFY------------PIDGALSLATLARACTMDKSLSRPNMA 576 (615)
Q Consensus 525 ~~~~~~~~~-------------~~~~~~~~---dp~l~~~~------------~~~~~~~l~~l~~~C~~~dP~~RPsm~ 576 (615)
..+...... ...+.... .......+ +......+.+|+.+||+.||++|||+.
T Consensus 245 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~ 324 (388)
T 3oz6_A 245 GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAN 324 (388)
T ss_dssp HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHH
Confidence 111000000 00000000 00000000 012234578999999999999999999
Q ss_pred HHHHH
Q 047629 577 EVVFN 581 (615)
Q Consensus 577 ev~~~ 581 (615)
|++++
T Consensus 325 e~l~H 329 (388)
T 3oz6_A 325 DALKH 329 (388)
T ss_dssp HHTTS
T ss_pred HHhCC
Confidence 99886
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=277.95 Aligned_cols=207 Identities=22% Similarity=0.278 Sum_probs=162.9
Q ss_pred ceEEEEEE--CCeEEEEEEccH---------------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCH
Q 047629 343 KSVYRATI--DGKVLAVKKIKE---------------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSL 405 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~---------------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL 405 (615)
|.||++.. +|+.||||.+.. .+.+|+++|++++||||+++++++.. + ..++||||+++|+|
T Consensus 24 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~-~~~lv~e~~~~~~L 101 (322)
T 2ycf_A 24 GEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E-DYYIVLELMEGGEL 101 (322)
T ss_dssp EEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES-S-SEEEEEECCTTEET
T ss_pred EEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC-C-ceEEEEecCCCCcH
Confidence 58999987 689999998742 26789999999999999999999864 3 58999999999999
Q ss_pred HHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCc---EEEeecCCCCCCC
Q 047629 406 DKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFK---AKIANFSLAAPAT 482 (615)
Q Consensus 406 ~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~---~kl~DFGla~~~~ 482 (615)
.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++. +||+|||+++...
T Consensus 102 ~~~~~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 168 (322)
T 2ycf_A 102 FDKVVGNK----------RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168 (322)
T ss_dssp HHHHSTTC----------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCTTCEECC
T ss_pred HHHHhccC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCccceecc
Confidence 99997643 3899999999999999999999998 999999999999987654 9999999986432
Q ss_pred -------------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHH
Q 047629 483 -------------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERL 537 (615)
Q Consensus 483 -------------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 537 (615)
..++.++||||||+++|||++|+.||......... ...+. ....
T Consensus 169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~---------~~~~ 237 (322)
T 2ycf_A 169 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--KDQIT---------SGKY 237 (322)
T ss_dssp CCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH--HHHHH---------HTCC
T ss_pred cccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH--HHHHH---------hCcc
Confidence 22467899999999999999999999765432211 11010 0000
Q ss_pred hhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 538 RNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 538 ~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
...+.. ..+....+.+++.+||+.||++||++.|+++.
T Consensus 238 --~~~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 238 --NFIPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp --CCCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --ccCchh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 000000 01223467899999999999999999999874
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=296.17 Aligned_cols=218 Identities=20% Similarity=0.262 Sum_probs=172.4
Q ss_pred ccccccccc----ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEE
Q 047629 334 NLSEHYSIG----KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVY 397 (615)
Q Consensus 334 ~~~~~~~iG----~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~ 397 (615)
+|.....+| |.||++.. +|+.||||+++. .+.+|+++|.+++||||+++++++.+. +..++||
T Consensus 185 ~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-~~l~lVm 263 (576)
T 2acx_A 185 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK-DALCLVL 263 (576)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEE
T ss_pred ceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeC-CEEEEEE
Confidence 344444555 58999998 689999999853 256899999999999999999998754 4799999
Q ss_pred eecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCC
Q 047629 398 EYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSL 477 (615)
Q Consensus 398 E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGl 477 (615)
||+++|+|.+++...... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 264 Ey~~gg~L~~~l~~~~~~--------~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGl 332 (576)
T 2acx_A 264 TLMNGGDLKFHIYHMGQA--------GFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGL 332 (576)
T ss_dssp CCCCSCBHHHHHHSSSSC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred EcCCCCcHHHHHHhcCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEeccc
Confidence 999999999999765421 3899999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCC----------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHH
Q 047629 478 AAPATN----------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREE 535 (615)
Q Consensus 478 a~~~~~----------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 535 (615)
++.... .++.++|||||||++|||++|+.||........... +..
T Consensus 333 a~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~---i~~---------- 399 (576)
T 2acx_A 333 AVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE---VER---------- 399 (576)
T ss_dssp CEECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHH---HHH----------
T ss_pred ceecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHH---HHH----------
Confidence 965321 245689999999999999999999986543221110 110
Q ss_pred HHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 047629 536 RLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRP-----NMAEVVFN 581 (615)
Q Consensus 536 ~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RP-----sm~ev~~~ 581 (615)
.+.. .. ..++......+.+|+..|++.||.+|| +++||+++
T Consensus 400 ~i~~-~~----~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 400 LVKE-VP----EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp HHHH-CC----CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred Hhhc-cc----ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 0111 11 123333445688999999999999999 78888765
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-31 Score=277.90 Aligned_cols=221 Identities=23% Similarity=0.331 Sum_probs=163.0
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcC-------CCcEEEEEeecCCCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDS-------QGNRFLVYEYAENGS 404 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~-------~~~~~lV~E~~~~Gs 404 (615)
|.||++.. +|+.||||++. ..+.+|++++++++|+||+++++++... .+..++||||+++ +
T Consensus 31 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~ 109 (351)
T 3mi9_A 31 GEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-D 109 (351)
T ss_dssp TSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-E
T ss_pred cEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCC-C
Confidence 58999998 68999999874 3577999999999999999999998753 2357999999984 8
Q ss_pred HHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--
Q 047629 405 LDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-- 482 (615)
Q Consensus 405 L~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-- 482 (615)
|.+.+..... .+++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 110 l~~~l~~~~~---------~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 177 (351)
T 3mi9_A 110 LAGLLSNVLV---------KFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLA 177 (351)
T ss_dssp HHHHHHCTTS---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCCC
T ss_pred HHHHHhhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhccccccc
Confidence 8887765433 3899999999999999999999998 9999999999999999999999999985321
Q ss_pred --------------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHH
Q 047629 483 --------------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREER 536 (615)
Q Consensus 483 --------------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 536 (615)
..++.++|||||||++|||++|+.||......... ..+........ ...
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---~~i~~~~~~~~--~~~ 252 (351)
T 3mi9_A 178 KNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL---ALISQLCGSIT--PEV 252 (351)
T ss_dssp SSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCC--TTT
T ss_pred ccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCC--hhh
Confidence 12467899999999999999999999764422211 11111100000 000
Q ss_pred Hhhh--------cCCcCCCCCCh-H------HHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 537 LRNW--------MDPNLESFYPI-D------GALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 537 ~~~~--------~dp~l~~~~~~-~------~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.... +.......... + ....+.+|+.+|++.||++|||++|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 0000 00000000000 0 02347899999999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=272.18 Aligned_cols=203 Identities=26% Similarity=0.403 Sum_probs=164.8
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||+|.. +|+.||||.++. .+.+|+.++++++|+||+++++++.+. +..++||||+++|+|.+++.
T Consensus 25 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~ 103 (276)
T 2h6d_A 25 GKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP-TDFFMVMEYVSGGELFDYIC 103 (276)
T ss_dssp EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEEEEECCCSCBHHHHHH
T ss_pred eEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC-CeEEEEEeccCCCcHHHHHh
Confidence 58999997 689999999853 366899999999999999999998754 47999999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCCC------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATND------ 484 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~------ 484 (615)
... .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++......
T Consensus 104 ~~~----------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 170 (276)
T 2h6d_A 104 KHG----------RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS 170 (276)
T ss_dssp HHC----------SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-------
T ss_pred ccC----------CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCCcceecc
Confidence 643 2899999999999999999999998 999999999999999999999999998653211
Q ss_pred -----------------CCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCC
Q 047629 485 -----------------VMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLES 547 (615)
Q Consensus 485 -----------------~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~ 547 (615)
.+.++||||||+++|||++|+.|+..... ..... .+... ...
T Consensus 171 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~--------------~~~~~-~~~--- 229 (276)
T 2h6d_A 171 CGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV---PTLFK--------------KIRGG-VFY--- 229 (276)
T ss_dssp ------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH--------------HHHHC-CCC---
T ss_pred cCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH---HHHHH--------------HhhcC-ccc---
Confidence 13579999999999999999999965431 11111 01110 011
Q ss_pred CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 548 FYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 548 ~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.+......+.+++.+|++.||.+|||+.|+++.
T Consensus 230 -~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 230 -IPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -CchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 222334568899999999999999999999985
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-33 Score=295.59 Aligned_cols=206 Identities=19% Similarity=0.198 Sum_probs=156.7
Q ss_pred ceEEEEEE--CCeEEEEEEcc----------HHHHHHH---HHHHhcCCCCcccEE-------EEEEcCCC---------
Q 047629 343 KSVYRATI--DGKVLAVKKIK----------EDVTEEL---RILQRINHANLVKLM-------GVSSDSQG--------- 391 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~----------~~~~~Ei---~~l~~l~H~niv~l~-------g~~~~~~~--------- 391 (615)
|.||+|.. +|+.||||+++ +.+.+|+ ++|++++|||||+++ +++.+.+.
T Consensus 87 g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (377)
T 3byv_A 87 YAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLD 166 (377)
T ss_dssp EEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC---
T ss_pred EEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccC
Confidence 58999996 69999999985 4577899 455566899999998 66554321
Q ss_pred -------cEEEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceee
Q 047629 392 -------NRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQL 464 (615)
Q Consensus 392 -------~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl 464 (615)
..++||||+ +|+|.+++....... .....++|..++.|+.|++.||+|||+++ |+||||||+|||+
T Consensus 167 ~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDikp~NIll 239 (377)
T 3byv_A 167 ERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHS---STHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVL 239 (377)
T ss_dssp ---CEEESEEEEEECC-SEEHHHHHHHHHHTT---TTTHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCceEEEEEEEEEecc-CCCHHHHHHhccccc---cccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 278999999 689999997642210 00123668999999999999999999998 9999999999999
Q ss_pred CCCCcEEEeecCCCCCCCC------------------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCC
Q 047629 465 DSRFKAKIANFSLAAPATN------------------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENG 514 (615)
Q Consensus 465 d~~~~~kl~DFGla~~~~~------------------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~ 514 (615)
+.++.+||+|||+++.... .++.++|||||||++|||++|+.||......
T Consensus 240 ~~~~~~kL~DFG~a~~~~~~~~~~~g~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~ 319 (377)
T 3byv_A 240 DQRGGVFLTGFEHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAAL 319 (377)
T ss_dssp CTTCCEEECCGGGCEETTCEEECCCCTTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred cCCCCEEEEechhheecCCcccCCCCcCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccc
Confidence 9999999999999864321 3667899999999999999999998643311
Q ss_pred hhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 515 KTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 515 ~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.. ...... .. ..+ ...+.+|+.+||+.||++||++.|+++.
T Consensus 320 ~~--------------------~~~~~~-~~-~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 320 GG--------------------SEWIFR-SC-KNI----PQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp CC--------------------SGGGGS-SC-CCC----CHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred cc--------------------hhhhhh-hc-cCC----CHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 10 111111 00 122 3457899999999999999999999974
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-32 Score=282.70 Aligned_cols=218 Identities=19% Similarity=0.352 Sum_probs=169.8
Q ss_pred cccccccccc----ceEEEEEE--CCeEEEEEEcc------HHHHHHHHHHHhc-CCCCcccEEEEEEcC-----CCcEE
Q 047629 333 MNLSEHYSIG----KSVYRATI--DGKVLAVKKIK------EDVTEELRILQRI-NHANLVKLMGVSSDS-----QGNRF 394 (615)
Q Consensus 333 ~~~~~~~~iG----~~Vy~~~~--~g~~vAvK~~~------~~~~~Ei~~l~~l-~H~niv~l~g~~~~~-----~~~~~ 394 (615)
..|.....+| |.||+|.. +|+.||||.+. ..+.+|+.++.++ +|+||+++++++... ++..+
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~ 103 (326)
T 2x7f_A 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 103 (326)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEE
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEE
Confidence 3444444444 58999998 78999999985 4688999999999 899999999998753 34689
Q ss_pred EEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEee
Q 047629 395 LVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIAN 474 (615)
Q Consensus 395 lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~D 474 (615)
+||||+++|+|.+++..... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 104 lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~D 172 (326)
T 2x7f_A 104 LVMEFCGAGSVTDLIKNTKG--------NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVD 172 (326)
T ss_dssp EEEECCTTEEHHHHHHHSGG--------GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECC
T ss_pred EEEEcCCCCcHHHHHHhccc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEee
Confidence 99999999999999976432 13899999999999999999999998 99999999999999999999999
Q ss_pred cCCCCCCC----------------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHH
Q 047629 475 FSLAAPAT----------------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREV 526 (615)
Q Consensus 475 FGla~~~~----------------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 526 (615)
||++.... ..++.++||||||+++|||++|+.|+........ ..
T Consensus 173 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~-- 244 (326)
T 2x7f_A 173 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA------LF-- 244 (326)
T ss_dssp CTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HH--
T ss_pred CcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH------HH--
Confidence 99986431 1245689999999999999999999865432110 00
Q ss_pred HhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 527 LKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 527 ~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.+.....+.+. +......+.+++.+||+.||.+||++.|+++.
T Consensus 245 ---------~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 245 ---------LIPRNPAPRLK---SKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp ---------HHHHSCCCCCS---CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ---------HhhcCccccCC---ccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 01111112221 12223467899999999999999999999984
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=280.85 Aligned_cols=221 Identities=26% Similarity=0.339 Sum_probs=163.8
Q ss_pred ceEEEEEE--CCeEEEEEEccH------------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHh
Q 047629 343 KSVYRATI--DGKVLAVKKIKE------------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKW 408 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~------------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~ 408 (615)
|.||++.. +|+.||||+++. .+.+|++++++++|+||+++++++.+. +..++||||+++ +|.++
T Consensus 24 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~-~l~~~ 101 (346)
T 1ua2_A 24 ATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK-SNISLVFDFMET-DLEVI 101 (346)
T ss_dssp EEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT-TCCEEEEECCSE-EHHHH
T ss_pred EEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC-CceEEEEEcCCC-CHHHH
Confidence 48999997 589999999852 467899999999999999999998654 478999999985 89999
Q ss_pred hccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC-----
Q 047629 409 LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN----- 483 (615)
Q Consensus 409 L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~----- 483 (615)
+..... .+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~ 169 (346)
T 1ua2_A 102 IKDNSL---------VLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY 169 (346)
T ss_dssp HTTCCS---------SCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCC
T ss_pred HHhcCc---------CCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceeccCCcccC
Confidence 876542 3888999999999999999999998 99999999999999999999999999865311
Q ss_pred -------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHh------
Q 047629 484 -------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLR------ 538 (615)
Q Consensus 484 -------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~------ 538 (615)
.++.++|||||||++|||++|+.|+......+. ...+....... ......
T Consensus 170 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~---~~~i~~~~~~~--~~~~~~~~~~~~ 244 (346)
T 1ua2_A 170 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---LTRIFETLGTP--TEEQWPDMCSLP 244 (346)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCC--CTTTSSSTTSST
T ss_pred CcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHHcCCC--ChhhhhhhccCc
Confidence 134578999999999999999999875442111 11111110000 000000
Q ss_pred hhcCCcCCCCCC-----hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047629 539 NWMDPNLESFYP-----IDGALSLATLARACTMDKSLSRPNMAEVVFNL 582 (615)
Q Consensus 539 ~~~dp~l~~~~~-----~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L 582 (615)
+.+........+ ......+.+|+.+|++.||.+|||+.|++++-
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 245 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred ccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 000000000011 12335689999999999999999999999864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=273.30 Aligned_cols=207 Identities=22% Similarity=0.310 Sum_probs=164.8
Q ss_pred ceEEEEEE--CCeEEEEEEcc----------------HHHHHHHHHHHhcC-CCCcccEEEEEEcCCCcEEEEEeecCCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK----------------EDVTEELRILQRIN-HANLVKLMGVSSDSQGNRFLVYEYAENG 403 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~----------------~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~~lV~E~~~~G 403 (615)
|.||++.. +|+.||||.++ +.+.+|+++++++. ||||+++++++.+. +..++||||+++|
T Consensus 31 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~-~~~~lv~e~~~~~ 109 (298)
T 1phk_A 31 SVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN-TFFFLVFDLMKKG 109 (298)
T ss_dssp EEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS-SEEEEEEECCTTC
T ss_pred eEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccC-CeEEEEEeccCCC
Confidence 58999998 68999999873 24668999999995 99999999998754 4799999999999
Q ss_pred CHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-
Q 047629 404 SLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT- 482 (615)
Q Consensus 404 sL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~- 482 (615)
+|.+++.... .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++....
T Consensus 110 ~L~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 176 (298)
T 1phk_A 110 ELFDYLTEKV----------TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 176 (298)
T ss_dssp BHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred cHHHHHhccC----------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccchhhcCC
Confidence 9999997643 3899999999999999999999998 9999999999999999999999999985431
Q ss_pred ---------------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHH
Q 047629 483 ---------------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREE 535 (615)
Q Consensus 483 ---------------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 535 (615)
..++.++||||||+++|||++|+.|+...... .... ..
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~---~~--------- 241 (298)
T 1phk_A 177 GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM---LMLR---MI--------- 241 (298)
T ss_dssp TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HH---------
T ss_pred CcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH---HHHH---HH---------
Confidence 12456899999999999999999998654321 1110 00
Q ss_pred HHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 536 RLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 536 ~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
..... .............+.+++.+||+.||.+|||+.|+++.
T Consensus 242 -~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 242 -MSGNY--QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp -HHTCC--CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred -hcCCc--ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 01101 11111112344568999999999999999999999864
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-31 Score=273.95 Aligned_cols=207 Identities=23% Similarity=0.392 Sum_probs=167.0
Q ss_pred ceEEEEEE--CCeEEEEEEcc-----HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK-----EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKS 415 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-----~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~ 415 (615)
|.||+|.. +|+.||||.+. ..+.+|+.++.+++|+||+++++++.+. +..++||||+++|+|.+++.....
T Consensus 43 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~- 120 (314)
T 3com_A 43 GSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKN-TDLWIVMEYCGAGSVSDIIRLRNK- 120 (314)
T ss_dssp CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEEEECCTTEEHHHHHHHHTC-
T ss_pred eEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC-CEEEEEeecCCCCCHHHHHHhcCC-
Confidence 58999998 58999999985 4688999999999999999999998754 478999999999999999974322
Q ss_pred CCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------------
Q 047629 416 SSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------------- 482 (615)
Q Consensus 416 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------------- 482 (615)
.+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++....
T Consensus 121 --------~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 189 (314)
T 3com_A 121 --------TLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTP 189 (314)
T ss_dssp --------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCCCCSCG
T ss_pred --------CCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCccCCCC
Confidence 3899999999999999999999998 9999999999999999999999999985431
Q ss_pred ----------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChH
Q 047629 483 ----------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPID 552 (615)
Q Consensus 483 ----------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~ 552 (615)
..++.++||||||+++|||++|+.||........ .. .+.....+.. ..+..
T Consensus 190 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~-----------~~~~~~~~~~--~~~~~ 250 (314)
T 3com_A 190 FWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA------IF-----------MIPTNPPPTF--RKPEL 250 (314)
T ss_dssp GGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HH-----------HHHHSCCCCC--SSGGG
T ss_pred CccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH------HH-----------HHhcCCCccc--CCccc
Confidence 1246689999999999999999999975432110 00 0111111111 11223
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 553 GALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 553 ~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
....+.+++..||+.||.+|||+.|+++.
T Consensus 251 ~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 251 WSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp SCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 34568899999999999999999999874
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-32 Score=285.64 Aligned_cols=218 Identities=23% Similarity=0.307 Sum_probs=170.7
Q ss_pred ccccccccc----ceEEEEEE-----CCeEEEEEEcc-----------HHHHHHHHHHHhc-CCCCcccEEEEEEcCCCc
Q 047629 334 NLSEHYSIG----KSVYRATI-----DGKVLAVKKIK-----------EDVTEELRILQRI-NHANLVKLMGVSSDSQGN 392 (615)
Q Consensus 334 ~~~~~~~iG----~~Vy~~~~-----~g~~vAvK~~~-----------~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 392 (615)
+|.....+| |.||++.. +|+.||||+++ +.+.+|+++|.++ +|+||+++++++... +.
T Consensus 55 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~~ 133 (355)
T 1vzo_A 55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-TK 133 (355)
T ss_dssp GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-TE
T ss_pred ceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC-ce
Confidence 344444454 58999987 68999999875 2356799999999 799999999998754 47
Q ss_pred EEEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEE
Q 047629 393 RFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKI 472 (615)
Q Consensus 393 ~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl 472 (615)
.++||||+++|+|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl 200 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRE----------RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVL 200 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHS----------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEE
T ss_pred EEEEeecCCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEE
Confidence 899999999999999997643 2899999999999999999999998 999999999999999999999
Q ss_pred eecCCCCCCC--------------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHH
Q 047629 473 ANFSLAAPAT--------------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREV 526 (615)
Q Consensus 473 ~DFGla~~~~--------------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 526 (615)
+|||+++... ..++.++|||||||++|||++|+.||............ ..
T Consensus 201 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~--~~-- 276 (355)
T 1vzo_A 201 TDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--SR-- 276 (355)
T ss_dssp SCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH--HH--
T ss_pred eeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHH--HH--
Confidence 9999885321 11456899999999999999999999754432221110 00
Q ss_pred HhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHH
Q 047629 527 LKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRP-----NMAEVVFNLS 583 (615)
Q Consensus 527 ~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RP-----sm~ev~~~L~ 583 (615)
.+.. ..+ .++.+....+.+|+.+||+.||.+|| +++|+++...
T Consensus 277 ---------~~~~-~~~----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 277 ---------RILK-SEP----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp ---------HHHH-CCC----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred ---------HHhc-cCC----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence 0110 112 23334445678999999999999999 9999988653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-32 Score=281.16 Aligned_cols=222 Identities=20% Similarity=0.345 Sum_probs=165.0
Q ss_pred ceEEEEEE--CCeEEEEEEccHH--------HHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATI--DGKVLAVKKIKED--------VTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~~--------~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
|.||+|.. +|+.||||+++.. +.+|++++++++|+||+++++++.+. +..++||||++ |+|.+++...
T Consensus 16 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~-~~l~~~~~~~ 93 (324)
T 3mtl_A 16 ATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE-KSLTLVFEYLD-KDLKQYLDDC 93 (324)
T ss_dssp EEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECS-SCEEEEEECCS-EEHHHHHHHT
T ss_pred EEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeC-CEEEEEecccc-cCHHHHHHhc
Confidence 58999998 6899999988632 34699999999999999999998754 47999999997 6999999765
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC----------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT---------- 482 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~---------- 482 (615)
.. .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 94 ~~---------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 161 (324)
T 3mtl_A 94 GN---------IINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEV 161 (324)
T ss_dssp TT---------CCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----------
T ss_pred CC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcccccccc
Confidence 43 3899999999999999999999998 9999999999999999999999999875321
Q ss_pred --------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHH-------HHHHHHhhhc
Q 047629 483 --------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEE-------KREERLRNWM 541 (615)
Q Consensus 483 --------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~-------~~~~~~~~~~ 541 (615)
..++.++|||||||++|||++|+.||......+.. ..+...+.... ..........
T Consensus 162 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (324)
T 3mtl_A 162 VTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQL---HFIFRILGTPTEETWPGILSNEEFKTYN 238 (324)
T ss_dssp -CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCTTTSTTGGGCHHHHHTC
T ss_pred CcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCChHhchhhhcchhhcccc
Confidence 22567899999999999999999999765422211 11111110000 0000000000
Q ss_pred CCcCCCC----CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 542 DPNLESF----YPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 542 dp~l~~~----~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.+..... ........+.+|+.+|++.||.+|||++|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 239 YPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp CCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 1110000 001223457899999999999999999999985
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=281.03 Aligned_cols=203 Identities=22% Similarity=0.350 Sum_probs=165.1
Q ss_pred ceEEEEEE--CCeEEEEEEcc----------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIK----------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~----------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||++.. +++.+|+|.+. +.+.+|+.++++++|+||+++++++.+. +..++||||+++++|.+++.
T Consensus 55 g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~ 133 (335)
T 2owb_A 55 AKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN-DFVFVVLELCRRRSLLELHK 133 (335)
T ss_dssp EEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEEEECCCTTCBHHHHHH
T ss_pred eEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-CeEEEEEecCCCCCHHHHHh
Confidence 48999998 57899999874 2467899999999999999999998764 47899999999999999987
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
... .+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 134 ~~~----------~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 200 (335)
T 2owb_A 134 RRK----------ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV 200 (335)
T ss_dssp HHC----------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred ccC----------CCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccCcccccc
Confidence 643 3899999999999999999999998 9999999999999999999999999986432
Q ss_pred ---------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCC
Q 047629 483 ---------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLES 547 (615)
Q Consensus 483 ---------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~ 547 (615)
...+.++||||||+++|||++|+.||......+ .+ .. +.. ....+
T Consensus 201 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~---~~-----------~~~-~~~~~-- 260 (335)
T 2owb_A 201 LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---TY---LR-----------IKK-NEYSI-- 260 (335)
T ss_dssp CCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH---HH-----------HHH-TCCCC--
T ss_pred cCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH---HH---HH-----------Hhc-CCCCC--
Confidence 114568999999999999999999997543211 00 00 000 01112
Q ss_pred CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 548 FYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 548 ~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
+......+.+++.+||+.||++||++.|+++.
T Consensus 261 --~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 261 --PKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred --CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 22333457899999999999999999999985
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.97 E-value=7.7e-32 Score=275.11 Aligned_cols=209 Identities=17% Similarity=0.310 Sum_probs=154.3
Q ss_pred ceEEEEEE--CCeEEEEEEccHH---------HHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIKED---------VTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~~---------~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
|.||++.. +|+.||||+++.. +.++...++.++||||+++++++.+. +..++||||++ |+|.+++..
T Consensus 21 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~-~~~~lv~e~~~-~~l~~~l~~ 98 (290)
T 3fme_A 21 GVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE-GDVWICMELMD-TSLDKFYKQ 98 (290)
T ss_dssp EEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SSEEEEEECCS-EEHHHHHHH
T ss_pred eEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc-CCEEEEEehhc-cchHHHHHH
Confidence 58999998 7999999998632 23444557788999999999998864 47999999997 588888764
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEH-AQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
..... ..+++..+..++.|++.||.|||++ + |+||||||+|||++.++.+||+|||+++...
T Consensus 99 ~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 169 (290)
T 3fme_A 99 VIDKG------QTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID 169 (290)
T ss_dssp HHHTT------CCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC---------------
T ss_pred HHhcC------CCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccccccccccc
Confidence 21100 1389999999999999999999997 7 9999999999999999999999999985421
Q ss_pred ------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCc
Q 047629 483 ------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPN 544 (615)
Q Consensus 483 ------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~ 544 (615)
..++.++||||||+++|||++|+.|+........ .+.. .... ..+.
T Consensus 170 ~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~----------~~~~-~~~~ 233 (290)
T 3fme_A 170 AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-----QLKQ----------VVEE-PSPQ 233 (290)
T ss_dssp CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-----HHHH----------HHHS-CCCC
T ss_pred CCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-----HHHH----------Hhcc-CCCC
Confidence 1245688999999999999999999975332111 0110 1111 1111
Q ss_pred CCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 545 LESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 545 l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
. .+......+.+++.+||+.||++|||+.|++++
T Consensus 234 ~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 234 L---PADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp C---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred c---ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 1 112334568899999999999999999999874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-31 Score=272.21 Aligned_cols=207 Identities=23% Similarity=0.385 Sum_probs=163.7
Q ss_pred ceEEEEEE--CCeEEEEEEcc------HHHHHHHHHHHhcCCCCcccEEEEEEcC------------CCcEEEEEeecCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK------EDVTEELRILQRINHANLVKLMGVSSDS------------QGNRFLVYEYAEN 402 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~------~~~~~Ei~~l~~l~H~niv~l~g~~~~~------------~~~~~lV~E~~~~ 402 (615)
|.||+|.. +|+.||||+++ ..+.+|+.++++++||||+++++++.+. .+..++||||+++
T Consensus 20 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~ 99 (303)
T 1zy4_A 20 GQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCEN 99 (303)
T ss_dssp EEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCS
T ss_pred EEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCC
Confidence 58999997 78999999985 3477899999999999999999987642 2357999999999
Q ss_pred CCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC
Q 047629 403 GSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT 482 (615)
Q Consensus 403 GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~ 482 (615)
|+|.+++..... .+++..++.++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++...
T Consensus 100 ~~L~~~l~~~~~---------~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 167 (303)
T 1zy4_A 100 GTLYDLIHSENL---------NQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVH 167 (303)
T ss_dssp CBHHHHHHHSCG---------GGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCCCSCTT
T ss_pred CCHHHhhhcccc---------ccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEeeCcchhhcc
Confidence 999999976432 3889999999999999999999998 9999999999999999999999999986431
Q ss_pred --------------------------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHH
Q 047629 483 --------------------------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIR 524 (615)
Q Consensus 483 --------------------------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~ 524 (615)
..++.++||||||+++|||++ |+....+ ... .
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~--~~~----~- 237 (303)
T 1zy4_A 168 RSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME--RVN----I- 237 (303)
T ss_dssp C-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH--HHH----H-
T ss_pred cccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh--HHH----H-
Confidence 124568999999999999998 4332110 000 0
Q ss_pred HHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 525 EVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 525 ~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
...+.. ....+...++......+.+++.+||+.||.+|||+.|+++.
T Consensus 238 ---------~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 238 ---------LKKLRS-VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp ---------HHHHHS-TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ---------HHhccc-cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 001111 12223334455555678999999999999999999999985
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-31 Score=279.96 Aligned_cols=242 Identities=19% Similarity=0.252 Sum_probs=177.4
Q ss_pred eHHHHHHHccccccccccc----ceEEEEEE-CCeEEEEEEcc------------------HHHHHHHHHHHhcCCCCcc
Q 047629 324 EIEVIMESTMNLSEHYSIG----KSVYRATI-DGKVLAVKKIK------------------EDVTEELRILQRINHANLV 380 (615)
Q Consensus 324 ~~~~l~~at~~~~~~~~iG----~~Vy~~~~-~g~~vAvK~~~------------------~~~~~Ei~~l~~l~H~niv 380 (615)
..+++......|.....+| |.||+|.. +|+.||||++. +.+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 3466777777777777776 58999987 78999999873 4578999999999999999
Q ss_pred cEEEEEEcCC----CcEEEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecC
Q 047629 381 KLMGVSSDSQ----GNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRD 456 (615)
Q Consensus 381 ~l~g~~~~~~----~~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrD 456 (615)
++++++...+ ...++||||++ |+|.+++..... .+++..+..++.|++.||.|||+++ |+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~D 159 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRI---------VISPQHIQYFMYHILLGLHVLHEAG---VVHRD 159 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTS---------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhccc---------CCCHHHHHHHHHHHHHHHHHHHHCc---CEecC
Confidence 9999885422 24799999998 689998875442 3899999999999999999999998 99999
Q ss_pred CCCCceeeCCCCcEEEeecCCCCCCC-----------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCC
Q 047629 457 IRTNNIQLDSRFKAKIANFSLAAPAT-----------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTEN 513 (615)
Q Consensus 457 lk~~NILld~~~~~kl~DFGla~~~~-----------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~ 513 (615)
|||+|||++.++.+||+|||+++... ..++.++|||||||++|||++|+.||.....
T Consensus 160 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 239 (362)
T 3pg1_A 160 LHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF 239 (362)
T ss_dssp CCGGGEEECTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred CChHHEEEcCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 99999999999999999999985321 2356789999999999999999999976442
Q ss_pred ChhHHHHHHHHHHHhHHHHH------HHHHhhhcCCcCCC-------CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047629 514 GKTAVLWKEIREVLKVEEKR------EERLRNWMDPNLES-------FYPIDGALSLATLARACTMDKSLSRPNMAEVVF 580 (615)
Q Consensus 514 ~~~~~l~~~~~~~~~~~~~~------~~~~~~~~dp~l~~-------~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~ 580 (615)
.+. ...+.......... .....+.+...+.. .........+.+|+..|++.||.+|||+.|+++
T Consensus 240 ~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 240 YNQ---LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHH---HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHH---HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 111 11111111000000 00111111111110 011122345889999999999999999999998
Q ss_pred H
Q 047629 581 N 581 (615)
Q Consensus 581 ~ 581 (615)
+
T Consensus 317 h 317 (362)
T 3pg1_A 317 H 317 (362)
T ss_dssp S
T ss_pred C
Confidence 5
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-31 Score=273.96 Aligned_cols=209 Identities=18% Similarity=0.308 Sum_probs=166.5
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||++.. +|+.||||.++ ..+.+|+.++.++ +|+||+++++++.+. +..++||||+++|+|.+++.
T Consensus 43 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~ 121 (327)
T 3lm5_A 43 AVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT-SEIILILEYAAGGEIFSLCL 121 (327)
T ss_dssp EEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEEEEEEECCTTEEGGGGGS
T ss_pred eEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC-CeEEEEEEecCCCcHHHHHH
Confidence 58999988 58999999885 3578899999999 569999999998754 47999999999999999996
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCC---CCcEEEeecCCCCCCC-----
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDS---RFKAKIANFSLAAPAT----- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~---~~~~kl~DFGla~~~~----- 482 (615)
..... .+++.+++.++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+++...
T Consensus 122 ~~~~~--------~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~ 190 (327)
T 3lm5_A 122 PELAE--------MVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL 190 (327)
T ss_dssp SCC-C--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC------
T ss_pred Hhccc--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCccccccCCcccc
Confidence 54321 3899999999999999999999998 999999999999998 7899999999986432
Q ss_pred -----------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcC
Q 047629 483 -----------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNL 545 (615)
Q Consensus 483 -----------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l 545 (615)
..++.++||||||+++|||++|+.||......+. . . .+.. .....
T Consensus 191 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~---~-----------~i~~-~~~~~ 252 (327)
T 3lm5_A 191 REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET---Y---L-----------NISQ-VNVDY 252 (327)
T ss_dssp ---CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H---H-----------HHHH-TCCCC
T ss_pred ccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH---H---H-----------HHHh-ccccc
Confidence 2246789999999999999999999976442111 0 0 0010 11111
Q ss_pred CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 546 ESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 546 ~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
...........+.+++.+||+.||.+|||+.|+++.
T Consensus 253 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 253 SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 112223344568899999999999999999999875
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=280.20 Aligned_cols=230 Identities=21% Similarity=0.335 Sum_probs=164.8
Q ss_pred ccccccccc----ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEe
Q 047629 334 NLSEHYSIG----KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYE 398 (615)
Q Consensus 334 ~~~~~~~iG----~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E 398 (615)
+|.....+| |.||++.. +|+.||||+++ ..+.+|++++++++|+||+++++++.+. ...++|||
T Consensus 35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e 113 (329)
T 3gbz_A 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN-HRLHLIFE 113 (329)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEET-TEEEEEEE
T ss_pred hEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecC-CEEEEEEe
Confidence 344444554 58999986 78999999985 2356899999999999999999998764 47999999
Q ss_pred ecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceee-----CCCCcEEEe
Q 047629 399 YAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQL-----DSRFKAKIA 473 (615)
Q Consensus 399 ~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl-----d~~~~~kl~ 473 (615)
|++ |+|.+++..... +++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+
T Consensus 114 ~~~-~~L~~~~~~~~~----------~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~ 179 (329)
T 3gbz_A 114 YAE-NDLKKYMDKNPD----------VSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIG 179 (329)
T ss_dssp CCS-EEHHHHHHHCTT----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEEC
T ss_pred cCC-CCHHHHHhhcCC----------CCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEEC
Confidence 998 599999976542 899999999999999999999998 9999999999999 455669999
Q ss_pred ecCCCCCCC------------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhH
Q 047629 474 NFSLAAPAT------------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKV 529 (615)
Q Consensus 474 DFGla~~~~------------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~ 529 (615)
|||+++... ..++.++|||||||++|||++|+.||......+. +.. +......
T Consensus 180 Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~-~~~~~~~ 256 (329)
T 3gbz_A 180 DFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ--LFK-IFEVLGL 256 (329)
T ss_dssp CTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHH-HHHHHCC
T ss_pred cCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH--HHH-HHHHhCC
Confidence 999874311 1257789999999999999999999976442111 111 1111000
Q ss_pred HHHH----HHHHhhhcC--CcCCCC-----CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 530 EEKR----EERLRNWMD--PNLESF-----YPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 530 ~~~~----~~~~~~~~d--p~l~~~-----~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.... ......+.+ +..... .+......+.+|+.+||+.||++|||+.|++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 257 PDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp CCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 0000 000000000 000000 001123567899999999999999999999864
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-31 Score=273.58 Aligned_cols=207 Identities=23% Similarity=0.347 Sum_probs=166.0
Q ss_pred ceEEEEEE--CCeEEEEEEcc-------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
|.||++.. +|+.||+|.++ ..+.+|++++++++||||+++++++.+. +..++||||+++|+|.+++....
T Consensus 23 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~ 101 (304)
T 2jam_A 23 SEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYEST-THYYLVMQLVSGGELFDRILERG 101 (304)
T ss_dssp EEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEECCCCSCBHHHHHHHHS
T ss_pred ceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccC-CEEEEEEEcCCCccHHHHHHHcC
Confidence 58999997 68999999985 2477899999999999999999998754 47899999999999999997543
Q ss_pred CCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceee---CCCCcEEEeecCCCCCCCC-------
Q 047629 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQL---DSRFKAKIANFSLAAPATN------- 483 (615)
Q Consensus 414 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl---d~~~~~kl~DFGla~~~~~------- 483 (615)
.+++..+..++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||+++....
T Consensus 102 ----------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 168 (304)
T 2jam_A 102 ----------VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTAC 168 (304)
T ss_dssp ----------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTTHHHH
T ss_pred ----------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCcccccc
Confidence 2899999999999999999999998 9999999999999 7889999999999865422
Q ss_pred --------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCC
Q 047629 484 --------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFY 549 (615)
Q Consensus 484 --------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~ 549 (615)
.++.++||||||+++|||++|+.||...... .+...+ ..... ......
T Consensus 169 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i-------------~~~~~--~~~~~~ 230 (304)
T 2jam_A 169 GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES---KLFEKI-------------KEGYY--EFESPF 230 (304)
T ss_dssp SCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHH-------------HHCCC--CCCTTT
T ss_pred CCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHH-------------HcCCC--CCCccc
Confidence 2456899999999999999999999754321 111100 00111 111122
Q ss_pred ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 550 PIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 550 ~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
..+....+.+++..|++.||++||++.|+++.
T Consensus 231 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 231 WDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 23344568999999999999999999999985
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-31 Score=272.61 Aligned_cols=207 Identities=22% Similarity=0.381 Sum_probs=165.6
Q ss_pred ceEEEEEE--CCeEEEEEEcc-------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
|.||+|.. +|+.||+|.+. ..+.+|++++++++||||+++++++.+. +..++||||+++|+|.+++....
T Consensus 33 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~l~~~~~~~~ 111 (302)
T 2j7t_A 33 GKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHD-GKLWIMIEFCPGGAVDAIMLELD 111 (302)
T ss_dssp CCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC--CEEEEEECCTTEEHHHHHHHHT
T ss_pred eEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC-CeEEEEEEeCCCCcHHHHHHhhc
Confidence 58999998 58999999885 3577899999999999999999998764 47999999999999999987543
Q ss_pred CCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCC------------
Q 047629 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA------------ 481 (615)
Q Consensus 414 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~------------ 481 (615)
. .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++...
T Consensus 112 ~---------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 179 (302)
T 2j7t_A 112 R---------GLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIG 179 (302)
T ss_dssp S---------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-----C
T ss_pred c---------CCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccccccccccC
Confidence 2 3899999999999999999999998 999999999999999999999999985210
Q ss_pred ----------------CCCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcC
Q 047629 482 ----------------TNDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNL 545 (615)
Q Consensus 482 ----------------~~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l 545 (615)
...++.++||||||+++|||++|+.|+........ ... +.....+.+
T Consensus 180 ~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~-----------~~~~~~~~~ 242 (302)
T 2j7t_A 180 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLK-----------IAKSDPPTL 242 (302)
T ss_dssp CGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHH-----------HHHSCCCCC
T ss_pred ChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH------HHH-----------HhccCCccc
Confidence 12356789999999999999999999875432110 000 111111111
Q ss_pred CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 546 ESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 546 ~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
..+......+.+++..||+.||.+|||+.|+++.
T Consensus 243 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 243 --LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp --SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred --CCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 1223344568999999999999999999999874
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-32 Score=278.56 Aligned_cols=220 Identities=21% Similarity=0.298 Sum_probs=157.5
Q ss_pred ceEEEEEE--CCeEEEEEEccH--------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATI--DGKVLAVKKIKE--------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~--------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
|.||++.. +|+.||||++.. .+.+|+.++++++||||+++++++... +..++||||+++|+|.+++...
T Consensus 29 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~ 107 (303)
T 2vwi_A 29 AVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK-DELWLVMKLLSGGSVLDIIKHI 107 (303)
T ss_dssp CCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESS-SCEEEEEECCTTCBHHHHHHHH
T ss_pred eEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeec-CCcEEEehhccCCchHHHHHHH
Confidence 48999986 789999998852 366899999999999999999998765 4799999999999999998641
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC----------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT---------- 482 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~---------- 482 (615)
..... .....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++...
T Consensus 108 ~~~~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 182 (303)
T 2vwi_A 108 VAKGE--HKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKV 182 (303)
T ss_dssp HHTTT--TTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHHHCC----------
T ss_pred hhccc--cccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhh
Confidence 10000 00013899999999999999999999998 9999999999999999999999999864321
Q ss_pred -------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHH-hhhcC
Q 047629 483 -------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERL-RNWMD 542 (615)
Q Consensus 483 -------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~-~~~~d 542 (615)
..++.++||||||+++|||++|+.||.......... ...... .... ....+
T Consensus 183 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~~~~~~---~~~~~~~~~~ 253 (303)
T 2vwi_A 183 RKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM------LTLQND---PPSLETGVQD 253 (303)
T ss_dssp -----CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH------HHHTSS---CCCTTC----
T ss_pred hcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH------HHhccC---CCcccccccc
Confidence 124678999999999999999999997654322110 000000 0000 00011
Q ss_pred CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 543 PNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 543 p~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
+.+.. .....+.+++.+||+.||.+||++.|+++.
T Consensus 254 ~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 254 KEMLK----KYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp -CCCC----CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred chhhh----hhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 11112 233457899999999999999999999874
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-31 Score=281.03 Aligned_cols=220 Identities=21% Similarity=0.356 Sum_probs=165.4
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCC-----CcEEEEEeecCCCCHH
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQ-----GNRFLVYEYAENGSLD 406 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~~lV~E~~~~GsL~ 406 (615)
|.||+|.. +|+.||||++. +.+.+|+++|++++|+||+++++++...+ ...++||||+ +++|.
T Consensus 39 g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~ 117 (367)
T 1cm8_A 39 GAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLG 117 (367)
T ss_dssp -CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHH
T ss_pred eEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHH
Confidence 58999997 68999999983 34678999999999999999999986432 2369999999 78999
Q ss_pred HhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC----
Q 047629 407 KWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT---- 482 (615)
Q Consensus 407 ~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~---- 482 (615)
+++... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 118 ~~~~~~-----------~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 183 (367)
T 1cm8_A 118 KLMKHE-----------KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT 183 (367)
T ss_dssp HHHHHC-----------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSSCC
T ss_pred HHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecccccccccC
Confidence 999753 2889999999999999999999998 9999999999999999999999999986431
Q ss_pred -----------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHH----------HHHHH
Q 047629 483 -----------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVE----------EKREE 535 (615)
Q Consensus 483 -----------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~----------~~~~~ 535 (615)
..++.++||||+||++|||++|+.||......+. ...+....... .....
T Consensus 184 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---l~~i~~~~g~~~~~~~~~~~~~~~~~ 260 (367)
T 1cm8_A 184 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ---LKEIMKVTGTPPAEFVQRLQSDEAKN 260 (367)
T ss_dssp SSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCHHHHHTCSCHHHHH
T ss_pred cCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCCHHHHHHhhhHHHHH
Confidence 2356789999999999999999999976542211 11111111000 00000
Q ss_pred HHhh---hcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 536 RLRN---WMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 536 ~~~~---~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.+.. .-...+. .........+.+|+.+|++.||.+|||+.|++++
T Consensus 261 ~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 261 YMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 0111 0011111 1122334568899999999999999999999985
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-31 Score=279.00 Aligned_cols=222 Identities=19% Similarity=0.288 Sum_probs=165.6
Q ss_pred ceEEEEEECCeEEEEEEcc------------------------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEe
Q 047629 343 KSVYRATIDGKVLAVKKIK------------------------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYE 398 (615)
Q Consensus 343 ~~Vy~~~~~g~~vAvK~~~------------------------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E 398 (615)
|.||++..+|+.||||.+. ..+.+|++++.+++||||+++++++.+. +..++|||
T Consensus 45 g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e 123 (348)
T 2pml_X 45 NKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNY-DEVYIIYE 123 (348)
T ss_dssp CCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEESS-SEEEEEEE
T ss_pred eEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEeeC-CeEEEEEe
Confidence 4899999999999999885 4578899999999999999999998764 47999999
Q ss_pred ecCCCCHHHh------hccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCceeeCCCCcEE
Q 047629 399 YAENGSLDKW------LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHE-HAQPSIVHRDIRTNNIQLDSRFKAK 471 (615)
Q Consensus 399 ~~~~GsL~~~------L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~NILld~~~~~k 471 (615)
|+++|+|.++ +..... ..+++..+..++.|++.||.|||+ ++ ++||||||+||+++.++.+|
T Consensus 124 ~~~~~~L~~~~~~~~~l~~~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~~~~~~~k 192 (348)
T 2pml_X 124 YMENDSILKFDEYFFVLDKNYT--------CFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILMDKNGRVK 192 (348)
T ss_dssp CCTTCBSSEESSSEESSCSSSC--------CCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEECTTSCEE
T ss_pred ccCCCcHHHHHHHhhhhhhccc--------cCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEEcCCCcEE
Confidence 9999999999 544211 148999999999999999999999 87 99999999999999999999
Q ss_pred EeecCCCCCCCC----------------------CCCC-cccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHh
Q 047629 472 IANFSLAAPATN----------------------DVMP-KFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLK 528 (615)
Q Consensus 472 l~DFGla~~~~~----------------------~~~~-k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~ 528 (615)
|+|||+++.... .++. ++||||||+++|||++|+.||........ ....+. .
T Consensus 193 l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~i~---~ 267 (348)
T 2pml_X 193 LSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE--LFNNIR---T 267 (348)
T ss_dssp ECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH--HHHHHT---S
T ss_pred EeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHh---c
Confidence 999999864311 1223 89999999999999999999976543211 111000 0
Q ss_pred HHHHHHHHHhhhcCCcC---CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 529 VEEKREERLRNWMDPNL---ESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 529 ~~~~~~~~~~~~~dp~l---~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
...........+..+.. ...........+.+++.+||+.||.+|||+.|++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 268 KNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp CCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00000000000000000 000012334568999999999999999999999885
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-31 Score=288.87 Aligned_cols=220 Identities=20% Similarity=0.307 Sum_probs=161.7
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCC-----CcEEEEEeecCCCCHH
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQ-----GNRFLVYEYAENGSLD 406 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~~lV~E~~~~GsL~ 406 (615)
|.||++.. +|+.||||++. +.+.+|+.+|++++||||+++++++...+ ...++||||+++ +|.
T Consensus 76 g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~ 154 (464)
T 3ttj_A 76 GIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLC 154 (464)
T ss_dssp CEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHH
T ss_pred eEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHH
Confidence 58999987 68999999985 24678999999999999999999986432 247999999976 577
Q ss_pred HhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC----
Q 047629 407 KWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT---- 482 (615)
Q Consensus 407 ~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~---- 482 (615)
+.+.. .+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 155 ~~~~~------------~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 219 (464)
T 3ttj_A 155 QVIQM------------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 219 (464)
T ss_dssp HHHTS------------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC-----CCC
T ss_pred HHHhh------------cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeeecCCCcc
Confidence 76643 2889999999999999999999998 9999999999999999999999999986532
Q ss_pred ------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHH-----HHHHHhh
Q 047629 483 ------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEK-----REERLRN 539 (615)
Q Consensus 483 ------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~-----~~~~~~~ 539 (615)
..++.++|||||||++|||++|+.||...... ..+..+...+..... .......
T Consensus 220 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~---~~~~~i~~~lg~p~~~~~~~~~~~~~~ 296 (464)
T 3ttj_A 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI---DQWNKVIEQLGTPCPEFMKKLQPTVRN 296 (464)
T ss_dssp C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCSCCHHHHTTSCHHHHH
T ss_pred cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCCHHHHHHcchhhhh
Confidence 12567899999999999999999999764421 122222221110000 0001111
Q ss_pred hcCCc--CCC-----CCC-----------hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 540 WMDPN--LES-----FYP-----------IDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 540 ~~dp~--l~~-----~~~-----------~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.++.. ... .++ ......+.+|+.+|++.||++|||++|++++
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 297 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11110 000 000 1124568999999999999999999999985
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.2e-32 Score=286.76 Aligned_cols=202 Identities=22% Similarity=0.277 Sum_probs=155.8
Q ss_pred ceEEEEEE--CCeEEEEEEccHH----------HHHHHHH-HHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATI--DGKVLAVKKIKED----------VTEELRI-LQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~~----------~~~Ei~~-l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
|.||++.. +|+.||||++++. +..|..+ ++.++||||+++++++.+. +..++||||+++|+|.+++
T Consensus 52 g~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~-~~~~lv~E~~~gg~L~~~l 130 (373)
T 2r5t_A 52 GKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA-DKLYFVLDYINGGELFYHL 130 (373)
T ss_dssp CEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECS-SEEEEEEECCCSCBHHHHH
T ss_pred eEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC-CEEEEEEeCCCCCcHHHHH
Confidence 58999998 6889999998632 3456665 4668999999999998764 4799999999999999999
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------- 482 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------- 482 (615)
.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 131 ~~~~----------~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~~~ 197 (373)
T 2r5t_A 131 QRER----------CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTS 197 (373)
T ss_dssp HHHS----------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCCCC
T ss_pred HhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccCCCccc
Confidence 7643 2889999999999999999999998 9999999999999999999999999986421
Q ss_pred ----------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCC
Q 047629 483 ----------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLE 546 (615)
Q Consensus 483 ----------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~ 546 (615)
..++.++|||||||++|||++|+.||..... ..... .. +.. ..
T Consensus 198 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---~~~~~---~i----------~~~--~~--- 256 (373)
T 2r5t_A 198 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT---AEMYD---NI----------LNK--PL--- 256 (373)
T ss_dssp SBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH---HHHHH---HH----------HHS--CC---
T ss_pred cccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH---HHHHH---HH----------Hhc--cc---
Confidence 1245789999999999999999999975432 11111 00 111 11
Q ss_pred CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047629 547 SFYPIDGALSLATLARACTMDKSLSRPNMAEVVF 580 (615)
Q Consensus 547 ~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~ 580 (615)
.++......+.+|+..|++.||.+||++.+.++
T Consensus 257 -~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~ 289 (373)
T 2r5t_A 257 -QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFM 289 (373)
T ss_dssp -CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHH
T ss_pred -CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHH
Confidence 122333456789999999999999999854333
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-31 Score=288.34 Aligned_cols=148 Identities=26% Similarity=0.478 Sum_probs=126.4
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCC----CcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQ----GNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~~lV~E~~~~GsL~~ 407 (615)
|.||++.. +|+.||||++. +.+.+|+++|++++|+||+++++++...+ ...++||||+. |+|.+
T Consensus 67 g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~ 145 (458)
T 3rp9_A 67 GHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKK 145 (458)
T ss_dssp -CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCCS-EEHHH
T ss_pred eEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEeccc-cchhh
Confidence 58999986 68999999885 34678999999999999999999985332 35899999984 79999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----- 482 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----- 482 (615)
++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 146 ~~~~~~----------~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 212 (458)
T 3rp9_A 146 LFRTPV----------YLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENG 212 (458)
T ss_dssp HHHSSC----------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTC
T ss_pred hcccCC----------CCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhccCcccc
Confidence 997643 3899999999999999999999998 9999999999999999999999999996531
Q ss_pred ----------------------------------------------CCCCCcccchhHHHHHHHHHcC
Q 047629 483 ----------------------------------------------NDVMPKFDVFAFGVVLLELLSG 504 (615)
Q Consensus 483 ----------------------------------------------~~~~~k~DV~SfGvvl~ElltG 504 (615)
..++.++|||||||+||||++|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 213 NSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 1245689999999999999994
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=293.73 Aligned_cols=207 Identities=26% Similarity=0.310 Sum_probs=165.7
Q ss_pred ceEEEEEE--CCeEEEEEEcc----------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIK----------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~----------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||++.. +|+.||||++. ..+.+|+.++++++||||+++++++.+ ++..++||||+++|+|.+++.
T Consensus 40 g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~ 118 (484)
T 3nyv_A 40 GEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED-KGYFYLVGEVYTGGELFDEII 118 (484)
T ss_dssp EEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEECCCCSCBHHHHHH
T ss_pred EEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCEEEEEEecCCCCCHHHHHH
Confidence 58999997 68999999974 347899999999999999999999875 447999999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceee---CCCCcEEEeecCCCCCCC-----
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQL---DSRFKAKIANFSLAAPAT----- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl---d~~~~~kl~DFGla~~~~----- 482 (615)
... .+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 119 ~~~----------~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~ 185 (484)
T 3nyv_A 119 SRK----------RFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM 185 (484)
T ss_dssp TCS----------CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSH
T ss_pred hcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccccc
Confidence 654 2899999999999999999999998 9999999999999 467899999999885432
Q ss_pred ----------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCC
Q 047629 483 ----------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLE 546 (615)
Q Consensus 483 ----------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~ 546 (615)
..++.++||||+||++|||++|+.||......+ ... .. .........
T Consensus 186 ~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~---~i----------~~~~~~~~~- 248 (484)
T 3nyv_A 186 KDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYD---ILK---KV----------EKGKYTFEL- 248 (484)
T ss_dssp HHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HH----------HHCCCCCCS-
T ss_pred ccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH---HHH---HH----------HcCCCCCCC-
Confidence 135678999999999999999999997644211 111 00 000011100
Q ss_pred CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 547 SFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 547 ~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.........+.+|+..||+.||.+|||+.|++++
T Consensus 249 -~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 249 -PQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp -GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -cccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 1112334568899999999999999999999975
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-31 Score=290.60 Aligned_cols=207 Identities=25% Similarity=0.310 Sum_probs=164.6
Q ss_pred ceEEEEEE--CCeEEEEEEccH---------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE---------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~---------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
|.||++.. +|+.||||++.. .+.+|+++|++++||||+++++++.+. +..++||||+++|+|.+++..
T Consensus 36 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~ 114 (486)
T 3mwu_A 36 GEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS-SSFYIVGELYTGGELFDEIIK 114 (486)
T ss_dssp SEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEECCCCSCBHHHHHHH
T ss_pred EEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcC-CEEEEEEEcCCCCcHHHHHHh
Confidence 58999997 689999999852 467899999999999999999998764 479999999999999999876
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeC---CCCcEEEeecCCCCCCCC-----
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLD---SRFKAKIANFSLAAPATN----- 483 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld---~~~~~kl~DFGla~~~~~----- 483 (615)
.. .+++..+..++.|++.||.|||+++ |+||||||+|||++ .++.+||+|||+++....
T Consensus 115 ~~----------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 181 (486)
T 3mwu_A 115 RK----------RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK 181 (486)
T ss_dssp HS----------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----
T ss_pred cC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCccC
Confidence 43 2899999999999999999999998 99999999999995 456799999999864321
Q ss_pred ----------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCC
Q 047629 484 ----------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLES 547 (615)
Q Consensus 484 ----------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~ 547 (615)
.++.++||||+||++|||++|+.||......+ .. ... .........
T Consensus 182 ~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~---~~i----------~~~~~~~~~-- 243 (486)
T 3mwu_A 182 DRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYD---IL---KRV----------ETGKYAFDL-- 243 (486)
T ss_dssp CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHH----------HHTCCCSCS--
T ss_pred CCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH---HHH----------HhCCCCCCC--
Confidence 24568999999999999999999997543211 11 100 000011000
Q ss_pred CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 548 FYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 548 ~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.........+.+++..||+.||.+|||+.|++++
T Consensus 244 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 244 PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0112234567899999999999999999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-31 Score=292.03 Aligned_cols=207 Identities=24% Similarity=0.316 Sum_probs=163.3
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
|.||++.. +|+.||||+++ ..+.+|+.++++++||||+++++++.+. +..++||||+++|+|.+++..
T Consensus 51 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv~e~~~~g~L~~~~~~ 129 (494)
T 3lij_A 51 GEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDK-RNYYLVMECYKGGELFDEIIH 129 (494)
T ss_dssp -EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEEEECCCSCBHHHHHHH
T ss_pred EEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-CEEEEEEecCCCCcHHHHHHH
Confidence 58999998 68999999985 3477899999999999999999998754 479999999999999998876
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCC---CcEEEeecCCCCCCC------
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSR---FKAKIANFSLAAPAT------ 482 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~---~~~kl~DFGla~~~~------ 482 (615)
.. .+++..+..++.|++.||.|||+++ |+||||||+|||++.+ +.+||+|||+++...
T Consensus 130 ~~----------~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~ 196 (494)
T 3lij_A 130 RM----------KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMK 196 (494)
T ss_dssp HS----------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBC
T ss_pred cC----------CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcccc
Confidence 43 3899999999999999999999998 9999999999999764 559999999985431
Q ss_pred ---------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCC
Q 047629 483 ---------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLES 547 (615)
Q Consensus 483 ---------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~ 547 (615)
..++.++|||||||++|||++|+.||......+ ....+. ..... ...
T Consensus 197 ~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~-------------~~~~~--~~~ 258 (494)
T 3lij_A 197 ERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE---ILRKVE-------------KGKYT--FDS 258 (494)
T ss_dssp CCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH-------------HTCCC--CCS
T ss_pred ccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH-------------hCCCC--CCc
Confidence 124678999999999999999999997644211 111000 00000 000
Q ss_pred CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 548 FYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 548 ~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.........+.+|+..||+.||.+|||+.|++++
T Consensus 259 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 259 PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred hhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 0011223457899999999999999999999875
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-32 Score=287.83 Aligned_cols=233 Identities=21% Similarity=0.289 Sum_probs=167.8
Q ss_pred cccccccccc----ceEEEEEE--CCeEEEEEEccHH---HHHHHHHHHhcCCCCcccEEEEEEcCC-------------
Q 047629 333 MNLSEHYSIG----KSVYRATI--DGKVLAVKKIKED---VTEELRILQRINHANLVKLMGVSSDSQ------------- 390 (615)
Q Consensus 333 ~~~~~~~~iG----~~Vy~~~~--~g~~vAvK~~~~~---~~~Ei~~l~~l~H~niv~l~g~~~~~~------------- 390 (615)
..|.....+| |.||++.. +|+.||||++..+ ..+|+++|++++|+||+++++++....
T Consensus 7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~ 86 (383)
T 3eb0_A 7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDH 86 (383)
T ss_dssp TTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC--------------
T ss_pred ceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCccccccccccccc
Confidence 3444444454 58999987 7899999998643 458999999999999999999885321
Q ss_pred ------------------------CcEEEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHh
Q 047629 391 ------------------------GNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHE 446 (615)
Q Consensus 391 ------------------------~~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~ 446 (615)
...++||||++ |+|.+.+....... ..+++..+..++.|++.||.|||+
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~ 159 (383)
T 3eb0_A 87 NKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSG------RSIPMNLISIYIYQLFRAVGFIHS 159 (383)
T ss_dssp -----------------------CCEEEEEECCCS-EEHHHHHHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred ccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHH
Confidence 23789999998 58877775421100 138999999999999999999999
Q ss_pred CCCCCeEecCCCCCceeeC-CCCcEEEeecCCCCCCC-----------------------CCCCCcccchhHHHHHHHHH
Q 047629 447 HAQPSIVHRDIRTNNIQLD-SRFKAKIANFSLAAPAT-----------------------NDVMPKFDVFAFGVVLLELL 502 (615)
Q Consensus 447 ~~~~~ivHrDlk~~NILld-~~~~~kl~DFGla~~~~-----------------------~~~~~k~DV~SfGvvl~Ell 502 (615)
++ |+||||||+|||++ .++.+||+|||+++... ..++.++|||||||++|||+
T Consensus 160 ~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 236 (383)
T 3eb0_A 160 LG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236 (383)
T ss_dssp TT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred Cc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHH
Confidence 98 99999999999998 68899999999996421 12567899999999999999
Q ss_pred cCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCC--------cCC-----CCCChHHHHHHHHHHHHhhhcCC
Q 047629 503 SGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDP--------NLE-----SFYPIDGALSLATLARACTMDKS 569 (615)
Q Consensus 503 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp--------~l~-----~~~~~~~~~~l~~l~~~C~~~dP 569 (615)
+|+.||......+. ...+...+.... .+.+.. +++ .+. ..++......+.+|+.+||+.||
T Consensus 237 ~g~~pf~~~~~~~~---~~~i~~~~g~p~--~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 237 LGKPLFSGETSIDQ---LVRIIQIMGTPT--KEQMIR-MNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp HSSCSSCCSSHHHH---HHHHHHHHCCCC--HHHHHH-HCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred hCCCCCCCCChHHH---HHHHHHHhCCCC--HHHHHH-hCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 99999976442221 111111111000 000110 111 110 11223344568999999999999
Q ss_pred CCCCCHHHHHHH
Q 047629 570 LSRPNMAEVVFN 581 (615)
Q Consensus 570 ~~RPsm~ev~~~ 581 (615)
.+|||+.|++++
T Consensus 311 ~~R~t~~e~l~h 322 (383)
T 3eb0_A 311 DLRINPYEAMAH 322 (383)
T ss_dssp GGSCCHHHHHTS
T ss_pred hhCCCHHHHhcC
Confidence 999999999874
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-31 Score=291.55 Aligned_cols=219 Identities=18% Similarity=0.271 Sum_probs=170.0
Q ss_pred ccccccccc----ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEE
Q 047629 334 NLSEHYSIG----KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVY 397 (615)
Q Consensus 334 ~~~~~~~iG----~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~ 397 (615)
+|.....+| |.||++.. +|+.||+|++++ .+.+|+++|.+++||||+++++++.+. ...++||
T Consensus 186 ~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-~~l~lVm 264 (543)
T 3c4z_A 186 WFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETK-TDLCLVM 264 (543)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEE
T ss_pred heEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeC-CEEEEEE
Confidence 344444455 58999998 689999999863 356799999999999999999998754 4799999
Q ss_pred eecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCC
Q 047629 398 EYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSL 477 (615)
Q Consensus 398 E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGl 477 (615)
||+++|+|.+++....... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 265 E~~~gg~L~~~l~~~~~~~------~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGl 335 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDN------PGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGL 335 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTS------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred EeccCCCHHHHHHHhhccc------ccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecce
Confidence 9999999999997643211 13899999999999999999999998 99999999999999999999999999
Q ss_pred CCCCC-----------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHH
Q 047629 478 AAPAT-----------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKRE 534 (615)
Q Consensus 478 a~~~~-----------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 534 (615)
++... ..++.++|||||||++|||++|+.||........... +..
T Consensus 336 a~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~---~~~--------- 403 (543)
T 3c4z_A 336 AVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE---LKQ--------- 403 (543)
T ss_dssp CEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHH---HHH---------
T ss_pred eeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHH---HHH---------
Confidence 85431 1245689999999999999999999976543211110 100
Q ss_pred HHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCH-----HHHHH
Q 047629 535 ERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNM-----AEVVF 580 (615)
Q Consensus 535 ~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm-----~ev~~ 580 (615)
..+. .. ..++......+.+|+..||+.||.+||++ .||.+
T Consensus 404 ~i~~----~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 404 RVLE----QA--VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp HHHH----CC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred HHhh----cc--cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 0011 11 12334445567899999999999999975 56654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-31 Score=291.93 Aligned_cols=207 Identities=24% Similarity=0.326 Sum_probs=163.9
Q ss_pred ceEEEEEE--CCeEEEEEEcc--------------------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeec
Q 047629 343 KSVYRATI--DGKVLAVKKIK--------------------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYA 400 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~--------------------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~ 400 (615)
|.||++.. +|+.||||+++ +.+.+|+.+|++++||||+++++++.+. +..++||||+
T Consensus 50 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv~e~~ 128 (504)
T 3q5i_A 50 GEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDK-KYFYLVTEFY 128 (504)
T ss_dssp EEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEEEEECC
T ss_pred eEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC-CEEEEEEecC
Confidence 58999997 67899999874 2367899999999999999999998754 4799999999
Q ss_pred CCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCC---cEEEeecCC
Q 047629 401 ENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRF---KAKIANFSL 477 (615)
Q Consensus 401 ~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~---~~kl~DFGl 477 (615)
++|+|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||+
T Consensus 129 ~gg~L~~~l~~~~----------~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 195 (504)
T 3q5i_A 129 EGGELFEQIINRH----------KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGL 195 (504)
T ss_dssp TTCBHHHHHHHHS----------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEEECCCTT
T ss_pred CCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEEEEECCC
Confidence 9999999997643 2899999999999999999999998 99999999999998775 699999999
Q ss_pred CCCCC---------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHH
Q 047629 478 AAPAT---------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREER 536 (615)
Q Consensus 478 a~~~~---------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 536 (615)
++... ..++.++|||||||++|||++|+.||......+ ....+.
T Consensus 196 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~------------ 260 (504)
T 3q5i_A 196 SSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD---IIKKVE------------ 260 (504)
T ss_dssp CEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH------------
T ss_pred CEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH------------
Confidence 86432 124678999999999999999999997644211 111000
Q ss_pred HhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 537 LRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 537 ~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
..... ............+.+|+..|++.||.+|||+.|++++
T Consensus 261 -~~~~~--~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 261 -KGKYY--FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp -HCCCC--CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -cCCCC--CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00000 0000001123457899999999999999999999875
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=283.37 Aligned_cols=152 Identities=25% Similarity=0.441 Sum_probs=131.4
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCC----CcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQ----GNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~~lV~E~~~~GsL~~ 407 (615)
|.||++.. +|+.||||+++ +.+.+|+++|++++|+||+++++++.... ...++||||++ |+|.+
T Consensus 40 g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~ 118 (432)
T 3n9x_A 40 GYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKK 118 (432)
T ss_dssp EEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHH
T ss_pred EEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHH
Confidence 58999987 68999999985 34678999999999999999999986543 36899999996 69999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----- 482 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----- 482 (615)
++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 119 ~~~~~~----------~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 185 (432)
T 3n9x_A 119 LFKTPI----------FLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDT 185 (432)
T ss_dssp HHHSSC----------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC------
T ss_pred HHhccC----------CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcccccccccc
Confidence 997643 3899999999999999999999998 9999999999999999999999999986421
Q ss_pred -----------------------------------------CCCCCcccchhHHHHHHHHHcCCCCC
Q 047629 483 -----------------------------------------NDVMPKFDVFAFGVVLLELLSGKKAT 508 (615)
Q Consensus 483 -----------------------------------------~~~~~k~DV~SfGvvl~ElltG~~p~ 508 (615)
..++.++|||||||++|||++|..|+
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 186 NIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp -------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 12456899999999999999865444
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-31 Score=274.57 Aligned_cols=221 Identities=23% Similarity=0.343 Sum_probs=161.8
Q ss_pred ceEEEEEE--CCeEEEEEEcc-------HHHHHHHHHHHhcCCCCcccEEEEEEc-------------CCCcEEEEEeec
Q 047629 343 KSVYRATI--DGKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVSSD-------------SQGNRFLVYEYA 400 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-------~~~~~Ei~~l~~l~H~niv~l~g~~~~-------------~~~~~~lV~E~~ 400 (615)
|.||+|.. +|+.||||++. +.+.+|++++++++||||+++++++.. .....++||||+
T Consensus 25 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~ 104 (320)
T 2i6l_A 25 GLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM 104 (320)
T ss_dssp -CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECC
T ss_pred eEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeecc
Confidence 48999998 48999999874 357789999999999999999998742 223579999999
Q ss_pred CCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeC-CCCcEEEeecCCCC
Q 047629 401 ENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLD-SRFKAKIANFSLAA 479 (615)
Q Consensus 401 ~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld-~~~~~kl~DFGla~ 479 (615)
+ |+|.+++... .+++..+..++.|++.||+|||+++ |+||||||+|||++ +++.+||+|||+++
T Consensus 105 ~-~~L~~~~~~~-----------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~ 169 (320)
T 2i6l_A 105 E-TDLANVLEQG-----------PLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLAR 169 (320)
T ss_dssp S-EEHHHHHTTC-----------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEECCCTTCB
T ss_pred C-CCHHHHhhcC-----------CccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEccCcccc
Confidence 8 6999999642 2889999999999999999999998 99999999999997 56799999999986
Q ss_pred CCC---------------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHh-HHH
Q 047629 480 PAT---------------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLK-VEE 531 (615)
Q Consensus 480 ~~~---------------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~-~~~ 531 (615)
... ..++.++||||||+++|||++|+.||......+. ...+..... ...
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~ 246 (320)
T 2i6l_A 170 IMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ---MQLILESIPVVHE 246 (320)
T ss_dssp CC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHSCCCCH
T ss_pred ccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCch
Confidence 531 1245578999999999999999999976542111 111111100 000
Q ss_pred HHHHHHhhh--------c-CCcCC-CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 532 KREERLRNW--------M-DPNLE-SFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 532 ~~~~~~~~~--------~-dp~l~-~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.....+... . .+... ..........+.+++.+||+.||++|||+.|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 247 EDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 000011100 0 01000 00111234568999999999999999999999875
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.9e-31 Score=283.65 Aligned_cols=157 Identities=20% Similarity=0.304 Sum_probs=135.1
Q ss_pred ceEEEEEE--CCeEEEEEEcc------HHHHHHHHHHHhc------CCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHh
Q 047629 343 KSVYRATI--DGKVLAVKKIK------EDVTEELRILQRI------NHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKW 408 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~------~~~~~Ei~~l~~l------~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~ 408 (615)
|.||+|.. +|+.||||+++ ..+.+|+.++..+ +|+||+++++++... +..++||||+. |+|.++
T Consensus 111 g~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~-~~~~lv~e~~~-~~L~~~ 188 (429)
T 3kvw_A 111 GQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR-NHICMTFELLS-MNLYEL 188 (429)
T ss_dssp EEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET-TEEEEEECCCC-CBHHHH
T ss_pred EEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC-CeEEEEEeccC-CCHHHH
Confidence 58999987 58999999985 3466799998887 577999999998754 47999999996 699999
Q ss_pred hccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCc--EEEeecCCCCCCC----
Q 047629 409 LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFK--AKIANFSLAAPAT---- 482 (615)
Q Consensus 409 L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~--~kl~DFGla~~~~---- 482 (615)
+...... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+++...
T Consensus 189 l~~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~~~ 257 (429)
T 3kvw_A 189 IKKNKFQ--------GFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY 257 (429)
T ss_dssp HHHTTTC--------CCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCEETTCCCC
T ss_pred HHhccCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccceecCCccc
Confidence 9875432 3899999999999999999999998 999999999999999887 9999999985432
Q ss_pred ----------------CCCCCcccchhHHHHHHHHHcCCCCCCCCC
Q 047629 483 ----------------NDVMPKFDVFAFGVVLLELLSGKKATRTTE 512 (615)
Q Consensus 483 ----------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~ 512 (615)
..++.++|||||||++|||++|+.||....
T Consensus 258 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 258 TYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp SSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 125678999999999999999999997654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.2e-31 Score=277.51 Aligned_cols=220 Identities=15% Similarity=0.161 Sum_probs=170.0
Q ss_pred ccccccccc----ceEEEEE-------ECCeEEEEEEcc----HHHHHHHHHHHhcC---CCCcccEEEEEEcCCCcEEE
Q 047629 334 NLSEHYSIG----KSVYRAT-------IDGKVLAVKKIK----EDVTEELRILQRIN---HANLVKLMGVSSDSQGNRFL 395 (615)
Q Consensus 334 ~~~~~~~iG----~~Vy~~~-------~~g~~vAvK~~~----~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~~l 395 (615)
.|.....+| |.||+|. .+++.||||+++ .++..|++++.+++ |+||+++++++... +..++
T Consensus 66 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~-~~~~l 144 (365)
T 3e7e_A 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ-NGSVL 144 (365)
T ss_dssp EEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS-SCEEE
T ss_pred EEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC-CCcEE
Confidence 344444454 4899993 268999999986 46788999999887 99999999998765 47899
Q ss_pred EEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCC---------
Q 047629 396 VYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDS--------- 466 (615)
Q Consensus 396 V~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~--------- 466 (615)
||||+++|+|.+++....... ...++|..++.|+.|++.||+|||+++ |+||||||+|||++.
T Consensus 145 v~e~~~~g~L~~~l~~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 145 VGELYSYGTLLNAINLYKNTP-----EKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp EECCCCSCBHHHHHHHHHTST-----TCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred EEeccCCCcHHHHHHHhhccc-----ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence 999999999999997522110 013999999999999999999999998 999999999999998
Q ss_pred --CCcEEEeecCCCCCCC-------------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHH
Q 047629 467 --RFKAKIANFSLAAPAT-------------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVL 519 (615)
Q Consensus 467 --~~~~kl~DFGla~~~~-------------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l 519 (615)
++.+||+|||+++... ..++.++|||||||++|||++|+.|+.....+..
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--- 293 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC--- 293 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE---
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce---
Confidence 8999999999994321 1256789999999999999999999865432110
Q ss_pred HHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCC-CCHHHHHHHHHhcccc
Q 047629 520 WKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSR-PNMAEVVFNLSVLTQS 588 (615)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~R-Psm~ev~~~L~~l~~~ 588 (615)
.++..+. .++ ....+.+++..|++.+|.+| |+++++.+.|+.+.+.
T Consensus 294 --------------------~~~~~~~-~~~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 294 --------------------KPEGLFR-RLP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp --------------------EECSCCT-TCS--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred --------------------eechhcc-ccC--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 0111111 112 13356789999999999998 6788888888766543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=268.48 Aligned_cols=205 Identities=22% Similarity=0.306 Sum_probs=161.6
Q ss_pred ceEEEEEE--CCeEEEEEEccH-----------HHHHHHHHHHhcCCCCcccEEEEEEcC-CCcEEEEEeecCCCCHHHh
Q 047629 343 KSVYRATI--DGKVLAVKKIKE-----------DVTEELRILQRINHANLVKLMGVSSDS-QGNRFLVYEYAENGSLDKW 408 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~-----------~~~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~~lV~E~~~~GsL~~~ 408 (615)
|.||++.. +|+.||||.++. .+.+|++++++++|+||+++++++.+. ....++||||+++| |.++
T Consensus 19 g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~ 97 (305)
T 2wtk_C 19 GKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEM 97 (305)
T ss_dssp CEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHH
T ss_pred eEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHH
Confidence 58999987 688999999853 367899999999999999999998533 34689999999876 7777
Q ss_pred hccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC-----
Q 047629 409 LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN----- 483 (615)
Q Consensus 409 L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~----- 483 (615)
+...... .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.....
T Consensus 98 ~~~~~~~--------~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~ 166 (305)
T 2wtk_C 98 LDSVPEK--------RFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADD 166 (305)
T ss_dssp HHHSTTC--------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSC
T ss_pred HHhCccc--------ccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccccCcccccc
Confidence 7654321 3899999999999999999999998 99999999999999999999999999864311
Q ss_pred ----------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhc
Q 047629 484 ----------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWM 541 (615)
Q Consensus 484 ----------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 541 (615)
..+.++||||||+++|||++|+.|+..... ..... .+.. .
T Consensus 167 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~--------------~i~~-~ 228 (305)
T 2wtk_C 167 TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI---YKLFE--------------NIGK-G 228 (305)
T ss_dssp EECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHH--------------HHHH-C
T ss_pred ccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH---HHHHH--------------HHhc-C
Confidence 014479999999999999999999975431 11110 0111 0
Q ss_pred CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 542 DPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 542 dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
... .+.+....+.+++.+||+.||.+|||++|++++
T Consensus 229 ~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 229 SYA----IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp CCC----CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CCC----CCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111 223334567899999999999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6.4e-31 Score=300.02 Aligned_cols=212 Identities=22% Similarity=0.322 Sum_probs=169.8
Q ss_pred cccccccccc----ceEEEEEE--CCeEEEEEEccHH----------HHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEE
Q 047629 333 MNLSEHYSIG----KSVYRATI--DGKVLAVKKIKED----------VTEELRILQRI-NHANLVKLMGVSSDSQGNRFL 395 (615)
Q Consensus 333 ~~~~~~~~iG----~~Vy~~~~--~g~~vAvK~~~~~----------~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~l 395 (615)
.+|.....|| |.||++.. +|+.||||+++++ +..|..+|..+ +|+||+++++++.+ .+.++|
T Consensus 341 ~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~-~~~~~l 419 (674)
T 3pfq_A 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-MDRLYF 419 (674)
T ss_dssp TTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC-SSEEEE
T ss_pred cceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe-CCEEEE
Confidence 3455455555 58999998 6889999998743 56788999887 79999999998764 447999
Q ss_pred EEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeec
Q 047629 396 VYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANF 475 (615)
Q Consensus 396 V~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DF 475 (615)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+||
T Consensus 420 V~E~~~gg~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DF 486 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQVG----------RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADF 486 (674)
T ss_dssp EEECCCSCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCC
T ss_pred EEeCcCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeec
Confidence 999999999999998654 2899999999999999999999998 999999999999999999999999
Q ss_pred CCCCCCC-----------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHH
Q 047629 476 SLAAPAT-----------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEK 532 (615)
Q Consensus 476 Gla~~~~-----------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 532 (615)
|+++... ..++.++|||||||+||||++|+.||...... .+
T Consensus 487 Gla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~---~~------------- 550 (674)
T 3pfq_A 487 GMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---EL------------- 550 (674)
T ss_dssp TTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH-------------
T ss_pred ceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH---HH-------------
Confidence 9986421 12567899999999999999999999764321 11
Q ss_pred HHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCH-----HHHHH
Q 047629 533 REERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNM-----AEVVF 580 (615)
Q Consensus 533 ~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm-----~ev~~ 580 (615)
+..++... ..+|......+.+|+..||+.||.+||++ +||.+
T Consensus 551 ----~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 551 ----FQSIMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ----HHHHHSSC--CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ----HHHHHhCC--CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 11111111 13444555678999999999999999997 67665
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-31 Score=280.55 Aligned_cols=227 Identities=20% Similarity=0.242 Sum_probs=165.4
Q ss_pred ceEEEEEE--CCeEEEEEEcc------HHHHHHHHHHHhcC--------CCCcccEEEEEEc---CCCcEEEEEeecCCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK------EDVTEELRILQRIN--------HANLVKLMGVSSD---SQGNRFLVYEYAENG 403 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~------~~~~~Ei~~l~~l~--------H~niv~l~g~~~~---~~~~~~lV~E~~~~G 403 (615)
|.||++.. +|+.||||+++ +.+.+|+.++++++ |+||+++++++.. .....++||||+ +|
T Consensus 51 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~ 129 (397)
T 1wak_A 51 STVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GH 129 (397)
T ss_dssp EEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CC
T ss_pred eeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEecc-Cc
Confidence 58999987 68999999986 34678999999985 7889999998762 223589999999 56
Q ss_pred CHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCceeeCCCC--------------
Q 047629 404 SLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEH-AQPSIVHRDIRTNNIQLDSRF-------------- 468 (615)
Q Consensus 404 sL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDlk~~NILld~~~-------------- 468 (615)
+|.+++...... .+++..+..++.|++.||.|||++ + |+||||||+|||++.++
T Consensus 130 ~l~~~~~~~~~~--------~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~~~~~~~~~~ 198 (397)
T 1wak_A 130 HLLKWIIKSNYQ--------GLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRLAAEATEWQ 198 (397)
T ss_dssp BHHHHHHHTTTS--------CCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHHHHHHHC---
T ss_pred cHHHHHHhcccC--------CCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhhhhhhhHHHh
Confidence 777776554321 389999999999999999999998 7 99999999999999775
Q ss_pred -----------------------------------cEEEeecCCCCCCC--------------------CCCCCcccchh
Q 047629 469 -----------------------------------KAKIANFSLAAPAT--------------------NDVMPKFDVFA 493 (615)
Q Consensus 469 -----------------------------------~~kl~DFGla~~~~--------------------~~~~~k~DV~S 493 (615)
.+||+|||+++... ..++.++||||
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 278 (397)
T 1wak_A 199 RSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWS 278 (397)
T ss_dssp ------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTSCCCTHHHHHH
T ss_pred hcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCCCCCcHHHHHH
Confidence 89999999985431 22567899999
Q ss_pred HHHHHHHHHcCCCCCCCCCCChhH---HHHHHHHHHHhHH---HHHHHH-HhhhcCCc--C-----------------CC
Q 047629 494 FGVVLLELLSGKKATRTTENGKTA---VLWKEIREVLKVE---EKREER-LRNWMDPN--L-----------------ES 547 (615)
Q Consensus 494 fGvvl~ElltG~~p~~~~~~~~~~---~l~~~~~~~~~~~---~~~~~~-~~~~~dp~--l-----------------~~ 547 (615)
|||++|||++|+.||......+.. .....+...+... ...... ..++.+.. + ..
T Consensus 279 lG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (397)
T 1wak_A 279 TACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKY 358 (397)
T ss_dssp HHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTS
T ss_pred HHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhc
Confidence 999999999999999765432211 1111111111000 000000 00001000 0 01
Q ss_pred CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 548 FYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 548 ~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
..+.+....+.+|+.+||+.||++|||+.|++++
T Consensus 359 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 359 EWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred ccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 3456677789999999999999999999999864
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=288.19 Aligned_cols=223 Identities=26% Similarity=0.356 Sum_probs=161.3
Q ss_pred ceEEEEEE--CCeEEEEEEccHH---HHHHHHHHHhcCCCCcccEEEEEEcCC---C--cEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATI--DGKVLAVKKIKED---VTEELRILQRINHANLVKLMGVSSDSQ---G--NRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~~---~~~Ei~~l~~l~H~niv~l~g~~~~~~---~--~~~lV~E~~~~GsL~~~L~~~ 412 (615)
|.||+|.. +|+.||||++..+ ..+|+++|++++|+||+++++++.... . .+++||||+++ +|.+.+...
T Consensus 68 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~ 146 (420)
T 1j1b_A 68 GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHY 146 (420)
T ss_dssp EEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHH
T ss_pred EEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHH
Confidence 58999998 6899999998632 457999999999999999999875321 1 26799999985 666665431
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCC-CcEEEeecCCCCCCC---------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSR-FKAKIANFSLAAPAT--------- 482 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~-~~~kl~DFGla~~~~--------- 482 (615)
.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++...
T Consensus 147 ~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~ 217 (420)
T 1j1b_A 147 SRAK------QTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 217 (420)
T ss_dssp HHTT------CCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCC
T ss_pred hhcc------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhhcccCCCceeee
Confidence 1000 13899999999999999999999998 9999999999999965 678999999996421
Q ss_pred --------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcC---
Q 047629 483 --------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNL--- 545 (615)
Q Consensus 483 --------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l--- 545 (615)
..++.++|||||||++|||++|+.||......+. +.. +...+... ..+.+.+ +++..
T Consensus 218 ~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~--l~~-i~~~lg~p--~~~~~~~-~~~~~~~~ 291 (420)
T 1j1b_A 218 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVE-IIKVLGTP--TREQIRE-MNPNYTEF 291 (420)
T ss_dssp SCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHH-HHHHHCSC--CHHHHHH-HCSCCCCC
T ss_pred eCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHHHhCCC--CHHHHHh-hChhhhhh
Confidence 1256789999999999999999999976442211 111 11111100 0111111 11111
Q ss_pred -----CC-----CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 546 -----ES-----FYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 546 -----~~-----~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.. .++......+.+|+.+||+.||.+||++.|++++
T Consensus 292 ~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 292 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp CCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 10 0122334568999999999999999999999875
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-31 Score=271.15 Aligned_cols=205 Identities=21% Similarity=0.369 Sum_probs=164.6
Q ss_pred ceEEEEEE-CCeEEEEEEcc---------HHHHHHHHHHHhcC--CCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI-DGKVLAVKKIK---------EDVTEELRILQRIN--HANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~-~g~~vAvK~~~---------~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||++.. +|+.||||.+. ..+.+|++++.+++ |+||+++++++.+. +..++||| +.+|+|.+++.
T Consensus 42 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~-~~~~lv~e-~~~~~L~~~l~ 119 (313)
T 3cek_A 42 SKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-QYIYMVME-CGNIDLNSWLK 119 (313)
T ss_dssp EEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS-SEEEEEEC-CCSEEHHHHHH
T ss_pred EEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC-CEEEEEEe-cCCCcHHHHHH
Confidence 58999987 68999999884 34778999999996 59999999998764 47899999 56889999998
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
... .+++.++..++.|++.||.|||+++ |+||||||+|||+++ +.+||+|||+++...
T Consensus 120 ~~~----------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~ 185 (313)
T 3cek_A 120 KKK----------SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVK 185 (313)
T ss_dssp HCS----------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC----------
T ss_pred hcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccccccCccccccc
Confidence 654 3899999999999999999999998 999999999999965 899999999986431
Q ss_pred ----------------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHH
Q 047629 483 ----------------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKRE 534 (615)
Q Consensus 483 ----------------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 534 (615)
..++.++||||||+++|||++|+.||.......
T Consensus 186 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~------------------- 246 (313)
T 3cek_A 186 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI------------------- 246 (313)
T ss_dssp ----CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-------------------
T ss_pred cCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH-------------------
Confidence 123457899999999999999999997543211
Q ss_pred HHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047629 535 ERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNL 582 (615)
Q Consensus 535 ~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L 582 (615)
..+...+++.....++......+.+++.+||+.||.+||++.|+++.-
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 247 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 112223334333334444455689999999999999999999999864
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=276.34 Aligned_cols=221 Identities=21% Similarity=0.288 Sum_probs=165.4
Q ss_pred ceEEEEEE--CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCC----CcEEEEEeecCCCCHHHh
Q 047629 343 KSVYRATI--DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQ----GNRFLVYEYAENGSLDKW 408 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~~lV~E~~~~GsL~~~ 408 (615)
|.||++.. +|+.||||++. ..+.+|++++.+++|+||+++++++.... ...++|+||++ |+|.++
T Consensus 41 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~ 119 (364)
T 3qyz_A 41 GMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKL 119 (364)
T ss_dssp EEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHH
T ss_pred eEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHH
Confidence 58999987 68999999985 35778999999999999999999986432 35899999997 599999
Q ss_pred hccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC------
Q 047629 409 LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------ 482 (615)
Q Consensus 409 L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------ 482 (615)
+... .+++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 120 l~~~-----------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 185 (364)
T 3qyz_A 120 LKTQ-----------HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 185 (364)
T ss_dssp HHHC-----------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBC
T ss_pred HHhC-----------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEecCCCCCcc
Confidence 9753 2899999999999999999999998 9999999999999999999999999985321
Q ss_pred ---------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHH---H-------
Q 047629 483 ---------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVE---E------- 531 (615)
Q Consensus 483 ---------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~------- 531 (615)
..++.++|||||||++|||++|+.||......+... .+...+... .
T Consensus 186 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~~~~ 262 (364)
T 3qyz_A 186 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN---HILGILGSPSQEDLNCIINL 262 (364)
T ss_dssp CTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHH---HHHHHHCSCCHHHHHTCCCH
T ss_pred ccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHH---HHHHHhCCCCHHHHHHhhhh
Confidence 114678999999999999999999997655333221 111111000 0
Q ss_pred HHHHHHhhhcCCcCC--CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 532 KREERLRNWMDPNLE--SFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 532 ~~~~~~~~~~dp~l~--~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
...........+.-. ..........+.+|+.+|++.||++|||+.|+++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000001111000000 00011223467899999999999999999999985
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=273.58 Aligned_cols=221 Identities=17% Similarity=0.267 Sum_probs=163.7
Q ss_pred ceEEEEEE--CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcC----CCcEEEEEeecCCCCHHHh
Q 047629 343 KSVYRATI--DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDS----QGNRFLVYEYAENGSLDKW 408 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~----~~~~~lV~E~~~~GsL~~~ 408 (615)
|.||+|.. +|+.||||+++ ..+.+|++++++++|+||+++++++... ....++||||++ |+|.++
T Consensus 25 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~ 103 (353)
T 2b9h_A 25 GVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRV 103 (353)
T ss_dssp EEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHH
T ss_pred eEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHH
Confidence 58999998 58999999985 2467899999999999999999987543 146899999997 699999
Q ss_pred hccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC------
Q 047629 409 LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------ 482 (615)
Q Consensus 409 L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------ 482 (615)
+... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 104 ~~~~-----------~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~ 169 (353)
T 2b9h_A 104 ISTQ-----------MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADN 169 (353)
T ss_dssp HHHC-----------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred Hhhc-----------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccccccccccc
Confidence 8753 2899999999999999999999998 9999999999999999999999999985421
Q ss_pred ----------------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhH-----
Q 047629 483 ----------------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKV----- 529 (615)
Q Consensus 483 ----------------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~----- 529 (615)
..++.++|||||||++|||++|+.||......+... .+......
T Consensus 170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~ 246 (353)
T 2b9h_A 170 SEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLL---LIFGIIGTPHSDN 246 (353)
T ss_dssp ----------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCCCSTT
T ss_pred cCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH---HHHHHhCCCchhc
Confidence 124557999999999999999999997654221111 11111000
Q ss_pred ------HHHHHHHHhhhcC-CcC-CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 530 ------EEKREERLRNWMD-PNL-ESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 530 ------~~~~~~~~~~~~d-p~l-~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.....+.+..... +.. ...........+.+|+.+||+.||++|||+.|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp TTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000110000 000 000011234467899999999999999999999885
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-32 Score=287.17 Aligned_cols=213 Identities=11% Similarity=0.030 Sum_probs=147.2
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhc--CCCCcccEE-------EEEEcCC-----------
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRI--NHANLVKLM-------GVSSDSQ----------- 390 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l--~H~niv~l~-------g~~~~~~----------- 390 (615)
|.||+|.. +|+.||||+++. .+.+|+.++..+ +||||++++ +++....
T Consensus 76 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~ 155 (371)
T 3q60_A 76 SVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQ 155 (371)
T ss_dssp EEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCSCC-
T ss_pred EEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeeccCCc
Confidence 58999997 789999999863 355775545444 699988755 4443211
Q ss_pred -----CcEEEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHH------HHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 047629 391 -----GNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQR------LRVALDVANGLQYMHEHAQPSIVHRDIRT 459 (615)
Q Consensus 391 -----~~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~ivHrDlk~ 459 (615)
...++||||++ |+|.+++..... .+.+..+ +.++.|++.||+|||+++ |+||||||
T Consensus 156 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---------~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---ivHrDikp 222 (371)
T 3q60_A 156 DDYAVANYLLLMPAAS-VDLELLFSTLDF---------VYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTP 222 (371)
T ss_dssp --CCEEEEEEEECCCS-EEHHHHHHHHHH---------SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred ccceeeeEEEEecCCC-CCHHHHHHHhcc---------ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---CccCcCCH
Confidence 23799999999 899999986432 2455555 788899999999999998 99999999
Q ss_pred CceeeCCCCcEEEeecCCCCCCC----------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhH
Q 047629 460 NNIQLDSRFKAKIANFSLAAPAT----------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTA 517 (615)
Q Consensus 460 ~NILld~~~~~kl~DFGla~~~~----------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~ 517 (615)
+|||++.++.+||+|||+++... ..++.++|||||||++|||++|+.||.........
T Consensus 223 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~ 302 (371)
T 3q60_A 223 DNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG 302 (371)
T ss_dssp GGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTT
T ss_pred HHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCccccc
Confidence 99999999999999999986432 12467899999999999999999999765322110
Q ss_pred HHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 518 VLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 518 ~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
. +. ...........+...........+.+|+.+||+.||++|||+.|++++
T Consensus 303 ~-~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 303 S-WK------------RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp C-CC------------BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred c-hh------------hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 00 000000011111111112345568999999999999999999999864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=266.72 Aligned_cols=207 Identities=26% Similarity=0.318 Sum_probs=163.7
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
|.||++.. +|+.||||++. ..+.+|++++++++||||+++++++.+. +..++|+||+++|+|.+++..
T Consensus 36 g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~ 114 (287)
T 2wei_A 36 GEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS-SSFYIVGELYTGGELFDEIIK 114 (287)
T ss_dssp EEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEEEECCCCSCBHHHHHHH
T ss_pred EEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCC-CeEEEEEEccCCCCHHHHHHh
Confidence 58999998 68999999974 3477899999999999999999998754 478999999999999999875
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCC---CcEEEeecCCCCCCCC-----
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSR---FKAKIANFSLAAPATN----- 483 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~---~~~kl~DFGla~~~~~----- 483 (615)
.. .+++.++..++.|++.||.|||+++ ++||||||+||+++.+ +.+||+|||+++....
T Consensus 115 ~~----------~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~ 181 (287)
T 2wei_A 115 RK----------RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK 181 (287)
T ss_dssp HS----------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCS
T ss_pred cC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceeecCCCccc
Confidence 43 2899999999999999999999998 9999999999999764 4799999999864321
Q ss_pred ----------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCC
Q 047629 484 ----------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLES 547 (615)
Q Consensus 484 ----------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~ 547 (615)
.++.++||||||+++|||++|+.|+...... .... .. ........+.
T Consensus 182 ~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~---~~----------~~~~~~~~~~- 244 (287)
T 2wei_A 182 DRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DILK---RV----------ETGKYAFDLP- 244 (287)
T ss_dssp CHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HH----------HHCCCCCCSG-
T ss_pred cccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHH---HHHH---HH----------HcCCCCCCch-
Confidence 2467899999999999999999999754321 1110 00 0011111110
Q ss_pred CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 548 FYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 548 ~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
........+.+++.+||+.||.+|||+.|+++.
T Consensus 245 -~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 245 -QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp -GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 001223457899999999999999999999984
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=274.29 Aligned_cols=239 Identities=18% Similarity=0.195 Sum_probs=166.6
Q ss_pred HHHHHccccccccccc----ceEEEEEE--CCeEEEEEEcc------HHHHHHHHHHHhcCCCCcccEEEEEEcCCC---
Q 047629 327 VIMESTMNLSEHYSIG----KSVYRATI--DGKVLAVKKIK------EDVTEELRILQRINHANLVKLMGVSSDSQG--- 391 (615)
Q Consensus 327 ~l~~at~~~~~~~~iG----~~Vy~~~~--~g~~vAvK~~~------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~--- 391 (615)
......++|.....+| |.||+|.. +|+.||||++. ....+|++.+.+++|+||+++++++.....
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 3445556666666666 58999997 58999999884 346778888899999999999999864321
Q ss_pred ---cEEEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHH--hCCCCCeEecCCCCCceeeCC
Q 047629 392 ---NRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMH--EHAQPSIVHRDIRTNNIQLDS 466 (615)
Q Consensus 392 ---~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~ivHrDlk~~NILld~ 466 (615)
..++||||+++ +|.+.+....... ..+++..+..++.|++.||.||| +++ |+||||||+|||++.
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~------~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~ 166 (360)
T 3e3p_A 97 RDIYLNVVMEYVPD-TLHRCCRNYYRRQ------VAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNE 166 (360)
T ss_dssp TCEEEEEEEECCSC-BHHHHHHHHHTTT------CCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEET
T ss_pred cceeEEEEeecccc-cHHHHHHHHhhcc------cCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeC
Confidence 17899999986 5554443211000 13889999999999999999999 776 999999999999997
Q ss_pred -CCcEEEeecCCCCCCC-----------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHH
Q 047629 467 -RFKAKIANFSLAAPAT-----------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKE 522 (615)
Q Consensus 467 -~~~~kl~DFGla~~~~-----------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 522 (615)
++.+||+|||+++... ..++.++|||||||++|||++|+.||........ ...
T Consensus 167 ~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~---~~~ 243 (360)
T 3e3p_A 167 ADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ---LHE 243 (360)
T ss_dssp TTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHH
T ss_pred CCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH---HHH
Confidence 8999999999996432 1146789999999999999999999976542211 111
Q ss_pred HHHHHhHHHHHHHHHhhhcCCcC----------------CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 523 IREVLKVEEKREERLRNWMDPNL----------------ESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~~dp~l----------------~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
+...+.... ...+ ..+++.. ....+......+.+|+.+||+.||.+|||+.|++++
T Consensus 244 ~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 244 IVRVLGCPS--REVL-RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHHCCCC--HHHH-HHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHcCCCC--HHHH-HhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 111111000 0011 1111110 011222345678999999999999999999999985
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-30 Score=275.26 Aligned_cols=221 Identities=21% Similarity=0.300 Sum_probs=161.2
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCC-----CcEEEEEeecCCCCHH
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQ-----GNRFLVYEYAENGSLD 406 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~~lV~E~~~~GsL~ 406 (615)
|.||++.. +|+.||||+++ ..+.+|+.++++++||||+++++++...+ ...++||||++ |+|.
T Consensus 39 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~ 117 (371)
T 2xrw_A 39 GIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLC 117 (371)
T ss_dssp EEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCS-EEHH
T ss_pred EEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCC-CCHH
Confidence 58999987 68999999985 24678999999999999999999986533 25799999997 5788
Q ss_pred HhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC----
Q 047629 407 KWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT---- 482 (615)
Q Consensus 407 ~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~---- 482 (615)
+++.. .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 118 ~~~~~------------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 182 (371)
T 2xrw_A 118 QVIQM------------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 182 (371)
T ss_dssp HHHHS------------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC---------
T ss_pred HHHhh------------ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecccccccccc
Confidence 88852 2889999999999999999999998 9999999999999999999999999986532
Q ss_pred ------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHH--HH---HHHHHhh
Q 047629 483 ------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVE--EK---REERLRN 539 (615)
Q Consensus 483 ------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~--~~---~~~~~~~ 539 (615)
..++.++|||||||++|||++|+.||......+ .+..+...+... .. ....+..
T Consensus 183 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~ 259 (371)
T 2xrw_A 183 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID---QWNKVIEQLGTPCPEFMKKLQPTVRT 259 (371)
T ss_dssp -------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHC-CCCCCHHHHTTSCHHHHH
T ss_pred cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHHHHhhhHHHH
Confidence 125678999999999999999999997644211 111111100000 00 0000000
Q ss_pred hc--CCcCC----------------CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047629 540 WM--DPNLE----------------SFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNL 582 (615)
Q Consensus 540 ~~--dp~l~----------------~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L 582 (615)
.+ .+... .+.+......+.+|+.+|++.||.+|||++|++++-
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 260 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320 (371)
T ss_dssp HHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred HHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence 00 01100 000112356789999999999999999999999863
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=271.03 Aligned_cols=226 Identities=17% Similarity=0.218 Sum_probs=166.4
Q ss_pred ceEEEEEE---CCeEEEEEEcc------HHHHHHHHHHHhcCCCC------cccEEEEEEcCCCcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATI---DGKVLAVKKIK------EDVTEELRILQRINHAN------LVKLMGVSSDSQGNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~---~g~~vAvK~~~------~~~~~Ei~~l~~l~H~n------iv~l~g~~~~~~~~~~lV~E~~~~GsL~~ 407 (615)
|.||++.. +|+.||||+++ +.+.+|++++.+++|+| ++++++++.+. +..++||||+ +|+|.+
T Consensus 28 g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~-~~~l~~ 105 (339)
T 1z57_A 28 GKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH-GHICIVFELL-GLSTYD 105 (339)
T ss_dssp EEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET-TEEEEEEECC-CCBHHH
T ss_pred eEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC-CcEEEEEcCC-CCCHHH
Confidence 58999986 68999999986 35778999999987654 99999998754 4899999999 889999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCC-------------------CC
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDS-------------------RF 468 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~-------------------~~ 468 (615)
++...... .+++.++..++.|++.||+|||+++ |+||||||+|||++. ++
T Consensus 106 ~l~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~ 174 (339)
T 1z57_A 106 FIKENGFL--------PFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP 174 (339)
T ss_dssp HHHHTTTC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CEEEEESCC
T ss_pred HHHhcCCC--------CCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccccccccccCC
Confidence 99765431 3889999999999999999999998 999999999999988 67
Q ss_pred cEEEeecCCCCCCC--------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHh
Q 047629 469 KAKIANFSLAAPAT--------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLK 528 (615)
Q Consensus 469 ~~kl~DFGla~~~~--------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~ 528 (615)
.+||+|||+++... ..++.++||||||+++|||++|+.||......+...........+.
T Consensus 175 ~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p 254 (339)
T 1z57_A 175 DIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLP 254 (339)
T ss_dssp CEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCC
T ss_pred CceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 89999999986432 1256789999999999999999999976543222111111100000
Q ss_pred HHHHH---------------------HHHHhhhcCCcC-CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 529 VEEKR---------------------EERLRNWMDPNL-ESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 529 ~~~~~---------------------~~~~~~~~dp~l-~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
..... ...+.....+.. ....+......+.+|+.+||+.||.+|||+.|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 255 KHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKH 329 (339)
T ss_dssp HHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcC
Confidence 00000 000000011100 011233456789999999999999999999999864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-30 Score=268.51 Aligned_cols=222 Identities=21% Similarity=0.326 Sum_probs=164.3
Q ss_pred ceEEEEEE---CCeEEEEEEcc---------HHHHHHHHHHHhc---CCCCcccEEEEEEc----CCCcEEEEEeecCCC
Q 047629 343 KSVYRATI---DGKVLAVKKIK---------EDVTEELRILQRI---NHANLVKLMGVSSD----SQGNRFLVYEYAENG 403 (615)
Q Consensus 343 ~~Vy~~~~---~g~~vAvK~~~---------~~~~~Ei~~l~~l---~H~niv~l~g~~~~----~~~~~~lV~E~~~~G 403 (615)
|.||++.. +|+.||||+++ ..+.+|+.+++++ +||||+++++++.. .....++||||++ |
T Consensus 25 g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~ 103 (326)
T 1blx_A 25 GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-Q 103 (326)
T ss_dssp EEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-C
T ss_pred EEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC-C
Confidence 58999987 47899999885 2467888888777 89999999999862 2335899999998 6
Q ss_pred CHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-
Q 047629 404 SLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT- 482 (615)
Q Consensus 404 sL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~- 482 (615)
+|.+++...... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 104 ~L~~~l~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (326)
T 1blx_A 104 DLTTYLDKVPEP--------GVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF 172 (326)
T ss_dssp BHHHHHHHSCTT--------CSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCCCCCG
T ss_pred CHHHHHHhcccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecCcccccccC
Confidence 999999765431 3899999999999999999999998 9999999999999999999999999986532
Q ss_pred ---------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhh--
Q 047629 483 ---------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRN-- 539 (615)
Q Consensus 483 ---------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~-- 539 (615)
..++.++||||||+++|||++|+.||......+ ....+........ ......
T Consensus 173 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~--~~~~~~~~ 247 (326)
T 1blx_A 173 QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPG--EEDWPRDV 247 (326)
T ss_dssp GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCC--GGGSCTTC
T ss_pred CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHHHcCCCC--cccCcccc
Confidence 124678999999999999999999997644211 1111111100000 000000
Q ss_pred -----hcC---CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 540 -----WMD---PNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 540 -----~~d---p~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
... ......+..+....+.+|+.+||+.||.+||++.|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 248 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp SSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000 000011222344567899999999999999999999864
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=277.31 Aligned_cols=221 Identities=22% Similarity=0.308 Sum_probs=155.0
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcC-----CCcEEEEEeecCCCCHH
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDS-----QGNRFLVYEYAENGSLD 406 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~~~lV~E~~~~GsL~ 406 (615)
|.||+|.. +|+.||||++. +.+.+|+++|++++|+||+++++++... ....++|+||+ +++|.
T Consensus 43 g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~ 121 (367)
T 2fst_X 43 GSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLN 121 (367)
T ss_dssp CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC
T ss_pred eEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHH
Confidence 58999986 78999999984 2466899999999999999999998643 13579999999 68999
Q ss_pred HhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC----
Q 047629 407 KWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT---- 482 (615)
Q Consensus 407 ~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~---- 482 (615)
+++... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 122 ~~~~~~-----------~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 187 (367)
T 2fst_X 122 NIVKCQ-----------KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT 187 (367)
T ss_dssp -----C-----------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC------------
T ss_pred HHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccccccccccCC
Confidence 988652 2899999999999999999999998 9999999999999999999999999986431
Q ss_pred -----------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHH---------HHHHH
Q 047629 483 -----------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEE---------KREER 536 (615)
Q Consensus 483 -----------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---------~~~~~ 536 (615)
..++.++|||||||++|||++|+.||......+. ...+...+.... .....
T Consensus 188 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---l~~i~~~~g~p~~~~~~~~~~~~~~~ 264 (367)
T 2fst_X 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ---LKLILRLVGTPGAELLKKISSESARN 264 (367)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCHHHHTTCCCHHHHH
T ss_pred CcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHHHHHhhhHHHHH
Confidence 2356789999999999999999999976542211 111111111000 00000
Q ss_pred HhhhcCCcCCCCC---ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 537 LRNWMDPNLESFY---PIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 537 ~~~~~dp~l~~~~---~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
....+...-...+ .......+.+|+.+|++.||.+|||+.|++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 265 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0010100000000 01123457899999999999999999999885
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-31 Score=284.46 Aligned_cols=226 Identities=21% Similarity=0.253 Sum_probs=160.3
Q ss_pred ceEEEEEE-CCeEEEEEEccH---HHHHHHHHHHhcCCCCcccEEEEEEcCCC-----cEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATI-DGKVLAVKKIKE---DVTEELRILQRINHANLVKLMGVSSDSQG-----NRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~-~g~~vAvK~~~~---~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-----~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
|.||++.. .+..+|+|++.. ...+|+++|++++|+||+++++++..... ..++||||++++.+........
T Consensus 54 g~V~~a~~~~~~~~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~ 133 (394)
T 4e7w_A 54 GVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAK 133 (394)
T ss_dssp EEEEEEEETTTEEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHH
T ss_pred eEEEEEEECCCCeEEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHh
Confidence 58999998 566799998853 24579999999999999999999864321 2789999998754433322111
Q ss_pred CCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeC-CCCcEEEeecCCCCCCC----------
Q 047629 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLD-SRFKAKIANFSLAAPAT---------- 482 (615)
Q Consensus 414 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld-~~~~~kl~DFGla~~~~---------- 482 (615)
.. ..+++..+..++.|++.||+|||+++ |+||||||+|||++ .++.+||+|||+++...
T Consensus 134 ~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~~~~~~~ 203 (394)
T 4e7w_A 134 LK-------QTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC 203 (394)
T ss_dssp TT-------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSSCS
T ss_pred hc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCCCccccc
Confidence 00 13899999999999999999999998 99999999999999 78999999999986421
Q ss_pred -------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHH--HHHHHHHhhhcCCcCC-
Q 047629 483 -------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVE--EKREERLRNWMDPNLE- 546 (615)
Q Consensus 483 -------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~~~~~dp~l~- 546 (615)
..++.++|||||||++|||++|+.||......+. +.. +...+... ......-....+..+.
T Consensus 204 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--l~~-i~~~~g~p~~~~~~~~~~~~~~~~~~~ 280 (394)
T 4e7w_A 204 SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ--LVE-IIKVLGTPSREQIKTMNPNYMEHKFPQ 280 (394)
T ss_dssp CGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHH-HHHHHCCCCHHHHHHHCGGGSSSCCCC
T ss_pred CcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHHHhCCCCHHHHHhhChhhhhhcccc
Confidence 1256789999999999999999999976542221 111 11111100 0000001111111111
Q ss_pred -------CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 547 -------SFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 547 -------~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
..++......+.+|+.+||+.||.+|||+.|++++
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 281 IRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp CCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 01122234568999999999999999999999975
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-30 Score=273.47 Aligned_cols=220 Identities=21% Similarity=0.310 Sum_probs=162.3
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCC-----cEEEEEeecCCCCHH
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQG-----NRFLVYEYAENGSLD 406 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-----~~~lV~E~~~~GsL~ 406 (615)
|.||+|.. +|+.||||+++ ..+.+|+.++++++|+||+++++++...+. ..++||||++ |+|.
T Consensus 56 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~ 134 (371)
T 4exu_A 56 GSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQ 134 (371)
T ss_dssp EEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHH
T ss_pred eEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHH
Confidence 58999987 68999999985 346789999999999999999999865432 1399999997 6898
Q ss_pred HhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC----
Q 047629 407 KWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT---- 482 (615)
Q Consensus 407 ~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~---- 482 (615)
+++.. .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 135 ~~~~~------------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 199 (371)
T 4exu_A 135 KIMGM------------EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT 199 (371)
T ss_dssp HHTTS------------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC--------
T ss_pred HHhhc------------CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcccccccCcC
Confidence 88742 2889999999999999999999998 9999999999999999999999999986431
Q ss_pred -----------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHH---------HHHHHH
Q 047629 483 -----------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVE---------EKREER 536 (615)
Q Consensus 483 -----------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~---------~~~~~~ 536 (615)
..++.++|||||||++|||++|+.||......+. ...+....... ......
T Consensus 200 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~ 276 (371)
T 4exu_A 200 GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTGVPGTEFVQKLNDKAAKS 276 (371)
T ss_dssp CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCHHHHTTCSCHHHHH
T ss_pred CcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCcHHHHHHhhhhhhhh
Confidence 2356789999999999999999999976442211 11111111000 000000
Q ss_pred HhhhcCCcCCCC---CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 537 LRNWMDPNLESF---YPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 537 ~~~~~dp~l~~~---~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
....+....... ........+.+|+.+|++.||++|||+.|+++.
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 277 YIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 111111111110 111234568999999999999999999999886
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=270.92 Aligned_cols=210 Identities=21% Similarity=0.337 Sum_probs=158.7
Q ss_pred ceEEEEEE--CCeEEEEEEccH--------HHHHHHH-HHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE--------DVTEELR-ILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~--------~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
|.||++.. +|+.||||+++. .+..|+. +++.++||||+++++++.+. +..++||||+++ +|.+++..
T Consensus 36 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~-~~~~lv~e~~~~-~l~~~~~~ 113 (327)
T 3aln_A 36 GSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE-GDCWICMELMST-SFDKFYKY 113 (327)
T ss_dssp EEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS-SEEEEEECCCSE-EHHHHHHH
T ss_pred EEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC-CceEEEEeecCC-ChHHHHHH
Confidence 58999998 589999998852 3445555 66778999999999998764 478999999984 88887753
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEH-AQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
..... ...+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++...
T Consensus 114 ~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 185 (327)
T 3aln_A 114 VYSVL-----DDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD 185 (327)
T ss_dssp HHHTT-----CCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC----------
T ss_pred HHhhh-----cccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecccccccccC
Confidence 11000 01389999999999999999999998 7 9999999999999999999999999986431
Q ss_pred ------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhc---
Q 047629 483 ------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWM--- 541 (615)
Q Consensus 483 ------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~--- 541 (615)
..++.++||||||+++|||++|+.||....... ..+...+
T Consensus 186 ~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------------------~~~~~~~~~~ 246 (327)
T 3aln_A 186 AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-------------------DQLTQVVKGD 246 (327)
T ss_dssp --------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------------------CCCCCSC
T ss_pred CCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-------------------HHHHHHhcCC
Confidence 124568999999999999999999997532100 0111111
Q ss_pred CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 542 DPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 542 dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.+.+...........+.+++..||+.||.+||++.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 247 PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 1222222222344568999999999999999999999875
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-30 Score=270.37 Aligned_cols=220 Identities=21% Similarity=0.310 Sum_probs=163.6
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCC-----cEEEEEeecCCCCHH
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQG-----NRFLVYEYAENGSLD 406 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-----~~~lV~E~~~~GsL~ 406 (615)
|.||+|.. +|+.||||++. ..+.+|+.++++++||||+++++++...+. ..++||||++ |+|.
T Consensus 38 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~ 116 (353)
T 3coi_A 38 GSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQ 116 (353)
T ss_dssp EEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGG
T ss_pred eEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHH
Confidence 58999987 68999999984 346789999999999999999999865432 2499999997 6898
Q ss_pred HhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC----
Q 047629 407 KWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT---- 482 (615)
Q Consensus 407 ~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~---- 482 (615)
+++.. .+++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 117 ~~~~~------------~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 181 (353)
T 3coi_A 117 KIMGL------------KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT 181 (353)
T ss_dssp GTTTS------------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC------
T ss_pred HHhcC------------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccCCCCCcc
Confidence 88742 2889999999999999999999998 9999999999999999999999999986431
Q ss_pred -----------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHH-H--------HHHHH
Q 047629 483 -----------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVE-E--------KREER 536 (615)
Q Consensus 483 -----------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~-~--------~~~~~ 536 (615)
..++.++||||||+++|||++|+.||......+ ....+....... . .....
T Consensus 182 ~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~ 258 (353)
T 3coi_A 182 GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVPGTEFVQKLNDKAAKS 258 (353)
T ss_dssp --CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH---HHHHHHHHHCBCCHHHHTTCSCHHHHH
T ss_pred ccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHHHHHhhHHHHH
Confidence 234678999999999999999999997644211 111111111000 0 00000
Q ss_pred HhhhcCCcCC---CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 537 LRNWMDPNLE---SFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 537 ~~~~~dp~l~---~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
....+..... ..........+.+++.+|++.||++|||+.|++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 259 YIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0011111001 11222345678999999999999999999999875
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-30 Score=270.05 Aligned_cols=215 Identities=18% Similarity=0.263 Sum_probs=155.4
Q ss_pred ceEEEEEE--CCeEEEEEEccH--HHHHHHH-HHHhcCCCCcccEEEEEEcC---CCcEEEEEeecCCCCHHHhhccCCC
Q 047629 343 KSVYRATI--DGKVLAVKKIKE--DVTEELR-ILQRINHANLVKLMGVSSDS---QGNRFLVYEYAENGSLDKWLHPKSK 414 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~--~~~~Ei~-~l~~l~H~niv~l~g~~~~~---~~~~~lV~E~~~~GsL~~~L~~~~~ 414 (615)
|.||++.. +|+.||||++.. ...+|+. .+..++|+||+++++++... +...++||||+++|+|.+++.....
T Consensus 43 g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~ 122 (336)
T 3fhr_A 43 GKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGD 122 (336)
T ss_dssp EEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-C
T ss_pred eEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCC
Confidence 58999998 589999999863 3334444 35667999999999997642 2247999999999999999986543
Q ss_pred CCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCC---CCcEEEeecCCCCCCCC--------
Q 047629 415 SSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDS---RFKAKIANFSLAAPATN-------- 483 (615)
Q Consensus 415 ~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~---~~~~kl~DFGla~~~~~-------- 483 (615)
. .+++.++..++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||+++....
T Consensus 123 ~--------~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 191 (336)
T 3fhr_A 123 Q--------AFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCY 191 (336)
T ss_dssp C--------CCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC----------
T ss_pred C--------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccceeccccccccCCC
Confidence 1 3899999999999999999999998 999999999999986 45599999999864321
Q ss_pred -------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 484 -------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 484 -------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
.++.++||||||+++|||++|+.||.......... ...... .... ........
T Consensus 192 t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~--------~~~~---~~~~~~~~ 257 (336)
T 3fhr_A 192 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP---GMKRRI--------RLGQ---YGFPNPEW 257 (336)
T ss_dssp ------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------------------CCCTTTS
T ss_pred CcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh---hHHHhh--------hccc---cccCchhh
Confidence 12357899999999999999999997543221100 000000 0000 01111111
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047629 551 IDGALSLATLARACTMDKSLSRPNMAEVVFNL 582 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L 582 (615)
......+.+|+.+||+.||.+|||+.|+++.-
T Consensus 258 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 289 (336)
T 3fhr_A 258 SEVSEDAKQLIRLLLKTDPTERLTITQFMNHP 289 (336)
T ss_dssp TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 23345688999999999999999999999853
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-30 Score=278.39 Aligned_cols=165 Identities=24% Similarity=0.420 Sum_probs=132.0
Q ss_pred ceEEEEEE----CCeEEEEEEcc-----HHHHHHHHHHHhcCCCCcccEEEEEEc-CCCcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATI----DGKVLAVKKIK-----EDVTEELRILQRINHANLVKLMGVSSD-SQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~----~g~~vAvK~~~-----~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
|.||+|.. +++.||||+++ ..+.+|+++|++++||||+++++++.. .+...++||||++ |+|.+++...
T Consensus 35 g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~ 113 (405)
T 3rgf_A 35 GHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFH 113 (405)
T ss_dssp -EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHH
T ss_pred eEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHh
Confidence 58999996 37889999986 468899999999999999999999864 3446899999997 5888887532
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceee----CCCCcEEEeecCCCCCCC------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQL----DSRFKAKIANFSLAAPAT------ 482 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl----d~~~~~kl~DFGla~~~~------ 482 (615)
..... ......+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 114 ~~~~~-~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 189 (405)
T 3rgf_A 114 RASKA-NKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 189 (405)
T ss_dssp HHHC--------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECCTTCCC---------
T ss_pred ccccc-cccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCccc
Confidence 21000 000123899999999999999999999998 9999999999999 778999999999996431
Q ss_pred ---------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCC
Q 047629 483 ---------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTE 512 (615)
Q Consensus 483 ---------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~ 512 (615)
..++.++|||||||++|||++|+.||....
T Consensus 190 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 190 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp -------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred ccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 124568999999999999999999997543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.5e-30 Score=277.84 Aligned_cols=213 Identities=18% Similarity=0.337 Sum_probs=156.7
Q ss_pred ceE-EEEEECCeEEEEEEccH----HHHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCCC
Q 047629 343 KSV-YRATIDGKVLAVKKIKE----DVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSS 416 (615)
Q Consensus 343 ~~V-y~~~~~g~~vAvK~~~~----~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~ 416 (615)
|.| +++..+|+.||||++.. .+.+|+++|.++ +||||+++++++.+. +..++||||++ |+|.+++.......
T Consensus 29 g~V~~~~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~-~~~~lv~E~~~-gsL~~~l~~~~~~~ 106 (434)
T 2rio_A 29 GTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTD-RFLYIALELCN-LNLQDLVESKNVSD 106 (434)
T ss_dssp TCEEEEEESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECS-SEEEEEECCCS-EEHHHHHHTC----
T ss_pred eEEEEEEEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecC-CeEEEEEecCC-CCHHHHHhccCCCc
Confidence 356 55556899999999863 467899999987 899999999998754 47899999995 79999998654321
Q ss_pred CCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCC-------------CCcEEEeecCCCCCCC-
Q 047629 417 SSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDS-------------RFKAKIANFSLAAPAT- 482 (615)
Q Consensus 417 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~-------------~~~~kl~DFGla~~~~- 482 (615)
.. ....++..++.++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+++...
T Consensus 107 ~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~ 180 (434)
T 2rio_A 107 EN---LKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180 (434)
T ss_dssp -----------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC
T ss_pred hh---hhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCC
Confidence 00 001234456789999999999999998 999999999999965 4589999999985321
Q ss_pred ---------------------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHh
Q 047629 483 ---------------------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLK 528 (615)
Q Consensus 483 ---------------------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~ 528 (615)
..++.++|||||||++|||++ |+.|+......+.
T Consensus 181 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~------------ 248 (434)
T 2rio_A 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES------------ 248 (434)
T ss_dssp --------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH------------
T ss_pred CCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH------------
Confidence 124567999999999999999 8999865432110
Q ss_pred HHHHHHHHHhhhcC-CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 529 VEEKREERLRNWMD-PNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 529 ~~~~~~~~~~~~~d-p~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
..+....+ +.+....+......+.+++.+||+.||.+|||+.||+++
T Consensus 249 ------~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 249 ------NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp ------HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ------HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 01111111 112222234566789999999999999999999999863
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.1e-30 Score=277.83 Aligned_cols=205 Identities=20% Similarity=0.323 Sum_probs=155.0
Q ss_pred eEEEEEECCeEEEEEEccH----HHHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCCCCC
Q 047629 344 SVYRATIDGKVLAVKKIKE----DVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSS 418 (615)
Q Consensus 344 ~Vy~~~~~g~~vAvK~~~~----~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~~~ 418 (615)
.||++..+|+.||||++.. .+.+|+++|+++ +|||||++++++.+. ...++||||++ |+|.+++......
T Consensus 40 V~~~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~-~~~~lv~E~~~-g~L~~~l~~~~~~--- 114 (432)
T 3p23_A 40 IVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDR-QFQYIAIELCA-ATLQEYVEQKDFA--- 114 (432)
T ss_dssp EEEEEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEET-TEEEEEEECCS-EEHHHHHHSSSCC---
T ss_pred EEEEEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecC-CEEEEEEECCC-CCHHHHHHhcCCC---
Confidence 3777778999999999864 367899999999 899999999998754 47899999996 6999999865431
Q ss_pred CCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeC-----CCCcEEEeecCCCCCCC-----------
Q 047629 419 SGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLD-----SRFKAKIANFSLAAPAT----------- 482 (615)
Q Consensus 419 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld-----~~~~~kl~DFGla~~~~----------- 482 (615)
+.+..+..++.|++.||.|||+++ |+||||||+|||++ .+.++||+|||+++...
T Consensus 115 ------~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~ 185 (432)
T 3p23_A 115 ------HLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSG 185 (432)
T ss_dssp ------CCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------
T ss_pred ------ccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccc
Confidence 444456789999999999999998 99999999999994 34578999999985431
Q ss_pred ------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCC
Q 047629 483 ------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDP 543 (615)
Q Consensus 483 ------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp 543 (615)
...+.++|||||||++|||++ |+.|+........ ..+......
T Consensus 186 ~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~------------------~~~~~~~~~ 247 (432)
T 3p23_A 186 VPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA------------------NILLGACSL 247 (432)
T ss_dssp CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH------------------HHHTTCCCC
T ss_pred cCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH------------------HHHhccCCc
Confidence 113447999999999999999 8888854332100 001111111
Q ss_pred cCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 544 NLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 544 ~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.. ...+......+.+|+.+||+.||.+|||+.||+++
T Consensus 248 ~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 248 DC-LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp TT-SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cc-cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 00 01122344557899999999999999999999953
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-30 Score=267.34 Aligned_cols=223 Identities=19% Similarity=0.255 Sum_probs=162.7
Q ss_pred ceEEEEEE--CC-eEEEEEEcc------HHHHHHHHHHHhcCCCC------cccEEEEEEcCCCcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATI--DG-KVLAVKKIK------EDVTEELRILQRINHAN------LVKLMGVSSDSQGNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~--~g-~~vAvK~~~------~~~~~Ei~~l~~l~H~n------iv~l~g~~~~~~~~~~lV~E~~~~GsL~~ 407 (615)
|.||++.. ++ +.||||.++ ..+.+|++++++++|+| ++.+.+++... +..++||||+ +|+|.+
T Consensus 33 g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~-~~~~lv~e~~-~~~l~~ 110 (355)
T 2eu9_A 33 GKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH-GHMCIAFELL-GKNTFE 110 (355)
T ss_dssp EEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET-TEEEEEEECC-CCBHHH
T ss_pred eEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC-CeEEEEEecc-CCChHH
Confidence 58999987 34 799999986 34678999999997766 89999988754 4899999999 667878
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceee-------------------CCCC
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQL-------------------DSRF 468 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl-------------------d~~~ 468 (615)
++...... .+++.++..++.|++.||.|||+++ |+||||||+|||+ +.++
T Consensus 111 ~l~~~~~~--------~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~ 179 (355)
T 2eu9_A 111 FLKENNFQ--------PYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNT 179 (355)
T ss_dssp HHHHTTTC--------CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCC
T ss_pred HHHhccCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccccccccCCC
Confidence 77654421 3899999999999999999999998 9999999999999 5678
Q ss_pred cEEEeecCCCCCCC--------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHh
Q 047629 469 KAKIANFSLAAPAT--------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLK 528 (615)
Q Consensus 469 ~~kl~DFGla~~~~--------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~ 528 (615)
.+||+|||+++... ..++.++|||||||++|||++|+.||......+.... +.....
T Consensus 180 ~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~---~~~~~~ 256 (355)
T 2eu9_A 180 SIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVM---MEKILG 256 (355)
T ss_dssp CEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHC
T ss_pred cEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHcC
Confidence 99999999986431 2356789999999999999999999976543222111 111110
Q ss_pred H---HHHH---------------------HHHHhhhcCCcC-CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 529 V---EEKR---------------------EERLRNWMDPNL-ESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 529 ~---~~~~---------------------~~~~~~~~dp~l-~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
. .... ...+.+...+.. ...........+.+|+.+||+.||++|||+.|++++
T Consensus 257 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 334 (355)
T 2eu9_A 257 PIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLH 334 (355)
T ss_dssp CCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 0000 000000000000 001122345678999999999999999999999864
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=6.8e-30 Score=265.59 Aligned_cols=197 Identities=21% Similarity=0.322 Sum_probs=160.3
Q ss_pred ceEEEEEE--CCeEEEEEEccHH-------------HHHHHHHHHhcC--CCCcccEEEEEEcCCCcEEEEEeecCC-CC
Q 047629 343 KSVYRATI--DGKVLAVKKIKED-------------VTEELRILQRIN--HANLVKLMGVSSDSQGNRFLVYEYAEN-GS 404 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~~-------------~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~~lV~E~~~~-Gs 404 (615)
|.||+|.. +|+.||||.++.. +.+|+.++++++ |+||+++++++.+. +..++|+|++.+ ++
T Consensus 57 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~~ 135 (320)
T 3a99_A 57 GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP-DSFVLILERPEPVQD 135 (320)
T ss_dssp CEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS-SEEEEEEECCSSEEE
T ss_pred eEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC-CcEEEEEEcCCCCcc
Confidence 58999987 7899999998632 457999999996 59999999998754 478999999976 89
Q ss_pred HHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeC-CCCcEEEeecCCCCCCCC
Q 047629 405 LDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLD-SRFKAKIANFSLAAPATN 483 (615)
Q Consensus 405 L~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld-~~~~~kl~DFGla~~~~~ 483 (615)
|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++ +++.+||+|||+++....
T Consensus 136 L~~~l~~~~----------~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~ 202 (320)
T 3a99_A 136 LFDFITERG----------ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKD 202 (320)
T ss_dssp HHHHHHHHC----------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCS
T ss_pred HHHHHhccC----------CCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeCcccccccc
Confidence 999997643 3899999999999999999999998 99999999999999 779999999999865422
Q ss_pred C----------------------CCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhc
Q 047629 484 D----------------------VMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWM 541 (615)
Q Consensus 484 ~----------------------~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 541 (615)
. .+.++||||||+++|||++|+.||..... .....
T Consensus 203 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----------------------~~~~~- 259 (320)
T 3a99_A 203 TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------------------IIRGQ- 259 (320)
T ss_dssp SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------------------HHHCC-
T ss_pred ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh----------------------hhccc-
Confidence 1 13578999999999999999999853210 00000
Q ss_pred CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 542 DPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 542 dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
... +......+.+++.+||+.||++|||+.|+++.
T Consensus 260 -~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 260 -VFF----RQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp -CCC----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -ccc----cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111 12233457899999999999999999999875
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4.2e-30 Score=272.04 Aligned_cols=227 Identities=19% Similarity=0.262 Sum_probs=163.9
Q ss_pred ceEEEEEE--CCeEEEEEEcc------HHHHHHHHHHHhcC-----------CCCcccEEEEEEcCC---CcEEEEEeec
Q 047629 343 KSVYRATI--DGKVLAVKKIK------EDVTEELRILQRIN-----------HANLVKLMGVSSDSQ---GNRFLVYEYA 400 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~------~~~~~Ei~~l~~l~-----------H~niv~l~g~~~~~~---~~~~lV~E~~ 400 (615)
|.||++.. +|+.||||.++ ..+.+|++++.+++ |+||+++++++...+ ...++||||+
T Consensus 33 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~ 112 (373)
T 1q8y_A 33 STVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL 112 (373)
T ss_dssp EEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC
T ss_pred eEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC
Confidence 58999996 78999999986 34678999999886 899999999986432 1478999999
Q ss_pred CCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCceeeC------CCCcEEEe
Q 047629 401 ENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEH-AQPSIVHRDIRTNNIQLD------SRFKAKIA 473 (615)
Q Consensus 401 ~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDlk~~NILld------~~~~~kl~ 473 (615)
+|+|.+++...... .+++..+..++.|++.||+|||++ + |+||||||+|||++ ..+.+||+
T Consensus 113 -~~~L~~~~~~~~~~--------~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~~~~~~kl~ 180 (373)
T 1q8y_A 113 -GENLLALIKKYEHR--------GIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIA 180 (373)
T ss_dssp -CEEHHHHHHHTTTS--------CCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEEEEEC
T ss_pred -CCCHHHHHHHhhcc--------CCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCcCcceEEEc
Confidence 88999999764431 389999999999999999999998 7 99999999999994 45589999
Q ss_pred ecCCCCCCC--------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChh---HHHHHHHHHHHhH-
Q 047629 474 NFSLAAPAT--------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKT---AVLWKEIREVLKV- 529 (615)
Q Consensus 474 DFGla~~~~--------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~---~~l~~~~~~~~~~- 529 (615)
|||+++... ..++.++|||||||++|||++|+.||........ ......+...+..
T Consensus 181 Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (373)
T 1q8y_A 181 DLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGEL 260 (373)
T ss_dssp CCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSC
T ss_pred ccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCC
Confidence 999986432 1256789999999999999999999975442111 0111111111100
Q ss_pred --HHHHH-HHHhhhcCCc-------------------CCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 530 --EEKRE-ERLRNWMDPN-------------------LESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 530 --~~~~~-~~~~~~~dp~-------------------l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
..... .....+.+.. -...++......+.+|+..||+.||++|||+.|++++
T Consensus 261 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 261 PSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 334 (373)
T ss_dssp CHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred CHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhC
Confidence 00000 0000001000 0113456777889999999999999999999999885
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=261.91 Aligned_cols=207 Identities=18% Similarity=0.332 Sum_probs=153.9
Q ss_pred ceEEEEEE--CCeEEEEEEccH---------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE---------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~---------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
+.||++.. +|+.||||+++. .+.++..+++.++|+||+++++++.+. +..++||||+ ++.+..+...
T Consensus 39 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~-~~~~lv~e~~-~~~~~~l~~~ 116 (318)
T 2dyl_A 39 GQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN-TDVFIAMELM-GTCAEKLKKR 116 (318)
T ss_dssp -CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEEEEEECCC-SEEHHHHHHH
T ss_pred eeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC-CcEEEEEecc-CCcHHHHHHH
Confidence 58999998 689999999852 133445567788999999999998764 4799999999 4455555543
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEH-AQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
... .+++..+..++.|++.||.|||+. + ++||||||+||+++.++.+||+|||+++...
T Consensus 117 ~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 184 (318)
T 2dyl_A 117 MQG---------PIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS 184 (318)
T ss_dssp HTS---------CCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC------------
T ss_pred hcc---------CCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCCcccccc
Confidence 222 389999999999999999999985 7 9999999999999999999999999985421
Q ss_pred -------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCC
Q 047629 483 -------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDP 543 (615)
Q Consensus 483 -------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp 543 (615)
..++.++||||||+++|||++|+.||........ . +.. +.....+
T Consensus 185 ~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~---~~~-----------~~~~~~~ 248 (318)
T 2dyl_A 185 AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE--V---LTK-----------VLQEEPP 248 (318)
T ss_dssp --CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--H---HHH-----------HHHSCCC
T ss_pred CCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH--H---HHH-----------HhccCCC
Confidence 1245689999999999999999999975432111 1 111 1111111
Q ss_pred cCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 544 NLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 544 ~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.+.. .......+.+++.+||+.||.+||++.|+++.
T Consensus 249 ~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 249 LLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp CCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1111 11233457899999999999999999999884
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=270.82 Aligned_cols=168 Identities=23% Similarity=0.286 Sum_probs=135.9
Q ss_pred ccccccccc----ceEEEEEE--CCeEEEEEEcc------HHHHHHHHHHHhcC-CC-----CcccEEEEEEcCCCcEEE
Q 047629 334 NLSEHYSIG----KSVYRATI--DGKVLAVKKIK------EDVTEELRILQRIN-HA-----NLVKLMGVSSDSQGNRFL 395 (615)
Q Consensus 334 ~~~~~~~iG----~~Vy~~~~--~g~~vAvK~~~------~~~~~Ei~~l~~l~-H~-----niv~l~g~~~~~~~~~~l 395 (615)
+|.....+| |.||+|.. +|+.||||+++ ..+..|+.++..++ |+ +|+++.+++... +..++
T Consensus 55 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~-~~~~l 133 (382)
T 2vx3_A 55 RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR-NHLCL 133 (382)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET-TEEEE
T ss_pred eEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC-CceEE
Confidence 344444454 58999987 68999999986 34567889998884 55 499999998764 47999
Q ss_pred EEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeC--CCCcEEEe
Q 047629 396 VYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLD--SRFKAKIA 473 (615)
Q Consensus 396 V~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld--~~~~~kl~ 473 (615)
||||++ |+|.+++...... .+++..+..++.|++.||.|||++ ..+|+||||||+|||++ .++.+||+
T Consensus 134 v~e~~~-~~L~~~l~~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 134 VFEMLS-YNLYDLLRNTNFR--------GVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp EEECCC-CBHHHHHHHTTTS--------CCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred EEecCC-CCHHHHHhhcCcC--------CCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEE
Confidence 999996 5999999865431 389999999999999999999953 12499999999999994 57889999
Q ss_pred ecCCCCCCC--------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCC
Q 047629 474 NFSLAAPAT--------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTE 512 (615)
Q Consensus 474 DFGla~~~~--------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~ 512 (615)
|||+++... ..++.++|||||||++|||++|+.||....
T Consensus 204 DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 204 DFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp CCTTCEETTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eccCceecccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999986432 125679999999999999999999998654
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-30 Score=265.36 Aligned_cols=197 Identities=23% Similarity=0.369 Sum_probs=157.8
Q ss_pred ceEEEEEE--CCeEEEEEEccH-------------HHHHHHHHHHhc----CCCCcccEEEEEEcCCCcEEEEEee-cCC
Q 047629 343 KSVYRATI--DGKVLAVKKIKE-------------DVTEELRILQRI----NHANLVKLMGVSSDSQGNRFLVYEY-AEN 402 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~-------------~~~~Ei~~l~~l----~H~niv~l~g~~~~~~~~~~lV~E~-~~~ 402 (615)
|.||+|.. +|+.||||.++. .+.+|+.++.++ +|+||+++++++... +..++|+|| +++
T Consensus 45 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~-~~~~~v~e~~~~~ 123 (312)
T 2iwi_A 45 GTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ-EGFMLVLERPLPA 123 (312)
T ss_dssp EEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC------CEEEEECCSSE
T ss_pred EEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecC-CeEEEEEEecCCC
Confidence 48999987 789999999852 134699999999 899999999998654 468999999 789
Q ss_pred CCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeC-CCCcEEEeecCCCCCC
Q 047629 403 GSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLD-SRFKAKIANFSLAAPA 481 (615)
Q Consensus 403 GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld-~~~~~kl~DFGla~~~ 481 (615)
|+|.+++.... .+++..++.++.|++.||+|||+++ |+||||||+||+++ .++.+||+|||+++..
T Consensus 124 ~~L~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~ 190 (312)
T 2iwi_A 124 QDLFDYITEKG----------PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALL 190 (312)
T ss_dssp EEHHHHHHHHC----------SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEECCCSSCEEC
T ss_pred CCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEEEcchhhhc
Confidence 99999997643 2899999999999999999999998 99999999999999 7899999999998654
Q ss_pred CCC---------------------C-CCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhh
Q 047629 482 TND---------------------V-MPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRN 539 (615)
Q Consensus 482 ~~~---------------------~-~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 539 (615)
... . +.++||||||+++|||++|+.||.... .. ...
T Consensus 191 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------------~~----------~~~ 248 (312)
T 2iwi_A 191 HDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------------EI----------LEA 248 (312)
T ss_dssp CSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HH----------HHT
T ss_pred ccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------------HH----------hhh
Confidence 211 1 237999999999999999999986311 00 000
Q ss_pred hcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 540 WMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 540 ~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.. .++......+.+++.+||+.||++|||+.|+++.
T Consensus 249 --~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 249 --EL----HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp --CC----CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred --cc----CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01 1223334567899999999999999999999975
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.6e-29 Score=283.01 Aligned_cols=200 Identities=18% Similarity=0.225 Sum_probs=156.0
Q ss_pred ceEEEEEE---CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCc----EEEEEeecCCCCHHH
Q 047629 343 KSVYRATI---DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGN----RFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~---~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~----~~lV~E~~~~GsL~~ 407 (615)
|.||++.. +|+.||||++. ..+.+|++++.+++||||+++++++...+.. .+|||||+++|+|.+
T Consensus 94 g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~ 173 (681)
T 2pzi_A 94 GWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKR 173 (681)
T ss_dssp EEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC-
T ss_pred eEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHH
Confidence 48999987 58999999884 2467899999999999999999998764422 699999999999998
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCCC---
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATND--- 484 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~--- 484 (615)
++.. .++|.+++.++.||+.||.|||+++ |+||||||+|||++.+ .+||+|||+++.....
T Consensus 174 ~~~~------------~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~~~~ 237 (681)
T 2pzi_A 174 SKGQ------------KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYL 237 (681)
T ss_dssp ---C------------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEETTCCSCC
T ss_pred HHhC------------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhcccCCcc
Confidence 7754 2899999999999999999999998 9999999999999986 8999999998654221
Q ss_pred ---------------CCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCC
Q 047629 485 ---------------VMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFY 549 (615)
Q Consensus 485 ---------------~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~ 549 (615)
.+.++|||||||++|||++|..|+......... ....
T Consensus 238 ~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~----------------------------~~~~ 289 (681)
T 2pzi_A 238 YGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP----------------------------EDDP 289 (681)
T ss_dssp CCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEECSSCC----------------------------TTCH
T ss_pred CCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCccccccccc----------------------------cccc
Confidence 245899999999999999999887542211000 0000
Q ss_pred ChHHHHHHHHHHHHhhhcCCCCCCC-HHHHHHHHHhcc
Q 047629 550 PIDGALSLATLARACTMDKSLSRPN-MAEVVFNLSVLT 586 (615)
Q Consensus 550 ~~~~~~~l~~l~~~C~~~dP~~RPs-m~ev~~~L~~l~ 586 (615)
.......+.+++.+||+.||.+||+ ++++...|..+.
T Consensus 290 ~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 290 VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 0112235789999999999999995 666766676554
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-28 Score=275.97 Aligned_cols=220 Identities=22% Similarity=0.296 Sum_probs=160.6
Q ss_pred ceEEEEEE--CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEc-----CCCcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATI--DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSD-----SQGNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~-----~~~~~~lV~E~~~~GsL~~ 407 (615)
|.||++.. +|+.||||+++ ..+.+|++++++++||||+++++++.. .++..++||||+++|+|.+
T Consensus 28 G~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~ 107 (676)
T 3qa8_A 28 GYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRK 107 (676)
T ss_dssp SBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHH
T ss_pred eEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHH
Confidence 48999987 68999999875 347789999999999999999998643 1345799999999999999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCc---EEEeecCCCCCCC--
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFK---AKIANFSLAAPAT-- 482 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~---~kl~DFGla~~~~-- 482 (615)
++...... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++. +||+|||+++...
T Consensus 108 ~L~~~~~~-------~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~ 177 (676)
T 3qa8_A 108 YLNQFENC-------CGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG 177 (676)
T ss_dssp HHHSSSCT-------TCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSC
T ss_pred HHHhcccC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccccccccccc
Confidence 99865421 13888999999999999999999998 999999999999997654 9999999986531
Q ss_pred --------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcC
Q 047629 483 --------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMD 542 (615)
Q Consensus 483 --------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~d 542 (615)
..++.++||||||+++|||++|+.||...... ..| .... ...........+...
T Consensus 178 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~---~~~--~~~i-~~~~~~~~~~~~~l~ 251 (676)
T 3qa8_A 178 ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP---VQW--HGKV-REKSNEHIVVYDDLT 251 (676)
T ss_dssp CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH---HHS--STTC-C------CCSCCCCS
T ss_pred cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch---hhh--hhhh-hcccchhhhhhhhhc
Confidence 12466899999999999999999999753211 000 0000 000000000000000
Q ss_pred C--------cCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHH
Q 047629 543 P--------NLESFYPIDGALSLATLARACTMDKSLSRPNMAEV 578 (615)
Q Consensus 543 p--------~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev 578 (615)
. .............+.+++..|++.||++|||+.|+
T Consensus 252 g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 252 GAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp SSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred cccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 0 01123445567889999999999999999999773
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-28 Score=263.81 Aligned_cols=215 Identities=18% Similarity=0.167 Sum_probs=150.8
Q ss_pred ccccccccc----ceEEEEEE--CCeEEEEEEcc----------HHHHHHHHHHHhcCC-CCcc----------c-----
Q 047629 334 NLSEHYSIG----KSVYRATI--DGKVLAVKKIK----------EDVTEELRILQRINH-ANLV----------K----- 381 (615)
Q Consensus 334 ~~~~~~~iG----~~Vy~~~~--~g~~vAvK~~~----------~~~~~Ei~~l~~l~H-~niv----------~----- 381 (615)
.|.....+| |.||+|.. +|+.||||+++ +.+.+|+.+++.++| +|.. .
T Consensus 79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 158 (413)
T 3dzo_A 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 158 (413)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence 344444555 58999997 59999999886 357899999999977 2211 1
Q ss_pred ------EEEEEEcC----CCcEEEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 047629 382 ------LMGVSSDS----QGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPS 451 (615)
Q Consensus 382 ------l~g~~~~~----~~~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 451 (615)
+..+.... ....+++|+++ +|+|.+++....... .....++|..++.++.|++.||+|||+++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 231 (413)
T 3dzo_A 159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHS---STHKSLVHHARLQLTLQVIRLLASLHHYG--- 231 (413)
T ss_dssp CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHT---TTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhccc---ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 11111110 11356677765 689999884210000 00024889999999999999999999998
Q ss_pred eEecCCCCCceeeCCCCcEEEeecCCCCCCCC-----------------------------CCCCcccchhHHHHHHHHH
Q 047629 452 IVHRDIRTNNIQLDSRFKAKIANFSLAAPATN-----------------------------DVMPKFDVFAFGVVLLELL 502 (615)
Q Consensus 452 ivHrDlk~~NILld~~~~~kl~DFGla~~~~~-----------------------------~~~~k~DV~SfGvvl~Ell 502 (615)
|+||||||+|||++.++.+||+|||+++.... .++.++|||||||++|||+
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell 311 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEEECCCCCTTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCccccCCCCceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence 99999999999999999999999999854321 1344899999999999999
Q ss_pred cCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 503 SGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 503 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
+|+.||......+. ....+.. ...++ ..+.+|+..||+.||++||++.|+++.
T Consensus 312 tg~~Pf~~~~~~~~--------------------~~~~~~~--~~~~~----~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 312 CADLPNTDDAALGG--------------------SEWIFRS--CKNIP----QPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HSSCCCCTTGGGSC--------------------SGGGGSS--CCCCC----HHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HCCCCCCCcchhhh--------------------HHHHHhh--cccCC----HHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 99999975432110 0111110 01223 458899999999999999998888653
|
| >4eby_A Chitin elicitor receptor kinase 1; pathogen-associated molecular patterns, pattern recognition receptors, LYSM, lysine chitin oligomer; HET: NAG BMA; 1.65A {Arabidopsis thaliana} PDB: 4ebz_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-26 Score=223.20 Aligned_cols=180 Identities=21% Similarity=0.394 Sum_probs=158.5
Q ss_pred Cccc-ceeeecccCCCCCCHHHHHHhhCCCh--------HHHHhhcCCCCCCCCCCCCccEEeeeeeccCCC-ceeeeee
Q 047629 39 PSCK-TYVAYFAQSPEFLDLSNISDLFGVSR--------LSIARASNLVSEDTPLVPKQLLLVPIICGCTGN-QYFANIT 108 (615)
Q Consensus 39 ~~C~-~~~~y~~~~~~~~~l~~i~~lf~~~~--------~~i~~~n~~~~~~~~~~~~~~~~vP~~C~C~~~-~~~~~~~ 108 (615)
++|+ ||+.|+.++. .||..||+.||++. .+|+.+|+...+++.|.+||.|+||++|.|.++ ...+...
T Consensus 3 ~~C~~a~~~Y~V~~G--DTL~~IA~~~~vsv~~~~~~~~~~I~~~Np~l~~~~~l~~Gq~L~IP~~~~~~~~~~~~~~~~ 80 (212)
T 4eby_A 3 TSCPLALASYYLENG--TTLSVINQNLNSSIAPYDQINFDPILRYNSNIKDKDRIQMGSRVLVPFPCECQPGDFLGHNFS 80 (212)
T ss_dssp CCCSCEEEEEECCTT--CCHHHHHHHTCCSSSCCCSSCCHHHHTTCTTCSCTTSCCTTCEEEEEECCEEETTTEEEEEEE
T ss_pred CCCccceEEEEeCCC--CCHHHHHHHHCCCchhccccCHHHHHHhccCCCCcCccCCCCEEEEeccccccCCccccCceE
Confidence 6899 9999999865 59999999999998 999999943445678999999999999999865 4457789
Q ss_pred EEeecCCchhhhhhhhcCCcchHHHHHHhCCCCCCCCcCCCcEEEEEeeccCCCCCCCCCCeeEEEEEecCCCCchhHHH
Q 047629 109 YQIKKGDSYYLVSITSFENLTNWHAVLEMNPGINPNLLQIGVKVTFPLFCKCPSKTNMEDGIENLITYVWQPGDDVSQVG 188 (615)
Q Consensus 109 y~v~~gdt~~~ia~~~~~~L~t~~~~~~~n~~~~~~~l~~G~~~~vpl~c~C~~~~~~s~~~~~l~ty~~~~gd~~~~ia 188 (615)
|+|++|||++.||...|.+|++++++...|+ ++++.+.+|++|.+|..|+|++. +.+.+..++.+|.|+.||++..||
T Consensus 81 Y~V~~GDTL~~IA~~~y~~lvt~~~L~~~N~-~~~~~l~~Gq~L~IP~~~~~~~~-~~~~~~~~~~~Y~V~~GDTL~~IA 158 (212)
T 4eby_A 81 YSVRQEDTYERVAISNYANLTTMESLQARNP-FPATNIPLSATLNVLVNCSCGDE-SVSKDFGLFVTYPLRPEDSLSSIA 158 (212)
T ss_dssp EECCTTCCHHHHHHTTTTTSSCHHHHHHHCC-SCTTCCCTTCEEEEEEECCCCCT-TTCSSCCCEEEEECCTTCCHHHHH
T ss_pred EEecCCCcHHHHHHHhcCCCCCHHHHHHhcC-CCcccCCCCCEEEEcCCCcCCCc-ccccCCCCeEEEEECCCCcHHHHH
Confidence 9999999999999888999999999999999 88899999999999999999874 455666777899999999999999
Q ss_pred HHhcCChhhHhhhccccCccccCccceeccccCCC
Q 047629 189 AKLNASSAAIETENEYRNFSEAVSLPVLIPVSQLP 223 (615)
Q Consensus 189 ~~F~~s~~~i~~~n~~~~~~~~~~~~~l~p~~~~p 223 (615)
.+||++...+..+|+..++....+. ++||.+...
T Consensus 159 ~~fgvsv~~L~~~N~~~~~~~~~g~-l~IP~~~~~ 192 (212)
T 4eby_A 159 RSSGVSADILQRYNPGVNFNSGNGI-VYVPGRDPN 192 (212)
T ss_dssp HHHTSCHHHHHHHSTTCCTTSCSSE-EEEECCCTT
T ss_pred HHHCcCHHHHHHhcCCCccCCCCCE-EEecCCCCC
Confidence 9999999999999998777666665 889987643
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-26 Score=241.89 Aligned_cols=202 Identities=15% Similarity=0.222 Sum_probs=151.8
Q ss_pred ceEEEEEECCeEEEEEEcc---------------HHHHHHHHHHHhcC---------CCCcccEEEEEEc----------
Q 047629 343 KSVYRATIDGKVLAVKKIK---------------EDVTEELRILQRIN---------HANLVKLMGVSSD---------- 388 (615)
Q Consensus 343 ~~Vy~~~~~g~~vAvK~~~---------------~~~~~Ei~~l~~l~---------H~niv~l~g~~~~---------- 388 (615)
|.||+|..+|+.||||+++ +.+.+|+.+|++++ |+|||++.+.+..
T Consensus 34 g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~ 113 (336)
T 2vuw_A 34 GEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLK 113 (336)
T ss_dssp EEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHH
T ss_pred eEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHH
Confidence 5899999999999999986 55789999999885 8888888887531
Q ss_pred -------------------CCCcEEEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHH-hCC
Q 047629 389 -------------------SQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMH-EHA 448 (615)
Q Consensus 389 -------------------~~~~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~ 448 (615)
.++..++||||+++|++.+.+... .+++.++..++.||+.||+||| +++
T Consensus 114 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~-----------~~~~~~~~~i~~qi~~aL~~lH~~~~ 182 (336)
T 2vuw_A 114 AWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK-----------LSSLATAKSILHQLTASLAVAEASLR 182 (336)
T ss_dssp HHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT-----------CCCHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred HHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc-----------CCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 145799999999999777666431 2899999999999999999999 888
Q ss_pred CCCeEecCCCCCceeeCCCC--------------------cEEEeecCCCCCCC-----------------CCCCCcccc
Q 047629 449 QPSIVHRDIRTNNIQLDSRF--------------------KAKIANFSLAAPAT-----------------NDVMPKFDV 491 (615)
Q Consensus 449 ~~~ivHrDlk~~NILld~~~--------------------~~kl~DFGla~~~~-----------------~~~~~k~DV 491 (615)
|+||||||+|||++.++ .+||+|||+|+... ...+.++||
T Consensus 183 ---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~~~~gt~~y~aPE~~~g~~~~~~Di 259 (336)
T 2vuw_A 183 ---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQFDI 259 (336)
T ss_dssp ---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETTEEECCCCTTCSGGGCCCSSHHHHH
T ss_pred ---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCCcEEEeecccChhhhcCCCccceeh
Confidence 99999999999999887 89999999997531 112568999
Q ss_pred hhHHHH-HHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhc--CCcCCCCCChHHHHHHHHHHHHhhhcC
Q 047629 492 FAFGVV-LLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWM--DPNLESFYPIDGALSLATLARACTMDK 568 (615)
Q Consensus 492 ~SfGvv-l~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~--dp~l~~~~~~~~~~~l~~l~~~C~~~d 568 (615)
||+|++ .+++++|..|+.. ..| .... ...+.... ........+......+.+|+.+|++.|
T Consensus 260 wsl~~~~~~~~~~g~~p~~~-------~~~--~~~~-------~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d 323 (336)
T 2vuw_A 260 YRLMKKENNNRWGEYHPYSN-------VLW--LHYL-------TDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS 323 (336)
T ss_dssp HHHHHHHHTTCTTSCCTHHH-------HHH--HHHH-------HHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS
T ss_pred hhhhCCCCcccccccCCCcc-------hhh--hhHH-------HHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC
Confidence 998777 7788889988732 111 1111 01111111 111111123356678999999999966
Q ss_pred CCCCCCHHHHH
Q 047629 569 SLSRPNMAEVV 579 (615)
Q Consensus 569 P~~RPsm~ev~ 579 (615)
|++|++
T Consensus 324 -----sa~e~l 329 (336)
T 2vuw_A 324 -----SATDLL 329 (336)
T ss_dssp -----SHHHHH
T ss_pred -----CHHHHH
Confidence 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.8e-23 Score=232.14 Aligned_cols=141 Identities=18% Similarity=0.253 Sum_probs=115.5
Q ss_pred CCeEEEEEEcc-----------------HHHHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 351 DGKVLAVKKIK-----------------EDVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 351 ~g~~vAvK~~~-----------------~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
.|+.+|||.+. +++.+|+++|+++ +|+||+++++++.+ ++..||||||+++|+|.++|...
T Consensus 258 fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed-~~~~yLVMEyv~G~~L~d~i~~~ 336 (569)
T 4azs_A 258 FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN-AQSGWLVMEKLPGRLLSDMLAAG 336 (569)
T ss_dssp ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC-SSEEEEEEECCCSEEHHHHHHTT
T ss_pred ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE-CCEEEEEEecCCCCcHHHHHHhC
Confidence 68889999884 2478899999999 79999999999875 45899999999999999999865
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCCC-CCCcccc
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATND-VMPKFDV 491 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~-~~~k~DV 491 (615)
.. ++.. +|+.||+.||+|+|+++ ||||||||+|||+++++++||+|||+|+..... ....+++
T Consensus 337 ~~----------l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~t~v 400 (569)
T 4azs_A 337 EE----------IDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPTNLV 400 (569)
T ss_dssp CC----------CCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSHHHH
T ss_pred CC----------CCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCCccccCce
Confidence 42 5543 47899999999999998 999999999999999999999999999876543 3456778
Q ss_pred hhHHHHHHHHHcCCCCC
Q 047629 492 FAFGVVLLELLSGKKAT 508 (615)
Q Consensus 492 ~SfGvvl~ElltG~~p~ 508 (615)
|+.|.+..|+++|+.++
T Consensus 401 GTp~YmAPE~l~g~~~~ 417 (569)
T 4azs_A 401 QSFFVFVNELFAENKSW 417 (569)
T ss_dssp HHHHHHHHHHC------
T ss_pred echhhccHHHhCCCCCC
Confidence 88888888888876543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=2.4e-19 Score=199.20 Aligned_cols=117 Identities=16% Similarity=0.238 Sum_probs=100.7
Q ss_pred ceEEEEEECCeEEEEEEcc---------------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATIDGKVLAVKKIK---------------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~~g~~vAvK~~~---------------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~ 407 (615)
+.||+|...++.+++|+.. +.+.+|+++|++++|+||+++..++... ...+|||||+++|+|.+
T Consensus 350 g~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~-~~~~lVmE~~~ggsL~~ 428 (540)
T 3en9_A 350 ADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDL-DNKRIMMSYINGKLAKD 428 (540)
T ss_dssp EEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEET-TTTEEEEECCCSEEHHH
T ss_pred EEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeC-CccEEEEECCCCCCHHH
Confidence 4899998899999999752 2368999999999999999555555443 36799999999999999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN 483 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~ 483 (615)
++.. +..++.|++.||+|||+++ |+||||||+|||++. ++||+|||+++....
T Consensus 429 ~l~~------------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 429 VIED------------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp HSTT------------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred HHHH------------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 9864 2478999999999999998 999999999999999 999999999987654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=1.2e-17 Score=170.27 Aligned_cols=116 Identities=16% Similarity=0.169 Sum_probs=95.7
Q ss_pred ceEEEEEE-CCeEEEEEEcc-------------------------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEE
Q 047629 343 KSVYRATI-DGKVLAVKKIK-------------------------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLV 396 (615)
Q Consensus 343 ~~Vy~~~~-~g~~vAvK~~~-------------------------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV 396 (615)
|.||+|.. +|+.||||.++ ..+.+|+++|++++| +++.+++.. +..++|
T Consensus 104 g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~~~~~~--~~~~lv 178 (282)
T 1zar_A 104 SAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVPKVYAW--EGNAVL 178 (282)
T ss_dssp EEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSCCEEEE--ETTEEE
T ss_pred ceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcCeEEec--cceEEE
Confidence 58999998 68999999984 236789999999994 555554432 357999
Q ss_pred EeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecC
Q 047629 397 YEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFS 476 (615)
Q Consensus 397 ~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFG 476 (615)
|||+++|+|.+ +... ....++.|++.||.|||+++ |+||||||+|||++ ++.+||+|||
T Consensus 179 mE~~~g~~L~~-l~~~----------------~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~DFG 237 (282)
T 1zar_A 179 MELIDAKELYR-VRVE----------------NPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFP 237 (282)
T ss_dssp EECCCCEEGGG-CCCS----------------CHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEECCCT
T ss_pred EEecCCCcHHH-cchh----------------hHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEEECC
Confidence 99999999998 4211 12368999999999999998 99999999999999 9999999999
Q ss_pred CCCCCCCC
Q 047629 477 LAAPATND 484 (615)
Q Consensus 477 la~~~~~~ 484 (615)
+++.....
T Consensus 238 ~a~~~~~~ 245 (282)
T 1zar_A 238 QSVEVGEE 245 (282)
T ss_dssp TCEETTST
T ss_pred CCeECCCC
Confidence 99876543
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=1.8e-15 Score=151.98 Aligned_cols=117 Identities=23% Similarity=0.236 Sum_probs=92.5
Q ss_pred ceEEEEEE--CCeE--EEEEEcc-------------------------------HHHHHHHHHHHhcCCCCc--ccEEEE
Q 047629 343 KSVYRATI--DGKV--LAVKKIK-------------------------------EDVTEELRILQRINHANL--VKLMGV 385 (615)
Q Consensus 343 ~~Vy~~~~--~g~~--vAvK~~~-------------------------------~~~~~Ei~~l~~l~H~ni--v~l~g~ 385 (615)
+.||+|.. +|+. ||||.++ ..+.+|+.+|.+++|+++ ..++++
T Consensus 61 g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~ 140 (258)
T 1zth_A 61 ANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAGVSVPQPYTY 140 (258)
T ss_dssp EEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTTCCCCCEEEE
T ss_pred EEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCCCCCCeEEEc
Confidence 48999998 8999 9999752 146789999999988864 344442
Q ss_pred EEcCCCcEEEEEeecC-CC----CHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHH-hCCCCCeEecCCCC
Q 047629 386 SSDSQGNRFLVYEYAE-NG----SLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMH-EHAQPSIVHRDIRT 459 (615)
Q Consensus 386 ~~~~~~~~~lV~E~~~-~G----sL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivHrDlk~ 459 (615)
...+|||||+. +| +|.++... +++.....++.|++.||.||| +.+ |+||||||
T Consensus 141 -----~~~~lVmE~~g~~g~~~~~L~~~~~~-------------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrDlkp 199 (258)
T 1zth_A 141 -----MKNVLLMEFIGEDELPAPTLVELGRE-------------LKELDVEGIFNDVVENVKRLYQEAE---LVHADLSE 199 (258)
T ss_dssp -----ETTEEEEECCEETTEECCBHHHHGGG-------------GGGSCHHHHHHHHHHHHHHHHHTSC---EECSSCST
T ss_pred -----CCCEEEEEecCCCCCccccHHHHhhc-------------cChHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCH
Confidence 14689999994 24 67666432 223456788999999999999 887 99999999
Q ss_pred CceeeCCCCcEEEeecCCCCCCC
Q 047629 460 NNIQLDSRFKAKIANFSLAAPAT 482 (615)
Q Consensus 460 ~NILld~~~~~kl~DFGla~~~~ 482 (615)
+|||++. .++|+|||+|....
T Consensus 200 ~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 200 YNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp TSEEESS--SEEECCCTTCEETT
T ss_pred HHEEEcC--cEEEEECcccccCC
Confidence 9999998 99999999987653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.27 E-value=7.9e-12 Score=131.56 Aligned_cols=115 Identities=11% Similarity=0.154 Sum_probs=84.8
Q ss_pred ceEEEEEE-CCeEEEEEEccH---------------------H--------HHHHHHHHHhcCCCCcc--cEEEEEEcCC
Q 047629 343 KSVYRATI-DGKVLAVKKIKE---------------------D--------VTEELRILQRINHANLV--KLMGVSSDSQ 390 (615)
Q Consensus 343 ~~Vy~~~~-~g~~vAvK~~~~---------------------~--------~~~Ei~~l~~l~H~niv--~l~g~~~~~~ 390 (615)
+.||+|.. +|+.||||.++. . ...|...|.++++.++. +.+++ .
T Consensus 109 a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp~p~~~--~-- 184 (397)
T 4gyi_A 109 SDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVPEPIAQ--S-- 184 (397)
T ss_dssp EEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCCCEEEE--E--
T ss_pred eEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCCeeeec--c--
Confidence 48999987 799999997631 1 12466777777555442 23322 1
Q ss_pred CcEEEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCC--
Q 047629 391 GNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRF-- 468 (615)
Q Consensus 391 ~~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~-- 468 (615)
..+|||||+++++|.++.... ....++.|++.+|.|||+++ ||||||||.|||+++++
T Consensus 185 -~~~LVME~i~G~~L~~l~~~~----------------~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 185 -RHTIVMSLVDALPMRQVSSVP----------------DPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp -TTEEEEECCSCEEGGGCCCCS----------------CHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEECS
T ss_pred -CceEEEEecCCccHhhhcccH----------------HHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCCc
Confidence 237999999998887654211 12457889999999999998 99999999999998876
Q ss_pred --------cEEEeecCCCCCC
Q 047629 469 --------KAKIANFSLAAPA 481 (615)
Q Consensus 469 --------~~kl~DFGla~~~ 481 (615)
.+.|.||+-+...
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEET
T ss_pred ccccccccceEEEEeCCcccC
Confidence 3899999987544
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.94 E-value=4.7e-09 Score=104.77 Aligned_cols=122 Identities=14% Similarity=0.160 Sum_probs=96.3
Q ss_pred ceEEEEEECCeEEEEEEccH-------HHHHHHHHHHhcC-CCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCC
Q 047629 343 KSVYRATIDGKVLAVKKIKE-------DVTEELRILQRIN-HANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSK 414 (615)
Q Consensus 343 ~~Vy~~~~~g~~vAvK~~~~-------~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~ 414 (615)
..||+....|+.+++|.... .+.+|.++++.+. |.++.++++++.+ .+..++||||+++.+|.+.+...
T Consensus 28 ~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-~~~~~lv~e~i~G~~l~~~~~~~-- 104 (263)
T 3tm0_A 28 AKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH-DGWSNLLMSEADGVLCSEEYEDE-- 104 (263)
T ss_dssp SEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-TTEEEEEEECCSSEEHHHHCCTT--
T ss_pred CeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec-CCceEEEEEecCCeehhhccCCc--
Confidence 46999887789999999863 4889999999994 6677789998765 45789999999999998764211
Q ss_pred CCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------------
Q 047629 415 SSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHA---------------------------------------------- 448 (615)
Q Consensus 415 ~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------------- 448 (615)
.+...++.+++.+|..||+..
T Consensus 105 -------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 171 (263)
T 3tm0_A 105 -------------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELY 171 (263)
T ss_dssp -------------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHH
T ss_pred -------------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHH
Confidence 122467889999999999811
Q ss_pred ----------CCCeEecCCCCCceeeCCCCcEEEeecCCCCC
Q 047629 449 ----------QPSIVHRDIRTNNIQLDSRFKAKIANFSLAAP 480 (615)
Q Consensus 449 ----------~~~ivHrDlk~~NILld~~~~~kl~DFGla~~ 480 (615)
.+.++|+|+++.|||++++..+.|.||+.+..
T Consensus 172 ~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 172 DFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 14599999999999998765667999997654
|
| >4eby_A Chitin elicitor receptor kinase 1; pathogen-associated molecular patterns, pattern recognition receptors, LYSM, lysine chitin oligomer; HET: NAG BMA; 1.65A {Arabidopsis thaliana} PDB: 4ebz_A* | Back alignment and structure |
|---|
Probab=98.85 E-value=7.8e-09 Score=99.64 Aligned_cols=112 Identities=17% Similarity=0.372 Sum_probs=88.1
Q ss_pred eeeeEEeecCCchhhhhhhhcCCcc-----hHHHHHHhCCCC-CCCCcCCCcEEEEEeeccCCCCCCCCCCeeEEEEEec
Q 047629 105 ANITYQIKKGDSYYLVSITSFENLT-----NWHAVLEMNPGI-NPNLLQIGVKVTFPLFCKCPSKTNMEDGIENLITYVW 178 (615)
Q Consensus 105 ~~~~y~v~~gdt~~~ia~~~~~~L~-----t~~~~~~~n~~~-~~~~l~~G~~~~vpl~c~C~~~~~~s~~~~~l~ty~~ 178 (615)
+-..|+|++|||++.||....-... .+.++...||.+ +++.+.+|+.|.+|..|.|.+.. ......+|.|
T Consensus 8 a~~~Y~V~~GDTL~~IA~~~~vsv~~~~~~~~~~I~~~Np~l~~~~~l~~Gq~L~IP~~~~~~~~~----~~~~~~~Y~V 83 (212)
T 4eby_A 8 ALASYYLENGTTLSVINQNLNSSIAPYDQINFDPILRYNSNIKDKDRIQMGSRVLVPFPCECQPGD----FLGHNFSYSV 83 (212)
T ss_dssp EEEEEECCTTCCHHHHHHHTCCSSSCCCSSCCHHHHTTCTTCSCTTSCCTTCEEEEEECCEEETTT----EEEEEEEEEC
T ss_pred ceEEEEeCCCCCHHHHHHHHCCCchhccccCHHHHHHhccCCCCcCccCCCCEEEEeccccccCCc----cccCceEEEe
Confidence 5568999999999999986543331 158899999767 58899999999999999996421 1223468999
Q ss_pred CCCCchhHHH-HHhc--CChhhHhhhccccCccccCccceecccc
Q 047629 179 QPGDDVSQVG-AKLN--ASSAAIETENEYRNFSEAVSLPVLIPVS 220 (615)
Q Consensus 179 ~~gd~~~~ia-~~F~--~s~~~i~~~n~~~~~~~~~~~~~l~p~~ 220 (615)
+.||++..|| .+|+ ++...+...|........+|..+.||..
T Consensus 84 ~~GDTL~~IA~~~y~~lvt~~~L~~~N~~~~~~l~~Gq~L~IP~~ 128 (212)
T 4eby_A 84 RQEDTYERVAISNYANLTTMESLQARNPFPATNIPLSATLNVLVN 128 (212)
T ss_dssp CTTCCHHHHHHTTTTTSSCHHHHHHHCCSCTTCCCTTCEEEEEEE
T ss_pred cCCCcHHHHHHHhcCCCCCHHHHHHhcCCCcccCCCCCEEEEcCC
Confidence 9999999999 7999 9999999999864444556777888864
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.75 E-value=2.8e-08 Score=98.42 Aligned_cols=120 Identities=17% Similarity=0.203 Sum_probs=88.5
Q ss_pred ceEEEEEE-CCeEEEEEEccH----HHHHHHHHHHhcCCCCc--ccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCC
Q 047629 343 KSVYRATI-DGKVLAVKKIKE----DVTEELRILQRINHANL--VKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKS 415 (615)
Q Consensus 343 ~~Vy~~~~-~g~~vAvK~~~~----~~~~Ei~~l~~l~H~ni--v~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~ 415 (615)
+.||+... +|+.+++|.... .+..|+++++.+++.++ .+++++..+ ++..++||||+++.+|. ...
T Consensus 34 ~~v~~~~~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~-~~~~~~v~e~i~G~~l~--~~~---- 106 (264)
T 1nd4_A 34 AAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTE-AGRDWLLLGEVPGQDLL--SSH---- 106 (264)
T ss_dssp CEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-SSCEEEEEECCSSEETT--TSC----
T ss_pred ceEEEEecCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccC-CCCCEEEEEecCCcccC--cCc----
Confidence 57999876 577899998753 47799999999965554 468887654 34689999999998884 211
Q ss_pred CCCCCcccccCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------------
Q 047629 416 SSSSGSVIFLTWSQRLRVALDVANGLQYMHEHA----------------------------------------------- 448 (615)
Q Consensus 416 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------------------------- 448 (615)
.+ ...++.+++..|..||+..
T Consensus 107 ---------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (264)
T 1nd4_A 107 ---------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL 174 (264)
T ss_dssp ---------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred ---------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHH
Confidence 11 1245667777777777642
Q ss_pred --------CCCeEecCCCCCceeeCCCCcEEEeecCCCCCC
Q 047629 449 --------QPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA 481 (615)
Q Consensus 449 --------~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~ 481 (615)
.+.++|+|++|.|||++++..++|.|||.+...
T Consensus 175 ~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 175 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred HHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 123999999999999988766779999987543
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.71 E-value=6.6e-08 Score=101.22 Aligned_cols=125 Identities=16% Similarity=0.285 Sum_probs=97.5
Q ss_pred eEEEEEECCeEEEEEEcc----------HHHHHHHHHHHhcC--CCCcccEEEEEEcCC--CcEEEEEeecCCCCHHHhh
Q 047629 344 SVYRATIDGKVLAVKKIK----------EDVTEELRILQRIN--HANLVKLMGVSSDSQ--GNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 344 ~Vy~~~~~g~~vAvK~~~----------~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~--~~~~lV~E~~~~GsL~~~L 409 (615)
.+|+....+..+++|+.. .++.+|..+++.++ +.++.++++++.+.+ +..++||||+++..+.+..
T Consensus 53 ~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~ 132 (359)
T 3dxp_A 53 PTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS 132 (359)
T ss_dssp CEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT
T ss_pred eEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCc
Confidence 688888777788888775 24678999999997 455788998876432 3579999999987774321
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHA----------------------------------------- 448 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------------------- 448 (615)
. ..++..++..++.++++.|..||...
T Consensus 133 ~------------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (359)
T 3dxp_A 133 L------------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSL 200 (359)
T ss_dssp C------------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHH
T ss_pred c------------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHH
Confidence 1 02778889999999999999999831
Q ss_pred --------------CCCeEecCCCCCceeeCCCCc--EEEeecCCCCC
Q 047629 449 --------------QPSIVHRDIRTNNIQLDSRFK--AKIANFSLAAP 480 (615)
Q Consensus 449 --------------~~~ivHrDlk~~NILld~~~~--~kl~DFGla~~ 480 (615)
.+.++|+|+++.|||++.++. +.|.||+.+..
T Consensus 201 ~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 201 MDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 256999999999999997753 68999998764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.28 E-value=1.9e-06 Score=87.83 Aligned_cols=144 Identities=21% Similarity=0.225 Sum_probs=98.7
Q ss_pred eEEEEEEcc-----HHHHHHHHHHHhc-CCCC--cccEEEEEEcCC--CcEEEEEeecCCCCHHHhhccCCCCCCCCCcc
Q 047629 353 KVLAVKKIK-----EDVTEELRILQRI-NHAN--LVKLMGVSSDSQ--GNRFLVYEYAENGSLDKWLHPKSKSSSSSGSV 422 (615)
Q Consensus 353 ~~vAvK~~~-----~~~~~Ei~~l~~l-~H~n--iv~l~g~~~~~~--~~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~ 422 (615)
+.+++|... ..+.+|.++|+.+ .+.. +.+.++.....+ +..|+|||++++.+|.+....
T Consensus 41 ~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~~----------- 109 (304)
T 3sg8_A 41 RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLLN----------- 109 (304)
T ss_dssp TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHHH-----------
T ss_pred CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCccccc-----------
Confidence 457788754 3477899999988 4433 335555432222 124889999999887653321
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhC-------------------------------------------------------
Q 047629 423 IFLTWSQRLRVALDVANGLQYMHEH------------------------------------------------------- 447 (615)
Q Consensus 423 ~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------------------- 447 (615)
.++..++..++.+++..|..||..
T Consensus 110 -~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~ 188 (304)
T 3sg8_A 110 -NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFK 188 (304)
T ss_dssp -TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTC
T ss_pred -cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhcccccc
Confidence 266777788888888888888862
Q ss_pred CCCCeEecCCCCCceeeCC--CCcEEEeecCCCCCCC----------C--CCC------------C------------cc
Q 047629 448 AQPSIVHRDIRTNNIQLDS--RFKAKIANFSLAAPAT----------N--DVM------------P------------KF 489 (615)
Q Consensus 448 ~~~~ivHrDlk~~NILld~--~~~~kl~DFGla~~~~----------~--~~~------------~------------k~ 489 (615)
..+.++|+|+++.||++++ ...+.|.||+.+.... . .+. . ..
T Consensus 189 ~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~ 268 (304)
T 3sg8_A 189 YYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKE 268 (304)
T ss_dssp CCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHH
T ss_pred CCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHH
Confidence 1245899999999999998 4567899999874321 0 011 0 14
Q ss_pred cchhHHHHHHHHHcCCCCC
Q 047629 490 DVFAFGVVLLELLSGKKAT 508 (615)
Q Consensus 490 DV~SfGvvl~ElltG~~p~ 508 (615)
+.|++|.++|++.+|+.++
T Consensus 269 ~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 269 KYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHHHHHHcCCHHH
Confidence 7788999999999887664
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.98 E-value=6.2e-05 Score=76.74 Aligned_cols=123 Identities=18% Similarity=0.240 Sum_probs=83.0
Q ss_pred eEEEEEECCeEEEEEEcc-----HHHHHHHHHHHhcCCC---CcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCC
Q 047629 344 SVYRATIDGKVLAVKKIK-----EDVTEELRILQRINHA---NLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKS 415 (615)
Q Consensus 344 ~Vy~~~~~g~~vAvK~~~-----~~~~~Ei~~l~~l~H~---niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~ 415 (615)
.||+. |+.+++|.-+ ..+.+|.++|..+.+. .+-+.+.++...++..++|||++++.+|.+....
T Consensus 34 ~v~~v---g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~~---- 106 (306)
T 3tdw_A 34 YAILV---NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGMA---- 106 (306)
T ss_dssp EEEEE---TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHHT----
T ss_pred eEEEE---CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhhh----
Confidence 46665 5667778754 3477899999999753 3557777765445678999999998887663211
Q ss_pred CCCCCcccccCHHHHHHHHHHHHHHHHHHHhC------------------------------------------------
Q 047629 416 SSSSGSVIFLTWSQRLRVALDVANGLQYMHEH------------------------------------------------ 447 (615)
Q Consensus 416 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------------ 447 (615)
.++..++..++.++++.|..||..
T Consensus 107 --------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 178 (306)
T 3tdw_A 107 --------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQS 178 (306)
T ss_dssp --------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHH
T ss_pred --------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHH
Confidence 133444444455555555554432
Q ss_pred ---------CCCCeEecCCCCCceeeCC---CCc-EEEeecCCCCCC
Q 047629 448 ---------AQPSIVHRDIRTNNIQLDS---RFK-AKIANFSLAAPA 481 (615)
Q Consensus 448 ---------~~~~ivHrDlk~~NILld~---~~~-~kl~DFGla~~~ 481 (615)
..+.++|+|+++.|||++. ++. ..|.||+.+...
T Consensus 179 ~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 179 YMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2345799999999999987 455 489999987653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.98 E-value=3.9e-05 Score=76.31 Aligned_cols=124 Identities=17% Similarity=0.163 Sum_probs=85.1
Q ss_pred ceEEEEEE--CCeEEEEEEcc----HHHHHHHHHHHhcC-CCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK----EDVTEELRILQRIN-HANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKS 415 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~----~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~ 415 (615)
..||+-.. ++..+.+|+-. .++.+|...|+.+. +--+-++++++.+. +..++|||++++.++.+......
T Consensus 39 ~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~-~~~~lvme~l~G~~~~~~~~~~~-- 115 (272)
T 4gkh_A 39 ATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTP-DDAWLLTTAIPGKTAFQVLEEYP-- 115 (272)
T ss_dssp CEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEET-TEEEEEEECCCSEEHHHHHHHCG--
T ss_pred CeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEEC-CeEEEEEEeeCCccccccccCCH--
Confidence 36888665 45678899875 35778999999884 33456788887654 47899999999887766543211
Q ss_pred CCCCCcccccCHHHHHHHHHHHHHHHHHHHh-------------------------------------------------
Q 047629 416 SSSSGSVIFLTWSQRLRVALDVANGLQYMHE------------------------------------------------- 446 (615)
Q Consensus 416 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~------------------------------------------------- 446 (615)
.....++.+++..|.-||.
T Consensus 116 ------------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 183 (272)
T 4gkh_A 116 ------------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEM 183 (272)
T ss_dssp ------------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHH
T ss_pred ------------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHH
Confidence 1122344445555555553
Q ss_pred --C----CCCCeEecCCCCCceeeCCCCcEEEeecCCCCCC
Q 047629 447 --H----AQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA 481 (615)
Q Consensus 447 --~----~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~ 481 (615)
. ..+.++|+|+.+.|||++++..+-|.||+.+...
T Consensus 184 ~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 184 HKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp HTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 1 1224899999999999998777779999987543
|
| >2l9y_A CVNH-LYSM lectin; carbohydrate, sugar binding protein; NMR {Magnaporthe oryzae 70-15} | Back alignment and structure |
|---|
Probab=97.47 E-value=2.7e-05 Score=71.90 Aligned_cols=94 Identities=13% Similarity=0.042 Sum_probs=68.8
Q ss_pred eeeeEEeecCCchhhhhhhhcCCcchHHHHHHhCCCCCCCCcCCCcEEEEEeeccCCCC-CCCCCCeeEEEEEecCCCCc
Q 047629 105 ANITYQIKKGDSYYLVSITSFENLTNWHAVLEMNPGINPNLLQIGVKVTFPLFCKCPSK-TNMEDGIENLITYVWQPGDD 183 (615)
Q Consensus 105 ~~~~y~v~~gdt~~~ia~~~~~~L~t~~~~~~~n~~~~~~~l~~G~~~~vpl~c~C~~~-~~~s~~~~~l~ty~~~~gd~ 183 (615)
+...|+|++|||++.||... + .+|.++...|...+|+.|.+|++|.+|..-.-+.. .... ..--..|+++.||+
T Consensus 61 ~~~~y~V~~GDTL~~IA~~~--~-~~~~~l~~~N~~~~~~~i~~Gq~L~ip~~~~~~~~~~~~~--~~~~~~~~v~~Gdt 135 (167)
T 2l9y_A 61 GTATVTVQQGDTLRDIGRRF--D-CDFHEIARRNNIQNEDLIYPGQVLQVPTKGGSGGGAGNFW--DSARDVRLVDGGKV 135 (167)
T ss_dssp SCEEEEECTTCCHHHHHHHT--T-CCHHHHHHHHTCCGGGCCCTTEEEEESCCCCCSSSSCCGG--GGEEEEEEETTTTE
T ss_pred CCceEEECCCCcHHHHHHHc--C-CCHHHHHHHcCCCCcccccCCCEEEEcCCCCccccccccc--cccceEEEeCCcCC
Confidence 45789999999999999864 3 56899999998888899999999999964321100 1111 11124688999999
Q ss_pred hhHHHHHhcCChhhHhhhcc
Q 047629 184 VSQVGAKLNASSAAIETENE 203 (615)
Q Consensus 184 ~~~ia~~F~~s~~~i~~~n~ 203 (615)
+..|+.++|.+....+..|.
T Consensus 136 L~aIA~r~G~~v~s~i~Ln~ 155 (167)
T 2l9y_A 136 LEAELRYSGGWNRSRIYLDE 155 (167)
T ss_dssp EEEEEEETTEEEEEEECGGG
T ss_pred hHHHHHHcCCceEEEEEccc
Confidence 99999888876655555543
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00027 Score=73.38 Aligned_cols=64 Identities=9% Similarity=0.215 Sum_probs=45.1
Q ss_pred eEEEEEEC--------CeEEEEEEcc----------HHHHHHHHHHHhcCC---CCcccEEEEEEcCC--CcEEEEEeec
Q 047629 344 SVYRATID--------GKVLAVKKIK----------EDVTEELRILQRINH---ANLVKLMGVSSDSQ--GNRFLVYEYA 400 (615)
Q Consensus 344 ~Vy~~~~~--------g~~vAvK~~~----------~~~~~Ei~~l~~l~H---~niv~l~g~~~~~~--~~~~lV~E~~ 400 (615)
.+|+.... |+.+++|.-. ..+.+|..+|+.+.. -.+-++++++.+.. +..++||||+
T Consensus 36 ~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l 115 (357)
T 3ats_A 36 ETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYV 115 (357)
T ss_dssp EEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECC
T ss_pred eEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEec
Confidence 57776654 6778888753 246789999998843 35667888765432 3568999999
Q ss_pred CCCCHHH
Q 047629 401 ENGSLDK 407 (615)
Q Consensus 401 ~~GsL~~ 407 (615)
++..+.+
T Consensus 116 ~G~~l~~ 122 (357)
T 3ats_A 116 EGVVPPD 122 (357)
T ss_dssp CCBCCCB
T ss_pred CCCChhh
Confidence 9876653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0025 Score=65.16 Aligned_cols=153 Identities=15% Similarity=0.222 Sum_probs=85.2
Q ss_pred ceEEEEEECCeEEEEEEccH---HHHHHHHHHHhcCC--CCcccEEEE-----EEcCCCcEEEEEeecCCCCHH------
Q 047629 343 KSVYRATIDGKVLAVKKIKE---DVTEELRILQRINH--ANLVKLMGV-----SSDSQGNRFLVYEYAENGSLD------ 406 (615)
Q Consensus 343 ~~Vy~~~~~g~~vAvK~~~~---~~~~Ei~~l~~l~H--~niv~l~g~-----~~~~~~~~~lV~E~~~~GsL~------ 406 (615)
..||+...++..+++|+... .+..|..++..+.. -.+.+++.. +....+..+++|||+++..+.
T Consensus 46 n~~~~v~~~~~~~vlk~~~~~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~ 125 (346)
T 2q83_A 46 ALVWKVHTDSGAVCLKRIHRPEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIEGRPFELTVKQD 125 (346)
T ss_dssp CEEEEEEETTEEEEEEEECSCHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCCCBCCCTTSHHH
T ss_pred CcEEEEEeCCCCEEEEecCCCHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeecCccCCCCCHHH
Confidence 47888887666799998863 34556777766631 122333321 111234678999999986542
Q ss_pred --------HhhccCCCCC-CCCC---cccccCHHHHH-------------------------------HHHHHHHHHHHH
Q 047629 407 --------KWLHPKSKSS-SSSG---SVIFLTWSQRL-------------------------------RVALDVANGLQY 443 (615)
Q Consensus 407 --------~~L~~~~~~~-~~~~---~~~~l~~~~~~-------------------------------~i~~~ia~gL~y 443 (615)
..+|.....- .+.. ....-.|.... .+...+...+.+
T Consensus 126 ~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (346)
T 2q83_A 126 LEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDGFIEDGLRIKDR 205 (346)
T ss_dssp HHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHHHHHHHHHHHHH
Confidence 1122111000 0000 00112343211 111123445667
Q ss_pred HHh----------CCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCCCCCCcccchhHHHHHHHHH
Q 047629 444 MHE----------HAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVMPKFDVFAFGVVLLELL 502 (615)
Q Consensus 444 LH~----------~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~k~DV~SfGvvl~Ell 502 (615)
|++ ...+.++|+|+++.|||++.+..+.|.||+.+..... +|-++.++..++
T Consensus 206 l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~g~~-------~~Dla~~l~~~~ 267 (346)
T 2q83_A 206 LLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSFDLP-------IRDLRKMIIPLL 267 (346)
T ss_dssp HHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEECCT-------HHHHHHHHHHHT
T ss_pred HHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcccCCh-------HHHHHHHHHHHH
Confidence 763 1245699999999999998888999999997654322 345566666654
|
| >2l9y_A CVNH-LYSM lectin; carbohydrate, sugar binding protein; NMR {Magnaporthe oryzae 70-15} | Back alignment and structure |
|---|
Probab=97.03 E-value=0.00053 Score=63.16 Aligned_cols=78 Identities=23% Similarity=0.229 Sum_probs=60.9
Q ss_pred ceeeecccCCCCCCHHHHHHhhCCChHHHHhhcCCCCCCCCCCCCccEEeeeeeccC---CCcee-eeeeEEeecCCchh
Q 047629 43 TYVAYFAQSPEFLDLSNISDLFGVSRLSIARASNLVSEDTPLVPKQLLLVPIICGCT---GNQYF-ANITYQIKKGDSYY 118 (615)
Q Consensus 43 ~~~~y~~~~~~~~~l~~i~~lf~~~~~~i~~~n~~~~~~~~~~~~~~~~vP~~C~C~---~~~~~-~~~~y~v~~gdt~~ 118 (615)
+-..|+.++.+ ||..||..|+++..+|+.+|++. +++.|.+||.|.||..-.=. ..... ....|.+++||++.
T Consensus 61 ~~~~y~V~~GD--TL~~IA~~~~~~~~~l~~~N~~~-~~~~i~~Gq~L~ip~~~~~~~~~~~~~~~~~~~~~v~~GdtL~ 137 (167)
T 2l9y_A 61 GTATVTVQQGD--TLRDIGRRFDCDFHEIARRNNIQ-NEDLIYPGQVLQVPTKGGSGGGAGNFWDSARDVRLVDGGKVLE 137 (167)
T ss_dssp SCEEEEECTTC--CHHHHHHHTTCCHHHHHHHHTCC-GGGCCCTTEEEEESCCCCCSSSSCCGGGGEEEEEEETTTTEEE
T ss_pred CCceEEECCCC--cHHHHHHHcCCCHHHHHHHcCCC-CcccccCCCEEEEcCCCCccccccccccccceEEEeCCcCChH
Confidence 44679998765 99999999999999999999864 67899999999999752210 01111 23568899999999
Q ss_pred hhhhh
Q 047629 119 LVSIT 123 (615)
Q Consensus 119 ~ia~~ 123 (615)
.++..
T Consensus 138 aIA~r 142 (167)
T 2l9y_A 138 AELRY 142 (167)
T ss_dssp EEEEE
T ss_pred HHHHH
Confidence 99987
|
| >1e0g_A Membrane-bound lytic murein transglycosylase D; cell WALL, hydrolase, glycosidase, lipoprotein, outer membrane, multigene family; NMR {Escherichia coli} SCOP: d.7.1.1 | Back alignment and structure |
|---|
Probab=96.87 E-value=0.00083 Score=47.84 Aligned_cols=44 Identities=23% Similarity=0.292 Sum_probs=38.6
Q ss_pred eecccCCCCCCHHHHHHhhCCChHHHHhhcCCCCCCCCCCCCccEEeee
Q 047629 46 AYFAQSPEFLDLSNISDLFGVSRLSIARASNLVSEDTPLVPKQLLLVPI 94 (615)
Q Consensus 46 ~y~~~~~~~~~l~~i~~lf~~~~~~i~~~n~~~~~~~~~~~~~~~~vP~ 94 (615)
.|..++. .||..||..|+++..+|..+|+ +++.+.+||.+.||.
T Consensus 4 ~y~V~~G--Dtl~~Ia~~~~~~~~~l~~~N~---~~~~l~~G~~l~ip~ 47 (48)
T 1e0g_A 4 TYRVRKG--DSLSSIAKRHGVNIKDVMRWNS---DTANLQPGDKLTLFV 47 (48)
T ss_dssp EEEECTT--CCHHHHHHHHTCCHHHHHHHCS---CGGGCCTTEEEECCC
T ss_pred EEEEcCC--CcHHHHHHHHCcCHHHHHHhCC---CCCcCCcCCEEEEec
Confidence 4777755 4999999999999999999998 467799999999996
|
| >2djp_A Hypothetical protein SB145; LYSM, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.86 E-value=0.00068 Score=53.89 Aligned_cols=62 Identities=10% Similarity=0.094 Sum_probs=49.7
Q ss_pred CCccEEeeeeeccCCCceeeeeeEEeecCCchhhhhhhhcCCcchHHHHHHhCCCCCCCCcCCCcEEEEEeec
Q 047629 86 PKQLLLVPIICGCTGNQYFANITYQIKKGDSYYLVSITSFENLTNWHAVLEMNPGINPNLLQIGVKVTFPLFC 158 (615)
Q Consensus 86 ~~~~~~vP~~C~C~~~~~~~~~~y~v~~gdt~~~ia~~~~~~L~t~~~~~~~n~~~~~~~l~~G~~~~vpl~c 158 (615)
.||.+.+|.. .....|+|++|||++.||...+ +++.++...|+..+++.+.+|+++.+|..-
T Consensus 3 ~Gq~l~ip~~--------~~~~~y~V~~GDTL~~IA~~~~---~~~~~l~~~N~l~~~~~l~~Gq~l~iP~~~ 64 (77)
T 2djp_A 3 SGSSGCSPVR--------ERRLEHQLEPGDTLAGLALKYG---VTMEQIKRANRLYTNDSIFLKKTLYIPILT 64 (77)
T ss_dssp CCCCCCCCCC--------EEEEEECCCTTCCHHHHHHHHT---CCHHHHHHHHTCCCSSCGGGSSCEEEEEEC
T ss_pred CCcEeeccCC--------CCcEEEEECCCCcHHHHHHHHC---cCHHHHHHHcCCCCccccCCCCEEEECCCC
Confidence 5788888753 2346799999999999998765 346788899987778899999999999753
|
| >2djp_A Hypothetical protein SB145; LYSM, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.75 E-value=0.002 Score=51.15 Aligned_cols=50 Identities=22% Similarity=0.371 Sum_probs=43.8
Q ss_pred ceeeecccCCCCCCHHHHHHhhCCChHHHHhhcCCCCCCCCCCCCccEEeeee
Q 047629 43 TYVAYFAQSPEFLDLSNISDLFGVSRLSIARASNLVSEDTPLVPKQLLLVPII 95 (615)
Q Consensus 43 ~~~~y~~~~~~~~~l~~i~~lf~~~~~~i~~~n~~~~~~~~~~~~~~~~vP~~ 95 (615)
.+..|+.++.+ ||..||..|+++..+|..+|++. +++.+.+||.|.||..
T Consensus 14 ~~~~y~V~~GD--TL~~IA~~~~~~~~~l~~~N~l~-~~~~l~~Gq~l~iP~~ 63 (77)
T 2djp_A 14 RRLEHQLEPGD--TLAGLALKYGVTMEQIKRANRLY-TNDSIFLKKTLYIPIL 63 (77)
T ss_dssp EEEEECCCTTC--CHHHHHHHHTCCHHHHHHHHTCC-CSSCGGGSSCEEEEEE
T ss_pred CcEEEEECCCC--cHHHHHHHHCcCHHHHHHHcCCC-CccccCCCCEEEECCC
Confidence 56789998665 99999999999999999999875 4578999999999985
|
| >1e0g_A Membrane-bound lytic murein transglycosylase D; cell WALL, hydrolase, glycosidase, lipoprotein, outer membrane, multigene family; NMR {Escherichia coli} SCOP: d.7.1.1 | Back alignment and structure |
|---|
Probab=96.72 E-value=0.0012 Score=46.99 Aligned_cols=45 Identities=33% Similarity=0.411 Sum_probs=38.1
Q ss_pred eeEEeecCCchhhhhhhhcCCcchHHHHHHhCCCCCCCCcCCCcEEEEEe
Q 047629 107 ITYQIKKGDSYYLVSITSFENLTNWHAVLEMNPGINPNLLQIGVKVTFPL 156 (615)
Q Consensus 107 ~~y~v~~gdt~~~ia~~~~~~L~t~~~~~~~n~~~~~~~l~~G~~~~vpl 156 (615)
..|+|++|||+..||...+- ++.++...|+ +++.+.+|+.+.+|+
T Consensus 3 ~~y~V~~GDtl~~Ia~~~~~---~~~~l~~~N~--~~~~l~~G~~l~ip~ 47 (48)
T 1e0g_A 3 ITYRVRKGDSLSSIAKRHGV---NIKDVMRWNS--DTANLQPGDKLTLFV 47 (48)
T ss_dssp CEEEECTTCCHHHHHHHHTC---CHHHHHHHCS--CGGGCCTTEEEECCC
T ss_pred EEEEEcCCCcHHHHHHHHCc---CHHHHHHhCC--CCCcCCcCCEEEEec
Confidence 46999999999999976643 3688889998 778899999999885
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=95.99 E-value=0.028 Score=57.35 Aligned_cols=134 Identities=11% Similarity=0.113 Sum_probs=73.6
Q ss_pred EEEEEEC-CeEEEEEEcc----HHHHHHHHHHHhcCCC--CcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCC--
Q 047629 345 VYRATID-GKVLAVKKIK----EDVTEELRILQRINHA--NLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKS-- 415 (615)
Q Consensus 345 Vy~~~~~-g~~vAvK~~~----~~~~~Ei~~l~~l~H~--niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~-- 415 (615)
+|+.... |+.+.+|... .++..|+.++..+... .+.+++.+.. .++ +++||++.+..+.+++......
T Consensus 35 ~~r~~~~~~~~~vlk~~~~~~~~~~~~e~~~l~~L~~~g~~vP~v~~~d~-~~g--~ll~e~l~~~~l~~~l~~~~~~~~ 111 (333)
T 3csv_A 35 YQRLRSPTGAKAVLMDWSPEEGGDTQPFVDLAQYLRNLDISAPEIYAEEH-ARG--LLLIEDLGDALFTEVINNDPAQEM 111 (333)
T ss_dssp CEEEECTTCCEEEEEECCTTTTCCSHHHHHHHHHHHHTTCBCCCEEEEET-TTT--EEEECCCCSCBHHHHHHHCGGGHH
T ss_pred EEEEEcCCCCeEEEEECCCCCCccccHHHHHHHHHHhCCCCCCceeeecC-CCC--EEEEeeCCCcchHHHhcCCCccHH
Confidence 5566553 6677777653 4567888888888432 3456777642 333 7899999776676554321100
Q ss_pred --------------CCCCCcccccCHHHHH-------H-------------HHHHHHHHHHHHH---hCCCCCeEecCCC
Q 047629 416 --------------SSSSGSVIFLTWSQRL-------R-------------VALDVANGLQYMH---EHAQPSIVHRDIR 458 (615)
Q Consensus 416 --------------~~~~~~~~~l~~~~~~-------~-------------i~~~ia~gL~yLH---~~~~~~ivHrDlk 458 (615)
.........++..... . ....+...++.+. ....+.++|+|+.
T Consensus 112 ~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~~~~~lvHgD~~ 191 (333)
T 3csv_A 112 PLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLEGDMVFVHRDFH 191 (333)
T ss_dssp HHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCCSCCEEECSCCS
T ss_pred HHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcccCCCeeEeCCcC
Confidence 0000000001111000 0 0011112223331 1224469999999
Q ss_pred CCceeeCCC----CcEEEeecCCCCCC
Q 047629 459 TNNIQLDSR----FKAKIANFSLAAPA 481 (615)
Q Consensus 459 ~~NILld~~----~~~kl~DFGla~~~ 481 (615)
+.|||++.+ ..+.|.||+.+...
T Consensus 192 ~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 192 AQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp GGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred cccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 999999874 67899999987654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=95.97 E-value=0.05 Score=55.29 Aligned_cols=131 Identities=16% Similarity=0.229 Sum_probs=81.5
Q ss_pred eEEEEEECCeEEEEEEcc----HHHHHHHHHHHhcC---CCCcccEEEEEEcCCCcEEEEEeecCCCCHH----------
Q 047629 344 SVYRATIDGKVLAVKKIK----EDVTEELRILQRIN---HANLVKLMGVSSDSQGNRFLVYEYAENGSLD---------- 406 (615)
Q Consensus 344 ~Vy~~~~~g~~vAvK~~~----~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~---------- 406 (615)
.+|+...++..+.+|... ..+..|.+.|+.+. ...+.++++++.. ++..++||||+++..+.
T Consensus 51 ~~y~v~~~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-~g~~~lvme~l~G~~~~~~~~~~lG~~ 129 (312)
T 3jr1_A 51 EIWLINDEVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNS-QGHSFLLLEALNKSKNKQSSFTIFAEK 129 (312)
T ss_dssp EEEEEESSSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-SSEEEEEEECCCCCCCCTTHHHHHHHH
T ss_pred eeeEEEECCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-CCceEEEEEeccCCCCCchhHHHHHHH
Confidence 688877777888999875 34788999999884 3567788888764 35789999999987652
Q ss_pred -HhhccCCCCCC---CCC----c-c----cccCHHHHH---HHHH--H--------------HHHHH-HHHHh-CCCCCe
Q 047629 407 -KWLHPKSKSSS---SSG----S-V----IFLTWSQRL---RVAL--D--------------VANGL-QYMHE-HAQPSI 452 (615)
Q Consensus 407 -~~L~~~~~~~~---~~~----~-~----~~l~~~~~~---~i~~--~--------------ia~gL-~yLH~-~~~~~i 452 (615)
..||....... ... . + -.-+|.... ++.. + +...+ ..|.. ...|.+
T Consensus 130 LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~~L~~~~~~~~l 209 (312)
T 3jr1_A 130 IAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVADTLSKHNPKPSI 209 (312)
T ss_dssp HHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHHHHTTCCCCCEE
T ss_pred HHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHHHhccCCCCcee
Confidence 12333221000 000 0 0 012565432 1111 1 11111 23332 235789
Q ss_pred EecCCCCCceeeCCCCcEEEeecC
Q 047629 453 VHRDIRTNNIQLDSRFKAKIANFS 476 (615)
Q Consensus 453 vHrDlk~~NILld~~~~~kl~DFG 476 (615)
+|+|+.+.|++++.++ +.|.||.
T Consensus 210 ~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 210 LHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp ECSSCSGGGEEEETTE-EEECSCC
T ss_pred EeCCCCcCcEeecCCC-eEEEcCc
Confidence 9999999999999887 8899974
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=95.81 E-value=0.038 Score=58.49 Aligned_cols=31 Identities=10% Similarity=0.273 Sum_probs=27.0
Q ss_pred CCCeEecCCCCCceeeCCCCcEEEeecCCCCC
Q 047629 449 QPSIVHRDIRTNNIQLDSRFKAKIANFSLAAP 480 (615)
Q Consensus 449 ~~~ivHrDlk~~NILld~~~~~kl~DFGla~~ 480 (615)
.+.++|+|+++.|||++.+. +++.||+.+..
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 45699999999999998876 99999998754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=95.72 E-value=0.035 Score=58.12 Aligned_cols=32 Identities=19% Similarity=0.319 Sum_probs=26.5
Q ss_pred CCCeEecCCCCCceeeCCCCcEEEeecCCCCCC
Q 047629 449 QPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA 481 (615)
Q Consensus 449 ~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~ 481 (615)
.+.++|+|+.+.|||++.+ .+++.||..+...
T Consensus 226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~G 257 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAFYG 257 (397)
T ss_dssp CCEEECSCCSGGGEEECSS-CEEECCCTTCEEE
T ss_pred CCceeeCCCCcCcEEEeCC-CeEEEeCcccccC
Confidence 3569999999999999876 4899999876543
|
| >2gu1_A Zinc peptidase; alpha/beta, beta barrel, structural genomics, PSI, protein structure initiative; 1.90A {Vibrio cholerae} | Back alignment and structure |
|---|
Probab=95.49 E-value=0.057 Score=56.01 Aligned_cols=108 Identities=13% Similarity=0.108 Sum_probs=72.5
Q ss_pred eeeecccCCCCCCHHHHHHhhCCChHHHHhhcCCCCC---CCCCCCCccEEeeeeeccCCCc------------------
Q 047629 44 YVAYFAQSPEFLDLSNISDLFGVSRLSIARASNLVSE---DTPLVPKQLLLVPIICGCTGNQ------------------ 102 (615)
Q Consensus 44 ~~~y~~~~~~~~~l~~i~~lf~~~~~~i~~~n~~~~~---~~~~~~~~~~~vP~~C~C~~~~------------------ 102 (615)
...|+.++. .||..|+..+|++..+|..+|+.... .+.|.+||.+.||.. ..+.
T Consensus 7 ~~~~~Vk~G--DTL~~Ia~r~gvs~~~l~~~n~~~~~~~~~~~L~~Gq~L~i~~~---~~~~l~~l~~~~~~~~~~~~~~ 81 (361)
T 2gu1_A 7 RIHYMVKVG--DTLSGIFAQLGVPYSILQKILSVDLDHLQLDMIQPGEELELMMD---DMGQLSRLIYHMSIVEKAIYTR 81 (361)
T ss_dssp CEEEECCTT--CCHHHHHHHTTCCHHHHHHHHHHGGGTCCGGGCCTTCEEEEEEC---TTSCEEEEEEEEETTEEEEEEE
T ss_pred ceEEEECCC--CcHHHHHHHcCCCHHHHHHHHhhcccccchhcCCCCCEEEEEEC---CCCcceEEEEEcCccceEEEEe
Confidence 456888765 59999999999999999999986432 467999999999974 1111
Q ss_pred -----ee----------eeeeEEeecCCchhhhhhhhcCCcchHHHHHHh-CCCCCC-CCcCCCcEEEEEe
Q 047629 103 -----YF----------ANITYQIKKGDSYYLVSITSFENLTNWHAVLEM-NPGINP-NLLQIGVKVTFPL 156 (615)
Q Consensus 103 -----~~----------~~~~y~v~~gdt~~~ia~~~~~~L~t~~~~~~~-n~~~~~-~~l~~G~~~~vpl 156 (615)
+. ....|.++.|||++.+|...+-.......+... ...+|. ..+.+|+++.++.
T Consensus 82 ~~~g~f~~~~~~~~~~~~~~~~~v~igdSL~~iA~~~Gvs~~~i~~ln~i~~~~idf~~~Lr~GD~l~V~~ 152 (361)
T 2gu1_A 82 ENDGSFSYDFQEISGEWREILFSGEINGSFSVSARRVGLTSSQVANITQVMKDKIDFSRSLRAGDRFDILV 152 (361)
T ss_dssp CTTSCEEEEEEECCCEEEEEEEEEESSSCHHHHHHHTTCCHHHHHHHHHHHTTTCCTTTCCCC-CEEEEEE
T ss_pred cCCCcceeeecccCceEEEEEEEEEECCcHHHHHHHcCCCHHHHHHHHHhhcccccccccCCCCCEEEEEE
Confidence 10 113467778999999998765443332222211 112332 4699999988885
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=94.59 E-value=0.13 Score=51.21 Aligned_cols=58 Identities=24% Similarity=0.344 Sum_probs=42.0
Q ss_pred ceEEEEEE-CCeEEEEEEcc-------HHHHHHHHHHHhcCCC---CcccEEEEEEcCCCcEEEEEeecCCCCH
Q 047629 343 KSVYRATI-DGKVLAVKKIK-------EDVTEELRILQRINHA---NLVKLMGVSSDSQGNRFLVYEYAENGSL 405 (615)
Q Consensus 343 ~~Vy~~~~-~g~~vAvK~~~-------~~~~~Ei~~l~~l~H~---niv~l~g~~~~~~~~~~lV~E~~~~GsL 405 (615)
..||+... +|+.+.+|+-. ..+..|...|+.+.-. -+.+++++ + .-++||||++.+..
T Consensus 29 ~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~---~~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 29 WHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D---DRTLAMEWVDERPP 97 (288)
T ss_dssp EEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E---TTEEEEECCCCCCC
T ss_pred eEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c---CceEEEEeecccCC
Confidence 37999998 79999999854 2478899999988432 24456654 2 23789999987653
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=94.50 E-value=0.12 Score=51.71 Aligned_cols=32 Identities=16% Similarity=0.147 Sum_probs=26.0
Q ss_pred CCCeEecCCCCCceeeCCCCcEEEeecCCCCCC
Q 047629 449 QPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA 481 (615)
Q Consensus 449 ~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~ 481 (615)
.+.++|+|+.+.||+ ..++.+.+.||..+...
T Consensus 172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp CCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred CceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 345899999999999 56667899999877543
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=94.50 E-value=0.069 Score=56.80 Aligned_cols=57 Identities=18% Similarity=0.222 Sum_probs=39.3
Q ss_pred eEEEEEEC---------CeEEEEEEcc-----HHHHHHHHHHHhcCCCCc-ccEEEEEEcCCCcEEEEEeecCCCCH
Q 047629 344 SVYRATID---------GKVLAVKKIK-----EDVTEELRILQRINHANL-VKLMGVSSDSQGNRFLVYEYAENGSL 405 (615)
Q Consensus 344 ~Vy~~~~~---------g~~vAvK~~~-----~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~~lV~E~~~~GsL 405 (615)
.+|+.... ++.+.+|+.. ..+..|..++..+...++ .++++.+ .+ .+|+||+++-+|
T Consensus 88 ~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~--~~---g~v~e~l~G~~l 159 (429)
T 1nw1_A 88 MLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF--SG---GRLEEYIPSRPL 159 (429)
T ss_dssp EEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE--TT---EEEECCCCEEEC
T ss_pred ceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEe--CC---CEEEEEeCCccc
Confidence 68887763 4678888762 457789999998854444 5677754 23 389999975343
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=94.41 E-value=0.051 Score=54.91 Aligned_cols=152 Identities=14% Similarity=0.184 Sum_probs=83.0
Q ss_pred eEEEEEECCeEEEEEEccH-----HHHHHHHHHHhcCCCCc--ccEEEEE-----EcCCCcEEEEEeecCCCCHHH----
Q 047629 344 SVYRATIDGKVLAVKKIKE-----DVTEELRILQRINHANL--VKLMGVS-----SDSQGNRFLVYEYAENGSLDK---- 407 (615)
Q Consensus 344 ~Vy~~~~~g~~vAvK~~~~-----~~~~Ei~~l~~l~H~ni--v~l~g~~-----~~~~~~~~lV~E~~~~GsL~~---- 407 (615)
.+|+...++..+++|.... .+..|..++..+...++ .+++... ...++..+++++|+++..+..
T Consensus 37 ~~~~v~~~~g~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~ 116 (322)
T 2ppq_A 37 SNFLLHTTKDPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAK 116 (322)
T ss_dssp EEEEEEESSCCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHH
T ss_pred ceEEEEeCCccEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHH
Confidence 6888777555688887653 46778888888743222 2333210 001245789999998755321
Q ss_pred ----------hhccCCCC-CCCC-CcccccCHHHHHHH------------HHHHHHHHHHHHhC----CCCCeEecCCCC
Q 047629 408 ----------WLHPKSKS-SSSS-GSVIFLTWSQRLRV------------ALDVANGLQYMHEH----AQPSIVHRDIRT 459 (615)
Q Consensus 408 ----------~L~~~~~~-~~~~-~~~~~l~~~~~~~i------------~~~ia~gL~yLH~~----~~~~ivHrDlk~ 459 (615)
.+|..... .... .......|...+.- ...+...++++++. ..+.++|+|+++
T Consensus 117 ~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~ 196 (322)
T 2ppq_A 117 HCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQ 196 (322)
T ss_dssp HHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCG
T ss_pred HHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCc
Confidence 12211100 0000 00001234332111 11244556666642 123599999999
Q ss_pred CceeeCCCCcEEEeecCCCCCCCCCCCCcccchhHHHHHHHHH
Q 047629 460 NNIQLDSRFKAKIANFSLAAPATNDVMPKFDVFAFGVVLLELL 502 (615)
Q Consensus 460 ~NILld~~~~~kl~DFGla~~~~~~~~~k~DV~SfGvvl~Ell 502 (615)
.|||++++..+.+.||+.+.... -+|-+++++..+.
T Consensus 197 ~Nil~~~~~~~~lIDf~~a~~g~-------~~~Dla~~l~~~~ 232 (322)
T 2ppq_A 197 DNVFFLGDELSGLIDFYFACNDL-------LAYDVSICLNAWC 232 (322)
T ss_dssp GGEEEETTEEEEECCCTTCEEEE-------HHHHHHHHHHHHS
T ss_pred cCEEEeCCceEEEecchhccCch-------hHHHHHHHHHHHH
Confidence 99999887656899999765421 2455666665543
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=94.30 E-value=0.093 Score=54.80 Aligned_cols=145 Identities=15% Similarity=0.208 Sum_probs=86.6
Q ss_pred eEEEEEEC---------CeEEEEEEcc------HHHHHHHHHHHhcCCCCc-ccEEEEEEcCCCcEEEEEeecCCCCHHH
Q 047629 344 SVYRATID---------GKVLAVKKIK------EDVTEELRILQRINHANL-VKLMGVSSDSQGNRFLVYEYAENGSLDK 407 (615)
Q Consensus 344 ~Vy~~~~~---------g~~vAvK~~~------~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~~lV~E~~~~GsL~~ 407 (615)
.+|+.... ++.+.+|+-. .+..+|..+++.+.-.++ -++++++. ++ +||||+++..|..
T Consensus 65 ~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~g---~v~e~i~G~~l~~ 139 (379)
T 3feg_A 65 LLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFP--EG---RLEQYIPSRPLKT 139 (379)
T ss_dssp CEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--TE---EEEECCSEEECCG
T ss_pred cEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--Cc---cEEEEecCccCCh
Confidence 57776652 3678888752 346689999988853333 46776652 32 8999998755431
Q ss_pred h-----------------hccCCCCCCCCCcccccCHHHHHHHHHHHHH-------------------HHHHHH----hC
Q 047629 408 W-----------------LHPKSKSSSSSGSVIFLTWSQRLRVALDVAN-------------------GLQYMH----EH 447 (615)
Q Consensus 408 ~-----------------L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~-------------------gL~yLH----~~ 447 (615)
- ||..... .+.....-|.++.++..++.. .+..|. ..
T Consensus 140 ~~l~~p~~~~~ia~~La~LH~~~~~---~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~ 216 (379)
T 3feg_A 140 QELREPVLSAAIATKMAQFHGMEMP---FTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLEST 216 (379)
T ss_dssp GGGGCHHHHHHHHHHHHHHHTCCCS---SCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTS
T ss_pred hHhCCHHHHHHHHHHHHHHhCCCCC---CCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhc
Confidence 1 2221110 010000124555555544321 233333 22
Q ss_pred C-CCCeEecCCCCCceeeCCC----CcEEEeecCCCCCCCCCCCCcccchhHHHHHHHHHc
Q 047629 448 A-QPSIVHRDIRTNNIQLDSR----FKAKIANFSLAAPATNDVMPKFDVFAFGVVLLELLS 503 (615)
Q Consensus 448 ~-~~~ivHrDlk~~NILld~~----~~~kl~DFGla~~~~~~~~~k~DV~SfGvvl~Ellt 503 (615)
. ...++|+|+.+.|||++.+ ..+.+.||..+.... =.|-+|..+.|...
T Consensus 217 ~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~~-------~~~Dla~~~~~~~~ 270 (379)
T 3feg_A 217 PSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYNY-------RGFDIGNHFCEWVY 270 (379)
T ss_dssp CCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEEE-------HHHHHHHHHHHTTE
T ss_pred CCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcCC-------hHHHHHHHHHHHHh
Confidence 2 3368999999999999876 789999998765432 24667888877663
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=94.19 E-value=0.19 Score=53.77 Aligned_cols=57 Identities=11% Similarity=0.071 Sum_probs=40.7
Q ss_pred eEEEEEECC--eEEEEEEccH------HHHHHHHHHHhcCCCCcc-cEEEEEEcCCCcEEEEEeecCCCCH
Q 047629 344 SVYRATIDG--KVLAVKKIKE------DVTEELRILQRINHANLV-KLMGVSSDSQGNRFLVYEYAENGSL 405 (615)
Q Consensus 344 ~Vy~~~~~g--~~vAvK~~~~------~~~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~~lV~E~~~~GsL 405 (615)
.+|+....+ ..+.+|+... +...|..++..+...++. ++++.+ .+ .+||||+++-+|
T Consensus 123 ~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~--~~---G~v~e~I~G~~l 188 (458)
T 2qg7_A 123 ILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF--TN---GRIEEFMDGYAL 188 (458)
T ss_dssp EEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE--TT---EEEEECCCSEEC
T ss_pred EEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe--CC---eEEEEeeCCccC
Confidence 688888865 7888887642 235899999999766664 677765 23 259999986444
|
| >2gu1_A Zinc peptidase; alpha/beta, beta barrel, structural genomics, PSI, protein structure initiative; 1.90A {Vibrio cholerae} | Back alignment and structure |
|---|
Probab=94.08 E-value=0.1 Score=54.13 Aligned_cols=95 Identities=12% Similarity=0.143 Sum_probs=64.6
Q ss_pred eeeEEeecCCchhhhhhhhcCCcchHHHHHHhCC-CCCCCCcCCCcEEEEEeeccCCCCCCC------------------
Q 047629 106 NITYQIKKGDSYYLVSITSFENLTNWHAVLEMNP-GINPNLLQIGVKVTFPLFCKCPSKTNM------------------ 166 (615)
Q Consensus 106 ~~~y~v~~gdt~~~ia~~~~~~L~t~~~~~~~n~-~~~~~~l~~G~~~~vpl~c~C~~~~~~------------------ 166 (615)
...|+|++|||+..|+...+-.......+..... ..+.+.|.+|+++.+|..- + ..+
T Consensus 7 ~~~~~Vk~GDTL~~Ia~r~gvs~~~l~~~n~~~~~~~~~~~L~~Gq~L~i~~~~---~-~~l~~l~~~~~~~~~~~~~~~ 82 (361)
T 2gu1_A 7 RIHYMVKVGDTLSGIFAQLGVPYSILQKILSVDLDHLQLDMIQPGEELELMMDD---M-GQLSRLIYHMSIVEKAIYTRE 82 (361)
T ss_dssp CEEEECCTTCCHHHHHHHTTCCHHHHHHHHHHGGGTCCGGGCCTTCEEEEEECT---T-SCEEEEEEEEETTEEEEEEEC
T ss_pred ceEEEECCCCcHHHHHHHcCCCHHHHHHHHhhcccccchhcCCCCCEEEEEECC---C-CcceEEEEEcCccceEEEEec
Confidence 3569999999999999876544443333333221 2345789999999999632 1 111
Q ss_pred -CCCe----------eEEEEEecCCCCchhHHHHHhcCChhhHhhhccc
Q 047629 167 -EDGI----------ENLITYVWQPGDDVSQVGAKLNASSAAIETENEY 204 (615)
Q Consensus 167 -s~~~----------~~l~ty~~~~gd~~~~ia~~F~~s~~~i~~~n~~ 204 (615)
.+.+ ....+|.++.+|++..+|.++|++...+...|..
T Consensus 83 ~~g~f~~~~~~~~~~~~~~~~~v~igdSL~~iA~~~Gvs~~~i~~ln~i 131 (361)
T 2gu1_A 83 NDGSFSYDFQEISGEWREILFSGEINGSFSVSARRVGLTSSQVANITQV 131 (361)
T ss_dssp TTSCEEEEEEECCCEEEEEEEEEESSSCHHHHHHHTTCCHHHHHHHHHH
T ss_pred CCCcceeeecccCceEEEEEEEEEECCcHHHHHHHcCCCHHHHHHHHHh
Confidence 0101 1123577788999999999999999999888876
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=93.67 E-value=0.38 Score=48.49 Aligned_cols=135 Identities=13% Similarity=0.154 Sum_probs=72.1
Q ss_pred eEEEEEE-CCeEEEEEEcc------HHHHHHHHHHHhcCCCC--cccEEEE----EEcCCCcEEEEEeecCCCCHH----
Q 047629 344 SVYRATI-DGKVLAVKKIK------EDVTEELRILQRINHAN--LVKLMGV----SSDSQGNRFLVYEYAENGSLD---- 406 (615)
Q Consensus 344 ~Vy~~~~-~g~~vAvK~~~------~~~~~Ei~~l~~l~H~n--iv~l~g~----~~~~~~~~~lV~E~~~~GsL~---- 406 (615)
.||+... +|+.+++|... ..+..|..++..+.... +.+++.. ....++..++++||+++..+.
T Consensus 40 ~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~ 119 (328)
T 1zyl_A 40 RVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNI 119 (328)
T ss_dssp EEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCH
T ss_pred ceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCCCCCCCCCH
Confidence 6888766 56679999874 35677888888874222 3444432 000134568899999874432
Q ss_pred -Hh---------hccCCCCCCCCCcccccCHHHH----HHH---------------HHHHHHHHHHHHhC----CCCCeE
Q 047629 407 -KW---------LHPKSKSSSSSGSVIFLTWSQR----LRV---------------ALDVANGLQYMHEH----AQPSIV 453 (615)
Q Consensus 407 -~~---------L~~~~~~~~~~~~~~~l~~~~~----~~i---------------~~~ia~gL~yLH~~----~~~~iv 453 (615)
.+ +|...... .......+++... ..+ ...+...++.+... ..+.++
T Consensus 120 ~~~~~~g~~La~lH~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~ 198 (328)
T 1zyl_A 120 DQMEAVGRYLGRMHQTGRKQ-LFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRL 198 (328)
T ss_dssp HHHHHHHHHHHHHHHHHTSS-CCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEEC
T ss_pred HHHHHHHHHHHHHHHhhccC-CCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeee
Confidence 10 11110000 0000001222211 000 11111223333321 234589
Q ss_pred ecCCCCCceeeCCCCcEEEeecCCCCCC
Q 047629 454 HRDIRTNNIQLDSRFKAKIANFSLAAPA 481 (615)
Q Consensus 454 HrDlk~~NILld~~~~~kl~DFGla~~~ 481 (615)
|+|+++.|||++ + .+.+.||+.+...
T Consensus 199 HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 199 HGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp CSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred eCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 999999999999 4 8999999876543
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.21 E-value=0.048 Score=37.69 Aligned_cols=22 Identities=23% Similarity=0.380 Sum_probs=9.7
Q ss_pred EeehhHHHHHHHHHHHHHHHHH
Q 047629 243 LIIPISAGGALLILLVAALVIY 264 (615)
Q Consensus 243 ~ii~i~~~~~~l~~~~~~~~~~ 264 (615)
.|++.+++++++++++++.+++
T Consensus 11 aIA~gVVgGv~~v~ii~~~~~~ 32 (44)
T 2l2t_A 11 LIAAGVIGGLFILVIVGLTFAV 32 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEeehHHHHHHHHHHHHHHH
Confidence 3445455544444444333333
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.19 E-value=0.058 Score=37.36 Aligned_cols=19 Identities=37% Similarity=0.319 Sum_probs=8.4
Q ss_pred EeehhHHHHHHHHHHHHHH
Q 047629 243 LIIPISAGGALLILLVAAL 261 (615)
Q Consensus 243 ~ii~i~~~~~~l~~~~~~~ 261 (615)
.|++.++++++++++++++
T Consensus 12 ~IA~gVVgGv~~~~ii~~~ 30 (44)
T 2ks1_B 12 SIATGMVGALLLLLVVALG 30 (44)
T ss_dssp SSTHHHHHHHHHHHHHHHH
T ss_pred eEEeehhHHHHHHHHHHHH
Confidence 3444444444444443333
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=93.10 E-value=0.21 Score=51.62 Aligned_cols=45 Identities=16% Similarity=0.211 Sum_probs=33.0
Q ss_pred CCeEecCCCCCceeeCCCCcEEEeecCCCCCCCCCCCCcccchhHHHHHHHHH
Q 047629 450 PSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVMPKFDVFAFGVVLLELL 502 (615)
Q Consensus 450 ~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~k~DV~SfGvvl~Ell 502 (615)
+.++|+|+++.|||++++. +.+.||..+.... =.|-+|..+.+..
T Consensus 212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~g~-------~~~Dla~~~~~~~ 256 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNKC-LRLIDFEYSGFNF-------LATDIANFFIETS 256 (369)
T ss_dssp EEEECSCCCGGGEEECC-C-EEECCCTTCEEEE-------HHHHHHHHHHGGG
T ss_pred eEEEeCCCCcccEEecCCc-EEEEEecCCCCCc-------hHHHHHHHHHHHh
Confidence 3589999999999998654 8999998765432 2355677777654
|
| >4a1k_A Putative L, D-transpeptidase YKUD; transferase, peptidoglycan synthesis; HET: CME; 1.75A {Bacillus subtilis} PDB: 4a1j_A 4a1i_A* 1y7m_A 3zqd_A 4a52_A* | Back alignment and structure |
|---|
Probab=92.29 E-value=0.12 Score=47.18 Aligned_cols=46 Identities=24% Similarity=0.403 Sum_probs=37.0
Q ss_pred EEEEecCCCCchhHHHHHhcCChhhHhhhccccCccccCccceecc
Q 047629 173 LITYVWQPGDDVSQVGAKLNASSAAIETENEYRNFSEAVSLPVLIP 218 (615)
Q Consensus 173 l~ty~~~~gd~~~~ia~~F~~s~~~i~~~n~~~~~~~~~~~~~l~p 218 (615)
+++|.|+.||++..||++|+.....+..+|...++-...+..+.+|
T Consensus 2 ~~~y~V~~GdtL~~IA~~f~~g~~~l~~aNp~vd~~l~~g~~i~ip 47 (165)
T 4a1k_A 2 MLTYQVKQGDTLNSIAADFRISTAALLQANPSLQAGLTAGQSIVIP 47 (165)
T ss_dssp CEEEECCTTCCHHHHHHHTTCCHHHHHHHCGGGGGCCCTTCEEEET
T ss_pred CEEEEECCCCCHHHHHHHhCCCHHHHHHhCccCCCccCCCccccCc
Confidence 3689999999999999999999999999997643333346666666
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=90.89 E-value=0.85 Score=43.43 Aligned_cols=89 Identities=17% Similarity=0.178 Sum_probs=60.6
Q ss_pred CCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCC--
Q 047629 403 GSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAP-- 480 (615)
Q Consensus 403 GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~-- 480 (615)
-||.+.|..... ++++.+.+.++.|.+.+|.-+-....+. .+=+-|..|++..+|.+...+ +.+..
T Consensus 33 vSL~eIL~~~~~---------PlsEEqaWALc~Qc~~~L~~~~~~~~~~--~~i~~~~~i~l~~dG~V~f~~-~~s~~~~ 100 (229)
T 2yle_A 33 LSLEEILRLYNQ---------PINEEQAWAVCYQCCGSLRAAARRRQPR--HRVRSAAQIRVWRDGAVTLAP-AADDAGE 100 (229)
T ss_dssp EEHHHHHHHHTS---------CCCHHHHHHHHHHHHHHHHHHHHTTCCC--CCCCSGGGEEEETTSCEEECC-C------
T ss_pred ccHHHHHHHcCC---------CcCHHHHHHHHHHHHHHHHhhhhcccCC--ceecCCcceEEecCCceeccc-ccccccc
Confidence 378898876554 5999999999999999987663222111 222346889999999988774 22210
Q ss_pred --C------CCCCCCcccchhHHHHHHHHHc
Q 047629 481 --A------TNDVMPKFDVFAFGVVLLELLS 503 (615)
Q Consensus 481 --~------~~~~~~k~DV~SfGvvl~Ellt 503 (615)
. ....+.+.=|||+|+++|.-+-
T Consensus 101 ~~~~~pe~~~~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 101 PPPVAGKLGYSQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ------CCSSSSSCHHHHHHHHHHHHHHHHT
T ss_pred cCCCChhhccccchHHHHHHHHHHHHHHHhh
Confidence 0 1122467789999999998876
|
| >4a1k_A Putative L, D-transpeptidase YKUD; transferase, peptidoglycan synthesis; HET: CME; 1.75A {Bacillus subtilis} PDB: 4a1j_A 4a1i_A* 1y7m_A 3zqd_A 4a52_A* | Back alignment and structure |
|---|
Probab=90.86 E-value=0.17 Score=46.14 Aligned_cols=47 Identities=19% Similarity=0.292 Sum_probs=38.9
Q ss_pred eeeecccCCCCCCHHHHHHhhCCChHHHHhhcCCCCCCCCCCCCccEEeee
Q 047629 44 YVAYFAQSPEFLDLSNISDLFGVSRLSIARASNLVSEDTPLVPKQLLLVPI 94 (615)
Q Consensus 44 ~~~y~~~~~~~~~l~~i~~lf~~~~~~i~~~n~~~~~~~~~~~~~~~~vP~ 94 (615)
+++|+.+.. .||..||..|+++..+|..+|+.. +..+++|+.+.||.
T Consensus 2 ~~~y~V~~G--dtL~~IA~~f~~g~~~l~~aNp~v--d~~l~~g~~i~ip~ 48 (165)
T 4a1k_A 2 MLTYQVKQG--DTLNSIAADFRISTAALLQANPSL--QAGLTAGQSIVIPG 48 (165)
T ss_dssp CEEEECCTT--CCHHHHHHHTTCCHHHHHHHCGGG--GGCCCTTCEEEETT
T ss_pred CEEEEECCC--CCHHHHHHHhCCCHHHHHHhCccC--CCccCCCccccCcc
Confidence 467888754 599999999999999999999854 23478999999984
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=90.46 E-value=0.18 Score=34.77 Aligned_cols=8 Identities=38% Similarity=0.468 Sum_probs=4.3
Q ss_pred EeehhHHH
Q 047629 243 LIIPISAG 250 (615)
Q Consensus 243 ~ii~i~~~ 250 (615)
.++++++|
T Consensus 13 ~Ia~~vVG 20 (44)
T 2jwa_A 13 SIISAVVG 20 (44)
T ss_dssp HHHHHHHH
T ss_pred chHHHHHH
Confidence 35555555
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=86.49 E-value=0.35 Score=32.35 Aligned_cols=24 Identities=17% Similarity=0.205 Sum_probs=13.5
Q ss_pred eeEeehhHHHHHHHHHHHHHHHHH
Q 047629 241 LTLIIPISAGGALLILLVAALVIY 264 (615)
Q Consensus 241 ~~~ii~i~~~~~~l~~~~~~~~~~ 264 (615)
...|++++++.++.+++++++.+|
T Consensus 10 ~GaIAGiVvG~v~gv~li~~l~~~ 33 (38)
T 2k1k_A 10 GGEIVAVIFGLLLGAALLLGILVF 33 (38)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCceeeeehHHHHHHHHHHHHHHH
Confidence 455677777766555544444433
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=83.48 E-value=2.6 Score=39.92 Aligned_cols=116 Identities=7% Similarity=0.052 Sum_probs=80.5
Q ss_pred CCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 047629 375 NHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVH 454 (615)
Q Consensus 375 ~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH 454 (615)
.||+++..- +-.+ ++...+.|+.-+ +...|-.- ..++...+++++.+|+.-..+++. -+|
T Consensus 43 ~~~~Fl~~~-I~e~-eD~v~~~y~~~~--~~~~f~~i-----------k~~~~~eKlr~l~ni~~l~~~~~~-----r~t 102 (215)
T 4ann_A 43 HSPYFIDAE-LTEL-RDSFQIHYDIND--NHTPFDNI-----------KSFTKNEKLRYLLNIKNLEEVNRT-----RYT 102 (215)
T ss_dssp CCTTBCCEE-EEEC-SSEEEEEECCCT--TSEEGGGG-----------GGSCHHHHHHHHHHGGGGGGGGGS-----SEE
T ss_pred cCCcccceE-EEEc-ccEEEEEEEcCc--ccCCHHHH-----------HhcCHHHHHHHHHHHHHHHHHhcC-----ceE
Confidence 788888663 3333 335555555443 33333221 127888999999999887755553 378
Q ss_pred cCCCCCceeeCCCCcEEEeecCCCCCCCCCCCCcccch-hHHHHHHHHHcCCCCCCC
Q 047629 455 RDIRTNNIQLDSRFKAKIANFSLAAPATNDVMPKFDVF-AFGVVLLELLSGKKATRT 510 (615)
Q Consensus 455 rDlk~~NILld~~~~~kl~DFGla~~~~~~~~~k~DV~-SfGvvl~ElltG~~p~~~ 510 (615)
--|.|+|+++|.++.+++.-.|+-......-..+-|-| .+=+++..+++++..|+.
T Consensus 103 f~L~P~NL~f~~~~~p~i~~RGik~~l~P~~~~ee~fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 103 FVLAPDELFFTRDGLPIAKTRGLQNVVDPLPVSEAEFLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp CCCSGGGEEECTTSCEEESCCEETTTBSCCCCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred EEEecceEEEcCCCCEEEEEccCccCCCCCCCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 88999999999999999999998655443333444555 688889999999888753
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 615 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-41 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-39 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-39 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-37 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-34 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-34 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-33 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-33 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 8e-33 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-32 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-32 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-32 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-32 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-32 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-32 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-32 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-31 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-31 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-31 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-30 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-30 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-30 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 8e-30 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-29 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-29 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-29 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-29 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-29 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-28 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-28 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-28 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 9e-28 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-27 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-27 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-25 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-25 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-25 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-24 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-24 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-23 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-23 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-23 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-22 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-22 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-22 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-21 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-21 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-21 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 8e-21 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-20 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-20 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-19 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-19 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-19 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-19 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-19 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 9e-18 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-17 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-17 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-17 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-16 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-13 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-09 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 8e-41
Identities = 64/297 (21%), Positives = 112/297 (37%), Gaps = 76/297 (25%)
Query: 337 EHYSIGK--------SVYRATIDGKVLAVKKIK---------EDVTEELRILQRINHANL 379
++G+ +VY+ G V AVK + + E+ +L++ H N+
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 66
Query: 380 VKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVAN 439
+ MG S+ +V ++ E SL LH + + +A A
Sbjct: 67 LLFMGYSTA--PQLAIVTQWCEGSSLYHHLHIIETK---------FEMIKLIDIARQTAQ 115
Query: 440 GLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA--------------------- 478
G+ Y+H SI+HRD+++NNI L KI +F LA
Sbjct: 116 GMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 172
Query: 479 -AP------ATNDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEE 531
AP N + DV+AFG+VL EL++G+ N ++
Sbjct: 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN---------------RDQ 217
Query: 532 KREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588
R ++ P+L + ++ L C K RP +++ ++ +L +S
Sbjct: 218 IIFMVGRGYLSPDLSKV-RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 4e-39
Identities = 61/271 (22%), Positives = 106/271 (39%), Gaps = 60/271 (22%)
Query: 341 IGK----SVYRATIDGKVLAVKKIKEDVTE-----ELRILQRINHANLVKLMGVSSDSQG 391
IGK V G +AVK IK D T E ++ ++ H+NLV+L+GV + +G
Sbjct: 15 IGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 74
Query: 392 NRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPS 451
++V EY GSL +L + +S L L+ +LDV ++Y+ + +
Sbjct: 75 GLYIVTEYMAKGSLVDYLRSRGRS--------VLGGDCLLKFSLDVCEAMEYLEGN---N 123
Query: 452 IVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVM--------------------PKFDV 491
VHRD+ N+ + AK+++F L A++ K DV
Sbjct: 124 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDV 183
Query: 492 FAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPI 551
++FG++L E+ S + K V R+ + P
Sbjct: 184 WSFGILLWEIYSFGRVPYPRIPLKDVV----------------PRVEKGYKMDAPDGCPP 227
Query: 552 DGALSLATLARACTMDKSLSRPNMAEVVFNL 582
+ + + C + RP+ ++ L
Sbjct: 228 A----VYEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 4e-39
Identities = 63/300 (21%), Positives = 112/300 (37%), Gaps = 64/300 (21%)
Query: 341 IGK----SVYRATIDGKVLAVKKIKEDVTE------ELRILQRINHANLVKLMGVSSDSQ 390
IGK V+R G+ +AVK E+ + H N++ + +
Sbjct: 11 IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN 70
Query: 391 GNR---FLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEH 447
G +LV +Y E+GSL +L+ + +T +++AL A+GL ++H
Sbjct: 71 GTWTQLWLVSDYHEHGSLFDYLNRYT-----------VTVEGMIKLALSTASGLAHLHME 119
Query: 448 A-----QPSIVHRDIRTNNIQLDSRFKAKIANFSLA------------------------ 478
+P+I HRD+++ NI + IA+ LA
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 479 AP---------ATNDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKV 529
AP + + D++A G+V E+ E+ + + + V
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL-PYYDLVPSDPSV 238
Query: 530 EEKREERLRNWMDPNLESFYPIDGAL-SLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588
EE R+ + PN+ + + AL +A + R C +R + LS L+Q
Sbjct: 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 4e-37
Identities = 60/293 (20%), Positives = 104/293 (35%), Gaps = 72/293 (24%)
Query: 337 EHYSIGK--------SVYRATI-DGKVLAVKKIK------EDVTEELRILQRINHANLVK 381
E + + V+ +AVK +K + E +++++ H LV+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 382 LMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGL 441
L V + +++ EY ENGSL +L S LT ++ L +A +A G+
Sbjct: 73 LYAVVTQ--EPIYIITEYMENGSLVDFLKTPSGIK--------LTINKLLDMAAQIAEGM 122
Query: 442 QYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA---------------------AP 480
++ E + +HRD+R NI + KIA+F LA AP
Sbjct: 123 AFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 179
Query: 481 A---TNDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERL 537
K DV++FG++L E+++ + + + L
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI----------------QNL 223
Query: 538 RNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQSTE 590
P + L L R C ++ RP + L +TE
Sbjct: 224 ERGYRMVRPDNCPEE----LYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 1e-34
Identities = 62/311 (19%), Positives = 102/311 (32%), Gaps = 81/311 (26%)
Query: 337 EHYSIGK--------SVYRATI-------DGKVLAVKKIK--------EDVTEELRILQR 373
S GK V AT +AVK +K E + EL++L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 374 I-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSV--------IF 424
+ NH N+V L+G + G ++ EY G L +L K S S + +
Sbjct: 83 LGNHMNIVNLLGACTI-GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 425 LTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATND 484
L L + VA G+ ++ + +HRD+ NI L KI +F LA ND
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKND 198
Query: 485 VM-------------------------PKFDVFAFGVVLLELLSGKKATRTTENGKTAVL 519
+ DV+++G+ L EL S +
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP------ 252
Query: 520 WKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVV 579
+ + + P + + + C L RP ++V
Sbjct: 253 -------------VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299
Query: 580 FNL-SVLTQST 589
+ +++ST
Sbjct: 300 QLIEKQISEST 310
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 1e-34
Identities = 41/200 (20%), Positives = 83/200 (41%), Gaps = 48/200 (24%)
Query: 341 IGK----SVYRAT--IDGKVLAVKKIKEDVTE--------ELRILQRINHANLVKLMGVS 386
+G V++ + G V+A K I ++ EL++L N +V G
Sbjct: 14 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 387 SDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHE 446
G + E+ + GSLD+ L + + +V++ V GL Y+ E
Sbjct: 74 YS-DGEISICMEHMDGGSLDQVLKKAGR----------IPEQILGKVSIAVIKGLTYLRE 122
Query: 447 HAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVM-------------------- 486
+ I+HRD++ +NI ++SR + K+ +F ++ + +
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHY 180
Query: 487 -PKFDVFAFGVVLLELLSGK 505
+ D+++ G+ L+E+ G+
Sbjct: 181 SVQSDIWSMGLSLVEMAVGR 200
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 3e-33
Identities = 51/288 (17%), Positives = 96/288 (33%), Gaps = 72/288 (25%)
Query: 337 EHYSIGK--------SVYRAT--IDGKVLAVKKIK---------EDVTEELRILQRINHA 377
E Y + + DGK+L K++ + + E+ +L+ + H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 378 NLVKLMGVSSDSQGNR-FLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALD 436
N+V+ D ++V EY E G L + +K +L LRV
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQ------YLDEEFVLRVMTQ 117
Query: 437 VANGLQYMHEH--AQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVM-------- 486
+ L+ H +++HRD++ N+ LD + K+ +F LA +D
Sbjct: 118 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGT 177
Query: 487 ---------------PKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEE 531
K D+++ G +L EL + + A
Sbjct: 178 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA-------------- 223
Query: 532 KREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVV 579
++R + Y + L + K RP++ E++
Sbjct: 224 ---GKIREGKFRRIPYRYSDE----LNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (316), Expect = 3e-33
Identities = 53/283 (18%), Positives = 104/283 (36%), Gaps = 68/283 (24%)
Query: 341 IGK----SVYRAT-IDGKVLAVKKIK------EDVTEELRILQRINHANLVKLMGVSSDS 389
IG V+ ++ +A+K I+ ED EE ++ +++H LV+L GV +
Sbjct: 13 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE- 71
Query: 390 QGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQ 449
Q LV+E+ E+G L +L + + L + LDV G+ Y+ E
Sbjct: 72 QAPICLVFEFMEHGCLSDYLRTQRGLFA---------AETLLGMCLDVCEGMAYLEEA-- 120
Query: 450 PSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVM----------------------- 486
++HRD+ N + K+++F + +D
Sbjct: 121 -CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179
Query: 487 -PKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNL 545
K DV++FGV++ E+ S K + + +
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRS--------------------NSEVVEDISTGF 219
Query: 546 ESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588
+ P + + + C ++ RP + ++ L+ + +S
Sbjct: 220 RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 126 bits (316), Expect = 8e-33
Identities = 59/325 (18%), Positives = 116/325 (35%), Gaps = 87/325 (26%)
Query: 323 YEIEVIMESTMNLSE-----HYSIGK--------SVYRATI-----DGKVLAVKKIKEDV 364
+ E E+ ++ I + V + +A+K +K
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 365 TE--------ELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSS 416
TE E I+ + +H N++ L GV + S ++ E+ ENGSLD +L
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS-TPVMIITEFMENGSLDSFLRQNDGQF 125
Query: 417 SSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFS 476
T Q + + +A G++Y+ + + VHRD+ NI ++S K+++F
Sbjct: 126 ---------TVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFG 173
Query: 477 LA-------------------------APA---TNDVMPKFDVFAFGVVLLELLSGKKAT 508
L+ AP DV+++G+V+ E++S +
Sbjct: 174 LSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE-- 231
Query: 509 RTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDK 568
+ + + N ++ + P+D +L L C
Sbjct: 232 ------------------RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKD 273
Query: 569 SLSRPNMAEVVFNLSVLTQSTETLE 593
RP ++V L + ++ +L+
Sbjct: 274 RNHRPKFGQIVNTLDKMIRNPNSLK 298
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 124 bits (313), Expect = 2e-32
Identities = 65/297 (21%), Positives = 108/297 (36%), Gaps = 82/297 (27%)
Query: 341 IGK----SVYRATI-------DGKVLAVKKIKEDVTE--------ELRILQRINHANLVK 381
IG+ V++A ++AVK +KE+ + E ++ ++ N+VK
Sbjct: 21 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 80
Query: 382 LMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSS--------------SSGSVIFLTW 427
L+GV + L++EY G L+++L S + SS L+
Sbjct: 81 LLGVCAV-GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 139
Query: 428 SQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVM- 486
+++L +A VA G+ Y+ E VHRD+ T N + KIA+F L+ +
Sbjct: 140 AEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 196
Query: 487 ------------------------PKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKE 522
+ DV+A+GVVL E+ S
Sbjct: 197 KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA--------- 247
Query: 523 IREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVV 579
EE + D N+ + P + L L L R C RP+ +
Sbjct: 248 ----------HEEVIYYVRDGNILAC-PENCPLELYNLMRLCWSKLPADRPSFCSIH 293
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 2e-32
Identities = 47/218 (21%), Positives = 83/218 (38%), Gaps = 58/218 (26%)
Query: 333 MNLSEHYSIGK--------SVYRAT--IDGKVLAVKKIK-------EDVTEELRILQRIN 375
+N + + I VY+A + A K I ED E+ IL +
Sbjct: 8 LNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD 67
Query: 376 HANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVAL 435
H N+VKL+ + N +++ E+ G++D + + LT SQ V
Sbjct: 68 HPNIVKLLDAFYY-ENNLWILIEFCAGGAVDAVMLELERP---------LTESQIQVVCK 117
Query: 436 DVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVM--------- 486
+ L Y+H++ I+HRD++ NI K+A+F ++A T +
Sbjct: 118 QTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTP 174
Query: 487 -------------------PKFDVFAFGVVLLELLSGK 505
K DV++ G+ L+E+ +
Sbjct: 175 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE 212
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 2e-32
Identities = 60/285 (21%), Positives = 105/285 (36%), Gaps = 68/285 (23%)
Query: 341 IGK----SVYRATI-DGKVLAVKKIK------EDVTEELRILQRINHANLVKLMGVSSDS 389
+G+ V+ T +A+K +K E +E ++++++ H LV+L V S
Sbjct: 25 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV--VS 82
Query: 390 QGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQ 449
+ ++V EY GSL +L ++ +L Q + +A +A+G+ Y+
Sbjct: 83 EEPIYIVTEYMSKGSLLDFLKGETGK--------YLRLPQLVDMAAQIASGMAYVERM-- 132
Query: 450 PSIVHRDIRTNNIQLDSRFKAKIANFSLA---------------------APA---TNDV 485
+ VHRD+R NI + K+A+F LA AP
Sbjct: 133 -NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 191
Query: 486 MPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNL 545
K DV++FG++L EL + + + + ++
Sbjct: 192 TIKSDVWSFGILLTELTTKGRVPYPGMV--------------------NREVLDQVERGY 231
Query: 546 ESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQSTE 590
P + SL L C + RP + L STE
Sbjct: 232 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 4e-32
Identities = 60/286 (20%), Positives = 100/286 (34%), Gaps = 47/286 (16%)
Query: 337 EHYSIGK--------SVYRA-------TIDGKVLAVKKIKEDVTE--------ELRILQR 373
E+ GK V A T +AVK +KE EL+++ +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 374 I-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSS-------------SS 419
+ +H N+V L+G + S G +L++EY G L +L K + S
Sbjct: 97 LGSHENIVNLLGACTLS-GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 420 GSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAA 479
+ LT+ L A VA G++++ S VHRD+ N+ + KI +F LA
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLAR 212
Query: 480 PATNDVMPKFDVFAFGVVLL---ELLSGKKATRTTENGKTAVLWKEI---REVLKVEEKR 533
+D A V E L T ++ +L EI
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272
Query: 534 EERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVV 579
+ + + P + + ++C S RP+ +
Sbjct: 273 DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 5e-32
Identities = 54/265 (20%), Positives = 101/265 (38%), Gaps = 32/265 (12%)
Query: 337 EHYSIGK--------SVYRATI-DGKVLAVKKIK------EDVTEELRILQRINHANLVK 381
+ + K V +A+K IK ++ EE +++ ++H LV+
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 382 LMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGL 441
L GV + Q F++ EY NG L +L Q L + DV +
Sbjct: 64 LYGVCTK-QRPIFIITEYMANGCLLNYLREMRHR---------FQTQQLLEMCKDVCEAM 113
Query: 442 QYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVMPKFDVFAFGVVLL-- 499
+Y+ +HRD+ N ++ + K+++F L+ +D F V
Sbjct: 114 EYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPP 170
Query: 500 ELLSGKKATRTTENGKTAVLWKEIREVLKV--EEKREERLRNWMDPNLESFYPIDGALSL 557
E+L K + ++ VL EI + K+ E + L + P + +
Sbjct: 171 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKV 230
Query: 558 ATLARACTMDKSLSRPNMAEVVFNL 582
T+ +C +K+ RP ++ N+
Sbjct: 231 YTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 123 bits (310), Expect = 6e-32
Identities = 51/288 (17%), Positives = 91/288 (31%), Gaps = 76/288 (26%)
Query: 334 NLSEHYS----IGK----SVYRAT--IDGKVLAVKKIK----------EDVTEELRILQR 373
+ + +S IG +VY A + +V+A+KK+ +D+ +E+R LQ+
Sbjct: 12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 71
Query: 374 INHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRV 433
+ H N ++ G + +LV EY + D K L + V
Sbjct: 72 LRHPNTIQYRGCYLR-EHTAWLVMEYCLGSASDLLEVHKKP----------LQEVEIAAV 120
Query: 434 ALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVM------- 486
GL Y+H H +++HRD++ NI L K+ +F A+
Sbjct: 121 THGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYW 177
Query: 487 ---------------PKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEE 531
K DV++ G+ +EL K
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF--------------------NM 217
Query: 532 KREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVV 579
L + + + +C RP ++
Sbjct: 218 NAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 265
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 6e-32
Identities = 59/296 (19%), Positives = 104/296 (35%), Gaps = 78/296 (26%)
Query: 343 KSVYRATIDGKVLAVKKIKEDVTE--------ELRILQRINHANLVKLMGVSSDSQGNRF 394
+ VYR +A+K +K+ + E +I+ ++++ +V+L+GV
Sbjct: 27 QGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE--ALM 84
Query: 395 LVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVH 454
LV E A G L K+L K + + S + V+ G++Y+ E + VH
Sbjct: 85 LVMEMAGGGPLHKFLVGKREE---------IPVSNVAELLHQVSMGMKYLEEK---NFVH 132
Query: 455 RDIRTNNIQLDSRFKAKIANFSLA-----------------------APA---TNDVMPK 488
RD+ N+ L +R AKI++F L+ AP +
Sbjct: 133 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 192
Query: 489 FDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESF 548
DV+++GV + E LS + G + +E+ + P
Sbjct: 193 SDVWSYGVTMWEALSYGQKPYKKMKGPEV--------MAFIEQGKRMECPPECPP----- 239
Query: 549 YPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQSTETLERSWTSGLEAEE 604
L L C + K RP+ V + + + S E
Sbjct: 240 -------ELYALMSDCWIYKWEDRPDFLTVE----------QRMRACYYSLASKVE 278
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 122 bits (306), Expect = 1e-31
Identities = 55/286 (19%), Positives = 106/286 (37%), Gaps = 68/286 (23%)
Query: 341 IGK----SVYRATI--DGKVLAVKKIKEDVTE------ELRILQRINHANLVKLMGVSSD 388
+G VY +AVK +KED E E +++ I H NLV+L+GV +
Sbjct: 25 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 84
Query: 389 SQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHA 448
+ +++ E+ G+L +L ++ ++ L +A +++ ++Y+ +
Sbjct: 85 -EPPFYIITEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAMEYLEKK- 134
Query: 449 QPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVM---------------------- 486
+ +HRD+ N + K+A+F L+ T D
Sbjct: 135 --NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 192
Query: 487 --PKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPN 544
K DV+AFGV+L E+ + + + ++ ++ +
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPGID--------------------LSQVYELLEKD 232
Query: 545 LESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQSTE 590
P + L RAC RP+ AE+ + Q +
Sbjct: 233 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 278
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 1e-31
Identities = 58/284 (20%), Positives = 100/284 (35%), Gaps = 77/284 (27%)
Query: 337 EHYSIGK--------SVYRAT--IDGKVLAVKKIK----------EDVTEELRILQRINH 376
E + IG+ +VY A +LA+K + + E+ I + H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 377 ANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALD 436
N+++L G D +L+ EYA G++ + L SK + +
Sbjct: 66 PNILRLYGYFHD-ATRVYLILEYAPLGTVYRELQKLSK----------FDEQRTATYITE 114
Query: 437 VANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVM---------- 486
+AN L Y H ++HRDI+ N+ L S + KIA+F + A +
Sbjct: 115 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYL 171
Query: 487 -----------PKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREE 535
K D+++ GV+ E L GK +E K + E
Sbjct: 172 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA----------NTYQETYKRISRVEF 221
Query: 536 RLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVV 579
+++ ++R + S RP + EV+
Sbjct: 222 TFPDFVTEGARDL-----------ISRLLKHNPS-QRPMLREVL 253
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 2e-31
Identities = 47/278 (16%), Positives = 95/278 (34%), Gaps = 69/278 (24%)
Query: 341 IGK----SVYRA--TIDGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGV 385
IG+ +VY+ T +A +++ + EE +L+ + H N+V+
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 386 ---SSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQ 442
+ + LV E +G+L +L + + GLQ
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----------MKIKVLRSWCRQILKGLQ 126
Query: 443 YMHEHAQPSIVHRDIRTNNIQLDSR-FKAKIANFSLA------------------AP--A 481
++H P I+HRD++ +NI + KI + LA AP
Sbjct: 127 FLHTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMY 185
Query: 482 TNDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWM 541
DV+AFG+ +LE+ + + +N A +++ + +
Sbjct: 186 EEKYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVT-----SGVKPASFDKVA 238
Query: 542 DPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVV 579
P ++ + C R ++ +++
Sbjct: 239 IPEVKE------------IIEGCIRQNKDERYSIKDLL 264
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 1e-30
Identities = 63/296 (21%), Positives = 116/296 (39%), Gaps = 69/296 (23%)
Query: 341 IGK----SVYRATIDG----KVLAVKKIKEDVTE--------ELRILQRI-NHANLVKLM 383
IG+ V +A I A+K++KE ++ EL +L ++ +H N++ L+
Sbjct: 18 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 77
Query: 384 GVSSDSQGNRFLVYEYAENGSLDKWLH------PKSKSSSSSGSVIFLTWSQRLRVALDV 437
G +G +L EYA +G+L +L + ++ + L+ Q L A DV
Sbjct: 78 GACEH-RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 136
Query: 438 ANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVM----------- 486
A G+ Y+ + +HRD+ NI + + AKIA+F L+ V
Sbjct: 137 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWM 193
Query: 487 -----------PKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREE 535
DV+++GV+L E++S
Sbjct: 194 AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--------------------CA 233
Query: 536 RLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQSTET 591
L + P++ + L R C +K RP+ A+++ +L+ + + +T
Sbjct: 234 ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 289
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 3e-30
Identities = 60/292 (20%), Positives = 107/292 (36%), Gaps = 76/292 (26%)
Query: 341 IGK----SVYRATID-----GKVLAVKKIK--------EDVTEELRILQRINHANLVKLM 383
IG+ VY T+ AVK + E I++ +H N++ L+
Sbjct: 35 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 384 GVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQY 443
G+ S+G+ +V Y ++G L ++ ++ T + L VA G+++
Sbjct: 95 GICLRSEGSPLVVLPYMKHGDLRNFIRNETH---------NPTVKDLIGFGLQVAKGMKF 145
Query: 444 MHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA---------------------- 481
+ VHRD+ N LD +F K+A+F LA
Sbjct: 146 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202
Query: 482 -----TNDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREER 536
T K DV++FGV+L EL++ N ++ ++ +R +
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY-------LLQGRRLLQ 255
Query: 537 LRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588
DP L + C K+ RP+ +E+V +S + +
Sbjct: 256 PEYCPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 3e-30
Identities = 55/285 (19%), Positives = 100/285 (35%), Gaps = 78/285 (27%)
Query: 341 IGK----SVYRATI----DGKVLAVKKIKEDVTE---------ELRILQRINHANLVKLM 383
+G +V + K +AVK +K + + E ++Q++++ +V+++
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 384 GVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQY 443
G+ + LV E AE G L+K+L + + + V+ G++Y
Sbjct: 75 GIC--EAESWMLVMEMAELGPLNKYLQQNRH----------VKDKNIIELVHQVSMGMKY 122
Query: 444 MHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA-----------------------AP 480
+ E + VHRD+ N+ L ++ AKI++F L+ AP
Sbjct: 123 LEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 179
Query: 481 ---ATNDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERL 537
K DV++FGV++ E S + G L
Sbjct: 180 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT----------------AML 223
Query: 538 RNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNL 582
+ P + + L C +RP A V L
Sbjct: 224 EKGERMGCPAGCPRE----MYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 8e-30
Identities = 52/286 (18%), Positives = 99/286 (34%), Gaps = 77/286 (26%)
Query: 337 EHYSIGK--------SVYRAT--IDGKVLAVKKIK--------EDVTEELRILQRINHAN 378
E + + + V A + + +AVK + E++ +E+ I + +NH N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 379 LVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVA 438
+VK G + ++L EY G L + P + R +
Sbjct: 65 VVKFYGHRREG-NIQYLFLEYCSGGELFDRIEPDIG----------MPEPDAQRFFHQLM 113
Query: 439 NGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVM------------ 486
G+ Y+H I HRDI+ N+ LD R KI++F LA +
Sbjct: 114 AGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 170
Query: 487 --------------PKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEK 532
DV++ G+VL +L+G+ + + + + + E+K
Sbjct: 171 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWK-----EKK 223
Query: 533 REERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEV 578
+D + L + + S +R + ++
Sbjct: 224 TYLNPWKKIDSAPLAL-----------LHKILVENPS-ARITIPDI 257
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 118 bits (296), Expect = 1e-29
Identities = 52/304 (17%), Positives = 107/304 (35%), Gaps = 79/304 (25%)
Query: 316 YLGKPIVYEIEVIMESTMNLSEHYSIGK--------SVYRAT--IDGKVLAVKKI----- 360
Y +P+ + + +++ HY I + V+R T G A K +
Sbjct: 12 YYPQPVEIKHDHVLD-------HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE 64
Query: 361 --KEDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSS 418
KE V +E++ + + H LV L D ++YE+ G L + + +
Sbjct: 65 SDKETVRKEIQTMSVLRHPTLVNLHDAFED-DNEMVMIYEFMSGGELFEKVADEHNK--- 120
Query: 419 SGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRF--KAKIANFS 476
++ + + V GL +MHE+ + VH D++ NI ++ + K+ +F
Sbjct: 121 ------MSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFG 171
Query: 477 LAAPATNDVM----------------------PKFDVFAFGVVLLELLSGKKATRTTENG 514
L A D+++ GV+ LLSG +
Sbjct: 172 LTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD 231
Query: 515 KTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPN 574
+T +R V + ++ + + + + F + + D + +R
Sbjct: 232 ET------LRNVKSCDWNMDDSAFSGISEDGKDF-----------IRKLLLADPN-TRMT 273
Query: 575 MAEV 578
+ +
Sbjct: 274 IHQA 277
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 1e-29
Identities = 60/305 (19%), Positives = 114/305 (37%), Gaps = 81/305 (26%)
Query: 337 EHYSIGK--------SVYRATIDG------KVLAVKKIKEDVTE--------ELRILQRI 374
+ K VY+ + +A+K +K TE E I+ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 375 NHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVA 434
+H N+++L GV S ++ EY ENG+LDK+L K + Q + +
Sbjct: 67 SHHNIIRLEGVISK-YKPMMIITEYMENGALDKFLREKDG---------EFSVLQLVGML 116
Query: 435 LDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA---------------- 478
+A G++Y+ + VHRD+ NI ++S K+++F L+
Sbjct: 117 RGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG 173
Query: 479 -------AP---ATNDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLK 528
AP + DV++FG+V+ E+++ +
Sbjct: 174 KIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP-------------------- 213
Query: 529 VEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588
E + ++ P+D ++ L C + RP A++V L L ++
Sbjct: 214 YWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273
Query: 589 TETLE 593
++L+
Sbjct: 274 PDSLK 278
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 117 bits (294), Expect = 2e-29
Identities = 53/286 (18%), Positives = 103/286 (36%), Gaps = 72/286 (25%)
Query: 334 NLSEHYSIGK--------SVYRAT--IDGKVLAVKKIK-------EDVTEELRILQRINH 376
++ ++Y I + V+R G+V K I V E+ I+ +++H
Sbjct: 26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH 85
Query: 377 ANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALD 436
L+ L D + L+ E+ G L + + ++ ++ +
Sbjct: 86 PKLINLHDAFED-KYEMVLILEFLSGGELFDRIAAEDYK---------MSEAEVINYMRQ 135
Query: 437 VANGLQYMHEHAQPSIVHRDIRTNNIQLDSRF--KAKIANFSLAAPATNDVM-------- 486
GL++MHEH SIVH DI+ NI +++ KI +F LA D +
Sbjct: 136 ACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATA 192
Query: 487 --------------PKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEK 532
D++A GV+ LLSG ++ +T ++ V + + +
Sbjct: 193 EFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET------LQNVKRCDWE 246
Query: 533 REERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEV 578
+E + + P + F + + R + +
Sbjct: 247 FDEDAFSSVSPEAKDF-----------IKNLLQKEPR-KRLTVHDA 280
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 5e-29
Identities = 53/292 (18%), Positives = 95/292 (32%), Gaps = 79/292 (27%)
Query: 337 EHYSIGK--------SVYRATI-----DGKVLAVKKIK--------EDVTEELRILQRIN 375
E +G+ V++ +A+K K E +E +++ +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 376 HANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVAL 435
H ++VKL+GV ++ +++ E G L +L + S L + + A
Sbjct: 67 HPHIVKLIGVITE--NPVWIIMELCTLGELRSFLQVRKYS---------LDLASLILYAY 115
Query: 436 DVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATND----------- 484
++ L Y+ VHRDI N+ + S K+ +F L+ +
Sbjct: 116 QLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 172
Query: 485 -------------VMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEE 531
DV+ FGV + E+L G + +V+
Sbjct: 173 IKWMAPESINFRRFTSASDVWMFGVCMWEILMH---------GVKPFQGVKNNDVI---- 219
Query: 532 KREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLS 583
R+ N + P L +L C RP E+ LS
Sbjct: 220 ---GRIENGERLPMPPNCPPT----LYSLMTKCWAYDPSRRPRFTELKAQLS 264
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 6e-29
Identities = 41/226 (18%), Positives = 86/226 (38%), Gaps = 61/226 (26%)
Query: 326 EVIME------STMNLSEHYSIGK--------SVYRAT--IDGKVLAVKKIK-------E 362
E I+E S + + Y+ + +VY A G+ +A++++ E
Sbjct: 3 EEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE 62
Query: 363 DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSV 422
+ E+ +++ + N+V + ++V EY GSL +
Sbjct: 63 LIINEILVMRENKNPNIVNYLDSYLV-GDELWVVMEYLAGGSLTDVVTETCMD------- 114
Query: 423 IFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT 482
Q V + L+++H + ++HRDI+++NI L K+ +F A T
Sbjct: 115 ----EGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167
Query: 483 NDVM-----------------------PKFDVFAFGVVLLELLSGK 505
+ PK D+++ G++ +E++ G+
Sbjct: 168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 1e-28
Identities = 60/307 (19%), Positives = 105/307 (34%), Gaps = 77/307 (25%)
Query: 337 EHYSIGK--------SVYRAT-------IDGKVLAVKKIKEDVT---------EELRILQ 372
+ +GK V A + +AVK +KE T E ++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 373 RINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSV------IFLT 426
+H N+V L+G + G ++ E+ + G+L +L K FLT
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 427 WSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATND-- 484
+ + VA G++++ +HRD+ NI L + KI +F LA D
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 485 -----------------------VMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWK 521
+ DV++FGV+L E+ S
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL---------------GA 234
Query: 522 EIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581
+K++E+ RL+ + + + C + RP +E+V +
Sbjct: 235 SPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEH 290
Query: 582 LSVLTQS 588
L L Q+
Sbjct: 291 LGNLLQA 297
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (282), Expect = 3e-28
Identities = 60/310 (19%), Positives = 109/310 (35%), Gaps = 81/310 (26%)
Query: 337 EHYSIGK--------SVYRAT---------IDGKVLAVKKIKEDVTE--------ELRIL 371
+ +GK V A +AVK +K D TE E+ ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 372 QRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSS------SSSGSVIF 424
+ I H N++ L+G + G +++ EYA G+L ++L + S
Sbjct: 73 KMIGKHKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 425 LTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATND 484
L+ + A VA G++Y+ +HRD+ N+ + KIA+F LA +
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 485 VM-------------------------PKFDVFAFGVVLLELLSGKKATRTTENGKTAVL 519
+ DV++FGV+L E+ + + L
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--VEEL 246
Query: 520 WKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVV 579
+K ++E +++ P + L + R C RP ++V
Sbjct: 247 FKLLKEGHRMD------------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 288
Query: 580 FNLSVLTQST 589
+L + T
Sbjct: 289 EDLDRIVALT 298
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 4e-28
Identities = 52/294 (17%), Positives = 104/294 (35%), Gaps = 72/294 (24%)
Query: 337 EHYSIGK--------SVYRATI-------DGKVLAVKKIKEDVTE--------ELRILQR 373
E ++ + VY +A+K + E + E +++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 374 INHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRV 433
N ++V+L+GV S ++ E G L +L + +++ + + S+ +++
Sbjct: 80 FNCHHVVRLLGVVSQ-GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138
Query: 434 ALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATND--------- 484
A ++A+G+ Y++ + VHRD+ N + F KI +F +
Sbjct: 139 AGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 195
Query: 485 ----------------VMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLK 528
DV++FGVVL E+ + + +
Sbjct: 196 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS--------------- 240
Query: 529 VEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNL 582
E+ LR M+ L P + L L R C RP+ E++ ++
Sbjct: 241 ----NEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 9e-28
Identities = 51/284 (17%), Positives = 87/284 (30%), Gaps = 71/284 (25%)
Query: 335 LSEHYSIGK--------SVYRA--TIDGKVLAVKKIK------EDVTEELRILQRINHAN 378
L E Y I + V+R T K K +K V +E+ IL H N
Sbjct: 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRN 62
Query: 379 LVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVA 438
++ L +++E+ + + ++ + L + + V
Sbjct: 63 ILHLHESFES-MEELVMIFEFISGLDIFERINTSAFE---------LNEREIVSYVHQVC 112
Query: 439 NGLQYMHEHAQPSIVHRDIRTNNIQLDSR--FKAKIANFSLAAPATNDVM---------- 486
LQ++H H +I H DIR NI +R KI F A
Sbjct: 113 EALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEY 169
Query: 487 ------------PKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKRE 534
D+++ G ++ LLSG N + I ++ E +
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI------IENIMNAEYTFD 223
Query: 535 ERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEV 578
E + F + R ++ SR +E
Sbjct: 224 EEAFKEISIEAMDF-----------VDRLLVKERK-SRMTASEA 255
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 5e-27
Identities = 59/284 (20%), Positives = 88/284 (30%), Gaps = 78/284 (27%)
Query: 341 IGK----SVYRATID-----GKVLAVKKIKEDVTE----------ELRILQRINHANLVK 381
+G V R D +AVK +K DV E+ + ++H NL++
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 382 LMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGL 441
L GV +V E A GSL L R A+ VA G+
Sbjct: 76 LYGVVLT--PPMKMVTELAPLGSLLDRLRKHQGH---------FLLGTLSRYAVQVAEGM 124
Query: 442 QYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA----------------------- 478
Y+ +HRD+ N+ L +R KI +F L
Sbjct: 125 GYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 479 AP---ATNDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREE 535
AP T D + FGV L E+ + + NG +I + E +R
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG------SQILHKIDKEGERLP 235
Query: 536 RLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVV 579
R + + + C K RP +
Sbjct: 236 RPEDCPQ-------------DIYNVMVQCWAHKPEDRPTFVALR 266
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 6e-27
Identities = 41/214 (19%), Positives = 75/214 (35%), Gaps = 59/214 (27%)
Query: 337 EHYSIGK--------SVYRAT--IDGKVLAVKKIK----------EDVTEELRILQRINH 376
E + GK +V A + A+K ++ VT E ++ R++H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 377 ANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALD 436
VKL D + YA+NG L K++ + +
Sbjct: 68 PFFVKLYFTFQD-DEKLYFGLSYAKNGELLKYIRKIGS----------FDETCTRFYTAE 116
Query: 437 VANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA------------------ 478
+ + L+Y+H I+HRD++ NI L+ +I +F A
Sbjct: 117 IVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 173
Query: 479 ----AP---ATNDVMPKFDVFAFGVVLLELLSGK 505
+P D++A G ++ +L++G
Sbjct: 174 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 207
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 105 bits (263), Expect = 1e-25
Identities = 54/288 (18%), Positives = 97/288 (33%), Gaps = 75/288 (26%)
Query: 334 NLSEHYSIGK--------SVYRAT--IDGKVLAVKKIKEDVTE--------ELRILQRIN 375
++ + Y V A K++A+K I + E E+ +L +I
Sbjct: 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK 65
Query: 376 HANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVAL 435
H N+V L + G+ +L+ + G L + K F T R+
Sbjct: 66 HPNIVALDDIYES-GGHLYLIMQLVSGGELFDRIVEKG----------FYTERDASRLIF 114
Query: 436 DVANGLQYMHEHAQPSIVHRDIRTNNI---QLDSRFKAKIANFSLA-------------- 478
V + ++Y+H+ IVHRD++ N+ LD K I++F L+
Sbjct: 115 QVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACG 171
Query: 479 -----AP---ATNDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVE 530
AP A D ++ GV+ LL G + K ++LK E
Sbjct: 172 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL------FEQILKAE 225
Query: 531 EKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEV 578
+ + + + + + F + D R +
Sbjct: 226 YEFDSPYWDDISDSAKDF-----------IRHLMEKDPE-KRFTCEQA 261
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 103 bits (258), Expect = 2e-25
Identities = 52/299 (17%), Positives = 94/299 (31%), Gaps = 91/299 (30%)
Query: 337 EHYSIGK--------SVYRAT--IDGKVLAVKKIK----------------EDVTEELRI 370
E+Y + V R K AVK I E +E+ I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 371 LQRIN-HANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQ 429
L++++ H N+++L + FLV++ + G L +L K L+ +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNT-FFFLVFDLMKKGELFDYLTEKVT----------LSEKE 111
Query: 430 RLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVM--- 486
++ + + +H+ +IVHRD++ NI LD K+ +F +
Sbjct: 112 TRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE 168
Query: 487 -------------------------PKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWK 521
+ D+++ GV++ LL+G
Sbjct: 169 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW------------ 216
Query: 522 EIREVLKVEEKREERLRNWMDPNLESFYPIDGALS--LATLARACTMDKSLSRPNMAEV 578
K+ LR M N + P S + L + + R E
Sbjct: 217 --------HRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 105 bits (263), Expect = 3e-25
Identities = 44/262 (16%), Positives = 81/262 (30%), Gaps = 69/262 (26%)
Query: 332 TMNLSEHYSIGK--------SVYRAT--IDGKVLAVKKIKEDVT-------------EEL 368
TMN +S+ + VY GK+ A+K + + L
Sbjct: 2 TMN---DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 58
Query: 369 RILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWS 428
++ + +V + + + G L L + +
Sbjct: 59 SLVSTGDCPFIVCMSYAFHT-PDKLSFILDLMNGGDLHYHLSQHGVF----------SEA 107
Query: 429 QRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVM-- 486
A ++ GL++MH +V+RD++ NI LD +I++ LA +
Sbjct: 108 DMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 164
Query: 487 --------------------PKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREV 526
D F+ G +L +LL G R + K+ E+
Sbjct: 165 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK-------TKDKHEI 217
Query: 527 LKVEEKREERLRNWMDPNLESF 548
++ L + P L S
Sbjct: 218 DRMTLTMAVELPDSFSPELRSL 239
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 1e-24
Identities = 40/273 (14%), Positives = 99/273 (36%), Gaps = 37/273 (13%)
Query: 341 IGK----SVYRAT--IDGKVL----AVKKIKEDVTE--------ELRILQRINHANLVKL 382
+G +VY+ +G+ + A+K+++E + E ++ +++ ++ +L
Sbjct: 17 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 76
Query: 383 MGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQ 442
+G+ L+ + G L ++ + L + +A G+
Sbjct: 77 LGICLT--STVQLITQLMPFGCLLDYVREHKDNIG---------SQYLLNWCVQIAKGMN 125
Query: 443 YMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAA---PATNDVMPKFDVFAFGVVLL 499
Y+ + +VHRD+ N+ + + KI +F LA + + + L
Sbjct: 126 YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 500 ELLSGKKATRTTENGKTAVLWKEIREVLKV--EEKREERLRNWMDPNLESFYPIDGALSL 557
E + + T ++ V E+ + + + ++ P + +
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 242
Query: 558 ATLARACTMDKSLSRPNMAEVVFNLSVLTQSTE 590
+ C M + SRP E++ S + + +
Sbjct: 243 YMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 275
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 101 bits (252), Expect = 2e-24
Identities = 42/221 (19%), Positives = 85/221 (38%), Gaps = 62/221 (28%)
Query: 334 NLSEHYSIGK--------SVYRAT--IDGKVLAVKKIKEDVTE----------ELRILQR 373
+LS+ Y +G+ V+ A + +AVK ++ D+ E +
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 374 INHANLVKLMGV---SSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQR 430
+NH +V + + + ++V EY + +L +H + +T +
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----------MTPKRA 113
Query: 431 LRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATND------ 484
+ V D L + H++ I+HRD++ NI + + K+ +F +A +
Sbjct: 114 IEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 170
Query: 485 --------------------VMPKFDVFAFGVVLLELLSGK 505
V + DV++ G VL E+L+G+
Sbjct: 171 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 211
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.9 bits (248), Expect = 2e-23
Identities = 53/247 (21%), Positives = 85/247 (34%), Gaps = 54/247 (21%)
Query: 341 IGK----SVYRAT--IDGKVLAVKKIKED---VTEELRILQRINHANLVKLMGVSSDSQG 391
IG VY+A G+++A+KK+ +D EL+I+++++H N+V+L S
Sbjct: 28 IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGE 87
Query: 392 NR-----FLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHE 446
+ LV +Y H + L + L Y+H
Sbjct: 88 KKDEVYLNLVLDYVPETVYRVARHYSRAKQT-------LPVIYVKLYMYQLFRSLAYIHS 140
Query: 447 HAQPSIVHRDIRTNNIQLDSR-FKAKIANFSLAAPATNDVM------------------- 486
I HRDI+ N+ LD K+ +F A
Sbjct: 141 F---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 197
Query: 487 ----PKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMD 542
DV++ G VL ELL G+ ++ E++KV M+
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSG------VDQLVEIIKVLGTPTREQIREMN 251
Query: 543 PNLESFY 549
PN F
Sbjct: 252 PNYTEFK 258
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.0 bits (246), Expect = 2e-23
Identities = 53/289 (18%), Positives = 90/289 (31%), Gaps = 70/289 (24%)
Query: 337 EHYSIGK--------SVYRAT--IDGKVLAVKKIKEDV-----------TEELRILQRIN 375
E + + K V+ A + A+K +K+DV E+ +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 376 HANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVAL 435
H L + + N F V EY G L + K S+ A
Sbjct: 62 HPFLTHMFCTFQT-KENLFFVMEYLNGGDLMYHIQSCHK----------FDLSRATFYAA 110
Query: 436 DVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA----------------- 478
++ GLQ++H IV+RD++ +NI LD KIA+F +
Sbjct: 111 EIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTP 167
Query: 479 ---AP---ATNDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEK 532
AP D ++FGV+L E+L G+ ++ E+
Sbjct: 168 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG----------QDEEELFHSIRM 217
Query: 533 REERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581
W++ + + R P E+ +
Sbjct: 218 DNPFYPRWLEKEAKDL--LVKLFVREPEKRLGVRGDIRQHPLFREINWE 264
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 98.4 bits (244), Expect = 3e-23
Identities = 41/299 (13%), Positives = 88/299 (29%), Gaps = 77/299 (25%)
Query: 329 MESTMNLSEHYSIGK--------SVYRAT--IDGKVLAVKKIK-----EDVTEELRILQR 373
ME + + Y +G+ +Y T G+ +A+K + E +I +
Sbjct: 1 ME--LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKM 58
Query: 374 INHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRV 433
+ + + +V E D + K + L +
Sbjct: 59 MQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK----------FSLKTVLLL 108
Query: 434 ALDVANGLQYMHEHAQPSIVHRDIRTNNI---QLDSRFKAKIANFSLA------------ 478
A + + ++Y+H + +HRD++ +N I +F LA
Sbjct: 109 ADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI 165
Query: 479 ---------------AP---ATNDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLW 520
+ + + D+ + G VL+ G +
Sbjct: 166 PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ----------G 215
Query: 521 KEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVV 579
+ + E+ E+ + L YP + AT C + +P+ + +
Sbjct: 216 LKAATKRQKYERISEKKMSTPIEVLCKGYPSE----FATYLNFCRSLRFDDKPDYSYLR 270
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 95.2 bits (236), Expect = 4e-22
Identities = 40/210 (19%), Positives = 75/210 (35%), Gaps = 54/210 (25%)
Query: 337 EHYSIGK--------SVYRAT--IDGKVLAVKKIK----------EDVTEELRILQRINH 376
+ + I + V+ +G+ A+K +K E +E +L + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 377 ANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALD 436
++++ G D F++ +Y E G L L + A +
Sbjct: 64 PFIIRMWGTFQD-AQQIFMIMDYIEGGELFSLLRKSQRFP----------NPVAKFYAAE 112
Query: 437 VANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVM---------- 486
V L+Y+H I++RD++ NI LD KI +F A +
Sbjct: 113 VCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIA 169
Query: 487 ----------PKFDVFAFGVVLLELLSGKK 506
D ++FG+++ E+L+G
Sbjct: 170 PEVVSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.2 bits (236), Expect = 6e-22
Identities = 32/202 (15%), Positives = 69/202 (34%), Gaps = 48/202 (23%)
Query: 341 IGK----SVYRAT--IDGKVLAVKKIK--EDVTEELRILQRI-NHANLVKLMGV---SSD 388
+G V + + A+K ++ E+ + R ++V+++ V
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYA 79
Query: 389 SQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHA 448
+ +V E + G L + + + T + + + +QY+H
Sbjct: 80 GRKCLLIVMECLDGGELFSRIQDRGDQA--------FTEREASEIMKSIGEAIQYLHSI- 130
Query: 449 QPSIVHRDIRTNNIQLDSRFK---AKIANFSLAAPATNDVM------------------- 486
+I HRD++ N+ S+ K+ +F A T+
Sbjct: 131 --NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPE 188
Query: 487 ---PKFDVFAFGVVLLELLSGK 505
D+++ GV++ LL G
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGY 210
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.1 bits (233), Expect = 7e-22
Identities = 58/294 (19%), Positives = 95/294 (32%), Gaps = 81/294 (27%)
Query: 334 NLSEHYSIGK--------SVYRAT--IDGKVLAVKKIK-------------EDVTEELRI 370
N+ ++Y G+ V + G A K IK ED+ E+ I
Sbjct: 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 66
Query: 371 LQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQR 430
L+ I H N++ L V + + + L+ E G L +L K LT +
Sbjct: 67 LKEIQHPNVITLHEVYEN-KTDVILILELVAGGELFDFLAEKES----------LTEEEA 115
Query: 431 LRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSR----FKAKIANFSLAAPATNDVM 486
+ NG+ Y+H I H D++ NI L R + KI +F LA
Sbjct: 116 TEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 172
Query: 487 ----------------------PKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIR 524
+ D+++ GV+ LLSG +T +
Sbjct: 173 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET------LA 226
Query: 525 EVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEV 578
V V + E+ + + F + R D R + +
Sbjct: 227 NVSAVNYEFEDEYFSNTSALAKDF-----------IRRLLVKDPK-KRMTIQDS 268
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.8 bits (232), Expect = 1e-21
Identities = 48/207 (23%), Positives = 81/207 (39%), Gaps = 56/207 (27%)
Query: 341 IGK----SVYRAT--IDGKVLAVKKIK------------EDVTEELRILQRINHANLVKL 382
+G+ +VY+A +++A+KKIK E+++LQ ++H N++ L
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 383 MGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQ 442
+ + N LV+++ E LT S L GL+
Sbjct: 66 LDAFGH-KSNISLVFDFMETDLEVIIKDNSLV----------LTPSHIKAYMLMTLQGLE 114
Query: 443 YMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVM---------------- 486
Y+H+H I+HRD++ NN+ LD K+A+F LA +
Sbjct: 115 YLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPEL 171
Query: 487 --------PKFDVFAFGVVLLELLSGK 505
D++A G +L ELL
Sbjct: 172 LFGARMYGVGVDMWAVGCILAELLLRV 198
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 92.3 bits (228), Expect = 3e-21
Identities = 53/283 (18%), Positives = 94/283 (33%), Gaps = 59/283 (20%)
Query: 341 IGK----SVYRAT-IDGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVS 386
IG+ VY+A G+ A+KKI+ E+ IL+ + H+N+VKL V
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 387 SDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHE 446
+ LV+E+ + + L L + NG+ Y H+
Sbjct: 70 HT-KKRLVLVFEHLDQDLKKLLDVCEGG----------LESVTAKSFLLQLLNGIAYCHD 118
Query: 447 HAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVM-------------------- 486
++HRD++ N+ ++ + KIA+F LA V
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 487 ----PKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMD 542
D+++ G + E+++G + I + D
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 543 PNLESFYPIDGALSLATLARACT--MDKSLS-----RPNMAEV 578
PN + P+ L L + + K L R +
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.6 bits (229), Expect = 5e-21
Identities = 40/223 (17%), Positives = 78/223 (34%), Gaps = 62/223 (27%)
Query: 331 STMNLSEHYSIGK--------SVYRAT--IDGKVLAVKKIK--------EDVTEELRILQ 372
++ Y+ V A ++ +A+KKI + E++IL
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 373 RINHANLVKLMGV---SSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQ 429
R H N++ + + + Q + + L K L + L+
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-----------LSNDH 110
Query: 430 RLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATND----- 484
+ GL+Y+H +++HRD++ +N+ L++ KI +F LA A D
Sbjct: 111 ICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 167
Query: 485 ----------------------VMPKFDVFAFGVVLLELLSGK 505
D+++ G +L E+LS +
Sbjct: 168 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 210
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.1 bits (225), Expect = 8e-21
Identities = 39/212 (18%), Positives = 79/212 (37%), Gaps = 56/212 (26%)
Query: 337 EHYSIGK--------SVYRAT--IDGKVLAVKKIK---------EDVTEELRILQRINHA 377
E++ + VY+A + G+V+A+KKI+ E+ +L+ +NH
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 378 NLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDV 437
N+VKL+ V + +LV+E+ + +
Sbjct: 62 NIVKLLDVIHT-ENKLYLVFEFLHQDLKKFMDASALTG---------IPLPLIKSYLFQL 111
Query: 438 ANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDV------------ 485
GL + H H ++HRD++ N+ +++ K+A+F LA V
Sbjct: 112 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 168
Query: 486 ------------MPKFDVFAFGVVLLELLSGK 505
D+++ G + E+++ +
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.7 bits (224), Expect = 1e-20
Identities = 48/297 (16%), Positives = 97/297 (32%), Gaps = 68/297 (22%)
Query: 337 EHYSIGK--------SVYRATI---DGKVLAVKKIKEDVTEE------------LRILQR 373
+ Y V++A G+ +A+K+++ EE LR L+
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 374 INHANLVKLMGVSSDSQGNR----FLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQ 429
H N+V+L V + S+ +R LV+E+ + +
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG---------VPTET 117
Query: 430 RLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVM--- 486
+ + GL ++H H +VHRD++ NI + S + K+A+F LA + +
Sbjct: 118 IKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS 174
Query: 487 -------------------PKFDVFAFGVVLLELLSGKKATRTTENGKT------AVLWK 521
D+++ G + E+ K R + + +
Sbjct: 175 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 234
Query: 522 EIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEV 578
+ + + + +E F L L + T + + R +
Sbjct: 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPA-KRISAYSA 290
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.2 bits (218), Expect = 5e-20
Identities = 36/219 (16%), Positives = 76/219 (34%), Gaps = 61/219 (27%)
Query: 335 LSEHYSIGK--------SVYRAT--IDGKVLAVKKIKED-------------VTEELRIL 371
L Y +G SVY D +A+K +++D V E+ +L
Sbjct: 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 372 QRIN--HANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQ 429
++++ + +++L+ + L+ E E + + L
Sbjct: 62 KKVSSGFSGVIRLLDWFER-PDSFVLILERPEPVQDLFDFITERGA---------LQEEL 111
Query: 430 RLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLD-SRFKAKIANFSLAAPATNDVM-- 486
V +++ H ++HRDI+ NI +D +R + K+ +F A + V
Sbjct: 112 ARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD 168
Query: 487 --------------------PKFDVFAFGVVLLELLSGK 505
V++ G++L +++ G
Sbjct: 169 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 207
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 87.6 bits (216), Expect = 1e-19
Identities = 34/295 (11%), Positives = 78/295 (26%), Gaps = 77/295 (26%)
Query: 335 LSEHYSIGK--------SVYRAT--IDGKVLAVKKIK-----EDVTEELRILQRINHANL 379
+ HY +G+ ++ T ++ + +A+K + +E R + +
Sbjct: 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTG 62
Query: 380 VKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVAN 439
+ + + LV + D K + A +
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK----------FSVKTVAMAAKQMLA 112
Query: 440 GLQYMHEHAQPSIVHRDIRTNNIQLDSRF-----KAKIANFSLA---------------- 478
+Q +HE S+V+RDI+ +N + + +F +
Sbjct: 113 RVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYRE 169
Query: 479 -----------AP---ATNDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIR 524
+ + + D+ A G V + L G + + ++ I
Sbjct: 170 KKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 229
Query: 525 EVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVV 579
E K E + + + P+ +
Sbjct: 230 E-KKQSTPLRELCAGFPEE-------------FYKYMHYARNLAFDATPDYDYLQ 270
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.3 bits (215), Expect = 2e-19
Identities = 45/215 (20%), Positives = 84/215 (39%), Gaps = 63/215 (29%)
Query: 341 IGK----SVYRAT--IDGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGV 385
IG+ V++A G+ +A+KK+ E++ILQ + H N+V L+ +
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77
Query: 386 SSD-------SQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVA 438
+G+ +LV+++ E+ + K T S+ RV +
Sbjct: 78 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK----------FTLSEIKRVMQMLL 127
Query: 439 NGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT---------------- 482
NGL Y+H + I+HRD++ N+ + K+A+F LA +
Sbjct: 128 NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184
Query: 483 ------------NDVMPKFDVFAFGVVLLELLSGK 505
D P D++ G ++ E+ +
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.6 bits (216), Expect = 2e-19
Identities = 48/306 (15%), Positives = 104/306 (33%), Gaps = 71/306 (23%)
Query: 328 IMESTMNLSEHYSIGK--------SVYRAT--IDGKVLAVKKIK---------EDVTEEL 368
+ ++ + Y + +V A G +A+KK+ + EL
Sbjct: 9 VTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYREL 68
Query: 369 RILQRINHANLVKLMGV-----SSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVI 423
R+L+ + H N++ L+ V + D + +LV + H K
Sbjct: 69 RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK----------- 117
Query: 424 FLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN 483
L + + + GL+Y+H HRD++ N+ ++ + KI +F LA A +
Sbjct: 118 -LGEDRIQFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADS 173
Query: 484 DVM---------------------PKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKE 522
++ D+++ G ++ E+++GK + +++ +
Sbjct: 174 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 233
Query: 523 I----------REVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSR 572
+ R + + L + S L++ L + +D R
Sbjct: 234 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAE-QR 292
Query: 573 PNMAEV 578
E
Sbjct: 293 VTAGEA 298
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.1 bits (215), Expect = 3e-19
Identities = 44/217 (20%), Positives = 68/217 (31%), Gaps = 60/217 (27%)
Query: 332 TMNLSEHYSIGK--------SVYRAT--IDGKVLAVKKIK----------EDVTEELRIL 371
TMN + K V G+ A+K ++ E R+L
Sbjct: 3 TMN---DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL 59
Query: 372 QRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRL 431
Q H L L V EYA G L L + T +
Sbjct: 60 QNTRHPFLTALKYAFQT-HDRLCFVMEYANGGELFFHLSRERV----------FTEERAR 108
Query: 432 RVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVM----- 486
++ + L+Y+H +V+RDI+ N+ LD KI +F L +D
Sbjct: 109 FYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 165
Query: 487 ------------------PKFDVFAFGVVLLELLSGK 505
D + GVV+ E++ G+
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.0 bits (212), Expect = 6e-19
Identities = 39/219 (17%), Positives = 77/219 (35%), Gaps = 63/219 (28%)
Query: 337 EHYSIGK--------SVYRAT-----IDGKVLAVKKIK-----------EDVTEELRILQ 372
E++ + K V+ GK+ A+K +K E E ++L+
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 373 RINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLR 432
I + + + + ++ L+ +Y G L L + + T +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----------FTEHEVQI 133
Query: 433 VALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVM------ 486
++ L+++H+ I++RDI+ NI LDS + +F L+ D
Sbjct: 134 YVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF 190
Query: 487 --------------------PKFDVFAFGVVLLELLSGK 505
D ++ GV++ ELL+G
Sbjct: 191 CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.9 bits (201), Expect = 9e-18
Identities = 45/285 (15%), Positives = 93/285 (32%), Gaps = 61/285 (21%)
Query: 341 IGK----SVYRAT--IDGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGV 385
IG+ +V++A +++A+K+++ E+ +L+ + H N+V+L V
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 386 SSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMH 445
+ LV+E+ + + L + GL + H
Sbjct: 70 LHSDK-KLTLVFEFCDQDLKKYFDSCNG----------DLDPEIVKSFLFQLLKGLGFCH 118
Query: 446 EHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDV-------------------- 485
+++HRD++ N+ ++ + K+ANF LA V
Sbjct: 119 SR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 486 ----MPKFDVFAFGVVLLELLSGKKATRTTENGK------TAVLWKEIREVLKVEEKREE 535
D+++ G + EL + + + +L E K +
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235
Query: 536 RLRNWMDPNLESFYPIDGALS--LATLARACTMDKSLSRPNMAEV 578
M P S + L+ L + + R + E
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 82.5 bits (203), Expect = 1e-17
Identities = 38/209 (18%), Positives = 68/209 (32%), Gaps = 54/209 (25%)
Query: 337 EHYSIGK--------SVYRAT--IDGKVLAVKKIK----------EDVTEELRILQRINH 376
+ + K V G A+K + E E RILQ +N
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 377 ANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALD 436
LVKL D+ N ++V EY G + L + + A
Sbjct: 101 PFLVKLEFSFKDNS-NLYMVMEYVAGGEMFSHLRRIGR----------FSEPHARFYAAQ 149
Query: 437 VANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVM---------- 486
+ +Y+H +++RD++ N+ +D + ++ +F A
Sbjct: 150 IVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALA 206
Query: 487 ----------PKFDVFAFGVVLLELLSGK 505
D +A GV++ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.1 bits (199), Expect = 3e-17
Identities = 45/231 (19%), Positives = 89/231 (38%), Gaps = 59/231 (25%)
Query: 319 KPIVYEIEVIMESTMNLSEHYSIGK--------SVYRA--TIDGKVLAVKKIK------- 361
+P Y E + ++ + E Y SV A T G +AVKK+
Sbjct: 1 RPTFYRQE-LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 59
Query: 362 --EDVTEELRILQRINHANLVKLMGVSSDSQ----GNRFLVYEYAENGSLDKWLHPKSKS 415
+ ELR+L+ + H N++ L+ V + ++ N + + L+ + +
Sbjct: 60 HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-- 117
Query: 416 SSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANF 475
LT + + GL+Y+H HRD++ +N+ ++ + KI +F
Sbjct: 118 ---------LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDF 165
Query: 476 SLAAPATNDVM---------------------PKFDVFAFGVVLLELLSGK 505
LA +++ D+++ G ++ ELL+G+
Sbjct: 166 GLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.4 bits (197), Expect = 6e-17
Identities = 40/229 (17%), Positives = 83/229 (36%), Gaps = 63/229 (27%)
Query: 323 YEIEVIMESTMNLSEHYSIGK--------SVYRAT--IDGKVLAVKKIK---------ED 363
Y +E + +ST + + Y K V A + + +A+KK+ +
Sbjct: 4 YSVE-VGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR 62
Query: 364 VTEELRILQRINHANLVKLMGV-----SSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSS 418
EL +++ +NH N++ L+ V + + + +LV E +
Sbjct: 63 AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD----- 117
Query: 419 SGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA 478
+ + + G++++H +HRD++ +NI + S KI +F LA
Sbjct: 118 --------HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLA 166
Query: 479 APATNDVM----------------------PKFDVFAFGVVLLELLSGK 505
A M D+++ G ++ E++ K
Sbjct: 167 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 79.1 bits (194), Expect = 1e-16
Identities = 34/209 (16%), Positives = 72/209 (34%), Gaps = 56/209 (26%)
Query: 337 EHYSIGK--------SVYRAT--IDGKVLAVKKIK----EDVTEELRILQRIN-HANLVK 381
+ Y + + V+ A + + + VK +K + + E++IL+ + N++
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIIT 94
Query: 382 LMGVSSDSQGNR-FLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANG 440
L + D LV+E+ N + LT ++
Sbjct: 95 LADIVKDPVSRTPALVFEHVNNTDFKQLYQT-------------LTDYDIRFYMYEILKA 141
Query: 441 LQYMHEHAQPSIVHRDIRTNNIQLDSRF-KAKIANFSLAAPATNDVM------------- 486
L Y H I+HRD++ +N+ +D K ++ ++ LA
Sbjct: 142 LDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 198
Query: 487 ----------PKFDVFAFGVVLLELLSGK 505
D+++ G +L ++ K
Sbjct: 199 ELLVDYQMYDYSLDMWSLGCMLASMIFRK 227
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 69.7 bits (169), Expect = 2e-13
Identities = 31/208 (14%), Positives = 73/208 (35%), Gaps = 45/208 (21%)
Query: 341 IGK----SVYRA--TIDGKVLAVKKIK------EDVTEELRILQRINHANLVKLMGVSSD 388
+G +V+ A ++ +A+K ++ E +E+++LQR+N A+ K + ++
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGAN 80
Query: 389 SQGNRFLVYEYAENGSLDKWLHP-----KSKSSSSSGSVIFLTWSQRLRVALDVANGLQY 443
+ + + + + + +++ + GL Y
Sbjct: 81 HILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDY 140
Query: 444 MHEHAQPSIVHRDIRTNNIQLDSR------FKAKIANFSLAAPATNDVM----------- 486
MH I+H DI+ N+ ++ + KIA+ A
Sbjct: 141 MHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSP 198
Query: 487 ---------PKFDVFAFGVVLLELLSGK 505
D+++ ++ EL++G
Sbjct: 199 EVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 55.2 bits (132), Expect = 2e-09
Identities = 28/171 (16%), Positives = 43/171 (25%), Gaps = 44/171 (25%)
Query: 339 YSIGK--------SVYRAT-IDGKVLAVKKIKEDVTE-----------------ELRILQ 372
+IGK +V+ VK K T
Sbjct: 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 61
Query: 373 RINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLR 432
R L KL G+ VY + N L + + K +
Sbjct: 62 RNEFRALQKLQGL------AVPKVYAWEGNAVLMELIDAKELY--------RVRVENPDE 107
Query: 433 VALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN 483
V + + + IVH D+ N+ L S I +F +
Sbjct: 108 VLDMILEEVAKFYHR---GIVHGDLSQYNV-LVSEEGIWIIDFPQSVEVGE 154
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 615 | |||
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.97 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.95 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.76 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.81 | |
| d1y7ma2 | 48 | Hypothetical protein YkuD, N-terminal domain {Baci | 97.46 | |
| d1e0ga_ | 48 | Membrane-bound lytic murein transclycosylase D, Ml | 97.41 | |
| d1y7ma2 | 48 | Hypothetical protein YkuD, N-terminal domain {Baci | 97.37 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.18 | |
| d1e0ga_ | 48 | Membrane-bound lytic murein transclycosylase D, Ml | 96.86 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 95.81 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 92.73 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 92.07 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-44 Score=371.37 Aligned_cols=236 Identities=25% Similarity=0.444 Sum_probs=181.6
Q ss_pred eeHHHHHHHccccccc---------cccc----ceEEEEEE--CC---eEEEEEEcc--------HHHHHHHHHHHhcCC
Q 047629 323 YEIEVIMESTMNLSEH---------YSIG----KSVYRATI--DG---KVLAVKKIK--------EDVTEELRILQRINH 376 (615)
Q Consensus 323 ~~~~~l~~at~~~~~~---------~~iG----~~Vy~~~~--~g---~~vAvK~~~--------~~~~~Ei~~l~~l~H 376 (615)
++|+++.+++.+|..+ ..+| |.||+|.. +| ..||||++. +.|.+|+++|++++|
T Consensus 7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H 86 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86 (299)
T ss_dssp GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC
Confidence 4556677777666532 2345 58999997 33 368999874 358899999999999
Q ss_pred CCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecC
Q 047629 377 ANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRD 456 (615)
Q Consensus 377 ~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrD 456 (615)
||||+++|+|.+. +..++|||||++|+|.+++..... .++|.+++.++.|||.||+|||+++ |+|||
T Consensus 87 pnIv~l~g~~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~---------~l~~~~~~~i~~qia~gl~yLH~~~---iiHrD 153 (299)
T d1jpaa_ 87 PNVIHLEGVVTKS-TPVMIITEFMENGSLDSFLRQNDG---------QFTVIQLVGMLRGIAAGMKYLADMN---YVHRD 153 (299)
T ss_dssp TTBCCEEEEECSS-SSCEEEEECCTTEEHHHHHHTTTT---------CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred CCCccEEEEEeeC-CEEEEEEEecCCCcceeeeccccC---------CCCHHHHHHHHHHHHHHHHHHhhCC---CccCc
Confidence 9999999998754 479999999999999999876543 3899999999999999999999998 99999
Q ss_pred CCCCceeeCCCCcEEEeecCCCCCCC----------------------------CCCCCcccchhHHHHHHHHHc-CCCC
Q 047629 457 IRTNNIQLDSRFKAKIANFSLAAPAT----------------------------NDVMPKFDVFAFGVVLLELLS-GKKA 507 (615)
Q Consensus 457 lk~~NILld~~~~~kl~DFGla~~~~----------------------------~~~~~k~DV~SfGvvl~Ellt-G~~p 507 (615)
|||+|||++.++.+||+|||+++... ..++.++|||||||+||||+| |+.|
T Consensus 154 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~P 233 (299)
T d1jpaa_ 154 LAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 233 (299)
T ss_dssp CCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred cccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCC
Confidence 99999999999999999999997531 124568999999999999998 8999
Q ss_pred CCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 047629 508 TRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQ 587 (615)
Q Consensus 508 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~ 587 (615)
|......+ +.. .+.. ......+.+.+..+.+|+.+||+.||++||||+||++.|+.+.+
T Consensus 234 f~~~~~~~---~~~--------------~i~~----~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 234 YWDMTNQD---VIN--------------AIEQ----DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp TTTCCHHH---HHH--------------HHHT----TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCHHH---HHH--------------HHHc----CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 87543211 110 1111 11122344556678999999999999999999999999998877
Q ss_pred chhhh
Q 047629 588 STETL 592 (615)
Q Consensus 588 ~~~~~ 592 (615)
+..++
T Consensus 293 ~p~sl 297 (299)
T d1jpaa_ 293 NPNSL 297 (299)
T ss_dssp SGGGG
T ss_pred ChhhC
Confidence 65443
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-44 Score=357.91 Aligned_cols=213 Identities=23% Similarity=0.423 Sum_probs=169.4
Q ss_pred ceEEEEEE-CCeEEEEEEcc------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCC
Q 047629 343 KSVYRATI-DGKVLAVKKIK------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKS 415 (615)
Q Consensus 343 ~~Vy~~~~-~g~~vAvK~~~------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~ 415 (615)
|.||+|.+ +++.||||+++ +++.+|++++++++|||||+++|+|.+. +..++||||+++|+|.+++.....
T Consensus 19 g~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~- 96 (263)
T d1sm2a_ 19 GLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-APICLVFEFMEHGCLSDYLRTQRG- 96 (263)
T ss_dssp CCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSCEEEEECCTTCBHHHHHHTTTT-
T ss_pred eEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccC-CceEEEEEecCCCcHHHHhhcccc-
Confidence 58999998 68899999986 4689999999999999999999999754 479999999999999999876543
Q ss_pred CCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------------
Q 047629 416 SSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------------- 482 (615)
Q Consensus 416 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------------- 482 (615)
.++|..++.++.|+|.||+|||+++ |+||||||+|||+|+++.+||+|||+++...
T Consensus 97 --------~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt 165 (263)
T d1sm2a_ 97 --------LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP 165 (263)
T ss_dssp --------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------------C
T ss_pred --------CCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCceeecceecC
Confidence 3899999999999999999999998 9999999999999999999999999986531
Q ss_pred -----------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCCh
Q 047629 483 -----------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPI 551 (615)
Q Consensus 483 -----------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~ 551 (615)
..++.|+|||||||++|||+||+.|+....... .... .+..... ...|.
T Consensus 166 ~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~--~~~~--------------~i~~~~~----~~~p~ 225 (263)
T d1sm2a_ 166 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVE--------------DISTGFR----LYKPR 225 (263)
T ss_dssp TTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH--HHHH--------------HHHHTCC----CCCCT
T ss_pred cccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH--HHHH--------------HHHhcCC----CCCcc
Confidence 125668999999999999999655544332211 1111 1111111 12233
Q ss_pred HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 552 DGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 552 ~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
.+..++.+|+..||+.||++||||+||++.|+++.++
T Consensus 226 ~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 4455789999999999999999999999999988654
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.9e-43 Score=357.77 Aligned_cols=214 Identities=25% Similarity=0.380 Sum_probs=175.7
Q ss_pred ceEEEEEE--CCeEEEEEEcc------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSK 414 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~ 414 (615)
|.||+|.+ +|+.||||+++ +++.+|+++|++++|||||+++|+|.+. +..++||||+++|+|.+++.....
T Consensus 31 g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~iv~E~~~~g~l~~~l~~~~~ 109 (287)
T d1opja_ 31 GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-PPFYIITEFMTYGNLLDYLRECNR 109 (287)
T ss_dssp SSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSCEEEEECCTTCBHHHHHHHSCT
T ss_pred eEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeC-CeeEEEeecccCcchHHHhhhccc
Confidence 58999998 58999999986 4588999999999999999999998754 478999999999999999976443
Q ss_pred CCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC-----------
Q 047629 415 SSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN----------- 483 (615)
Q Consensus 415 ~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~----------- 483 (615)
. .++|..++.|+.|||.||+|||+++ |+||||||+|||+++++.+||+|||+|+....
T Consensus 110 ~--------~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g 178 (287)
T d1opja_ 110 Q--------EVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 178 (287)
T ss_dssp T--------TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEE
T ss_pred c--------chHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCceeeccccc
Confidence 2 4899999999999999999999998 99999999999999999999999999976532
Q ss_pred -------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 484 -------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 484 -------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
.++.|+|||||||++|||++|+.|+....+.. ... . .+.. ......+
T Consensus 179 ~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~--~~~----~----------~i~~----~~~~~~~ 238 (287)
T d1opja_ 179 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVY----E----------LLEK----DYRMERP 238 (287)
T ss_dssp CGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHH----H----------HHHT----TCCCCCC
T ss_pred cccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH--HHH----H----------HHhc----CCCCCCC
Confidence 24668999999999999999877765433211 111 1 1111 1222334
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 551 IDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
...+..+.+|+..||+.||++||||+||++.|+.+.+.
T Consensus 239 ~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 239 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 44556789999999999999999999999999887654
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-43 Score=355.85 Aligned_cols=215 Identities=28% Similarity=0.471 Sum_probs=173.7
Q ss_pred ceEEEEEECCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATIDGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
|.||+|.+++ .||||+++ +.|.+|+++|++++|||||+++|++.+ +..++||||+++|+|.+++....
T Consensus 22 g~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~--~~~~lv~Ey~~~g~L~~~l~~~~ 98 (276)
T d1uwha_ 22 GTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA--PQLAIVTQWCEGSSLYHHLHIIE 98 (276)
T ss_dssp CEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSCEEEEECCCEEEHHHHHHTSC
T ss_pred cEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec--cEEEEEEecCCCCCHHHHHhhcc
Confidence 5899998766 59999985 358899999999999999999999753 46899999999999999997654
Q ss_pred CCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----------
Q 047629 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----------- 482 (615)
Q Consensus 414 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----------- 482 (615)
. .++|.+++.++.|||.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 99 ~---------~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~ 166 (276)
T d1uwha_ 99 T---------KFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL 166 (276)
T ss_dssp C---------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC------------C
T ss_pred C---------CCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCCccccccc
Confidence 3 3899999999999999999999997 9999999999999999999999999986431
Q ss_pred -----------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcC
Q 047629 483 -----------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNL 545 (615)
Q Consensus 483 -----------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l 545 (615)
..++.++|||||||+||||+||+.||......... ... .......|.+
T Consensus 167 ~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~------~~~---------~~~~~~~p~~ 231 (276)
T d1uwha_ 167 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI------IFM---------VGRGYLSPDL 231 (276)
T ss_dssp CCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH------HHH---------HHHTSCCCCG
T ss_pred ccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH------HHH---------HhcCCCCCcc
Confidence 11456899999999999999999999765432111 111 0112223322
Q ss_pred CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 546 ESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 546 ~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
...+.+.+..+.+|+.+||+.||++||||+||++.|+.+.++
T Consensus 232 -~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 232 -SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp -GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 123334456789999999999999999999999999988764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-43 Score=353.48 Aligned_cols=213 Identities=26% Similarity=0.409 Sum_probs=171.2
Q ss_pred ceEEEEEE-CCeEEEEEEcc------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCC
Q 047629 343 KSVYRATI-DGKVLAVKKIK------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKS 415 (615)
Q Consensus 343 ~~Vy~~~~-~g~~vAvK~~~------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~ 415 (615)
|.||+|.+ +++.||||+++ +.+.+|+++|++++|||||+++|++.+ +..++||||+++|+|.+++.....
T Consensus 27 g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~--~~~~iv~Ey~~~g~L~~~~~~~~~- 103 (272)
T d1qpca_ 27 GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ--EPIYIITEYMENGSLVDFLKTPSG- 103 (272)
T ss_dssp EEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEEECCTTCBHHHHTTSHHH-
T ss_pred cEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc--CCeEEEEEeCCCCcHHHHHhhcCC-
Confidence 58999999 56889999986 358999999999999999999998753 467999999999999998865432
Q ss_pred CCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC------------
Q 047629 416 SSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------------ 483 (615)
Q Consensus 416 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------------ 483 (615)
..++|.++++|+.||+.||.|||+++ |+||||||+|||+++++.+||+|||+|+....
T Consensus 104 -------~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt 173 (272)
T d1qpca_ 104 -------IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 173 (272)
T ss_dssp -------HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCC
T ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCccccccccCCc
Confidence 23899999999999999999999998 99999999999999999999999999975421
Q ss_pred ------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCCh
Q 047629 484 ------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPI 551 (615)
Q Consensus 484 ------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~ 551 (615)
.++.++|||||||++|||+||+.|+....... ... ..+.....+. .|.
T Consensus 174 ~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~--~~~--------------~~i~~~~~~~----~p~ 233 (272)
T d1qpca_ 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVI--------------QNLERGYRMV----RPD 233 (272)
T ss_dssp TTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHH--------------HHHHTTCCCC----CCT
T ss_pred ccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH--HHH--------------HHHHhcCCCC----Ccc
Confidence 13568999999999999999766654333211 111 1122222222 233
Q ss_pred HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 552 DGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 552 ~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
.....+.+|+.+||+.||++||||+||++.|+.+-.+
T Consensus 234 ~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 4445689999999999999999999999999876543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-42 Score=349.67 Aligned_cols=226 Identities=26% Similarity=0.441 Sum_probs=176.3
Q ss_pred cccccccc----ceEEEEEECC------eEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEE
Q 047629 335 LSEHYSIG----KSVYRATIDG------KVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLV 396 (615)
Q Consensus 335 ~~~~~~iG----~~Vy~~~~~g------~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV 396 (615)
|...+.|| |.||+|.+.+ ..||||+++ .+|.+|+++|++++|||||+++|+|.+. +..++|
T Consensus 9 ~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~-~~~~~v 87 (283)
T d1mqba_ 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY-KPMMII 87 (283)
T ss_dssp EEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-SSEEEE
T ss_pred eEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC-CceEEE
Confidence 33444455 5899999732 479999985 2578999999999999999999998754 479999
Q ss_pred EeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecC
Q 047629 397 YEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFS 476 (615)
Q Consensus 397 ~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFG 476 (615)
|||+.+|+|.+++..... .++|.+++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 88 ~e~~~~~~l~~~~~~~~~---------~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG 155 (283)
T d1mqba_ 88 TEYMENGALDKFLREKDG---------EFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFG 155 (283)
T ss_dssp EECCTTEEHHHHHHHTTT---------CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCC
T ss_pred EEecccCcchhhhhcccc---------cccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccc
Confidence 999999999998876543 3999999999999999999999998 9999999999999999999999999
Q ss_pred CCCCCCC--------------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHH
Q 047629 477 LAAPATN--------------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVE 530 (615)
Q Consensus 477 la~~~~~--------------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 530 (615)
+++.... .++.++|||||||++|||++|+.|+........ ...
T Consensus 156 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~--~~~--------- 224 (283)
T d1mqba_ 156 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--VMK--------- 224 (283)
T ss_dssp C-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHH---------
T ss_pred hhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH--HHH---------
Confidence 9975311 245689999999999999997766554332111 110
Q ss_pred HHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccchhhhh
Q 047629 531 EKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQSTETLE 593 (615)
Q Consensus 531 ~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~~~~~ 593 (615)
.+. .......+.+.+..+.+|+.+||+.||++||||+||++.|+.+.+..++++
T Consensus 225 -----~i~----~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~~l~ 278 (283)
T d1mqba_ 225 -----AIN----DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLK 278 (283)
T ss_dssp -----HHH----TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGGG
T ss_pred -----HHh----ccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCccccc
Confidence 111 112223445556678999999999999999999999999998887665444
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-42 Score=348.31 Aligned_cols=208 Identities=26% Similarity=0.421 Sum_probs=169.7
Q ss_pred ceEEEEEE----CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATI----DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~----~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
|.||+|.+ .++.||||+++ +.+.+|+++|++++|||||+++|+|.+ + ..+|||||+++|+|.+++
T Consensus 21 G~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~-~~~lvmE~~~~g~L~~~l 98 (277)
T d1xbba_ 21 GTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-E-SWMLVMEMAELGPLNKYL 98 (277)
T ss_dssp EEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-S-SEEEEEECCTTEEHHHHH
T ss_pred eEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-C-CEEEEEEcCCCCcHHHHH
Confidence 58999987 24789999985 247899999999999999999999864 3 689999999999999999
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------ 483 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------ 483 (615)
.... .++|.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 99 ~~~~----------~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 99 QQNR----------HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp HHCT----------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred hhcc----------CCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 8654 3999999999999999999999998 99999999999999999999999999975321
Q ss_pred --------------------CCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcC
Q 047629 484 --------------------DVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMD 542 (615)
Q Consensus 484 --------------------~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~d 542 (615)
.++.++|||||||++|||+| |+.||......+ +.. .+.+-..
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~-------~~~----------~i~~~~~ 228 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTA----------MLEKGER 228 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHH----------HHHTTCC
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH-------HHH----------HHHcCCC
Confidence 13458999999999999998 899997543211 111 1111111
Q ss_pred CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 047629 543 PNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLT 586 (615)
Q Consensus 543 p~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~ 586 (615)
...|...+..+.+|+.+||+.||++||||+||++.|+...
T Consensus 229 ----~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 229 ----MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ----CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 1234445567899999999999999999999999887654
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-42 Score=348.86 Aligned_cols=211 Identities=27% Similarity=0.387 Sum_probs=171.9
Q ss_pred ceEEEEEE----CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI----DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~----~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||+|.+ ++..||||+++ +.|.+|+++|++++|||||+++|+|.+ +..++||||+++|+|.+++.
T Consensus 23 g~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~~lvmE~~~~g~L~~~l~ 100 (285)
T d1u59a_ 23 GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--EALMLVMEMAGGGPLHKFLV 100 (285)
T ss_dssp EEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES--SSEEEEEECCTTEEHHHHHT
T ss_pred eEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc--CeEEEEEEeCCCCcHHHHhh
Confidence 58999986 35579999985 357899999999999999999999864 36899999999999999987
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC-------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------- 483 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------- 483 (615)
.... .++|.+++.++.|+|.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 101 ~~~~---------~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 168 (285)
T d1u59a_ 101 GKRE---------EIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 168 (285)
T ss_dssp TCTT---------TSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECC
T ss_pred cccc---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccccccccccc
Confidence 6543 3999999999999999999999998 99999999999999999999999999965321
Q ss_pred -------------------CCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCC
Q 047629 484 -------------------DVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDP 543 (615)
Q Consensus 484 -------------------~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp 543 (615)
.++.++|||||||++|||+| |+.||......+. .. .+.+-..+
T Consensus 169 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~---~~--------------~i~~~~~~ 231 (285)
T d1u59a_ 169 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---MA--------------FIEQGKRM 231 (285)
T ss_dssp CCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH---HH--------------HHHTTCCC
T ss_pred ccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHH---HH--------------HHHcCCCC
Confidence 13568999999999999998 8999976543111 11 11111112
Q ss_pred cCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 544 NLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 544 ~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
..|...+..+.+|+..||+.||++||||.+|++.|+....+
T Consensus 232 ----~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 232 ----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp ----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 23444556789999999999999999999999999866543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-41 Score=339.63 Aligned_cols=209 Identities=24% Similarity=0.404 Sum_probs=172.2
Q ss_pred ceEEEEEE-CCeEEEEEEcc------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCC
Q 047629 343 KSVYRATI-DGKVLAVKKIK------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKS 415 (615)
Q Consensus 343 ~~Vy~~~~-~g~~vAvK~~~------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~ 415 (615)
|.||+|.+ +++.||||+++ +++.+|++++++++|||||+++|+|.+. +..++||||+++|+|.+++.....
T Consensus 18 g~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~-~~~~iv~Ey~~~g~l~~~~~~~~~- 95 (258)
T d1k2pa_ 18 GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-RPIFIITEYMANGCLLNYLREMRH- 95 (258)
T ss_dssp EEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCS-SSEEEEEECCTTEEHHHHHHSGGG-
T ss_pred eEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeC-CceEEEEEccCCCcHHHhhhcccc-
Confidence 58999999 67799999986 4689999999999999999999998754 579999999999999999866543
Q ss_pred CCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC------------
Q 047629 416 SSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------------ 483 (615)
Q Consensus 416 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------------ 483 (615)
.++|..+.+++.|+++||+|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 96 --------~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t 164 (258)
T d1k2pa_ 96 --------RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP 164 (258)
T ss_dssp --------CCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCC
T ss_pred --------CCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCceeecccCCC
Confidence 3899999999999999999999998 99999999999999999999999999964311
Q ss_pred ------------CCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 484 ------------DVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 484 ------------~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
.++.|+|||||||++|||+| |+.||......+ +. ..+.+... ...|
T Consensus 165 ~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~-------~~----------~~i~~~~~----~~~p 223 (258)
T d1k2pa_ 165 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-------TA----------EHIAQGLR----LYRP 223 (258)
T ss_dssp GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-------HH----------HHHHTTCC----CCCC
T ss_pred CCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH-------HH----------HHHHhCCC----CCCc
Confidence 14568999999999999998 788987554211 11 01111111 1233
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 047629 551 IDGALSLATLARACTMDKSLSRPNMAEVVFNLSVL 585 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l 585 (615)
......+.+|+.+||+.||++|||++||++.|..+
T Consensus 224 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 44456789999999999999999999999998653
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-42 Score=345.21 Aligned_cols=213 Identities=25% Similarity=0.415 Sum_probs=172.3
Q ss_pred ceEEEEEECCeEEEEEEcc-----HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCCCC
Q 047629 343 KSVYRATIDGKVLAVKKIK-----EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKSSS 417 (615)
Q Consensus 343 ~~Vy~~~~~g~~vAvK~~~-----~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~~ 417 (615)
|.||+|.+.|+.||||+++ +.+.+|+++|++++|||||+++|+|.+.++.+++||||+++|+|.++|.....
T Consensus 21 g~Vy~~~~~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--- 97 (262)
T d1byga_ 21 GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR--- 97 (262)
T ss_dssp CEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHH---
T ss_pred eEEEEEEECCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCC---
Confidence 5899999999999999996 46889999999999999999999987655568999999999999999975432
Q ss_pred CCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC---------------
Q 047629 418 SSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT--------------- 482 (615)
Q Consensus 418 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~--------------- 482 (615)
..++|..+++|+.||+.||.|||+.+ |+||||||+|||++.++.+|++|||+++...
T Consensus 98 -----~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~~~~~~~~y~aP 169 (262)
T d1byga_ 98 -----SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAP 169 (262)
T ss_dssp -----HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------------CCTTTSCH
T ss_pred -----CCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCCCccccccccCCCh
Confidence 24899999999999999999999987 9999999999999999999999999997542
Q ss_pred -----CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHH
Q 047629 483 -----NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALS 556 (615)
Q Consensus 483 -----~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~ 556 (615)
..+++++|||||||++|||+| |+.|+......+. . ..+.+-..+ +.+......
T Consensus 170 E~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~---~--------------~~i~~~~~~----~~~~~~~~~ 228 (262)
T d1byga_ 170 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---V--------------PRVEKGYKM----DAPDGCPPA 228 (262)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---H--------------HHHTTTCCC----CCCTTCCHH
T ss_pred HHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHH---H--------------HHHHcCCCC----CCCccCCHH
Confidence 125679999999999999999 6777665432211 1 112222222 334444567
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 047629 557 LATLARACTMDKSLSRPNMAEVVFNLSVLTQ 587 (615)
Q Consensus 557 l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~ 587 (615)
+.+|+.+||+.||.+||||.||+++|+.++.
T Consensus 229 ~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 229 VYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 8999999999999999999999999988753
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-41 Score=341.14 Aligned_cols=214 Identities=26% Similarity=0.397 Sum_probs=172.5
Q ss_pred ceEEEEEE-CCeEEEEEEcc------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCC
Q 047629 343 KSVYRATI-DGKVLAVKKIK------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKS 415 (615)
Q Consensus 343 ~~Vy~~~~-~g~~vAvK~~~------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~ 415 (615)
|.||+|.. +++.||||+++ +.|.+|+.+|++++|+|||+++|+|.+ +..++||||+++|+|.+++......
T Consensus 31 g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~--~~~~lv~Ey~~~g~l~~~~~~~~~~ 108 (285)
T d1fmka3 31 GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTEYMSKGSLLDFLKGETGK 108 (285)
T ss_dssp CEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEECCCTTCBHHHHHSHHHHT
T ss_pred eEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec--CCeEEEEEecCCCchhhhhhhcccc
Confidence 58999998 56789999986 468999999999999999999999853 3689999999999999999764321
Q ss_pred CCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------------
Q 047629 416 SSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------------- 482 (615)
Q Consensus 416 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------------- 482 (615)
.++|.+++.++.||+.||+|||+++ |+||||||+|||+|+++.+||+|||+++...
T Consensus 109 --------~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt 177 (285)
T d1fmka3 109 --------YLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 177 (285)
T ss_dssp --------TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------------CC
T ss_pred --------cchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCceeecccccc
Confidence 3999999999999999999999998 9999999999999999999999999997542
Q ss_pred -----------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCCh
Q 047629 483 -----------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPI 551 (615)
Q Consensus 483 -----------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~ 551 (615)
..++.++|||||||++|||++|+.|+........ ... .+..-.. ...+.
T Consensus 178 ~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~--~~~--------------~i~~~~~----~~~~~ 237 (285)
T d1fmka3 178 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLD--------------QVERGYR----MPCPP 237 (285)
T ss_dssp GGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHH--------------HHHTTCC----CCCCT
T ss_pred ccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH--HHH--------------HHHhcCC----CCCCc
Confidence 1245689999999999999998777654432111 110 1111111 22344
Q ss_pred HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccch
Q 047629 552 DGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQST 589 (615)
Q Consensus 552 ~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~ 589 (615)
+...++.+++.+||+.||++||||+||++.|+....+.
T Consensus 238 ~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 238 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 45567899999999999999999999999998766553
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-41 Score=345.02 Aligned_cols=223 Identities=26% Similarity=0.405 Sum_probs=175.5
Q ss_pred ccccccccc--ceEEEEEEC---C--eEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEe
Q 047629 334 NLSEHYSIG--KSVYRATID---G--KVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYE 398 (615)
Q Consensus 334 ~~~~~~~iG--~~Vy~~~~~---g--~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E 398 (615)
+|.+..+-| |.||+|.+. + ..||||+++ ++|.+|+++|++++|||||+++|+|.+.++..++|||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 444444444 589999982 2 368999985 3588999999999999999999998876668999999
Q ss_pred ecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCC
Q 047629 399 YAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA 478 (615)
Q Consensus 399 ~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla 478 (615)
||++|+|.+++..... .+++..+++++.|+|.||.|||+.+ |+||||||+|||+|+++.+||+|||++
T Consensus 110 ~~~~g~l~~~~~~~~~---------~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~ 177 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETH---------NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLA 177 (311)
T ss_dssp CCTTCBHHHHHHCTTC---------CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGG
T ss_pred EeecCchhhhhccccc---------cchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccch
Confidence 9999999999986543 3789999999999999999999998 999999999999999999999999999
Q ss_pred CCCCC---------------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHH
Q 047629 479 APATN---------------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEE 531 (615)
Q Consensus 479 ~~~~~---------------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 531 (615)
+.... .++.++||||||+++|||+||+.|+......... . .
T Consensus 178 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~--~---~------- 245 (311)
T d1r0pa_ 178 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--T---V------- 245 (311)
T ss_dssp CCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------C--H---H-------
T ss_pred hhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHH--H---H-------
Confidence 75421 1456899999999999999988887643321110 0 0
Q ss_pred HHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 532 KREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 532 ~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
.+..-..+ ..|......+.+|+.+||+.||++||+|.||++.|+.+.++
T Consensus 246 ----~i~~g~~~----~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 246 ----YLLQGRRL----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp ----HHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ----HHHcCCCC----CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 01111111 12334445689999999999999999999999999988654
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-40 Score=332.58 Aligned_cols=203 Identities=26% Similarity=0.377 Sum_probs=167.7
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||+|.. +|+.||||++.+ .+.+|+++|++++|||||++++++.+. +..++||||+++|+|.+++.
T Consensus 20 g~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-~~~~ivmEy~~~g~L~~~l~ 98 (263)
T d2j4za1 20 GNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-TRVYLILEYAPLGTVYRELQ 98 (263)
T ss_dssp EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEEEEECCTTCBHHHHHH
T ss_pred cEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC-CEEEEEEeecCCCcHHHHHh
Confidence 48999998 689999999852 367899999999999999999998864 47999999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC-------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------- 483 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------- 483 (615)
... .+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 99 ~~~----------~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~ 165 (263)
T d2j4za1 99 KLS----------KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC 165 (263)
T ss_dssp HHS----------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCCEETT
T ss_pred hcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCCcccccC
Confidence 644 3899999999999999999999998 99999999999999999999999999975422
Q ss_pred --------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCC
Q 047629 484 --------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFY 549 (615)
Q Consensus 484 --------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~ 549 (615)
.++.++|||||||+||||++|+.||...... .... .+.. .++. +
T Consensus 166 Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~--------------~i~~-~~~~----~ 223 (263)
T d2j4za1 166 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ---ETYK--------------RISR-VEFT----F 223 (263)
T ss_dssp EEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHH--------------HHHT-TCCC----C
T ss_pred CCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH---HHHH--------------HHHc-CCCC----C
Confidence 2567999999999999999999999654311 1111 0100 1122 2
Q ss_pred ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 550 PIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 550 ~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
|......+.+|+.+||+.||++|||++|++++
T Consensus 224 p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 224 PDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred CccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 33344567899999999999999999999863
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-40 Score=335.84 Aligned_cols=206 Identities=23% Similarity=0.347 Sum_probs=165.0
Q ss_pred ceEEEEEE--CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATI--DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
|.||+|.. +|+.||||+++ +.+.+|+++|++++|||||++++++.+. +..++||||+++|+|.++|...
T Consensus 19 g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~-~~~~ivmEy~~gg~L~~~l~~~ 97 (271)
T d1nvra_ 19 GEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG-NIQYLFLEYCSGGELFDRIEPD 97 (271)
T ss_dssp EEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEEEECCTTEEGGGGSBTT
T ss_pred eEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-ceeEEEEeccCCCcHHHHHhcC
Confidence 58999997 68999999874 2478899999999999999999998764 4799999999999999999754
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC----------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT---------- 482 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~---------- 482 (615)
. .+++.++..++.|++.||+|||+++ |+||||||+|||+++++++||+|||+|+...
T Consensus 98 ~----------~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~ 164 (271)
T d1nvra_ 98 I----------GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 164 (271)
T ss_dssp T----------BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCC
T ss_pred C----------CCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCccccccc
Confidence 3 3899999999999999999999998 9999999999999999999999999996431
Q ss_pred ---------------CC-CCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCC
Q 047629 483 ---------------ND-VMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLE 546 (615)
Q Consensus 483 ---------------~~-~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~ 546 (615)
.. .+.++|||||||++|||++|+.||....+..... .. .......
T Consensus 165 ~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~--~~-----------------~~~~~~~ 225 (271)
T d1nvra_ 165 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY--SD-----------------WKEKKTY 225 (271)
T ss_dssp CCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH--HH-----------------HHTTCTT
T ss_pred eeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH--HH-----------------HhcCCCC
Confidence 01 2347899999999999999999997654322111 00 0000000
Q ss_pred CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 547 SFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 547 ~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
..........+.+|+.+||+.||++|||++|++++
T Consensus 226 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 226 LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11112233457899999999999999999998753
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.8e-41 Score=342.42 Aligned_cols=230 Identities=28% Similarity=0.390 Sum_probs=176.2
Q ss_pred cccccccccc----ceEEEEEEC-------CeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcE
Q 047629 333 MNLSEHYSIG----KSVYRATID-------GKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNR 393 (615)
Q Consensus 333 ~~~~~~~~iG----~~Vy~~~~~-------g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 393 (615)
++|.....|| |.||+|.+. ++.||||+++ +++.+|+++|++++||||++++++|.+. +..
T Consensus 13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-~~~ 91 (301)
T d1lufa_ 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG-KPM 91 (301)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-SSC
T ss_pred HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccC-Cce
Confidence 4454444555 589999873 4789999985 3588999999999999999999998754 479
Q ss_pred EEEEeecCCCCHHHhhccCCCCCC--------------CCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 047629 394 FLVYEYAENGSLDKWLHPKSKSSS--------------SSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRT 459 (615)
Q Consensus 394 ~lV~E~~~~GsL~~~L~~~~~~~~--------------~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~ 459 (615)
+++|||+++|+|.++|........ .......++|.+++.|+.|++.||+|||+++ ++||||||
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp 168 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLAT 168 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcc
Confidence 999999999999999975432110 0011124899999999999999999999998 99999999
Q ss_pred CceeeCCCCcEEEeecCCCCCCC-------------------------CCCCCcccchhHHHHHHHHHcCCC-CCCCCCC
Q 047629 460 NNIQLDSRFKAKIANFSLAAPAT-------------------------NDVMPKFDVFAFGVVLLELLSGKK-ATRTTEN 513 (615)
Q Consensus 460 ~NILld~~~~~kl~DFGla~~~~-------------------------~~~~~k~DV~SfGvvl~ElltG~~-p~~~~~~ 513 (615)
+|||+|.++.+||+|||+|+... ..++.++|||||||++|||++|.. |+.....
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH
Confidence 99999999999999999985321 125679999999999999999864 5654332
Q ss_pred ChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 047629 514 GKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQ 587 (615)
Q Consensus 514 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~ 587 (615)
.+ .. ..+.+--.+ ..+.+.+..+.+|+.+||+.||++||||.||++.|+++.+
T Consensus 249 ~e---~~--------------~~v~~~~~~----~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 249 EE---VI--------------YYVRDGNIL----ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp HH---HH--------------HHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HH---HH--------------HHHHcCCCC----CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11 00 011111112 2344445578999999999999999999999999998753
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-40 Score=343.30 Aligned_cols=217 Identities=27% Similarity=0.422 Sum_probs=169.7
Q ss_pred ceEEEEEEC--C-----eEEEEEEcc--------HHHHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCHH
Q 047629 343 KSVYRATID--G-----KVLAVKKIK--------EDVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLD 406 (615)
Q Consensus 343 ~~Vy~~~~~--g-----~~vAvK~~~--------~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~ 406 (615)
|.||+|... + ..||||.+. ..+.+|+.+|.++ +|||||+++|++.+. +..++||||+++|+|.
T Consensus 51 G~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~-~~~~lv~Ey~~~g~L~ 129 (325)
T d1rjba_ 51 GKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS-GPIYLIFEYCCYGDLL 129 (325)
T ss_dssp EEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSCEEEEECCTTCBHH
T ss_pred eEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC-CeEEEEEEcCCCCcHH
Confidence 589999872 2 369999884 3477899999998 899999999998754 4799999999999999
Q ss_pred HhhccCCCCCCC-------------CCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEe
Q 047629 407 KWLHPKSKSSSS-------------SGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIA 473 (615)
Q Consensus 407 ~~L~~~~~~~~~-------------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~ 473 (615)
++|+........ ......++|..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 130 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~Nill~~~~~~Kl~ 206 (325)
T d1rjba_ 130 NYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKIC 206 (325)
T ss_dssp HHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEETTTEEEEC
T ss_pred HHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchhccccccCCeEEEe
Confidence 999765421000 001124899999999999999999999998 9999999999999999999999
Q ss_pred ecCCCCCCC-------------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHH
Q 047629 474 NFSLAAPAT-------------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVL 527 (615)
Q Consensus 474 DFGla~~~~-------------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 527 (615)
|||+|+... ..++.++|||||||+||||+| |+.||........ +.. .
T Consensus 207 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~--~~~----~- 279 (325)
T d1rjba_ 207 DFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN--FYK----L- 279 (325)
T ss_dssp CCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--HHH----H-
T ss_pred eccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHH--HHH----H-
Confidence 999996531 124668999999999999998 8999976543221 111 1
Q ss_pred hHHHHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047629 528 KVEEKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLS 583 (615)
Q Consensus 528 ~~~~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~ 583 (615)
+..-.. .+.|......+.+|+.+||+.||++||||+||+++|.
T Consensus 280 ---------~~~~~~----~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 280 ---------IQNGFK----MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp ---------HHTTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ---------HhcCCC----CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 111111 2234445567899999999999999999999999985
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-40 Score=333.45 Aligned_cols=215 Identities=20% Similarity=0.367 Sum_probs=167.8
Q ss_pred cccccc--ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcC---CCcEEEEEeec
Q 047629 337 EHYSIG--KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDS---QGNRFLVYEYA 400 (615)
Q Consensus 337 ~~~~iG--~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~---~~~~~lV~E~~ 400 (615)
++.+-| |.||+|.. +|+.||+|+++ +.+.+|+++|++++|||||++++++.+. +..+++||||+
T Consensus 15 ~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~ 94 (270)
T d1t4ha_ 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 94 (270)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECC
T ss_pred eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCC
Confidence 333444 58999998 68899999875 2477899999999999999999997642 23479999999
Q ss_pred CCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeC-CCCcEEEeecCCCC
Q 047629 401 ENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLD-SRFKAKIANFSLAA 479 (615)
Q Consensus 401 ~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld-~~~~~kl~DFGla~ 479 (615)
++|+|.+++.... .+++..+..++.||+.||+|||+++ ++|+||||||+|||++ +++.+||+|||+|+
T Consensus 95 ~~g~L~~~l~~~~----------~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 95 TSGTLKTYLKRFK----------VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp CSCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred CCCcHHHHHhccc----------cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence 9999999997653 3899999999999999999999975 4599999999999996 57899999999996
Q ss_pred CCC--------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhh
Q 047629 480 PAT--------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRN 539 (615)
Q Consensus 480 ~~~--------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 539 (615)
... ..++.++|||||||++|||++|+.||....+... +.. .+..
T Consensus 164 ~~~~~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~~~--------------~i~~ 227 (270)
T d1t4ha_ 164 LKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYR--------------RVTS 227 (270)
T ss_dssp GCCTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHH--------------HHTT
T ss_pred eccCCccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--HHH--------------HHHc
Confidence 532 1256789999999999999999999975432111 110 1111
Q ss_pred hcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 540 WMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 540 ~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
...|. .++.....++.+|+.+||+.||++|||+.|++++
T Consensus 228 ~~~~~---~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 228 GVKPA---SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp TCCCG---GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCc---ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 11111 1122233457899999999999999999999763
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-39 Score=331.21 Aligned_cols=205 Identities=21% Similarity=0.360 Sum_probs=167.4
Q ss_pred ceEEEEEE--CCeEEEEEEcc-------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
|.||+|.. +|+.||||+++ +.+.+|+++|++++|||||++++++.+.+ ..++||||+++|+|.+++...
T Consensus 34 g~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~ivmEy~~gg~L~~~~~~~- 111 (293)
T d1yhwa1 34 GTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-ELWVVMEYLAGGSLTDVVTET- 111 (293)
T ss_dssp CEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-EEEEEEECCTTCBHHHHHHHS-
T ss_pred cEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC-EEEEEEEecCCCcHHHHhhcc-
Confidence 58999996 69999999885 34789999999999999999999987654 799999999999999988653
Q ss_pred CCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----------
Q 047629 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----------- 482 (615)
Q Consensus 414 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----------- 482 (615)
.+++.++..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+...
T Consensus 112 ----------~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~g 178 (293)
T d1yhwa1 112 ----------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG 178 (293)
T ss_dssp ----------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCS
T ss_pred ----------CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccccccccccc
Confidence 2899999999999999999999998 9999999999999999999999999996531
Q ss_pred ------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 483 ------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 483 ------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
..++.++|||||||++|||++|+.||......+ .+ ... .. .-.+.+ ..+
T Consensus 179 t~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~----~~~----------~~-~~~~~~--~~~ 239 (293)
T d1yhwa1 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--AL----YLI----------AT-NGTPEL--QNP 239 (293)
T ss_dssp CGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HH----HHH----------HH-HCSCCC--SSG
T ss_pred CCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH--HH----HHH----------Hh-CCCCCC--CCc
Confidence 125679999999999999999999997543211 11 100 00 011111 223
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 551 IDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
......+.+|+.+||+.||++|||+.|++++
T Consensus 240 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp GGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 3445568899999999999999999999864
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-41 Score=342.77 Aligned_cols=234 Identities=24% Similarity=0.360 Sum_probs=173.1
Q ss_pred ceEEEEEECCeEEEEEEccH----HHHHHHH--HHHhcCCCCcccEEEEEEcCCC---cEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATIDGKVLAVKKIKE----DVTEELR--ILQRINHANLVKLMGVSSDSQG---NRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~~g~~vAvK~~~~----~~~~Ei~--~l~~l~H~niv~l~g~~~~~~~---~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
|.||+|+++|+.||||+++. ++..|.+ .+.+++|||||+++|+|.+.++ .+++|||||++|+|.++|+..
T Consensus 17 g~Vy~~~~~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~- 95 (303)
T d1vjya_ 17 GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY- 95 (303)
T ss_dssp SEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC-
T ss_pred eEEEEEEECCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcC-
Confidence 48999999999999999863 3334444 4567899999999999975442 478999999999999999764
Q ss_pred CCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCCC----
Q 047629 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHA-----QPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATND---- 484 (615)
Q Consensus 414 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~---- 484 (615)
.++|.++++++.|+|.||+|||+.. .++|+||||||+|||++.++.+||+|||+++.....
T Consensus 96 ----------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~ 165 (303)
T d1vjya_ 96 ----------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 165 (303)
T ss_dssp ----------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEE
T ss_pred ----------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcce
Confidence 2899999999999999999999741 345999999999999999999999999998643110
Q ss_pred -----------------------------CCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHH
Q 047629 485 -----------------------------VMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREE 535 (615)
Q Consensus 485 -----------------------------~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 535 (615)
++.|+|||||||+||||+||+.|+........... ...............
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 244 (303)
T d1vjya_ 166 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY-DLVPSDPSVEEMRKV 244 (303)
T ss_dssp CC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT-TTSCSSCCHHHHHHH
T ss_pred eccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchh-hcccccchHHHHHHH
Confidence 23478999999999999999988754332111000 000000000011122
Q ss_pred HHhhhcCCcCCCCCC-hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 536 RLRNWMDPNLESFYP-IDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 536 ~~~~~~dp~l~~~~~-~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
...+.++|.+...+. .+....+.+|+.+||+.||++||||.||++.|+++.+.
T Consensus 245 ~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 245 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 233344555543332 34566799999999999999999999999999988754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-41 Score=336.92 Aligned_cols=211 Identities=23% Similarity=0.340 Sum_probs=159.1
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcC-CCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDS-QGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||+|.. +|+.||||.++ +.+.+|+++|++++|||||++++++.+. ++.+++||||+++|+|.+++.
T Consensus 18 g~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~ 97 (269)
T d2java1 18 GRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVIT 97 (269)
T ss_dssp EEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHH
T ss_pred eEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHH
Confidence 48999987 68999999874 2377899999999999999999998753 345899999999999999986
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHA--QPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------ 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------ 482 (615)
...... ..+++..++.++.|++.||+|||+++ ..+|+||||||+|||++.++.+||+|||+|+...
T Consensus 98 ~~~~~~------~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 171 (269)
T d2java1 98 KGTKER------QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA 171 (269)
T ss_dssp HHHHHT------CCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-------
T ss_pred hccccC------CCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCCCcc
Confidence 532110 13999999999999999999999864 2359999999999999999999999999985431
Q ss_pred -----------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcC
Q 047629 483 -----------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNL 545 (615)
Q Consensus 483 -----------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l 545 (615)
..++.++|||||||++|||++|+.||...... .+.. .+.+.--+.+
T Consensus 172 ~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~---~~~~--------------~i~~~~~~~~ 234 (269)
T d2java1 172 KAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELAG--------------KIREGKFRRI 234 (269)
T ss_dssp ----CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHH--------------HHHHTCCCCC
T ss_pred ccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH---HHHH--------------HHHcCCCCCC
Confidence 22567999999999999999999999754321 1110 1111111122
Q ss_pred CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047629 546 ESFYPIDGALSLATLARACTMDKSLSRPNMAEVVF 580 (615)
Q Consensus 546 ~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~ 580 (615)
+......+.+|+.+||+.||++|||+.|+++
T Consensus 235 ----~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 235 ----PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 2333446889999999999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-39 Score=331.76 Aligned_cols=207 Identities=24% Similarity=0.343 Sum_probs=168.5
Q ss_pred ceEEEEEE--CCeEEEEEEcc-------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
|.||+|.. +|+.||||+++ +.+.+|+++|++++|||||++++++.+. +..++||||+++|+|.+++....
T Consensus 26 g~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-~~~~lvmEy~~~g~L~~~~~~~~ 104 (288)
T d2jfla1 26 GKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-NNLWILIEFCAGGAVDAVMLELE 104 (288)
T ss_dssp EEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEECCTTEEHHHHHHHHT
T ss_pred cEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-CeEEEEEecCCCCcHHHHHHhcC
Confidence 58999997 68999999985 3578999999999999999999998764 47999999999999999986543
Q ss_pred CCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCC------------
Q 047629 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA------------ 481 (615)
Q Consensus 414 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~------------ 481 (615)
. .+++.++..++.||+.||.|||+++ |+||||||+|||++.++++||+|||+|+..
T Consensus 105 ~---------~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~~G 172 (288)
T d2jfla1 105 R---------PLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIG 172 (288)
T ss_dssp S---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTCCCS
T ss_pred C---------CCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCccccccccc
Confidence 2 3999999999999999999999998 999999999999999999999999998532
Q ss_pred ----------------CCCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcC
Q 047629 482 ----------------TNDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNL 545 (615)
Q Consensus 482 ----------------~~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l 545 (615)
...++.++|||||||++|||++|+.||......+.. .. +...-.+.+
T Consensus 173 t~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~------~~-----------i~~~~~~~~ 235 (288)
T d2jfla1 173 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL------LK-----------IAKSEPPTL 235 (288)
T ss_dssp CCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH------HH-----------HHHSCCCCC
T ss_pred ccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHH------HH-----------HHcCCCCCC
Confidence 112467899999999999999999999765432211 00 011011111
Q ss_pred CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 546 ESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 546 ~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
..+......+.+|+.+||+.||++|||+.|++++
T Consensus 236 --~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 236 --AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp --SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred --CccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2233445568999999999999999999999764
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-40 Score=331.93 Aligned_cols=209 Identities=26% Similarity=0.351 Sum_probs=166.3
Q ss_pred ceEEEEEEC---C--eEEEEEEcc----------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATID---G--KVLAVKKIK----------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~~---g--~~vAvK~~~----------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~ 407 (615)
|.||+|.++ + ..||||+++ ++|.+|+++|++++|||||+++|+|.+ +..++||||+++|+|.+
T Consensus 22 g~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~--~~~~lv~e~~~~~~l~~ 99 (273)
T d1u46a_ 22 GVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT--PPMKMVTELAPLGSLLD 99 (273)
T ss_dssp CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEEECCTTCBHHH
T ss_pred eEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--cchheeeeeecCcchhh
Confidence 589999872 2 478999885 247899999999999999999999864 36789999999999999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCCC---
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATND--- 484 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~--- 484 (615)
++..... .++|..+++++.|+|.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 100 ~~~~~~~---------~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~ 167 (273)
T d1u46a_ 100 RLRKHQG---------HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 167 (273)
T ss_dssp HHHHHGG---------GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCE
T ss_pred hhhcccC---------CCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhcccCCCc
Confidence 8876443 4999999999999999999999998 999999999999999999999999999754211
Q ss_pred -----------------------CCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhh
Q 047629 485 -----------------------VMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNW 540 (615)
Q Consensus 485 -----------------------~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 540 (615)
++.++|||||||++|||+| |+.||......+. +..+
T Consensus 168 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~--------------------~~~i 227 (273)
T d1u46a_ 168 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI--------------------LHKI 227 (273)
T ss_dssp EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--------------------HHHH
T ss_pred ceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH--------------------HHHH
Confidence 3457999999999999998 8999875432110 0011
Q ss_pred cCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 047629 541 MDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVL 585 (615)
Q Consensus 541 ~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l 585 (615)
.......+.+...+..+.+|+..||+.||++||||.||++.|.+.
T Consensus 228 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 228 DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111111122334445689999999999999999999999988764
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.1e-40 Score=337.24 Aligned_cols=213 Identities=24% Similarity=0.363 Sum_probs=169.9
Q ss_pred cccccccc----ceEEEEEE--CCeEEEEEEcc----------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEe
Q 047629 335 LSEHYSIG----KSVYRATI--DGKVLAVKKIK----------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYE 398 (615)
Q Consensus 335 ~~~~~~iG----~~Vy~~~~--~g~~vAvK~~~----------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E 398 (615)
|.....+| |.||+|.. +|+.||||+++ +.+.+|+++|++++|||||++++++.+. +..++|||
T Consensus 17 y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-~~~~iv~E 95 (309)
T d1u5ra_ 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-HTAWLVME 95 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-TEEEEEEE
T ss_pred cEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC-CEEEEEEE
Confidence 44444454 58999997 78999999884 2477899999999999999999998764 47999999
Q ss_pred ecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCC
Q 047629 399 YAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA 478 (615)
Q Consensus 399 ~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla 478 (615)
||++|+|..++.... .+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 96 ~~~~g~l~~~~~~~~----------~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a 162 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKK----------PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSA 162 (309)
T ss_dssp CCSEEHHHHHHHHTS----------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTC
T ss_pred ecCCCchHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccc
Confidence 999999987776543 3899999999999999999999998 999999999999999999999999999
Q ss_pred CCCC----------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHH
Q 047629 479 APAT----------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREER 536 (615)
Q Consensus 479 ~~~~----------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 536 (615)
+... ..++.++|||||||++|||++|+.||......+ . +..
T Consensus 163 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~--~----~~~----------- 225 (309)
T d1u5ra_ 163 SIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--A----LYH----------- 225 (309)
T ss_dssp BSSSSBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--H----HHH-----------
T ss_pred cccCCCCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH--H----HHH-----------
Confidence 6532 125678999999999999999999997543211 0 111
Q ss_pred HhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 537 LRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 537 ~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
+...-.+.+. +......+.+|+.+||+.||++|||+.|++++
T Consensus 226 i~~~~~~~~~---~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 226 IAQNESPALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp HHHSCCCCCS---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred HHhCCCCCCC---CCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 1111122221 12233467899999999999999999999873
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-39 Score=335.99 Aligned_cols=222 Identities=29% Similarity=0.476 Sum_probs=172.1
Q ss_pred ceEEEEEE--CCe--EEEEEEcc--------HHHHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATI--DGK--VLAVKKIK--------EDVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~--~g~--~vAvK~~~--------~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
|.||+|.+ +|. .||||+++ +++.+|+++|+++ +|||||+++|+|.+. +..++||||+++|+|.++|
T Consensus 24 g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~-~~~~iV~ey~~~g~L~~~l 102 (309)
T d1fvra_ 24 GQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-GYLYLAIEYAPHGNLLDFL 102 (309)
T ss_dssp CEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-TEEEEEECCCTTCBHHHHH
T ss_pred cEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC-CeeEEEEEecCCCcHHHHH
Confidence 58999998 454 57888874 2578999999999 799999999999864 4899999999999999999
Q ss_pred ccCCCCCC------CCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-
Q 047629 410 HPKSKSSS------SSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT- 482 (615)
Q Consensus 410 ~~~~~~~~------~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~- 482 (615)
+....... .......|+|.++++++.|||.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 103 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~ 179 (309)
T d1fvra_ 103 RKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEV 179 (309)
T ss_dssp HTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEESSCE
T ss_pred hhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCceEEccccccccccc
Confidence 76421000 0001124999999999999999999999998 9999999999999999999999999986532
Q ss_pred ---------------------CCCCCcccchhHHHHHHHHHcCCC-CCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhh
Q 047629 483 ---------------------NDVMPKFDVFAFGVVLLELLSGKK-ATRTTENGKTAVLWKEIREVLKVEEKREERLRNW 540 (615)
Q Consensus 483 ---------------------~~~~~k~DV~SfGvvl~ElltG~~-p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 540 (615)
..++.++|||||||++|||++|.. |+..... ..+. ..+.+.
T Consensus 180 ~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~---~~~~--------------~~i~~~ 242 (309)
T d1fvra_ 180 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELY--------------EKLPQG 242 (309)
T ss_dssp ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHH--------------HHGGGT
T ss_pred cccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH---HHHH--------------HHHHhc
Confidence 114568999999999999999775 5543221 1110 112221
Q ss_pred cCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccch
Q 047629 541 MDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQST 589 (615)
Q Consensus 541 ~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~ 589 (615)
..+ ..+......+.+|+.+||+.||++||||+||++.|+++.+..
T Consensus 243 ~~~----~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 243 YRL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp CCC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred CCC----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 222 234445567899999999999999999999999999887543
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-40 Score=331.09 Aligned_cols=211 Identities=24% Similarity=0.375 Sum_probs=166.0
Q ss_pred ceEEEEEEC-----CeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATID-----GKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~~-----g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
|.||+|.+. +..||||+++ +.+.+|+++|++++|||||+++|++.+ +..++||||+++|+|.+++
T Consensus 21 g~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~iv~E~~~~g~l~~~~ 98 (273)
T d1mp8a_ 21 GDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--NPVWIIMELCTLGELRSFL 98 (273)
T ss_dssp SEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSCEEEEECCTTEEHHHHH
T ss_pred cEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--CeEEEEEEeccCCcHHhhh
Confidence 589999872 3569999885 347899999999999999999999853 4789999999999999998
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------ 483 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------ 483 (615)
..... .+++.+++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+|+....
T Consensus 99 ~~~~~---------~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~ 166 (273)
T d1mp8a_ 99 QVRKY---------SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA 166 (273)
T ss_dssp HHTTT---------TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------------
T ss_pred hccCC---------CCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccCCcceec
Confidence 76543 3899999999999999999999998 99999999999999999999999999975421
Q ss_pred ------------------CCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCc
Q 047629 484 ------------------DVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPN 544 (615)
Q Consensus 484 ------------------~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~ 544 (615)
.++.++|||||||++|||++ |+.|+......+. .. .+.....+
T Consensus 167 ~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~---~~--------------~i~~~~~~- 228 (273)
T d1mp8a_ 167 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IG--------------RIENGERL- 228 (273)
T ss_dssp ----CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HH--------------HHHTTCCC-
T ss_pred cceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH---HH--------------HHHcCCCC-
Confidence 24568999999999999998 8888876543221 11 11111111
Q ss_pred CCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 545 LESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 545 l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
..+...+..+.+|+..||+.||++|||+.||++.|+.+.+.
T Consensus 229 ---~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 229 ---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 23344556789999999999999999999999999987654
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-40 Score=338.13 Aligned_cols=219 Identities=20% Similarity=0.381 Sum_probs=173.5
Q ss_pred cccccccc----ceEEEEEE--CCe----EEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEE
Q 047629 335 LSEHYSIG----KSVYRATI--DGK----VLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLV 396 (615)
Q Consensus 335 ~~~~~~iG----~~Vy~~~~--~g~----~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV 396 (615)
|.....+| |.||+|.+ +|+ .||||+++ +.+.+|+++|++++|||||+++|+|.+ +..+++
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--~~~~~v 88 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT--STVQLI 88 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES--SSEEEE
T ss_pred CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCeeEE
Confidence 34344454 58999987 443 68999875 358899999999999999999999975 367899
Q ss_pred EeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecC
Q 047629 397 YEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFS 476 (615)
Q Consensus 397 ~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFG 476 (615)
+||+.+|+|.+++..... .++|..+++++.|||.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 89 ~e~~~~~~l~~~~~~~~~---------~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFG 156 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREHKD---------NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFG 156 (317)
T ss_dssp EECCTTCBHHHHHHHTSS---------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCS
T ss_pred EEeccCCccccccccccc---------CCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccc
Confidence 999999999999876543 3899999999999999999999998 9999999999999999999999999
Q ss_pred CCCCCC-------------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHH
Q 047629 477 LAAPAT-------------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVE 530 (615)
Q Consensus 477 la~~~~-------------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 530 (615)
+|+... ..++.++|||||||++|||+| |+.|+......+. .. .
T Consensus 157 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~---~~----~---- 225 (317)
T d1xkka_ 157 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---SS----I---- 225 (317)
T ss_dssp HHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH---HH----H----
T ss_pred cceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH---HH----H----
Confidence 986431 124678999999999999999 7888865443221 11 1
Q ss_pred HHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 531 EKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 531 ~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
+..-.. ...|..+...+.+|+.+||+.||++||||+||++.|..+...
T Consensus 226 ------i~~~~~----~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 226 ------LEKGER----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp ------HHHTCC----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ------HHcCCC----CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 111111 123445556789999999999999999999999999877544
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-39 Score=337.42 Aligned_cols=232 Identities=21% Similarity=0.360 Sum_probs=172.4
Q ss_pred cccccccccc----ceEEEEEE--CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEe
Q 047629 333 MNLSEHYSIG----KSVYRATI--DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYE 398 (615)
Q Consensus 333 ~~~~~~~~iG----~~Vy~~~~--~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E 398 (615)
++|.....+| |.||+|.. +|+.||+|+++ ..+.+|+.+|++++|||||++++++.+. +..++|||
T Consensus 6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-~~~~iVmE 84 (322)
T d1s9ja_ 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-GEISICME 84 (322)
T ss_dssp GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS-SEEEEEEE
T ss_pred cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEEE
Confidence 3444444555 58999997 68999999985 3478899999999999999999999864 47999999
Q ss_pred ecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCceeeCCCCcEEEeecCC
Q 047629 399 YAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEH-AQPSIVHRDIRTNNIQLDSRFKAKIANFSL 477 (615)
Q Consensus 399 ~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDlk~~NILld~~~~~kl~DFGl 477 (615)
|+++|+|.+++.+.. .+++..+..++.|++.||.|||++ + |+||||||+|||++.++++||+|||+
T Consensus 85 y~~gg~L~~~l~~~~----------~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGl 151 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAG----------RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGV 151 (322)
T ss_dssp CCTTEEHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCC
T ss_pred cCCCCcHHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCC
Confidence 999999999997654 289999999999999999999974 6 99999999999999999999999999
Q ss_pred CCCC---------------------CCCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHH-HHHHHHhHH-----
Q 047629 478 AAPA---------------------TNDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWK-EIREVLKVE----- 530 (615)
Q Consensus 478 a~~~---------------------~~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~-~~~~~~~~~----- 530 (615)
|+.. ...++.++||||+||++|||++|+.||......+...... .........
T Consensus 152 a~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (322)
T d1s9ja_ 152 SGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231 (322)
T ss_dssp CHHHHHHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------
T ss_pred ccccCCCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccc
Confidence 9532 1236789999999999999999999997654332211100 000000000
Q ss_pred -------------------HHHHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 531 -------------------EKREERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 531 -------------------~~~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
............|.+.. .....++.+|+.+|++.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPS---GVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp --------------CCCCHHHHHHHHHTSCCCCCCB---TTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccccchhHHHHHhhhhccCCccCcc---ccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00000000001111111 1123457899999999999999999999885
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-39 Score=331.94 Aligned_cols=223 Identities=26% Similarity=0.386 Sum_probs=164.5
Q ss_pred ceEEEEEE-------CCeEEEEEEccH--------HHHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCHH
Q 047629 343 KSVYRATI-------DGKVLAVKKIKE--------DVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLD 406 (615)
Q Consensus 343 ~~Vy~~~~-------~g~~vAvK~~~~--------~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~ 406 (615)
|.||+|.. +++.||||+++. .+.+|..++.++ +|+|||++++++.+.+...++||||+++|+|.
T Consensus 27 G~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~ 106 (299)
T d1ywna1 27 GQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLS 106 (299)
T ss_dssp CEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHH
T ss_pred eEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHH
Confidence 58999986 247899999863 356788888877 78999999999876665789999999999999
Q ss_pred HhhccCCCCCCC------CCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCC
Q 047629 407 KWLHPKSKSSSS------SGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAP 480 (615)
Q Consensus 407 ~~L~~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~ 480 (615)
++|+........ ......++|.+++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.
T Consensus 107 ~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~~~~~~Kl~DFGla~~ 183 (299)
T d1ywna1 107 TYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARD 183 (299)
T ss_dssp HHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECC------
T ss_pred HHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeECCCCcEEEccCcchhh
Confidence 999764321000 001124899999999999999999999998 99999999999999999999999999964
Q ss_pred CCC-------------------------CCCCcccchhHHHHHHHHHcCC-CCCCCCCCChhHHHHHHHHHHHhHHHHHH
Q 047629 481 ATN-------------------------DVMPKFDVFAFGVVLLELLSGK-KATRTTENGKTAVLWKEIREVLKVEEKRE 534 (615)
Q Consensus 481 ~~~-------------------------~~~~k~DV~SfGvvl~ElltG~-~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 534 (615)
... .++.++|||||||++|||+||. .|+......+. +. .
T Consensus 184 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~--~~----~--------- 248 (299)
T d1ywna1 184 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FC----R--------- 248 (299)
T ss_dssp CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH--HH----H---------
T ss_pred ccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH--HH----H---------
Confidence 311 1456899999999999999975 46654432221 11 1
Q ss_pred HHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 535 ERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 535 ~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
.+.+-..+. .+......+.+++.+||+.||++||||+||+++|+.+.++
T Consensus 249 -~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 249 -RLKEGTRMR----APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp -HHHHTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHhcCCCCC----CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 111112222 2333445689999999999999999999999999988654
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-39 Score=333.22 Aligned_cols=222 Identities=23% Similarity=0.367 Sum_probs=171.7
Q ss_pred ceEEEEEEC-------CeEEEEEEccH--------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATID-------GKVLAVKKIKE--------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~~-------g~~vAvK~~~~--------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~ 407 (615)
|.||+|.+. ++.||||+++. .+.+|++++++++|||||+++|+|... +..++||||+++|+|.+
T Consensus 34 G~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~-~~~~lv~e~~~~g~l~~ 112 (308)
T d1p4oa_ 34 GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG-QPTLVIMELMTRGDLKS 112 (308)
T ss_dssp SEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS-SSCEEEEECCTTCBHHH
T ss_pred eEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC-CceeEEEeecCCCCHHH
Confidence 589999873 47899999962 378999999999999999999998754 47899999999999999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----- 482 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----- 482 (615)
++...............++|.++.+++.|+|.||.|||+++ |+||||||+|||+|+++++||+|||+|+...
T Consensus 113 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~ 189 (308)
T d1p4oa_ 113 YLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 189 (308)
T ss_dssp HHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCE
T ss_pred HHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEeecccceeccCCcce
Confidence 98753210000001123799999999999999999999997 9999999999999999999999999997541
Q ss_pred --------------------CCCCCcccchhHHHHHHHHHcCC-CCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhc
Q 047629 483 --------------------NDVMPKFDVFAFGVVLLELLSGK-KATRTTENGKTAVLWKEIREVLKVEEKREERLRNWM 541 (615)
Q Consensus 483 --------------------~~~~~k~DV~SfGvvl~ElltG~-~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 541 (615)
..+++++||||||+++|||+||+ .|+......+ .+..+.
T Consensus 190 ~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~--------------------~~~~i~ 249 (308)
T d1p4oa_ 190 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--------------------VLRFVM 249 (308)
T ss_dssp EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH--------------------HHHHHH
T ss_pred eeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH--------------------HHHHHH
Confidence 12456899999999999999986 5554332110 011111
Q ss_pred CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccch
Q 047629 542 DPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQST 589 (615)
Q Consensus 542 dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~~ 589 (615)
+... ...+......+.+|+.+||+.||++||||.||+++|++..+..
T Consensus 250 ~~~~-~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~ 296 (308)
T d1p4oa_ 250 EGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296 (308)
T ss_dssp TTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred hCCC-CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 1111 1223344457899999999999999999999999998776653
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-39 Score=325.86 Aligned_cols=203 Identities=21% Similarity=0.340 Sum_probs=166.4
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||+|.. +|+.||||+++. .+.+|+++|++++|||||++++++.+. +..++||||+++|+|.+++.
T Consensus 22 g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-~~~~ivmEy~~gg~L~~~~~ 100 (288)
T d1uu3a_ 22 STVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD-EKLYFGLSYAKNGELLKYIR 100 (288)
T ss_dssp CEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS-SEEEEEECCCTTEEHHHHHH
T ss_pred eEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC-CEEEEEEEccCCCCHHHhhh
Confidence 58999997 689999999852 367899999999999999999998754 47999999999999999987
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
... .+++.++..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+...
T Consensus 101 ~~~----------~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~ 167 (288)
T d1uu3a_ 101 KIG----------SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 167 (288)
T ss_dssp HHS----------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred ccC----------CCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCCccccc
Confidence 654 3899999999999999999999998 9999999999999999999999999996532
Q ss_pred -----------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcC
Q 047629 483 -----------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNL 545 (615)
Q Consensus 483 -----------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l 545 (615)
..++.++|||||||++|||++|+.||..... ..+. .. +.. .++.
T Consensus 168 ~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~~~~---~~-----------i~~-~~~~- 228 (288)
T d1uu3a_ 168 NSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---YLIF---QK-----------IIK-LEYD- 228 (288)
T ss_dssp --CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH---HH-----------HHT-TCCC-
T ss_pred ccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH---HHHH---HH-----------HHc-CCCC-
Confidence 1245689999999999999999999975431 1111 00 110 1122
Q ss_pred CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 546 ESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 546 ~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
+|......+.+|+.+||+.||++|||++|++..
T Consensus 229 ---~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 229 ---FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp ---CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred ---CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 233344567899999999999999999997654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-38 Score=324.09 Aligned_cols=207 Identities=23% Similarity=0.350 Sum_probs=161.6
Q ss_pred ceEEEEEE--CCeEEEEEEccH--------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATI--DGKVLAVKKIKE--------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~--------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
|.||+|.. +|+.||||++.. .+.+|+++|++++|||||++++++.+. +..++||||+++|+|.++|...
T Consensus 23 g~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-~~~~lvmE~~~gg~L~~~l~~~ 101 (307)
T d1a06a_ 23 SEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESG-GHLYLIMQLVSGGELFDRIVEK 101 (307)
T ss_dssp GGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECS-SEEEEEECCCCSCBHHHHHHTC
T ss_pred eEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEEeccCCCcHHHhhhcc
Confidence 58999997 689999999852 356899999999999999999998754 5799999999999999999764
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeC---CCCcEEEeecCCCCCCC-------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLD---SRFKAKIANFSLAAPAT------- 482 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld---~~~~~kl~DFGla~~~~------- 482 (615)
. .+++.++..++.|++.||+|||+++ |+||||||+|||+. +++.+||+|||+|+...
T Consensus 102 ~----------~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~ 168 (307)
T d1a06a_ 102 G----------FYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST 168 (307)
T ss_dssp S----------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC--------------
T ss_pred c----------CCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccCCCeeee
Confidence 3 3999999999999999999999998 99999999999994 57899999999996531
Q ss_pred ---------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCC
Q 047629 483 ---------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLES 547 (615)
Q Consensus 483 ---------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~ 547 (615)
..++.++|||||||++|||++|+.||...... .... . ... .+.....
T Consensus 169 ~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~~---~----------i~~--~~~~~~~ 230 (307)
T d1a06a_ 169 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA---KLFE---Q----------ILK--AEYEFDS 230 (307)
T ss_dssp ----CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHH---H----------HHT--TCCCCCT
T ss_pred eeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH---HHHH---H----------Hhc--cCCCCCC
Confidence 12567999999999999999999999754321 1111 0 011 1111222
Q ss_pred CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 548 FYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 548 ~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
..+.+....+.+|+.+||+.||++|||+.|++++
T Consensus 231 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 231 PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 2233444568899999999999999999999885
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4e-38 Score=318.68 Aligned_cols=207 Identities=22% Similarity=0.312 Sum_probs=167.3
Q ss_pred ceEEEEEE--CCeEEEEEEcc----------------HHHHHHHHHHHhcC-CCCcccEEEEEEcCCCcEEEEEeecCCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK----------------EDVTEELRILQRIN-HANLVKLMGVSSDSQGNRFLVYEYAENG 403 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~----------------~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~~lV~E~~~~G 403 (615)
|.||++.. +|+.||||+++ +.+.+|+.+|++++ |||||++++++.+. +..|+||||+++|
T Consensus 17 g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~-~~~~ivmE~~~~g 95 (277)
T d1phka_ 17 SVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN-TFFFLVFDLMKKG 95 (277)
T ss_dssp EEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS-SEEEEEEECCTTC
T ss_pred eEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC-cceEEEEEcCCCc
Confidence 58999997 78999999974 23678999999997 99999999998764 4899999999999
Q ss_pred CHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC
Q 047629 404 SLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN 483 (615)
Q Consensus 404 sL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~ 483 (615)
+|.++|.... .+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 96 ~L~~~l~~~~----------~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 162 (277)
T d1phka_ 96 ELFDYLTEKV----------TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 162 (277)
T ss_dssp BHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred hHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchheeEccC
Confidence 9999997643 3999999999999999999999998 99999999999999999999999999965321
Q ss_pred ----------------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHH
Q 047629 484 ----------------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREE 535 (615)
Q Consensus 484 ----------------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 535 (615)
.++.++||||+||++|||++|+.||......+ .. ...
T Consensus 163 ~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~---~~---~~i--------- 227 (277)
T d1phka_ 163 GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML---ML---RMI--------- 227 (277)
T ss_dssp TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHH---------
T ss_pred CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH---HH---HHH---------
Confidence 13568999999999999999999997644211 11 111
Q ss_pred HHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 536 RLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 536 ~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
... ..............++.+|+++||+.||.+|||+.||+++
T Consensus 228 -~~~--~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 228 -MSG--NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp -HHT--CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred -HhC--CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 111 1111112223444568999999999999999999998764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-38 Score=328.38 Aligned_cols=221 Identities=25% Similarity=0.395 Sum_probs=170.4
Q ss_pred ceEEEEEE-------CCeEEEEEEcc--------HHHHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCCHH
Q 047629 343 KSVYRATI-------DGKVLAVKKIK--------EDVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGSLD 406 (615)
Q Consensus 343 ~~Vy~~~~-------~g~~vAvK~~~--------~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~ 406 (615)
|.||+|++ +++.||||+++ ..+.+|+.+++++ +|||||+++|+|.+. ...++||||+++|+|.
T Consensus 37 g~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~-~~~~lvmE~~~~g~l~ 115 (311)
T d1t46a_ 37 GKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG-GPTLVITEYCCYGDLL 115 (311)
T ss_dssp EEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSCEEEEECCTTEEHH
T ss_pred eEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC-CEEEEEEEcCCCCCHH
Confidence 58999986 34789999986 2478899999999 799999999999764 4789999999999999
Q ss_pred HhhccCCCCCCC--------CCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCC
Q 047629 407 KWLHPKSKSSSS--------SGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA 478 (615)
Q Consensus 407 ~~L~~~~~~~~~--------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla 478 (615)
++++........ ......+++..+.+++.||+.||+|||+++ ++||||||+|||++.++.+|++|||++
T Consensus 116 ~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~~~~~~ki~DfG~~ 192 (311)
T d1t46a_ 116 NFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLA 192 (311)
T ss_dssp HHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEEEECCCGGG
T ss_pred HHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccccccCcccccccchh
Confidence 999765421100 011124899999999999999999999998 999999999999999999999999999
Q ss_pred CCCCC-------------------------CCCCcccchhHHHHHHHHHcCCCC-CCCCCCChhHHHHHHHHHHHhHHHH
Q 047629 479 APATN-------------------------DVMPKFDVFAFGVVLLELLSGKKA-TRTTENGKTAVLWKEIREVLKVEEK 532 (615)
Q Consensus 479 ~~~~~-------------------------~~~~k~DV~SfGvvl~ElltG~~p-~~~~~~~~~~~l~~~~~~~~~~~~~ 532 (615)
+.... .++.++|||||||++|||+|++.| +......+. +.. .
T Consensus 193 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~--~~~----~------ 260 (311)
T d1t46a_ 193 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--FYK----M------ 260 (311)
T ss_dssp SCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--HHH----H------
T ss_pred eeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH--HHH----H------
Confidence 75422 145689999999999999995554 443332211 111 1
Q ss_pred HHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 047629 533 REERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQ 587 (615)
Q Consensus 533 ~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~ 587 (615)
+..-..+ ..+......+.+|+.+||+.||++||||.||+++|+++..
T Consensus 261 ----i~~~~~~----~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 261 ----IKEGFRM----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp ----HHHTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HhcCCCC----CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 1111112 2233444568999999999999999999999999986543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-38 Score=324.23 Aligned_cols=220 Identities=25% Similarity=0.397 Sum_probs=170.4
Q ss_pred ceEEEEEEC---------CeEEEEEEcc--------HHHHHHHHHHHhc-CCCCcccEEEEEEcCCCcEEEEEeecCCCC
Q 047629 343 KSVYRATID---------GKVLAVKKIK--------EDVTEELRILQRI-NHANLVKLMGVSSDSQGNRFLVYEYAENGS 404 (615)
Q Consensus 343 ~~Vy~~~~~---------g~~vAvK~~~--------~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~lV~E~~~~Gs 404 (615)
|.||+|... +..||||+++ .++.+|...+.++ +|||||+++|+|.+. +..++||||+++|+
T Consensus 27 g~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~-~~~~~v~e~~~~g~ 105 (299)
T d1fgka_ 27 GQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD-GPLYVIVEYASKGN 105 (299)
T ss_dssp -CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSCEEEECCCTTCB
T ss_pred cEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC-CeEEEEEEccCCCc
Confidence 589999862 2479999985 3467799999888 899999999999754 57999999999999
Q ss_pred HHHhhccCCCCCC------CCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCC
Q 047629 405 LDKWLHPKSKSSS------SSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLA 478 (615)
Q Consensus 405 L~~~L~~~~~~~~------~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla 478 (615)
|.++|........ .......+++.++++++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 106 l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~~~~~~kl~dfg~~ 182 (299)
T d1fgka_ 106 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLA 182 (299)
T ss_dssp HHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSTTCC
T ss_pred HHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeecCCCCeEeccchhh
Confidence 9999976542110 0011124899999999999999999999998 999999999999999999999999998
Q ss_pred CCCC-------------------------CCCCCcccchhHHHHHHHHHc-CCCCCCCCCCChhHHHHHHHHHHHhHHHH
Q 047629 479 APAT-------------------------NDVMPKFDVFAFGVVLLELLS-GKKATRTTENGKTAVLWKEIREVLKVEEK 532 (615)
Q Consensus 479 ~~~~-------------------------~~~~~k~DV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 532 (615)
+... ..+++|+|||||||++|||++ |+.|+...... ..+.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~---~~~~----------- 248 (299)
T d1fgka_ 183 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---ELFK----------- 248 (299)
T ss_dssp CCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHH-----------
T ss_pred ccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH---HHHH-----------
Confidence 7541 125678999999999999998 67777543311 1111
Q ss_pred HHHHHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 047629 533 REERLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQ 587 (615)
Q Consensus 533 ~~~~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~ 587 (615)
.+..-..+ ..+......+.+|+.+||+.||++|||+.||++.|+++..
T Consensus 249 ---~i~~~~~~----~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 249 ---LLKEGHRM----DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp ---HHHTTCCC----CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHHcCCCC----CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 11111222 2333445568999999999999999999999999988754
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.1e-38 Score=328.57 Aligned_cols=208 Identities=22% Similarity=0.292 Sum_probs=168.0
Q ss_pred ceEEEEEE--CCeEEEEEEcc-------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
|.||+|.. +|+.||||+++ ..+.+|+++|++++|||||++++++.+. +.+++||||+++|+|.+++....
T Consensus 43 g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-~~~~ivmE~~~gg~L~~~~~~~~ 121 (352)
T d1koba_ 43 GVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK-YEMVLILEFLSGGELFDRIAAED 121 (352)
T ss_dssp EEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS-SEEEEEEECCCCCBHHHHTTCTT
T ss_pred eEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEEEcCCCChHHHHHHhcC
Confidence 58999997 69999999985 2467899999999999999999998754 58999999999999999887654
Q ss_pred CCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeC--CCCcEEEeecCCCCCCC---------
Q 047629 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLD--SRFKAKIANFSLAAPAT--------- 482 (615)
Q Consensus 414 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld--~~~~~kl~DFGla~~~~--------- 482 (615)
. .|++.++..|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|+...
T Consensus 122 ~---------~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~~~ 189 (352)
T d1koba_ 122 Y---------KMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT 189 (352)
T ss_dssp C---------CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEEC
T ss_pred C---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCCceeecc
Confidence 3 3999999999999999999999998 99999999999998 56899999999996542
Q ss_pred -------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCC
Q 047629 483 -------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFY 549 (615)
Q Consensus 483 -------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~ 549 (615)
..++.++||||+||++|||++|+.||......+ .. .. +.. .+.......
T Consensus 190 gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~~---~~-----------i~~-~~~~~~~~~ 251 (352)
T d1koba_ 190 ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---TL---QN-----------VKR-CDWEFDEDA 251 (352)
T ss_dssp SSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HH---HH-----------HHH-CCCCCCSST
T ss_pred CcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HH---HH-----------HHh-CCCCCCccc
Confidence 125678999999999999999999997544211 11 10 000 112222222
Q ss_pred ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 550 PIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 550 ~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.......+.+|+.+||+.||.+|||+.|++++
T Consensus 252 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 252 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 33344567899999999999999999999874
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-38 Score=323.26 Aligned_cols=207 Identities=25% Similarity=0.340 Sum_probs=165.9
Q ss_pred ceEEEEEE--CCeEEEEEEcc-------------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATI--DGKVLAVKKIK-------------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-------------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~ 407 (615)
|.||+|.. +|+.||||+++ +.+.+|+++|++++|||||++++++.+. +..++|||||++|+|.+
T Consensus 24 g~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~iv~E~~~gg~L~~ 102 (293)
T d1jksa_ 24 AVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK-TDVILILELVAGGELFD 102 (293)
T ss_dssp EEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEEECCCSCBHHH
T ss_pred eEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEEEcCCCccccc
Confidence 58999997 68999999874 3578999999999999999999998764 48999999999999999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCC----cEEEeecCCCCCCC-
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRF----KAKIANFSLAAPAT- 482 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~----~~kl~DFGla~~~~- 482 (615)
++.... .+++.++..++.|++.||+|||+++ |+||||||+|||++.++ .+|++|||+|+...
T Consensus 103 ~i~~~~----------~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~ 169 (293)
T d1jksa_ 103 FLAEKE----------SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 169 (293)
T ss_dssp HHHHHS----------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTT
T ss_pred hhcccc----------ccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhhhhcCC
Confidence 997653 3899999999999999999999998 99999999999998776 59999999986432
Q ss_pred ---------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhc
Q 047629 483 ---------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWM 541 (615)
Q Consensus 483 ---------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 541 (615)
..++.++|||||||++|||++|+.||......+ .. ... .. .
T Consensus 170 ~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~---~~i-----------~~-~ 231 (293)
T d1jksa_ 170 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TL---ANV-----------SA-V 231 (293)
T ss_dssp SCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHH-----------HT-T
T ss_pred CccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH---HH---HHH-----------Hh-c
Confidence 125679999999999999999999997543211 11 110 00 0
Q ss_pred CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 542 DPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 542 dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
........+......+.+|+++||+.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 232 NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp CCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111111111233457899999999999999999999874
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.9e-38 Score=326.83 Aligned_cols=208 Identities=22% Similarity=0.276 Sum_probs=166.3
Q ss_pred ceEEEEEE--CCeEEEEEEcc-------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK-------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKS 413 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~ 413 (615)
|.||+|.. +|+.||||++. +.+.+|+++|++++|||||++++++.+. +..++|||||++|+|.+++....
T Consensus 40 g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~ivmE~~~gg~L~~~l~~~~ 118 (350)
T d1koaa2 40 GVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD-NEMVMIYEFMSGGELFEKVADEH 118 (350)
T ss_dssp EEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET-TEEEEEECCCCSCBHHHHHTCTT
T ss_pred eEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEEEcCCCCCHHHHHHhhc
Confidence 58999997 69999999985 3477899999999999999999998764 58999999999999999996543
Q ss_pred CCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCC--CCcEEEeecCCCCCCCC--------
Q 047629 414 KSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDS--RFKAKIANFSLAAPATN-------- 483 (615)
Q Consensus 414 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~--~~~~kl~DFGla~~~~~-------- 483 (615)
. .+++..+..|+.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+|+....
T Consensus 119 ~---------~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~ 186 (350)
T d1koaa2 119 N---------KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT 186 (350)
T ss_dssp S---------CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEEEC
T ss_pred C---------CCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccccccceec
Confidence 2 3999999999999999999999998 999999999999954 67899999999965421
Q ss_pred --------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCC
Q 047629 484 --------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFY 549 (615)
Q Consensus 484 --------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~ 549 (615)
.++.++|||||||++|||++|+.||...... .... .. .. .+.......
T Consensus 187 gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~---~i----------~~--~~~~~~~~~ 248 (350)
T d1koaa2 187 GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---ETLR---NV----------KS--CDWNMDDSA 248 (350)
T ss_dssp SCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HH----------HH--TCCCSCCGG
T ss_pred CcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH---HHHH---HH----------Hh--CCCCCCccc
Confidence 2456899999999999999999999754321 1111 10 00 111111111
Q ss_pred ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 550 PIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 550 ~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.......+.+|+.+||+.||++|||++|++++
T Consensus 249 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 249 FSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 22334567899999999999999999999885
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-37 Score=319.46 Aligned_cols=203 Identities=24% Similarity=0.325 Sum_probs=166.5
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||++.. +|+.||||++++ .+.+|+.+|++++|||||++++++.+. ..+++||||+++|+|.+++.
T Consensus 19 g~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-~~~~iv~ey~~gg~L~~~~~ 97 (337)
T d1o6la_ 19 GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-DRLCFVMEYANGGELFFHLS 97 (337)
T ss_dssp EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS-SEEEEEEECCTTCBHHHHHH
T ss_pred eEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccc-cccccceeccCCCchhhhhh
Confidence 58999997 799999999863 256899999999999999999998865 47999999999999999998
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
.... +++.....++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 98 ~~~~----------~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~~~ 164 (337)
T d1o6la_ 98 RERV----------FTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 164 (337)
T ss_dssp HHSC----------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCC
T ss_pred cccC----------CcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccCCccccc
Confidence 7543 889999999999999999999998 9999999999999999999999999997532
Q ss_pred ---------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCC
Q 047629 483 ---------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLES 547 (615)
Q Consensus 483 ---------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~ 547 (615)
..++.++||||+||++|||++|+.||......+ +.. . ... -.+.
T Consensus 165 ~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~---~~~----~---------i~~--~~~~--- 223 (337)
T d1o6la_ 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFE----L---------ILM--EEIR--- 223 (337)
T ss_dssp CEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----H---------HHH--CCCC---
T ss_pred ceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH---HHH----H---------Hhc--CCCC---
Confidence 125679999999999999999999997644211 110 0 001 1122
Q ss_pred CCChHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 047629 548 FYPIDGALSLATLARACTMDKSLSRPN-----MAEVVFN 581 (615)
Q Consensus 548 ~~~~~~~~~l~~l~~~C~~~dP~~RPs-----m~ev~~~ 581 (615)
+|......+.+|+..||+.||.+||+ +.|++++
T Consensus 224 -~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 224 -FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 23334455789999999999999995 7888764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.9e-37 Score=317.25 Aligned_cols=203 Identities=21% Similarity=0.329 Sum_probs=166.3
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||++.. +|+.||||++++ .+.+|+.+|++++|||||++++++.+. +..++||||+++|+|.+++.
T Consensus 18 g~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~ivmE~~~gg~l~~~~~ 96 (316)
T d1fota_ 18 GRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA-QQIFMIMDYIEGGELFSLLR 96 (316)
T ss_dssp CEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS-SEEEEEECCCCSCBHHHHHH
T ss_pred cEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeC-CeeeeEeeecCCcccccccc
Confidence 48999997 699999999863 366899999999999999999998754 48999999999999999998
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-------- 482 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-------- 482 (615)
.... +++.....++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 97 ~~~~----------~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~G 163 (316)
T d1fota_ 97 KSQR----------FPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCG 163 (316)
T ss_dssp HTSS----------CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSCBCCCCS
T ss_pred cccc----------ccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccccccccC
Confidence 7653 788999999999999999999998 9999999999999999999999999996542
Q ss_pred ------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 483 ------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 483 ------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
..++.++|||||||++|||++|+.||...... ... ... .. ... .+|
T Consensus 164 t~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~---~~i----------~~--~~~----~~p 221 (316)
T d1fota_ 164 TPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM---KTY---EKI----------LN--AEL----RFP 221 (316)
T ss_dssp CTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHH---HHH----------HH--CCC----CCC
T ss_pred cccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH---HHH---HHH----------Hc--CCC----CCC
Confidence 22567999999999999999999999754321 111 111 01 011 223
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 047629 551 IDGALSLATLARACTMDKSLSRP-----NMAEVVFN 581 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RP-----sm~ev~~~ 581 (615)
......+.+++.+|++.||.+|| |++|++++
T Consensus 222 ~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 222 PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 33345578999999999999996 89998864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5e-37 Score=322.55 Aligned_cols=206 Identities=20% Similarity=0.227 Sum_probs=163.4
Q ss_pred ceEEEEEE--CCeEEEEEEccHH----------HHH---HHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATI--DGKVLAVKKIKED----------VTE---ELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~~----------~~~---Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~ 407 (615)
|.||+|.. +|+.||||++... +.+ |+++++.++|||||++++++.+. +..++||||+++|+|.+
T Consensus 18 g~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~-~~~~ivmE~~~gg~L~~ 96 (364)
T d1omwa3 18 GEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP-DKLSFILDLMNGGDLHY 96 (364)
T ss_dssp CEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS-SEEEEEECCCCSCBHHH
T ss_pred eEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC-CEEEEEEEecCCCcHHH
Confidence 58999998 6999999998532 333 46667777899999999998764 47999999999999999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----- 482 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----- 482 (615)
+|.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 97 ~l~~~~----------~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~~~ 163 (364)
T d1omwa3 97 HLSQHG----------VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 163 (364)
T ss_dssp HHHHHC----------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECSSSCCC
T ss_pred HHHhcc----------cccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecCCCccc
Confidence 997654 3889999999999999999999998 9999999999999999999999999986432
Q ss_pred -----------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcC
Q 047629 483 -----------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNL 545 (615)
Q Consensus 483 -----------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l 545 (615)
..+++++|||||||+||||++|+.||......+...+ ........
T Consensus 164 ~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~-----------------~~~~~~~~- 225 (364)
T d1omwa3 164 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-----------------DRMTLTMA- 225 (364)
T ss_dssp SCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH-----------------HHHSSSCC-
T ss_pred ccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH-----------------HHhcccCC-
Confidence 1256789999999999999999999976543322110 01111111
Q ss_pred CCCCChHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 047629 546 ESFYPIDGALSLATLARACTMDKSLSRPN-----MAEVVFN 581 (615)
Q Consensus 546 ~~~~~~~~~~~l~~l~~~C~~~dP~~RPs-----m~ev~~~ 581 (615)
..++......+.+|+.+||+.||++||| +.|++++
T Consensus 226 -~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 226 -VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp -CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred -CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 1223333445789999999999999999 6888763
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-37 Score=318.22 Aligned_cols=208 Identities=20% Similarity=0.252 Sum_probs=165.2
Q ss_pred ceEEEEEE--CCeEEEEEEcc------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSK 414 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~ 414 (615)
|.||+|.. +|+.||||.++ ..+.+|+++|++++|||||++++++.+. +..|+||||+++|+|.+++.....
T Consensus 19 g~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-~~~~lvmE~~~gg~L~~~i~~~~~ 97 (321)
T d1tkia_ 19 GIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESM-EELVMIFEFISGLDIFERINTSAF 97 (321)
T ss_dssp EEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEET-TEEEEEECCCCCCBHHHHHTSSSC
T ss_pred eEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-CEEEEEEecCCCCcHHHHHHhcCC
Confidence 58999997 68999999986 2467999999999999999999998754 589999999999999999976542
Q ss_pred CCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCC--CcEEEeecCCCCCCCC---------
Q 047629 415 SSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSR--FKAKIANFSLAAPATN--------- 483 (615)
Q Consensus 415 ~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~--~~~kl~DFGla~~~~~--------- 483 (615)
.+++.++..++.||+.||+|||+++ |+||||||+|||++.+ ..+||+|||+++....
T Consensus 98 ---------~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~~~ 165 (321)
T d1tkia_ 98 ---------ELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT 165 (321)
T ss_dssp ---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEES
T ss_pred ---------CCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccCCccccccc
Confidence 3899999999999999999999998 9999999999999854 5899999999975422
Q ss_pred -------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 484 -------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 484 -------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
.++.++||||+||++|||++|+.||......+ .. .... .. ...+.....
T Consensus 166 t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~---~~---~~i~----------~~--~~~~~~~~~ 227 (321)
T d1tkia_ 166 APEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---II---ENIM----------NA--EYTFDEEAF 227 (321)
T ss_dssp CGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH---HHHH----------HT--CCCCCHHHH
T ss_pred ccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH---HH---HHHH----------hC--CCCCChhhc
Confidence 14568999999999999999999997644211 11 1110 00 000100000
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 551 IDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.+....+.+|+..|+..||++|||+.|++++
T Consensus 228 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 228 KEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1123457899999999999999999999874
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.4e-37 Score=311.26 Aligned_cols=213 Identities=22% Similarity=0.313 Sum_probs=169.6
Q ss_pred ceEEEEEE--CCeEEEEEEcc----------HHHHHHHHHHHhcCCCCcccEEEEEEcCCC---cEEEEEeecCCCCHHH
Q 047629 343 KSVYRATI--DGKVLAVKKIK----------EDVTEELRILQRINHANLVKLMGVSSDSQG---NRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~----------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~---~~~lV~E~~~~GsL~~ 407 (615)
|.||+|.. +|+.||||+++ ..+.+|+++|++++|||||++++++...+. ..|+||||+++|+|.+
T Consensus 21 g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~ 100 (277)
T d1o6ya_ 21 SEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD 100 (277)
T ss_dssp EEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHH
T ss_pred eEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehh
Confidence 48999997 69999999984 247789999999999999999998865432 3789999999999999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-----
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT----- 482 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~----- 482 (615)
++.... .+++.+++.++.||+.||+|||+++ |+||||||+|||++.++..+++|||+++...
T Consensus 101 ~~~~~~----------~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~ 167 (277)
T d1o6ya_ 101 IVHTEG----------PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 167 (277)
T ss_dssp HHHHHC----------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEECC-----
T ss_pred hhcccC----------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhhcccccc
Confidence 987654 3899999999999999999999998 9999999999999999999999999875321
Q ss_pred ---------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhc
Q 047629 483 ---------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWM 541 (615)
Q Consensus 483 ---------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 541 (615)
..+++++|||||||++|||+||+.||......+ .+ .. .+..
T Consensus 168 ~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--~~----~~----------~~~~-- 229 (277)
T d1o6ya_ 168 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS--VA----YQ----------HVRE-- 229 (277)
T ss_dssp -----------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HH----HH----------HHHC--
T ss_pred ccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH--HH----HH----------HHhc--
Confidence 125678999999999999999999997543211 11 11 1111
Q ss_pred CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHhcc
Q 047629 542 DPNLESFYPIDGALSLATLARACTMDKSLSRP-NMAEVVFNLSVLT 586 (615)
Q Consensus 542 dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RP-sm~ev~~~L~~l~ 586 (615)
++........+....+.+++.+|++.||.+|| |++|+...|.++.
T Consensus 230 ~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 230 DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 11111111223345688999999999999999 8999999987764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-37 Score=313.72 Aligned_cols=220 Identities=26% Similarity=0.319 Sum_probs=162.5
Q ss_pred ceEEEEEE--CCeEEEEEEccH------------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHh
Q 047629 343 KSVYRATI--DGKVLAVKKIKE------------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKW 408 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~------------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~ 408 (615)
|.||+|.. +|+.||||+++. .+.+|+++|++++|||||++++++.+. +..++||||+++|++..+
T Consensus 12 g~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~-~~~~ivmE~~~~~~~~~~ 90 (299)
T d1ua2a_ 12 ATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK-SNISLVFDFMETDLEVII 90 (299)
T ss_dssp EEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT-TCCEEEEECCSEEHHHHH
T ss_pred eEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccC-CceeehhhhhcchHHhhh
Confidence 58999997 689999999852 367899999999999999999998754 479999999998877766
Q ss_pred hccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC-----
Q 047629 409 LHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN----- 483 (615)
Q Consensus 409 L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~----- 483 (615)
..... .+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 91 ~~~~~----------~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~ 157 (299)
T d1ua2a_ 91 KDNSL----------VLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY 157 (299)
T ss_dssp TTCCS----------SCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCC
T ss_pred hhccc----------CCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcccc
Confidence 54432 3888899999999999999999998 99999999999999999999999999865321
Q ss_pred -------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhc---
Q 047629 484 -------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWM--- 541 (615)
Q Consensus 484 -------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~--- 541 (615)
.++.++|||||||++|||++|+.||....+.+. ...+.+.+.... ........
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~---l~~i~~~~~~~~--~~~~~~~~~~~ 232 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---LTRIFETLGTPT--EEQWPDMCSLP 232 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCC--TTTSSSTTSST
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH---HHHHHHhcCCCC--hhhccchhccc
Confidence 145689999999999999999999875442211 111111110000 00000000
Q ss_pred CC-cCC--CCCC-----hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 542 DP-NLE--SFYP-----IDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 542 dp-~l~--~~~~-----~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
+. ... ...+ ......+.+|+.+|++.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 00 000 0011 1123468899999999999999999999764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-37 Score=317.35 Aligned_cols=212 Identities=17% Similarity=0.230 Sum_probs=164.2
Q ss_pred ceEEEEEE--CCeEEEEEEcc--HHHHHHHHHHHhc-CCCCcccEEEEEEc---CCCcEEEEEeecCCCCHHHhhccCCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK--EDVTEELRILQRI-NHANLVKLMGVSSD---SQGNRFLVYEYAENGSLDKWLHPKSK 414 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~--~~~~~Ei~~l~~l-~H~niv~l~g~~~~---~~~~~~lV~E~~~~GsL~~~L~~~~~ 414 (615)
|.||+|.. +|+.||||+++ ..+.+|++++.++ +|||||++++++.+ .+...|+|||||++|+|.++|.....
T Consensus 26 g~Vy~a~~~~~~~~vAiK~i~~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~ 105 (335)
T d2ozaa1 26 GKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD 105 (335)
T ss_dssp CEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSC
T ss_pred eEEEEEEECCCCCEEEEEEECCcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCC
Confidence 58999997 68999999996 4678899997765 89999999998753 23358999999999999999976432
Q ss_pred CCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCC---CCcEEEeecCCCCCCCC--------
Q 047629 415 SSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDS---RFKAKIANFSLAAPATN-------- 483 (615)
Q Consensus 415 ~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~---~~~~kl~DFGla~~~~~-------- 483 (615)
. .|++.++..|+.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+|+....
T Consensus 106 ~--------~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~ 174 (335)
T d2ozaa1 106 Q--------AFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC 174 (335)
T ss_dssp C--------CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCS
T ss_pred C--------CcCHHHHHHHHHHHHHHHHHHHHcC---CccccccccccccccccccccccccccceeeeccCCCcccccc
Confidence 1 3999999999999999999999998 999999999999986 46799999999964321
Q ss_pred --------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcC--CC
Q 047629 484 --------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNL--ES 547 (615)
Q Consensus 484 --------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l--~~ 547 (615)
.++.++|||||||+||||+||+.||.......... .....+..... ..
T Consensus 175 gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~----------------~~~~~i~~~~~~~~~ 238 (335)
T d2ozaa1 175 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP----------------GMKTRIRMGQYEFPN 238 (335)
T ss_dssp CCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------------------CCCSCSSSCCT
T ss_pred CCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH----------------HHHHHHhcCCCCCCC
Confidence 14568999999999999999999997644322110 00011111111 11
Q ss_pred CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 548 FYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 548 ~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.........+.+|+.+|++.||++|||+.|++++
T Consensus 239 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1112334568999999999999999999999874
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-36 Score=317.56 Aligned_cols=203 Identities=20% Similarity=0.294 Sum_probs=166.0
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhc
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLH 410 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~ 410 (615)
|.||++.. +|+.||||+++. .+.+|+++|++++|||||++++++.+. ...++||||+.+|+|.+++.
T Consensus 55 g~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-~~~~~v~e~~~~g~l~~~l~ 133 (350)
T d1rdqe_ 55 GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN-SNLYMVMEYVAGGEMFSHLR 133 (350)
T ss_dssp CEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEEEECCTTCBHHHHHH
T ss_pred cEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccc-cccccccccccccchhhhHh
Confidence 58999997 699999999853 367899999999999999999998764 47899999999999999997
Q ss_pred cCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC-------
Q 047629 411 PKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN------- 483 (615)
Q Consensus 411 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~------- 483 (615)
... .+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 134 ~~~----------~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~~~~~G 200 (350)
T d1rdqe_ 134 RIG----------RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCG 200 (350)
T ss_dssp HHC----------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSCBCCCEE
T ss_pred hcC----------CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccccccccC
Confidence 654 2899999999999999999999998 99999999999999999999999999975422
Q ss_pred -------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCCCCC
Q 047629 484 -------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLESFYP 550 (615)
Q Consensus 484 -------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~~~~ 550 (615)
.++.++|||||||++|||++|+.||..... ..... .. ... .+. .+
T Consensus 201 t~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~~~---~i----------~~~--~~~----~p 258 (350)
T d1rdqe_ 201 TPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYE---KI----------VSG--KVR----FP 258 (350)
T ss_dssp CGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---HH----------HHC--CCC----CC
T ss_pred ccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH---HHHHH---HH----------hcC--CCC----CC
Confidence 256789999999999999999999975431 11111 00 011 111 22
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 047629 551 IDGALSLATLARACTMDKSLSRP-----NMAEVVFN 581 (615)
Q Consensus 551 ~~~~~~l~~l~~~C~~~dP~~RP-----sm~ev~~~ 581 (615)
......+.+++.+||+.||.+|+ |++|++++
T Consensus 259 ~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 259 SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 33344678999999999999994 89998863
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-36 Score=311.59 Aligned_cols=222 Identities=21% Similarity=0.353 Sum_probs=162.1
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
|.||+|.. +|+.||||+++ ..+.+|+++|++++|||||++++++.+. +..++||||+.+ ++.+++..
T Consensus 16 g~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~-~~~~iv~e~~~~-~~~~~~~~ 93 (298)
T d1gz8a_ 16 GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE-NKLYLVFEFLHQ-DLKKFMDA 93 (298)
T ss_dssp SEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET-TEEEEEEECCSE-EHHHHHHH
T ss_pred eEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccc-cceeEEEeecCC-chhhhhhh
Confidence 58999997 68999999984 3477899999999999999999998764 489999999975 45555543
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC---------
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT--------- 482 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~--------- 482 (615)
.... .+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 94 ~~~~--------~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~~ 162 (298)
T d1gz8a_ 94 SALT--------GIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE 162 (298)
T ss_dssp TTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTTCC
T ss_pred hccc--------CCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCcccceee
Confidence 3221 3999999999999999999999998 9999999999999999999999999984321
Q ss_pred ---------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCCC
Q 047629 483 ---------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLES 547 (615)
Q Consensus 483 ---------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~~ 547 (615)
...+.++|||||||++|||++|+.||...... ..+.................... .+....
T Consensus 163 ~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~ 238 (298)
T d1gz8a_ 163 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRIFRTLGTPDEVVWPGVTS--MPDYKP 238 (298)
T ss_dssp BCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCTTTSTTGGG--STTCCT
T ss_pred cccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH--HHHHHHHHhcCCCchhhcccccc--cccccc
Confidence 11357899999999999999999999754321 11111111000000000000000 000100
Q ss_pred CCC-----------hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 548 FYP-----------IDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 548 ~~~-----------~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.++ ......+.+|+.+|++.||++|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 100 1123467899999999999999999999875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-36 Score=314.01 Aligned_cols=202 Identities=25% Similarity=0.366 Sum_probs=163.3
Q ss_pred ceEEEEEE--CCeEEEEEEccH----------HHHHHHHHHH-hcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATI--DGKVLAVKKIKE----------DVTEELRILQ-RINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~----------~~~~Ei~~l~-~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L 409 (615)
|.||+|.. +|+.||||++++ .+..|..++. .++|||||++++++.+. +..|+||||+++|+|.+++
T Consensus 16 g~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~-~~~yivmEy~~~g~L~~~i 94 (320)
T d1xjda_ 16 GKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK-ENLFFVMEYLNGGDLMYHI 94 (320)
T ss_dssp SEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS-SEEEEEEECCTTCBHHHHH
T ss_pred cEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC-CceeEEEeecCCCcHHHHh
Confidence 58999998 799999999963 2456777665 68999999999998764 4799999999999999999
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------- 482 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------- 482 (615)
..... +++.++..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+++...
T Consensus 95 ~~~~~----------~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~~ 161 (320)
T d1xjda_ 95 QSCHK----------FDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN 161 (320)
T ss_dssp HHHSS----------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBC
T ss_pred hccCC----------CCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccccccccc
Confidence 76543 889999999999999999999998 9999999999999999999999999997532
Q ss_pred ----------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcCCcCC
Q 047629 483 ----------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMDPNLE 546 (615)
Q Consensus 483 ----------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~dp~l~ 546 (615)
..++.++|||||||++|||++|+.||..... ..++.. +. ...+.
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~---~~~~~~--------------i~-~~~~~-- 221 (320)
T d1xjda_ 162 TFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---EELFHS--------------IR-MDNPF-- 221 (320)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHH--------------HH-HCCCC--
T ss_pred ccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH---HHHHHH--------------HH-cCCCC--
Confidence 1256799999999999999999999975432 111110 11 11222
Q ss_pred CCCChHHHHHHHHHHHHhhhcCCCCCCCHH-HHHH
Q 047629 547 SFYPIDGALSLATLARACTMDKSLSRPNMA-EVVF 580 (615)
Q Consensus 547 ~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~-ev~~ 580 (615)
+|......+.+|+.+||+.||.+||++. |+++
T Consensus 222 --~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 222 --YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp --CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred --CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 2333345578999999999999999995 6754
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=8.5e-37 Score=310.50 Aligned_cols=222 Identities=23% Similarity=0.305 Sum_probs=165.1
Q ss_pred ceEEEEEE-CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATI-DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~-~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
|.||+|.. +|+.||||+++ +.+.+|+.+|++++|||||++++++.+. +..++++||+.++.+..+....
T Consensus 16 g~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-~~~~i~~e~~~~~~~~~~~~~~ 94 (286)
T d1ob3a_ 16 GVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-KRLVLVFEHLDQDLKKLLDVCE 94 (286)
T ss_dssp EEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-SCEEEEEECCSEEHHHHHHTST
T ss_pred cEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccC-CceeEEEEeehhhhHHHHHhhc
Confidence 48999998 78999999984 3588999999999999999999998864 4799999999887777766544
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC----------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT---------- 482 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~---------- 482 (615)
. .+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++....
T Consensus 95 ~----------~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 161 (286)
T d1ob3a_ 95 G----------GLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEI 161 (286)
T ss_dssp T----------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------
T ss_pred C----------CcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCccccceec
Confidence 3 3999999999999999999999998 9999999999999999999999999974321
Q ss_pred --------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHH-HHHHHHhhh--cCCcC
Q 047629 483 --------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEE-KREERLRNW--MDPNL 545 (615)
Q Consensus 483 --------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~-~~~~~~~~~--~dp~l 545 (615)
..++.++|||||||++|||++|+.||....+.+ .+.. +........ ..-...... .+...
T Consensus 162 ~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~--~~~~-i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T d1ob3a_ 162 VTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--QLMR-IFRILGTPNSKNWPNVTELPKYDPNF 238 (286)
T ss_dssp CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHH-HHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred ccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH--HHHH-HHHhhCCCChhhccchhhhhhccccc
Confidence 124679999999999999999999997543211 1111 111110000 000000000 00000
Q ss_pred -------CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 546 -------ESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 546 -------~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
...........+.+|+.+|++.||++|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011122234567899999999999999999999753
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-35 Score=299.39 Aligned_cols=197 Identities=21% Similarity=0.330 Sum_probs=159.2
Q ss_pred ceEEEEEE--CCeEEEEEEccHH-------------HHHHHHHHHhcC--CCCcccEEEEEEcCCCcEEEEEeecCC-CC
Q 047629 343 KSVYRATI--DGKVLAVKKIKED-------------VTEELRILQRIN--HANLVKLMGVSSDSQGNRFLVYEYAEN-GS 404 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~~-------------~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~~lV~E~~~~-Gs 404 (615)
|.||+|.. +|+.||||+++.+ +.+|+.+|++++ |||||++++++.+. +..++||||+.+ ++
T Consensus 18 g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~-~~~~lv~e~~~~~~~ 96 (273)
T d1xwsa_ 18 GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP-DSFVLILERPEPVQD 96 (273)
T ss_dssp EEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS-SEEEEEEECCSSEEE
T ss_pred eEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC-CeEEEEEEeccCcch
Confidence 48999997 6899999998632 468999999996 89999999998764 479999999975 68
Q ss_pred HHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCC-CcEEEeecCCCCCCCC
Q 047629 405 LDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSR-FKAKIANFSLAAPATN 483 (615)
Q Consensus 405 L~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~-~~~kl~DFGla~~~~~ 483 (615)
+.+++.... .+++.++..++.|++.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+....
T Consensus 97 l~~~~~~~~----------~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~ 163 (273)
T d1xwsa_ 97 LFDFITERG----------ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKD 163 (273)
T ss_dssp HHHHHHHHC----------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCS
T ss_pred HHHHHhccC----------CCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccceeccc
Confidence 888886543 3899999999999999999999998 9999999999999854 7999999999965421
Q ss_pred C----------------------CCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhc
Q 047629 484 D----------------------VMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWM 541 (615)
Q Consensus 484 ~----------------------~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 541 (615)
. .+.++|||||||++|||++|+.||.... . + ...
T Consensus 164 ~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----~-----i-------------~~~-- 219 (273)
T d1xwsa_ 164 TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----E-----I-------------IRG-- 219 (273)
T ss_dssp SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----H-----H-------------HHC--
T ss_pred ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----H-----H-------------hhc--
Confidence 1 2346899999999999999999986421 0 0 000
Q ss_pred CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 542 DPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 542 dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
...+...+ ...+.+|+.+||+.||++|||++|++++
T Consensus 220 ~~~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 220 QVFFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp CCCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ccCCCCCC----CHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 11122223 3457899999999999999999999874
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-35 Score=311.13 Aligned_cols=226 Identities=24% Similarity=0.287 Sum_probs=161.0
Q ss_pred ceEEEEEE--CCeEEEEEEccH---HHHHHHHHHHhcCCCCcccEEEEEEcC-----CCcEEEEEeecCCCCHHHhhccC
Q 047629 343 KSVYRATI--DGKVLAVKKIKE---DVTEELRILQRINHANLVKLMGVSSDS-----QGNRFLVYEYAENGSLDKWLHPK 412 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~---~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~~~lV~E~~~~GsL~~~L~~~ 412 (615)
|.||+|.. +|+.||||+++. ...+|+++|++++|+||+++++++... ...+++||||+++|.+.......
T Consensus 34 g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~ 113 (350)
T d1q5ka_ 34 GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS 113 (350)
T ss_dssp EEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHH
T ss_pred eEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhh
Confidence 58999998 689999999864 356899999999999999999998532 12378999999876433333211
Q ss_pred CCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCC-cEEEeecCCCCCCC---------
Q 047629 413 SKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRF-KAKIANFSLAAPAT--------- 482 (615)
Q Consensus 413 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~-~~kl~DFGla~~~~--------- 482 (615)
... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++...
T Consensus 114 ~~~-------~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~ 183 (350)
T d1q5ka_ 114 RAK-------QTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183 (350)
T ss_dssp HTT-------CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSCCCSCC
T ss_pred hcc-------CCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhccCCccccccc
Confidence 110 13999999999999999999999998 99999999999999774 89999999986431
Q ss_pred --------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhH--HHHHHHHHhhhcCCcCC
Q 047629 483 --------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKV--EEKREERLRNWMDPNLE 546 (615)
Q Consensus 483 --------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~dp~l~ 546 (615)
..++.++||||+||++|||++|+.||......+. +.. +...+.. ............+..+.
T Consensus 184 gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~--l~~-i~~~~g~~~~~~~~~~~~~~~~~~~~ 260 (350)
T d1q5ka_ 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVE-IIKVLGTPTREQIREMNPNYTEFKFP 260 (350)
T ss_dssp SCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH--HHH-HHHHHCCCCHHHHHHHCC---CCCCC
T ss_pred ccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH--HHH-HHHHhCCChHHhhhhhccchhhcccc
Confidence 1256789999999999999999999976543221 111 1111110 00001111111111110
Q ss_pred --------CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 547 --------SFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 547 --------~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
..........+.+|+.+|++.||++|||+.|++++
T Consensus 261 ~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 261 QIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp CCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11112234467899999999999999999999874
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-35 Score=302.98 Aligned_cols=222 Identities=20% Similarity=0.294 Sum_probs=161.9
Q ss_pred ceEEEEEE---CCeEEEEEEcc---------HHHHHHHHHHHhc---CCCCcccEEEEEEc----CCCcEEEEEeecCCC
Q 047629 343 KSVYRATI---DGKVLAVKKIK---------EDVTEELRILQRI---NHANLVKLMGVSSD----SQGNRFLVYEYAENG 403 (615)
Q Consensus 343 ~~Vy~~~~---~g~~vAvK~~~---------~~~~~Ei~~l~~l---~H~niv~l~g~~~~----~~~~~~lV~E~~~~G 403 (615)
|.||+|.. +++.||||+++ ..+.+|+++|+.+ +||||+++++++.. .+...++++||+++|
T Consensus 21 g~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~ 100 (305)
T d1blxa_ 21 GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD 100 (305)
T ss_dssp EEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCB
T ss_pred eEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCC
Confidence 58999986 36789999985 2467888887776 89999999998853 223579999999988
Q ss_pred CHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-
Q 047629 404 SLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT- 482 (615)
Q Consensus 404 sL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~- 482 (615)
++......... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 101 ~~~~~~~~~~~---------~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~ 168 (305)
T d1blxa_ 101 LTTYLDKVPEP---------GVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF 168 (305)
T ss_dssp HHHHHHHSCTT---------CSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCCCCCG
T ss_pred chhhhhhccCC---------CCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchhhhhhhcc
Confidence 77655544332 3899999999999999999999998 9999999999999999999999999986531
Q ss_pred ---------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhh--
Q 047629 483 ---------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRN-- 539 (615)
Q Consensus 483 ---------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~-- 539 (615)
..++.++||||+||++|||++|+.||......+. ...+........ ......
T Consensus 169 ~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~~~~--~~~~~~~~ 243 (305)
T d1blxa_ 169 QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKILDVIGLPG--EEDWPRDV 243 (305)
T ss_dssp GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCC--GGGSCTTC
T ss_pred cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH---HHHHHHhhCCCc--hhcccccc
Confidence 2367899999999999999999999976442111 111111110000 000000
Q ss_pred -----hc---CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 540 -----WM---DPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 540 -----~~---dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.. .+.....+.......+.+|+.+|++.||++|||+.|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp SSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 0000011222334567899999999999999999999875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-34 Score=294.91 Aligned_cols=223 Identities=17% Similarity=0.236 Sum_probs=166.9
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhcc
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHP 411 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~ 411 (615)
|.||+|+. +|+.||||+++ ..+.+|+.+|++++|+||+++++++.+.+ ..++|+|++.+++|..++..
T Consensus 16 g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~-~~~iv~~~~~~~~l~~~~~~ 94 (292)
T d1unla_ 16 GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK-KLTLVFEFCDQDLKKYFDSC 94 (292)
T ss_dssp SEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-EEEEEEECCSEEHHHHHHHT
T ss_pred eEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccccc-ceeEEeeecccccccccccc
Confidence 58999997 78999999974 35779999999999999999999998654 78999999999999888765
Q ss_pred CCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC--------
Q 047629 412 KSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN-------- 483 (615)
Q Consensus 412 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~-------- 483 (615)
.. .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++....
T Consensus 95 ~~----------~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~~ 161 (292)
T d1unla_ 95 NG----------DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE 161 (292)
T ss_dssp TT----------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCSC
T ss_pred cc----------ccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCCccceee
Confidence 44 2889999999999999999999998 99999999999999999999999999964321
Q ss_pred ----------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHH-HHHHHhhhcCC---
Q 047629 484 ----------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEK-REERLRNWMDP--- 543 (615)
Q Consensus 484 ----------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~dp--- 543 (615)
..+.++|||||||++|||++|+.|+....+... ....+......... ......+..+.
T Consensus 162 ~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (292)
T d1unla_ 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239 (292)
T ss_dssp CSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred ccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH--HHHHHHhhcCCCChhhhhhhhhccccccc
Confidence 146789999999999999999999765443211 11111111100000 00000000000
Q ss_pred -cC-----CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 544 -NL-----ESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 544 -~l-----~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.. ...........+.+|+.+|++.||++|||++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 011222334467899999999999999999998764
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-34 Score=300.80 Aligned_cols=228 Identities=20% Similarity=0.336 Sum_probs=165.9
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcCC-----CcEEEEEeecCCCCHH
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDSQ-----GNRFLVYEYAENGSLD 406 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~~lV~E~~~~GsL~ 406 (615)
|.||+|.. +|+.||||+++ +.+.+|+++|++++|||||++++++...+ ...++||||+ +++|.
T Consensus 32 g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~ 110 (346)
T d1cm8a_ 32 GAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLG 110 (346)
T ss_dssp -CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHH
T ss_pred eEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHH
Confidence 58999997 69999999985 24678999999999999999999986533 2469999999 45788
Q ss_pred HhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC---
Q 047629 407 KWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN--- 483 (615)
Q Consensus 407 ~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~--- 483 (615)
.+++.. .|++..+..++.|++.||+|||+++ |+||||||+|||++.++.+|++|||+|+....
T Consensus 111 ~~~~~~-----------~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~~~ 176 (346)
T d1cm8a_ 111 KLMKHE-----------KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT 176 (346)
T ss_dssp HHHHHC-----------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSSCC
T ss_pred HHHHhc-----------cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceeccCCccc
Confidence 877543 2899999999999999999999998 99999999999999999999999999965422
Q ss_pred ------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHH--------HhHHH--HHHH
Q 047629 484 ------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREV--------LKVEE--KREE 535 (615)
Q Consensus 484 ------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~--------~~~~~--~~~~ 535 (615)
..+.++||||+||++|||++|+.||.................. ..... ....
T Consensus 177 ~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (346)
T d1cm8a_ 177 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMK 256 (346)
T ss_dssp SSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHH
T ss_pred cccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhc
Confidence 2467899999999999999999999765432211111000000 00000 0000
Q ss_pred HHhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHhcc
Q 047629 536 RLRNWMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN--LSVLT 586 (615)
Q Consensus 536 ~~~~~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~--L~~l~ 586 (615)
.+.+.....+. .........+.+|+.+|+..||.+|||++|++++ ++.+.
T Consensus 257 ~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 257 GLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred cCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 01111111111 1112223457899999999999999999999986 44443
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-34 Score=298.61 Aligned_cols=222 Identities=20% Similarity=0.263 Sum_probs=161.8
Q ss_pred ceEEEEEE--CCeEEEEEEcc--------HHHHHHHHHHHhcCCCCcccEEEEEEcCCC---cEEEEEeecCCCCHHHhh
Q 047629 343 KSVYRATI--DGKVLAVKKIK--------EDVTEELRILQRINHANLVKLMGVSSDSQG---NRFLVYEYAENGSLDKWL 409 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~---~~~lV~E~~~~GsL~~~L 409 (615)
|.||+|.. +|+.||||+++ +.+.+|+++|++++||||+++++++..... ..+++++|+.+|+|.+++
T Consensus 22 g~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l 101 (345)
T d1pmea_ 22 GMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL 101 (345)
T ss_dssp CCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHH
T ss_pred eEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhh
Confidence 58999987 69999999985 246789999999999999999999864321 234555667799999999
Q ss_pred ccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC-------
Q 047629 410 HPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT------- 482 (615)
Q Consensus 410 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------- 482 (615)
... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~~~-----------~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~ 167 (345)
T d1pmea_ 102 KTQ-----------HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 167 (345)
T ss_dssp HHC-----------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCC
T ss_pred hcC-----------CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccCCCccce
Confidence 653 2899999999999999999999998 9999999999999999999999999985321
Q ss_pred --------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHH-------HHHH
Q 047629 483 --------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEE-------KREE 535 (615)
Q Consensus 483 --------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~-------~~~~ 535 (615)
..+++++||||+||++|||++|+.||......+................ ....
T Consensus 168 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (345)
T d1pmea_ 168 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 247 (345)
T ss_dssp TTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHH
T ss_pred eeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhc
Confidence 1145689999999999999999999976543221111100000000000 0000
Q ss_pred HHhhhcCCcCCCCCCh-----HHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 536 RLRNWMDPNLESFYPI-----DGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 536 ~~~~~~dp~l~~~~~~-----~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.... .+.. ...+. ....++.+|+..|++.||.+|||+.|++++
T Consensus 248 ~~~~--~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 248 YLLS--LPHK-NKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHT--SCCC-CCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccc--CCcc-CCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 1111 11111 122357899999999999999999999975
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-34 Score=293.44 Aligned_cols=221 Identities=21% Similarity=0.307 Sum_probs=160.2
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcC-------CCcEEEEEeecCCCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDS-------QGNRFLVYEYAENGS 404 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~-------~~~~~lV~E~~~~Gs 404 (615)
|.||+|.. +|+.||||+++ ..+.+|+++|++++|+||+++++++... ++..++||||++++.
T Consensus 24 g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~ 103 (318)
T d3blha1 24 GEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDL 103 (318)
T ss_dssp SEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEH
T ss_pred eEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCc
Confidence 58999997 68999999874 3477999999999999999999987542 235799999999877
Q ss_pred HHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC--
Q 047629 405 LDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT-- 482 (615)
Q Consensus 405 L~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~-- 482 (615)
+..+..... .++...+..++.|++.||.|||+++ |+||||||+|||++.++.+|++|||+++...
T Consensus 104 ~~~~~~~~~----------~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~ 170 (318)
T d3blha1 104 AGLLSNVLV----------KFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLA 170 (318)
T ss_dssp HHHHTCTTC----------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCC-
T ss_pred cchhhhccc----------ccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecceeeecccc
Confidence 766554433 2888999999999999999999998 9999999999999999999999999985321
Q ss_pred --------------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHH
Q 047629 483 --------------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREER 536 (615)
Q Consensus 483 --------------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 536 (615)
..+++++|||||||++|||++|+.||....+.+.. ..+........ ...
T Consensus 171 ~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~---~~i~~~~~~~~--~~~ 245 (318)
T d3blha1 171 KNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL---ALISQLCGSIT--PEV 245 (318)
T ss_dssp ----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCC--TTT
T ss_pred cccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHH---HHHHHhcCCCC--hhh
Confidence 12567999999999999999999999754421111 11111110000 000
Q ss_pred Hhhh--------cCCcCCCCCChH-------HHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 537 LRNW--------MDPNLESFYPID-------GALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 537 ~~~~--------~dp~l~~~~~~~-------~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.... .........+.. ....+.+|+.+||+.||++|||++|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0000 000000001111 12246789999999999999999999875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.5e-33 Score=292.12 Aligned_cols=221 Identities=19% Similarity=0.275 Sum_probs=163.4
Q ss_pred ceEEEEEE--CCeEEEEEEcc----HHHHHHHHHHHhcC-CCCcccEEEEEEcC-CCcEEEEEeecCCCCHHHhhccCCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK----EDVTEELRILQRIN-HANLVKLMGVSSDS-QGNRFLVYEYAENGSLDKWLHPKSK 414 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~----~~~~~Ei~~l~~l~-H~niv~l~g~~~~~-~~~~~lV~E~~~~GsL~~~L~~~~~ 414 (615)
|.||+|+. +|+.||||+++ +.+.+|+++|++++ ||||+++++++... ....++||||+++|+|.++..
T Consensus 49 g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~---- 124 (328)
T d3bqca1 49 SEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---- 124 (328)
T ss_dssp EEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTTT----
T ss_pred eEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHhc----
Confidence 58999997 69999999986 46789999999995 99999999998643 345899999999999987642
Q ss_pred CCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCC-cEEEeecCCCCCCCC----------
Q 047629 415 SSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRF-KAKIANFSLAAPATN---------- 483 (615)
Q Consensus 415 ~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~-~~kl~DFGla~~~~~---------- 483 (615)
.+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+....
T Consensus 125 ---------~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t 192 (328)
T d3bqca1 125 ---------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS 192 (328)
T ss_dssp ---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCCSCCSC
T ss_pred ---------CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCCCcccccccC
Confidence 2889999999999999999999998 99999999999998654 689999999864321
Q ss_pred -------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHH--HHHhhhcCCcC---
Q 047629 484 -------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKRE--ERLRNWMDPNL--- 545 (615)
Q Consensus 484 -------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~--~~~~~~~dp~l--- 545 (615)
.++.++||||+||+++||++|+.||........ ....+...+....... .......++..
T Consensus 193 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~--~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~ 270 (328)
T d3bqca1 193 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD--QLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI 270 (328)
T ss_dssp GGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH--HHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGT
T ss_pred ccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHH--HHHHHHHHHCCchhhhhhhhcccccCcccchh
Confidence 146789999999999999999999976543221 1111222221111000 00000000000
Q ss_pred -------------CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 546 -------------ESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 546 -------------~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
...........+.+|+.+|++.||++|||++|++++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 271 LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp CCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 001111233467899999999999999999999863
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-33 Score=289.36 Aligned_cols=218 Identities=17% Similarity=0.208 Sum_probs=161.6
Q ss_pred ceEEEEEE--CCeEEEEEEcc-----HHHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK-----EDVTEELRILQRINHANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSKS 415 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-----~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~ 415 (615)
|.||+|.. +|+.||||.++ ..+..|++++++++|+|++..++.+....+..++||||+. |+|.+.+.....
T Consensus 21 G~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~-~~l~~~~~~~~~- 98 (299)
T d1ckia_ 21 GDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG-PSLEDLFNFCSR- 98 (299)
T ss_dssp SEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTT-
T ss_pred cEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC-CchhhhhhhccC-
Confidence 58999997 68999999875 3588899999999888877776666555557899999995 567666654433
Q ss_pred CCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCC---CCcEEEeecCCCCCCCC---------
Q 047629 416 SSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDS---RFKAKIANFSLAAPATN--------- 483 (615)
Q Consensus 416 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~---~~~~kl~DFGla~~~~~--------- 483 (615)
.+++..+..++.|++.||+|||+++ |+||||||+|||++. +..+|++|||+|+....
T Consensus 99 --------~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~ 167 (299)
T d1ckia_ 99 --------KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY 167 (299)
T ss_dssp --------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCC
T ss_pred --------CCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccccccccceec
Confidence 3899999999999999999999998 999999999998764 56799999999964311
Q ss_pred ---------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhhhcC
Q 047629 484 ---------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRNWMD 542 (615)
Q Consensus 484 ---------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~d 542 (615)
.++.++|||||||++|||++|+.||................ ...... -.
T Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~---------~~~~~~-~~ 237 (299)
T d1ckia_ 168 RENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS---------EKKMST-PI 237 (299)
T ss_dssp CBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHH---------HHHHHS-CH
T ss_pred cccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhh---------cccCCC-Ch
Confidence 14568999999999999999999997654322211111000 000000 00
Q ss_pred CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 047629 543 PNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQ 587 (615)
Q Consensus 543 p~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~ 587 (615)
+.+...+ +.++.+++..||+.||++||++.++.+.|+.+..
T Consensus 238 ~~~~~~~----p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 238 EVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HHHTTTS----CHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred hHhccCC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 0111122 3457899999999999999999999988886643
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-34 Score=297.62 Aligned_cols=207 Identities=23% Similarity=0.318 Sum_probs=163.9
Q ss_pred ceEEEEEE-----CCeEEEEEEcc-----------HHHHHHHHHHHhcCC-CCcccEEEEEEcCCCcEEEEEeecCCCCH
Q 047629 343 KSVYRATI-----DGKVLAVKKIK-----------EDVTEELRILQRINH-ANLVKLMGVSSDSQGNRFLVYEYAENGSL 405 (615)
Q Consensus 343 ~~Vy~~~~-----~g~~vAvK~~~-----------~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~~lV~E~~~~GsL 405 (615)
|.||+|.. +|+.||||.++ +.+.+|+++|++++| |||+++++++.+. ...+++|||+.+|+|
T Consensus 38 g~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~-~~~~~v~e~~~~~~L 116 (322)
T d1vzoa_ 38 GKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-TKLHLILDYINGGEL 116 (322)
T ss_dssp EEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-TEEEEEECCCCSCBH
T ss_pred eEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC-CceeeeeecccccHH
Confidence 58999975 47899999874 236689999999966 8999999998765 479999999999999
Q ss_pred HHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC--
Q 047629 406 DKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN-- 483 (615)
Q Consensus 406 ~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~-- 483 (615)
.+++..... ++......++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 117 ~~~i~~~~~----------~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~ 183 (322)
T d1vzoa_ 117 FTHLSQRER----------FTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE 183 (322)
T ss_dssp HHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECCGGG
T ss_pred HHHHHhccc----------ccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhhhcccc
Confidence 999976553 678889999999999999999998 99999999999999999999999999864311
Q ss_pred ------------------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhh
Q 047629 484 ------------------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRN 539 (615)
Q Consensus 484 ------------------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 539 (615)
.++.++|||||||+||||++|+.||......+.... +. .....
T Consensus 184 ~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~---i~---------~~~~~- 250 (322)
T d1vzoa_ 184 TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE---IS---------RRILK- 250 (322)
T ss_dssp GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH---HH---------HHHHH-
T ss_pred cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HH---------Hhccc-
Confidence 145689999999999999999999976543322111 00 00111
Q ss_pred hcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 047629 540 WMDPNLESFYPIDGALSLATLARACTMDKSLSRPN-----MAEVVFN 581 (615)
Q Consensus 540 ~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPs-----m~ev~~~ 581 (615)
..+ .++.+....+.+++.+||+.||++||| ++|++++
T Consensus 251 -~~~----~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 251 -SEP----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp -CCC----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -CCC----CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 111 233445567899999999999999995 7888753
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-33 Score=288.96 Aligned_cols=220 Identities=22% Similarity=0.305 Sum_probs=159.8
Q ss_pred ceEEEEEE--CCeEEEEEEcc---------HHHHHHHHHHHhcCCCCcccEEEEEEcC----CCcEEEEEeecCCCCHHH
Q 047629 343 KSVYRATI--DGKVLAVKKIK---------EDVTEELRILQRINHANLVKLMGVSSDS----QGNRFLVYEYAENGSLDK 407 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~---------~~~~~Ei~~l~~l~H~niv~l~g~~~~~----~~~~~lV~E~~~~GsL~~ 407 (615)
|.||+|.. +|+.||||+++ +.+.+|+++|++++|+|+|++++++... +...+++++|+.+|+|.+
T Consensus 32 g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~ 111 (348)
T d2gfsa1 32 GSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN 111 (348)
T ss_dssp SSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHH
T ss_pred eEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhh
Confidence 58999986 79999999985 2467899999999999999999987532 223466778888999999
Q ss_pred hhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCC----
Q 047629 408 WLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATN---- 483 (615)
Q Consensus 408 ~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~---- 483 (615)
++... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++.....
T Consensus 112 ~~~~~-----------~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~~~~ 177 (348)
T d2gfsa1 112 IVKCQ-----------KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 177 (348)
T ss_dssp HHTTC-----------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CCTGGGSS
T ss_pred hcccc-----------cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcccCccccc
Confidence 99643 2899999999999999999999998 99999999999999999999999999865421
Q ss_pred -----------------CCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHH---------HHHHHH
Q 047629 484 -----------------DVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEE---------KREERL 537 (615)
Q Consensus 484 -----------------~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---------~~~~~~ 537 (615)
..+.++|||||||++|||++|+.||........ ...+........ ......
T Consensus 178 ~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~ 254 (348)
T d2gfsa1 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ---LKLILRLVGTPGAELLKKISSESARNY 254 (348)
T ss_dssp SCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCHHHHTTCCCHHHHHH
T ss_pred ccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCChHHhhhccchhhhhh
Confidence 246799999999999999999999976542211 111111110000 000000
Q ss_pred hhhcCCcCCCCCC-----hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 538 RNWMDPNLESFYP-----IDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 538 ~~~~dp~l~~~~~-----~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
.... +.. ...+ ......+.+|+.+|++.||.+|||++|++++
T Consensus 255 ~~~~-~~~-~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 255 IQSL-TQM-PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HTTS-CCC-CCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhc-ccC-CCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 0000 000 0001 1123457899999999999999999999874
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.3e-32 Score=278.64 Aligned_cols=218 Identities=16% Similarity=0.180 Sum_probs=167.9
Q ss_pred ceEEEEEE--CCeEEEEEEcc-----HHHHHHHHHHHhcCC-CCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK-----EDVTEELRILQRINH-ANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSK 414 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~-----~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~ 414 (615)
|.||+|+. +|+.||||.++ ..+.+|++++..++| +|++.+++++.+ ++..++||||+ +|+|.+++.....
T Consensus 19 G~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-~~~~~~vme~~-~~~l~~~~~~~~~ 96 (293)
T d1csna_ 19 GVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE-GLHNVLVIDLL-GPSLEDLLDLCGR 96 (293)
T ss_dssp CEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEE-TTEEEEEEECC-CCBHHHHHHHTTT
T ss_pred eEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeec-CCccEEEEEec-CCCHHHHHHhhcc
Confidence 58999997 68999999875 347889999999965 899999998765 44789999999 6899999876543
Q ss_pred CCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCC-----CCcEEEeecCCCCCCC-------
Q 047629 415 SSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDS-----RFKAKIANFSLAAPAT------- 482 (615)
Q Consensus 415 ~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~-----~~~~kl~DFGla~~~~------- 482 (615)
.+++.++..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+|+...
T Consensus 97 ---------~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~ 164 (293)
T d1csna_ 97 ---------KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQH 164 (293)
T ss_dssp ---------CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCB
T ss_pred ---------chhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEcccCccccc
Confidence 3899999999999999999999998 999999999999975 5689999999996431
Q ss_pred -----------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhHHHHHHHHHhh
Q 047629 483 -----------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKVEEKREERLRN 539 (615)
Q Consensus 483 -----------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 539 (615)
..++.++|||||||++|||++|+.||..............+.... ......+
T Consensus 165 ~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~-----~~~~~~~ 239 (293)
T d1csna_ 165 IPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK-----QSTPLRE 239 (293)
T ss_dssp CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH-----HHSCHHH
T ss_pred eeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc-----CCCChHH
Confidence 114568999999999999999999998655433322211111110 0000111
Q ss_pred hcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 047629 540 WMDPNLESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFNLSVLTQS 588 (615)
Q Consensus 540 ~~dp~l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~L~~l~~~ 588 (615)
+...+| .++.+++..|++.+|++||+++.+.+.|+.+.+.
T Consensus 240 -----l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~ 279 (293)
T d1csna_ 240 -----LCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279 (293)
T ss_dssp -----HTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred -----hcCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHH
Confidence 112223 4578999999999999999999998888776543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.2e-32 Score=285.13 Aligned_cols=220 Identities=20% Similarity=0.251 Sum_probs=159.1
Q ss_pred ceEEEEEE--CCeEEEEEEccH---------HHHHHHHHHHhcCCCCcccEEEEEEcC-----CCcEEEEEeecCCCCHH
Q 047629 343 KSVYRATI--DGKVLAVKKIKE---------DVTEELRILQRINHANLVKLMGVSSDS-----QGNRFLVYEYAENGSLD 406 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~~---------~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~~~lV~E~~~~GsL~ 406 (615)
|.||+|.. +|+.||||+++. .+.+|+.+|++++|||||++++++... ....|+||||+.+|.+
T Consensus 31 g~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~- 109 (355)
T d2b1pa1 31 GIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC- 109 (355)
T ss_dssp CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHH-
T ss_pred eEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchHHH-
Confidence 58999997 699999999852 367899999999999999999998532 2368999999976544
Q ss_pred HhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCC----
Q 047629 407 KWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPAT---- 482 (615)
Q Consensus 407 ~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~---- 482 (615)
+.+.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+++...
T Consensus 110 ~~~~~------------~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~~ 174 (355)
T d2b1pa1 110 QVIQM------------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 174 (355)
T ss_dssp HHHTS------------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred Hhhhc------------CCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhccccccc
Confidence 44432 2889999999999999999999998 9999999999999999999999999875431
Q ss_pred ------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCChhHHHHHHHHHHHhH---------HHHHHH
Q 047629 483 ------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGKTAVLWKEIREVLKV---------EEKREE 535 (615)
Q Consensus 483 ------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~---------~~~~~~ 535 (615)
..+++++||||+||+++||++|+.||........ ...+...... ......
T Consensus 175 ~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~ 251 (355)
T d2b1pa1 175 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ---WNKVIEQLGTPCPEFMKKLQPTVRN 251 (355)
T ss_dssp ------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCHHHHTTSCHHHHH
T ss_pred cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHH---HHHHHHhccCCCHHHHHHhhhhHHH
Confidence 2356799999999999999999999975432111 1111111000 000000
Q ss_pred HHhhhc-----------CCcCC---CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 536 RLRNWM-----------DPNLE---SFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 536 ~~~~~~-----------dp~l~---~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
...... ..... ..........+.+|+++|++.||++|||++|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 001100 00000 01112345568899999999999999999999875
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.95 E-value=3.2e-28 Score=254.73 Aligned_cols=227 Identities=19% Similarity=0.258 Sum_probs=154.0
Q ss_pred ceEEEEEE--CCeEEEEEEcc------HHHHHHHHHHHhcC-----------CCCcccEEEEEEcC-CCcEEEEEeecCC
Q 047629 343 KSVYRATI--DGKVLAVKKIK------EDVTEELRILQRIN-----------HANLVKLMGVSSDS-QGNRFLVYEYAEN 402 (615)
Q Consensus 343 ~~Vy~~~~--~g~~vAvK~~~------~~~~~Ei~~l~~l~-----------H~niv~l~g~~~~~-~~~~~lV~E~~~~ 402 (615)
|.||+|+. +|+.||||+++ +.+.+|++++++++ |+||+++++++... ....+++++++..
T Consensus 27 g~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~ 106 (362)
T d1q8ya_ 27 STVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL 106 (362)
T ss_dssp EEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC
T ss_pred eEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeeccc
Confidence 58999987 79999999986 34578999998875 57899999887532 2345677777655
Q ss_pred CC-HHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCceeeCCCC------cEEEee
Q 047629 403 GS-LDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHE-HAQPSIVHRDIRTNNIQLDSRF------KAKIAN 474 (615)
Q Consensus 403 Gs-L~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~NILld~~~------~~kl~D 474 (615)
+. .......... ..+++..+..++.||+.||+|||+ ++ |+||||||+|||++.++ .+|++|
T Consensus 107 ~~~~~~~~~~~~~--------~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~~~kl~d 175 (362)
T d1q8ya_ 107 GENLLALIKKYEH--------RGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIAD 175 (362)
T ss_dssp CEEHHHHHHHTTT--------SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEEEEECC
T ss_pred ccccccccccccc--------cCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccceeeEee
Confidence 44 3333332222 138899999999999999999998 66 99999999999998664 489999
Q ss_pred cCCCCCCC--------------------CCCCCcccchhHHHHHHHHHcCCCCCCCCCCCh----hHHHHHHHHHHHhH-
Q 047629 475 FSLAAPAT--------------------NDVMPKFDVFAFGVVLLELLSGKKATRTTENGK----TAVLWKEIREVLKV- 529 (615)
Q Consensus 475 FGla~~~~--------------------~~~~~k~DV~SfGvvl~ElltG~~p~~~~~~~~----~~~l~~~~~~~~~~- 529 (615)
||.++... ..++.++||||+||+++||++|+.||....... ...+...+ ..+..
T Consensus 176 fg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~-~~lg~~ 254 (362)
T d1q8ya_ 176 LGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII-ELLGEL 254 (362)
T ss_dssp CTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHH-HHHCSC
T ss_pred cccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHH-HHhCCC
Confidence 99985431 225678999999999999999999987543211 11111111 11100
Q ss_pred --HHHHH-HHHhhhcCC-----c--------------CCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047629 530 --EEKRE-ERLRNWMDP-----N--------------LESFYPIDGALSLATLARACTMDKSLSRPNMAEVVFN 581 (615)
Q Consensus 530 --~~~~~-~~~~~~~dp-----~--------------l~~~~~~~~~~~l~~l~~~C~~~dP~~RPsm~ev~~~ 581 (615)
+.... .......+. . ............+.+|+.+|++.||.+|||++|++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 255 PSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 328 (362)
T ss_dssp CHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred CHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00000 000111110 0 0122345667789999999999999999999999875
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.76 E-value=1.1e-18 Score=164.99 Aligned_cols=114 Identities=17% Similarity=0.174 Sum_probs=92.0
Q ss_pred ceEEEEEE-CCeEEEEEEccH-------------------------HHHHHHHHHHhcCCCCcccEEEEEEcCCCcEEEE
Q 047629 343 KSVYRATI-DGKVLAVKKIKE-------------------------DVTEELRILQRINHANLVKLMGVSSDSQGNRFLV 396 (615)
Q Consensus 343 ~~Vy~~~~-~g~~vAvK~~~~-------------------------~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~lV 396 (615)
|.||+|.. +|+.||||.++. ....|...+.+++|.+++..+++. ..+++
T Consensus 14 g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~-----~~~lv 88 (191)
T d1zara2 14 SAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE-----GNAVL 88 (191)
T ss_dssp EEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE-----TTEEE
T ss_pred eEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec-----CCEEE
Confidence 48999987 899999997531 134588899999999999988752 23799
Q ss_pred EeecCCCCHHHhhccCCCCCCCCCcccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceeeCCCCcEEEeecC
Q 047629 397 YEYAENGSLDKWLHPKSKSSSSSGSVIFLTWSQRLRVALDVANGLQYMHEHAQPSIVHRDIRTNNIQLDSRFKAKIANFS 476 (615)
Q Consensus 397 ~E~~~~GsL~~~L~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFG 476 (615)
|||++++.+.+ +++....+++.|++.+|.|||+++ |+||||||+|||++++ .++|.|||
T Consensus 89 me~~~~~~~~~-----------------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liDFG 147 (191)
T d1zara2 89 MELIDAKELYR-----------------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDFP 147 (191)
T ss_dssp EECCCCEEGGG-----------------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECCCT
T ss_pred EEeeccccccc-----------------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEECC
Confidence 99998765533 223334678999999999999998 9999999999999865 58999999
Q ss_pred CCCCCC
Q 047629 477 LAAPAT 482 (615)
Q Consensus 477 la~~~~ 482 (615)
+|....
T Consensus 148 ~a~~~~ 153 (191)
T d1zara2 148 QSVEVG 153 (191)
T ss_dssp TCEETT
T ss_pred CcccCC
Confidence 997654
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.81 E-value=7.3e-05 Score=71.50 Aligned_cols=136 Identities=13% Similarity=0.177 Sum_probs=88.5
Q ss_pred ceEEEEEECCeEEEEEEccH-------HHHHHHHHHHhcC-CCCcccEEEEEEcCCCcEEEEEeecCCCCHHHhhccCCC
Q 047629 343 KSVYRATIDGKVLAVKKIKE-------DVTEELRILQRIN-HANLVKLMGVSSDSQGNRFLVYEYAENGSLDKWLHPKSK 414 (615)
Q Consensus 343 ~~Vy~~~~~g~~vAvK~~~~-------~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~ 414 (615)
..||+...+++.+.+|+... .+.+|...+..+. +--+-+++.+..+ ++..++||+++++.++.+......
T Consensus 28 ~~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~-~~~~~lv~~~l~G~~~~~~~~~~~- 105 (263)
T d1j7la_ 28 AKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH-DGWSNLLMSEADGVLCSEEYEDEQ- 105 (263)
T ss_dssp SEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-TTEEEEEEECCSSEEHHHHTTTCS-
T ss_pred CcEEEEEeCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEec-CCceEEEEEecccccccccccccc-
Confidence 37999887888888998753 3678999988874 3335577777654 457899999999888765432211
Q ss_pred CCCCCCcccccCHHHHHHHHHHHHHHHHHHHh------------------------------------------------
Q 047629 415 SSSSSGSVIFLTWSQRLRVALDVANGLQYMHE------------------------------------------------ 446 (615)
Q Consensus 415 ~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~------------------------------------------------ 446 (615)
. ...++.++++.+..||+
T Consensus 106 -----------~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (263)
T d1j7la_ 106 -----------S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELY 171 (263)
T ss_dssp -----------C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHH
T ss_pred -----------c---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHH
Confidence 1 11223334444444442
Q ss_pred -----C---CCCCeEecCCCCCceeeCCCCcEEEeecCCCCCCCCCCCCcccchhHHHHHHHH
Q 047629 447 -----H---AQPSIVHRDIRTNNIQLDSRFKAKIANFSLAAPATNDVMPKFDVFAFGVVLLEL 501 (615)
Q Consensus 447 -----~---~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~k~DV~SfGvvl~El 501 (615)
. ..+.++|+|+.+.|||++++...-|.||+.+..... .|-++.+++.+
T Consensus 172 ~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g~~-------~~Dla~~~~~~ 227 (263)
T d1j7la_ 172 DFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRADK-------WYDIAFCVRSI 227 (263)
T ss_dssp HHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEEEH-------HHHHHHHHHHH
T ss_pred HHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcccCCH-------HHHHHHHHHHh
Confidence 1 122489999999999999876667999997654321 23455555554
|
| >d1y7ma2 d.7.1.1 (A:1-48) Hypothetical protein YkuD, N-terminal domain {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: LysM domain superfamily: LysM domain family: LysM domain domain: Hypothetical protein YkuD, N-terminal domain species: Bacillus subtilis [TaxId: 1423]
Probab=97.46 E-value=2.7e-05 Score=54.23 Aligned_cols=45 Identities=20% Similarity=0.394 Sum_probs=39.6
Q ss_pred eeecccCCCCCCHHHHHHhhCCChHHHHhhcCCCCCCCCCCCCccEEee
Q 047629 45 VAYFAQSPEFLDLSNISDLFGVSRLSIARASNLVSEDTPLVPKQLLLVP 93 (615)
Q Consensus 45 ~~y~~~~~~~~~l~~i~~lf~~~~~~i~~~n~~~~~~~~~~~~~~~~vP 93 (615)
+.|+.++.+ ||..||..|+++..+|+.+|+.. + +.+.+||.++||
T Consensus 2 i~y~V~~GD--TL~~IA~~y~v~~~~i~~~N~~~-~-~~l~~Gq~L~IP 46 (48)
T d1y7ma2 2 LTYQVKQGD--TLNSIAADFRISTAALLQANPSL-Q-AGLTAGQSIVIP 46 (48)
T ss_dssp EEEECCTTC--CHHHHHHHTTSCCCCCCCTSCTT-C-SSCCTTCEEEET
T ss_pred EEEEECCCC--CHHHHHHHhCCCHHHHHHHcCCC-C-CCCCCCCEEEeC
Confidence 578888665 99999999999999999999975 3 469999999998
|
| >d1e0ga_ d.7.1.1 (A:) Membrane-bound lytic murein transclycosylase D, MltD {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: LysM domain superfamily: LysM domain family: LysM domain domain: Membrane-bound lytic murein transclycosylase D, MltD species: Escherichia coli [TaxId: 562]
Probab=97.41 E-value=6.6e-05 Score=52.06 Aligned_cols=45 Identities=22% Similarity=0.309 Sum_probs=39.4
Q ss_pred eeecccCCCCCCHHHHHHhhCCChHHHHhhcCCCCCCCCCCCCccEEeee
Q 047629 45 VAYFAQSPEFLDLSNISDLFGVSRLSIARASNLVSEDTPLVPKQLLLVPI 94 (615)
Q Consensus 45 ~~y~~~~~~~~~l~~i~~lf~~~~~~i~~~n~~~~~~~~~~~~~~~~vP~ 94 (615)
++|+.++.+ ||..||..|+++..+|+.+|+.. +.+.+||.|.||+
T Consensus 3 v~y~V~~GD--Tl~~IA~~y~vs~~~i~~~N~l~---~~l~~Gq~L~i~v 47 (48)
T d1e0ga_ 3 ITYRVRKGD--SLSSIAKRHGVNIKDVMRWNSDT---ANLQPGDKLTLFV 47 (48)
T ss_dssp CEEEECTTC--CHHHHHHHHTCCHHHHHHHCSCG---GGCCTTEEEECCC
T ss_pred EEEEECCCC--CHHHHHHHHCCCHHHHHHHcCCc---ccCcCCCEEEEEe
Confidence 468887665 99999999999999999999874 3599999999997
|
| >d1y7ma2 d.7.1.1 (A:1-48) Hypothetical protein YkuD, N-terminal domain {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: LysM domain superfamily: LysM domain family: LysM domain domain: Hypothetical protein YkuD, N-terminal domain species: Bacillus subtilis [TaxId: 1423]
Probab=97.37 E-value=5.2e-05 Score=52.71 Aligned_cols=45 Identities=24% Similarity=0.391 Sum_probs=37.8
Q ss_pred EEEecCCCCchhHHHHHhcCChhhHhhhccccCccccCccceecc
Q 047629 174 ITYVWQPGDDVSQVGAKLNASSAAIETENEYRNFSEAVSLPVLIP 218 (615)
Q Consensus 174 ~ty~~~~gd~~~~ia~~F~~s~~~i~~~n~~~~~~~~~~~~~l~p 218 (615)
++|.|+.|||+..||.+|+++...+..+|+..+....+|..+.+|
T Consensus 2 i~y~V~~GDTL~~IA~~y~v~~~~i~~~N~~~~~~l~~Gq~L~IP 46 (48)
T d1y7ma2 2 LTYQVKQGDTLNSIAADFRISTAALLQANPSLQAGLTAGQSIVIP 46 (48)
T ss_dssp EEEECCTTCCHHHHHHHTTSCCCCCCCTSCTTCSSCCTTCEEEET
T ss_pred EEEEECCCCCHHHHHHHhCCCHHHHHHHcCCCCCCCCCCCEEEeC
Confidence 689999999999999999999999999998854445566666665
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.18 E-value=0.00045 Score=65.37 Aligned_cols=133 Identities=17% Similarity=0.175 Sum_probs=77.6
Q ss_pred ceEEEEEEC-CeEEEEEEcc----HHHHHHHHHHHhcCCCC--cccEEEEEEcCCCcEEEEEeecCCCCHHHh-------
Q 047629 343 KSVYRATID-GKVLAVKKIK----EDVTEELRILQRINHAN--LVKLMGVSSDSQGNRFLVYEYAENGSLDKW------- 408 (615)
Q Consensus 343 ~~Vy~~~~~-g~~vAvK~~~----~~~~~Ei~~l~~l~H~n--iv~l~g~~~~~~~~~~lV~E~~~~GsL~~~------- 408 (615)
..||+...+ |..+.+|.-. .++..|...++.+.... +-++++++.+ ++..++|||++++-++.+.
T Consensus 25 ~~v~r~~~~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~-~~~~~~v~~~i~G~~~~~~~~~~~~~ 103 (255)
T d1nd4a_ 25 AAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTE-AGRDWLLLGEVPGQDLLSSHLAPAEK 103 (255)
T ss_dssp CEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-SSCEEEEEECCSSEETTTSCCCHHHH
T ss_pred CeEEEEEeCCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeeccc-ccceEEEEEeeeccccccccccHHHH
Confidence 468988774 5567888765 34778999998875433 4567777664 4578999999987554321
Q ss_pred ----------hccCCCCCCCCCcccccCHHHHHHHH--------------------HHHHHHHHHHHhCC----CCCeEe
Q 047629 409 ----------LHPKSKSSSSSGSVIFLTWSQRLRVA--------------------LDVANGLQYMHEHA----QPSIVH 454 (615)
Q Consensus 409 ----------L~~~~~~~~~~~~~~~l~~~~~~~i~--------------------~~ia~gL~yLH~~~----~~~ivH 454 (615)
||......... .-.+.....-. ......+..+.... .+.++|
T Consensus 104 ~~~l~~~la~LH~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~liH 179 (255)
T d1nd4a_ 104 VSIMADAMRRLHTLDPATCPF----DHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTH 179 (255)
T ss_dssp HHHHHHHHHHHTTSCGGGCCC----BCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEEC
T ss_pred HHHHHHHHHHHccCChhhCCC----cccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccCCceEEe
Confidence 11111000000 00111110000 01112233343321 234899
Q ss_pred cCCCCCceeeCCCCcEEEeecCCCCC
Q 047629 455 RDIRTNNIQLDSRFKAKIANFSLAAP 480 (615)
Q Consensus 455 rDlk~~NILld~~~~~kl~DFGla~~ 480 (615)
+|+.+.|||++++..+-|.||+.+..
T Consensus 180 gD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 180 GDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp SSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCCCCcceEEeCCceEEEEEchhccc
Confidence 99999999999876678999997654
|
| >d1e0ga_ d.7.1.1 (A:) Membrane-bound lytic murein transclycosylase D, MltD {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: LysM domain superfamily: LysM domain family: LysM domain domain: Membrane-bound lytic murein transclycosylase D, MltD species: Escherichia coli [TaxId: 562]
Probab=96.86 E-value=0.00045 Score=47.65 Aligned_cols=45 Identities=18% Similarity=0.162 Sum_probs=36.5
Q ss_pred EEEecCCCCchhHHHHHhcCChhhHhhhccccCccccCccceeccc
Q 047629 174 ITYVWQPGDDVSQVGAKLNASSAAIETENEYRNFSEAVSLPVLIPV 219 (615)
Q Consensus 174 ~ty~~~~gd~~~~ia~~F~~s~~~i~~~n~~~~~~~~~~~~~l~p~ 219 (615)
++|.|+.||++..||.+|+++...+...|+..+ ...+|..+.+|+
T Consensus 3 v~y~V~~GDTl~~IA~~y~vs~~~i~~~N~l~~-~l~~Gq~L~i~v 47 (48)
T d1e0ga_ 3 ITYRVRKGDSLSSIAKRHGVNIKDVMRWNSDTA-NLQPGDKLTLFV 47 (48)
T ss_dssp CEEEECTTCCHHHHHHHHTCCHHHHHHHCSCGG-GCCTTEEEECCC
T ss_pred EEEEECCCCCHHHHHHHHCCCHHHHHHHcCCcc-cCcCCCEEEEEe
Confidence 479999999999999999999999999998743 344566555554
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=95.81 E-value=0.018 Score=58.05 Aligned_cols=31 Identities=19% Similarity=0.332 Sum_probs=26.2
Q ss_pred CCeEecCCCCCceeeCCCCcEEEeecCCCCCC
Q 047629 450 PSIVHRDIRTNNIQLDSRFKAKIANFSLAAPA 481 (615)
Q Consensus 450 ~~ivHrDlk~~NILld~~~~~kl~DFGla~~~ 481 (615)
+.++|+|+.+.|||++++ .++|.||..+...
T Consensus 223 ~~LiHGDl~~gNIlv~~~-~~~vID~E~a~~G 253 (392)
T d2pula1 223 ETLIHGDLHTGSIFASEH-ETKVIDPEFAFYG 253 (392)
T ss_dssp CEEECSCCCGGGEEECSS-CEEECCCTTCEEE
T ss_pred cceeccCCcCCceeEcCC-ceEEechhhcccC
Confidence 459999999999999876 4899999887654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=92.73 E-value=0.067 Score=52.05 Aligned_cols=59 Identities=19% Similarity=0.271 Sum_probs=38.5
Q ss_pred eEEEEEE-CCeEEEEEEcc------HHHHHHHHHHHhcCCCCc--ccEEEE----EEcCCCcEEEEEeecCC
Q 047629 344 SVYRATI-DGKVLAVKKIK------EDVTEELRILQRINHANL--VKLMGV----SSDSQGNRFLVYEYAEN 402 (615)
Q Consensus 344 ~Vy~~~~-~g~~vAvK~~~------~~~~~Ei~~l~~l~H~ni--v~l~g~----~~~~~~~~~lV~E~~~~ 402 (615)
.||+... +|+.+++|..+ +++..|...+..|...++ +..+.. ....++..+.+++++++
T Consensus 37 ~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 37 RVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp EEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred eeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 7999987 78889999864 457789998888743222 111110 01123457889999875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=92.07 E-value=0.2 Score=49.88 Aligned_cols=57 Identities=18% Similarity=0.213 Sum_probs=37.3
Q ss_pred eEEEEEEC---------CeEEEEEEcc-----HHHHHHHHHHHhcCCCCcc-cEEEEEEcCCCcEEEEEeecCCCCH
Q 047629 344 SVYRATID---------GKVLAVKKIK-----EDVTEELRILQRINHANLV-KLMGVSSDSQGNRFLVYEYAENGSL 405 (615)
Q Consensus 344 ~Vy~~~~~---------g~~vAvK~~~-----~~~~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~~lV~E~~~~GsL 405 (615)
.+|+.... .+.|.++..- .+..+|..+++.+.-.++. ++++++. + .+|+||+++-.|
T Consensus 57 ~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~--~---g~I~efi~g~~l 128 (395)
T d1nw1a_ 57 MLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFS--G---GRLEEYIPSRPL 128 (395)
T ss_dssp EEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T---EEEECCCCEEEC
T ss_pred ceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcC--C---ceEEEEeccccC
Confidence 68887762 2446665532 3456899999988544555 7777652 2 589999986443
|